<SEC-DOCUMENT>0000764180-20-000106.txt : 20201030
<SEC-HEADER>0000764180-20-000106.hdr.sgml : 20201030
<ACCEPTANCE-DATETIME>20201030103447
ACCESSION NUMBER:		0000764180-20-000106
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201030
DATE AS OF CHANGE:		20201030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTRIA GROUP, INC.
		CENTRAL INDEX KEY:			0000764180
		STANDARD INDUSTRIAL CLASSIFICATION:	CIGARETTES [2111]
		IRS NUMBER:				133260245
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08940
		FILM NUMBER:		201275613

	BUSINESS ADDRESS:	
		STREET 1:		6601 WEST BROAD STREET
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23230
		BUSINESS PHONE:		(804) 274-2200

	MAIL ADDRESS:	
		STREET 1:		6601 WEST BROAD STREET
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALTRIA GROUP INC
		DATE OF NAME CHANGE:	20030127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIP MORRIS COMPANIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mo-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:e67beae8-252b-44fc-aaf0-eb6cb882e4c7,g:3f7a85d8-ce11-4daa-b845-1d29043d3872,d:85986654d18d42b3b8b96449288f0b8f--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:mo="http://www.altria.com/20200930" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mo-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M18xLTEtMS0xLTA_669ab71f-744d-4ff3-894d-f81621d61342">false</ix:nonNumeric><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M18yLTEtMS0xLTA_89ee4e38-d9ee-4e6a-a778-cc4ebef837fb">2020</ix:nonNumeric><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M18zLTEtMS0xLTA_f8638f29-86d5-4a5b-af1a-fb1c3c0e7a0e">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M180LTEtMS0xLTA_12d2c99e-a8b6-4765-b8fb-d912e62441cd">0000764180</ix:nonNumeric><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M181LTEtMS0xLTA_4e3c7f35-611e-4dcb-bddb-3e79cecc0f59">12/31</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMy9mcmFnOmQyZjQ2NTdmOTM3NzRmOWRiMWNlODkxODlkMjhiMTkwL3RhYmxlOjMwZmRjNWQzZGIyZjQ2MTU4YjA3YTkzZGFjNDg5NzNmL3RhYmxlcmFuZ2U6MzBmZGM1ZDNkYjJmNDYxNThiMDdhOTNkYWM0ODk3M2ZfMy0xLTEtMS0w_a9c1cc00-54a8-4b83-969e-194ca7c9cc40">0.3333</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMy9mcmFnOmQyZjQ2NTdmOTM3NzRmOWRiMWNlODkxODlkMjhiMTkwL3RhYmxlOjMwZmRjNWQzZGIyZjQ2MTU4YjA3YTkzZGFjNDg5NzNmL3RhYmxlcmFuZ2U6MzBmZGM1ZDNkYjJmNDYxNThiMDdhOTNkYWM0ODk3M2ZfMy0yLTEtMS0w_5089fd4e-9587-4b7d-8fdb-311484463477">0.3333</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt-sec:numwordsen" name="mo:AllowanceForSalesDiscountsGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80OS9mcmFnOjAyY2UxOGI1YzI0NTQ2MzJhNmEyZGMyMDdlOWJiNDcxL3RleHRyZWdpb246MDJjZTE4YjVjMjQ1NDYzMmE2YTJkYzIwN2U5YmI0NzFfNDY_b52272ac-83ae-4a99-9cd6-83a7a5f351fd">no</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="mo:AllowanceForSalesDiscountsGoods" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80OS9mcmFnOjAyY2UxOGI1YzI0NTQ2MzJhNmEyZGMyMDdlOWJiNDcxL3RleHRyZWdpb246MDJjZTE4YjVjMjQ1NDYzMmE2YTJkYzIwN2U5YmI0NzFfODc_98f9cd14-8a24-4cfc-893a-076c5884e815">0</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mo-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib44959adae174705840aea192a7e8046_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44440fa474754cb99393173d190110ec_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock0.3313ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b31e1162044436b80fd4386757ac7bc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.000NotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6745877610b42c1afa4746d9658080a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.700NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba03e348bf44a90a5e2da0fb8a1bcba_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock2.200NotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba9d9ce80bd4640949c31fb4e52f3d3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock3.125NotesDue2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i26603be02f7f4bf3b037387b1d8ccb26_I20201021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ia293f60845e647b181cfb7a59955fc58_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72e09db783364478aeb09576c9febdcb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3656833207b740358727e6740c6f5754_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04b4defec05c47cebe3e08fabfbe59fe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a1fe382d2b64cedb36fbab69f63bb0b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbb23df3172c47a6ad9b939e24083612_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5979906ef954a38814196686ea7e5cc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7046cbf69cc14b679f3ace4e97364019_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied0ebb716fa943be849401de264b7398_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6729fd45e0e470ea191552125f035b0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f38bf7309bc47bcb39556c8eb9545d7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5e6cf6324ab408596c1e32ba2460534_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9cda828d4e847eb909e17085a8abf3d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff26aeafc2654f32b63277057cb5ba1f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb61dea03e9f42f9b875b85705945971_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d40817fa304462992d884e8d54ded54_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2165dd6285c436395dd6d4adac5414f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdcf612da0684543843d2a7497e76e83_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34df390bf1094b3299c4c826e85fb609_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabbca98f017e44a690fafbff723997c4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389f8b70a3a74262938c581680019e9d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68d18d178b0741ad9d0db863ab4222bc_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i820a924d574a40d381950cff0e1a0426_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42ee75101e094c558a156cae6a325229_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i661a0f364aa74a089c89d944ccfa84de_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fdefa86b95345148bfdd3202813cfe1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65f80ce3d24c4093bace02242bc24d95_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec8f8e259dd94eb9a288d8c6d9cdef4a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie610fa8db60e477bbafca3e2effe7047_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3ab6e26183345d0b7aea46529dc8a26_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3652032d649844d6829c5e19d2777520_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if85dc54c29fd4cf9846de7781b260f8a_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic05a291f6c85442a9f8f27adea6622f7_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4251896369a74d0aa90e3bc70584b869_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i119ca81462df4b8ab11c4bb6d9bd28ff_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ab95fccd8da4c0088db681978b22c60_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd09282688b34d21a437df741d91f326_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720245015bd147958536b177867849c0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03988acbbbf545258118de92761502f9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee87940e501948388212ffaea5ef7269_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib857eef0de4e443fa7bfba0c972defc6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic28b55d0ec6f4c50b6d76a2006c84218_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80b099f650834cefb3014164e0c16515_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i670aed569ab54abeacf39bd2a4edb1d7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb6e42abcfda4205a7d8215451ffab57_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaab8a9d57c31475c8fa53d7137c08e2c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef8ce9277d64657ac41a5a6e20db257_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ef63c18b31a43aa813ce3956360d746_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ef7fefce2f4952b179cadedd6fa194_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2beebe6a93944228898bd1516baf7e5b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43fbee378dc74b97a01b3c84b49540ae_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib371c96cf5004c8b8e72e342916dd913_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad1f4f9717f400dbf8bc1045b4fb85a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38c16b54c71e4403ba91ef509c462a80_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad67a6f5836647b68468a7cfc5e379e6_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41826b41dd65441cab13757f1fda2bcf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dc586e8441b48ad8423fa2f8e43592c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47a6eaa90bd54796b8d3ac775e6acc2b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id40ae23bb96f4b34b5fff2e26a482860_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i52d5750b3f6b4059b628cc5c6120ffb1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc0e7480ae994bbfae8f564a569b78db_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9925579f99854b05a2c1b01eab01c950_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacac7d034158497ea761b6128d276bc9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96e18cf03e374d0e8e09d680fdb0eb63_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i071cc6de3a8a4d14b919af0f81bed549_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i193bdf7d0e214572a3f99ff6320d3da9_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eccbcc083c844ac8c436b9f78601a58_I20180131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia217b44568db4f7bab6aa96e06106ae0_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a66e6dc6fc14f578f3db7088eb5c228_D20180101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica759e56c7514b8ba6b11550c9f189e7_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0268f17a4fd248279ae397980a380ee7_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b7cdb52d8b648f0ae0d6f3123ee3585_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2a909e9cbdb4c8d915bced44fe70c76_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19988383bb3043e881752078a8364530_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65a6568d2e72475ba89df5fcc752c87d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c9cc8a9510f4a2382edf4448aedc3ca_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i414a3270f11947418d6c2125e509944a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dae5a2ab67f4bb9bd50da276ee4860c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76c7d7d2fbc34685ae18727c4cd65f70_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61784cf3f3fc455b92d1549db42be0cc_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i966e35b143ba4a7cbf9890b21f017d74_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i513f9aefe4864f918aef77ec9b9464ca_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8c284910f9462da3a11aa8a2bdd9aa_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2db2f30e181740b58612f500d9f2221c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:MarketingAdministrationAndResearchCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad12458b42414f73b54a930bd3423a7d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b301f3d97e7423587fd5da2e57c027d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7138bb35916249cbb738270fd6fe93d7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21ce1a07a551424683dbafbcfa3df273_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9cd0e274519474a97c80be2216cc392_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4296ad893da549f0938808b2978e8ff6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id587ee8978da4dd9bfa35f34f890d144_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4076276bf701434cafde95786366cd18_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:MarketingAdministrationAndResearchCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7474f88612244c1b64f1822399d6fb5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0d8a29fd04b4af1b5328f9a73ce53e9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75b30cbed6b345b390d2b06e4121969e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mo:InventoryWriteOffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddfa3fe8e4ab41d696ebeee595b37982_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:PurchaseCommitmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41086d5eceba4b10be60ded534b538d4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:PurchaseCommitmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45fce82014e048088ddb663834e5b226_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c9f46db82b544bca919d37b619fa3c6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfc10374e49f4210b26d83818840cffa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c602bc808fd43b3aa8af711c461d8bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ab87ccfd644d7bbd87a7f9d985ce3a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3301a69f1fc4456bc6cd43d61e2358b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a07225f603b469a9e16277e68062cf2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4baac6d362ff43e1a624d2ca9bd47b9a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d483982eca44108fadfd7036741d3f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia87b4f2ccfa44ef480a0166d44944b46_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44203766c22e443f90913f61f95be1a8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c3480e95d1469da93a1e2056153e63_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib911f814538a479eb5056f3c19bfd6c3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie496e5bcf31f4c2a9d472e2beb032d40_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if013f6bbc85345f1930ed240ff09ccf9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64cdb3928d7c4bc89feb76f18d5b07e5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c252077957546b2880b8ef2724625a6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f3984a7b55343788f33878623e29f88_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a153648856343c9b0ba005f24161faf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0119e1289b840b9a4e48f08e6d51eb4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90f0e22caf6240a283094f0495f14ec0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i581024f3ed014433a29610e67306704e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6aea41f4cd944cbb4018c25bf22065f_D20181201-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f8ac2e81fbf415d96b01883453526d6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-28</xbrli:startDate><xbrli:endDate>2020-01-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibafdec850b6b45c6a0a6ebb40779d823_I20200128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="director"><xbrli:measure>mo:director</xbrli:measure></xbrli:unit><xbrli:context id="i3a6bc5655b5c4d76b14ec49b161c5464_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c77db08d832433681380e92e80fbc1c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5093f64aaa8d463a86be2d64338151f4_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2202ef19f99485aaf1594cd36889bcf_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03dc33411a5749d79909086adf33043e_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cadPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ide407e15cf49487193634a2048179491_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f6eaaca8b0c4eeab6e988d2d5cad4b1_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i789ffb64479c427c97456e2372a5a744_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79d16ce41a6d4fb6a123927ea6298fb9_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60560d0e627c422e839a25225ee19787_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i914d4a901ff34993a138eacf6ee3171c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie295981559fa47e9a12e6456173c067f_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieede284c3acf473cad8c0420cae67a03_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23418c15a4834d4882c474b871c10616_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="board_member"><xbrli:measure>mo:board_member</xbrli:measure></xbrli:unit><xbrli:context id="i2ab928952e6f4199a2156a1db1c2ae25_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff5dff53efdd45618f3b407706808ee9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0926d28c94bd4f0688d1cd87daf48de9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if543b4ab8bbb4e4cb31ce281dfc2c883_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i482f5b595eb642e1acc2d81bfa6d836f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8c6262959ff4200998c8e9eaf5d9144_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19091e36268a46e3b8306ee404fba8a2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03cfa027e2c542a89ca61cb7216820a3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i327669e434c540969eed7f12fc78caa6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f17aceb05f84391bfff69ba804a2d18_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i762330360e39458f831a1f465d0c4616_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i780f2a71201c4ff3bd694ea104911a0e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8c7c188084b42a8ae2031212a1d2288_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11a81bbc4f84fc78fa4cbe8a44fdf78_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a8e1bf900f64f8b92b366a2c2d76fd1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="year"><xbrli:measure>mo:year</xbrli:measure></xbrli:unit><xbrli:context id="i6cf3b63a008b40428ca6039b7d9a5c4b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2c14274a4d64108b882de55d4502603_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic93a49eda1a94589ac79dd8b3c1b3e97_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i626546e4b3ef4715b47df81b5bb8b7b1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i429277c86fbe4b21bc95bdd8fbf00861_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc73a7084aef4a0b8ed318ebd0e7d738_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a183827598f443697de775b3cf99058_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic366f1f1f531476a8cd247a911c006fc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34064c893e694b50b8144376830b31e3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7227fbea894a4ca2b29fd716f8fd79a6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f2e75b2f0094022af0e857ba9c1a24a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fc7d0eb19de480baea8a1af985038d5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb03a2d5afcb4c62b621f8167bf67e8e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8781d7757594520903cdddf6282cbf8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i086ec560279e4dfaa1563b87dbdbba88_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8990ee747e90489e8c4c40c9dd340a9e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35e343023746419a9425bb816ac2a8e8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42e4e208cef648d2a2e36df3b10bfc74_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ecca4f968bc4f8daed7042afbac66f7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31465b7042ac470797adf3cc3f8f4b1f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i519edb627c4f47b197d3fd3fb078bb6d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i932dd517d7a44c81ba630d3f06428863_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c04c699c1c74515acd46e2303002b0b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85c2ed22b70546a9afeb76348ddc2b55_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3969c366e174823ba5e447d4d1d11fa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic79ee6d1277340d2a65bf968adbff27f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3023df6730344ca3962ddfd40ecab100_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a361f15685848a39cda05ed04452b34_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i820ba03288e34f15a3e93d22d715d5cb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4788092f78a4eb2b15070f6da8c3dea_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffbb907af8094973ab26d4b85b6cb2e1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i490b0ad606f344d2b124a44527e6c990_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i895313ba107a45389016a7bbcfbd9f48_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb9212e88ebc4edd9d9a294e59c26753_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia65e91236a75413e94604e3795d0d4c4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i156d7b2e0ad84e2c8f2f415b7dcf205c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i709075a698fa4b7a895a75a9c6c5d1f4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55629557f8fa4801a2be7e0427b33b06_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa5700c0ced144f8ae5b03950397055c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37e31bd7e2634c1dac8c62603a80a737_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04baa8b6c1f845fa8d7e480d95aabb67_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce59a1fcfb7407fa566d25fc62260e2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb38fc3f5d2f4e6da207670f4cc54dd2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d187570aa2540a88ab160136d28dc72_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4215578af3347b0b7a3b29a129d6de7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7f91a436b28422ea64fe38b472a5589_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib52d5131c24e46128d6b79389a025d30_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e3ba701be024d09a42df0979733dce2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i742228ca73ae4006a165d270426b66aa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe60396dea9d4e139bc5adf4aaef4cbc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22bd417720914dd1a0bdbd9c0d152323_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaad15e2268ac481db81ebc0d57dbb586_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief8d5ed5a7444a258532f6236eb7d10d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie54adf4b4f114073a2bbd31a27d6fbdc_D20190331-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69363bfcc8fd412bbdb34aec0878e470_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9da1982838c6484db523839f9172e06b_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i315cf96c2e2b4f1389be73d9bad6e25d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75648dd74466420b86f28b4ffb6ef292_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb694c29f27a46e4a6697f065ee75e35_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3703b6ae7e7341b18c2d327b431712cc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c5bddfe927640169c96483cddb17379_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41c9b1d77add44b9be802e5dd01b56c1_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2513d47f23844d9ba0ac7bdcd5c64e15_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i924ac9b83e4c4f0fb5b946287281a5bc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic095b1d9445c4bb79ac2c008e4f6fa83_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6858797d755940d5af5d63d4ebd944d0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i182d9ee236a64eff889aab36500df3ed_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i351326e926924511b4abbac946829f4c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6377dd911ef4b1ab1d8dfb3730af782_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36d2d484cfba4fb6ad475e2cfcf66462_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5162cf1b3ad7427d95b3b1edd5f61452_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87eaf39b7366430e9f68266017701b5b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ff69a497b0648929df0cbfb8bd32e75_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10a65e697a2e4b2b84e0947bc730b6a7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc218d99dbae4bc6925e235fb558f052_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1610ea0297f041709a85e25af892c5f4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ce36a3023924317bfdc3b0e1809fdb9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20745bf90a514b81888839906b4a8175_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0026447ea51456899a37ff23aae7db6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fc8febe647949e79218601be9537698_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i142eff51b3ab421c889c6d2bb5e2ac10_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0494c954d344876932c1bdd4e2367e0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46102449b128460b8ae18a5fe9e0fd56_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf39d90acfc94fa8ae8510b5ee508977_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f18c4a56df2461bbfd5d9dee8b61589_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba075e861d6f4cc9998f78ffd3276986_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie22dd2129baa4a278c19c2b770f10c74_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d44379763c14be6b50fdea177e1105a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4ba820f281e46a0856811d6505d6c82_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56d081780d6247f2a8f44b0cbac75f0e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b93afd3a9384878a3d23d915edb9d34_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9531ea2ec134d779a09cfd6999071fc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic552776954674567ad8ceaf455ff2df2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd559242c87a4839848dc76f7cdba2b9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id30c8f591ff348eca5e129c73179556d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7749829bc252472e80afff2f43879e0c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbdba2ebc8d24db9bde9d1ceeec106c5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8ebfa9f82c6400c86cea2fa523e12bb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a7d8dce58e1418492926f41ccd0a901_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i782ce7d0d6c04e66b91c4c3a13f4828b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea1e2ba6af9c41ddb6f6b2e16f649711_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2714d6deaf540cb865eebe43194b5a9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40628f1e5dbf41ee82713505cf35318f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49c01bfae724b45b528bcb25e34b3b5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e3a17982ab540cdb38e40eaa9011fb7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d1129c13a243cfae74e7a2b330f4fb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52bc6e7cfc6045cba8bc9b490b1083c3_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id84c0fe23d3344d8a09f8c4b47549357_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib56362e25fab48b69747801fbc413df0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a22405436fc4f51965d8d905f04bd29_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c10cef408f4866a62e645271641b17_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7049d97f344641a984e6e5beb764d3d1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dfaf8cc27be4772b848b7c1b8493b7c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d1032796fa64fa4895bcb9f14b70233_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id429b5bd1c8d41978646f0f7f455e19f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i878e052a32df4da7a15671ffe7f6c60b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7356c82749654030be8f256d9f9a9745_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba85968187d436ab30ed84caf5e41e0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i494ba59d5d0346ec8380c947bd3eb17e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e6a83106cfb4c60a62a2096cd79a1bd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c2ac469222e4237be6dcf3d6fa61beb_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6023956547cd406696d7cc717c5d63cc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2854d38153284db69df70b1b30e12c8b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aa10928c42c437b8022ccb9de74838c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf791c5f8e154ea99ad6848bebce7aea_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i763e7a556b7d49d7899ca7b7ab4b3ab5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6bebe9ebc8645cc9f8335c03695b4c1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if454389f3a1945179f947caaa65a6c31_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic979af41ab9d413bb1ae38f66b2d9d11_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3e639fdb4824b70bb2643899d44c0d0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b13b9a1e91f4d60bd633bbdac2d3a0e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18072db8ab9f45d4adbc775ff5720df9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe3f5acfbb75415db5d1a986b38445b0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a01c76ce7db4a9bb38f21611772ae4c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffb9bd71b05044f1960dbd29fea9824d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4789cad0b6a54baaad569d4c6f6fbc61_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i941f9b86f58e457f869c24db7d24bb4d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b48ad0497744f6aa97be20fde34f963_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f398c78ea464bc29dfde286f3202ac5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04eaaa915aec49bd9b52703167950623_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8c1acc07f234535b9f59b5c08a35421_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia114b8b08be943bbaeec192f0c9546eb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie55438acc01a4f80a2a779c29e334eac_D20180801-20180801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55306d8676154351af21f6cfd76b5f55_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="extension"><xbrli:measure>mo:Extension</xbrli:measure></xbrli:unit><xbrli:context id="i56d738cab03146c5bcd9b95595aee05e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15d84c7d97cd4a05857ded13946f92fe_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3eeb744b8954855a6ff7c699a798982_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cc84f59a87f4be8a5e634d905b909b6_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i004b9c845a7c477e9f161677be47d470_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDueTwoThousandAndTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if92a65bfb9bf4139b4848310f21e030e_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDueTwoThousandAndThirtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5bb50e3bc8e46f396e19b3dcbc7cefc_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDueTwoThousandandFiftyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6166eaee58bc4486a1dcd77e46be7115_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i524852ef9cf241f693dd67511cfcf6d0_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mo:state</xbrli:measure></xbrli:unit><xbrli:unit id="claim"><xbrli:measure>mo:claim</xbrli:measure></xbrli:unit><xbrli:context id="i9f83a67a0b1041928670ec284b9f04b4_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe6c5f25c0a14432894f98e00b688af4_I20191028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i088fe65173a649629285b737326fc8af_I20181022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa8f7e9351fa463481a1396bb9dbb0b3_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6a114c3739645fb99b67e8b402fb09d_I20191028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida5ccc93d1ad4e17b978d254db30a29b_I20181022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1938f36d8dd1444f846a2c358e51a292_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6b92183e81f4270b9b287aa21dc48b3_I20191028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if79ba42880fa4632945934c13e5390f4_I20181022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic50f46d379fe4cb283f17d07d3231cca_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i991d327d70354aee8acfa77292becaf9_I20191028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if09d494ca9c04e36a8555873cb6b8cd5_I20181022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74ee67e0b3a6432c9aa843c7b05d3a21_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i288268f2ad2f4afba0fe6dc3e2d647fc_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b3f238e8c2e470f941d469281cb5f59_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mo:case</xbrli:measure></xbrli:unit><xbrli:context id="i90eafa508851421c88a1386dd9e708a7_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79786dc9d3a34fe9b84f2581a59eae3c_D20180301-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>mo:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="if906b9f3c170440f94e6baae57a1e8af_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759cc82368a24da9b90d561f09b6df19_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6732b65e853a4a2ebc98fc8672546c08_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b52d1ccf10645b8ac9e77afdbf09979_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitFiledBySchoolDistrictMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i327f425f4c0a4b958f4eb1c1e8e5b7a8_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03acf33061544727a951d220b422409e_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1a4cb788be34b7294823653c0ded68b_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5370156fe8d14a8e8da1520ca797a308_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ae72485bc604c34b056b72db7e10bf3_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib640ca736ea64adfabeed83e8a20dfe7_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AK</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42faf7ae646d43888ef8eb211eacf9ac_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f8e9338933b4ee6a3aa3a93e8059c2d_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38158ae67bae43879aa2672ca2ab9fd5_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccba1eb229bd4dc390001b5b8df2bc45_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9da4b44582904192921e6072055b4ac3_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc1e2b1908b54d0ca3e4f21bb1d1e630_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MS</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21bfaa9469a247b5bd27e94518726cb0_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MO</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae2caef6740d40259c9f84a490569169_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied53055005344f3bb2c452924e5a1528_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ae1fff42746471eb1d0f51a965259ab_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31692ae6ae0d48948fb604426688e995_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic44878beb09c49beaa5574aad702cf2b_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie663a64cadad400db55d3b0fef5bd7d7_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:RI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i722c6dc101334a06958236d747b37fa6_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77665d9f65aa408b8de4b3aff7a6e23a_D19990101-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b76f4a06e0d4000be39f89a1b20a4d9_D20041001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib42610cd85574a85ac22adfbd9232cc4_D20041001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic94346e89f4f4ef7864d5068b90b4f4e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dd2f6de615e40518cd41e25874f2500_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ef32b625acf4bd79754f47e5d1ec753_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee3815bd69824e13833b90871d61a946_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6bb1353452c4523bedf46d84d63f40c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51f7bad91af248dcba16157131428d9c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i853e7e20eb29408fb2d7f8a14a1797da_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f7118f93b4345d89a25d75afdb5a262_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie30f52b0c96d49a3a478a6a1e2ce47c4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:PreTrialResolutionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e5bbf67f98443c0b7edd73a8250aa82_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:PreTrialResolutionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03e3139f46334e698285c1dea0152ad0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:PreTrialResolutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cd199ca5a0f48ddb7de573598ef316e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:PreTrialResolutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib01325dc5c474ef0a0a12a154bd77c51_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81b724d4a8dd4812b7033d86eb830073_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCasePrincipeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7396e108206b484f903a260197ded70e_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id267dd8564a3488b94c7ba44126c87e8_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebfc83154ce48dea39e1eade2ed1f02_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08ab18a08fc2443ab1242f3a205e3fe4_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGentileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if550a6c83d0d4c6292eefe757d6d7946_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGentileMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a81a944b81a45a9b4aabeb561b3c720_I20000731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2000-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8237cac01f4de89881354f8056ccab_I20000731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2000-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21e01176f3244941b8c2577c07af928b_D20060701-20060731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-07-01</xbrli:startDate><xbrli:endDate>2006-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2753d6b653574d7997560005050e6a03_I20080131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2008-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i282f01973b7a450996c72e13d164a16a_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="plantiff"><xbrli:measure>mo:plantiff</xbrli:measure></xbrli:unit><xbrli:context id="iab0a7a02a22144d58d64538e4a422159_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78d2755130534b9f968f4c9ae194baf1_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFederalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc72644f82dd4c06995b160fa2ebf6ac_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i121c8c8c92154161b47ce45a7725da25_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i386be72127664d83ad959975ff8d48c4_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPearsonDCohenCollarChaconMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0790b75d3ef64acda7cf88fa64505882_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesReiderandBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id594dce411764c92b6f7ed94ea6a2dee_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesWeingartandHancockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i055fbe8d8f0144a7aeb8622777fb5fb4_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPollariMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id660194fbef544acb7a9ac3e9edd669b_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerRintoulandDuignamMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bfe653a65cc453d9adba37e43c082ee_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFreemanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09102d7949074727b6b071832c9c9a1b_I20140930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68e27be8c5e340d2b5ab22ec89c6fbff_I20140930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i763f26f3f9864550bce1cb5f1d139b5f_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f379dd774a84c178271dd8ddf630a75_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83bc2d39c8314c73ac43d49baca414d7_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a8b0e0c65974548b24e515426fd6cb4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54e27c4d0aa94139a647bf051cb35c24_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73562f0789564c4ca3b746d86736d7f1_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee24c1e556fd401ebf1c14cc046a2c47_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720d17586fc04494803d6a38d0d0a43a_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb420eb62e1c4abda0c90da42623cf66_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRintoulMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0334756982249f5a738ecdc55a81329_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRintoulMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i473d370813804ee9923d2d9d90726e86_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e8a0f49c0334761b75e98dc0a5ae0e3_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cb77069bc64499a9599c4b95646cbbc_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib37d24d3b5fc4f8d8fe8d58c3e41ba9b_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7391ca337c34ee3812079caa09a47a8_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNeffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e8ceb1484f445ba829b403f9ca487cb_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNeffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8ee87d2eab14b2dadd569b18425aac6_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFrogelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i157ee62daa634c5baba2332dda040742_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMahfuzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccb40a3f593e44f1945490c8afa74e4a_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMahfuzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa873ae904e843a68f15a429f1ddca30_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbdcfd0b02f340638485ef5bf9030554_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i262382c0015d432f842b18237e28071e_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ba2f37bcf6a402cbdc706a9755f41eb_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7c4b24571604e75af7f7e9f3bb4d335_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35caf9a0d822450fa81f75e68cd02338_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3bacb16e4784de892ae8b6b2205a876_I20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb589bcaaa645de9d8fdc23492ff483_I20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67739f053413439ebc96236f3209b74e_I20170430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78f0ea0e26e943ae806d1225535249a8_I20170430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0c617d528d64ef7961c5cff9cbf15ec_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06074dee810942e292ea731bda7a36a0_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6797d3f0b35047dda7ab8a8ec5357129_I20150131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a54fa21dad34042b8f605536d155127_I20150131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82c91aed7e2542169faf3a41146a2257_I20140731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHarrisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i490bb998e16344949c52ff8781d7eb75_I20140731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHarrisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fedb4dbaee5495fb6536ab744945764_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDeanKerrivanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62c4a7eb460c47c4abeef12cfe44cd6d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLandiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bac0925a60d445ea8ad330c550cde67_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesTheisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica94d523154c4c0fbf78887c8b5a2ecf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNaugleGoreM.BrownJordanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06e101deca564c7faf4a806f5acf2373_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNaugleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05be0cce4caa4d2b8616b1209601e242_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8ade17230a6455891f64fe763188b45_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesM.BrownMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7458b6e8570f46858d3d5cfb65f8fed0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesJordanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ced792544c54268bd9593f35eddb549_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fcc4a28b47f436c803de4971a69b758_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2af34da3eecf4a8ebf87a01b040a2639_I20090630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2009-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56d82ed761ef41faa02538a434851cba_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i478232b2660949908a92fbab33c32522_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33543518d6fe4ed1953a1556411870d8_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a8b9d0cebed4ddb9c87e8c9b6beb170_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if01eeea512324def8fe5ddadb4933fad_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DC</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i699b979bc3384548b7b8bea7e04b6c80_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff54182d2e14c58b237baad2a9f2b83_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21d1ad4f96264abdb7cc9a9a8779a95c_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93b4623007a1413fa49810d6fcdcc0b4_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i838f2633ed9f400bbf26ccb953378742_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf31645f50824ffea06b19db990ee06c_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65cd4161393b493e93229e0b24630447_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i776efbde1566429f802bd97c318bb9de_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1eed415a7f14ab7906e4688e423ad63_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NV</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3f246771a94496a8fe79e88a4c244f8_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i808cf4a891d345f1b854305991736a14_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i207d1b533ad342f0869af8557c242e8a_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fa168360477427daf858f964b5cb335_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56a3c4325e724588a97c6020a21a678d_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ce9b9f166c94ef2abf45bab5d8b92ad_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffac1ae1843149e283a93385a7627136_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e4937e663604dd08163acaf12477d40_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:SC</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6abd61ba1fd4819a6eb7a7144ab2ed8_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fb064a2cc7d473e8f865cbc2fb8885f_D19960501-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WI</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3f5b7c4027d400398db6b1ad78239ab_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:BritishColumbiaSaskatchewanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="manufacture"><xbrli:measure>mo:manufacture</xbrli:measure></xbrli:unit><xbrli:context id="i3f3875700c6945e4837cd9e5bda1f32b_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="ruling"><xbrli:measure>mo:ruling</xbrli:measure></xbrli:unit><xbrli:context id="idc79629711204f43abfeca4b62d5c1d8_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8949cd3b364e4768928464fc8e22ebae_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0f294b9d70d421f83088c1d9d8b30a9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169d27beb37c49c5bf82654208714375_D19981101-19981130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1998-11-01</xbrli:startDate><xbrli:endDate>1998-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97d740917fe440d1a50498a05140608e_I19981130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>1998-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff56a70694624f4a924402ecc251143a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i047334242a4e4b4e9a23b88b2217bc5c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06cf35adf4314057a6229713af6fc6f9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fc84a4adae148e8b5c911a64d52cfdd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie19865eab4224177afee834778e21a4a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e86e226235c4990a36636532147b9b9_D20171001-20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="settlement_development"><xbrli:measure>mo:settlement_development</xbrli:measure></xbrli:unit><xbrli:context id="i53f369577bd3484cbaee39e41e064c6b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib07a762a7c314cb981274ba805f9f3d9_D20171001-20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7136524f70a44118cc4469581d243c9_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i905cb71d55944236820d53a9f8ba97b4_D20180401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18398105d8324ad6807cd23593a48335_D20180401-20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7127e4e55f3b48cca9b37c8e7582d3db_D20190401-20190430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i173ce1f840bf44efa105eaef9092cd54_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71dd2d406d224d878f3ef54f28a29459_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1b513fdea0b44b19d5975639617c3f4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2269ecdf1c64fb98097f29ff6e22692_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dc2309f4c184f1d91f181d088250c1c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i632a162da722437e9880fd3bbac52897_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e5e9c280fc9404d8b6763a66a3c305f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-09-01</xbrli:startDate><xbrli:endDate>2013-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa9e64d794b84e179af595a489042961_D20130901-20130930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-09-01</xbrli:startDate><xbrli:endDate>2013-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icad6887108624ef19b7c544b38df9e85_D20130901-20130930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:MarylandMissouriNewMexicoandPennsylvaniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-09-01</xbrli:startDate><xbrli:endDate>2013-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic184ac8ea193498a824e11bb3c6a380e_D20130901-20130930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-09-01</xbrli:startDate><xbrli:endDate>2013-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32b1d9a333c54d99b2ca2e70af628ad9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30652171c168469b95e7a480823eec6a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e1757eedc104e8fb665fd9663ddfecc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42170c8f1d6444caac8ca0392f6a2276_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bc886e153d544dba8474e1686d381cc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77fb9eb402e744f8b24e8258a74cd29f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if33f95674df24a7981e5f92d55c32bc3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i129667b4722345049e3eacc64888eda2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23e21af60d684691875ed325f6132e92_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a91eaf68d5c43dd926983f95d778cea_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2189369e507844d7aa734b62200b5014_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i320fe601fb2e4afa8201647bbf6c161e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c75caeda0440b2b7a8b44f6a3af45a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cf05e684bcf452b891b222faeba6f5d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i024ba7dd2cb546cb91939fb3c737b4cd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i497ca0f28e5442c59124520e63eb5149_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3254354ec2ca4cc19c1da242682ccd9a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70337240f7a84b3788b6f48a11439d6f_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherDisputesUndertheStateSettlementAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8789e2bcbf64769a038755249460300_D20060801-20060831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-08-01</xbrli:startDate><xbrli:endDate>2006-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14beba11ec90485cb8c96048f72ff73f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae00eba7cfd48bb8a759ff60030320a_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c5a0e12db7b469bbcc33e36f758341a_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib15d032499ec49ce814afe877066b823_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb0e875b3484b01ad06905775a8272b_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="court"><xbrli:measure>mo:court</xbrli:measure></xbrli:unit><xbrli:context id="i6f6c0c255f674e16970fc172f56b0c52_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4a3638d5c14dd6930a6317db7cb2fe_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0cadfd7091b4c52acbda0b9e5844949_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsUltraLightsClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i365934f7ac7f46b589e0fbf8c5a01204_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:USTLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a9a9ea271534fef8e2574fa16175c11_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94b8b0bd9cd64fb1b726bdd03fce49cf_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shareholder"><xbrli:measure>mo:shareholder</xbrli:measure></xbrli:unit><xbrli:context id="ibaad81b69d5b4f30a76662311f1a3c69_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e48f7ae862f4927a706bfb1d1bdff5f_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i221381c6c8174016a6e3bd28d276c6f7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e875a907d9e4fc9a48992750104acbd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtNi0xLTEtMA_152297ec-d10d-4dae-a5da-3ef65d848c38 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTQtMS0xLTA_32bef1b2-a36e-4bb9-8683-bebcf17c1d46 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy02LTEtMS0w_b057b873-ca49-491d-896f-78e148d40186 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xNC0xLTEtMA_de3e948b-bbca-4c2e-b5e7-5f50627b0389 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xMi0xLTEtMA_92b43da6-2611-4ca9-a4aa-fe91a87e8d2c id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTItMS0xLTA_ddaf8c78-7472-4f94-ae7b-8f418194e190" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItMi0xLTEtMA_8b2de181-c594-4861-82f2-16775637f7aa id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtNC0xLTEtMA_f860a248-690d-4c89-b56c-5007bb75c513 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItNC0xLTEtMA_fb9e1f1b-6613-49b9-a770-61217d261122 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtMi0xLTEtMA_7c50127c-8405-4552-83d6-3a0c8f1f729a" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RleHRyZWdpb246YTY0NjhiZGQ5MGE5NGMwYjk0NDkyN2JlN2FjZjBhMDZfNTQ1_d0bfd329-a1e4-4202-8c50-456f2cc3558d" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xMi0xLTEtMA_daa767f6-3e95-44c7-89d5-cafc550d0300 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy02LTEtMS0w_25371da7-04cc-4898-985d-73ebdb05a779 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xNC0xLTEtMA_277440a4-0139-4102-93a7-427461701cb4 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy02LTEtMS0w_c1ac318b-9f4f-474a-8516-8447b3e09bc6 id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xMi0xLTEtMA_6374442d-f542-43ff-996c-cd0f38a9d2ed id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xNC0xLTEtMA_1365353b-ff29-4c18-9e19-f97fac58e22c" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i85986654d18d42b3b8b96449288f0b8f_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl84Mg_a2af7003-0997-4b08-b23a-c88babd4214f">10-Q</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:5pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6ZWI5YTkxNDZkMGJhNGNkYzg3ZTg2Yjc4YmEyMmMzZWIvdGFibGVyYW5nZTplYjlhOTE0NmQwYmE0Y2RjODdlODZiNzhiYTIyYzNlYl8wLTAtMS0xLTA_912107c3-b816-4d5d-836e-b83a287b9559">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMTk5MDIzMjU3Njcw_19b26ac8-1c98-41be-89f2-a45a5df4c718">September 30, 2020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6ZGMyZTFjOWIyNzZiNDY5YTk3NWQzODk2M2EzNWUzZTgvdGFibGVyYW5nZTpkYzJlMWM5YjI3NmI0NjlhOTc1ZDM4OTYzYTM1ZTNlOF8wLTAtMS0xLTA_003d4466-4323-4716-b347-d763c055ecd7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDg1_96ec2ce7-a26f-460b-8a8e-84fbd44bf686">1-08940</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDc5_711bb92f-8532-452a-bb4f-7cbec4e1d29d">Altria Group, Inc.</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV8xLTAtMS0xLTA_30b9e669-690b-4caa-80ca-5f7d64e838ac">Virginia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV8xLTMtMS0xLTA_6c537e67-54fc-4fe7-bcbe-6bbdf0f06e5e">13-3260245</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV80LTAtMS0xLTA_83539a03-64e9-4893-8cca-d07290af52df">6601 West Broad Street,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV80LTEtMS0xLTA_36a2de22-25a1-43c9-9393-0653d351527b">Richmond,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV80LTItMS0xLTA_fb52be4b-6a08-4b1a-9a47-836a27478775">Virginia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV80LTMtMS0xLTA_087eb9e6-adde-4b5e-a680-b679bdfa8c5b">23230</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;(<ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDgw_a6c2ccba-182c-4fa6-92a3-41f02b1d8abd">804</ix:nonNumeric>) <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDgx_a4cf30e7-edd6-4402-b513-4bd9ac25e9b6">274-2200</ix:nonNumeric>&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Former name, former address and former fiscal year, if changed since last report</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title of each class&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbols</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i44440fa474754cb99393173d190110ec_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8xLTAtMS0xLTA_7db07c55-a621-4556-9f59-99f4c11c37af">Common Stock, $0.33 1/3 par value</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i44440fa474754cb99393173d190110ec_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8xLTEtMS0xLTA_b8da2937-d9aa-4136-a5b2-9ce3bf1dffc0">MO</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i44440fa474754cb99393173d190110ec_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8xLTItMS0xLTA_af1dbf4e-32ba-438d-822a-080eac5d2640">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b31e1162044436b80fd4386757ac7bc_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8yLTAtMS0xLTA_1d4e9bf1-ee64-4202-992b-c6322966576d">1.000% Notes due 2023</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b31e1162044436b80fd4386757ac7bc_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8yLTEtMS0xLTA_99f776f6-d453-494b-a5d7-36edd0f8ff06">MO23A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b31e1162044436b80fd4386757ac7bc_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8yLTItMS0xLTA_3ce54218-9b54-4fbe-8d7c-b583c0375e0c">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic6745877610b42c1afa4746d9658080a_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8zLTAtMS0xLTA_7be88df8-7fcb-4cad-b7da-bffc0039e3c9">1.700% Notes due 2025</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic6745877610b42c1afa4746d9658080a_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8zLTEtMS0xLTA_b40fd2e4-7420-477a-a570-13c5d32fb4a0">MO25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic6745877610b42c1afa4746d9658080a_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8zLTItMS0xLTA_0abfb757-d383-4156-b3e9-0664532eea40">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ba03e348bf44a90a5e2da0fb8a1bcba_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV80LTAtMS0xLTA_fdc8ee78-aaba-49fe-87ee-fab324464635">2.200% Notes due 2027</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ba03e348bf44a90a5e2da0fb8a1bcba_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV80LTEtMS0xLTA_d6fecea0-1db8-4a38-878a-34e1c4e5d096">MO27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ba03e348bf44a90a5e2da0fb8a1bcba_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV80LTItMS0xLTA_6f1536cc-2903-4633-a9a1-12400fb04085">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ba9d9ce80bd4640949c31fb4e52f3d3_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV81LTAtMS0xLTA_d0eb8b1d-5687-4fab-8b7e-13d367a7fd71">3.125% Notes due 2031</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ba9d9ce80bd4640949c31fb4e52f3d3_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV81LTEtMS0xLTA_0e4d36fb-95fe-4ef0-989b-d670365b2033">MO31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ba9d9ce80bd4640949c31fb4e52f3d3_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV81LTItMS0xLTA_9d5ecd0e-aa34-42a7-ac01-49ee49eecfff">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDgy_ddb60a8b-4242-4674-b2a2-69f5c7223d5b">Yes</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; No&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDgz_cc41c93d-7e5b-4899-88b7-3e5a0ea91b1c">Yes</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:21.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6Yjc1MjZkOTU5ZTU3NDBmMjkwZGUzODlhMmZkYjNjZmMvdGFibGVyYW5nZTpiNzUyNmQ5NTllNTc0MGYyOTBkZTM4OWEyZmRiM2NmY18wLTAtMS0xLTA_2ad0a278-d071-4f61-9b2b-a8532c8697e4">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6Yjc1MjZkOTU5ZTU3NDBmMjkwZGUzODlhMmZkYjNjZmMvdGFibGVyYW5nZTpiNzUyNmQ5NTllNTc0MGYyOTBkZTM4OWEyZmRiM2NmY18yLTYtMS0xLTA_f25e3eac-9321-4d6f-9362-bd2b2744510e">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6Yjc1MjZkOTU5ZTU3NDBmMjkwZGUzODlhMmZkYjNjZmMvdGFibGVyYW5nZTpiNzUyNmQ5NTllNTc0MGYyOTBkZTM4OWEyZmRiM2NmY18zLTYtMS0xLTA_24acafd5-e6ed-4059-a278-a0f79aa77dc0">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDg0_40c0fa0a-afac-4742-9c1c-ab16e6d01783">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At October  21, 2020, there were <ix:nonFraction unitRef="shares" contextRef="i26603be02f7f4bf3b037387b1d8ccb26_I20201021" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMTk5MDIzMjU4NDMw_743676f3-6afc-47a1-b5fd-1bb660fdfeee">1,858,419,165</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock, par value $0.33 1/3&#160;per share.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALTRIA GROUP, INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.330%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART&#160;I -</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_10">Condensed Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_10"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_10">September </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_10">30, 2020 and December 31, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_10">3</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_16">Condensed Consolidated Statements of Earnings for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_16"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_16">Nine </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_16">and Three Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_16">September </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_16">30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_16">5</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_19">Condensed Consolidated Statements of Comprehensive Earnings for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_19"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_19">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_19"> and Three Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_19">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_19"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_19">6</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_22">Condensed Consolidated Statements of Stockholders&#8217; Equity for the</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_22"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_22">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_22"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_22"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_22">7</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:45pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_28">Three Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_28"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_28">8</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_34">Condensed Consolidated Statements of Cash Flows for the</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_34"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_34">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_34"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_34">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_34"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_34">9</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_40">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_37">11</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_157">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_157">45</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_202">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_202">84</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_205">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_205">84</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART&#160;II -</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_208">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_208">84</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_211">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_211">84</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_1827">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_1827">85</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_214">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_214">86</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_217">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_217">87</a></span></div></td></tr></table></div><div style="margin-top:14pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART I - FINANCIAL INFORMATION </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.  Financial Statements.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited) </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMi0yLTEtMS0w_7f1bf063-9111-4638-8855-46a835790356">4,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMi00LTEtMS0w_f5f00405-5baf-4b2a-878f-1e521332c217">2,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMy0yLTEtMS0w_2a26747e-039b-4b1b-a6a4-3e2ed5bec629">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMy00LTEtMS0w_a323705b-0e55-43a2-bd5c-5cc62da88973">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leaf tobacco</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="mo:InventoryRawMaterialsPlantMaterialNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNS0yLTEtMS0w_5c79d9bf-2c71-426b-86dd-472b96041d73">754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="mo:InventoryRawMaterialsPlantMaterialNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNS00LTEtMS0w_73bbe89b-b848-49f7-888b-8225c1238b47">874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other raw materials</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="mo:OtherInventoryRawMaterialsNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNi0yLTEtMS0w_99f2e703-a3a8-485d-bfa2-aab5222c6cae">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="mo:OtherInventoryRawMaterialsNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNi00LTEtMS0w_159b36db-cfd8-4b19-a8c3-2d8154b67161">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNy0yLTEtMS0w_ed26ebfb-9814-42c1-928e-dfa26abb6dd0">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNy00LTEtMS0w_d359ce25-7a2c-49ca-b0a5-e0684f1d8282">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfOC0yLTEtMS0w_94470ed6-bdad-47c5-9d01-eb69c769d67b">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfOC00LTEtMS0w_1fed5bc7-f54b-4fab-b802-ec44df9f68b3">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfOS0yLTEtMS0w_4ea51589-95ae-4757-b823-cb03908c9ffb">1,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfOS00LTEtMS0w_ba69d808-feba-4ef1-9f81-3b309ee1032b">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTEtMi0xLTEtMA_c659759e-b7f6-438b-9955-b0ca20a73699">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTEtNC0xLTEtMA_6d3a222e-de4a-403c-a15f-da0045db8b52">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTItMi0xLTEtMA_86505920-696d-424f-a742-88936224d0b7">6,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTItNC0xLTEtMA_25b9bbe8-6640-401a-bf66-b00ee2f5e00e">4,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTMtMi0xLTEtMA_765070cc-66b4-403f-8e78-813f79944d06">5,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTMtNC0xLTEtMA_816b43a0-01d6-47d9-941e-d22076fd44c5">5,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTQtMi0xLTEtMA_a17da068-7b67-42eb-b72f-da33e6c01aa5">3,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTQtNC0xLTEtMA_a8c7cd91-3102-4907-9d65-407dc813107e">3,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTUtMi0xLTEtMA_3fb95610-3fe1-457e-86ef-1f17342769af">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTUtNC0xLTEtMA_5fda5c40-d6b6-4eb9-8727-0e0f16b260d2">1,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTYtMi0xLTEtMA_d5074d7e-03a8-479e-82b9-1eddd4e0e9b4">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTYtNC0xLTEtMA_33240f0d-61bb-4a68-9972-33f2fe7d476a">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTctMi0xLTEtMA_2d5ab521-8067-46da-99f8-a93280524a50">12,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTctNC0xLTEtMA_236a1957-78cd-4749-b324-4960d2e606fb">12,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:EquitySecurityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTgtMi0xLTEtMA_debb4f36-c96a-431c-bfd4-1d0b0341aaad">19,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="mo:EquitySecurityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTgtNC0xLTEtMA_0e9e25fd-c753-41dc-a027-7b611ec62803">23,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMjAtMi0xLTEtMA_44e84a59-776c-4905-9bd5-00c2f92f04e0">1,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMjAtNC0xLTEtMA_1d120f5e-f0c4-4c63-bf07-a3777b75acb1">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMjEtMi0xLTEtMA_17fa434c-8a05-490f-a022-7d1953e847ac">46,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMjEtNC0xLTEtMA_f220c897-e28e-4e16-b4f1-7623db220e0c">49,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMy0yLTEtMS0w_4a5225ef-4221-4958-bbda-63d5d796fcfb">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMy00LTEtMS0w_0661345e-9a78-4a16-85b9-524d73883e3d">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfNC0yLTEtMS0w_95a3fbb9-8355-4a3a-a846-493c91e6eb12">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfNC00LTEtMS0w_1c2a61d4-e265-4448-ae9c-79b76461881e">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfNi0yLTEtMS0w_9c4e6383-5fe3-4aac-b1b5-4be6e230c383">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfNi00LTEtMS0w_6f868611-966a-4dc8-9aba-d2845709340f">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:AccruedSettlementLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfOS0yLTEtMS0w_8e2ea8cb-ef86-4c1a-91df-d1218b0f361d">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="mo:AccruedSettlementLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfOS00LTEtMS0w_3d6fc19e-e348-45cd-8cb9-bff34d3e4029">3,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTAtMi0xLTEtMA_87c6dfaf-93ed-43e4-8e45-5e5ffb5f31d6">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTAtNC0xLTEtMA_9a6687cf-9fa3-4df9-8480-6ebdcf3a9373">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTItMi0xLTEtMA_adeec0db-57cf-4503-b493-db27694da8c5">1,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTItNC0xLTEtMA_a5bfd674-4094-4bd5-8412-fccf87567e34">1,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTMtMi0xLTEtMA_e29505fd-0099-4812-94a8-d8f38f370e46">8,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTMtNC0xLTEtMA_66f31144-f4dd-46cc-ba92-65c26e842a3b">8,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTQtMi0xLTEtMA_f5547bc0-2cd1-405b-81ea-004a10151046">27,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTQtNC0xLTEtMA_f43cb255-0197-41ee-a462-7e948dced1c2">27,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTUtMi0xLTEtMA_31ae09da-7373-410c-b45b-2099a442bed0">4,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTUtNC0xLTEtMA_08a5615a-6373-4613-939d-1b72d05c4609">5,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTYtMi0xLTEtMA_5522ecf4-a768-4884-a22c-5e4b794e6329">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTYtNC0xLTEtMA_e61f0786-4b8f-4265-83f8-a6abc02954b8">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued postretirement health care costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTctMi0xLTEtMA_c4e864ce-6112-4785-a7e4-d88991aff303">1,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTctNC0xLTEtMA_b252b27f-7c86-4119-b7ce-b08443f3711f">1,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTgtMi0xLTEtMA_c41c564a-f58e-4253-807f-af0723303e18">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTgtNC0xLTEtMA_5bd2ef27-5dc3-442f-b6ca-dd94416e2cf3">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTktMi0xLTEtMA_82db3dd1-8a6b-49c5-b7a7-50f64f77d74c">43,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTktNC0xLTEtMA_83fd4929-3d3e-4aef-9531-1e4803da681b">42,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingencies (Note 12)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjAtMi0xLTEtMA_70adc128-7f9b-4265-9725-61b4620af902"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjAtNC0xLTEtMA_1708b5dc-d462-445b-9061-353197ef2383"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjEtMi0xLTEtMA_56bc1eab-0ffc-4ef2-ae16-0b8e1b740615">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjEtNC0xLTEtMA_2de94c3a-693b-4244-a9d6-ab88e4ef5414">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $0.33 1/3&#160;per share</span></div><div style="padding-left:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmE1ZDZmM2JhZDU2MDRmNzJhMzA0Yjg3YmU4NGQ0MTAxXzIxOTkwMjMyNTU2MzA_a7ec046e-98f4-4fcd-9956-01041f6dd826"><ix:nonFraction unitRef="shares" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmE1ZDZmM2JhZDU2MDRmNzJhMzA0Yjg3YmU4NGQ0MTAxXzIxOTkwMjMyNTU2MzA_dc3fb5e3-daac-4cff-84b7-23daf509ed67">2,805,961,317</ix:nonFraction></ix:nonFraction> shares issued)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjMtMi0xLTEtMA_60d7580d-67c2-4322-a91b-a8ccee9db44b">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjMtNC0xLTEtMA_f2f80d16-e626-4dcd-916d-a1d127a97dad">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjQtMi0xLTEtMA_f4f4f63c-4085-4713-b2c0-a6c7d4d3c118">5,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjQtNC0xLTEtMA_588e846c-a172-4243-a1dc-7fae98bbafda">5,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings reinvested in the business</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjUtMi0xLTEtMA_cacf06d7-08d5-4e2c-a056-414b78566f65">34,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjUtNC0xLTEtMA_bb15e0ba-db0f-4c4a-afbd-d493dcfc21f3">36,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjYtMi0xLTEtMA_97971a62-c9df-491d-9669-941813e5ca7f">3,781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjYtNC0xLTEtMA_e2319bd2-e683-4f22-83da-8ed8df8fab2f">2,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of repurchased stock</span></div><div style="padding-left:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjQ2YTU5MGI5ZmYyZTQ5MDRhYmY4YjdhOWE2MjFmMWVkXzIxOTkwMjMyNTU3NDQ_fa5377a4-55ed-41cb-9551-3514510301dd">947,542,152</ix:nonFraction> shares at September 30, 2020 and </span></div><div style="padding-left:22.5pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjQ2YTU5MGI5ZmYyZTQ5MDRhYmY4YjdhOWE2MjFmMWVkXzIxOTkwMjMyNTU3NTc_c4227816-095f-4a49-83a7-f2a61dc026ac">947,979,763</ix:nonFraction> shares at December 31, 2019)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjctMi0xLTEtMA_0930df9c-5c82-4915-af79-e259d3f3274a">34,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjctNC0xLTEtMA_c0331b92-1fa0-41e6-948d-fde0e2e2b4c3">34,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity attributable to Altria</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjgtMi0xLTEtMA_0867272e-1d66-4fea-a2ff-180d89ce9323">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjgtNC0xLTEtMA_12540b2d-c5a4-418c-81cc-e3199da76171">6,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjktMi0xLTEtMA_9c2c39f9-e6d5-46ff-a2bf-656c0069d4f3">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjktNC0xLTEtMA_bd576ce8-fa97-4e94-852f-227d06e73220">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMzAtMi0xLTEtMA_86121d63-2fc7-4ae4-a853-19df80f9eebe">3,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMzAtNC0xLTEtMA_26a636f7-ecfa-48d0-a945-ff30ccb6bbb0">6,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities and Stockholders&#8217; Equity</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMzEtMi0xLTEtMA_13d0e936-9c36-42ce-a7d5-6273243eef7c">46,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMzEtNC0xLTEtMA_e4c99c6b-dad6-4ed5-a660-b3d4c747fb83">49,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Earnings</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMi0yLTEtMS0w_5ff63e3e-6f9b-4ae6-8ae0-6b1ed254b277">19,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMi00LTEtMS0w_bdf66785-abe0-4520-9b65-663a2942f29f">19,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMi02LTEtMS0w_5dd897fe-76ac-41dd-b7b0-b960c4d2b47a">7,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMi04LTEtMS0w_8aef5495-d01a-42af-9b65-1e60ec93ab21">6,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMy0yLTEtMS0w_da2181eb-ba9b-46a0-9180-3e6e3e5dc8a0">5,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMy00LTEtMS0w_c8382f7d-04c2-4294-ae14-e0ab389c89f2">5,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMy02LTEtMS0w_d3b05373-a429-420e-ade4-b24e6c254e2c">1,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMy04LTEtMS0w_68b5140d-f1a3-4b28-9576-098821d29118">1,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes on products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNC0yLTEtMS0w_a84ea930-fbba-440d-aee1-8ced096deac8">4,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNC00LTEtMS0w_2e06f76a-9b3b-4e55-9109-9864949e73a7">4,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNC02LTEtMS0w_1eedce6e-cc99-4a13-8a18-4ddf45d002ee">1,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherCostOfOperatingRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNC04LTEtMS0w_ba2f6e38-8925-4cfa-bf27-9f264793a849">1,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNS0yLTEtMS0w_fc77a94c-7bc9-4b98-b6a5-055997d26d83">9,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNS00LTEtMS0w_cc533590-3cc5-4dbf-b0c0-21770d3a60cb">9,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNS02LTEtMS0w_87d02eff-2171-490a-8ade-fcb70ce8aa14">3,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNS04LTEtMS0w_a568324f-e0c2-4fdd-93df-53d467073088">3,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNi0yLTEtMS0w_e6f5c725-b58b-46d1-8f25-39482389a774">1,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNi00LTEtMS0w_3e324201-ffcd-400c-b262-541e422851ad">1,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNi02LTEtMS0w_1596dc3c-b8f1-49b4-b649-f4ca18b736f6">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNi04LTEtMS0w_c8e712cd-2b4d-41ee-91d5-02eb1dbb70ee">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment and exit costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNy0yLTEtMS0w_2bb28d94-3dd9-461c-a1ad-cfb7e3e395cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNy00LTEtMS0w_f94ba20d-4022-4943-aa5f-c080974c51df">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNy02LTEtMS0w_49565975-8b43-4cdd-b95b-ab01b98bb80f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNy04LTEtMS0w_3599ea8a-be02-4225-bf4f-8af32617611b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOC0yLTEtMS0w_568d374c-7d4d-4879-bbfe-4d8c4b63d980">8,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOC00LTEtMS0w_a39872df-243a-44e2-8a6d-39f02456df4b">7,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOC02LTEtMS0w_930d42c5-a106-4170-b60c-84cc69907ce5">3,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOC04LTEtMS0w_d60101db-c9dc-4948-aa01-2533ab8da93e">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOS0yLTEtMS0w_84c41910-be05-41c9-ad87-04fcc0445fbd">893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOS00LTEtMS0w_50066aba-85ca-4094-aafe-6dc9b43a11ac">989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOS02LTEtMS0w_0484f6c8-87a3-4a73-8711-daa69dcd7998">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOS04LTEtMS0w_3feaa674-fb08-4d38-bd42-f73fcab1e78e">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTAtMi0xLTEtMA_506241c3-4186-4151-9763-ba56ea408720">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTAtNC0xLTEtMA_dbe852d8-383f-4a49-a054-0a98c754d778">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTAtNi0xLTEtMA_dd386e5b-f41c-4375-a8eb-53653988483b">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTAtOC0xLTEtMA_2049f4e2-5e20-4f7e-a767-30eeed88219b">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Earnings) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTEtMi0xLTEtMA_846cf895-f0db-4857-b2d5-c10244880ff7">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTEtNC0xLTEtMA_b093e567-fd64-42df-bc0f-4f9ba2f2724c">866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTEtNi0xLTEtMA_be73b0f9-416e-4c27-a0bd-751d79034cf3">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTEtOC0xLTEtMA_4e064ac4-5e28-4e12-9243-dfa4ebba2a4b">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTItMi0xLTEtMA_66da33cf-7166-4035-af3b-0020286e7001">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTItNC0xLTEtMA_83daaa2d-53d4-4004-81ad-04224e77e2ae">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTItNi0xLTEtMA_3638b101-3c80-4652-88b7-242c0930170b">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTItOC0xLTEtNDk3_34ae785f-33b9-4bce-886e-3c01d45e4309">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTMtMi0xLTEtMA_453d1fac-2b9c-441d-9a71-821c3b87ddfc">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTMtNC0xLTEtMA_c564898b-083e-4b9d-a9ac-41f0432e9019">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTMtNi0xLTEtMA_62ca772d-4db0-4673-b864-a61bc559f7fa">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTMtOC0xLTEtMA_8b8df587-df63-4dfb-b433-ea3913ab8dad">636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTUtMi0xLTEtMA_5486961d-4d5e-44f5-838d-533a295b8298">4,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTUtNC0xLTEtMA_5ddacdb8-1b7a-40e9-931e-efa045d5681b">1,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTUtNi0xLTEtMA_2e7419b6-06f4-40a9-aaa9-683628ad8440">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTUtOC0xLTEtMA_428547da-7ab6-42ae-839c-5d90835627cb">2,128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTYtMi0xLTEtMA_41c3e43a-f937-4e5e-9cd5-772d8d1ece7c">1,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTYtNC0xLTEtMA_63834175-b423-4312-a43f-569e63fb2594">1,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTYtNi0xLTEtMA_211b17cf-c48c-479f-98b8-6b005bfb102b">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTYtOC0xLTEtMA_f9d0aa16-8848-4274-ade0-0c4b5e4293eb">474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTctMi0xLTEtMA_9afec5a5-9e7a-4f90-9266-7a98837c06c7">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTctNC0xLTEtMA_4eb6092b-da0f-4b0e-9c25-942449c5f84b">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTctNi0xLTEtMA_9906f6f4-bde1-4780-a69d-81993fb7d620">956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTctOC0xLTEtMA_ee6b13a7-f337-4b72-a4ef-7247de3d902b">2,602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (earnings) losses attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTgtMi0xLTEtMA_552078dc-3645-4d42-a082-f9463a2523f1">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTgtNC0xLTEtMA_deee0ef2-b91a-45f9-bab6-e053b43a9123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTgtNi0xLTEtMA_62399e5f-c598-419f-9400-29b58c51b565">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTgtOC0xLTEtMA_eea83b58-ad08-4964-8484-ec0f834d2e06">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTktMi0xLTEtMA_384e3240-b573-4f25-a307-abefe39039a7">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTktNC0xLTEtMA_c4603b6c-d59d-4ecd-aa5c-b56e72ee9a72">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTktNi0xLTEtMA_3e3fc365-af04-4c61-9c50-353ec7cb67f8">952</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTktOC0xLTEtMA_2174132f-21a1-428d-9bbf-b288d2597889">2,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (losses) per share attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjEtMi0xLTEtMA_8c5974e4-ef40-40fe-aace-28b759f8cf83">1.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjEtNC0xLTEtMA_9652c60a-9922-4004-a740-54404dffa50d">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjEtNi0xLTEtMA_57898316-45b0-4ca4-a6db-2bbc4982fcef">0.51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjEtOC0xLTEtMA_3310e51a-6d1a-4a23-822c-35dea0380636">1.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (losses) per share attributable to Altria</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjItMi0xLTEtMA_1dff095e-c1a4-4a35-8df4-1fe54af1b9b1">1.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjItNC0xLTEtMA_a3f10f90-68e7-4144-a69b-981e5702cac7">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjItNi0xLTEtMA_2bb8d743-81ea-4f29-872d-62a5118878c3">0.51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjItOC0xLTEtMA_8160423d-295f-468e-854c-e9b53bdb4995">1.39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Comprehensive Earnings</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMi0yLTEtMS0w_8c4c7d14-f017-4a8b-a59a-77ed2fd68a19">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMi00LTEtMS0w_d33519cd-f6de-449b-8475-9f1ed0f69255">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMi02LTEtMS0w_81c4b748-03f8-4447-95d6-c779416319ff">956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMi04LTEtMS0w_bb623d61-4116-447f-9b7e-1fecfb4f71dc">2,602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNC0yLTEtMS0w_e6f08a7c-4edf-4642-b035-c2fe8b704a5f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNC00LTEtMS0w_0b6767ce-234f-4ece-8c3e-a952a7912272">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNC02LTEtMS0w_4a60c6aa-69ca-42ed-a7a9-cc92cbe477db">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNC04LTEtMS0w_c2cf363e-295a-4d42-9de8-6a9e6bc0505b">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNS0yLTEtMS0w_9d91001a-2fd0-4510-bb64-9c91d68f2016">928</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNS00LTEtMS0w_0330bb21-3942-45a8-af40-ee18b883b67d">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNS02LTEtMS0w_19d763eb-e06e-4762-86c5-8851a33e9bd8">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNS04LTEtMS0w_26c4bebf-fef4-4c05-9d38-d8bc005d7fd0">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNi0yLTEtMS0w_48e16e8f-b115-4067-a72f-80880ea12528">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNi00LTEtMS0w_42f5a44f-e8aa-4c44-9c49-d24fe57ef295">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNi02LTEtMS0w_c442eb00-2b28-46ac-9fca-2c4a36eb67e3">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNi04LTEtMS0w_095e783e-4d25-4ffe-bc8b-7cd1d8e2b365">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred </span></div><div style="padding-left:51.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNy0yLTEtMS0w_5e178052-cdee-4248-a15a-0e60b7b7692c">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNy00LTEtMS0w_f26b00b0-d843-4539-95de-3325af092e53">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNy02LTEtMS0w_9a30862d-da9d-4ae1-86ce-60bbf6b8135f">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNy04LTEtMS0w_e0355b2e-4ddf-4484-b005-0aefcd77dd69">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfOS0yLTEtMS0w_66aee009-ac7e-4e7c-9779-01501165cd92">1,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfOS00LTEtMS0w_c320ef0f-5ea5-4eca-a0b4-ef2784892551">661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfOS02LTEtMS0w_7049eb86-a451-4c44-bc08-f6d1612eb8da">963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfOS04LTEtMS0w_935516f2-94d9-444a-91c3-2f7f80e8239f">2,358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (earnings) losses attributable to noncontrolling interests</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTAtMi0xLTEtMA_b58a1a90-9628-440b-83c9-2106fe2ed73b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTAtNC0xLTEtMA_01c4f0a5-57f7-4d8c-b502-18c5aecb163f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTAtNi0xLTEtMA_58976d07-1905-4648-aa8e-20445816f3b3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTAtOC0xLTEtMA_ab54f21c-0c4e-479b-a5d7-b2b835dbee4b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTEtMi0xLTEtMA_68b9cbb8-dd66-4ecf-a2f0-f61fcf04946b">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTEtNC0xLTEtMA_77d7e1d4-fc7d-4966-ba6a-2f62bf378657">661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTEtNi0xLTEtMA_27121a4d-e3dc-465b-a834-d45e907ee6ab">959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTEtOC0xLTEtMA_d328eeaa-afb7-4ae5-b692-3d14ce3478c7">2,356</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the Nine Months Ended September 30, 2020 and 2019 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:23.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04b4defec05c47cebe3e08fabfbe59fe_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi0yLTEtMS0w_8202220a-7c1a-4b29-ad13-21dc0ad50c2f">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1fe382d2b64cedb36fbab69f63bb0b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi00LTEtMS0w_c44eefaa-8722-48e1-b87e-5b9d03e6fe65">5,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb23df3172c47a6ad9b939e24083612_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi02LTEtMS0w_3981d9e0-6e2e-482d-ad48-f21502b34ddd">36,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5979906ef954a38814196686ea7e5cc_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi04LTEtMS0w_12bc0421-aaa4-4631-989e-84044cdd1f87">2,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7046cbf69cc14b679f3ace4e97364019_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi0xMC0xLTEtMA_2a1f9c4b-002e-4735-8c69-d537d33bb4b1">34,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0ebb716fa943be849401de264b7398_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi0xMi0xLTEtMA_5c588e88-7506-4b31-8438-ff73675938cf">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi0xNC0xLTEtMA_bdf49528-e4a7-44ac-ae1e-a218bd6a65b7">6,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6729fd45e0e470ea191552125f035b0_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy02LTEtMS0w_c1ac318b-9f4f-474a-8516-8447b3e09bc6">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f38bf7309bc47bcb39556c8eb9545d7_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xMi0xLTEtMA_daa767f6-3e95-44c7-89d5-cafc550d0300">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xNC0xLTEtMA_277440a4-0139-4102-93a7-427461701cb4">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNC04LTEtMS0w_926db531-40ea-492a-bf1e-dad3f829abf1">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNC0xNC0xLTEtMA_4651206b-b6ae-4e20-ac78-19b9dd412de6">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e6cf6324ab408596c1e32ba2460534_D20200101-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNS00LTEtMS0w_a891884a-a1da-4ed5-83ef-266281b758c4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9cda828d4e847eb909e17085a8abf3d_D20200101-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNS0xMC0xLTEtMA_3b700d63-08ab-492d-b45b-17688e8b29c8">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNS0xNC0xLTEtMA_af3ad8e4-ee3b-4d03-8e8d-4888b1cd7356">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNi0wLTEtMS0wL3RleHRyZWdpb246ZjEyZDUwNzRlMmNiNDQ0NThlNTIwOWE1M2RkOThmOTdfMjE5OTAyMzI1NTY1MQ_d32a564d-2552-418b-a85e-2605fd52f2a2">2.54</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6729fd45e0e470ea191552125f035b0_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNi02LTEtMS0w_efe2c54a-56e8-4101-ace1-220404843e0a">4,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNi0xNC0xLTEtMA_51c3c5fd-5250-49fc-a877-f529b3f08366">4,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f38bf7309bc47bcb39556c8eb9545d7_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOC0xMi0xLTEtMA_f5eff5a3-3dc8-4e45-bc3a-737539f75ebe">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOC0xNC0xLTEtMA_80c638bc-48c8-4135-8b11-5cdca2342462">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff26aeafc2654f32b63277057cb5ba1f_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS0yLTEtMS0w_bc05a035-63ca-42d6-bd87-492b2991aa78">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb61dea03e9f42f9b875b85705945971_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS00LTEtMS0w_bcd1c5d5-c5c9-4b0c-8370-1877305d6e78">5,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d40817fa304462992d884e8d54ded54_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS02LTEtMS0w_5da692c5-1a89-4d47-abcd-9836e327d3e8">34,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2165dd6285c436395dd6d4adac5414f_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS04LTEtMS0w_06d2d16d-8d90-498e-ac5f-5378d6fb3b74">3,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdcf612da0684543843d2a7497e76e83_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS0xMC0xLTEtMA_39797eac-9c2d-4860-b6a9-359a90ea02fb">34,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34df390bf1094b3299c4c826e85fb609_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS0xMi0xLTEtMA_e8ebb361-b871-4444-a5e7-c26caf642d55">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS0xNC0xLTEtMA_673f9232-72fe-4f80-ac0f-641a911ffd42">3,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:23.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabbca98f017e44a690fafbff723997c4_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi0yLTEtMS0w_50d7c774-3e37-4694-86ab-6d2caccf0365">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389f8b70a3a74262938c581680019e9d_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi00LTEtMS0w_1538580b-d6e3-4714-9e30-c15fac132a18">5,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d18d178b0741ad9d0db863ab4222bc_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi02LTEtMS0w_06140f65-86c5-4ba5-b8e5-4257e14c0294">43,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820a924d574a40d381950cff0e1a0426_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi04LTEtMS0w_82d10965-bbd6-4100-855d-7acda886dcb5">2,547</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42ee75101e094c558a156cae6a325229_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi0xMC0xLTEtMA_ba6cea10-830e-4d2f-8911-5665432ef5f7">33,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i661a0f364aa74a089c89d944ccfa84de_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi0xMi0xLTEtMA_19d351c2-04f3-46bd-88d5-5e0e17bfa47c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdefa86b95345148bfdd3202813cfe1_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi0xNC0xLTEtMA_714decaa-e260-4a40-88d1-023ccc2b1749">14,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65f80ce3d24c4093bace02242bc24d95_D20190101-20190930" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy02LTEtMS0w_25371da7-04cc-4898-985d-73ebdb05a779">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec8f8e259dd94eb9a288d8c6d9cdef4a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xMi0xLTEtMA_6374442d-f542-43ff-996c-cd0f38a9d2ed">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xNC0xLTEtMA_1365353b-ff29-4c18-9e19-f97fac58e22c">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNC04LTEtMS0w_70fe6df2-a4df-4d3f-9c6d-204762f78a20">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNC0xNC0xLTEtMA_7da8364a-e8d0-49ae-833f-6b955d83f1a6">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie610fa8db60e477bbafca3e2effe7047_D20190101-20190930" decimals="-6" sign="-" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNS00LTEtMS0w_c85b6e15-e041-4bc7-a433-40ece3a4233d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3ab6e26183345d0b7aea46529dc8a26_D20190101-20190930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNS0xMC0xLTEtMA_d93371bc-0ff9-4e0b-8475-b8ed9f41f7fc">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNS0xNC0xLTEtMA_7bea7fa4-dd07-4468-b0b3-99da38e01a07">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNi0wLTEtMS0wL3RleHRyZWdpb246NzBjNTExYmJiOTZjNDNiZTg2OWYyMWM2NzYxOWFkZGFfMjE5OTAyMzI1NTY1MA_0c1e8e7f-7434-43e7-b85f-745076b1dd28">2.44</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65f80ce3d24c4093bace02242bc24d95_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNi02LTEtMS0w_099e7c31-2790-48ae-b7c1-f7a6823dfb9f">4,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNi0xNC0xLTEtMA_d6b08a56-f369-4ea7-845a-0b1df3c909a9">4,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3ab6e26183345d0b7aea46529dc8a26_D20190101-20190930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNy0xMC0xLTEtMA_6d1840c0-eae0-4373-950e-ee1796c3fdd8">346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNy0xNC0xLTEtMA_bd29c101-8e50-4694-8a74-c93036f803bb">346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of noncontrolling interest in Helix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8f8e259dd94eb9a288d8c6d9cdef4a_D20190101-20190930" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOC0xMi0xLTEtMzYy_bd43e41f-ce7e-434e-b6a4-e6e02e1b3e7d">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOC0xNC0xLTEtNzAy_62e666eb-e89c-4fdd-b176-3912d032f102">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8f8e259dd94eb9a288d8c6d9cdef4a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOC0xMi0xLTEtMA_43a05af1-21cc-4c75-9c6d-f490e18e66d6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOC0xNC0xLTEtMA_e9375009-135b-4d2e-861d-761fbba879bc">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3652032d649844d6829c5e19d2777520_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS0yLTEtMS0w_c9dc9901-a8f6-47d0-9bd6-85e61a42c873">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if85dc54c29fd4cf9846de7781b260f8a_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS00LTEtMS0w_4aa2314d-1adf-4892-8c1f-3c14cfd02507">5,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05a291f6c85442a9f8f27adea6622f7_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS02LTEtMS0w_30a75314-7382-4622-b292-716e02d52078">39,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4251896369a74d0aa90e3bc70584b869_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS04LTEtMS0w_3fb18d6c-cd1e-48da-8239-ae74514f7575">2,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119ca81462df4b8ab11c4bb6d9bd28ff_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS0xMC0xLTEtMA_f8e16327-5526-4e1e-ac02-40b80502ce30">33,858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab95fccd8da4c0088db681978b22c60_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS0xMi0xLTEtMA_cf553848-5403-4c2d-a24f-82fcfdc24100">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd09282688b34d21a437df741d91f326_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS0xNC0xLTEtMA_962b1e19-f450-436e-acac-2a51a0f1f764">10,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts attributable to noncontrolling interests for the nine months ended September 30, 2020 and 2019 exclude net earnings of $<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfMjE5OTAyMzI1NjE1OA_e3231a07-09b1-401b-a140-4b20efabce26">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfMjE5OTAyMzI1NjE3NA_23620a66-a59c-4648-a296-cce5c4a058e6">3</ix:nonFraction> million, respectively, due to the redeemable noncontrolling interest related to Stag&#8217;s Leap Wine Cellars</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets. </span></ix:footnote></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the Three Months Ended September 30, 2020 and 2019 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:23.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720245015bd147958536b177867849c0_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi0yLTEtMS0w_b3c33c53-9590-4b2d-b2c2-971a1b3ef001">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03988acbbbf545258118de92761502f9_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi00LTEtMS0w_9a1d1c09-fbed-4d2b-8f7b-8c23ff499e48">5,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee87940e501948388212ffaea5ef7269_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi02LTEtMS0w_654979d0-6941-4157-b1b5-562237fee103">36,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib857eef0de4e443fa7bfba0c972defc6_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi04LTEtMS0w_ee4d6649-b558-4b43-8640-824d491e6e10">3,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic28b55d0ec6f4c50b6d76a2006c84218_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi0xMC0xLTEtMA_0ece479d-1c31-45c0-aa5a-6e8b8ba36e26">34,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b099f650834cefb3014164e0c16515_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi0xMi0xLTEtMA_03d0a209-9605-4c73-b4e8-0dc54b0884a7">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670aed569ab54abeacf39bd2a4edb1d7_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi0xNC0xLTEtMA_b13defd1-4680-4811-a17e-a5a1a46bbfb4">5,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6e42abcfda4205a7d8215451ffab57_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy02LTEtMS0w_b057b873-ca49-491d-896f-78e148d40186">952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaab8a9d57c31475c8fa53d7137c08e2c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xMi0xLTEtMA_92b43da6-2611-4ca9-a4aa-fe91a87e8d2c">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xNC0xLTEtMA_de3e948b-bbca-4c2e-b5e7-5f50627b0389">957</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNC04LTEtMS0w_57c617af-3b1a-4e72-85b4-8918aacb4d02">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNC0xNC0xLTEtMA_c13c35cd-04fb-465e-adfd-24c47f6fa7a0">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef8ce9277d64657ac41a5a6e20db257_D20200701-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNS00LTEtMS0w_285c2364-f5d3-4474-aa90-0a540dd99ab8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef63c18b31a43aa813ce3956360d746_D20200701-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNS0xMC0xLTEtMA_6caa13d4-87a5-46c8-912b-1dd66687eb38">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNS0xNC0xLTEtMA_ee90b27a-24f7-4a56-a6a4-4bf12193acd8">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNi0wLTEtMS0wL3RleHRyZWdpb246MjcwMTA1MDYwMTBkNGY1OThlNzg5YThkYWUwMWM1NDlfMjE5OTAyMzI1NTY0OA_1670a0e1-6227-4bdc-98a7-974ec1db0b44">0.86</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb6e42abcfda4205a7d8215451ffab57_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNi02LTEtMS0w_4e69f7c2-b30f-434b-8328-b306acbf2dd7">1,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNi0xNC0xLTEtMA_517be789-1691-4302-a68e-906e38b672fd">1,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff26aeafc2654f32b63277057cb5ba1f_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC0yLTEtMS0w_ea3624a7-7381-4b88-b03c-49e0a9a3bcfe">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb61dea03e9f42f9b875b85705945971_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC00LTEtMS0w_19db87d4-342b-4f5f-9ac2-1736a1dd6e26">5,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d40817fa304462992d884e8d54ded54_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC02LTEtMS0w_32653eed-89a8-484b-a20f-0a4e270c3923">34,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2165dd6285c436395dd6d4adac5414f_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC04LTEtMS0w_6d89d0a6-5623-4a05-8454-67bbf177ba0d">3,781</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdcf612da0684543843d2a7497e76e83_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC0xMC0xLTEtMA_3a57723f-659f-44be-9276-f3b3554c969f">34,344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34df390bf1094b3299c4c826e85fb609_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC0xMi0xLTEtMA_46381f2d-bb7d-4361-a1f0-41e3a0d80a63">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC0xNC0xLTEtMA_796c0c11-36ae-4086-81ae-edd5d9a40683">3,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:23.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20ef7fefce2f4952b179cadedd6fa194_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS0yLTEtMS0w_9bbe6930-f19f-4499-98b9-cb6bd791e493">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2beebe6a93944228898bd1516baf7e5b_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS00LTEtMS0w_8d836b1c-41f8-4aba-a0ae-0a8cf10bc6a5">5,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43fbee378dc74b97a01b3c84b49540ae_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS02LTEtMS0w_4e27b8f4-a586-4180-957c-b9c16c086251">44,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib371c96cf5004c8b8e72e342916dd913_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS04LTEtMS0w_3293cc0a-9c45-43b1-8e72-bb6de90af1d7">2,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad1f4f9717f400dbf8bc1045b4fb85a_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS0xMC0xLTEtMA_8613f973-ee79-4e8a-85c2-8ca34135c733">33,859</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38c16b54c71e4403ba91ef509c462a80_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS0xMi0xLTEtMA_ad263072-bcf3-4402-9c93-332265901f97">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad67a6f5836647b68468a7cfc5e379e6_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS0xNC0xLTEtMA_954266b6-1cc9-472a-a976-90920ae3c09b">14,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings (losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41826b41dd65441cab13757f1fda2bcf_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtNi0xLTEtMA_152297ec-d10d-4dae-a5da-3ef65d848c38">2,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dc586e8441b48ad8423fa2f8e43592c_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTItMS0xLTA_ddaf8c78-7472-4f94-ae7b-8f418194e190">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTQtMS0xLTA_32bef1b2-a36e-4bb9-8683-bebcf17c1d46">2,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTEtOC0xLTEtMA_e0b9468b-63bb-40ac-9ce6-51a310abea09">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTEtMTQtMS0xLTA_d9d0ffdf-d0c2-4fc8-a54b-7dfcbeee037a">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a6eaa90bd54796b8d3ac775e6acc2b_D20190701-20190930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTItNC0xLTEtMA_c36016df-aac9-4b58-a675-6e5134ff8a34">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40ae23bb96f4b34b5fff2e26a482860_D20190701-20190930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTItMTAtMS0xLTA_f43af357-bf48-41b2-a6d5-750613352296">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTItMTQtMS0xLTA_74ebebe2-160d-41b6-bb70-d80caa407f75">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjhkNDQ2ZmJmMGRiNTQ4OTg5YWNhMWZkYzFlZjdhOTllXzIxOTkwMjMyNTU2NDc_7a6a5f67-7d43-4989-bd7f-7f3ad27e66f3">0.84</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41826b41dd65441cab13757f1fda2bcf_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTMtNi0xLTEtMA_4b50f2aa-39e3-4ca5-adab-2c13bfe580d5">1,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTMtMTQtMS0xLTA_bff3ea0b-b685-4253-85ef-36796c6a10ae">1,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of noncontrolling interest in Helix</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc586e8441b48ad8423fa2f8e43592c_D20190701-20190930" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTQtMTItMS0xLTA_a911f5fb-095a-4e27-b688-8019a748efde">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTQtMTQtMS0xLTA_e3a0c405-faf6-4351-bd4a-0d5426e8f2b7">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc586e8441b48ad8423fa2f8e43592c_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTUtMTItMS0xLTQ0NQ_275fa855-8862-496a-b5d1-7bf7e32db7d5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTUtMTQtMS0xLTY3Nw_5aae8876-b7f0-4cd6-98b4-85fe2205f350">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, September 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3652032d649844d6829c5e19d2777520_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtMi0xLTEtMA_9aedd18e-3501-490a-837d-5b3e820a9668">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if85dc54c29fd4cf9846de7781b260f8a_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtNC0xLTEtMA_9201f088-16ee-4451-a21e-7001ccdb3ab3">5,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05a291f6c85442a9f8f27adea6622f7_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtNi0xLTEtMA_0828f7ff-8bc8-4dfc-a0e1-df2c935d8316">39,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4251896369a74d0aa90e3bc70584b869_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtOC0xLTEtMA_c9096b60-f8d7-4e0e-a80f-29a90f97b51b">2,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119ca81462df4b8ab11c4bb6d9bd28ff_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtMTAtMS0xLTA_9ebec0d8-c6be-4293-bcd3-89a201406909">33,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab95fccd8da4c0088db681978b22c60_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtMTItMS0xLTA_ac93b8f8-7301-40b1-9231-4d8b9825f201">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd09282688b34d21a437df741d91f326_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtMTQtMS0xLTA_127843b7-e315-4d9b-b72c-9ecb1ea7eb11">10,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0" continuedAt="i4f594078b4864141a6884361ce5185f6" footnoteRole="http://www.xbrl.org/2003/role/footnote">Amounts attributable to noncontrolling interests for the three months ended September 30, 2020 and 2019 exclude net earnings of $<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfMjE5OTAyMzI1NjIyMw_0b9ad177-1131-49b1-8884-bec3694cf889"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfMjE5OTAyMzI1NjIyMw_33504470-5e56-40f3-803e-b4b4364853d2">1</ix:nonFraction></ix:nonFraction> million due to the redeemable noncontrolling interest related to Stag&#8217;s Leap Wine Cellars</ix:footnote></span><ix:continuation id="i4f594078b4864141a6884361ce5185f6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets. </span></ix:continuation></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 4.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMy0yLTEtMS0w_b43c9131-f019-4f26-a880-63a3fbe806d0">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMy00LTEtMS0w_bea1157a-58f4-4718-9a9d-9e470705db49">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings (losses) to operating cash flows:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNS0yLTEtMS0w_5a66aff7-17e7-403a-aefb-dcb7a189589f">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNS00LTEtMS0w_026ff775-1530-4fa9-882f-c95d01a88b85">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNi0yLTEtMS0w_909dbb6f-4910-47ee-9979-45620573d47e">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNi00LTEtMS0w_c32b91d3-49de-45e3-b4ff-513fc22167a0">261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Earnings) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNy0yLTEtMS0w_60f129ec-c9d9-4ca7-bce0-a88630ba7684">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNy00LTEtMS0w_f70dc7a2-1877-4900-bb12-cd771a759088">866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from ABI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfOC0yLTEtMS0w_8d7aaea5-263f-4105-b0d5-4032dadfea92">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfOC00LTEtMS0w_bb303773-af2d-4f75-a37f-d735b7733f22">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTAtMi0xLTEtMA_437e4d79-19c6-4128-90c4-a91b1eaa2e23">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTAtNC0xLTEtMA_7d3dc172-cc4e-4719-8a33-151e2b164040">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTEtMi0xLTEtMzc2OQ_36631cab-5253-473c-ac5b-bae778d00ea0">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTEtNC0xLTEtMjQ0OA_9d5fb701-26d3-4a1e-ba3e-c394b1876f2f">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment and exit costs, net of cash paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTItMi0xLTEtMA_203eb2db-9678-4d1e-94c6-758c945e0d79">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTItNC0xLTEtMA_8b7a6c3c-1b99-494c-80ef-500e8624fc03">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash effects of changes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTUtMi0xLTEtMA_23c1dfb0-f3a6-412e-b478-85b4a99fcdaf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTUtNC0xLTEtMA_9769c128-8c90-4a5f-8ac3-c4e69d81231f">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTYtMi0xLTEtMA_648efbbb-fc4a-4440-a370-f38cc9464532">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTYtNC0xLTEtMA_24f7bdf3-8e4f-470d-a763-e1acef2d9281">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTctMi0xLTEtMA_8c796d3e-76ea-46c0-bcea-24c5e567c5bc">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTctNC0xLTEtMA_08ac022d-b847-4590-957f-6517231bbb4e">157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTgtMi0xLTEtMA_5cc3f1a8-f074-40ec-be54-e0807f6ae114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTgtNC0xLTEtMA_675f608f-e9be-4bb0-b01d-1937175d2ec3">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTktMi0xLTEtMA_226cfea1-b155-4efd-8bde-2536e155be5f">504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTktNC0xLTEtMA_cee50f82-4a75-4761-a2e1-f30a515b72c1">359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued settlement charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="mo:IncreaseDecreaseInSettlementPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjAtMi0xLTEtMA_557fc222-ba64-4e9a-aa7e-6ea5ad920bad">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="mo:IncreaseDecreaseInSettlementPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjAtNC0xLTEtMA_8dabc6d7-5166-41c3-acde-f6f8f3cc7d0a">360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjEtMi0xLTEtMA_2cbd41dc-26ea-46c0-9987-7fb17ee1397f">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjEtNC0xLTEtMA_007df296-e28b-41f1-8050-51bab85532b1">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension provisions and postretirement, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjItMi0xLTEtMA_7a473e02-f135-4914-bcea-59948fa0b361">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjItNC0xLTEtMA_e97ee8c8-086b-4dc2-8491-383c96fa6740">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjMtMi0xLTEtMA_12364489-6954-45d0-b62b-c2c2ad6ec365">591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjMtNC0xLTEtMA_0230745f-9e94-444f-b79f-13ea3699d179">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjQtMi0xLTEtMA_f793873a-cf72-4e2d-b3f6-dacdaee581c8">5,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjQtNC0xLTEtMA_647fd7ac-67db-48a4-b87f-28be7e9a7c99">5,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjYtMi0xLTEtMA_697da6ff-6d8c-454d-a751-442c74f1a573">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjYtNC0xLTEtMA_bc6a0641-0eaf-45b6-a713-0c2f2d741bff">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Cronos</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjctMi0xLTEtMA_f1d7a3b8-c6e6-4342-ae16-e352a1b9f36f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="mo:PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjctNC0xLTEtMA_d4fd6bfb-de6e-49f0-945b-cfe424ccbe41">1,863</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions of businesses and assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:PaymentsToAcquireBusinessesAndAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjgtMi0xLTEtMA_8874725b-a1d5-41d5-b3ee-def56fa8a84b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:PaymentsToAcquireBusinessesAndAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjgtNC0xLTEtMA_bbaaaa12-04fe-470b-a8f2-14131fe0cafe">421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMzEtMi0xLTEtMA_c6021888-e7fc-4c0e-8214-dbb1ee6ff87f">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMzEtNC0xLTEtMA_71d68403-22c0-486e-9c65-df2f3d0ebd38">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMzItMi0xLTEtMA_7869c579-8d12-4ed4-b66f-d96b78726ddb">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMzItNC0xLTEtMA_0d6193cf-fe2e-4cdd-aa79-0c3799c1d30c">2,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited) </span></div><div style="margin-bottom:11pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended <br/>September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMy0yLTEtMS0w_5df41593-14c6-4b20-bf29-e5c58f8fba73">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMy00LTEtMS0w_b7d886f9-f458-400f-a841-909aa3d74247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of short-term borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNC0yLTEtMS0w_4b4cdaa7-11be-41c2-96ce-17be9efdbd01">3,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNC00LTEtMS0w_e30f21db-ae75-4916-8565-1f070a2fe367">12,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNS0yLTEtMS0w_d0fdf83e-8410-45a6-a80a-56e9a7c1e32f">1,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNS00LTEtMS0w_a4cc487a-4191-4819-a6fb-14a0670950f4">16,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt repaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNi0yLTEtMS0w_821b288c-b484-43a3-83d4-ee60ec23618e">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNi00LTEtMS0w_bf01b047-3cce-42a5-b733-9b3c2a8705b4">1,144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNy0yLTEtMS0w_601a3d3f-38b7-4536-9db2-7e5d664da481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNy00LTEtMS0w_d8f92e5b-c20f-42ac-87e9-103459b0fe57">346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfOC0yLTEtMS0w_a00d28a3-56e3-4139-ac15-e04af22a8b32">4,690</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfOC00LTEtMS0w_36627edb-43ee-43e1-b9a4-4339fcc9517c">4,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTItMi0xLTEtMA_b92610f4-8f36-4e69-8f72-a4d73b5c6296">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTItNC0xLTEtMA_f7d78f85-fbd3-4cc5-864c-dd4eabe57f9f">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTMtMi0xLTEtMA_922286d2-9452-4211-b461-50498d96a06f">3,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTMtNC0xLTEtMA_20212dd6-ab86-4483-8974-f79287cc1be7">2,650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTUtMi0xLTEtMA_84cb9016-f09a-4736-9650-89bb4ed51c24">2,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTUtNC0xLTEtMA_064d8866-7da0-41ec-adb6-b1743171445b">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTYtMi0xLTEtMA_f369fb74-9ad1-4b48-afe1-26298562f077">2,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdefa86b95345148bfdd3202813cfe1_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTYtNC0xLTEtMA_e8f24368-bd18-4475-a984-6411d67b3e21">1,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTctMi0xLTEtMA_651c41b2-b93d-4a31-8ff3-aaae200e1200">4,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd09282688b34d21a437df741d91f326_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTctNC0xLTEtMA_445f5976-2849-4f41-b727-fa52fcd55539">1,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following table provides a reconciliation of cash, cash equivalents and restricted cash to the amounts reported on Altria&#8217;s condensed consolidated balance sheets:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjEtMi0xLTEtMA_cf5245d2-ddb9-466a-a94c-81d1f3cd36b0">4,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjEtNC0xLTEtMA_a65fa8f8-4199-4a9c-a515-aa6e3005ca0b">2,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItMi0xLTEtMA_8b2de181-c594-4861-82f2-16775637f7aa">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItNC0xLTEtMA_fb9e1f1b-6613-49b9-a770-61217d261122">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtMi0xLTEtMA_7c50127c-8405-4552-83d6-3a0c8f1f729a">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtNC0xLTEtMA_f860a248-690d-4c89-b56c-5007bb75c513">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjQtMi0xLTEtMA_3ff3207c-7f74-401f-b61f-002fe7d0eb55">4,184</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjQtNC0xLTEtMA_e151c54e-eb13-45d1-b774-2c3d07219c4f">2,160</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RleHRyZWdpb246YTY0NjhiZGQ5MGE5NGMwYjk0NDkyN2JlN2FjZjBhMDZfNTQ1_d0bfd329-a1e4-4202-8c50-456f2cc3558d" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></ix:footnote></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_40"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 1. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMTg2OTE2OTc2ODA1OTY_050dfdac-663a-4c0e-aefa-0a1378605a70" continuedAt="i14d03f1f93eb45d3acb79df3432b0aba" escape="true">Background and Basis of Presentation:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i14d03f1f93eb45d3acb79df3432b0aba" continuedAt="i3f418bea3f24434da616a6ddf7d224c6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in these notes, the term "Altria&#8221; refers to Altria Group, Inc. and its subsidiaries, unless otherwise specified or unless otherwise required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria Group, Inc.&#8217;s wholly owned subsidiaries included Philip Morris USA Inc. (&#8220;PM USA&#8221;), which is engaged in the manufacture and sale of cigarettes in the United States (including super premium cigarettes previously manufactured and sold by Sherman Holdings, LLC and its subsidiaries (&#8220;Nat Sherman&#8221;)); John Middleton Co. (&#8220;Middleton&#8221;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA;  UST LLC (&#8220;UST&#8221;), which through its wholly owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;) and Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;), is engaged in the manufacture and sale of moist smokeless tobacco (&#8220;MST&#8221;) and snus products and wine; and Philip Morris Capital Corporation (&#8220;PMCC&#8221;), which maintains a portfolio of finance assets, substantially all of which are leveraged leases.  In addition, Altria owned an <ix:nonFraction unitRef="number" contextRef="i52d5750b3f6b4059b628cc5c6120ffb1_I20200930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMjE5OTAyMzI2Mzc1Mw_4050bdd6-76a1-454e-8766-654b0bb25eef">80</ix:nonFraction>% interest in Helix Innovations LLC (&#8220;Helix&#8221;), which is engaged in the manufacture and sale of oral nicotine pouches.  Other Altria wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries.  Altria&#8217;s access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  At September&#160;30, 2020, Altria&#8217;s significant wholly owned subsidiaries were not limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a <ix:nonFraction unitRef="number" contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMjIzNQ_1350fda7-8542-4496-822c-c69a2a16fc27">10.0</ix:nonFraction>% ownership in Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;), which Altria accounts for under the equity method of accounting using a one-quarter lag.  Altria receives cash dividends on its interest in ABI and will continue to do so as long as ABI pays dividends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a <ix:nonFraction unitRef="number" contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMjUxMQ_2bc1443a-0ac3-4209-b010-3a96a4b98878">35</ix:nonFraction>% economic interest in JUUL Labs, Inc. (&#8220;JUUL&#8221;), which Altria accounts for as an investment in an equity security.  JUUL is engaged in the manufacture and sale of e-vapor products in the U.S. and certain international markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, Helix acquired Burger S&#246;hne Holding and its subsidiaries as well as certain affiliated companies (the &#8220;Burger Group&#8221;) that are engaged in the manufacture and sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> oral nicotine pouches.  At closing, Altria indirectly owned an <ix:nonFraction unitRef="number" contextRef="iacac7d034158497ea761b6128d276bc9_I20190930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzAwNA_75251fbd-859e-418f-89ee-1a612c9fcdf3">80</ix:nonFraction>% interest in Helix, for which Altria paid $<ix:nonFraction unitRef="usd" contextRef="i96e18cf03e374d0e8e09d680fdb0eb63_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzA0OA_f8fafd0e-609e-4bc7-ae67-b5da64ed665c">353</ix:nonFraction> million in third quarter of 2019.  The financial results of Helix are included in Altria&#8217;s condensed consolidated financial statements as part of its oral tobacco products segment (formerly smokeless products segment), with the <ix:nonFraction unitRef="number" contextRef="i52d5750b3f6b4059b628cc5c6120ffb1_I20200930" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzI3MQ_7e2ee29b-5024-4496-ba00-74fff9a38ea7">20</ix:nonFraction>% minority ownership interest in Helix (held by the former shareholders of the Burger Group) included as a non-controlling interest.  The purchase price allocation has been completed, and there were no changes subsequent to the acquisition date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a <ix:nonFraction unitRef="number" contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzUxODQzNzIwOTgzMzE_dffbad4c-bf74-454b-af91-008bab9ac1ea">44</ix:nonFraction>% ownership in Cronos Group Inc. (&#8220;Cronos&#8221;), a global cannabinoid company headquartered in Toronto, Canada, which Altria accounts for under the equity method of accounting using a one-quarter lag. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of Altria&#8217;s investments in equity securities, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends and Share Repurchases </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, Altria&#8217;s Board of Directors (the &#8220;Board of Directors&#8221;) declared a <ix:nonFraction unitRef="number" contextRef="i071cc6de3a8a4d14b919af0f81bed549_D20200701-20200731" decimals="3" name="mo:CommonStockDividendRatePercentageIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzk4Nw_0b993bca-6ca0-4fcb-aba0-9324f683aa3b">2.4</ix:nonFraction>% increase in the quarterly dividend rate to $<ix:nonFraction unitRef="usdPerShare" contextRef="i071cc6de3a8a4d14b919af0f81bed549_D20200701-20200731" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDAzMw_7699ca7b-38d4-4873-a083-728eb998a18d">0.86</ix:nonFraction> per share of Altria common stock versus the previous rate of $<ix:nonFraction unitRef="usdPerShare" contextRef="i193bdf7d0e214572a3f99ff6320d3da9_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDA5Nw_ac170d2a-92ae-4fb7-830e-bc33a1f23d6a">0.84</ix:nonFraction> per share.  The current annualized dividend rate is $<ix:nonFraction unitRef="usdPerShare" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="2" name="mo:CommonStockDividendRateAnnualPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDE1Mg_2d8e15f8-8080-4bde-9624-b7789e9fe8b5">3.44</ix:nonFraction>.  Future dividend payments remain subject to the discretion of the Board of Directors.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the Board of Directors authorized a $<ix:nonFraction unitRef="usd" contextRef="i0eccbcc083c844ac8c436b9f78601a58_I20180131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDMzMg_39d6a615-b147-4dd1-b8cf-6940fea46c92">1.0</ix:nonFraction> billion share repurchase program that it expanded to $<ix:nonFraction unitRef="usd" contextRef="ia217b44568db4f7bab6aa96e06106ae0_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDM4MA_76520363-d7b0-4d3b-983b-969d5a26eac7">2.0</ix:nonFraction> billion in May 2018 (as expanded, the &#8220;January 2018 share repurchase program&#8221;).  In June 2019, Altria completed the January 2018 share </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i3f418bea3f24434da616a6ddf7d224c6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">repurchase program, under which it purchased a total of <ix:nonFraction unitRef="shares" contextRef="i6a66e6dc6fc14f578f3db7088eb5c228_D20180101-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDU2Ng_ea2bba61-4c24-4246-87ea-7e9384ec272c">34.0</ix:nonFraction> million shares of its common stock at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6a66e6dc6fc14f578f3db7088eb5c228_D20180101-20190630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDYxOQ_05db92ff-8a84-4b1b-a3b7-a8723c927729">58.86</ix:nonFraction> per share. </span></div><div><span><br/></span></div><div style="padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board of Directors authorized a $<ix:nonFraction unitRef="usd" contextRef="ica759e56c7514b8ba6b11550c9f189e7_I20190731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDY4NQ_21a453cd-f2c7-4b70-b6a5-1d86d65fabb9">1.0</ix:nonFraction> billion share repurchase program (the &#8220;July 2019 share repurchase program&#8221;).  In April 2020, the Board of Directors rescinded the $<ix:nonFraction unitRef="usd" contextRef="i0268f17a4fd248279ae397980a380ee7_I20200430" decimals="-6" format="ixt:numdotdecimal" name="mo:StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDgxMA_86f959a6-711b-45bf-9408-cf432471677d">500</ix:nonFraction> million remaining in this program as part of Altria&#8217;s efforts to enhance its liquidity position in response to the COVID-19 pandemic.  There were <ix:nonFraction unitRef="shares" contextRef="i9b7cdb52d8b648f0ae0d6f3123ee3585_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDkyMA_c9fcd3e9-e3dc-479f-b520-212e97cab412">no</ix:nonFraction> share repurchases made in 2020. </span></div><div style="padding-right:15.75pt"><span><br/></span></div><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfODE5MQ_e38defcf-00f5-4aa0-b4cb-68d2b95ad164" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s 2019 share repurchase activity was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.447%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2a909e9cbdb4c8d915bced44fe70c76_D20190101-20190930" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMS0yLTEtMS0w_836feeb7-1e1d-45aa-b5ea-2606dc46775a">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i19988383bb3043e881752078a8364530_D20190701-20190930" decimals="-5" format="ixt:zerodash" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMS02LTEtMS0w_af212298-7f89-442a-b038-fe44970f2610">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2a909e9cbdb4c8d915bced44fe70c76_D20190101-20190930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMi0yLTEtMS0w_4e1e85a3-4c95-429e-a140-c1df1de03978">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19988383bb3043e881752078a8364530_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMi02LTEtMS0w_300a9461-2565-470a-979c-c8146e2892c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic2a909e9cbdb4c8d915bced44fe70c76_D20190101-20190930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMy0yLTEtMS0w_a1622bc1-8a56-4d43-8dbd-07548247c621">54.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i19988383bb3043e881752078a8364530_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMy02LTEtMS0w_cf99d833-af2c-4a20-8914-f624c1d1f896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements of Altria are unaudited.  It is the opinion of Altria&#8217;s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain immaterial prior year amounts have been reclassified to conform with the current year&#8217;s presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements should be read in conjunction with Altria&#8217;s audited consolidated financial statements and related notes, which appear in Altria&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfODE4NQ_369b0d9c-75b6-441a-abe8-97dfe4034a56" continuedAt="i62293bef5d67444996f2d9f1c95490f1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, Altria began complying early, as permitted, with Regulation S-X Rules 13-01 and 13-02 regarding the financial disclosure requirements for registered debt securities with subsidiary guarantees.  On October 23, 2020, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-09,  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt (Topic 470): Amendments to SEC Paragraphs Pursuant to SEC Release No. 33-10762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to reflect changes the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) has made to its disclosure rules on guaranteed debt securities offerings.  The new rules replace the previously required condensed consolidating financial information with summarized financial information of the issuer and the guarantor and, among other things, require expanded qualitative disclosures.  Altria has elected to provide this information in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section in its Quarterly Report on Form 10-Q as permitted by the new rules.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, Altria adopted ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and all related ASU amendments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(collectively &#8220;ASU No. 2016-13&#8221;).  This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity&#8217;s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses.  The adoption of ASU No. 2016-13 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU No. 2018-15&#8221;).  This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license).  The adoption of ASU No. 2018-15 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_46"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 2. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTg2OTE2OTc2NzYzMTM_94c796ad-07aa-469a-b340-34543243b9d3" continuedAt="ib2281191d7564ef2a555dfd2a3b7f993" escape="true">Revenues from Contracts with Customers:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib2281191d7564ef2a555dfd2a3b7f993"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria disaggregates net revenues based on product type.  For further discussion, see Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses offer cash discounts to customers for prompt payment and calculate cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms.  Altria&#8217;s businesses record an allowance for cash discounts, which is included as a contra-asset against receivables on Altria&#8217;s condensed consolidated balance sheets.  Cash discounts at September&#160;30, 2020 and December&#160;31, 2019 were de minimis, and there were no differences between amounts recorded as an allowance for cash discounts and cash discounts subsequently given to customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses that receive payments in advance of product shipment record such payments as deferred revenue.  These payments are included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue was $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTAyMA_0954771d-cc08-4401-8c31-2448c9701f4f">250</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTAyNw_cb6df361-a24a-495b-95b3-ff53039eb067">362</ix:nonFraction> million at September&#160;30, 2020 and December&#160;31, 2019, respectively.  When cash is received in advance of product shipment, Altria&#8217;s businesses satisfy their performance obligations within <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:RevenuePerformanceObligationDescriptionOfTiming" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTE3OA_93237773-b1cb-4f08-8aaf-d3e17bb769ae">three days</ix:nonNumeric> of receiving payment.  At September&#160;30, 2020 and December&#160;31, 2019, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables, which primarily reflect sales of wine produced and/or distributed by Ste. Michelle, were $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTQ0MA_fa55f202-0811-4bb9-af5a-a935efc59842">151</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTQ0Nw_a81cf03f-3b73-41fd-9c06-685d58200513">152</ix:nonFraction> million at September&#160;30, 2020 and December&#160;31, 2019, respectively.  At September&#160;30, 2020 and December&#160;31, 2019, there were no expected differences between amounts recorded and subsequently received, and Altria&#8217;s businesses did not record an allowance for doubtful accounts against these receivables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.  While all of Altria&#8217;s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC&#8217;s MST and snus products.  Altria&#8217;s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  Altria&#8217;s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on Altria&#8217;s condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, Altria&#8217;s businesses do not record an asset for their right to recover goods from customers upon return.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales incentives include variable payments related to goods sold by Altria&#8217;s businesses.  Altria&#8217;s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Price promotion payments- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses make price promotion payments, substantially all of which are made to their retail partners, to incent the promotion of certain product offerings in select geographic areas. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wholesale and retail participation payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Altria&#8217;s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business&#8217;s trade agreements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 3. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMTg2OTE2OTc2NzYwMTY_2fe4de01-a60e-40db-9bf0-cf0d587cd23b" continuedAt="i4359fd0abfef4d04a84524b837321f59" escape="true">Asset Impairment, Exit and Implementation Costs:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4359fd0abfef4d04a84524b837321f59" continuedAt="i8d2f8515b39d4303a378ba3f310e009e"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMzU4Mw_7d2d100d-b3d1-4e87-97b9-5ed49bb5e37d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax asset impairment, exit and implementation costs consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.022%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.388%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Impairment and Exit Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a6568d2e72475ba89df5fcc752c87d_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC00LTEtMS0w_d3ed3abb-ee8b-4247-8dd1-db2906731973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65a6568d2e72475ba89df5fcc752c87d_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC02LTEtMS0w_1dd2ed34-a6e2-456b-a994-81a37cd61166">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9cc8a9510f4a2382edf4448aedc3ca_D20190101-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC04LTEtMS0w_fd16d78b-dbc0-4f20-b805-cefc9e7b8317">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9cc8a9510f4a2382edf4448aedc3ca_D20190101-20190930" decimals="-6" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC0xMC0xLTEtMA_e435d38d-9231-4078-a6bb-2d3621281e6a">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9cc8a9510f4a2382edf4448aedc3ca_D20190101-20190930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC0xMi0xLTEtMA_7b14043d-dab5-4c71-b80d-a6d980b02819">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414a3270f11947418d6c2125e509944a_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS00LTEtMS0w_11c67e6e-d717-4f96-bff9-f13505c1e836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414a3270f11947418d6c2125e509944a_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS02LTEtMS0w_4368455b-b692-4eb0-b8de-7fbf498cb866">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dae5a2ab67f4bb9bd50da276ee4860c_D20190101-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS04LTEtMS0w_af59264e-2499-413c-9c4e-9952f89b5d36">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dae5a2ab67f4bb9bd50da276ee4860c_D20190101-20190930" decimals="-6" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS0xMC0xLTEtMA_481b4cca-e4ba-4287-bdea-97c5ecbda69f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dae5a2ab67f4bb9bd50da276ee4860c_D20190101-20190930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS0xMi0xLTEtMA_63d3835d-f995-4316-9422-3f38393588b5">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76c7d7d2fbc34685ae18727c4cd65f70_D20200101-20200930" decimals="-6" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi00LTEtMS0w_11fa4157-4c14-4e69-aec3-c75d6f1eb2b2">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76c7d7d2fbc34685ae18727c4cd65f70_D20200101-20200930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi02LTEtMS0w_97f765ac-9924-44cb-856e-eeeedc798414">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61784cf3f3fc455b92d1549db42be0cc_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi04LTEtMS0w_e68f6e8b-4b18-43fd-a3c4-7d19fe519dc4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61784cf3f3fc455b92d1549db42be0cc_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi0xMC0xLTEtMA_e4da0185-992a-4ac7-afe3-311d99936bf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61784cf3f3fc455b92d1549db42be0cc_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi0xMi0xLTEtMA_44934038-8463-47c1-8b46-3b95bcc1deb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966e35b143ba4a7cbf9890b21f017d74_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy00LTEtMS0w_05c0b342-5778-4d15-a0e7-4a1b682b821d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966e35b143ba4a7cbf9890b21f017d74_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy02LTEtMS0w_69ccb17b-5c99-4f62-a588-694e348aad4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513f9aefe4864f918aef77ec9b9464ca_D20190101-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy04LTEtMS0w_c214da07-5d4e-4648-8c55-4ae5a0123372">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i513f9aefe4864f918aef77ec9b9464ca_D20190101-20190930" decimals="-6" sign="-" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy0xMC0xLTEtMA_0e8981da-4def-4a71-a4ea-d1fa28c03122">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513f9aefe4864f918aef77ec9b9464ca_D20190101-20190930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy0xMi0xLTEtMA_76a999fe-8075-4998-8c7e-4f63391556ea">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC00LTEtMS0w_0ed93712-1eca-41bc-a999-7a2c9f730b7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC02LTEtMS0w_cbc70bdb-a8aa-43e1-97e3-81f6bb48d90b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC04LTEtMS0w_100bac85-1cf7-4e98-a602-736eff7f2e2a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC0xMC0xLTEtMA_5eeda246-9bfb-4e44-b337-85fcc0a60473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC0xMi0xLTEtMA_78d73fcb-89fd-4372-b91c-1ad90648cbc0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS00LTEtMS0w_6701c392-e11e-4f58-8c18-e95a1a5ec4e0">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS02LTEtMS0w_42e44862-141f-4ac1-8950-603c7cc3a3a8">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS04LTEtMS0w_0034cb81-d480-40c4-b907-9e8e0dcc8a1f">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS0xMC0xLTEtMA_d6dd34eb-bba4-4942-a1b6-ab18f4a96b2c">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS0xMi0xLTEtMA_5ea6b742-7818-464e-a668-01d55b35d051">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus amounts included in net periodic benefit income, excluding </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">service cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtNC0xLTEtMA_eac5cffe-a49e-46fc-a333-c75e6ef906e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtNi0xLTEtMA_ddfbe43d-348f-4029-85b0-ee9b8e833f4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtOC0xLTEtMA_0657c792-6bb4-47a9-b567-c7255f7c35d2">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtMTAtMS0xLTA_0f0dcf51-2733-46d4-9cfb-e5bfcf24e10b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtMTItMS0xLTA_b3e06410-315c-4f8a-86b5-cef13d175f56">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtNC0xLTEtMA_a4bed3d4-8b3b-425f-8083-c07c19bec6d1">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtNi0xLTEtMA_532b758c-63ae-4fb7-93e1-aeb449e9846d">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtOC0xLTEtMA_4ac380af-07b2-4d51-868e-56c49de9a2f3">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtMTAtMS0xLTA_fc545758-aab6-43e0-bd11-c2c51e9f4bec">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtMTItMS0xLTA_17fe45a8-059d-4d30-ac50-7c059997a50c">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Included in cost of sales ($<ix:nonFraction unitRef="usd" contextRef="i6b8c284910f9462da3a11aa8a2bdd9aa_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMjY1_34ab7bb8-17ef-4c4a-bc02-bd0a2e237ad6">1</ix:nonFraction> million cost reversal) and marketing, administration and research costs ($<ix:nonFraction unitRef="usd" contextRef="i2db2f30e181740b58612f500d9f2221c_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMzMz_7867a8b1-8d31-4837-adf9-33913c572841">26</ix:nonFraction> million) in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Represents curtailment costs.  See Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:30.811%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Impairment and Exit Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad12458b42414f73b54a930bd3423a7d_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC0zLTEtMS0w_e610404c-6c96-479f-ae63-007cec295ae9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad12458b42414f73b54a930bd3423a7d_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC01LTEtMS0w_b9f6a132-48b9-4c41-adc4-3afab5507de9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b301f3d97e7423587fd5da2e57c027d_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC03LTEtMS0w_f975e278-eb89-443b-9de3-78717ca34baa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b301f3d97e7423587fd5da2e57c027d_D20190701-20190930" decimals="-6" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC05LTEtMS0w_892f3a7b-ea93-4fb7-bf6b-36d89e584236">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b301f3d97e7423587fd5da2e57c027d_D20190701-20190930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC0xMS0xLTEtMA_5c4ed204-c868-4427-83dc-775669c4e829">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7138bb35916249cbb738270fd6fe93d7_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS0zLTEtMS0w_c1ff3c6a-4d52-42af-a069-7246045bde33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7138bb35916249cbb738270fd6fe93d7_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS01LTEtMS0w_1053704d-c817-44db-a464-22cc0df74a3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ce1a07a551424683dbafbcfa3df273_D20190701-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS03LTEtMS0w_abd1caa9-ee0c-4f80-a2a5-266511dbd8c8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ce1a07a551424683dbafbcfa3df273_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS05LTEtMS0w_0fedf376-4d83-4d3d-a5fb-43612a480671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ce1a07a551424683dbafbcfa3df273_D20190701-20190930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS0xMS0xLTEtMA_626c8ae1-bf17-42a8-ac72-4e31d534f21b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9cd0e274519474a97c80be2216cc392_D20200701-20200930" decimals="-6" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi0zLTEtMS0w_f33fc45a-6649-44f5-98d6-95958e6cf10f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9cd0e274519474a97c80be2216cc392_D20200701-20200930" decimals="-6" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi01LTEtMS0w_39ec64ed-b144-4665-bb38-3c46399c93ad">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4296ad893da549f0938808b2978e8ff6_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi03LTEtMS0w_ea569bbd-7ae8-4a0e-a4ee-a320cf83fb79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4296ad893da549f0938808b2978e8ff6_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi05LTEtMS0w_aa1c7e8a-9e36-4a97-abf8-a270c80df3da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4296ad893da549f0938808b2978e8ff6_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="mo:RestructuringChargesIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi0xMS0xLTEtMA_570991fa-c23d-4e5b-b402-141c2ff61b27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS0zLTEtMS0w_a7f5583a-4841-4f09-8a78-757c79044780">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS01LTEtMS0w_614b9413-51fe-4883-bcd6-9c883ae9c950">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS03LTEtMS0w_a3b7222f-203d-4d29-84be-8b96440193d2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS05LTEtMS0w_f9b9afee-0b8b-4605-af37-c59b21424267">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS0xMS0xLTEtMA_a0da3b07-3a81-4e34-a714-1f2e80630f11">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Included in cost of sales ($<ix:nonFraction unitRef="usd" contextRef="id587ee8978da4dd9bfa35f34f890d144_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfNTc1_e17329d9-bbc0-4f1d-a651-3d213bed92fb">1</ix:nonFraction> million) and marketing, administration and research costs ($<ix:nonFraction unitRef="usd" contextRef="i4076276bf701434cafde95786366cd18_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="mo:OtherRestructuringCostsIncludingNetPensionCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfNjQz_52ce203d-72b6-451c-97e6-d6ef5ed307c0">3</ix:nonFraction> million) in Altria&#8217;s condensed consolidated statements of earnings.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Implementation costs for 2020 were related to Ste. Michelle&#8217;s strategic reset as discussed below.  The 2019 pre-tax asset impairment, exit and implementation costs were primarily related to the cost reduction program announced in December 2018, which was completed in 2019.  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMzYwNA_0595a41a-b47d-4fb9-8022-7663e5eae6ff" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.631%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjVmMDM1ZjAzZDZiMDRlNmI5ZTEwMTVmYmFmNGYzMjdhL3RhYmxlcmFuZ2U6NWYwMzVmMDNkNmIwNGU2YjllMTAxNWZiYWY0ZjMyN2FfMS0xLTEtMS0w_02312625-0dc7-4d7b-b0be-7a2c5f8e8e4a">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjVmMDM1ZjAzZDZiMDRlNmI5ZTEwMTVmYmFmNGYzMjdhL3RhYmxlcmFuZ2U6NWYwMzVmMDNkNmIwNGU2YjllMTAxNWZiYWY0ZjMyN2FfMi0xLTEtMS0w_e326837d-60c4-461b-b7bd-63b69f53b686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash spent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjVmMDM1ZjAzZDZiMDRlNmI5ZTEwMTVmYmFmNGYzMjdhL3RhYmxlcmFuZ2U6NWYwMzVmMDNkNmIwNGU2YjllMTAxNWZiYWY0ZjMyN2FfMy0xLTEtMS0w_65af6721-17a4-4b2a-88cf-2e9a3ca86bab">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjVmMDM1ZjAzZDZiMDRlNmI5ZTEwMTVmYmFmNGYzMjdhL3RhYmxlcmFuZ2U6NWYwMzVmMDNkNmIwNGU2YjllMTAxNWZiYWY0ZjMyN2FfNC0xLTEtMS0w_1effd47a-d969-49a8-a40b-ddd480a703e9">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Wine Business Strategic Reset</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolving adult consumer preferences have posed strategic challenges for Ste. Michelle, which has seen slowing growth in the wine category and increased inventory levels in recent periods.  Against a backdrop of product volume demand uncertainty and long-term non-cancelable grape purchase commitments, which have been further negatively impacted by government actions which restrict direct-to-consumer sales and on-premise sales and economic uncertainty surrounding the COVID-19 pandemic, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i8d2f8515b39d4303a378ba3f310e009e" continuedAt="ia6f3060851474e0dba837d5a413be492"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ste. Michelle experienced additional increases in inventory levels that at March 31, 2020 significantly exceeded long-term forecasted demand. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine and three months ended September 30, 2020, Ste. Michelle recorded pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="ia7474f88612244c1b64f1822399d6fb5_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMTg5Mw_217782bf-33cb-47ee-9f23-6f72946f8844">395</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib0d8a29fd04b4af1b5328f9a73ce53e9_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMTkwMA_d5e97ea1-8b11-4e30-9c00-779784d11acd">1</ix:nonFraction> million, respectively, which were included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings.  The charges consisted primarily of the following: (i) write-off of inventory ($<ix:nonFraction unitRef="usd" contextRef="i75b30cbed6b345b390d2b06e4121969e_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMjA4Mg_3f26ab7f-0f67-41bc-9af3-3a2131f6300e">292</ix:nonFraction> million recorded in the first quarter of 2020) as Ste. Michelle no longer believes that the benefit of the blending and production plans for its inventory outweighs inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believes no longer have a future economic benefit ($<ix:nonFraction unitRef="usd" contextRef="iddfa3fe8e4ab41d696ebeee595b37982_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMjQ1MQ_a1e797ef-1942-46b8-b4e8-705691071968">100</ix:nonFraction> million recorded in the first quarter of 2020).  The non-cancelable grape purchase commitments will continue to require cash payments as grape commitments are fulfilled over the next <ix:nonNumeric contextRef="i41086d5eceba4b10be60ded534b538d4_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:LongtermPurchaseCommitmentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMjcyNw_cfbb40e4-0026-4adc-85e6-1d6e48f4b41c">five years</ix:nonNumeric>.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given such uncertainty in economic conditions and product volume demand, as well as long-term supply-side contractual challenges, Altria and Ste. Michelle undertook a review of the wine business.  As a result, Altria and Ste. Michelle implemented a strategic reset in order to maximize Ste. Michelle&#8217;s profitability and achieve improved long-term cash-flow generation.  This strategic reset includes: (i) an updated approach to forecasting demand; (ii) supply chain optimization; (iii) SKU rationalization to reduce the number of products and eliminate underperforming brands; and (iv) streamlining operations by reducing future capital expenditures, working capital requirements and ongoing operating costs. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia6f3060851474e0dba837d5a413be492">Ste. Michelle expects to record charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i45fce82014e048088ddb663834e5b226_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMzUxMw_a13d7622-fb1c-4412-868e-a5822e6564c0">20</ix:nonFraction> million in 2020, consisting of inventory disposal costs and other charges.</ix:continuation> </span></div><div id="i85986654d18d42b3b8b96449288f0b8f_61"></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_64"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 4. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfODc5NjA5MzAyODQxNA_4d4f15b6-1412-450c-a80b-1c2b1a1a20ec" continuedAt="i2b81c2a614ad412381ecdf0833d48ef8" escape="true">Investments in Equity Securities:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2b81c2a614ad412381ecdf0833d48ef8" continuedAt="iaf37d28f5e9e405bab4fb659fd8c9350"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:InvestmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNTI0OA_21a633d7-5680-45c2-b620-c7775852a59b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s investments consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.885%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfMy0yLTEtMS0w_ae34113a-c1ba-422b-b857-e507cb27b605">16,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9f46db82b544bca919d37b619fa3c6_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfMy00LTEtMS0w_cbf2443a-bf87-474d-935d-54dfe0f5b133">18,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNC0yLTEtMS0w_cd84a6ea-a958-4396-a7cb-08675d15877a">1,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfc10374e49f4210b26d83818840cffa_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNC00LTEtMS0w_1bf464ad-008d-4812-9a79-929d36189b77">4,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNS0yLTEtMS0w_37f490da-4b0b-4bf9-8b43-14a52dfb3bb6">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c602bc808fd43b3aa8af711c461d8bb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNS00LTEtMS0w_73a08134-2297-4ed1-998b-ab7a8b362b4e">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNi0yLTEtMS0w_981b2675-2ec0-40f4-b7ac-41328a8acf73">19,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNi00LTEtMS0w_f249c7de-f122-455a-83e3-0400d114f28d">23,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> September 30, 2020 includes Altria&#8217;s equity method investment in Cronos ($<ix:nonFraction unitRef="usd" contextRef="ia5ab87ccfd644d7bbd87a7f9d985ce3a_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNjIy_ad58066c-fdc0-4390-a07c-ba8c69cd4a61">986</ix:nonFraction> million), the Cronos warrant ($<ix:nonFraction unitRef="usd" contextRef="ie3301a69f1fc4456bc6cd43d61e2358b_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNjQ3_2d245a58-c50e-4604-85a1-8e68d3306aac">86</ix:nonFraction> million) and the Fixed-price Preemptive Rights ($<ix:nonFraction unitRef="usd" contextRef="i3a07225f603b469a9e16277e68062cf2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNjkw_732e12cf-9a3a-423f-bf60-61e7ffe7fd49">15</ix:nonFraction> million) and December 31, 2019 includes Altria&#8217;s equity method investment in Cronos ($<ix:nonFraction unitRef="usd" contextRef="i4baac6d362ff43e1a624d2ca9bd47b9a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNzcw_be780405-4f00-49c3-868f-90727b96c03a">1,002</ix:nonFraction> million), the Cronos warrant ($<ix:nonFraction unitRef="usd" contextRef="i94d483982eca44108fadfd7036741d3f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNzk1_37f97c6a-b8ce-4d07-85d0-79a0b94c7dd0">234</ix:nonFraction> million) and the Fixed -price Preemptive Rights ($<ix:nonFraction unitRef="usd" contextRef="ia87b4f2ccfa44ef480a0166d44944b46_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfODM5_be8b831f-0060-465e-80ee-4b457b9e5e31">69</ix:nonFraction> million), as discussed further below.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNTI1Mw_52e2e6d7-2f8b-4c62-9e83-d9af819048ab" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (losses) from equity investments accounted for under the equity method of accounting consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:47.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.504%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44203766c22e443f90913f61f95be1a8_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfMy0yLTEtMS0w_87a992aa-c0e1-4d15-923e-460af32bc085">306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c3480e95d1469da93a1e2056153e63_D20190101-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfMy00LTEtMS0w_59616e2e-9337-4abb-82d4-6eab871bd45e">640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib911f814538a479eb5056f3c19bfd6c3_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfMy02LTEtMS0w_65f8b769-0ac3-45b1-9f87-524c6fae5f47">418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie496e5bcf31f4c2a9d472e2beb032d40_D20190701-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfMy04LTEtMS0w_d606fd70-429d-4380-a25d-56793c744350">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if013f6bbc85345f1930ed240ff09ccf9_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNC0yLTEtMS0w_f841deb5-b571-453a-bb02-663c77a1da9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64cdb3928d7c4bc89feb76f18d5b07e5_D20190101-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNC00LTEtMS0w_a618794f-abfe-4ca5-a2d1-bfa6491415f7">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c252077957546b2880b8ef2724625a6_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNC02LTEtMS0w_dab572b3-a863-48ca-96a3-535b4fc49c80">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f3984a7b55343788f33878623e29f88_D20190701-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNC04LTEtMS0w_3ae33be8-97b5-4d24-a9c6-f43956183502">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNS0yLTEtMS0w_1cbc07d5-826a-4869-8fa4-31ab7052b6d2">306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNS00LTEtMS0w_93695126-cd1f-4ba2-a32f-5590098ff727">866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNS02LTEtMS0w_9e6f3c88-e3ce-4afe-bf31-322b38090534">472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNS04LTEtMS0w_804713f4-1209-4986-aed7-6c1ab27dbd01">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> At September 30, 2020 Altria recorded pre-tax losses associated with its share of ABI&#8217;s completion of the sale of its Australia subsidiary and ABI&#8217;s goodwill impairment charge associated with its Africa businesses.  These amounts include Altria&#8217;s share of amounts recorded by ABI in its second quarter of 2020, as well as additional adjustments related to (i) conversion from international financial reporting standards to United States generally accepted accounting principles, and (ii) adjustments to Altria&#8217;s investment required under the equity method of accounting.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNTI1Ng_5413e16a-9c3b-4318-8aaf-14ef89059224" continuedAt="i45490ac185ac4af181def6b11fbc7d03" escape="true">Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value.  If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="iaf37d28f5e9e405bab4fb659fd8c9350" continuedAt="i6070bace650a46d3bc86a2dcae82c85d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i45490ac185ac4af181def6b11fbc7d03" continuedAt="id5ecd7608ce34597ab6eafe4a0eb6564">Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements.  If this qualitative assessment indicates that Altria&#8217;s investment in JUUL may be impaired, a quantitative assessment is performed.  If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value.  </ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a <ix:nonFraction unitRef="number" contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMTU2OQ_1350fda7-8542-4496-822c-c69a2a16fc27">10.0</ix:nonFraction>% ownership in ABI, consisting of <ix:nonFraction unitRef="shares" contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentNumberofSharesOwnedRestricted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMTYwNA_974d0dc9-c41e-4600-b5fb-4c777990f20d">185</ix:nonFraction> million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and <ix:nonFraction unitRef="shares" contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentNumberofSharesOwnedCommon" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMTY2Mg_e89bb733-628d-44fd-ac82-d0aeba695713">12</ix:nonFraction> million ordinary shares of ABI.  Altria&#8217;s ownership percentage decreased from <ix:nonFraction unitRef="number" contextRef="i8a153648856343c9b0ba005f24161faf_I20200331" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMTczOQ_623ebdbc-dfa1-4b27-97d3-39f3037086d4">10.1</ix:nonFraction>% at March 31, 2020 due to the issuance of additional shares by ABI.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, Altria participates in ABI policy making processes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria reports its share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for Altria to record them in the concurrent period.</span></div><div style="margin-bottom:4pt;text-align:justify"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id5ecd7608ce34597ab6eafe4a0eb6564" continuedAt="i975a027d195c4fad900a04e00050d9c3">The fair value of Altria&#8217;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares.  In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</ix:continuation>  </span></div><div style="padding-right:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity investment in ABI at September&#160;30, 2020 and December&#160;31, 2019 was $<ix:nonFraction unitRef="usd" contextRef="ib0119e1289b840b9a4e48f08e6d51eb4_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzIxMg_2137815d-7e92-4904-a690-9b03d879acbd">10.7</ix:nonFraction> billion (carrying value of $<ix:nonFraction unitRef="usd" contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzIzNA_c93bb390-0ea6-4ecf-a783-5d20b4f90e14">16.7</ix:nonFraction> billion) and $<ix:nonFraction unitRef="usd" contextRef="i90f0e22caf6240a283094f0495f14ec0_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzI0Mg_ecd49b30-9865-4769-b4ed-deb07dc7622d">16.1</ix:nonFraction> billion (carrying value of $<ix:nonFraction unitRef="usd" contextRef="i5c9f46db82b544bca919d37b619fa3c6_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzI2NA_9d90e4ba-2c30-4fc8-afc6-3ec7ab2c0509">18.1</ix:nonFraction> billion), respectively, which was less than its carrying value by approximately <ix:nonFraction unitRef="number" contextRef="i44203766c22e443f90913f61f95be1a8_D20200101-20200930" decimals="2" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzMzOQ_f4b5f0e7-362c-4231-8a2d-c74b6b238176">36</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i581024f3ed014433a29610e67306704e_D20190101-20191231" decimals="2" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzM0Ng_70a33d34-6df8-4eab-a3f3-6aaadee47ca4">11</ix:nonFraction>%, respectively.  In October 2019, the fair value of Altria&#8217;s equity investment in ABI declined below its carrying value and has not recovered.  Altria has evaluated the factors related to the fair value decline, including the recent impact on the fair value of ABI&#8217;s shares amidst the COVID-19 pandemic.  The economic uncertainties of the COVID-19 pandemic have also impacted ABI&#8217;s business.  Altria has evaluated the duration and magnitude of the fair value decline at September 30, 2020, ABI&#8217;s financial condition and near-term prospects, and Altria&#8217;s intent and ability to hold its investment in ABI until recovery.  Altria concluded, both at September 30, 2020 and December 31, 2019, that the decline in fair value of its investment in ABI below its carrying value was temporary and, therefore, <ix:nonFraction unitRef="usd" contextRef="i581024f3ed014433a29610e67306704e_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquityMethodInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNDM5MQ_597329d0-0401-45d5-9745-d4deac7590e6"><ix:nonFraction unitRef="usd" contextRef="i44203766c22e443f90913f61f95be1a8_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquityMethodInvestmentImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNDM5MQ_be9ad233-18e4-4396-b901-8cc66980d6d3">no</ix:nonFraction></ix:nonFraction> impairment was recorded.</span></div></ix:continuation><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_70"></div><ix:continuation id="i6070bace650a46d3bc86a2dcae82c85d" continuedAt="i83a1ee8b1c6e425683f47c95a94f7c19"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, Altria made a minority investment in JUUL for $<ix:nonFraction unitRef="usd" contextRef="id6aea41f4cd944cbb4018c25bf22065f_D20181201-20181231" decimals="-8" format="ixt:numdotdecimal" name="mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfODk_042a49a5-b5a7-4514-aab9-de548a44959e">12.8</ix:nonFraction> billion.  In exchange for the investment, Altria received a <ix:nonFraction unitRef="number" contextRef="icfc10374e49f4210b26d83818840cffa_I20191231" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTQ0_624efe59-6ce8-4318-b7c2-1a427a40974d"><ix:nonFraction unitRef="number" contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTQ0_ae24a49a-a4a5-4252-aeed-2ee6ebae2a90">35</ix:nonFraction></ix:nonFraction>% economic interest in JUUL through non-voting shares, which are convertible at Altria&#8217;s election into voting shares (&#8220;Share Conversion&#8221;), and for no additional payment, a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#8220;JUUL Transaction&#8221;).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its <ix:nonFraction unitRef="number" contextRef="i0f8ac2e81fbf415d96b01883453526d6_I20181231" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfOTI5_c5d6a5a1-69d9-44d1-a4bf-313d5ad13599">35</ix:nonFraction>% interest.  Furthermore, Altria agreed not to sell or transfer any of its JUUL shares until December 20, 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 28, 2020, Altria and JUUL amended certain JUUL Transaction agreements and entered into a new cooperation agreement, which included the following provisions:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Altria will continue to provide regulatory affairs support for JUUL&#8217;s pursuit of its pre-market tobacco applications (&#8220;PMTA&#8221;) and/or its modified risk tobacco products authorization (&#8220;MRTP&#8221;) and discontinued all other services as of March 31, 2020;</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Altria will have the option to be released from its non-compete obligation (i) in the event JUUL is prohibited by federal law from selling e-vapor products in the U.S. for a continuous period of at least <ix:nonNumeric contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128" format="ixt-sec:durmonth" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTY2Mg_97f57bb6-f81b-4031-a61e-462be30684fc">12</ix:nonNumeric> months (subject to tolling of this period in certain circumstances) or (ii) if the carrying value of Altria&#8217;s investment in JUUL is not more than <ix:nonFraction unitRef="number" contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTgwNA_bcdf61cb-52f3-4be2-a0ed-d480dfa9032c">10</ix:nonFraction>% of its initial carrying value of $<ix:nonFraction unitRef="usd" contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128" decimals="-8" format="ixt:numdotdecimal" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTg0MA_f4de12e6-ac3b-4a13-9a95-e0b01f8b5cff">12.8</ix:nonFraction> billion;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i83a1ee8b1c6e425683f47c95a94f7c19" continuedAt="i5fcc2d7bbe1a40359375bb8253b37915"><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Altria and JUUL agreed that for a period of <ix:nonNumeric contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128" format="ixt-sec:durwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTg4OA_51d5d509-e900-4278-8cb2-43d732011b7c">one year</ix:nonNumeric> they will not pursue any litigation against each other in connection with any conduct that occurred prior to the date of such cooperation agreement, with statutes of limitation being tolled during the one-year period; </span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">with respect to certain litigation in which Altria and JUUL are both defendants against third-party plaintiffs, Altria will not pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against Altria and JUUL; and</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">in the event of Share Conversion, JUUL will:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restructure JUUL&#8217;s current <ix:nonFraction unitRef="director" contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjQ5OQ_8f3a580c-f264-456e-84f5-f3678071a1d5">seven</ix:nonFraction>-member board of directors to a <ix:nonFraction unitRef="director" contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjUzMw_01753f9e-f3a8-43c4-917f-10a30f07fdf7">nine</ix:nonFraction>-member board that will include independent board members.  The new structure will include: (i) <ix:nonFraction unitRef="director" contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjYzMQ_76725bc4-6f6b-4370-a951-c4083ae9fb53">three</ix:nonFraction> independent directors (<ix:nonFraction unitRef="director" contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjY1Nw_54825eed-832f-4c6a-a28c-052ffbc7d94d">one</ix:nonFraction> of whom will be designated by Altria and <ix:nonFraction unitRef="director" contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjcwMQ_10e75a5f-69b3-4c1b-8c92-f35d3d02362d">two</ix:nonFraction> of whom will be designated by JUUL stockholders other than Altria) unanimously certified as independent by a nominating committee, which will include at least <ix:nonFraction unitRef="director" contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjg2Mw_75614e2c-cb14-49d1-9ecc-eee5d98df24a">one</ix:nonFraction> Altria designee, (ii) <ix:nonFraction unitRef="director" contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjg4OA_c6ca1373-de67-4693-acf9-ab9fde33ae38">two</ix:nonFraction> directors designated by Altria, (iii) <ix:nonFraction unitRef="director" contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjkyOQ_ff0fc084-2d21-4419-a1bc-31bf01f7e0f0">three</ix:nonFraction> directors designated by JUUL stockholders other than Altria, and (iv) the JUUL Chief Executive Officer; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">create a Litigation Oversight Committee, which will include <ix:nonFraction unitRef="director" contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMzEwMA_f726765e-fb39-4c50-b293-80908ca506b7">two</ix:nonFraction> Altria designated directors (<ix:nonFraction unitRef="director" contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMzEzMg_4f9e8361-5bd1-4c41-bb70-7eec26b0471e">one</ix:nonFraction> of whom will chair the Litigation Oversight Committee) that will have oversight authority and review of litigation management for matters in which JUUL and Altria are co-defendants and have or reasonably could have a written joint defense agreement in effect between them.  Subject to certain limitations, the Litigation Oversight Committee will recommend to JUUL changes to outside counsel and litigation strategy by majority vote, with disagreements by JUUL&#8217;s management being resolved by majority vote of JUUL&#8217;s board of directors.</span></div><div style="margin-bottom:5pt;padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the U.S. Federal Trade Commission (&#8220;FTC&#8221;) issued an administrative complaint challenging Altria&#8217;s investment in JUUL.  The FTC has not sought to preliminarily enjoin Altria from converting its non-voting JUUL shares to voting shares.  Altria has not converted its non-voting JUUL shares to voting shares and is considering whether to do so as well as which, if any, of its voting and governance rights to exercise if Altria does elect to effect such conversion.  Altria has until November 30, 2020 to convert its JUUL shares under the regulations of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (&#8220;HSR Act&#8221;), after which Altria would have to re-file for antitrust review with the FTC to again seek the ability to convert.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion on the FTC litigation, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies -&#160; Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of Share Conversion, Altria expects to account for its investment in JUUL under the fair value option.  Under this option, Altria&#8217;s consolidated statement of earnings will include any cash dividends received from its investment in JUUL as well as any changes in the fair value of the investment, which will be calculated quarterly. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and December&#160;31, 2019, Altria had a <ix:nonFraction unitRef="number" contextRef="icfc10374e49f4210b26d83818840cffa_I20191231" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfNDE2Mw_624efe59-6ce8-4318-b7c2-1a427a40974d"><ix:nonFraction unitRef="number" contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfNDE2Mw_ae24a49a-a4a5-4252-aeed-2ee6ebae2a90">35</ix:nonFraction></ix:nonFraction>% economic interest in JUUL.  <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfNjEyNA_f433a6c2-bb49-46af-a685-f4b3dc9f2adb" continuedAt="ie610c99e57084948892e9bf93f1eb00b" escape="true">Altria accounted for its investment in JUUL as an investment in an equity security as of September&#160;30, 2020.  Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There have been <ix:nonFraction unitRef="usd" contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfNDYxMw_dc0850eb-6abc-48ca-acb7-c3f2f153ec8f">no</ix:nonFraction> upward or downward adjustments to the carrying value of Altria&#8217;s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through September 30, 2020.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie610c99e57084948892e9bf93f1eb00b">JUUL announced a strategic update in September 2020, which includes its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of Altria&#8217;s financial statements for the period ended September 30, 2020, Altria performed its qualitative assessment of impairment indicators for its investment in JUUL and determined that JUUL&#8217;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#8217;s business prospects.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the existence of this impairment indicator, Altria performed a quantitative valuation of its investment in JUUL as of September 30, 2020 and recorded a non-cash pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i3a6bc5655b5c4d76b14ec49b161c5464_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODU1Ng_a815b32b-2b63-4847-87d7-40b0fbb2d086">2.6</ix:nonFraction> billion for the nine and three months ended September 30, 2020, reported as impairment of JUUL equity securities in its condensed consolidated statements of earnings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The impairment charge was driven by Altria&#8217;s projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of: (i) JUUL&#8217;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, Altria recorded total non-cash pre-tax impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i5c77db08d832433681380e92e80fbc1c_D20190101-20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODU2Mg_80c1a4f9-7e91-4c68-bfe9-b3e18be5034e">8.6</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i5093f64aaa8d463a86be2d64338151f4_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODU4OQ_4cb530b1-1a56-487c-a13f-efd1afff4858">4.5</ix:nonFraction> billion in the third quarter of 2019 and $<ix:nonFraction unitRef="usd" contextRef="ib2202ef19f99485aaf1594cd36889bcf_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODYwNQ_c4eba859-416b-48af-bb9c-8b44665fb1fe">4.1</ix:nonFraction> billion in the fourth quarter of 2019) related to its investment in JUUL resulting in a $<ix:nonFraction unitRef="usd" contextRef="icfc10374e49f4210b26d83818840cffa_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODYyNw_601c75a8-8abb-4f49-beb6-5369ff353000">4.2</ix:nonFraction> billion carrying value of its investment in JUUL at December 31, 2019.  </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i5fcc2d7bbe1a40359375bb8253b37915" continuedAt="i16371d934fe54eaf8fb96f4bde29cb81"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2019, Altria performed a qualitative assessment for impairment indicators and concluded that impairment indicators existed.  These indicators included significant adverse changes in both the e-vapor regulatory environment and the industry in which JUUL operates.  While there was no single determinative event or factor, Altria considered in totality the following indicators of impairment: the increased likelihood of a United States Food and Drug Administration (&#8220;FDA&#8221;) compliance policy prohibiting the sale of certain flavored e-vapor products in the U.S. market without a pre-market authorization; various e-vapor bans put in place by certain states and cities in the U.S. and in certain international markets, coupled with the increased potential for additional bans in the future; and the impact of heightened adverse publicity, including news reports and public health advisories concerning vaping-related lung injuries and deaths.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its quantitative valuation of its investment in JUUL, the third-quarter 2019 impairment charge was due primarily to lower e-vapor sales volume assumptions in the U.S. and international markets and a delay in achieving operating margin performance as compared to the assumptions at the time of the JUUL Transaction, which resulted in a non-cash pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i5093f64aaa8d463a86be2d64338151f4_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfODc5NjA5MzA1MDMyOA_ba7002b5-bdad-4ee6-b52f-eda4863810df">4.5</ix:nonFraction> billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2019, Altria determined that a significant increase in the number of legal cases pending against JUUL in the fourth quarter of 2019 resulted in an additional indicator of impairment, which included a variety of class action lawsuits and personal injury claims, as well as cases brought by state attorneys general and local governments.  The fourth-quarter impairment charge resulted substantially from increased discount rates applied to future cash flow projections, due to the significant risk created by the increase in the number of legal cases pending against JUUL, which resulted in an additional non-cash pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="ib2202ef19f99485aaf1594cd36889bcf_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfODc5NjA5MzA1MDMyNw_400a0297-dd5d-472e-99b8-1ed76d716cfd">4.1</ix:nonFraction> billion at December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria used an income approach to estimate the fair value of its investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.  Future cash flows were based on a range of scenarios that consider various potential regulatory and market outcomes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the fair value of its investment in JUUL as of September 30, 2020, December 31, 2019 and September 30, 2019, Altria made various judgments, estimates and assumptions, the most significant of which were sales volume, operating margins, discount rates and perpetual growth rates.  Additionally, Altria made significant assumptions regarding the likelihood and extent of various potential regulatory actions and the continued adverse public perception impacting the e-vapor category and specifically JUUL, as well as expectations of competitive dynamics and the future state of the e-vapor category.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_76"></div><ix:continuation id="i16371d934fe54eaf8fb96f4bde29cb81" continuedAt="i1d33ef9dd38643f2ae5229761c8ba46b"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Altria completed its acquisition of:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"><ix:nonFraction unitRef="shares" contextRef="i03dc33411a5749d79909086adf33043e_I20190331" decimals="-5" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentNumberofSharesOwnedCommon" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfODA_09b51d69-b9c5-45fb-992c-3f85876cafa0">149.8</ix:nonFraction> million newly issued common shares of Cronos (&#8220;Acquired Common Shares&#8221;), which represented a <ix:nonFraction unitRef="number" contextRef="i03dc33411a5749d79909086adf33043e_I20190331" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTY4_11446299-a41b-454a-af11-ebad2f500290">45</ix:nonFraction>% economic and voting interest; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain its ownership percentage.  Certain of the anti-dilution protections provide Altria the ability to purchase additional Cronos common shares at a per share exercise price of Canadian dollar (&#8220;CAD&#8221;) $<ix:nonFraction unitRef="cadPerShare" contextRef="ide407e15cf49487193634a2048179491_I20190331" decimals="INF" name="mo:EquityMethodInvestmentPricePerShareIfExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfNTEw_2c3da9bb-f238-4d64-bb0d-5b423360f0b8">16.25</ix:nonFraction> upon the occurrence of specified events (&#8220;Fixed-price Preemptive Rights&#8221;).  Based on Altria&#8217;s assumptions as of September 30, 2020, Altria estimates the Fixed-price  Preemptive Rights allows Altria to purchase up to an additional approximately <ix:nonFraction unitRef="shares" contextRef="i3a07225f603b469a9e16277e68062cf2_I20200930" decimals="-3" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjE5OTAyMzI1OTQ1OQ_a3d86160-7e2f-467b-b0c3-02b60e5222d0">35</ix:nonFraction> million common shares of Cronos; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a warrant providing Altria the ability to purchase up to an additional <ix:nonFraction unitRef="number" contextRef="i3f6eaaca8b0c4eeab6e988d2d5cad4b1_I20190331" decimals="INF" name="mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfODU1_55a13e52-efa7-4392-bd83-1e58471c5611">10</ix:nonFraction>% of common shares of Cronos (approximately  <ix:nonFraction unitRef="shares" contextRef="ie3301a69f1fc4456bc6cd43d61e2358b_I20200930" decimals="-3" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjE5OTAyMzI1OTQ0OA_de7da6af-eb43-48d0-b1ef-0a72b4a6160f">79</ix:nonFraction> million common shares at September 30, 2020) at a per share exercise price of CAD $<ix:nonFraction unitRef="cadPerShare" contextRef="i3f6eaaca8b0c4eeab6e988d2d5cad4b1_I20190331" decimals="INF" name="mo:EquityMethodInvestmentPricePerShareIfExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfOTcz_4366efbf-4513-4180-a197-668493b53773">19.00</ix:nonFraction>, which expires on March 8, 2023.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price for the Acquired Common Shares, Fixed-price Preemptive Rights and warrant (collectively, &#8220;Investment in Cronos&#8221;) was CAD $<ix:nonFraction unitRef="cad" contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331" decimals="-8" format="ixt:numdotdecimal" name="mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTE1NQ_d907b072-9542-432e-b13a-95f4043a954e">2.4</ix:nonFraction> billion (U.S. dollar (&#8220;USD&#8221;) $<ix:nonFraction unitRef="usd" contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331" decimals="-8" format="ixt:numdotdecimal" name="mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTE3OQ_651eda54-87eb-45c3-99e5-9454175a5ab7">1.8</ix:nonFraction> billion).  Upon full exercise of the Fixed-price Preemptive Rights, to the extent such rights become available, and the warrant, Altria would own a maximum of <ix:nonFraction unitRef="number" contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331" decimals="INF" name="mo:EquityMethodInvestmentWarrantExercisedOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTMzMw_989ec378-1ab8-4f07-bb62-9d2764103748">55</ix:nonFraction>% of the outstanding common shares of Cronos. </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for the acquisition of these assets as of the date of closing, the Fixed-price Preemptive Rights and warrant were recorded at each of their fair values using Black-Scholes option-pricing models, based on the assumptions described in Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In addition, a deferred tax liability related to the Fixed-price Preemptive Rights and warrant was </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i1d33ef9dd38643f2ae5229761c8ba46b" continuedAt="ifa1b923962a84756969a200e1c19ae6f"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded.  The residual of the purchase price was allocated to the Acquired Common Shares.  Accordingly, the CAD $<ix:nonFraction unitRef="cad" contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331" decimals="-8" format="ixt:numdotdecimal" name="mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTg2OA_722e405f-5627-4313-a5ce-028ea0a85ca5">2.4</ix:nonFraction> billion (USD $<ix:nonFraction unitRef="usd" contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331" decimals="-8" format="ixt:numdotdecimal" name="mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTg3Ng_88a0840e-d006-45a9-b34d-46c09aefbe41">1.8</ix:nonFraction> billion) purchase price was recorded in USD as follows:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="i789ffb64479c427c97456e2372a5a744_D20190301-20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:PaymentsForDerivativeInstrumentInvestingActivities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTkyOA_4287b7c7-2126-42cc-b27a-5ac54fc33e9a">1.2</ix:nonFraction> billion to the warrant;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="i79d16ce41a6d4fb6a123927ea6298fb9_D20190301-20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:PaymentsForDerivativeInstrumentInvestingActivities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTk0Nw_f25fd6cc-6aed-4bd8-8d09-606221df5aaf">0.5</ix:nonFraction> billion to the Fixed-price Preemptive Rights; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTk4OQ_441e272c-46e1-4678-9cc2-a5d7fdce5e98">0.4</ix:nonFraction> billion to the Acquired Common Shares; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="i03dc33411a5749d79909086adf33043e_I20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjAyOA_34f50c90-a331-4466-b26f-881ede806467">0.3</ix:nonFraction> billion to a deferred tax liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $<ix:nonFraction unitRef="cad" contextRef="i60560d0e627c422e839a25225ee19787_D20200101-20200930" decimals="-8" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentAggregateExercisePrice" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjE3Ng_a25e0681-4742-4991-9554-5805faaa8308">1.5</ix:nonFraction> billion and CAD $<ix:nonFraction unitRef="cad" contextRef="i914d4a901ff34993a138eacf6ee3171c_D20200101-20200930" decimals="-8" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentAggregateExercisePrice" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjE4Nw_bd5bc8f0-f7c6-4231-b2d3-cb7e23672a54">0.6</ix:nonFraction> billion (approximately USD $<ix:nonFraction unitRef="usd" contextRef="ie295981559fa47e9a12e6456173c067f_D20201027-20201027" decimals="-8" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentAggregateExercisePrice" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjIwOQ_dca58a76-442d-485a-a0cd-e579c72b04f1">1.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ieede284c3acf473cad8c0420cae67a03_D20201027-20201027" decimals="-8" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentAggregateExercisePrice" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjIxNg_ac0ee6a8-a91d-4831-9b2c-6dce457925f3">0.4</ix:nonFraction> billion, respectively, based on the CAD to USD exchange rate on October 27, 2020). </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of derivatives related to Altria&#8217;s investment in Cronos, including Altria&#8217;s accounting for changes in the fair value of these derivatives, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a <ix:nonFraction unitRef="number" contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjQ5OQ_dffbad4c-bf74-454b-af91-008bab9ac1ea">44</ix:nonFraction>% ownership in Cronos, consisting of <ix:nonFraction unitRef="shares" contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930" decimals="-5" format="ixt:numdotdecimal" name="mo:EquityMethodInvestmentNumberofSharesOwnedCommon" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTU5NDI5MTg2MDY4MTU_771156b0-5a64-44d5-bc2c-c23bd7dddd17">156.6</ix:nonFraction>&#160;million shares, which Altria accounts for under the equity method of accounting.  Altria&#8217;s ownership percentage decreased from <ix:nonFraction unitRef="number" contextRef="i23418c15a4834d4882c474b871c10616_I20200630" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTUzOTMxNjI3OTMwODU_d08d87e4-ebf5-4241-9b23-bbdaa1b34626">45</ix:nonFraction>% at June 30, 2020 due to the issuance of additional shares by Cronos.  Altria reports its share of Cronos&#8217;s results using a one-quarter lag because Cronos&#8217;s results are not available in time for Altria to record them in the concurrent period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria nominated <ix:nonFraction unitRef="director" contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mo:NumberofDirectorsNominated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjc4MA_105700a1-1455-4481-8566-10956c9dc75a">four</ix:nonFraction> directors, including <ix:nonFraction unitRef="director" contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mo:EquityMethodInvestmentNumberofIndependentDirectorsNominated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjgwNA_a297e73e-effd-4db0-a128-2cea971f6cd1">one</ix:nonFraction> director who is independent from Altria, who serve on Cronos&#8217;s <ix:nonFraction unitRef="board_member" contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mo:NumberofMembersOntheBoardofDirectors" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjg3MA_30db830f-f3ea-48e6-9a51-326f7af1ad40">seven</ix:nonFraction>-member board of directors.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifa1b923962a84756969a200e1c19ae6f"><ix:continuation id="i975a027d195c4fad900a04e00050d9c3">The fair value of Altria&#8217;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.</ix:continuation>  The fair value of Altria&#8217;s equity method investment in Cronos at September&#160;30, 2020 and December&#160;31, 2019 was $<ix:nonFraction unitRef="usd" contextRef="i2ab928952e6f4199a2156a1db1c2ae25_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMzE4NA_9fe14d61-cea3-4772-9d14-8043fb231858">0.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="iff5dff53efdd45618f3b407706808ee9_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMzE5MQ_cd180e55-ba37-4701-b31b-0643791b2a70">1.2</ix:nonFraction> billion, respectively, compared with its carrying value of $<ix:nonFraction unitRef="usd" contextRef="i4baac6d362ff43e1a624d2ca9bd47b9a_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTY0OTI2NzQ0MjA2MDg_144a1f52-67df-4639-9934-8384a9f4e313"><ix:nonFraction unitRef="usd" contextRef="ia5ab87ccfd644d7bbd87a7f9d985ce3a_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTY0OTI2NzQ0MjA2MDg_32a89ccb-a2a6-4c6f-bca4-db433d5286ff">1.0</ix:nonFraction></ix:nonFraction> billion at September&#160;30, 2020 and December&#160;31, 2019.  At September&#160;30, 2020, the fair value of Altria&#8217;s equity method investment in Cronos was less than its carrying value by approximately <ix:nonFraction unitRef="number" contextRef="if013f6bbc85345f1930ed240ff09ccf9_D20200101-20200930" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTY0OTI2NzQ0MjA2Mjg_d4a62b17-2436-4cbb-af88-47aa61c20ff6">20</ix:nonFraction>%.  Based on Altria&#8217;s evaluation of the duration and magnitude of the fair value decline, Altria&#8217;s evaluation of Cronos&#8217;s financial condition (including its strong cash position) and near-term prospects and Altria&#8217;s intent and ability to hold its investment in Cronos until recovery, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, <ix:nonFraction unitRef="usd" contextRef="i0926d28c94bd4f0688d1cd87daf48de9_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMzgxMQ_267eeb2e-4e0f-4601-ac3e-7dc6e62cd779">no</ix:nonFraction> impairment was recorded.</ix:continuation> </span></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_82"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 5. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNjk4NA_f17eaae5-1eda-443b-b654-55f12d37277a" continuedAt="i3c5c0b0469ce4b0eb646b8823fea378e" escape="true">Financial Instruments:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3c5c0b0469ce4b0eb646b8823fea378e" continuedAt="id4b3729a9fa3470099fa5be9fbba7735"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria enters into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  Altria uses various types of derivative financial instruments, including forward contracts, options and swaps.  Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s investment in ABI, whose functional currency is the Euro, exposes Altria to foreign currency exchange risk on the carrying value of its investment.  To manage this risk, Altria designates certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#8220;foreign currency contracts&#8221;), and Euro denominated unsecured long-term notes (&#8220;foreign currency denominated debt&#8221;) as net investment hedges of Altria&#8217;s investment in ABI.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 and December&#160;31, 2019, Altria had foreign currency contracts with aggregate notional amounts of $<ix:nonFraction unitRef="usd" contextRef="if543b4ab8bbb4e4cb31ce281dfc2c883_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfOTgx_877ab7e9-0589-4507-a806-933230fbfe98">1,402</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i482f5b595eb642e1acc2d81bfa6d836f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfOTg4_9b8a02f2-8609-42de-80cf-e331532c5de3">2,246</ix:nonFraction> million, respectively.  At September&#160;30, 2020, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $<ix:nonFraction unitRef="usd" contextRef="if8c6262959ff4200998c8e9eaf5d9144_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTExMA_3cc12614-571e-4f61-aa7d-4274fab463de">5,368</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8c6262959ff4200998c8e9eaf5d9144_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTExNw_7200a847-9c36-4dbe-84a3-8b9cf4a31f07">4,960</ix:nonFraction> million, respectively.  At December&#160;31, 2019, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $<ix:nonFraction unitRef="usd" contextRef="i19091e36268a46e3b8306ee404fba8a2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTIzOQ_67764d75-849a-4427-b16b-d3bd09fa581f">5,057</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i19091e36268a46e3b8306ee404fba8a2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTI0Ng_6b2daafb-9609-434b-a9c3-422ca69938ed">4,741</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s estimates of the fair values of its foreign currency contracts are determined using valuation models with significant inputs that are readily available in public markets, or can be derived from observable market transactions, and therefore are classified in Level 2 of the fair value hierarchy.  An adjustment for credit risk and nonperformance risk is included in the fair values of foreign currency contracts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s estimate of the fair value of its total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.  The aggregate fair value of Altria&#8217;s total long-term debt at September&#160;30, 2020 and December&#160;31, 2019 was $<ix:nonFraction unitRef="usd" contextRef="i03cfa027e2c542a89ca61cb7216820a3_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTk3MA_addabe35-3cc9-4677-98f0-b905d72a7fbb">33.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i327669e434c540969eed7f12fc78caa6_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTk3Nw_f7d5c74d-7992-4bbe-b6da-72288177bdcb">30.7</ix:nonFraction> billion, respectively, as compared with its carrying value of $<ix:nonFraction unitRef="usd" contextRef="i2f17aceb05f84391bfff69ba804a2d18_I20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMjAzNA_55f3299a-782d-4ad9-b4f6-42d272709d14">29.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i762330360e39458f831a1f465d0c4616_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMjA0MQ_f450af3f-65ba-4a78-abb5-992197759f3f">28.0</ix:nonFraction> billion, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="id4b3729a9fa3470099fa5be9fbba7735" continuedAt="id509f8b27dc9492397ca9b394c349c93"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fixed-price Preemptive Rights and Cronos warrant, which are further discussed in Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are derivative financial instruments, which are required to be recorded at fair value.  <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNzAwNQ_7554fb25-21ed-41a7-8523-222fe8b95232" continuedAt="i5797f7253db045eb9ae569d964fa128c" escape="true">The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:</ix:nonNumeric></span></div><ix:continuation id="i5797f7253db045eb9ae569d964fa128c"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.571%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Warrant</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="number" contextRef="i780f2a71201c4ff3bd694ea104911a0e_I20200930" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMi0yLTEtMS0w_9c007e8a-a7ef-4c1a-bd5f-d65464c46df9">6.69</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="number" contextRef="ia8c7c188084b42a8ae2031212a1d2288_I20191231" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMi00LTEtMS0w_6a2f18c3-8791-4a79-adf0-3685153eed59">9.97</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="number" contextRef="id11a81bbc4f84fc78fa4cbe8a44fdf78_I20200930" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMi02LTEtMS0w_dc032b92-1842-4204-af90-dcadf34455e7">6.69</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="number" contextRef="i0a8e1bf900f64f8b92b366a2c2d76fd1_I20191231" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMi04LTEtMS0w_cbd73833-4df8-4b42-94ee-0f31a96c0941">9.97</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="i6cf3b63a008b40428ca6039b7d9a5c4b_I20200930" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMy0yLTEtMS0w_2f0bb635-29d2-48eb-8d64-2a43e8c0606d">1.18</ix:nonFraction> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="ia2c14274a4d64108b882de55d4502603_I20191231" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMy00LTEtMS0w_6fe3512e-eb90-4a4e-b6e8-943ba08be23d">1.67</ix:nonFraction> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="ic93a49eda1a94589ac79dd8b3c1b3e97_I20200930" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMy02LTEtMS0w_18bc9a2f-e2a0-44c9-be84-dda3168c20ce">2.43</ix:nonFraction> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="i626546e4b3ef4715b47df81b5bb8b7b1_I20191231" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMy04LTEtMS0w_249548d3-290e-4780-b229-fb8414b9187a">3.18</ix:nonFraction> years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i429277c86fbe4b21bc95bdd8fbf00861_I20200930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNC0yLTEtMS0w_bdc3f217-cdda-491b-8bf0-4ba2f38417d1">80.68</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc73a7084aef4a0b8ed318ebd0e7d738_I20191231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNC00LTEtMS0w_f3f56300-1879-429b-b4eb-127f64b797bf">81.61</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a183827598f443697de775b3cf99058_I20200930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNC02LTEtMS0w_81785ac1-3508-4341-8d89-308ab6e41b9e">80.68</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic366f1f1f531476a8cd247a911c006fc_I20191231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNC04LTEtMS0w_793ba327-3ee6-43a9-8278-865df3b10c90">81.61</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34064c893e694b50b8144376830b31e3_I20200930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNS0yLTEtMS0w_b3262313-98fa-481e-94aa-70a0b3f7e64d">0.20</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7227fbea894a4ca2b29fd716f8fd79a6_I20191231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNS00LTEtMS0w_1406f441-024e-488e-8b6b-b3b44b2b0409">1.71</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f2e75b2f0094022af0e857ba9c1a24a_I20200930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNS02LTEtMS0w_f29e11a2-1983-4d8a-a3d9-6153ec836e00">0.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fc7d0eb19de480baea8a1af985038d5_I20191231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNS04LTEtMS0w_936e85c1-0f92-464c-8078-03b5934a1b25">1.69</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieb03a2d5afcb4c62b621f8167bf67e8e_I20200930" decimals="2" format="ixt:zerodash" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNi0yLTEtMS0w_5cf5b0c0-a61f-4f37-8d74-d546d91bc672">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8781d7757594520903cdddf6282cbf8_I20191231" decimals="2" format="ixt:zerodash" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNi00LTEtMS0w_ab057994-b33f-4a9f-ba77-ff57387cf003">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i086ec560279e4dfaa1563b87dbdbba88_I20200930" decimals="2" format="ixt:zerodash" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNi02LTEtMS0w_88096c05-6b05-40e2-ba97-c58494a2be1a">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8990ee747e90489e8c4c40c9dd340a9e_I20191231" decimals="2" format="ixt:zerodash" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNi04LTEtMS0w_5c7beac9-b7f4-4f53-b77c-7d8a2f848489">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately <ix:nonFraction unitRef="year" contextRef="i35e343023746419a9425bb816ac2a8e8_I20200930" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzAyMQ_1f45d96a-255a-4d5f-9c23-dc1be21fd8b2">0.25</ix:nonFraction> year to <ix:nonFraction unitRef="year" contextRef="i42e4e208cef648d2a2e36df3b10bfc74_I20200930" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzAzMg_0d450695-1506-4f83-bdbb-6e32f7cee330">5.25</ix:nonFraction> years at September 30, 2020 and <ix:nonFraction unitRef="year" contextRef="i6ecca4f968bc4f8daed7042afbac66f7_I20191231" decimals="2" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzUxODQzNzIwOTU5OTc_20b3f0d9-166c-4dbd-8643-971b1f036ad8">0.25</ix:nonFraction> year to <ix:nonFraction unitRef="year" contextRef="i31465b7042ac470797adf3cc3f8f4b1f_I20191231" decimals="1" name="us-gaap:DerivativeAssetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzUxODQzNzIwOTYwMDk_ba062f0b-0685-4a0e-a195-9e53f177a43c">6</ix:nonFraction> years at December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately <ix:nonFraction unitRef="year" contextRef="i519edb627c4f47b197d3fd3fb078bb6d_I20200930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzM3Mw_ca089004-5ffb-4def-8818-42c0c4f27e31">0.12</ix:nonFraction>% to <ix:nonFraction unitRef="year" contextRef="i932dd517d7a44c81ba630d3f06428863_I20200930" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzM3OQ_798ad78f-de76-4be3-92b4-092c31cd1c5b">0.36</ix:nonFraction>% at September 30, 2020 and <ix:nonFraction unitRef="year" contextRef="i4c04c699c1c74515acd46e2303002b0b_I20191231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzQwMw_622feb4c-b516-4d82-88b9-23347752c49a">1.66</ix:nonFraction>% to <ix:nonFraction unitRef="year" contextRef="i85c2ed22b70546a9afeb76348ddc2b55_I20191231" decimals="4" name="us-gaap:DerivativeAssetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzQwOQ_71c3bf8b-f973-4f8e-99dc-1e82494f52d1">1.74</ix:nonFraction>% at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6) Based on Cronos&#8217;s expected dividend payments.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNjk5MA_cc40d854-91d9-448d-976a-13bed3978edc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.861%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3969c366e174823ba5e447d4d1d11fa_I20191231" decimals="-6" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjA2ODY3NjllOWJiMTRjYjNiZWNlYjUxMDVlMWM3YTJhL3RhYmxlcmFuZ2U6MDY4Njc2OWU5YmIxNGNiM2JlY2ViNTEwNWUxYzdhMmFfMS0yLTEtMS0w_8d869f85-ace4-4aca-bd89-3d002acdb3d0">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax earnings (losses) recognized in net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic79ee6d1277340d2a65bf968adbff27f_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjA2ODY3NjllOWJiMTRjYjNiZWNlYjUxMDVlMWM3YTJhL3RhYmxlcmFuZ2U6MDY4Njc2OWU5YmIxNGNiM2JlY2ViNTEwNWUxYzdhMmFfMy0yLTEtMS0w_76cc63fd-4892-4a10-859b-83c209ff4393">202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3023df6730344ca3962ddfd40ecab100_I20200930" decimals="-6" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjA2ODY3NjllOWJiMTRjYjNiZWNlYjUxMDVlMWM3YTJhL3RhYmxlcmFuZ2U6MDY4Njc2OWU5YmIxNGNiM2JlY2ViNTEwNWUxYzdhMmFfNC0yLTEtMS0w_97f39f01-8ee0-4f26-bf1b-b79e5bdd63d6">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria elects to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on its condensed consolidated balance sheets.  <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNjk5Mw_6ca3f769-7ad7-483e-9859-1e4a6e0fef81" continuedAt="i4ca5e1534f354bb5b1a47f715f978969" escape="true">The fair values of Altria&#8217;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i4ca5e1534f354bb5b1a47f715f978969"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:23.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.034%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair Value of Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></div></td><td colspan="30" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a361f15685848a39cda05ed04452b34_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMy0zLTEtMS0w_7723b86f-b133-44a2-8654-726546f68911">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820ba03288e34f15a3e93d22d715d5cb_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMy01LTEtMS0w_34c5f03d-7706-44c5-8322-72b3aed29b65">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4788092f78a4eb2b15070f6da8c3dea_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMy04LTEtMS0w_7c25ce2e-2634-404e-96b7-b630aa89c309">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbb907af8094973ab26d4b85b6cb2e1_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMy0xMC0xLTEtMA_ecaf899b-b3f2-483c-b6fd-b57096b6b7a6">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i490b0ad606f344d2b124a44527e6c990_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNC0zLTEtMS0w_9a0e5f61-07c9-430a-8970-48faf3353d57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895313ba107a45389016a7bbcfbd9f48_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNC01LTEtMS0w_cb7c9f4d-8cb5-4814-87ab-445fbcac8a5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb9212e88ebc4edd9d9a294e59c26753_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNC04LTEtMS0w_09062aac-fe80-4c22-9cb8-909f10f726e1">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65e91236a75413e94604e3795d0d4c4_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNC0xMC0xLTEtMA_1458fae2-8cb1-4101-ab1a-2178b27d347e">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i156d7b2e0ad84e2c8f2f415b7dcf205c_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNi0zLTEtMS0w_01433f68-eef0-48fa-87ff-720e9527ebaa">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i709075a698fa4b7a895a75a9c6c5d1f4_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNi01LTEtMS0w_bf4d850e-8681-4829-8d7a-b62f6cf06de9">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i156d7b2e0ad84e2c8f2f415b7dcf205c_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNi04LTEtMS0w_d939e6e0-a666-432a-86c2-c19d52cc49b8">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i709075a698fa4b7a895a75a9c6c5d1f4_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNi0xMC0xLTEtMA_2378bf8c-3631-48fb-9eff-1b42d79ecaea">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cronos warrant</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55629557f8fa4801a2be7e0427b33b06_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfOS0zLTEtMS0w_33289f7c-db3b-4191-80a1-3840e15d67c0">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5700c0ced144f8ae5b03950397055c_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfOS01LTEtMS0w_0192ba64-7f90-42ee-89bd-014cf92670e0">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37e31bd7e2634c1dac8c62603a80a737_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTAtMy0xLTEtMA_c93113f4-47b5-4c2c-96ae-e9dbf8c75c87">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04baa8b6c1f845fa8d7e480d95aabb67_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTAtNS0xLTEtMA_d07e7d0a-462a-4f30-b1a5-30972eb601fd">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce59a1fcfb7407fa566d25fc62260e2_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTEtMy0xLTEtMA_cdbcf02d-9b15-4376-bcd4-dcf37b5156c5">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb38fc3f5d2f4e6da207670f4cc54dd2_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTEtNS0xLTEtMA_e9cbf535-ea97-47c7-acea-73c2e344e2b4">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d187570aa2540a88ab160136d28dc72_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTMtMy0xLTEtMA_1486761e-02b7-4084-94c0-40ee6a089b81">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4215578af3347b0b7a3b29a129d6de7_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTMtNS0xLTEtMA_8b9af06c-3934-4bb3-bf97-292ea86a4a17">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d187570aa2540a88ab160136d28dc72_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTMtOC0xLTEtMA_5a806ec8-2768-4046-b462-cbd753800d40">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4215578af3347b0b7a3b29a129d6de7_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTMtMTAtMS0xLTA_b820e1bd-a4ce-4c0f-ae2c-9d05e357146b">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="id509f8b27dc9492397ca9b394c349c93"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria records in its condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.  <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNjk4OA_b0411b5b-f994-4996-b362-c53c914e7f63" continuedAt="ifaa1beaac9bc4de0bc28d896368ca229" escape="true">For the nine and three months ended September&#160;30, 2020 and 2019, Altria recognized pre-tax unrealized gains/(losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ifaa1beaac9bc4de0bc28d896368ca229" continuedAt="i9d5c16b1b1ee4bf4a1e4cfcf119272b6"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f91a436b28422ea64fe38b472a5589_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfMy0xLTEtMS0w_da0cf5a7-b7d8-45ed-97cb-e77fad7f9eb7">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib52d5131c24e46128d6b79389a025d30_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfMy0zLTEtMS0w_d5271dd8-7e52-45d6-a2d6-db37d5f0bd32">400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e3ba701be024d09a42df0979733dce2_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfMy01LTEtMS0w_100024f4-9c3f-4762-a500-705a449863e4">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i742228ca73ae4006a165d270426b66aa_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfMy03LTEtMS0w_c7a2043f-2b0b-4aef-9cad-fc4f8a5a0c13">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe60396dea9d4e139bc5adf4aaef4cbc_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNC0xLTEtMS0w_ce9134fb-2f08-4861-97a0-400b152908a9">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22bd417720914dd1a0bdbd9c0d152323_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNC0zLTEtMS0w_13b9c006-f5c2-476d-ada9-e2273a3fc92d">896</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaad15e2268ac481db81ebc0d57dbb586_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNC01LTEtMS0w_3a86e94e-a74d-4290-b7a8-65afb5e26b96">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief8d5ed5a7444a258532f6236eb7d10d_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNC03LTEtMS0w_1b85b9b2-0133-4e4e-a84d-838df68c3330">448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNS0xLTEtMS0w_69b4102e-c968-4cf0-a694-2800071c4171">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNS0zLTEtMS0w_c6a09fb7-69fe-473e-9ee8-ea7947f23907">1,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNS01LTEtMS0w_3a7261d5-d324-461e-bde4-16a8f83f7639">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNS03LTEtMS0w_fedec2ad-ba2d-42e4-a588-557bf1ec9de1">636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in January and February 2019, Altria entered into derivative financial instruments in the form of forward contracts, which were settled in March 2019, to hedge Altria&#8217;s exposure to CAD to USD foreign currency exchange rate movements, in relation to the CAD $<ix:nonFraction unitRef="cad" contextRef="ie54adf4b4f114073a2bbd31a27d6fbdc_D20190331-20190331" decimals="-8" format="ixt:numdotdecimal" name="mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNDk3Nw_a75fbd11-30ae-408a-ae8b-ee7e55755050">2.4</ix:nonFraction> billion purchase price for the Cronos transaction.  The aggregate notional amounts of the forward contracts were USD $<ix:nonFraction unitRef="usd" contextRef="i69363bfcc8fd412bbdb34aec0878e470_I20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNTA4OQ_8e41bf08-9050-4339-8a63-2e8bfc50cf22">1.8</ix:nonFraction> billion (CAD $<ix:nonFraction unitRef="cad" contextRef="i69363bfcc8fd412bbdb34aec0878e470_I20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNTA5Nw_49bcea4b-8593-47f8-894b-8804b4d0403e">2.4</ix:nonFraction> billion).  The forward contracts did not qualify for hedge accounting; therefore, in the first quarter of 2019, pre-tax losses of USD $<ix:nonFraction unitRef="usd" contextRef="i9da1982838c6484db523839f9172e06b_D20190101-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNTIyNg_a2960963-acfe-4e0f-8a48-58dd922051d5">31</ix:nonFraction> million representing changes in the fair values of the forward contracts were recorded in loss on Cronos-related financial instruments in Altria&#8217;s condensed consolidated statement of earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Counterparties to Altria&#8217;s foreign currency contracts are domestic and international financial institutions.  Altria is exposed to potential losses due to non-performance by these counterparties.  Altria manages its credit risk by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure Altria has with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require Altria to maintain an investment grade credit rating.  In the event Altria&#8217;s credit rating falls below investment grade, counterparties to Altria&#8217;s foreign currency contracts can require Altria to post collateral.  No collateral was received or posted related to derivative assets and liabilities at September&#160;30, 2020 and December&#160;31, 2019. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedging</span></div><div><span><br/></span></div><ix:continuation id="i9d5c16b1b1ee4bf4a1e4cfcf119272b6" continuedAt="ia0f746aaff994b9e9b085a10fac477e3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of Altria&#8217;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:20.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Net Earnings (Losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Net Earnings (Losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="45" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i315cf96c2e2b4f1389be73d9bad6e25d_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0yLTEtMS0w_ad520db6-0921-4170-ac6a-72645cdb15d1">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75648dd74466420b86f28b4ffb6ef292_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC00LTEtMS0w_f17a8e90-be6a-4c72-88b1-b589e448e5dd">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315cf96c2e2b4f1389be73d9bad6e25d_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC02LTEtMS0w_e6e80018-97e7-4247-9985-e9713255ecab">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75648dd74466420b86f28b4ffb6ef292_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC04LTEtMS0w_728bc527-3582-412e-bb34-0ae48a1cbd27">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb694c29f27a46e4a6697f065ee75e35_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0xMC0xLTEtMA_a1bdc566-f4b2-4c7f-8918-4d18325a8e50">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3703b6ae7e7341b18c2d327b431712cc_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0xMi0xLTEtMA_1781db1c-1080-4a53-ad06-f71c1e5236e1">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb694c29f27a46e4a6697f065ee75e35_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0xNC0xLTEtMA_21f70c5c-ad08-4ea5-a358-93b7b04e51c7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3703b6ae7e7341b18c2d327b431712cc_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0xNi0xLTEtMA_b3b9bdd4-874d-44ae-a0ba-1565687d8cd0">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c5bddfe927640169c96483cddb17379_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0yLTEtMS0w_02706222-6fc3-4351-892c-f4578a5b0c1d">215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c9b1d77add44b9be802e5dd01b56c1_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS00LTEtMS0w_33af89e2-dab3-476b-bc86-9f03509da62e">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c5bddfe927640169c96483cddb17379_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS02LTEtMS0w_fe52828c-e45d-4ef5-8e45-b1c9a90b4561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c9b1d77add44b9be802e5dd01b56c1_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS04LTEtMS0w_4f89b179-c768-47db-9995-e4fd51f8d662">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2513d47f23844d9ba0ac7bdcd5c64e15_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0xMC0xLTEtMA_840fbc43-b27e-4e4a-adaa-74a8fc1723ca">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i924ac9b83e4c4f0fb5b946287281a5bc_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0xMi0xLTEtMA_36d80e5c-a380-4dcd-80f8-79f213fb964d">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2513d47f23844d9ba0ac7bdcd5c64e15_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0xNC0xLTEtMA_675fac3a-5659-4e61-bf5b-33337551ec04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i924ac9b83e4c4f0fb5b946287281a5bc_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0xNi0xLTEtMA_9c809fba-dcd4-4538-a8f9-9d45e0362b2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic095b1d9445c4bb79ac2c008e4f6fa83_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0yLTEtMS0w_79d631db-bbc8-44bc-aad5-de88f0291132">243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6858797d755940d5af5d63d4ebd944d0_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi00LTEtMS0w_aea9f528-a46b-44a2-aeef-d424570dc52d">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic095b1d9445c4bb79ac2c008e4f6fa83_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi02LTEtMS0w_c2f8a2b0-d8bf-4f97-8790-a5ea5fe8abfa">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6858797d755940d5af5d63d4ebd944d0_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi04LTEtMS0w_db581505-299d-425e-bb2b-3af806ed2c53">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i182d9ee236a64eff889aab36500df3ed_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0xMC0xLTEtMA_c5a0fa65-116c-46f4-977c-5c3fa5ce8598">272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i351326e926924511b4abbac946829f4c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0xMi0xLTEtMA_7d5c6de5-cc5b-41a8-8506-e818fb563ffb">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i182d9ee236a64eff889aab36500df3ed_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0xNC0xLTEtMA_8aedcc57-dc5c-42cf-a1d9-2adb5f8e22f1">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i351326e926924511b4abbac946829f4c_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0xNi0xLTEtMA_8954626d-388d-4ee0-9224-434a9dd849d3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ia0f746aaff994b9e9b085a10fac477e3">(1) Related to amounts excluded from effectiveness testing.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to USD exchange rate were recognized in accumulated other comprehensive losses related to ABI.  Gains on the foreign currency contracts arising from components excluded from effectiveness testing were recognized in interest and other debt expense, net in the condensed consolidated statements of earnings based on an amortization approach.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 6. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfMTI5MA_835d9c7e-eb7e-4363-9f5b-2c688971b159" continuedAt="i91e5743adcb34513b678768c4c17163a" escape="true">Benefit Plans:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i91e5743adcb34513b678768c4c17163a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of Net Periodic Benefit (Income) Cost</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfMTI3OA_0daba9f9-fa6f-47d9-9c0f-4e1ee124c7b0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit (income) cost consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Postretirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0xLTEtMS0w_77c83c96-7fe0-4752-ab6a-7d1cf6698cab">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0zLTEtMS0w_43a9d2f1-bd88-420e-9b06-6f8e750024ac">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC01LTEtMS0w_84bae343-0240-414c-b386-b7dc7a38905f">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC03LTEtMS0w_6a113346-6683-42f6-aa12-692f3984950c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC05LTEtMS0w_04de6a3b-dc1d-40df-93d1-2e91bac3ca7a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0xMS0xLTEtMA_1554041d-adb7-4211-abb2-83001e976981">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0xMy0xLTEtMA_546811c2-c6ac-44f7-95d0-091847718d06">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0xNS0xLTEtMA_66b71099-4e36-4ee0-9680-c82f6d9db98e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0xLTEtMS0w_43235172-4ec9-462d-8e70-26ca3c6f70f2">188</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0zLTEtMS0w_a8c6e026-3d60-4cae-9e7f-6d802de9d326">229</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS01LTEtMS0w_ada65c57-a81e-4282-85a8-57b48e722861">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS03LTEtMS0w_df914989-9927-4f43-a67a-faabae1f2823">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS05LTEtMS0w_727a6dce-3f8e-43cb-b0f2-5d0239e00de9">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0xMS0xLTEtMA_f096002f-8b2d-458d-a6db-96179579641f">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0xMy0xLTEtMA_e64746a8-547a-4b02-913b-1e97c72e2c83">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0xNS0xLTEtMA_53f03056-634e-4d1c-9ae3-199913489a24">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0xLTEtMS0w_70ca375e-b8ea-4316-b36c-45fdf76c535e">376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0zLTEtMS0w_fc2e7e8a-3388-49d5-af8c-c6c6f76154b3">431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi01LTEtMS0w_012284f5-8180-4044-b2c4-6cb2b2c882d3">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi03LTEtMS0w_111ffd94-9350-4b44-a2f9-ea6d1012024a">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi05LTEtMS0w_ddd5f819-e770-400b-acd5-11bcec6fe2c0">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0xMS0xLTEtMA_77f04eb5-4d25-45b9-83cc-5f344fdb7aba">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0xMy0xLTEtMA_3e533794-a534-4e10-bcc0-6a7b6c893e45">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0xNS0xLTEtMA_2422ad25-b217-49dd-93d7-aec7db42f28c">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0xLTEtMS0w_137906e0-16aa-4c98-a81e-2c8ea8f2aefc">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0zLTEtMS0w_37b0eb1e-cdc3-44cb-86de-fc1e55e0eb8b">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC01LTEtMS0w_5657088f-8328-4177-8430-0341389e8a91">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC03LTEtMS0w_cd69548b-c74c-4274-9dbc-ebb0eb404178">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC05LTEtMS0w_787783fb-bad2-4afa-aadb-1c80b4923655">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0xMS0xLTEtMA_1c82e241-a88d-4aeb-8b53-0e21b3f68b5a">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0xMy0xLTEtMA_fd2207a6-d263-4476-ad82-f88f30da674f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0xNS0xLTEtMA_1505395d-a145-461c-979c-36de49e111dc">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0xLTEtMS0w_cef2360f-c8e1-426f-aa72-02c836e89d65">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0zLTEtMS0w_c3523aa4-3135-44f5-b3fe-fd0e315c518b">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS01LTEtMS0w_a4d8ac43-ea09-4f2e-8e0f-074759a80ba7">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS03LTEtMS0w_e1fe5f0c-09f3-49a3-90f4-2ee14a74c2b6">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS05LTEtMS0w_08bf4f8d-16a2-4738-8052-bc98030648f4">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0xMS0xLTEtMA_61c5f2df-b411-4c97-b068-ada3aaeda4f3">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0xMy0xLTEtMA_6155d876-787d-4204-9592-84d5f4332b00">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0xNS0xLTEtMA_6468ca6c-588a-4b63-8b95-a0354752d46a">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMS0xLTEtMA_dcd04cc6-3009-48df-b996-46e9c34155ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMy0xLTEtMA_bb3d5299-15fc-4aa9-82a5-bbb60a2939fb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtNS0xLTEtMA_985704db-c62e-40ec-86c4-160eb2a76a66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtNy0xLTEtMA_ba4c704e-2098-4a87-a238-bc6050e9b594">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtOS0xLTEtMA_b3c71060-2657-40ae-aaab-d95395950d62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMTEtMS0xLTA_7ff635c0-dae1-40e7-9b43-ea2285fcb22a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMTMtMS0xLTA_cabfe343-e5ef-4fe5-b292-c0b69fd086c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMTUtMS0xLTA_8a9639a5-e736-44ca-ba34-273ad356fa72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit </span></div><div style="padding-left:9pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(income) cost </span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMS0xLTEtMA_8929a806-d2b0-499d-adc8-6f4fd1e447b7">21</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMy0xLTEtMA_26c2cf3c-7d2f-47ae-a0ad-a19091f835e5">20</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtNS0xLTEtMA_8eea666e-b7f3-443e-9873-aea2a092551a">31</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtNy0xLTEtMA_92bac6af-d191-4d70-a0d1-84673e2294e7">44</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtOS0xLTEtMA_064b00c5-7dc0-41f1-b4a1-b489bb88322d">12</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMTEtMS0xLTA_449a124d-4769-4d92-aa07-f051fc756984">9</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMTMtMS0xLTA_85665319-54e7-461e-9583-489a7a566f39">8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMTUtMS0xLTA_a50b7356-320b-4110-824d-088a3666d42f">6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Curtailment costs shown in the table above were related to the cost reduction program announced in December 2018, which was completed in 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations.  Altria made employer contributions of $<ix:nonFraction unitRef="usd" contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfNTgz_cf0dc59e-f87b-41aa-bb8d-c47f5762ab34">16</ix:nonFraction> million to its pension plans during the nine months ended September 30, 2020.  Currently, Altria anticipates making additional employer contributions to its pension plans during the remainder of 2020 of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ie6377dd911ef4b1ab1d8dfb3730af782_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfNzY1_e09a7b52-5484-4772-8be7-aa03fdc18fd0">20</ix:nonFraction> million based on current tax law.  Altria did <ix:nonFraction unitRef="usd" contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfODA2_09194448-a111-4090-a8dc-b491c6960ae4">no</ix:nonFraction>t make any employer contributions to its postretirement plans during the nine months ended September 30, 2020.  Currently, Altria anticipates making employer contributions to its postretirement plans of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i36d2d484cfba4fb6ad475e2cfcf66462_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfOTk3_d952c784-574b-42d0-aad8-fce08a2e23cf">60</ix:nonFraction> million  in 2020.  However, these estimates may be subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on assets, changes in interest rates or other considerations.</span></div></ix:continuation><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_91"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 7. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RleHRyZWdpb246MmVmOTYzYTQ2NTY4NGJhMjlmNTI5YzliNTU3OWRjNWNfMTE2_6eb650f5-2939-446e-b770-b4f1ad941953" continuedAt="i9b7146ba323f45d398f1f7335fcdae43" escape="true">Earnings (Losses) Per Share:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9b7146ba323f45d398f1f7335fcdae43"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RleHRyZWdpb246MmVmOTYzYTQ2NTY4NGJhMjlmNTI5YzliNTU3OWRjNWNfMTI3_503ca56a-663e-4814-a967-c685be8e35ef" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (losses) per share (&#8220;EPS&#8221;) were calculated using the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:47.211%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfMy0yLTEtMS0w_522870bb-9626-41cf-88ab-2ee8bb5330da">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfMy00LTEtMS0w_3d71242e-88e6-4009-abbb-d4bfceb0d2ef">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfMy02LTEtMS0w_e8b84380-064a-4c1f-a1f2-22bc0995f7b2">952</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfMy04LTEtMS0w_0e8f2694-bc0d-4226-86ab-d696f2f30082">2,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNC0yLTEtMS0w_b9058027-969e-4fbf-9287-a9e9c07a52a0">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNC00LTEtMS0w_5f9d7b28-5808-488a-8cbe-492efcbabbf7">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNC02LTEtMS0w_fecde2a8-5d10-4844-a306-d3b8e1ab5753">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNC04LTEtMS0w_302d38ed-8bc5-4341-a770-fae008038c9a">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNS0yLTEtMS0w_5092efa7-ddb1-496b-9ba1-bdf9ac0ae9f8">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNS00LTEtMS0w_5aea139d-56d8-4606-81a2-12f6d4197bfb">511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNS02LTEtMS0w_9b5f73f9-9f6d-4140-b21a-ce734205532d">953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNS04LTEtMS0w_7edc9f6b-7978-4dd5-9a87-91bac6181713">2,601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNy0yLTEtMS0w_0a6b2dd5-267d-48a0-8331-835eb3e8594d">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNy00LTEtMS0w_b51dabd4-8c59-4be2-9b9d-7b7c27dc8396">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNy02LTEtMS0w_d32bea14-d7cb-4f38-8ef8-ea7792f8425a">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNy04LTEtMS0w_f3368589-6f28-42ec-9c86-eeb339c1f373">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: contingently issuable performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOC0yLTEtMS0w_2eec08d0-8d46-4f3e-ac57-3179ce49b757">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOC00LTEtMS0w_d9eef664-7b4e-42a4-a28e-6d41f98db348">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOC02LTEtMS0w_37536914-1272-41a4-ba79-b40f1af420c3">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOC04LTEtMS0w_0188a3a5-6622-4499-9c19-ef44c28cea0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOS0yLTEtMS0w_f3a631ce-9d60-4b0d-941c-a45af28847e1">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOS00LTEtMS0w_1bfd30d4-ad54-41a7-82d9-b9152d26f523">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOS02LTEtMS0w_3f72f9e4-a2e7-45aa-aec2-d086367246a1">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOS04LTEtMS0w_7cc35c27-3fbb-4a79-9148-6b2768d418b2">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 8. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RleHRyZWdpb246Y2JjN2NjYmVjOTRmNGFjZWIyYzg5MjQ0MzU0ZjA1ZTdfMjE4_3c22321d-9b88-4688-888a-3bee355eceec" continuedAt="i7138692f47ec4d0e85d2daae8ee1d16b" escape="true">Other Comprehensive Earnings/Losses:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7138692f47ec4d0e85d2daae8ee1d16b" continuedAt="i634135e93899499f80c3c7aacb2f82aa"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RleHRyZWdpb246Y2JjN2NjYmVjOTRmNGFjZWIyYzg5MjQ0MzU0ZjA1ZTdfMjM4_e5b314d9-40f9-4d3f-8ddc-d56996df37cd" continuedAt="i8e45d9c2b02846d091ae6531b488b16d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5162cf1b3ad7427d95b3b1edd5f61452_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMy0yLTEtMS0w_01776931-34ef-4b08-b4f9-f7f22a28dc83">2,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87eaf39b7366430e9f68266017701b5b_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMy00LTEtMS0w_29394bb9-d103-4b6b-90bb-0912e5c38cc5">693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff69a497b0648929df0cbfb8bd32e75_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMy02LTEtMS0w_e0737d29-1cea-4de3-b93a-35d5c66d0ad8">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5979906ef954a38814196686ea7e5cc_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMy04LTEtMS0w_29f1f477-8fa8-498d-8be6-3739568cfe52">2,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNS0yLTEtMS0w_e229107e-df8d-4bb9-98ac-0cad103a6b67">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNS00LTEtMS0w_31c2349e-777b-4ce3-bdc1-f7a5489ffa76">1,211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNS02LTEtMS0w_3be17f94-0d78-4e34-b910-74ffda1af2f9">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNS04LTEtMS0w_5bda9a29-153d-4979-8c95-b9a7e7a7633e">1,302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNi0yLTEtMS0w_e1af82e4-ff3b-440f-a12e-ba1d6fba2ae5">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNi00LTEtMS0w_86680e5c-acc9-4fb5-ac58-8a264ef5bfea">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNi02LTEtMS0w_7f42e21a-4a2e-4266-9fe0-68d4fc68e359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNi04LTEtMS0w_b9ef50a3-bd2e-41c6-af03-d2190e7c70b7">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNy0yLTEtMS0w_d1806930-3ba1-40d2-955f-915c53f73d8f">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNy00LTEtMS0w_03c8327a-584e-4776-845f-33ee14781d5e">951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNy02LTEtMS0w_1f0ff1a3-06b1-4e04-9a04-129bf95f9840">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNy04LTEtMS0w_6ed088bf-8dbb-4278-994e-5c2d18ce47f8">1,023</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfOS0yLTEtMS0w_bcbc9b5e-abc6-46f4-b4bf-db49b50a737b">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfOS00LTEtMS0w_67df19ad-3346-4c45-b06d-c605dacf6a9f">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfOS02LTEtMS0w_5de2dc82-49d5-44cc-ba12-b4d258263e66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfOS04LTEtMS0w_1a7c8603-93be-453a-a599-86814edfd7af">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTAtMi0xLTEtMA_1e930764-1f2c-401e-859d-9bbdb1a6e769">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTAtNC0xLTEtMA_216c35d0-9fb6-4fb7-89ee-1e0498879627">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTAtNi0xLTEtMA_84ff658f-19b4-4c6b-b4e2-da686b707c53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTAtOC0xLTEtMA_e7651f7e-4d1b-44b0-a408-19ac7c7862d4">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTEtMi0xLTEtMA_c4757430-3aa6-4328-85ad-363d6ee35915">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTEtNC0xLTEtMA_acf9e124-9bc1-41a8-b779-a0d989e8d84b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTEtNi0xLTEtMA_7bcfaa5c-08be-433b-8db3-4dab74528745">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTEtOC0xLTEtMA_01607795-52d5-467f-9627-af619a792406">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTMtMi0xLTEtMA_847a21a0-2812-4217-bf7c-5865a0a7ff58">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTMtNC0xLTEtMA_5a44f1b3-ac68-4a41-86d7-4475d37dd79b">928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTMtNi0xLTEtMA_57e72510-6c73-4144-be74-a20cbbabf9f3">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTMtOC0xLTEtMA_257ea399-7ef3-484e-889b-734b192a5047">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10a65e697a2e4b2b84e0947bc730b6a7_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTUtMi0xLTEtMA_b49306bb-9c16-4e4c-a1b8-252ed143b564">2,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc218d99dbae4bc6925e235fb558f052_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTUtNC0xLTEtMA_9cf8a736-fa4d-4253-9902-91bf27fc6c74">1,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1610ea0297f041709a85e25af892c5f4_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTUtNi0xLTEtMA_0f342253-d9ae-4496-a8af-e98c3d2fd24f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2165dd6285c436395dd6d4adac5414f_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTUtOC0xLTEtMA_a8b0d55b-ca5d-4b8a-840e-1fc48058eb8f">3,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_97"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i634135e93899499f80c3c7aacb2f82aa" continuedAt="i3b69182852be49b5b719ba32a302e5ac"><ix:continuation id="i8e45d9c2b02846d091ae6531b488b16d" continuedAt="ie866ff01c4934043813539281bc54cfe"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ce36a3023924317bfdc3b0e1809fdb9_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMy0yLTEtMS0w_39ed5c01-2d30-4f9b-8865-f7158b40d070">2,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20745bf90a514b81888839906b4a8175_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMy00LTEtMS0w_88eb34fd-c333-41e2-9427-e8c55ca7bdef">1,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0026447ea51456899a37ff23aae7db6_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMy02LTEtMS0w_95ada13f-63bd-4181-84b2-db0b1833f54c">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib857eef0de4e443fa7bfba0c972defc6_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMy04LTEtMS0w_949f2957-6a16-48d1-becb-5717f311df37">3,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNS0yLTEtMS0w_74b3c574-f44c-4839-b800-32fce0e6a572">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNS00LTEtMS0w_5c8dc006-c153-40bc-8b7c-79e98f666a27">71</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNS02LTEtMS0w_e2e80348-e22b-4043-b730-4eca7e7c96e0">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNS04LTEtMS0w_e4779e63-fec5-40a1-92f6-bc991fe1f3a9">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNi0yLTEtMS0w_b1f0a022-c46e-4fd3-bfbb-c990c6af404d">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNi00LTEtMS0w_165e0447-c068-4dc6-95bb-4bbdb1d7b02b">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNi02LTEtMS0w_99403d5c-8118-44c4-8995-a23edfc493a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNi04LTEtMS0w_8639b72d-842f-4651-a758-e57d6f7283ee">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNy0yLTEtMS0w_d88fbef6-d36c-4075-9a0f-ec247e8a4f34">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNy00LTEtMS0w_d5c45b5c-3dc1-47b0-88f5-2c95b056416e">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNy02LTEtMS0w_a1055008-f7e2-431c-a6f2-c6812fd84d7b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNy04LTEtMS0w_c690a611-65ec-4aa2-b397-96a8d09e79e4">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfOS0yLTEtMS0w_af379a14-0d95-4bda-bee7-9e094a8ff49d">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfOS00LTEtMS0w_3ed33d14-d7cd-4841-b927-c8e68a11cd31">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfOS02LTEtMS0w_e8528ae8-0c9b-4604-87c1-3e86a0ca3fa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfOS04LTEtMS0w_90b9b2a4-b86f-48d1-831e-1d50f801e4fe">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTAtMi0xLTEtMA_b5da8e14-2ba6-4184-8af1-a4a055cefa3b">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTAtNC0xLTEtMA_b64fa3ec-ecee-4bf5-947f-f3220abeadfa">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTAtNi0xLTEtMA_b527b84e-794c-44ee-a615-5c2b9b5f2859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTAtOC0xLTEtMA_59795e50-3886-4e99-b6ac-58e76fef797a">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTEtMi0xLTEtMA_1a1bcfcd-a65d-41c5-8f9f-15752c8ec783">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTEtNC0xLTEtMA_c3fe04b4-8b56-4412-9716-cec0864a4c93">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTEtNi0xLTEtMA_013e2030-ed29-4c13-8e49-00fc0e7ca58e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTEtOC0xLTEtMA_1f094215-f9c3-483e-9950-b271ec31e16d">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTMtMi0xLTEtMA_0e8f9253-4a9d-46b6-bcb3-8d8344234494">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTMtNC0xLTEtMA_f8efd309-19e3-4f44-81e9-04626cfbd2bb">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTMtNi0xLTEtMA_14a71913-c04a-400b-9c79-3c5575c0c816">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTMtOC0xLTEtMA_ab48970d-35dd-43cd-aabc-efade4581d83">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10a65e697a2e4b2b84e0947bc730b6a7_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTUtMi0xLTEtMA_e3b7c6be-fa83-4038-8c08-42b71feaaeb0">2,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc218d99dbae4bc6925e235fb558f052_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTUtNC0xLTEtMA_db22853c-7c39-4e65-8c2b-2a74dcee5d27">1,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1610ea0297f041709a85e25af892c5f4_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTUtNi0xLTEtMA_c4167e1d-85f0-4dab-8bf3-22c94a2e49f9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2165dd6285c436395dd6d4adac5414f_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTUtOC0xLTEtMA_ec059890-6d19-40b4-ac98-6212e4921be8">3,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i3b69182852be49b5b719ba32a302e5ac" continuedAt="i36c61007ae50476696e6b312f9b52f24"><ix:continuation id="ie866ff01c4934043813539281bc54cfe" continuedAt="iefaab1571dbe4972a5e4c88c9511be38"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i142eff51b3ab421c889c6d2bb5e2ac10_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzMtMi0xLTEtMA_788af74d-462d-49a8-aa2e-336665d916e2">2,168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0494c954d344876932c1bdd4e2367e0_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzMtNC0xLTEtMA_f6ac480d-0431-4296-a9b6-090ec7c2f8b1">374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46102449b128460b8ae18a5fe9e0fd56_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzMtNi0xLTEtMA_0abd4670-219d-4780-b75d-218ae4db20e3">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820a924d574a40d381950cff0e1a0426_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzMtOC0xLTEtMA_5cd018cb-32d8-48c6-b255-32371698818d">2,547</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzUtMi0xLTEtMA_47c1cae2-edc2-48e5-b854-42c3d4d17f3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzUtNC0xLTEtMA_3bd925b3-c1ef-4986-9c6d-b4a3f54677ca">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzUtNi0xLTEtMA_8e0b7aa5-480e-414c-9178-b11f252949dc">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzUtOC0xLTEtMA_8f08abbe-0d4f-4e92-8c5a-f36f2d86e02d">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzYtMi0xLTEtMA_e457ad37-6d08-4c29-be70-458de7bb72b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzYtNC0xLTEtMA_b5f1fb86-d343-4c7e-9e64-141a1a3d64b3">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzYtNi0xLTEtMA_84e4a8ed-a727-41b2-9bcd-8e96391ce38d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzYtOC0xLTEtMA_04c9ce14-0bed-4abb-b1c1-43cfe9859bf9">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzctMi0xLTEtMA_fadf3dab-5357-4a4c-bf53-ad73b6026987">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzctNC0xLTEtMA_4f0c3ccb-0b7f-4807-a616-71d35c7f7f37">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzctNi0xLTEtMA_7fead27a-2c69-431a-8389-69e1cc31170e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzctOC0xLTEtMA_6a4c49d9-c1bf-42dc-9c6d-16f7e6c905f3">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzktMi0xLTEtMA_f437700f-1db9-4746-a2da-3b0cadc54ce6">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzktNC0xLTEtMA_9843deda-0d9d-4762-81d7-fe481a7a2814">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzktNi0xLTEtMA_f62315c8-2a77-43b2-aba4-f67ab07ac1d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzktOC0xLTEtMA_7f6d7d95-1573-40ac-8115-4c87d9e7c360">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEwLTItMS0xLTA_c1fca43e-7f10-4f72-a6af-48c949001b15">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEwLTQtMS0xLTA_18666ca2-2035-4889-9218-8d376dd95a43">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEwLTYtMS0xLTA_0396260e-9bdf-4eb8-abf6-828f4930aad5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEwLTgtMS0xLTA_1153b85e-26ab-4934-bf94-6d879603a653">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzExLTItMS0xLTA_db199b4d-45aa-4cf3-b8bd-9f37b56ee118">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzExLTQtMS0xLTA_44ac2c21-576d-42a5-84ab-13f3e00cdce8">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzExLTYtMS0xLTA_dab4da2b-1ef8-4eba-88f2-34f68f57223a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzExLTgtMS0xLTA_2f82a92b-2ec0-4e1c-814b-a64032da5828">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEzLTItMS0xLTA_c961b7f5-e4d3-4782-9edb-6c73a28a030d">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEzLTQtMS0xLTA_0679d710-341f-484a-8291-1409b5edf05f">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEzLTYtMS0xLTA_668a6ba0-95b7-4a3d-b9c4-73e06fd8ade6">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEzLTgtMS0xLTA_a02a050e-3489-4440-9f45-2b0b4bb9c6d7">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf39d90acfc94fa8ae8510b5ee508977_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzE1LTItMS0xLTA_cb54544a-0818-49d1-94a9-1fa533e72b66">2,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f18c4a56df2461bbfd5d9dee8b61589_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzE1LTQtMS0xLTA_f522dab0-a22a-433f-9a96-c631c0ab6cf7">321</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba075e861d6f4cc9998f78ffd3276986_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzE1LTYtMS0xLTA_510b7c68-3e6c-4d39-bf9d-bb48685ded64">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4251896369a74d0aa90e3bc70584b869_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzE1LTgtMS0xLTA_bb5d2821-5c98-4628-a1db-ce50e550b0bf">2,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_103"></div><ix:continuation id="i36c61007ae50476696e6b312f9b52f24" continuedAt="i865a33fd9a29437a993465c9e618a1ee"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="iefaab1571dbe4972a5e4c88c9511be38"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie22dd2129baa4a278c19c2b770f10c74_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzMtMi0xLTEtMA_21a4a630-6ae6-4035-9149-a46ceb1026e4">2,110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d44379763c14be6b50fdea177e1105a_I20190630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzMtNC0xLTEtMA_e80e039e-e7c2-48fc-8f26-3002b6cb77d8">542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4ba820f281e46a0856811d6505d6c82_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzMtNi0xLTEtMA_20f92a37-0c7d-4203-aad0-4d9d974580fa">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib371c96cf5004c8b8e72e342916dd913_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzMtOC0xLTEtMA_445a29e0-dc76-4b04-af8a-293338d4759c">2,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzUtMi0xLTEtMA_ef9b02b8-d448-424f-9593-87b9273243d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzUtNC0xLTEtMA_f744f853-b7c8-4c41-a486-34c8e4ed10f1">290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzUtNi0xLTEtMA_bd2680b2-3203-4fca-94b9-98dd37518fad">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzUtOC0xLTEtMA_9f252d71-03c8-4a87-8f34-91fdfacc43db">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzYtMi0xLTEtMA_5c1e42b1-4a44-4790-98a9-2623e59ca37d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzYtNC0xLTEtMA_3ab90dcb-7d58-441d-a467-942d053efd13">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzYtNi0xLTEtMA_2cfde99f-f82f-4813-a8ca-1beb3ad186a7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzYtOC0xLTEtMA_fdcea9d0-5bd9-4138-8c08-b4e0174047d5">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzctMi0xLTEtMA_a10c8aad-ee00-4ebb-80e4-23f779830a76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzctNC0xLTEtMA_0e275e03-05b5-4f84-ac15-78e9bbd37a9c">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzctNi0xLTEtMA_8bab11d2-d229-4b24-938b-1daa07a0ddf5">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzctOC0xLTEtMA_622cb131-6a1e-4b16-af35-4321b9068fb2">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzktMi0xLTEtMA_d557023f-a9ee-47fd-8e1d-c1565796f3f8">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzktNC0xLTEtMA_911f9058-8755-4d4b-894a-f166d3cee72f">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzktNi0xLTEtMA_3d798cf6-ac09-43b9-acc0-9a65ae61db40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzktOC0xLTEtMA_6206473e-8567-4026-ba13-f02605f27c8d">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEwLTItMS0xLTA_3bc8cf5f-be8a-4590-b011-3ff651b35700">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEwLTQtMS0xLTA_5ebc71e8-b5aa-4543-9007-6a655ece3ba2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEwLTYtMS0xLTA_cb4cb947-c99f-43f8-a8c3-6d12c08f465f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEwLTgtMS0xLTA_b68690f1-1779-441c-8cb1-2695b354a8d8">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzExLTItMS0xLTA_a96bbf8f-c5ac-4eeb-a9bf-8ddca29380dd">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzExLTQtMS0xLTA_610b82c3-e3a4-4ec8-a87a-eb675b839a15">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzExLTYtMS0xLTA_4b4d9cd6-19c6-4cf9-9e82-9b4ec661dd80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzExLTgtMS0xLTA_9dae156a-0812-4948-9ef2-d3724270f615">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEzLTItMS0xLTA_b32e4c61-2af8-48ed-8418-3b3944663f88">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEzLTQtMS0xLTA_8a40a41e-de7e-40d1-a138-4505a9211644">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEzLTYtMS0xLTA_9ad6d1cd-b6b5-4920-9256-3420f10610bb">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEzLTgtMS0xLTA_95940239-2abc-40ae-bdf1-dd6a0296effe">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf39d90acfc94fa8ae8510b5ee508977_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzE1LTItMS0xLTA_f71dc47f-fdef-47c9-9ee6-bece5d20e95e">2,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f18c4a56df2461bbfd5d9dee8b61589_I20190930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzE1LTQtMS0xLTA_4592b858-fa5f-4109-9e24-070e802d0e5b">321</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba075e861d6f4cc9998f78ffd3276986_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzE1LTYtMS0xLTA_65bad788-8a2f-4428-b54a-a0108866f958">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4251896369a74d0aa90e3bc70584b869_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzE1LTgtMS0xLTA_2405fd91-9982-4914-b3ce-b75183692c91">2,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Primarily reflects Altria&#8217;s share of ABI&#8217;s currency translation adjustments and the impact of Altria&#8217;s designated net investment hedges.  For further discussion of designated net investment hedges, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i865a33fd9a29437a993465c9e618a1ee"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90ZXh0cmVnaW9uOmE1YTAyNjlmNzAyMDQ1YjU4NjQ3MzY4MmU2ZDNlNzVmXzM5Ng_5708dd12-4881-49f4-a82c-8d6b918b6b0e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):  </span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d081780d6247f2a8f44b0cbac75f0e_D20200101-20200930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzQtMi0xLTEtMA_26de25e6-f559-40a5-ba6c-8beb7eda3e71">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b93afd3a9384878a3d23d915edb9d34_D20190101-20190930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzQtNC0xLTEtMA_d65fa2a4-bd87-4893-aa27-6ced4f652e4b">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9531ea2ec134d779a09cfd6999071fc_D20200701-20200930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzQtNi0xLTEtMA_2c317cc5-2da9-46a9-8577-e4a64841d8df">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic552776954674567ad8ceaf455ff2df2_D20190701-20190930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzQtOC0xLTEtMA_fdee35c5-ba70-4c5c-9bf6-171776644697">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd559242c87a4839848dc76f7cdba2b9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzUtMi0xLTEtMA_87c80ff2-31ef-4cf4-874f-b42b6ef8057b">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id30c8f591ff348eca5e129c73179556d_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzUtNC0xLTEtMA_68355a7b-6964-4f83-8c86-74817327fef0">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7749829bc252472e80afff2f43879e0c_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzUtNi0xLTEtMA_8cccb8fd-5181-4734-961d-95e12575812f">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbdba2ebc8d24db9bde9d1ceeec106c5_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzUtOC0xLTEtMA_a2b675ec-e3ad-405f-96c7-2970630c86ae">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ebfa9f82c6400c86cea2fa523e12bb_D20200101-20200930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzYtMi0xLTEtMA_11577b97-7845-44c2-b016-b433c09609f6">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a7d8dce58e1418492926f41ccd0a901_D20190101-20190930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzYtNC0xLTEtMA_f3ef7430-e1df-425a-bfa3-a9c69ac8a67a">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i782ce7d0d6c04e66b91c4c3a13f4828b_D20200701-20200930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzYtNi0xLTEtMA_279a48b9-e40d-45c3-b411-092696e19682">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea1e2ba6af9c41ddb6f6b2e16f649711_D20190701-20190930" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzYtOC0xLTEtMA_b2bb68b2-2521-4542-9079-dc322b48a989">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2714d6deaf540cb865eebe43194b5a9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzgtMi0xLTEtMA_1f6a7844-277c-4db2-8400-02c18c6e6d5a">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40628f1e5dbf41ee82713505cf35318f_D20190101-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzgtNC0xLTEtMA_8b51c257-86c3-4d75-9a43-1494aa6225c8">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib49c01bfae724b45b528bcb25e34b3b5_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzgtNi0xLTEtMA_969a28d6-2d7f-4ec8-8c7a-fb38fe286f1d">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e3a17982ab540cdb38e40eaa9011fb7_D20190701-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzgtOC0xLTEtMA_b683f7db-230a-45c0-bc67-8006f78ee12c">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2714d6deaf540cb865eebe43194b5a9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzEwLTItMS0xLTA_5a391c3b-aacc-481c-b976-38b0ede0ec9d">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40628f1e5dbf41ee82713505cf35318f_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzEwLTQtMS0xLTA_74c87d80-6b5a-4c17-bbcf-5b9e983ad41b">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib49c01bfae724b45b528bcb25e34b3b5_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzEwLTYtMS0xLTA_7c5e25d9-aab3-4be8-b59e-90022f073208">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e3a17982ab540cdb38e40eaa9011fb7_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzEwLTgtMS0xLTA_6455d999-fe18-4bb5-9e77-f226a7446a11">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Amounts are included in net defined benefit plan costs.  For further details, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Amounts are included in earnings (losses) from equity investments.  For further information, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_109"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 9. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzMwOTM_1f615e55-860a-4952-aefc-7431e856d884" continuedAt="iaef4952420084ac7bb0771fbdf447300" escape="true">Segment Reporting:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="iaef4952420084ac7bb0771fbdf447300" continuedAt="i5ae96340d54a475c8a37a7b843ac1fb9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products of Altria&#8217;s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA (including super premium cigarettes previously manufactured and sold by Nat Sherman), machine-made large cigars and pipe tobacco manufactured and sold by Middleton; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC and oral nicotine pouches manufactured and sold by Helix; and wine produced and/or distributed by Ste. Michelle.  The products and services of these subsidiaries constitute Altria&#8217;s reportable segments of smokeable products, oral tobacco products (formerly smokeless products) and wine.  The financial services and the innovative tobacco products businesses are included in all other. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) reviews operating companies income (loss) (&#8220;OCI&#8221;) to evaluate the performance of, and allocate resources to, the segments.  OCI for the segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, net periodic benefit income/cost, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i5ae96340d54a475c8a37a7b843ac1fb9" continuedAt="i7d64e28d0c974ac6b21e23c972ccbdd7"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzMwOTA_ad23ac4b-a95d-4f14-ad26-968b5dbeb86c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d1129c13a243cfae74e7a2b330f4fb_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzQtMi0xLTEtMA_414be3e4-d827-44e4-a27e-216e1afe6fe0">17,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52bc6e7cfc6045cba8bc9b490b1083c3_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzQtNC0xLTEtMA_b71ea26b-d188-435a-a01a-9988dc80ed6b">16,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id84c0fe23d3344d8a09f8c4b47549357_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzQtNi0xLTEtMA_a27f3f58-1762-448a-9c92-b983aef73fbc">6,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib56362e25fab48b69747801fbc413df0_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzQtOC0xLTEtMA_2d8bbaef-5274-4472-a80c-bd17a76cf1d0">6,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a22405436fc4f51965d8d905f04bd29_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzUtMi0xLTEtMA_11a24340-503f-4909-a5e3-14791179694a">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c10cef408f4866a62e645271641b17_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzUtNC0xLTEtMA_02b9ed1a-359f-444a-977d-69de9593e370">1,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7049d97f344641a984e6e5beb764d3d1_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzUtNi0xLTEtMA_a71ba2f1-5b70-4ef9-b179-5cceac9b3942">640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfaf8cc27be4772b848b7c1b8493b7c_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzUtOC0xLTEtMA_9d3f5b2e-802c-4ac5-b4ec-2d2ab9123938">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1032796fa64fa4895bcb9f14b70233_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzYtMi0xLTEtMA_e0529a84-e8b7-44d7-b1a6-5fc8b3d5d2b5">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id429b5bd1c8d41978646f0f7f455e19f_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzYtNC0xLTEtMA_7ec1c31f-8661-49c1-810a-bf5e97f7ceb9">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i878e052a32df4da7a15671ffe7f6c60b_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzYtNi0xLTEtMA_7e9a86fe-627d-4656-8036-4085ebc58b93">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7356c82749654030be8f256d9f9a9745_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzYtOC0xLTEtMA_7ef249ab-d81f-4842-a5e6-55bcee4d3250">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icba85968187d436ab30ed84caf5e41e0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzctMi0xLTEtMA_2dc999cc-55a3-4a94-9cb9-acbffbb1bba3">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494ba59d5d0346ec8380c947bd3eb17e_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzctNC0xLTEtMA_865194b7-b821-469f-b23d-bb0f3be74f00">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e6a83106cfb4c60a62a2096cd79a1bd_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzctNi0xLTEtMA_7883877a-2dba-48ae-9198-8753d5356bac">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c2ac469222e4237be6dcf3d6fa61beb_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzctOC0xLTEtMA_abc3383b-cf90-4f02-b22b-be9495051e5e">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzgtMi0xLTEtMA_06a6a063-dbaf-4d17-8528-efa1aad8e38c">19,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzgtNC0xLTEtMA_25b0a936-7da3-4f44-8ad6-fd4d14e00783">19,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzgtNi0xLTEtMA_a06d90be-8946-46aa-a466-da5c3b69536a">7,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzgtOC0xLTEtMA_f8550de2-24d5-409b-9bae-6874c875f83b">6,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d1129c13a243cfae74e7a2b330f4fb_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzExLTItMS0xLTA_dfeb313e-ca25-423f-a124-9ba02d9975b4">7,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52bc6e7cfc6045cba8bc9b490b1083c3_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzExLTQtMS0xLTA_48d1ef34-baff-4472-9f56-22684610bf4c">6,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id84c0fe23d3344d8a09f8c4b47549357_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzExLTYtMS0xLTA_9e16cd73-9f68-40c4-b1f4-122391627a52">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib56362e25fab48b69747801fbc413df0_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzExLTgtMS0xLTA_446881b1-eef1-4d39-9b5e-0853e535cbbe">2,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a22405436fc4f51965d8d905f04bd29_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEyLTItMS0xLTA_d194265c-d418-4a32-846f-312a1d8b15c0">1,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c10cef408f4866a62e645271641b17_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEyLTQtMS0xLTA_91fc7e51-bb21-426f-b3b0-cb7d44e4cce4">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7049d97f344641a984e6e5beb764d3d1_D20200701-20200930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEyLTYtMS0xLTA_ba68b170-e0b2-4c6e-b7fc-b5e8ac6d18ab">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfaf8cc27be4772b848b7c1b8493b7c_D20190701-20190930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEyLTgtMS0xLTA_f847bb81-68e3-47fe-9e15-4e2e3f448345">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d1032796fa64fa4895bcb9f14b70233_D20200101-20200930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEzLTItMS0xLTA_fa1ead7e-9ec4-4a92-a23a-10513ac414e7">347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id429b5bd1c8d41978646f0f7f455e19f_D20190101-20190930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEzLTQtMS0xLTA_3583234e-45b5-4440-836a-72e6351f9b8f">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i878e052a32df4da7a15671ffe7f6c60b_D20200701-20200930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEzLTYtMS0xLTA_77eda22c-33f5-45f3-8c89-4a95c182067e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7356c82749654030be8f256d9f9a9745_D20190701-20190930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEzLTgtMS0xLTA_2cdbe929-d376-489a-8675-203fc1bd1c65">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icba85968187d436ab30ed84caf5e41e0_D20200101-20200930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE0LTItMS0xLTA_f624f45f-c96f-4bec-acac-d1aa33613d58">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i494ba59d5d0346ec8380c947bd3eb17e_D20190101-20190930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE0LTQtMS0xLTA_961cb490-f233-4bd3-b5c2-6520119cabf8">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e6a83106cfb4c60a62a2096cd79a1bd_D20200701-20200930" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE0LTYtMS0xLTA_c3367265-9d9f-40c9-b6e1-3d555b978051">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c2ac469222e4237be6dcf3d6fa61beb_D20190701-20190930" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE0LTgtMS0xLTA_b5814a4e-0827-4410-8921-ae1b47c176a1">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6023956547cd406696d7cc717c5d63cc_D20200101-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE1LTItMS0xLTA_01bda48d-405c-4700-8d09-56e9ab85064e">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2854d38153284db69df70b1b30e12c8b_D20190101-20190930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE1LTQtMS0xLTA_6a02f7a8-8798-498c-a765-16c8fb274602">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5aa10928c42c437b8022ccb9de74838c_D20200701-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE1LTYtMS0xLTA_49876dfa-988e-460d-b285-c6e424e7824f">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf791c5f8e154ea99ad6848bebce7aea_D20190701-20190930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE1LTgtMS0xLTA_f029592a-5f95-46b2-9075-dc4e8b66fea2">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE2LTItMS0xLTA_fe555abe-bb11-4c2f-bf1e-edb98cfd1af0">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE2LTQtMS0xLTA_e4cfdc04-8450-41f9-86bd-6bc49dd4b9bd">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i763e7a556b7d49d7899ca7b7ab4b3ab5_D20200701-20200930" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE2LTYtMS0xLTA_3b0e0045-a25e-4a67-b79f-2e2cab757704">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6bebe9ebc8645cc9f8335c03695b4c1_D20190701-20190930" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE2LTgtMS0xLTA_ee329958-e9d1-43f5-ae0f-bcc9c4013eed">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset impairment and exit costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="mo:AssetImpairmentandBusinessExitCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE3LTItMS0xLTA_0730a2e4-809f-4fa9-b744-b2f8e6230857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930" decimals="-6" name="mo:AssetImpairmentandBusinessExitCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE3LTQtMS0xLTA_86ea3109-ad8d-483c-9dd5-e7b807a4973c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763e7a556b7d49d7899ca7b7ab4b3ab5_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="mo:AssetImpairmentandBusinessExitCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE3LTYtMS0xLTA_b02a2e76-7669-4f36-ad19-37334eb64cc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6bebe9ebc8645cc9f8335c03695b4c1_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="mo:AssetImpairmentandBusinessExitCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE3LTgtMS0xLTA_5796fd71-ffff-49b0-a5e2-3bb9be89b015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE4LTItMS0xLTA_3c9f1746-ece4-4498-8f69-41e88c548635">8,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE4LTQtMS0xLTA_66be1db5-545e-467f-8705-b2b8ac2b38df">7,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE4LTYtMS0xLTA_773a0b62-ea2a-43ec-a42d-d48fb09080c7">3,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE4LTgtMS0xLTA_cf6f986f-f4d2-4951-a419-6b677645bd29">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE5LTItMS0xLTA_de82dace-78d2-40d2-a051-bdaf50665f87">893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE5LTQtMS0xLTA_16e797d5-713f-4628-9413-5f4ca0620308">989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE5LTYtMS0xLTA_f169d3fa-4866-401f-9f26-e1ce8e2f7e03">310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE5LTgtMS0xLTA_5c839ef3-b9d7-4742-86c8-ee39c7045c63">293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIwLTItMS0xLTA_92c7a852-5459-41ef-bffe-57d01f37133c">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIwLTQtMS0xLTA_f1d43101-e8b0-4b97-8d99-e5475150fc6f">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIwLTYtMS0xLTA_4dce8b96-6675-4337-b8bd-204f29e0df51">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIwLTgtMS0xLTA_c4779c5f-7f2c-4fd3-9e42-e6b84f568112">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIxLTItMS0xLTA_e7b31a90-d66e-4e55-a4ef-4d569ff1a062">306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIxLTQtMS0xLTA_6f110e85-7132-4e07-ae22-71d618ffc0b6">866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIxLTYtMS0xLTA_3f9b5e4d-a54e-402e-8267-51e0fe9aaaa6">472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIxLTgtMS0xLTA_7d51e856-ded3-4e59-8d83-0231622c5fd6">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTItMS0xLTE0NzM_9990c180-cdf7-4d90-be55-21cf8061afad">2,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTQtMS0xLTE0Nzc_e2dcdfac-632a-4629-a784-534c0a07120c">4,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTYtMS0xLTE0ODE_13c8218d-e313-4a5d-b035-20aa5e1026ff">2,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTgtMS0xLTE0ODU_e0093db5-5fe1-4d4d-b34b-04aa0a68d010">4,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTItMS0xLTA_dc95cb3b-53db-4247-9c3a-54eab029c247">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTQtMS0xLTA_bec251b0-b935-4545-b932-5f702ffe5270">1,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTYtMS0xLTA_26b79f93-e960-4844-bb0e-7b93b4a7108c">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTgtMS0xLTA_53506f46-caf0-4223-899c-c7df1aa55fc9">636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIzLTItMS0xLTA_8a64e7b5-c50e-427d-8008-97ad111a19db">4,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIzLTQtMS0xLTA_77c52a9b-c10e-4306-8f58-0ca90f9a5348">1,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIzLTYtMS0xLTA_e6e576f3-f114-4fb6-bd37-c14fd59740d2">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIzLTgtMS0xLTA_c096e07d-6f87-48ff-82f3-0546b548ce0a">2,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparability of OCI for the reportable segments was affected by the following:</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzMwOTg_c748df39-069e-4d48-81ee-f95410a96326" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco and Health Litigation Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria&#8217;s condensed consolidated statements of earnings as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if454389f3a1945179f947caaa65a6c31_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzMtMi0xLTEtMA_ba0d4632-0808-4c5c-9aef-4ef62b979a8e">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic979af41ab9d413bb1ae38f66b2d9d11_D20190101-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzMtNC0xLTEtMA_5585702e-09da-4eaf-9ee5-cd8c9f207369">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e639fdb4824b70bb2643899d44c0d0_D20200701-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzMtNi0xLTEtMA_00d02700-aa8f-41bb-a842-73da8026a9b6">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b13b9a1e91f4d60bd633bbdac2d3a0e_D20190701-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzMtOC0xLTEtMA_2181036e-35ef-4239-84d8-99fb52ac77f0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18072db8ab9f45d4adbc775ff5720df9_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzQtMi0xLTEtMA_4575b4f3-109e-4c6b-9503-4bd8b058f0a3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe3f5acfbb75415db5d1a986b38445b0_D20190101-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzQtNC0xLTEtMA_533da7cf-cf05-41fc-8707-6babe9ed60d2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a01c76ce7db4a9bb38f21611772ae4c_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzQtNi0xLTEtMA_743a4c89-4179-4a79-92be-5270916d5d58">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb9bd71b05044f1960dbd29fea9824d_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzQtOC0xLTEtMA_5c56d32a-4fe7-4240-b32a-00b0f86c577f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4789cad0b6a54baaad569d4c6f6fbc61_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzUtMi0xLTEtMA_952b3e30-65fc-43ae-a09c-60d4e30c3a97">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i941f9b86f58e457f869c24db7d24bb4d_D20190101-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzUtNC0xLTEtMA_3a0a80d8-6e98-4207-8b4b-dc4c30152b05">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b48ad0497744f6aa97be20fde34f963_D20200701-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzUtNi0xLTEtMA_12d74eb3-36ac-40e0-b687-4e35fe47e1a3">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f398c78ea464bc29dfde286f3202ac5_D20190701-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzUtOC0xLTEtMA_39ffed3e-ea22-4aca-ae7a-3d362c2cefdc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts shown in the table above for the smokeable products segment were recorded in marketing, administration and research costs.  For further discussion, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i7d64e28d0c974ac6b21e23c972ccbdd7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Special Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Net pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i04eaaa915aec49bd9b52703167950623_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzM4NDgyOTA3MDI4MDM_08417dac-67aa-48fc-916f-69c5fb230f39">50</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="ia8c1acc07f234535b9f59b5c08a35421_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzM4NDgyOTA3MDI4MDg_ddc2a6a1-abc4-4d5e-b37c-5ab1403a18d5">41</ix:nonFraction> million in the smokeable products segment and $<ix:nonFraction unitRef="usd" contextRef="ia114b8b08be943bbaeec192f0c9546eb_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzM4NDgyOTA3MDI4NTA_b045dee2-1282-487b-80de-9e0c9bf44e08">9</ix:nonFraction> million in the oral tobacco products segment) related to COVID-19 were recorded in Altria&#8217;s condensed consolidated statements of earnings for the nine months ended September 30, 2020.  The net pre-tax charges, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic, were all recorded in costs of sales in the second quarter of 2020 and included premium pay, personal protective equipment and health screenings, which were partially offset by certain employment tax credits.  The COVID-19 special items do not include the inventory-related implementation costs associated with the wine business strategic reset, which are included in asset impairment, exit and implementation costs.  These implementation costs were due to increased inventory levels, which were further negatively impacted by government restrictions and economic uncertainty surrounding the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment, Exit and Implementation Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - See Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment, Exit and Implementation Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a breakdown of these costs by segment.</span></div></ix:continuation><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_118"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 10. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzQ0NTM_750c4584-bef9-4bcd-adad-5bc41c2a56e4" continuedAt="ic556efe16d314323997fcb01356816a5" escape="true">Debt:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic556efe16d314323997fcb01356816a5" continuedAt="i9d452e07847247f8a08a882eceb844d9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Borrowings and Borrowing Arrangements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and December 31, 2019, Altria had <ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzExNw_a0091be3-9270-4893-b5eb-51e404b1903a"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzExNw_b8a13924-9682-4c06-95cb-e3834a4047f5">no</ix:nonFraction></ix:nonFraction> short-term borrowings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, Altria had a senior unsecured <ix:nonNumeric contextRef="ie55438acc01a4f80a2a779c29e334eac_D20180801-20180801" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzE5Mg_161c19cb-02b8-4733-9cc7-c75d05821df8">5</ix:nonNumeric>-year revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;) that provides for borrowings up to an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i55306d8676154351af21f6cfd76b5f55_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzM1NQ_b51900f0-2634-4f8a-a8c4-d689dbc5a226">3.0</ix:nonFraction> billion.  The Credit Agreement, which is used for general corporate purposes, expires on August&#160;1, 2023 and includes an option, subject to certain conditions, for Altria to extend the Credit Agreement for <ix:nonFraction unitRef="extension" contextRef="i55306d8676154351af21f6cfd76b5f55_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mo:DebtInstrumentNumberofExtensions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzU1NQ_d6f44eb0-0ab8-44b7-987a-aef6988ece3f">two</ix:nonFraction> additional <ix:nonNumeric contextRef="i56d738cab03146c5bcd9b95595aee05e_D20200101-20200930" format="ixt-sec:durwordsen" name="mo:DebtInstrumentExtensionTerm" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzg3OTYwOTMwMjY3NTU_3708630e-5153-476d-8927-e52153053320">one-year</ix:nonNumeric> periods.  Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of Altria&#8217;s long-term senior unsecured debt.  Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate (&#8220;LIBOR&#8221;), or a mutually agreed upon benchmark rate, plus a percentage based on the higher of the ratings of Altria&#8217;s long-term senior unsecured debt from Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and Standard&#160;&amp; Poor&#8217;s Ratings Services (&#8220;Standard &amp; Poor&#8217;s&#8221;).  The applicable percentage based on Altria&#8217;s long-term senior unsecured debt ratings&#160;at September 30, 2020 for borrowings under the Credit Agreement was <ix:nonFraction unitRef="number" contextRef="i15d84c7d97cd4a05857ded13946f92fe_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzEyNzI_387345e8-2b7e-4210-991b-88d34093e2a0">1.0</ix:nonFraction>%.  The Credit Agreement does not include any other rating triggers, or any provisions that could require the posting of collateral.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, due to the uncertainty at that time in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the full $<ix:nonFraction unitRef="usd" contextRef="ic3eeb744b8954855a6ff7c699a798982_D20200301-20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzE2MDE_3d5d9cc0-e862-48f8-afc4-830e3401d994">3.0</ix:nonFraction> billion available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility.  In June 2020, Altria repaid the full amount outstanding under the Credit Agreement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) to Consolidated Interest Expense of not less than <ix:nonFraction unitRef="number" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="INF" name="mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzIwNTk_f7111392-640a-4383-9f81-79e3c3c98ecd">4.0</ix:nonFraction> to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At September 30, 2020, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was <ix:nonFraction unitRef="number" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="INF" name="mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzIyOTc_a23eacb0-7751-4e70-ad19-ca6af249a312">9.2</ix:nonFraction> to 1.0.  At September 30, 2020, Altria was in compliance with its covenants in the Credit Agreement.  The terms &#8220;Consolidated EBITDA&#8221; and &#8220;Consolidated Interest Expense,&#8221; each as defined in the Credit Agreement, include certain adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM&#160;USA. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="i9d452e07847247f8a08a882eceb844d9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying value of Altria&#8217;s total long-term debt at September 30, 2020 and December 31, 2019 was $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzI3NDg3NzkwNzQ1NjA_8053f668-372d-4bfa-92f0-1384cf3d9ed1">29.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzI3NDg3NzkwNzQ1Nzg_9d17605e-6e7e-4782-81a1-51560cd988dd">28.0</ix:nonFraction> billion, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Altria issued USD denominated long-term senior unsecured notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i8cc84f59a87f4be8a5e634d905b909b6_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzI3NzM_28999e6a-094d-4269-b397-1143feb3b587">2.0</ix:nonFraction> billion (collectively, the &#8220;Notes&#8221;).  The net proceeds from the Notes were used for general corporate purposes, which included repayment of the outstanding balance of the Credit Agreement.  The Notes contain the following terms:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="i004b9c845a7c477e9f161677be47d470_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzI5OTk_f39772c4-db87-49a4-b5e0-2420c9c4f332">0.750</ix:nonFraction> billion at <ix:nonFraction unitRef="number" contextRef="i004b9c845a7c477e9f161677be47d470_I20200531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMwMDU_5c580e74-58f5-4bbb-8fec-f8d6f7f8f86f">2.350</ix:nonFraction>%, due 2025, interest payable semiannually beginning November 6, 2020;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="if92a65bfb9bf4139b4848310f21e030e_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMwNzc_14101d3e-db84-4f4e-9c04-8ab26806cc30">0.750</ix:nonFraction> billion at <ix:nonFraction unitRef="number" contextRef="if92a65bfb9bf4139b4848310f21e030e_I20200531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMwODM_a0e81944-e558-42a2-83ee-8c0fc5c8c376">3.400</ix:nonFraction>%, due 2030, interest payable semiannually beginning November 6, 2020; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$<ix:nonFraction unitRef="usd" contextRef="ib5bb50e3bc8e46f396e19b3dcbc7cefc_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMxNTk_2885d2c8-9e5c-4ea0-9b53-a65c0f62bc33">0.500</ix:nonFraction> billion at <ix:nonFraction unitRef="number" contextRef="ib5bb50e3bc8e46f396e19b3dcbc7cefc_I20200531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMxNjU_2dbff8ae-2d85-4d5f-9088-068b7a5d63b2">4.450</ix:nonFraction>%, due 2050, interest payable semiannually beginning November 6, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are Altria&#8217;s senior unsecured obligations and rank equally in right of payment with all of Altria&#8217;s existing and future senior unsecured indebtedness.  Upon the occurrence of both (i) a change of control of Altria and (ii) the Notes ceasing to be rated investment grade by each of Moody&#8217;s, Standard &amp; Poor&#8217;s and Fitch Ratings Ltd. within a specified time period, Altria will be required to make an offer to purchase the Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="i6166eaee58bc4486a1dcd77e46be7115_D20200501-20200531" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzM2OTQ_87def520-e97e-4064-89c6-91b6417bb825">101</ix:nonFraction>% of the aggregate principal amount of such Notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the Notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of Altria under the Notes are guaranteed by PM USA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, Altria repaid in full at maturity senior unsecured notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i524852ef9cf241f693dd67511cfcf6d0_D20200101-20200331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzQwNjM_f273eebf-5609-4021-b5c4-c06eeae9e4ee">1.0</ix:nonFraction> billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 and December&#160;31, 2019, accrued interest on long-term debt of $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzQxMjA_0b6bc7f3-bf5b-447d-9dcd-764929a20888">244</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzQxMjc_b3f69faa-d9c5-49f7-a148-34fad4ecc341">470</ix:nonFraction> million, respectively, was included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the fair value of Altria&#8217;s long-term debt and the designation of its Euro denominated senior unsecured notes as a net investment hedge of its investment in ABI, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_124"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 11. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI1ODY_a931af1e-e39c-43b0-9f04-a892489446cc" continuedAt="i427b9dfdaaa2447489eba899c1a7973b" escape="true">Income Taxes:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i427b9dfdaaa2447489eba899c1a7973b" continuedAt="i1e9c82dd471248ea96fb428edb77841e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax rate for the nine and three months ended September 30, 2020 was <ix:nonFraction unitRef="number" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzQ5NDc4MDIzMjgxNzI_fc4dcacf-7fac-4be7-a873-71fa16d9cf4d">41.8</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzM4NDgyOTA3MDgwOTA_bd57a4fd-3135-40b3-abbb-fbefd6898c43">195.1</ix:nonFraction>)%, respectively, versus <ix:nonFraction unitRef="number" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzQ5NDc4MDIzMjg0MjA_e59de28e-b59f-4769-b1f6-bfe130638fb0">74.1</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzM4NDgyOTA3MDgwMTQ_d4927672-4a41-426f-b70e-6531eff2643b">22.3</ix:nonFraction>)% for the nine and three months ended September 30, 2019, respectively.  The changes in the tax rates were due primarily to the following:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a full valuation allowance in 2019 attributable to the tax benefits associated with the impairment of JUUL equity securities;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a full valuation allowance in 2020 attributable to the tax benefits associated with the impairment of JUUL equity securities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">tax benefits recorded in 2019 for the reversal of tax accruals no longer required;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">net tax expense in 2020 related to Altria&#8217;s equity investment in Cronos, which included a valuation allowance release on a deferred tax asset; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">net tax benefit in 2019 related to Altria&#8217;s equity investment in Cronos, which included a valuation allowance release on a deferred tax asset.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i1e9c82dd471248ea96fb428edb77841e"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI1OTI_c6270d19-d1ae-4819-8993-1ee986217764" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending valuation allowances for the period ended September 30, 2020 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzEtMi0xLTEtMA_d9cb3d64-af1c-43b3-b1f4-cf411837e489">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetIncreaseInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzItMi0xLTEtMA_078cec05-0531-44b3-8779-d7291cb61381">673</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetDecreaseInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzMtMi0xLTEtMA_0b688811-cf07-49a7-9cf7-82c4f9428795">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="mo:ValuationAllowanceForeignCurrencyTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzQtMi0xLTEtMA_fa0c44c5-1ad2-4268-80c8-cd51330807de">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzUtMi0xLTEtMA_c0a18578-c46f-4670-ae86-1dfa15c4f9f1">2,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current year addition to the valuation allowance was due primarily to valuation allowances recorded for deferred tax assets related to Altria&#8217;s equity investments in JUUL and Cronos.  The current year reduction to the valuation allowance was due primarily to the write-off of a deferred tax asset related to Altria&#8217;s equity investment in Cronos for which a valuation allowance had previously been established.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria is subject to income taxation in many jurisdictions.  Unrecognized tax benefits reflect the difference between tax positions taken or expected to be taken on income tax returns and the amounts recognized in the financial statements.  Resolution of the related tax positions with the relevant tax authorities may take many years to complete, and such timing is not entirely within the control of Altria.  At September&#160;30, 2020, Altria&#8217;s total unrecognized tax benefits were $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzIwNDI_959c0757-0b67-4f95-8d33-830de2e72195">74</ix:nonFraction> million.  The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at September&#160;30, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzIxNTQ_e68b9250-bb3a-4824-8d78-0221e183473a">41</ix:nonFraction> million, along with $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzIxNjk_52640bce-2d63-45e6-a69f-ede17658a3fe">33</ix:nonFraction> million affecting deferred taxes.  It is reasonably possible that within the next 12 months certain examinations will be resolved, which could result in a decrease in unrecognized tax benefits of approximately $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzIzNzQ_1a5aa852-c4dd-4afb-bca1-698c570d2d1b">8</ix:nonFraction> million.  At December 31, 2019, Altria&#8217;s total unrecognized tax benefits were $<ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI0Mjk_6fc48421-eba7-4f35-ad1f-8fd0062295c2">64</ix:nonFraction> million.  The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December&#160;31, 2019 was $<ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI1NDE_4a87a0a1-07b0-4109-8c3e-5d2d2d23dbfc">40</ix:nonFraction> million, along with $<ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI1NTY_5fe11333-3498-4f4c-8151-0d22c9d6c7f6">24</ix:nonFraction> million affecting deferred taxes.</span></div></ix:continuation><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 12. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU4NjYx_8bd29255-88d3-4068-bc87-0ce55e42e81f" continuedAt="ic717d9108d5f404a8f05eb5e0618f0cf" escape="true">Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic717d9108d5f404a8f05eb5e0618f0cf" continuedAt="id944403a469e465bbef683a4c01d6ba0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and its subsidiaries, including PM USA and USSTC, as well as their respective indemnitees and Altria&#8217;s investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#8217; liability is joint and several.  In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries also may be required to pay interest and attorneys&#8217; fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that <ix:nonFraction unitRef="state" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="INF" name="mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxOTQ_d1f6336e-f127-4818-b9c7-8e637cba2b5b">47</ix:nonFraction> states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#8217;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="id944403a469e465bbef683a4c01d6ba0" continuedAt="ic6ed59ee1cd64f7383d04d662aa286e7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts.  Each of the companies has defended, and will continue to defend, vigorously against litigation challenges.  However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Altria and/or PM USA Tobacco-Related Litigation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Types and Number of U.S. Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), fraud, failure to warn, design defect, negligence and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#8217; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg3OTYwOTMwODUyMzk_ef510992-22fc-45a3-985c-863ffd61fe58" continuedAt="i0db8e079d52b40238696f290dc00de08" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 27, 2020, October 28, 2019 and October 22, 2018:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:59.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 27, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 22, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i9f83a67a0b1041928670ec284b9f04b4_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzEtMS0xLTEtMA_3e391cb5-b603-4fcc-8700-9fe0abbca17e">142</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ibe6c5f25c0a14432894f98e00b688af4_I20191028" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzEtMy0xLTEtMA_28da82b8-1d70-439c-ab1e-241c8e259b57">95</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i088fe65173a649629285b737326fc8af_I20181022" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzEtNS0xLTEtMA_2bda5b11-e7d7-4b35-ba7e-e20fd4dfb523">101</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ifa8f7e9351fa463481a1396bb9dbb0b3_I20201027" decimals="INF" format="ixt:zerodash" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzItMS0xLTEtMA_492d56dc-4748-4ec7-99d5-10811aa47d37">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ib6a114c3739645fb99b67e8b402fb09d_I20191028" decimals="INF" format="ixt:zerodash" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzItMy0xLTEtMA_c8f0c24c-eb7c-4798-bc35-9ae73c2919b3">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ida5ccc93d1ad4e17b978d254db30a29b_I20181022" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzItNS0xLTEtMA_4a638e17-9290-401a-9396-28423733c05e">1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i1938f36d8dd1444f846a2c358e51a292_I20201027" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzMtMS0xLTEtMA_a5f14ee5-dc1a-4f6c-8171-9fcc7b9bb8fb">1,145</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="claim" contextRef="ib6b92183e81f4270b9b287aa21dc48b3_I20191028" xsi:nil="true" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzMtMy0xLTEtMA_0fbfb025-0bda-4456-9551-93380360ce9e"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="claim" contextRef="if79ba42880fa4632945934c13e5390f4_I20181022" xsi:nil="true" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzMtNS0xLTEtMA_10a40247-333a-4d93-8112-8664d54d508a"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ic50f46d379fe4cb283f17d07d3231cca_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzQtMS0xLTEtMA_95fbf382-b769-4be8-b8b3-16eda0d4c8ca">4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i991d327d70354aee8acfa77292becaf9_I20191028" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzQtMy0xLTEtMA_15b9b2c6-18f5-471c-832c-e2f2d6ac8d1e">4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="if09d494ca9c04e36a8555873cb6b8cd5_I20181022" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzQtNS0xLTEtMA_35fd0f08-9232-4ac4-a8ae-266b16fd7e19">4</ix:nonFraction></span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes <ix:nonFraction unitRef="claim" contextRef="i74ee67e0b3a6432c9aa843c7b05d3a21_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTkwNzY_23a1cd24-8e49-43e4-871f-2ff5d601238f">15</ix:nonFraction> cases filed in New Mexico, <ix:nonFraction unitRef="claim" contextRef="i288268f2ad2f4afba0fe6dc3e2d647fc_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU5NDI_188e8dee-e7ae-476e-b65f-d65f2494cf48">26</ix:nonFraction> cases filed in Massachusetts and <ix:nonFraction unitRef="claim" contextRef="i1b3f238e8c2e470f941d469281cb5f59_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU5Nzg_fc870b6f-1879-4c45-a6ea-6328fe6a8a4b">54</ix:nonFraction> non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include <ix:nonFraction unitRef="case" contextRef="i90eafa508851421c88a1386dd9e708a7_D20201027-20201027" decimals="INF" format="ixt:numdotdecimal" name="mo:LossContingencyNumberOfCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzYzMTc_314edf96-def4-4a9b-97ed-54ed83cfed78">1,471</ix:nonFraction> cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  In March 2018, <ix:nonFraction unitRef="case" contextRef="i79786dc9d3a34fe9b84f2581a59eae3c_D20180301-20180331" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzY4MjA_374db4e4-34c8-4ef2-ae1a-64d4bc58c555">923</ix:nonFraction> of these cases were voluntarily dismissed without prejudice.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes <ix:nonFraction unitRef="lawsuit" contextRef="i1938f36d8dd1444f846a2c358e51a292_I20201027" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzY5ODI_84af76d7-a3c9-4920-94c4-ba8f40235beb">25</ix:nonFraction> class action lawsuits, <ix:nonFraction unitRef="lawsuit" contextRef="if906b9f3c170440f94e6baae57a1e8af_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTgyNDQ_fb7df670-9bad-4133-a28d-bd59aa73ffea">two</ix:nonFraction> of which were filed in Canada, <ix:nonFraction unitRef="claim" contextRef="i759cc82368a24da9b90d561f09b6df19_I20201027" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzcwMDg_b4ec6655-50df-4861-b6de-323be1b06137">1,064</ix:nonFraction> individual lawsuits, <ix:nonFraction unitRef="claim" contextRef="i6732b65e853a4a2ebc98fc8672546c08_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzcwMzI_d18ed7f1-e71f-4455-80b6-da5ce370cd45">31</ix:nonFraction> state or local government lawsuits and <ix:nonFraction unitRef="claim" contextRef="i7b52d1ccf10645b8ac9e77afdbf09979_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzcwNzQ_6fd9b088-f248-4890-8f75-afed2d961b6c">25</ix:nonFraction> lawsuits filed by school districts relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes <ix:nonFraction unitRef="case" contextRef="ic50f46d379fe4cb283f17d07d3231cca_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfInactiveCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzcyMjc_60c51320-69ad-4e28-8af5-3d96b3adc89e">two</ix:nonFraction> inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including <ix:nonFraction unitRef="case" contextRef="ic50f46d379fe4cb283f17d07d3231cca_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfCasesTriedinASingleProceeding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzc0NDI_f9ef736d-a95a-49b9-9b0b-1144d1a7e978">one</ix:nonFraction> case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and <ix:nonFraction unitRef="case" contextRef="ic50f46d379fe4cb283f17d07d3231cca_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfInactiveClassActionLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzc1NjI_d946ae7a-69f7-44a3-b941-62fd58aaa562">two</ix:nonFraction> inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="ic6ed59ee1cd64f7383d04d662aa286e7" continuedAt="if183535380dd4108a96c4e763926505e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Tobacco-Related Cases  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, Altria is named as a defendant in <ix:nonFraction unitRef="claim" contextRef="i327f425f4c0a4b958f4eb1c1e8e5b7a8_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTgyNTA_fdd7574c-8787-4c53-ba00-a3ba0d2a6229">two</ix:nonFraction> e-vapor class action lawsuits in Canada.  PM USA also is a named defendant in <ix:nonFraction unitRef="claim" contextRef="i03acf33061544727a951d220b422409e_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzc4ODg_6a723861-e1c3-4877-bd18-63a3e7fb46ad">10</ix:nonFraction> health care cost recovery actions in Canada, <ix:nonFraction unitRef="claim" contextRef="ie1a4cb788be34b7294823653c0ded68b_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzc5MzY_ab913ef0-e3ee-4b2c-afbc-f37ea457a1e1">eight</ix:nonFraction> of which also name Altria as a defendant.  PM USA and Altria are also named defendants in <ix:nonFraction unitRef="claim" contextRef="i5370156fe8d14a8e8da1520ca797a308_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzgwMjk_df40c37a-d1b4-45eb-8710-fbe8a8773222">seven</ix:nonFraction> smoking and health class actions filed in various Canadian provinces.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (&#8220;PMI&#8221;) that provides for indemnities for certain liabilities concerning tobacco products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco-Related Cases Set for Trial  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, <ix:nonFraction unitRef="case" contextRef="i5ae72485bc604c34b056b72db7e10bf3_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofCasesSetforTrial" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg0MDI_2ab3f13d-e989-4afb-9254-be80ff3ed275">no</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases or individual smoking and health cases against PM USA are set for trial through December 31, 2020.  Cases against other companies in the tobacco industry may be scheduled for trial during this period.  Trial dates are subject to change and some trials have been postponed due to the COVID-19 pandemic.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trial Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1999, excluding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases (separately discussed below), verdicts have been returned in <ix:nonFraction unitRef="case" contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg4NjI_217e5852-f2d9-4264-81a8-0c3e55d5d1c8">69</ix:nonFraction> tobacco-related cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in <ix:nonFraction unitRef="case" contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg5ODY_e37fbc76-6744-46af-9c2a-6d7c6a6c2a50">44</ix:nonFraction> of the <ix:nonFraction unitRef="case" contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg5OTY_217e5852-f2d9-4264-81a8-0c3e55d5d1c8">69</ix:nonFraction> cases.  These <ix:nonFraction unitRef="case" contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwMTM_e37fbc76-6744-46af-9c2a-6d7c6a6c2a50">44</ix:nonFraction> cases were tried in Alaska (<ix:nonFraction unitRef="case" contextRef="ib640ca736ea64adfabeed83e8a20dfe7_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwNDQ_e24a375a-c79c-4f15-acfe-6bd5504e6619">1</ix:nonFraction>), California (<ix:nonFraction unitRef="case" contextRef="i42faf7ae646d43888ef8eb211eacf9ac_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwNjE_cebb520b-1931-4c30-8aa2-a66b49491a7a">7</ix:nonFraction>), Connecticut (<ix:nonFraction unitRef="case" contextRef="i0f8e9338933b4ee6a3aa3a93e8059c2d_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwNzk_c00916ea-06cc-473b-86d3-a2f1e0a70d09">1</ix:nonFraction>), Florida (<ix:nonFraction unitRef="case" contextRef="i38158ae67bae43879aa2672ca2ab9fd5_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwOTM_d88dcad0-b170-4c57-86c8-65b73c2aaee6">10</ix:nonFraction>), Louisiana (<ix:nonFraction unitRef="case" contextRef="iccba1eb229bd4dc390001b5b8df2bc45_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxMDk_e31057ec-781c-4a92-983d-1a5c5e467df7">1</ix:nonFraction>), Massachusetts (<ix:nonFraction unitRef="case" contextRef="i9da4b44582904192921e6072055b4ac3_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxMjk_cbef2f94-c0a4-42a1-bcf2-8b438875edd7">4</ix:nonFraction>), Mississippi (<ix:nonFraction unitRef="case" contextRef="ibc1e2b1908b54d0ca3e4f21bb1d1e630_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxNDc_400c0561-cc90-4140-a05f-a5408ff2996a">1</ix:nonFraction>), Missouri (<ix:nonFraction unitRef="case" contextRef="i21bfaa9469a247b5bd27e94518726cb0_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxNjI_a8e25998-45ea-40f9-83f5-25f69057da5d">4</ix:nonFraction>), New Hampshire (<ix:nonFraction unitRef="case" contextRef="iae2caef6740d40259c9f84a490569169_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxODI_0b0880c1-0e58-4289-bde5-472af3f22a09">1</ix:nonFraction>), New Jersey (<ix:nonFraction unitRef="case" contextRef="ied53055005344f3bb2c452924e5a1528_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxOTk_2fc9841c-0e70-44ce-9cb0-38b4f74a4c84">1</ix:nonFraction>), New York (<ix:nonFraction unitRef="case" contextRef="i3ae1fff42746471eb1d0f51a965259ab_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyMTQ_55683e56-19ec-4a6a-8d81-ffd255eb9713">5</ix:nonFraction>), Ohio (<ix:nonFraction unitRef="case" contextRef="i31692ae6ae0d48948fb604426688e995_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyMjU_95bcc905-1aef-4c1b-80ba-b1b2faca2622">2</ix:nonFraction>), Pennsylvania (<ix:nonFraction unitRef="case" contextRef="ic44878beb09c49beaa5574aad702cf2b_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyNDQ_192e5a42-cde9-44a0-a7d2-589e8e489516">1</ix:nonFraction>), Rhode Island (<ix:nonFraction unitRef="case" contextRef="ie663a64cadad400db55d3b0fef5bd7d7_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyNjM_058b4f55-b3e1-4aa9-9edb-0381a6c0de2d">1</ix:nonFraction>), Tennessee (<ix:nonFraction unitRef="case" contextRef="i722c6dc101334a06958236d747b37fa6_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyNzk_aa965775-b12c-47a6-8a1b-90f9456a207b">2</ix:nonFraction>) and West Virginia (<ix:nonFraction unitRef="case" contextRef="i77665d9f65aa408b8de4b3aff7a6e23a_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzMDI_a83888e3-1e23-4ae2-b145-efdb0dd36d7b">2</ix:nonFraction>).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the <ix:nonFraction unitRef="case" contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedUnfavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzMTU_ea3da7f8-4333-4511-b0c5-4f978636540a">25</ix:nonFraction> non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs, <ix:nonFraction unitRef="case" contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027" decimals="INF" name="mo:LossContingencyClaimsResolvedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzOTg_a81e089e-b9ef-4994-af82-0b7c0bb33758">20</ix:nonFraction> have reached final resolution, and <ix:nonFraction unitRef="case" contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyVerdictReversedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzk0MzY_cf614c72-7384-4255-bbad-d15d06892f4f">one</ix:nonFraction> case (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gentile</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that was initially returned in favor of plaintiff was reversed post-trial and remains pending. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of verdicts in state and federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA as of October 27, 2020.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Judgments Paid and Provisions for Tobacco and Health Litigation Items (Including Engle Progeny Litigation)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i7b76f4a06e0d4000be39f89a1b20a4d9_D20041001-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwMDgw_713158a1-2bc6-45f2-a168-c86084a7b044">798</ix:nonFraction> million and interest totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i7b76f4a06e0d4000be39f89a1b20a4d9_D20041001-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwMTE5_4e4ee0c4-cd9f-4d35-8592-cb683a112017">217</ix:nonFraction> million as of September 30, 2020.  These amounts include payments for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny judgments (and related costs and fees) totaling approximately $<ix:nonFraction unitRef="usd" contextRef="ib42610cd85574a85ac22adfbd9232cc4_D20041001-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesPaidValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwMjU1_71b13c8b-9d5a-436c-bc1d-75e57154a31d">364</ix:nonFraction> million and related interest totaling approximately $<ix:nonFraction unitRef="usd" contextRef="ib42610cd85574a85ac22adfbd9232cc4_D20041001-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwMzAy_32c6f53e-bbe8-4fba-a9ca-2db6ac726f02">55</ix:nonFraction> million.</span></div><div><span><br/></span></div><ix:continuation id="i0db8e079d52b40238696f290dc00de08" continuedAt="id04baff9d63c4a6da92184fd97251949"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in Altria&#8217;s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:54.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:2.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health litigation items at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e09db783364478aeb09576c9febdcb_I20191231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzItMS0xLTEtMA_9f8161e9-e59d-46f0-8152-6436a69ce6f8">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fdefa86b95345148bfdd3202813cfe1_I20181231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzItMy0xLTEtMA_26fa191a-9804-4616-a7ef-cf4c4c9d21d1">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670aed569ab54abeacf39bd2a4edb1d7_I20200630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzItNy0xLTEtMA_32a48943-14e0-495c-b0ab-05bbe08236c9">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad67a6f5836647b68468a7cfc5e379e6_I20190630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzItOS0xLTEtMA_106d4af4-8bd2-4ea0-a5fc-552e0787cb9d">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic94346e89f4f4ef7864d5068b90b4f4e_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzQtMS0xLTEtMA_fce2048b-f096-4e83-87d7-cc68dd403475">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd2f6de615e40518cd41e25874f2500_D20190101-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzQtMy0xLTEtMA_67a79eba-4fdb-4c88-8d0e-7ec71eedb57c">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ef32b625acf4bd79754f47e5d1ec753_D20200701-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzQtNy0xLTEtMA_6f9b8d31-19b6-4daa-aac0-7cd67a784d54">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3815bd69824e13833b90871d61a946_D20190701-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzQtOS0xLTEtMA_b7354810-1026-42d2-938d-efd3e58c0d31">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bb1353452c4523bedf46d84d63f40c_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzUtMS0xLTEtMA_a6adb4a1-7f2a-40f5-b309-c46242498eb1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f7bad91af248dcba16157131428d9c_D20190101-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzUtMy0xLTEtMA_e18079b4-a613-4647-8f39-78a11850c512">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i853e7e20eb29408fb2d7f8a14a1797da_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzUtNy0xLTEtMA_f618337b-41df-48a0-8370-b16be35274b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f7118f93b4345d89a25d75afdb5a262_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzUtOS0xLTEtMA_82ceb4f1-0714-41e7-9fa0-6c191ea55554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzktMS0xLTEtMA_d58e249c-5cf2-4d74-951e-b690b9039d2f">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzktMy0xLTEtMA_3162a89d-4d09-4245-b6ab-49479c0b7ad1">151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzktNy0xLTEtMA_24a1aa6c-9bcd-47d0-98f0-7ee17c8c9f79">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzktOS0xLTEtMA_e53c554a-ad08-4a91-9aea-4f25bc03a209">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health litigation items at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzEwLTEtMS0xLTA_b0aae36f-a268-4d79-acfa-5b60d5ad63b5">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd09282688b34d21a437df741d91f326_I20190930" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzEwLTMtMS0xLTA_887551a9-599b-432c-8f05-b66829169ef0">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzEwLTctMS0xLTA_636fb22e-3ed7-46bb-90d2-42e141b4271b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd09282688b34d21a437df741d91f326_I20190930" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzEwLTktMS0xLTA_06549db9-678d-4c46-9bbd-9254f6c4487b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes amounts related to the costs of implementing the corrective communications remedy related to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> discussed below.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes approximately $<ix:nonFraction unitRef="usd" contextRef="ie30f52b0c96d49a3a478a6a1e2ce47c4_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwNjU3_f8bdd502-9aa0-4fba-871a-587af9fdff6f">20</ix:nonFraction> million related to pre-trial resolution of approximately <ix:nonFraction unitRef="case" contextRef="i1e5bbf67f98443c0b7edd73a8250aa82_I20200930" decimals="0" name="mo:LossContingencyNumberOfPreTrialResolutionCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwNzA5_01f0cefd-0672-43f2-99a8-bfe6f1328f07">240</ix:nonFraction> tobacco and health cases.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes approximately $<ix:nonFraction unitRef="usd" contextRef="i03e3139f46334e698285c1dea0152ad0_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwNzY1_4c2553dd-23a8-4e40-9f2a-21740c89b676">20</ix:nonFraction> million in payments related to above-mentioned pre-trial resolution of approximately <ix:nonFraction unitRef="case" contextRef="i1e5bbf67f98443c0b7edd73a8250aa82_I20200930" decimals="0" name="mo:LossContingencyNumberOfPreTrialResolutionCases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwODQ1_01f0cefd-0672-43f2-99a8-bfe6f1328f07">240</ix:nonFraction> tobacco and health cases and $<ix:nonFraction unitRef="usd" contextRef="i0cd199ca5a0f48ddb7de573598ef316e_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwODc3_a90505d2-0fbb-4845-9e5d-3b7f5ed44086">2</ix:nonFraction> million for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">. </span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="if183535380dd4108a96c4e763926505e" continuedAt="i8f0e103242aa44f8a56e4bb7dd326ec0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accrued liability for tobacco and health litigation items, including related interest costs, was included in accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.  Pre-tax charges for tobacco and health litigation were included in marketing, administration and research costs on Altria&#8217;s condensed consolidated statements of earnings.  Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria&#8217;s condensed consolidated statements of earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security for Judgments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of September 30, 2020, PM USA has posted appeal bonds totaling approximately $<ix:nonFraction unitRef="usd" contextRef="ib01325dc5c474ef0a0a12a154bd77c51_I20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationEscrowDeposit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzExNzE1_c890cab2-2e7c-4f36-8b0d-670eb7c263cb">61</ix:nonFraction> million, which have been collateralized with restricted cash that are included in assets on the condensed consolidated balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smoking and Health Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs&#8217; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Engle Progeny Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny smoking and health cases pending during 2020 in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases can be found in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="i81b724d4a8dd4812b7033d86eb830073_I20200229" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEzMzk5_9a220da1-977d-487a-9712-f033254e3e90">11</ix:nonFraction> million in compensatory damages.  There was <ix:nonFraction unitRef="usd" contextRef="i81b724d4a8dd4812b7033d86eb830073_I20200229" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEzNDM4_d89fac75-4803-4cf9-a953-4211af53e674">no</ix:nonFraction> claim for punitive damages.  PM USA&#8217;s appeal is pending in the Third District Court of Appeal.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="i7396e108206b484f903a260197ded70e_I20190930" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEzNjkw_db97ef30-ac59-410e-a15e-f13f22cba5e0">10</ix:nonFraction> million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#8217; remaining claim and trebled the compensatory damages award to approximately $<ix:nonFraction unitRef="usd" contextRef="id267dd8564a3488b94c7ba44126c87e8_I20200531" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEzODM5_d3729bf1-422c-4536-a9dd-c1a47698b80e">30</ix:nonFraction> million.  PM USA plans to file post-trial motions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laramie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff, awarding $<ix:nonFraction unitRef="usd" contextRef="i3ebfc83154ce48dea39e1eade2ed1f02_I20190831" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MDAx_69d99574-0104-4f54-bdb8-f351d07d2341">11</ix:nonFraction> million in compensatory damages and $<ix:nonFraction unitRef="usd" contextRef="i3ebfc83154ce48dea39e1eade2ed1f02_I20190831" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MDMy_273d0a3d-b1c6-4b74-a7d2-3ffb535222a4">10</ix:nonFraction> million in punitive damages.  PM USA and plaintiff have appealed.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gentile</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="i08ab18a08fc2443ab1242f3a205e3fe4_I20171031" decimals="-5" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MjIw_1d79499c-b1d5-46c2-9bf0-5faecc4e555d">7.1</ix:nonFraction> million in compensatory damages and allocating <ix:nonFraction unitRef="number" contextRef="if550a6c83d0d4c6292eefe757d6d7946_I20171031" decimals="2" name="mo:LossContingencyCompensatoryDamagesAwardedAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MjYy_9a663463-836b-44df-ab62-84d60f80bb7d">75</ix:nonFraction>% of the fault to PM USA (an amount of approximately $<ix:nonFraction unitRef="usd" contextRef="if550a6c83d0d4c6292eefe757d6d7946_I20171031" decimals="-5" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MzE2_d0a3c8c4-a3ac-4dcc-a1bd-9046f0479318">5.3</ix:nonFraction> million).  PM USA appealed.  In September 2019, the Florida Fourth District Court of Appeal reversed the judgment entered by the trial court, granted PM USA judgment on certain claims and remanded for a new trial on the remaining claims.  Plaintiff has petitioned the Florida Supreme Court for further review.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the verdict and post-trial developments in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> health care cost recovery case.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle Class Action</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2000, in the second phase of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i1a81a944b81a45a9b4aabeb561b3c720_I20000731" decimals="-9" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE1MDQz_4702c120-124b-41ce-97e5-5757bd8d969f">145</ix:nonFraction> billion against various defendants, including $<ix:nonFraction unitRef="usd" contextRef="ibf8237cac01f4de89881354f8056ccab_I20000731" decimals="-9" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE1MDg0_d3e2cdf2-9e6e-4e1f-b40f-11b9178c4757">74</ix:nonFraction> billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="i8f0e103242aa44f8a56e4bb7dd326ec0" continuedAt="i3d66202379614a849beafcf716349479"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within <ix:nonNumeric contextRef="i21e01176f3244941b8c2577c07af928b_D20060701-20060731" format="ixt-sec:durwordsen" name="mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE1NjQ5_8639da94-58fd-4f48-99b1-d1379f557f7e">one year</ix:nonNumeric> of issuance of the mandate.  The court further declared the following Phase I findings are entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect in such individual actions brought within <ix:nonNumeric contextRef="i21e01176f3244941b8c2577c07af928b_D20060701-20060731" format="ixt-sec:durwordsen" name="mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE1ODE3_80fc853f-405e-40a4-9739-f5df1fb46689">one year</ix:nonNumeric> of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#8217; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pending Engle Progeny Cases  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deadline for filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases expired in January 2008, at which point a total of approximately <ix:nonFraction unitRef="claim" contextRef="i2753d6b653574d7997560005050e6a03_I20080131" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE3NTUx_b97d5378-3a78-4a60-a53f-7c1694c0ce13">9,300</ix:nonFraction> federal and state claims were pending.  As of October 27, 2020, approximately <ix:nonFraction unitRef="claim" contextRef="i282f01973b7a450996c72e13d164a16a_I20201027" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE3NjI5_31b66d63-6142-4e80-86c3-c993b8be8379">1,300</ix:nonFraction> state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately <ix:nonFraction unitRef="plantiff" contextRef="iab0a7a02a22144d58d64538e4a422159_D20201027-20201027" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE3NzQ5_d091a7a0-a731-424b-9b7a-fa3a990a5411">1,600</ix:nonFraction> state court plaintiffs.&#160; Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates.  While the Federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement (discussed below) resolved nearly all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases pending in federal court, as of October 27, 2020, <ix:nonFraction unitRef="claim" contextRef="i78d2755130534b9f968f4c9ae194baf1_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4MDU5_fdeb333f-801a-4839-988b-b3515b824c90">three</ix:nonFraction> cases were pending against PM USA in federal court representing the cases excluded from that agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, <ix:nonFraction unitRef="case" contextRef="ibc72644f82dd4c06995b160fa2ebf6ac_D20201027-20201027" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4MjE5_c2008196-1210-42d7-9b41-0f399ac0d557">134</ix:nonFraction> federal and state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decision.  <ix:nonFraction unitRef="case" contextRef="ibc72644f82dd4c06995b160fa2ebf6ac_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedUnfavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4MzUy_e4bfe089-4812-4764-ab28-284ea93a6c5a">Seventy-eight</ix:nonFraction> verdicts were returned in favor of plaintiffs and <ix:nonFraction unitRef="case" contextRef="i5ae72485bc604c34b056b72db7e10bf3_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyUnfavorableVerdictsPendingReversed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4NDA1_96305386-aa5a-4a8f-9871-38de2a9531cc">five</ix:nonFraction> verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skolnick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Calloway</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oshinsky-Blacker,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCoy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Frogel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="ibc72644f82dd4c06995b160fa2ebf6ac_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4NTc4_83793f35-a9ca-4385-aaf7-567081a150fb">Forty-eight</ix:nonFraction> verdicts were returned in favor of PM USA, of which <ix:nonFraction unitRef="case" contextRef="i121c8c8c92154161b47ce45a7725da25_D20201027-20201027" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4NjMz_7144ae83-9fde-49be-9b54-1ac70eded347">43</ix:nonFraction> were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of October 27, 2020.  <ix:nonFraction unitRef="case" contextRef="i386be72127664d83ad959975ff8d48c4_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyVerdictReversedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4Nzc2_dbc26d4e-542d-4ba4-b661-0c5e4659dd55">Four</ix:nonFraction> verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearson, D. Cohen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collar </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chacon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in <ix:nonFraction unitRef="case" contextRef="i0790b75d3ef64acda7cf88fa64505882_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyZeroDamagesVerdicts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4OTE5_a1a81ae4-0383-432e-ad8e-2bc3d6011979">two</ix:nonFraction> cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reider </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Banks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">returned <ix:nonFraction unitRef="usd" contextRef="i0790b75d3ef64acda7cf88fa64505882_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyDamagesAwardedValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4OTU2_c132523f-47cb-4c88-be03-43ae08b59c54">zero</ix:nonFraction> damages verdicts in favor of PM USA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Juries in <ix:nonFraction unitRef="case" contextRef="id594dce411764c92b6f7ed94ea6a2dee_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyZeroDamagesVerdictModified" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5MDA3_1d3c072c-6da8-42ae-9ae3-6f1f20a904d4">two</ix:nonFraction> other cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Weingart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hancock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned verdicts against PM USA awarding <ix:nonFraction unitRef="usd" contextRef="id594dce411764c92b6f7ed94ea6a2dee_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyDamagesAwardedValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5MDg3_591e7ebc-d7cf-4d21-ab60-c48da2de16d0">no</ix:nonFraction> damages, but the trial court in each case decided to award plaintiffs damages.  <ix:nonFraction unitRef="case" contextRef="i055fbe8d8f0144a7aeb8622777fb5fb4_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5MTcw_85a9ca38-60ba-461b-b4f3-1ba09b17923c">One</ix:nonFraction> case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pollari, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Appeals by plaintiff and defendants are pending.  <ix:nonFraction unitRef="case" contextRef="id660194fbef544acb7a9ac3e9edd669b_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5MzU0_296725c5-f8cb-4ba0-92c2-9922929bcddb">Three</ix:nonFraction> cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  Post-trial motions or appeals are pending.  <ix:nonFraction unitRef="case" contextRef="i0bfe653a65cc453d9adba37e43c082ee_D20201027-20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5NTYy_7319e02a-6281-47ad-a08d-ca5a086c736c">One</ix:nonFraction> case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freeman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below list the verdicts and post-trial developments in certain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists such cases that are pending as of October 27, 2020 where PM USA has recorded a provision in its consolidated financial statements because PM USA has determined that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated; the second chart lists other such cases that are pending as of October 27, 2020 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated; and the third chart lists other such cases that have concluded within the previous 12 months.  Unless otherwise noted for a particular case, the jury&#8217;s award for compensatory damages will not be reduced by any finding of plaintiff&#8217;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i3d66202379614a849beafcf716349479" continuedAt="i5345767f706d48fd8ef6b6bec88f0265"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Accrued Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><ix:continuation id="id04baff9d63c4a6da92184fd97251949" continuedAt="i37443d4ecc0e41129161f9dd71459760"><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages (All Defendants)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages (PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Berger </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cote</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2014</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i09102d7949074727b6b071832c9c9a1b_I20140930" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzEtNC0xLTEtMC90ZXh0cmVnaW9uOjk5YmM1Y2MxMWE1MzQwZjVhMjBjZDIwYjQzYWE0NzUxXzkzNDU4NDg4MzYxMjA_bbe051ab-73a2-4b82-930c-e7e774cca099">6</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i68e27be8c5e340d2b5ab22ec89c6fbff_I20140930" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzEtNS0xLTEtMC90ZXh0cmVnaW9uOjQ4MjFmMTE2ZGRjNDQwNjg5ZTkzODdjNzBkZjZkODZmXzkzNDU4NDg4MzYxMjI_adbca49f-f38e-4bea-944d-ec74528a7d59">21</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court.  PM USA&#8217;s challenge to the punitive damages award was denied by the district court.  Appeal by PM USA to Eleventh Circuit Court of Appeals pending.</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i763f26f3f9864550bce1cb5f1d139b5f_D20181001-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzEtNy0xLTEtMC90ZXh0cmVnaW9uOjgyYTY5NTZiZDU1NjQzNjFhNGExZGNlZTI0MTIxOTg2XzkzNDU4NDg4MzYxNjE_5a85c535-fc3a-47a2-9fb2-5cdccaf4de67">6</ix:nonFraction>&#160;million accrual in the fourth quarter of 2018</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Santoro</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2017</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA, R.J. Reynolds and Liggett Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i2f379dd774a84c178271dd8ddf630a75_I20170331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzItNC0xLTEtMC90ZXh0cmVnaW9uOjNmNmY5YWM0MWVlOTRlNDc5ZDEyMWU0NWUwMjkwMTVhXzkzNDU4NDg4MzYxNDE_ae874734-11fc-4f4c-a606-2cad553d8a19">2</ix:nonFraction>&#160;million (&lt;$<ix:nonFraction unitRef="usd" contextRef="i83bc2d39c8314c73ac43d49baca414d7_I20170331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzItNC0xLTEtMC90ZXh0cmVnaW9uOjNmNmY5YWM0MWVlOTRlNDc5ZDEyMWU0NWUwMjkwMTVhXzkzNDU4NDg4MzYxOTU_32fa515d-f151-436e-9bd8-59a5ec4c15d1">1</ix:nonFraction>&#160;million PM USA) </span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="i83bc2d39c8314c73ac43d49baca414d7_I20170331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzItNS0xLTEtMC90ZXh0cmVnaW9uOjJkMTdmY2QzNDQwODQ3NjQ5N2IxMDBkZTQ2YjJmZjk0XzkzNDU4NDg4MzYxMjI_f41912f0-4283-4835-ae31-c4142265cc50">1</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Fourth District Court of Appeal affirmed the compensatory damages award and reinstated the punitive damages award.  Defendants&#8217; motion for rehearing was denied. Appeal by defendants of punitive damages award to Florida Supreme Court pending.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="i8a8b0e0c65974548b24e515426fd6cb4_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzItNy0xLTEtMC90ZXh0cmVnaW9uOmJkN2VjNjdmZjVhOTQ2MDk5ZDdlYjEwNDlhMTJjODllXzkzNDU4NDg4MzYxOTA_cefe3bed-e568-412c-a2fa-6e98ab151313">1</ix:nonFraction> million accrual for compensatory damages award in the second quarter of 2020</span></div></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrual amounts include interest and associated costs, if applicable.  For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff&#8217;s favor after taking into account any portion potentially payable by the other defendant(s). </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> References to &#8220;R.J. Reynolds,&#8221; &#8220;Lorillard&#8221; and &#8220;Liggett Group&#8221; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and <br/>R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i54e27c4d0aa94139a647bf051cb35c24_I20200229" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEtNC0xLTEtMC90ZXh0cmVnaW9uOjgxOGU3ZjJhODJjZjQyNDNhYTMwYjU1YjQ4NzhmNTE2XzE4NjkxNjk3NjcyMjE2_26f54060-f544-494b-803c-3c6a1b8c84a0">3</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i73562f0789564c4ca3b746d86736d7f1_I20200229" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEtNS0xLTEtMC90ZXh0cmVnaW9uOjJiNDM1MWQ0NDdhNDRiMWM5ZWFiNmM2NTZlOWI4NjBhXzE4NjkxNjk3NjcyMjE4_cd61018b-ea5d-4a2f-91b0-8b70bd237a16">12</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Second District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iee24c1e556fd401ebf1c14cc046a2c47_I20200131" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzItNC0xLTEtMC90ZXh0cmVnaW9uOjg0MmMzZjMzMTBlNjQzYmU4NjA4OGJmY2I0MDBhYzFhXzg3OTYwOTMwMjIyMzI_6bf291d9-93df-4bcb-8c36-3b5fe4cf62dc">3</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i720d17586fc04494803d6a38d0d0a43a_I20200131" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzItNS0xLTEtMC90ZXh0cmVnaW9uOjAxZWRhNmU1OGQxYzQ0Mzg4NTkwOWViN2I3ZGNlOGIyXzg3OTYwOTMwMjIyMTQ_19963286-de04-47d2-8d3c-c910bdfbffba">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by plaintiff and defendant to First District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icb420eb62e1c4abda0c90da42623cf66_I20191130" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzMtNC0xLTEtMC90ZXh0cmVnaW9uOmUzYWEwNWUyM2ExYjQxYWY5ODFmMWI0YWFhYjA3OTI0Xzg3OTYwOTMwMjIyNTI_c0e7390d-82ee-4ccb-90f3-393deaf09c37">9</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ic0334756982249f5a738ecdc55a81329_I20191130" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzMtNC0xLTEtMC90ZXh0cmVnaW9uOmUzYWEwNWUyM2ExYjQxYWY5ODFmMWI0YWFhYjA3OTI0Xzg3OTYwOTMwMjIyNjU_43fa99a4-112f-48dc-81bf-c2f385a239c0">5</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic0334756982249f5a738ecdc55a81329_I20191130" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzMtNS0xLTEtMC90ZXh0cmVnaW9uOmZhODE4NzNjNGQzMDQyODRiOGZkNDJmNWE3YmQ0OWViXzg3OTYwOTMwMjIyMzQ_1f96162f-bc21-456b-a68e-99ffdfc993e4">74</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Gloger</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i473d370813804ee9923d2d9d90726e86_I20191130" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzQtNC0xLTEtMC90ZXh0cmVnaW9uOmZiNjhkYmE5NWI4YTQzNmY4NTI0ZTEzZjZmMzU1ZjM3Xzg3OTYwOTMwMjIyNTQ_63ff815f-7398-42f9-b878-2a45467747a1">15</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i5e8a0f49c0334761b75e98dc0a5ae0e3_I20191130" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzQtNC0xLTEtMC90ZXh0cmVnaW9uOmZiNjhkYmE5NWI4YTQzNmY4NTI0ZTEzZjZmMzU1ZjM3Xzg3OTYwOTMwMjIyNjc_a3e53b76-f438-48ad-ad92-6c573ed594c6">5</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5e8a0f49c0334761b75e98dc0a5ae0e3_I20191130" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzQtNS0xLTEtMC90ZXh0cmVnaW9uOjY1NDQzMzQyODFmMzQ4YjViOWMzZTgxZmJjNzVlYmM0Xzg3OTYwOTMwMjIyMzQ_fe2ab3da-a737-4c9a-b93d-760e33ddf03c">11</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="i7cb77069bc64499a9599c4b95646cbbc_I20190331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzUtNC0xLTEtMC90ZXh0cmVnaW9uOjdiOTc4Yzg2MThhMDRkZGNiMmYzYTJmM2U2NTIwN2M5Xzg3OTYwOTMwMjIyNTQ_7f685b92-3236-4fdc-b7f7-cc56a172c4c5">1</ix:nonFraction>&#160;million (&lt;$<ix:nonFraction unitRef="usd" contextRef="ib37d24d3b5fc4f8d8fe8d58c3e41ba9b_I20190331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzUtNC0xLTEtMC90ZXh0cmVnaW9uOjdiOTc4Yzg2MThhMDRkZGNiMmYzYTJmM2U2NTIwN2M5Xzg3OTYwOTMwMjIyNjc_cbb1f3cb-ddf9-4819-bb5c-9723f3019da8">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="ib37d24d3b5fc4f8d8fe8d58c3e41ba9b_I20190331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzUtNS0xLTEtMC90ZXh0cmVnaW9uOmRjN2Y0YzMxOTFiNjRiOTI5OWY0Mjg3Y2Q2MTZkOTJhXzg3OTYwOTMwMjIyMzM_8aea9007-61ad-49df-9e88-50cc08aa30b3">1</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial ordered on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Neff</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if7391ca337c34ee3812079caa09a47a8_I20190331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzYtNC0xLTEtMC90ZXh0cmVnaW9uOjZhMjdjYmQwYWYzODQ4MDE5NWUwNjAzNTM0NmVkNzhkXzg3OTYwOTMwMjIyMzI_aa49390f-5dc9-4a9f-926f-50d2af088786">4</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9e8ceb1484f445ba829b403f9ca487cb_I20190331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzYtNS0xLTEtMC90ZXh0cmVnaW9uOjE3NmQwMzY1YWZlMzQ5NjlhN2FkZGMwMjk4MzAxYmUzXzg3OTYwOTMwMjIyMzI_883ee8a8-46a3-43ef-9103-dce2594114ec">2</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Frogel</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palm Beach</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="ie8ee87d2eab14b2dadd569b18425aac6_I20190331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzctNC0xLTEtMC90ZXh0cmVnaW9uOjg1NWQzMWE2Y2EzNzRmOTk4YzQyNmE2NTBiOWM3NmMzXzg3OTYwOTMwMjIyNTQ_a6bbd16e-0604-496d-ad7b-93561bccf8b4">1</ix:nonFraction>&#160;million (&lt;$<ix:nonFraction unitRef="usd" contextRef="ie8ee87d2eab14b2dadd569b18425aac6_I20190331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzctNC0xLTEtMC90ZXh0cmVnaW9uOjg1NWQzMWE2Y2EzNzRmOTk4YzQyNmE2NTBiOWM3NmMzXzg3OTYwOTMwMjIyNjc_32b7c3b7-57de-489b-8624-2fe62ddbd302">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie8ee87d2eab14b2dadd569b18425aac6_I20190331" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzctNS0xLTEtMC90ZXh0cmVnaW9uOjkwZmMwOTJmZWZhNjQ0MzhhMzg3MTE2NDVlZTE3OGFkXzg3OTYwOTMwMjIyMTQ_d80f4987-307a-4afe-ab09-f31794f424f5">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal reversed the judgment against PM USA and ordered a new trial.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Mahfuz</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i157ee62daa634c5baba2332dda040742_I20190228" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzgtNC0xLTEtMC90ZXh0cmVnaW9uOmRlYzJhZDE1NjVjYjQ0MDI5YjMzNWZlNDA3Y2ZlZjlkXzg3OTYwOTMwMjIyMzQ_5669ce12-c80f-4c25-a32c-5ba899163560">12</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iccb40a3f593e44f1945490c8afa74e4a_I20190228" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzgtNS0xLTEtMC90ZXh0cmVnaW9uOjI3MGU5NWNmM2ZjNDRlOWFhNGM3ZTM5YzJlYTE2MzJjXzg3OTYwOTMwMjIyMzQ_f21fda08-b463-4470-b4d2-b02490e1d72c">10</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iaa873ae904e843a68f15a429f1ddca30_I20190228" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzktNC0xLTEtMC90ZXh0cmVnaW9uOjEwZWU0MmVmMDYxYTQ4MTBhNTU5MGQzYTA4NTM0ZDRiXzg3OTYwOTMwMjIyMzI_5acc4765-5846-4b90-b757-948b4a0713f8">3</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="idbdcfd0b02f340638485ef5bf9030554_I20190228" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzktNS0xLTEtMC90ZXh0cmVnaW9uOjM3NDhhMzk3NDFkYzRjNTJhNmIyNWZjZTU4N2U0ODA0Xzg3OTYwOTMwMjIyMTQ_e9266db3-f298-4210-8ab2-501515567e75">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendant&#8217;s appeal to Third District Court of Appeal pending.</span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i5345767f706d48fd8ef6b6bec88f0265" continuedAt="i4db579a26b4142f7a60d9cc30ca08e30"><ix:continuation id="i37443d4ecc0e41129161f9dd71459760"><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i262382c0015d432f842b18237e28071e_I20180930" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEwLTQtMS0xLTAvdGV4dHJlZ2lvbjpkMmUyNDgzMTYyYzU0NTIxYjA3MTFiZmQ3N2IzNTA0NF84Nzk2MDkzMDIyMjMy_b937fc8d-d55d-4e0a-8df4-17b72afe193a">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7ba2f37bcf6a402cbdc706a9755f41eb_I20180930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEwLTUtMS0xLTAvdGV4dHJlZ2lvbjpmZWM0NzBlZTUyMDQ0N2I0YTlkZGM5YzZjY2I4NGY4M184Nzk2MDkzMDIyMjE0_fcf5fd08-f947-4416-96b1-d2babba8ff05">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie7c4b24571604e75af7f7e9f3bb4d335_I20180731" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzExLTQtMS0xLTAvdGV4dHJlZ2lvbjo0NTk2ODJmZTNlMWY0Y2FkODMzMzI2MjA3OWM3ZmIxZl84Nzk2MDkzMDIyMjMy_14dbc155-a50b-4308-a339-a6939792da48">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i35caf9a0d822450fa81f75e68cd02338_I20180731" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzExLTUtMS0xLTAvdGV4dHJlZ2lvbjo2ZjIzZTdhZjU4YTg0NTkyYTUxZmQ5ZDI1M2FmNjFiYl84Nzk2MDkzMDIyMjI4_a7959e6e-fb80-467b-ba75-872178573e3a">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">R. Douglas</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="ia3bacb16e4784de892ae8b6b2205a876_I20171130" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEyLTQtMS0xLTAvdGV4dHJlZ2lvbjo2Y2VhYTg2OGJmYmI0NjY0OWU0ZDBmZGJiZmI4NzJiMF84Nzk2MDkzMDIyMjMz_3286e52f-f33c-4152-b17b-5f84c0746e54">1</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0cb589bcaaa645de9d8fdc23492ff483_I20171130" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEyLTUtMS0xLTAvdGV4dHJlZ2lvbjpkNmU5ZmY5ZWEyNGE0NmI4YjFhZDNkMmE1NmVhMjNkZF84Nzk2MDkzMDIyMjE2_4bc8b7a7-40ee-4041-8ff3-b7e8dffdaec9">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awaiting entry of final judgment by the trial court.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Sommers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2017</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i67739f053413439ebc96236f3209b74e_I20170430" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEzLTQtMS0xLTAvdGV4dHJlZ2lvbjoxNTgxMjNlMjZhYmQ0N2UxOTg0MDE0M2Q2NjE1YzZiMl84Nzk2MDkzMDIyMjMy_91e20f8e-3617-4e11-b2a0-f595c542690e">1</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i78f0ea0e26e943ae806d1225535249a8_I20170430" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEzLTUtMS0xLTAvdGV4dHJlZ2lvbjo1N2Q5YmVjYjcwYWY0NTJjYjY4Nzk1NjdlMDIzYjQyOF84Nzk2MDkzMDIyMjE2_02360d2b-2e22-4bef-8dfd-350772a33c92">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA's petition for review.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper (Blackwood)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia0c617d528d64ef7961c5cff9cbf15ec_I20150930" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE0LTQtMS0xLTAvdGV4dHJlZ2lvbjo1NDVkNThiNjA2ZWE0MTEzYmU3ZTBhNzk4Mzg5NzllYl84Nzk2MDkzMDIyMjU0_bd640148-8ddd-4d8e-8d6d-97229ca3b3c6">5</ix:nonFraction>&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$<ix:nonFraction unitRef="usd" contextRef="i06074dee810942e292ea731bda7a36a0_I20150930" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE0LTQtMS0xLTAvdGV4dHJlZ2lvbjo1NDVkNThiNjA2ZWE0MTEzYmU3ZTBhNzk4Mzg5NzllYl84Nzk2MDkzMDIyMjY3_9171fe15-79f5-4ba8-b4f4-7565d66bfdf9">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i06074dee810942e292ea731bda7a36a0_I20150930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE0LTUtMS0xLTAvdGV4dHJlZ2lvbjoyY2ViYmVhMGViMWE0OGI1ODQ3ZDI2MzQyNGI0NDAzY184Nzk2MDkzMDIyMjE2_e461fc5b-4151-45e1-8617-206abcf7c8d8">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6797d3f0b35047dda7ab8a8ec5357129_I20150131" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE1LTQtMS0xLTAvdGV4dHJlZ2lvbjowMGM0NDZhYmVhZTA0OGQxOTE4NjRmNWU4ZGFlYjEwNF84Nzk2MDkzMDIyMjMy_e4cb4861-094c-43b6-86b5-eb9dd1a0fbeb">8</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9a54fa21dad34042b8f605536d155127_I20150131" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE1LTUtMS0xLTAvdGV4dHJlZ2lvbjo5MWEyZDAzODJkYzQ0MDE2ODA5YTk0NTYyOTk3MjgwZl84Nzk2MDkzMDIyMjMy_017f9d24-26db-45ca-bd22-4f37628dd7a6">9</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Harris</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2014</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA, <br/>R.J. Reynolds and Lorillard</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i82c91aed7e2542169faf3a41146a2257_I20140731" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE3LTQtMS0xLTAvdGV4dHJlZ2lvbjo2YmU1NWQwYzYxMGY0NWNjYWExZTY1MmEyNzAwNWY2Y184Nzk2MDkzMDIyMjU0_8716d35a-be28-424b-b00e-ed4aca7906df">2</ix:nonFraction>&#160;million (&lt;$<ix:nonFraction unitRef="usd" contextRef="i490bb998e16344949c52ff8781d7eb75_I20140731" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyCompensatoryDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE3LTQtMS0xLTAvdGV4dHJlZ2lvbjo2YmU1NWQwYzYxMGY0NWNjYWExZTY1MmEyNzAwNWY2Y184Nzk2MDkzMDIyMjY4_794f18d4-5615-49cd-83a2-3f8ba36a796e">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i490bb998e16344949c52ff8781d7eb75_I20140731" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE3LTUtMS0xLTAvdGV4dHJlZ2lvbjpjZGE0N2RkMmQ5ZjA0NjJiOWZjMjc1NGI3OWNhOWFhZl84Nzk2MDkzMDIyMjE2_b8d3114e-bcb3-42a5-935c-d2e4378d5e76">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in this case.</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.196%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount<br/>(if any)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Dean (Kerrivan)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2014</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5fedb4dbaee5495fb6536ab744945764_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo4ODQ5NDZjYWEzYjQ0YTEyOTM0OGQ1MGUzNjg1NTU0My90YWJsZXJhbmdlOjg4NDk0NmNhYTNiNDRhMTI5MzQ4ZDUwZTM2ODU1NTQzXzEtNS0xLTEtMzg1NS90ZXh0cmVnaW9uOjI5YWE2NDJlNGVkMjQ0ZmViMDM3YjkzMWQ5MGRhNTg3Xzg3OTYwOTMwMjIyMzQ_358e07a5-61e7-48ed-9131-4a03638122c6">26</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i62c4a7eb460c47c4abeef12cfe44cd6d_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo4ODQ5NDZjYWEzYjQ0YTEyOTM0OGQ1MGUzNjg1NTU0My90YWJsZXJhbmdlOjg4NDk0NmNhYTNiNDRhMTI5MzQ4ZDUwZTM2ODU1NTQzXzEtNS0xLTEtMC90ZXh0cmVnaW9uOjQxNmZlOWRlNDUzZjRkMWNiMTEyNzMzNGU4ZGQzNzYwXzg3OTYwOTMwMjIyMzQ_e5353ce4-ac40-4a5e-945c-68389ef42ca4">10</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Theis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and <br/>R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sarasota</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">First quarter of 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5bac0925a60d445ea8ad330c550cde67_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo4ODQ5NDZjYWEzYjQ0YTEyOTM0OGQ1MGUzNjg1NTU0My90YWJsZXJhbmdlOjg4NDk0NmNhYTNiNDRhMTI5MzQ4ZDUwZTM2ODU1NTQzXzItNS0xLTEtMC90ZXh0cmVnaW9uOmM2MDU1OGNhZTBkMDQzY2RiNmRlMjJkNWJiMTc4M2NkXzg3OTYwOTMwMjIyMzQ_25ba6ff8-7450-4f8e-9c2e-0f649c225c8f">17</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In <ix:nonFraction unitRef="case" contextRef="ica94d523154c4c0fbf78887c8b5a2ecf_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxNjk3_baa8d7df-88be-4741-ac4f-d7dc337f2f0d">four</ix:nonFraction> cases in which PM USA paid the judgments more than a year ago, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Naugle,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Gore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">M. Brown </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Jordan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, plaintiffs were awarded approximately $<ix:nonFraction unitRef="usd" contextRef="i06e101deca564c7faf4a806f5acf2373_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxODM2_128df1be-dcf9-4db6-83d2-43ab8f85b1f8">8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i05be0cce4caa4d2b8616b1209601e242_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxODQw_ea7c01ec-17dd-46e9-9482-88554b43cc4e">2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id8ade17230a6455891f64fe763188b45_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxODQ0_282f8b24-45b4-4ee7-b2da-13381f017895">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7458b6e8570f46858d3d5cfb65f8fed0_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxODUx_6b149a3d-c5aa-4403-8566-fda5228a26ee">4</ix:nonFraction> million in fees and costs, respectively.  PM USA has appealed in all of these cases. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In August 2020, the U.S. Court of Appeals for the Eleventh Circuit denied the defendants&#8217; petition for rehearing.  As a result, in the third quarter of 2020, PM USA recorded a pre-tax provision of approximately $<ix:nonFraction unitRef="usd" contextRef="i5fedb4dbaee5495fb6536ab744945764_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg5MDMyMzU_358e07a5-61e7-48ed-9131-4a03638122c6">26</ix:nonFraction> million, reflecting its portion of the judgment plus interest, and paid this amount in August 2020.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In June 2020, the Fourth District Court of Appeal affirmed the compensatory damages award.  As a result, in the second quarter of 2020, PM USA recorded a pre-tax provision of approximately $<ix:nonFraction unitRef="usd" contextRef="i4ced792544c54268bd9593f35eddb549_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="mo:PreTaxChargesGainIncludedinNetEarning" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIyMjM2_b4c730d5-aa28-419b-8773-613f990e2911">10</ix:nonFraction> million for the judgment plus interest and paid this amount in July 2020.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In February 2020, the Florida Second District Court of Appeal denied PM USA&#8217;s petition for review.&#160; As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately $<ix:nonFraction unitRef="usd" contextRef="i3fcc4a28b47f436c803de4971a69b758_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="mo:PreTaxChargesGainIncludedinNetEarning" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIyNTA1_d8f35fd6-63fc-483a-bb93-25aee930af18">17</ix:nonFraction> million for the judgment plus interest and paid this amount.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i4db579a26b4142f7a60d9cc30ca08e30" continuedAt="ifd192ff5e6ff42a39dca9e1c4edb6dbc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Florida Bond Statute  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2009, Florida amended its existing bond cap statute by adding a $<ix:nonFraction unitRef="usd" contextRef="i2af34da3eecf4a8ebf87a01b040a2639_I20090630" decimals="INF" format="ixt:numdotdecimal" name="mo:MaximumBondForAllDefendants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIyNjU4_e2e00175-4926-4295-86a6-ea14d1791dd3">200</ix:nonFraction> million bond cap that applies to all state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny lawsuits in the aggregate and establishes individual bond caps for individual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases tried in federal court.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases purport to be brought on behalf of residents of a particular state or states (although a few cases purport to be nationwide in scope) and raise addiction claims and, in many cases, claims of physical injury as well.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class certification has been denied or reversed by courts in <ix:nonFraction unitRef="case" contextRef="i56d82ed761ef41faa02538a434851cba_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIzOTI5_61f56a36-a6c9-4a98-b455-e23aadc2f34f">61</ix:nonFraction> smoking and health class actions involving PM USA in Arkansas (<ix:nonFraction unitRef="case" contextRef="i478232b2660949908a92fbab33c32522_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIzOTk1_85f90b9b-45c5-4572-8c6d-984497ffebd5">1</ix:nonFraction>), California (<ix:nonFraction unitRef="case" contextRef="i33543518d6fe4ed1953a1556411870d8_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDEy_d07d7ba8-725d-4c82-b4b7-7d29d9f472ef">1</ix:nonFraction>), Delaware (<ix:nonFraction unitRef="case" contextRef="i6a8b9d0cebed4ddb9c87e8c9b6beb170_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDI3_546d28d9-9909-4958-b53f-2e787f5e3f17">1</ix:nonFraction>), the District of Columbia (<ix:nonFraction unitRef="case" contextRef="if01eeea512324def8fe5ddadb4933fad_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDU4_a89799b7-7c54-4682-b9d5-9029c2e9007c">2</ix:nonFraction>), Florida (<ix:nonFraction unitRef="case" contextRef="i699b979bc3384548b7b8bea7e04b6c80_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDcy_f8164133-f86c-4946-91c0-be1025ffb853">2</ix:nonFraction>), Illinois (<ix:nonFraction unitRef="case" contextRef="i4ff54182d2e14c58b237baad2a9f2b83_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDg3_43954d27-b195-4ad5-8689-419d72923910">3</ix:nonFraction>), Iowa (<ix:nonFraction unitRef="case" contextRef="i21d1ad4f96264abdb7cc9a9a8779a95c_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDk4_91f8a91c-6414-45d6-9391-a6d82b842e50">1</ix:nonFraction>), Kansas (<ix:nonFraction unitRef="case" contextRef="i93b4623007a1413fa49810d6fcdcc0b4_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTEx_34f50511-9dc2-409d-9ec5-fe35bae0f38c">1</ix:nonFraction>), Louisiana (<ix:nonFraction unitRef="case" contextRef="i838f2633ed9f400bbf26ccb953378742_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTI3_4c65cb6b-f352-41c2-a6cb-b0573b64f62b">1</ix:nonFraction>), Maryland (<ix:nonFraction unitRef="case" contextRef="icf31645f50824ffea06b19db990ee06c_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTQy_01fef3f8-da3b-40d8-8636-f9140c187f80">1</ix:nonFraction>), Michigan (<ix:nonFraction unitRef="case" contextRef="i65cd4161393b493e93229e0b24630447_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTU3_ebb8b8e7-33b3-4ff0-a257-e15693d1cbfd">1</ix:nonFraction>), Minnesota (<ix:nonFraction unitRef="case" contextRef="i776efbde1566429f802bd97c318bb9de_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTcz_8e18d650-acfe-4c0a-b22d-644859fe7e97">1</ix:nonFraction>), Nevada (<ix:nonFraction unitRef="case" contextRef="ia1eed415a7f14ab7906e4688e423ad63_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTg2_3d6ee935-e9c1-4c56-a7c2-92b7b19a589a">29</ix:nonFraction>), New Jersey (<ix:nonFraction unitRef="case" contextRef="ib3f246771a94496a8fe79e88a4c244f8_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjAz_d34cf1f1-bf84-4309-a02a-2e98b5c529e1">6</ix:nonFraction>), New York (<ix:nonFraction unitRef="case" contextRef="i808cf4a891d345f1b854305991736a14_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjE4_cd3607a1-f660-4d73-8b6e-71e7dc28da92">2</ix:nonFraction>), Ohio (<ix:nonFraction unitRef="case" contextRef="i207d1b533ad342f0869af8557c242e8a_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjI5_af11b620-4f19-4643-a6bc-1bc71246aacc">1</ix:nonFraction>), Oklahoma (<ix:nonFraction unitRef="case" contextRef="i6fa168360477427daf858f964b5cb335_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjQ0_1094bbe4-51e0-442c-9c17-6c0826675e7c">1</ix:nonFraction>), Oregon (<ix:nonFraction unitRef="case" contextRef="i56a3c4325e724588a97c6020a21a678d_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjU3_dd760f60-6c7e-498c-a1b6-cefe1e136274">1</ix:nonFraction>), Pennsylvania (<ix:nonFraction unitRef="case" contextRef="i3ce9b9f166c94ef2abf45bab5d8b92ad_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0Mjc2_fb9b066f-eae2-4199-9287-cdf1113a6ad8">1</ix:nonFraction>), Puerto Rico (<ix:nonFraction unitRef="case" contextRef="iffac1ae1843149e283a93385a7627136_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0Mjk0_264d4da5-e4ed-4e0a-8f8c-f4371cd29de6">1</ix:nonFraction>), South Carolina (<ix:nonFraction unitRef="case" contextRef="i2e4937e663604dd08163acaf12477d40_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MzE1_aefcbd67-e17b-4c83-a056-081a3f5dd864">1</ix:nonFraction>), Texas (<ix:nonFraction unitRef="case" contextRef="id6abd61ba1fd4819a6eb7a7144ab2ed8_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MzI3_613de21b-c918-4da0-837e-4be063e7b5b0">1</ix:nonFraction>)&#160;and Wisconsin (<ix:nonFraction unitRef="case" contextRef="i0fb064a2cc7d473e8f865cbc2fb8885f_D19960501-20200930" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MzQ2_1ceabfc4-8521-4b49-9740-4a3c092b89c9">1</ix:nonFraction>).  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; class action cases and medical monitoring class action cases pending against PM USA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in <ix:nonFraction unitRef="claim" contextRef="i5370156fe8d14a8e8da1520ca797a308_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0NjQ3_90a9974c-2cf3-4536-a8fb-6bbb2ef62181">seven</ix:nonFraction> class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (<ix:nonFraction unitRef="claim" contextRef="id3f5b7c4027d400398db6b1ad78239ab_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0ODEx_0e5aa241-8782-430c-8ec2-159f31bd1a0a">two</ix:nonFraction> separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#8217; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#8217; cigarettes.  In March 2019, all of these class actions were stayed as a result of <ix:nonFraction unitRef="manufacture" contextRef="i3f3875700c6945e4837cd9e5bda1f32b_I20190331" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI1MzAz_2277ace6-4a20-4596-bf4d-01fff3444db9">three</ix:nonFraction> Canadian tobacco manufacturers (none of which is related to Altria or its subsidiaries) seeking protection under Canada&#8217;s Companies&#8217; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the U.S.).  The companies entered into these proceedings following a Canadian appellate court upholding <ix:nonFraction unitRef="ruling" contextRef="i3f3875700c6945e4837cd9e5bda1f32b_I20190331" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyVerdictsUpheld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI1NjE1_bfc2496e-5001-4815-8819-d760df2a1978">two</ix:nonFraction> smoking and health class action verdicts against those companies totaling approximately CAD $<ix:nonFraction unitRef="cad" contextRef="idc79629711204f43abfeca4b62d5c1d8_D20190301-20190331" decimals="-9" format="ixt:numdotdecimal" name="mo:AmountAwardedtoOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI1NzEw_799793a7-ddfe-4a8b-b1db-f2aff5d4474f">13</ix:nonFraction> billion.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Cost Recovery Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there have been some decisions to the contrary, most judicial decisions in the U.S. have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#8217; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The United States Supreme Court has refused to consider plaintiffs&#8217; appeals from the cases decided by five federal circuit courts of appeal. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="ifd192ff5e6ff42a39dca9e1c4edb6dbc" continuedAt="i0cd15417821844ac99e31a29df68d6a4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the cases brought in the U.S., health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (<ix:nonFraction unitRef="claim" contextRef="i8949cd3b364e4768928464fc8e22ebae_I20200930" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI3Mjg0_b39d9384-b332-4c34-8d47-1352d4d8f619">10</ix:nonFraction> cases),&#160;and other entities have stated that they are considering filing such actions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving <ix:nonFraction unitRef="manufacture" contextRef="id0f294b9d70d421f83088c1d9d8b30a9_I20190930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI4MTY2_47c288c9-a238-4497-8334-98d321700166">three</ix:nonFraction> tobacco manufacturers (none of which are affiliated with Altria or its subsidiaries) under the Companies&#8217; Creditors Arrangement Act discussed above.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for a discussion of these proceedings.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Settlements of Health Care Cost Recovery Litigation  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, PM USA and certain other tobacco product manufacturers entered into the MSA with <ix:nonFraction unitRef="state" contextRef="i169d27beb37c49c5bf82654208714375_D19981101-19981130" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI4Nzc1_e3561a28-e932-446a-8709-5e6a75bc4570">46</ix:nonFraction> states, the District of Columbia and certain U.S. territories to settle asserted and unasserted health care cost recovery and other claims. PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#8220;State Settlement Agreements&#8221;). The State Settlement Agreements require that the original participating manufacturers or &#8220;OPMs&#8221; (now PM USA and R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#8220;ITG&#8221;)) make annual payments of approximately $<ix:nonFraction unitRef="usd" contextRef="i169d27beb37c49c5bf82654208714375_D19981101-19981130" decimals="-8" format="ixt:numdotdecimal" name="mo:LitigationSettlementAnnualPaymentAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI5Mzc2_97d3c690-7091-4d2f-8b4f-c4475fd84e48">9.4</ix:nonFraction> billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#8217; attorneys&#8217; fees, subject to an annual cap of $<ix:nonFraction unitRef="usd" contextRef="i97d740917fe440d1a50498a05140608e_I19981130" decimals="INF" format="ixt:numdotdecimal" name="mo:LitigationSettlementAnnualLegalFeesPayableMaximum" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI5NTg4_6e1484db-8045-483e-b477-aa58db07543d">500</ix:nonFraction> million.  For the three months ended September 30, 2020 and 2019, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $<ix:nonFraction unitRef="usd" contextRef="iff56a70694624f4a924402ecc251143a_D20200701-20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI5NzU3_17f20300-e148-449c-a8f5-13d6fe9f9892">1.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i047334242a4e4b4e9a23b88b2217bc5c_D20190701-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI5NzY0_0da9a087-8f8f-45f8-aa0d-2263772a4faa">1.1</ix:nonFraction> billion, respectively.  For the nine months ended September 30, 2020 and 2019, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $<ix:nonFraction unitRef="usd" contextRef="i06cf35adf4314057a6229713af6fc6f9_D20200101-20200930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTc5NTc_9ffcdb22-d682-408e-9f09-12459e7b7fa6">3.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i6fc84a4adae148e8b5c911a64d52cfdd_D20190101-20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzk4OTU2MDQ3MTE4NjU_15439107-38ec-42e1-a77c-ee6d3bded959">3.2</ix:nonFraction> billion, respectively.  These amounts include PM USA&#8217;s estimate of amounts related to NPM Adjustments discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA is participating in proceedings regarding the NPM Adjustment for 2003-2019.  The &#8220;NPM Adjustment&#8221; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#8220;participating manufacturers&#8221; or &#8220;PMs&#8221;) that applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses. The independent auditor (the &#8220;IA&#8221;) appointed under the MSA calculates the maximum amount of the NPM Adjustment, if any, for each year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NPM Adjustment Disputes - Settlement with <ix:nonFraction unitRef="state" contextRef="ie19865eab4224177afee834778e21a4a_D20200101-20200930" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMwNzIy_bfb45f72-02bd-4711-832f-7f45cbd3bdf2">36</ix:nonFraction> States and Territories and Settlement with New York</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has entered into <ix:nonFraction unitRef="claim" contextRef="ie19865eab4224177afee834778e21a4a_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencySettlementAgreementsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMwODA0_7f356d5e-c116-443f-9f76-02c3f194384d">two</ix:nonFraction> settlements of NPM Adjustment disputes with a total of <ix:nonFraction unitRef="state" contextRef="ie19865eab4224177afee834778e21a4a_D20200101-20200930" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMwODYy_65054ebe-d6d4-4f93-92c9-62f81b39d201">37</ix:nonFraction> states and territories, one with <ix:nonFraction unitRef="state" contextRef="ie19865eab4224177afee834778e21a4a_D20200101-20200930" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMwODk4_b1df4e09-75a9-42d9-923a-a2105b16e568">36</ix:nonFraction> states and territories (the &#8220;multi-state settlement&#8221;) and the other with the State of New York.  In the multi-state settlement, PM USA, by the end of October 2017, had settled the NPM Adjustment disputes for 2003-2015 with <ix:nonFraction unitRef="state" contextRef="i3e86e226235c4990a36636532147b9b9_D20171001-20171031" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxMTI0_b3e6018d-2da1-4a7b-9309-571ce72bb6a0">26</ix:nonFraction> states in exchange for a total of $<ix:nonFraction unitRef="usd" contextRef="i3e86e226235c4990a36636532147b9b9_D20171001-20171031" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyProceedsfromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxMTYx_11eb95ed-8b05-439d-9e23-4f6218c6f055">740</ix:nonFraction> million.  In 2018, there were <ix:nonFraction unitRef="settlement_development" contextRef="i53f369577bd3484cbaee39e41e064c6b_I20181231" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofSettlementDevelopments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxMTg2_1a7e7eb8-0294-4163-97d1-a4be8d9b7059">two</ix:nonFraction> principal developments with respect to this settlement.  First, PM USA agreed to settle the NPM Adjustment disputes for 2016 and 2017 with the <ix:nonFraction unitRef="state" contextRef="i3e86e226235c4990a36636532147b9b9_D20171001-20171031" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxMzMy_724f48a3-8f02-4122-b459-b426cf82c6d8">26</ix:nonFraction> states mentioned above.  Second, PM USA settled the NPM Adjustment disputes for 2004-2017 with <ix:nonFraction unitRef="state" contextRef="ib07a762a7c314cb981274ba805f9f3d9_D20171001-20171031" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofAdditionalStateswithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNDMw_31d5201c-6b60-4a82-b468-dccd4899ec99">ten</ix:nonFraction> additional states.  As a result of these <ix:nonFraction unitRef="settlement_development" contextRef="ib7136524f70a44118cc4469581d243c9_I20171231" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofSettlementDevelopments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNDc0_7c452cc4-cc2a-43fb-b1d7-a03cc09d1d66">two</ix:nonFraction> developments, PM USA will receive approximately $<ix:nonFraction unitRef="usd" contextRef="i905cb71d55944236820d53a9f8ba97b4_D20180401-20200430" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNTI1_462fe3f6-9371-45b6-abe2-da5faa2dd81b">248</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i18398105d8324ad6807cd23593a48335_D20180401-20180430" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNTI5_bbac8b5e-1d3c-4c0c-9c75-a81049c30f0d">68</ix:nonFraction> million of which it received in April 2018, $<ix:nonFraction unitRef="usd" contextRef="i7127e4e55f3b48cca9b37c8e7582d3db_D20190401-20190430" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNTY4_2ca32cd7-10bf-44da-8bf6-c2eea960ccca">121</ix:nonFraction> million of which it received in April 2019 and $<ix:nonFraction unitRef="usd" contextRef="i173ce1f840bf44efa105eaef9092cd54_D20200401-20200430" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNjEw_0814e5d7-2207-4b29-bac4-1592c2978471">47</ix:nonFraction> million of which it received in April 2020.  In connection with these <ix:nonFraction unitRef="settlement_development" contextRef="ib7136524f70a44118cc4469581d243c9_I20171231" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofSettlementDevelopments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNjc1_7c452cc4-cc2a-43fb-b1d7-a03cc09d1d66">two</ix:nonFraction> developments, PM USA recorded a reduction to cost of sales in the amount of $<ix:nonFraction unitRef="usd" contextRef="i71dd2d406d224d878f3ef54f28a29459_D20170101-20171231" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyReductionToCostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNzU0_e6243023-3602-4a78-a6f7-575fd41cc94e">39</ix:nonFraction> million in 2017 and in the amount of $<ix:nonFraction unitRef="usd" contextRef="ib1b513fdea0b44b19d5975639617c3f4_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyReductionToCostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNzg2_5124874c-c0b8-4086-b52d-584cb13ab7c3">209</ix:nonFraction> million in 2018.  In the first quarter of 2019, PM USA also recorded a reduction to cost of sales in the amount of $<ix:nonFraction unitRef="usd" contextRef="ic2269ecdf1c64fb98097f29ff6e22692_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyReductionToCostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxODk2_848ff402-06e5-4e4b-8edf-4f509815a88f">52</ix:nonFraction> million for its estimate of the 2018 NPM Adjustment settlement credit it expects to receive under the multi-state settlement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, the PMs agreed that certain conditions set forth in the multi-state settlement had been met.  As a result, PM USA&#8217;s and the other PMs&#8217; settlement with Pennsylvania was extended to include NPM Adjustments for 2018-2024.  In the third quarter of 2020, PM USA and the other PMs also agreed with the other <ix:nonFraction unitRef="state" contextRef="i5dc2309f4c184f1d91f181d088250c1c_D20200701-20200930" decimals="INF" name="mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMyMzU1_afa7a133-38b3-4b46-bbb7-165a6e219039">35</ix:nonFraction> states to extend the settlement with those </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i0cd15417821844ac99e31a29df68d6a4" continuedAt="i72d48a906f8f4893a11293f7f4f6242c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">states to include NPM Adjustments for 2018-2022.  As a result of these two developments, PM USA will receive approximately $<ix:nonFraction unitRef="usd" contextRef="i632a162da722437e9880fd3bbac52897_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMyNDg5_c7a84dd5-399c-4850-ab11-ec930f172bd0">361</ix:nonFraction> million in credits to offset PM USA&#8217;s MSA payments over the following <ix:nonNumeric contextRef="i632a162da722437e9880fd3bbac52897_D20200701-20200930" format="ixt-sec:durwordsen" name="mo:LossContingencySettlementAgreementPaymentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMyNTQw_5f075b8f-fc6e-44a2-a70d-3e14c476e380">nine years</ix:nonNumeric>.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the NPM Adjustment settlement with New York, which was entered into in 2015, PM USA has received approximately $<ix:nonFraction unitRef="usd" contextRef="i9e5e9c280fc9404d8b6763a66a3c305f_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyProceedsfromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMyNjU5_8e8cced4-f47e-4327-9a0b-44dd9d3b0a4b">317</ix:nonFraction> million for 2004-2018.  PM USA and the other participating manufacturers are involved in a proceeding pursuant to the New York settlement in which an independent investigator will determine the amounts due to the participating manufacturers from New York for 2019 and 2020.  PM USA expects to receive such amounts in April 2021 and April 2022, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the New York settlement and the multi-state settlement also contain provisions resolving certain disputes regarding the application of the NPM Adjustment going forward.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2003 and Subsequent NPM Adjustments - Continuing Disputes with States that have not Settled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2003 NPM Adjustment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  In September 2013, an arbitration panel issued rulings regarding the <ix:nonFraction unitRef="state" contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930" decimals="INF" name="mo:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzMzc2_7ef66d6a-16ba-4bcf-ad6c-96baa5a1719a">15</ix:nonFraction> states and territories that remained in the arbitration, ruling that <ix:nonFraction unitRef="state" contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofStatesWithoutDefense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNDQ4_a618b649-9a51-476e-add5-68c69099a9a7">six</ix:nonFraction> of them did not establish valid defenses to the NPM Adjustment for 2003.  In June 2014, <ix:nonFraction unitRef="state" contextRef="ifa9e64d794b84e179af595a489042961_D20130901-20130930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofStateswithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNTM5_4de767bb-a255-4534-85ba-7a89f4eb6dfb">two</ix:nonFraction> of these <ix:nonFraction unitRef="state" contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofStatesWithoutDefense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNTUx_59504c57-116f-4c56-a152-10b823f46853">six</ix:nonFraction> states joined the multi-state settlement discussed above.  With respect to the remaining <ix:nonFraction unitRef="state" contextRef="icad6887108624ef19b7c544b38df9e85_D20130901-20130930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofStatesRemaining" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNjQz_1208b1b7-af5f-49f8-bae7-90b7313fffef">four</ix:nonFraction> states, following the outcome of challenges in state courts, PM USA ultimately recorded $<ix:nonFraction unitRef="usd" contextRef="ic184ac8ea193498a824e11bb3c6a380e_D20130901-20130930" decimals="-6" format="ixt:numdotdecimal" name="mo:LossContingencyReductionToCostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNzM0_e8e959b1-39ea-4955-ae92-8e9e1ba6b62c">74</ix:nonFraction> million primarily as a reduction to cost of sales, with the final adjustment being recorded in the third quarter of 2017.  Subsequently, another one of the <ix:nonFraction unitRef="state" contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofStatesWithoutDefense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzODg0_59504c57-116f-4c56-a152-10b823f46853">six</ix:nonFraction> states joined the multi-state settlement.  <ix:nonFraction unitRef="state" contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfDisputesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzOTMw_15d32232-7306-472d-ba18-c02673b378e9">Two</ix:nonFraction> potential disputes remain outstanding regarding the amount of interest due to PM USA and there is no assurance that PM USA will prevail in either of these disputes.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2004 and Subsequent NPM Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  PM USA has continued to pursue the NPM Adjustments for 2004 and subsequent years in multi-state arbitrations against the states that did not join either of the settlements discussed above.   In September 2019, a New Mexico state appellate court affirmed a trial court&#8217;s order compelling New Mexico to arbitrate the 2004 NPM Adjustment claims in the multi-state arbitration with the other states.  In November 2019, the New Mexico Supreme Court declined to review that decision.  The arbitration hearing has not yet been scheduled.  The Montana state courts ruled that Montana may litigate its claims in state court, rather than participate in a multi-state arbitration and the PMs have agreed not to contest the applicability of the 2004 NPM Adjustment to Montana.  In April 2020, the State of Montana filed a motion in Montana state court against the PMs, including PM USA, claiming that Montana&#8217;s share of the NPM Adjustment amounts should be paid to the state in advance of the resolution of disputes over the applicability of those adjustments.  PM USA has been placing the disputed NPM Adjustment amounts in the disputed payments account established pursuant to the terms of the MSA.  Montana seeks a total of approximately $<ix:nonFraction unitRef="usd" contextRef="i32b1d9a333c54d99b2ca2e70af628ad9_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM1NDI2_ada8f005-27f1-4410-a0c6-6b425a854e1a">43</ix:nonFraction> million in disputed payments from all defendants combined, as well as treble and punitive damages.  </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than Montana and New Mexico, all of the non-settling states participated in a 2004 multi-state arbitration.  That arbitration initially concluded in July 2019, although Missouri was granted a hearing in June 2020.  As of October 27, 2020, no decisions have resulted from the arbitration.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PMs have reached an agreement with the states that have not settled (with the exception of Missouri and Montana) that the next round of NPM arbitrations will encompass three years, 2005-2007, and the parties have selected an arbitration panel for the 2005-2007 arbitration.  Missouri is participating in the arbitration, but has agreed to arbitrate only one year, 2005, before the panel.  The hearings in this arbitration have not yet been scheduled.  No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IA has calculated that PM USA&#8217;s share of the maximum potential NPM Adjustments for 2004-2019 is (exclusive of interest or earnings): $<ix:nonFraction unitRef="usd" contextRef="i30652171c168469b95e7a480823eec6a_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTE4_ed8ef021-1701-4ea4-bd6f-ec0b8cdd2217">388</ix:nonFraction> million for 2004; $<ix:nonFraction unitRef="usd" contextRef="i0e1757eedc104e8fb665fd9663ddfecc_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTMx_0526665d-8888-4eed-bbb1-f95e7117b54e">181</ix:nonFraction> million for 2005; $<ix:nonFraction unitRef="usd" contextRef="i42170c8f1d6444caac8ca0392f6a2276_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTQ0_a0bb7f88-cb9f-40eb-8a10-3729279d45ec">154</ix:nonFraction> million for 2006; $<ix:nonFraction unitRef="usd" contextRef="i4bc886e153d544dba8474e1686d381cc_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTU3_c94d65c5-c16c-4b46-9d77-ba7c82106372">185</ix:nonFraction> million for 2007; $<ix:nonFraction unitRef="usd" contextRef="i77fb9eb402e744f8b24e8258a74cd29f_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTcw_f6b208bb-b3fd-4d6a-8921-5430f5a56b8a">250</ix:nonFraction> million for 2008; $<ix:nonFraction unitRef="usd" contextRef="if33f95674df24a7981e5f92d55c32bc3_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTgz_3e51aba7-dbf5-447f-aec1-0552992a0d26">211</ix:nonFraction> million for 2009; $<ix:nonFraction unitRef="usd" contextRef="i129667b4722345049e3eacc64888eda2_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTk2_8de25229-3ea6-4f18-a255-1319c98a733d">218</ix:nonFraction> million for 2010; $<ix:nonFraction unitRef="usd" contextRef="i23e21af60d684691875ed325f6132e92_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjA5_66e0bd0c-3af9-4609-96df-420eb91cb5cf">166</ix:nonFraction> million for 2011; $<ix:nonFraction unitRef="usd" contextRef="i4a91eaf68d5c43dd926983f95d778cea_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjIy_42037af6-22f2-43ed-a875-74185761fd24">214</ix:nonFraction> million for 2012; $<ix:nonFraction unitRef="usd" contextRef="i2189369e507844d7aa734b62200b5014_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjM1_5ce8ff97-0dd5-45fe-9dfb-948e973409a0">224</ix:nonFraction> million for 2013; $<ix:nonFraction unitRef="usd" contextRef="i320fe601fb2e4afa8201647bbf6c161e_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjQ4_dc8f73df-b898-4b34-89a0-26b9d58bdc9d">258</ix:nonFraction> million for 2014; $<ix:nonFraction unitRef="usd" contextRef="ic9c75caeda0440b2b7a8b44f6a3af45a_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjYx_2e96af9f-9b8f-4c4e-a97e-ddc7814154e3">313</ix:nonFraction> million for 2015; $<ix:nonFraction unitRef="usd" contextRef="i5cf05e684bcf452b891b222faeba6f5d_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2Njc0_5a38eb1e-5049-4154-9980-77897d6f3066">305</ix:nonFraction> million for 2016; $<ix:nonFraction unitRef="usd" contextRef="i024ba7dd2cb546cb91939fb3c737b4cd_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2Njg3_c2aa232f-f531-4868-a688-d6cb126d5d88">297</ix:nonFraction> million for 2017; $<ix:nonFraction unitRef="usd" contextRef="i497ca0f28e5442c59124520e63eb5149_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NzAw_e0e67375-b321-4196-9dd6-27bc91807619">340</ix:nonFraction> million for 2018 and $<ix:nonFraction unitRef="usd" contextRef="i3254354ec2ca4cc19c1da242682ccd9a_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="mo:LitigationSettlementEstimateofPossibleGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NzE2_ef980a67-9a95-462f-947a-44e62f59fa51">441</ix:nonFraction> million for 2019.  These maximum amounts will be reduced, likely substantially, to reflect the settlements with the signatory states and New York, and potentially for current and future calculation disputes and other developments. Finally, PM USA&#8217;s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs. </span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i72d48a906f8f4893a11293f7f4f6242c" continuedAt="i4c20519ef27a42128f1f762de42ba669"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Disputes Under the State Settlement Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#8217;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#8220;ITG brands&#8221;).  In particular, R.J. Reynolds and ITG have asserted that they do not have to make payments on the ITG brands under the Florida, Minnesota and Texas State Settlement Agreements or include the ITG brands for purposes of certain calculations under the State Settlement Agreements. PM USA believes that R.J. Reynolds&#8217;s and ITG&#8217;s position violates the State Settlement Agreements and applicable law.  PM USA further believes that these actions: (i) improperly increased PM USA&#8217;s payments for 2015-2019; (ii) may improperly increase PM USA&#8217;s payments for subsequent years; (iii) improperly decreased PM USA&#8217;s share of the 2015-2019 NPM Adjustments and of the settlements of related disputes; and (iv) may improperly decrease PM USA&#8217;s share of NPM Adjustments and related settlements for subsequent years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, PM USA and the State of Florida each filed a motion in Florida state court against R.J. Reynolds and ITG seeking to enforce the Florida State Settlement Agreement.  In August 2018, the Florida trial court entered final judgment ruling that R.J. Reynolds (and not ITG) must make settlement payments under the Florida State Settlement Agreement on the ITG brands, and ordering R.J. Reynolds to pay PM USA approximately $<ix:nonFraction unitRef="usd" contextRef="i70337240f7a84b3788b6f48a11439d6f_D20180801-20180831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM4NzYz_0b38e9aa-942e-43b9-9e57-6b9ecc5c411a">9.8</ix:nonFraction> million (inclusive of interest) for the 2015-2017 period.  Both R.J. Reynolds and PM USA filed notices of appeal and, in July 2020, the Florida Fourth District Court of Appeal affirmed the trial court&#8217;s decision.  In September 2020, the Florida Fourth District Court of Appeal denied R.J. Reynolds&#8217;s motions for rehearing.  In October 2020, R.J. Reynolds petitioned the Florida Supreme Court to review the appellate court decision.     </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, PM USA and the State of Minnesota filed pleadings in Minnesota state court asserting claims against R.J. Reynolds and ITG, similar to those made in Florida, and seeking to enforce the Minnesota State Settlement Agreement.  In September 2019, the Minnesota court granted the State of Minnesota&#8217;s and PM USA&#8217;s motions to enforce the agreement against R.J. Reynolds.  The Minnesota court concluded, however, that it could not yet resolve the question of ITG&#8217;s liability under the Minnesota State Settlement Agreement.  An evidentiary hearing on the question of ITG&#8217;s potential liability was held in the third quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, PM USA filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against R.J. Reynolds and ITG with respect to the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of payments relating to the ITG brands.  A hearing in the case is currently scheduled for May 2021.  In December 2019, in a separate matter, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the calculation of the April 2019 payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, PM USA and the State of Texas each filed a motion in federal court in the Eastern District of Texas asserting claims against R.J. Reynolds and ITG, similar to those made in Florida and Minnesota, seeking to enforce the Texas State Settlement Agreement.  On February 25, 2020, the Texas court granted the State of Texas&#8217; and PM USA&#8217;s motions to enforce the settlement agreement against R.J. Reynolds.  The Texas court, however, deferred the ultimate resolution of the motions to enforce against ITG, because it concluded that question was dependent upon the outcome of separate litigation pending between ITG and R.J. Reynolds in the Delaware Court of Chancery.  In August 2020, R.J. Reynolds appealed the Eastern District of Texas&#8217;s ruling to the U.S. Court of Appeals for the Fifth Circuit.  ITG and the State of Texas also have filed notices of appeal, each of which is limited to the issue of how payments of statutory fees are treated under the Eastern District of Texas&#8217;s ruling.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999, the United States government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#8220;sub-schemes&#8221; to defraud that the government had alleged.  Specifically, the court found that: </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants hid from the public that cigarette smoking and nicotine are addictive; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely marketed and promoted &#8220;low tar/light&#8221; cigarettes as less harmful than full-flavor cigarettes; </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i4c20519ef27a42128f1f762de42ba669" continuedAt="ie8e5d694f3f64214a16bc16576ae9f76"><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they intentionally marketed to youth; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants publicly and falsely denied that ETS is hazardous to non-smokers; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants suppressed scientific research.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#8220;committing any act of racketeering&#8221; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii)&#160;an injunction against &#8220;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#8221; (iv)&#160;an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#8220;lights,&#8221; &#8220;ultra lights&#8221; and &#8220;low tar,&#8221; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v)&#160;the issuance of &#8220;corrective statements&#8221; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#8220;low tar&#8221; or &#8220;light&#8221; cigarettes, defendants&#8217; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi)&#160;the disclosure on defendants&#8217; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of <ix:nonNumeric contextRef="ie8789e2bcbf64769a038755249460300_D20060801-20060831" format="ixt-sec:duryear" name="mo:FederalTradeCommissionDisclosurePeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ0MTY3_e3808e63-a55a-4a8d-b500-086b2d8a9633">10</ix:nonNumeric> years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the U.S.; and (ix)&#160;payment of the government&#8217;s costs in bringing the action.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#8217; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014 and 2019, Altria and PM USA recorded provisions totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i14beba11ec90485cb8c96048f72ff73f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ1MTI0_4354c339-ca93-4178-9674-cad2ee90b74b"><ix:nonFraction unitRef="usd" contextRef="iaae00eba7cfd48bb8a759ff60030320a_D20140101-20141231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ1MTI0_4eca7335-355c-4686-bb51-402a735acd56"><ix:nonFraction unitRef="usd" contextRef="i1c5a0e12db7b469bbcc33e36f758341a_D20140101-20141231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ1MTI0_534d2d24-cac4-4812-a254-36becd2296d1"><ix:nonFraction unitRef="usd" contextRef="ib15d032499ec49ce814afe877066b823_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ1MTI0_84474a19-24b3-4cf3-9f59-7e4ece334a73">36</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million for the estimated costs of implementing the corrective communications remedy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The requirements related to corrective statements at point-of-sale remain outstanding.  In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014.  In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing is currently scheduled for July 2021.    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the United States government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a heated tobacco product used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device.  In August 2020, Altria and PM USA filed an opposition to the government&#8217;s motion and, in the alternative, a motion to modify the injunction to make clear it does not apply to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of the district court&#8217;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the FDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E-vapor Product Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, Altria and/or its subsidiaries, including PM USA, were named as defendants in <ix:nonFraction unitRef="claim" contextRef="ifdb0e875b3484b01ad06905775a8272b_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ2MDU5_2d1d705e-f803-4aef-a6ad-489ea11612ba">25</ix:nonFraction> class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs also sought to add antitrust claims due to the recent action by the FTC.  Although the court denied this request in the class action lawsuits, the individual antitrust claims remain pending before the same court.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for further discussion.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and/or its subsidiaries, including PM USA, also have been named as defendants in other lawsuits involving JUUL e-vapor products, including <ix:nonFraction unitRef="claim" contextRef="i759cc82368a24da9b90d561f09b6df19_I20201027" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ2ODcw_2ce3ddb3-7100-4aaf-b551-db9f9997a78f">1,064</ix:nonFraction> individual lawsuits, <ix:nonFraction unitRef="claim" contextRef="i7b52d1ccf10645b8ac9e77afdbf09979_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ2ODk0_6bb4ecbd-20fc-489c-a953-2bf7f2706c5b">25</ix:nonFraction> lawsuits filed by school districts and <ix:nonFraction unitRef="claim" contextRef="i6732b65e853a4a2ebc98fc8672546c08_I20201027" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ2OTM2_2d8fb717-1e91-47be-a53c-cffbe2643375">31</ix:nonFraction> lawsuits filed by state or local governments, including the state of Hawaii.  JUUL is an additional named defendant in each of these lawsuits.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="ie8e5d694f3f64214a16bc16576ae9f76" continuedAt="ie6a12211310d449588d05051b3992b3e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the individual and class action lawsuits mentioned above were filed in federal court.  In October 2019, the United States Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of these lawsuits in the U.S. District Court for the Northern District of California for pretrial purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Altria and its subsidiaries filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="claim" contextRef="i1938f36d8dd1444f846a2c358e51a292_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberofCasesSetforTrial" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ3ODYw_d7458cd8-327c-48f1-a170-7196a6264a3d">No</ix:nonFraction> case in which Altria or any of its subsidiaries is named has been set for trial.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of its subsidiaries is currently named.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Other Tobacco-Related Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate Philip Morris Products S.A., in the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims of patent infringement based on the sale of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#8217; fees.  Altria and PMI have been dismissed from the lawsuit.  In June 2020, the remaining defendants filed a motion to dismiss certain of plaintiffs&#8217; claims and also filed counterclaims against the plaintiffs for infringement of various patents owned by the remaining defendants.      </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in April 2020, a related action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the United States International Trade Commission (&#8220;ITC&#8221;).  There, the plaintiffs also allege patent infringement, but the remedies sought include a prohibition on the importation of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and component parts into the United States.  No damages are recoverable in the proceedings before the ITC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Lights/Ultra Lights&#8221; Cases and Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#8220;Lights&#8221; and/or &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or its other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment. <ix:nonFraction unitRef="court" contextRef="i6f6c0c255f674e16970fc172f56b0c52_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyStateCourtsNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4NjkxNjk3NzM0MDgy_760f585b-69f8-4137-aa43-1d0766080c73">Twenty-one</ix:nonFraction> state courts in <ix:nonFraction unitRef="case" contextRef="i3a4a3638d5c14dd6930a6317db7cb2fe_I20201027" decimals="INF" name="mo:LossContingencyClaimsNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUwNDQy_dce2f515-a876-4723-aa3e-22ca7de108d5">23</ix:nonFraction> &#8220;Lights&#8221; cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of October 27, 2020, <ix:nonFraction unitRef="claim" contextRef="i3a4a3638d5c14dd6930a6317db7cb2fe_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUwNjQ3_78bef126-c005-4082-8f73-3d0ab771998f">two</ix:nonFraction> &#8220;Lights/Ultra Lights&#8221; class actions are pending in U.S. state court.  Neither case is active.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, <ix:nonFraction unitRef="claim" contextRef="if0cadfd7091b4c52acbda0b9e5844949_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUwNzY2_85b92ac2-3657-4787-b70e-0a9f2a123f22">two</ix:nonFraction> smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, are pending in their respective U.S. state courts.  Neither case is active.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="ie6a12211310d449588d05051b3992b3e" continuedAt="i2676d8becf8840a688a8ad1a59f81bdc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">UST Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#8217; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases include lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of October 27, 2020, there is <ix:nonFraction unitRef="claim" contextRef="i365934f7ac7f46b589e0fbf8c5a01204_I20201027" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUxODIy_71319e4b-e701-4523-9086-675496106271">one</ix:nonFraction> case pending against USSTC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria&#8217;s <ix:nonFraction unitRef="number" contextRef="i5a9a9ea271534fef8e2574fa16175c11_I20200430" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUxOTgy_b2fe9379-382f-4785-8b39-b855fcf2bf60">35</ix:nonFraction>% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#8220;Sherman Act&#8221;) and Section 5 of the Federal Trade Commission Act of 1914 (&#8220;FTC Act&#8221;), and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#8220;Clayton Act&#8221;).  If the FTC&#8217;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of Altria&#8217;s minority investment in JUUL, rescission of the transaction and all associated agreements, and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors.  The administrative trial will take place before an FTC administrative law judge and is currently scheduled to begin April 2021.  The administrative law judge&#8217;s decision is then submitted to the FTC, which decision is subject to review by the FTC on its own motion or at the request of any party.  The FTC then issues its ruling, which is subject to appellate review.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as of October 27, 2020, <ix:nonFraction unitRef="lawsuit" contextRef="i94b8b0bd9cd64fb1b726bdd03fce49cf_I20201027" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzk4OTU2MDQ3MTA2NDE_95f1659a-8131-42df-a353-90e4812d978b">16</ix:nonFraction> putative class action lawsuits have been filed against Altria and JUUL in the United States District Court for the Northern District of California.  The lawsuits cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act, Section 7 of the Clayton Act and various state antitrust laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#8217; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of Altria&#8217;s minority investment in JUUL and rescission of the transaction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither the FTC nor the private plaintiffs has sought to preliminarily enjoin Altria from converting Altria&#8217;s non-voting JUUL shares to voting shares or appointing directors to the JUUL board of directors.  As of October 27, 2020, Altria has not exercised these rights, but has until November 30, 2020 to convert its JUUL shares under the regulations of the HSR Act, after which Altria would have to re-file for antitrust review with the FTC to again seek the ability to convert.  For further discussion of Altria&#8217;s rights in the event of share conversion, see Note. 4.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities - Investment in JUUL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Class Action and Shareholder Derivative Lawsuits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October and December 2019, <ix:nonFraction unitRef="shareholder" contextRef="ibaad81b69d5b4f30a76662311f1a3c69_D20191201-20191231" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU0MDQx_758fa7bb-fad5-4cef-b795-e66f4f4bf461">two</ix:nonFraction> purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, Altria&#8217;s former Chairman and Chief Executive Officer, and William F. Gifford, Jr., Altria&#8217;s former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the United States District Court for the Eastern District of New York.  In December 2019, the court consolidated the <ix:nonFraction unitRef="shareholder" contextRef="ibaad81b69d5b4f30a76662311f1a3c69_D20191201-20191231" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU0NDQ4_758fa7bb-fad5-4cef-b795-e66f4f4bf461">two</ix:nonFraction> lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders, and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to Altria&#8217;s investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#8217; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#8217; claims. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, <ix:nonFraction unitRef="shareholder" contextRef="i5e48f7ae862f4927a706bfb1d1bdff5f_D20200801-20200831" decimals="INF" format="ixt-sec:numwordsen" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTc5Mjk_bf06a951-1c32-479c-b4a8-e50001ea5ea4">two</ix:nonFraction> purported Altria shareholders filed separate derivative lawsuits in the United States District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of its executives and officers.  These derivative lawsuits relate to Altria&#8217;s investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  A third derivative lawsuit was filed in September 2020 in the Circuit Court for Henrico County, Virginia against Mr. Willard, Mr. Gifford, Kevin C. Crosthwaite, Altria&#8217;s former Chief Growth Officer and current JUUL Chief Executive Officer, and members of Altria&#8217;s Board of Directors.  This suit asserts a claim for breach of fiduciary duty.  Plaintiffs seek various remedies, including damages, disgorgement of profits, reformation of Altria&#8217;s corporate governance and internal procedures, and attorneys&#8217; fees.  The plaintiffs have agreed to stay the Virginia derivative case pending the outcome of defendants&#8217; motions to dismiss the shareholder class action.  A fourth derivative lawsuit was filed in October 2020 in the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><ix:continuation id="i2676d8becf8840a688a8ad1a59f81bdc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States District Court for the Eastern District of Virginia against the same defendants in the Virginia lawsuit, JUUL, its founders and some of its current and former executives.  The remedies sought are similar to those sought by plaintiffs in the Virginia lawsuit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  Altria&#8217;s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that subsidiaries of Altria may undertake in the future.  In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria&#8217;s consolidated results of operations, capital expenditures, financial position or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Similar Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, certain subsidiaries of Altria have agreed to indemnify a limited number of third parties in the event of future litigation.  At September&#160;30, 2020, Altria and certain of its subsidiaries (i) had $<ix:nonFraction unitRef="usd" contextRef="i221381c6c8174016a6e3bd28d276c6f7_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU3MDM2_9b78f1d5-03dd-4c33-93b0-097b895564c1">49</ix:nonFraction> million of unused letters of credit obtained in the ordinary course of business; (ii) were contingently liable for guarantees related to their own performance, including $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GuaranteeObligationsMaximumExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU3MjAx_2da11c4c-b0aa-46c3-87cf-716f2fd0d19b">25</ix:nonFraction> million for surety bonds; and (iii) had a redeemable noncontrolling interest of $<ix:nonFraction unitRef="usd" contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU3Mjc2_56bc1eab-0ffc-4ef2-ae16-0b8e1b740615">39</ix:nonFraction> million recorded on its condensed consolidated balance sheet.  In addition, from time to time, subsidiaries of Altria issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on Altria&#8217;s liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of a distribution agreement between Altria and PMI (the &#8220;Distribution Agreement&#8221;), entered into as a result of Altria&#8217;s 2008 spin-off of its former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  Altria does not have a related liability recorded on its condensed consolidated balance sheet at September&#160;30, 2020 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent litigation discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation - IQOS Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has issued guarantees relating to Altria&#8217;s obligations under its outstanding debt securities, borrowings under its $<ix:nonFraction unitRef="usd" contextRef="i4e875a907d9e4fc9a48992750104acbd_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU4NTc3_6b3eb6ac-933d-41af-96e6-7476cdddf3b6">3.0</ix:nonFraction> billion Credit Agreement and amounts outstanding under its commercial paper program.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_151"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 13. <ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNTEvZnJhZzphNDVhZGJkYmNkOTg0MGMyYTBmNTRjMjgzODZmZGJlMS90ZXh0cmVnaW9uOmE0NWFkYmRiY2Q5ODQwYzJhMGY1NGMyODM4NmZkYmUxXzE4Ng_802fa562-4b80-4f17-928d-9cc194a42720" continuedAt="if2d6ffb554634683b4a246a49a6b6bb5" escape="true">New Accounting Guidance Not Yet Adopted:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if2d6ffb554634683b4a246a49a6b6bb5"><ix:nonNumeric contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNTEvZnJhZzphNDVhZGJkYmNkOTg0MGMyYTBmNTRjMjgzODZmZGJlMS90ZXh0cmVnaW9uOmE0NWFkYmRiY2Q5ODQwYzJhMGY1NGMyODM4NmZkYmUxXzE3NA_b03382eb-3c57-410e-9f30-065d6479a241" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i62293bef5d67444996f2d9f1c95490f1"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:16.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2019-12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Simplifying the Accounting for Income Taxes (Topic 740)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-01 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Accounting for Convertible Instruments and Contracts in an Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">s Own Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.<br/></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. </span></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_157"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 2.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-top:9pt"><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_160"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of the Company</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in this Quarterly Report on Form 10-Q (&#8220;Form 10-Q&#8221;), the terms &#8220;Altria,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refers to Altria Group, Inc. and its subsidiaries, unless otherwise specified or unless otherwise required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of Altria, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Background</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Part I, Item 1. Financial Statements of this Form 10-Q (&#8220;Item 1&#8221;). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.  Altria&#8217;s reportable segments are smokeable products, oral tobacco products and wine.  The financial services and the innovative tobacco products businesses are included in an all other category due to the continued reduction of the lease portfolio of Philip Morris Capital Corporation and the relative financial contribution of Altria&#8217;s innovative tobacco products businesses to Altria&#8217;s consolidated results.</span></div><div id="i85986654d18d42b3b8b96449288f0b8f_163"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section, Altria refers to the following &#8220;adjusted&#8221; financial measures: adjusted operating companies income (loss) (&#8220;OCI&#8221;); adjusted OCI margins; adjusted net earnings attributable to Altria; adjusted diluted earnings per share attributable to Altria; and adjusted effective tax rates.  These adjusted financial measures are not required by, or calculated in accordance with, United States generally accepted accounting principles (&#8220;GAAP&#8221;) and may not be calculated the same as similarly titled measures used by other companies.  These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.  Except as noted in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Forecasted Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below, when Altria provides a non-GAAP measure in this Form 10-Q, it also provides a reconciliation of that non-GAAP financial measure to the most directly comparable GAAP financial measure.  For a further description of these non-GAAP financial measures, see the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has led to adverse impacts on the U.S. and global economies and continues to create economic uncertainty.  Although much uncertainty still surrounds the pandemic, including its duration and ultimate overall impact on U.S and global economies, our subsidiaries&#8217; operations and those of Altria&#8217;s investees, Altria continues to monitor the macroeconomic risks of COVID-19 and to carefully evaluate potential outcomes and work to mitigate risks.  Specifically, Altria remains focused on any potential impact to its liquidity, operations, supply and distribution chains and on economic conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In terms of Altria&#8217;s liquidity, despite some volatility in the commercial paper market in March 2020, Altria believes it is in a solid financial position and continues to maintain a higher cash balance than normal to preserve its financial flexibility.  As a precautionary measure, in March 2020, Altria borrowed the full $3.0 billion available under its senior unsecured 5-year revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;), which Altria subsequently repaid in full in June 2020.  In May 2020, Altria issued $2.0 billion of long-term debt in the form of senior unsecured notes.  In April 2020, Altria&#8217;s Board of Directors (the &#8220;Board of Directors&#8221;) rescinded the $500 million remaining in the previously authorized $1.0 billion share repurchase program.  Altria did not repurchase any shares in the nine months ended September 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As with so many other companies throughout the U.S. and globally, Altria&#8217;s operations have been affected by COVID-19.  Altria has implemented remote working for many employees and aligned with the social distancing protocols recommended by public health authorities.  To date, Altria believes its tobacco businesses have not experienced any material adverse effects associated with governmental actions to restrict consumer movement or business operations, but continues to monitor these factors.  Altria continues to believe that remote working due to the COVID-19 pandemic has had minimal impact on productivity.  Also, Altria&#8217;s critical information technology systems have remained operational.  Although Altria&#8217;s tobacco businesses previously suspended operations temporarily at several of their manufacturing facilities, all manufacturing facilities are currently operational under enhanced safety protocols.  In addition, Helix Innovations LLC (&#8220;Helix&#8221;) continues to build domestic manufacturing capacity for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Richmond Manufacturing Center and expand distribution.  Altria continues to monitor the risks associated with facility disruptions and workforce availability as a result of COVID-19 uncertainty.  </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s suppliers and those within its distribution chain are also subject to government actions that may require the closure of a facility and remote working protocols.  To date, Altria has not experienced any material disruptions to its supply chains or distribution systems, but is continuing to monitor these factors.  The majority of retail stores in which Altria&#8217;s tobacco products are sold, including convenience stores, have been deemed to be essential businesses by authorities and have remained open.  Altria continues to monitor the risk that one or more suppliers, distributors or any other entities within our supply and distribution chain closes temporarily or permanently.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, Philip Morris USA Inc. (&#8220;PM USA&#8221;) re-opened its Atlanta and Richmond </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stores, and in July 2020, PM USA launched</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Charlotte, with all stores operating under enhanced safety protocols. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of 2020, Altria incurred net pre-tax charges of $50 million, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic.  These costs, which were recorded in the second quarter and excluded from Altria&#8217;s adjusted results, included premium pay, personal protective equipment and health screenings, partially offset by certain employment tax credits.  These net pre-tax charges do not include the inventory-related implementation costs associated with the wine business strategic reset. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Altria&#8217;s tobacco businesses have not been materially impacted to date by COVID-19, there is continued uncertainty as to how COVID-19 may impact adult tobacco consumers in the future.  Altria continues to monitor the macro-economic risks of COVID-19 and their effect on adult tobacco consumers, including unemployment rates, disposable income (which may be impacted by potential future changes in government stimulus and federal unemployment benefit payments) and mobility.   Altria also continues to monitor adult tobacco consumers&#8217; purchasing behaviors, including overall tobacco product expenditures, mix between premium and discount brand purchases and interest in noncombustible products.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Altria&#8217;s tobacco businesses have not been materially impacted to date by COVID-19, Altria has experienced adverse impacts to its alcohol assets.  In the wine business, Ste. Michelle Wine Estates Ltd.&#8217;s (&#8220;Ste. Michelle&#8221;) direct-to-consumer sales and on-premise wine sales in restaurants, bars and hospitality venues and on cruise lines have been, and continue to be, negatively impacted by disruptions arising from the COVID-19 pandemic, which also may have an impact on adult wine consumers going forward.  In the first quarter of 2020, Ste. Michelle recorded pre-tax charges of $392 million consisting of (i) the write-off of inventory and (ii) estimated losses on future non-cancelable grape purchase commitments associated with product volume demand uncertainty, which were further impacted by government restrictions and the economic uncertainty surrounding the COVID-19 pandemic.  Altria and Ste. Michelle also undertook a review of the wine business resulting in a strategic reset.  Ste. Michelle continues to monitor the impact of COVID-19 associated risks to its business, results of operations, cash flows or financial position.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;) has also been impacted by COVID-19, including a 50% reduction to its final 2019 dividend paid in the second quarter of 2020 and its recent announcement to forgo its interim 2020 dividend that would have been paid in the fourth quarter of 2020; the withdrawal of its guidance for 2020 due to the uncertainty, volatility and impact of COVID-19; and a goodwill impairment charge related to its Africa businesses in its second quarter of 2020 (which Altria recorded in the third quarter of 2020 due to its one-quarter lag in reporting ABI&#8217;s results).  ABI expects its performance in the second half of this year to be better than the first, although the environment remains volatile and uncertain, including potential renewed restrictions in several markets.  As a result of these actions, Altria has reduced expectations for equity earnings and cash dividends from ABI in 2020.   In addition, the extreme market disruption and volatility associated with COVID-19 resulted in a steep decline in ABI&#8217;s stock price in the first half of 2020, and the fair value of Altria&#8217;s investment in ABI is below the carrying value.  While Altria believes that this decline is temporary, it will continue to monitor its investment in ABI, including the impact of COVID-19 on ABI&#8217;s business and market valuation.  If Altria were to conclude that the decline in fair value is other than temporary, Altria would determine and recognize, in the period identified, the impairment of its investment, which could be material. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria considered the impact of COVID-19 on the business of JUUL Labs, Inc. (&#8220;JUUL&#8221;), including its sales, distribution, operations, supply chain and liquidity, in conducting its periodic impairment assessment.  While the impact of COVID-19 was considered in our quantitative valuation that resulted in a non-cash pre-tax impairment charge of $2.6 billion for the period ended September 30, 2020, it was not an indicator of impairment for this assessment.  Altria will continue to monitor its investment in JUUL and the impact of COVID-19 on JUUL&#8217;s business. </span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria has considered the impact of COVID-19 on the business of Cronos Group Inc. (&#8220;Cronos&#8221;), including its sales, distribution, operations, supply chain and liquidity.  Cronos continues to be impacted by COVID-19, due in part to government action requiring closures or limited occupancy of retail stores in the United States.  During the second quarter of 2020, Cronos recorded an impairment charge on goodwill and intangible assets as a result of the impact of COVID-19 (which Altria recorded </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the third quarter of 2020 due to its one-quarter lag in reporting Cronos&#8217;s results).  In addition, the fair value of Altria&#8217;s equity method investment in Cronos was approximately 20% less than its carrying value of $1.0 billion at September 30, 2020.  While Altria believes that this decline in fair value is temporary, it will continue to monitor its equity method investment in Cronos, including the impact of COVID-19 on Cronos&#8217;s business and market valuation.  If Altria were to conclude that the decline in fair value is other than temporary, Altria would determine and recognize, in the period identified, the impairment of its equity method investment, which could be material.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Results of Operations for the Nine Months Ended September 30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  The changes in net earnings (losses) attributable to Altria and diluted earnings (losses) per share (&#8220;EPS&#8221;) attributable to Altria for the nine months ended September 30, 2020, from the nine months ended September 30, 2019, were due primarily to the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings (Losses)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the nine months ended September 30, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Asset impairment, exit, implementation and acquisition-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Tobacco and health litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 ABI-related special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2019 special items</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Implementation and acquisition-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Tobacco and health litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 ABI-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 COVID-19 special items </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2020 special items</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,733)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.01)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fewer shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the nine months ended September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Reported Net Earnings (Losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Reported Net Earnings (Losses)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%+</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Adjusted Net Earnings and Adjusted Diluted EPS</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Adjusted Net Earnings and Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Prior period amounts have been recast to conform with current period presentation for certain ABI mark-to-market adjustments that were not previously identified as special items and that are now excluded from Altria&#8217;s adjusted financial measures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For further discussion, see below.</span></div><div style="padding-left:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of events affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fewer Shares Outstanding:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fewer shares outstanding during the nine months ended September 30, 2020 compared with the prior-year period were due primarily to shares repurchased by Altria in the fourth quarter of 2019 under its share repurchase program.</span></div><div><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in tax rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  The change in the tax rate was driven primarily by lower dividends from ABI.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  The increase of $367 million in operations shown in the table above was due primarily to higher income from the smokeable products and oral tobacco products segments, partially offset by lower earnings from Altria&#8217;s equity investments in ABI and Cronos.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For further details, see the Consolidated Operating Results and Operating Results by Business Segment sections below.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Results of Operations for the Three Months Ended September 30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  The changes in net earnings (losses) attributable to Altria and diluted EPS attributable to Altria for the three months ended September 30, 2020, from the three months ended September 30, 2019, were due primarily to the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings (Losses)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the three months ended September 30, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Asset impairment, exit, implementation and acquisition-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Tobacco and health litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 ABI-related special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2019 special items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Implementation and acquisition-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Tobacco and health litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 ABI-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2020 special items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,167)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the three months ended September 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.51)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Reported Net Earnings (Losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Reported Net Earnings (Losses)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Adjusted Net Earnings and Adjusted Diluted EPS</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Adjusted Net Earnings and Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Prior period amounts have been recast to conform with current period presentation for certain ABI mark-to-market adjustments that were not previously identified as special items and that are now excluded from Altria&#8217;s adjusted financial measures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For further discussion, see below.</span></div><div style="padding-left:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of events affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in tax rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  The change in tax rate was driven primarily by lower dividends from ABI.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  The increase of $51 million in operations shown in the table above was due primarily to higher income from the smokeable products segment, partially offset by lower earnings from Altria&#8217;s equity investments in ABI and Cronos.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For further details, see the Consolidated Operating Results and Operating Results by Business Segment sections below.</span></div><div><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Forecasted Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Altria narrowed its 2020 full-year adjusted diluted EPS to be in the range of $4.30 to $4.38, representing a growth rate in the range of 2% to 4% over its 2019 full-year adjusted diluted EPS base of $4.21.  This forecasted growth rate excludes the 2020 forecasted income and expense items in the second table below.  Altria&#8217;s 2020 full-year earnings guidance is based on Altria&#8217;s year-to-date performance and insight into an additional quarter of ABI earnings contributions.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hile the 2020 full-year adjusted diluted EPS guidance accounts for a range of scenarios, the external environment remains dynamic.  Altria will continue to monitor conditions for adult tobacco consumers, including unemployment rates, disposable income (which may be impacted by potential future changes in government stimulus and federal unemployment benefit payments), mobility and purchasing behaviors. Altria also narrowed its expectations for its 2020 full-year adjusted effective tax rate to be in a range of 24.5% to 25.5%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of 2019 Reported Diluted EPS to 2019 Adjusted Diluted EPS</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Reported diluted EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation and acquisition-related costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment in JUUL equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Adjusted diluted EPS</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> This amount has been recast to conform with current period presentation for certain ABI mark-to-market adjustments that were not previously identified as special items and that are now excluded from Altria&#8217;s adjusted financial measures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;padding-right:9pt"><span><br/></span></div><div style="margin-top:3pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following (income) expense items are excluded from Altria&#8217;s 2020 forecasted growth rate provided above:</span></div><div style="margin-bottom:5pt;margin-top:8pt;padding-right:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:84.019%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Income) Expense Excluded from 2020 Forecasted Adjusted Diluted EPS</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation and acquisition-related costs </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment in JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:4.5pt;padding-right:9pt;text-indent:-4.5pt"><span><br/></span></div><div style="margin-top:3pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of certain income and expense items excluded from the forecasted results above, see the Consolidated Operating Results section below.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s full-year adjusted diluted EPS guidance and full-year forecast for its adjusted effective tax rate exclude the impact of certain income and expense items, including those items noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below, that management believes are not part of underlying operations.  Altria&#8217;s management cannot estimate on a forward-looking basis the impact of these items on its reported diluted EPS or its reported effective tax rate because these items, which could be significant, may be unusual or infrequent, are difficult to predict and may be highly variable.  As a result, Altria does not provide a corresponding GAAP measure for, or reconciliation to, its adjusted diluted EPS guidance or its adjusted effective </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tax rate forecast.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The factors described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cautionary Factors That May Affect Future Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of the following </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discussion and Analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> represent continuing risks to this forecast and to the other forward-looking statements made in this Form 10-Q.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_166"></div><div style="padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discussion and Analysis</span></div><div style="padding-right:20.25pt"><span><br/></span></div><div style="padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="padding-right:20.25pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s critical accounting policies and estimates are discussed in its Annual Report on Form 10-K for the year ended December 31, 2019 (the &#8220;2019 Form 10-K&#8221;); there have been no material changes to these critical accounting policies and estimates, except as noted below.</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Investments in ABI, Cronos and JUUL:</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment at least quarterly in connection with the preparation of its financial statements by comparing the fair value of each of its investments to their carrying value.  If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements.  If this qualitative assessment indicates that Altria&#8217;s investment in JUUL may be impaired, a quantitative assessment is performed.  If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value, and the impairment is recognized in the period identified. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, Altria&#8217;s investment in ABI consisted of 185 million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and 12 million ordinary shares of ABI.  The fair value of Altria&#8217;s equity investment in ABI is based on: (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets, for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares.  In the event the pledgee or security interest holder were to foreclose on the Restricted Shares, the encumbered Restricted Shares will be automatically converted, one-for-one, into ordinary shares.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity investment in ABI at September 30, 2020 and December 31, 2019 was $10.7 billion (carrying value of $16.7 billion) and $16.1 billion (carrying value of $18.1 billion), respectively, which was less than its carrying value by approximately 36% and 11%, respectively.  At October 27, 2020, the fair value of Altria&#8217;s investment increased to approximately $11.0 billion (approximately 34% below its carrying value).  In October 2019, the fair value of Altria&#8217;s equity investment in ABI declined below its carrying value and has not recovered.  Altria has evaluated the factors related to the fair value decline, including the recent impact on the fair value of ABI&#8217;s shares amidst the COVID-19 pandemic.  The economic uncertainties of the COVID-19 pandemic have also impacted ABI&#8217;s business.  Altria has also evaluated the duration and magnitude of the fair value decline at September 30, 2020, ABI&#8217;s financial condition and near-term prospects, and Altria&#8217;s intent and ability to hold its investment in ABI until recovery.  Altria concluded at September 30, 2020, the decline in fair value of its investment in ABI below its carrying value is temporary and, therefore, no impairment was recorded. This conclusion was based on the following factors:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the fair value of Altria&#8217;s equity investment in ABI historically exceeding its carrying value since October 2016, when Altria obtained its ownership interest in ABI, with the exception of certain periods starting in September 2018;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a history of significant recovery in stock price during 2019, as well as an increase from March 31, 2020 to October 27, 2020, which Altria believes indicates investor confidence in ABI&#8217;s ability to implement its business strategies and deleveraging plans;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the period of time (approximately 12 months) that ABI shares have traded below Altria&#8217;s carrying value;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the continued industry disruption and volatility associated with the COVID-19 pandemic, resulting in stock performance among ABI competitors that Altria does not believe are reflective of actual underlying equity values; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ABI&#8217;s recent proactive actions to preserve financial flexibility and commitment to its long-term deleveraging initiative, including the following actions since December 31, 2019: (i) ABI&#8217;s 50% reduction to its final 2019 dividend paid in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the second quarter of 2020 and its recent announcement to forgo its interim 2020 dividend that would have been paid in the fourth quarter of 2020; (ii) ABI&#8217;s completion of the sale of its Australia subsidiary in the second quarter of 2020 for $11 billion and affirmation that substantially all proceeds from the divestiture will be used to reduce debt; and (iii) ABI&#8217;s aggregate refinancing of $11 billion through issuance and redemption activity, specifically front-end maturities into longer dated maturities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ABI&#8217;s global platform (world&#8217;s largest brewer by volume and one of the world&#8217;s top ten consumer products companies by revenue) with strong market positions in key markets, geographic diversification, experienced management team, strict financial discipline (cost management and efficiency) and expected earnings and history of performance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the strategic plans implemented by ABI in response to the adverse impacts of the COVID-19 pandemic, including the ability to leverage learnings from recovering markets, to better position ABI for a robust recovery as evidenced by  ABI&#8217;s expectation that its performance in the second half of this year will be better than the first, although the environment remains volatile and uncertain, including potential renewed restrictions in several markets; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Altria&#8217;s ownership of restricted shares being subject to a five-year lock-up (subject to limited exceptions) ending October 10, 2021, which Altria believes provides sufficient time to allow for an anticipated recovery in the fair value of its investment in ABI.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria will continue to monitor its investment in ABI, including the impact of the COVID-19 pandemic on ABI&#8217;s business and market valuation.  If Altria were to conclude that the decline in fair value is other than temporary, Altria would determine and recognize, in the period identified, the impairment of its investment, which could result in a material adverse effect on Altria&#8217;s consolidated financial position or earnings.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.  The fair value of Altria&#8217;s equity method investment in Cronos at September 30, 2020 and December 31, 2019 was $0.8 billion and $1.2 billion, respectively, compared with its carrying value of $1.0 billion at September 30, 2020 and December 31, 2019.  At September 30, 2020, the fair value of Altria&#8217;s equity method investment in Cronos was below its carrying value by approximately 20%.  Cronos&#8217;s share price has continued to be volatile during the third quarter of 2020 and October 2020.  While the fair value of Altria&#8217;s equity method investment in Cronos was below its carrying value at September 30, 2020, the fair value of Altria&#8217;s equity method investment exceeded its carrying value at certain times during the third quarter of 2020, and at October 27, 2020, the fair value of Altria&#8217;s equity method investment in Cronos increased to approximately $0.9 billion (approximately 12% below its carrying value).  Altria has evaluated the factors related to the fair value decline, including the recent impact on the fair value of Cronos&#8217;s shares as a result of the COVID-19 pandemic.  Cronos continues to be impacted by COVID-19, due in part to government action requiring closures or limited occupancy of retail stores in the United States.  In addition, during the second quarter of 2020, Cronos recorded an impairment charge on goodwill and intangible assets as a result of the impact of COVID-19.  Based on Altria&#8217;s evaluation of the duration (fairly short period of time) and magnitude of the fair value decline at September 30, 2020, Altria&#8217;s evaluation of Cronos&#8217;s financial condition (including its strong cash position) and near-term prospects, and Altria&#8217;s intent and ability to hold its investment in Cronos until recovery, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria will continue to monitor its equity method investment in Cronos, including the impact of the COVID-19 pandemic on Cronos&#8217;s business and market valuation.  If Altria were to conclude that the decline in fair value is other than temporary, Altria would determine and recognize, in the period identified, the impairment of its equity method investment, which could result in a material adverse effect on Altria&#8217;s consolidated financial position or earnings.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of Altria&#8217;s investments in ABI and Cronos, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1 (&#8220;Note 4&#8221;).</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preparation of its financial statements for the periods ended September 30, 2020 and 2019 and December 31, 2019, Altria performed qualitative assessments of impairment indicators for its investment in JUUL and determined that indicators of impairment existed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL announced a strategic update in September 2020, which includes its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of Altria&#8217;s financial statements for the period ended September 30, 2020, Altria performed its qualitative assessment of impairment indicators for its investment in JUUL and determined that JUUL&#8217;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#8217;s business prospects. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the existence of this impairment indicator, Altria performed a quantitative valuation of its investment in JUUL as of September 30, 2020 and recorded a non-cash pre-tax charge of $2.6 billion for the nine and three months ended September 30, 2020, reported as impairment of JUUL equity securities in its condensed consolidated statements of earnings.  The impairment charge was driven by Altria&#8217;s projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of: (i) JUUL&#8217;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, Altria recorded total non-cash pre-tax impairment charges of $8.6 billion ($4.5 billion in the third quarter of 2019 and $4.1 billion in the fourth quarter of 2019) related to its investment in JUUL resulting in a $4.2 billion carrying value of its investment in JUUL at December 31, 2019.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2019, Altria performed a qualitative assessment for impairment indicators and concluded that impairment indicators existed.  These indicators included significant adverse changes in both the e-vapor regulatory environment and the industry in which JUUL operates. While there was no single determinative event or factor, Altria considered in totality the following indicators of impairment: the increased likelihood of a United States Food and Drug Administration (&#8220;FDA&#8221;) compliance policy prohibiting the sale of certain flavored e-vapor products in the U.S. market without a pre-market authorization; various e-vapor bans put in place by certain states and cities in the U.S. and in certain international markets, coupled with the increased potential for additional bans in the future; and the impact of heightened adverse publicity, including news reports and public health advisories concerning vaping-related lung injuries and deaths.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its quantitative valuation of its investment in JUUL, the third-quarter 2019 impairment charge was due primarily to lower e-vapor sales volume assumptions in the U.S. and international markets and a delay in achieving operating margin performance, as compared to the assumptions at the time of the JUUL Transaction, which resulted in a pre-tax charge of $4.5 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2019, Altria determined that a significant increase in the number of legal cases pending against JUUL in the fourth quarter of 2019 resulted in an additional indicator of impairment, which  included a variety of class action lawsuits and personal injury claims, as well as cases brought by state attorneys general and local governments resulted in an indicator of impairment.  The fourth-quarter impairment charge resulted substantially from increased discount rates applied to future cash flow projections, due to the significant risk created by the increase in the number of legal cases pending against JUUL, which resulted in an additional pre-tax charge of $4.1 billion at December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria used an income approach to estimate the fair value of its investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and certain international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.  Future cash flows were based on a range of scenarios that consider various potential regulatory, legislative and market outcomes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the fair value of its investment in JUUL, Altria made various judgments, estimates and assumptions, the most significant of which were sales volume, operating margins, discount rates and perpetual growth rates.  The discount rates used in performing the valuations ranged from 17.0% to 20.5% at September 30, 2020, 13.5% to 16.5% at September 30, 2019 and 19.5% to 23.0% at December 31, 2019.  The perpetual growth rates used in performing the valuations remained unchanged, ranging from (0.5%) to 0.0% at September 30, 2020 and 2019 and December 31, 2019.  Additionally, Altria made significant assumptions regarding the likelihood and extent of various potential regulatory and legislative actions and the continued adverse public perception impacting the e-vapor category and specifically JUUL, as well as expectations of competitive dynamics and the future state of the e-vapor category.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Altria&#8217;s discounted cash flow analyses were based on assumptions that Altria&#8217;s management considered reasonable and are based on the best available information at the time that the analyses were developed, there is significant judgment used in determining future cash flows.  Altria believes the following factors have the most potential to impact projected future cash flows and, therefore, Altria&#8217;s valuation of JUUL: federal, state, local and international regulatory and legislative developments; JUUL&#8217;s execution of its strategy; category growth rates; e-vapor-related litigation against JUUL; consumer preferences; and competitive dynamics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Altria&#8217;s management believes that the estimated fair value of its investment in JUUL as of September 30, 2020 is appropriate, JUUL&#8217;s actual performance in the short term or long term could be significantly different from forecasted </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance due to changes in the factors noted above.  One or more such changes could result in additional impairment charges to Altria&#8217;s investment in JUUL in future periods. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on Altria&#8217;s investment in JUUL, see Note 4.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Consolidated Operating Results</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:34.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.733%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,849&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,103&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,856&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes on products:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes on products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset impairment and exit</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,899&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-right:20.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed further in Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1 (&#8220;Note 9&#8221;), Altria&#8217;s chief operating decision maker (&#8220;CODM&#8221;) reviews OCI to evaluate the performance of, and allocate resources to, the segments.  OCI for the segments is defined as operating income before general corporate expenses and amortization of intangibles.  </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of adjusted net earnings (losses) attributable to Altria and adjusted diluted EPS attributable to Altria for the nine months ended September 30:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.541%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions of dollars, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Losses) before Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings (Losses)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings (Losses) Attributable <br/>to Altria</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation and acquisition-related costs </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Adjusted for Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Reported</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation and acquisition-related costs </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation items </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Adjusted for Special Items</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,856&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,984&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,984&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prior period amounts have been recast to conform with current period presentation for certain ABI mark-to-market adjustments that were not previously identified as special items and that are now excluded from Altria&#8217;s adjusted financial measures.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of adjusted net earnings (losses) attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended September 30:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.541%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions of dollars, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Losses) before Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings (Losses)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings (Losses) Attributable <br/>to Altria</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(956)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.51)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation and acquisition-related costs </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Adjusted for Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Reported</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,602)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation and acquisition-related costs </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation items </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Adjusted for Special Items</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,222&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.19&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:9pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prior period amounts have been recast to conform with current period presentation for certain ABI mark-to-market adjustments that were not previously identified as special items and that are now excluded from Altria&#8217;s adjusted financial measures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following events that occurred during the nine and three months ended September 30, 2020 and 2019 affected the comparability of statements of earnings amounts:</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Tobacco and Health Litigation Items:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of tobacco and health litigation items and a breakdown of these costs by segment, see Note 12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the condensed consolidated financial statements in Item 1 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12&#8221;) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco and Health Litigation Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 9, respectively.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Asset Impairment, Exit, Implementation and Acquisition-Related Costs:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax implementation and acquisition-related costs were $415 million and $12 million for the nine and three months ended September 30, 2020, respectively.  Pre-tax asset impairment, exit, implementation and acquisition-related costs were $215 million and $11 million for the nine and three months ended September 30, 2019, respectively. </span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolving adult consumer preferences have posed strategic challenges for Ste. Michelle, which has seen slowing growth in the wine category and increased inventory levels in recent periods.  In addition, Ste. Michelle&#8217;s direct-to-consumer sales and on-premise wine sales in restaurants, bars and hospitality venues and on cruise lines have been, and continue to be, negatively impacted by disruptions arising from the COVID-19 pandemic.  For the nine and three months ended September 30, 2020, Ste. Michelle recorded pre-tax charges of $395 million and $1 million, respectively, which were included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings.  The charges consisted primarily of the following:  (i) write-off of inventory ($292 million recorded in the first quarter of 2020); and (ii) estimated losses on future non-cancelable grape purchase commitments associated with product volume demand uncertainty, which was further impacted by the economic uncertainty surrounding the COVID-19 pandemic ($100 million recorded in the first quarter of 2020).  Altria and Ste. Michelle also undertook a review of the wine business resulting in a strategic reset in the first quarter of 2020 in order to maximize Ste. Michelle&#8217;s profitability and achieve improved long-term cash-flow generation.  Ste. Michelle expects the reset to deliver pre-tax cost savings of approximately $15 million and pre-tax cash savings of approximately $40 million annually by 2021.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, Altria announced a cost reduction program (which included workforce reductions and third-party </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">spending across the businesses) that delivered approximately $600 million in annualized cost savings in 2019.  The program was completed in 2019.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion on asset impairment, exit and implementation costs, including a breakdown of these costs by segment, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment, Exit and Implementation Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1 (&#8220;Note 3&#8221;).</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine and three months ended September 30, 2019, Altria incurred pre-tax acquisition-related costs of $104 million and $6 million, respectively.  Substantially all of the pre-tax acquisition-related costs were for the write-off of debt issuance costs related to Altria&#8217;s short-term borrowings under the term loan agreement that Altria entered into in connection with its investments in JUUL and Cronos.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Impairment of JUUL equity securities: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine and three months ended September 30, 2020 and 2019, Altria recorded non-cash pre-tax impairment charges of $2,600 million and $4,500 million, respectively, reported as impairment of JUUL equity securities in its condensed consolidated statements of earnings.  A full tax valuation was recorded in 2020 and 2019 attributable to the tax benefit associated with the impairment charges.  For further discussion, see Note 4 and Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1 (&#8220;Note 11&#8221;).</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.78pt">ABI-Related Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s losses from its equity investment in ABI for the nine months ended September 30, 2020 included net pre-tax charges of $689 million, consisting primarily of Altria&#8217;s share of ABI&#8217;s (i)  mark-to-market losses on certain ABI financial instruments associated with its share commitments, (ii) completion of the sale of its Australia subsidiary and (iii) goodwill impairment charge associated with its Africa businesses.  </span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s losses from its equity investment in ABI for the three months ended September 30, 2020 included net pre-tax charges of $513 million, consisting primarily of Altria&#8217;s share of ABI&#8217;s completion of the sale of its Australia subsidiary and ABI&#8217;s goodwill impairment charge associated with its Africa businesses.  </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts include Altria&#8217;s share of amounts recorded by ABI in the second quarter of 2020, as well as additional adjustments related to (i) conversion from international financial reporting standards to GAAP, and (ii) adjustments to Altria&#8217;s investment required under the equity method of accounting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Cronos-Related Special Items:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine and three months ended September 30, 2020 and 2019, Altria recorded net pre-tax (income) expense consisting of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:48.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.267%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Earnings) losses from equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total Cronos-related special items - (income) expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The 2020 amounts and substantially all of the 2019 amounts are related to the non-cash change in the fair value of the warrant and certain anti-dilution protections (the &#8220;Fixed-price Preemptive Rights&#8221;) acquired in the Cronos transaction.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Amounts include Altria&#8217;s share of Cronos&#8217;s non-cash change in the fair value of Cronos&#8217;s derivative financial instruments associated with the issuance of additional shares. Amounts in 2020 also include Altria&#8217;s share of Cronos&#8217;s impairment charge on goodwill and intangible assets.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">COVID-19 Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2020, Altria recorded net pre-tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charges totaling $50 million directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic.  These net pre-tax charges, all of which were recorded in the second quarter of 2020, included premium pay, personal protective equipment and health screenings, partially offset by certain employment tax credits.  The COVID-19 special items do not include the inventory-related implementation costs associated with the wine business strategic reset.  These implementation costs discussed above were due to increased inventory levels, which were further negatively impacted by government restrictions and economic uncertainty surrounding the COVID-19 pandemic.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Tax Items:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax items for the nine months ended September 30, 2020 included net tax expense of $38 million due primarily to tax expense of $17 million for a tax basis adjustment to Altria&#8217;s investment in ABI and net tax expense of $12 million for adjustments resulting from amended returns and audit adjustments related to prior years.  Tax items for the three months ended September 30, 2020 included tax benefits of $13 million, due primarily to tax benefits of $17 million for a tax basis adjustment of Altria&#8217;s investment in ABI. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax items for the nine and three months ended September 30, 2019 included net tax benefits of $56 million and $97 million, respectively, due primarily to tax benefits of $91 million for the reversal of tax accruals no longer required and $30 million for the release of a valuation allowance on Altria&#8217;s equity investment in Cronos, partially offset by tax expense of $63 million and $21 million, respectively, for a tax basis adjustment to Altria&#8217;s equity investment in ABI. </span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Results of Operations for the Nine Months Ended September&#160;30, 2020 versus the Nine Months Ended September&#160;30, 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, increased $746 million (3.9%), due to higher net revenues in the smokeable products and oral tobacco products segments, partially offset by lower net revenues in the wine segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased $542 million (10.1%), due primarily to the inventory-related charges in the wine segment in 2020 (as discussed above), higher per unit settlement charges and COVID-19 special items in 2020, partially offset by lower shipment volume in the smokeable products and wine segments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excise taxes on products decreased $46 million (1.1%), due primarily to lower smokeable products shipment volume.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, administration and research costs decreased $69 million (4.2%), due primarily to lower spending in the smokeable products segment, partially offset by higher amortization expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income increased $393 million (5.0%), due primarily to higher operating results from the smokeable products and oral tobacco products segments, partially offset by lower operating results from the wine segment and higher amortization expense. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other debt expense, net, decreased $96 million (9.7%), due primarily to debt issuance costs in 2019 for borrowings associated with the JUUL and Cronos transactions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (losses) from Altria&#8217;s equity investments decreased $1,172 million (100.0%+), which were negatively impacted by ABI and Cronos special items and the impact of the COVID-19 pandemic on ABI&#8217;s ongoing operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rate decreased 32.3 percentage points to 41.8%, due primarily to a full valuation allowance in 2019 attributable to the tax benefits associated with the impairment of JUUL equity securities, partially offset by a full valuation allowance in 2020 attributable to the tax benefits associated with the impairment of JUUL equity securities.  For further discussion, see Note 11.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported net earnings (losses) attributable to Altria of $2,543 million increased $2,027 million (100.0%+), due primarily to the 2019 impairment of JUUL equity securities, lower loss on Cronos-related financial instruments, higher operating income and the write-off of debt issuance costs in 2019 associated with the JUUL and Cronos transactions, partially offset by the 2020 impairment of JUUL equity securities and losses from Altria&#8217;s equity investments.  Reported diluted and basic EPS attributable to Altria of $1.36 and $1.37, respectively, each increased by 100.0%+, due to higher net earnings (losses) attributable to Altria and fewer shares outstanding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings attributable to Altria of $6,276 million increased $292 million (4.9%), due primarily to higher adjusted OCI in the smokeable products and oral tobacco products segments, partially offset by lower adjusted earnings from Altria&#8217;s equity investments and higher income taxes.  Adjusted diluted EPS attributable to Altria of $3.37 increased by 5.6%, due to higher adjusted net earnings attributable to Altria and fewer shares outstanding.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Results of Operations for the Three Months Ended September&#160;30, 2020 versus the Three Months Ended September&#160;30, 2019 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, increased $267 million (3.9%), due to higher net revenues in the smokeable products segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales increased $46 million (2.4%), due primarily to higher per unit settlement charges, partially offset by lower manufacturing costs in the smokeable products segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income increased $216 million (7.3%), due primarily to higher operating results from the smokeable products segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (losses) from Altria&#8217;s equity investments, which decreased $805 million (100.0%+), were negatively impacted by ABI and Cronos special items and the impact of the COVID-19 pandemic on ABI&#8217;s ongoing operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s income tax rate decreased 172.8 percentage points to (195.1)%, due primarily to a full valuation allowance in 2019 attributable to the tax benefits associated with the impairment of JUUL equity securities, partially offset by a full valuation allowance in 2020 attributable to the tax benefits associated with the impairment of JUUL equity securities.  For further discussion, see Note 11. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported net earnings (losses) attributable to Altria of $(952) million increased $1,648 million (63.4%), due primarily to the 2019 impairment of JUUL equity securities, a lower loss on Cronos-related financial instruments and higher operating income, partially offset by the 2020 impairment of JUUL equity securities, 2020 losses from Altria&#8217;s equity investments in ABI and Cronos compared with earnings in 2019 and higher income taxes.  Reported diluted and basic EPS attributable to Altria of $(0.51), each increased by 63.3%, due to higher net earnings (losses) attributable to Altria. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings attributable to Altria of $2,215 million were essentially unchanged as lower adjusted earnings from Altria&#8217;s equity investments in ABI and Cronos and higher income taxes were offset by higher adjusted OCI in the smokeable products segment.  Adjusted diluted EPS attributable to Altria of $1.19 was unchanged.  </span></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_169"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Altria reports its financial results in accordance with GAAP, its management reviews certain financial results, including OCI, OCI margins, net earnings (losses) attributable to Altria and diluted EPS, on an adjusted basis, which exclude certain income and expense items that management believes are not part of underlying operations.  These items may include, for example, restructuring charges, asset impairment charges, acquisition-related costs, COVID-19 special items, equity investment-related special items (including any changes in fair value for the equity investment and any related warrants and preemptive rights), certain tax items, charges associated with tobacco and health litigation items, and resolutions of certain nonparticipating manufacturer (&#8220;NPM&#8221;) adjustment disputes under the 1998 Master Settlement Agreement (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221; and are more fully described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in  Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s management does not view any of these special items to be part of Altria&#8217;s underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results.  Altria&#8217;s management also reviews income tax rates on an adjusted basis.  Altria&#8217;s adjusted effective tax rate may exclude certain tax items from its reported effective tax rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s management believes that adjusted financial measures provide useful additional insight into underlying business trends and results, and provide a more meaningful comparison of year-over-year results.  Adjusted financial measures are used by management and regularly provided to Altria&#8217;s CODM for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets.  These adjusted financial measures are not required by, or calculated in accordance with GAAP and may not be calculated the same as similarly titled measures used by other companies.  These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_172"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Results by Business Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Tobacco Space</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Environment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. tobacco industry faces a number of business and legal challenges that have adversely affected and may adversely affect the business and sales volume of Altria&#8217;s tobacco subsidiaries and investees and Altria&#8217;s consolidated results of operations, cash flows or financial position.  These challenges, some of which are discussed in more detail below, in Note 12 and in Part II, Item 1A. Risk Factors of this Form 10-Q (&#8220;Item 1A&#8221;), include: </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">pending and threatened litigation and bonding requirements; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">restrictions and requirements imposed by the Family Smoking Prevention and Tobacco Control Act (&#8220;FSPTCA&#8221;), and restrictions and requirements (and related enforcement actions) that have been, and in the future will be, imposed by the FDA;  </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">actual and proposed excise tax increases, as well as changes in tax structures and tax stamping requirements; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">bans and restrictions on tobacco use imposed by governmental entities and private establishments and employers; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">other federal, state and local government actions, including: </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">restrictions on the sale of certain tobacco products, the sale of tobacco products by certain retail establishments, the sale of certain tobacco products with certain characterizing flavors and the sale of tobacco products in certain package sizes; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">additional restrictions on the advertising and promotion of tobacco products; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">other actual and proposed tobacco-related legislation and regulation; and </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">governmental investigations; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">the diminishing prevalence of cigarette smoking;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">increased efforts by tobacco control advocates and other private sector entities (including retail establishments) to further restrict the availability and use of tobacco products; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">changes in adult tobacco consumer purchase behavior, which is influenced by various factors such as economic conditions, excise taxes and price gap relationships, may result in adult tobacco consumers switching to discount products or other lower-priced tobacco products;  </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">the highly competitive nature of all tobacco categories, including, without limitation, competitive disadvantages related to cigarette price increases attributable to the settlement of certain litigation; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">illicit trade in tobacco products; </span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">potential adverse changes in prices, availability and quality of tobacco, other raw materials and components; and </span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">the COVID-19 pandemic.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to and in connection with the foregoing, evolving adult tobacco consumer preferences pose challenges for Altria&#8217;s tobacco subsidiaries.  Altria&#8217;s tobacco subsidiaries believe that a significant number of adult tobacco consumers switch among tobacco categories, use multiple forms of tobacco products and try innovative tobacco products, such as e-vapor products and oral nicotine pouches.  In fact, a growing number of adult smokers are converting from cigarettes to exclusive use of non-combustible tobacco product alternatives.  Up until the second half of 2019, the e-vapor category had experienced significant growth in recent years, and the number of adults who exclusively used e-vapor products also increased during that time which, along with growth in oral nicotine pouches, negatively impacted consumption levels and sales volume of cigarettes and moist smokeless tobacco (&#8220;MST&#8221;).  While growth of oral nicotine pouches has continued, growth in the e-vapor category has been negatively impacted by the legislative and regulatory activities discussed below and is increasingly competitive.  Altria and its tobacco subsidiaries believe the innovative tobacco products category (in particular, e-vapor) will continue to be dynamic as adult tobacco consumers explore a variety of tobacco product options and as the regulatory environment for these innovative tobacco products evolves.  For the cigarette category, based on year-to-date industry performance and expectations for continued category resilience, in October 2020, Altria revised its 2020 estimated full-year domestic cigarette industry adjusted volume to be in a range of unchanged versus the prior year to down 1.5%. This range replaces Altria&#8217;s previous estimate of down 2% to 3.5% versus the prior year.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic conditions also impact adult tobacco consumer purchase behavior.  Prior economic downturns have resulted in adult tobacco consumers choosing discount products and other lower-priced tobacco products.  As a result of the current economic downturn resulting from the COVID-19 pandemic, adult tobacco consumers may increasingly choose these products.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Summary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">above for further discussion. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its tobacco subsidiaries work to meet these evolving adult tobacco consumer preferences over time by developing, manufacturing, marketing and distributing products both within and outside the U.S. through innovation and adjacency growth strategies (including, where appropriate, arrangements with, or investments in, third parties). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">FSPTCA and FDA Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Regulatory Framework</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA, its implementing regulations and its 2016 deeming regulations establish broad FDA regulatory authority over all tobacco products and, among other provisions: </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">impose restrictions on the advertising, promotion, sale and distribution of tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Final Tobacco Marketing Rule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below);</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">establish pre-market review pathways for new and modified tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below); </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">prohibit any express or implied claims that a tobacco product is or may be less harmful than other tobacco products without FDA authorization;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">authorize the FDA to impose tobacco product standards that are appropriate for the protection of the public health; and </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">equip the FDA with a variety of investigatory and enforcement tools, including the authority to inspect product manufacturing and other facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA also bans descriptors such as &#8220;light,&#8221; &#8220;low&#8221; or &#8220;mild&#8221; when used as descriptors of modified risk, unless expressly authorized by the FDA.  In connection with a 2016 lawsuit initiated by Middleton, the Department of Justice, on behalf of the FDA, informed Middleton that at present, the FDA does not intend to bring an enforcement action against Middleton for the use of the term &#8220;mild&#8221; in the trademark &#8220;Black &amp; Mild.&#8221;  Consequently, Middleton dismissed its lawsuit without prejudice.  If the FDA were to change its position at some later date, Middleton would have the opportunity to bring another lawsuit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Final Tobacco Marketing Rule</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by the FSPTCA, in March 2010 the FDA promulgated a wide range of advertising and promotion restrictions for cigarettes and smokeless tobacco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products (the &#8220;Final Tobacco Marketing Rule&#8221;).  The May 2016 deeming regulations amended the Final Tobacco Marketing Rule to expand specific provisions to all tobacco products, including cigars, e-vapor products containing nicotine or other tobacco derivatives, pipe tobacco and oral nicotine pouches, but do not include any component or part that is not made or derived from tobacco.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Final Tobacco Marketing Rule, as amended, among other things:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">restricts the use of non-tobacco trade and brand names on cigarettes and smokeless tobacco products; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">prohibits sampling of all tobacco products except that sampling of smokeless tobacco products is permitted in qualified adult-only facilities;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">prohibits the sale or distribution of items such as hats and tee shirts with cigarette or smokeless tobacco brands or logos; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">prohibits cigarettes and smokeless tobacco brand name sponsorship of any athletic, musical, artistic or other social or cultural event, or any entry or team in any event; and </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">requires the development by the FDA of graphic warnings for cigarettes, establishes warning requirements for other tobacco products, and gives the FDA the authority to require new warnings for any type of tobacco product (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA Regulatory Actions - Graphic Warnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">_____________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Smokeless tobacco,&#8221; as used in this section of this Form 10-Q, refers to smokeless tobacco products first regulated by the FDA in 2009, including MST.  It excludes oral nicotine pouches, which were first regulated by the FDA in 2016.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain limitations arising from legal challenges, the Final Tobacco Marketing Rule took effect in June 2010 for cigarettes and smokeless tobacco products and in August 2016 for all other tobacco products.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of the promulgation of the Final Tobacco Marketing Rule, the FDA also issued an Advance Notice of Proposed Rulemaking (&#8220;ANPRM&#8221;) to establish restrictions on the placement of outdoor tobacco advertising in relation to schools and playgrounds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rulemaking and Guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for further description of the rulemaking process.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rulemaking and Guidance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the FDA issues proposed rules or guidance, which may be issued in draft or final form, generally involve public comment and may include scientific review.  The FDA also may request comments on broad topics through an ANPRM.  Altria&#8217;s tobacco subsidiaries actively engage with the FDA to develop and implement the FSPTCA&#8217;s regulatory framework, including submission of comments to various FDA policies and proposals and participation in public hearings and engagement sessions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA&#8217;s implementation of the FSPTCA and related regulations and guidance also may have an impact on enforcement efforts by U.S. states, territories and localities of their laws and regulations as well as of the State Settlement Agreements discussed below (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Settlement Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).&#160; Such enforcement efforts may adversely affect the ability of Altria&#8217;s tobacco subsidiaries and investees to market and sell regulated tobacco products in those states, territories and localities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA&#8217;s Comprehensive Plan for Tobacco and Nicotine Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the FDA announced a &#8220;Comprehensive Plan for Tobacco and Nicotine Regulation&#8221; (&#8220;Comprehensive Plan&#8221;) designed to strike a balance between regulation and encouraging the development of innovative tobacco products that may be less risky than cigarettes.  Since then, the FDA has issued additional information about its Comprehensive Plan in response to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">concerns associated with the rise in the use of e-vapor products by youth, and the potential youth appeal of flavored tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underage Access and Use of Certain Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).  As part of the Comprehensive Plan, the FDA: </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">issued ANPRMs relating to potential product standards for nicotine in cigarettes, flavors in all tobacco products (including menthol in cigarettes and characterizing flavors in all cigars); and, for e-vapor products, to protect against known public health risks such as concerns about youth exposure to liquid nicotine; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">took actions to restrict youth access to e-vapor products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">reconsidered the processes used by the FDA to review certain reports and new product applications; and </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">revisited the timelines (previously extended by the FDA) to submit applications for tobacco products first regulated by the FDA in 2016.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA permits the sale of tobacco products commercially marketed as of February 15, 2007 and not subsequently modified (&#8220;Grandfathered Products&#8221;) and new or modified products authorized through the Pre-market Tobacco Product Application (&#8220;PMTA&#8221;), Substantial Equivalence (&#8220;SE&#8221;) or SE Exemption pathways.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA pre-market authorization enforcement policy varies based on product type and date of availability in the market; specifically: </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">All tobacco products on the market as of February 15, 2007, and not subsequently modified, are Grandfathered Products and exempt from the pre-market authorization requirement; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">Cigarette and smokeless tobacco products that were modified or first introduced into the market between February 15, 2007 and March 22, 2011 are generally considered &#8220;Provisional Products&#8221; for which SE reports were required to be filed by March 22, 2011.  These reports must demonstrate that the product has the same characteristics as a product on the market as of February 15, 2007 or to a product previously determined to be substantially equivalent, or has different characteristics but does not raise different questions of public health; and </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">Tobacco products that were first regulated by the FDA in 2016, including cigars, e-vapor products and oral nicotine pouches that are not Grandfathered Products, are generally products for which either an SE report or PMTA needed to be filed by September 9, 2020.</span></div><div style="margin-bottom:3pt;text-indent:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-indent:9pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Modifications to currently marketed products, including modifications that result from, for example, changes to the quantity of tobacco product(s) in a package, a manufacturer being unable to acquire ingredients or a supplier being unable to maintain the consistency required in ingredients, also can trigger the FDA&#8217;s pre-market review process.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provisional Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most cigarette and smokeless tobacco products currently marketed by PM USA and U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;) are Provisional Products.  Altria&#8217;s subsidiaries timely submitted SE reports for these Provisional Products.  PM USA and USSTC have received SE determinations on certain Provisional Products. Those that were found to be not substantially equivalent (certain smokeless tobacco products) had been discontinued for business reasons prior to the FDA&#8217;s determinations; therefore, those determinations did not impact business results.  PM USA and USSTC have other Provisional Products that continue to be subject to the FDA&#8217;s pre-market review process.  In the meantime, they can continue marketing these products unless the FDA determines that a specific Provisional Product is not substantially equivalent.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the FDA has communicated that it will not review a certain subset of Provisional Product SE reports and that the products that are the subject of those reports can generally continue to be legally marketed without further FDA review.  PM USA and USSTC have Provisional Products included in this subset of products.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Altria&#8217;s cigarette and smokeless tobacco subsidiaries believe their current Provisional Products meet the statutory requirements of the FSPTCA, they cannot predict how the FDA will ultimately apply law, regulation and guidance to their various SE reports. Should Altria&#8217;s cigarette and smokeless tobacco subsidiaries receive unfavorable determinations on any SE reports currently pending with the FDA, they believe they can replace the vast majority of their respective product volumes with other FDA authorized products or with Grandfathered Products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Provisional Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Cigarette and smokeless tobacco products introduced into the market or modified after March 22, 2011 are &#8220;Non-Provisional Products&#8221; and must receive a marketing order from the FDA prior to being offered for sale.  Marketing orders for Non-Provisional Products may be obtained by filing an SE report, PMTA or using another pre-market pathway established by the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products Regulated in 2016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Manufacturers of products first regulated by the FDA in 2016, including cigars, oral nicotine pouches and e-vapor products, that were on the market as of August 8, 2016 and not subsequently modified must have filed an SE report or PMTA by the filing deadline of September 9, 2020 in order for their products to remain on the market.  At the FDA&#8217;s discretion, these products can remain on the market during FDA review for up to one year from the date of the application with additional case-by-case discretion to remain on the market after that time, so long as the report or application was timely filed with the FDA.  For products (new or modified) not on the market as of August 8, 2016, manufacturers must file an SE report or PMTA and receive FDA authorization prior to marketing the product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helix submitted a PMTA for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;on!&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oral nicotine pouches on May 15, 2020.  Middleton has received market orders or exemptions that cover over 97% of its cigar product volume and filed SE reports for its remaining cigar product volume by the filing deadline.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2013, Altria&#8217;s subsidiaries entered into a series of agreements with PMI, including an agreement that grants Altria an exclusive right to commercialize certain of PMI&#8217;s heated tobacco products in the United States, subject to FDA authorization of the applicable products.  PMI submitted a PMTA and a modified risk tobacco product application with the FDA for its electronically heated tobacco products comprising the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In April 2019, the FDA authorized the PMTA for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and in July 2020, the FDA authorized the marketing of these systems as modified risk tobacco products with a reduced exposure claim.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device heats but does not burn tobacco. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers that receive product authorizations through the PMTA process must submit post-market records and reports, as detailed in market orders.  The FDA may withdraw a market order based on this information if, among other reasons, it determines that the continued marketing of the product is no longer appropriate for the protection of the public health.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effect of Adverse FDA Determinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  FDA review time frames have varied.  It is therefore difficult to predict the duration of FDA reviews of SE reports or PMTAs.  Failure of manufacturers to submit applications by the applicable deadline, an unfavorable determination on an application or the withdrawal by the FDA of a prior marketing order could result in the removal of products from the market.  These manufacturers would have the option of marketing products that have received FDA pre-market authorization or Grandfathered Products.  A &#8220;not substantially equivalent&#8221; determination, a denial of a PMTA or a marketing order withdrawal by the FDA on one or more products could have a material adverse impact on the business and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated results of operations of our tobacco subsidiaries and investees, and the cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA Regulatory Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Graphic Warnings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FDA issued a final rule requiring 11 textual warnings accompanied by color graphics depicting the negative health consequences of smoking on cigarette packaging and advertising.  The final rule requires that the graphic health warnings (i) be located beneath the cellophane and comprise the top 50% of the front and rear panels of cigarette packages and (ii) occupy 20% of a cigarette advertisement and be located at the top of the advertisement.  As a result of a court order related to the COVID-19 pandemic, the final rule will be effective October 16, 2021.  PM USA and other cigarette manufacturers have filed lawsuits challenging the final rule on substantive and procedural grounds. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the preamble to the final rule, the FDA stated that it would not exempt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a heated tobacco product</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, as part of the rulemaking, but would consider the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> marketing order, and other marketing orders, on a case-by-case basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underage Access and Use of Certain Tobacco Products</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA announced regulatory actions in September 2018 to address underage access and use of e-vapor products.  Altria has engaged with the FDA on this topic and has reaffirmed to the FDA its ongoing and long-standing investment in underage tobacco use prevention efforts.  For example, during 2019, Altria advocated raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels to further address underage tobacco use, which is now federal law.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for further discussion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the FDA issued draft guidance further proposing restrictions to address youth e-vapor use.  This guidance, which the FDA finalized in January 2020, states that the FDA intends to prioritize enforcement action against:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">cartridge-based, flavored e-vapor products (other than tobacco and menthol flavors) unless such products have received market authorization from the FDA; and </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">all e-vapor products (in any format or flavor):</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">for which a manufacturer has failed or is failing to take adequate measures to prevent access by those under the age of 21 (referred to in the FDA guidance as &#8220;minors&#8221;); </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">targeted to minors and the marketing for which is likely to promote use of such products by minors; or</span></div><div style="margin-bottom:3pt;padding-left:72pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">offered for sale after the court-ordered filing deadline and for which the manufacturer has either not submitted a PMTA or for which an application was timely filed but an adverse decision on the application was issued by the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E-vapor product manufacturers, however, may continue to file PMTAs for flavored tobacco products.  FDA enforcement action could result in tobacco products being removed from the market unless and until these products receive pre-market authorization from the FDA.  JUUL ceased its sales of all cartridge-based, flavored e-vapor products (other than tobacco and menthol) in 2019.  If FDA enforcement action is taken against currently marketed JUUL e-vapor products, and a significant number of those products are removed from the market or if the FDA does not ultimately allow for the reintroduction of flavors other than tobacco and menthol, it could adversely affect the value of Altria&#8217;s investment in JUUL and have a material adverse effect on Altria&#8217;s consolidated financial position or earnings. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The January 2020 guidance effectively permits the continued sale (subject to the exceptions discussed above) of certain flavored e-vapor products, including flavored disposable e-vapor products.  If, as a result, these flavored e-vapor products are sold in higher volumes than JUUL&#8217;s e-vapor products, it could adversely affect the value of Altria&#8217;s investment in JUUL and have a material adverse effect on Altria&#8217;s consolidated financial position or earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Product Standards</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.46pt">Nicotine in cigarettes and other combustible tobacco products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the FDA issued an ANPRM seeking comments on the potential public health benefits and any possible adverse effects of lowering nicotine in combustible cigarettes to non-addictive or minimally addictive levels.  Among other issues, the FDA sought comments on (i) </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:3pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">whether smokers would compensate by smoking more cigarettes to obtain the same level of nicotine as with their current product and (ii) whether the proposed rule would create an illicit trade of cigarettes containing nicotine at levels higher than a non-addictive threshold that may be established by the FDA.  The FDA also sought comments on whether a nicotine product standard should apply to other combustible tobacco products, including cigars.  Were the FDA to develop and finalize a product standard for nicotine in combustible products, and if the standard was appealed and upheld in the courts, it could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries.</span></div><div style="margin-bottom:3pt;padding-left:36pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.46pt">Flavors in tobacco products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA&#8217;s Comprehensive Plan for Tobacco and Nicotine Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the FDA indicated that it is considering proposing rulemaking for a product standard that would seek to ban menthol in combustible tobacco products, including cigarettes and cigars, and that it intends to propose a product standard that would ban characterizing flavors in all cigars, including Grandfathered Products and those that have received SE determinations from the FDA - an intention reiterated in the FDA&#8217;s January 2020 guidance.  In March 2018, the FDA issued an ANPRM seeking comments on the role, if any, that flavors (including menthol) in tobacco products may play in attracting youth and in helping some smokers switch to potentially less harmful forms of nicotine delivery.  While the FDA has yet to define &#8220;characterizing flavors&#8221; with respect to cigars, most of Middleton&#8217;s cigar products contain added flavors and may be subject to any action by the FDA to ban flavors in cigars.  The FDA also may ban characterizing flavors in all other tobacco products, including oral nicotine pouches.  If these regulations become final and are appealed and upheld in the courts, it could have a material adverse effect on the business of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.46pt">NNN in Smokeless Tobacco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FDA proposed a product standard for N-nitrosonornicotine (&#8220;NNN&#8221;) levels in finished smokeless tobacco products.&#160; If the proposed rule, in present form, were to become final and was appealed and upheld in the courts, it could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and USSTC.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Good Manufacturing Practices</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA requires that the FDA promulgate good manufacturing practice regulations (referred to by the FDA as &#8220;Requirements for Tobacco Product Manufacturing Practice&#8221;) for tobacco product manufacturers, but does not specify a timeframe for such regulations.  Compliance with any such regulations could result in increased costs, which may have a material adverse effect on the financial position of Altria, its tobacco subsidiaries and its investees, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact on Our Business; Compliance Costs and User Fees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA regulatory actions under the FSPTCA could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries in various ways.  For example, actions by the FDA could:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">impact the consumer acceptability of tobacco products; </span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">delay, discontinue or prevent the sale or distribution of existing, new or modified tobacco products; </span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">limit adult tobacco consumer choices; </span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">impose restrictions on communications with adult tobacco consumers; </span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">create a competitive advantage or disadvantage for certain tobacco companies; </span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">impose additional manufacturing, labeling or packaging requirements;</span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">impose additional restrictions at retail;</span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">result in increased illicit trade in tobacco products; and/or</span></div><div style="padding-left:36pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">otherwise significantly increase the cost of doing business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure to comply with FDA regulatory requirements, even inadvertently, and FDA enforcement actions also could have a material adverse effect on the business of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA imposes user fees on cigarette, cigarette tobacco, smokeless tobacco, cigar and pipe tobacco manufacturers and importers to pay for the cost of regulation and other matters.  The FSPTCA does not impose user fees on e-vapor or oral nicotine pouch manufacturers.  The cost of the FDA user fee is allocated&#160;first among tobacco product categories subject to FDA regulation and then among manufacturers and importers within each respective category based on their relative market shares, all as prescribed by the FSPTCA and FDA regulations.  Payments for user fees are adjusted for several factors, including inflation, market share and industry volume.  For a discussion of the impact of the FDA user fee payments on Altria, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt and Liquidity - Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.  In addition, compliance with the FSPTCA&#8217;s regulatory requirements has resulted, and will continue to result, in additional costs for Altria&#8217;s tobacco businesses.  The amount of additional compliance and related costs has not been material in any given quarter or year to date period but could become material, either individually or in the aggregate, to one or more of Altria&#8217;s tobacco subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investigation and Enforcement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has a number of investigatory and enforcement tools available to it, including document requests and other required information submissions, facility inspections, examinations and investigations, injunction proceedings, monetary penalties, product withdrawal and recall orders, and product seizures.  Investigations or enforcement actions could result in significant costs or otherwise have a material adverse effect on the business of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Excise Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tobacco products are subject to substantial excise taxes in the U.S.  Significant increases in tobacco-related taxes or fees have been proposed or enacted (including with respect to e-vapor products) and are likely to continue to be proposed or enacted at the federal, state and local levels within the U.S., including as a result of the COVID-19 pandemic as a way for governments to address potential budget shortfalls.  The frequency and magnitude of excise tax increases can be influenced by various factors, including the composition of executive and legislative bodies.      </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state and local cigarette excise taxes have increased substantially over the past two decades, far outpacing the rate of inflation.  Between the end of 1998 and October 27, 2020, the weighted-average state cigarette excise tax increased from $0.36 to $1.83 per pack.  As of October 27, 2020, one state has increased cigarette excise taxes in 2020 and various increases are under consideration or have been proposed. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of states currently tax MST using an ad valorem method, which is calculated as a percentage of the price of the product, typically the wholesale price. This ad valorem method results in more tax being paid on premium products than is paid on lower-priced products of equal weight.  Altria&#8217;s subsidiaries support legislation to convert ad valorem taxes on MST to a weight-based methodology because, unlike the ad valorem tax, a weight-based tax subjects cans of equal weight to the same tax.  As of October 27, 2020, the federal government, 23 states, Puerto Rico, Philadelphia, Pennsylvania and Cook County, Illinois have adopted a weight-based tax methodology for MST.  </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increasing number of states and localities also are imposing excise taxes on e-vapor and oral nicotine pouches.  As of October 27, 2020, 26 states, the District of Columbia, Puerto Rico and a number of cities and counties have enacted legislation to tax e-vapor products.  These taxes are calculated in varying ways and may differ based on the e-vapor product form.  Similarly, 10 states and the District of Columbia have enacted legislation to tax oral nicotine pouches.  Tax increases could have an adverse impact on the sales of these products.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax increases are expected to continue to have an adverse impact on sales of cigarettes and MST products of Altria&#8217;s tobacco subsidiaries through lower consumption levels and the potential shift in adult consumer purchases from the premium to the non-premium or discount segments, or to counterfeit and contraband products.  Such shifts may have an adverse impact on the sales volume and reported share performance of cigarettes and MST products of Altria&#8217;s tobacco subsidiaries.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">International Treaty on Tobacco Control </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The World Health Organization&#8217;s Framework Convention on Tobacco Control (the &#8220;FCTC&#8221;) entered into force in February&#160;2005.  As of October 27, 2020, 181 countries, as well as the European Community, have become parties to the FCTC.  While the U.S. is a signatory of the FCTC, it is not currently a party to the agreement, as the agreement has not been submitted to, or ratified by, the United States Senate.  The FCTC is the first international public health treaty and its objective is to establish a global agenda for tobacco regulation with the purpose of reducing initiation of tobacco use and encouraging cessation.  The treaty recommends (and in certain instances, requires) signatory nations to enact legislation that would address various tobacco-related issues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of proposals currently under consideration by the governing body of the FCTC, some of which call for substantial restrictions on the manufacture, marketing, distribution and sale of tobacco products.  It is not possible to predict the outcome of these proposals or the impact of any FCTC actions on legislation or regulation in the U.S., either indirectly or as a result of the U.S. becoming a party to the FCTC, or whether or how these actions might indirectly influence FDA regulation and enforcement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">State Settlement Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 12, during 1997 and 1998, PM USA and other major domestic tobacco product manufacturers entered into the State Settlement Agreements.  These settlements require participating manufacturers to make substantial annual payments, which are adjusted for several factors, including inflation, operating income, market share and industry volume.  For a discussion of the impact of the State Settlement Agreements on Altria, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt and Liquidity - Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below and Note 12.  The State Settlement Agreements also place numerous requirements and restrictions on participating manufacturers&#8217; business operations, including prohibitions and restrictions on the advertising and marketing of cigarettes and smokeless tobacco products.  Among these are prohibitions of outdoor and transit brand advertising, payments for product placement and free sampling (except in adult-only facilities).  The State Settlement Agreements also place restrictions on the use of brand name sponsorships and brand name non-tobacco products and prohibitions on targeting youth and the use of cartoon characters.  In addition, the State Settlement Agreements require companies to affirm corporate principles directed at reducing underage use of cigarettes; impose requirements regarding lobbying activities; mandate public disclosure of certain industry documents; limit the industry&#8217;s ability to challenge certain tobacco control and underage use laws; and provide for the dissolution of certain tobacco-related organizations and place restrictions on the establishment of any replacement organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998,&#160;USSTC entered into the Smokeless Tobacco Master Settlement Agreement (the &#8220;STMSA&#8221;) with the attorneys general of various states and U.S. territories to resolve the remaining health care cost reimbursement cases initiated against&#160;USSTC.  The STMSA required USSTC to adopt various marketing and advertising restrictions.  USSTC is the only smokeless tobacco manufacturer to sign the STMSA.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Other International, Federal, State and Local Regulation and Governmental and Private Activity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International, Federal, State and Local Regulation  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of states and localities have enacted or proposed legislation that imposes restrictions on tobacco products (including cigarettes, smokeless tobacco, cigars and e-vapor products), such as legislation that (1) prohibits the sale of tobacco product categories, such as e-vapor, (2) prohibits the sale of tobacco products with certain characterizing flavors, such as menthol cigarettes, (3) requires the disclosure of health information separate from or in addition to federally mandated health warnings and (4) restricts commercial speech or imposes additional restrictions on the marketing or sale of tobacco products (including proposals to ban all tobacco product sales).  The legislation varies in terms of the type of tobacco products, the conditions under which such products are or would be restricted or prohibited, and exceptions to the restrictions or prohibitions.  For example, a number of proposals involving characterizing flavors would prohibit smokeless tobacco products with characterizing flavors without providing an exception for mint- or wintergreen-flavored products.  As of October 27, 2020, 16 states and the District of Columbia have proposed legislation to ban flavors in one or more tobacco products, and five states, California, Massachusetts, New Jersey, Utah and New York, have passed such legislation.  Similar legislation has been introduced in the U.S. Congress and was passed by the U.S. House of Representatives in 2020.  Some of these states, such as New York and Utah, exempt certain products that have received FDA market authorization through the PMTA pathway.  The legislation in California bans the sale of most tobacco products with characterizing flavors, including menthol, mint and wintergreen, effective January 1, 2021.  Following enactment of the flavor ban in August 2020, several registered California voters filed a referendum against the legislation.  Over 600,000 registered voter signatures must be collected to place the issue on the 2022 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ballot, which, if successfully completed, would delay its implementation until after a vote on the referendum occurs.  Altria&#8217;s tobacco operating companies, in conjunction with other companies, are funding this effort.  Additionally, in October 2020, Altria&#8217;s tobacco operating companies, along with several other parties including R.J. Reynolds, filed a lawsuit challenging the flavor ban and seeking to enjoin its implementation.  Massachusetts passed legislation capping the amount of nicotine in e-vapor products.  Similar legislation is pending in three other states. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to legislation, some state governors had imposed restrictions on tobacco products through executive action.  For example, in response to reports of lung injuries and deaths related to e-vapor product use, the governors of eight states exercised executive action to temporarily prohibit either the sale of all e-vapor products or e-vapor products with flavors other than tobacco.  Some of those executive actions have been challenged in the courts and many of those executive actions have expired.  Restrictions on e-vapor products also have been instituted or proposed internationally.  For example, India and Singapore have instituted bans on e-vapor products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s tobacco subsidiaries have challenged and will continue to challenge certain federal, state and local legislation and other governmental action, including through litigation.  It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that could have a material adverse impact on the business and volume of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a number of states and localities proposed and enacted legislation to increase the minimum age to purchase all tobacco products, including e-vapor products, in December 2019, the federal government passed legislation increasing the minimum age to purchase all tobacco products, including e-vapor products, to 21 nationwide.  Although an increase in the minimum age to purchase tobacco products may have a negative impact on sales volume of our tobacco businesses, as discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underage Access and Use of Certain Tobacco Products,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Altria supported raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels, reflecting its longstanding commitment to combat underage tobacco use.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Effects of Tobacco Products, Including E-vapor Products</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reports with respect to the health effects of smoking have been publicized for many years, including various reports by the U.S. Surgeon General.  In 2019, there were public health advisories concerning vaping-related lung injuries and deaths and more recently, there have been health concerns raised about potential increased risks associated with COVID-19 among smokers and vapers.  Altria and its tobacco subsidiaries believe that the public should be guided by the messages of the U.S. Surgeon General and public health authorities worldwide in making decisions concerning the use of tobacco products.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most jurisdictions within the U.S. have restricted smoking in public places and some have restricted vaping in public places.  Some public health groups have called for, and various jurisdictions have adopted or proposed, bans on smoking and vaping in outdoor places, in private apartments and in cars transporting children.  It is not possible to predict the results of ongoing scientific research or the types of future scientific research into the health risks of tobacco exposure and the impact of such research on legislation and regulation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legislation or Governmental Initiatives</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the actions discussed above, other regulatory initiatives affecting the tobacco industry have been adopted or are being considered at the federal level and in a number of state and local jurisdictions.  For example, amid the COVID-19 pandemic, state and local governments have required additional health and safety requirements of all businesses, including tobacco manufacturing and other facilities.  State and local governments also have mandated the temporary closure of some businesses.  It is possible that tobacco manufacturing and other facilities could be subject to these government-mandated temporary closures.  Additionally, in recent years, legislation has been introduced or enacted at the state or local level to subject tobacco products to various reporting requirements and performance standards; establish educational campaigns relating to tobacco consumption or tobacco control programs or provide additional funding for governmental tobacco control activities; restrict the sale of tobacco products in certain retail establishments and the sale of tobacco products in certain package sizes; require tax stamping of smokeless tobacco products; require the use of state tax stamps using data encryption technology; and further restrict the sale, marketing and advertising of cigarettes and other tobacco products.  Such legislation may be subject to constitutional or other challenges on various grounds, which may or may not be successful.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not possible to predict what, if any, additional legislation, regulation or other governmental action will be enacted or implemented (and, if challenged, upheld) relating to the manufacturing, design, packaging, marketing, advertising, sale or use of tobacco products, or the tobacco industry generally.  It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that could have a material adverse impact on the business and volume of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria&#8217;s investment in JUUL.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governmental Investigations </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, Altria, its subsidiaries and investees are subject to governmental investigations on a range of matters.&#160; For example: (i) the Federal Trade Commission (&#8220;FTC&#8221;) issued a Civil Investigative Demand (&#8220;CID&#8221;) to Altria while conducting its antitrust review of Altria&#8217;s investment in JUUL seeking information regarding, among other things, Altria&#8217;s role in the resignation of JUUL&#8217;s former chief executive officer and the hiring by JUUL of any current or former Altria director, executive or employee; (ii) the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) commenced an investigation relating to Altria&#8217;s disclosures and accounting</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">controls in connection with the JUUL investment; and (iii) the Attorney General of the State of Minnesota issued a CID relating to the marketing of Nu Mark LLC (&#8220;Nu Mark&#8221;) e-vapor products, which were discontinued in 2018.  Additionally, JUUL is currently under investigation by various federal and state agencies, including the SEC, the FDA and the FTC, and state attorneys general.&#160; Such investigations vary in scope but at least some appear to include JUUL&#8217;s marketing practices; particularly as such practices relate to youth, and Altria may be asked in the context of those investigations to provide information concerning its investment in JUUL or relating to its marketing of Nu Mark e-vapor products.&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Sector Activity on E-Vapor</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of retailers, including national chains, have discontinued the sale of e-vapor products.  Reasons for the discontinuation include reported illnesses related to e-vapor product use and the uncertain regulatory environment.  It is possible that this private sector activity could adversely affect the value of Altria&#8217;s investment in JUUL and have a material adverse effect on Altria&#8217;s consolidated financial position or earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Illicit Trade in Tobacco Products</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Illicit trade in tobacco products can have an adverse impact on the businesses of Altria, its tobacco subsidiaries and investees.  Illicit trade can take many forms, including the sale of counterfeit tobacco products; the sale of tobacco products in the U.S. that are intended for sale outside the country; the sale of untaxed tobacco products over the Internet and by other means designed to avoid the collection of applicable taxes; and diversion into one taxing jurisdiction of tobacco products intended for sale in another.  Counterfeit tobacco products, for example, are manufactured by unknown third parties in unregulated environments.  Counterfeit versions of our tobacco subsidiaries&#8217; and investees&#8217; products can negatively affect adult tobacco consumer experiences with and opinions of those brands.  Illicit trade in tobacco products also harms law-abiding wholesalers and retailers by depriving them of lawful sales and undermines the significant investment Altria&#8217;s tobacco subsidiaries and investees have made in legitimate distribution channels.  Moreover, illicit trade in tobacco products results in federal, state and local governments losing tax revenues.  Losses in tax revenues can cause such governments to take various actions, including increasing excise taxes; imposing legislative or regulatory requirements that may adversely impact Altria&#8217;s consolidated results of operations and cash flows, including adversely affecting the value of Altria&#8217;s investment in JUUL, and the businesses of its tobacco subsidiaries and investees; or asserting claims against manufacturers of tobacco products or members of the trade channels through which such tobacco products are distributed and sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s tobacco subsidiaries communicate with wholesale and retail trade members regarding illicit trade in tobacco products and how they can help prevent such activities; enforce wholesale and retail trade programs and policies that address illicit trade in tobacco products and, when necessary, litigate to protect their trademarks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Price, Availability and Quality of Tobacco, Other Raw Materials and Component Parts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shifts in crops (such as those driven by economic conditions and adverse weather patterns), government restrictions and mandated prices, economic trade sanctions, import duties and tariffs, geopolitical instability and&#160;production control programs may increase or decrease the cost or reduce the supply or quality&#160;of tobacco and other raw materials or component parts used to manufacture our companies&#8217; products.  Any significant change in the price, quality or availability of tobacco, other raw materials or component parts used to manufacture our products could restrict our subsidiaries&#8217; ability to continue marketing existing products or impact adult consumer product acceptability and adversely affect our&#160;subsidiaries&#8217; profitability and businesses.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to tobacco, as with other agricultural commodities, crop quality&#160;and availability can be influenced by variations in weather patterns, including those caused by climate change.  Additionally, the price of tobacco leaf can be influenced by&#160;economic conditions and imbalances in supply and demand.  Economic conditions, including the economic effects of the COVID-19 pandemic, are unpredictable, which, among other economic factors, may result in changes in the patterns of demand for agricultural products&#160;and the cost of tobacco production which could impact tobacco leaf prices and tobacco supply.  Tobacco production in certain countries also is subject to a variety of controls, including government-mandated prices and production control programs.&#160; Moreover, certain types of tobacco are only available in limited geographies, including geographies experiencing political instability or government prohibitions on the import or export of tobacco, and loss of their availability could impair our subsidiaries&#8217; ability to continue marketing existing products or impact adult tobacco consumer product acceptability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic also may limit access to and increase the cost of raw materials, component parts and personal protective equipment as U.S. and global suppliers temporarily shut down facilities in order to address exposure to the virus or as a result of a government mandate.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Timing of Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, our tobacco subsidiaries are subject to many influences that can impact the timing of sales to customers, including the timing of holidays and other annual or special events, the timing of promotions, customer incentive programs and customer inventory programs, as well as the actual or speculated timing of pricing actions and tax-driven price increases.</span></div><div id="i85986654d18d42b3b8b96449288f0b8f_175"></div><div style="margin-top:12pt;padding-right:9pt;text-align:justify"><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_178"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Smokeable products segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for the smokeable products segment:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Results</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,950)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit and implementation costs</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 special items</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 pp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 pp</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 pp</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 pp</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, for the nine months ended September 30, 2020 increased $685 million (4.1%), due primarily to higher pricing ($920 million), which includes higher promotional investments, partially offset by lower shipment volume ($189 million).  </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI for the nine months ended September&#160;30, 2020 increased $745 million (10.9%), due primarily to higher pricing ($920 million), which includes higher promotional investments, lower costs ($165 million) and 2019 asset impairment, exit and implementation costs ($79 million), partially offset by higher per unit settlement charges, lower shipment volume ($126 million), COVID-19 special items ($41 million) and higher tobacco and health litigation items ($30 million). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI for the nine months ended September&#160;30, 2020 increased $737 million (10.5%), due primarily to higher pricing ($920 million), which includes higher promotional investments, and lower costs ($165 million), partially offset by higher per unit settlement charges and lower shipment volume ($126 million). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, for the three months ended September&#160;30, 2020 increased $264 million (4.4%), due primarily to higher pricing ($280 million), which includes higher promotional investments.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI for the three months ended September&#160;30, 2020 increased $228 million (8.9%), due primarily to higher pricing ($280 million), which includes higher promotional investments, and lower costs ($58 million), partially offset by higher per unit settlement charges and higher tobacco and health litigation items ($31 million). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI for the three months ended September&#160;30, 2020 increased $255 million (9.9%), due primarily to higher pricing ($280 million), which includes higher promotional investments, and lower costs ($58 million), partially offset by higher per unit settlement charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the smokeable products segment shipment volume performance:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shipment Volume</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(sticks in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigarettes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Marlboro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigarettes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigars:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Black &amp; Mild</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigars</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total smokeable products</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,921&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,090&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,160&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cigarettes shipment volume includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; Other premium brands, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Virginia Slims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Parliament</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Benson &amp; Hedges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nat&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; and Discount brands, which include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">L&amp;M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cigarettes volume includes units sold as well as promotional units, but excludes units sold for distribution to Puerto Rico, and units sold in U.S. Territories, to overseas military and by Philip Morris Duty Free Inc., none of which, individually or in the aggregate, is material to the smokeable products segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cigarettes retail share performance:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage Point Change</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage Point Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigarettes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Marlboro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigarettes</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retail share results for cigarettes are based on data from IRI/Management Science Associates, Inc., a tracking service that uses a sample of stores and certain wholesale shipments to project market share and depict share trends.  This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes.  For other trade classes selling cigarettes, retail share is based on shipments from wholesalers to retailers through the Store Tracking Analytical Reporting System (&#8220;STARS&#8221;).  This service is not designed to capture sales through other channels, including the internet, direct mail and some illicitly tax-advantaged outlets.  It is IRI&#8217;s standard practice to periodically refresh its services, which could restate retail share results that were previously released in this service. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of volume trends and factors that impact volume and retail share performance, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The smokeable products segment&#8217;s reported domestic cigarettes shipment volume for the nine months ended September&#160;30, 2020 decreased 1.4%, driven primarily by retail share losses, partially offset by calendar differences and inventory trade movements.  When adjusted for calendar differences, trade inventory movements and other factors, the smokeable products segment&#8217;s reported domestic cigarettes shipment volume for the nine months ended September&#160;30, 2020 decreased by an estimated 2%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When adjusted for calendar differences, trade inventory movements and other factors, estimated total domestic cigarette industry volumes for the nine months ended September&#160;30, 2020 were unchanged.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The smokeable products segment&#8217;s reported domestic cigarettes shipment volume for the three months ended September&#160;30, 2020 decreased 0.4%, driven primarily by retail share losses and other factors, partially offset by the industry&#8217;s growth rate and trade inventory movements.  When adjusted for trade inventory movements, the smokeable products segment&#8217;s reported domestic cigarettes shipment volume for the three months ended September&#160;30, 2020 decreased by an estimated 1%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When adjusted for trade inventory movements, estimated total domestic cigarette industry volumes for the three months ended September&#160;30, 2020 increased by 1%. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipments of premium cigarettes accounted for 92.0% and 92.3% of smokeable products&#8217; reported domestic cigarettes shipment volume for the nine and three months ended September&#160;30, 2020, respectively, versus 91.7% and 91.5% for the nine  and three months ended September&#160;30, 2019, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sequentially, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s retail share of the total cigarette category for the three months ended September&#160;30, 2020 increased 0.5 share points from the second quarter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cigarettes industry discount category retail share increased 0.4 share points to 24.5% and 0.2 share points to 24.3% for the nine and three months ended September&#160;30, 2020, respectively.  Sequentially, total discount retail share decreased 0.3 share points from the second quarter of 2020.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA and Middleton executed the following pricing and promotional allowance actions during 2020 and 2019:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective June 21, 2020, PM USA increased the list price on all of its cigarette brands by $0.11 per pack.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective February 16, 2020, PM USA increased the list price on all of its cigarette brands by $0.08 per pack.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 12, 2020, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.08 per five-pack.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective October 20, 2019, PM USA increased the list price on all of its cigarette brands by $0.08 per pack.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective August 4, 2019, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.04 per five-pack.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective June 16, 2019, PM USA increased the list price on all of its cigarette brands by $0.06 per pack, except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">L&amp;M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which had no list price change.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective February 24, 2019, PM USA increased the list price on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">L&amp;M </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by $0.11 per pack and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Parliament </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Virginia Slims </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by $0.16 per pack.  In addition, PM USA increased the list price on all of its other cigarette brands by $0.31 per pack.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition on October 28, 2020, PM USA announced a list price increase effective November 1, 2020 on all of its cigarette brands by $0.13 per pack. </span></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_181"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Oral tobacco products segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for the oral tobacco products segment:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Results</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation and acquisition-related costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,211&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 pp</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 pp</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 pp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 pp</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, for the nine months ended September&#160;30, 2020 increased $139 million (7.9%), due primarily to higher pricing ($105 million), which includes higher promotional investments, and higher shipment volume ($31 million).  Reported OCI for the nine months ended September&#160;30, 2020 increased $102 million (8.5%), due primarily to higher pricing ($105 million), which includes higher promotional investments, and higher volume ($18 million), partially offset by higher investments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI for the nine months ended September&#160;30, 2020 increased $101 million (8.3%), due primarily to higher pricing ($105 million), which includes higher promotional investments, and higher volume ($18 million), partially offset by higher investments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, for the three months ended September&#160;30, 2020 increased $20 million (3.2%), due primarily to higher pricing ($26 million), which includes higher promotional investments, partially offset by lower shipment volume ($8 million).  Reported OCI for the three months ended September&#160;30, 2020 increased $19 million (4.6%), due primarily to higher pricing ($26 million), which includes higher promotional investments, partially offset by lower shipment volume ($10 million). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI for the three months ended September&#160;30, 2020 increased $18 million (4.3%),due primarily to higher pricing ($26 million), which includes higher promotional investments, partially offset by lower shipment volume ($10 million).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes oral tobacco products segment shipment volume performance:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shipment Volume</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(cans and packs in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Copenhagen</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Skoal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s estimated oral tobacco industry shipment volume for the current and comparable periods includes MST, snus and oral nicotine pouch products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oral tobacco products shipment volume includes cans and packs sold, as well as promotional units, but excludes international volume, which is currently not material to the oral tobacco products segment.  New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis.  To calculate volumes of cans and packs shipped, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, in the first quarter of 2020, Altria&#8217;s smokeless products segment was renamed the oral tobacco products segment.  Prior to 2020, the smokeless products segment retail share performance and category industry volume estimates included MST and snus products, but excluded oral nicotine pouch products.  Altria has restated prior period retail share performance data and estimated category industry volume to reflect the inclusion of oral nicotine pouch products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes oral tobacco products segment retail share performance (excluding international volume):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage Point Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage Point Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Copenhagen</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Skoal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retail share results for oral tobacco products are based on data from IRI InfoScan, a tracking service that uses a sample of stores to project market share and depict share trends.&#160; This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes on the number of cans and packs sold.&#160; Oral tobacco products is defined by IRI as MST, snus and oral nicotine pouches.  New types of oral tobacco products, as well as new packaging </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis.  For example, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST.  Because this service represents retail share performance only in key trade channels, it should not be considered a precise measurement of actual retail share.&#160; It is IRI&#8217;s standard practice to periodically refresh its InfoScan services, which could restate retail share results that were previously released in this service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of volume trends and factors that impact volume and retail share performance, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The oral tobacco products segment&#8217;s reported domestic shipment volume increased 1.4% for the nine months ended September&#160;30, 2020, driven primarily by the industry&#8217;s growth rate, partially offset by retail share losses (primarily due to the growth of oral nicotine pouches).  When adjusted for trade inventory movements and other factors, the oral tobacco products segment&#8217;s reported domestic shipment volume for the nine months ended September&#160;30, 2020 increased by an estimated 1.5%. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The oral tobacco products segment&#8217;s reported domestic shipment volume decreased 1.1% for the three months ended September&#160;30, 2020, driven primarily by retail share losses (primarily due to the growth of oral nicotine pouches), calendar differences and trade inventory movements, partially offset by the industry&#8217;s growth rate and other factors.  When adjusted for calendar differences, trade inventory movements and other factors, the oral tobacco products segment&#8217;s reported domestic shipment volume for the three months ended September&#160;30, 2020 increased by an estimated 4%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total oral tobacco products category industry volume increased by an estimated 6.5% over the past six months, driven primarily by growth in oral nicotine pouches.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The oral tobacco products segment&#8217;s retail share was 50.1% and 49.9% for the nine and three months ended September&#160;30, 2020, respectively, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> continued to be the leading oral tobacco brand with retail share of 32.1% and 31.8% for the nine and three months ended September&#160;30, 2020, respectively.  Share losses for both the segment and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n were due to the growth of oral nicotine pouches.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In stores with distribution, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> achieved a retail share of 2.1 percentage points of the oral tobacco category for the nine months ended September 30, 2020.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USSTC executed the following pricing actions during 2020 and 2019: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Effective October 20, 2020, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Blend products by $0.15 per can.  USSTC also increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Red Seal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">brands and its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> popular price products by $0.08 per can.  In addition, USSTC increased the list price on the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> products by $0.07 per can.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective July 21, 2020, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.15 per can.&#160; USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.07 per can.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective February 18, 2020, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X-TRA products by $0.56 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.16 cents per can and increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.07 per can.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective October 22, 2019, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X-TRA products and select </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products by $0.09 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.04 per can.   </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective July 23, 2019, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> X-TRA products and select </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.08 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products by $0.03 per can.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective April 30, 2019, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> X-TRA products and select </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.17 per can.&#160; USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> popular price products by $0.12 per can.&#160; In addition, USSTC increased the list price on the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products by $0.07 per can.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="padding-left:36pt"><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_184"></div><div style="padding-right:9pt;text-align:justify"><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_187"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Wine Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Environment </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ste. Michelle is a leading producer of Washington state wines, primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chateau Ste. Michelle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">14 Hands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and owns wineries in or distributes wines from several other domestic and foreign wine regions.  Ste. Michelle holds an 85% ownership interest in Michelle-Antinori, LLC, which owns </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stag&#8217;s Leap Wine Cellars</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Napa Valley.  Ste. Michelle also owns </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conn Creek</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Napa Valley, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patz &amp; Hall</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Sonoma and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Erath</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Oregon.  In addition, Ste. Michelle imports and markets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Antinori</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Villa Maria Estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> wines and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Champagne Nicolas Feuillatte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States.  Ste. Michelle works to meet evolving adult consumer preferences over time by developing, marketing and distributing products through innovation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ste. Michelle&#8217;s business is subject to significant competition, including competition from many larger, well-established domestic and international companies, as well as from many smaller wine producers.  Wine segment competition is primarily based on quality, price, consumer and trade wine tastings, competitive wine judging, third-party acclaim and advertising.  Substantially all of Ste. Michelle&#8217;s sales occur in the United States through state-licensed distributors.  Ste. Michelle also sells to domestic consumers through retail and e-commerce channels and exports wines to international distributors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adult consumer preferences among alcohol categories and within the wine category can shift due to a variety of factors, including changes in taste preferences, demographics or social trends, and changes in leisure, dining and beverage consumption patterns and economic conditions.  Evolving adult consumer preferences pose challenges to the wine category, which has seen slowing volume growth and increases in inventory levels.  Ste. Michelle has been experiencing product volume demand uncertainty, which has been further negatively impacted in the first nine months of 2020 by the economic uncertainty surrounding the COVID-19 pandemic.  Ste. Michelle&#8217;s direct-to-consumer sales and on-premise sales in restaurants, bars and hospitality venues and on cruise lines have been, and continue to be, negatively impacted by disruptions arising from the COVID-19 pandemic, which also may have an impact on adult wine consumers going forward.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of wine inventory levels significantly exceeding forecasted product volume demand, Ste. Michelle recorded pre-tax charges of $395 million in the first nine months of 2020.  The charges primarily included a $292 million inventory write off and estimated losses of $100 million on future non-cancelable grape purchase commitments recorded in the first quarter of 2020.  Ste. Michelle expects to record charges of approximately $20 million in 2020, consisting of inventory disposal costs and other charges.  For further discussion see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment, Exit and Implementation Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 3.  Evolving adult consumer preferences, the current economic downturn, an extended disruption in on-premise sales or facility shutdowns, either voluntary or government-mandated, could result in a further slowdown in the wine category and otherwise have a material adverse effect on Ste. Michelle&#8217;s wine business, the consolidated results of operations, cash flows or financial position of Ste. Michelle.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As with other agricultural commodities, grape quality&#160;and availability can be influenced by plant disease and infestation, as well as by variations in weather patterns, such as fires and smoke damage from fires, including those caused by climate change.  For example, in 2019, freezing temperatures reduced grape production and resulted in fewer grapes being available to Ste. Michelle.  Additionally, Ste. Michelle has experienced some impact from the ongoing fires in the western United States.  As of October 27, 2020, the impact has not been material to Altria, but Ste. Michelle continues to monitor the situation.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state and local governmental agencies regulate the beverage alcohol industry through various means, including licensing requirements, pricing rules, labeling and advertising restrictions, and distribution and production policies.  Further regulatory restrictions or additional excise or other taxes on the manufacture and sale of alcoholic beverages could have an adverse effect on&#160;Ste. Michelle&#8217;s wine business.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_190"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for the wine segment:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Results</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)%+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1 </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93.3) pp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 pp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 pp</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 pp</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, for the nine months ended September&#160;30, 2020 decreased $49 million (10.1%), due primarily to lower shipment volume, partially offset by higher pricing, which includes lower promotional investments.  Reported OCI for the nine months ended September&#160;30, 2020 decreased $397 million (100.0%+), due primarily to the inventory-related charges discussed above (included in implementation costs and charged to cost of sales) and lower shipment volume, partially offset by higher pricing, which includes lower promotional investments, and lower costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI for the nine months ended September&#160;30, 2020 decreased $2 million (4.0%), due primarily to lower shipment volume, partially offset by higher pricing, which includes lower promotional investments, and lower costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, for the three months ended September&#160;30, 2020 decreased $10 million (6.0%), due primarily to lower shipment volume.  Reported OCI for the three months ended September&#160;30, 2020 increased $3 million (18.8%), due primarily to lower selling, general and administrative costs, partially offset by lower shipment volume.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI for the three months ended September&#160;30, 2020 increased $4 million (25.0%), due primarily to lower selling, general and administrative costs, partially offset by lower shipment volume. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine and three months ended September&#160;30, 2020, Ste. Michelle&#8217;s reported wine shipment volume of 5,182 and 1,885 thousand cases, decreased 11.4% and 3.9%, respectively.</span></div><div id="i85986654d18d42b3b8b96449288f0b8f_193"></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Financial Review</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Provided by/Used in Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2020, net cash provided by operating activities was $5,844 million compared with $5,274 million during the first nine months of 2019.  This increase was due primarily to higher net revenues in the smokeable products and oral tobacco products segments, lower payments as a result of savings from the cost reduction program announced in December 2018 and lower payments for tobacco and health litigation items, partially offset by higher income tax payments, timing of long-term debt interest payments, and lower dividends received from ABI in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria had a working capital deficit at September 30, 2020 and December&#160;31, 2019.   Altria&#8217;s management believes that Altria has the ability to fund working capital deficits with cash provided by operating activities and borrowings through its access to credit and capital markets, as discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt and Liquidity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Provided by/Used in Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2020, net cash used in investing activities was $107 million compared with $2,412 million during the first nine months of 2019.  This decrease was due primarily to the investment in Cronos in 2019 and Helix&#8217;s third quarter 2019 acquisition of Burger S&#246;hne Holding and its subsidiaries as well as certain affiliated companies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Provided by/Used in Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2020, net cash used in financing activities was $3,713 million compared with $2,650 million during the first nine months of 2019.  This increase was due primarily to the following:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">proceeds of $16.3 billion from the issuance of long-term senior unsecured notes in 2019;  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repayment of $1.0 billion in full of Altria senior unsecured notes at scheduled maturity in January 2020; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">higher dividends paid in 2020;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repayments of $12.8 billion of short-term borrowings in 2019;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">proceeds of $2.0 billion from the issuance of long-term senior unsecured notes in 2020;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repayment of $1.1 billion in full of Altria senior unsecured notes at scheduled maturity in August 2019; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repurchases of common stock in 2019.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Debt and Liquidity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Altria&#8217;s cost and terms of financing and its access to commercial paper markets may be impacted by applicable credit ratings.  The impact of credit ratings on the cost of borrowings under the Credit Agreement is discussed below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the credit ratings and outlook for Altria&#8217;s indebtedness by major credit rating agencies were:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:52.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;P-2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;A3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Stable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard &amp; Poor&#8217;s Ratings Services (&#8220;Standard &amp; Poor&#8217;s&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;A-2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BBB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Stable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fitch Ratings Ltd.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;F2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BBB</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Stable</span></td></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Lines</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - From time to time, Altria has short-term borrowing needs to meet its working capital requirements and generally uses its commercial paper program to meet those needs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement, which is used for general corporate purposes, provides for borrowings up to an aggregate principal amount of $3.0 billion.  In March 2020, due to the uncertainty at the time in the global capital markets (including the commercial paper markets) resulting from the COVID-19 pandemic, Altria borrowed the full $3.0 billion available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility.  In June 2020, Altria repaid the full amount outstanding under the Credit Agreement and currently has $3.0 billion available under the Credit Agreement.  For further discussion, including interest and covenants in the Credit Agreement, see Note 10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the condensed consolidated financial statements in Item 1 (&#8220;Note 10&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM USA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Market Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Altria believes it has adequate liquidity and access to financial resources to meet its anticipated obligations and ongoing business needs in the foreseeable future.  Altria monitors the credit quality of its bank group and is not aware of any potential non-performing credit provider in that group. </span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty surrounding the COVID-19 pandemic, including its duration, severity and ultimate overall impact on the global and U.S. economies and the businesses of Altria&#8217;s operating companies, Altria continues to maintain a higher than normal cash balance to preserve its financial flexibility.  In addition to the borrowing under the Credit Agreement discussed above, Altria has taken the following actions to increase its cash position:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">issued $2.0 billion of long-term senior unsecured notes; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">has not repurchased any shares during 2020 (in April 2020, the Board of Directors rescinded the $500 million remaining in its $1.0 billion share repurchase program).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, Altria&#8217;s receivables primarily reflect sales of wine produced and/or distributed by Ste. Michelle.  Altria&#8217;s businesses anticipate that the COVID-19 pandemic may present challenges in ensuring timely payment and collection of accounts receivable for some of its customers.  Altria will closely monitor these situations and will record an allowance for doubtful accounts against such receivables, if such conditions arise.  As of the date of this Form 10-Q, Altria was not aware of any such conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - At September&#160;30, 2020 and December&#160;31, 2019, Altria&#8217;s total debt was $29.3 billion and $28.0 billion, respectively.  The increase in debt was due to Altria&#8217;s May 2020 issuance of USD denominated long-term senior unsecured notes in the aggregate principal amount of $2.0 billion, the proceeds from which were used for general corporate purposes, which included repayment of the full amount borrowed under the Credit Agreement in the first quarter of 2020, partially offset by the repayment in full of $1.0 billion of Altria senior unsecured notes at scheduled maturity in January 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details on short-term borrowings and long-term debt, see Note 10.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- As discussed in Note 12, Altria and certain of its subsidiaries had unused letters of credit obtained in the ordinary course of business, guarantees (including third-party guarantees) and a redeemable noncontrolling interest outstanding at September&#160;30, 2020.  From time to time, subsidiaries of Altria also issue lines of credit to affiliated entities.  In addition, as discussed in Supplemental Guarantor Financial Information below, PM USA has issued guarantees relating to Altria&#8217;s obligations under its outstanding debt securities, borrowings under the Credit Agreement and amounts outstanding under the commercial paper program.  These items have not had, and are not expected to have, a significant impact on Altria&#8217;s liquidity.  For further discussion regarding Altria&#8217;s liquidity, see the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Debt and Liquidity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- As discussed previously and in Note 12, PM USA has entered into State Settlement Agreements with the states and territories of the United States that call for certain payments.  In addition, PM USA, Middleton and USSTC are subject to quarterly user fees imposed by the FDA as a result of the FSPTCA.  Altria&#8217;s subsidiaries recorded $3.6 billion and $3.4 billion of charges to cost of sales for the nine months ended September 30, 2020 and 2019, respectively, and $1.3 billion and $1.2 billion of charges to cost of sales for the three months ended September 30, 2020 and 2019, in connection with the State Settlement Agreements and FDA user fees.  For further discussion of the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the MSA, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 12.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current agreements, 2019 market share and estimated annual industry volume decline rates, the estimated amounts that Altria&#8217;s subsidiaries may charge to cost of sales for payments related to State Settlement Agreements and FDA user fees approximate $4.5 billion in 2020, $4.3 billion in 2021 and $4.2 billion each year thereafter.  These amounts exclude the potential impact of any NPM Adjustment Items.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amounts due under the State Settlement Agreements charged to cost of sales in each year would generally be paid in the following year.  The amounts charged to cost of sales for FDA user fees are generally paid in the quarter in which the fees are incurred.  As previously stated, the payments due under the terms of the State Settlement Agreements and FDA user fees are subject to adjustment for several factors, including volume, operating income, inflation and certain contingent events and, in general, are allocated based on each manufacturer&#8217;s market share.  The future payment amounts discussed above are estimates, and actual payment amounts will differ to the extent underlying assumptions differ from actual future results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-Related Deposits and Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - With respect to certain adverse verdicts currently on appeal, to obtain stays of judgments pending appeals, as of September&#160;30, 2020, PM USA had posted appeal bonds totaling $61 million, which have been collateralized with restricted cash that is included in assets on the condensed consolidated balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although litigation is subject to uncertainty and an adverse outcome or settlement of litigation could have a material adverse effect on the financial position, cash flows or results of operations of PM USA, UST LLC (&#8220;UST&#8221;) or Altria in a particular fiscal quarter or fiscal year, as more fully disclosed in Note 12, management expects cash flow from operations, together with Altria&#8217;s access to capital markets, to provide sufficient liquidity to meet ongoing business needs.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity and Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, Altria granted an aggregate of 0.9 million restricted stock units (&#8220;RSUs&#8221;) and 0.2 million performance stock units (&#8220;PSUs&#8221;) to eligible employees.  The service restrictions for the RSUs and the PSUs lapse in the first quarter of 2023.  In addition, the vesting of the PSUs depends first on Altria&#8217;s performance on certain financial metrics over the three-year vesting period.  The payout resulting from the performance metrics is then scaled up or down by a total shareholder return (&#8220;TSR&#8221;) performance multiplier, which depends on Altria&#8217;s relative TSR against a predetermined peer group.  The market value per share of the RSUs and the PSUs granted was $42.61 and $43.28, respectively, on the date of grant.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, 0.6 million shares of RSUs and PSUs vested.  The total fair value of RSUs and PSUs that vested during the nine months ended September&#160;30, 2020 was $27 million.  The weighted-average grant date fair value per share of these awards was $66.62.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends paid during the first nine months of 2020 and 2019 were $4,690 million and $4,498 million, respectively, an increase of 4.3%, reflecting a higher dividend rate, partially offset by fewer shares outstanding as a result of shares repurchased by Altria in 2019 under its share repurchase programs.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Board of Directors declared a 2.4% increase in the quarterly dividend rate to $0.86 per share of Altria common stock versus the previous rate of $0.84 per share.  The current annualized dividend rate is $3.44 per share.   Altria has a long-term objective of a dividend payout ratio target of approximately 80% of its adjusted diluted EPS.  Future dividend payments remain subject to the discretion of the Board of Directors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of Altria&#8217;s share repurchase programs, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated financial statements in Item 1.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">New Accounting Guidance Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the condensed consolidated financial statements in Item 1 for a discussion of issued accounting guidance applicable to, but not yet adopted by, Altria. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingencies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 for a discussion of contingencies.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_196"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%;text-decoration:underline">Supplemental Guarantor Financial Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA (the &#8220;Guarantor&#8221;), which is a 100% owned subsidiary of Altria Group, Inc. (the &#8220;Parent&#8221;), has guaranteed the Parent&#8217;s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its&#160;commercial paper program (the &#8220;Guarantees&#8221;).  Pursuant to&#160;the Guarantees, the Guarantor fully and unconditionally guarantees, as primary obligor, the payment and performance of the Parent&#8217;s obligations under the guaranteed debt instruments (the &#8220;Obligations&#8221;), subject to release under certain customary circumstances as noted below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantees provide that the Guarantor guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations.  The liability of the Guarantor under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Parent or the Guarantor.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under applicable provisions of federal bankruptcy law or comparable provisions of state fraudulent transfer law, the Guarantees could be voided, or claims in respect of the Guarantees could be subordinated to the debts of the Guarantor, if, among other things, the Guarantor, at the time it incurred the Obligations evidenced by the Guarantees:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">received less than reasonably equivalent value or fair consideration therefore; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">either:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">was insolvent or rendered insolvent by reason of such occurrence;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">was engaged in a business or transaction for which the assets of the Guarantor constituted unreasonably small capital; or</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">intended to incur, or believed that it would incur, debts beyond its ability to pay such debts as they mature.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under such circumstances, the payment of amounts by the Guarantor pursuant to the Guarantees could be voided and required to be returned to the Guarantor, or to a fund for the benefit of the Guarantor, as the case may be.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measures of insolvency for purposes of the foregoing considerations will vary depending upon the law applied in any proceeding with respect to the foregoing. Generally, however, the Guarantor would be considered insolvent if:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the sum of its debts, including contingent liabilities, was greater than the saleable value of its assets, all at a fair valuation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the present fair saleable value of its assets was less than the amount that would be required to pay its probable liability on its existing debts, including contingent liabilities, as they become absolute and mature; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">it could not pay its debts as they become due.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent the Guarantees are voided as a fraudulent conveyance or held unenforceable for any other reason, the holders of the guaranteed debt obligations would not have any claim against the Guarantor and would be creditors solely of the Parent.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of the Guarantor under the Guarantees are limited to the maximum amount as will not result in the Guarantor&#8217;s obligations under the Guarantees constituting a fraudulent transfer or conveyance, after giving effect to such maximum amount and all other contingent and fixed liabilities of the Guarantor that are relevant under Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to the Guarantees.  For this purpose, &#8220;Bankruptcy Law&#8221; means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantor will be unconditionally released and discharged from the Obligations upon the earliest to occur of:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the date, if any, on which the Guarantor consolidates with or merges into the Parent or any successor;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the date, if any, on which the Parent or any successor consolidates with or merges into the Guarantor;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the payment in full of the Obligations pertaining to such Guarantees; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the rating of the Parent&#8217;s long-term senior unsecured debt by Standard&#160;&amp; Poor&#8217;s Ratings Services of A or higher.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parent is a holding company; therefore, its access to the operating cash flows of its wholly owned subsidiaries consists of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  Neither the Guarantor nor other 100% owned subsidiaries of the Parent that are not guarantors of the debt (&#8220;Non-Guarantor Subsidiaries&#8221;) are limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables include summarized financial information for the Parent and the Guarantor.  Transactions between the Parent and the Guarantor (including investment and intercompany balances as well as equity earnings) have been eliminated.  The Parent&#8217;s and the Guarantor&#8217;s intercompany balances with Non-Guarantor Subsidiaries have been presented separately.  This summarized financial information is not intended to present the financial position or results of operations of the Parent or the Guarantor in accordance with GAAP.</span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized Balance Sheets </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.427%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantor</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,551&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,422&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized Statements of Earnings</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions of dollars)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.139%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.427%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantor</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended <br/>September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Year Ended December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine <br/>Months Ended <br/>September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,783&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,065&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(892)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">For the nine months ended September 30, 2020 and for the year ended December 31, 2019, net earnings (losses) includes $139 million and $124 million, respectively, of intercompany interest income from non-guarantor subsidiaries.   </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_199"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Factors That May Affect Future Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking and Cautionary Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time make written or oral forward-looking statements, including earnings guidance and other statements contained in filings with the SEC, reports to security holders, press releases and investor webcasts.  You can identify these forward-looking statements by use of words such  as &#8220;strategy,&#8221; &#8220;expects,&#8221; &#8220;continues,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;will,&#8221; &#8220;estimates,&#8221; &#8220;forecasts,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;goals,&#8221; &#8220;objectives,&#8221; &#8220;guidance,&#8221; &#8220;targets&#8221; and other words of similar meaning.  You can also identify them by the fact that they do not relate strictly to historical or current facts.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans, estimates and assumptions.  Achievement of future results is subject to risks, uncertainties and assumptions that may prove to be inaccurate.  Should known or unknown risks or uncertainties materialize, or should underlying estimates or assumptions prove inaccurate, actual results could differ materially from those anticipated, estimated or projected.  You should bear this in mind as you consider forward-looking statements and whether to invest in or remain invested in Altria&#8217;s securities. In connection with the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, we are identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in, or implied by, any forward-looking statements made by us; any such statement is qualified by reference to the following cautionary statements.  We elaborate on these important factors and the risks we face throughout this Form 10-Q, particularly in Item 1A and in the &#8220;Business Environment&#8221; sections preceding our discussion of the operating results of our subsidiaries&#8217; businesses, and in our publicly filed reports, including our 2019 Form 10-K, our Quarterly Report on Form 10-Q for the period ended March 31, 2020 (&#8220;First Quarter 2020 Form 10-Q&#8221;) and our Quarterly Report on Form 10-Q for the period ended June 30, 2020 (&#8220;Second Quarter 2020 Form 10-Q&#8221;).  These factors include the following:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">unfavorable litigation outcomes, including risks associated with adverse jury and judicial determinations, courts and arbitrators reaching conclusions at variance with our, our subsidiaries&#8217; or our investees&#8217; understanding of applicable law, bonding requirements in the jurisdictions that do not limit the dollar amount of appeal bonds, and certain challenges to bond cap statutes; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">government (including FDA) and private sector actions that impact adult tobacco consumer acceptability of, or access to, tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">tobacco product taxation, including lower tobacco product consumption levels and potential shifts in adult consumer purchases as a result of federal, state and local excise tax increases;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">unfavorable outcomes of any government investigations of Altria, our subsidiaries or investees;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a successful challenge to our tax positions;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risks related to our and our investees&#8217; international business operations, including failure to prevent violations of various U.S. and foreign laws and regulations such as laws prohibiting bribery and corruption;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risks associated with health epidemics and pandemics, including the COVID-19 pandemic and similar outbreaks, such as their impact on our financial performance and financial condition and on our subsidiaries&#8217; and investees&#8217; ability to continue manufacturing and distributing products, and the impact of health epidemics and pandemics on general economic conditions (including any resulting recession or other economic crisis) and, in turn, adult consumer purchasing behavior which may be further impacted by any changes in government stimulus or unemployment payments; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the failure of our tobacco and wine subsidiaries and our investees to compete effectively in their respective markets;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the growth of the e-vapor category and other innovative tobacco products contributing to reductions in cigarette and MST consumption levels and sales volume; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">our tobacco and wine subsidiaries&#8217; and our investees&#8217; continued ability to promote brand equity successfully; to anticipate and respond to evolving adult consumer preferences; to develop, manufacture, market and distribute products that appeal to adult consumers (including, where appropriate, through arrangements with, and investments in third parties); to improve productivity; and to protect or enhance margins through cost savings and price increases; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">changes, including in economic conditions (due to the COVID-19 pandemic or otherwise), that result in adult consumers choosing lower-priced brands including discount brands;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the unsuccessful commercialization of adjacent products or processes by our tobacco subsidiaries and investees, including innovative tobacco products that may reduce the health risks associated with cigarettes and other traditional tobacco products, and that appeal to adult tobacco consumers;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">significant changes in price, availability or quality of tobacco, other raw materials or component parts, including as a result of the COVID-19 pandemic;  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risks related to the reliance by our tobacco and wine subsidiaries on a few significant facilities and a small number of key suppliers and distributors, and the risk of an extended disruption at a facility of, or of service by, a supplier or distributor of our tobacco or wine subsidiaries or investees, including as a result of the COVID-19 pandemic; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">required or voluntary product recalls as a result of various circumstances such as product contamination or FDA or other regulatory action;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the failure of our information systems or service providers&#8217; information systems to function as intended, or cyber-attacks or security breaches;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">our inability to attract and retain the best talent due to the impact of decreasing social acceptance of tobacco usage and tobacco control actions; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the adverse effect of acquisitions, investments, dispositions or other events on our credit rating;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">our inability to acquire attractive businesses or make attractive investments on favorable terms, or at all, or to realize the anticipated benefits from an acquisition or investment and our inability to dispose of businesses or investments on favorable terms or at all;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risks related to disruption and uncertainty in the credit and capital markets, including risk of access to these markets both generally and at current prevailing rates, which may adversely affect our earnings or dividend rate or both; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impairment losses as a result of the write down of intangible assets, including goodwill;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risks related to Ste. Michelle&#8217;s wine business, including competition, unfavorable changes in grape supply, and changes in adult consumer preferences that have resulted and may continue to result in increased inventory levels and inventory write offs, and governmental regulations; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risk that any challenge to our investment in JUUL, if successful, could result in a broad range of resolutions such as divestiture of the investment or rescission of the transaction; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risks generally related to our investments in JUUL and Cronos, including our inability to realize the expected benefits of our investments in the expected time frames, or at all, due to the risks encountered by our investees in their businesses, such as operational, compliance and regulatory risks at the international, federal, state and local levels, including actions by the FDA, and adverse publicity; potential disruptions to our investees&#8217; management or current or future plans and operations; domestic or international litigation developments, government investigations, tax disputes or otherwise; and impairment of our investments;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risks related to our inability to acquire a controlling interest in JUUL as a result of standstill restrictions or to control the material decisions of JUUL, restrictions on our ability to sell or otherwise transfer our shares of JUUL until December 20, 2024, and non-competition restrictions for the same time period subject to certain exceptions;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the adverse effects of risks encountered by ABI in its business, including effects of the COVID-19 pandemic, foreign currency exchange rates and the impact of movements in ABI&#8217;s stock price on our equity investment in ABI, including on our reported earnings from and carrying value of our investment in ABI, which could result in impairment of our investment, and the dividends paid by ABI on the shares we own; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risks related to our inability to transfer our equity securities in ABI until October 10, 2021, and, if our ownership percentage decreases below certain levels, the adverse effects of additional tax liabilities, a reduction in the number of directors that we have the right to have appointed to the ABI board of directors, and our potential inability to use the equity method of accounting for our investment in ABI;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risk of challenges to the tax treatment of the consideration we received in the ABI/SABMiller business combination and the tax treatment of our equity investment; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the risks, including criminal, civil or tax liability for Altria, related to Cronos&#8217;s or Altria&#8217;s failure to comply with applicable laws, including cannabis laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should understand that it is not possible to predict or identify all factors and risks.  Consequently, you should not consider the foregoing list to be complete.  We do not undertake to update any forward-looking statement that we may make from time to time except as required by applicable law.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_202"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 3.  Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 and December&#160;31, 2019, the fair value of Altria&#8217;s long-term debt, all of which is fixed-rate debt, was $33.8 billion and $30.7 billion, respectively.  The fair value of Altria&#8217;s long-term debt is subject to fluctuations resulting from changes in market interest rates.  A 1% increase in market interest rates at September&#160;30, 2020 and December&#160;31, 2019 would decrease the fair value of Altria&#8217;s long-term debt by $2.7 billion and $2.4 billion, respectively.  A 1% decrease in market interest rates at September&#160;30, 2020 and December&#160;31, 2019 would increase the fair value of Altria&#8217;s long-term debt by $3.0 billion and $2.7 billion, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate (&#8220;LIBOR&#8221;), or a mutually agreed upon benchmark rate, plus a percentage based on the higher of the ratings of Altria&#8217;s long-term senior unsecured debt from Moody&#8217;s and Standard&#160;&amp; Poor&#8217;s.  The applicable percentage based on Altria&#8217;s long-term senior unsecured debt ratings&#160;at September 30, 2020 for borrowings under the Credit Agreement was 1.0%.  At September 30, 2020 and December 31, 2019, Altria had no borrowings under the Credit Agreement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Price Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of the Fixed-price Preemptive Rights and the Cronos warrant are subject to equity price risk.  The Fixed-price Preemptive Rights and warrant are recorded at fair value, which is estimated using Black-Scholes option-pricing models.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are subject to fluctuations resulting from changes in the quoted market price of Cronos shares, the underlying equity security.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the fair values of the Fixed-price Preemptive Rights and Cronos warrant were $15 million and $86 million, respectively.  At December 31, 2019, the fair values of the Fixed-price Preemptive Rights and Cronos warrant were $69 million and $234 million, respectively.  A 10% increase or decrease in the quoted market price of Cronos shares at September&#160;30, 2020 would increase or decrease the fair values of the Fixed-price Preemptive Rights and Cronos warrant by approximately $4 million and $17 million, respectively.   A 10% increase or decrease in the quoted market price of Cronos shares at December 31, 2019 would increase or decrease the fair values of the Fixed-price Preemptive Rights and Cronos warrant by approximately $13 million and $37 million, respectively.</span></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_205"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 4.  Controls and Procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria carried out an evaluation, with the participation of Altria&#8217;s management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of its disclosure controls and procedures (as defined in Rule 13a-15(e)) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Form 10-Q.  Based upon that evaluation, Altria&#8217;s Chief Executive Officer and Chief Financial Officer concluded that Altria&#8217;s disclosure controls and procedures are effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in Altria&#8217;s internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_208"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part II &#8211; OTHER INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.  Legal Proceedings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 for a discussion of legal proceedings pending against Altria and its subsidiaries.  See also Exhibits 99.1 and 99.2 to this Form 10-Q.</span></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_211"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1A.  Risk Factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Risk Factors appears in Part I, Item 1A. Risk Factors of the 2019 Form 10-K and in Part II, Item 1A. Risk Factors of the First Quarter 2020 Form 10-Q and the Second Quarter 2020 Form 10-Q.  Except as set forth below, there have been no material changes to the risk factors previously disclosed in the 2019 Form 10-K, the First Quarter 2020 Form 10-Q and the Second Quarter 2020 Form 10-Q.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The expected benefits of the JUUL transaction may not materialize in the expected manner or timeframe or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regardless of whether antitrust clearance is obtained, the expected benefits of the JUUL transaction may not materialize in the expected manner or timeframe or at all, including due to the risks encountered by JUUL in its business, such as operational risks and regulatory and legislative risks at the international, federal, state and local levels, including actions by the FDA, and adverse publicity due to underage use of e-vapor products and other factors; unanticipated impacts on JUUL&#8217;s relationships with employees, customers, suppliers and other third parties; potential disruptions to JUUL&#8217;s management or current or future plans and operations; or domestic or international litigation developments, investigations, or otherwise.  As discussed in Note 12, JUUL and Altria and/or its subsidiaries, including PM USA, are named as defendants in various individual and class action lawsuits.  JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor its subsidiaries is a party.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Item 2 for a discussion of certain FDA-related regulatory risks applicable to the e-vapor category, including the potential removal of certain e-vapor products from the market as a result of FDA enforcement action and the potential denial of new tobacco product applications for e-vapor products.  Failure to realize the expected benefits of our JUUL investment could adversely affect the value of the investment.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 4, in 2019, as part of the preparation of our financial statements for the periods ended September 30, 2019, December 31, 2019 and September 30, 2020, we performed valuations of our investment in JUUL.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we determined that our investment in JUUL was impaired and recorded total non-cash pre-tax impairment charges of $11.2 billion.  Of this amount, Altria recorded non-cash pre-tax charges of $4.5 billion in the third quarter of 2019, $4.1 billion in the fourth quarter of 2019, and $2.6 billion in the third quarter of 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The third quarter 2019 impairment charge was due primarily to lower e-vapor sales volume assumptions in the U.S. and international markets and a delay in achieving operating margin performance, as compared to the assumptions at the time of the JUUL transaction.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fourth quarter 2019 impairment charge resulted substantially from increased discount rates applied to future cash flow projections, due to the increase in the number and type of legal cases pending against JUUL during the fourth quarter of 2019.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The third quarter 2020 impairment charge resulted substantially from our projections of (i) a delay in JUUL&#8217;s international market expansion plans resulting in lower JUUL e-vapor sales volume and operating margin performance and (ii) JUUL experiencing downward pressure on revenues and gross margins due to our observed increase in competition in the U.S. e-vapor market.  While we believe the September 30, 2020 valuation of $1.6 billion is the appropriate current fair value of our investment, the risks identified in this paragraph, some of which are also further discussed in Note 12 and in Item 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are ongoing with respect to the current fair value.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the fair value of our investment in JUUL continues to decrease, it could have a material adverse effect on Altria&#8217;s consolidated financial position or earnings.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i85986654d18d42b3b8b96449288f0b8f_1827"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board of Directors authorized a new $1.0 billion share repurchase program.  In April 2020, the Board of Directors rescinded the $500 million remaining in this share repurchase program.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s share repurchase activity for each of the three months in the period ended September 30, 2020, was as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1-31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1-31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1-30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,270&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The total number of shares purchased represents shares withheld by Altria in an amount equal to the statutory withholding taxes for vested stock-based awards previously granted to eligible employees.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_214"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i85986654d18d42b3b8b96449288f0b8f_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 6.  Exhibits. </span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span><br/></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.1&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418020000074/exhibit221q22020.htm">Guarantor Subsidiary of the Registrant.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended June 30, 2020 (File No. 1-08940).</a></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span><br/></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit311q32020.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span><br/></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit312q32020.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span><br/></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit321q32020.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span><br/></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.2&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit322q32020.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div><div style="padding-right:15.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1 &#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit991q32020.htm">Certain Litigation Matters.</a></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span><br/></span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.2&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit992q32020.htm">Trial Schedule for Certain Cases.</a></span></div><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH XBRL Taxonomy Extension Schema.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL XBRL Taxonomy Extension Calculation Linkbase.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF XBRL Taxonomy Extension Definition Linkbase.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB XBRL Taxonomy Extension Label Linkbase.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE XBRL Taxonomy Extension Presentation Linkbase.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i85986654d18d42b3b8b96449288f0b8f_217"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALTRIA GROUP, INC.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="padding-right:24.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ SALVATORE MANCUSO</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Salvatore Mancuso</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President and</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 30, 2020</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311q32020.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i8d12c741a13949a8bde1251cd8cb042a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:49.5pt;padding-right:15.75pt;text-align:center;text-indent:-29.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certifications</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, William F. Gifford, Jr., certify that&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Altria Group, Inc.&#59;</font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:40.5pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;  October 30, 2020</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-right:15.75pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:64.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; WILLIAM F. GIFFORD, JR.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William F. Gifford, Jr.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer </font></div></td></tr></table></div><div style="padding-right:15.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312q32020.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i9b4bdbf357dc467d89f1e8c2e0a790dc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certifications</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Salvatore Mancuso, certify that&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Altria Group, Inc.&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="padding-left:58.5pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:40.5pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;  October 30, 2020</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-right:15.75pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:64.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; SALVATORE MANCUSO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salvatore Mancuso</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </font></div><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321q32020.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i62b40d0ab0db4b95897f3aeaee77cb30_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="padding-right:15.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="padding-right:15.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="padding-right:15.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="padding-right:15.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="padding-right:15.75pt;text-align:center"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Altria Group, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, William F. Gifford, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; WILLIAM F. GIFFORD, JR.</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">William F. Gifford, Jr.</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Executive Officer</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">October 30, 2020</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322q32020.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i7199a153a90248d780ad95c7ebf85b78_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="padding-right:15.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="padding-right:15.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="padding-right:15.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="padding-right:15.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="padding-right:15.75pt;text-align:center"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Altria Group, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Salvatore Mancuso, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; SALVATORE MANCUSO</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Salvatore Mancuso</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive Vice President and</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">October 30, 2020</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>exhibit991q32020.htm
<DESCRIPTION>CERTAIN LITIGATION MATTERS
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i8e429c503cfd43dd92c0b3a7d4926634_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN LITIGATION MATTERS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to Altria Group, Inc.&#8217;s (&#8220;Altria&#8221;) condensed consolidated financial statements in Part 1, Item 1 of the Quarterly Report on Form 10-Q to which this Exhibit 99.1 is attached (&#8220;Note 12&#8221;), there are legal proceedings covering a wide range of matters pending or threatened in various United States and foreign jurisdictions against Altria, its subsidiaries, including Philip Morris USA Inc. (&#8220;PM USA&#8221;), and their respective indemnitees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors.  Claims related to tobacco products generally fall within the following categories&#58; (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs, (ii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including cases in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, (iii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and&#47;or disgorgement of profits, (iv) class action suits alleging that the use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law fraud or statutory fraud, unjust enrichment, breach of warranty, or violations of the Racketeer Influenced and Corrupt Organizations Act, (v) class action suits involving e-vapor products and (vi) international cases.  The following lists certain of the pending claims against Altria and PM USA included in these and other categories.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SMOKING AND HEALTH LITIGATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists the consolidated individual smoking and health cases as well as smoking and health class actions pending against PM USA and, in some cases, Altria and&#47;or its other subsidiaries and affiliates, as of October 27, 2020.  See </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Cases </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a list of smoking and health class actions pending in Canada.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Flight Attendant Litigation</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The settlement agreement entered into in 1997 in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broin, et al. v. Philip Morris Companies Inc., et al.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was brought by flight attendants seeking damages for personal injuries allegedly caused by environmental tobacco smoke, allowed members of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broin </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">class to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  See Note 12 for a discussion of this litigation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Domestic Class Actions</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle, et al. v. R.J. Reynolds Tobacco Co., et al., Circuit Court, Eleventh Judicial Circuit, Dade County, Florida, filed May 5, 1994.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12 for a discussion of this case (which has concluded) and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny litigation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Young, et al. v. The American Tobacco Company, et al., Civil District Court, Orleans Parish, Louisiana, filed November 12, 1997.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cypret, et al. v. The American Tobacco Company, et al., Circuit Court, Jackson County, Missouri, filed December 22, 1998.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HEALTH CARE COST RECOVERY LITIGATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists a health care cost recovery action pending against PM USA and Altria as of October 27, 2020.  See </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Cases </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a list of international health care cost recovery actions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Department of Justice Case</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The United States of America v. Philip Morris Incorporated, et al., United States District Court, District of Columbia, filed September 22, 1999</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LIGHTS&#47;ULTRA LIGHTS&#8221; CASES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists the &#8220;Lights&#47;Ultra Lights&#8221; class actions pending against Altria and&#47;or its various subsidiaries and others as of October 27, 2020. </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moore, et al. v. Philip Morris Incorporated, et al., Circuit Court, Marshall County, West Virginia, filed September 17, 2001.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Virden v. Altria Group, Inc., et al., Circuit Court, Hancock County, West Virginia, filed March 28, 2003.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CLASS ACTION LAWSUITS INVOLVING E-VAPOR PRODUCTS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists class action lawsuits relating to e-vapor products that are pending against Altria and&#47;or its various subsidiaries and others as of October 27, 2020. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NesSmith, et al. v. JUUL Labs Inc., et al., United States District Court, Middle District of Florida, filed April 15, 2019.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peavy (formerly Swearingen), et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed May 31, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R.E., et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of West Virginia, filed August 13, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">M.D., et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Mississippi, filed August 15, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Phillips, et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Missouri, filed August 21, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oberhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed September 12, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hochhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of New York, filed October 1, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emidy et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Tennessee, filed October 2, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">La Conner School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Washington, filed October 7, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Montgomery County, Maryland, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Maryland, filed October 11, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">King County, Washington, et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Washington, filed October 16, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Rochester, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed November 6, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jefferson County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of Mississippi, filed December 5, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ledbetter, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed December 12, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Escambia County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Florida, filed December 18, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">School Board of Miami-Dade County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The School Board of Broward County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Frederick County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Imani, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Oregon, filed December 20, 2019.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cooper, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Texas, filed January 9, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">O&#8217;Reilly, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed January 13, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gabbard, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of Kentucky, filed February 21, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peoria Public Schools v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed May 15, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 for a discussion of these cases.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> LITIGATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RAI Strategic Holdings, Inc., et al. v. Altria Client Services, LLC, et al., United States District Court, Eastern District of Virginia, filed April 9, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Tobacco Heating Articles and Components Thereof, United States International Trade Commission, filed April 9, 2020.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANTITRUST LITIGATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Altria Group, Inc., et al., United States of America Before the Federal Trade Commission, filed April 1, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reece, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 7, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blomquist, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 13, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Martinez, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 14, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deadwyler, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 20, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licari, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 21, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flannery, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 27, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Walsh, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 8, 2020.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redfield, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 15, 2020.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carlson, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 21, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">B&#38;C Retail, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sofijon, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noor Baig, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Somerset Party Store, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 18, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jackson, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 25, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McGhee, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed July 1, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irwindale Fuel Station, Inc. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed July 15, 2020.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHAREHOLDER CLASS ACTION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Klein, et al. v. Altria Group, Inc., et al., United States District Court, Eastern District of Virginia, filed October 2, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHAREHOLDER DERIVATIVE LAWSUITS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sandys, et al. v. Willard, et al., United States District Court, Northern District of California, filed August 7, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lorca, et al. v. Gifford, et al., United States District Court, Northern District of California, filed August 27, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cohen, et al. v. Willard, et al., Circuit Court for Henrico County, Virginia, filed September 14, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gilbert, et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed October 1, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See  Note 12 for a discussion of these cases.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL CASES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists cases pending against Altria and&#47;or its subsidiaries in foreign jurisdictions as of October 27, 2020.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Canada</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Salvatore, et al. v. JUUL Labs Canada, Ltd., et al., Quebec, District of Montreal Superior Court, filed June 12, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E-vapor class action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stephens, et al. v. JUUL Labs, Inc., et al., British Columbia, Canada Supreme Court, filed October 1, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E-vapor class action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of New Brunswick v. Rothmans, Inc., et al., Court of Queen&#8217;s Bench of New Brunswick Judicial District of Fredericton, Canada, filed March 13, 2008.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dorion v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench of Alberta, Judicial District of Calgary, Canada, filed on or about June 17, 2009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Smoking and health class action.  See Note 12 for a discussion of this case. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Semple v. Canadian Tobacco Manufacturers&#8217; Council, et al., Supreme Court of Nova Scotia, Canada, filed on or about June 18, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kunta v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed on an unknown date in June 2009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Smoking and health class action.  See Note 12 for a discussion of this case. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adams v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench for Saskatchewan, Judicial Centre of Regina, Canada, filed on or about July 10, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Superior Court of Justice of Ontario, Canada, filed on or about September 30, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, Trial Division, Canada, filed February 8, 2011</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.  See Note 12 for a discussion of this case. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Quebec v. Imperial Tobacco Canada Limited, et al., Superior Court of Quebec, Montreal District, Canada, filed June 8, 2012</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Court of Queen&#8217;s Bench of Alberta, Judicial District of Calgary, Canada, filed June 8, 2012</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in the Right of Manitoba v. Rothmans, Benson &#38; Hedges Inc., et al., Court of Queen&#8217;s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed May 31, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of Saskatchewan v. Rothmans, Benson &#38; Hedges Inc., et al., Court of Queen&#8217;s Bench of Saskatchewan, Judicial Centre of Saskatoon, Canada, filed on June 8, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty in the Right of the Province of Prince Edward Island v. Rothmans, Benson &#38; Hedges, Inc., et al., Supreme Court of Prince Edward Island, filed on September 10, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of Nova Scotia v. Benson &#38; Hedges, Inc., et al., Supreme Court of Nova Scotia, filed on January 2, 2015.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jacklin v. Canadian Tobacco Manufacturers&#8217; Council et al., Ontario Superior Court of Justice, Case No. 5379412, Ontario, Canada, filed on or about June 27, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 12 for a discussion of this case.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>exhibit992q32020.htm
<DESCRIPTION>TRIAL SCHEDULE FOR CERTAIN CASES
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i76fb05c2a23e4c829feb500df2b01142_1"></div><div style="min-height:42.75pt;width:100%;"><div style="text-align:right;"><font><br></font></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Exhibit 99.2</font></div><div style="text-align:right;"><font><br></font></div></div><div style="text-align:center;margin-top:9pt;"><font><br></font></div><div style="text-align:center;margin-top:9pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">TRIAL SCHEDULE FOR CERTAIN CASES </font></div><div><font><br></font></div><div style="margin-top:4.5pt;margin-bottom:5pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Below is a schedule, as of October 27, 2020, setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for but not in trial through December 31, 2020. </font></div><div style="margin-top:4.5pt;margin-bottom:5pt;"><font><br></font></div><div style="margin-top:4.5pt;margin-bottom:5pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">2020</font></div><div style="margin-top:4.5pt;margin-bottom:5pt;"><font><br></font></div><div style="margin-top:4.5pt;margin-bottom:5pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Engle</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> progeny&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:10pt;margin-bottom:10pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:25.146%;"><tr><td style="width:1.0%;"></td><td style="width:76.225%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:21.575%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">October</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0</font></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">November</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0</font></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0</font></td></tr></table></div><div style="margin-bottom:4.4pt;"><font><br></font></div><div style="margin-bottom:4.4pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of October 27, 2020, there are no </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Engle</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> progeny cases in trial.</font></div><div style="margin-top:4.5pt;margin-bottom:5pt;"><font><br></font></div><div style="margin-top:4.5pt;margin-bottom:5pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other Individual Smoking&#160;&#38; Health </font></div><div style="margin-top:9.5pt;margin-bottom:10pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:25.146%;"><tr><td style="width:1.0%;"></td><td style="width:76.225%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:21.575%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">October</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0</font></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">November</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0</font></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0</font></td></tr></table></div><div style="text-align:center;margin-top:4.5pt;margin-bottom:5pt;"><font><br></font></div><div style="margin-bottom:4.4pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of October 27, 2020, there are no non-</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Engle </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">progeny cases in trial.</font></div><div style="margin-bottom:4.4pt;"><font><br></font></div><div style="margin-bottom:4.4pt;"><font><br></font></div><div style="margin-top:4.5pt;margin-bottom:5pt;"><font><br></font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>mo-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e67beae8-252b-44fc-aaf0-eb6cb882e4c7,g:3f7a85d8-ce11-4daa-b845-1d29043d3872-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mo="http://www.altria.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.altria.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.altria.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEarnings" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveEarnings" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentation" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation">
        <link:definition>2101101 - Disclosure - Background and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationPolicies" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Background and Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationTables" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationTables">
        <link:definition>2303301 - Disclosure - Background and Basis of Presentation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationNarrativeDetails" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails">
        <link:definition>2404401 - Disclosure - Background and Basis of Presentation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationShareRepurchaseTableDetails" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails">
        <link:definition>2405402 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomers" roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers">
        <link:definition>2106102 - Disclosure - Revenues from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomersNarrativeDetails" roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails">
        <link:definition>2407403 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairmentExitandImplementationCosts" roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCosts">
        <link:definition>2108103 - Disclosure - Asset Impairment, Exit and Implementation Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairmentExitandImplementationCostsTables" roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables">
        <link:definition>2309302 - Disclosure - Asset Impairment, Exit and Implementation Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails" roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails">
        <link:definition>2410404 - Disclosure - Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails" roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails">
        <link:definition>2411405 - Disclosure - Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairmentExitandImplementationCostsNarrativeDetails" roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails">
        <link:definition>2412406 - Disclosure - Asset Impairment, Exit and Implementation Costs (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecurities" roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities">
        <link:definition>2113104 - Disclosure - Investments in Equity Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables">
        <link:definition>2314303 - Disclosure - Investments in Equity Securities Investments in Equity Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails">
        <link:definition>2415407 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails">
        <link:definition>2416408 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails">
        <link:definition>2417409 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails">
        <link:definition>2418410 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails">
        <link:definition>2419411 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.altria.com/role/FinancialInstruments">
        <link:definition>2120105 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.altria.com/role/FinancialInstrumentsTables">
        <link:definition>2321304 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>2422412 - Disclosure - Financial Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails">
        <link:definition>2423413 - Disclosure - Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails">
        <link:definition>2424414 - Disclosure - Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails">
        <link:definition>2425415 - Disclosure - Financial Instruments (Fair Value Derivative Financial Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails">
        <link:definition>2426416 - Disclosure - Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails">
        <link:definition>2427417 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.altria.com/role/BenefitPlans">
        <link:definition>2128106 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.altria.com/role/BenefitPlansTables">
        <link:definition>2329305 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails">
        <link:definition>2430418 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansNarrativeDetails" roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails">
        <link:definition>2431419 - Disclosure - Benefit Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossesPerShare" roleURI="http://www.altria.com/role/EarningsLossesPerShare">
        <link:definition>2132107 - Disclosure - Earnings (Losses) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossesPerShareTables" roleURI="http://www.altria.com/role/EarningsLossesPerShareTables">
        <link:definition>2333306 - Disclosure - Earnings (Losses) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails" roleURI="http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails">
        <link:definition>2434420 - Disclosure - Earnings (Losses) Per Share (Basic and Diluted Earnings Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLosses" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses">
        <link:definition>2135108 - Disclosure - Other Comprehensive Earnings/Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesTables" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables">
        <link:definition>2336307 - Disclosure - Other Comprehensive Earnings/Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails">
        <link:definition>2437421 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesReclassificationsDetails" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails">
        <link:definition>2438422 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.altria.com/role/SegmentReporting">
        <link:definition>2139109 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.altria.com/role/SegmentReportingTables">
        <link:definition>2340308 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSegmentDataScheduleDetails" roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails">
        <link:definition>2441423 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails" roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails">
        <link:definition>2442424 - Disclosure - Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofCOVID19RelatedItemsDetails" roleURI="http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails">
        <link:definition>2443425 - Disclosure - Segment Reporting (Schedule of COVID-19 Related Items (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.altria.com/role/Debt">
        <link:definition>2144110 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.altria.com/role/DebtNarrativeDetails">
        <link:definition>2445426 - Disclosure - Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.altria.com/role/IncomeTaxes">
        <link:definition>2146111 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesupdateTables" roleURI="http://www.altria.com/role/IncomeTaxesupdateTables">
        <link:definition>2347309 - Disclosure - Income Taxes update (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.altria.com/role/IncomeTaxesDetails">
        <link:definition>2448427 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.altria.com/role/Contingencies">
        <link:definition>2149112 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesTables" roleURI="http://www.altria.com/role/ContingenciesTables">
        <link:definition>2350310 - Disclosure - Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesGeneralInformationDetails" roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails">
        <link:definition>2451428 - Disclosure - Contingencies (General Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesScheduleofPendingCasesDetails" roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails">
        <link:definition>2452429 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails">
        <link:definition>2453430 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails">
        <link:definition>2454431 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNonEngleProgenyLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails">
        <link:definition>2455432 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails">
        <link:definition>2456433 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails">
        <link:definition>2457434 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesFloridaBondStatuteDetails" roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails">
        <link:definition>2458435 - Disclosure - Contingencies (Florida Bond Statute) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOtherSmokingandHealthClassActionsDetails" roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails">
        <link:definition>2459436 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesHealthCareCostRecoveryLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails">
        <link:definition>2460437 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails" roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails">
        <link:definition>2461438 - Disclosure - Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails">
        <link:definition>2462439 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesFederalGovernmentsLawsuitDetails" roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails">
        <link:definition>2463440 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEvaporProductLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails">
        <link:definition>2464441 - Disclosure - Contingencies (E-vapor Product Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesLightsUltraLightsCasesDetails" roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails">
        <link:definition>2465442 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesUSTLitigationsNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails">
        <link:definition>2466443 - Disclosure - Contingencies (UST Litigations Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails">
        <link:definition>2467444 - Disclosure - Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails">
        <link:definition>2468445 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingGuidanceNotYetAdopted" roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted">
        <link:definition>2169113 - Disclosure - New Accounting Guidance Not Yet Adopted</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingGuidanceNotYetAdoptedTables" roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables">
        <link:definition>2370311 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" abstract="true" name="ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_LossContingencyNumberofStatesWithoutDefense" abstract="false" name="LossContingencyNumberofStatesWithoutDefense" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_ETSSmokingandHealthCaseFlightAttendantsMember" abstract="true" name="ETSSmokingandHealthCaseFlightAttendantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2008NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions20042017Member" abstract="true" name="HealthCareCostRecoveryActions20042017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotesDueTwoThousandAndThirtyMember" abstract="true" name="USDDenominatedNotesDueTwoThousandAndThirtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_WineSegmentMember" abstract="true" name="WineSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2003NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsMember" abstract="true" name="HealthCareCostRecoveryActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2009NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mo_LossContingencyNumberofSettlementDevelopments" abstract="false" name="LossContingencyNumberofSettlementDevelopments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberofStatesRemaining" abstract="false" name="LossContingencyNumberofStatesRemaining" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesLandiMember" abstract="true" name="EngleProgenyCasesLandiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_CommonStock1.000NotesDue2023Member" abstract="true" name="CommonStock1.000NotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_CanadianTobaccoManufacturersMember" abstract="true" name="CanadianTobaccoManufacturersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" abstract="false" name="StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2017NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesR.DouglasMember" abstract="true" name="EngleProgenyCasesR.DouglasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofManufacturers" abstract="false" name="LossContingencyNumberofManufacturers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CronosGroupInc.Member" abstract="true" name="CronosGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" abstract="false" name="AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" abstract="false" name="LossContingencyNumberOfShareholdersFilingClassActionLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" abstract="true" name="NonEngleProgenySmokingAndHealthCasePrincipeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" abstract="false" name="LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" abstract="false" name="AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2012NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" abstract="false" name="NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_AccruedSettlementLiabilityCurrent" abstract="false" name="AccruedSettlementLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesWeingartandHancockMember" abstract="true" name="EngleProgenyCasesWeingartandHancockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesMcCallMember" abstract="true" name="EngleProgenyCasesMcCallMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_PendingLawsuitFiledBySchoolDistrictMember" abstract="true" name="PendingLawsuitFiledBySchoolDistrictMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2007NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_MeasurementInputWeightedAverageExpectedTermMember" abstract="true" name="MeasurementInputWeightedAverageExpectedTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecidedUnfavorableNumber" abstract="false" name="LossContingencyClaimsDecidedUnfavorableNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_OtherDisputesUndertheStateSettlementAgreementsMember" abstract="true" name="OtherDisputesUndertheStateSettlementAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" abstract="false" name="EquityMethodInvestmentNumberofSharesOwnedRestricted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" abstract="false" name="NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesFederalMember" abstract="true" name="EngleProgenyCasesFederalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_DebtInstrumentExtensionTerm" abstract="false" name="DebtInstrumentExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_TobaccoandHealthJudgmentMember" abstract="true" name="TobaccoandHealthJudgmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesSommersMember" abstract="true" name="EngleProgenyCasesSommersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsNotCertifiedNumber" abstract="false" name="LossContingencyClaimsNotCertifiedNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberOfDisputesOutstanding" abstract="false" name="LossContingencyNumberOfDisputesOutstanding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberofStateswithSettledLitigation" abstract="false" name="LossContingencyNumberofStateswithSettledLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LightsMember" abstract="true" name="LightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" abstract="true" name="ScheduleofPretaxTobaccoandHealthLitigationChargesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_OtherAccruedLiabilitiesMember" abstract="true" name="OtherAccruedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_NumberofMembersOntheBoardofDirectors" abstract="false" name="NumberofMembersOntheBoardofDirectors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesPollariMember" abstract="true" name="EngleProgenyCasesPollariMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_OtherTabaccoRelatedCasesMember" abstract="true" name="OtherTabaccoRelatedCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" abstract="false" name="ValuationAllowanceDeferredTaxAssetDecreaseInAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_MarketingAdministrationAndResearchCostsMember" abstract="true" name="MarketingAdministrationAndResearchCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" abstract="false" name="EquityMethodInvestmentPercentageofSharesEligibleForPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mo_LitigationSettlementEstimateofPossibleGain" abstract="false" name="LitigationSettlementEstimateofPossibleGain" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_PhilipMorrisUSAMember" abstract="true" name="PhilipMorrisUSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2019NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EvaporLitigationMember" abstract="true" name="EvaporLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesFrogelMember" abstract="true" name="EngleProgenyCasesFrogelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesD.BrownMember" abstract="true" name="EngleProgenyCasesD.BrownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_NumberofDirectorsNominated" abstract="false" name="NumberofDirectorsNominated" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2015NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsTransitionYears20042018Member" abstract="true" name="HealthCareCostRecoveryActionsTransitionYears20042018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_IndividualSmokingAndHealthCasesMember" abstract="true" name="IndividualSmokingAndHealthCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingandHealthCaseGentileMember" abstract="true" name="NonEngleProgenySmokingandHealthCaseGentileMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_PreTaxChargesGainIncludedinNetEarning" abstract="false" name="PreTaxChargesGainIncludedinNetEarning" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyProceedsfromLegalSettlements" abstract="false" name="LossContingencyProceedsfromLegalSettlements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_CommonStock1.700NotesDue2025Member" abstract="true" name="CommonStock1.700NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_MaximumBondForAllDefendants" abstract="false" name="MaximumBondForAllDefendants" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_OtherInventoryRawMaterialsNetofReserves" abstract="false" name="OtherInventoryRawMaterialsNetofReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_PaymentsToAcquireBusinessesAndAssets" abstract="false" name="PaymentsToAcquireBusinessesAndAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_SmokeableProductsSegmentMember" abstract="true" name="SmokeableProductsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts" abstract="false" name="NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_MarylandMissouriNewMexicoandPennsylvaniaMember" abstract="true" name="MarylandMissouriNewMexicoandPennsylvaniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2013NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_AltriaGroupMember" abstract="true" name="AltriaGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyCompensatoryDamagesAwardedValue" abstract="false" name="LossContingencyCompensatoryDamagesAwardedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesMember" abstract="true" name="EngleProgenyCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyVerdictReversedNumber" abstract="false" name="LossContingencyVerdictReversedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" abstract="false" name="LossContingencyCompensatoryDamagesAwardedAllocationPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mo_LitigationSettlementAnnualLegalFeesPayableMaximum" abstract="false" name="LitigationSettlementAnnualLegalFeesPayableMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_AmountAwardedtoOtherParty" abstract="false" name="AmountAwardedtoOtherParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" abstract="false" name="ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_InventoryRawMaterialsPlantMaterialNetofReserves" abstract="false" name="InventoryRawMaterialsPlantMaterialNetofReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_RevolvingCreditFacilityDueAugust2023Member" abstract="true" name="RevolvingCreditFacilityDueAugust2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" abstract="false" name="PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ABInBevMember" abstract="true" name="ABInBevMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCasesTriedinASingleProceeding" abstract="false" name="LossContingencyNumberOfCasesTriedinASingleProceeding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesRintoulMember" abstract="true" name="EngleProgenyCasesRintoulMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LitigationCasesResultsMember" abstract="true" name="LitigationCasesResultsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" abstract="false" name="EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mo_ClassActionLawsuitMember" abstract="true" name="ClassActionLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_WineBusinessStrategicResetMember" abstract="true" name="WineBusinessStrategicResetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_NonEngleProgenyCasesMember" abstract="true" name="NonEngleProgenyCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_CommonStock2.200NotesDue2027Member" abstract="true" name="CommonStock2.200NotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesOwnedCommon" abstract="false" name="EquityMethodInvestmentNumberofSharesOwnedCommon" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_MarketingAdministrationandResearchCosts" abstract="false" name="MarketingAdministrationandResearchCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyClassNotCertifiedNumber" abstract="false" name="LossContingencyClassNotCertifiedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" abstract="true" name="SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" abstract="false" name="ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2018NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquityContractWarrantMember" abstract="true" name="EquityContractWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_BritishColumbiaSaskatchewanMember" abstract="true" name="BritishColumbiaSaskatchewanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyUnfavorableVerdictsPendingReversed" abstract="false" name="LossContingencyUnfavorableVerdictsPendingReversed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_FederalTradeCommissionDisclosurePeriod" abstract="false" name="FederalTradeCommissionDisclosurePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_AllowanceForSalesDiscountsGoods" abstract="false" name="AllowanceForSalesDiscountsGoods" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencySettlementAgreementsNumber" abstract="false" name="LossContingencySettlementAgreementsNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCases" abstract="false" name="LossContingencyNumberOfCases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesNaugleMember" abstract="true" name="EngleProgenyCasesNaugleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LitigationEscrowDeposit" abstract="false" name="LitigationEscrowDeposit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesM.BrownMember" abstract="true" name="EngleProgenyCasesM.BrownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_AssetImpairmentandBusinessExitCosts" abstract="false" name="AssetImpairmentandBusinessExitCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberOfInactiveCases" abstract="false" name="LossContingencyNumberOfInactiveCases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesFreemanMember" abstract="true" name="EngleProgenyCasesFreemanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_RestructuringChargesIncludingNetPensionCostCredit" abstract="false" name="RestructuringChargesIncludingNetPensionCostCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ScheduleOfPretaxCOVID19ChargesTable" abstract="true" name="ScheduleOfPretaxCOVID19ChargesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2006NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_OtherRestructuringCostsIncludingNetPensionCostCredit" abstract="false" name="OtherRestructuringCostsIncludingNetPensionCostCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_IncreaseDecreaseInSettlementPayable" abstract="false" name="IncreaseDecreaseInSettlementPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_InventoryWriteOffMember" abstract="true" name="InventoryWriteOffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotesDueTwoThousandandFiftyMember" abstract="true" name="USDDenominatedNotesDueTwoThousandandFiftyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesTheisMember" abstract="true" name="EngleProgenyCasesTheisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_ImplementationofCorrectiveCommunicationsMember" abstract="true" name="ImplementationofCorrectiveCommunicationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" abstract="false" name="DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" abstract="false" name="ValuationAllowanceForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_PendingIndividualLawsuitsMember" abstract="true" name="PendingIndividualLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ValuationAllowanceRollforwardRollForward" abstract="true" name="ValuationAllowanceRollforwardRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_DebtInstrumentNumberofExtensions" abstract="false" name="DebtInstrumentNumberofExtensions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_PhilipMorrisUSAandAltriaGroupMember" abstract="true" name="PhilipMorrisUSAandAltriaGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecidedFavorableNumber" abstract="false" name="LossContingencyClaimsDecidedFavorableNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquityMethodInvestmentAggregateExercisePrice" abstract="false" name="EquityMethodInvestmentAggregateExercisePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesJordanMember" abstract="true" name="EngleProgenyCasesJordanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" abstract="false" name="LossContingencyNumberofStateswithSettledLitigationSettlementOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" abstract="false" name="LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingandHealthCaseLaramieMember" abstract="true" name="NonEngleProgenySmokingandHealthCaseLaramieMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" abstract="false" name="DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mo_LossContingencyClaimsResolvedNumber" abstract="false" name="LossContingencyClaimsResolvedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_FederalGovernmentsLawsuitMember" abstract="true" name="FederalGovernmentsLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyStateCourtsNumber" abstract="false" name="LossContingencyStateCourtsNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2005NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentImpairment" abstract="false" name="EquityMethodInvestmentImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_InvestmentsInEquitySecuritiesMember" abstract="true" name="InvestmentsInEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecided" abstract="false" name="LossContingencyClaimsDecided" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember" abstract="true" name="EngleProgenyCasesNaugleGoreM.BrownJordanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LitigationSettlementAnnualPaymentAmount" abstract="false" name="LitigationSettlementAnnualPaymentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" abstract="false" name="OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyZeroDamagesVerdicts" abstract="false" name="LossContingencyZeroDamagesVerdicts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesKaplanMember" abstract="true" name="EngleProgenyCasesKaplanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyVerdictsUpheld" abstract="false" name="LossContingencyVerdictsUpheld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesDeanKerrivanMember" abstract="true" name="EngleProgenyCasesDeanKerrivanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_JUULMember" abstract="true" name="JUULMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesGoreMember" abstract="true" name="EngleProgenyCasesGoreMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesGlogerRintoulandDuignamMember" abstract="true" name="EngleProgenyCasesGlogerRintoulandDuignamMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesHarrisMember" abstract="true" name="EngleProgenyCasesHarrisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" abstract="true" name="PendingLawsuitsFiledByStateOrLocalGovernmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_InvestmentsTable" abstract="true" name="InvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_OralTobaccoSegmentMember" abstract="true" name="OralTobaccoSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyPunitiveDamagesAwardedValue" abstract="false" name="LossContingencyPunitiveDamagesAwardedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquityMethodInvestmentPricePerShareIfExercised" abstract="false" name="EquityMethodInvestmentPricePerShareIfExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mo_LossContingencyNumberOfPreTrialResolutionCases" abstract="false" name="LossContingencyNumberOfPreTrialResolutionCases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" abstract="true" name="AccumulatedEquityMethodInvestmentsAttributableToParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" abstract="true" name="EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2011NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyClassActionLawsuit" abstract="false" name="LossContingencyClassActionLawsuit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesBergerMember" abstract="true" name="EngleProgenyCasesBergerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" abstract="false" name="LossContingencyNumberofStatesThatCapBondorRequireNoBond" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" abstract="false" name="NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesDuignanMember" abstract="true" name="EngleProgenyCasesDuignanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyReductionToCostOfSales" abstract="false" name="LossContingencyReductionToCostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HelixInnovationsLLCMember" abstract="true" name="HelixInnovationsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_InterestExpenseRelatedToLitigationMember" abstract="true" name="InterestExpenseRelatedToLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesGlogerMember" abstract="true" name="EngleProgenyCasesGlogerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesStateMember" abstract="true" name="EngleProgenyCasesStateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofAdditionalStateswithSettledLitigation" abstract="false" name="LossContingencyNumberofAdditionalStateswithSettledLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotesMember" abstract="true" name="USDDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" abstract="false" name="PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_January2018ShareRepurchaseProgramMember" abstract="true" name="January2018ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesCuddiheeMember" abstract="true" name="EngleProgenyCasesCuddiheeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquitySecurityInvestments" abstract="false" name="EquitySecurityInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ScheduleOfPretaxCOVID19ChargesLineItems" abstract="true" name="ScheduleOfPretaxCOVID19ChargesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember" abstract="true" name="USDDenominatedNotesDueTwoThousandAndTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesCooperMember" abstract="true" name="EngleProgenyCasesCooperMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_CommonStockDividendRatePercentageIncrease" abstract="false" name="CommonStockDividendRatePercentageIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mo_LossContingencySettlementAgreementPaymentPeriod" abstract="false" name="LossContingencySettlementAgreementPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_EngleProgenyCasesChadwellMember" abstract="true" name="EngleProgenyCasesChadwellMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" abstract="false" name="UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2014NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_PreTrialResolutionMember" abstract="true" name="PreTrialResolutionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyZeroDamagesVerdictModified" abstract="false" name="LossContingencyZeroDamagesVerdictModified" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingandHealthCaseGreeneMember" abstract="true" name="NonEngleProgenySmokingandHealthCaseGreeneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" abstract="false" name="ValuationAllowanceDeferredTaxAssetIncreaseInAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2004NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofStates" abstract="false" name="LossContingencyNumberofStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" abstract="false" name="PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberOfInactiveClassActionLawsuits" abstract="false" name="LossContingencyNumberOfInactiveClassActionLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesSantoroMember" abstract="true" name="EngleProgenyCasesSantoroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" abstract="false" name="EquityMethodInvestmentNumberofSharesEligibleForPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2010NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesMahfuzMember" abstract="true" name="EngleProgenyCasesMahfuzMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_USTLitigationMember" abstract="true" name="USTLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_July2019ShareRepurchaseProgramMember" abstract="true" name="July2019ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_InvestmentsLineItems" abstract="true" name="InvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions20032015NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofCasesSetforTrial" abstract="false" name="LossContingencyNumberofCasesSetforTrial" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_TobaccoandHealthLitigationCasesMember" abstract="true" name="TobaccoandHealthLitigationCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_CommonStockDividendRateAnnualPerShare" abstract="false" name="CommonStockDividendRateAnnualPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CommonStock0.3313ParValueMember" abstract="true" name="CommonStock0.3313ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesNeffMember" abstract="true" name="EngleProgenyCasesNeffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated" abstract="false" name="EquityMethodInvestmentNumberofIndependentDirectorsNominated" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LightsUltraLightsClassActionsMember" abstract="true" name="LightsUltraLightsClassActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_COVID19Member" abstract="true" name="COVID19Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesReiderandBanksMember" abstract="true" name="EngleProgenyCasesReiderandBanksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" abstract="false" name="EquityMethodInvestmentWarrantExercisedOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mo_EngleProgenyCasesHollimanMember" abstract="true" name="EngleProgenyCasesHollimanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" abstract="false" name="LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquityContractPreemptiveRIghtsMember" abstract="true" name="EquityContractPreemptiveRIghtsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_CommonStock3.125NotesDue2031Member" abstract="true" name="CommonStock3.125NotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" abstract="true" name="HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>mo-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e67beae8-252b-44fc-aaf0-eb6cb882e4c7,g:3f7a85d8-ce11-4daa-b845-1d29043d3872-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.altria.com/role/CoverPage" xlink:type="simple" xlink:href="mo-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e33b0ecc-62b7-494c-b012-b88d40d5b61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_46a3d771-fc3a-47a2-b512-c8e327135dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e33b0ecc-62b7-494c-b012-b88d40d5b61e" xlink:to="loc_us-gaap_InventoryNet_46a3d771-fc3a-47a2-b512-c8e327135dd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c6b02ac2-c182-4be3-b047-9ea3f0b07c5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e33b0ecc-62b7-494c-b012-b88d40d5b61e" xlink:to="loc_us-gaap_OtherAssetsCurrent_c6b02ac2-c182-4be3-b047-9ea3f0b07c5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9b8fce2-0512-43b4-ab03-012a61042dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e33b0ecc-62b7-494c-b012-b88d40d5b61e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a9b8fce2-0512-43b4-ab03-012a61042dc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_fa6b9a0b-4b99-4d9b-9acd-b7991d0332e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e33b0ecc-62b7-494c-b012-b88d40d5b61e" xlink:to="loc_us-gaap_ReceivablesNetCurrent_fa6b9a0b-4b99-4d9b-9acd-b7991d0332e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_891ba9d3-1640-436d-ac44-5132e6f00536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c8dca1b0-27ce-4c81-9c91-91623dd21409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_891ba9d3-1640-436d-ac44-5132e6f00536" xlink:to="loc_us-gaap_AssetsCurrent_c8dca1b0-27ce-4c81-9c91-91623dd21409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_695928e4-b102-4fb0-ad77-ade6f7367f20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_891ba9d3-1640-436d-ac44-5132e6f00536" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_695928e4-b102-4fb0-ad77-ade6f7367f20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_07cb1aa9-4914-4108-8a05-59e104376a96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_891ba9d3-1640-436d-ac44-5132e6f00536" xlink:to="loc_us-gaap_Goodwill_07cb1aa9-4914-4108-8a05-59e104376a96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7a6f41f2-8c45-4fab-8231-172382c5accd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_891ba9d3-1640-436d-ac44-5132e6f00536" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7a6f41f2-8c45-4fab-8231-172382c5accd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecurityInvestments_b8d64854-fa4b-4e45-a889-b2fd2d7ee036" xlink:href="mo-20200930.xsd#mo_EquitySecurityInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_891ba9d3-1640-436d-ac44-5132e6f00536" xlink:to="loc_mo_EquitySecurityInvestments_b8d64854-fa4b-4e45-a889-b2fd2d7ee036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b59867d1-c48c-40b3-8e6c-5cbf327b243a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_891ba9d3-1640-436d-ac44-5132e6f00536" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b59867d1-c48c-40b3-8e6c-5cbf327b243a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_24eaefdd-c357-4b33-84fe-ea2520697101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d62edc4c-0e94-476c-8cbc-6c58896bd8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_24eaefdd-c357-4b33-84fe-ea2520697101" xlink:to="loc_us-gaap_Liabilities_d62edc4c-0e94-476c-8cbc-6c58896bd8b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_08524d15-ad1d-47c9-ad0a-f9ed6901e693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_24eaefdd-c357-4b33-84fe-ea2520697101" xlink:to="loc_us-gaap_CommitmentsAndContingencies_08524d15-ad1d-47c9-ad0a-f9ed6901e693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_da485b57-bae5-4bac-aa21-0390c0b9198f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_24eaefdd-c357-4b33-84fe-ea2520697101" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_da485b57-bae5-4bac-aa21-0390c0b9198f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_c91c1698-12b6-4872-b2ef-44f7707bb625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_24eaefdd-c357-4b33-84fe-ea2520697101" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_c91c1698-12b6-4872-b2ef-44f7707bb625" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3e743365-483b-4314-9e71-5a7032cf6f6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_ab5d24d8-8d5d-4677-a443-25a5ed330331" xlink:href="mo-20200930.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3e743365-483b-4314-9e71-5a7032cf6f6c" xlink:to="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_ab5d24d8-8d5d-4677-a443-25a5ed330331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves_bdfcf806-420f-4c30-8633-699873ba8524" xlink:href="mo-20200930.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3e743365-483b-4314-9e71-5a7032cf6f6c" xlink:to="loc_mo_OtherInventoryRawMaterialsNetofReserves_bdfcf806-420f-4c30-8633-699873ba8524" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_aa7766c8-e41b-4ca1-af5d-90280469ff65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3e743365-483b-4314-9e71-5a7032cf6f6c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_aa7766c8-e41b-4ca1-af5d-90280469ff65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4f75cbdc-9802-45a8-9eba-8065376daf75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3e743365-483b-4314-9e71-5a7032cf6f6c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4f75cbdc-9802-45a8-9eba-8065376daf75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57d8b9b4-0af2-4065-9dfa-d31e65a0f559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6803cb67-0afc-4b75-b9d0-6d604c94e37d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57d8b9b4-0af2-4065-9dfa-d31e65a0f559" xlink:to="loc_us-gaap_StockholdersEquity_6803cb67-0afc-4b75-b9d0-6d604c94e37d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_24690d33-0401-4ee0-9edd-c86e0d6f123c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57d8b9b4-0af2-4065-9dfa-d31e65a0f559" xlink:to="loc_us-gaap_MinorityInterest_24690d33-0401-4ee0-9edd-c86e0d6f123c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9e40c73f-bc90-4cf0-a7cf-a896c4cc4195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b592684c-2874-4dba-b8f8-983537b0a6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9e40c73f-bc90-4cf0-a7cf-a896c4cc4195" xlink:to="loc_us-gaap_LiabilitiesCurrent_b592684c-2874-4dba-b8f8-983537b0a6a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_82e524da-67a1-489f-ab8b-368755fbe17c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9e40c73f-bc90-4cf0-a7cf-a896c4cc4195" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_82e524da-67a1-489f-ab8b-368755fbe17c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a80645ab-6fac-44cc-b5c2-1509c4d90eea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9e40c73f-bc90-4cf0-a7cf-a896c4cc4195" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a80645ab-6fac-44cc-b5c2-1509c4d90eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_fc58d046-86f0-4755-a359-3a78abf4f2ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9e40c73f-bc90-4cf0-a7cf-a896c4cc4195" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_fc58d046-86f0-4755-a359-3a78abf4f2ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_c408e044-d585-4f36-9817-0b0d12c316ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9e40c73f-bc90-4cf0-a7cf-a896c4cc4195" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_c408e044-d585-4f36-9817-0b0d12c316ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2bfddcdb-c1c4-4c83-af1d-7978834ac163" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9e40c73f-bc90-4cf0-a7cf-a896c4cc4195" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2bfddcdb-c1c4-4c83-af1d-7978834ac163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4940f984-d228-41b8-bd19-7ca7dadaaafb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6824aa62-fce9-4b50-b0f8-16dec6074adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4940f984-d228-41b8-bd19-7ca7dadaaafb" xlink:to="loc_us-gaap_CommonStockValue_6824aa62-fce9-4b50-b0f8-16dec6074adb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8481fce5-5fc5-42c1-9827-aa422c711b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4940f984-d228-41b8-bd19-7ca7dadaaafb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8481fce5-5fc5-42c1-9827-aa422c711b98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_296c1881-975e-48db-a6e2-536555a66472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4940f984-d228-41b8-bd19-7ca7dadaaafb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_296c1881-975e-48db-a6e2-536555a66472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_41316641-e15c-4fa7-a8be-960a5f1aa0d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4940f984-d228-41b8-bd19-7ca7dadaaafb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_41316641-e15c-4fa7-a8be-960a5f1aa0d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_e2b015a9-7e63-4971-b375-ef28b424d5a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4940f984-d228-41b8-bd19-7ca7dadaaafb" xlink:to="loc_us-gaap_TreasuryStockValue_e2b015a9-7e63-4971-b375-ef28b424d5a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cfd9f3ab-23fa-4fb9-8251-76c589422dee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_980971fa-14dd-4be0-afba-2bb1bca526c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cfd9f3ab-23fa-4fb9-8251-76c589422dee" xlink:to="loc_us-gaap_LongTermDebtCurrent_980971fa-14dd-4be0-afba-2bb1bca526c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_768a66d2-85db-4c6d-95c8-b8c08d169456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cfd9f3ab-23fa-4fb9-8251-76c589422dee" xlink:to="loc_us-gaap_AccountsPayableCurrent_768a66d2-85db-4c6d-95c8-b8c08d169456" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_694a94d2-11f2-436a-8830-3a50d295664a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cfd9f3ab-23fa-4fb9-8251-76c589422dee" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_694a94d2-11f2-436a-8830-3a50d295664a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent_998f409d-34e7-4b41-9962-30864538379c" xlink:href="mo-20200930.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cfd9f3ab-23fa-4fb9-8251-76c589422dee" xlink:to="loc_mo_AccruedSettlementLiabilityCurrent_998f409d-34e7-4b41-9962-30864538379c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_71e3cdda-55e5-497f-90cb-fd0508a468fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cfd9f3ab-23fa-4fb9-8251-76c589422dee" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_71e3cdda-55e5-497f-90cb-fd0508a468fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_a133d8d4-1c32-478c-b636-e0b8e97a42cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cfd9f3ab-23fa-4fb9-8251-76c589422dee" xlink:to="loc_us-gaap_DividendsPayableCurrent_a133d8d4-1c32-478c-b636-e0b8e97a42cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b44d3bf9-dbb3-483f-9858-983e8d5bf7ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_761b00aa-5bed-457b-b1c0-9bc56c68efca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_b44d3bf9-dbb3-483f-9858-983e8d5bf7ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_761b00aa-5bed-457b-b1c0-9bc56c68efca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_044a9fc2-e2a5-4e08-a1ff-949d0ed4a2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_b44d3bf9-dbb3-483f-9858-983e8d5bf7ca" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_044a9fc2-e2a5-4e08-a1ff-949d0ed4a2cf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofEarnings"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f9edfe93-b6c9-4a5c-a330-e3b61d6dff97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ca2af174-14b8-478e-8e83-019b1a78e5e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f9edfe93-b6c9-4a5c-a330-e3b61d6dff97" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ca2af174-14b8-478e-8e83-019b1a78e5e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_1af9e313-3be2-49b0-b595-785115bb0db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f9edfe93-b6c9-4a5c-a330-e3b61d6dff97" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_1af9e313-3be2-49b0-b595-785115bb0db1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_46bc79fa-9813-49b5-91a3-997481501917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f9edfe93-b6c9-4a5c-a330-e3b61d6dff97" xlink:to="loc_us-gaap_OperatingIncomeLoss_46bc79fa-9813-49b5-91a3-997481501917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_66fb1dbe-6e7b-4215-b369-9c9015bc07bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f9edfe93-b6c9-4a5c-a330-e3b61d6dff97" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_66fb1dbe-6e7b-4215-b369-9c9015bc07bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5c0bd820-7b97-4d8b-8d58-3c8c3fc2c8b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f9edfe93-b6c9-4a5c-a330-e3b61d6dff97" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5c0bd820-7b97-4d8b-8d58-3c8c3fc2c8b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_28e7d990-a1fb-441d-be1b-afc1a5ded850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f9edfe93-b6c9-4a5c-a330-e3b61d6dff97" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_28e7d990-a1fb-441d-be1b-afc1a5ded850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_19964d25-2774-49ff-abb4-ec49a81bef2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a3f34fc-f65c-4189-b169-14c89e554490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_19964d25-2774-49ff-abb4-ec49a81bef2f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a3f34fc-f65c-4189-b169-14c89e554490" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ed042c30-3a3d-44e8-a382-14a65d826e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_19964d25-2774-49ff-abb4-ec49a81bef2f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ed042c30-3a3d-44e8-a382-14a65d826e03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue_b6897be4-de74-4330-a242-12023b024942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_19964d25-2774-49ff-abb4-ec49a81bef2f" xlink:to="loc_us-gaap_OtherCostOfOperatingRevenue_b6897be4-de74-4330-a242-12023b024942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_93fa2ebc-09a4-48aa-987c-fe8f933a4807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_65c225dd-52ee-4fb2-9470-6e95c5f86f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93fa2ebc-09a4-48aa-987c-fe8f933a4807" xlink:to="loc_us-gaap_ProfitLoss_65c225dd-52ee-4fb2-9470-6e95c5f86f16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_08311c8e-e755-451d-b620-39e668e04886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93fa2ebc-09a4-48aa-987c-fe8f933a4807" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_08311c8e-e755-451d-b620-39e668e04886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7e624e5f-1a87-4617-8738-3996bff202de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a9276472-ff55-412b-a66e-f0d84c79dcde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7e624e5f-1a87-4617-8738-3996bff202de" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a9276472-ff55-412b-a66e-f0d84c79dcde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6d926983-586e-4498-8b46-bb5589150667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7e624e5f-1a87-4617-8738-3996bff202de" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6d926983-586e-4498-8b46-bb5589150667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7cfcce28-eb43-4d89-9d84-066c4aae7f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_112ae796-bff7-481e-bb40-0cc74138d54f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7cfcce28-eb43-4d89-9d84-066c4aae7f3b" xlink:to="loc_us-gaap_GrossProfit_112ae796-bff7-481e-bb40-0cc74138d54f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts_46180751-d418-4f0d-b1cb-338b3c35d927" xlink:href="mo-20200930.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7cfcce28-eb43-4d89-9d84-066c4aae7f3b" xlink:to="loc_mo_MarketingAdministrationandResearchCosts_46180751-d418-4f0d-b1cb-338b3c35d927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_f6a33933-fcab-40e4-9d6d-87eb34c47214" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7cfcce28-eb43-4d89-9d84-066c4aae7f3b" xlink:to="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_f6a33933-fcab-40e4-9d6d-87eb34c47214" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveEarnings"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64570709-0647-45f8-9da1-9c2f56bae202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_32b3005c-fda4-4e3c-b709-07f75b615250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64570709-0647-45f8-9da1-9c2f56bae202" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_32b3005c-fda4-4e3c-b709-07f75b615250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax_01de3e76-e56a-49bb-9634-b6886f130597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64570709-0647-45f8-9da1-9c2f56bae202" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTax_01de3e76-e56a-49bb-9634-b6886f130597" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fc002f27-f750-48cf-ba24-f3f691690df2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64570709-0647-45f8-9da1-9c2f56bae202" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fc002f27-f750-48cf-ba24-f3f691690df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f9454a74-320d-4ee9-a5bb-24fe04603951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_508c74bb-b527-4790-b8e7-fdac8aa72da6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f9454a74-320d-4ee9-a5bb-24fe04603951" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_508c74bb-b527-4790-b8e7-fdac8aa72da6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d5860d71-636b-460a-81a2-bfe6cf0c4505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f9454a74-320d-4ee9-a5bb-24fe04603951" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d5860d71-636b-460a-81a2-bfe6cf0c4505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5e573398-41c3-4593-93d2-f83936d75db0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6cf5ffd4-b6aa-4a8f-97e5-4407c0d50e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5e573398-41c3-4593-93d2-f83936d75db0" xlink:to="loc_us-gaap_ProfitLoss_6cf5ffd4-b6aa-4a8f-97e5-4407c0d50e33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_07fe8a2f-a145-4eb0-8b17-7ec6e17a29ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5e573398-41c3-4593-93d2-f83936d75db0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_07fe8a2f-a145-4eb0-8b17-7ec6e17a29ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f265c825-9f5f-4f59-b4b9-211d4c185dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_aadbc684-a4de-4ade-97aa-841c857b189b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f265c825-9f5f-4f59-b4b9-211d4c185dac" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_aadbc684-a4de-4ade-97aa-841c857b189b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_f812843a-1c11-4770-a16b-7062fdde2426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f265c825-9f5f-4f59-b4b9-211d4c185dac" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_f812843a-1c11-4770-a16b-7062fdde2426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_987046e7-bb4d-4ebf-bc6b-c778dedfdb47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f265c825-9f5f-4f59-b4b9-211d4c185dac" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_987046e7-bb4d-4ebf-bc6b-c778dedfdb47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_1801a11f-2e80-44f0-9d7c-97515c49bb9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f265c825-9f5f-4f59-b4b9-211d4c185dac" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_1801a11f-2e80-44f0-9d7c-97515c49bb9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_77950df7-c2ce-42a7-85dd-2b247769e15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f265c825-9f5f-4f59-b4b9-211d4c185dac" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_77950df7-c2ce-42a7-85dd-2b247769e15a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_4a8bd154-bd94-4a10-a646-e3a22fff6bc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f265c825-9f5f-4f59-b4b9-211d4c185dac" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_4a8bd154-bd94-4a10-a646-e3a22fff6bc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0735d164-d70b-4a84-9e2c-8e52d935ae79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f265c825-9f5f-4f59-b4b9-211d4c185dac" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0735d164-d70b-4a84-9e2c-8e52d935ae79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_245dd518-58b7-4e0f-bfff-6bbbd1917112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd6498b9-6bbe-4837-9112-e43bdf0b475b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_245dd518-58b7-4e0f-bfff-6bbbd1917112" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd6498b9-6bbe-4837-9112-e43bdf0b475b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f932ab1-7c7e-491b-b887-32e4e9c7a739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_245dd518-58b7-4e0f-bfff-6bbbd1917112" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f932ab1-7c7e-491b-b887-32e4e9c7a739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_62945c74-0297-4556-afa7-cfa875003c76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_245dd518-58b7-4e0f-bfff-6bbbd1917112" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_62945c74-0297-4556-afa7-cfa875003c76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_36d8cfc7-5c92-4b37-8b5b-e9c7c30a51e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities_2ffc08c4-408a-41fc-995e-a728ef1b6022" xlink:href="mo-20200930.xsd#mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_36d8cfc7-5c92-4b37-8b5b-e9c7c30a51e0" xlink:to="loc_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities_2ffc08c4-408a-41fc-995e-a728ef1b6022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0fac4a5-00bf-4cb2-a913-f9889d26bd52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_36d8cfc7-5c92-4b37-8b5b-e9c7c30a51e0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0fac4a5-00bf-4cb2-a913-f9889d26bd52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentsToAcquireBusinessesAndAssets_ac4b60d1-a914-4918-b89a-21dac2516729" xlink:href="mo-20200930.xsd#mo_PaymentsToAcquireBusinessesAndAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_36d8cfc7-5c92-4b37-8b5b-e9c7c30a51e0" xlink:to="loc_mo_PaymentsToAcquireBusinessesAndAssets_ac4b60d1-a914-4918-b89a-21dac2516729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_230f0e8d-fea1-41cc-92ad-541d71b2f6fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_36d8cfc7-5c92-4b37-8b5b-e9c7c30a51e0" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_230f0e8d-fea1-41cc-92ad-541d71b2f6fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_543b04b7-e01f-4b2a-a7a1-e8f9a1d6e6da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_ProfitLoss_543b04b7-e01f-4b2a-a7a1-e8f9a1d6e6da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_846a77f1-b8e9-427b-b48b-34451f8ca360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_846a77f1-b8e9-427b-b48b-34451f8ca360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_efed3047-c577-4232-908a-ae558f3d465d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_efed3047-c577-4232-908a-ae558f3d465d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_02520228-f1ed-4775-93fa-b4306409d4b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_02520228-f1ed-4775-93fa-b4306409d4b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d0e8bbdf-98d3-484b-bdae-b51a9c575a10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d0e8bbdf-98d3-484b-bdae-b51a9c575a10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_3ff9da9f-4f0a-47fb-a913-318b64953103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_RestructuringCosts_3ff9da9f-4f0a-47fb-a913-318b64953103" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_2a9f3072-84a2-49a8-82ff-aa51ffe1c4a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_2a9f3072-84a2-49a8-82ff-aa51ffe1c4a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5d34bae0-bf04-47a7-9b70-48c1f6f67030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5d34bae0-bf04-47a7-9b70-48c1f6f67030" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b29b1458-8fbb-4182-a67d-1de96828e425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b29b1458-8fbb-4182-a67d-1de96828e425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_17216858-9fcb-4db0-988b-1dbcf9579a72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_17216858-9fcb-4db0-988b-1dbcf9579a72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable_c9d94739-8e5d-4eb3-a363-4b4d8882a881" xlink:href="mo-20200930.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_mo_IncreaseDecreaseInSettlementPayable_c9d94739-8e5d-4eb3-a363-4b4d8882a881" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_e3792526-9c2f-45e5-a384-fffdf5e78f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_e3792526-9c2f-45e5-a384-fffdf5e78f1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_8d434c23-4ab4-42b9-9133-78cb8a60e3af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_8d434c23-4ab4-42b9-9133-78cb8a60e3af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_9f7bdaa3-686e-4aae-9945-c08f428fedf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_9f7bdaa3-686e-4aae-9945-c08f428fedf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_737c0295-a2c3-4cf9-95c8-7ce862acd1f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_737c0295-a2c3-4cf9-95c8-7ce862acd1f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d742fcbe-6cd4-47e1-adc8-f39baab81c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d742fcbe-6cd4-47e1-adc8-f39baab81c66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_ac722b1a-d95d-434c-98f4-cc78dbd1bf69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2e1e2699-b9b4-420d-a31e-89a3508b77bf" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_ac722b1a-d95d-434c-98f4-cc78dbd1bf69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bdacd0df-77a6-4c6c-84c9-ff75c1b149cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dabd04b6-954b-46b9-b87c-305afa0c88e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bdacd0df-77a6-4c6c-84c9-ff75c1b149cb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dabd04b6-954b-46b9-b87c-305afa0c88e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_27b14576-3fb3-4815-b3d1-cbbbc4d88c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bdacd0df-77a6-4c6c-84c9-ff75c1b149cb" xlink:to="loc_us-gaap_RestrictedCashCurrent_27b14576-3fb3-4815-b3d1-cbbbc4d88c59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_3f3fea51-d40d-4128-8acb-6a45592843d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bdacd0df-77a6-4c6c-84c9-ff75c1b149cb" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_3f3fea51-d40d-4128-8acb-6a45592843d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentation"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationPolicies"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationShareRepurchaseTableDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="simple" xlink:href="mo-20200930.xsd#RevenuesfromContractswithCustomers"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCosts" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCosts"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCosts" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_79a5a076-855b-4651-b99b-9206ec95fd15" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_a3a72b43-8365-45e2-ad6e-5367b3b3d2b9" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_79a5a076-855b-4651-b99b-9206ec95fd15" xlink:to="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_a3a72b43-8365-45e2-ad6e-5367b3b3d2b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_ec63f1aa-66f8-439f-bbef-fb4b64c13395" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_79a5a076-855b-4651-b99b-9206ec95fd15" xlink:to="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_ec63f1aa-66f8-439f-bbef-fb4b64c13395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestructuringChargesIncludingNetPensionCostCredit_178efa81-1faa-470d-808b-8f51d80c22e7" xlink:href="mo-20200930.xsd#mo_RestructuringChargesIncludingNetPensionCostCredit"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_6656b1d8-42d0-40ef-8fc8-8ec655a537b4" xlink:href="mo-20200930.xsd#mo_OtherRestructuringCostsIncludingNetPensionCostCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_RestructuringChargesIncludingNetPensionCostCredit_178efa81-1faa-470d-808b-8f51d80c22e7" xlink:to="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_6656b1d8-42d0-40ef-8fc8-8ec655a537b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_1e410861-6dcf-4fdd-b661-5228810b7da4" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_RestructuringChargesIncludingNetPensionCostCredit_178efa81-1faa-470d-808b-8f51d80c22e7" xlink:to="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_1e410861-6dcf-4fdd-b661-5228810b7da4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCosts_3c073886-2439-48b0-9c06-972a08a114a4" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_6f48beba-f20b-40b3-bac1-e1f09af6293d" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_AssetImpairmentandBusinessExitCosts_3c073886-2439-48b0-9c06-972a08a114a4" xlink:to="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_6f48beba-f20b-40b3-bac1-e1f09af6293d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_a01b3ab4-1a02-46fe-858d-b8bd5752e8c9" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_AssetImpairmentandBusinessExitCosts_3c073886-2439-48b0-9c06-972a08a114a4" xlink:to="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_a01b3ab4-1a02-46fe-858d-b8bd5752e8c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_ab5922d1-ea38-4e17-922d-1f18f65edc66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_5d60e5c5-8c49-4819-a410-425cbb9fc5c8" xlink:href="mo-20200930.xsd#mo_OtherRestructuringCostsIncludingNetPensionCostCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherRestructuringCosts_ab5922d1-ea38-4e17-922d-1f18f65edc66" xlink:to="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_5d60e5c5-8c49-4819-a410-425cbb9fc5c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_4296d4cb-a80d-4c4e-8c93-767e18cdbb0f" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherRestructuringCosts_ab5922d1-ea38-4e17-922d-1f18f65edc66" xlink:to="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_4296d4cb-a80d-4c4e-8c93-767e18cdbb0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9304e753-4a32-4388-a146-ed6529c662c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCosts_0e25206b-b529-43c5-9fa1-27566653fb21" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_9304e753-4a32-4388-a146-ed6529c662c0" xlink:to="loc_mo_AssetImpairmentandBusinessExitCosts_0e25206b-b529-43c5-9fa1-27566653fb21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_0ff9079d-3a3b-4f29-8621-61ee27456e96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_9304e753-4a32-4388-a146-ed6529c662c0" xlink:to="loc_us-gaap_OtherRestructuringCosts_0ff9079d-3a3b-4f29-8621-61ee27456e96" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecurities"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_68e440f7-6773-448e-aae3-11c71ebf29ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_7bc229df-0bcc-4acd-b8e5-04420f2ffcea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_68e440f7-6773-448e-aae3-11c71ebf29ab" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_7bc229df-0bcc-4acd-b8e5-04420f2ffcea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_6a651ddb-076c-446f-8840-8de60e3eaf99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_68e440f7-6773-448e-aae3-11c71ebf29ab" xlink:to="loc_us-gaap_EquityMethodInvestments_6a651ddb-076c-446f-8840-8de60e3eaf99" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstruments"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/FinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlans" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlans"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlansTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_249d97a2-d70e-4096-b2a8-9cf6471e2aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_81588881-74bf-4a97-9726-a92d4a1e0a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_249d97a2-d70e-4096-b2a8-9cf6471e2aa1" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_81588881-74bf-4a97-9726-a92d4a1e0a4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_fffa94e3-8d55-424b-9701-1ddedb380146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_249d97a2-d70e-4096-b2a8-9cf6471e2aa1" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_fffa94e3-8d55-424b-9701-1ddedb380146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e2743884-1c75-44b0-9d91-7d9e23d2d69d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_249d97a2-d70e-4096-b2a8-9cf6471e2aa1" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_e2743884-1c75-44b0-9d91-7d9e23d2d69d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_39fae8d1-cd89-4f7e-8ac4-cbc9756f0347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_249d97a2-d70e-4096-b2a8-9cf6471e2aa1" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_39fae8d1-cd89-4f7e-8ac4-cbc9756f0347" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b13466c5-3f5b-4b73-ba9e-68475c4178f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_249d97a2-d70e-4096-b2a8-9cf6471e2aa1" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b13466c5-3f5b-4b73-ba9e-68475c4178f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_5ebe1d21-c48b-40c9-9ecb-10175ac986a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_249d97a2-d70e-4096-b2a8-9cf6471e2aa1" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_5ebe1d21-c48b-40c9-9ecb-10175ac986a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlansNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesPerShare" xlink:type="simple" xlink:href="mo-20200930.xsd#EarningsLossesPerShare"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/EarningsLossesPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesPerShareTables" xlink:type="simple" xlink:href="mo-20200930.xsd#EarningsLossesPerShareTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/EarningsLossesPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted_ac48aa6f-bd0b-4ad3-9e31-9b1761e1241f" xlink:href="mo-20200930.xsd#mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4bb4caf0-1387-4502-8011-50f029b3c7ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted_ac48aa6f-bd0b-4ad3-9e31-9b1761e1241f" xlink:to="loc_us-gaap_NetIncomeLoss_4bb4caf0-1387-4502-8011-50f029b3c7ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_fd49f43d-3a26-4778-bbb4-b63795ed616b" xlink:href="mo-20200930.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted_ac48aa6f-bd0b-4ad3-9e31-9b1761e1241f" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_fd49f43d-3a26-4778-bbb4-b63795ed616b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLosses"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLossesTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9654b98b-5ba5-421c-9567-47b635470cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_eae30adc-1d52-41e5-9acb-ca7dc7b73a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9654b98b-5ba5-421c-9567-47b635470cbe" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_eae30adc-1d52-41e5-9acb-ca7dc7b73a73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_cd45a5c5-53b5-4cdc-affe-919c9602734e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9654b98b-5ba5-421c-9567-47b635470cbe" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_cd45a5c5-53b5-4cdc-affe-919c9602734e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_48db0567-8ce5-4820-a457-8af24b3ee170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7198aade-6b35-42c2-8296-b722d4dd79f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_48db0567-8ce5-4820-a457-8af24b3ee170" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7198aade-6b35-42c2-8296-b722d4dd79f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_5866465d-5641-49a3-820e-6b8d05a95e65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_48db0567-8ce5-4820-a457-8af24b3ee170" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_5866465d-5641-49a3-820e-6b8d05a95e65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4718b6ce-bd0e-413c-a82f-374bc8417f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_02de6a25-a51f-4ff6-9183-66aaea731b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4718b6ce-bd0e-413c-a82f-374bc8417f4d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_02de6a25-a51f-4ff6-9183-66aaea731b0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_24f88f45-dff8-4598-a294-cabc7bc3bfc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4718b6ce-bd0e-413c-a82f-374bc8417f4d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_24f88f45-dff8-4598-a294-cabc7bc3bfc9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLossesReclassificationsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReporting" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReporting"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/SegmentReporting" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/SegmentReportingTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingSegmentDataScheduleDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingScheduleofCOVID19RelatedItemsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/Debt" xlink:type="simple" xlink:href="mo-20200930.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#DebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mo-20200930.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="simple" xlink:href="mo-20200930.xsd#IncomeTaxesupdateTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/Contingencies" xlink:type="simple" xlink:href="mo-20200930.xsd#Contingencies"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/Contingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesTables" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesGeneralInformationDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesScheduleofPendingCasesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesNonEngleProgenyLitigationDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesFloridaBondStatuteDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesOtherSmokingandHealthClassActionsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesHealthCareCostRecoveryLitigationDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesFederalGovernmentsLawsuitDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesEvaporProductLitigationDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesLightsUltraLightsCasesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesUSTLitigationsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="simple" xlink:href="mo-20200930.xsd#NewAccountingGuidanceNotYetAdopted"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="simple" xlink:href="mo-20200930.xsd#NewAccountingGuidanceNotYetAdoptedTables"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>mo-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e67beae8-252b-44fc-aaf0-eb6cb882e4c7,g:3f7a85d8-ce11-4daa-b845-1d29043d3872-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.altria.com/role/CoverPage" xlink:type="simple" xlink:href="mo-20200930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CoverPage" xlink:type="extended" id="i0b0c4989f1944b64b459c43634224f1e_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_206f33d4-8f9f-4e4f-991c-3d96d297e1d0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentType_206f33d4-8f9f-4e4f-991c-3d96d297e1d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_2693ae4c-9dab-4ca5-aaa0-bfd4c383635d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentQuarterlyReport_2693ae4c-9dab-4ca5-aaa0-bfd4c383635d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c075da2c-0fe7-44e3-94dd-89a488edb111" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentPeriodEndDate_c075da2c-0fe7-44e3-94dd-89a488edb111" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f8da45ec-e2e2-4bb0-acac-b1e538818b39" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentTransitionReport_f8da45ec-e2e2-4bb0-acac-b1e538818b39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_517cf0b9-d01c-4e28-8293-b94737481721" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityFileNumber_517cf0b9-d01c-4e28-8293-b94737481721" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e49260dd-431a-457e-8250-22086359a357" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityRegistrantName_e49260dd-431a-457e-8250-22086359a357" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e6684d3e-b16b-43a2-81b6-ef18c77dd59a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e6684d3e-b16b-43a2-81b6-ef18c77dd59a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8c7bf3d3-377e-49fb-b597-3f6b4ed8611d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityTaxIdentificationNumber_8c7bf3d3-377e-49fb-b597-3f6b4ed8611d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_95744500-0254-4a09-a45e-dc21d824d904" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityAddressAddressLine1_95744500-0254-4a09-a45e-dc21d824d904" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3e9e06d9-30fd-4845-8332-13441ffaaf40" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityAddressCityOrTown_3e9e06d9-30fd-4845-8332-13441ffaaf40" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7ccc1e2f-cf51-4fcb-9cfa-e71808b62108" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityAddressStateOrProvince_7ccc1e2f-cf51-4fcb-9cfa-e71808b62108" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9b26f25d-b501-4b28-9393-b70c1a5a9d9a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityAddressPostalZipCode_9b26f25d-b501-4b28-9393-b70c1a5a9d9a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_898af1e6-057e-4d08-9867-a6be535c1715" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_CityAreaCode_898af1e6-057e-4d08-9867-a6be535c1715" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_876b02b8-e36d-4128-8335-622c789c183b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_LocalPhoneNumber_876b02b8-e36d-4128-8335-622c789c183b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a8553527-410e-4430-a221-3d8e88827da7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_Security12bTitle_a8553527-410e-4430-a221-3d8e88827da7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9c3c6771-2397-4c22-af4a-f0c383e89444" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_TradingSymbol_9c3c6771-2397-4c22-af4a-f0c383e89444" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_69968397-2ca7-4fcf-9b04-d02eefabed60" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_SecurityExchangeName_69968397-2ca7-4fcf-9b04-d02eefabed60" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_229c6a33-2dd6-45d0-a8f1-19a538c2f57b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityCurrentReportingStatus_229c6a33-2dd6-45d0-a8f1-19a538c2f57b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_110c9d3b-feb6-40e5-a4bc-239d8707b80a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityInteractiveDataCurrent_110c9d3b-feb6-40e5-a4bc-239d8707b80a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_81b56f17-bbfc-47a8-8568-c927321c3294" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityFilerCategory_81b56f17-bbfc-47a8-8568-c927321c3294" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4949b3b7-8cb0-4f8f-a292-e6b040a2e331" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntitySmallBusiness_4949b3b7-8cb0-4f8f-a292-e6b040a2e331" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b1569633-f7a8-4315-a0e4-2cc0b4f40eaa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityEmergingGrowthCompany_b1569633-f7a8-4315-a0e4-2cc0b4f40eaa" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3f37c26f-e25c-4bc3-8e8e-6500cc3b85b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityShellCompany_3f37c26f-e25c-4bc3-8e8e-6500cc3b85b5" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_bec33123-358d-47f6-9683-a9f6c1989a62" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_bec33123-358d-47f6-9683-a9f6c1989a62" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_730da968-4720-43d7-9e63-a88b3aaca30b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_AmendmentFlag_730da968-4720-43d7-9e63-a88b3aaca30b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ff8a42f6-4ff9-4e8c-ac8e-610e465be7ab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentFiscalYearFocus_ff8a42f6-4ff9-4e8c-ac8e-610e465be7ab" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8301e6fe-e95f-415f-aa29-5d9bda0657e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8301e6fe-e95f-415f-aa29-5d9bda0657e4" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a6674263-8a0f-47c0-9354-ce4a16aaf548" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityCentralIndexKey_a6674263-8a0f-47c0-9354-ce4a16aaf548" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_48158696-f533-4aa2-bf3e-7b0cef12f435" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_CurrentFiscalYearEndDate_48158696-f533-4aa2-bf3e-7b0cef12f435" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_70381b76-bfed-4c42-b34f-b961aa739a2d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntitiesTable_70381b76-bfed-4c42-b34f-b961aa739a2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bbcaf8ba-e090-4ac7-9354-7881298c69b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_70381b76-bfed-4c42-b34f-b961aa739a2d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bbcaf8ba-e090-4ac7-9354-7881298c69b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bbcaf8ba-e090-4ac7-9354-7881298c69b8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bbcaf8ba-e090-4ac7-9354-7881298c69b8" xlink:to="loc_us-gaap_ClassOfStockDomain_bbcaf8ba-e090-4ac7-9354-7881298c69b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bbcaf8ba-e090-4ac7-9354-7881298c69b8" xlink:to="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember_7cd69b35-d6b2-48a2-be23-bcc9d9560094" xlink:href="mo-20200930.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock0.3313ParValueMember_7cd69b35-d6b2-48a2-be23-bcc9d9560094" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.000NotesDue2023Member_3cd01dd5-deb6-4710-8c17-325fa349ed40" xlink:href="mo-20200930.xsd#mo_CommonStock1.000NotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock1.000NotesDue2023Member_3cd01dd5-deb6-4710-8c17-325fa349ed40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member_292df015-0fcc-4687-98d5-b5d72cc33006" xlink:href="mo-20200930.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock1.700NotesDue2025Member_292df015-0fcc-4687-98d5-b5d72cc33006" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member_a6465094-18a6-4ace-922c-6006c6fa8b57" xlink:href="mo-20200930.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock2.200NotesDue2027Member_a6465094-18a6-4ace-922c-6006c6fa8b57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member_2c57732f-15e3-4749-b91e-f48a9fb14649" xlink:href="mo-20200930.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock3.125NotesDue2031Member_2c57732f-15e3-4749-b91e-f48a9fb14649" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i77e0137f2baf4b939794c4c3ab0d5e43_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i06ef94c888534a319f00d22a2bcd41e9_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofEarnings"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="extended" id="i5806d17161974b55945222fbae2502c9_CondensedConsolidatedStatementsofEarnings"/>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveEarnings"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended" id="if0b643ada43d4f4e9d15c3278a52d6fe_CondensedConsolidatedStatementsofComprehensiveEarnings"/>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="ib4c118ad82804532a37db55082dafbd9_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fc1710f9-d568-40f0-9821-e97f823e96a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fc1710f9-d568-40f0-9821-e97f823e96a8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0714c387-3a97-44d6-aa3b-97b167f9503c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0714c387-3a97-44d6-aa3b-97b167f9503c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_a045cd65-3440-4bcb-a339-4b0df05a2bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_a045cd65-3440-4bcb-a339-4b0df05a2bf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d72d25d2-f9c0-4a18-930e-b70b28f12f65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d72d25d2-f9c0-4a18-930e-b70b28f12f65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_d59ae52f-df14-4750-8329-d8bd6c087144" xlink:href="mo-20200930.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_d59ae52f-df14-4750-8329-d8bd6c087144" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e123668f-d46c-45cb-aeea-e01e998b6fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_DividendsCommonStockCash_e123668f-d46c-45cb-aeea-e01e998b6fe2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_405038c0-270d-4d0e-9503-ba8b8c151c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_405038c0-270d-4d0e-9503-ba8b8c151c66" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_69230ab4-bda9-496f-a7a9-acdea8b1a9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_69230ab4-bda9-496f-a7a9-acdea8b1a9e4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_f6100314-36c2-431a-b6d0-f77fca75d2f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_StockholdersEquityOther_f6100314-36c2-431a-b6d0-f77fca75d2f8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_74d235d1-4457-4b14-88d8-83084ab7d883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_072dee3a-b7c2-46fa-816f-e8a07a50e5a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fc1710f9-d568-40f0-9821-e97f823e96a8" xlink:to="loc_us-gaap_StatementTable_072dee3a-b7c2-46fa-816f-e8a07a50e5a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e4a28331-604c-4b3e-951f-e77a4eb5fa25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_072dee3a-b7c2-46fa-816f-e8a07a50e5a4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e4a28331-604c-4b3e-951f-e77a4eb5fa25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e4a28331-604c-4b3e-951f-e77a4eb5fa25_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4a28331-604c-4b3e-951f-e77a4eb5fa25" xlink:to="loc_us-gaap_EquityComponentDomain_e4a28331-604c-4b3e-951f-e77a4eb5fa25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4a28331-604c-4b3e-951f-e77a4eb5fa25" xlink:to="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_97443164-c3f4-4276-9791-e9e583d9be38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_CommonStockMember_97443164-c3f4-4276-9791-e9e583d9be38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0127dae9-bd74-4ab8-8b93-5c42ebec6996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0127dae9-bd74-4ab8-8b93-5c42ebec6996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0a9e7d54-2d4c-4d5e-910d-f4d114174417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_RetainedEarningsMember_0a9e7d54-2d4c-4d5e-910d-f4d114174417" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fdc355e2-e88c-470f-9e00-c2e180b8d8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fdc355e2-e88c-470f-9e00-c2e180b8d8e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_626cf20d-18ab-4964-8ba4-d6bbff3289b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_TreasuryStockMember_626cf20d-18ab-4964-8ba4-d6bbff3289b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_055a7a8d-8034-4ad0-a29b-de6f593202b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_NoncontrollingInterestMember_055a7a8d-8034-4ad0-a29b-de6f593202b9" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended" id="i2b6b255a832a4a2d8bd3e10f49b7fee2_CondensedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="i905f58d68e9f457ab6d5ee5efb1d112b_CondensedConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentation"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="extended" id="ifb02680bea8e496c95fa3432041170df_BackgroundandBasisofPresentation"/>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationPolicies"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="extended" id="i9b6679efedf3481d96ca6af09736fb00_BackgroundandBasisofPresentationPolicies"/>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="extended" id="i9b992e41289f4beeae265b5c5219be80_BackgroundandBasisofPresentationTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="extended" id="i3f93381c031f403bbbf96de364aecc2c_BackgroundandBasisofPresentationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_d0012f9c-5021-408e-980c-9da3c43f90d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_d0012f9c-5021-408e-980c-9da3c43f90d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dcda0b3e-d450-4fbf-b86e-40bc9dd55a93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dcda0b3e-d450-4fbf-b86e-40bc9dd55a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_33a527c2-a827-4739-b0b2-5f08dda7befe" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_33a527c2-a827-4739-b0b2-5f08dda7befe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2d3d894b-ab24-4387-8d26-d929687bf677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2d3d894b-ab24-4387-8d26-d929687bf677" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c7c7733c-c200-4593-94a3-6788b15104a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c7c7733c-c200-4593-94a3-6788b15104a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRatePercentageIncrease_3488c96a-eefd-44fd-9c42-b92b600dd390" xlink:href="mo-20200930.xsd#mo_CommonStockDividendRatePercentageIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_mo_CommonStockDividendRatePercentageIncrease_3488c96a-eefd-44fd-9c42-b92b600dd390" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_c50de208-5800-4989-ba3c-5f02e612e7de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_c50de208-5800-4989-ba3c-5f02e612e7de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRateAnnualPerShare_17c9c670-22ca-4d87-be0d-9af170b65c8e" xlink:href="mo-20200930.xsd#mo_CommonStockDividendRateAnnualPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_mo_CommonStockDividendRateAnnualPerShare_17c9c670-22ca-4d87-be0d-9af170b65c8e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_50f17bfb-512b-4d1c-bc07-7852d1346d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_50f17bfb-512b-4d1c-bc07-7852d1346d3b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_47f879ad-e765-44b8-8f4f-75d9a0ea1b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_47f879ad-e765-44b8-8f4f-75d9a0ea1b23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7825232e-041a-4fbc-bc72-3301a3d4d821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7825232e-041a-4fbc-bc72-3301a3d4d821" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_cb85c564-7e18-4a9e-b590-26f1ab4ce5d2" xlink:href="mo-20200930.xsd#mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_cb85c564-7e18-4a9e-b590-26f1ab4ce5d2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_081b4b89-69b8-4691-a97e-faa16905ecc7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:to="loc_srt_OwnershipAxis_081b4b89-69b8-4691-a97e-faa16905ecc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_081b4b89-69b8-4691-a97e-faa16905ecc7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_081b4b89-69b8-4691-a97e-faa16905ecc7" xlink:to="loc_srt_OwnershipDomain_081b4b89-69b8-4691-a97e-faa16905ecc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_dd8d1246-1dd2-4956-b61b-f8ea6c91bd43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_081b4b89-69b8-4691-a97e-faa16905ecc7" xlink:to="loc_srt_OwnershipDomain_dd8d1246-1dd2-4956-b61b-f8ea6c91bd43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember_d3644455-dacb-4d7f-85d2-49f500e09711" xlink:href="mo-20200930.xsd#mo_HelixInnovationsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_dd8d1246-1dd2-4956-b61b-f8ea6c91bd43" xlink:to="loc_mo_HelixInnovationsLLCMember_d3644455-dacb-4d7f-85d2-49f500e09711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ff80ccaa-a8dc-4ef8-ab97-46738ae0ecdf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:to="loc_dei_LegalEntityAxis_ff80ccaa-a8dc-4ef8-ab97-46738ae0ecdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ff80ccaa-a8dc-4ef8-ab97-46738ae0ecdf_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ff80ccaa-a8dc-4ef8-ab97-46738ae0ecdf" xlink:to="loc_dei_EntityDomain_ff80ccaa-a8dc-4ef8-ab97-46738ae0ecdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4432dd97-14cd-4e9a-9945-420c66ffb314" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ff80ccaa-a8dc-4ef8-ab97-46738ae0ecdf" xlink:to="loc_dei_EntityDomain_4432dd97-14cd-4e9a-9945-420c66ffb314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember_469a2a06-7367-47cc-95ba-a51864679b54" xlink:href="mo-20200930.xsd#mo_HelixInnovationsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4432dd97-14cd-4e9a-9945-420c66ffb314" xlink:to="loc_mo_HelixInnovationsLLCMember_469a2a06-7367-47cc-95ba-a51864679b54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f903d622-fab3-4696-92f3-0d3aa2e4d09d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f903d622-fab3-4696-92f3-0d3aa2e4d09d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_f903d622-fab3-4696-92f3-0d3aa2e4d09d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f903d622-fab3-4696-92f3-0d3aa2e4d09d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_f903d622-fab3-4696-92f3-0d3aa2e4d09d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4405e8a9-668e-471c-be3c-2ff7ecbd45a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f903d622-fab3-4696-92f3-0d3aa2e4d09d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4405e8a9-668e-471c-be3c-2ff7ecbd45a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2018ShareRepurchaseProgramMember_af812ce8-6682-46d2-9bfc-31b4575a0c9d" xlink:href="mo-20200930.xsd#mo_January2018ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4405e8a9-668e-471c-be3c-2ff7ecbd45a3" xlink:to="loc_mo_January2018ShareRepurchaseProgramMember_af812ce8-6682-46d2-9bfc-31b4575a0c9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_July2019ShareRepurchaseProgramMember_5dc6e4b9-4b02-4fba-856a-ce2a3786a1b8" xlink:href="mo-20200930.xsd#mo_July2019ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4405e8a9-668e-471c-be3c-2ff7ecbd45a3" xlink:to="loc_mo_July2019ShareRepurchaseProgramMember_5dc6e4b9-4b02-4fba-856a-ce2a3786a1b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f42e9e54-d8e6-472e-a966-a9e691fdfc41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f42e9e54-d8e6-472e-a966-a9e691fdfc41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f42e9e54-d8e6-472e-a966-a9e691fdfc41_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f42e9e54-d8e6-472e-a966-a9e691fdfc41" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f42e9e54-d8e6-472e-a966-a9e691fdfc41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f42e9e54-d8e6-472e-a966-a9e691fdfc41" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_fbffb675-43c8-449c-bba0-e4041e088a4f" xlink:href="mo-20200930.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:to="loc_mo_ABInBevMember_fbffb675-43c8-449c-bba0-e4041e088a4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_24882cc0-8e29-4907-9b61-274b3144927a" xlink:href="mo-20200930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:to="loc_mo_JUULMember_24882cc0-8e29-4907-9b61-274b3144927a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_a523cc4d-678e-406e-9e14-c571a55f178e" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:to="loc_mo_CronosGroupInc.Member_a523cc4d-678e-406e-9e14-c571a55f178e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationShareRepurchaseTableDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="extended" id="i216a675ac2dc4a48bcd6a0634eef4fb6_BackgroundandBasisofPresentationShareRepurchaseTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_b72014bc-6c0d-41c1-9b47-da557dda5e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_b72014bc-6c0d-41c1-9b47-da557dda5e9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4365e1ea-fa4e-4999-95f2-1309be74515c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4365e1ea-fa4e-4999-95f2-1309be74515c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_63b3c3fe-bf03-42d6-9bdb-934ddb27574f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_63b3c3fe-bf03-42d6-9bdb-934ddb27574f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_b6bf6e3e-3eef-4c67-9b2e-7aefc5b1979f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_b6bf6e3e-3eef-4c67-9b2e-7aefc5b1979f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_da096769-1083-42bc-b6db-611857328589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_b6bf6e3e-3eef-4c67-9b2e-7aefc5b1979f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_da096769-1083-42bc-b6db-611857328589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_da096769-1083-42bc-b6db-611857328589_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_da096769-1083-42bc-b6db-611857328589" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_da096769-1083-42bc-b6db-611857328589_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_33491b2b-6bf5-4c38-a248-b12cf3fe4ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_da096769-1083-42bc-b6db-611857328589" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_33491b2b-6bf5-4c38-a248-b12cf3fe4ee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2018ShareRepurchaseProgramMember_6551c02a-a3ae-4848-be8f-7bda6d7bfb3b" xlink:href="mo-20200930.xsd#mo_January2018ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_33491b2b-6bf5-4c38-a248-b12cf3fe4ee6" xlink:to="loc_mo_January2018ShareRepurchaseProgramMember_6551c02a-a3ae-4848-be8f-7bda6d7bfb3b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="simple" xlink:href="mo-20200930.xsd#RevenuesfromContractswithCustomers"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="extended" id="iae950247482849c1abb6430d07f044ae_RevenuesfromContractswithCustomers"/>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended" id="id231ca1fea994099a5b5e147edd5b5cd_RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCosts" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCosts"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCosts" xlink:type="extended" id="i9f508ec7c590416c9acf41a6cd9e4f49_AssetImpairmentExitandImplementationCosts"/>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables" xlink:type="extended" id="i2bfa025d667748ef8554b84693d90b2c_AssetImpairmentExitandImplementationCostsTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails" xlink:type="extended" id="i2ca20f2322f643409006e5ab6849e3dd_AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_e6703f78-6e61-4a75-80e0-b337bd903a13" xlink:href="mo-20200930.xsd#mo_OtherRestructuringCostsIncludingNetPensionCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_e6703f78-6e61-4a75-80e0-b337bd903a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_af48368e-fe6a-4ce8-8e00-abba93a074b5" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_af48368e-fe6a-4ce8-8e00-abba93a074b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_5de5a9e3-2125-4244-86b0-ca143a28c9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_us-gaap_OtherRestructuringCosts_5de5a9e3-2125-4244-86b0-ca143a28c9c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestructuringChargesIncludingNetPensionCostCredit_ff1dbddc-11b4-4a89-ac01-042cb696f10c" xlink:href="mo-20200930.xsd#mo_RestructuringChargesIncludingNetPensionCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_RestructuringChargesIncludingNetPensionCostCredit_ff1dbddc-11b4-4a89-ac01-042cb696f10c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_e05f679a-68e1-45a8-8930-f0fb2e886a22" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_e05f679a-68e1-45a8-8930-f0fb2e886a22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3ab22b82-176b-46df-a00a-1b7b91c9eb4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_us-gaap_RestructuringCharges_3ab22b82-176b-46df-a00a-1b7b91c9eb4c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_7773e54b-5196-4da0-90a0-44e7fe5d2a2f" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_7773e54b-5196-4da0-90a0-44e7fe5d2a2f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_829957c4-5a66-4603-8e01-68f47063cc7f" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_829957c4-5a66-4603-8e01-68f47063cc7f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCosts_d5a07f8c-1747-4268-a649-f7a22928579a" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_AssetImpairmentandBusinessExitCosts_d5a07f8c-1747-4268-a649-f7a22928579a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_318c8e8a-08d1-4bf7-8a0b-aba707aed570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_318c8e8a-08d1-4bf7-8a0b-aba707aed570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_318c8e8a-08d1-4bf7-8a0b-aba707aed570_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_318c8e8a-08d1-4bf7-8a0b-aba707aed570" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_318c8e8a-08d1-4bf7-8a0b-aba707aed570_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a92b7e9d-7887-4c24-b87f-0963b12d6140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_318c8e8a-08d1-4bf7-8a0b-aba707aed570" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a92b7e9d-7887-4c24-b87f-0963b12d6140" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e34a1b60-a1b0-4eb1-85c9-1b37ca41736e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a92b7e9d-7887-4c24-b87f-0963b12d6140" xlink:to="loc_us-gaap_CostOfSalesMember_e34a1b60-a1b0-4eb1-85c9-1b37ca41736e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember_7c1c4e77-0be4-47de-8be4-ddfefd7ea263" xlink:href="mo-20200930.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a92b7e9d-7887-4c24-b87f-0963b12d6140" xlink:to="loc_mo_MarketingAdministrationAndResearchCostsMember_7c1c4e77-0be4-47de-8be4-ddfefd7ea263" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a6741e98-0695-457f-bfe1-9ec51e591901" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:to="loc_srt_ConsolidationItemsAxis_a6741e98-0695-457f-bfe1-9ec51e591901" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a6741e98-0695-457f-bfe1-9ec51e591901_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a6741e98-0695-457f-bfe1-9ec51e591901" xlink:to="loc_srt_ConsolidationItemsDomain_a6741e98-0695-457f-bfe1-9ec51e591901_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b74ff165-e338-4318-a96e-97c4197d07fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a6741e98-0695-457f-bfe1-9ec51e591901" xlink:to="loc_srt_ConsolidationItemsDomain_b74ff165-e338-4318-a96e-97c4197d07fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fa7c876c-9fce-45bb-bc99-a06cf57810aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b74ff165-e338-4318-a96e-97c4197d07fd" xlink:to="loc_us-gaap_OperatingSegmentsMember_fa7c876c-9fce-45bb-bc99-a06cf57810aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_2c50910f-642b-419a-90cb-cf0590fd6234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b74ff165-e338-4318-a96e-97c4197d07fd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_2c50910f-642b-419a-90cb-cf0590fd6234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f3f11b11-d93c-450c-a50f-fb5da319e57f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f3f11b11-d93c-450c-a50f-fb5da319e57f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f3f11b11-d93c-450c-a50f-fb5da319e57f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f3f11b11-d93c-450c-a50f-fb5da319e57f" xlink:to="loc_us-gaap_SegmentDomain_f3f11b11-d93c-450c-a50f-fb5da319e57f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f3f11b11-d93c-450c-a50f-fb5da319e57f" xlink:to="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_9e2675d0-b0ce-49fe-b0b1-fe7e5fa3dd3a" xlink:href="mo-20200930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:to="loc_mo_SmokeableProductsSegmentMember_9e2675d0-b0ce-49fe-b0b1-fe7e5fa3dd3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_9ac4e1e0-884b-4457-bee6-80ad4ae7d502" xlink:href="mo-20200930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:to="loc_mo_OralTobaccoSegmentMember_9ac4e1e0-884b-4457-bee6-80ad4ae7d502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_7b992a2b-86d5-4b3a-806d-bb26e5ecd4c2" xlink:href="mo-20200930.xsd#mo_WineSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:to="loc_mo_WineSegmentMember_7b992a2b-86d5-4b3a-806d-bb26e5ecd4c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_c034b189-ff62-40b5-a7e5-1249e4d635df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:to="loc_us-gaap_AllOtherSegmentsMember_c034b189-ff62-40b5-a7e5-1249e4d635df" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails" xlink:type="extended" id="if98111f8aed444a8996417da021d84d2_AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails" xlink:type="extended" id="i69def124273541b7aae235397fecf0b7_AssetImpairmentExitandImplementationCostsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f95031ef-44bd-4e0c-972d-ec96d0caf1e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8d318e6a-860c-4773-8dbd-1d49d772ea44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f95031ef-44bd-4e0c-972d-ec96d0caf1e3" xlink:to="loc_us-gaap_RestructuringCharges_8d318e6a-860c-4773-8dbd-1d49d772ea44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_999338d1-1ef2-4063-9213-6deb908fb251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f95031ef-44bd-4e0c-972d-ec96d0caf1e3" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_999338d1-1ef2-4063-9213-6deb908fb251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f95031ef-44bd-4e0c-972d-ec96d0caf1e3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f55501cd-f5ce-4767-bba8-e149f8138262" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:to="loc_srt_StatementScenarioAxis_f55501cd-f5ce-4767-bba8-e149f8138262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f55501cd-f5ce-4767-bba8-e149f8138262_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_f55501cd-f5ce-4767-bba8-e149f8138262" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f55501cd-f5ce-4767-bba8-e149f8138262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fa368e8a-70e0-49ff-bcc9-523a85fb0c1c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_f55501cd-f5ce-4767-bba8-e149f8138262" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fa368e8a-70e0-49ff-bcc9-523a85fb0c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_27a7a679-e5e1-4377-8b9a-7a2bf8d97d73" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_fa368e8a-70e0-49ff-bcc9-523a85fb0c1c" xlink:to="loc_srt_ScenarioForecastMember_27a7a679-e5e1-4377-8b9a-7a2bf8d97d73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_56da376f-70fc-49a0-8614-cd7c2cc5df6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_56da376f-70fc-49a0-8614-cd7c2cc5df6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_56da376f-70fc-49a0-8614-cd7c2cc5df6a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_56da376f-70fc-49a0-8614-cd7c2cc5df6a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_56da376f-70fc-49a0-8614-cd7c2cc5df6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_4bb441bf-75b2-4b56-a511-77ae25f37909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_56da376f-70fc-49a0-8614-cd7c2cc5df6a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_4bb441bf-75b2-4b56-a511-77ae25f37909" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryWriteOffMember_f69c23b5-757b-4b2c-b08d-041312ef0eb4" xlink:href="mo-20200930.xsd#mo_InventoryWriteOffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_4bb441bf-75b2-4b56-a511-77ae25f37909" xlink:to="loc_mo_InventoryWriteOffMember_f69c23b5-757b-4b2c-b08d-041312ef0eb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentMember_9979f440-4650-4c9c-9d11-071f307b7b70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_4bb441bf-75b2-4b56-a511-77ae25f37909" xlink:to="loc_us-gaap_PurchaseCommitmentMember_9979f440-4650-4c9c-9d11-071f307b7b70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_c2fb53a4-cc6e-4b83-8fb2-371ecbfec9f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:to="loc_us-gaap_RestructuringPlanAxis_c2fb53a4-cc6e-4b83-8fb2-371ecbfec9f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_c2fb53a4-cc6e-4b83-8fb2-371ecbfec9f2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_c2fb53a4-cc6e-4b83-8fb2-371ecbfec9f2" xlink:to="loc_us-gaap_RestructuringPlanDomain_c2fb53a4-cc6e-4b83-8fb2-371ecbfec9f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_4281fce1-07b8-4c41-a35e-bcc21ef75e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_c2fb53a4-cc6e-4b83-8fb2-371ecbfec9f2" xlink:to="loc_us-gaap_RestructuringPlanDomain_4281fce1-07b8-4c41-a35e-bcc21ef75e2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineBusinessStrategicResetMember_6c572109-f14d-4fa6-9598-efb077805c8a" xlink:href="mo-20200930.xsd#mo_WineBusinessStrategicResetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_4281fce1-07b8-4c41-a35e-bcc21ef75e2e" xlink:to="loc_mo_WineBusinessStrategicResetMember_6c572109-f14d-4fa6-9598-efb077805c8a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecurities"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="extended" id="i2e9e0efee7fc4c5daa205a2487ad5b7e_InvestmentsinEquitySecurities"/>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables" xlink:type="extended" id="ic56e8923f71b41718b9b6f6cf52baede_InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended" id="icdf9426b37a1414991e68a00cd92568b_InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:href="mo-20200930.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b951372b-f3f0-44dd-8191-0f9d78aac179" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:to="loc_us-gaap_EquityMethodInvestments_b951372b-f3f0-44dd-8191-0f9d78aac179" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_8bc30f55-4add-442a-afec-d355d4d63947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_8bc30f55-4add-442a-afec-d355d4d63947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_9808d8f3-4966-4ee6-ad4f-e0e217af2df8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:to="loc_us-gaap_Investments_9808d8f3-4966-4ee6-ad4f-e0e217af2df8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_3e5cad1b-722e-456e-ba89-5acdfa61e564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_3e5cad1b-722e-456e-ba89-5acdfa61e564" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:href="mo-20200930.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:to="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cb0d89b0-a8d0-43d5-919a-bc39f075b83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cb0d89b0-a8d0-43d5-919a-bc39f075b83b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb0d89b0-a8d0-43d5-919a-bc39f075b83b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cb0d89b0-a8d0-43d5-919a-bc39f075b83b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb0d89b0-a8d0-43d5-919a-bc39f075b83b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eca4ded8-65d5-4cdd-b61d-cabc6ae3848b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cb0d89b0-a8d0-43d5-919a-bc39f075b83b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eca4ded8-65d5-4cdd-b61d-cabc6ae3848b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4e64be27-0538-4362-bb13-5e5d11bc7642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eca4ded8-65d5-4cdd-b61d-cabc6ae3848b" xlink:to="loc_us-gaap_CommonStockMember_4e64be27-0538-4362-bb13-5e5d11bc7642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a1b8228e-1e8b-4fdd-96be-a3a809052a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a1b8228e-1e8b-4fdd-96be-a3a809052a44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a1b8228e-1e8b-4fdd-96be-a3a809052a44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a1b8228e-1e8b-4fdd-96be-a3a809052a44" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a1b8228e-1e8b-4fdd-96be-a3a809052a44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4e2d6bb0-6ec6-4768-a52d-4630f81b5002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a1b8228e-1e8b-4fdd-96be-a3a809052a44" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4e2d6bb0-6ec6-4768-a52d-4630f81b5002" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_82c07389-6348-44e2-bc75-f3582ad8a8d5" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e2d6bb0-6ec6-4768-a52d-4630f81b5002" xlink:to="loc_mo_EquityContractWarrantMember_82c07389-6348-44e2-bc75-f3582ad8a8d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_6c36acc9-bceb-44a4-8997-edc07e93f721" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e2d6bb0-6ec6-4768-a52d-4630f81b5002" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_6c36acc9-bceb-44a4-8997-edc07e93f721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_017cc01d-012d-4234-8c1e-3cab686b4c5c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_017cc01d-012d-4234-8c1e-3cab686b4c5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_017cc01d-012d-4234-8c1e-3cab686b4c5c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_017cc01d-012d-4234-8c1e-3cab686b4c5c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_017cc01d-012d-4234-8c1e-3cab686b4c5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_017cc01d-012d-4234-8c1e-3cab686b4c5c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_c90b6e7f-7ab8-4bb4-a7a5-2ba0a9d17312" xlink:href="mo-20200930.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:to="loc_mo_ABInBevMember_c90b6e7f-7ab8-4bb4-a7a5-2ba0a9d17312" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_8bf9fa5f-7612-409a-9a92-1b1738513b64" xlink:href="mo-20200930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:to="loc_mo_JUULMember_8bf9fa5f-7612-409a-9a92-1b1738513b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_a3e02b83-078c-42bc-b843-95d7f18c6788" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:to="loc_mo_CronosGroupInc.Member_a3e02b83-078c-42bc-b843-95d7f18c6788" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="extended" id="i3c04a1e906024917a5f4ee975e357858_InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4467cd7-9718-47bb-8f11-28e685821b41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6ca3bd80-1988-4c6f-a090-9a91114f1d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4467cd7-9718-47bb-8f11-28e685821b41" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6ca3bd80-1988-4c6f-a090-9a91114f1d13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fff8a5e7-1021-47fa-804c-dfb7553381c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4467cd7-9718-47bb-8f11-28e685821b41" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fff8a5e7-1021-47fa-804c-dfb7553381c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7c7a6cb3-ae63-416c-8ad7-bfc699518191" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fff8a5e7-1021-47fa-804c-dfb7553381c6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7c7a6cb3-ae63-416c-8ad7-bfc699518191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7c7a6cb3-ae63-416c-8ad7-bfc699518191_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7c7a6cb3-ae63-416c-8ad7-bfc699518191" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7c7a6cb3-ae63-416c-8ad7-bfc699518191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f9b5f996-fca8-480b-bca2-f2a48b0a15b3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7c7a6cb3-ae63-416c-8ad7-bfc699518191" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f9b5f996-fca8-480b-bca2-f2a48b0a15b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_c2a9b28a-5650-4eb3-b026-5304d9e1e9bf" xlink:href="mo-20200930.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f9b5f996-fca8-480b-bca2-f2a48b0a15b3" xlink:to="loc_mo_ABInBevMember_c2a9b28a-5650-4eb3-b026-5304d9e1e9bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_7f4860bd-ac1f-451a-a28f-9ae683ec0421" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f9b5f996-fca8-480b-bca2-f2a48b0a15b3" xlink:to="loc_mo_CronosGroupInc.Member_7f4860bd-ac1f-451a-a28f-9ae683ec0421" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="extended" id="iddc83e59d3a8434dbed487c347b07ee3_InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_31dd60e6-a8b2-46b8-914c-3ece9da651c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_31dd60e6-a8b2-46b8-914c-3ece9da651c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_0a86cba3-4396-4cb0-a248-65c9f1587147" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_0a86cba3-4396-4cb0-a248-65c9f1587147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_d2fbade9-31d7-427e-9d44-d06aa7664c9f" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_d2fbade9-31d7-427e-9d44-d06aa7664c9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_ab925c5a-10b0-45e7-a62a-e5cfd439faae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_ab925c5a-10b0-45e7-a62a-e5cfd439faae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d1f496bd-2bb5-48a9-ad87-07e084f58e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_us-gaap_EquityMethodInvestments_d1f496bd-2bb5-48a9-ad87-07e084f58e8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_87d72223-62bc-4370-94a0-0a992f117385" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_87d72223-62bc-4370-94a0-0a992f117385" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_3b86e14d-1e1f-478b-98cb-9859c8b75264" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_mo_EquityMethodInvestmentImpairment_3b86e14d-1e1f-478b-98cb-9859c8b75264" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_84ee9c76-2961-42ac-8123-731939ef7b39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_84ee9c76-2961-42ac-8123-731939ef7b39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2799c02-9fee-4bc4-891d-9b496d8acdc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_84ee9c76-2961-42ac-8123-731939ef7b39" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2799c02-9fee-4bc4-891d-9b496d8acdc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2799c02-9fee-4bc4-891d-9b496d8acdc3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2799c02-9fee-4bc4-891d-9b496d8acdc3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2799c02-9fee-4bc4-891d-9b496d8acdc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72b021d1-cb74-44bc-8ed7-b7853a3bc1ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2799c02-9fee-4bc4-891d-9b496d8acdc3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72b021d1-cb74-44bc-8ed7-b7853a3bc1ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f69b079e-a27c-4b12-9027-f937e9cfdf68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72b021d1-cb74-44bc-8ed7-b7853a3bc1ba" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f69b079e-a27c-4b12-9027-f937e9cfdf68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d6493a0-1fe3-40b6-920f-1819bb052941" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_84ee9c76-2961-42ac-8123-731939ef7b39" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d6493a0-1fe3-40b6-920f-1819bb052941" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3d6493a0-1fe3-40b6-920f-1819bb052941_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d6493a0-1fe3-40b6-920f-1819bb052941" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3d6493a0-1fe3-40b6-920f-1819bb052941_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7dce432a-059b-410d-a245-a9fab9e921a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d6493a0-1fe3-40b6-920f-1819bb052941" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7dce432a-059b-410d-a245-a9fab9e921a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_9bb9b4cd-6fb5-4311-a5f1-dd9c7f2f5ff0" xlink:href="mo-20200930.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7dce432a-059b-410d-a245-a9fab9e921a2" xlink:to="loc_mo_ABInBevMember_9bb9b4cd-6fb5-4311-a5f1-dd9c7f2f5ff0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="extended" id="i3e092dc0ca184c01b64cb3fef92b3b78_InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_dbb984e3-66c9-4034-acfb-12213288f97d" xlink:href="mo-20200930.xsd#mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_dbb984e3-66c9-4034-acfb-12213288f97d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_60d84ee4-0c3e-4ff5-ab9d-bcc5d0c0c6bf" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_60d84ee4-0c3e-4ff5-ab9d-bcc5d0c0c6bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_b73d8640-80e3-4639-8b49-f7eefb90dede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_b73d8640-80e3-4639-8b49-f7eefb90dede" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod_c9afa0cb-5846-4340-880e-320aaec3486d" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod_c9afa0cb-5846-4340-880e-320aaec3486d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_34fb2c47-5939-4dfb-ba2e-acfe97c93f9b" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_34fb2c47-5939-4dfb-ba2e-acfe97c93f9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_31a2dade-6c5b-4fae-98f2-6d58daa07bca" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_31a2dade-6c5b-4fae-98f2-6d58daa07bca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod_4e915c85-2485-42a4-953e-9191f742cf21" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod_4e915c85-2485-42a4-953e-9191f742cf21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_677e4b14-357e-49e1-94f8-fbeede7c424d" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_677e4b14-357e-49e1-94f8-fbeede7c424d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_e262d422-594c-4d70-827e-e104d1b5f306" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_e262d422-594c-4d70-827e-e104d1b5f306" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_716a78d5-c55c-4031-b920-c224852c02f5" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_716a78d5-c55c-4031-b920-c224852c02f5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_79d12957-13ae-4eb4-8ef3-a0bcff38c2df" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_79d12957-13ae-4eb4-8ef3-a0bcff38c2df" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_c7e1dc11-b392-4f11-84ef-bef657f04578" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_c7e1dc11-b392-4f11-84ef-bef657f04578" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_a7f8d438-5517-4723-8146-c70c5cd2171b" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_a7f8d438-5517-4723-8146-c70c5cd2171b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_e177e752-566d-4125-be48-529affdaf2cf" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_e177e752-566d-4125-be48-529affdaf2cf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_d8629dc2-a9b3-4175-8e15-73b7ccd874fc" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_d8629dc2-a9b3-4175-8e15-73b7ccd874fc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_02a831d2-6787-4841-bd0a-8381f93b5a61" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_02a831d2-6787-4841-bd0a-8381f93b5a61" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_658bc042-e814-4daa-a968-085afe2f4297" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_658bc042-e814-4daa-a968-085afe2f4297" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_ad13fc2c-0b40-4032-b5d8-254f45a6040c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_ad13fc2c-0b40-4032-b5d8-254f45a6040c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d72041db-2793-485a-961f-dc64f899933f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d72041db-2793-485a-961f-dc64f899933f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_700b31e1-1e21-46ba-9952-f36be93363c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_700b31e1-1e21-46ba-9952-f36be93363c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc20cc14-a79b-411d-a0b2-305c99dc2145" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_700b31e1-1e21-46ba-9952-f36be93363c8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc20cc14-a79b-411d-a0b2-305c99dc2145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_cc20cc14-a79b-411d-a0b2-305c99dc2145_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc20cc14-a79b-411d-a0b2-305c99dc2145" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_cc20cc14-a79b-411d-a0b2-305c99dc2145_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d827cfdc-fffb-4243-bf73-ef2e0d0fe0bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc20cc14-a79b-411d-a0b2-305c99dc2145" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d827cfdc-fffb-4243-bf73-ef2e0d0fe0bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_bd0da532-e9b5-4dfd-8ad9-ecf6d541763e" xlink:href="mo-20200930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d827cfdc-fffb-4243-bf73-ef2e0d0fe0bb" xlink:to="loc_mo_JUULMember_bd0da532-e9b5-4dfd-8ad9-ecf6d541763e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="extended" id="ia93d551ae9494bd1a94473a7738c0fda_InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:href="mo-20200930.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_9473f570-ce2a-4165-9039-792a2a95edde" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_9473f570-ce2a-4165-9039-792a2a95edde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dd24b7fb-3e25-4c92-a179-80cb27c8c082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dd24b7fb-3e25-4c92-a179-80cb27c8c082" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_2f813049-d33d-415c-b198-e772c777b4c1" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_2f813049-d33d-415c-b198-e772c777b4c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_8c184c52-59f4-4a0a-b065-fb7cfed81307" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_8c184c52-59f4-4a0a-b065-fb7cfed81307" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_98e739ad-5eb4-47f7-9da7-5311ee0c3cef" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_98e739ad-5eb4-47f7-9da7-5311ee0c3cef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_25ceba3d-3aca-4937-8b42-e057ba0fe9c7" xlink:href="mo-20200930.xsd#mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_25ceba3d-3aca-4937-8b42-e057ba0fe9c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_bf79b5cb-7839-419e-ac98-c552aab8cc3c" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_bf79b5cb-7839-419e-ac98-c552aab8cc3c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities_6bc0177a-3421-4012-ae77-f99f61e734d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities_6bc0177a-3421-4012-ae77-f99f61e734d7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cc79f717-546f-47d6-b715-3fc23975bd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cc79f717-546f-47d6-b715-3fc23975bd2f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_99ce5257-3039-47ec-8ea9-428f2ac23205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_99ce5257-3039-47ec-8ea9-428f2ac23205" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentAggregateExercisePrice_2056478c-6b91-4f06-8e09-0add76db352e" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentAggregateExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentAggregateExercisePrice_2056478c-6b91-4f06-8e09-0add76db352e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberofDirectorsNominated_a5c7b120-dcf0-43a7-91f8-1c5f29701940" xlink:href="mo-20200930.xsd#mo_NumberofDirectorsNominated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_NumberofDirectorsNominated_a5c7b120-dcf0-43a7-91f8-1c5f29701940" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated_e99054c4-3106-479a-9f95-684305494fb8" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated_e99054c4-3106-479a-9f95-684305494fb8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberofMembersOntheBoardofDirectors_3cba34d9-bdc8-4a3c-8ff5-78921b996d4f" xlink:href="mo-20200930.xsd#mo_NumberofMembersOntheBoardofDirectors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_NumberofMembersOntheBoardofDirectors_3cba34d9-bdc8-4a3c-8ff5-78921b996d4f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_56e1eeba-03e5-4f08-b09e-b9539f291852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_56e1eeba-03e5-4f08-b09e-b9539f291852" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_dc76d607-06c0-4eac-85d7-ab935eeb1b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_EquityMethodInvestments_dc76d607-06c0-4eac-85d7-ab935eeb1b7d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_8f9f827b-3c71-402b-a7e2-e9fc70cd2d9c" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_8f9f827b-3c71-402b-a7e2-e9fc70cd2d9c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_6dbc69e9-a845-4fbe-a644-59d8b52634d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_6dbc69e9-a845-4fbe-a644-59d8b52634d1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:href="mo-20200930.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7b7e8e9-d8a9-430c-9b20-2342a83325ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7b7e8e9-d8a9-430c-9b20-2342a83325ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b7e8e9-d8a9-430c-9b20-2342a83325ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7b7e8e9-d8a9-430c-9b20-2342a83325ee" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e7b7e8e9-d8a9-430c-9b20-2342a83325ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0e9438a9-ad5f-45e3-90b7-89ef9908e632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7b7e8e9-d8a9-430c-9b20-2342a83325ee" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0e9438a9-ad5f-45e3-90b7-89ef9908e632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9dfe600c-1106-404b-a1e7-4ffa063e3d60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0e9438a9-ad5f-45e3-90b7-89ef9908e632" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9dfe600c-1106-404b-a1e7-4ffa063e3d60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6c7d63b0-dc10-44f8-9295-2aac31a46a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6c7d63b0-dc10-44f8-9295-2aac31a46a0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c7d63b0-dc10-44f8-9295-2aac31a46a0a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6c7d63b0-dc10-44f8-9295-2aac31a46a0a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c7d63b0-dc10-44f8-9295-2aac31a46a0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c8eda7b3-cd46-4344-a233-d66d913396c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6c7d63b0-dc10-44f8-9295-2aac31a46a0a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c8eda7b3-cd46-4344-a233-d66d913396c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_33a54e4e-f46e-46ff-be6d-f06bdea855aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c8eda7b3-cd46-4344-a233-d66d913396c0" xlink:to="loc_us-gaap_CommonStockMember_33a54e4e-f46e-46ff-be6d-f06bdea855aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_21db62d1-e983-4f45-8e34-818ee6ab67ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_21db62d1-e983-4f45-8e34-818ee6ab67ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_21db62d1-e983-4f45-8e34-818ee6ab67ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21db62d1-e983-4f45-8e34-818ee6ab67ba" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_21db62d1-e983-4f45-8e34-818ee6ab67ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_091b3814-12bd-48b4-901b-e7915c205718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21db62d1-e983-4f45-8e34-818ee6ab67ba" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_091b3814-12bd-48b4-901b-e7915c205718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_afeb8029-f479-44d9-a7f4-385b277c0372" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_091b3814-12bd-48b4-901b-e7915c205718" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_afeb8029-f479-44d9-a7f4-385b277c0372" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_7aa9be14-3a41-4a75-9386-b98530445904" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_091b3814-12bd-48b4-901b-e7915c205718" xlink:to="loc_mo_EquityContractWarrantMember_7aa9be14-3a41-4a75-9386-b98530445904" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f58584e5-8d3c-420e-a6d5-4aa4ae361057" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f58584e5-8d3c-420e-a6d5-4aa4ae361057" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f58584e5-8d3c-420e-a6d5-4aa4ae361057_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f58584e5-8d3c-420e-a6d5-4aa4ae361057" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f58584e5-8d3c-420e-a6d5-4aa4ae361057_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_50f7efaa-a34d-45eb-a2e4-98d6ef60031e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f58584e5-8d3c-420e-a6d5-4aa4ae361057" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_50f7efaa-a34d-45eb-a2e4-98d6ef60031e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_9de12027-49d2-46c6-86bb-78eb7cdc9fa8" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_50f7efaa-a34d-45eb-a2e4-98d6ef60031e" xlink:to="loc_mo_CronosGroupInc.Member_9de12027-49d2-46c6-86bb-78eb7cdc9fa8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9c4d349c-4aac-42c1-a1ac-daa8ec2b31ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9c4d349c-4aac-42c1-a1ac-daa8ec2b31ad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9c4d349c-4aac-42c1-a1ac-daa8ec2b31ad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9c4d349c-4aac-42c1-a1ac-daa8ec2b31ad" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9c4d349c-4aac-42c1-a1ac-daa8ec2b31ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_171bfc35-fe7c-4553-adff-7fd1c0d22600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9c4d349c-4aac-42c1-a1ac-daa8ec2b31ad" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_171bfc35-fe7c-4553-adff-7fd1c0d22600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_699673f7-7cec-4535-8c35-d328d074e051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_171bfc35-fe7c-4553-adff-7fd1c0d22600" xlink:to="loc_us-gaap_SubsequentEventMember_699673f7-7cec-4535-8c35-d328d074e051" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstruments"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstruments" xlink:type="extended" id="i7c94d8e2546e46379eb3ab3965fa980d_FinancialInstruments"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="extended" id="i835d8869f5444e8894fd225616be5146_FinancialInstrumentsTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" id="i3cac168473a84116a3344f1da4458fdf_FinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d97b2ff2-0f6e-4a85-be95-83dfaa16df7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d97b2ff2-0f6e-4a85-be95-83dfaa16df7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_0cab26c7-5780-4000-a0ab-294c1ce0b8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_DebtInstrumentFairValue_0cab26c7-5780-4000-a0ab-294c1ce0b8da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_97316b27-d83d-4df3-aaa9-b197596d5365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_LongTermDebt_97316b27-d83d-4df3-aaa9-b197596d5365" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_1142e203-bcba-41ac-a004-e6787fc8c6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_LongTermDebtFairValue_1142e203-bcba-41ac-a004-e6787fc8c6ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_6bbe6364-08bf-4fb3-ade5-5b1137a7e39e" xlink:href="mo-20200930.xsd#mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_6bbe6364-08bf-4fb3-ade5-5b1137a7e39e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_eb2ff9ff-ccf7-4370-aa17-9f90a81bb8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_eb2ff9ff-ccf7-4370-aa17-9f90a81bb8f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_ad044e6b-4701-4384-ae2a-75d494fec4ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_ad044e6b-4701-4384-ae2a-75d494fec4ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2ff331e3-54d6-4cf3-b210-4ffe2e085e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2ff331e3-54d6-4cf3-b210-4ffe2e085e79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ff331e3-54d6-4cf3-b210-4ffe2e085e79_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2ff331e3-54d6-4cf3-b210-4ffe2e085e79" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2ff331e3-54d6-4cf3-b210-4ffe2e085e79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a5c7569-38d3-4a36-9cf3-53e964a77514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2ff331e3-54d6-4cf3-b210-4ffe2e085e79" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a5c7569-38d3-4a36-9cf3-53e964a77514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fe80c6fc-45e4-4e7f-bfd9-f1a415527bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a5c7569-38d3-4a36-9cf3-53e964a77514" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fe80c6fc-45e4-4e7f-bfd9-f1a415527bca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_4e145af5-68d5-45b3-85fe-dd6439c9e80f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_4e145af5-68d5-45b3-85fe-dd6439c9e80f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4e145af5-68d5-45b3-85fe-dd6439c9e80f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4e145af5-68d5-45b3-85fe-dd6439c9e80f" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4e145af5-68d5-45b3-85fe-dd6439c9e80f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_283572ab-fc64-4fba-af55-791fc588b7d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4e145af5-68d5-45b3-85fe-dd6439c9e80f" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_283572ab-fc64-4fba-af55-791fc588b7d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7fa2ca-c371-491c-84fd-4af78a625862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_283572ab-fc64-4fba-af55-791fc588b7d1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7fa2ca-c371-491c-84fd-4af78a625862" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_bd1c029c-5891-4581-95d6-890fe26a809f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7fa2ca-c371-491c-84fd-4af78a625862" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_bd1c029c-5891-4581-95d6-890fe26a809f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_2630debd-dc12-4d3d-8b51-288bdb83ca72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7fa2ca-c371-491c-84fd-4af78a625862" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_2630debd-dc12-4d3d-8b51-288bdb83ca72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21c6c279-7c21-474b-bf1b-528e55065ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21c6c279-7c21-474b-bf1b-528e55065ed6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_21c6c279-7c21-474b-bf1b-528e55065ed6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21c6c279-7c21-474b-bf1b-528e55065ed6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_21c6c279-7c21-474b-bf1b-528e55065ed6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a470e92e-2c77-4986-abb0-4511cf5ee199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21c6c279-7c21-474b-bf1b-528e55065ed6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a470e92e-2c77-4986-abb0-4511cf5ee199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_169a7078-d0c1-40da-aa2b-c7990119fa44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a470e92e-2c77-4986-abb0-4511cf5ee199" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_169a7078-d0c1-40da-aa2b-c7990119fa44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8c56b3d6-d8f1-4035-b9e0-67fee2ed95a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_DebtInstrumentAxis_8c56b3d6-d8f1-4035-b9e0-67fee2ed95a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8c56b3d6-d8f1-4035-b9e0-67fee2ed95a1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8c56b3d6-d8f1-4035-b9e0-67fee2ed95a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8c56b3d6-d8f1-4035-b9e0-67fee2ed95a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2197deef-6bb4-4c8a-8c37-f4579beb5ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8c56b3d6-d8f1-4035-b9e0-67fee2ed95a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2197deef-6bb4-4c8a-8c37-f4579beb5ec4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_7dd1bb9b-5030-4ddb-a744-31bc2a8aab47" xlink:href="mo-20200930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2197deef-6bb4-4c8a-8c37-f4579beb5ec4" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_7dd1bb9b-5030-4ddb-a744-31bc2a8aab47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e3d914c1-7588-49df-9b67-04fa4cc89005" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e3d914c1-7588-49df-9b67-04fa4cc89005" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e3d914c1-7588-49df-9b67-04fa4cc89005_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e3d914c1-7588-49df-9b67-04fa4cc89005" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e3d914c1-7588-49df-9b67-04fa4cc89005_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1f77b44c-f39e-48f0-bee1-16358d46c0f2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e3d914c1-7588-49df-9b67-04fa4cc89005" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1f77b44c-f39e-48f0-bee1-16358d46c0f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_4f9e211a-3680-46a3-8294-315e606a071b" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1f77b44c-f39e-48f0-bee1-16358d46c0f2" xlink:to="loc_mo_CronosGroupInc.Member_4f9e211a-3680-46a3-8294-315e606a071b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8d69f3bb-2157-48af-ac9e-5bcefae8b1a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_HedgingDesignationAxis_8d69f3bb-2157-48af-ac9e-5bcefae8b1a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8d69f3bb-2157-48af-ac9e-5bcefae8b1a5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_8d69f3bb-2157-48af-ac9e-5bcefae8b1a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_8d69f3bb-2157-48af-ac9e-5bcefae8b1a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_23558242-407b-4de8-a0da-4ed6cb552a79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_8d69f3bb-2157-48af-ac9e-5bcefae8b1a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_23558242-407b-4de8-a0da-4ed6cb552a79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f312d30e-157f-4132-b321-c1c3ecbf240e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_23558242-407b-4de8-a0da-4ed6cb552a79" xlink:to="loc_us-gaap_NondesignatedMember_f312d30e-157f-4132-b321-c1c3ecbf240e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6bdcafa9-c5fa-460a-9c5f-94fddd445f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6bdcafa9-c5fa-460a-9c5f-94fddd445f55" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6bdcafa9-c5fa-460a-9c5f-94fddd445f55_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6bdcafa9-c5fa-460a-9c5f-94fddd445f55" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6bdcafa9-c5fa-460a-9c5f-94fddd445f55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_80d2bb48-b69e-4ffa-b0c9-f411ddb14115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6bdcafa9-c5fa-460a-9c5f-94fddd445f55" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_80d2bb48-b69e-4ffa-b0c9-f411ddb14115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6d5176b9-bc74-4b8e-8b3d-4432f10e20f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_80d2bb48-b69e-4ffa-b0c9-f411ddb14115" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6d5176b9-bc74-4b8e-8b3d-4432f10e20f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_3c235a95-a9a1-4448-8aee-48d0bcf01cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_80d2bb48-b69e-4ffa-b0c9-f411ddb14115" xlink:to="loc_us-gaap_ForwardContractsMember_3c235a95-a9a1-4448-8aee-48d0bcf01cf2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="extended" id="id0c2348b566f47d1943d9e2dc22280ea_FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_22e074e6-47ba-400c-bf6f-13c74f6809bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetMeasurementInput_e183bbb0-d841-45c1-8ad6-9060edf6716a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_22e074e6-47ba-400c-bf6f-13c74f6809bb" xlink:to="loc_us-gaap_DerivativeAssetMeasurementInput_e183bbb0-d841-45c1-8ad6-9060edf6716a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_22e074e6-47ba-400c-bf6f-13c74f6809bb" xlink:to="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_4cceb66d-a73d-4feb-810b-5815ffecb90b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_4cceb66d-a73d-4feb-810b-5815ffecb90b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_4cceb66d-a73d-4feb-810b-5815ffecb90b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_4cceb66d-a73d-4feb-810b-5815ffecb90b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_4cceb66d-a73d-4feb-810b-5815ffecb90b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_4cceb66d-a73d-4feb-810b-5815ffecb90b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_69f7ab0a-7d4b-4fbc-ac40-c8d738394a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_69f7ab0a-7d4b-4fbc-ac40-c8d738394a6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1505a36f-fd1c-4922-8f05-dfb280f5d3a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1505a36f-fd1c-4922-8f05-dfb280f5d3a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_70292fc1-1c52-45f7-90d4-890f62797040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_70292fc1-1c52-45f7-90d4-890f62797040" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_ee519854-f9d2-4eed-a2b0-25c239ed0cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_ee519854-f9d2-4eed-a2b0-25c239ed0cd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_586d06f8-65e0-4f1e-b660-e9ac7be9ba4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_586d06f8-65e0-4f1e-b660-e9ac7be9ba4c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MeasurementInputWeightedAverageExpectedTermMember_a15d290c-3a4c-40da-8299-193f7adc5d5d" xlink:href="mo-20200930.xsd#mo_MeasurementInputWeightedAverageExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_mo_MeasurementInputWeightedAverageExpectedTermMember_a15d290c-3a4c-40da-8299-193f7adc5d5d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_372e7630-c192-4333-b4bf-51f4448b2868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_372e7630-c192-4333-b4bf-51f4448b2868" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_372e7630-c192-4333-b4bf-51f4448b2868_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_372e7630-c192-4333-b4bf-51f4448b2868" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_372e7630-c192-4333-b4bf-51f4448b2868_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b2d109a9-8df0-4377-b2cb-05efec8a81a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_372e7630-c192-4333-b4bf-51f4448b2868" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b2d109a9-8df0-4377-b2cb-05efec8a81a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_02391c88-77a0-40c5-8ac3-073b1e7e3380" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2d109a9-8df0-4377-b2cb-05efec8a81a1" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_02391c88-77a0-40c5-8ac3-073b1e7e3380" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_17e9906e-5354-40f7-a7d2-4c203bddf622" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2d109a9-8df0-4377-b2cb-05efec8a81a1" xlink:to="loc_mo_EquityContractWarrantMember_17e9906e-5354-40f7-a7d2-4c203bddf622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e445241f-d8a5-43dd-ad89-1adbd8558ab2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:to="loc_srt_RangeAxis_e445241f-d8a5-43dd-ad89-1adbd8558ab2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e445241f-d8a5-43dd-ad89-1adbd8558ab2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e445241f-d8a5-43dd-ad89-1adbd8558ab2" xlink:to="loc_srt_RangeMember_e445241f-d8a5-43dd-ad89-1adbd8558ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_85b8c78c-6946-43f8-b1c1-3bcc97bc9786" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e445241f-d8a5-43dd-ad89-1adbd8558ab2" xlink:to="loc_srt_RangeMember_85b8c78c-6946-43f8-b1c1-3bcc97bc9786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6644b99c-b1d3-4ad7-8180-2752ae8bb9a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_85b8c78c-6946-43f8-b1c1-3bcc97bc9786" xlink:to="loc_srt_MinimumMember_6644b99c-b1d3-4ad7-8180-2752ae8bb9a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3f1db805-bcd8-46e2-a614-e1faebcef393" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_85b8c78c-6946-43f8-b1c1-3bcc97bc9786" xlink:to="loc_srt_MaximumMember_3f1db805-bcd8-46e2-a614-e1faebcef393" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="extended" id="i1d62d802f569426e9e0f5dd27001eec0_FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_186b0c21-7c86-4281-b7bb-a794609e0db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_cb886d08-df23-4078-b638-a684e9240270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_186b0c21-7c86-4281-b7bb-a794609e0db4" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_cb886d08-df23-4078-b638-a684e9240270" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_dd5c739e-d021-4c9a-bf1d-65773f075ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_cb886d08-df23-4078-b638-a684e9240270" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_dd5c739e-d021-4c9a-bf1d-65773f075ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3faa6f37-272b-4ce0-a02c-5694eacd8a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_cb886d08-df23-4078-b638-a684e9240270" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3faa6f37-272b-4ce0-a02c-5694eacd8a7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_07db8a64-c90a-40af-ac2a-98c7dbc0485f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_82d4877c-37e2-42eb-8055-d3d3a38c8f64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_186b0c21-7c86-4281-b7bb-a794609e0db4" xlink:to="loc_us-gaap_DerivativeTable_82d4877c-37e2-42eb-8055-d3d3a38c8f64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0b592c6-b20c-4f0a-81c6-5169edb454a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_82d4877c-37e2-42eb-8055-d3d3a38c8f64" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0b592c6-b20c-4f0a-81c6-5169edb454a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0b592c6-b20c-4f0a-81c6-5169edb454a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0b592c6-b20c-4f0a-81c6-5169edb454a3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0b592c6-b20c-4f0a-81c6-5169edb454a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_400714ee-714c-406e-a7ff-fedff473e9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0b592c6-b20c-4f0a-81c6-5169edb454a3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_400714ee-714c-406e-a7ff-fedff473e9d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_44b529a2-1483-4591-bf85-977c7b771329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_400714ee-714c-406e-a7ff-fedff473e9d2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_44b529a2-1483-4591-bf85-977c7b771329" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5cbe6c0d-7759-4ec3-bb3b-2beac55cd7e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_82d4877c-37e2-42eb-8055-d3d3a38c8f64" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5cbe6c0d-7759-4ec3-bb3b-2beac55cd7e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5cbe6c0d-7759-4ec3-bb3b-2beac55cd7e0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5cbe6c0d-7759-4ec3-bb3b-2beac55cd7e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5cbe6c0d-7759-4ec3-bb3b-2beac55cd7e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9d2d6b9f-35fe-4d5d-ac1a-c062cde37694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5cbe6c0d-7759-4ec3-bb3b-2beac55cd7e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9d2d6b9f-35fe-4d5d-ac1a-c062cde37694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember_700a81ea-90e1-4db1-b0f7-d725bbde4f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d2d6b9f-35fe-4d5d-ac1a-c062cde37694" xlink:to="loc_us-gaap_EquityContractMember_700a81ea-90e1-4db1-b0f7-d725bbde4f63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="extended" id="i6760e98199044de190d4d369f35ee33e_FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_8939d71f-bfc3-48a8-a3e4-4a1bc2e13390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6c475999-fcca-400a-87ff-99e4b2190baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_8939d71f-bfc3-48a8-a3e4-4a1bc2e13390" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6c475999-fcca-400a-87ff-99e4b2190baa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_fa3c5283-73f1-4812-9338-b705a0d4a905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_8939d71f-bfc3-48a8-a3e4-4a1bc2e13390" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_fa3c5283-73f1-4812-9338-b705a0d4a905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_8939d71f-bfc3-48a8-a3e4-4a1bc2e13390" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4512b6c8-458d-4629-96a0-ac680ba93dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4512b6c8-458d-4629-96a0-ac680ba93dd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4512b6c8-458d-4629-96a0-ac680ba93dd1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4512b6c8-458d-4629-96a0-ac680ba93dd1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4512b6c8-458d-4629-96a0-ac680ba93dd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6f328697-14f8-4842-9d94-0aed49d8f118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4512b6c8-458d-4629-96a0-ac680ba93dd1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6f328697-14f8-4842-9d94-0aed49d8f118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_bd8db0cc-4a88-48bc-b69d-10307aaac712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6f328697-14f8-4842-9d94-0aed49d8f118" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_bd8db0cc-4a88-48bc-b69d-10307aaac712" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_56b33efb-b72e-4ba6-a301-fb42ebfb6af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_56b33efb-b72e-4ba6-a301-fb42ebfb6af3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_56b33efb-b72e-4ba6-a301-fb42ebfb6af3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_56b33efb-b72e-4ba6-a301-fb42ebfb6af3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_56b33efb-b72e-4ba6-a301-fb42ebfb6af3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e34fb8ba-8254-4e2d-9320-351e43586f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_56b33efb-b72e-4ba6-a301-fb42ebfb6af3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e34fb8ba-8254-4e2d-9320-351e43586f39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6cbae582-d159-4dca-bd77-bcec6b00035f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e34fb8ba-8254-4e2d-9320-351e43586f39" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6cbae582-d159-4dca-bd77-bcec6b00035f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember_f05e5b2a-f81f-4688-95ae-67167d8d7746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e34fb8ba-8254-4e2d-9320-351e43586f39" xlink:to="loc_us-gaap_EquityContractMember_f05e5b2a-f81f-4688-95ae-67167d8d7746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_e6ff19fb-4afc-4564-8c99-e04cfb033748" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityContractMember_f05e5b2a-f81f-4688-95ae-67167d8d7746" xlink:to="loc_mo_EquityContractWarrantMember_e6ff19fb-4afc-4564-8c99-e04cfb033748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_366b04bc-f7af-43c5-92e5-b6562f21a345" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityContractMember_f05e5b2a-f81f-4688-95ae-67167d8d7746" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_366b04bc-f7af-43c5-92e5-b6562f21a345" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_29c5947c-0a65-490a-a8be-f29470c0fb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:to="loc_us-gaap_HedgingDesignationAxis_29c5947c-0a65-490a-a8be-f29470c0fb5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_29c5947c-0a65-490a-a8be-f29470c0fb5d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_29c5947c-0a65-490a-a8be-f29470c0fb5d" xlink:to="loc_us-gaap_HedgingDesignationDomain_29c5947c-0a65-490a-a8be-f29470c0fb5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b479948b-9fa9-4cb6-a353-98118d13ec6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_29c5947c-0a65-490a-a8be-f29470c0fb5d" xlink:to="loc_us-gaap_HedgingDesignationDomain_b479948b-9fa9-4cb6-a353-98118d13ec6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e6eee2f5-c810-449e-b84b-277b8fb2a62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b479948b-9fa9-4cb6-a353-98118d13ec6a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e6eee2f5-c810-449e-b84b-277b8fb2a62b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_1427953c-8d79-479f-a226-dcbbb51553e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b479948b-9fa9-4cb6-a353-98118d13ec6a" xlink:to="loc_us-gaap_NondesignatedMember_1427953c-8d79-479f-a226-dcbbb51553e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8c359a69-9803-452e-ba8a-3c755e03213e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8c359a69-9803-452e-ba8a-3c755e03213e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8c359a69-9803-452e-ba8a-3c755e03213e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8c359a69-9803-452e-ba8a-3c755e03213e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8c359a69-9803-452e-ba8a-3c755e03213e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8c359a69-9803-452e-ba8a-3c755e03213e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_5e7ac845-a430-494c-8cd1-aa0a044ba1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_5e7ac845-a430-494c-8cd1-aa0a044ba1e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_c9f4178f-0dc6-439d-9654-04d56c40cfc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_us-gaap_OtherAssetsMember_c9f4178f-0dc6-439d-9654-04d56c40cfc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherAccruedLiabilitiesMember_6b47310e-b2e1-4899-a067-123cd5fe829f" xlink:href="mo-20200930.xsd#mo_OtherAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_mo_OtherAccruedLiabilitiesMember_6b47310e-b2e1-4899-a067-123cd5fe829f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_a5f52178-1944-43e4-9566-624528b22e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_us-gaap_OtherLiabilitiesMember_a5f52178-1944-43e4-9566-624528b22e77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsInEquitySecuritiesMember_0e4bc43e-807a-4c39-9447-49d13e0f2d5d" xlink:href="mo-20200930.xsd#mo_InvestmentsInEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_mo_InvestmentsInEquitySecuritiesMember_0e4bc43e-807a-4c39-9447-49d13e0f2d5d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="extended" id="i1b612bd38c474a3db6250cdb22fabb57_FinancialInstrumentsPretaxUnrealizedGainsLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2a5cfbbd-349a-4dc0-ab93-9699aeaed476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_f81274a4-0b5f-462b-82c6-555ee957a3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_2a5cfbbd-349a-4dc0-ab93-9699aeaed476" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_f81274a4-0b5f-462b-82c6-555ee957a3ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f3422914-0951-4885-bdae-7de4b2d63102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_2a5cfbbd-349a-4dc0-ab93-9699aeaed476" xlink:to="loc_us-gaap_DerivativeTable_f3422914-0951-4885-bdae-7de4b2d63102" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4127108e-b607-4500-84df-e110552e562d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f3422914-0951-4885-bdae-7de4b2d63102" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4127108e-b607-4500-84df-e110552e562d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4127108e-b607-4500-84df-e110552e562d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4127108e-b607-4500-84df-e110552e562d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4127108e-b607-4500-84df-e110552e562d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_70f260e4-82fe-4c09-8de8-0a4f45f5477b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4127108e-b607-4500-84df-e110552e562d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_70f260e4-82fe-4c09-8de8-0a4f45f5477b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_f45c38c0-381a-4e79-8016-6f7787b96f5f" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_70f260e4-82fe-4c09-8de8-0a4f45f5477b" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_f45c38c0-381a-4e79-8016-6f7787b96f5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_401f3868-ac98-4c3b-a52c-94692ed183c0" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_70f260e4-82fe-4c09-8de8-0a4f45f5477b" xlink:to="loc_mo_EquityContractWarrantMember_401f3868-ac98-4c3b-a52c-94692ed183c0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended" id="if91bc78477024ae4ac9308cf698d16ec_FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0b442634-8cdd-40b6-b5d6-cd2503bb1455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_76effc15-22e2-4406-aae1-33b9b3195ea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0b442634-8cdd-40b6-b5d6-cd2503bb1455" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_76effc15-22e2-4406-aae1-33b9b3195ea4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_031b88c8-e236-4115-bfa8-6ac81eb4f88d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0b442634-8cdd-40b6-b5d6-cd2503bb1455" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_031b88c8-e236-4115-bfa8-6ac81eb4f88d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c7f38f62-dbf9-45f3-9300-e5037fac116e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0b442634-8cdd-40b6-b5d6-cd2503bb1455" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c7f38f62-dbf9-45f3-9300-e5037fac116e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e3bc3511-eb03-4cfd-9306-0817e438d9fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c7f38f62-dbf9-45f3-9300-e5037fac116e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e3bc3511-eb03-4cfd-9306-0817e438d9fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e3bc3511-eb03-4cfd-9306-0817e438d9fd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e3bc3511-eb03-4cfd-9306-0817e438d9fd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e3bc3511-eb03-4cfd-9306-0817e438d9fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0f44ffd1-d6eb-4b63-b978-8bec3b1b3cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e3bc3511-eb03-4cfd-9306-0817e438d9fd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0f44ffd1-d6eb-4b63-b978-8bec3b1b3cb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ac0827ca-28b7-499d-8560-747a152ca3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0f44ffd1-d6eb-4b63-b978-8bec3b1b3cb6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ac0827ca-28b7-499d-8560-747a152ca3ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_f6dba211-c0f7-4850-b35d-8c6783e3a67b" xlink:href="mo-20200930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0f44ffd1-d6eb-4b63-b978-8bec3b1b3cb6" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_f6dba211-c0f7-4850-b35d-8c6783e3a67b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d243d66d-3ff0-4603-b7a8-87ad0cf9f914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c7f38f62-dbf9-45f3-9300-e5037fac116e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d243d66d-3ff0-4603-b7a8-87ad0cf9f914" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d243d66d-3ff0-4603-b7a8-87ad0cf9f914_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d243d66d-3ff0-4603-b7a8-87ad0cf9f914" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d243d66d-3ff0-4603-b7a8-87ad0cf9f914_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_05409272-5136-43c8-9517-1e646dae1e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d243d66d-3ff0-4603-b7a8-87ad0cf9f914" xlink:to="loc_us-gaap_HedgingRelationshipDomain_05409272-5136-43c8-9517-1e646dae1e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_404067fd-76e6-4ca8-b094-d4f6309a0f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_05409272-5136-43c8-9517-1e646dae1e7e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_404067fd-76e6-4ca8-b094-d4f6309a0f3c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlans" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlans"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlans" xlink:type="extended" id="i434684be89094cadadb0e00728e75b3b_BenefitPlans"/>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlansTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansTables" xlink:type="extended" id="i93856e1869d740bd926d9c01bcc50092_BenefitPlansTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="extended" id="i38863c9667ea4da6a1bad5421e9c98a2_BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_8675b0cb-fc5c-4ee6-a349-a5679631fb02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_8675b0cb-fc5c-4ee6-a349-a5679631fb02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_4c29c7a7-b86a-47d1-9309-bb7ef634d418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_4c29c7a7-b86a-47d1-9309-bb7ef634d418" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bab9750c-c0a4-4697-b6b6-d9feefca8ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bab9750c-c0a4-4697-b6b6-d9feefca8ad9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b89b1ebb-e66c-4c11-a031-27f98f9c221a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b89b1ebb-e66c-4c11-a031-27f98f9c221a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e9d98f12-eddc-423b-9bc1-50fba972a2bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b89b1ebb-e66c-4c11-a031-27f98f9c221a" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e9d98f12-eddc-423b-9bc1-50fba972a2bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1f4703ab-4eab-4a01-85d9-71fa77f00a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b89b1ebb-e66c-4c11-a031-27f98f9c221a" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1f4703ab-4eab-4a01-85d9-71fa77f00a49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_59a8dbc1-90c3-4df4-809d-259817aaa95d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_59a8dbc1-90c3-4df4-809d-259817aaa95d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_07af0c77-e45e-4f42-be26-6d8cae646db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_07af0c77-e45e-4f42-be26-6d8cae646db8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5d6df4d8-efb1-4be3-9078-2feb46ea3a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5d6df4d8-efb1-4be3-9078-2feb46ea3a4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_69404a96-f726-4ca2-8685-80f369e7acaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5d6df4d8-efb1-4be3-9078-2feb46ea3a4f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_69404a96-f726-4ca2-8685-80f369e7acaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_69404a96-f726-4ca2-8685-80f369e7acaf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_69404a96-f726-4ca2-8685-80f369e7acaf" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_69404a96-f726-4ca2-8685-80f369e7acaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f39faa23-8876-4d0d-8b53-2e30ca206fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_69404a96-f726-4ca2-8685-80f369e7acaf" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f39faa23-8876-4d0d-8b53-2e30ca206fb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_34e8b751-2eb0-4ba2-8bc1-c3c82b11b120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f39faa23-8876-4d0d-8b53-2e30ca206fb3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_34e8b751-2eb0-4ba2-8bc1-c3c82b11b120" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_64525dab-064a-4fce-9a1c-799cab019ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f39faa23-8876-4d0d-8b53-2e30ca206fb3" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_64525dab-064a-4fce-9a1c-799cab019ff4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="extended" id="ic99225d9b97246218c37f8fac8da7b4b_BenefitPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5371937f-f6ad-4f52-a94e-6ae2a82f670d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d5f88b9f-6de9-4dda-9b3c-21e9602d7f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5371937f-f6ad-4f52-a94e-6ae2a82f670d" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d5f88b9f-6de9-4dda-9b3c-21e9602d7f5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_0a49f449-63c7-4d42-947e-72a659639632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5371937f-f6ad-4f52-a94e-6ae2a82f670d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_0a49f449-63c7-4d42-947e-72a659639632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93fea49b-5279-4749-827e-a847b39efc03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5371937f-f6ad-4f52-a94e-6ae2a82f670d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93fea49b-5279-4749-827e-a847b39efc03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e8722979-998d-45f1-ab45-70e7cae549db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93fea49b-5279-4749-827e-a847b39efc03" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e8722979-998d-45f1-ab45-70e7cae549db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e8722979-998d-45f1-ab45-70e7cae549db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e8722979-998d-45f1-ab45-70e7cae549db" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e8722979-998d-45f1-ab45-70e7cae549db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a0b067c1-56c3-404e-b6cd-7e1a987352f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e8722979-998d-45f1-ab45-70e7cae549db" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a0b067c1-56c3-404e-b6cd-7e1a987352f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_342cf366-5805-4e36-88fb-75b01605c809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a0b067c1-56c3-404e-b6cd-7e1a987352f9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_342cf366-5805-4e36-88fb-75b01605c809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_684bd1bc-1fa1-4ce7-9a43-af9115e2c962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a0b067c1-56c3-404e-b6cd-7e1a987352f9" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_684bd1bc-1fa1-4ce7-9a43-af9115e2c962" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_586db45f-5c32-47e7-a058-785b4fe32651" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93fea49b-5279-4749-827e-a847b39efc03" xlink:to="loc_srt_RangeAxis_586db45f-5c32-47e7-a058-785b4fe32651" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_586db45f-5c32-47e7-a058-785b4fe32651_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_586db45f-5c32-47e7-a058-785b4fe32651" xlink:to="loc_srt_RangeMember_586db45f-5c32-47e7-a058-785b4fe32651_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b9ddd663-a4db-4e23-8851-0b64d141cbc8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_586db45f-5c32-47e7-a058-785b4fe32651" xlink:to="loc_srt_RangeMember_b9ddd663-a4db-4e23-8851-0b64d141cbc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_00043f06-491a-4aec-8765-2efac21463e0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b9ddd663-a4db-4e23-8851-0b64d141cbc8" xlink:to="loc_srt_MaximumMember_00043f06-491a-4aec-8765-2efac21463e0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesPerShare" xlink:type="simple" xlink:href="mo-20200930.xsd#EarningsLossesPerShare"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/EarningsLossesPerShare" xlink:type="extended" id="idaf779b148e7462bbd6dc947e132774b_EarningsLossesPerShare"/>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesPerShareTables" xlink:type="simple" xlink:href="mo-20200930.xsd#EarningsLossesPerShareTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/EarningsLossesPerShareTables" xlink:type="extended" id="i9e8162ff770646b486a6b6785efd11d7_EarningsLossesPerShareTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails" xlink:type="extended" id="i8904525ce5dc4a7db694f8852f17235d_EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"/>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLosses"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="extended" id="i30a1ddfc194f4b65973351ca5fc1c025_OtherComprehensiveEarningsLosses"/>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLossesTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="extended" id="i567b1ca8e98a4fec816abe6f85b9bc58_OtherComprehensiveEarningsLossesTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended" id="i575a432a1b00456792d439442b819f25_OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da4a700f-9deb-4c9d-a55b-966f16199ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da4a700f-9deb-4c9d-a55b-966f16199ffc" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_441ac343-d757-4dc6-88d9-ca4f2f72b6d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_441ac343-d757-4dc6-88d9-ca4f2f72b6d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1a058528-f88d-4581-bb6e-23bdc7c2ee75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1a058528-f88d-4581-bb6e-23bdc7c2ee75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_177f0d40-23f5-4843-aa54-92c47e64aae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_177f0d40-23f5-4843-aa54-92c47e64aae4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_955be092-cee6-446c-8051-de95685ca8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_955be092-cee6-446c-8051-de95685ca8fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_bdc17a64-65d2-493a-8fda-6b0f925335eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_bdc17a64-65d2-493a-8fda-6b0f925335eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_d223ffd3-8051-4d7d-949c-a7513ba04c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_d223ffd3-8051-4d7d-949c-a7513ba04c7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e53f7182-8057-48d4-9d20-861a481739cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e53f7182-8057-48d4-9d20-861a481739cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e28dd70-0ee3-46da-b9f9-ac53c27f4609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e28dd70-0ee3-46da-b9f9-ac53c27f4609" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f322514-941f-4de0-ad15-1a8741a4abb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8ec683c2-0e16-4f1f-927a-b61d2fde047e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da4a700f-9deb-4c9d-a55b-966f16199ffc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8ec683c2-0e16-4f1f-927a-b61d2fde047e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f80b04cf-1dad-412f-9ee1-2cc87390ff88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8ec683c2-0e16-4f1f-927a-b61d2fde047e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f80b04cf-1dad-412f-9ee1-2cc87390ff88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f80b04cf-1dad-412f-9ee1-2cc87390ff88_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f80b04cf-1dad-412f-9ee1-2cc87390ff88" xlink:to="loc_us-gaap_EquityComponentDomain_f80b04cf-1dad-412f-9ee1-2cc87390ff88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_299a1b3b-d253-43b0-b18b-71d5a62efb53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f80b04cf-1dad-412f-9ee1-2cc87390ff88" xlink:to="loc_us-gaap_EquityComponentDomain_299a1b3b-d253-43b0-b18b-71d5a62efb53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_299a1b3b-d253-43b0-b18b-71d5a62efb53" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d3f93910-d46c-404c-858b-83d9c44a6e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d3f93910-d46c-404c-858b-83d9c44a6e0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_2d503b13-12be-4a43-8d9e-deb2a313d280" xlink:href="mo-20200930.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_2d503b13-12be-4a43-8d9e-deb2a313d280" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a771ab65-060e-455b-a3d6-2ba8f07d02de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a771ab65-060e-455b-a3d6-2ba8f07d02de" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLossesReclassificationsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="extended" id="if064deb89e6e4d76b29dc58d93a39d97_OtherComprehensiveEarningsLossesReclassificationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_c5e0faa7-6a5f-4d04-acb9-c1f28b756ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_c5e0faa7-6a5f-4d04-acb9-c1f28b756ccc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_516e1e0f-7ccc-4846-a1b4-dfaf59c88baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_516e1e0f-7ccc-4846-a1b4-dfaf59c88baf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_57cacd54-81f6-496d-b43f-6b764b9d9376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:to="loc_us-gaap_ProfitLoss_57cacd54-81f6-496d-b43f-6b764b9d9376" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_527d65e2-9105-44b5-a11b-9e0ab4cced8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_527d65e2-9105-44b5-a11b-9e0ab4cced8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0a2590eb-ee9c-49b3-9991-c0bb03ccfd02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_527d65e2-9105-44b5-a11b-9e0ab4cced8e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0a2590eb-ee9c-49b3-9991-c0bb03ccfd02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0a2590eb-ee9c-49b3-9991-c0bb03ccfd02_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0a2590eb-ee9c-49b3-9991-c0bb03ccfd02" xlink:to="loc_us-gaap_EquityComponentDomain_0a2590eb-ee9c-49b3-9991-c0bb03ccfd02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2a3263f8-a41d-4cfb-81e7-3ac27a4927d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0a2590eb-ee9c-49b3-9991-c0bb03ccfd02" xlink:to="loc_us-gaap_EquityComponentDomain_2a3263f8-a41d-4cfb-81e7-3ac27a4927d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dba9270a-fb1d-4d0b-b1f3-605e2c6b2a10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2a3263f8-a41d-4cfb-81e7-3ac27a4927d7" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dba9270a-fb1d-4d0b-b1f3-605e2c6b2a10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3eb1d10f-d263-4457-a355-d6c799ec3c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dba9270a-fb1d-4d0b-b1f3-605e2c6b2a10" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3eb1d10f-d263-4457-a355-d6c799ec3c19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_c6188342-91c0-4b64-932d-d5a3c3a7bf2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dba9270a-fb1d-4d0b-b1f3-605e2c6b2a10" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_c6188342-91c0-4b64-932d-d5a3c3a7bf2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f46a084b-faa7-4222-92c1-d0350f2b7dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_527d65e2-9105-44b5-a11b-9e0ab4cced8e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f46a084b-faa7-4222-92c1-d0350f2b7dc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_f46a084b-faa7-4222-92c1-d0350f2b7dc0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f46a084b-faa7-4222-92c1-d0350f2b7dc0" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_f46a084b-faa7-4222-92c1-d0350f2b7dc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7e87dea5-99ac-4181-9566-49e887fb4c01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f46a084b-faa7-4222-92c1-d0350f2b7dc0" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7e87dea5-99ac-4181-9566-49e887fb4c01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_257315ad-855d-4b73-a15c-642ed84908af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7e87dea5-99ac-4181-9566-49e887fb4c01" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_257315ad-855d-4b73-a15c-642ed84908af" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReporting" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReporting"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReporting" xlink:type="extended" id="i0249a8538ad34dd3acd51c0eccad8bd3_SegmentReporting"/>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingTables" xlink:type="extended" id="i0f5847c580fd492e8122365c49e9ca10_SegmentReportingTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingSegmentDataScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="extended" id="if2acbc441c2c4c3ba76c13bb05f30512_SegmentReportingSegmentDataScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30007a0f-7eee-4923-993c-8e263c87447f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30007a0f-7eee-4923-993c-8e263c87447f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_4bca9a67-60f3-4ca6-904f-beefbedb4816" xlink:href="mo-20200930.xsd#mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_4bca9a67-60f3-4ca6-904f-beefbedb4816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5d5de548-67c3-4046-8278-e89fa675036b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5d5de548-67c3-4046-8278-e89fa675036b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c532abf9-a183-477a-abef-1288e189e36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c532abf9-a183-477a-abef-1288e189e36b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCosts_2706f314-ce83-4f7f-9c9c-7d2805f3ca01" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_mo_AssetImpairmentandBusinessExitCosts_2706f314-ce83-4f7f-9c9c-7d2805f3ca01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e133532e-64e7-4c83-9aaa-f6dd7f54ef5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_OperatingIncomeLoss_e133532e-64e7-4c83-9aaa-f6dd7f54ef5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4317292b-5329-4c34-b371-847c78e7788f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_4317292b-5329-4c34-b371-847c78e7788f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_3a5f2b0f-6a09-40e0-9df5-9eadde3bad13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_3a5f2b0f-6a09-40e0-9df5-9eadde3bad13" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ea6951aa-efa5-44a6-b6ab-a52b09b1cbc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ea6951aa-efa5-44a6-b6ab-a52b09b1cbc9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_26bd14cd-6af0-45e0-b835-54119fbf741a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_26bd14cd-6af0-45e0-b835-54119fbf741a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_4050afa6-f3ed-4059-be1e-70184a429636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_4050afa6-f3ed-4059-be1e-70184a429636" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d661d-6c4e-4731-b6dd-e8d79f757a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d661d-6c4e-4731-b6dd-e8d79f757a22" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5b47ada-580b-4a64-b530-1152daaba70a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5b47ada-580b-4a64-b530-1152daaba70a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b991e804-c3d3-4ca0-8777-121cc5b28374" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5b47ada-580b-4a64-b530-1152daaba70a" xlink:to="loc_srt_ConsolidationItemsAxis_b991e804-c3d3-4ca0-8777-121cc5b28374" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b991e804-c3d3-4ca0-8777-121cc5b28374_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b991e804-c3d3-4ca0-8777-121cc5b28374" xlink:to="loc_srt_ConsolidationItemsDomain_b991e804-c3d3-4ca0-8777-121cc5b28374_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0b24a542-5e4e-4488-9fab-71d5620077f9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b991e804-c3d3-4ca0-8777-121cc5b28374" xlink:to="loc_srt_ConsolidationItemsDomain_0b24a542-5e4e-4488-9fab-71d5620077f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_c486cae8-eb26-43e5-9a39-65ff1a12a9fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0b24a542-5e4e-4488-9fab-71d5620077f9" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_c486cae8-eb26-43e5-9a39-65ff1a12a9fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_11a5f332-5e0c-4cfd-a2c5-bc023c8f2498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_0b24a542-5e4e-4488-9fab-71d5620077f9" xlink:to="loc_us-gaap_CorporateNonSegmentMember_11a5f332-5e0c-4cfd-a2c5-bc023c8f2498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_22da0502-c97f-4dc1-b456-1806a70988d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5b47ada-580b-4a64-b530-1152daaba70a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_22da0502-c97f-4dc1-b456-1806a70988d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_22da0502-c97f-4dc1-b456-1806a70988d2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_22da0502-c97f-4dc1-b456-1806a70988d2" xlink:to="loc_us-gaap_SegmentDomain_22da0502-c97f-4dc1-b456-1806a70988d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_22da0502-c97f-4dc1-b456-1806a70988d2" xlink:to="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_77a50fef-a02e-4e9b-81fd-5de89e4bcbf5" xlink:href="mo-20200930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:to="loc_mo_SmokeableProductsSegmentMember_77a50fef-a02e-4e9b-81fd-5de89e4bcbf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_63b823e2-3059-4298-8256-ba1a32f57e39" xlink:href="mo-20200930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:to="loc_mo_OralTobaccoSegmentMember_63b823e2-3059-4298-8256-ba1a32f57e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_1f33280e-89dc-428e-8c91-4c5102e6c4fb" xlink:href="mo-20200930.xsd#mo_WineSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:to="loc_mo_WineSegmentMember_1f33280e-89dc-428e-8c91-4c5102e6c4fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_4b59bd24-e66e-4bf8-9dc0-059f81bfac6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:to="loc_us-gaap_AllOtherSegmentsMember_4b59bd24-e66e-4bf8-9dc0-059f81bfac6b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails" xlink:type="extended" id="ic34d6fb12c9040d8bf6430c2df9446a3_SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_ba245171-c7dc-4322-9bba-643040a5612e" xlink:href="mo-20200930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_c5c6d37c-f2d3-48f5-b429-a7c2ee8dd4f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_ba245171-c7dc-4322-9bba-643040a5612e" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_c5c6d37c-f2d3-48f5-b429-a7c2ee8dd4f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:href="mo-20200930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_ba245171-c7dc-4322-9bba-643040a5612e" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f0aaf8c6-547d-4fe8-a51e-1ae2ca4a7666" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:to="loc_dei_LegalEntityAxis_f0aaf8c6-547d-4fe8-a51e-1ae2ca4a7666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f0aaf8c6-547d-4fe8-a51e-1ae2ca4a7666_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f0aaf8c6-547d-4fe8-a51e-1ae2ca4a7666" xlink:to="loc_dei_EntityDomain_f0aaf8c6-547d-4fe8-a51e-1ae2ca4a7666_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_942fc619-a5c4-4884-95ba-208ff59b2883" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f0aaf8c6-547d-4fe8-a51e-1ae2ca4a7666" xlink:to="loc_dei_EntityDomain_942fc619-a5c4-4884-95ba-208ff59b2883" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_6575950f-df5a-42d0-9be2-9db6fe0a78a5" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_942fc619-a5c4-4884-95ba-208ff59b2883" xlink:to="loc_mo_PhilipMorrisUSAMember_6575950f-df5a-42d0-9be2-9db6fe0a78a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cf7ed144-449e-46ab-b636-bf82dfebd3a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:to="loc_srt_LitigationCaseAxis_cf7ed144-449e-46ab-b636-bf82dfebd3a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_cf7ed144-449e-46ab-b636-bf82dfebd3a9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_cf7ed144-449e-46ab-b636-bf82dfebd3a9" xlink:to="loc_srt_LitigationCaseTypeDomain_cf7ed144-449e-46ab-b636-bf82dfebd3a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_355270b2-bef2-43c5-b857-2d3de0a6f91c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_cf7ed144-449e-46ab-b636-bf82dfebd3a9" xlink:to="loc_srt_LitigationCaseTypeDomain_355270b2-bef2-43c5-b857-2d3de0a6f91c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_56f2f191-a767-488c-84fd-e01c79c11f4f" xlink:href="mo-20200930.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_355270b2-bef2-43c5-b857-2d3de0a6f91c" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_56f2f191-a767-488c-84fd-e01c79c11f4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d5d34e8d-bf76-4d45-a2ce-edbba97ef2c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:to="loc_srt_ConsolidationItemsAxis_d5d34e8d-bf76-4d45-a2ce-edbba97ef2c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d5d34e8d-bf76-4d45-a2ce-edbba97ef2c2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_d5d34e8d-bf76-4d45-a2ce-edbba97ef2c2" xlink:to="loc_srt_ConsolidationItemsDomain_d5d34e8d-bf76-4d45-a2ce-edbba97ef2c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_10df5d28-07be-463d-92ae-31cb4c98f1c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_d5d34e8d-bf76-4d45-a2ce-edbba97ef2c2" xlink:to="loc_srt_ConsolidationItemsDomain_10df5d28-07be-463d-92ae-31cb4c98f1c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_012f5ad1-4b27-437b-8c7f-fc70230d18c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_10df5d28-07be-463d-92ae-31cb4c98f1c7" xlink:to="loc_us-gaap_OperatingSegmentsMember_012f5ad1-4b27-437b-8c7f-fc70230d18c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_045a2a79-46c3-4107-b2d1-a18ab757bee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_10df5d28-07be-463d-92ae-31cb4c98f1c7" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_045a2a79-46c3-4107-b2d1-a18ab757bee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07873462-82f8-4f22-b9d9-93ea17a77329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07873462-82f8-4f22-b9d9-93ea17a77329" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07873462-82f8-4f22-b9d9-93ea17a77329_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07873462-82f8-4f22-b9d9-93ea17a77329" xlink:to="loc_us-gaap_SegmentDomain_07873462-82f8-4f22-b9d9-93ea17a77329_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fa949a4b-f480-477f-b341-7c4568a23daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07873462-82f8-4f22-b9d9-93ea17a77329" xlink:to="loc_us-gaap_SegmentDomain_fa949a4b-f480-477f-b341-7c4568a23daf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_fcffedce-c5f7-47a5-a1ca-e6a303caa74d" xlink:href="mo-20200930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fa949a4b-f480-477f-b341-7c4568a23daf" xlink:to="loc_mo_SmokeableProductsSegmentMember_fcffedce-c5f7-47a5-a1ca-e6a303caa74d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingScheduleofCOVID19RelatedItemsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails" xlink:type="extended" id="i231acce635c147718e114bacfb26845a_SegmentReportingScheduleofCOVID19RelatedItemsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfPretaxCOVID19ChargesLineItems_885f7233-cd88-4f36-a48f-e306dc789e75" xlink:href="mo-20200930.xsd#mo_ScheduleOfPretaxCOVID19ChargesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2e2e81ed-52a5-48cd-87ab-7ef58c95a1b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesLineItems_885f7233-cd88-4f36-a48f-e306dc789e75" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2e2e81ed-52a5-48cd-87ab-7ef58c95a1b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfPretaxCOVID19ChargesTable_d8022f52-adaf-4878-8539-e75dfa27647b" xlink:href="mo-20200930.xsd#mo_ScheduleOfPretaxCOVID19ChargesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesLineItems_885f7233-cd88-4f36-a48f-e306dc789e75" xlink:to="loc_mo_ScheduleOfPretaxCOVID19ChargesTable_d8022f52-adaf-4878-8539-e75dfa27647b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_5a9c43e0-1cf6-4c6a-b277-b09ada7bcce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesTable_d8022f52-adaf-4878-8539-e75dfa27647b" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_5a9c43e0-1cf6-4c6a-b277-b09ada7bcce1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_5a9c43e0-1cf6-4c6a-b277-b09ada7bcce1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_5a9c43e0-1cf6-4c6a-b277-b09ada7bcce1" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_5a9c43e0-1cf6-4c6a-b277-b09ada7bcce1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_47b3bf2d-7e57-4702-b88e-f89d584dd3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_5a9c43e0-1cf6-4c6a-b277-b09ada7bcce1" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_47b3bf2d-7e57-4702-b88e-f89d584dd3f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_COVID19Member_8c8e4360-5a69-475b-9c3a-bab77bdf9ba9" xlink:href="mo-20200930.xsd#mo_COVID19Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_47b3bf2d-7e57-4702-b88e-f89d584dd3f5" xlink:to="loc_mo_COVID19Member_8c8e4360-5a69-475b-9c3a-bab77bdf9ba9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3a55a26c-2454-4e40-8817-3a643209b660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesTable_d8022f52-adaf-4878-8539-e75dfa27647b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3a55a26c-2454-4e40-8817-3a643209b660" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3a55a26c-2454-4e40-8817-3a643209b660_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3a55a26c-2454-4e40-8817-3a643209b660" xlink:to="loc_us-gaap_SegmentDomain_3a55a26c-2454-4e40-8817-3a643209b660_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f0ddfa1-b0ba-4fca-b3fb-72c0a7888a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3a55a26c-2454-4e40-8817-3a643209b660" xlink:to="loc_us-gaap_SegmentDomain_7f0ddfa1-b0ba-4fca-b3fb-72c0a7888a6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_6233d962-ea4a-441e-812a-a2678816d8e7" xlink:href="mo-20200930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f0ddfa1-b0ba-4fca-b3fb-72c0a7888a6e" xlink:to="loc_mo_SmokeableProductsSegmentMember_6233d962-ea4a-441e-812a-a2678816d8e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_c9c8bcf7-8ae4-47f0-93fe-98502dde3e03" xlink:href="mo-20200930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f0ddfa1-b0ba-4fca-b3fb-72c0a7888a6e" xlink:to="loc_mo_OralTobaccoSegmentMember_c9c8bcf7-8ae4-47f0-93fe-98502dde3e03" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/Debt" xlink:type="simple" xlink:href="mo-20200930.xsd#Debt"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/Debt" xlink:type="extended" id="i870c83581e3b40b1aa18b43d764eec90_Debt"/>
  <link:roleRef roleURI="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="extended" id="i69ba4c96d2ed462a9a3a79e812e5839d_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_084fc157-034b-46af-b548-9f7b68e6b2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_ShortTermBorrowings_084fc157-034b-46af-b548-9f7b68e6b2fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_9ac3ca58-d006-4ab5-8593-684a90e4e247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentTerm_9ac3ca58-d006-4ab5-8593-684a90e4e247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5bcdac0b-8626-41aa-833b-3e0877b4c03d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5bcdac0b-8626-41aa-833b-3e0877b4c03d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentNumberofExtensions_aed16d7e-9c1e-4e7e-b666-7881a1fc5f5b" xlink:href="mo-20200930.xsd#mo_DebtInstrumentNumberofExtensions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_mo_DebtInstrumentNumberofExtensions_aed16d7e-9c1e-4e7e-b666-7881a1fc5f5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentExtensionTerm_04c91804-612a-4933-a7d4-50b384233d5b" xlink:href="mo-20200930.xsd#mo_DebtInstrumentExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_mo_DebtInstrumentExtensionTerm_04c91804-612a-4933-a7d4-50b384233d5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cf6df82e-fa54-4686-9f3a-7786b29dfe68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cf6df82e-fa54-4686-9f3a-7786b29dfe68" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_d8dce062-d822-4149-a83c-a766648d0729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_d8dce062-d822-4149-a83c-a766648d0729" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_6541711a-33c5-4160-b173-4cc266e9dc4d" xlink:href="mo-20200930.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_6541711a-33c5-4160-b173-4cc266e9dc4d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_2f73efd3-3355-41b6-bfd8-4bea851908cd" xlink:href="mo-20200930.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_2f73efd3-3355-41b6-bfd8-4bea851908cd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e22def75-9526-4cb5-91e6-125bb3d385b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_LongTermDebt_e22def75-9526-4cb5-91e6-125bb3d385b5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_934511b6-5139-4144-8062-3afaa1f9e187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_934511b6-5139-4144-8062-3afaa1f9e187" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_a7b2ceef-3f1d-46aa-a623-b0a9ba4da710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_a7b2ceef-3f1d-46aa-a623-b0a9ba4da710" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8d6c55c4-8f86-45be-90ca-bc8967039667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8d6c55c4-8f86-45be-90ca-bc8967039667" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_471c4830-da12-4cb2-a766-c67f46704161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_471c4830-da12-4cb2-a766-c67f46704161" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c6992173-7690-4e76-9027-3dd883b34d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c6992173-7690-4e76-9027-3dd883b34d5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c6992173-7690-4e76-9027-3dd883b34d5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c6992173-7690-4e76-9027-3dd883b34d5e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_c6992173-7690-4e76-9027-3dd883b34d5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2432ba33-87aa-44ce-a2eb-df6ebb091306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c6992173-7690-4e76-9027-3dd883b34d5e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2432ba33-87aa-44ce-a2eb-df6ebb091306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_83a00ff3-daa4-4590-8197-20d3156d2d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2432ba33-87aa-44ce-a2eb-df6ebb091306" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_83a00ff3-daa4-4590-8197-20d3156d2d17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_342e3a16-1742-4d6e-9e1c-e1c1e5b93608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_VariableRateAxis_342e3a16-1742-4d6e-9e1c-e1c1e5b93608" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_342e3a16-1742-4d6e-9e1c-e1c1e5b93608_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_342e3a16-1742-4d6e-9e1c-e1c1e5b93608" xlink:to="loc_us-gaap_VariableRateDomain_342e3a16-1742-4d6e-9e1c-e1c1e5b93608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_739a6246-162b-4603-b706-7672f1a2fb7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_342e3a16-1742-4d6e-9e1c-e1c1e5b93608" xlink:to="loc_us-gaap_VariableRateDomain_739a6246-162b-4603-b706-7672f1a2fb7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d50c71cb-d830-4573-a045-15b57bbd0b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_739a6246-162b-4603-b706-7672f1a2fb7b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d50c71cb-d830-4573-a045-15b57bbd0b23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_76793346-ba38-4944-a1b0-9f13ad5924bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_CreditFacilityAxis_76793346-ba38-4944-a1b0-9f13ad5924bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_76793346-ba38-4944-a1b0-9f13ad5924bf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_76793346-ba38-4944-a1b0-9f13ad5924bf" xlink:to="loc_us-gaap_CreditFacilityDomain_76793346-ba38-4944-a1b0-9f13ad5924bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0caa897f-8180-43f7-be39-344125b2b243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_76793346-ba38-4944-a1b0-9f13ad5924bf" xlink:to="loc_us-gaap_CreditFacilityDomain_0caa897f-8180-43f7-be39-344125b2b243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_867ccbe8-a4c1-4d4f-a3b8-eb396cc8ed91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0caa897f-8180-43f7-be39-344125b2b243" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_867ccbe8-a4c1-4d4f-a3b8-eb396cc8ed91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4843bc21-d539-4720-988b-7176bfbf55a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4843bc21-d539-4720-988b-7176bfbf55a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4843bc21-d539-4720-988b-7176bfbf55a6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4843bc21-d539-4720-988b-7176bfbf55a6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4843bc21-d539-4720-988b-7176bfbf55a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_de19a4d0-2188-45a9-ad2b-26aeb5714b54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4843bc21-d539-4720-988b-7176bfbf55a6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_de19a4d0-2188-45a9-ad2b-26aeb5714b54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_4b7f7529-d1b6-4ffe-a0ed-c50471c513c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de19a4d0-2188-45a9-ad2b-26aeb5714b54" xlink:to="loc_us-gaap_LineOfCreditMember_4b7f7529-d1b6-4ffe-a0ed-c50471c513c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_de643ff4-059a-4b84-a772-8bf0cfd7140b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de19a4d0-2188-45a9-ad2b-26aeb5714b54" xlink:to="loc_us-gaap_SeniorNotesMember_de643ff4-059a-4b84-a772-8bf0cfd7140b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dcb62794-b09c-43a2-94fc-3d48a86d6a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_DebtInstrumentAxis_dcb62794-b09c-43a2-94fc-3d48a86d6a8a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dcb62794-b09c-43a2-94fc-3d48a86d6a8a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dcb62794-b09c-43a2-94fc-3d48a86d6a8a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dcb62794-b09c-43a2-94fc-3d48a86d6a8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dcb62794-b09c-43a2-94fc-3d48a86d6a8a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2023Member_7f8d4a63-cae8-4c7e-88db-7e276c32b863" xlink:href="mo-20200930.xsd#mo_RevolvingCreditFacilityDueAugust2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_RevolvingCreditFacilityDueAugust2023Member_7f8d4a63-cae8-4c7e-88db-7e276c32b863" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember_c8de4b57-8340-4660-b119-ce928bee50c7" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_USDDenominatedNotesMember_c8de4b57-8340-4660-b119-ce928bee50c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember_ed4d2108-3699-4a09-b300-819eceae1aa3" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember_ed4d2108-3699-4a09-b300-819eceae1aa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember_1bffd12f-d756-4577-b2dc-1b228ee2a76a" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesDueTwoThousandAndThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember_1bffd12f-d756-4577-b2dc-1b228ee2a76a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDueTwoThousandandFiftyMember_d1b0ccd9-5d56-4889-bc0b-e86fd887b82f" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesDueTwoThousandandFiftyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_USDDenominatedNotesDueTwoThousandandFiftyMember_d1b0ccd9-5d56-4889-bc0b-e86fd887b82f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mo-20200930.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/IncomeTaxes" xlink:type="extended" id="ie513ce894f4b4326a1d3b4de55ab7dcb_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="simple" xlink:href="mo-20200930.xsd#IncomeTaxesupdateTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="extended" id="iba832709acca4e3cb628ec9e6008267d_IncomeTaxesupdateTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="extended" id="i410d6ba5efb5412c85065c6a2cf70cca_IncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.altria.com/role/Contingencies" xlink:type="simple" xlink:href="mo-20200930.xsd#Contingencies"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/Contingencies" xlink:type="extended" id="i3da285d1314245739432c48267e2f03c_Contingencies"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesTables" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesTables" xlink:type="extended" id="if1fa0d5b801943c49e405105c8287933_ContingenciesTables"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesGeneralInformationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="extended" id="i1698d19845c24b2c9d3893087c629e87_ContingenciesGeneralInformationDetails"/>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesScheduleofPendingCasesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="extended" id="i0ba13c173fd24024b38e329fb3f52b14_ContingenciesScheduleofPendingCasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_2f986970-f556-477d-9bda-b2d0692a763b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_2f986970-f556-477d-9bda-b2d0692a763b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases_5a67b920-2ebb-495b-91ef-43e4549ab05a" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyNumberOfCases_5a67b920-2ebb-495b-91ef-43e4549ab05a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_decfe8f8-c6f6-43bd-8393-e7ec0c984f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_decfe8f8-c6f6-43bd-8393-e7ec0c984f4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_f6158d0e-2a7d-4ff5-98df-3b814851abeb" xlink:href="mo-20200930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyClassActionLawsuit_f6158d0e-2a7d-4ff5-98df-3b814851abeb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases_d9549811-d72c-47f4-aa73-a2e10d967da2" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyNumberOfInactiveCases_d9549811-d72c-47f4-aa73-a2e10d967da2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesTriedinASingleProceeding_d77888ac-9091-4573-b041-ef0d9c29e542" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfCasesTriedinASingleProceeding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyNumberOfCasesTriedinASingleProceeding_d77888ac-9091-4573-b041-ef0d9c29e542" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_af549c66-a52b-434a-9f5b-752f00af612c" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_af549c66-a52b-434a-9f5b-752f00af612c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_40409361-81df-4df4-bf1b-c6572747950b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_40409361-81df-4df4-bf1b-c6572747950b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_40409361-81df-4df4-bf1b-c6572747950b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_40409361-81df-4df4-bf1b-c6572747950b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_40409361-81df-4df4-bf1b-c6572747950b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b52e6b05-2383-4491-bd8d-70039183ee36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_40409361-81df-4df4-bf1b-c6572747950b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b52e6b05-2383-4491-bd8d-70039183ee36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c228790f-5f41-4e07-a71a-eb6912c42ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b52e6b05-2383-4491-bd8d-70039183ee36" xlink:to="loc_us-gaap_SubsequentEventMember_c228790f-5f41-4e07-a71a-eb6912c42ca2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7201e3fd-ac4d-44d8-ba57-43b6bb53108e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:to="loc_srt_LitigationCaseAxis_7201e3fd-ac4d-44d8-ba57-43b6bb53108e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7201e3fd-ac4d-44d8-ba57-43b6bb53108e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_7201e3fd-ac4d-44d8-ba57-43b6bb53108e" xlink:to="loc_srt_LitigationCaseTypeDomain_7201e3fd-ac4d-44d8-ba57-43b6bb53108e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_7201e3fd-ac4d-44d8-ba57-43b6bb53108e" xlink:to="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_d5aad542-0490-4fed-9571-ab1e328bd12b" xlink:href="mo-20200930.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_d5aad542-0490-4fed-9571-ab1e328bd12b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_9a380de1-60c7-40cc-82e0-a207b4a40bc3" xlink:href="mo-20200930.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember_d5aad542-0490-4fed-9571-ab1e328bd12b" xlink:to="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_9a380de1-60c7-40cc-82e0-a207b4a40bc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_ed282df3-d3f1-440a-a120-76b8ba2fd3fd" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_ed282df3-d3f1-440a-a120-76b8ba2fd3fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_6990ae99-ec94-48ba-b46b-f05314159c18" xlink:href="mo-20200930.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:to="loc_mo_EvaporLitigationMember_6990ae99-ec94-48ba-b46b-f05314159c18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember_8da1448c-1bea-453c-9a2c-5ed212854583" xlink:href="mo-20200930.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:to="loc_mo_OtherTabaccoRelatedCasesMember_8da1448c-1bea-453c-9a2c-5ed212854583" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d484599e-289c-4e61-9202-e84a98cd91d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:to="loc_us-gaap_LitigationStatusAxis_d484599e-289c-4e61-9202-e84a98cd91d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d484599e-289c-4e61-9202-e84a98cd91d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_d484599e-289c-4e61-9202-e84a98cd91d7" xlink:to="loc_us-gaap_LitigationStatusDomain_d484599e-289c-4e61-9202-e84a98cd91d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_d484599e-289c-4e61-9202-e84a98cd91d7" xlink:to="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_7c2e47e4-5d49-4c3c-9540-f598efd76a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:to="loc_us-gaap_PendingLitigationMember_7c2e47e4-5d49-4c3c-9540-f598efd76a16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_79eee961-fe20-4a4d-ba6d-972062de576f" xlink:href="mo-20200930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:to="loc_mo_PendingIndividualLawsuitsMember_79eee961-fe20-4a4d-ba6d-972062de576f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_091b92f2-2de8-4d6b-9f16-060030eaf09f" xlink:href="mo-20200930.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_091b92f2-2de8-4d6b-9f16-060030eaf09f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_d595f269-6ba9-4cd1-b062-f223f56b0a30" xlink:href="mo-20200930.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:to="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_d595f269-6ba9-4cd1-b062-f223f56b0a30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4e920801-b041-4487-8e50-33b43b0ac9e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:to="loc_srt_StatementGeographicalAxis_4e920801-b041-4487-8e50-33b43b0ac9e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4e920801-b041-4487-8e50-33b43b0ac9e6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_4e920801-b041-4487-8e50-33b43b0ac9e6" xlink:to="loc_srt_SegmentGeographicalDomain_4e920801-b041-4487-8e50-33b43b0ac9e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_4e920801-b041-4487-8e50-33b43b0ac9e6" xlink:to="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_b59e6df0-7e8b-4600-8568-8c19b6a131d2" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NM"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:to="loc_stpr_NM_b59e6df0-7e8b-4600-8568-8c19b6a131d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_94b94b61-c74c-459a-944e-24dc011c2f7b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:to="loc_stpr_MA_94b94b61-c74c-459a-944e-24dc011c2f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_34bfb70f-be66-44b8-8cc9-ced6ee80fb4d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:to="loc_stpr_FL_34bfb70f-be66-44b8-8cc9-ced6ee80fb4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_72261714-e909-4c12-95f7-43dc63aea7c2" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:to="loc_country_CA_72261714-e909-4c12-95f7-43dc63aea7c2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="extended" id="i8f8264739d174e89a64ea10caece287c_ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_94ccb52b-ff3f-42e5-aa4e-f88cbcbcdc19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_94ccb52b-ff3f-42e5-aa4e-f88cbcbcdc19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_c83290ba-b9c5-49ef-b6bf-97b81d8922f3" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_c83290ba-b9c5-49ef-b6bf-97b81d8922f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_18ec271a-cec5-4d25-97f3-ef0112f96466" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyClaimsDecided_18ec271a-cec5-4d25-97f3-ef0112f96466" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_7d8535c5-b1ca-4285-a397-6d73f2f1a9dd" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_7d8535c5-b1ca-4285-a397-6d73f2f1a9dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_71dba0de-3d2c-4232-bef8-84b6fa78886b" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_71dba0de-3d2c-4232-bef8-84b6fa78886b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber_69c4287e-6a69-4dad-b3d8-d6da5a378184" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyClaimsResolvedNumber_69c4287e-6a69-4dad-b3d8-d6da5a378184" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_c009ad33-d398-4725-85b6-7d272c529809" xlink:href="mo-20200930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_c009ad33-d398-4725-85b6-7d272c529809" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3c21b5a6-e3dd-4217-bab3-710ffe8c4e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3c21b5a6-e3dd-4217-bab3-710ffe8c4e68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3c21b5a6-e3dd-4217-bab3-710ffe8c4e68_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3c21b5a6-e3dd-4217-bab3-710ffe8c4e68" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3c21b5a6-e3dd-4217-bab3-710ffe8c4e68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ca8785eb-9b2a-4326-b1ea-cc8b13eea281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3c21b5a6-e3dd-4217-bab3-710ffe8c4e68" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ca8785eb-9b2a-4326-b1ea-cc8b13eea281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9468030b-55e1-4ec6-aff4-a87ec6c310e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ca8785eb-9b2a-4326-b1ea-cc8b13eea281" xlink:to="loc_us-gaap_SubsequentEventMember_9468030b-55e1-4ec6-aff4-a87ec6c310e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_88dcb54b-e536-4fec-93ea-cd35f11c60e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:to="loc_dei_LegalEntityAxis_88dcb54b-e536-4fec-93ea-cd35f11c60e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_88dcb54b-e536-4fec-93ea-cd35f11c60e4_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_88dcb54b-e536-4fec-93ea-cd35f11c60e4" xlink:to="loc_dei_EntityDomain_88dcb54b-e536-4fec-93ea-cd35f11c60e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f353836d-bd75-4b4e-a985-114573005430" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_88dcb54b-e536-4fec-93ea-cd35f11c60e4" xlink:to="loc_dei_EntityDomain_f353836d-bd75-4b4e-a985-114573005430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_b97f3026-5ba1-409a-999c-ca96e86112c5" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f353836d-bd75-4b4e-a985-114573005430" xlink:to="loc_mo_PhilipMorrisUSAMember_b97f3026-5ba1-409a-999c-ca96e86112c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_1e4a809f-3fb1-4eed-b17d-90672a589753" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f353836d-bd75-4b4e-a985-114573005430" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_1e4a809f-3fb1-4eed-b17d-90672a589753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_399a9125-b8a4-4424-8ae3-07d2f48e7744" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:to="loc_srt_LitigationCaseAxis_399a9125-b8a4-4424-8ae3-07d2f48e7744" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_399a9125-b8a4-4424-8ae3-07d2f48e7744_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_399a9125-b8a4-4424-8ae3-07d2f48e7744" xlink:to="loc_srt_LitigationCaseTypeDomain_399a9125-b8a4-4424-8ae3-07d2f48e7744_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_399a9125-b8a4-4424-8ae3-07d2f48e7744" xlink:to="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_fc8c67da-adb5-4bee-a1ed-7e29813fbb19" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_fc8c67da-adb5-4bee-a1ed-7e29813fbb19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_d3fb638e-b90e-446c-b71d-d0201b4f3b7e" xlink:href="mo-20200930.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_d3fb638e-b90e-446c-b71d-d0201b4f3b7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_9cce6622-00b5-4be2-bdbf-44d7e613dcb6" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_EngleProgenyCasesMember_9cce6622-00b5-4be2-bdbf-44d7e613dcb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_e6240c30-765a-49c8-8c1f-1192deb517a3" xlink:href="mo-20200930.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_e6240c30-765a-49c8-8c1f-1192deb517a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember_caaf9a62-bdf3-4182-a944-6454c6f6359e" xlink:href="mo-20200930.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_NonEngleProgenyCasesMember_caaf9a62-bdf3-4182-a944-6454c6f6359e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2bdc07b5-41a6-4393-a14b-8b3ffe6633c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:to="loc_srt_StatementGeographicalAxis_2bdc07b5-41a6-4393-a14b-8b3ffe6633c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2bdc07b5-41a6-4393-a14b-8b3ffe6633c7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2bdc07b5-41a6-4393-a14b-8b3ffe6633c7" xlink:to="loc_srt_SegmentGeographicalDomain_2bdc07b5-41a6-4393-a14b-8b3ffe6633c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2bdc07b5-41a6-4393-a14b-8b3ffe6633c7" xlink:to="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_c18e8fc7-3948-4ff9-9622-9f3e717dd318" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_country_CA_c18e8fc7-3948-4ff9-9622-9f3e717dd318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK_cfe83448-b38f-44fd-8102-92010fac59d2" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_AK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_AK_cfe83448-b38f-44fd-8102-92010fac59d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_a534739c-68bf-4688-bb07-7dfbb5974a8e" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_CA_a534739c-68bf-4688-bb07-7dfbb5974a8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_810c3122-a054-4c2a-b5a7-1dd5b497f14b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_CT_810c3122-a054-4c2a-b5a7-1dd5b497f14b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_5e733a6e-bac0-4fca-afa7-5d5e686b0a77" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_FL_5e733a6e-bac0-4fca-afa7-5d5e686b0a77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_e6f9bba3-584d-4ed2-88c8-01db60d7e18f" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_LA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_LA_e6f9bba3-584d-4ed2-88c8-01db60d7e18f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_91f23c42-1ec6-48c7-a28b-b852179f5e7b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_MA_91f23c42-1ec6-48c7-a28b-b852179f5e7b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS_b7b4f48d-a014-4367-9c66-0789ba171d98" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_MS_b7b4f48d-a014-4367-9c66-0789ba171d98" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO_f0dada42-66c6-43e1-8da7-638c1765f9c0" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_MO_f0dada42-66c6-43e1-8da7-638c1765f9c0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH_eca94b46-cb0a-478c-87e3-62f1c6994a9d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_NH_eca94b46-cb0a-478c-87e3-62f1c6994a9d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_3bb8cccd-182f-421c-b1f5-c72269aa45b2" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_NJ_3bb8cccd-182f-421c-b1f5-c72269aa45b2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_a84e43f8-2d1b-4957-804c-43e151347fc1" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_NY_a84e43f8-2d1b-4957-804c-43e151347fc1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_91e209d7-2108-4a1a-843f-29ec4775af50" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_OH_91e209d7-2108-4a1a-843f-29ec4775af50" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_007aaca6-73de-4698-8c69-e89dd2f824c7" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_PA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_PA_007aaca6-73de-4698-8c69-e89dd2f824c7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI_1ef68016-c9ab-4623-ab86-8fa43841aea1" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_RI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_RI_1ef68016-c9ab-4623-ab86-8fa43841aea1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_a8c018c7-b89f-46db-9054-ebf9bfe6fedd" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_TN_a8c018c7-b89f-46db-9054-ebf9bfe6fedd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_79ad522e-72e5-4cf6-9622-c6f64cacc867" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_WV"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_WV_79ad522e-72e5-4cf6-9622-c6f64cacc867" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="extended" id="ieeb6a9daf26f4684aa647554b2efeb85_ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_14ac5f68-e065-4ccc-ab55-92afd15a35a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_14ac5f68-e065-4ccc-ab55-92afd15a35a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_a7ba74e2-5c94-44a0-97b2-6070b0372a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_us-gaap_LitigationSettlementInterest_a7ba74e2-5c94-44a0-97b2-6070b0372a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_ae288739-8e35-474d-9747-9cbcabcf03b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_ae288739-8e35-474d-9747-9cbcabcf03b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_5b88bea3-f73b-42bd-b571-f9b673164b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_5b88bea3-f73b-42bd-b571-f9b673164b3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_1d30f388-4915-4389-a65c-704df16581a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_1d30f388-4915-4389-a65c-704df16581a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_da238a04-b9cd-424a-8ba8-0007da5147f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPreTrialResolutionCases_0e28f5c1-2a78-40e4-93e4-63f625980218" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfPreTrialResolutionCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_mo_LossContingencyNumberOfPreTrialResolutionCases_0e28f5c1-2a78-40e4-93e4-63f625980218" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit_3e9f2d1c-fa0e-4347-9537-36c09d7e6d48" xlink:href="mo-20200930.xsd#mo_LitigationEscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_mo_LitigationEscrowDeposit_3e9f2d1c-fa0e-4347-9537-36c09d7e6d48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_15e06959-5fbe-4f27-af42-74110ba50e25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_srt_LitigationCaseAxis_15e06959-5fbe-4f27-af42-74110ba50e25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_15e06959-5fbe-4f27-af42-74110ba50e25_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_15e06959-5fbe-4f27-af42-74110ba50e25" xlink:to="loc_srt_LitigationCaseTypeDomain_15e06959-5fbe-4f27-af42-74110ba50e25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_040518bd-faac-4889-8c2f-511f8abb11e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_15e06959-5fbe-4f27-af42-74110ba50e25" xlink:to="loc_srt_LitigationCaseTypeDomain_040518bd-faac-4889-8c2f-511f8abb11e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_997a5ed3-5619-4b8a-8a07-5cc4e07a5eb4" xlink:href="mo-20200930.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_040518bd-faac-4889-8c2f-511f8abb11e6" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_997a5ed3-5619-4b8a-8a07-5cc4e07a5eb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_26be2935-dcc7-4576-971b-07facb0ae6ff" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_040518bd-faac-4889-8c2f-511f8abb11e6" xlink:to="loc_mo_EngleProgenyCasesMember_26be2935-dcc7-4576-971b-07facb0ae6ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e054b27a-e3d7-4a7f-aaee-daf2ac535d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e054b27a-e3d7-4a7f-aaee-daf2ac535d26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e054b27a-e3d7-4a7f-aaee-daf2ac535d26_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e054b27a-e3d7-4a7f-aaee-daf2ac535d26" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e054b27a-e3d7-4a7f-aaee-daf2ac535d26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8236dde5-12d0-44dc-9064-fdc4c576d8ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e054b27a-e3d7-4a7f-aaee-daf2ac535d26" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8236dde5-12d0-44dc-9064-fdc4c576d8ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_48963f71-ccf2-4db4-8574-4f97e28b7ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8236dde5-12d0-44dc-9064-fdc4c576d8ca" xlink:to="loc_us-gaap_AssetsMember_48963f71-ccf2-4db4-8574-4f97e28b7ab8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_7092a120-3848-4d5b-a67d-3e3b8d559875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_us-gaap_LitigationStatusAxis_7092a120-3848-4d5b-a67d-3e3b8d559875" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7092a120-3848-4d5b-a67d-3e3b8d559875_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_7092a120-3848-4d5b-a67d-3e3b8d559875" xlink:to="loc_us-gaap_LitigationStatusDomain_7092a120-3848-4d5b-a67d-3e3b8d559875_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_df0fbb02-2104-4ddb-b1ec-c6865eb012cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_7092a120-3848-4d5b-a67d-3e3b8d559875" xlink:to="loc_us-gaap_LitigationStatusDomain_df0fbb02-2104-4ddb-b1ec-c6865eb012cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_f5dbe8f3-5a29-47ac-9f99-de8caf005c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_df0fbb02-2104-4ddb-b1ec-c6865eb012cd" xlink:to="loc_us-gaap_PendingLitigationMember_f5dbe8f3-5a29-47ac-9f99-de8caf005c95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0e5be90f-d7f5-4faf-841e-9edde3ecf8b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_dei_LegalEntityAxis_0e5be90f-d7f5-4faf-841e-9edde3ecf8b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0e5be90f-d7f5-4faf-841e-9edde3ecf8b5_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_0e5be90f-d7f5-4faf-841e-9edde3ecf8b5" xlink:to="loc_dei_EntityDomain_0e5be90f-d7f5-4faf-841e-9edde3ecf8b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_772ccd83-ed40-4b8f-bf69-d29be1fc7c63" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_0e5be90f-d7f5-4faf-841e-9edde3ecf8b5" xlink:to="loc_dei_EntityDomain_772ccd83-ed40-4b8f-bf69-d29be1fc7c63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_bbcc5e50-aab2-41d2-8991-32254e18a828" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_772ccd83-ed40-4b8f-bf69-d29be1fc7c63" xlink:to="loc_mo_PhilipMorrisUSAMember_bbcc5e50-aab2-41d2-8991-32254e18a828" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7013b3c6-4b35-4def-9a4e-7ef0bc3d5070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7013b3c6-4b35-4def-9a4e-7ef0bc3d5070" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_7013b3c6-4b35-4def-9a4e-7ef0bc3d5070_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7013b3c6-4b35-4def-9a4e-7ef0bc3d5070" xlink:to="loc_us-gaap_LossContingencyNatureDomain_7013b3c6-4b35-4def-9a4e-7ef0bc3d5070_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7013b3c6-4b35-4def-9a4e-7ef0bc3d5070" xlink:to="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PreTrialResolutionMember_9efb54b2-66aa-473f-a9b9-25b91222cbb4" xlink:href="mo-20200930.xsd#mo_PreTrialResolutionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:to="loc_mo_PreTrialResolutionMember_9efb54b2-66aa-473f-a9b9-25b91222cbb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_b9ea16fe-366b-496c-8e67-c8fe0c41e4d0" xlink:href="mo-20200930.xsd#mo_LitigationCasesResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:to="loc_mo_LitigationCasesResultsMember_b9ea16fe-366b-496c-8e67-c8fe0c41e4d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember_39b63967-fe28-465b-ba22-cc728d131b20" xlink:href="mo-20200930.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:to="loc_mo_InterestExpenseRelatedToLitigationMember_39b63967-fe28-465b-ba22-cc728d131b20" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesNonEngleProgenyLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="extended" id="ic82b669fbc1a40eb9305f78ee6004666_ContingenciesNonEngleProgenyLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_270d1e20-759e-43ed-88af-95f2cc2138f1" xlink:href="mo-20200930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_270d1e20-759e-43ed-88af-95f2cc2138f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_2b39e9b6-6255-4b47-8a32-a81366dcc5bf" xlink:href="mo-20200930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_2b39e9b6-6255-4b47-8a32-a81366dcc5bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_628a65d5-23f3-4b4b-a4d2-034f9c301413" xlink:href="mo-20200930.xsd#mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_628a65d5-23f3-4b4b-a4d2-034f9c301413" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_be480105-bed8-4845-8875-fdbdeae55cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:to="loc_us-gaap_LossContingenciesTable_be480105-bed8-4845-8875-fdbdeae55cea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_da41b7d4-dad4-489a-940b-540d15020661" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_be480105-bed8-4845-8875-fdbdeae55cea" xlink:to="loc_srt_LitigationCaseAxis_da41b7d4-dad4-489a-940b-540d15020661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_da41b7d4-dad4-489a-940b-540d15020661_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_da41b7d4-dad4-489a-940b-540d15020661" xlink:to="loc_srt_LitigationCaseTypeDomain_da41b7d4-dad4-489a-940b-540d15020661_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_da41b7d4-dad4-489a-940b-540d15020661" xlink:to="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_175e535a-a421-46a3-9e8f-0cb71dd46b2f" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_175e535a-a421-46a3-9e8f-0cb71dd46b2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_b2ac48f2-c0ea-4c26-a29a-83d5fbcf979e" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_b2ac48f2-c0ea-4c26-a29a-83d5fbcf979e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_40050cac-770c-4728-a4b5-c720712460fe" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingandHealthCaseLaramieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_40050cac-770c-4728-a4b5-c720712460fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember_73f6d1e1-8ed9-4682-825c-a94569c3e38d" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingandHealthCaseGentileMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember_73f6d1e1-8ed9-4682-825c-a94569c3e38d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d2df54b1-5f93-4191-8376-21ceecf5a04c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_be480105-bed8-4845-8875-fdbdeae55cea" xlink:to="loc_dei_LegalEntityAxis_d2df54b1-5f93-4191-8376-21ceecf5a04c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d2df54b1-5f93-4191-8376-21ceecf5a04c_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_d2df54b1-5f93-4191-8376-21ceecf5a04c" xlink:to="loc_dei_EntityDomain_d2df54b1-5f93-4191-8376-21ceecf5a04c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6a048340-3d1f-4dd5-bdb5-7ec9aa2381f4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_d2df54b1-5f93-4191-8376-21ceecf5a04c" xlink:to="loc_dei_EntityDomain_6a048340-3d1f-4dd5-bdb5-7ec9aa2381f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a773d0df-2131-4ace-b72d-3f51552f0f01" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_6a048340-3d1f-4dd5-bdb5-7ec9aa2381f4" xlink:to="loc_mo_PhilipMorrisUSAMember_a773d0df-2131-4ace-b72d-3f51552f0f01" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="extended" id="ie8d1f8e501ec4c03be07f06755e947aa_ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_b1b3d205-e36b-4816-9d49-434c44598739" xlink:href="mo-20200930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_b1b3d205-e36b-4816-9d49-434c44598739" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_afd16f3b-e95f-481b-988c-184f382c371a" xlink:href="mo-20200930.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_afd16f3b-e95f-481b-988c-184f382c371a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d4d1e020-ee8e-4589-aaa1-a2ac74679f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d4d1e020-ee8e-4589-aaa1-a2ac74679f18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_3ad0f044-b981-436f-9c24-66ad1281579c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_3ad0f044-b981-436f-9c24-66ad1281579c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_a854e2e1-f596-457f-b4d0-6e3b9791f0be" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyClaimsDecided_a854e2e1-f596-457f-b4d0-6e3b9791f0be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_7e96b7f0-def7-41b6-b317-33ea6a90b569" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_7e96b7f0-def7-41b6-b317-33ea6a90b569" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_1aabc981-4df4-4fef-a49f-8f9af752e443" xlink:href="mo-20200930.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_1aabc981-4df4-4fef-a49f-8f9af752e443" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_62430f8b-c1f9-4a62-a509-2b30688a6d10" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_62430f8b-c1f9-4a62-a509-2b30688a6d10" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_4471c262-55dd-4ff5-ae9d-a40fbc64e746" xlink:href="mo-20200930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_4471c262-55dd-4ff5-ae9d-a40fbc64e746" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts_6debc7fb-9075-45c8-b4b3-364ed57cfdae" xlink:href="mo-20200930.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyZeroDamagesVerdicts_6debc7fb-9075-45c8-b4b3-364ed57cfdae" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_f6bbf987-f779-4760-8a91-e430cf9a2207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_f6bbf987-f779-4760-8a91-e430cf9a2207" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified_b881065f-a136-4b6d-9d7d-0905c6a467a6" xlink:href="mo-20200930.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyZeroDamagesVerdictModified_b881065f-a136-4b6d-9d7d-0905c6a467a6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ea486f34-4033-4bc6-bad2-257928747e0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ea486f34-4033-4bc6-bad2-257928747e0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ea486f34-4033-4bc6-bad2-257928747e0d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ea486f34-4033-4bc6-bad2-257928747e0d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ea486f34-4033-4bc6-bad2-257928747e0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5f09fb07-bbca-4953-a39a-a639d91e12e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ea486f34-4033-4bc6-bad2-257928747e0d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5f09fb07-bbca-4953-a39a-a639d91e12e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ffe70b82-3a64-4167-abb4-722587767187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5f09fb07-bbca-4953-a39a-a639d91e12e2" xlink:to="loc_us-gaap_SubsequentEventMember_ffe70b82-3a64-4167-abb4-722587767187" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0405c15a-1081-4021-a27b-622331bfb3ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:to="loc_srt_LitigationCaseAxis_0405c15a-1081-4021-a27b-622331bfb3ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0405c15a-1081-4021-a27b-622331bfb3ea_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_0405c15a-1081-4021-a27b-622331bfb3ea" xlink:to="loc_srt_LitigationCaseTypeDomain_0405c15a-1081-4021-a27b-622331bfb3ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_0405c15a-1081-4021-a27b-622331bfb3ea" xlink:to="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_c2b4db31-a0ac-4a6d-a2aa-900c0d3d06dc" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesMember_c2b4db31-a0ac-4a6d-a2aa-900c0d3d06dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_1f7ffa64-f5f0-4322-ad24-e08eeac64239" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_EngleProgenyCasesMember_c2b4db31-a0ac-4a6d-a2aa-900c0d3d06dc" xlink:to="loc_mo_EngleProgenyCasesStateMember_1f7ffa64-f5f0-4322-ad24-e08eeac64239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFederalMember_c48d2952-8183-4bfb-b254-edb9f353b6ab" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesFederalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_EngleProgenyCasesMember_c2b4db31-a0ac-4a6d-a2aa-900c0d3d06dc" xlink:to="loc_mo_EngleProgenyCasesFederalMember_c48d2952-8183-4bfb-b254-edb9f353b6ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_ead144b5-d140-4b48-a03a-33c914717703" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_ead144b5-d140-4b48-a03a-33c914717703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember_851fbf95-d02c-4709-9d3b-da875b875f55" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesReiderandBanksMember_851fbf95-d02c-4709-9d3b-da875b875f55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember_8aa01131-aae5-4c95-9c09-9837b3f73461" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesWeingartandHancockMember_8aa01131-aae5-4c95-9c09-9837b3f73461" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember_a65aa050-6e1e-4acd-9a5d-519abd8d06c3" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesPollariMember_a65aa050-6e1e-4acd-9a5d-519abd8d06c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_621bbe4e-705a-45bd-a99a-e7b88a86d726" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_621bbe4e-705a-45bd-a99a-e7b88a86d726" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanMember_751178fd-9d64-414e-be37-a1a328f61f3e" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesFreemanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesFreemanMember_751178fd-9d64-414e-be37-a1a328f61f3e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_94dd2826-36dc-451a-9198-e78bc967d38f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:to="loc_dei_LegalEntityAxis_94dd2826-36dc-451a-9198-e78bc967d38f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_94dd2826-36dc-451a-9198-e78bc967d38f_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_94dd2826-36dc-451a-9198-e78bc967d38f" xlink:to="loc_dei_EntityDomain_94dd2826-36dc-451a-9198-e78bc967d38f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9df42339-800c-4100-bcc4-bb18debd343b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_94dd2826-36dc-451a-9198-e78bc967d38f" xlink:to="loc_dei_EntityDomain_9df42339-800c-4100-bcc4-bb18debd343b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_efaecbb3-8255-42c5-a07c-559b1617ef3e" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9df42339-800c-4100-bcc4-bb18debd343b" xlink:to="loc_mo_PhilipMorrisUSAMember_efaecbb3-8255-42c5-a07c-559b1617ef3e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="extended" id="i133ae8d4c2fb4b05880641991cfbec7e_ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_a4ab923e-7621-4f28-8c8b-d73a9d5035c2" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_a4ab923e-7621-4f28-8c8b-d73a9d5035c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_7dfdb270-22d0-4f4d-85dd-dcac82b15334" xlink:href="mo-20200930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_7dfdb270-22d0-4f4d-85dd-dcac82b15334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_d22d4fd1-0bff-4e79-972d-a65875a61113" xlink:href="mo-20200930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_d22d4fd1-0bff-4e79-972d-a65875a61113" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_27a9507a-b1d2-447d-b755-0e3e07894651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_27a9507a-b1d2-447d-b755-0e3e07894651" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_33254847-c37e-49a9-b325-bfa2a661d0ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_33254847-c37e-49a9-b325-bfa2a661d0ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PreTaxChargesGainIncludedinNetEarning_20797381-30f7-4af3-9a60-d6ae80a0e229" xlink:href="mo-20200930.xsd#mo_PreTaxChargesGainIncludedinNetEarning"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_mo_PreTaxChargesGainIncludedinNetEarning_20797381-30f7-4af3-9a60-d6ae80a0e229" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a38aafe7-6857-4f2a-b12c-337ecb9d512a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:to="loc_srt_LitigationCaseAxis_a38aafe7-6857-4f2a-b12c-337ecb9d512a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a38aafe7-6857-4f2a-b12c-337ecb9d512a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_a38aafe7-6857-4f2a-b12c-337ecb9d512a" xlink:to="loc_srt_LitigationCaseTypeDomain_a38aafe7-6857-4f2a-b12c-337ecb9d512a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_a38aafe7-6857-4f2a-b12c-337ecb9d512a" xlink:to="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesBergerMember_9d20e29c-eb8d-4695-8db1-4f1bf5c6b4e9" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesBergerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesBergerMember_9d20e29c-eb8d-4695-8db1-4f1bf5c6b4e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSantoroMember_56624f78-8008-4ee3-86ad-dfc021a1381b" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesSantoroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesSantoroMember_56624f78-8008-4ee3-86ad-dfc021a1381b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember_15606cad-e13b-41f5-9203-4179a66fab03" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesDuignanMember_15606cad-e13b-41f5-9203-4179a66fab03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember_6fc24e49-e55a-4d5f-b3e5-2a7abba3ddb1" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesCuddiheeMember_6fc24e49-e55a-4d5f-b3e5-2a7abba3ddb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesRintoulMember_3404ac0b-4424-4d8f-8095-598478121504" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesRintoulMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesRintoulMember_3404ac0b-4424-4d8f-8095-598478121504" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerMember_2c0850d8-3573-477d-9293-7b7121d6d11d" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesGlogerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesGlogerMember_2c0850d8-3573-477d-9293-7b7121d6d11d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember_9b59109e-fdc4-4eed-ba40-9904e3ef4995" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesMcCallMember_9b59109e-fdc4-4eed-ba40-9904e3ef4995" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNeffMember_4fb53488-2c7d-4c54-876f-37198b0339e4" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesNeffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesNeffMember_4fb53488-2c7d-4c54-876f-37198b0339e4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFrogelMember_09b51e14-8d2a-4460-ba12-4222645feeb1" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesFrogelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesFrogelMember_09b51e14-8d2a-4460-ba12-4222645feeb1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMahfuzMember_5f4e9bec-bfbf-45ec-849c-733209e6ebd1" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMahfuzMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesMahfuzMember_5f4e9bec-bfbf-45ec-849c-733209e6ebd1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember_5e71a55f-fa01-4320-a313-e2f405e57481" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesHollimanMember_5e71a55f-fa01-4320-a313-e2f405e57481" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember_3198dc76-a216-40f7-9919-8e791ffa6c7c" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesChadwellMember_3198dc76-a216-40f7-9919-8e791ffa6c7c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMember_a0114f4b-acd2-4768-b2cb-4cd13b138a4f" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesKaplanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesKaplanMember_a0114f4b-acd2-4768-b2cb-4cd13b138a4f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember_ab316085-164d-4b5c-9c81-ba21ef70d65d" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesR.DouglasMember_ab316085-164d-4b5c-9c81-ba21ef70d65d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSommersMember_2e1249ab-8720-4876-9800-17b775d84081" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesSommersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesSommersMember_2e1249ab-8720-4876-9800-17b775d84081" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember_87d6d05c-2209-4de4-8af1-d7f673c34cb1" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesCooperMember_87d6d05c-2209-4de4-8af1-d7f673c34cb1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember_b9fd48a6-fa69-438b-a66b-b345d3fdca36" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesD.BrownMember_b9fd48a6-fa69-438b-a66b-b345d3fdca36" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHarrisMember_467b4b77-2818-482b-bfd0-9c97355ce88e" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesHarrisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesHarrisMember_467b4b77-2818-482b-bfd0-9c97355ce88e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDeanKerrivanMember_74104e13-95ff-47cd-9c4b-9f2719679a7e" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesDeanKerrivanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesDeanKerrivanMember_74104e13-95ff-47cd-9c4b-9f2719679a7e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLandiMember_cb981fef-81d9-4cc5-b44d-1be9151b41da" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesLandiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesLandiMember_cb981fef-81d9-4cc5-b44d-1be9151b41da" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesTheisMember_c797239b-bde1-4eb4-86c3-39a0d2e68c2d" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesTheisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesTheisMember_c797239b-bde1-4eb4-86c3-39a0d2e68c2d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember_f27021cd-0f1c-4024-94b7-1f54684a8d6a" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember_f27021cd-0f1c-4024-94b7-1f54684a8d6a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleMember_d0147038-60ce-49ac-a3a4-7c84fd0aaba8" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesNaugleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesNaugleMember_d0147038-60ce-49ac-a3a4-7c84fd0aaba8" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGoreMember_f42faf90-599b-419a-9a69-936fce20a0bf" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesGoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesGoreMember_f42faf90-599b-419a-9a69-936fce20a0bf" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesM.BrownMember_ec5ca906-8aaa-414d-abf2-2618084aeb1b" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesM.BrownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesM.BrownMember_ec5ca906-8aaa-414d-abf2-2618084aeb1b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesJordanMember_a7eca840-dbe0-44e2-9e0a-b3b93d3aeea5" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesJordanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesJordanMember_a7eca840-dbe0-44e2-9e0a-b3b93d3aeea5" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_75afeab6-190e-487d-8135-ee8882fbc1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:to="loc_us-gaap_LitigationStatusAxis_75afeab6-190e-487d-8135-ee8882fbc1c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_75afeab6-190e-487d-8135-ee8882fbc1c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_75afeab6-190e-487d-8135-ee8882fbc1c1" xlink:to="loc_us-gaap_LitigationStatusDomain_75afeab6-190e-487d-8135-ee8882fbc1c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a8a9ed4c-8767-4ef1-aa8d-e6cea2b66c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_75afeab6-190e-487d-8135-ee8882fbc1c1" xlink:to="loc_us-gaap_LitigationStatusDomain_a8a9ed4c-8767-4ef1-aa8d-e6cea2b66c7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_670ad84d-7eff-42b6-9450-d1a5f4c0603e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_a8a9ed4c-8767-4ef1-aa8d-e6cea2b66c7f" xlink:to="loc_us-gaap_PendingLitigationMember_670ad84d-7eff-42b6-9450-d1a5f4c0603e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_dfe17dd2-eba9-4621-b4df-8df4e70f572d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_a8a9ed4c-8767-4ef1-aa8d-e6cea2b66c7f" xlink:to="loc_us-gaap_SettledLitigationMember_dfe17dd2-eba9-4621-b4df-8df4e70f572d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_97633d4a-70af-4580-a002-bb9c63013098" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:to="loc_dei_LegalEntityAxis_97633d4a-70af-4580-a002-bb9c63013098" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_97633d4a-70af-4580-a002-bb9c63013098_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_97633d4a-70af-4580-a002-bb9c63013098" xlink:to="loc_dei_EntityDomain_97633d4a-70af-4580-a002-bb9c63013098_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9a378eb7-72b4-4371-8749-65334c6474df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_97633d4a-70af-4580-a002-bb9c63013098" xlink:to="loc_dei_EntityDomain_9a378eb7-72b4-4371-8749-65334c6474df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_3d4fb5c6-8b0f-48ce-bca9-e4d93e0a20b3" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9a378eb7-72b4-4371-8749-65334c6474df" xlink:to="loc_mo_PhilipMorrisUSAMember_3d4fb5c6-8b0f-48ce-bca9-e4d93e0a20b3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesFloridaBondStatuteDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="extended" id="i4af1478172cc40ab9205490fb23ba9b3_ContingenciesFloridaBondStatuteDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_57058b5f-6110-47ed-96a6-a3697ce773ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants_d707f0bb-577e-4e81-a33a-4675d49af8d5" xlink:href="mo-20200930.xsd#mo_MaximumBondForAllDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_57058b5f-6110-47ed-96a6-a3697ce773ac" xlink:to="loc_mo_MaximumBondForAllDefendants_d707f0bb-577e-4e81-a33a-4675d49af8d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_04260f8f-2867-4938-9426-3ab467ed4272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_57058b5f-6110-47ed-96a6-a3697ce773ac" xlink:to="loc_us-gaap_LossContingenciesTable_04260f8f-2867-4938-9426-3ab467ed4272" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_671a51c7-754b-4373-bba5-726fc389d14e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_04260f8f-2867-4938-9426-3ab467ed4272" xlink:to="loc_srt_StatementGeographicalAxis_671a51c7-754b-4373-bba5-726fc389d14e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_671a51c7-754b-4373-bba5-726fc389d14e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_671a51c7-754b-4373-bba5-726fc389d14e" xlink:to="loc_srt_SegmentGeographicalDomain_671a51c7-754b-4373-bba5-726fc389d14e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bf1e932b-4ecc-419c-95e9-04e74f05fefe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_671a51c7-754b-4373-bba5-726fc389d14e" xlink:to="loc_srt_SegmentGeographicalDomain_bf1e932b-4ecc-419c-95e9-04e74f05fefe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_8bed1f8c-d528-4785-b97f-848f2944f187" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bf1e932b-4ecc-419c-95e9-04e74f05fefe" xlink:to="loc_stpr_FL_8bed1f8c-d528-4785-b97f-848f2944f187" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2dc15d60-f3bc-4ac9-ba21-53636b24b61f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_04260f8f-2867-4938-9426-3ab467ed4272" xlink:to="loc_srt_LitigationCaseAxis_2dc15d60-f3bc-4ac9-ba21-53636b24b61f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2dc15d60-f3bc-4ac9-ba21-53636b24b61f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_2dc15d60-f3bc-4ac9-ba21-53636b24b61f" xlink:to="loc_srt_LitigationCaseTypeDomain_2dc15d60-f3bc-4ac9-ba21-53636b24b61f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9023fa1b-a143-4d1e-863e-54f85a736598" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_2dc15d60-f3bc-4ac9-ba21-53636b24b61f" xlink:to="loc_srt_LitigationCaseTypeDomain_9023fa1b-a143-4d1e-863e-54f85a736598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_09073b22-3d1f-42a2-880b-ab63d3e6e831" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9023fa1b-a143-4d1e-863e-54f85a736598" xlink:to="loc_mo_EngleProgenyCasesStateMember_09073b22-3d1f-42a2-880b-ab63d3e6e831" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesOtherSmokingandHealthClassActionsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="extended" id="iffd2bfd25b464bacb99d67c1e5373572_ContingenciesOtherSmokingandHealthClassActionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber_08e3196f-2b4c-4671-b0ef-86057b00e178" xlink:href="mo-20200930.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_mo_LossContingencyClassNotCertifiedNumber_08e3196f-2b4c-4671-b0ef-86057b00e178" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d33e3b51-1dcb-4240-a70d-b0f444e711ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d33e3b51-1dcb-4240-a70d-b0f444e711ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_acc4d089-c86e-4404-a5ec-a6a426ccca04" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_mo_LossContingencyNumberofManufacturers_acc4d089-c86e-4404-a5ec-a6a426ccca04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld_36a38aa5-d55b-4cf4-8517-e9488849f923" xlink:href="mo-20200930.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_mo_LossContingencyVerdictsUpheld_36a38aa5-d55b-4cf4-8517-e9488849f923" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty_bb339309-6834-40d7-bbf9-affde7d55f5e" xlink:href="mo-20200930.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_mo_AmountAwardedtoOtherParty_bb339309-6834-40d7-bbf9-affde7d55f5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ea0cf159-b969-4025-841f-39e36d96cbe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ea0cf159-b969-4025-841f-39e36d96cbe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ea0cf159-b969-4025-841f-39e36d96cbe1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ea0cf159-b969-4025-841f-39e36d96cbe1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ea0cf159-b969-4025-841f-39e36d96cbe1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f7c2113c-1d14-468b-a3fc-1c71156b0724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ea0cf159-b969-4025-841f-39e36d96cbe1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f7c2113c-1d14-468b-a3fc-1c71156b0724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_15d84cf3-9036-4109-8c64-abf6c73b064b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f7c2113c-1d14-468b-a3fc-1c71156b0724" xlink:to="loc_us-gaap_SubsequentEventMember_15d84cf3-9036-4109-8c64-abf6c73b064b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9739fb0a-89f0-45d6-8ce5-42d594e34391" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:to="loc_srt_StatementGeographicalAxis_9739fb0a-89f0-45d6-8ce5-42d594e34391" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9739fb0a-89f0-45d6-8ce5-42d594e34391_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9739fb0a-89f0-45d6-8ce5-42d594e34391" xlink:to="loc_srt_SegmentGeographicalDomain_9739fb0a-89f0-45d6-8ce5-42d594e34391_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9739fb0a-89f0-45d6-8ce5-42d594e34391" xlink:to="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_9257309f-1b64-4472-97c4-c3d461912e44" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_AR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_AR_9257309f-1b64-4472-97c4-c3d461912e44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_bed36a8d-d37c-4df8-90f8-14fde4c2951b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_CA_bed36a8d-d37c-4df8-90f8-14fde4c2951b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE_29fcdcbb-164f-46b7-84f0-d2d7573e204c" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_DE_29fcdcbb-164f-46b7-84f0-d2d7573e204c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC_3984f23e-e1ba-4e61-a062-78359ebaf5c8" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_DC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_DC_3984f23e-e1ba-4e61-a062-78359ebaf5c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_08a27338-bfff-470a-9944-9166b215adca" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_FL_08a27338-bfff-470a-9944-9166b215adca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_9286b4ee-059b-499d-ba85-134bbd23ff3d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_IL_9286b4ee-059b-499d-ba85-134bbd23ff3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_32bfb1a1-1842-403c-bd86-208a5601fc3d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_IA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_IA_32bfb1a1-1842-403c-bd86-208a5601fc3d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_427dafa5-2675-4dfe-8d7f-f58b14cfb2a4" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_KS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_KS_427dafa5-2675-4dfe-8d7f-f58b14cfb2a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_04b257fc-01aa-4bcb-a0bd-d6143056c4c5" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_LA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_LA_04b257fc-01aa-4bcb-a0bd-d6143056c4c5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD_8515e1d5-c2a9-4f56-948e-2a22f42174c5" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_MD_8515e1d5-c2a9-4f56-948e-2a22f42174c5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_d5894bfa-21df-4ba8-b00c-693b23b93b1a" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_MI_d5894bfa-21df-4ba8-b00c-693b23b93b1a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_e03a8cee-f7d8-41d6-8c2d-5e9acc1d0ef9" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_MN_e03a8cee-f7d8-41d6-8c2d-5e9acc1d0ef9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV_032f5652-8726-48ea-9ea3-ece3d1ce1c11" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NV"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_NV_032f5652-8726-48ea-9ea3-ece3d1ce1c11" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_9a94e077-2214-4ab3-b8a5-8e46641a617b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_NJ_9a94e077-2214-4ab3-b8a5-8e46641a617b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_44aca307-c41a-4c52-9794-4efdeb2a823d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_NY_44aca307-c41a-4c52-9794-4efdeb2a823d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_29f046ad-bd02-4d04-9c29-95dc5d648e80" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_OH_29f046ad-bd02-4d04-9c29-95dc5d648e80" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_435d7a87-e7a2-4b40-a9b0-eae69923f72c" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_OK_435d7a87-e7a2-4b40-a9b0-eae69923f72c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR_8a18b183-8857-49ed-87da-656053569506" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_OR_8a18b183-8857-49ed-87da-656053569506" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_5edcfe7b-d3dd-43ac-ad20-c542ffdbdbfc" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_PA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_PA_5edcfe7b-d3dd-43ac-ad20-c542ffdbdbfc" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_2653a3f1-f040-41c4-9414-35f7657a768f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_PR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_country_PR_2653a3f1-f040-41c4-9414-35f7657a768f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC_a45d19b6-753a-48ce-a65c-796f18d72cf4" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_SC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_SC_a45d19b6-753a-48ce-a65c-796f18d72cf4" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_31b5761b-20d5-4b2a-b6ed-418bd0816906" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_TX_31b5761b-20d5-4b2a-b6ed-418bd0816906" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI_e9123136-b52f-4886-8be1-5f65ed343066" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_WI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_WI_e9123136-b52f-4886-8be1-5f65ed343066" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_3e1c4a0c-dfe9-4b2f-b602-92359ce110a1" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_country_CA_3e1c4a0c-dfe9-4b2f-b602-92359ce110a1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember_3ab04624-08db-47a5-9f8c-9140f9dc377f" xlink:href="mo-20200930.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_mo_BritishColumbiaSaskatchewanMember_3ab04624-08db-47a5-9f8c-9140f9dc377f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_149386ae-7e74-4d5d-bb94-d06f010fdc07" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:to="loc_dei_LegalEntityAxis_149386ae-7e74-4d5d-bb94-d06f010fdc07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_149386ae-7e74-4d5d-bb94-d06f010fdc07_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_149386ae-7e74-4d5d-bb94-d06f010fdc07" xlink:to="loc_dei_EntityDomain_149386ae-7e74-4d5d-bb94-d06f010fdc07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_149386ae-7e74-4d5d-bb94-d06f010fdc07" xlink:to="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_6a0ae144-e312-44a4-ba11-f46ec32eb5f5" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:to="loc_mo_PhilipMorrisUSAMember_6a0ae144-e312-44a4-ba11-f46ec32eb5f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_cf636ab7-286d-4b17-971a-3212527f890b" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_cf636ab7-286d-4b17-971a-3212527f890b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_67e247ec-0387-4785-bc64-2bc3508f133c" xlink:href="mo-20200930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_67e247ec-0387-4785-bc64-2bc3508f133c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e10ba02c-893f-477f-b3ef-7916c75b477b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:to="loc_srt_LitigationCaseAxis_e10ba02c-893f-477f-b3ef-7916c75b477b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e10ba02c-893f-477f-b3ef-7916c75b477b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_e10ba02c-893f-477f-b3ef-7916c75b477b" xlink:to="loc_srt_LitigationCaseTypeDomain_e10ba02c-893f-477f-b3ef-7916c75b477b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e7146400-a2d4-44ff-b6b2-60856159bba7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_e10ba02c-893f-477f-b3ef-7916c75b477b" xlink:to="loc_srt_LitigationCaseTypeDomain_e7146400-a2d4-44ff-b6b2-60856159bba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_53bd797f-b791-4150-8df3-5eafb93c74b4" xlink:href="mo-20200930.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e7146400-a2d4-44ff-b6b2-60856159bba7" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_53bd797f-b791-4150-8df3-5eafb93c74b4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesHealthCareCostRecoveryLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="extended" id="i652a74ebe70a44b69d6fa072038d7326_ContingenciesHealthCareCostRecoveryLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_1d613e7f-ab92-4862-8c1f-fb09424733bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_1d613e7f-ab92-4862-8c1f-fb09424733bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_8cfe3c8d-e41c-4b42-9da9-062b85f26dd4" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_mo_LossContingencyNumberofManufacturers_8cfe3c8d-e41c-4b42-9da9-062b85f26dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_5c4cbec9-41ad-4681-876b-a6fd240d679c" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_5c4cbec9-41ad-4681-876b-a6fd240d679c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount_02cad2f5-5e34-42c6-a01c-c923be607907" xlink:href="mo-20200930.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_mo_LitigationSettlementAnnualPaymentAmount_02cad2f5-5e34-42c6-a01c-c923be607907" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_f2f932a3-f64b-476d-897f-aaf3271df74c" xlink:href="mo-20200930.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_f2f932a3-f64b-476d-897f-aaf3271df74c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_16d829f3-a1a8-4722-91de-80371ea85594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_16d829f3-a1a8-4722-91de-80371ea85594" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_781f6299-4f21-4c69-81e1-d12b4ce4e563" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:to="loc_dei_LegalEntityAxis_781f6299-4f21-4c69-81e1-d12b4ce4e563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_781f6299-4f21-4c69-81e1-d12b4ce4e563_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_781f6299-4f21-4c69-81e1-d12b4ce4e563" xlink:to="loc_dei_EntityDomain_781f6299-4f21-4c69-81e1-d12b4ce4e563_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c7ca7c43-5d78-4811-8110-3de348d5b163" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_781f6299-4f21-4c69-81e1-d12b4ce4e563" xlink:to="loc_dei_EntityDomain_c7ca7c43-5d78-4811-8110-3de348d5b163" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_b3c8aa42-4bfc-4a7c-b6f8-1ad52557c52e" xlink:href="mo-20200930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c7ca7c43-5d78-4811-8110-3de348d5b163" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_b3c8aa42-4bfc-4a7c-b6f8-1ad52557c52e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c27fb628-f675-4432-a5de-609f7518610e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:to="loc_us-gaap_LitigationStatusAxis_c27fb628-f675-4432-a5de-609f7518610e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c27fb628-f675-4432-a5de-609f7518610e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_c27fb628-f675-4432-a5de-609f7518610e" xlink:to="loc_us-gaap_LitigationStatusDomain_c27fb628-f675-4432-a5de-609f7518610e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c94c9254-071f-45e2-97f5-7c2e887e031c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_c27fb628-f675-4432-a5de-609f7518610e" xlink:to="loc_us-gaap_LitigationStatusDomain_c94c9254-071f-45e2-97f5-7c2e887e031c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_898aeae4-1721-4308-8c2e-192c69a3bee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_c94c9254-071f-45e2-97f5-7c2e887e031c" xlink:to="loc_us-gaap_ThreatenedLitigationMember_898aeae4-1721-4308-8c2e-192c69a3bee5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8bb535b0-ecd0-4bb2-bf4a-a15520669961" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:to="loc_srt_StatementGeographicalAxis_8bb535b0-ecd0-4bb2-bf4a-a15520669961" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8bb535b0-ecd0-4bb2-bf4a-a15520669961_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8bb535b0-ecd0-4bb2-bf4a-a15520669961" xlink:to="loc_srt_SegmentGeographicalDomain_8bb535b0-ecd0-4bb2-bf4a-a15520669961_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1e07ec91-a5c6-4e2e-a392-283510c304bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8bb535b0-ecd0-4bb2-bf4a-a15520669961" xlink:to="loc_srt_SegmentGeographicalDomain_1e07ec91-a5c6-4e2e-a392-283510c304bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_646f9ed0-5d8b-4c5d-9984-0014e9b5ed21" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1e07ec91-a5c6-4e2e-a392-283510c304bd" xlink:to="loc_country_CA_646f9ed0-5d8b-4c5d-9984-0014e9b5ed21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cdca13df-e8c6-4d06-8ca3-f6f00a30a119" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:to="loc_srt_LitigationCaseAxis_cdca13df-e8c6-4d06-8ca3-f6f00a30a119" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_cdca13df-e8c6-4d06-8ca3-f6f00a30a119_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_cdca13df-e8c6-4d06-8ca3-f6f00a30a119" xlink:to="loc_srt_LitigationCaseTypeDomain_cdca13df-e8c6-4d06-8ca3-f6f00a30a119_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e645de20-594b-42e0-a109-12b4d63aa319" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_cdca13df-e8c6-4d06-8ca3-f6f00a30a119" xlink:to="loc_srt_LitigationCaseTypeDomain_e645de20-594b-42e0-a109-12b4d63aa319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_187e00e8-b76c-4fcd-b9a3-5f4050a29d7d" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e645de20-594b-42e0-a109-12b4d63aa319" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_187e00e8-b76c-4fcd-b9a3-5f4050a29d7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_8b7cc263-7823-4b5d-916f-5b6ea05b1ad7" xlink:href="mo-20200930.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e645de20-594b-42e0-a109-12b4d63aa319" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_8b7cc263-7823-4b5d-916f-5b6ea05b1ad7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails" xlink:type="extended" id="i854b0cddf45446cea9bff4ab56821b8a_ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_25ca5a3f-6568-4a9a-aff1-30e3b23c0e14" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_25ca5a3f-6568-4a9a-aff1-30e3b23c0e14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencySettlementAgreementsNumber_cec6bae8-f183-4d74-a97c-2d5c7a1d76bc" xlink:href="mo-20200930.xsd#mo_LossContingencySettlementAgreementsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencySettlementAgreementsNumber_cec6bae8-f183-4d74-a97c-2d5c7a1d76bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_68dde1b0-bec5-46c6-989f-61944548000e" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_68dde1b0-bec5-46c6-989f-61944548000e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyProceedsfromLegalSettlements_77c107c9-a12a-45a0-ac11-028464718357" xlink:href="mo-20200930.xsd#mo_LossContingencyProceedsfromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyProceedsfromLegalSettlements_77c107c9-a12a-45a0-ac11-028464718357" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofSettlementDevelopments_a83d073e-5e4e-4153-b982-453abe4bd9ef" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofSettlementDevelopments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofSettlementDevelopments_a83d073e-5e4e-4153-b982-453abe4bd9ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation_6086321d-30bc-463b-af67-c4d2c76632b6" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofAdditionalStateswithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation_6086321d-30bc-463b-af67-c4d2c76632b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_aa8f4b61-4c0e-4f3d-92d2-8b6dd1ec61dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_aa8f4b61-4c0e-4f3d-92d2-8b6dd1ec61dc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales_35e9dd4a-d801-4542-8e3a-863c346a0522" xlink:href="mo-20200930.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyReductionToCostOfSales_35e9dd4a-d801-4542-8e3a-863c346a0522" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_3e27a7b3-61c9-4ec7-a9f7-d872b8c389e7" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_3e27a7b3-61c9-4ec7-a9f7-d872b8c389e7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29ae44e2-d233-4952-b924-ff9dd8c7f4d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29ae44e2-d233-4952-b924-ff9dd8c7f4d3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencySettlementAgreementPaymentPeriod_51ac5302-71ed-4999-b255-177079f4fc3e" xlink:href="mo-20200930.xsd#mo_LossContingencySettlementAgreementPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencySettlementAgreementPaymentPeriod_51ac5302-71ed-4999-b255-177079f4fc3e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStates_219f3ab8-19d6-4571-b5ff-952ed20c58b7" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStates_219f3ab8-19d6-4571-b5ff-952ed20c58b7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesWithoutDefense_4390ed74-5975-40b0-8399-533a0237d94c" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStatesWithoutDefense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStatesWithoutDefense_4390ed74-5975-40b0-8399-533a0237d94c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesRemaining_69ec9b75-0706-49a2-9ac0-36c002c6bc87" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStatesRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStatesRemaining_69ec9b75-0706-49a2-9ac0-36c002c6bc87" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfDisputesOutstanding_a591380e-996d-4815-8ed5-4a196374a1b9" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfDisputesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberOfDisputesOutstanding_a591380e-996d-4815-8ed5-4a196374a1b9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain_70869828-2899-414b-8ed8-be53214b4716" xlink:href="mo-20200930.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LitigationSettlementEstimateofPossibleGain_70869828-2899-414b-8ed8-be53214b4716" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9a3c6f76-96d0-4353-b932-5e5f262acbc2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_srt_StatementGeographicalAxis_9a3c6f76-96d0-4353-b932-5e5f262acbc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9a3c6f76-96d0-4353-b932-5e5f262acbc2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9a3c6f76-96d0-4353-b932-5e5f262acbc2" xlink:to="loc_srt_SegmentGeographicalDomain_9a3c6f76-96d0-4353-b932-5e5f262acbc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_21b0f455-8b0a-4366-aa87-ba2bda7b54c6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9a3c6f76-96d0-4353-b932-5e5f262acbc2" xlink:to="loc_srt_SegmentGeographicalDomain_21b0f455-8b0a-4366-aa87-ba2bda7b54c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_875179e3-653f-4d64-8844-48ebe781fb0d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_21b0f455-8b0a-4366-aa87-ba2bda7b54c6" xlink:to="loc_stpr_NY_875179e3-653f-4d64-8844-48ebe781fb0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarylandMissouriNewMexicoandPennsylvaniaMember_84908601-21c8-4cd1-bd82-8fde03c0334f" xlink:href="mo-20200930.xsd#mo_MarylandMissouriNewMexicoandPennsylvaniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_21b0f455-8b0a-4366-aa87-ba2bda7b54c6" xlink:to="loc_mo_MarylandMissouriNewMexicoandPennsylvaniaMember_84908601-21c8-4cd1-bd82-8fde03c0334f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c8a35a25-17c1-45ad-b6ed-ec4f004ec86f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_dei_LegalEntityAxis_c8a35a25-17c1-45ad-b6ed-ec4f004ec86f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c8a35a25-17c1-45ad-b6ed-ec4f004ec86f_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c8a35a25-17c1-45ad-b6ed-ec4f004ec86f" xlink:to="loc_dei_EntityDomain_c8a35a25-17c1-45ad-b6ed-ec4f004ec86f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5f853c49-5500-4707-acce-f78b8f4323c1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c8a35a25-17c1-45ad-b6ed-ec4f004ec86f" xlink:to="loc_dei_EntityDomain_5f853c49-5500-4707-acce-f78b8f4323c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_f42585f8-bc18-48c0-b06b-462a550841fd" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5f853c49-5500-4707-acce-f78b8f4323c1" xlink:to="loc_mo_PhilipMorrisUSAMember_f42585f8-bc18-48c0-b06b-462a550841fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cc7e2488-d711-4b9b-b462-9e832d6eec0f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_srt_LitigationCaseAxis_cc7e2488-d711-4b9b-b462-9e832d6eec0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_cc7e2488-d711-4b9b-b462-9e832d6eec0f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_cc7e2488-d711-4b9b-b462-9e832d6eec0f" xlink:to="loc_srt_LitigationCaseTypeDomain_cc7e2488-d711-4b9b-b462-9e832d6eec0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_11273e4c-9eb8-47d5-96f9-dd6d6fcc2e99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_cc7e2488-d711-4b9b-b462-9e832d6eec0f" xlink:to="loc_srt_LitigationCaseTypeDomain_11273e4c-9eb8-47d5-96f9-dd6d6fcc2e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_11273e4c-9eb8-47d5-96f9-dd6d6fcc2e99" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember_19b7cb3d-131d-4dff-b3f1-74bbfa5c89b7" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember_19b7cb3d-131d-4dff-b3f1-74bbfa5c89b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20042017Member_9abb68db-1e87-4c31-8180-76a5aa32c53a" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions20042017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions20042017Member_9abb68db-1e87-4c31-8180-76a5aa32c53a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member_a1f14fb4-dc63-423b-8459-80b83d29c80e" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member_a1f14fb4-dc63-423b-8459-80b83d29c80e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember_2fc79949-a7d3-4495-8bbd-7e2c2468d5c5" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember_2fc79949-a7d3-4495-8bbd-7e2c2468d5c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_4a6b053b-e206-474b-9d3e-456143438b96" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_4a6b053b-e206-474b-9d3e-456143438b96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_95b2a165-7224-4c0a-b642-2967e6eedd91" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_95b2a165-7224-4c0a-b642-2967e6eedd91" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_94fb1a75-6c9d-4cc9-b8e0-8500fc243de6" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_94fb1a75-6c9d-4cc9-b8e0-8500fc243de6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_88589e6c-6f2e-4b5e-b651-eb212e08f833" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_88589e6c-6f2e-4b5e-b651-eb212e08f833" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_ebf7626d-f892-4a62-848e-4703cfb154ee" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_ebf7626d-f892-4a62-848e-4703cfb154ee" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_758e3c50-4348-4cf8-b86e-884c816c1720" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_758e3c50-4348-4cf8-b86e-884c816c1720" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_fc3f8f82-3e34-46b3-a505-d21bc820f35f" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_fc3f8f82-3e34-46b3-a505-d21bc820f35f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_9cfadda3-dbdc-4775-8cd6-731404142af7" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_9cfadda3-dbdc-4775-8cd6-731404142af7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_3db9f9e4-b180-425b-87d4-385c57621eea" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_3db9f9e4-b180-425b-87d4-385c57621eea" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_16c49283-2b06-471d-bc17-a23003f93664" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_16c49283-2b06-471d-bc17-a23003f93664" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_306b38c7-8f75-43d5-a984-3c9c030b2e03" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_306b38c7-8f75-43d5-a984-3c9c030b2e03" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_599590e5-f5b0-4ab6-9edf-b459e333dc3f" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_599590e5-f5b0-4ab6-9edf-b459e333dc3f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_13453ae1-eef0-43b6-8304-6c15dda2ccac" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_13453ae1-eef0-43b6-8304-6c15dda2ccac" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_d503a6f1-274e-44a5-bcbc-5ee116906e30" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_d503a6f1-274e-44a5-bcbc-5ee116906e30" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_7bf0eff2-2e50-46b6-910a-0e68caee14e7" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_7bf0eff2-2e50-46b6-910a-0e68caee14e7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_5b99539e-36f6-4c2d-b579-33e36a7914a0" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_5b99539e-36f6-4c2d-b579-33e36a7914a0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember_04ec7f47-e422-4822-9a39-9cb9509074ad" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_11273e4c-9eb8-47d5-96f9-dd6d6fcc2e99" xlink:to="loc_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember_04ec7f47-e422-4822-9a39-9cb9509074ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9d1a7872-e504-412d-a520-800b9b3cf2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_us-gaap_LitigationStatusAxis_9d1a7872-e504-412d-a520-800b9b3cf2a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9d1a7872-e504-412d-a520-800b9b3cf2a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_9d1a7872-e504-412d-a520-800b9b3cf2a3" xlink:to="loc_us-gaap_LitigationStatusDomain_9d1a7872-e504-412d-a520-800b9b3cf2a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1e769194-19fe-432c-864d-c21a12d5bcdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_9d1a7872-e504-412d-a520-800b9b3cf2a3" xlink:to="loc_us-gaap_LitigationStatusDomain_1e769194-19fe-432c-864d-c21a12d5bcdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_57531319-927d-4797-a4b8-5882c1e58a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_1e769194-19fe-432c-864d-c21a12d5bcdc" xlink:to="loc_us-gaap_SettledLitigationMember_57531319-927d-4797-a4b8-5882c1e58a8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_3a39d948-f501-4c7e-845a-12e8fdf97981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_1e769194-19fe-432c-864d-c21a12d5bcdc" xlink:to="loc_us-gaap_PendingLitigationMember_3a39d948-f501-4c7e-845a-12e8fdf97981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b6d65649-74bb-4449-9bfd-793360d583e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b6d65649-74bb-4449-9bfd-793360d583e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b6d65649-74bb-4449-9bfd-793360d583e4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b6d65649-74bb-4449-9bfd-793360d583e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b6d65649-74bb-4449-9bfd-793360d583e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8a3b93e4-83a5-4e86-880a-e4a4e4b71e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b6d65649-74bb-4449-9bfd-793360d583e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8a3b93e4-83a5-4e86-880a-e4a4e4b71e06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e45e90ee-c16d-4f23-a36a-3be42e9c66c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8a3b93e4-83a5-4e86-880a-e4a4e4b71e06" xlink:to="loc_us-gaap_CostOfSalesMember_e45e90ee-c16d-4f23-a36a-3be42e9c66c4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="extended" id="ic7cb91e39ee94bfa8d0510977b2b79e2_ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_70c716ab-664d-4b33-b684-be0f739d70af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_831597de-eeed-4534-bd69-1fae49fb90ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70c716ab-664d-4b33-b684-be0f739d70af" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_831597de-eeed-4534-bd69-1fae49fb90ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f165a7ad-035b-4d74-86a5-c8037af3f720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_70c716ab-664d-4b33-b684-be0f739d70af" xlink:to="loc_us-gaap_LossContingenciesTable_f165a7ad-035b-4d74-86a5-c8037af3f720" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e5fba95a-5efc-480f-9023-05ba892cd20f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f165a7ad-035b-4d74-86a5-c8037af3f720" xlink:to="loc_dei_LegalEntityAxis_e5fba95a-5efc-480f-9023-05ba892cd20f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e5fba95a-5efc-480f-9023-05ba892cd20f_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e5fba95a-5efc-480f-9023-05ba892cd20f" xlink:to="loc_dei_EntityDomain_e5fba95a-5efc-480f-9023-05ba892cd20f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_dd28eaae-af21-42e2-97a1-3c9d4003e729" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e5fba95a-5efc-480f-9023-05ba892cd20f" xlink:to="loc_dei_EntityDomain_dd28eaae-af21-42e2-97a1-3c9d4003e729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_ecdb2a9e-366b-4da2-8aaa-4f09108c493c" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_dd28eaae-af21-42e2-97a1-3c9d4003e729" xlink:to="loc_mo_PhilipMorrisUSAMember_ecdb2a9e-366b-4da2-8aaa-4f09108c493c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8d5a00e6-5297-4ac4-981f-6d1d4747fa91" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f165a7ad-035b-4d74-86a5-c8037af3f720" xlink:to="loc_srt_LitigationCaseAxis_8d5a00e6-5297-4ac4-981f-6d1d4747fa91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8d5a00e6-5297-4ac4-981f-6d1d4747fa91_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8d5a00e6-5297-4ac4-981f-6d1d4747fa91" xlink:to="loc_srt_LitigationCaseTypeDomain_8d5a00e6-5297-4ac4-981f-6d1d4747fa91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6a0ee179-02a9-48b9-91a6-a50d2f60df1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8d5a00e6-5297-4ac4-981f-6d1d4747fa91" xlink:to="loc_srt_LitigationCaseTypeDomain_6a0ee179-02a9-48b9-91a6-a50d2f60df1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_abda2d5d-333b-4e51-b48b-2745b3ed1600" xlink:href="mo-20200930.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_6a0ee179-02a9-48b9-91a6-a50d2f60df1d" xlink:to="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_abda2d5d-333b-4e51-b48b-2745b3ed1600" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesFederalGovernmentsLawsuitDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="extended" id="id3f82e875a4d43d08cfa21f595ce4104_ContingenciesFederalGovernmentsLawsuitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2651ac23-a7bc-4f08-8d42-78d4cfc25ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod_3b1b827d-f695-42af-8f3b-a2e62bdaa547" xlink:href="mo-20200930.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2651ac23-a7bc-4f08-8d42-78d4cfc25ea5" xlink:to="loc_mo_FederalTradeCommissionDisclosurePeriod_3b1b827d-f695-42af-8f3b-a2e62bdaa547" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_d22032a7-9870-4de2-94f3-c73a8f03b6af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2651ac23-a7bc-4f08-8d42-78d4cfc25ea5" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_d22032a7-9870-4de2-94f3-c73a8f03b6af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_2651ac23-a7bc-4f08-8d42-78d4cfc25ea5" xlink:to="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9a1b2f4c-b17a-44cb-b93b-d2cbb1bc96a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9a1b2f4c-b17a-44cb-b93b-d2cbb1bc96a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9a1b2f4c-b17a-44cb-b93b-d2cbb1bc96a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9a1b2f4c-b17a-44cb-b93b-d2cbb1bc96a3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9a1b2f4c-b17a-44cb-b93b-d2cbb1bc96a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9e838207-f937-4e38-a951-82f22990fc38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9a1b2f4c-b17a-44cb-b93b-d2cbb1bc96a3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9e838207-f937-4e38-a951-82f22990fc38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember_79722aba-1c57-4806-a48c-d4fabbf92444" xlink:href="mo-20200930.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9e838207-f937-4e38-a951-82f22990fc38" xlink:to="loc_mo_ImplementationofCorrectiveCommunicationsMember_79722aba-1c57-4806-a48c-d4fabbf92444" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2e115b9e-b962-475f-a6dc-0ca923f6e282" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:to="loc_srt_LitigationCaseAxis_2e115b9e-b962-475f-a6dc-0ca923f6e282" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2e115b9e-b962-475f-a6dc-0ca923f6e282_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_2e115b9e-b962-475f-a6dc-0ca923f6e282" xlink:to="loc_srt_LitigationCaseTypeDomain_2e115b9e-b962-475f-a6dc-0ca923f6e282_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8088779b-5e86-422a-89fd-9780e1558065" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_2e115b9e-b962-475f-a6dc-0ca923f6e282" xlink:to="loc_srt_LitigationCaseTypeDomain_8088779b-5e86-422a-89fd-9780e1558065" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember_dc80118f-85eb-4ff9-9076-6f040111cefa" xlink:href="mo-20200930.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_8088779b-5e86-422a-89fd-9780e1558065" xlink:to="loc_mo_FederalGovernmentsLawsuitMember_dc80118f-85eb-4ff9-9076-6f040111cefa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2e2cec8b-ecb8-4995-9533-2f8b7985de59" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:to="loc_dei_LegalEntityAxis_2e2cec8b-ecb8-4995-9533-2f8b7985de59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2e2cec8b-ecb8-4995-9533-2f8b7985de59_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2e2cec8b-ecb8-4995-9533-2f8b7985de59" xlink:to="loc_dei_EntityDomain_2e2cec8b-ecb8-4995-9533-2f8b7985de59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5111ac39-0eb3-4e10-8a76-5149982dfc05" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2e2cec8b-ecb8-4995-9533-2f8b7985de59" xlink:to="loc_dei_EntityDomain_5111ac39-0eb3-4e10-8a76-5149982dfc05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_38dd296c-2672-4a57-88ec-91bca1c8d3a2" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5111ac39-0eb3-4e10-8a76-5149982dfc05" xlink:to="loc_mo_PhilipMorrisUSAMember_38dd296c-2672-4a57-88ec-91bca1c8d3a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_10960776-8b73-454c-9199-c2c9fbbac289" xlink:href="mo-20200930.xsd#mo_AltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5111ac39-0eb3-4e10-8a76-5149982dfc05" xlink:to="loc_mo_AltriaGroupMember_10960776-8b73-454c-9199-c2c9fbbac289" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesEvaporProductLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails" xlink:type="extended" id="ie596a2c75b3040e3a908de7d4eccebbe_ContingenciesEvaporProductLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1b3eb614-783e-4f80-a0dd-d2562a38759c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_11db8c62-c2f9-472c-ac67-1dc75639f70e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1b3eb614-783e-4f80-a0dd-d2562a38759c" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_11db8c62-c2f9-472c-ac67-1dc75639f70e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_1877dac2-e7b5-4319-a65b-3278d385cccd" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1b3eb614-783e-4f80-a0dd-d2562a38759c" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_1877dac2-e7b5-4319-a65b-3278d385cccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_1b3eb614-783e-4f80-a0dd-d2562a38759c" xlink:to="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_1ceb5f26-d05f-4429-bd4a-e09b71159f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:to="loc_us-gaap_LitigationStatusAxis_1ceb5f26-d05f-4429-bd4a-e09b71159f37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1ceb5f26-d05f-4429-bd4a-e09b71159f37_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_1ceb5f26-d05f-4429-bd4a-e09b71159f37" xlink:to="loc_us-gaap_LitigationStatusDomain_1ceb5f26-d05f-4429-bd4a-e09b71159f37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_1ceb5f26-d05f-4429-bd4a-e09b71159f37" xlink:to="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_afc3c06b-1571-406c-917d-aa734e9b6f95" xlink:href="mo-20200930.xsd#mo_ClassActionLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:to="loc_mo_ClassActionLawsuitMember_afc3c06b-1571-406c-917d-aa734e9b6f95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_8e0f5498-bc41-47d4-bbb7-0b5d44cc5907" xlink:href="mo-20200930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:to="loc_mo_PendingIndividualLawsuitsMember_8e0f5498-bc41-47d4-bbb7-0b5d44cc5907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_9874e287-163b-4842-b5f8-6b65ef7805e0" xlink:href="mo-20200930.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_9874e287-163b-4842-b5f8-6b65ef7805e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_dbd21346-6c58-42cf-9d4c-af33936cab0f" xlink:href="mo-20200930.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:to="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_dbd21346-6c58-42cf-9d4c-af33936cab0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_eb607f70-4a99-4654-a961-d17fd3fa27f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_eb607f70-4a99-4654-a961-d17fd3fa27f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_eb607f70-4a99-4654-a961-d17fd3fa27f6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_eb607f70-4a99-4654-a961-d17fd3fa27f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_eb607f70-4a99-4654-a961-d17fd3fa27f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f081bec6-59f1-466e-bac6-07c66a1020bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_eb607f70-4a99-4654-a961-d17fd3fa27f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f081bec6-59f1-466e-bac6-07c66a1020bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_49493a8d-02c5-47cb-b737-61cd26286d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f081bec6-59f1-466e-bac6-07c66a1020bd" xlink:to="loc_us-gaap_SubsequentEventMember_49493a8d-02c5-47cb-b737-61cd26286d2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a6b54cc0-d8fc-4242-90fc-8c5cda51d750" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:to="loc_srt_LitigationCaseAxis_a6b54cc0-d8fc-4242-90fc-8c5cda51d750" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a6b54cc0-d8fc-4242-90fc-8c5cda51d750_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_a6b54cc0-d8fc-4242-90fc-8c5cda51d750" xlink:to="loc_srt_LitigationCaseTypeDomain_a6b54cc0-d8fc-4242-90fc-8c5cda51d750_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c73efb1d-9dda-4a68-a327-5ac62e7e491e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_a6b54cc0-d8fc-4242-90fc-8c5cda51d750" xlink:to="loc_srt_LitigationCaseTypeDomain_c73efb1d-9dda-4a68-a327-5ac62e7e491e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_0ded9af9-96c6-4980-9517-14fe708b2737" xlink:href="mo-20200930.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c73efb1d-9dda-4a68-a327-5ac62e7e491e" xlink:to="loc_mo_EvaporLitigationMember_0ded9af9-96c6-4980-9517-14fe708b2737" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesLightsUltraLightsCasesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="extended" id="i0bc316cf211e4284be743ce7df6a692d_ContingenciesLightsUltraLightsCasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber_bfcdf439-3894-470c-9066-253ad594a39d" xlink:href="mo-20200930.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:to="loc_mo_LossContingencyStateCourtsNumber_bfcdf439-3894-470c-9066-253ad594a39d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber_04b51b26-4264-4099-ab60-f845bc7fd244" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:to="loc_mo_LossContingencyClaimsNotCertifiedNumber_04b51b26-4264-4099-ab60-f845bc7fd244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_bf0e91d8-8e30-41d9-a376-3650b2835c8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_bf0e91d8-8e30-41d9-a376-3650b2835c8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:to="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_649d6fd9-208e-4d53-958a-46d29c3ad035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_649d6fd9-208e-4d53-958a-46d29c3ad035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_649d6fd9-208e-4d53-958a-46d29c3ad035_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_649d6fd9-208e-4d53-958a-46d29c3ad035" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_649d6fd9-208e-4d53-958a-46d29c3ad035_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_db9f97e2-946f-45c8-8114-ddf0e827a549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_649d6fd9-208e-4d53-958a-46d29c3ad035" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_db9f97e2-946f-45c8-8114-ddf0e827a549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c296d0f2-8913-4abe-b8c4-8326b062a13a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_db9f97e2-946f-45c8-8114-ddf0e827a549" xlink:to="loc_us-gaap_SubsequentEventMember_c296d0f2-8913-4abe-b8c4-8326b062a13a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ed38f675-bd9d-4682-927a-dd812663952f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:to="loc_srt_LitigationCaseAxis_ed38f675-bd9d-4682-927a-dd812663952f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ed38f675-bd9d-4682-927a-dd812663952f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_ed38f675-bd9d-4682-927a-dd812663952f" xlink:to="loc_srt_LitigationCaseTypeDomain_ed38f675-bd9d-4682-927a-dd812663952f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b2e4a58b-0b6d-4091-bdbf-4dd557ae32f5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_ed38f675-bd9d-4682-927a-dd812663952f" xlink:to="loc_srt_LitigationCaseTypeDomain_b2e4a58b-0b6d-4091-bdbf-4dd557ae32f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember_805373e5-cd0e-4d7f-b310-b1dfb1d17767" xlink:href="mo-20200930.xsd#mo_LightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b2e4a58b-0b6d-4091-bdbf-4dd557ae32f5" xlink:to="loc_mo_LightsMember_805373e5-cd0e-4d7f-b310-b1dfb1d17767" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsUltraLightsClassActionsMember_aa065741-c22b-4187-901b-f07ea20d3ccc" xlink:href="mo-20200930.xsd#mo_LightsUltraLightsClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b2e4a58b-0b6d-4091-bdbf-4dd557ae32f5" xlink:to="loc_mo_LightsUltraLightsClassActionsMember_aa065741-c22b-4187-901b-f07ea20d3ccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a5cdb52a-497b-4bc6-b70e-7bfeda8775b7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:to="loc_dei_LegalEntityAxis_a5cdb52a-497b-4bc6-b70e-7bfeda8775b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a5cdb52a-497b-4bc6-b70e-7bfeda8775b7_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a5cdb52a-497b-4bc6-b70e-7bfeda8775b7" xlink:to="loc_dei_EntityDomain_a5cdb52a-497b-4bc6-b70e-7bfeda8775b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8009c09b-8d5c-4059-927c-5d727802e177" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a5cdb52a-497b-4bc6-b70e-7bfeda8775b7" xlink:to="loc_dei_EntityDomain_8009c09b-8d5c-4059-927c-5d727802e177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_fa07d957-c5d4-4822-909a-832408e43c3d" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8009c09b-8d5c-4059-927c-5d727802e177" xlink:to="loc_mo_PhilipMorrisUSAMember_fa07d957-c5d4-4822-909a-832408e43c3d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesUSTLitigationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="extended" id="i2f8485e598604304b1948adfd6b23df4_ContingenciesUSTLitigationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_06043d07-3675-4311-901e-49622e790359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_77a78e85-c02d-4766-bf27-fe197f295f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06043d07-3675-4311-901e-49622e790359" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_77a78e85-c02d-4766-bf27-fe197f295f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_06043d07-3675-4311-901e-49622e790359" xlink:to="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_71269ed3-77b9-4912-ab63-afc3fcc07684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:to="loc_us-gaap_LitigationStatusAxis_71269ed3-77b9-4912-ab63-afc3fcc07684" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_71269ed3-77b9-4912-ab63-afc3fcc07684_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_71269ed3-77b9-4912-ab63-afc3fcc07684" xlink:to="loc_us-gaap_LitigationStatusDomain_71269ed3-77b9-4912-ab63-afc3fcc07684_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_98bfd4a3-6cca-4bfb-925f-29bcd3d5d119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_71269ed3-77b9-4912-ab63-afc3fcc07684" xlink:to="loc_us-gaap_LitigationStatusDomain_98bfd4a3-6cca-4bfb-925f-29bcd3d5d119" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_58030352-4103-41d4-bab1-218d9b5385c4" xlink:href="mo-20200930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_98bfd4a3-6cca-4bfb-925f-29bcd3d5d119" xlink:to="loc_mo_PendingIndividualLawsuitsMember_58030352-4103-41d4-bab1-218d9b5385c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_86d784db-e8ee-4afa-9384-f018f4e232cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_86d784db-e8ee-4afa-9384-f018f4e232cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_86d784db-e8ee-4afa-9384-f018f4e232cd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_86d784db-e8ee-4afa-9384-f018f4e232cd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_86d784db-e8ee-4afa-9384-f018f4e232cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7fc56eac-645a-43f4-8f86-0a8171ae8722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_86d784db-e8ee-4afa-9384-f018f4e232cd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7fc56eac-645a-43f4-8f86-0a8171ae8722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_11fe91cc-5bc9-461d-815f-9062bb063b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7fc56eac-645a-43f4-8f86-0a8171ae8722" xlink:to="loc_us-gaap_SubsequentEventMember_11fe91cc-5bc9-461d-815f-9062bb063b6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_718f387e-e274-4649-b12e-732b56c3f9a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:to="loc_srt_LitigationCaseAxis_718f387e-e274-4649-b12e-732b56c3f9a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_718f387e-e274-4649-b12e-732b56c3f9a2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_718f387e-e274-4649-b12e-732b56c3f9a2" xlink:to="loc_srt_LitigationCaseTypeDomain_718f387e-e274-4649-b12e-732b56c3f9a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_5ad01a9b-78a7-4fbf-9606-b316c3dedd0a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_718f387e-e274-4649-b12e-732b56c3f9a2" xlink:to="loc_srt_LitigationCaseTypeDomain_5ad01a9b-78a7-4fbf-9606-b316c3dedd0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_ece3688a-2d11-44c8-abb5-c4a4a235da55" xlink:href="mo-20200930.xsd#mo_USTLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_5ad01a9b-78a7-4fbf-9606-b316c3dedd0a" xlink:to="loc_mo_USTLitigationMember_ece3688a-2d11-44c8-abb5-c4a4a235da55" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="extended" id="i329445e225f647d8ab3c50500862d5a0_ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_27cea787-51e6-4fba-81fd-955fc95ee2d3" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_27cea787-51e6-4fba-81fd-955fc95ee2d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_adc4044b-2d17-49b0-8841-627d8f1488e8" xlink:href="mo-20200930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:to="loc_mo_LossContingencyClassActionLawsuit_adc4044b-2d17-49b0-8841-627d8f1488e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_ec4a7030-5406-4c18-ba86-e13e63ab6a2b" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_ec4a7030-5406-4c18-ba86-e13e63ab6a2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1e7bf31e-3b4f-48cd-8de7-003b1e7af033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:to="loc_us-gaap_LossContingenciesTable_1e7bf31e-3b4f-48cd-8de7-003b1e7af033" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b12ee297-41a7-4e19-8370-2d7d7d56e940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1e7bf31e-3b4f-48cd-8de7-003b1e7af033" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b12ee297-41a7-4e19-8370-2d7d7d56e940" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b12ee297-41a7-4e19-8370-2d7d7d56e940_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b12ee297-41a7-4e19-8370-2d7d7d56e940" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b12ee297-41a7-4e19-8370-2d7d7d56e940_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d850b12c-819c-4a49-b67c-9a72595d8ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b12ee297-41a7-4e19-8370-2d7d7d56e940" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d850b12c-819c-4a49-b67c-9a72595d8ea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_702f8557-f738-4789-a558-dc2abe8ba838" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d850b12c-819c-4a49-b67c-9a72595d8ea6" xlink:to="loc_us-gaap_SubsequentEventMember_702f8557-f738-4789-a558-dc2abe8ba838" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2200dc0e-9cd5-4e03-b8c7-372d24ad63db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1e7bf31e-3b4f-48cd-8de7-003b1e7af033" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2200dc0e-9cd5-4e03-b8c7-372d24ad63db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2200dc0e-9cd5-4e03-b8c7-372d24ad63db_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2200dc0e-9cd5-4e03-b8c7-372d24ad63db" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2200dc0e-9cd5-4e03-b8c7-372d24ad63db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0750d720-acc2-4256-94f5-86cddcfbf8ae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2200dc0e-9cd5-4e03-b8c7-372d24ad63db" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0750d720-acc2-4256-94f5-86cddcfbf8ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_6205a2c1-ff53-46b6-996b-a7f39a9b927d" xlink:href="mo-20200930.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_0750d720-acc2-4256-94f5-86cddcfbf8ae" xlink:to="loc_mo_JUULMember_6205a2c1-ff53-46b6-996b-a7f39a9b927d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="extended" id="ifd86792150b84c5b815cf9fe8e309d9f_ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eedb7180-ae88-4729-8f36-339a53bf0481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eedb7180-ae88-4729-8f36-339a53bf0481" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_42ddeabd-85ad-4bcc-8e00-1aa552cf2bc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_42ddeabd-85ad-4bcc-8e00-1aa552cf2bc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_af9a9c7d-c29a-4014-99da-a0c1301896e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_af9a9c7d-c29a-4014-99da-a0c1301896e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:to="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_152b36ff-ac4b-40ee-8ef2-8ed827cff5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_152b36ff-ac4b-40ee-8ef2-8ed827cff5e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_152b36ff-ac4b-40ee-8ef2-8ed827cff5e3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_152b36ff-ac4b-40ee-8ef2-8ed827cff5e3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_152b36ff-ac4b-40ee-8ef2-8ed827cff5e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b8002bf7-623b-4f13-815e-8ee87001c9af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_152b36ff-ac4b-40ee-8ef2-8ed827cff5e3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b8002bf7-623b-4f13-815e-8ee87001c9af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5800e980-0ba8-4c6f-a135-2dc6b7404088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b8002bf7-623b-4f13-815e-8ee87001c9af" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5800e980-0ba8-4c6f-a135-2dc6b7404088" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5895e6c4-3efd-4971-862e-d85d2247c4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:to="loc_us-gaap_DebtInstrumentAxis_5895e6c4-3efd-4971-862e-d85d2247c4f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5895e6c4-3efd-4971-862e-d85d2247c4f4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5895e6c4-3efd-4971-862e-d85d2247c4f4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5895e6c4-3efd-4971-862e-d85d2247c4f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eb172aee-c574-4e90-918c-51273813a7fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5895e6c4-3efd-4971-862e-d85d2247c4f4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eb172aee-c574-4e90-918c-51273813a7fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember_3718d367-e2f6-467d-8b5e-66eba8066d01" xlink:href="mo-20200930.xsd#mo_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eb172aee-c574-4e90-918c-51273813a7fb" xlink:to="loc_mo_CreditAgreementMember_3718d367-e2f6-467d-8b5e-66eba8066d01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0c4bd7f4-301e-46b1-bcad-13597f7ff766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:to="loc_us-gaap_CreditFacilityAxis_0c4bd7f4-301e-46b1-bcad-13597f7ff766" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0c4bd7f4-301e-46b1-bcad-13597f7ff766_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0c4bd7f4-301e-46b1-bcad-13597f7ff766" xlink:to="loc_us-gaap_CreditFacilityDomain_0c4bd7f4-301e-46b1-bcad-13597f7ff766_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_891463b4-d648-483d-8fb3-d9afc68a0d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0c4bd7f4-301e-46b1-bcad-13597f7ff766" xlink:to="loc_us-gaap_CreditFacilityDomain_891463b4-d648-483d-8fb3-d9afc68a0d2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_88ecc12a-5ca9-4a9d-8f8c-6daac0c7aa73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_891463b4-d648-483d-8fb3-d9afc68a0d2f" xlink:to="loc_us-gaap_LetterOfCreditMember_88ecc12a-5ca9-4a9d-8f8c-6daac0c7aa73" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="simple" xlink:href="mo-20200930.xsd#NewAccountingGuidanceNotYetAdopted"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="extended" id="i1eb8735cb65b40b7bb59ba07281eed78_NewAccountingGuidanceNotYetAdopted"/>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="simple" xlink:href="mo-20200930.xsd#NewAccountingGuidanceNotYetAdoptedTables"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="extended" id="i81b359e129c94fe6ad2b9052f38f60ef_NewAccountingGuidanceNotYetAdoptedTables"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>mo-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e67beae8-252b-44fc-aaf0-eb6cb882e4c7,g:3f7a85d8-ce11-4daa-b845-1d29043d3872-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_mo_InvestmentsLineItems_d66feb5f-4a5e-46f0-8e0f-2c6db15038d4_terseLabel_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_mo_InvestmentsLineItems_label_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_mo_InvestmentsLineItems_documentation_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems" xlink:href="mo-20200930.xsd#mo_InvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsLineItems" xlink:to="lab_mo_InvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_95a15988-7242-45ff-9af7-760ade689896_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, consolidated EBITDA to interest expense ratio</link:label>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_label_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</link:label>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_documentation_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:href="mo-20200930.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:to="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2902c872-d081-41ec-94e7-11083e2db1c2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_7967d5c0-640b-4a3c-a025-a1b8c91aa599_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_SC_4ff53f79-0f06-4e84-8626-b86be6668769_terseLabel_en-US" xlink:label="lab_stpr_SC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Carolina [Member]</link:label>
    <link:label id="lab_stpr_SC_label_en-US" xlink:label="lab_stpr_SC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOUTH CAROLINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_SC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_SC" xlink:to="lab_stpr_SC" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_July2019ShareRepurchaseProgramMember_99e9a00d-54d5-451c-85a1-64a5749c1e76_terseLabel_en-US" xlink:label="lab_mo_July2019ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_July2019ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_mo_July2019ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_July2019ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_mo_July2019ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_July2019ShareRepurchaseProgramMember" xlink:href="mo-20200930.xsd#mo_July2019ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_July2019ShareRepurchaseProgramMember" xlink:to="lab_mo_July2019ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_5bb24339-8970-4bbf-89d5-6fb531c5186f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Repurchased Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_c8738917-3380-4646-bd5a-36e43f7eb0ea_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments received from litigation settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_f89ee216-5ced-43da-b930-ca5799b43373_negatedTerseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between carrying amount and fair value, percentage (approximately)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_8d394e2e-6ef0-4db0-9596-e10e8147f6f4_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, difference between carrying amount and fair value, percentage (approximately)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:to="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_ead32918-06cd-4b90-8017-ab78fe8eedee_terseLabel_en-US" xlink:label="lab_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus amounts included in net periodic benefit income, excluding service cost, Asset Impairment and Exit Costs</link:label>
    <link:label id="lab_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_label_en-US" xlink:label="lab_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Income (Reversal of Income), Excluding Service Cost Component, Asset Impairment And Business Exit Costs</link:label>
    <link:label id="lab_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_documentation_en-US" xlink:label="lab_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Income (Reversal of Income), Excluding Service Cost Component, Asset Impairment And Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts" xlink:to="lab_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_4d7610b9-bf90-4f8f-9181-91b415e6eea9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_721fa6ec-4eaf-4fad-9e53-e7c0a56c4a26_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_0969f249-260e-4fc3-922e-eb8c720aa752_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_47ae77e4-a8d5-4408-9209-4cffcb600e7c_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ordinary shares owned (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_37a168ee-74ef-44eb-b7d5-4b2cd91e8b74_verboseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ordinary shares owned (approximately) (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Common</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Common</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_febfbe31-1042-4953-baa6-eed92cbae7fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTax_a7666ad3-6d10-4f12-9209-33055185b93a_terseLabel_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI</link:label>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTax_label_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Equity Method Investment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:to="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_c741242c-7001-4824-a090-8e797e60cdb7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_65b2f95a-f859-4d07-b4e0-50ac61f94132_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_c2d6877f-0aa9-4e91-ba6d-1a1c2e357ad0_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_052fcb5b-cf62-45c2-bbe7-8d3726b9bbd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_890b1707-bea8-454a-a64e-05da6510a680_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum</link:label>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_label_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</link:label>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_documentation_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:href="mo-20200930.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:to="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_e166257a-8fca-4f88-bbc1-c5653d2714a8_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember" xlink:to="lab_mo_HealthCareCostRecoveryActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_9b939415-41d7-4d81-b89b-88ee7e3e0c7c_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d79045d4-72cb-4a88-96d9-f9df025ffdfe_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_0b3a533a-fb6d-479b-9d0e-f79d8f282004_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStates_618d2fe2-a1cb-424c-821b-c6d9f6995d5f_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStates_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStates_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStates" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStates" xlink:to="lab_mo_LossContingencyNumberofStates" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_RI_2fed73d5-a739-429c-9efe-53a9af3ab97e_terseLabel_en-US" xlink:label="lab_stpr_RI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhode Island [Member]</link:label>
    <link:label id="lab_stpr_RI_label_en-US" xlink:label="lab_stpr_RI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RHODE ISLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_RI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_RI" xlink:to="lab_stpr_RI" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_29314e9c-54fe-436b-8a32-1e169028d9e1_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_31e6873b-3608-4899-aaee-0ca70ad8cebb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_67f36cbc-3216-4d1f-acb2-7e04df8f3a32_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1e65d6bc-de93-41e6-8cf0-8639044cf37d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_56674400-17a6-42ef-b19f-6aa688efe063_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_047c8a2e-c0e1-4c26-b1d6-0cad10ea14b0_terseLabel_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI [Member]</link:label>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_label_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Equity Method Investments Attributable To Parent [Member]</link:label>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_documentation_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Equity Method Investments Attributable To Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:href="mo-20200930.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:to="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_43ee2173-c59d-48ec-8ed7-9e9e8d37e6ed_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of favorable verdicts</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Favorable, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Favorable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:to="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f3fe4fbb-e5b4-4c83-b318-c3c7f46f08d1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_c1f1b567-a8d8-47c7-ab39-8c9c0832b4c1_terseLabel_en-US" xlink:label="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus amounts included in net period benefit income, excluding service cost, Implementation Costs</link:label>
    <link:label id="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_label_en-US" xlink:label="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Implementation Costs</link:label>
    <link:label id="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_documentation_en-US" xlink:label="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Implementation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" xlink:to="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5a81484f-029b-4574-87c2-dcc689ef42c4_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_1c7177f8-e1f7-4500-8817-e0aa620cded8_terseLabel_en-US" xlink:label="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity securities</link:label>
    <link:label id="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities Without Readily Determinable Fair Value</link:label>
    <link:label id="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_documentation_en-US" xlink:label="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities Without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:href="mo-20200930.xsd#mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:to="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_cece00de-feaf-4856-84b0-8e135ea480d5_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to valuation allowance charged to income tax expense</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase In Amount</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase In Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:href="mo-20200930.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_016f56d3-326b-46c9-a2d2-5e2990b99a1b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt issued</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6b7f3742-e4da-4702-82db-d343e78e7fb3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c4a6f4da-3662-498f-90aa-16b611e235f7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_e6c4d700-f428-4001-a97a-34bf9613c3f9_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of inactive class action lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Class Action Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:to="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1b868d06-36f1-47c8-9546-bca59f423086_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleOfPretaxCOVID19ChargesTable_b4bd641c-f8a1-46bf-a0fe-6a2d949e1dfa_terseLabel_en-US" xlink:label="lab_mo_ScheduleOfPretaxCOVID19ChargesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Pre-tax COVID-19 Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleOfPretaxCOVID19ChargesTable_label_en-US" xlink:label="lab_mo_ScheduleOfPretaxCOVID19ChargesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Pre-tax COVID-19 Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleOfPretaxCOVID19ChargesTable_documentation_en-US" xlink:label="lab_mo_ScheduleOfPretaxCOVID19ChargesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Pre-tax COVID-19 Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfPretaxCOVID19ChargesTable" xlink:href="mo-20200930.xsd#mo_ScheduleOfPretaxCOVID19ChargesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesTable" xlink:to="lab_mo_ScheduleOfPretaxCOVID19ChargesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_405446b9-237d-43c6-9ed8-876d3cb27cfc_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_b8a50805-50cc-49f8-af0d-817f583b8556_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_52ebfc79-30d2-4d78-8c99-af77cb260cd0_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible gain</link:label>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_label_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Estimate of Possible Gain</link:label>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_documentation_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Estimate of Possible Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain" xlink:href="mo-20200930.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementEstimateofPossibleGain" xlink:to="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4f13c3eb-39c2-4dab-9d87-31d6cdfdc677_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_1f1179df-b3da-4e2e-8468-06d21a35e0be_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_db0212a8-770a-44fa-b9e4-6f00b6836fc0_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of noncontrolling interest in Helix</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_79197565-b2ef-45d3-98a0-55933a9f1c86_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_8c393b00-ced0-4654-8c6d-cfa1a66cc3b0_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_054b031d-33ad-4363-832f-3f4822dc088b_verboseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5f1ebe5e-2e5c-451f-aed8-094070cdf335_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesSommersMember_ccc457ae-10e9-4340-9a87-4696d17cbe67_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesSommersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Sommers [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSommersMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesSommersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Sommers [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSommersMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesSommersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Sommers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSommersMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesSommersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesSommersMember" xlink:to="lab_mo_EngleProgenyCasesSommersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6d6fce73-1b24-4434-8f72-d596b2f4710e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_9c916d2d-630f-4e52-a23e-e64bbb38fc26_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_ff003559-0724-4f59-b837-d7053397f0ac_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Earnings/Losses</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AltriaGroupMember_67ce020b-07bd-4471-b792-efd84d889720_terseLabel_en-US" xlink:label="lab_mo_AltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group [Member]</link:label>
    <link:label id="lab_mo_AltriaGroupMember_label_en-US" xlink:label="lab_mo_AltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group [Member]</link:label>
    <link:label id="lab_mo_AltriaGroupMember_documentation_en-US" xlink:label="lab_mo_AltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember" xlink:href="mo-20200930.xsd#mo_AltriaGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AltriaGroupMember" xlink:to="lab_mo_AltriaGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_43d11d5a-649e-4f95-afb3-390a97d2ea94_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings reinvested in the business</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_7f333472-8b17-48fd-a620-6d44bbde8293_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, percentage of shares eligible for purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Percentage of Shares Eligible For Purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Percentage of Shares Eligible For Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:to="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_21826ca8-0f00-4205-b844-daca430b4aa2_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesChadwellMember" xlink:to="lab_mo_EngleProgenyCasesChadwellMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStatesWithoutDefense_a50fce5a-aa7d-48bd-bf5b-d9c0ad4f1829_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesWithoutDefense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states without defense</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesWithoutDefense_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesWithoutDefense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States Without Defense</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesWithoutDefense_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesWithoutDefense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States Without Defense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesWithoutDefense" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStatesWithoutDefense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStatesWithoutDefense" xlink:to="lab_mo_LossContingencyNumberofStatesWithoutDefense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_c4d0e9af-e804-4e07-924b-5ec135232ffe_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_216cd413-ad9f-4cba-9de0-e1ca36814601_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of shares repurchased (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_af8071b4-d77c-41d0-8d52-9b7c65bd8c7c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_PA_2bdd9642-9cf7-47f9-9b64-7f8be0c7973a_terseLabel_en-US" xlink:label="lab_stpr_PA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pennsylvania [Member]</link:label>
    <link:label id="lab_stpr_PA_label_en-US" xlink:label="lab_stpr_PA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PENNSYLVANIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_PA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_PA" xlink:to="lab_stpr_PA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_44bd3f33-1f1d-4ca9-ac4d-1da0b4737b45_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NumberofDirectorsNominated_651c415d-9476-40d4-a93f-d3d321a0a94d_terseLabel_en-US" xlink:label="lab_mo_NumberofDirectorsNominated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of directors nominated</link:label>
    <link:label id="lab_mo_NumberofDirectorsNominated_label_en-US" xlink:label="lab_mo_NumberofDirectorsNominated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Directors Nominated</link:label>
    <link:label id="lab_mo_NumberofDirectorsNominated_documentation_en-US" xlink:label="lab_mo_NumberofDirectorsNominated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Directors Nominated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberofDirectorsNominated" xlink:href="mo-20200930.xsd#mo_NumberofDirectorsNominated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NumberofDirectorsNominated" xlink:to="lab_mo_NumberofDirectorsNominated" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_da73af8c-559a-420f-9a13-8cf4bb7fdccf_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesHollimanMember" xlink:to="lab_mo_EngleProgenyCasesHollimanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d79ea520-cd0a-4b82-bda1-f003be3a448c_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_431c4df8-a313-456d-90ac-65486dbcca94_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada [Member]</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_a4090297-8f33-4fd4-855b-d2e80ac5e5e6_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liability related to performance surety bonds</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OR_2bd843d5-3fb7-4c75-9a46-76586a432222_terseLabel_en-US" xlink:label="lab_stpr_OR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oregon [Member]</link:label>
    <link:label id="lab_stpr_OR_label_en-US" xlink:label="lab_stpr_OR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OREGON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OR" xlink:to="lab_stpr_OR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_16b06230-1755-4cba-af12-1af7e56ce8ec_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_cab84b3d-44cd-4ab9-8b8e-5c96955e4e2c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_0f3b84a5-67f0-4915-88fa-3b20f1996513_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases set for trial</link:label>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_label_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Set for Trial</link:label>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Set for Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofCasesSetforTrial" xlink:to="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e30595c6-a913-4a95-823b-b0d8e943c0a5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_9b41d212-e59d-42a0-ab18-85a80ae47836_terseLabel_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of state courts</link:label>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_label_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, State Courts, Number</link:label>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, State Courts, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber" xlink:href="mo-20200930.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyStateCourtsNumber" xlink:to="lab_mo_LossContingencyStateCourtsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_4cb222aa-86ab-4435-a6b1-ec58e5fd816a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationCasesResultsMember_9819cc3d-eecd-4799-acbe-773f81d1f0a4_terseLabel_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Cases Results [Member]</link:label>
    <link:label id="lab_mo_LitigationCasesResultsMember_label_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Cases Results [Member]</link:label>
    <link:label id="lab_mo_LitigationCasesResultsMember_documentation_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Cases Results [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember" xlink:href="mo-20200930.xsd#mo_LitigationCasesResultsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationCasesResultsMember" xlink:to="lab_mo_LitigationCasesResultsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_e320dc94-8b47-4086-89a8-663300e3b470_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4cc0ca4a-34e3-416e-a799-2546d8f6b667_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_a2c549f0-58a6-4c85-bbf2-b65ebfaf9a5b_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_2b8e7a89-27fc-4022-a77d-e36f308543fc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_0edf235c-2ea5-4dd4-95e6-98a824a039d4_terseLabel_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_03aaf50f-8270-4441-8d88-077fc1306806_verboseLabel_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_label_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_documentation_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember" xlink:href="mo-20200930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtMember" xlink:to="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_47b0d98d-2642-43c2-bfa6-524f8650ffa7_terseLabel_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded to other party</link:label>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_label_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Awarded to Other Party</link:label>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_documentation_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty" xlink:href="mo-20200930.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AmountAwardedtoOtherParty" xlink:to="lab_mo_AmountAwardedtoOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WI_db0bd7be-7672-441e-8d63-5889d9990af2_terseLabel_en-US" xlink:label="lab_stpr_WI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wisconsin [Member]</link:label>
    <link:label id="lab_stpr_WI_label_en-US" xlink:label="lab_stpr_WI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WISCONSIN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_WI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WI" xlink:to="lab_stpr_WI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_7cdf8730-811e-43e6-a02a-095e8fe708ee_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a4a6972e-da6f-4834-8f0e-9791cc2649c3_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0415871b-7d55-4da8-8ba7-d2e34951301c_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WV_7f7f2b21-901b-4c61-896f-3094a8480aa5_terseLabel_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Virginia [Member]</link:label>
    <link:label id="lab_stpr_WV_label_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEST VIRGINIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_WV"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WV" xlink:to="lab_stpr_WV" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_f3c27a62-707e-4e56-b781-a4e6a01cfbb2_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceRollforwardRollForward_1ba89f1e-7313-4e62-9ad6-c3cda798960e_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance Rollforward [Roll Forward]</link:label>
    <link:label id="lab_mo_ValuationAllowanceRollforwardRollForward_label_en-US" xlink:label="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance Rollforward [Roll Forward]</link:label>
    <link:label id="lab_mo_ValuationAllowanceRollforwardRollForward_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance Rollforward [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceRollforwardRollForward" xlink:href="mo-20200930.xsd#mo_ValuationAllowanceRollforwardRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward" xlink:to="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember_4c58d1fb-676b-4ca7-9304-cc3b269960ad_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember_label_en-US" xlink:label="lab_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due Two Thousand And Twenty Five [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due Two Thousand And Twenty Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember" xlink:to="lab_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_59b89f76-506f-4eb2-a44e-476bc86de468_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticipated additional employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_ae58d689-a655-4a94-87b9-1d4d98614d92_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_cd334931-5cc4-41e8-b784-beefe5999888_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_8f687b0a-66fd-42cd-b03f-80bcb039cf34_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_4249f053-9267-4e6b-88b3-d4e001de97aa_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of equity investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_b31512a1-6823-4aec-b4bb-e8c5d5d2f3aa_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_992a6956-50d8-469b-abac-a7907a12313d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_a6f7ad52-1839-41dc-8280-a4d5f5d0a261_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20042017Member_0b6be11e-0acc-44df-adb0-4fd8c44b5f32_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20042017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004-2017 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20042017Member_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20042017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004-2017 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20042017Member_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20042017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004-2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20042017Member" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions20042017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions20042017Member" xlink:to="lab_mo_HealthCareCostRecoveryActions20042017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_304e7169-498d-49e4-8159-9e5b78c4c07b_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesD.BrownMember" xlink:to="lab_mo_EngleProgenyCasesD.BrownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_89129b75-7684-4ea0-b7fa-cdf511f72b51_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states that cap bond or require no bond</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States That Cap Bond or Require No Bond</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States That Cap Bond or Require No Bond</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:to="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_90f70a6c-37fa-4d9c-b596-8819cb08dcd4_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4eeb8c70-887b-4aca-a1eb-a7670e9277cd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember_76b92f80-67a1-4886-843b-31e481b1718a_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 And Subsequent NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 And Subsequent NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 And Subsequent NPM Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_0a83aaae-484b-4f7e-b22c-9c22e4fc5cad_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_39409503-a903-441f-964b-a18d81c616a5_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_9d418183-f22a-461b-b967-ed9413c212ca_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_f9f26988-a82e-4290-9d5e-98a55489ca19_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of additional states extended with settled litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_label_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States Extended with Settled Litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States Extended with Settled Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:to="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_d20254b8-e6f5-4b93-9f9b-a3a49cadb055_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_ee1b86a4-1bb8-460d-ad75-66a092e45910_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, fair value disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStockDividendRatePercentageIncrease_47e243e6-de6e-44d1-bbda-53a6595098fa_terseLabel_en-US" xlink:label="lab_mo_CommonStockDividendRatePercentageIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, dividend rate, percentage increase</link:label>
    <link:label id="lab_mo_CommonStockDividendRatePercentageIncrease_label_en-US" xlink:label="lab_mo_CommonStockDividendRatePercentageIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Rate, Percentage Increase</link:label>
    <link:label id="lab_mo_CommonStockDividendRatePercentageIncrease_documentation_en-US" xlink:label="lab_mo_CommonStockDividendRatePercentageIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Rate, Percentage Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRatePercentageIncrease" xlink:href="mo-20200930.xsd#mo_CommonStockDividendRatePercentageIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStockDividendRatePercentageIncrease" xlink:to="lab_mo_CommonStockDividendRatePercentageIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_be565861-b980-43fc-ba65-ed9141266f2b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_9530f74b-e60c-47ed-a523-cec2e18fdfa6_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0ff8bea2-5f4b-44bb-b24f-861fb6d3314a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecurityInvestments_783a4700-71ca-4c69-9240-3ffb1cff10cb_verboseLabel_en-US" xlink:label="lab_mo_EquitySecurityInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_mo_EquitySecurityInvestments_label_en-US" xlink:label="lab_mo_EquitySecurityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Security Investments</link:label>
    <link:label id="lab_mo_EquitySecurityInvestments_documentation_en-US" xlink:label="lab_mo_EquitySecurityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Security Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecurityInvestments" xlink:href="mo-20200930.xsd#mo_EquitySecurityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecurityInvestments" xlink:to="lab_mo_EquitySecurityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_adb955d0-2d73-4aa4-8500-4868fb9881f8_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesStateMember" xlink:to="lab_mo_EngleProgenyCasesStateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_be31981e-a4d3-4e00-a454-3ce4eb9533cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a0b4df3-ce10-4d85-b5ac-5147baada5ae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_7bf32573-1d33-4236-8838-64a6d43adf15_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturers</link:label>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_label_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofManufacturers" xlink:to="lab_mo_LossContingencyNumberofManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_a49c9230-41ec-49d5-a890-d97b585ab5e6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_3e848f0f-596e-4daf-a51c-3d58cfdeb9c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CreditAgreementMember_9f7505a8-ef1e-4611-bafa-5a0ac2e03dfa_terseLabel_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_mo_CreditAgreementMember_label_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_mo_CreditAgreementMember_documentation_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember" xlink:href="mo-20200930.xsd#mo_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CreditAgreementMember" xlink:to="lab_mo_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8b6228a3-669c-4c4e-8354-617126dd9d69_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_bec224cf-4734-48f1-810f-d78127dc6255_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_2d3a7a68-5c6b-4119-8e5a-654fad17a809_terseLabel_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes due 2031 [Member]</link:label>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_label_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 3.125% Notes Due 2031 [Member]</link:label>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_documentation_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 3.125% Notes Due 2031 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member" xlink:href="mo-20200930.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock3.125NotesDue2031Member" xlink:to="lab_mo_CommonStock3.125NotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_411af190-1820-4a2b-8e6e-c7ff0e7dbd17_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_10ab4c2d-25ce-4899-80b8-9fc535741b95_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleOfPretaxCOVID19ChargesLineItems_93670c90-eb3c-42ec-862c-2bbef84f5e25_terseLabel_en-US" xlink:label="lab_mo_ScheduleOfPretaxCOVID19ChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Pre-tax COVID-19 Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleOfPretaxCOVID19ChargesLineItems_label_en-US" xlink:label="lab_mo_ScheduleOfPretaxCOVID19ChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Pre-tax COVID-19 Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleOfPretaxCOVID19ChargesLineItems_documentation_en-US" xlink:label="lab_mo_ScheduleOfPretaxCOVID19ChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule Of Pre-tax COVID-19 Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfPretaxCOVID19ChargesLineItems" xlink:href="mo-20200930.xsd#mo_ScheduleOfPretaxCOVID19ChargesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesLineItems" xlink:to="lab_mo_ScheduleOfPretaxCOVID19ChargesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_07d18220-70ad-4529-8d2a-f98c1c52319c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_ca3f233a-377c-4416-b576-1fd03a6d6d14_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_9f60f9fd-d464-4001-a08c-caa08e9e7e44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Repurchase Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_2c6155ee-77ab-4013-93b4-83643e5d39b9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_30591166-4817-4763-8db6-813a364fd13a_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas [Member]</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_62e0225b-2a34-48b5-9e6a-c1892640fced_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_f4597e91-e4fb-42c4-820e-0ce6bf444556_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_ba6eb604-ce7b-45c3-b218-7b4ebf0b49da_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ee4fc0e6-7bdd-4bb7-b794-008da1981f9f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0be69c7b-9ae7-44f2-9971-2e98789bb319_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment, Exit and Implementation Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_JUULMember_6e2876f2-4ff7-421d-bcd0-6b292e279474_terseLabel_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:label id="lab_mo_JUULMember_label_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:label id="lab_mo_JUULMember_documentation_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember" xlink:href="mo-20200930.xsd#mo_JUULMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_JUULMember" xlink:to="lab_mo_JUULMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_df84bcf0-1fa7-4709-a04a-ca27bd5d1521_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities:</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_7a447b6d-8947-4d46-809b-08b4635b21af_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class not certified</link:label>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Not Certified, Number</link:label>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Not Certified, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber" xlink:href="mo-20200930.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClassNotCertifiedNumber" xlink:to="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_1cf4aaed-90a4-4e9d-bece-4b705946500a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_435a6eca-5a34-4674-be2b-f3a92f1efafc_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_f93261ee-334b-402b-85a4-e51c57a13b48_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_f756ea18-46ab-46d4-84b0-b87d6b1a5d00_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_5ae7fe39-1acd-4fc9-bb4e-4d7d64996577_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Cronos-related financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_24e3eec1-2f60-49ab-8fcd-72c6c2b255d1_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Cronos-related financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_886a712c-34e1-48e9-ba63-62b23ae64c0e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Cronos-related financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TN_5455a788-efd2-436c-b019-d95d4463ae1e_terseLabel_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tennessee [Member]</link:label>
    <link:label id="lab_stpr_TN_label_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TENNESSEE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TN" xlink:to="lab_stpr_TN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_8610221c-c426-40e3-92a7-6202efc1bacd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_b95295f2-39d6-4f28-8c3c-ea2d9cc59b74_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_b1433531-06b8-4988-bc11-e5bebe80f3b4_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_1deddd3d-2794-4355-8bde-84abe137e056_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_8eeef267-7571-405e-a307-24bd4ce387a9_terseLabel_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_label_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_documentation_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember" xlink:href="mo-20200930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CanadianTobaccoManufacturersMember" xlink:to="lab_mo_CanadianTobaccoManufacturersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_47e73311-01f1-4009-a667-1fc640dd293c_terseLabel_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_label_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking And Health Class Actions And Aggregated Claims Litigation [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_documentation_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:href="mo-20200930.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:to="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_9e14f772-b81c-43ff-9de6-37226b3a1e62_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_e99ac8b9-775b-4628-84f0-f30ffb79021c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InvestmentsTable_22d4624d-8405-4289-b27a-618db6fb033f_terseLabel_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_mo_InvestmentsTable_label_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_mo_InvestmentsTable_documentation_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable" xlink:href="mo-20200930.xsd#mo_InvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsTable" xlink:to="lab_mo_InvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_103cfe35-f1b5-4cdd-acf0-68c309fe4557_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_dd527e05-99de-466d-95b2-824f38e6055b_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_197211b2-5252-4e15-bf9f-a22764a60b6e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued postretirement health care costs</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Other Postretirement Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_0965455f-3280-4491-b334-4446a25ada4c_terseLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit income, excluding service cost</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_6de88a38-90be-49cd-afcd-94095b46877c_negatedLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit income, excluding service cost</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_label_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:to="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStatesRemaining_80b64f64-66fe-4fd4-bf3b-42d4a08da62b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states remaining</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesRemaining_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States Remaining</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesRemaining_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesRemaining" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStatesRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStatesRemaining" xlink:to="lab_mo_LossContingencyNumberofStatesRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_9d79d83e-8ab5-4ec2-a6c9-7bdebe2b6b04_terseLabel_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_label_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_documentation_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:href="mo-20200930.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:to="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d381cb67-2a2a-4af4-ac53-a9c29e655cf6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentImpairment_a4a71ffd-1622-4773-8b01-5af127add7d2_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, impairment</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentImpairment_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Impairment</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentImpairment_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentImpairment" xlink:to="lab_mo_EquityMethodInvestmentImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesLandiMember_1849bd67-5d0c-4160-93b7-3fd6d9846300_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesLandiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Landi [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLandiMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesLandiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Landi [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLandiMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesLandiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Landi [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLandiMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesLandiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesLandiMember" xlink:to="lab_mo_EngleProgenyCasesLandiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_bf085079-eb8f-4e01-b407-e4590ef1277a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_caaa5c5b-a773-41df-a6b2-079c75422fc6_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_8015ccaf-ebfd-41cb-bce2-a8469a54a5a8_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Dividend Yield [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8602a762-29f0-444c-927d-8a97f0b29a76_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_e13804ca-a82d-40fd-814d-6592dade1dac_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_879747a7-eb0f-4df3-8e31-01875d9f20db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_938aef51-d38d-4417-8522-e3b0094b6ee9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price of repurchased shares, per share (usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e3ef1c93-0ce8-468e-8f9c-c06bb6589352_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share of shares repurchased (usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_ae9bda04-ef27-456b-be2f-0e70c262ad1b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensatory damages award, allocation percentage</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_label_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Allocation Percentage</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_documentation_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Allocation Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:href="mo-20200930.xsd#mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:to="lab_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_82702681-2dbd-4a5a-83ae-8e456a306f62_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyProceedsfromLegalSettlements_d7573195-0ff3-4bca-854a-ff49bcc9e46a_terseLabel_en-US" xlink:label="lab_mo_LossContingencyProceedsfromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#8203;Proceeds from legal settlements</link:label>
    <link:label id="lab_mo_LossContingencyProceedsfromLegalSettlements_label_en-US" xlink:label="lab_mo_LossContingencyProceedsfromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, &#8203;Proceeds from Legal Settlements</link:label>
    <link:label id="lab_mo_LossContingencyProceedsfromLegalSettlements_documentation_en-US" xlink:label="lab_mo_LossContingencyProceedsfromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, &#8203;Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyProceedsfromLegalSettlements" xlink:href="mo-20200930.xsd#mo_LossContingencyProceedsfromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyProceedsfromLegalSettlements" xlink:to="lab_mo_LossContingencyProceedsfromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_58f55275-63c9-4c31-949d-8231f55bbe4d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_e63dc9ff-f222-47ce-b40a-516894258bcb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_5f77d756-270b-4b19-b644-fa41158e285a_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D Cohen, Collar, Chacon [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:to="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_b7713146-4879-4f4e-90fd-a13aba1e309a_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_9600bee6-993e-49cb-b975-75417eb47c3a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2023Member_d83a1607-5a8a-497f-9e53-0a9886cc4e7c_terseLabel_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2023 [Member]</link:label>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2023Member_label_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2023 [Member]</link:label>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2023Member_documentation_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2023Member" xlink:href="mo-20200930.xsd#mo_RevolvingCreditFacilityDueAugust2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_RevolvingCreditFacilityDueAugust2023Member" xlink:to="lab_mo_RevolvingCreditFacilityDueAugust2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_602b5249-425d-4c10-92db-986c6670c312_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_b96600ed-7572-45a9-8e6f-fee1c23724ed_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_23a99406-9b68-4f4b-8f19-4b9933b5b71a_terseLabel_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts upheld</link:label>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_label_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdicts Upheld</link:label>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_documentation_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdicts Upheld</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld" xlink:href="mo-20200930.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyVerdictsUpheld" xlink:to="lab_mo_LossContingencyVerdictsUpheld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_e042fd4a-50fa-440e-acdf-cfe5770a16c2_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_3f1b2f9d-c934-41e2-a576-4c634be6e97a_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_b8929814-dd77-4337-9b69-7d6b38bba61a_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LightsMember_6c88b936-ed3b-4194-bbdc-b8465f774cf5_terseLabel_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:label id="lab_mo_LightsMember_label_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:label id="lab_mo_LightsMember_documentation_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember" xlink:href="mo-20200930.xsd#mo_LightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LightsMember" xlink:to="lab_mo_LightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_d76d97b4-3307-430b-b289-869bc3512827_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision related to litigation recorded</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ca6ff6d0-6308-4df4-80ec-22af8b3cd63a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_dfc13d2e-2798-4a85-84e5-2e522403a339_verboseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, warrant exercised, ownership percentage (approximately)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Warrant Exercised, Ownership Percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Warrant Exercised, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:to="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_94cf7e8b-b899-4370-9bbd-03c2a64542df_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1a42f0e9-0791-4925-a34e-5288fea0d38e_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_IL_62fc452d-ccd9-48af-972d-33b862605f87_terseLabel_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Illinois [Member]</link:label>
    <link:label id="lab_stpr_IL_label_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ILLINOIS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_IL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IL" xlink:to="lab_stpr_IL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_128dbceb-19c0-4fdb-9641-69865ab364a0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_RestructuringChargesIncludingNetPensionCostCredit_8a25c730-64ea-4192-9a5c-a8028ead75e7_totalLabel_en-US" xlink:label="lab_mo_RestructuringChargesIncludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring</link:label>
    <link:label id="lab_mo_RestructuringChargesIncludingNetPensionCostCredit_label_en-US" xlink:label="lab_mo_RestructuringChargesIncludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Including Net Pension Cost (Credit)</link:label>
    <link:label id="lab_mo_RestructuringChargesIncludingNetPensionCostCredit_documentation_en-US" xlink:label="lab_mo_RestructuringChargesIncludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Including Net Pension Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestructuringChargesIncludingNetPensionCostCredit" xlink:href="mo-20200930.xsd#mo_RestructuringChargesIncludingNetPensionCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_RestructuringChargesIncludingNetPensionCostCredit" xlink:to="lab_mo_RestructuringChargesIncludingNetPensionCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_c82c86da-c5ea-4ec7-9106-12ac2aa06931_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_f102a9fb-cb42-4cad-accf-de8d5dd75995_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_dd015457-2231-4acb-a35f-040ead51b0e1_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_8a152235-35b2-45fa-b6a4-6c8a8305831f_terseLabel_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued settlement charges</link:label>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_label_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Settlement Payable</link:label>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_documentation_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the period in Settlement payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable" xlink:href="mo-20200930.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IncreaseDecreaseInSettlementPayable" xlink:to="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_ed6411f5-3a5b-4cb5-be2e-d159da5a00b5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest on long-term debt</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesNeffMember_fdcf118c-c582-4dc3-b031-17018a1bbe17_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesNeffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Neff [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNeffMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesNeffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Neff [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNeffMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesNeffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Neff [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNeffMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesNeffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesNeffMember" xlink:to="lab_mo_EngleProgenyCasesNeffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_c00013e4-96b6-447c-9bf9-1eb81a2c14b9_negatedLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_42655987-9dfd-4af8-9d8e-4f98dfdb577d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_ffef173a-ddec-4b9b-9545-c54b24827232_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesCooperMember" xlink:to="lab_mo_EngleProgenyCasesCooperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_f6cf1d33-6e05-473d-8682-069e39cc17f2_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, number of shares eligible for purchase (approximately) (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Eligible For Purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Eligible For Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_31c41545-eb57-440c-876f-33e4b549eb96_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_35b7e6c9-101a-4f28-be75-26450a9c86ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Guidance Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_30d9b490-582d-48b7-8fa0-51472167590a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_d88e7d1a-5b87-4f60-b9bd-5d0821b7e872_terseLabel_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_label_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_documentation_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember" xlink:href="mo-20200930.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ImplementationofCorrectiveCommunicationsMember" xlink:to="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_7fb27c69-a6bc-4eb7-b5e5-e893d4b05161_terseLabel_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure period</link:label>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_label_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Trade Commission, Disclosure Period</link:label>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_documentation_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Trade Commission, Disclosure Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod" xlink:href="mo-20200930.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_FederalTradeCommissionDisclosurePeriod" xlink:to="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentExtensionTerm_d05c3036-8d45-4127-a960-6881638f3a00_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension term</link:label>
    <link:label id="lab_mo_DebtInstrumentExtensionTerm_label_en-US" xlink:label="lab_mo_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:label id="lab_mo_DebtInstrumentExtensionTerm_documentation_en-US" xlink:label="lab_mo_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentExtensionTerm" xlink:href="mo-20200930.xsd#mo_DebtInstrumentExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentExtensionTerm" xlink:to="lab_mo_DebtInstrumentExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_2169b788-3836-4bb9-a357-4ed64cab30fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost/credit [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_IA_dd3be2e2-409d-49f2-9810-adeb8ec16cdd_terseLabel_en-US" xlink:label="lab_stpr_IA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Iowa [Member]</link:label>
    <link:label id="lab_stpr_IA_label_en-US" xlink:label="lab_stpr_IA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IOWA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_IA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IA" xlink:to="lab_stpr_IA" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_7a95a47f-675a-47c7-831e-18257889d65d_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Punitive damages awarded</link:label>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_label_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Awarded, Value</link:label>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_documentation_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:href="mo-20200930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:to="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities_50073ac3-c861-4b40-ae9f-2e1f37fea042_negatedTerseLabel_en-US" xlink:label="lab_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Cronos</link:label>
    <link:label id="lab_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities_label_en-US" xlink:label="lab_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Equity Method Investments And Derivative Instruments, Investing Activities</link:label>
    <link:label id="lab_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities_documentation_en-US" xlink:label="lab_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Equity Method Investments And Derivative Instruments, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" xlink:href="mo-20200930.xsd#mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" xlink:to="lab_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_3d2786e2-50ce-46b3-8ad4-2e775fa661b3_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_9b448d2d-1dba-4597-b7a3-263cc8b4ca9a_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_6dc79d13-f46f-400e-a1c4-4809aa434974_verboseLabel_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_d4fc0a8b-8adb-450c-bf39-a688c5f3a9a6_terseLabel_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed-price Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_label_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive RIghts [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_documentation_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive RIghts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractPreemptiveRIghtsMember" xlink:to="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_73c75f26-4562-4869-ae14-5bc0f5267b8a_terseLabel_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking and Health Cases [Member]</link:label>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_label_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking And Health Cases [Member]</link:label>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_documentation_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking and Health Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember" xlink:href="mo-20200930.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember" xlink:to="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_8ec97dc3-d093-4488-919e-30afcfe281f6_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:to="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4dc24205-10b8-4d71-b480-deefb22db510_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherAccruedLiabilitiesMember_0508d2fb-e478-460e-bf17-a6f5ae53eb23_terseLabel_en-US" xlink:label="lab_mo_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:label id="lab_mo_OtherAccruedLiabilitiesMember_label_en-US" xlink:label="lab_mo_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:label id="lab_mo_OtherAccruedLiabilitiesMember_documentation_en-US" xlink:label="lab_mo_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherAccruedLiabilitiesMember" xlink:href="mo-20200930.xsd#mo_OtherAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherAccruedLiabilitiesMember" xlink:to="lab_mo_OtherAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_a3348ca0-3bbd-465e-a982-bd985ddccd35_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_5b11f81b-e2ec-42b1-bd5f-00bea3b28737_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_46e679a6-a9bf-4fa9-a634-996978204b38_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted shares owned (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Restricted</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Restricted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_a25969eb-507b-41f5-9cb8-7023ff0d4b56_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_6608da09-f623-47a6-8e65-64af99703c66_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_3497d1b6-95f1-467c-9cd5-b74412422ff4_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_95f6dca8-f8c4-459b-9d64-43b884cf0ab5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_06bd5417-a900-4ef8-942c-b6ec96486ef7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_January2018ShareRepurchaseProgramMember_ead1ba24-e21e-4ab6-a2df-803a15161603_terseLabel_en-US" xlink:label="lab_mo_January2018ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2018 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_January2018ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_mo_January2018ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2018 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_January2018ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_mo_January2018ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2018 Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2018ShareRepurchaseProgramMember" xlink:href="mo-20200930.xsd#mo_January2018ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_January2018ShareRepurchaseProgramMember" xlink:to="lab_mo_January2018ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_543a2ca0-0862-4fad-a1ab-6991d0f03127_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_c729f0b0-88c8-41c5-af52-dfd1f99e80a8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_55c1b3e0-2acc-4635-8352-63b8332394f5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_f2295478-5605-4eaa-829b-4dbcb88e1676_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Life [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_ceb1a8b1-4528-4bfe-ae0a-466c4be1da46_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_97aba4c9-b01d-469c-b295-b5d2516538b5_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_627d00a5-68cd-46fe-995e-f05051751561_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims not certified, number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Not Certified, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Not Certified, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsNotCertifiedNumber" xlink:to="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_c87712cb-4632-44b3-817e-baab69de6617_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_0768a0a2-2241-41e1-aed6-60f9f967df56_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_6fd81d5d-0ca9-498f-86a2-6228d9cb1c7c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cost of shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e43781d-a9a8-41c6-84d1-76b8c22f52c6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings (losses) to operating cash flows:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_4f8d791f-3004-47ea-9373-3317107a6a6f_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_f2b2f333-866f-46dd-9218-3a80941ddee2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_2c8db789-074a-4ddb-aa29-c48dc28a9d44_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_acec0438-5feb-4762-acfc-a434aaf60d7b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_5c7ce928-6e9c-4f72-8404-5760fcfffc99_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_a0cdbd5f-4459-4c91-a77a-5062933fcef7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_845498ee-5894-4c1e-a491-914d09fe114e_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_15f78317-347a-4d50-b393-d62a269351ac_negatedLabel_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Distributed and undistributed earnings attributable to share-based awards</link:label>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_label_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</link:label>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_documentation_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:href="mo-20200930.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:to="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member_13c71b93-4858-4740-9d69-e1302e3c5112_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member" xlink:to="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_7457a508-12ec-4e35-aa04-597e2429d5a9_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_58a26202-b97a-4e7d-9aed-821ecb49c363_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_6734f8b5-fbc2-45b3-b9e7-6337daf4af84_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3c102102-7d17-45f6-b65e-822d188670d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_5e4db507-e80a-4261-846a-7d90ee338a8d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OH_89a186da-dda0-4abc-b40d-eea17117c1b8_terseLabel_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ohio [Member]</link:label>
    <link:label id="lab_stpr_OH_label_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OHIO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OH" xlink:to="lab_stpr_OH" xlink:type="arc" order="1"/>
    <link:label id="lab_country_PR_157d1203-d990-440c-93c9-67e3575363fe_terseLabel_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Puerto Rico [Member]</link:label>
    <link:label id="lab_country_PR_label_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PUERTO RICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_PR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_PR" xlink:to="lab_country_PR" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember_6087f622-9754-49e4-bb1d-a6d4d9ffe256_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PreTaxChargesGainIncludedinNetEarning_347d0a22-6414-4568-8fa4-e75884ba0b86_terseLabel_en-US" xlink:label="lab_mo_PreTaxChargesGainIncludedinNetEarning" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charges (gain) included in net earning</link:label>
    <link:label id="lab_mo_PreTaxChargesGainIncludedinNetEarning_label_en-US" xlink:label="lab_mo_PreTaxChargesGainIncludedinNetEarning" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Tax Charges (Gain) Included in Net Earning</link:label>
    <link:label id="lab_mo_PreTaxChargesGainIncludedinNetEarning_documentation_en-US" xlink:label="lab_mo_PreTaxChargesGainIncludedinNetEarning" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Tax Charges (Gain) Included in Net Earning</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PreTaxChargesGainIncludedinNetEarning" xlink:href="mo-20200930.xsd#mo_PreTaxChargesGainIncludedinNetEarning"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PreTaxChargesGainIncludedinNetEarning" xlink:to="lab_mo_PreTaxChargesGainIncludedinNetEarning" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_1d429257-df60-41d8-9efd-da335ff46add_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMcCallMember" xlink:to="lab_mo_EngleProgenyCasesMcCallMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_c2bc9e50-171b-4238-aa62-2c7e833beb66_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_e8180f51-a6a3-46a1-b415-c36484a2aaa3_terseLabel_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other raw materials</link:label>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_label_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_documentation_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves" xlink:href="mo-20200930.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherInventoryRawMaterialsNetofReserves" xlink:to="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OK_62bb5c58-d9e2-4e2c-bff8-2a884213bd4e_terseLabel_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma [Member]</link:label>
    <link:label id="lab_stpr_OK_label_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OKLAHOMA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OK" xlink:to="lab_stpr_OK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_c84f3cbc-8b3e-45fd-8f3c-7ece52de360b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_000a7645-3868-48b2-bc10-f3409a52a287_terseLabel_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims with unfavorable verdicts pending/reversed</link:label>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_label_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Unfavorable Verdicts Pending/Reversed</link:label>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_documentation_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Unfavorable Verdicts Pending/Reversed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:href="mo-20200930.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:to="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCases_f7fa7a11-e59d-465a-a096-6595b2a12239_verboseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCases_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCases_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCases" xlink:to="lab_mo_LossContingencyNumberOfCases" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted_ded17105-7d86-4802-b173-b59e3d51f274_totalLabel_en-US" xlink:label="lab_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) for basic and diluted EPS</link:label>
    <link:label id="lab_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted_label_en-US" xlink:label="lab_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic and Diluted</link:label>
    <link:label id="lab_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted_documentation_en-US" xlink:label="lab_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" xlink:href="mo-20200930.xsd#mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" xlink:to="lab_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_07e9afd5-e3a1-4bae-a0b6-6a428be2e69b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InvestmentsInEquitySecuritiesMember_b7f0ae36-e7ee-489d-9b1c-0547ee682b74_terseLabel_en-US" xlink:label="lab_mo_InvestmentsInEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Securities [Member]</link:label>
    <link:label id="lab_mo_InvestmentsInEquitySecuritiesMember_label_en-US" xlink:label="lab_mo_InvestmentsInEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Securities [Member]</link:label>
    <link:label id="lab_mo_InvestmentsInEquitySecuritiesMember_documentation_en-US" xlink:label="lab_mo_InvestmentsInEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsInEquitySecuritiesMember" xlink:href="mo-20200930.xsd#mo_InvestmentsInEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsInEquitySecuritiesMember" xlink:to="lab_mo_InvestmentsInEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NY_ea4f0845-acec-4040-8dbe-ea460578362b_terseLabel_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York [Member]</link:label>
    <link:label id="lab_stpr_NY_label_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NY" xlink:to="lab_stpr_NY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_66158c9e-bcdc-4c37-8a8a-b6c5b6f70b7e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NV_2a918b1b-41cc-4408-a3e8-1dc0846e3e43_terseLabel_en-US" xlink:label="lab_stpr_NV" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nevada [Member]</link:label>
    <link:label id="lab_stpr_NV_label_en-US" xlink:label="lab_stpr_NV" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEVADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NV"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NV" xlink:to="lab_stpr_NV" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGlogerMember_02da31f1-f69d-4c31-803d-44832da08da3_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesGlogerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGlogerMember" xlink:to="lab_mo_EngleProgenyCasesGlogerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f6a9cea0-8f34-402f-8926-96ece35a5fa8_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_6e0c2c91-2825-41be-a80c-259f491bd370_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesFreemanMember_e1b7ffc8-eb2f-499d-bbcc-0b8d0e2f23ed_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFreemanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFreemanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesFreemanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesFreemanMember" xlink:to="lab_mo_EngleProgenyCasesFreemanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_64f61ae6-0b7c-46f9-9892-485570f363ac_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Losses [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_cffb5bd1-df62-41b9-bd48-44e89bd10429_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases With Payments A Year Or More Ago</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases With Payments A Year Or More Ago</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases With Payments A Year Or More Ago</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:to="lab_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PreTrialResolutionMember_bee5a5a3-9a5e-4968-a7ef-1b0fce1f70e1_terseLabel_en-US" xlink:label="lab_mo_PreTrialResolutionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Trial Resolution [Member]</link:label>
    <link:label id="lab_mo_PreTrialResolutionMember_label_en-US" xlink:label="lab_mo_PreTrialResolutionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Trial Resolution [Member]</link:label>
    <link:label id="lab_mo_PreTrialResolutionMember_documentation_en-US" xlink:label="lab_mo_PreTrialResolutionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Trial Resolution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PreTrialResolutionMember" xlink:href="mo-20200930.xsd#mo_PreTrialResolutionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PreTrialResolutionMember" xlink:to="lab_mo_PreTrialResolutionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_032f6d9f-2b95-4eda-9a73-5da57d3fbb21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NH_40ef9516-9ccd-4b48-8017-77dd88016234_terseLabel_en-US" xlink:label="lab_stpr_NH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Hampshire [Member]</link:label>
    <link:label id="lab_stpr_NH_label_en-US" xlink:label="lab_stpr_NH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW HAMPSHIRE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NH" xlink:to="lab_stpr_NH" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8016273d-ff96-4e48-9c25-263fcfdbc9a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation_4ebe6647-13fc-4577-8bf7-b962001beecc_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of additional states added</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation_label_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States with Settled Litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States with Settled Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofAdditionalStateswithSettledLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation" xlink:to="lab_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_25d09aa5-8d5a-427c-9050-4226eb4e9e5f_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:to="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NumberofMembersOntheBoardofDirectors_1d0a431e-1793-4450-a89e-3aebec69ec78_terseLabel_en-US" xlink:label="lab_mo_NumberofMembersOntheBoardofDirectors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of members on the Board of Directors</link:label>
    <link:label id="lab_mo_NumberofMembersOntheBoardofDirectors_label_en-US" xlink:label="lab_mo_NumberofMembersOntheBoardofDirectors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Members On the Board of Directors</link:label>
    <link:label id="lab_mo_NumberofMembersOntheBoardofDirectors_documentation_en-US" xlink:label="lab_mo_NumberofMembersOntheBoardofDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Members On the Board of Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberofMembersOntheBoardofDirectors" xlink:href="mo-20200930.xsd#mo_NumberofMembersOntheBoardofDirectors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NumberofMembersOntheBoardofDirectors" xlink:to="lab_mo_NumberofMembersOntheBoardofDirectors" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NM_5e1188c7-7c43-423e-82f4-4b3ce4818fe3_terseLabel_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW MEXICO</link:label>
    <link:label id="lab_stpr_NM_label_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW MEXICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NM"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NM" xlink:to="lab_stpr_NM" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_018db55b-214c-48cd-86be-230389980bbb_terseLabel_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leaf tobacco</link:label>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_label_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Plant Material, Net of Reserves</link:label>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_documentation_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:href="mo-20200930.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:to="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NJ_233fb49a-b0dd-4fa4-a4bb-e6780d8f9e8e_terseLabel_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey [Member]</link:label>
    <link:label id="lab_stpr_NJ_label_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW JERSEY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NJ"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NJ" xlink:to="lab_stpr_NJ" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MO_7fc53b23-709f-46f7-9e34-7230c66145dd_terseLabel_en-US" xlink:label="lab_stpr_MO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Missouri [Member]</link:label>
    <link:label id="lab_stpr_MO_label_en-US" xlink:label="lab_stpr_MO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MISSOURI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MO" xlink:to="lab_stpr_MO" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MN_fcb4b847-3922-492c-bdfd-fef802204f85_terseLabel_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minnesota [Member]</link:label>
    <link:label id="lab_stpr_MN_label_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MINNESOTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MN" xlink:to="lab_stpr_MN" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_e7bbef90-3a3c-4d77-beba-b76f42d2e66f_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states with settled litigation including New York, subsequent expansion</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation, Settlement One</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation, Settlement One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:to="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MS_a736df74-7f7b-43d7-897a-b940bac839f9_terseLabel_en-US" xlink:label="lab_stpr_MS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mississippi [Member]</link:label>
    <link:label id="lab_stpr_MS_label_en-US" xlink:label="lab_stpr_MS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MISSISSIPPI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MS" xlink:to="lab_stpr_MS" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_a385de90-9c92-4e54-8da6-555b3655d4e6_terseLabel_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts reversed</link:label>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_label_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdict Reversed, Number</link:label>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdict Reversed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber" xlink:href="mo-20200930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyVerdictReversedNumber" xlink:to="lab_mo_LossContingencyVerdictReversedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e9c2b960-208a-492c-8e12-1f491ba0b065_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings (losses) attributable to Altria</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_0fed2490-0f4c-4eb5-a77f-dd476fb0d06b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of shareholders filing class action lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:to="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencySettlementAgreementPaymentPeriod_a78ab79a-1877-4c5a-a8dd-ee32ca6c9ff4_terseLabel_en-US" xlink:label="lab_mo_LossContingencySettlementAgreementPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, settlement agreement, payment period</link:label>
    <link:label id="lab_mo_LossContingencySettlementAgreementPaymentPeriod_label_en-US" xlink:label="lab_mo_LossContingencySettlementAgreementPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Payment Period</link:label>
    <link:label id="lab_mo_LossContingencySettlementAgreementPaymentPeriod_documentation_en-US" xlink:label="lab_mo_LossContingencySettlementAgreementPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencySettlementAgreementPaymentPeriod" xlink:href="mo-20200930.xsd#mo_LossContingencySettlementAgreementPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencySettlementAgreementPaymentPeriod" xlink:to="lab_mo_LossContingencySettlementAgreementPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities_9e9af5c9-20a2-4353-9293-32c1c30db8ce_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for derivative instrument, investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_97a2766c-8da1-41ec-b562-a079739cf0c0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MD_c170be88-9493-4cf5-81eb-41ad1934e9d0_terseLabel_en-US" xlink:label="lab_stpr_MD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maryland [Member]</link:label>
    <link:label id="lab_stpr_MD_label_en-US" xlink:label="lab_stpr_MD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MARYLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MD" xlink:to="lab_stpr_MD" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_5da1abf0-0c2c-471e-9e5f-389e7af59dbc_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_4ec75d8f-cbc4-4b50-839a-275c3a166012_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MA_059224f1-a6ee-497b-a594-443fd4c0d96c_verboseLabel_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts [Member]</link:label>
    <link:label id="lab_stpr_MA_label_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MASSACHUSETTS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MA" xlink:to="lab_stpr_MA" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_650cd898-7545-43cb-a32f-b3caa4b943f4_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_83bbcb75-1a09-4a94-912e-fac28f4529a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ca19190c-bc6c-4bd0-81e1-a5625d5f66d7_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_d3ab3bf8-390b-4531-8bae-1989b592931f_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_b88aa682-9c60-4d2b-9b9b-1ede9592a27e_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7a93951e-7292-4e77-b256-46346ce151c5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MI_6b12a51b-d069-42e1-84d0-5eabeca49175_terseLabel_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michigan [Member]</link:label>
    <link:label id="lab_stpr_MI_label_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MICHIGAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MI" xlink:to="lab_stpr_MI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_bb045054-922f-4381-b861-446d85ca1b95_periodStartLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liability for tobacco and health litigation items at beginning of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_33c2e7c2-8277-48b4-8daa-e2c62880d6b8_periodEndLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liability for tobacco and health litigation items at end of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_3257b13b-6e17-4602-81db-63fc3fef7f18_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_3b466ace-1d83-4cff-854d-014f4c564fa2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Earnings) losses from equity investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_4fa3c6d8-de1b-4b94-be84-ade43b27bbbe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) from equity investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_803d3770-6a0c-4535-877e-9d4fbe78a323_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned share repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember_33f9c901-2e3a-4fac-89f3-3072e2500337_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember" xlink:to="lab_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_c5ddbe6c-1646-4aa9-a18e-cca0aae705ec_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_d2595ca8-d6bd-4b90-8b18-c8b12e1bdae6_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_e07da292-5e82-49c8-927d-6dc918302b3f_negatedLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_1f5342c2-7944-46fb-af39-79a8d575ce48_terseLabel_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_label_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_documentation_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember" xlink:href="mo-20200930.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherTabaccoRelatedCasesMember" xlink:to="lab_mo_OtherTabaccoRelatedCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2a9bf682-29f4-444b-8d21-d2943603f4a9_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to net earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_6e093eed-5bf5-4eec-b335-9ef0502d57a4_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6a4311a6-a4bc-47b3-8dfd-9f3fdb47e4e8_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_f8292686-1fd2-4f96-9fb3-919020d32cf0_negatedTerseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions to valuation allowance credited to income tax benefit</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Decrease In Amount</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Decrease In Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:href="mo-20200930.xsd#mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_LA_3c16fda0-07c0-469d-a86c-d0a0d6daa1c7_terseLabel_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Louisiana [Member]</link:label>
    <link:label id="lab_stpr_LA_label_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOUISIANA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_LA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_LA" xlink:to="lab_stpr_LA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f5034842-abd3-4e8b-b806-68c94213589d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_42b88221-e678-4f33-bc56-87e23bc862fd_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_05af14cf-8535-460a-b6f9-9360258661f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_f23ba2b3-0a3b-4c25-8161-36266fb84788_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_d1875c6d-e5ef-4781-86f8-b9b8b2403b06_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_31c65bfb-5aca-4650-b928-47c123ddeb43_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_b9137c98-b027-4bce-bd36-ac58f10a4624_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a863dc74-7dde-4dc1-92cb-bf5c295d87c1_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_607a343f-0526-494f-9ce9-300bb39e826f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fulfillment term</link:label>
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_label_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:to="lab_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_a1d317ff-0edd-477a-937c-53be578b61dd_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_bb2f3537-b1a9-401b-b6dc-0582ff52fa97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_f5662e53-6b53-4e98-b5ea-e9a6129eb184_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_857afc00-7358-4170-9b7a-50fccc6441da_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_97902e65-1dff-44d4-9a74-adcdf27dd595_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends from ABI</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_75c7ee5b-e1f7-4ab2-b013-558458599e8e_terseLabel_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement charges</link:label>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_label_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Liability, Current</link:label>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_documentation_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent" xlink:href="mo-20200930.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AccruedSettlementLiabilityCurrent" xlink:to="lab_mo_AccruedSettlementLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesFrogelMember_46a7df55-ed5f-417e-91dd-e97947ac8f58_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesFrogelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Frogel [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFrogelMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesFrogelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Frogel [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFrogelMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesFrogelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Frogel [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFrogelMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesFrogelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesFrogelMember" xlink:to="lab_mo_EngleProgenyCasesFrogelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesM.BrownMember_f10c18cc-cdb9-40f5-a7c9-83d78b49bd67_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesM.BrownMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, M. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesM.BrownMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesM.BrownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, M. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesM.BrownMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesM.BrownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, M. Brown [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesM.BrownMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesM.BrownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesM.BrownMember" xlink:to="lab_mo_EngleProgenyCasesM.BrownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_0c76e785-5a31-45a3-8809-8bdd0780178c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_KS_0a2fd84a-2253-4c28-9234-fd511de7be37_terseLabel_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kansas [Member]</link:label>
    <link:label id="lab_stpr_KS_label_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_KS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_KS" xlink:to="lab_stpr_KS" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_36906006-25a8-4e8b-84a5-94a4381aff0d_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, ownership percentage</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_7a9b3884-6b16-404e-8671-54093d436c80_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesR.DouglasMember" xlink:to="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_6421f084-de71-4ce5-b060-7a7aeb9c2fc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingencies</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_0891f708-d02f-423f-b9ed-9095ac949f08_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MeasurementInputWeightedAverageExpectedTermMember_8a8bc5fe-e3e6-4a7e-94ca-3c7121aa0566_terseLabel_en-US" xlink:label="lab_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Expected Term [Member]</link:label>
    <link:label id="lab_mo_MeasurementInputWeightedAverageExpectedTermMember_label_en-US" xlink:label="lab_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Weighted Average Expected Term [Member]</link:label>
    <link:label id="lab_mo_MeasurementInputWeightedAverageExpectedTermMember_documentation_en-US" xlink:label="lab_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Weighted Average Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:href="mo-20200930.xsd#mo_MeasurementInputWeightedAverageExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:to="lab_mo_MeasurementInputWeightedAverageExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_941cca57-27b4-4b4a-a95d-140d12598c3a_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_fa8a531b-c6c9-490c-82d9-36979491cc7a_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_7647b609-fd04-4d35-9ff3-f3364c5066b1_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_5027944b-6c43-49b1-9ebf-1a638b1e6b60_terseLabel_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.700% Notes due 2025 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_label_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.700% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_documentation_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.700% Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member" xlink:href="mo-20200930.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock1.700NotesDue2025Member" xlink:to="lab_mo_CommonStock1.700NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_a164e8c8-73b0-40a9-a13c-abbd7fec47ad_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_01d27359-2db3-45aa-ac6f-84a74ea8d689_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGoreMember_37f137eb-ee41-4e1b-9717-868b040ad232_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGoreMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gore [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGoreMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGoreMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gore [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGoreMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGoreMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gore [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGoreMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesGoreMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGoreMember" xlink:to="lab_mo_EngleProgenyCasesGoreMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_daa0185c-b313-4679-8424-b001a13fe2b1_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California [Member]</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7e2336e7-5a89-44d6-8f35-7a48c82e1361_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e13b47ef-c736-4c1e-a197-9294f8ffa75a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_52359bcd-6622-4af1-a171-a03ae4c0211c_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases pending</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_4eedd1cc-729e-4b57-a83d-693324d30dce_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims filed, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_10eae434-a9b9-4680-b31a-ab1940ea1cda_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims resolved</link:label>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Resolved, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Resolved, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsResolvedNumber" xlink:to="lab_mo_LossContingencyClaimsResolvedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_9d46f664-02b9-471b-ad1f-8326a30e9207_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished product</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_b02b2a08-0fe4-4c69-95fa-4ca11498fb41_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Recognized in Net Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_e18547fb-fff6-494e-b7d1-b10297aec208_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_9232769d-0a52-435e-b0bd-b598de87287b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_daa0e501-9d50-4449-8eb7-4031c389fc7b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_c4cf58ea-6846-4fe5-9fff-fd1dba5b96af_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, impairment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_d448e6d9-7ca2-4c14-87e6-49fe77544cea_terseLabel_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_label_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_documentation_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember" xlink:href="mo-20200930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SmokeableProductsSegmentMember" xlink:to="lab_mo_SmokeableProductsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesSantoroMember_8b11a5dd-c2c1-41d8-bc4c-926679ba4854_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesSantoroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Santoro [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSantoroMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesSantoroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Santoro [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSantoroMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesSantoroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Santoro [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSantoroMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesSantoroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesSantoroMember" xlink:to="lab_mo_EngleProgenyCasesSantoroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_c31d7cfa-bbd9-4382-84fc-e01b55cf71b3_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of board members</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_730c6a3f-0c86-47a7-bd88-72fd713686a3_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesCuddiheeMember" xlink:to="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AR_cd2c0305-c836-4cc6-940f-60da4b2d5ebc_terseLabel_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkansas [Member]</link:label>
    <link:label id="lab_stpr_AR_label_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ARKANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_AR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AR" xlink:to="lab_stpr_AR" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OralTobaccoSegmentMember_94640f04-5597-4f7b-8662-a54d86950637_verboseLabel_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_b498b400-cb85-46d3-af01-53bba3edd407_terseLabel_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_label_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_documentation_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember" xlink:href="mo-20200930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OralTobaccoSegmentMember" xlink:to="lab_mo_OralTobaccoSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_fd921ee4-0268-4f12-a16d-d733a19cf2db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (earnings) losses attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_0bc22355-eee0-420a-99b9-64c08cd1aa66_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:to="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_313034c5-c2f9-4d46-b200-c3a095b9fc33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostOfOperatingRevenue_5036103d-e6d6-4f93-a3ab-0bcde67db6fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise taxes on products</link:label>
    <link:label id="lab_us-gaap_OtherCostOfOperatingRevenue_label_en-US" xlink:label="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost of Operating Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostOfOperatingRevenue" xlink:to="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3bf3d0c3-488a-4d4c-817e-c19865b3a520_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesNaugleMember_cc07198e-b660-4b76-98cf-f85e9e06ba58_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNaugleMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesNaugleMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesNaugleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Naugle [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesNaugleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesNaugleMember" xlink:to="lab_mo_EngleProgenyCasesNaugleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_e0fc8a28-6b73-4ba1-919e-e84ecf22eb08_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_14e16942-4200-4266-9739-c4b39775dad4_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d628fd43-bb7a-40f9-af0b-826ef49035b4_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit (income) cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentNumberofExtensions_12bca3fc-34c6-4caa-abff-ad245eaa3c55_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentNumberofExtensions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, number of extensions</link:label>
    <link:label id="lab_mo_DebtInstrumentNumberofExtensions_label_en-US" xlink:label="lab_mo_DebtInstrumentNumberofExtensions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Extensions</link:label>
    <link:label id="lab_mo_DebtInstrumentNumberofExtensions_documentation_en-US" xlink:label="lab_mo_DebtInstrumentNumberofExtensions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Extensions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentNumberofExtensions" xlink:href="mo-20200930.xsd#mo_DebtInstrumentNumberofExtensions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentNumberofExtensions" xlink:to="lab_mo_DebtInstrumentNumberofExtensions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_08e9a98d-9b19-4d41-8c30-031a8830f6c8_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesFederalMember_54c82865-7fea-496b-a505-d1fbc4ed397f_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesFederalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Federal [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFederalMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesFederalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Federal [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFederalMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesFederalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Federal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFederalMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesFederalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesFederalMember" xlink:to="lab_mo_EngleProgenyCasesFederalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_9494f91d-70a1-4058-b077-d32f6b889d66_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, period for decertified class members to file individual actions against defendants</link:label>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_label_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</link:label>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_documentation_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:href="mo-20200930.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:to="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_666320ea-386a-4a74-ba90-4766b25bf370_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_723031ee-122d-4f30-acf3-c8b1d52e6785_terseLabel_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, administration and research costs</link:label>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_label_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, Administration and Research Costs</link:label>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_documentation_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts" xlink:href="mo-20200930.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MarketingAdministrationandResearchCosts" xlink:to="lab_mo_MarketingAdministrationandResearchCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesMember_3015312e-8a4d-423b-853c-aa6956f9ba85_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesMember_label_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesMember_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesMember" xlink:to="lab_mo_USDDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_7c721214-75d3-47f5-ba6d-3730485e9c5e_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesDueTwoThousandandFiftyMember_edf65d2c-ee2c-4c58-8922-44902550bfd4_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesDueTwoThousandandFiftyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2050 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDueTwoThousandandFiftyMember_label_en-US" xlink:label="lab_mo_USDDenominatedNotesDueTwoThousandandFiftyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due Two Thousand and Fifty [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDueTwoThousandandFiftyMember_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesDueTwoThousandandFiftyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due Two Thousand and Fifty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDueTwoThousandandFiftyMember" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesDueTwoThousandandFiftyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesDueTwoThousandandFiftyMember" xlink:to="lab_mo_USDDenominatedNotesDueTwoThousandandFiftyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_bd94343f-58d2-4f74-b51e-dd0a9a9e25e4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_2e8ebe74-fa98-4e5a-9c66-86c6b32c35bc_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AK_96bd8d77-5d65-4ee5-93c2-2d0d7abd9021_terseLabel_en-US" xlink:label="lab_stpr_AK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alaska [Member]</link:label>
    <link:label id="lab_stpr_AK_label_en-US" xlink:label="lab_stpr_AK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALASKA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_AK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AK" xlink:to="lab_stpr_AK" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_ddbff13d-329e-4046-b73e-29ddb29fab71_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_90f4fffa-f754-4355-a9a8-38d3cbe60736_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_6a63c2e8-0fb9-4d7d-8b68-83835a9a6efa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_704f5f55-b5a3-48d6-b849-d354c22a95d4_terseLabel_en-US" xlink:label="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, rescinded authorized repurchase amount</link:label>
    <link:label id="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_label_en-US" xlink:label="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Rescinded Authorized Repurchase Amount</link:label>
    <link:label id="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_documentation_en-US" xlink:label="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Rescinded Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:href="mo-20200930.xsd#mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:to="lab_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_5cde9c9b-6b02-410c-a7cd-2df1d19f3791_terseLabel_en-US" xlink:label="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI</link:label>
    <link:label id="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_label_en-US" xlink:label="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles</link:label>
    <link:label id="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_documentation_en-US" xlink:label="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:href="mo-20200930.xsd#mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:to="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_ab362f11-17f3-433d-8e07-221a95ac1693_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_4ca1b150-bee7-4401-be64-014be9bc8b17_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofSettlementDevelopments_f2616dc0-17a8-44cf-a8fd-5f8006600265_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofSettlementDevelopments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of settlement developments</link:label>
    <link:label id="lab_mo_LossContingencyNumberofSettlementDevelopments_label_en-US" xlink:label="lab_mo_LossContingencyNumberofSettlementDevelopments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Settlement Developments</link:label>
    <link:label id="lab_mo_LossContingencyNumberofSettlementDevelopments_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofSettlementDevelopments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Settlement Developments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofSettlementDevelopments" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofSettlementDevelopments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofSettlementDevelopments" xlink:to="lab_mo_LossContingencyNumberofSettlementDevelopments" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CronosGroupInc.Member_a814d868-b36d-4c7f-b52a-cfa09487ae00_verboseLabel_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos [Member]</link:label>
    <link:label id="lab_mo_CronosGroupInc.Member_label_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group Inc. [Member]</link:label>
    <link:label id="lab_mo_CronosGroupInc.Member_documentation_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CronosGroupInc.Member" xlink:to="lab_mo_CronosGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_f42cd20b-f55f-4846-a25c-6c32e025d356_terseLabel_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_label_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_documentation_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember" xlink:href="mo-20200930.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TobaccoandHealthLitigationCasesMember" xlink:to="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_fb70a446-ffae-48e6-8193-4bcfaaa206d8_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_e4e8c4d7-9c18-4663-a4f2-26c96e418e8f_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Possible decrease in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_abae2b46-0253-4924-aa0d-80d60aeef6bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MarketingAdministrationAndResearchCostsMember_9ede8e0a-5fd0-46c5-a317-dab9467fed74_terseLabel_en-US" xlink:label="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Administration And Research Costs [Member]</link:label>
    <link:label id="lab_mo_MarketingAdministrationAndResearchCostsMember_label_en-US" xlink:label="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Administration And Research Costs [Member]</link:label>
    <link:label id="lab_mo_MarketingAdministrationAndResearchCostsMember_documentation_en-US" xlink:label="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Administration And Research Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember" xlink:href="mo-20200930.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MarketingAdministrationAndResearchCostsMember" xlink:to="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_66dc4509-7906-45a7-8fb5-4eef510f0ded_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_dc85b7fb-4303-489f-8471-e213c0525f7b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, upward price adjustment, cumulative amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_67195964-e995-4430-ab41-bf720368ef3f_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_a4381b7b-c48e-44de-b62e-c8cff105aed1_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStockDividendRateAnnualPerShare_9b9f9beb-1bb6-40f9-8ac2-1a3ec8924a80_terseLabel_en-US" xlink:label="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, dividend rate, annual (in usd per share)</link:label>
    <link:label id="lab_mo_CommonStockDividendRateAnnualPerShare_label_en-US" xlink:label="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Rate, Annual, Per Share</link:label>
    <link:label id="lab_mo_CommonStockDividendRateAnnualPerShare_documentation_en-US" xlink:label="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Rate, Annual, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRateAnnualPerShare" xlink:href="mo-20200930.xsd#mo_CommonStockDividendRateAnnualPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStockDividendRateAnnualPerShare" xlink:to="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_9eaf1893-9c98-4529-ae77-b3f860d81a1e_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e4ed6290-fb77-4ddf-b7fa-7d65e11d1b02_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_03739546-f888-4bbb-9ad7-df3b3bca71be_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_6d1028da-1a4c-4cc4-a6d1-ac03b9ff7df9_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_eed8d437-dd89-4480-bd95-23287ffed449_terseLabel_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Governments Lawsuit [Member]</link:label>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_label_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Governments Lawsuit [Member]</link:label>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_documentation_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Government's Lawsuit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember" xlink:href="mo-20200930.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_FederalGovernmentsLawsuitMember" xlink:to="lab_mo_FederalGovernmentsLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_d52d39ad-f90c-4f4e-b8f3-87b99a9ed73a_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states with settled litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:to="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_7683169b-0b27-449b-abe0-26cdc1bef273_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, beginning of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_b974d932-b88e-440d-9839-1f0952cd035e_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, end of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EvaporLitigationMember_88a61f35-7888-4371-bbb5-2e3240bf8495_terseLabel_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:label id="lab_mo_EvaporLitigationMember_label_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:label id="lab_mo_EvaporLitigationMember_documentation_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember" xlink:href="mo-20200930.xsd#mo_EvaporLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EvaporLitigationMember" xlink:to="lab_mo_EvaporLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_e2d9553b-907e-421f-9e2b-72ffcfc5cee8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward" xlink:to="lab_us-gaap_LossContingencyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_12a7e369-221d-4723-bd45-c239f2a6c220_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_cc3bb296-6d08-4e51-a10a-60576fcf9ccf_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesHarrisMember_e897e626-ee2a-4f42-ad99-a78402d805c1_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesHarrisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Harris [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHarrisMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesHarrisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Harris [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHarrisMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesHarrisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Harris [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHarrisMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesHarrisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesHarrisMember" xlink:to="lab_mo_EngleProgenyCasesHarrisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_2b4d218f-143f-4f27-bd0e-008cd87ec5ce_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:href="mo-20200930.xsd#mo_ValuationAllowanceForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:to="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b1c8e1aa-b1ec-4b7c-9c41-6d1c5824512e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod_adfe7cb5-d6dd-4fb1-97f9-fe889bf5455c_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, no litigation period</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, No Litigation Period</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, No Litigation Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecided_df8bffde-16e4-4d27-ba3a-ce3af5bf35b2_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts returned</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecided_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecided_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecided" xlink:to="lab_mo_LossContingencyClaimsDecided" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_38fe505c-7745-4562-87fe-8da15cda659c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares for basic and diluted EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_8cc1a3a3-bb2e-4381-bd8e-55b9cc60294f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment and exit costs, net of cash paid</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfDisputesOutstanding_9ad5fc8f-bbff-46d2-b34a-5ca78fdd8c33_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfDisputesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of disputes outstanding</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfDisputesOutstanding_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfDisputesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Disputes Outstanding</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfDisputesOutstanding_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfDisputesOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Disputes Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfDisputesOutstanding" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfDisputesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfDisputesOutstanding" xlink:to="lab_mo_LossContingencyNumberOfDisputesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_29f773ae-e005-4b3c-b598-2de88078e852_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at begging of period</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_9a69d67b-4684-49c4-9588-a90e40007552_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_0e084059-1cad-43fb-be00-455715af6206_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_3e1357be-39f1-4faf-9444-a2d570e157ed_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash spent</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_bd51cceb-9238-4047-8075-ba359aa5f5c3_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_83899893-ed15-46cf-bad2-d933914fd491_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_7ef590b9-1239-49d8-a14a-a3793f2038f3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingLawsuitFiledBySchoolDistrictMember_8fd98f6c-141b-498c-8a56-864e1366d031_terseLabel_en-US" xlink:label="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuit Filed By School District [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitFiledBySchoolDistrictMember_label_en-US" xlink:label="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuit Filed By School District [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitFiledBySchoolDistrictMember_documentation_en-US" xlink:label="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuit Filed By School District [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:href="mo-20200930.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:to="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_0db887c3-f156-452c-bbe9-d0a8cd014d7c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_5e758e54-fbd9-4d4f-967d-c45f5ad1661a_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_COVID19Member_ff259ef2-3e8a-4b34-8571-39a6491d4306_terseLabel_en-US" xlink:label="lab_mo_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:label id="lab_mo_COVID19Member_label_en-US" xlink:label="lab_mo_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:label id="lab_mo_COVID19Member_documentation_en-US" xlink:label="lab_mo_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_COVID19Member" xlink:href="mo-20200930.xsd#mo_COVID19Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_COVID19Member" xlink:to="lab_mo_COVID19Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_b3ead113-8710-4179-90ff-434ddacfa660_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value, gross asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_10a3b01a-7687-4660-90d5-2deca7c1d1ed_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6c33d06c-ece2-4de2-a322-b09bfd40558b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_3274547f-38f3-4f2a-95f8-4070d709d46a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesTheisMember_fb832e50-2e5b-46c3-830f-0a3a650a93d4_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesTheisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Theis [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesTheisMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesTheisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Theis [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesTheisMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesTheisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Theis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesTheisMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesTheisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesTheisMember" xlink:to="lab_mo_EngleProgenyCasesTheisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1a7c24a3-0873-4590-ba69-84fb52ad113f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_48f35a3e-0f9b-40eb-80ae-4b6963bf86ab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember_10acb162-2a09-48d6-b664-9fd2e51caba9_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due 2030 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember_label_en-US" xlink:label="lab_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due Two Thousand And Thirty [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes Due Two Thousand And Thirty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesDueTwoThousandAndThirtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember" xlink:to="lab_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_45fee2fd-30a7-40b5-90e4-980d48307a98_terseLabel_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, reduction to cost of sales</link:label>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_label_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Reduction To Cost Of Sales</link:label>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_documentation_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Reduction To Cost Of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales" xlink:href="mo-20200930.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyReductionToCostOfSales" xlink:to="lab_mo_LossContingencyReductionToCostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_af58608a-3827-4d02-8511-cdb4dcd03652_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_e7093084-d505-42ab-921d-fceb7f4aa3dd_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_14c76145-5cbb-499f-9556-bbfb2760e556_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesDuignanMember" xlink:to="lab_mo_EngleProgenyCasesDuignanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_2ebbf7aa-f63a-4a83-8cad-02449ab53f31_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:href="mo-20200930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_035b50a4-4b62-445f-8c70-c28f95d09951_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_bce8098f-5512-42ca-b323-a90a1eee8dac_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_2a662ce8-bb80-43a8-b977-6394cf9e53b6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_03636b62-63ce-4d5a-b8d0-36e028e191a1_terseLabel_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $0.33 1/3 par value [Member]</link:label>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_label_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 0.33 1/3 Par Value [Member]</link:label>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_documentation_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 0.33 1/3 Par Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember" xlink:href="mo-20200930.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock0.3313ParValueMember" xlink:to="lab_mo_CommonStock0.3313ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_9803741e-3309-4426-8090-7e8b4789ad7e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_9fff6361-4352-476b-9426-46a42f839804_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected period for satisfaction of performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:to="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_f5f8fd0e-46af-4d14-bf7e-9bf458377892_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_243adbe3-58ad-4490-a959-fd4fe5930da9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_f84ef8ad-0e6b-4c57-afce-b7df6c3a60ce_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_39e42347-bfd0-45c9-8124-ac1f954d724c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_680898c6-53fc-4fac-b187-6df30036a530_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_FL_b5f0f9c3-9ed8-4abb-b992-e6db68e60072_terseLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Florida [Member]</link:label>
    <link:label id="lab_stpr_FL_label_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLORIDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_FL" xlink:to="lab_stpr_FL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63748dcc-3968-4a0a-9050-0ba0538430ed_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares for diluted EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_00a1881b-2e6b-4cee-a98f-3cc30274e19a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_e17f2b71-ea18-4499-ab25-a6ba8438111f_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_4e41b683-fd55-483d-9343-b24d45400b3c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_e930040b-5716-43f0-88e4-9bbd4d6bf52b_verboseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d6ab95a1-4a49-4dbd-9016-8b4f8a83ca65_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (losses) per share attributable to Altria (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_58fb49e9-06f4-484a-901d-ac70889d222b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b17a42a6-85b6-4b50-a641-80b218b70d5b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_e30d1254-3af9-42e6-b30e-bdd6a92776f3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_07928f0a-1eb5-4ca0-9f18-9afd4a2cd9b7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_940fa389-d4d8-4fb1-ae7a-a82a8891d426_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentMember_6a3dc4a5-f461-4e45-8265-66cb90780748_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment [Member]</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentMember_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentMember" xlink:to="lab_us-gaap_PurchaseCommitmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_981fd7d7-121a-4e74-9064-400a09b80399_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesPollariMember" xlink:to="lab_mo_EngleProgenyCasesPollariMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisUSAMember_6ff6641a-b2a2-4507-91a0-e37844c3d6a6_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PM USA [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAMember_label_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisUSAMember" xlink:to="lab_mo_PhilipMorrisUSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_19460d83-72a5-4f9d-b98b-252688cb8c4a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_48d168f1-469c-420b-9d38-a52280ef157d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_adfd1b5c-321f-4b99-add7-28768313cf17_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ClassActionLawsuitMember_8cf0d5fa-c63a-40f6-9433-3fc6776ce3d4_terseLabel_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_ClassActionLawsuitMember_label_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_ClassActionLawsuitMember_documentation_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember" xlink:href="mo-20200930.xsd#mo_ClassActionLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ClassActionLawsuitMember" xlink:to="lab_mo_ClassActionLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_d97614e2-6196-44e7-a8e9-fa919a4cf98f_netLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement interest expense (income)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementInterest" xlink:to="lab_us-gaap_LitigationSettlementInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_5810e6e3-3bd2-4d0d-916d-aba894f85d62_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, credits to offset payments</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_d673f427-bc23-491e-96ef-635ee8d2a33d_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount ordered to be paid from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_dc7e2c4f-078f-4f24-8e6e-9e7bbfccc4bc_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AllowanceForSalesDiscountsGoods_d8a18293-cbe9-4e57-ac34-c23473ca9c10_terseLabel_en-US" xlink:label="lab_mo_AllowanceForSalesDiscountsGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for sales discounts, goods</link:label>
    <link:label id="lab_mo_AllowanceForSalesDiscountsGoods_label_en-US" xlink:label="lab_mo_AllowanceForSalesDiscountsGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Sales Discounts, Goods</link:label>
    <link:label id="lab_mo_AllowanceForSalesDiscountsGoods_documentation_en-US" xlink:label="lab_mo_AllowanceForSalesDiscountsGoods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Sales Discounts, Goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AllowanceForSalesDiscountsGoods" xlink:href="mo-20200930.xsd#mo_AllowanceForSalesDiscountsGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AllowanceForSalesDiscountsGoods" xlink:to="lab_mo_AllowanceForSalesDiscountsGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_313ba506-8486-4f2b-a4a5-c8169cf8286a_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_d46e9b38-0c6a-417d-80e2-ab728efbbfd6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_a97f4d5a-3a91-4153-8415-d5888b29e138_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_label_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember" xlink:href="mo-20200930.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenyCasesMember" xlink:to="lab_mo_NonEngleProgenyCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_adc1ed0b-e97d-4c17-8c7b-ea9377eed1ad_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_f5f012ad-49d2-4b63-84a5-43d38213f9e4_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_0ff12e72-3924-4bc6-bdb0-0694bb62024e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_8afa3e8b-5e0a-4e0d-99cf-eac8682b59c6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.33 1/3&#160;per share (2,805,961,317 shares issued)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USTLitigationMember_9a02c0f0-92bd-4fb6-91ea-102786be9b07_terseLabel_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:label id="lab_mo_USTLitigationMember_label_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:label id="lab_mo_USTLitigationMember_documentation_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember" xlink:href="mo-20200930.xsd#mo_USTLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USTLitigationMember" xlink:to="lab_mo_USTLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_703654ed-3840-418c-919a-a0cf48e53873_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_86b0bea6-bfbd-4f4a-9e54-13f98a4d9bc5_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, shares purchased, (CAD per share)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Price Per Share If Exercised</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Price Per Share If Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:to="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_0663f6b0-76da-4dc8-bc7a-87283d536408_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_abcaca7f-6ba5-43b5-96ed-49d7c075c188_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_06363c16-f185-42b9-8da4-5cffda9a01a8_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_b56b362a-d755-4a3b-a97f-e1644f208f7e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Volatility [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_103dae1f-d81f-4b50-a0cf-9e927ea8455d_terseLabel_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.200% Notes due 2027 [Member]</link:label>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_label_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 2.200% Notes Due 2027 [Member]</link:label>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_documentation_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 2.200% Notes Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member" xlink:href="mo-20200930.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock2.200NotesDue2027Member" xlink:to="lab_mo_CommonStock2.200NotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_e571907b-371f-42f2-b7db-1b26c027845e_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_4d989aea-8c89-479f-aba8-172057ef31d6_terseLabel_en-US" xlink:label="lab_mo_OtherRestructuringCostsIncludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Implementation Costs</link:label>
    <link:label id="lab_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_label_en-US" xlink:label="lab_mo_OtherRestructuringCostsIncludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs, Including Net Pension Cost (Credit)</link:label>
    <link:label id="lab_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_documentation_en-US" xlink:label="lab_mo_OtherRestructuringCostsIncludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs, Including Net Pension Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit" xlink:href="mo-20200930.xsd#mo_OtherRestructuringCostsIncludingNetPensionCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit" xlink:to="lab_mo_OtherRestructuringCostsIncludingNetPensionCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_a452792e-2336-4df4-9581-bc4c439c12d6_terseLabel_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_label_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_documentation_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember" xlink:href="mo-20200930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingIndividualLawsuitsMember" xlink:to="lab_mo_PendingIndividualLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ae9d0e95-8bd5-438d-95e6-147794dba23a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_49550b03-6cef-472a-bb8a-5255b1f8b934_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_5bc923f3-902b-4996-bcad-337ea3e7c7e0_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_6178e86c-d4cb-4074-a788-04df98c7837d_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_11a9df00-02f1-404c-ac1f-4af47d9508ec_terseLabel_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_label_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_documentation_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:href="mo-20200930.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:to="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_d4c8a009-b732-4a40-a57a-b6e2c59bed57_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_DE_2eb21d15-0dcd-44b9-ad37-86b71edc1f6a_terseLabel_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delaware [Member]</link:label>
    <link:label id="lab_stpr_DE_label_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DELAWARE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_DE" xlink:to="lab_stpr_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_278e5c8f-63e1-4698-bb4d-d5626a8b0c62_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of inactive cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfInactiveCases" xlink:to="lab_mo_LossContingencyNumberOfInactiveCases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_08ad150f-5668-4c44-a742-e0b374a83c6c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_73a4e28c-9cfa-463c-8075-46394860c20e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_bf794364-6c40-47d0-8d72-f243a6632f46_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_be6186c5-8718-4503-affc-1230478318ca_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_43499e08-892f-496f-9c9c-c26c5d860d97_verboseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Free Interest Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37d45f9b-0396-49fb-967f-6860505bd609_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_f79c2bab-5ebc-40a7-b08d-8845be6474ec_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_2a7e5f7a-5dbb-419f-8895-f47125a0514f_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_985f8fd9-6cbb-4053-8cd9-60681238f5a0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMember_bb25a40e-a407-49c7-bc40-b35ec04a824a_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMember" xlink:to="lab_mo_EngleProgenyCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_32df089b-a0b8-468b-ba08-894f44ba79da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CT_4133bb5f-7f90-4738-ad33-086bcc1afa5a_terseLabel_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Connecticut [Member]</link:label>
    <link:label id="lab_stpr_CT_label_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONNECTICUT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CT" xlink:to="lab_stpr_CT" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_b59fefed-7b2b-443b-bd6c-80bbbf175bc0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_70c74ea5-7a10-4121-bfae-41fba59eeaf2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_2d2ee81c-c569-4be7-b615-44609019d055_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity attributable to Altria</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_72acbd52-12d8-4918-a417-63ae3e23f81c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_d1359274-3438-4d08-b272-98f1c59f48ec_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_DC_110a06a2-41f9-4a90-8403-64bbae3d6873_terseLabel_en-US" xlink:label="lab_stpr_DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">District of Columbia [Member]</link:label>
    <link:label id="lab_stpr_DC_label_en-US" xlink:label="lab_stpr_DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISTRICT OF COLUMBIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_DC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_DC" xlink:to="lab_stpr_DC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_c11303db-b306-4c8f-a8f3-54617bbcea21_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Equity Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_0b5f9865-31bd-46d5-8fc9-0301d2d57c55_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9cc1df85-35a2-47a0-8f12-42fd75f60ef3_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive losses</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_bf3a90ac-467c-4a7c-9994-a352c86763e2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_22270653-1595-4de6-928b-aab84d5970a9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_956b5cf5-0f52-409d-8436-f4f0f53d00fb_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ffdef1c7-f1ce-489e-b63c-1f732e6e0e1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_e0751c38-5c3f-404a-a91c-c80740665f91_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded, value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_1e124a8f-9ba4-4b1a-827b-e7dd0519f39e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_2be26fec-e886-4f8f-8f85-e95fe17288ca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3b3233a8-9e1b-4b35-a20a-df1b6829364c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_d2163112-d703-482b-a770-018fc2532f2a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_19acb85a-ae23-44cb-9d3f-d5bb88233581_totalLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_b4956061-6fc9-4656-b7a0-587e2a91d554_terseLabel_en-US" xlink:label="lab_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment and exit costs</link:label>
    <link:label id="lab_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_791b6b2e-5733-49f3-b697-eac0c75f5e25_verboseLabel_en-US" xlink:label="lab_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, Asset Impairment and Exit Costs</link:label>
    <link:label id="lab_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_label_en-US" xlink:label="lab_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit)</link:label>
    <link:label id="lab_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_documentation_en-US" xlink:label="lab_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" xlink:to="lab_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_45853405-7270-4eec-8ecd-c6d19b8b511e_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesWeingartandHancockMember" xlink:to="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencySettlementAgreementsNumber_1d7bd452-11d5-4792-8af7-59bbe1c6e2c4_terseLabel_en-US" xlink:label="lab_mo_LossContingencySettlementAgreementsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement agreements, number</link:label>
    <link:label id="lab_mo_LossContingencySettlementAgreementsNumber_label_en-US" xlink:label="lab_mo_LossContingencySettlementAgreementsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreements, Number</link:label>
    <link:label id="lab_mo_LossContingencySettlementAgreementsNumber_documentation_en-US" xlink:label="lab_mo_LossContingencySettlementAgreementsNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreements, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencySettlementAgreementsNumber" xlink:href="mo-20200930.xsd#mo_LossContingencySettlementAgreementsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencySettlementAgreementsNumber" xlink:to="lab_mo_LossContingencySettlementAgreementsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_2552c3ba-fed2-4688-8562-c5a647d42971_terseLabel_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia and Saskatchewan [Member]</link:label>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_label_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia, Saskatchewan [Member]</link:label>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_documentation_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia, Saskatchewan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember" xlink:href="mo-20200930.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_BritishColumbiaSaskatchewanMember" xlink:to="lab_mo_BritishColumbiaSaskatchewanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HelixInnovationsLLCMember_445a230b-b14b-4bf0-bb3b-57acf27a133d_terseLabel_en-US" xlink:label="lab_mo_HelixInnovationsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Helix Innovations LLC [Member]</link:label>
    <link:label id="lab_mo_HelixInnovationsLLCMember_label_en-US" xlink:label="lab_mo_HelixInnovationsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Helix Innovations LLC [Member]</link:label>
    <link:label id="lab_mo_HelixInnovationsLLCMember_documentation_en-US" xlink:label="lab_mo_HelixInnovationsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Helix Innovations LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember" xlink:href="mo-20200930.xsd#mo_HelixInnovationsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HelixInnovationsLLCMember" xlink:to="lab_mo_HelixInnovationsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_7645c0e6-c170-4786-8aa6-f25708ed5b7f_terseLabel_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero damages verdicts</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_label_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdicts</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_documentation_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdicts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts" xlink:href="mo-20200930.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyZeroDamagesVerdicts" xlink:to="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesJordanMember_b88a923b-08ef-4e00-ae3f-d1a22e8a9172_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesJordanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Jordan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesJordanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesJordanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Jordan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesJordanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesJordanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Jordan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesJordanMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesJordanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesJordanMember" xlink:to="lab_mo_EngleProgenyCasesJordanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_398896c7-ad9c-4fdd-9cef-b694cd70475f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_426d3baa-846f-4299-8f8b-adcaaaec488a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_32ea564c-62eb-4ecc-8dd7-063c1cb37592_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_8c50872d-82fb-4b3a-85e6-ddc33e8aa3e2_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_115dc58a-446c-4eb9-b441-5c39a70bcdb0_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_b4d35748-60d3-4126-bb21-bbaaa780c232_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_b5b5b5ef-9adb-4eee-a056-e21b5c045cb3_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_d60cd2ee-6408-45e9-b40b-8e942b5bd929_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:href="mo-20200930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_029271f4-3723-40f3-a63a-d3f771460cca_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_16b917cb-e463-4cdc-84d2-2e2fd92d515f_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State settlement agreements attorney fees annual cap</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_label_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Legal Fees Payable, Maximum</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Legal Fees Payable, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:href="mo-20200930.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:to="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c47409a1-9cf9-4b90-8f02-4bfbafbf9df1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_d71b7eae-7569-43eb-8e22-a1de2d83d938_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgments paid (approximately)</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_c8969467-99e0-474d-bf2e-92d58c9decaa_terseLabel_en-US" xlink:label="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact deferred taxes</link:label>
    <link:label id="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_label_en-US" xlink:label="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Deferred Tax Rate</link:label>
    <link:label id="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_documentation_en-US" xlink:label="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Deferred Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:href="mo-20200930.xsd#mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:to="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_f91cacaf-7240-4948-a6ad-9e80430f9b2a_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of independent board members upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_4fa0e558-58c5-4b5b-b549-688cbd8d4d74_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses) attributable to Altria</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_7eab0a4f-e86e-4c7f-96a9-48c0dd8a7a4c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses) attributable to Altria</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39d52c59-c05d-4b5e-a24c-543d2c9ca852_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash effects of changes:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_528d467d-1817-45b1-a528-1efe56b7dc14_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_875300fc-0b8f-4a61-97e0-97db7d4c0b5e_verboseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_7243f408-3fbc-4f2d-b349-bdf28022d86c_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a1006d5e-f490-4e3b-a5c1-a09f782c369e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_885896f5-3bd7-41d4-812f-c04bd2715c17_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock1.000NotesDue2023Member_37b2d920-0ed0-4960-a1a3-271a29a4acd5_terseLabel_en-US" xlink:label="lab_mo_CommonStock1.000NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2023 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.000NotesDue2023Member_label_en-US" xlink:label="lab_mo_CommonStock1.000NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.000% Notes Due 2023 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.000NotesDue2023Member_documentation_en-US" xlink:label="lab_mo_CommonStock1.000NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.000% Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.000NotesDue2023Member" xlink:href="mo-20200930.xsd#mo_CommonStock1.000NotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock1.000NotesDue2023Member" xlink:to="lab_mo_CommonStock1.000NotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_8d2f9f5b-7b25-4581-b067-f55801f2f816_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_5e6e8dde-2de0-4891-bf3c-bd59b803d7b7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d1ed27a5-d66a-4f47-9043-35bfcdd150d0_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_8588461a-9e68-47b4-9ee3-5e026ffb4295_terseLabel_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Guidance Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_label_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:to="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4200f0c2-47eb-4c77-8082-f1b0ad8d6e45_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (earnings) losses attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_b2c0d8fb-d08c-41ee-8c4a-f1232ea04f15_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share data:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LightsUltraLightsClassActionsMember_f8c3a56c-c5fc-4334-8e22-3bfcf752083a_terseLabel_en-US" xlink:label="lab_mo_LightsUltraLightsClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights Ultra Lights Class Actions [Member]</link:label>
    <link:label id="lab_mo_LightsUltraLightsClassActionsMember_label_en-US" xlink:label="lab_mo_LightsUltraLightsClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights Ultra Lights Class Actions [Member]</link:label>
    <link:label id="lab_mo_LightsUltraLightsClassActionsMember_documentation_en-US" xlink:label="lab_mo_LightsUltraLightsClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights/Ultra Lights Class Actions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsUltraLightsClassActionsMember" xlink:href="mo-20200930.xsd#mo_LightsUltraLightsClassActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LightsUltraLightsClassActionsMember" xlink:to="lab_mo_LightsUltraLightsClassActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_abf17ff8-ebb5-4654-baa2-78a9290f1319_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_e4d0fc34-150a-4dee-99e0-34dd45036632_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_c45a976d-03ca-4e88-ba25-c7bc92ed510e_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_label_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:to="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_b2d2cb23-f7d4-453b-8de0-3379fa8e9b5a_terseLabel_en-US" xlink:label="lab_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments, purchase price</link:label>
    <link:label id="lab_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_label_en-US" xlink:label="lab_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments and Derivative Instruments, Investing</link:label>
    <link:label id="lab_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_documentation_en-US" xlink:label="lab_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments and Derivative Instruments, Investing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" xlink:href="mo-20200930.xsd#mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" xlink:to="lab_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityContractMember_75db85af-8b6a-457c-9a52-9a48712054a7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract [Member]</link:label>
    <link:label id="lab_us-gaap_EquityContractMember_label_en-US" xlink:label="lab_us-gaap_EquityContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityContractMember" xlink:to="lab_us-gaap_EquityContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesDeanKerrivanMember_019daeff-8c24-4346-aa58-6cb4a9acf815_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesDeanKerrivanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Dean (Kerrivan) [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDeanKerrivanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesDeanKerrivanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Dean Kerrivan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDeanKerrivanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesDeanKerrivanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Dean Kerrivan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDeanKerrivanMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesDeanKerrivanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesDeanKerrivanMember" xlink:to="lab_mo_EngleProgenyCasesDeanKerrivanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember_098966d9-e5d1-4ad2-8ad8-648d33376570_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ed1ea9e2-a0ef-4b5a-9b88-ed194bbf1c77_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6d068832-ef9b-4b9c-8158-db2a44f99868_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b2956b0f-0d43-4a90-abac-1ffc80ed8623_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_WineSegmentMember_9d4b2649-dcfe-4d08-a4be-855acb6e7648_terseLabel_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:label id="lab_mo_WineSegmentMember_label_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:label id="lab_mo_WineSegmentMember_documentation_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember" xlink:href="mo-20200930.xsd#mo_WineSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_WineSegmentMember" xlink:to="lab_mo_WineSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_3d58f974-67d6-49aa-a9de-d13d09f2ce56_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pension costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PaymentsToAcquireBusinessesAndAssets_b00d10b6-a363-43c1-8b76-c29f40f51fdd_negatedTerseLabel_en-US" xlink:label="lab_mo_PaymentsToAcquireBusinessesAndAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of businesses and assets</link:label>
    <link:label id="lab_mo_PaymentsToAcquireBusinessesAndAssets_label_en-US" xlink:label="lab_mo_PaymentsToAcquireBusinessesAndAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses And Assets</link:label>
    <link:label id="lab_mo_PaymentsToAcquireBusinessesAndAssets_documentation_en-US" xlink:label="lab_mo_PaymentsToAcquireBusinessesAndAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses And Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentsToAcquireBusinessesAndAssets" xlink:href="mo-20200930.xsd#mo_PaymentsToAcquireBusinessesAndAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PaymentsToAcquireBusinessesAndAssets" xlink:to="lab_mo_PaymentsToAcquireBusinessesAndAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_af0ed447-a092-4845-a703-4c082ab0097d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, plan assets, contributions by employer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesRintoulMember_9b770c6f-3b01-4d8b-bb96-d6578f92c1d2_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesRintoulMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Rintoul [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesRintoulMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesRintoulMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Rintoul [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesRintoulMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesRintoulMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Rintoul</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesRintoulMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesRintoulMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesRintoulMember" xlink:to="lab_mo_EngleProgenyCasesRintoulMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_53bd362f-fe30-457b-82fc-60ca62fa8198_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ff4892c9-157e-45c2-b3fb-0d38564c892d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_d695fc43-2686-46bc-9262-a3c97a818703_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_9832ada0-6c14-4000-adab-c5ebac35450e_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Laramie [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Laramie [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Laramie [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingandHealthCaseLaramieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:to="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_fd9513e5-679c-462c-af6e-38d1c6d54cda_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation Adjustments and Other [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_dccbeaf1-24bc-4d16-8a75-04ac27b6a7d9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_a364f52c-46c1-4ccd-adc7-f96621d41612_terseLabel_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award activity</link:label>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_label_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net</link:label>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_documentation_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:href="mo-20200930.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:to="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_ceb4b42d-26a0-40f6-bed8-961ec399e258_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod_e28934c9-0492-44d8-8d57-3a80240e57f9_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, non-compete release trigger period</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Period</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentAggregateExercisePrice_018d14c0-f52a-4d69-84f4-4083e622b910_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, aggregate exercise price</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentAggregateExercisePrice_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Exercise Price</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentAggregateExercisePrice_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentAggregateExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:to="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_515576c7-7287-480a-9708-132b00b8ee45_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMember_a9633059-c5c1-4ce9-af39-d2816a6c4bb7_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesKaplanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesKaplanMember" xlink:to="lab_mo_EngleProgenyCasesKaplanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_d8130ddc-b1f1-4ea8-8ad2-15f2c5181530_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_cae91604-3c6f-4f29-8026-d96381d92433_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension provisions and postretirement, net</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_e88e2cfc-2c2d-4a8f-af01-b3a59b6e50dc_terseLabel_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Related to Litigation [Member]</link:label>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_label_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Related To Litigation [Member]</link:label>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_documentation_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Related To Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember" xlink:href="mo-20200930.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InterestExpenseRelatedToLitigationMember" xlink:to="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_673edbf7-7c68-46bf-b029-2a81fea4c9af_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_74d55be9-0a6f-4fad-9830-934d863ea4ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ce885990-4af2-47c0-b6f9-2b4ac8f9d6a9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_189c2d23-74af-4b5f-be6a-24bc5b49dde3_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_786fa5e5-0a8c-4880-8f75-f5ba57d530d3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_c5e721d5-e12e-4907-91b4-c2eb33b91f73_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax earnings (losses) recognized in net earnings</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e3222889-0095-40ef-85ba-632a3a03a64a_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease)</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_f04d1b8e-be74-46bc-aff0-285877d0e7b3_terseLabel_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero damages verdict modified</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_label_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdict Modified</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_documentation_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdict Modified</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified" xlink:href="mo-20200930.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyZeroDamagesVerdictModified" xlink:to="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_09f35225-4ae1-4cda-89cb-45978b55c1be_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesReiderandBanksMember" xlink:to="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_9d4bd712-eebf-4578-90e4-cbabc108fe46_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_119ee6f9-6c62-42a5-b10e-7c1e5fabf208_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesBergerMember_b630c7ba-8d4b-4244-bbc1-f69bed1d77b2_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesBergerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Berger [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesBergerMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesBergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Berger [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesBergerMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesBergerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Berger [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesBergerMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesBergerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesBergerMember" xlink:to="lab_mo_EngleProgenyCasesBergerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_43a61974-d7d8-4b0c-b5a9-047000626e46_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_295c73ab-7846-4468-95f3-463e20a069ce_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State settlement agreements annual payments</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_label_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Payment Amount</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Payment Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount" xlink:href="mo-20200930.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAnnualPaymentAmount" xlink:to="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMahfuzMember_f8984690-6ca5-45d4-9df6-ef5aa5da2356_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMahfuzMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Mahfuz [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMahfuzMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMahfuzMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Mahfuz [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMahfuzMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMahfuzMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Mahfuz [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMahfuzMember" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMahfuzMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMahfuzMember" xlink:to="lab_mo_EngleProgenyCasesMahfuzMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCasesTriedinASingleProceeding_54a00429-1995-46a3-81c5-8230132d1c74_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesTriedinASingleProceeding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of cases tried in a single proceeding</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesTriedinASingleProceeding_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesTriedinASingleProceeding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases Tried in A Single Proceeding</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesTriedinASingleProceeding_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesTriedinASingleProceeding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases Tried in A Single Proceeding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesTriedinASingleProceeding" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfCasesTriedinASingleProceeding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCasesTriedinASingleProceeding" xlink:to="lab_mo_LossContingencyNumberOfCasesTriedinASingleProceeding" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember_eeb51ca6-0a36-4e6a-a21b-bf33af4f3088_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Gentile [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Gentile [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Gentile</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingandHealthCaseGentileMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:to="lab_mo_NonEngleProgenySmokingandHealthCaseGentileMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_1406533c-6523-47d3-b1d3-f5801bc8b134_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7eca7deb-0a1c-4279-a57d-43145ee62591_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_474613a8-572a-4b4e-b00d-8cce49bbf96b_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_673799fd-2304-4820-ae05-fcac562e3e1b_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9e488d26-081d-48e5-b440-2cbbe01d6dc4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_8fcb7aa1-0e08-4e5e-b4f3-0eb35da5a71b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_4f66a10b-cb16-4def-b87b-2901680e5956_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_f822a08e-058a-4abb-a0fb-0c9a8349232a_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_141b1322-161f-45c2-af67-d6dfee1b3469_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetMeasurementInput_5045054e-a417-48d8-b8cb-c45a099952c7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, measurement input</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetMeasurementInput" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetMeasurementInput" xlink:to="lab_us-gaap_DerivativeAssetMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_92ef05c9-6b06-44bc-82ee-35467f594a99_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from Contracts with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_df6d0276-24a1-4b88-85af-709e095dd45a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_71df0b6d-d836-4869-b7c3-2694a13117c0_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage (approximately)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_b9564f3f-be2c-4fa1-8345-05ece2d4edb3_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_10d19000-4682-452f-9f7b-5066900befd0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f2399625-8c0b-4199-9b4f-b62d83877895_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6e3ba9b2-1416-4ac3-b4b9-49d12d3061bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a78acb97-1753-4cf4-ac47-0a76318d1282_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Background and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_0cc764cc-4b05-4f8a-a82e-a2999ede9b59_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Items</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table Text Block]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:href="mo-20200930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_4c0610f0-7a3d-47fc-9f15-a14a2b94a995_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTableTextBlock" xlink:to="lab_us-gaap_InvestmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_d946e4ee-15bd-4eff-a356-0d41314ae134_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_a817e11e-d44b-4e43-87dc-a5f32d0b565f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_f46cbcc4-6fe6-4bd4-bd1f-4f2a7b493657_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: contingently issuable performance stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Contingently Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_d1171fdb-6b69-4cc5-9f7b-667b50320596_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cf106ea5-9790-4739-a656-11287664461b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_88176f93-e624-471f-90c7-030b69889299_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_42df9914-1419-4745-a053-fee5c9a3cddf_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19f1fcd4-10d3-430a-8e52-c29cd0a0d3f5_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_92f84f43-e5e0-4edc-9b1a-0d729e72dc29_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (losses) per share attributable to Altria (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractWarrantMember_8c531d31-298d-403c-8cb4-dc6d2588690c_terseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_35e1dfcc-4f2a-4d29-9baf-01aed34a06c0_verboseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_label_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_documentation_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractWarrantMember" xlink:to="lab_mo_EquityContractWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AssetImpairmentandBusinessExitCosts_42175953-4b6f-4701-b939-efe233b668fb_totalLabel_en-US" xlink:label="lab_mo_AssetImpairmentandBusinessExitCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment and Exit Costs</link:label>
    <link:label id="lab_mo_AssetImpairmentandBusinessExitCosts_b69dc970-39f5-4538-9184-d8097344ede8_negatedTerseLabel_en-US" xlink:label="lab_mo_AssetImpairmentandBusinessExitCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate asset impairment and exit costs</link:label>
    <link:label id="lab_mo_AssetImpairmentandBusinessExitCosts_label_en-US" xlink:label="lab_mo_AssetImpairmentandBusinessExitCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment and Business Exit Costs</link:label>
    <link:label id="lab_mo_AssetImpairmentandBusinessExitCosts_documentation_en-US" xlink:label="lab_mo_AssetImpairmentandBusinessExitCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment and Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCosts" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AssetImpairmentandBusinessExitCosts" xlink:to="lab_mo_AssetImpairmentandBusinessExitCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3df03b9d-4061-4113-8396-833c553f16a2_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_252fc70a-6815-4d71-82cd-9c5117292336_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated_78777a3e-5416-403c-95ee-5ed5906c466c_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, number of independent directors nominated</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Independent Directors Nominated</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Independent Directors Nominated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated" xlink:to="lab_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_eef64f88-e965-49e2-bf89-c864b00d801d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_04052105-634e-4d67-ad0e-7aa2642033ad_totalLabel_en-US" xlink:label="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus amounts included in net periodic benefit income, excluding service cost, Total</link:label>
    <link:label id="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_label_en-US" xlink:label="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Restructuring Charges</link:label>
    <link:label id="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_documentation_en-US" xlink:label="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" xlink:to="lab_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_54b725c7-be97-4cf8-82a8-8ed8b625c0d7_terseLabel_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensatory damages awarded</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_label_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Value</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_documentation_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:href="mo-20200930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:to="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InventoryWriteOffMember_adb9ca7c-5e6c-420b-b28b-28b23ba94d70_terseLabel_en-US" xlink:label="lab_mo_InventoryWriteOffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-Off [Member]</link:label>
    <link:label id="lab_mo_InventoryWriteOffMember_label_en-US" xlink:label="lab_mo_InventoryWriteOffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-Off [Member]</link:label>
    <link:label id="lab_mo_InventoryWriteOffMember_documentation_en-US" xlink:label="lab_mo_InventoryWriteOffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-Off [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryWriteOffMember" xlink:href="mo-20200930.xsd#mo_InventoryWriteOffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InventoryWriteOffMember" xlink:to="lab_mo_InventoryWriteOffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_242124ae-26cf-411e-96a7-c83cf9e83dc8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_b8690f89-4f39-41ab-a90b-d8f801c8b197_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unfavorable verdicts</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Unfavorable, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Unfavorable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:to="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_547af818-977a-4695-a959-fbca78bba087_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of JUUL equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_4ab1169f-a6aa-481b-9a1b-c3d0b16db44a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of JUUL equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MaximumBondForAllDefendants_ab5ac679-1174-49a4-b23b-837e9049a924_terseLabel_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum bond for all defendants</link:label>
    <link:label id="lab_mo_MaximumBondForAllDefendants_label_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Bond For All Defendants</link:label>
    <link:label id="lab_mo_MaximumBondForAllDefendants_documentation_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Bond For All Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants" xlink:href="mo-20200930.xsd#mo_MaximumBondForAllDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MaximumBondForAllDefendants" xlink:to="lab_mo_MaximumBondForAllDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_adccf775-a39d-479b-b6da-2ead631b2ec1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_5d3ebebe-795a-49e6-85d9-0243a4d434f2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_17e73e7d-712c-44c4-9fa6-4ec70755c05e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_6d169b23-5881-4dfa-85ff-f8e9cf54d066_terseLabel_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_label_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ThreatenedLitigationMember" xlink:to="lab_us-gaap_ThreatenedLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_5cd88d6d-a9bd-4129-95f6-1605daa45a90_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_da1ef959-b0fd-4331-8a0e-354efdaad567_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_cc4558ca-c12f-4426-ac8d-5b64c725af26_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_WineBusinessStrategicResetMember_d936d057-4f12-4b7f-8f4d-19d79658bc49_terseLabel_en-US" xlink:label="lab_mo_WineBusinessStrategicResetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Business Strategic Reset [Member]</link:label>
    <link:label id="lab_mo_WineBusinessStrategicResetMember_label_en-US" xlink:label="lab_mo_WineBusinessStrategicResetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Business Strategic Reset [Member]</link:label>
    <link:label id="lab_mo_WineBusinessStrategicResetMember_documentation_en-US" xlink:label="lab_mo_WineBusinessStrategicResetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Business Strategic Reset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineBusinessStrategicResetMember" xlink:href="mo-20200930.xsd#mo_WineBusinessStrategicResetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_WineBusinessStrategicResetMember" xlink:to="lab_mo_WineBusinessStrategicResetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_24bee823-daf3-466c-8953-7fb4491c6484_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit line available under the agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_20437b23-a937-40ff-a896-bd68e8047bf6_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_a5f0b24b-5b32-4241-87a6-00e927976ef3_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, class action lawsuit</link:label>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_label_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action Lawsuit</link:label>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_documentation_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action Lawsuit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit" xlink:href="mo-20200930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClassActionLawsuit" xlink:to="lab_mo_LossContingencyClassActionLawsuit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_34fc89c6-2eae-4b6e-b234-be550cc43628_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_0d61ffa9-e309-4682-9823-b7744392bbd4_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_8d061802-3cc4-474d-a5a5-b1858addee88_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests [Member]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_a4f19b8c-c909-43dd-adc7-1df1b6a38070_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_af4985fc-444c-4955-85d1-6d60048a7fae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_418eed90-7a6f-4ed5-a852-75694f098e65_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_1fd933cc-f094-458f-a721-acd87009ddb1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Reinvested in the Business [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_221696fc-3dd4-412b-b81c-88cf7c4e09d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bb9b4922-44b4-4138-b3aa-9b989f78ef87_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_002ead5a-45bf-4d31-8ca9-bf6563fa532a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit (Income) Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_d1fbe000-8997-4687-82a4-de5ee0c10f27_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ABInBevMember_80cf08b1-e42a-4400-84ae-6ef387840ac6_terseLabel_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI [Member]</link:label>
    <link:label id="lab_mo_ABInBevMember_label_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AB InBev [Member]</link:label>
    <link:label id="lab_mo_ABInBevMember_documentation_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AB InBev [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember" xlink:href="mo-20200930.xsd#mo_ABInBevMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ABInBevMember" xlink:to="lab_mo_ABInBevMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_10567922-d237-4b33-8884-fc9fea58a961_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_988eb54d-97b3-43e7-af9e-e394c6e50dd5_terseLabel_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_label_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_documentation_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:href="mo-20200930.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:to="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MarylandMissouriNewMexicoandPennsylvaniaMember_6d58fd76-92bd-438c-985c-790ae469382d_terseLabel_en-US" xlink:label="lab_mo_MarylandMissouriNewMexicoandPennsylvaniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maryland, Missouri, New Mexico and Pennsylvania [Member]</link:label>
    <link:label id="lab_mo_MarylandMissouriNewMexicoandPennsylvaniaMember_label_en-US" xlink:label="lab_mo_MarylandMissouriNewMexicoandPennsylvaniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maryland, Missouri, New Mexico and Pennsylvania [Member]</link:label>
    <link:label id="lab_mo_MarylandMissouriNewMexicoandPennsylvaniaMember_documentation_en-US" xlink:label="lab_mo_MarylandMissouriNewMexicoandPennsylvaniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maryland, Missouri, New Mexico and Pennsylvania [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarylandMissouriNewMexicoandPennsylvaniaMember" xlink:href="mo-20200930.xsd#mo_MarylandMissouriNewMexicoandPennsylvaniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MarylandMissouriNewMexicoandPennsylvaniaMember" xlink:to="lab_mo_MarylandMissouriNewMexicoandPennsylvaniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7493ffb3-6cbb-4e17-a7d6-0f69e2af6f38_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement [Member]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6ad1b0a3-934c-47ac-9711-260164e6e116_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d89eff53-2176-4b03-8ab3-96cdec4dc493_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_da155963-54ed-4c15-824b-45c0570c0efc_terseLabel_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_label_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_documentation_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember" xlink:href="mo-20200930.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TobaccoandHealthJudgmentMember" xlink:to="lab_mo_TobaccoandHealthJudgmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_3bc0b994-8d29-4434-aa8a-e8dae0d4b8fc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_568ed7ad-67af-46a7-aba9-2d99f9735300_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfPreTrialResolutionCases_6b2c30e7-3f58-40dc-9d54-98a5e8b972c9_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfPreTrialResolutionCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of pre-trial resolution cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfPreTrialResolutionCases_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfPreTrialResolutionCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Pre-Trial Resolution Cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfPreTrialResolutionCases_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfPreTrialResolutionCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Pre-Trial Resolution Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPreTrialResolutionCases" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfPreTrialResolutionCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfPreTrialResolutionCases" xlink:to="lab_mo_LossContingencyNumberOfPreTrialResolutionCases" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationEscrowDeposit_564b7870-4756-42ef-add6-ad3c7fab3535_terseLabel_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security posted for appeal of judgments</link:label>
    <link:label id="lab_mo_LitigationEscrowDeposit_label_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Escrow Deposit</link:label>
    <link:label id="lab_mo_LitigationEscrowDeposit_documentation_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit" xlink:href="mo-20200930.xsd#mo_LitigationEscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationEscrowDeposit" xlink:to="lab_mo_LitigationEscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_46af4aef-6ea4-4770-acb2-4d98d1578e4f_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_a6d58ad3-1b96-41b8-ae70-497f3a26d643_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of repurchased stock (947,542,152 shares at September 30, 2020 and 947,979,763 shares at December 31, 2019)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_defc6d26-0ac2-4a89-8606-ed0b08604472_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Losses) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_10a21ac2-4f0d-4ac4-906b-50c0c509c89e_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_ae2612ce-d619-4feb-b37d-13a6cfed9f95_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ad62e716-bc4f-45d9-8ca7-438abb5dcc2b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_0a2972f4-505d-47d9-9ca7-0cc31f1aa523_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_77fd1ed4-b12f-4584-91eb-168cc9bce7f6_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_d5e43a44-aad8-45f5-ad9c-c35f04ced312_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_31905b70-7fe8-4ee8-a5f1-e375dea48619_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions_46fb12a3-675b-4517-a246-043e59a96241_negatedLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan contributions</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Pension and Other Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_14b7c4a6-505e-45d7-a6d7-fc8653975676_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_25bb5af4-e8e5-4a8a-9185-42469f5ff7d7_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of board members upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_32cb2e45-2a45-49cd-a1ca-8647c9abc0e9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>mo-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e67beae8-252b-44fc-aaf0-eb6cb882e4c7,g:3f7a85d8-ce11-4daa-b845-1d29043d3872-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.altria.com/role/CoverPage" xlink:type="simple" xlink:href="mo-20200930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7e1ca0eb-2399-47fb-a324-fffac31ec8f6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_70381b76-bfed-4c42-b34f-b961aa739a2d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1ca0eb-2399-47fb-a324-fffac31ec8f6" xlink:to="loc_dei_EntitiesTable_70381b76-bfed-4c42-b34f-b961aa739a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bbcaf8ba-e090-4ac7-9354-7881298c69b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_70381b76-bfed-4c42-b34f-b961aa739a2d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bbcaf8ba-e090-4ac7-9354-7881298c69b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bbcaf8ba-e090-4ac7-9354-7881298c69b8" xlink:to="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember_7cd69b35-d6b2-48a2-be23-bcc9d9560094" xlink:href="mo-20200930.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock0.3313ParValueMember_7cd69b35-d6b2-48a2-be23-bcc9d9560094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.000NotesDue2023Member_3cd01dd5-deb6-4710-8c17-325fa349ed40" xlink:href="mo-20200930.xsd#mo_CommonStock1.000NotesDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock1.000NotesDue2023Member_3cd01dd5-deb6-4710-8c17-325fa349ed40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member_292df015-0fcc-4687-98d5-b5d72cc33006" xlink:href="mo-20200930.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock1.700NotesDue2025Member_292df015-0fcc-4687-98d5-b5d72cc33006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member_a6465094-18a6-4ace-922c-6006c6fa8b57" xlink:href="mo-20200930.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock2.200NotesDue2027Member_a6465094-18a6-4ace-922c-6006c6fa8b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member_2c57732f-15e3-4749-b91e-f48a9fb14649" xlink:href="mo-20200930.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_459112c8-7691-4e27-a1ab-b4f65962e067" xlink:to="loc_mo_CommonStock3.125NotesDue2031Member_2c57732f-15e3-4749-b91e-f48a9fb14649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_70381b76-bfed-4c42-b34f-b961aa739a2d" xlink:to="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_206f33d4-8f9f-4e4f-991c-3d96d297e1d0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentType_206f33d4-8f9f-4e4f-991c-3d96d297e1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_2693ae4c-9dab-4ca5-aaa0-bfd4c383635d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentQuarterlyReport_2693ae4c-9dab-4ca5-aaa0-bfd4c383635d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c075da2c-0fe7-44e3-94dd-89a488edb111" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentPeriodEndDate_c075da2c-0fe7-44e3-94dd-89a488edb111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f8da45ec-e2e2-4bb0-acac-b1e538818b39" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentTransitionReport_f8da45ec-e2e2-4bb0-acac-b1e538818b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_517cf0b9-d01c-4e28-8293-b94737481721" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityFileNumber_517cf0b9-d01c-4e28-8293-b94737481721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e49260dd-431a-457e-8250-22086359a357" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityRegistrantName_e49260dd-431a-457e-8250-22086359a357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e6684d3e-b16b-43a2-81b6-ef18c77dd59a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e6684d3e-b16b-43a2-81b6-ef18c77dd59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8c7bf3d3-377e-49fb-b597-3f6b4ed8611d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityTaxIdentificationNumber_8c7bf3d3-377e-49fb-b597-3f6b4ed8611d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_95744500-0254-4a09-a45e-dc21d824d904" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityAddressAddressLine1_95744500-0254-4a09-a45e-dc21d824d904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3e9e06d9-30fd-4845-8332-13441ffaaf40" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityAddressCityOrTown_3e9e06d9-30fd-4845-8332-13441ffaaf40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7ccc1e2f-cf51-4fcb-9cfa-e71808b62108" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityAddressStateOrProvince_7ccc1e2f-cf51-4fcb-9cfa-e71808b62108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9b26f25d-b501-4b28-9393-b70c1a5a9d9a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityAddressPostalZipCode_9b26f25d-b501-4b28-9393-b70c1a5a9d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_898af1e6-057e-4d08-9867-a6be535c1715" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_CityAreaCode_898af1e6-057e-4d08-9867-a6be535c1715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_876b02b8-e36d-4128-8335-622c789c183b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_LocalPhoneNumber_876b02b8-e36d-4128-8335-622c789c183b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a8553527-410e-4430-a221-3d8e88827da7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_Security12bTitle_a8553527-410e-4430-a221-3d8e88827da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9c3c6771-2397-4c22-af4a-f0c383e89444" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_TradingSymbol_9c3c6771-2397-4c22-af4a-f0c383e89444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_69968397-2ca7-4fcf-9b04-d02eefabed60" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_SecurityExchangeName_69968397-2ca7-4fcf-9b04-d02eefabed60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_229c6a33-2dd6-45d0-a8f1-19a538c2f57b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityCurrentReportingStatus_229c6a33-2dd6-45d0-a8f1-19a538c2f57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_110c9d3b-feb6-40e5-a4bc-239d8707b80a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityInteractiveDataCurrent_110c9d3b-feb6-40e5-a4bc-239d8707b80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_81b56f17-bbfc-47a8-8568-c927321c3294" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityFilerCategory_81b56f17-bbfc-47a8-8568-c927321c3294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4949b3b7-8cb0-4f8f-a292-e6b040a2e331" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntitySmallBusiness_4949b3b7-8cb0-4f8f-a292-e6b040a2e331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b1569633-f7a8-4315-a0e4-2cc0b4f40eaa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityEmergingGrowthCompany_b1569633-f7a8-4315-a0e4-2cc0b4f40eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3f37c26f-e25c-4bc3-8e8e-6500cc3b85b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityShellCompany_3f37c26f-e25c-4bc3-8e8e-6500cc3b85b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_bec33123-358d-47f6-9683-a9f6c1989a62" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_bec33123-358d-47f6-9683-a9f6c1989a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_730da968-4720-43d7-9e63-a88b3aaca30b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_AmendmentFlag_730da968-4720-43d7-9e63-a88b3aaca30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ff8a42f6-4ff9-4e8c-ac8e-610e465be7ab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentFiscalYearFocus_ff8a42f6-4ff9-4e8c-ac8e-610e465be7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8301e6fe-e95f-415f-aa29-5d9bda0657e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8301e6fe-e95f-415f-aa29-5d9bda0657e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a6674263-8a0f-47c0-9354-ce4a16aaf548" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_EntityCentralIndexKey_a6674263-8a0f-47c0-9354-ce4a16aaf548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_48158696-f533-4aa2-bf3e-7b0cef12f435" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_bc8b7a69-97bc-4a73-b007-2b10b1c8b611" xlink:to="loc_dei_CurrentFiscalYearEndDate_48158696-f533-4aa2-bf3e-7b0cef12f435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6555c84c-af9b-42c6-adb9-97ecea851265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6555c84c-af9b-42c6-adb9-97ecea851265" xlink:to="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe3ab551-3006-4e84-a205-652db316b81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe3ab551-3006-4e84-a205-652db316b81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_4ed77d7d-dad9-4807-b851-7f071a28fe82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_ReceivablesNetCurrent_4ed77d7d-dad9-4807-b851-7f071a28fe82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_b2b4b1e3-dd96-4222-b116-a0899db436ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_InventoryNetAbstract_b2b4b1e3-dd96-4222-b116-a0899db436ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_7255d2d4-1fb6-465b-8976-ab78d0956100" xlink:href="mo-20200930.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b2b4b1e3-dd96-4222-b116-a0899db436ef" xlink:to="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_7255d2d4-1fb6-465b-8976-ab78d0956100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves_887ecefc-7439-4910-a60a-cadd4266b946" xlink:href="mo-20200930.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b2b4b1e3-dd96-4222-b116-a0899db436ef" xlink:to="loc_mo_OtherInventoryRawMaterialsNetofReserves_887ecefc-7439-4910-a60a-cadd4266b946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_43bc4fca-fbf3-4e57-ad3c-c39bc4b429a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b2b4b1e3-dd96-4222-b116-a0899db436ef" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_43bc4fca-fbf3-4e57-ad3c-c39bc4b429a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_7853a69d-3be5-43a7-ba92-4f3f695fbec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b2b4b1e3-dd96-4222-b116-a0899db436ef" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_7853a69d-3be5-43a7-ba92-4f3f695fbec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_327f0c97-8aca-4be7-83ea-844d3f43b1cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b2b4b1e3-dd96-4222-b116-a0899db436ef" xlink:to="loc_us-gaap_InventoryNet_327f0c97-8aca-4be7-83ea-844d3f43b1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_1beea7fc-b231-4d19-a0d2-8c8295dfd127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_OtherAssetsCurrent_1beea7fc-b231-4d19-a0d2-8c8295dfd127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a15d3ed1-7246-4d6e-a5ca-b2d60a092911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_AssetsCurrent_a15d3ed1-7246-4d6e-a5ca-b2d60a092911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_66e11dc0-5b46-420a-81b4-16595e019204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_66e11dc0-5b46-420a-81b4-16595e019204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_40d27dc7-4bcb-49e0-8e15-fee619d4b6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_40d27dc7-4bcb-49e0-8e15-fee619d4b6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d96c7c6f-6b2e-4456-a8a1-5663e34d77b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d96c7c6f-6b2e-4456-a8a1-5663e34d77b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_09b18c3d-ee6b-4be3-b3a2-8a88bf443add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_Goodwill_09b18c3d-ee6b-4be3-b3a2-8a88bf443add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_48df270b-442e-4b44-9c4d-20cf6d24e92d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_48df270b-442e-4b44-9c4d-20cf6d24e92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecurityInvestments_b44b0ea8-9ace-4ffa-a064-5f5875904bf8" xlink:href="mo-20200930.xsd#mo_EquitySecurityInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_mo_EquitySecurityInvestments_b44b0ea8-9ace-4ffa-a064-5f5875904bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6660f0f1-96c5-4be2-8e9c-b990ca0369b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6660f0f1-96c5-4be2-8e9c-b990ca0369b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e61f7053-adba-481b-aa28-68c9a3a47a63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9a89531f-8a90-4389-8877-05ee1ab31257" xlink:to="loc_us-gaap_Assets_e61f7053-adba-481b-aa28-68c9a3a47a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6555c84c-af9b-42c6-adb9-97ecea851265" xlink:to="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_14ac1d16-e908-46dc-878d-f6a21b4a2e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_LongTermDebtCurrent_14ac1d16-e908-46dc-878d-f6a21b4a2e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7d4a57a9-fc5c-4811-b686-b30f1f4cf467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_AccountsPayableCurrent_7d4a57a9-fc5c-4811-b686-b30f1f4cf467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_854359d7-5079-4799-a2ac-6ee07c616d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_854359d7-5079-4799-a2ac-6ee07c616d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_3f00d948-e8d3-4cec-bf41-154c915b7578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_854359d7-5079-4799-a2ac-6ee07c616d51" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_3f00d948-e8d3-4cec-bf41-154c915b7578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent_15c93ec6-3d48-46d1-88cd-5419cff81cf1" xlink:href="mo-20200930.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_854359d7-5079-4799-a2ac-6ee07c616d51" xlink:to="loc_mo_AccruedSettlementLiabilityCurrent_15c93ec6-3d48-46d1-88cd-5419cff81cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_37b719b7-0893-46ed-9b93-8f1809d66278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_854359d7-5079-4799-a2ac-6ee07c616d51" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_37b719b7-0893-46ed-9b93-8f1809d66278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_e5963994-5f2f-4af0-9d12-1ee8ea840d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_DividendsPayableCurrent_e5963994-5f2f-4af0-9d12-1ee8ea840d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fa77c61c-1d92-4c64-8d09-5d0c9652d735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_LiabilitiesCurrent_fa77c61c-1d92-4c64-8d09-5d0c9652d735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e074854f-fe99-42ec-9cb8-794f791507c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e074854f-fe99-42ec-9cb8-794f791507c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_99fc240c-42f1-4d82-82b0-40bafc6ba852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_99fc240c-42f1-4d82-82b0-40bafc6ba852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_64335f32-bca8-403a-b879-6657010caa7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_64335f32-bca8-403a-b879-6657010caa7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_abdc6642-6e2b-432f-8506-8d1bcc9af68a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_abdc6642-6e2b-432f-8506-8d1bcc9af68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9dbe7eb4-1b2a-463d-91c8-7746e2d6f819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9dbe7eb4-1b2a-463d-91c8-7746e2d6f819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0de6b1e0-f204-4712-986e-4c715c0512ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_26713667-6ab5-4ffc-8733-6703ee86f3e7" xlink:to="loc_us-gaap_Liabilities_0de6b1e0-f204-4712-986e-4c715c0512ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6cf1db46-6bdf-44e5-965f-71759e137c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6555c84c-af9b-42c6-adb9-97ecea851265" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6cf1db46-6bdf-44e5-965f-71759e137c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3761f03a-fb08-4c61-96db-3ed02d5e4111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6555c84c-af9b-42c6-adb9-97ecea851265" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3761f03a-fb08-4c61-96db-3ed02d5e4111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6555c84c-af9b-42c6-adb9-97ecea851265" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d0e1a667-a45f-410d-948a-ef8608a44e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:to="loc_us-gaap_CommonStockValue_d0e1a667-a45f-410d-948a-ef8608a44e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ac1e2c57-402e-4b64-8d39-e2cd11e99841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ac1e2c57-402e-4b64-8d39-e2cd11e99841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29944642-1bd8-4bdf-be7f-03d368058483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29944642-1bd8-4bdf-be7f-03d368058483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e0fb0c94-c813-4864-b4b4-2f8a277af539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e0fb0c94-c813-4864-b4b4-2f8a277af539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_3d766eb6-16df-40d4-888e-58c51c8877e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:to="loc_us-gaap_TreasuryStockValue_3d766eb6-16df-40d4-888e-58c51c8877e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_de769d3c-65cc-40f8-9b05-dcb23745f85d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:to="loc_us-gaap_StockholdersEquity_de769d3c-65cc-40f8-9b05-dcb23745f85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_35577e97-c4b9-42b6-b2a2-8c3c59e74e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:to="loc_us-gaap_MinorityInterest_35577e97-c4b9-42b6-b2a2-8c3c59e74e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_188aba75-4307-4cff-8f06-2a59a16a9e0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_94cb6cb1-ace8-45dd-bc8a-e267d1e00850" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_188aba75-4307-4cff-8f06-2a59a16a9e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_61b1c033-47b9-4d2c-a325-278042868d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6555c84c-af9b-42c6-adb9-97ecea851265" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_61b1c033-47b9-4d2c-a325-278042868d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_fe5b0148-3ec2-48ab-923a-14cde646cbdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_07d138e5-02b9-4a03-af47-2a1d2e539821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fe5b0148-3ec2-48ab-923a-14cde646cbdd" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_07d138e5-02b9-4a03-af47-2a1d2e539821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3fb29dfd-360b-4f68-ab88-656e5b50bb92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_07d138e5-02b9-4a03-af47-2a1d2e539821" xlink:to="loc_us-gaap_CommonStockSharesIssued_3fb29dfd-360b-4f68-ab88-656e5b50bb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1c5dc41-f02d-4f4a-a647-b816082d359d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_07d138e5-02b9-4a03-af47-2a1d2e539821" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1c5dc41-f02d-4f4a-a647-b816082d359d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_0b2a19ca-a370-43cf-a52f-1884eacff94c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_07d138e5-02b9-4a03-af47-2a1d2e539821" xlink:to="loc_us-gaap_TreasuryStockCommonShares_0b2a19ca-a370-43cf-a52f-1884eacff94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofEarnings"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db7e6ee9-5f1a-407e-874f-617daf829aa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db7e6ee9-5f1a-407e-874f-617daf829aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_33a49abf-a590-4e2a-8283-21b6ca15e0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_33a49abf-a590-4e2a-8283-21b6ca15e0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue_88d81b2c-8c5d-4350-aa07-1836e7f5ef9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_OtherCostOfOperatingRevenue_88d81b2c-8c5d-4350-aa07-1836e7f5ef9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9d81398e-403c-428f-9583-723da6c8a9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_GrossProfit_9d81398e-403c-428f-9583-723da6c8a9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts_541b73db-2763-4f52-a63a-5da022ddf178" xlink:href="mo-20200930.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_mo_MarketingAdministrationandResearchCosts_541b73db-2763-4f52-a63a-5da022ddf178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_307a0d5e-ca1b-49d5-b642-0035ac4df5dc" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_307a0d5e-ca1b-49d5-b642-0035ac4df5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_17026e69-b103-4dda-bd0d-091db8749a91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_OperatingIncomeLoss_17026e69-b103-4dda-bd0d-091db8749a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_2b8adde4-05c0-4ce8-b438-bdd7bd43025e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_2b8adde4-05c0-4ce8-b438-bdd7bd43025e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_f37c6c9f-bf5e-4041-8d9e-7a5ef4333003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_f37c6c9f-bf5e-4041-8d9e-7a5ef4333003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8949a070-f7fa-4741-9789-14922a4baa4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8949a070-f7fa-4741-9789-14922a4baa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_0c9102de-4690-4a75-80d9-7a2a2c2719fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_0c9102de-4690-4a75-80d9-7a2a2c2719fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_dcc05a09-d0b3-42ff-a5b7-f08f42af392e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_dcc05a09-d0b3-42ff-a5b7-f08f42af392e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b39f224f-5d4c-48ff-ad3e-884bf207ea81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b39f224f-5d4c-48ff-ad3e-884bf207ea81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fd718c75-001d-42f4-937b-42ead7185e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fd718c75-001d-42f4-937b-42ead7185e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e250b3cb-39e0-4503-b9ed-31dfeb75d62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_ProfitLoss_e250b3cb-39e0-4503-b9ed-31dfeb75d62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_22dd8b08-d369-47ef-a181-f1e42872f369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_22dd8b08-d369-47ef-a181-f1e42872f369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b41cd62d-1001-40e1-a1ad-a3838c0fc0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_NetIncomeLoss_b41cd62d-1001-40e1-a1ad-a3838c0fc0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_554588d8-cf50-41fd-be96-fd8ef95bb98a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c792a271-2f93-4146-b8f6-7aa7b604af99" xlink:to="loc_us-gaap_EarningsPerShareAbstract_554588d8-cf50-41fd-be96-fd8ef95bb98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_49226e59-9202-455a-8ffc-409f2c0cd207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_554588d8-cf50-41fd-be96-fd8ef95bb98a" xlink:to="loc_us-gaap_EarningsPerShareBasic_49226e59-9202-455a-8ffc-409f2c0cd207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4ccd4fd2-1241-46c0-8b5d-1ba028535923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_554588d8-cf50-41fd-be96-fd8ef95bb98a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4ccd4fd2-1241-46c0-8b5d-1ba028535923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveEarnings"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cf92d488-2bdd-4c4d-85e1-6076ed8f4de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9a1a5a61-ac67-4db3-afb1-69e5df09d187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cf92d488-2bdd-4c4d-85e1-6076ed8f4de5" xlink:to="loc_us-gaap_ProfitLoss_9a1a5a61-ac67-4db3-afb1-69e5df09d187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4c1e584a-5e8d-4396-a407-c4d38a6836b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cf92d488-2bdd-4c4d-85e1-6076ed8f4de5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4c1e584a-5e8d-4396-a407-c4d38a6836b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9c43ce86-df45-4654-8a14-9074613fd7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4c1e584a-5e8d-4396-a407-c4d38a6836b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9c43ce86-df45-4654-8a14-9074613fd7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax_8008eaab-049d-4a46-9454-922b188c8d34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4c1e584a-5e8d-4396-a407-c4d38a6836b9" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTax_8008eaab-049d-4a46-9454-922b188c8d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d2117809-9c28-4d04-9f78-4e455f3c7d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4c1e584a-5e8d-4396-a407-c4d38a6836b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d2117809-9c28-4d04-9f78-4e455f3c7d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c326f4c8-695c-4e28-847a-8c791c22bdf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4c1e584a-5e8d-4396-a407-c4d38a6836b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c326f4c8-695c-4e28-847a-8c791c22bdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9a3ff77c-8c45-4cee-81a2-c77141ce7335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cf92d488-2bdd-4c4d-85e1-6076ed8f4de5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9a3ff77c-8c45-4cee-81a2-c77141ce7335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b6a105c3-95ec-48b3-bdf9-64681765eaeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cf92d488-2bdd-4c4d-85e1-6076ed8f4de5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b6a105c3-95ec-48b3-bdf9-64681765eaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d9d951f1-a68d-481e-8f06-abfab046016b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cf92d488-2bdd-4c4d-85e1-6076ed8f4de5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d9d951f1-a68d-481e-8f06-abfab046016b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_92ff689d-4fdb-4126-a13b-0543b4b68a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_072dee3a-b7c2-46fa-816f-e8a07a50e5a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_92ff689d-4fdb-4126-a13b-0543b4b68a6b" xlink:to="loc_us-gaap_StatementTable_072dee3a-b7c2-46fa-816f-e8a07a50e5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e4a28331-604c-4b3e-951f-e77a4eb5fa25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_072dee3a-b7c2-46fa-816f-e8a07a50e5a4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e4a28331-604c-4b3e-951f-e77a4eb5fa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4a28331-604c-4b3e-951f-e77a4eb5fa25" xlink:to="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_97443164-c3f4-4276-9791-e9e583d9be38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_CommonStockMember_97443164-c3f4-4276-9791-e9e583d9be38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0127dae9-bd74-4ab8-8b93-5c42ebec6996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0127dae9-bd74-4ab8-8b93-5c42ebec6996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0a9e7d54-2d4c-4d5e-910d-f4d114174417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_RetainedEarningsMember_0a9e7d54-2d4c-4d5e-910d-f4d114174417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fdc355e2-e88c-470f-9e00-c2e180b8d8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fdc355e2-e88c-470f-9e00-c2e180b8d8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_626cf20d-18ab-4964-8ba4-d6bbff3289b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_TreasuryStockMember_626cf20d-18ab-4964-8ba4-d6bbff3289b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_055a7a8d-8034-4ad0-a29b-de6f593202b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ff69a6ec-9c88-44b3-93c0-ea1a796e0c7c" xlink:to="loc_us-gaap_NoncontrollingInterestMember_055a7a8d-8034-4ad0-a29b-de6f593202b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fc1710f9-d568-40f0-9821-e97f823e96a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_072dee3a-b7c2-46fa-816f-e8a07a50e5a4" xlink:to="loc_us-gaap_StatementLineItems_fc1710f9-d568-40f0-9821-e97f823e96a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fc1710f9-d568-40f0-9821-e97f823e96a8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0714c387-3a97-44d6-aa3b-97b167f9503c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0714c387-3a97-44d6-aa3b-97b167f9503c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_a045cd65-3440-4bcb-a339-4b0df05a2bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_a045cd65-3440-4bcb-a339-4b0df05a2bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d72d25d2-f9c0-4a18-930e-b70b28f12f65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d72d25d2-f9c0-4a18-930e-b70b28f12f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_d59ae52f-df14-4750-8329-d8bd6c087144" xlink:href="mo-20200930.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_d59ae52f-df14-4750-8329-d8bd6c087144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e123668f-d46c-45cb-aeea-e01e998b6fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_DividendsCommonStockCash_e123668f-d46c-45cb-aeea-e01e998b6fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_405038c0-270d-4d0e-9503-ba8b8c151c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_405038c0-270d-4d0e-9503-ba8b8c151c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_69230ab4-bda9-496f-a7a9-acdea8b1a9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_69230ab4-bda9-496f-a7a9-acdea8b1a9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_f6100314-36c2-431a-b6d0-f77fca75d2f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_StockholdersEquityOther_f6100314-36c2-431a-b6d0-f77fca75d2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_74d235d1-4457-4b14-88d8-83084ab7d883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d2c788-698d-4b8f-a2c3-e50ce4c643bd" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_74d235d1-4457-4b14-88d8-83084ab7d883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_74d17285-b540-49d4-b627-2c648ff85601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_eb0912d7-1927-498a-ab25-83425a45eb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_74d17285-b540-49d4-b627-2c648ff85601" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_eb0912d7-1927-498a-ab25-83425a45eb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_6d3f80f6-fa82-4ff4-bd2a-93c085fbea7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_74d17285-b540-49d4-b627-2c648ff85601" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_6d3f80f6-fa82-4ff4-bd2a-93c085fbea7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mo-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_47df13e6-8c84-41fa-89f0-45a0ca927aee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2236946-3e21-4e58-94e1-5adaa4b67b3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_47df13e6-8c84-41fa-89f0-45a0ca927aee" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2236946-3e21-4e58-94e1-5adaa4b67b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8ff15c30-2110-45d0-bfd6-2b6f362ce15b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2236946-3e21-4e58-94e1-5adaa4b67b3d" xlink:to="loc_us-gaap_ProfitLoss_8ff15c30-2110-45d0-bfd6-2b6f362ce15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2236946-3e21-4e58-94e1-5adaa4b67b3d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_87438b33-43ec-40a5-a33b-581c87ef831f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_87438b33-43ec-40a5-a33b-581c87ef831f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c8b648f5-8bb7-4fe7-9dd0-2cfcba49b093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c8b648f5-8bb7-4fe7-9dd0-2cfcba49b093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0f19b87d-6ad9-4401-829d-a39049df7cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0f19b87d-6ad9-4401-829d-a39049df7cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_bf6e83bc-2527-450a-8407-47e7b2e10e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_bf6e83bc-2527-450a-8407-47e7b2e10e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_8eccf5a6-4a8b-4639-9c57-d23d73484a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_8eccf5a6-4a8b-4639-9c57-d23d73484a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_c4a91f58-7bdb-40c6-a8aa-b64e05b5e1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_c4a91f58-7bdb-40c6-a8aa-b64e05b5e1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_a7ee6a44-c9a4-4957-8dc8-6c6b3e038b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_RestructuringCosts_a7ee6a44-c9a4-4957-8dc8-6c6b3e038b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fe41dc7c-0167-42bc-852e-65e8d0998b60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fe41dc7c-0167-42bc-852e-65e8d0998b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_0d9cb261-2ec7-4957-bf4c-a85c37be7b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fe41dc7c-0167-42bc-852e-65e8d0998b60" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_0d9cb261-2ec7-4957-bf4c-a85c37be7b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f3312864-32de-4032-af45-6bf33c618bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fe41dc7c-0167-42bc-852e-65e8d0998b60" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f3312864-32de-4032-af45-6bf33c618bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e2c1961e-0ee2-4803-91a2-a9b4311fdda4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fe41dc7c-0167-42bc-852e-65e8d0998b60" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e2c1961e-0ee2-4803-91a2-a9b4311fdda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b9d16e6a-1acf-4fea-93f7-de29fc06c925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fe41dc7c-0167-42bc-852e-65e8d0998b60" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b9d16e6a-1acf-4fea-93f7-de29fc06c925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_d5482bcb-ef82-454f-a07e-8821e0c6a44c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fe41dc7c-0167-42bc-852e-65e8d0998b60" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_d5482bcb-ef82-454f-a07e-8821e0c6a44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable_329de23e-29be-4950-a175-68e813187f53" xlink:href="mo-20200930.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fe41dc7c-0167-42bc-852e-65e8d0998b60" xlink:to="loc_mo_IncreaseDecreaseInSettlementPayable_329de23e-29be-4950-a175-68e813187f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_56043343-a33a-4ba7-b85a-9c06bcd040a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_56043343-a33a-4ba7-b85a-9c06bcd040a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_80317d34-3987-4fad-a8e9-ff651ac1f420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_80317d34-3987-4fad-a8e9-ff651ac1f420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f62d388f-c5dd-4996-870a-c2c8dcdaa23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_532efbe8-8fc1-44f1-b951-4f181ec91889" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f62d388f-c5dd-4996-870a-c2c8dcdaa23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0039c65e-f7f9-43e1-84bf-2d9e21569b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c2236946-3e21-4e58-94e1-5adaa4b67b3d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0039c65e-f7f9-43e1-84bf-2d9e21569b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d8724997-a701-49e5-ab14-c7c5864f78db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_47df13e6-8c84-41fa-89f0-45a0ca927aee" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d8724997-a701-49e5-ab14-c7c5864f78db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cb708685-7c1d-4b7e-80db-3597deec9e07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d8724997-a701-49e5-ab14-c7c5864f78db" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cb708685-7c1d-4b7e-80db-3597deec9e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities_b40fd598-111a-4b3a-901c-7e9e4db74a77" xlink:href="mo-20200930.xsd#mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d8724997-a701-49e5-ab14-c7c5864f78db" xlink:to="loc_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities_b40fd598-111a-4b3a-901c-7e9e4db74a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentsToAcquireBusinessesAndAssets_3927db47-c278-46f3-a9ea-3942e4f1140b" xlink:href="mo-20200930.xsd#mo_PaymentsToAcquireBusinessesAndAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d8724997-a701-49e5-ab14-c7c5864f78db" xlink:to="loc_mo_PaymentsToAcquireBusinessesAndAssets_3927db47-c278-46f3-a9ea-3942e4f1140b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c967d2b8-bcfc-4e09-b304-c1e5dcbc67ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d8724997-a701-49e5-ab14-c7c5864f78db" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c967d2b8-bcfc-4e09-b304-c1e5dcbc67ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c00975f-f2c2-49cc-92bd-c957df8344c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d8724997-a701-49e5-ab14-c7c5864f78db" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c00975f-f2c2-49cc-92bd-c957df8344c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_47df13e6-8c84-41fa-89f0-45a0ca927aee" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_ec824e20-1d9b-4541-9db9-f0e615739791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_ec824e20-1d9b-4541-9db9-f0e615739791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_6eaa9fdf-fc36-45de-bf64-f1a68c8ee003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_6eaa9fdf-fc36-45de-bf64-f1a68c8ee003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2ed35c82-85ea-44c9-b559-90d03cf5221b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2ed35c82-85ea-44c9-b559-90d03cf5221b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f0d029d4-6fec-40c3-9b96-e5c4d899f917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f0d029d4-6fec-40c3-9b96-e5c4d899f917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_dd2a7760-1a8f-4c44-a0a5-3aa7d68df88a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_dd2a7760-1a8f-4c44-a0a5-3aa7d68df88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8feb8f05-502d-4774-8655-495f65e0ece2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8feb8f05-502d-4774-8655-495f65e0ece2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_df90d1ab-de3f-4473-b697-b8a142423ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_df90d1ab-de3f-4473-b697-b8a142423ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a03b7f5d-1076-4605-a232-f673fdfe555b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8ecc789a-732d-42c2-a59e-1426b83ceb8f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a03b7f5d-1076-4605-a232-f673fdfe555b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_31970192-2d9d-4161-ada0-b6c34435a980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_47df13e6-8c84-41fa-89f0-45a0ca927aee" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_31970192-2d9d-4161-ada0-b6c34435a980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_435c66a3-7e10-47a0-83d3-abf9a2a8e3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_31970192-2d9d-4161-ada0-b6c34435a980" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_435c66a3-7e10-47a0-83d3-abf9a2a8e3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5826490c-2db6-4f1d-b2d7-572d78a1554a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_31970192-2d9d-4161-ada0-b6c34435a980" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5826490c-2db6-4f1d-b2d7-572d78a1554a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1620a347-42d4-41ed-8346-21541170b953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_31970192-2d9d-4161-ada0-b6c34435a980" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1620a347-42d4-41ed-8346-21541170b953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_47900631-3270-434f-8360-a0ee4d46cf5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_47df13e6-8c84-41fa-89f0-45a0ca927aee" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_47900631-3270-434f-8360-a0ee4d46cf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_bc5874f7-0b98-47a9-b37d-6efa05b3612a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_47df13e6-8c84-41fa-89f0-45a0ca927aee" xlink:to="loc_us-gaap_RestrictedCashCurrent_bc5874f7-0b98-47a9-b37d-6efa05b3612a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_0fffb41e-e788-4c46-bd84-858869533d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_47df13e6-8c84-41fa-89f0-45a0ca927aee" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_0fffb41e-e788-4c46-bd84-858869533d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e0cf4a9c-9516-4ef8-91b5-58751ea24cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_47df13e6-8c84-41fa-89f0-45a0ca927aee" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e0cf4a9c-9516-4ef8-91b5-58751ea24cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61966546-b586-419c-bf13-0bd6b8a0dccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_95297297-5589-4dbf-8e98-44b95e41744d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61966546-b586-419c-bf13-0bd6b8a0dccb" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_95297297-5589-4dbf-8e98-44b95e41744d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_817b70b8-2c1a-41b1-8ba1-087f6bfa0f64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4a197de2-d278-40a5-9dd7-e217d7b6b01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_817b70b8-2c1a-41b1-8ba1-087f6bfa0f64" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4a197de2-d278-40a5-9dd7-e217d7b6b01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_109fdb7c-52e4-4ce0-9054-95e541021847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_817b70b8-2c1a-41b1-8ba1-087f6bfa0f64" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_109fdb7c-52e4-4ce0-9054-95e541021847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_9e72e4e8-07ad-4940-b592-e926487715a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_817b70b8-2c1a-41b1-8ba1-087f6bfa0f64" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_9e72e4e8-07ad-4940-b592-e926487715a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d40810a-a2bd-477f-9da6-7d56100030b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_21d03451-7b63-4338-8f92-a9ec02d002e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d40810a-a2bd-477f-9da6-7d56100030b3" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_21d03451-7b63-4338-8f92-a9ec02d002e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_79376db0-af49-42fa-84d0-8cf25c7beb0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_79376db0-af49-42fa-84d0-8cf25c7beb0f" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_081b4b89-69b8-4691-a97e-faa16905ecc7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:to="loc_srt_OwnershipAxis_081b4b89-69b8-4691-a97e-faa16905ecc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_dd8d1246-1dd2-4956-b61b-f8ea6c91bd43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_081b4b89-69b8-4691-a97e-faa16905ecc7" xlink:to="loc_srt_OwnershipDomain_dd8d1246-1dd2-4956-b61b-f8ea6c91bd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember_d3644455-dacb-4d7f-85d2-49f500e09711" xlink:href="mo-20200930.xsd#mo_HelixInnovationsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_dd8d1246-1dd2-4956-b61b-f8ea6c91bd43" xlink:to="loc_mo_HelixInnovationsLLCMember_d3644455-dacb-4d7f-85d2-49f500e09711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ff80ccaa-a8dc-4ef8-ab97-46738ae0ecdf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:to="loc_dei_LegalEntityAxis_ff80ccaa-a8dc-4ef8-ab97-46738ae0ecdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4432dd97-14cd-4e9a-9945-420c66ffb314" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ff80ccaa-a8dc-4ef8-ab97-46738ae0ecdf" xlink:to="loc_dei_EntityDomain_4432dd97-14cd-4e9a-9945-420c66ffb314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember_469a2a06-7367-47cc-95ba-a51864679b54" xlink:href="mo-20200930.xsd#mo_HelixInnovationsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4432dd97-14cd-4e9a-9945-420c66ffb314" xlink:to="loc_mo_HelixInnovationsLLCMember_469a2a06-7367-47cc-95ba-a51864679b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_f903d622-fab3-4696-92f3-0d3aa2e4d09d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_f903d622-fab3-4696-92f3-0d3aa2e4d09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4405e8a9-668e-471c-be3c-2ff7ecbd45a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_f903d622-fab3-4696-92f3-0d3aa2e4d09d" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4405e8a9-668e-471c-be3c-2ff7ecbd45a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2018ShareRepurchaseProgramMember_af812ce8-6682-46d2-9bfc-31b4575a0c9d" xlink:href="mo-20200930.xsd#mo_January2018ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4405e8a9-668e-471c-be3c-2ff7ecbd45a3" xlink:to="loc_mo_January2018ShareRepurchaseProgramMember_af812ce8-6682-46d2-9bfc-31b4575a0c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_July2019ShareRepurchaseProgramMember_5dc6e4b9-4b02-4fba-856a-ce2a3786a1b8" xlink:href="mo-20200930.xsd#mo_July2019ShareRepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_4405e8a9-668e-471c-be3c-2ff7ecbd45a3" xlink:to="loc_mo_July2019ShareRepurchaseProgramMember_5dc6e4b9-4b02-4fba-856a-ce2a3786a1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f42e9e54-d8e6-472e-a966-a9e691fdfc41" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f42e9e54-d8e6-472e-a966-a9e691fdfc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f42e9e54-d8e6-472e-a966-a9e691fdfc41" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_fbffb675-43c8-449c-bba0-e4041e088a4f" xlink:href="mo-20200930.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:to="loc_mo_ABInBevMember_fbffb675-43c8-449c-bba0-e4041e088a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_24882cc0-8e29-4907-9b61-274b3144927a" xlink:href="mo-20200930.xsd#mo_JUULMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:to="loc_mo_JUULMember_24882cc0-8e29-4907-9b61-274b3144927a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_a523cc4d-678e-406e-9e14-c571a55f178e" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b6a037e8-be01-4d19-bd36-1a3d3baac4ac" xlink:to="loc_mo_CronosGroupInc.Member_a523cc4d-678e-406e-9e14-c571a55f178e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ca6b5770-a557-402e-9503-1322dc97bea1" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_d0012f9c-5021-408e-980c-9da3c43f90d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_d0012f9c-5021-408e-980c-9da3c43f90d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dcda0b3e-d450-4fbf-b86e-40bc9dd55a93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dcda0b3e-d450-4fbf-b86e-40bc9dd55a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_33a527c2-a827-4739-b0b2-5f08dda7befe" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_33a527c2-a827-4739-b0b2-5f08dda7befe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2d3d894b-ab24-4387-8d26-d929687bf677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2d3d894b-ab24-4387-8d26-d929687bf677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c7c7733c-c200-4593-94a3-6788b15104a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c7c7733c-c200-4593-94a3-6788b15104a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRatePercentageIncrease_3488c96a-eefd-44fd-9c42-b92b600dd390" xlink:href="mo-20200930.xsd#mo_CommonStockDividendRatePercentageIncrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_mo_CommonStockDividendRatePercentageIncrease_3488c96a-eefd-44fd-9c42-b92b600dd390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_c50de208-5800-4989-ba3c-5f02e612e7de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_c50de208-5800-4989-ba3c-5f02e612e7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRateAnnualPerShare_17c9c670-22ca-4d87-be0d-9af170b65c8e" xlink:href="mo-20200930.xsd#mo_CommonStockDividendRateAnnualPerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_mo_CommonStockDividendRateAnnualPerShare_17c9c670-22ca-4d87-be0d-9af170b65c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_50f17bfb-512b-4d1c-bc07-7852d1346d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_50f17bfb-512b-4d1c-bc07-7852d1346d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_47f879ad-e765-44b8-8f4f-75d9a0ea1b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_47f879ad-e765-44b8-8f4f-75d9a0ea1b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7825232e-041a-4fbc-bc72-3301a3d4d821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_7825232e-041a-4fbc-bc72-3301a3d4d821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_cb85c564-7e18-4a9e-b590-26f1ab4ce5d2" xlink:href="mo-20200930.xsd#mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e37975ad-8410-4d06-bfe0-3ec4dff93a0c" xlink:to="loc_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount_cb85c564-7e18-4a9e-b590-26f1ab4ce5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BackgroundandBasisofPresentationShareRepurchaseTableDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d9ccfc16-5f67-4f97-9bf9-06cd83c78cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_b6bf6e3e-3eef-4c67-9b2e-7aefc5b1979f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d9ccfc16-5f67-4f97-9bf9-06cd83c78cca" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_b6bf6e3e-3eef-4c67-9b2e-7aefc5b1979f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_da096769-1083-42bc-b6db-611857328589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_b6bf6e3e-3eef-4c67-9b2e-7aefc5b1979f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_da096769-1083-42bc-b6db-611857328589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_33491b2b-6bf5-4c38-a248-b12cf3fe4ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_da096769-1083-42bc-b6db-611857328589" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_33491b2b-6bf5-4c38-a248-b12cf3fe4ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2018ShareRepurchaseProgramMember_6551c02a-a3ae-4848-be8f-7bda6d7bfb3b" xlink:href="mo-20200930.xsd#mo_January2018ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_33491b2b-6bf5-4c38-a248-b12cf3fe4ee6" xlink:to="loc_mo_January2018ShareRepurchaseProgramMember_6551c02a-a3ae-4848-be8f-7bda6d7bfb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_b6bf6e3e-3eef-4c67-9b2e-7aefc5b1979f" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_b72014bc-6c0d-41c1-9b47-da557dda5e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_b72014bc-6c0d-41c1-9b47-da557dda5e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4365e1ea-fa4e-4999-95f2-1309be74515c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4365e1ea-fa4e-4999-95f2-1309be74515c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_63b3c3fe-bf03-42d6-9bdb-934ddb27574f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ca0d9eb5-bb84-4d43-b980-abab5e89b704" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_63b3c3fe-bf03-42d6-9bdb-934ddb27574f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="simple" xlink:href="mo-20200930.xsd#RevenuesfromContractswithCustomers"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ea4d0eae-1264-4ce1-a720-69c8143c8f52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_982d63f4-88bc-41f2-bfd4-aeb6fe07a7b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ea4d0eae-1264-4ce1-a720-69c8143c8f52" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_982d63f4-88bc-41f2-bfd4-aeb6fe07a7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4aa490e3-b240-43c4-891a-13611ff4a6f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AllowanceForSalesDiscountsGoods_8c6bdad1-c3c9-4de9-92d7-ffe1a3352355" xlink:href="mo-20200930.xsd#mo_AllowanceForSalesDiscountsGoods"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4aa490e3-b240-43c4-891a-13611ff4a6f2" xlink:to="loc_mo_AllowanceForSalesDiscountsGoods_8c6bdad1-c3c9-4de9-92d7-ffe1a3352355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_0457e82d-31ea-40f4-831c-fc55b3b744ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4aa490e3-b240-43c4-891a-13611ff4a6f2" xlink:to="loc_us-gaap_ContractWithCustomerLiability_0457e82d-31ea-40f4-831c-fc55b3b744ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_b86832de-5a08-458f-8d80-61728721f988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4aa490e3-b240-43c4-891a-13611ff4a6f2" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_b86832de-5a08-458f-8d80-61728721f988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_5edfc5a9-9742-4bc9-8659-f3b433d43f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4aa490e3-b240-43c4-891a-13611ff4a6f2" xlink:to="loc_us-gaap_ReceivablesNetCurrent_5edfc5a9-9742-4bc9-8659-f3b433d43f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCosts" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCosts"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_afbf9806-f8dd-4cbd-bd35-d9ff8d7e1028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_c4e8bc6b-19d9-4a37-b690-21fb9759e121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_afbf9806-f8dd-4cbd-bd35-d9ff8d7e1028" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_c4e8bc6b-19d9-4a37-b690-21fb9759e121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bd22d42d-a51f-4a2e-8368-302589741570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_095c0ae4-84ff-4ea9-8e4b-ced41e707481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bd22d42d-a51f-4a2e-8368-302589741570" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_095c0ae4-84ff-4ea9-8e4b-ced41e707481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_463bf0cf-8035-456e-ab3a-bf4675b94a05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_bd22d42d-a51f-4a2e-8368-302589741570" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_463bf0cf-8035-456e-ab3a-bf4675b94a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_794a389b-0ad3-49bc-8b7e-5b117e0cc000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_794a389b-0ad3-49bc-8b7e-5b117e0cc000" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_318c8e8a-08d1-4bf7-8a0b-aba707aed570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_318c8e8a-08d1-4bf7-8a0b-aba707aed570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a92b7e9d-7887-4c24-b87f-0963b12d6140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_318c8e8a-08d1-4bf7-8a0b-aba707aed570" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a92b7e9d-7887-4c24-b87f-0963b12d6140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e34a1b60-a1b0-4eb1-85c9-1b37ca41736e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a92b7e9d-7887-4c24-b87f-0963b12d6140" xlink:to="loc_us-gaap_CostOfSalesMember_e34a1b60-a1b0-4eb1-85c9-1b37ca41736e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember_7c1c4e77-0be4-47de-8be4-ddfefd7ea263" xlink:href="mo-20200930.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a92b7e9d-7887-4c24-b87f-0963b12d6140" xlink:to="loc_mo_MarketingAdministrationAndResearchCostsMember_7c1c4e77-0be4-47de-8be4-ddfefd7ea263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a6741e98-0695-457f-bfe1-9ec51e591901" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:to="loc_srt_ConsolidationItemsAxis_a6741e98-0695-457f-bfe1-9ec51e591901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b74ff165-e338-4318-a96e-97c4197d07fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a6741e98-0695-457f-bfe1-9ec51e591901" xlink:to="loc_srt_ConsolidationItemsDomain_b74ff165-e338-4318-a96e-97c4197d07fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_fa7c876c-9fce-45bb-bc99-a06cf57810aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b74ff165-e338-4318-a96e-97c4197d07fd" xlink:to="loc_us-gaap_OperatingSegmentsMember_fa7c876c-9fce-45bb-bc99-a06cf57810aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_2c50910f-642b-419a-90cb-cf0590fd6234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b74ff165-e338-4318-a96e-97c4197d07fd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_2c50910f-642b-419a-90cb-cf0590fd6234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f3f11b11-d93c-450c-a50f-fb5da319e57f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f3f11b11-d93c-450c-a50f-fb5da319e57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f3f11b11-d93c-450c-a50f-fb5da319e57f" xlink:to="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_9e2675d0-b0ce-49fe-b0b1-fe7e5fa3dd3a" xlink:href="mo-20200930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:to="loc_mo_SmokeableProductsSegmentMember_9e2675d0-b0ce-49fe-b0b1-fe7e5fa3dd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_9ac4e1e0-884b-4457-bee6-80ad4ae7d502" xlink:href="mo-20200930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:to="loc_mo_OralTobaccoSegmentMember_9ac4e1e0-884b-4457-bee6-80ad4ae7d502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_7b992a2b-86d5-4b3a-806d-bb26e5ecd4c2" xlink:href="mo-20200930.xsd#mo_WineSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:to="loc_mo_WineSegmentMember_7b992a2b-86d5-4b3a-806d-bb26e5ecd4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_c034b189-ff62-40b5-a7e5-1249e4d635df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_16786091-30eb-47b7-8be2-6938c0063c82" xlink:to="loc_us-gaap_AllOtherSegmentsMember_c034b189-ff62-40b5-a7e5-1249e4d635df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b3ec9a66-c6ab-41cd-8039-74a527bdd680" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_e6703f78-6e61-4a75-80e0-b337bd903a13" xlink:href="mo-20200930.xsd#mo_OtherRestructuringCostsIncludingNetPensionCostCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_OtherRestructuringCostsIncludingNetPensionCostCredit_e6703f78-6e61-4a75-80e0-b337bd903a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_af48368e-fe6a-4ce8-8e00-abba93a074b5" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts_af48368e-fe6a-4ce8-8e00-abba93a074b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_5de5a9e3-2125-4244-86b0-ca143a28c9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_us-gaap_OtherRestructuringCosts_5de5a9e3-2125-4244-86b0-ca143a28c9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestructuringChargesIncludingNetPensionCostCredit_ff1dbddc-11b4-4a89-ac01-042cb696f10c" xlink:href="mo-20200930.xsd#mo_RestructuringChargesIncludingNetPensionCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_RestructuringChargesIncludingNetPensionCostCredit_ff1dbddc-11b4-4a89-ac01-042cb696f10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_e05f679a-68e1-45a8-8930-f0fb2e886a22" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges_e05f679a-68e1-45a8-8930-f0fb2e886a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_3ab22b82-176b-46df-a00a-1b7b91c9eb4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_us-gaap_RestructuringCharges_3ab22b82-176b-46df-a00a-1b7b91c9eb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_7773e54b-5196-4da0-90a0-44e7fe5d2a2f" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit_7773e54b-5196-4da0-90a0-44e7fe5d2a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_829957c4-5a66-4603-8e01-68f47063cc7f" xlink:href="mo-20200930.xsd#mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts_829957c4-5a66-4603-8e01-68f47063cc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCosts_d5a07f8c-1747-4268-a649-f7a22928579a" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2ba2aa44-52fc-4315-bee5-8473ad6d8ac8" xlink:to="loc_mo_AssetImpairmentandBusinessExitCosts_d5a07f8c-1747-4268-a649-f7a22928579a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_43c80201-e73b-4cfb-86c2-ce9320d02a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_4b80d9ec-eadf-4602-b714-59101848f3b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_43c80201-e73b-4cfb-86c2-ce9320d02a6a" xlink:to="loc_us-gaap_RestructuringReserveRollForward_4b80d9ec-eadf-4602-b714-59101848f3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_27c7ea29-c5dd-41a7-9a31-2b293da22b65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_4b80d9ec-eadf-4602-b714-59101848f3b3" xlink:to="loc_us-gaap_RestructuringReserve_27c7ea29-c5dd-41a7-9a31-2b293da22b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_68745286-6543-43ba-bec6-c097fee5d043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_4b80d9ec-eadf-4602-b714-59101848f3b3" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_68745286-6543-43ba-bec6-c097fee5d043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_285af21d-d7bd-4133-9835-5c6b5ddcb5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_4b80d9ec-eadf-4602-b714-59101848f3b3" xlink:to="loc_us-gaap_PaymentsForRestructuring_285af21d-d7bd-4133-9835-5c6b5ddcb5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_534428a0-9eba-4541-9584-3b24dfb81b11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_4b80d9ec-eadf-4602-b714-59101848f3b3" xlink:to="loc_us-gaap_RestructuringReserve_534428a0-9eba-4541-9584-3b24dfb81b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#AssetImpairmentExitandImplementationCostsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3599d80a-5b37-4f8b-baed-78dd7393c30b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3599d80a-5b37-4f8b-baed-78dd7393c30b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f55501cd-f5ce-4767-bba8-e149f8138262" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:to="loc_srt_StatementScenarioAxis_f55501cd-f5ce-4767-bba8-e149f8138262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fa368e8a-70e0-49ff-bcc9-523a85fb0c1c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f55501cd-f5ce-4767-bba8-e149f8138262" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fa368e8a-70e0-49ff-bcc9-523a85fb0c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_27a7a679-e5e1-4377-8b9a-7a2bf8d97d73" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_fa368e8a-70e0-49ff-bcc9-523a85fb0c1c" xlink:to="loc_srt_ScenarioForecastMember_27a7a679-e5e1-4377-8b9a-7a2bf8d97d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_56da376f-70fc-49a0-8614-cd7c2cc5df6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_56da376f-70fc-49a0-8614-cd7c2cc5df6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_4bb441bf-75b2-4b56-a511-77ae25f37909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_56da376f-70fc-49a0-8614-cd7c2cc5df6a" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_4bb441bf-75b2-4b56-a511-77ae25f37909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryWriteOffMember_f69c23b5-757b-4b2c-b08d-041312ef0eb4" xlink:href="mo-20200930.xsd#mo_InventoryWriteOffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_4bb441bf-75b2-4b56-a511-77ae25f37909" xlink:to="loc_mo_InventoryWriteOffMember_f69c23b5-757b-4b2c-b08d-041312ef0eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentMember_9979f440-4650-4c9c-9d11-071f307b7b70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_4bb441bf-75b2-4b56-a511-77ae25f37909" xlink:to="loc_us-gaap_PurchaseCommitmentMember_9979f440-4650-4c9c-9d11-071f307b7b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_c2fb53a4-cc6e-4b83-8fb2-371ecbfec9f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:to="loc_us-gaap_RestructuringPlanAxis_c2fb53a4-cc6e-4b83-8fb2-371ecbfec9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_4281fce1-07b8-4c41-a35e-bcc21ef75e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_c2fb53a4-cc6e-4b83-8fb2-371ecbfec9f2" xlink:to="loc_us-gaap_RestructuringPlanDomain_4281fce1-07b8-4c41-a35e-bcc21ef75e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineBusinessStrategicResetMember_6c572109-f14d-4fa6-9598-efb077805c8a" xlink:href="mo-20200930.xsd#mo_WineBusinessStrategicResetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_4281fce1-07b8-4c41-a35e-bcc21ef75e2e" xlink:to="loc_mo_WineBusinessStrategicResetMember_6c572109-f14d-4fa6-9598-efb077805c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f95031ef-44bd-4e0c-972d-ec96d0caf1e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_30461229-566d-46da-ae1d-5554d1844cb9" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_f95031ef-44bd-4e0c-972d-ec96d0caf1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8d318e6a-860c-4773-8dbd-1d49d772ea44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f95031ef-44bd-4e0c-972d-ec96d0caf1e3" xlink:to="loc_us-gaap_RestructuringCharges_8d318e6a-860c-4773-8dbd-1d49d772ea44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_999338d1-1ef2-4063-9213-6deb908fb251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f95031ef-44bd-4e0c-972d-ec96d0caf1e3" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_999338d1-1ef2-4063-9213-6deb908fb251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecurities"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_af631629-28b0-40b0-8a09-b7ebaf97c52b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_c9c932cb-158b-4198-9098-4713e0004d60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_af631629-28b0-40b0-8a09-b7ebaf97c52b" xlink:to="loc_us-gaap_InvestmentTextBlock_c9c932cb-158b-4198-9098-4713e0004d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_4c86a4f1-b2e0-4c49-a37f-7e89fd1afc40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock_ff5e87c6-d587-48a2-b6a1-15c616d0aaf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_4c86a4f1-b2e0-4c49-a37f-7e89fd1afc40" xlink:to="loc_us-gaap_InvestmentTableTextBlock_ff5e87c6-d587-48a2-b6a1-15c616d0aaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_062316e1-4e49-4a27-bc10-c4b0e9adc058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_4c86a4f1-b2e0-4c49-a37f-7e89fd1afc40" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_062316e1-4e49-4a27-bc10-c4b0e9adc058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_022a164a-5e2c-44eb-aace-34fdd9a53f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:href="mo-20200930.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_022a164a-5e2c-44eb-aace-34fdd9a53f39" xlink:to="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cb0d89b0-a8d0-43d5-919a-bc39f075b83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cb0d89b0-a8d0-43d5-919a-bc39f075b83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eca4ded8-65d5-4cdd-b61d-cabc6ae3848b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cb0d89b0-a8d0-43d5-919a-bc39f075b83b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eca4ded8-65d5-4cdd-b61d-cabc6ae3848b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4e64be27-0538-4362-bb13-5e5d11bc7642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eca4ded8-65d5-4cdd-b61d-cabc6ae3848b" xlink:to="loc_us-gaap_CommonStockMember_4e64be27-0538-4362-bb13-5e5d11bc7642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_a1b8228e-1e8b-4fdd-96be-a3a809052a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_a1b8228e-1e8b-4fdd-96be-a3a809052a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4e2d6bb0-6ec6-4768-a52d-4630f81b5002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_a1b8228e-1e8b-4fdd-96be-a3a809052a44" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4e2d6bb0-6ec6-4768-a52d-4630f81b5002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_82c07389-6348-44e2-bc75-f3582ad8a8d5" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e2d6bb0-6ec6-4768-a52d-4630f81b5002" xlink:to="loc_mo_EquityContractWarrantMember_82c07389-6348-44e2-bc75-f3582ad8a8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_6c36acc9-bceb-44a4-8997-edc07e93f721" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4e2d6bb0-6ec6-4768-a52d-4630f81b5002" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_6c36acc9-bceb-44a4-8997-edc07e93f721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_017cc01d-012d-4234-8c1e-3cab686b4c5c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_017cc01d-012d-4234-8c1e-3cab686b4c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_017cc01d-012d-4234-8c1e-3cab686b4c5c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_c90b6e7f-7ab8-4bb4-a7a5-2ba0a9d17312" xlink:href="mo-20200930.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:to="loc_mo_ABInBevMember_c90b6e7f-7ab8-4bb4-a7a5-2ba0a9d17312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_8bf9fa5f-7612-409a-9a92-1b1738513b64" xlink:href="mo-20200930.xsd#mo_JUULMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:to="loc_mo_JUULMember_8bf9fa5f-7612-409a-9a92-1b1738513b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_a3e02b83-078c-42bc-b843-95d7f18c6788" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_59af9135-ba31-42ea-b152-f771d1fea29e" xlink:to="loc_mo_CronosGroupInc.Member_a3e02b83-078c-42bc-b843-95d7f18c6788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:href="mo-20200930.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_56aa2994-4f7b-4156-89d8-5a9659127c79" xlink:to="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b951372b-f3f0-44dd-8191-0f9d78aac179" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:to="loc_us-gaap_EquityMethodInvestments_b951372b-f3f0-44dd-8191-0f9d78aac179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_8bc30f55-4add-442a-afec-d355d4d63947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_8bc30f55-4add-442a-afec-d355d4d63947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_9808d8f3-4966-4ee6-ad4f-e0e217af2df8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:to="loc_us-gaap_Investments_9808d8f3-4966-4ee6-ad4f-e0e217af2df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_3e5cad1b-722e-456e-ba89-5acdfa61e564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_7cd56c8c-4ae0-418d-ab9f-06bd9b28307a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_3e5cad1b-722e-456e-ba89-5acdfa61e564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_1f88ec51-f17a-42d7-b8b6-675df1082cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fff8a5e7-1021-47fa-804c-dfb7553381c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_1f88ec51-f17a-42d7-b8b6-675df1082cfc" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fff8a5e7-1021-47fa-804c-dfb7553381c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7c7a6cb3-ae63-416c-8ad7-bfc699518191" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fff8a5e7-1021-47fa-804c-dfb7553381c6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7c7a6cb3-ae63-416c-8ad7-bfc699518191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f9b5f996-fca8-480b-bca2-f2a48b0a15b3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7c7a6cb3-ae63-416c-8ad7-bfc699518191" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f9b5f996-fca8-480b-bca2-f2a48b0a15b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_c2a9b28a-5650-4eb3-b026-5304d9e1e9bf" xlink:href="mo-20200930.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f9b5f996-fca8-480b-bca2-f2a48b0a15b3" xlink:to="loc_mo_ABInBevMember_c2a9b28a-5650-4eb3-b026-5304d9e1e9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_7f4860bd-ac1f-451a-a28f-9ae683ec0421" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f9b5f996-fca8-480b-bca2-f2a48b0a15b3" xlink:to="loc_mo_CronosGroupInc.Member_7f4860bd-ac1f-451a-a28f-9ae683ec0421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4467cd7-9718-47bb-8f11-28e685821b41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_fff8a5e7-1021-47fa-804c-dfb7553381c6" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4467cd7-9718-47bb-8f11-28e685821b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6ca3bd80-1988-4c6f-a090-9a91114f1d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e4467cd7-9718-47bb-8f11-28e685821b41" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6ca3bd80-1988-4c6f-a090-9a91114f1d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_1b508f02-9466-4046-ab3c-070ae6b0b56d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_84ee9c76-2961-42ac-8123-731939ef7b39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_1b508f02-9466-4046-ab3c-070ae6b0b56d" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_84ee9c76-2961-42ac-8123-731939ef7b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2799c02-9fee-4bc4-891d-9b496d8acdc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_84ee9c76-2961-42ac-8123-731939ef7b39" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2799c02-9fee-4bc4-891d-9b496d8acdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72b021d1-cb74-44bc-8ed7-b7853a3bc1ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2799c02-9fee-4bc4-891d-9b496d8acdc3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72b021d1-cb74-44bc-8ed7-b7853a3bc1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f69b079e-a27c-4b12-9027-f937e9cfdf68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72b021d1-cb74-44bc-8ed7-b7853a3bc1ba" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f69b079e-a27c-4b12-9027-f937e9cfdf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d6493a0-1fe3-40b6-920f-1819bb052941" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_84ee9c76-2961-42ac-8123-731939ef7b39" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d6493a0-1fe3-40b6-920f-1819bb052941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7dce432a-059b-410d-a245-a9fab9e921a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3d6493a0-1fe3-40b6-920f-1819bb052941" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7dce432a-059b-410d-a245-a9fab9e921a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_9bb9b4cd-6fb5-4311-a5f1-dd9c7f2f5ff0" xlink:href="mo-20200930.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7dce432a-059b-410d-a245-a9fab9e921a2" xlink:to="loc_mo_ABInBevMember_9bb9b4cd-6fb5-4311-a5f1-dd9c7f2f5ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_84ee9c76-2961-42ac-8123-731939ef7b39" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_31dd60e6-a8b2-46b8-914c-3ece9da651c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_31dd60e6-a8b2-46b8-914c-3ece9da651c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_0a86cba3-4396-4cb0-a248-65c9f1587147" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_0a86cba3-4396-4cb0-a248-65c9f1587147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_d2fbade9-31d7-427e-9d44-d06aa7664c9f" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_d2fbade9-31d7-427e-9d44-d06aa7664c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_ab925c5a-10b0-45e7-a62a-e5cfd439faae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_ab925c5a-10b0-45e7-a62a-e5cfd439faae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d1f496bd-2bb5-48a9-ad87-07e084f58e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_us-gaap_EquityMethodInvestments_d1f496bd-2bb5-48a9-ad87-07e084f58e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_87d72223-62bc-4370-94a0-0a992f117385" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_87d72223-62bc-4370-94a0-0a992f117385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_3b86e14d-1e1f-478b-98cb-9859c8b75264" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0496be7a-d322-4783-8551-ede9cd5614f3" xlink:to="loc_mo_EquityMethodInvestmentImpairment_3b86e14d-1e1f-478b-98cb-9859c8b75264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_13716ea2-8197-45fb-87b0-2d61fa68ac07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_700b31e1-1e21-46ba-9952-f36be93363c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_13716ea2-8197-45fb-87b0-2d61fa68ac07" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_700b31e1-1e21-46ba-9952-f36be93363c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc20cc14-a79b-411d-a0b2-305c99dc2145" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_700b31e1-1e21-46ba-9952-f36be93363c8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc20cc14-a79b-411d-a0b2-305c99dc2145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d827cfdc-fffb-4243-bf73-ef2e0d0fe0bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cc20cc14-a79b-411d-a0b2-305c99dc2145" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d827cfdc-fffb-4243-bf73-ef2e0d0fe0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_bd0da532-e9b5-4dfd-8ad9-ecf6d541763e" xlink:href="mo-20200930.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d827cfdc-fffb-4243-bf73-ef2e0d0fe0bb" xlink:to="loc_mo_JUULMember_bd0da532-e9b5-4dfd-8ad9-ecf6d541763e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_700b31e1-1e21-46ba-9952-f36be93363c8" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_dbb984e3-66c9-4034-acfb-12213288f97d" xlink:href="mo-20200930.xsd#mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_dbb984e3-66c9-4034-acfb-12213288f97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_60d84ee4-0c3e-4ff5-ab9d-bcc5d0c0c6bf" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_60d84ee4-0c3e-4ff5-ab9d-bcc5d0c0c6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_b73d8640-80e3-4639-8b49-f7eefb90dede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_b73d8640-80e3-4639-8b49-f7eefb90dede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod_c9afa0cb-5846-4340-880e-320aaec3486d" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod_c9afa0cb-5846-4340-880e-320aaec3486d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_34fb2c47-5939-4dfb-ba2e-acfe97c93f9b" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_34fb2c47-5939-4dfb-ba2e-acfe97c93f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_31a2dade-6c5b-4fae-98f2-6d58daa07bca" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_31a2dade-6c5b-4fae-98f2-6d58daa07bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod_4e915c85-2485-42a4-953e-9191f742cf21" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod_4e915c85-2485-42a4-953e-9191f742cf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_677e4b14-357e-49e1-94f8-fbeede7c424d" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_677e4b14-357e-49e1-94f8-fbeede7c424d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_e262d422-594c-4d70-827e-e104d1b5f306" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_e262d422-594c-4d70-827e-e104d1b5f306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_716a78d5-c55c-4031-b920-c224852c02f5" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_716a78d5-c55c-4031-b920-c224852c02f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_79d12957-13ae-4eb4-8ef3-a0bcff38c2df" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_79d12957-13ae-4eb4-8ef3-a0bcff38c2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_c7e1dc11-b392-4f11-84ef-bef657f04578" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_c7e1dc11-b392-4f11-84ef-bef657f04578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_a7f8d438-5517-4723-8146-c70c5cd2171b" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_a7f8d438-5517-4723-8146-c70c5cd2171b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_e177e752-566d-4125-be48-529affdaf2cf" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_e177e752-566d-4125-be48-529affdaf2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_d8629dc2-a9b3-4175-8e15-73b7ccd874fc" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_d8629dc2-a9b3-4175-8e15-73b7ccd874fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_02a831d2-6787-4841-bd0a-8381f93b5a61" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_02a831d2-6787-4841-bd0a-8381f93b5a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_658bc042-e814-4daa-a968-085afe2f4297" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_658bc042-e814-4daa-a968-085afe2f4297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_ad13fc2c-0b40-4032-b5d8-254f45a6040c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_ad13fc2c-0b40-4032-b5d8-254f45a6040c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d72041db-2793-485a-961f-dc64f899933f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_159045d5-9139-4d2c-bcf8-0cf1a63497c7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d72041db-2793-485a-961f-dc64f899933f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_81cd9f9c-01ed-4b67-bb97-7f2da9118172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:href="mo-20200930.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_81cd9f9c-01ed-4b67-bb97-7f2da9118172" xlink:to="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7b7e8e9-d8a9-430c-9b20-2342a83325ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7b7e8e9-d8a9-430c-9b20-2342a83325ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0e9438a9-ad5f-45e3-90b7-89ef9908e632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e7b7e8e9-d8a9-430c-9b20-2342a83325ee" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0e9438a9-ad5f-45e3-90b7-89ef9908e632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9dfe600c-1106-404b-a1e7-4ffa063e3d60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0e9438a9-ad5f-45e3-90b7-89ef9908e632" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9dfe600c-1106-404b-a1e7-4ffa063e3d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6c7d63b0-dc10-44f8-9295-2aac31a46a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6c7d63b0-dc10-44f8-9295-2aac31a46a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c8eda7b3-cd46-4344-a233-d66d913396c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6c7d63b0-dc10-44f8-9295-2aac31a46a0a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c8eda7b3-cd46-4344-a233-d66d913396c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_33a54e4e-f46e-46ff-be6d-f06bdea855aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c8eda7b3-cd46-4344-a233-d66d913396c0" xlink:to="loc_us-gaap_CommonStockMember_33a54e4e-f46e-46ff-be6d-f06bdea855aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_21db62d1-e983-4f45-8e34-818ee6ab67ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_21db62d1-e983-4f45-8e34-818ee6ab67ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_091b3814-12bd-48b4-901b-e7915c205718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21db62d1-e983-4f45-8e34-818ee6ab67ba" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_091b3814-12bd-48b4-901b-e7915c205718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_afeb8029-f479-44d9-a7f4-385b277c0372" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_091b3814-12bd-48b4-901b-e7915c205718" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_afeb8029-f479-44d9-a7f4-385b277c0372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_7aa9be14-3a41-4a75-9386-b98530445904" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_091b3814-12bd-48b4-901b-e7915c205718" xlink:to="loc_mo_EquityContractWarrantMember_7aa9be14-3a41-4a75-9386-b98530445904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f58584e5-8d3c-420e-a6d5-4aa4ae361057" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f58584e5-8d3c-420e-a6d5-4aa4ae361057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_50f7efaa-a34d-45eb-a2e4-98d6ef60031e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f58584e5-8d3c-420e-a6d5-4aa4ae361057" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_50f7efaa-a34d-45eb-a2e4-98d6ef60031e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_9de12027-49d2-46c6-86bb-78eb7cdc9fa8" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_50f7efaa-a34d-45eb-a2e4-98d6ef60031e" xlink:to="loc_mo_CronosGroupInc.Member_9de12027-49d2-46c6-86bb-78eb7cdc9fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9c4d349c-4aac-42c1-a1ac-daa8ec2b31ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9c4d349c-4aac-42c1-a1ac-daa8ec2b31ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_171bfc35-fe7c-4553-adff-7fd1c0d22600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9c4d349c-4aac-42c1-a1ac-daa8ec2b31ad" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_171bfc35-fe7c-4553-adff-7fd1c0d22600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_699673f7-7cec-4535-8c35-d328d074e051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_171bfc35-fe7c-4553-adff-7fd1c0d22600" xlink:to="loc_us-gaap_SubsequentEventMember_699673f7-7cec-4535-8c35-d328d074e051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:href="mo-20200930.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_bfde98f8-25f9-416c-a06a-6f9568e84eac" xlink:to="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_9473f570-ce2a-4165-9039-792a2a95edde" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_9473f570-ce2a-4165-9039-792a2a95edde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dd24b7fb-3e25-4c92-a179-80cb27c8c082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dd24b7fb-3e25-4c92-a179-80cb27c8c082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_2f813049-d33d-415c-b198-e772c777b4c1" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_2f813049-d33d-415c-b198-e772c777b4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_8c184c52-59f4-4a0a-b065-fb7cfed81307" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_8c184c52-59f4-4a0a-b065-fb7cfed81307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_98e739ad-5eb4-47f7-9da7-5311ee0c3cef" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_98e739ad-5eb4-47f7-9da7-5311ee0c3cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_25ceba3d-3aca-4937-8b42-e057ba0fe9c7" xlink:href="mo-20200930.xsd#mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_25ceba3d-3aca-4937-8b42-e057ba0fe9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_bf79b5cb-7839-419e-ac98-c552aab8cc3c" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_bf79b5cb-7839-419e-ac98-c552aab8cc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities_6bc0177a-3421-4012-ae77-f99f61e734d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities_6bc0177a-3421-4012-ae77-f99f61e734d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cc79f717-546f-47d6-b715-3fc23975bd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_cc79f717-546f-47d6-b715-3fc23975bd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_99ce5257-3039-47ec-8ea9-428f2ac23205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_99ce5257-3039-47ec-8ea9-428f2ac23205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentAggregateExercisePrice_2056478c-6b91-4f06-8e09-0add76db352e" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentAggregateExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentAggregateExercisePrice_2056478c-6b91-4f06-8e09-0add76db352e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberofDirectorsNominated_a5c7b120-dcf0-43a7-91f8-1c5f29701940" xlink:href="mo-20200930.xsd#mo_NumberofDirectorsNominated"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_NumberofDirectorsNominated_a5c7b120-dcf0-43a7-91f8-1c5f29701940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated_e99054c4-3106-479a-9f95-684305494fb8" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated_e99054c4-3106-479a-9f95-684305494fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberofMembersOntheBoardofDirectors_3cba34d9-bdc8-4a3c-8ff5-78921b996d4f" xlink:href="mo-20200930.xsd#mo_NumberofMembersOntheBoardofDirectors"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_NumberofMembersOntheBoardofDirectors_3cba34d9-bdc8-4a3c-8ff5-78921b996d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_56e1eeba-03e5-4f08-b09e-b9539f291852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_56e1eeba-03e5-4f08-b09e-b9539f291852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_dc76d607-06c0-4eac-85d7-ab935eeb1b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_EquityMethodInvestments_dc76d607-06c0-4eac-85d7-ab935eeb1b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_8f9f827b-3c71-402b-a7e2-e9fc70cd2d9c" xlink:href="mo-20200930.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_8f9f827b-3c71-402b-a7e2-e9fc70cd2d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_6dbc69e9-a845-4fbe-a644-59d8b52634d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_1bc86140-7c13-474a-8337-4a59416fe896" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_6dbc69e9-a845-4fbe-a644-59d8b52634d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_72d4cebc-f2b4-46ad-aefa-3b7b529992f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d0faeacb-825d-485d-8934-1e94b77e2733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_72d4cebc-f2b4-46ad-aefa-3b7b529992f1" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d0faeacb-825d-485d-8934-1e94b77e2733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cdefd332-449b-4053-b371-389832102b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a2954311-ad81-459a-b043-65bb57bf816a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cdefd332-449b-4053-b371-389832102b84" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_a2954311-ad81-459a-b043-65bb57bf816a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_4a37a02c-87e7-4f6a-a9ac-f8b63851e474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cdefd332-449b-4053-b371-389832102b84" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_4a37a02c-87e7-4f6a-a9ac-f8b63851e474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_0e71be81-5fb5-4ecf-9c57-c0ed68aa8ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cdefd332-449b-4053-b371-389832102b84" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_0e71be81-5fb5-4ecf-9c57-c0ed68aa8ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_7a9c07c8-0c70-40d1-96b9-b3b81e1c6157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cdefd332-449b-4053-b371-389832102b84" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_7a9c07c8-0c70-40d1-96b9-b3b81e1c6157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2e871c89-0852-44ea-af88-3ed03ad33d7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2e871c89-0852-44ea-af88-3ed03ad33d7d" xlink:to="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2ff331e3-54d6-4cf3-b210-4ffe2e085e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2ff331e3-54d6-4cf3-b210-4ffe2e085e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a5c7569-38d3-4a36-9cf3-53e964a77514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2ff331e3-54d6-4cf3-b210-4ffe2e085e79" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a5c7569-38d3-4a36-9cf3-53e964a77514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fe80c6fc-45e4-4e7f-bfd9-f1a415527bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3a5c7569-38d3-4a36-9cf3-53e964a77514" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fe80c6fc-45e4-4e7f-bfd9-f1a415527bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_4e145af5-68d5-45b3-85fe-dd6439c9e80f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_4e145af5-68d5-45b3-85fe-dd6439c9e80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_283572ab-fc64-4fba-af55-791fc588b7d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4e145af5-68d5-45b3-85fe-dd6439c9e80f" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_283572ab-fc64-4fba-af55-791fc588b7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7fa2ca-c371-491c-84fd-4af78a625862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_283572ab-fc64-4fba-af55-791fc588b7d1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7fa2ca-c371-491c-84fd-4af78a625862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_bd1c029c-5891-4581-95d6-890fe26a809f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7fa2ca-c371-491c-84fd-4af78a625862" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_bd1c029c-5891-4581-95d6-890fe26a809f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_2630debd-dc12-4d3d-8b51-288bdb83ca72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7fa2ca-c371-491c-84fd-4af78a625862" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_2630debd-dc12-4d3d-8b51-288bdb83ca72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21c6c279-7c21-474b-bf1b-528e55065ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21c6c279-7c21-474b-bf1b-528e55065ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a470e92e-2c77-4986-abb0-4511cf5ee199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21c6c279-7c21-474b-bf1b-528e55065ed6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a470e92e-2c77-4986-abb0-4511cf5ee199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_169a7078-d0c1-40da-aa2b-c7990119fa44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a470e92e-2c77-4986-abb0-4511cf5ee199" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_169a7078-d0c1-40da-aa2b-c7990119fa44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8c56b3d6-d8f1-4035-b9e0-67fee2ed95a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_DebtInstrumentAxis_8c56b3d6-d8f1-4035-b9e0-67fee2ed95a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2197deef-6bb4-4c8a-8c37-f4579beb5ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8c56b3d6-d8f1-4035-b9e0-67fee2ed95a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2197deef-6bb4-4c8a-8c37-f4579beb5ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_7dd1bb9b-5030-4ddb-a744-31bc2a8aab47" xlink:href="mo-20200930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2197deef-6bb4-4c8a-8c37-f4579beb5ec4" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_7dd1bb9b-5030-4ddb-a744-31bc2a8aab47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e3d914c1-7588-49df-9b67-04fa4cc89005" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e3d914c1-7588-49df-9b67-04fa4cc89005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1f77b44c-f39e-48f0-bee1-16358d46c0f2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e3d914c1-7588-49df-9b67-04fa4cc89005" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1f77b44c-f39e-48f0-bee1-16358d46c0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_4f9e211a-3680-46a3-8294-315e606a071b" xlink:href="mo-20200930.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1f77b44c-f39e-48f0-bee1-16358d46c0f2" xlink:to="loc_mo_CronosGroupInc.Member_4f9e211a-3680-46a3-8294-315e606a071b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8d69f3bb-2157-48af-ac9e-5bcefae8b1a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_HedgingDesignationAxis_8d69f3bb-2157-48af-ac9e-5bcefae8b1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_23558242-407b-4de8-a0da-4ed6cb552a79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_8d69f3bb-2157-48af-ac9e-5bcefae8b1a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_23558242-407b-4de8-a0da-4ed6cb552a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f312d30e-157f-4132-b321-c1c3ecbf240e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_23558242-407b-4de8-a0da-4ed6cb552a79" xlink:to="loc_us-gaap_NondesignatedMember_f312d30e-157f-4132-b321-c1c3ecbf240e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6bdcafa9-c5fa-460a-9c5f-94fddd445f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6bdcafa9-c5fa-460a-9c5f-94fddd445f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_80d2bb48-b69e-4ffa-b0c9-f411ddb14115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6bdcafa9-c5fa-460a-9c5f-94fddd445f55" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_80d2bb48-b69e-4ffa-b0c9-f411ddb14115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6d5176b9-bc74-4b8e-8b3d-4432f10e20f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_80d2bb48-b69e-4ffa-b0c9-f411ddb14115" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6d5176b9-bc74-4b8e-8b3d-4432f10e20f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_3c235a95-a9a1-4448-8aee-48d0bcf01cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_80d2bb48-b69e-4ffa-b0c9-f411ddb14115" xlink:to="loc_us-gaap_ForwardContractsMember_3c235a95-a9a1-4448-8aee-48d0bcf01cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_083e8c3d-819e-413d-8565-fb21195f79ba" xlink:to="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_d97b2ff2-0f6e-4a85-be95-83dfaa16df7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_DerivativeNotionalAmount_d97b2ff2-0f6e-4a85-be95-83dfaa16df7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_0cab26c7-5780-4000-a0ab-294c1ce0b8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_DebtInstrumentFairValue_0cab26c7-5780-4000-a0ab-294c1ce0b8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_97316b27-d83d-4df3-aaa9-b197596d5365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_LongTermDebt_97316b27-d83d-4df3-aaa9-b197596d5365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_1142e203-bcba-41ac-a004-e6787fc8c6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_LongTermDebtFairValue_1142e203-bcba-41ac-a004-e6787fc8c6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_6bbe6364-08bf-4fb3-ade5-5b1137a7e39e" xlink:href="mo-20200930.xsd#mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting_6bbe6364-08bf-4fb3-ade5-5b1137a7e39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_eb2ff9ff-ccf7-4370-aa17-9f90a81bb8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_eb2ff9ff-ccf7-4370-aa17-9f90a81bb8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_ad044e6b-4701-4384-ae2a-75d494fec4ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b81e4a3a-d360-42a1-9f92-5ab06918f0df" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_ad044e6b-4701-4384-ae2a-75d494fec4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0e098d8c-dc27-43c8-9806-56cb8e58972c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0e098d8c-dc27-43c8-9806-56cb8e58972c" xlink:to="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_4cceb66d-a73d-4feb-810b-5815ffecb90b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_4cceb66d-a73d-4feb-810b-5815ffecb90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_4cceb66d-a73d-4feb-810b-5815ffecb90b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_69f7ab0a-7d4b-4fbc-ac40-c8d738394a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_69f7ab0a-7d4b-4fbc-ac40-c8d738394a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1505a36f-fd1c-4922-8f05-dfb280f5d3a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1505a36f-fd1c-4922-8f05-dfb280f5d3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_70292fc1-1c52-45f7-90d4-890f62797040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_70292fc1-1c52-45f7-90d4-890f62797040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_ee519854-f9d2-4eed-a2b0-25c239ed0cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_ee519854-f9d2-4eed-a2b0-25c239ed0cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_586d06f8-65e0-4f1e-b660-e9ac7be9ba4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_586d06f8-65e0-4f1e-b660-e9ac7be9ba4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MeasurementInputWeightedAverageExpectedTermMember_a15d290c-3a4c-40da-8299-193f7adc5d5d" xlink:href="mo-20200930.xsd#mo_MeasurementInputWeightedAverageExpectedTermMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_a0b44636-c7b5-492e-b053-4b1e5d67513d" xlink:to="loc_mo_MeasurementInputWeightedAverageExpectedTermMember_a15d290c-3a4c-40da-8299-193f7adc5d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_372e7630-c192-4333-b4bf-51f4448b2868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_372e7630-c192-4333-b4bf-51f4448b2868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b2d109a9-8df0-4377-b2cb-05efec8a81a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_372e7630-c192-4333-b4bf-51f4448b2868" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b2d109a9-8df0-4377-b2cb-05efec8a81a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_02391c88-77a0-40c5-8ac3-073b1e7e3380" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2d109a9-8df0-4377-b2cb-05efec8a81a1" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_02391c88-77a0-40c5-8ac3-073b1e7e3380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_17e9906e-5354-40f7-a7d2-4c203bddf622" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b2d109a9-8df0-4377-b2cb-05efec8a81a1" xlink:to="loc_mo_EquityContractWarrantMember_17e9906e-5354-40f7-a7d2-4c203bddf622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e445241f-d8a5-43dd-ad89-1adbd8558ab2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:to="loc_srt_RangeAxis_e445241f-d8a5-43dd-ad89-1adbd8558ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_85b8c78c-6946-43f8-b1c1-3bcc97bc9786" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e445241f-d8a5-43dd-ad89-1adbd8558ab2" xlink:to="loc_srt_RangeMember_85b8c78c-6946-43f8-b1c1-3bcc97bc9786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6644b99c-b1d3-4ad7-8180-2752ae8bb9a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_85b8c78c-6946-43f8-b1c1-3bcc97bc9786" xlink:to="loc_srt_MinimumMember_6644b99c-b1d3-4ad7-8180-2752ae8bb9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3f1db805-bcd8-46e2-a614-e1faebcef393" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_85b8c78c-6946-43f8-b1c1-3bcc97bc9786" xlink:to="loc_srt_MaximumMember_3f1db805-bcd8-46e2-a614-e1faebcef393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_22e074e6-47ba-400c-bf6f-13c74f6809bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_cf83a9a1-5b5f-436b-bada-44ced77a83af" xlink:to="loc_us-gaap_DerivativeLineItems_22e074e6-47ba-400c-bf6f-13c74f6809bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetMeasurementInput_e183bbb0-d841-45c1-8ad6-9060edf6716a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_22e074e6-47ba-400c-bf6f-13c74f6809bb" xlink:to="loc_us-gaap_DerivativeAssetMeasurementInput_e183bbb0-d841-45c1-8ad6-9060edf6716a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9d864c46-2891-4a2d-84c2-1a29860cd73e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_82d4877c-37e2-42eb-8055-d3d3a38c8f64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9d864c46-2891-4a2d-84c2-1a29860cd73e" xlink:to="loc_us-gaap_DerivativeTable_82d4877c-37e2-42eb-8055-d3d3a38c8f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0b592c6-b20c-4f0a-81c6-5169edb454a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_82d4877c-37e2-42eb-8055-d3d3a38c8f64" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0b592c6-b20c-4f0a-81c6-5169edb454a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_400714ee-714c-406e-a7ff-fedff473e9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0b592c6-b20c-4f0a-81c6-5169edb454a3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_400714ee-714c-406e-a7ff-fedff473e9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_44b529a2-1483-4591-bf85-977c7b771329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_400714ee-714c-406e-a7ff-fedff473e9d2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_44b529a2-1483-4591-bf85-977c7b771329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5cbe6c0d-7759-4ec3-bb3b-2beac55cd7e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_82d4877c-37e2-42eb-8055-d3d3a38c8f64" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5cbe6c0d-7759-4ec3-bb3b-2beac55cd7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9d2d6b9f-35fe-4d5d-ac1a-c062cde37694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5cbe6c0d-7759-4ec3-bb3b-2beac55cd7e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9d2d6b9f-35fe-4d5d-ac1a-c062cde37694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember_700a81ea-90e1-4db1-b0f7-d725bbde4f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9d2d6b9f-35fe-4d5d-ac1a-c062cde37694" xlink:to="loc_us-gaap_EquityContractMember_700a81ea-90e1-4db1-b0f7-d725bbde4f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_186b0c21-7c86-4281-b7bb-a794609e0db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_82d4877c-37e2-42eb-8055-d3d3a38c8f64" xlink:to="loc_us-gaap_DerivativeLineItems_186b0c21-7c86-4281-b7bb-a794609e0db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_cb886d08-df23-4078-b638-a684e9240270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_186b0c21-7c86-4281-b7bb-a794609e0db4" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_cb886d08-df23-4078-b638-a684e9240270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_dd5c739e-d021-4c9a-bf1d-65773f075ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_cb886d08-df23-4078-b638-a684e9240270" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_dd5c739e-d021-4c9a-bf1d-65773f075ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3faa6f37-272b-4ce0-a02c-5694eacd8a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_cb886d08-df23-4078-b638-a684e9240270" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_3faa6f37-272b-4ce0-a02c-5694eacd8a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_07db8a64-c90a-40af-ac2a-98c7dbc0485f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_cb886d08-df23-4078-b638-a684e9240270" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_07db8a64-c90a-40af-ac2a-98c7dbc0485f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_38bb863f-11cc-41db-bab8-36f395fc0509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_38bb863f-11cc-41db-bab8-36f395fc0509" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4512b6c8-458d-4629-96a0-ac680ba93dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4512b6c8-458d-4629-96a0-ac680ba93dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6f328697-14f8-4842-9d94-0aed49d8f118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4512b6c8-458d-4629-96a0-ac680ba93dd1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6f328697-14f8-4842-9d94-0aed49d8f118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_bd8db0cc-4a88-48bc-b69d-10307aaac712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_6f328697-14f8-4842-9d94-0aed49d8f118" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_bd8db0cc-4a88-48bc-b69d-10307aaac712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_56b33efb-b72e-4ba6-a301-fb42ebfb6af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_56b33efb-b72e-4ba6-a301-fb42ebfb6af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e34fb8ba-8254-4e2d-9320-351e43586f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_56b33efb-b72e-4ba6-a301-fb42ebfb6af3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e34fb8ba-8254-4e2d-9320-351e43586f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6cbae582-d159-4dca-bd77-bcec6b00035f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e34fb8ba-8254-4e2d-9320-351e43586f39" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6cbae582-d159-4dca-bd77-bcec6b00035f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityContractMember_f05e5b2a-f81f-4688-95ae-67167d8d7746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e34fb8ba-8254-4e2d-9320-351e43586f39" xlink:to="loc_us-gaap_EquityContractMember_f05e5b2a-f81f-4688-95ae-67167d8d7746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_e6ff19fb-4afc-4564-8c99-e04cfb033748" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityContractMember_f05e5b2a-f81f-4688-95ae-67167d8d7746" xlink:to="loc_mo_EquityContractWarrantMember_e6ff19fb-4afc-4564-8c99-e04cfb033748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_366b04bc-f7af-43c5-92e5-b6562f21a345" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityContractMember_f05e5b2a-f81f-4688-95ae-67167d8d7746" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_366b04bc-f7af-43c5-92e5-b6562f21a345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_29c5947c-0a65-490a-a8be-f29470c0fb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:to="loc_us-gaap_HedgingDesignationAxis_29c5947c-0a65-490a-a8be-f29470c0fb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b479948b-9fa9-4cb6-a353-98118d13ec6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_29c5947c-0a65-490a-a8be-f29470c0fb5d" xlink:to="loc_us-gaap_HedgingDesignationDomain_b479948b-9fa9-4cb6-a353-98118d13ec6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e6eee2f5-c810-449e-b84b-277b8fb2a62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b479948b-9fa9-4cb6-a353-98118d13ec6a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e6eee2f5-c810-449e-b84b-277b8fb2a62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_1427953c-8d79-479f-a226-dcbbb51553e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b479948b-9fa9-4cb6-a353-98118d13ec6a" xlink:to="loc_us-gaap_NondesignatedMember_1427953c-8d79-479f-a226-dcbbb51553e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8c359a69-9803-452e-ba8a-3c755e03213e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8c359a69-9803-452e-ba8a-3c755e03213e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8c359a69-9803-452e-ba8a-3c755e03213e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_5e7ac845-a430-494c-8cd1-aa0a044ba1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_5e7ac845-a430-494c-8cd1-aa0a044ba1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_c9f4178f-0dc6-439d-9654-04d56c40cfc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_us-gaap_OtherAssetsMember_c9f4178f-0dc6-439d-9654-04d56c40cfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherAccruedLiabilitiesMember_6b47310e-b2e1-4899-a067-123cd5fe829f" xlink:href="mo-20200930.xsd#mo_OtherAccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_mo_OtherAccruedLiabilitiesMember_6b47310e-b2e1-4899-a067-123cd5fe829f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_a5f52178-1944-43e4-9566-624528b22e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_us-gaap_OtherLiabilitiesMember_a5f52178-1944-43e4-9566-624528b22e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsInEquitySecuritiesMember_0e4bc43e-807a-4c39-9447-49d13e0f2d5d" xlink:href="mo-20200930.xsd#mo_InvestmentsInEquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1901eccc-3243-4454-b5c1-1394aa0784c6" xlink:to="loc_mo_InvestmentsInEquitySecuritiesMember_0e4bc43e-807a-4c39-9447-49d13e0f2d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_8939d71f-bfc3-48a8-a3e4-4a1bc2e13390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b590368b-5614-4c87-8f6c-de2ce007d820" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_8939d71f-bfc3-48a8-a3e4-4a1bc2e13390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6c475999-fcca-400a-87ff-99e4b2190baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_8939d71f-bfc3-48a8-a3e4-4a1bc2e13390" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6c475999-fcca-400a-87ff-99e4b2190baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_fa3c5283-73f1-4812-9338-b705a0d4a905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_8939d71f-bfc3-48a8-a3e4-4a1bc2e13390" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_fa3c5283-73f1-4812-9338-b705a0d4a905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a9299d01-73bd-469a-a63b-a136a7c6728c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f3422914-0951-4885-bdae-7de4b2d63102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a9299d01-73bd-469a-a63b-a136a7c6728c" xlink:to="loc_us-gaap_DerivativeTable_f3422914-0951-4885-bdae-7de4b2d63102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4127108e-b607-4500-84df-e110552e562d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f3422914-0951-4885-bdae-7de4b2d63102" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4127108e-b607-4500-84df-e110552e562d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_70f260e4-82fe-4c09-8de8-0a4f45f5477b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4127108e-b607-4500-84df-e110552e562d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_70f260e4-82fe-4c09-8de8-0a4f45f5477b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_f45c38c0-381a-4e79-8016-6f7787b96f5f" xlink:href="mo-20200930.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_70f260e4-82fe-4c09-8de8-0a4f45f5477b" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_f45c38c0-381a-4e79-8016-6f7787b96f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_401f3868-ac98-4c3b-a52c-94692ed183c0" xlink:href="mo-20200930.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_70f260e4-82fe-4c09-8de8-0a4f45f5477b" xlink:to="loc_mo_EquityContractWarrantMember_401f3868-ac98-4c3b-a52c-94692ed183c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2a5cfbbd-349a-4dc0-ab93-9699aeaed476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f3422914-0951-4885-bdae-7de4b2d63102" xlink:to="loc_us-gaap_DerivativeLineItems_2a5cfbbd-349a-4dc0-ab93-9699aeaed476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_f81274a4-0b5f-462b-82c6-555ee957a3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2a5cfbbd-349a-4dc0-ab93-9699aeaed476" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_f81274a4-0b5f-462b-82c6-555ee957a3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d7f0c6b4-cdad-4e4f-9e79-b64ee7945cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c7f38f62-dbf9-45f3-9300-e5037fac116e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d7f0c6b4-cdad-4e4f-9e79-b64ee7945cf1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c7f38f62-dbf9-45f3-9300-e5037fac116e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e3bc3511-eb03-4cfd-9306-0817e438d9fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c7f38f62-dbf9-45f3-9300-e5037fac116e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e3bc3511-eb03-4cfd-9306-0817e438d9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0f44ffd1-d6eb-4b63-b978-8bec3b1b3cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e3bc3511-eb03-4cfd-9306-0817e438d9fd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0f44ffd1-d6eb-4b63-b978-8bec3b1b3cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ac0827ca-28b7-499d-8560-747a152ca3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0f44ffd1-d6eb-4b63-b978-8bec3b1b3cb6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ac0827ca-28b7-499d-8560-747a152ca3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_f6dba211-c0f7-4850-b35d-8c6783e3a67b" xlink:href="mo-20200930.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0f44ffd1-d6eb-4b63-b978-8bec3b1b3cb6" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_f6dba211-c0f7-4850-b35d-8c6783e3a67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d243d66d-3ff0-4603-b7a8-87ad0cf9f914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c7f38f62-dbf9-45f3-9300-e5037fac116e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d243d66d-3ff0-4603-b7a8-87ad0cf9f914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_05409272-5136-43c8-9517-1e646dae1e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d243d66d-3ff0-4603-b7a8-87ad0cf9f914" xlink:to="loc_us-gaap_HedgingRelationshipDomain_05409272-5136-43c8-9517-1e646dae1e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_404067fd-76e6-4ca8-b094-d4f6309a0f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_05409272-5136-43c8-9517-1e646dae1e7e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_404067fd-76e6-4ca8-b094-d4f6309a0f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0b442634-8cdd-40b6-b5d6-cd2503bb1455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c7f38f62-dbf9-45f3-9300-e5037fac116e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0b442634-8cdd-40b6-b5d6-cd2503bb1455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_76effc15-22e2-4406-aae1-33b9b3195ea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0b442634-8cdd-40b6-b5d6-cd2503bb1455" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_76effc15-22e2-4406-aae1-33b9b3195ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_031b88c8-e236-4115-bfa8-6ac81eb4f88d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0b442634-8cdd-40b6-b5d6-cd2503bb1455" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_031b88c8-e236-4115-bfa8-6ac81eb4f88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlans" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4dce9524-f33d-4b10-878f-6fad568c4461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ca6d5ed8-9f2d-42ab-9ddb-fdc7e24dacf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4dce9524-f33d-4b10-878f-6fad568c4461" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ca6d5ed8-9f2d-42ab-9ddb-fdc7e24dacf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c5ee6362-a891-41b8-88f2-1a9a33cadbb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_53a40b70-123f-4d91-884c-2c370c1adb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c5ee6362-a891-41b8-88f2-1a9a33cadbb2" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_53a40b70-123f-4d91-884c-2c370c1adb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9320bdb4-2f1b-4e40-8e50-e668b3d36e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5d6df4d8-efb1-4be3-9078-2feb46ea3a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9320bdb4-2f1b-4e40-8e50-e668b3d36e03" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5d6df4d8-efb1-4be3-9078-2feb46ea3a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_69404a96-f726-4ca2-8685-80f369e7acaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5d6df4d8-efb1-4be3-9078-2feb46ea3a4f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_69404a96-f726-4ca2-8685-80f369e7acaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f39faa23-8876-4d0d-8b53-2e30ca206fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_69404a96-f726-4ca2-8685-80f369e7acaf" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f39faa23-8876-4d0d-8b53-2e30ca206fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_34e8b751-2eb0-4ba2-8bc1-c3c82b11b120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f39faa23-8876-4d0d-8b53-2e30ca206fb3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_34e8b751-2eb0-4ba2-8bc1-c3c82b11b120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_64525dab-064a-4fce-9a1c-799cab019ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f39faa23-8876-4d0d-8b53-2e30ca206fb3" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_64525dab-064a-4fce-9a1c-799cab019ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5d6df4d8-efb1-4be3-9078-2feb46ea3a4f" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_8675b0cb-fc5c-4ee6-a349-a5679631fb02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_8675b0cb-fc5c-4ee6-a349-a5679631fb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_4c29c7a7-b86a-47d1-9309-bb7ef634d418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_4c29c7a7-b86a-47d1-9309-bb7ef634d418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bab9750c-c0a4-4697-b6b6-d9feefca8ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bab9750c-c0a4-4697-b6b6-d9feefca8ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b89b1ebb-e66c-4c11-a031-27f98f9c221a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b89b1ebb-e66c-4c11-a031-27f98f9c221a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e9d98f12-eddc-423b-9bc1-50fba972a2bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b89b1ebb-e66c-4c11-a031-27f98f9c221a" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e9d98f12-eddc-423b-9bc1-50fba972a2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1f4703ab-4eab-4a01-85d9-71fa77f00a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b89b1ebb-e66c-4c11-a031-27f98f9c221a" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1f4703ab-4eab-4a01-85d9-71fa77f00a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_59a8dbc1-90c3-4df4-809d-259817aaa95d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_59a8dbc1-90c3-4df4-809d-259817aaa95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_07af0c77-e45e-4f42-be26-6d8cae646db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d5e07887-47e7-4557-8d62-aea3f0b7c532" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_07af0c77-e45e-4f42-be26-6d8cae646db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#BenefitPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9b952021-e9fa-4a5f-801d-d8d65ec1e237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93fea49b-5279-4749-827e-a847b39efc03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9b952021-e9fa-4a5f-801d-d8d65ec1e237" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93fea49b-5279-4749-827e-a847b39efc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e8722979-998d-45f1-ab45-70e7cae549db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93fea49b-5279-4749-827e-a847b39efc03" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e8722979-998d-45f1-ab45-70e7cae549db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a0b067c1-56c3-404e-b6cd-7e1a987352f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e8722979-998d-45f1-ab45-70e7cae549db" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a0b067c1-56c3-404e-b6cd-7e1a987352f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_342cf366-5805-4e36-88fb-75b01605c809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a0b067c1-56c3-404e-b6cd-7e1a987352f9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_342cf366-5805-4e36-88fb-75b01605c809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_684bd1bc-1fa1-4ce7-9a43-af9115e2c962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a0b067c1-56c3-404e-b6cd-7e1a987352f9" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_684bd1bc-1fa1-4ce7-9a43-af9115e2c962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_586db45f-5c32-47e7-a058-785b4fe32651" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93fea49b-5279-4749-827e-a847b39efc03" xlink:to="loc_srt_RangeAxis_586db45f-5c32-47e7-a058-785b4fe32651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b9ddd663-a4db-4e23-8851-0b64d141cbc8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_586db45f-5c32-47e7-a058-785b4fe32651" xlink:to="loc_srt_RangeMember_b9ddd663-a4db-4e23-8851-0b64d141cbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_00043f06-491a-4aec-8765-2efac21463e0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b9ddd663-a4db-4e23-8851-0b64d141cbc8" xlink:to="loc_srt_MaximumMember_00043f06-491a-4aec-8765-2efac21463e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5371937f-f6ad-4f52-a94e-6ae2a82f670d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_93fea49b-5279-4749-827e-a847b39efc03" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5371937f-f6ad-4f52-a94e-6ae2a82f670d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d5f88b9f-6de9-4dda-9b3c-21e9602d7f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5371937f-f6ad-4f52-a94e-6ae2a82f670d" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d5f88b9f-6de9-4dda-9b3c-21e9602d7f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_0a49f449-63c7-4d42-947e-72a659639632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5371937f-f6ad-4f52-a94e-6ae2a82f670d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_0a49f449-63c7-4d42-947e-72a659639632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesPerShare" xlink:type="simple" xlink:href="mo-20200930.xsd#EarningsLossesPerShare"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsLossesPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3afb52d4-ea00-425b-bae7-bc501f0dcbe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_5e460854-e6cd-418a-9e98-639788ceba9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3afb52d4-ea00-425b-bae7-bc501f0dcbe2" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_5e460854-e6cd-418a-9e98-639788ceba9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesPerShareTables" xlink:type="simple" xlink:href="mo-20200930.xsd#EarningsLossesPerShareTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsLossesPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c9dec31b-3d36-42d8-8d55-0a62e8d25683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_dcf2ed33-d7d6-437e-ad9b-bb40f4644ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c9dec31b-3d36-42d8-8d55-0a62e8d25683" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_dcf2ed33-d7d6-437e-ad9b-bb40f4644ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6c7d1c27-a871-4660-b67e-9176b88fc683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_36858673-065a-407f-940c-1e3e4660799c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c7d1c27-a871-4660-b67e-9176b88fc683" xlink:to="loc_us-gaap_NetIncomeLoss_36858673-065a-407f-940c-1e3e4660799c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_ced4e46d-ca79-4750-ab5c-d9d04eb930e8" xlink:href="mo-20200930.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c7d1c27-a871-4660-b67e-9176b88fc683" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_ced4e46d-ca79-4750-ab5c-d9d04eb930e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted_bd99ff8e-482c-422e-974a-0010ee32cf4c" xlink:href="mo-20200930.xsd#mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c7d1c27-a871-4660-b67e-9176b88fc683" xlink:to="loc_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted_bd99ff8e-482c-422e-974a-0010ee32cf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_8a9f3457-ec30-43dd-8393-dd853dfc5fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c7d1c27-a871-4660-b67e-9176b88fc683" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_8a9f3457-ec30-43dd-8393-dd853dfc5fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_ee3e079e-ebd6-4ad7-af4a-0f8cc28d0bd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c7d1c27-a871-4660-b67e-9176b88fc683" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_ee3e079e-ebd6-4ad7-af4a-0f8cc28d0bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3e35200e-bfc5-4825-9a8a-cdcb8ebeef3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6c7d1c27-a871-4660-b67e-9176b88fc683" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3e35200e-bfc5-4825-9a8a-cdcb8ebeef3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLosses"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_09357476-03c8-432f-93a0-9fb06644551c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_bb22f579-7aad-4bb7-b775-8fc1b6eae8b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_09357476-03c8-432f-93a0-9fb06644551c" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_bb22f579-7aad-4bb7-b775-8fc1b6eae8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLossesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_312c2892-11af-42d6-9735-38496b6b8838" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f4aa09d2-c91b-4ae8-bfe9-c874e21e654f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_312c2892-11af-42d6-9735-38496b6b8838" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f4aa09d2-c91b-4ae8-bfe9-c874e21e654f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_268550f3-3c5a-48ae-9ada-6a68bbbe2edc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_312c2892-11af-42d6-9735-38496b6b8838" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_268550f3-3c5a-48ae-9ada-6a68bbbe2edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c489bdb8-87cc-4d5a-9e3a-fc7f56b77d67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8ec683c2-0e16-4f1f-927a-b61d2fde047e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c489bdb8-87cc-4d5a-9e3a-fc7f56b77d67" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8ec683c2-0e16-4f1f-927a-b61d2fde047e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f80b04cf-1dad-412f-9ee1-2cc87390ff88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8ec683c2-0e16-4f1f-927a-b61d2fde047e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f80b04cf-1dad-412f-9ee1-2cc87390ff88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_299a1b3b-d253-43b0-b18b-71d5a62efb53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f80b04cf-1dad-412f-9ee1-2cc87390ff88" xlink:to="loc_us-gaap_EquityComponentDomain_299a1b3b-d253-43b0-b18b-71d5a62efb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_299a1b3b-d253-43b0-b18b-71d5a62efb53" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d3f93910-d46c-404c-858b-83d9c44a6e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d3f93910-d46c-404c-858b-83d9c44a6e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_2d503b13-12be-4a43-8d9e-deb2a313d280" xlink:href="mo-20200930.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_2d503b13-12be-4a43-8d9e-deb2a313d280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a771ab65-060e-455b-a3d6-2ba8f07d02de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_431f9ac6-9f1a-4477-b8fb-bce0fb0b5e53" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a771ab65-060e-455b-a3d6-2ba8f07d02de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da4a700f-9deb-4c9d-a55b-966f16199ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8ec683c2-0e16-4f1f-927a-b61d2fde047e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da4a700f-9deb-4c9d-a55b-966f16199ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_da4a700f-9deb-4c9d-a55b-966f16199ffc" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_441ac343-d757-4dc6-88d9-ca4f2f72b6d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_441ac343-d757-4dc6-88d9-ca4f2f72b6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1a058528-f88d-4581-bb6e-23bdc7c2ee75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1a058528-f88d-4581-bb6e-23bdc7c2ee75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_177f0d40-23f5-4843-aa54-92c47e64aae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_177f0d40-23f5-4843-aa54-92c47e64aae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_955be092-cee6-446c-8051-de95685ca8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_955be092-cee6-446c-8051-de95685ca8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_bdc17a64-65d2-493a-8fda-6b0f925335eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_bdc17a64-65d2-493a-8fda-6b0f925335eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_d223ffd3-8051-4d7d-949c-a7513ba04c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_d223ffd3-8051-4d7d-949c-a7513ba04c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e53f7182-8057-48d4-9d20-861a481739cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e53f7182-8057-48d4-9d20-861a481739cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e28dd70-0ee3-46da-b9f9-ac53c27f4609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0e28dd70-0ee3-46da-b9f9-ac53c27f4609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f322514-941f-4de0-ad15-1a8741a4abb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7e5f6b54-0b79-4097-94c3-70d0c22c3c37" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f322514-941f-4de0-ad15-1a8741a4abb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#OtherComprehensiveEarningsLossesReclassificationsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5219f117-f471-4a2c-acc0-8c7d6d59e76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_527d65e2-9105-44b5-a11b-9e0ab4cced8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5219f117-f471-4a2c-acc0-8c7d6d59e76b" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_527d65e2-9105-44b5-a11b-9e0ab4cced8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0a2590eb-ee9c-49b3-9991-c0bb03ccfd02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_527d65e2-9105-44b5-a11b-9e0ab4cced8e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0a2590eb-ee9c-49b3-9991-c0bb03ccfd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2a3263f8-a41d-4cfb-81e7-3ac27a4927d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0a2590eb-ee9c-49b3-9991-c0bb03ccfd02" xlink:to="loc_us-gaap_EquityComponentDomain_2a3263f8-a41d-4cfb-81e7-3ac27a4927d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dba9270a-fb1d-4d0b-b1f3-605e2c6b2a10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2a3263f8-a41d-4cfb-81e7-3ac27a4927d7" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dba9270a-fb1d-4d0b-b1f3-605e2c6b2a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3eb1d10f-d263-4457-a355-d6c799ec3c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dba9270a-fb1d-4d0b-b1f3-605e2c6b2a10" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3eb1d10f-d263-4457-a355-d6c799ec3c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_c6188342-91c0-4b64-932d-d5a3c3a7bf2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dba9270a-fb1d-4d0b-b1f3-605e2c6b2a10" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_c6188342-91c0-4b64-932d-d5a3c3a7bf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f46a084b-faa7-4222-92c1-d0350f2b7dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_527d65e2-9105-44b5-a11b-9e0ab4cced8e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f46a084b-faa7-4222-92c1-d0350f2b7dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7e87dea5-99ac-4181-9566-49e887fb4c01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_f46a084b-faa7-4222-92c1-d0350f2b7dc0" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7e87dea5-99ac-4181-9566-49e887fb4c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_257315ad-855d-4b73-a15c-642ed84908af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7e87dea5-99ac-4181-9566-49e887fb4c01" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_257315ad-855d-4b73-a15c-642ed84908af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_527d65e2-9105-44b5-a11b-9e0ab4cced8e" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_c5e0faa7-6a5f-4d04-acb9-c1f28b756ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_c5e0faa7-6a5f-4d04-acb9-c1f28b756ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_516e1e0f-7ccc-4846-a1b4-dfaf59c88baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_516e1e0f-7ccc-4846-a1b4-dfaf59c88baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_57cacd54-81f6-496d-b43f-6b764b9d9376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_dd85dd7f-60c0-4536-aa24-6bb250fefd36" xlink:to="loc_us-gaap_ProfitLoss_57cacd54-81f6-496d-b43f-6b764b9d9376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReporting" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c563ea45-d381-47f5-a00e-2aa8bd02d5c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_3d7a4085-871f-41a3-9a32-966d13a660de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c563ea45-d381-47f5-a00e-2aa8bd02d5c9" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_3d7a4085-871f-41a3-9a32-966d13a660de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ca19ab4c-11a8-4693-8a30-36834af1b42c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_26cf56f5-7997-4178-97f7-3f3a90cfda87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ca19ab4c-11a8-4693-8a30-36834af1b42c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_26cf56f5-7997-4178-97f7-3f3a90cfda87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_3eb3f22e-3338-44ed-8438-1380dc1e8027" xlink:href="mo-20200930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ca19ab4c-11a8-4693-8a30-36834af1b42c" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock_3eb3f22e-3338-44ed-8438-1380dc1e8027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingSegmentDataScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3909085a-3cb0-40a0-8248-e57c588e2021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5b47ada-580b-4a64-b530-1152daaba70a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3909085a-3cb0-40a0-8248-e57c588e2021" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5b47ada-580b-4a64-b530-1152daaba70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b991e804-c3d3-4ca0-8777-121cc5b28374" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5b47ada-580b-4a64-b530-1152daaba70a" xlink:to="loc_srt_ConsolidationItemsAxis_b991e804-c3d3-4ca0-8777-121cc5b28374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0b24a542-5e4e-4488-9fab-71d5620077f9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b991e804-c3d3-4ca0-8777-121cc5b28374" xlink:to="loc_srt_ConsolidationItemsDomain_0b24a542-5e4e-4488-9fab-71d5620077f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_c486cae8-eb26-43e5-9a39-65ff1a12a9fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0b24a542-5e4e-4488-9fab-71d5620077f9" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_c486cae8-eb26-43e5-9a39-65ff1a12a9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_11a5f332-5e0c-4cfd-a2c5-bc023c8f2498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_0b24a542-5e4e-4488-9fab-71d5620077f9" xlink:to="loc_us-gaap_CorporateNonSegmentMember_11a5f332-5e0c-4cfd-a2c5-bc023c8f2498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_22da0502-c97f-4dc1-b456-1806a70988d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5b47ada-580b-4a64-b530-1152daaba70a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_22da0502-c97f-4dc1-b456-1806a70988d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_22da0502-c97f-4dc1-b456-1806a70988d2" xlink:to="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_77a50fef-a02e-4e9b-81fd-5de89e4bcbf5" xlink:href="mo-20200930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:to="loc_mo_SmokeableProductsSegmentMember_77a50fef-a02e-4e9b-81fd-5de89e4bcbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_63b823e2-3059-4298-8256-ba1a32f57e39" xlink:href="mo-20200930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:to="loc_mo_OralTobaccoSegmentMember_63b823e2-3059-4298-8256-ba1a32f57e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_1f33280e-89dc-428e-8c91-4c5102e6c4fb" xlink:href="mo-20200930.xsd#mo_WineSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:to="loc_mo_WineSegmentMember_1f33280e-89dc-428e-8c91-4c5102e6c4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_4b59bd24-e66e-4bf8-9dc0-059f81bfac6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aa003048-f258-4d4a-9c84-78d7842d5ffe" xlink:to="loc_us-gaap_AllOtherSegmentsMember_4b59bd24-e66e-4bf8-9dc0-059f81bfac6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f5b47ada-580b-4a64-b530-1152daaba70a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30007a0f-7eee-4923-993c-8e263c87447f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30007a0f-7eee-4923-993c-8e263c87447f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_4bca9a67-60f3-4ca6-904f-beefbedb4816" xlink:href="mo-20200930.xsd#mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_4bca9a67-60f3-4ca6-904f-beefbedb4816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5d5de548-67c3-4046-8278-e89fa675036b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5d5de548-67c3-4046-8278-e89fa675036b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c532abf9-a183-477a-abef-1288e189e36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c532abf9-a183-477a-abef-1288e189e36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetImpairmentandBusinessExitCosts_2706f314-ce83-4f7f-9c9c-7d2805f3ca01" xlink:href="mo-20200930.xsd#mo_AssetImpairmentandBusinessExitCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_mo_AssetImpairmentandBusinessExitCosts_2706f314-ce83-4f7f-9c9c-7d2805f3ca01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e133532e-64e7-4c83-9aaa-f6dd7f54ef5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_OperatingIncomeLoss_e133532e-64e7-4c83-9aaa-f6dd7f54ef5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_4317292b-5329-4c34-b371-847c78e7788f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_4317292b-5329-4c34-b371-847c78e7788f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_3a5f2b0f-6a09-40e0-9df5-9eadde3bad13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_3a5f2b0f-6a09-40e0-9df5-9eadde3bad13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ea6951aa-efa5-44a6-b6ab-a52b09b1cbc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ea6951aa-efa5-44a6-b6ab-a52b09b1cbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_26bd14cd-6af0-45e0-b835-54119fbf741a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_26bd14cd-6af0-45e0-b835-54119fbf741a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_4050afa6-f3ed-4059-be1e-70184a429636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_4050afa6-f3ed-4059-be1e-70184a429636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d661d-6c4e-4731-b6dd-e8d79f757a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_33cfafc2-c554-4e01-946b-2020d95846fc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d661d-6c4e-4731-b6dd-e8d79f757a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a49fcc75-8044-4498-9a0d-a762d50324ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:href="mo-20200930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a49fcc75-8044-4498-9a0d-a762d50324ee" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f0aaf8c6-547d-4fe8-a51e-1ae2ca4a7666" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:to="loc_dei_LegalEntityAxis_f0aaf8c6-547d-4fe8-a51e-1ae2ca4a7666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_942fc619-a5c4-4884-95ba-208ff59b2883" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f0aaf8c6-547d-4fe8-a51e-1ae2ca4a7666" xlink:to="loc_dei_EntityDomain_942fc619-a5c4-4884-95ba-208ff59b2883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_6575950f-df5a-42d0-9be2-9db6fe0a78a5" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_942fc619-a5c4-4884-95ba-208ff59b2883" xlink:to="loc_mo_PhilipMorrisUSAMember_6575950f-df5a-42d0-9be2-9db6fe0a78a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cf7ed144-449e-46ab-b636-bf82dfebd3a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:to="loc_srt_LitigationCaseAxis_cf7ed144-449e-46ab-b636-bf82dfebd3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_355270b2-bef2-43c5-b857-2d3de0a6f91c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_cf7ed144-449e-46ab-b636-bf82dfebd3a9" xlink:to="loc_srt_LitigationCaseTypeDomain_355270b2-bef2-43c5-b857-2d3de0a6f91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_56f2f191-a767-488c-84fd-e01c79c11f4f" xlink:href="mo-20200930.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_355270b2-bef2-43c5-b857-2d3de0a6f91c" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_56f2f191-a767-488c-84fd-e01c79c11f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d5d34e8d-bf76-4d45-a2ce-edbba97ef2c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:to="loc_srt_ConsolidationItemsAxis_d5d34e8d-bf76-4d45-a2ce-edbba97ef2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_10df5d28-07be-463d-92ae-31cb4c98f1c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_d5d34e8d-bf76-4d45-a2ce-edbba97ef2c2" xlink:to="loc_srt_ConsolidationItemsDomain_10df5d28-07be-463d-92ae-31cb4c98f1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_012f5ad1-4b27-437b-8c7f-fc70230d18c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_10df5d28-07be-463d-92ae-31cb4c98f1c7" xlink:to="loc_us-gaap_OperatingSegmentsMember_012f5ad1-4b27-437b-8c7f-fc70230d18c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_045a2a79-46c3-4107-b2d1-a18ab757bee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_10df5d28-07be-463d-92ae-31cb4c98f1c7" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_045a2a79-46c3-4107-b2d1-a18ab757bee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_07873462-82f8-4f22-b9d9-93ea17a77329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_07873462-82f8-4f22-b9d9-93ea17a77329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fa949a4b-f480-477f-b341-7c4568a23daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_07873462-82f8-4f22-b9d9-93ea17a77329" xlink:to="loc_us-gaap_SegmentDomain_fa949a4b-f480-477f-b341-7c4568a23daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_fcffedce-c5f7-47a5-a1ca-e6a303caa74d" xlink:href="mo-20200930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fa949a4b-f480-477f-b341-7c4568a23daf" xlink:to="loc_mo_SmokeableProductsSegmentMember_fcffedce-c5f7-47a5-a1ca-e6a303caa74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_ba245171-c7dc-4322-9bba-643040a5612e" xlink:href="mo-20200930.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_ae7edd1d-3c87-474d-8306-9316c2ab6777" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_ba245171-c7dc-4322-9bba-643040a5612e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_c5c6d37c-f2d3-48f5-b429-a7c2ee8dd4f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_ba245171-c7dc-4322-9bba-643040a5612e" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_c5c6d37c-f2d3-48f5-b429-a7c2ee8dd4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#SegmentReportingScheduleofCOVID19RelatedItemsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1138c801-1272-438b-bbbf-53419c2c03f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfPretaxCOVID19ChargesTable_d8022f52-adaf-4878-8539-e75dfa27647b" xlink:href="mo-20200930.xsd#mo_ScheduleOfPretaxCOVID19ChargesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1138c801-1272-438b-bbbf-53419c2c03f4" xlink:to="loc_mo_ScheduleOfPretaxCOVID19ChargesTable_d8022f52-adaf-4878-8539-e75dfa27647b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_5a9c43e0-1cf6-4c6a-b277-b09ada7bcce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesTable_d8022f52-adaf-4878-8539-e75dfa27647b" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_5a9c43e0-1cf6-4c6a-b277-b09ada7bcce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_47b3bf2d-7e57-4702-b88e-f89d584dd3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_5a9c43e0-1cf6-4c6a-b277-b09ada7bcce1" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_47b3bf2d-7e57-4702-b88e-f89d584dd3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_COVID19Member_8c8e4360-5a69-475b-9c3a-bab77bdf9ba9" xlink:href="mo-20200930.xsd#mo_COVID19Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_47b3bf2d-7e57-4702-b88e-f89d584dd3f5" xlink:to="loc_mo_COVID19Member_8c8e4360-5a69-475b-9c3a-bab77bdf9ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3a55a26c-2454-4e40-8817-3a643209b660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesTable_d8022f52-adaf-4878-8539-e75dfa27647b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3a55a26c-2454-4e40-8817-3a643209b660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f0ddfa1-b0ba-4fca-b3fb-72c0a7888a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3a55a26c-2454-4e40-8817-3a643209b660" xlink:to="loc_us-gaap_SegmentDomain_7f0ddfa1-b0ba-4fca-b3fb-72c0a7888a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_6233d962-ea4a-441e-812a-a2678816d8e7" xlink:href="mo-20200930.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f0ddfa1-b0ba-4fca-b3fb-72c0a7888a6e" xlink:to="loc_mo_SmokeableProductsSegmentMember_6233d962-ea4a-441e-812a-a2678816d8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_c9c8bcf7-8ae4-47f0-93fe-98502dde3e03" xlink:href="mo-20200930.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f0ddfa1-b0ba-4fca-b3fb-72c0a7888a6e" xlink:to="loc_mo_OralTobaccoSegmentMember_c9c8bcf7-8ae4-47f0-93fe-98502dde3e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfPretaxCOVID19ChargesLineItems_885f7233-cd88-4f36-a48f-e306dc789e75" xlink:href="mo-20200930.xsd#mo_ScheduleOfPretaxCOVID19ChargesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesTable_d8022f52-adaf-4878-8539-e75dfa27647b" xlink:to="loc_mo_ScheduleOfPretaxCOVID19ChargesLineItems_885f7233-cd88-4f36-a48f-e306dc789e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2e2e81ed-52a5-48cd-87ab-7ef58c95a1b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleOfPretaxCOVID19ChargesLineItems_885f7233-cd88-4f36-a48f-e306dc789e75" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2e2e81ed-52a5-48cd-87ab-7ef58c95a1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/Debt" xlink:type="simple" xlink:href="mo-20200930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c60939e0-1bf4-49c0-a235-44a4fdc82c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_57498f31-41c0-423c-8ae6-523ede15c190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c60939e0-1bf4-49c0-a235-44a4fdc82c7d" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_57498f31-41c0-423c-8ae6-523ede15c190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_212e93dd-7454-45a9-a756-8630f3daa25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_212e93dd-7454-45a9-a756-8630f3daa25c" xlink:to="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c6992173-7690-4e76-9027-3dd883b34d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c6992173-7690-4e76-9027-3dd883b34d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2432ba33-87aa-44ce-a2eb-df6ebb091306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_c6992173-7690-4e76-9027-3dd883b34d5e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2432ba33-87aa-44ce-a2eb-df6ebb091306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_83a00ff3-daa4-4590-8197-20d3156d2d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2432ba33-87aa-44ce-a2eb-df6ebb091306" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_83a00ff3-daa4-4590-8197-20d3156d2d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_342e3a16-1742-4d6e-9e1c-e1c1e5b93608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_VariableRateAxis_342e3a16-1742-4d6e-9e1c-e1c1e5b93608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_739a6246-162b-4603-b706-7672f1a2fb7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_342e3a16-1742-4d6e-9e1c-e1c1e5b93608" xlink:to="loc_us-gaap_VariableRateDomain_739a6246-162b-4603-b706-7672f1a2fb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d50c71cb-d830-4573-a045-15b57bbd0b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_739a6246-162b-4603-b706-7672f1a2fb7b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d50c71cb-d830-4573-a045-15b57bbd0b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_76793346-ba38-4944-a1b0-9f13ad5924bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_CreditFacilityAxis_76793346-ba38-4944-a1b0-9f13ad5924bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0caa897f-8180-43f7-be39-344125b2b243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_76793346-ba38-4944-a1b0-9f13ad5924bf" xlink:to="loc_us-gaap_CreditFacilityDomain_0caa897f-8180-43f7-be39-344125b2b243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_867ccbe8-a4c1-4d4f-a3b8-eb396cc8ed91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0caa897f-8180-43f7-be39-344125b2b243" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_867ccbe8-a4c1-4d4f-a3b8-eb396cc8ed91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4843bc21-d539-4720-988b-7176bfbf55a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4843bc21-d539-4720-988b-7176bfbf55a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_de19a4d0-2188-45a9-ad2b-26aeb5714b54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4843bc21-d539-4720-988b-7176bfbf55a6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_de19a4d0-2188-45a9-ad2b-26aeb5714b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_4b7f7529-d1b6-4ffe-a0ed-c50471c513c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de19a4d0-2188-45a9-ad2b-26aeb5714b54" xlink:to="loc_us-gaap_LineOfCreditMember_4b7f7529-d1b6-4ffe-a0ed-c50471c513c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_de643ff4-059a-4b84-a772-8bf0cfd7140b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_de19a4d0-2188-45a9-ad2b-26aeb5714b54" xlink:to="loc_us-gaap_SeniorNotesMember_de643ff4-059a-4b84-a772-8bf0cfd7140b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dcb62794-b09c-43a2-94fc-3d48a86d6a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_DebtInstrumentAxis_dcb62794-b09c-43a2-94fc-3d48a86d6a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dcb62794-b09c-43a2-94fc-3d48a86d6a8a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2023Member_7f8d4a63-cae8-4c7e-88db-7e276c32b863" xlink:href="mo-20200930.xsd#mo_RevolvingCreditFacilityDueAugust2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_RevolvingCreditFacilityDueAugust2023Member_7f8d4a63-cae8-4c7e-88db-7e276c32b863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember_c8de4b57-8340-4660-b119-ce928bee50c7" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_USDDenominatedNotesMember_c8de4b57-8340-4660-b119-ce928bee50c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember_ed4d2108-3699-4a09-b300-819eceae1aa3" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember_ed4d2108-3699-4a09-b300-819eceae1aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember_1bffd12f-d756-4577-b2dc-1b228ee2a76a" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesDueTwoThousandAndThirtyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_USDDenominatedNotesDueTwoThousandAndThirtyMember_1bffd12f-d756-4577-b2dc-1b228ee2a76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesDueTwoThousandandFiftyMember_d1b0ccd9-5d56-4889-bc0b-e86fd887b82f" xlink:href="mo-20200930.xsd#mo_USDDenominatedNotesDueTwoThousandandFiftyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_62671a44-f6f5-4aa0-be01-845ad13f50ca" xlink:to="loc_mo_USDDenominatedNotesDueTwoThousandandFiftyMember_d1b0ccd9-5d56-4889-bc0b-e86fd887b82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d7d0e0db-88bd-4e81-bbf3-1f4a35f03506" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_084fc157-034b-46af-b548-9f7b68e6b2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_ShortTermBorrowings_084fc157-034b-46af-b548-9f7b68e6b2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_9ac3ca58-d006-4ab5-8593-684a90e4e247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentTerm_9ac3ca58-d006-4ab5-8593-684a90e4e247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5bcdac0b-8626-41aa-833b-3e0877b4c03d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5bcdac0b-8626-41aa-833b-3e0877b4c03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentNumberofExtensions_aed16d7e-9c1e-4e7e-b666-7881a1fc5f5b" xlink:href="mo-20200930.xsd#mo_DebtInstrumentNumberofExtensions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_mo_DebtInstrumentNumberofExtensions_aed16d7e-9c1e-4e7e-b666-7881a1fc5f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentExtensionTerm_04c91804-612a-4933-a7d4-50b384233d5b" xlink:href="mo-20200930.xsd#mo_DebtInstrumentExtensionTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_mo_DebtInstrumentExtensionTerm_04c91804-612a-4933-a7d4-50b384233d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cf6df82e-fa54-4686-9f3a-7786b29dfe68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cf6df82e-fa54-4686-9f3a-7786b29dfe68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_d8dce062-d822-4149-a83c-a766648d0729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_d8dce062-d822-4149-a83c-a766648d0729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_6541711a-33c5-4160-b173-4cc266e9dc4d" xlink:href="mo-20200930.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_6541711a-33c5-4160-b173-4cc266e9dc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_2f73efd3-3355-41b6-bfd8-4bea851908cd" xlink:href="mo-20200930.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_2f73efd3-3355-41b6-bfd8-4bea851908cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e22def75-9526-4cb5-91e6-125bb3d385b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_LongTermDebt_e22def75-9526-4cb5-91e6-125bb3d385b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_934511b6-5139-4144-8062-3afaa1f9e187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_934511b6-5139-4144-8062-3afaa1f9e187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_a7b2ceef-3f1d-46aa-a623-b0a9ba4da710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_a7b2ceef-3f1d-46aa-a623-b0a9ba4da710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8d6c55c4-8f86-45be-90ca-bc8967039667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8d6c55c4-8f86-45be-90ca-bc8967039667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_471c4830-da12-4cb2-a766-c67f46704161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f9d9bde8-ff2f-4ec5-a953-5c530031c31b" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_471c4830-da12-4cb2-a766-c67f46704161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mo-20200930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3308d9c5-c4c9-452f-b0ce-5291acb6088a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_0966954e-12c2-4763-a9dd-92a1b69ab42f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3308d9c5-c4c9-452f-b0ce-5291acb6088a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_0966954e-12c2-4763-a9dd-92a1b69ab42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="simple" xlink:href="mo-20200930.xsd#IncomeTaxesupdateTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9965da3c-0cb0-487d-adfa-4c3d68d245a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_67bbb6a0-ed22-4a12-b23f-fd7806354d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9965da3c-0cb0-487d-adfa-4c3d68d245a6" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_67bbb6a0-ed22-4a12-b23f-fd7806354d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_83258ea8-7230-4cbc-84f6-e22110ecf4c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f09d306b-6d5d-4dfa-94b9-913806d5444b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83258ea8-7230-4cbc-84f6-e22110ecf4c3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f09d306b-6d5d-4dfa-94b9-913806d5444b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceRollforwardRollForward_2aa0c072-3673-4d0d-8fa0-908a16e768bc" xlink:href="mo-20200930.xsd#mo_ValuationAllowanceRollforwardRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83258ea8-7230-4cbc-84f6-e22110ecf4c3" xlink:to="loc_mo_ValuationAllowanceRollforwardRollForward_2aa0c072-3673-4d0d-8fa0-908a16e768bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b21305a4-9371-43b1-be80-e051ed8e608a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_2aa0c072-3673-4d0d-8fa0-908a16e768bc" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b21305a4-9371-43b1-be80-e051ed8e608a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_a3f9e585-ebdf-4065-9fd0-ad6aa38c69f3" xlink:href="mo-20200930.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_2aa0c072-3673-4d0d-8fa0-908a16e768bc" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_a3f9e585-ebdf-4065-9fd0-ad6aa38c69f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_f56ffdc0-2509-4ab6-bcbb-e12e0dd844af" xlink:href="mo-20200930.xsd#mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_2aa0c072-3673-4d0d-8fa0-908a16e768bc" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_f56ffdc0-2509-4ab6-bcbb-e12e0dd844af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_4659aeb7-028e-4b0e-99b5-2bba3283847a" xlink:href="mo-20200930.xsd#mo_ValuationAllowanceForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_2aa0c072-3673-4d0d-8fa0-908a16e768bc" xlink:to="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_4659aeb7-028e-4b0e-99b5-2bba3283847a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_690c30a0-818c-4912-8038-37d949f23609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_2aa0c072-3673-4d0d-8fa0-908a16e768bc" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_690c30a0-818c-4912-8038-37d949f23609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_279e3fdc-aaee-42be-b5f8-0efa27780dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83258ea8-7230-4cbc-84f6-e22110ecf4c3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_279e3fdc-aaee-42be-b5f8-0efa27780dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_090bc869-9b23-49d3-baed-6f412de1237f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83258ea8-7230-4cbc-84f6-e22110ecf4c3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_090bc869-9b23-49d3-baed-6f412de1237f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_e01ca7f1-1ade-47af-be06-543a703ceec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83258ea8-7230-4cbc-84f6-e22110ecf4c3" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_e01ca7f1-1ade-47af-be06-543a703ceec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_08dc8611-2d11-4329-97af-27456e1a2db8" xlink:href="mo-20200930.xsd#mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_83258ea8-7230-4cbc-84f6-e22110ecf4c3" xlink:to="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_08dc8611-2d11-4329-97af-27456e1a2db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/Contingencies" xlink:type="simple" xlink:href="mo-20200930.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ae8b830d-cdf7-4e2e-b0b9-7070429707c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_ef356873-2d2f-4e46-bddc-d5cdc0214b70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ae8b830d-cdf7-4e2e-b0b9-7070429707c1" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_ef356873-2d2f-4e46-bddc-d5cdc0214b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesTables" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08e64768-b8de-44b2-8196-a79c76a7e51e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_7cd9b0dd-295c-4fde-a710-d737e7627344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08e64768-b8de-44b2-8196-a79c76a7e51e" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_7cd9b0dd-295c-4fde-a710-d737e7627344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesGeneralInformationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a45a64d5-d628-48ce-9d92-4c01a01b85f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_a4248c5f-ac36-4146-b10b-0de1ff437d62" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a45a64d5-d628-48ce-9d92-4c01a01b85f4" xlink:to="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_a4248c5f-ac36-4146-b10b-0de1ff437d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesScheduleofPendingCasesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a75a4d7d-c6d0-46b7-a329-626ffee657e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a75a4d7d-c6d0-46b7-a329-626ffee657e7" xlink:to="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_40409361-81df-4df4-bf1b-c6572747950b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_40409361-81df-4df4-bf1b-c6572747950b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b52e6b05-2383-4491-bd8d-70039183ee36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_40409361-81df-4df4-bf1b-c6572747950b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b52e6b05-2383-4491-bd8d-70039183ee36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c228790f-5f41-4e07-a71a-eb6912c42ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b52e6b05-2383-4491-bd8d-70039183ee36" xlink:to="loc_us-gaap_SubsequentEventMember_c228790f-5f41-4e07-a71a-eb6912c42ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7201e3fd-ac4d-44d8-ba57-43b6bb53108e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:to="loc_srt_LitigationCaseAxis_7201e3fd-ac4d-44d8-ba57-43b6bb53108e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_7201e3fd-ac4d-44d8-ba57-43b6bb53108e" xlink:to="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_d5aad542-0490-4fed-9571-ab1e328bd12b" xlink:href="mo-20200930.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_d5aad542-0490-4fed-9571-ab1e328bd12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_9a380de1-60c7-40cc-82e0-a207b4a40bc3" xlink:href="mo-20200930.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember_d5aad542-0490-4fed-9571-ab1e328bd12b" xlink:to="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_9a380de1-60c7-40cc-82e0-a207b4a40bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_ed282df3-d3f1-440a-a120-76b8ba2fd3fd" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_ed282df3-d3f1-440a-a120-76b8ba2fd3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_6990ae99-ec94-48ba-b46b-f05314159c18" xlink:href="mo-20200930.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:to="loc_mo_EvaporLitigationMember_6990ae99-ec94-48ba-b46b-f05314159c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember_8da1448c-1bea-453c-9a2c-5ed212854583" xlink:href="mo-20200930.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_893e6921-378d-4e17-acc4-cf809e603799" xlink:to="loc_mo_OtherTabaccoRelatedCasesMember_8da1448c-1bea-453c-9a2c-5ed212854583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d484599e-289c-4e61-9202-e84a98cd91d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:to="loc_us-gaap_LitigationStatusAxis_d484599e-289c-4e61-9202-e84a98cd91d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_d484599e-289c-4e61-9202-e84a98cd91d7" xlink:to="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_7c2e47e4-5d49-4c3c-9540-f598efd76a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:to="loc_us-gaap_PendingLitigationMember_7c2e47e4-5d49-4c3c-9540-f598efd76a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_79eee961-fe20-4a4d-ba6d-972062de576f" xlink:href="mo-20200930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:to="loc_mo_PendingIndividualLawsuitsMember_79eee961-fe20-4a4d-ba6d-972062de576f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_091b92f2-2de8-4d6b-9f16-060030eaf09f" xlink:href="mo-20200930.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_091b92f2-2de8-4d6b-9f16-060030eaf09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_d595f269-6ba9-4cd1-b062-f223f56b0a30" xlink:href="mo-20200930.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_66377f86-4b6e-4287-9a55-110ab4c2f56b" xlink:to="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_d595f269-6ba9-4cd1-b062-f223f56b0a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4e920801-b041-4487-8e50-33b43b0ac9e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:to="loc_srt_StatementGeographicalAxis_4e920801-b041-4487-8e50-33b43b0ac9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4e920801-b041-4487-8e50-33b43b0ac9e6" xlink:to="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_b59e6df0-7e8b-4600-8568-8c19b6a131d2" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NM"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:to="loc_stpr_NM_b59e6df0-7e8b-4600-8568-8c19b6a131d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_94b94b61-c74c-459a-944e-24dc011c2f7b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:to="loc_stpr_MA_94b94b61-c74c-459a-944e-24dc011c2f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_34bfb70f-be66-44b8-8cc9-ced6ee80fb4d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:to="loc_stpr_FL_34bfb70f-be66-44b8-8cc9-ced6ee80fb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_72261714-e909-4c12-95f7-43dc63aea7c2" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0a5f7cfd-1d1c-466d-b28e-26cbeeb2ed37" xlink:to="loc_country_CA_72261714-e909-4c12-95f7-43dc63aea7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4a532f30-451a-4a88-8969-9b1b8a265de5" xlink:to="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_2f986970-f556-477d-9bda-b2d0692a763b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_2f986970-f556-477d-9bda-b2d0692a763b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases_5a67b920-2ebb-495b-91ef-43e4549ab05a" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfCases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyNumberOfCases_5a67b920-2ebb-495b-91ef-43e4549ab05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_decfe8f8-c6f6-43bd-8393-e7ec0c984f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_decfe8f8-c6f6-43bd-8393-e7ec0c984f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_f6158d0e-2a7d-4ff5-98df-3b814851abeb" xlink:href="mo-20200930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyClassActionLawsuit_f6158d0e-2a7d-4ff5-98df-3b814851abeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases_d9549811-d72c-47f4-aa73-a2e10d967da2" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyNumberOfInactiveCases_d9549811-d72c-47f4-aa73-a2e10d967da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesTriedinASingleProceeding_d77888ac-9091-4573-b041-ef0d9c29e542" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfCasesTriedinASingleProceeding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyNumberOfCasesTriedinASingleProceeding_d77888ac-9091-4573-b041-ef0d9c29e542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_af549c66-a52b-434a-9f5b-752f00af612c" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1250752d-ff73-4a01-b1a6-0e6d4d6b9bdb" xlink:to="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_af549c66-a52b-434a-9f5b-752f00af612c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_890debd0-e367-411d-8b80-9e52b38209bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_890debd0-e367-411d-8b80-9e52b38209bf" xlink:to="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3c21b5a6-e3dd-4217-bab3-710ffe8c4e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3c21b5a6-e3dd-4217-bab3-710ffe8c4e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ca8785eb-9b2a-4326-b1ea-cc8b13eea281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3c21b5a6-e3dd-4217-bab3-710ffe8c4e68" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ca8785eb-9b2a-4326-b1ea-cc8b13eea281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9468030b-55e1-4ec6-aff4-a87ec6c310e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ca8785eb-9b2a-4326-b1ea-cc8b13eea281" xlink:to="loc_us-gaap_SubsequentEventMember_9468030b-55e1-4ec6-aff4-a87ec6c310e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_88dcb54b-e536-4fec-93ea-cd35f11c60e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:to="loc_dei_LegalEntityAxis_88dcb54b-e536-4fec-93ea-cd35f11c60e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f353836d-bd75-4b4e-a985-114573005430" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_88dcb54b-e536-4fec-93ea-cd35f11c60e4" xlink:to="loc_dei_EntityDomain_f353836d-bd75-4b4e-a985-114573005430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_b97f3026-5ba1-409a-999c-ca96e86112c5" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f353836d-bd75-4b4e-a985-114573005430" xlink:to="loc_mo_PhilipMorrisUSAMember_b97f3026-5ba1-409a-999c-ca96e86112c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_1e4a809f-3fb1-4eed-b17d-90672a589753" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f353836d-bd75-4b4e-a985-114573005430" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_1e4a809f-3fb1-4eed-b17d-90672a589753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_399a9125-b8a4-4424-8ae3-07d2f48e7744" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:to="loc_srt_LitigationCaseAxis_399a9125-b8a4-4424-8ae3-07d2f48e7744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_399a9125-b8a4-4424-8ae3-07d2f48e7744" xlink:to="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_fc8c67da-adb5-4bee-a1ed-7e29813fbb19" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_fc8c67da-adb5-4bee-a1ed-7e29813fbb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_d3fb638e-b90e-446c-b71d-d0201b4f3b7e" xlink:href="mo-20200930.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_d3fb638e-b90e-446c-b71d-d0201b4f3b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_9cce6622-00b5-4be2-bdbf-44d7e613dcb6" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_EngleProgenyCasesMember_9cce6622-00b5-4be2-bdbf-44d7e613dcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_e6240c30-765a-49c8-8c1f-1192deb517a3" xlink:href="mo-20200930.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_e6240c30-765a-49c8-8c1f-1192deb517a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember_caaf9a62-bdf3-4182-a944-6454c6f6359e" xlink:href="mo-20200930.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c6c045a5-0047-477f-8906-bf9a8fb050f4" xlink:to="loc_mo_NonEngleProgenyCasesMember_caaf9a62-bdf3-4182-a944-6454c6f6359e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2bdc07b5-41a6-4393-a14b-8b3ffe6633c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:to="loc_srt_StatementGeographicalAxis_2bdc07b5-41a6-4393-a14b-8b3ffe6633c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2bdc07b5-41a6-4393-a14b-8b3ffe6633c7" xlink:to="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_c18e8fc7-3948-4ff9-9622-9f3e717dd318" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_country_CA_c18e8fc7-3948-4ff9-9622-9f3e717dd318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK_cfe83448-b38f-44fd-8102-92010fac59d2" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_AK"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_AK_cfe83448-b38f-44fd-8102-92010fac59d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_a534739c-68bf-4688-bb07-7dfbb5974a8e" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_CA_a534739c-68bf-4688-bb07-7dfbb5974a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_810c3122-a054-4c2a-b5a7-1dd5b497f14b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_CT_810c3122-a054-4c2a-b5a7-1dd5b497f14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_5e733a6e-bac0-4fca-afa7-5d5e686b0a77" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_FL_5e733a6e-bac0-4fca-afa7-5d5e686b0a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_e6f9bba3-584d-4ed2-88c8-01db60d7e18f" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_LA"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_LA_e6f9bba3-584d-4ed2-88c8-01db60d7e18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_91f23c42-1ec6-48c7-a28b-b852179f5e7b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_MA_91f23c42-1ec6-48c7-a28b-b852179f5e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS_b7b4f48d-a014-4367-9c66-0789ba171d98" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MS"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_MS_b7b4f48d-a014-4367-9c66-0789ba171d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO_f0dada42-66c6-43e1-8da7-638c1765f9c0" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MO"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_MO_f0dada42-66c6-43e1-8da7-638c1765f9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH_eca94b46-cb0a-478c-87e3-62f1c6994a9d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NH"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_NH_eca94b46-cb0a-478c-87e3-62f1c6994a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_3bb8cccd-182f-421c-b1f5-c72269aa45b2" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NJ"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_NJ_3bb8cccd-182f-421c-b1f5-c72269aa45b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_a84e43f8-2d1b-4957-804c-43e151347fc1" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_NY_a84e43f8-2d1b-4957-804c-43e151347fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_91e209d7-2108-4a1a-843f-29ec4775af50" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_OH_91e209d7-2108-4a1a-843f-29ec4775af50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_007aaca6-73de-4698-8c69-e89dd2f824c7" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_PA"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_PA_007aaca6-73de-4698-8c69-e89dd2f824c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI_1ef68016-c9ab-4623-ab86-8fa43841aea1" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_RI"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_RI_1ef68016-c9ab-4623-ab86-8fa43841aea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_a8c018c7-b89f-46db-9054-ebf9bfe6fedd" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TN"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_TN_a8c018c7-b89f-46db-9054-ebf9bfe6fedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_79ad522e-72e5-4cf6-9622-c6f64cacc867" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_WV"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_feb463c5-407a-49f3-a415-a18afe3c959b" xlink:to="loc_stpr_WV_79ad522e-72e5-4cf6-9622-c6f64cacc867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_268bcdf7-c34e-4265-91ef-5e2f2c5eed5c" xlink:to="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_94ccb52b-ff3f-42e5-aa4e-f88cbcbcdc19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_94ccb52b-ff3f-42e5-aa4e-f88cbcbcdc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_c83290ba-b9c5-49ef-b6bf-97b81d8922f3" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_c83290ba-b9c5-49ef-b6bf-97b81d8922f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_18ec271a-cec5-4d25-97f3-ef0112f96466" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyClaimsDecided_18ec271a-cec5-4d25-97f3-ef0112f96466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_7d8535c5-b1ca-4285-a397-6d73f2f1a9dd" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_7d8535c5-b1ca-4285-a397-6d73f2f1a9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_71dba0de-3d2c-4232-bef8-84b6fa78886b" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_71dba0de-3d2c-4232-bef8-84b6fa78886b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber_69c4287e-6a69-4dad-b3d8-d6da5a378184" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyClaimsResolvedNumber_69c4287e-6a69-4dad-b3d8-d6da5a378184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_c009ad33-d398-4725-85b6-7d272c529809" xlink:href="mo-20200930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_66e3ccb4-c712-430e-9735-f1066bf6fb53" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_c009ad33-d398-4725-85b6-7d272c529809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_561b1ea4-a946-42eb-80f4-00ed579a5169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_561b1ea4-a946-42eb-80f4-00ed579a5169" xlink:to="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_15e06959-5fbe-4f27-af42-74110ba50e25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_srt_LitigationCaseAxis_15e06959-5fbe-4f27-af42-74110ba50e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_040518bd-faac-4889-8c2f-511f8abb11e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_15e06959-5fbe-4f27-af42-74110ba50e25" xlink:to="loc_srt_LitigationCaseTypeDomain_040518bd-faac-4889-8c2f-511f8abb11e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_997a5ed3-5619-4b8a-8a07-5cc4e07a5eb4" xlink:href="mo-20200930.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_040518bd-faac-4889-8c2f-511f8abb11e6" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_997a5ed3-5619-4b8a-8a07-5cc4e07a5eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_26be2935-dcc7-4576-971b-07facb0ae6ff" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_040518bd-faac-4889-8c2f-511f8abb11e6" xlink:to="loc_mo_EngleProgenyCasesMember_26be2935-dcc7-4576-971b-07facb0ae6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e054b27a-e3d7-4a7f-aaee-daf2ac535d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e054b27a-e3d7-4a7f-aaee-daf2ac535d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8236dde5-12d0-44dc-9064-fdc4c576d8ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e054b27a-e3d7-4a7f-aaee-daf2ac535d26" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8236dde5-12d0-44dc-9064-fdc4c576d8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_48963f71-ccf2-4db4-8574-4f97e28b7ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8236dde5-12d0-44dc-9064-fdc4c576d8ca" xlink:to="loc_us-gaap_AssetsMember_48963f71-ccf2-4db4-8574-4f97e28b7ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_7092a120-3848-4d5b-a67d-3e3b8d559875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_us-gaap_LitigationStatusAxis_7092a120-3848-4d5b-a67d-3e3b8d559875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_df0fbb02-2104-4ddb-b1ec-c6865eb012cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_7092a120-3848-4d5b-a67d-3e3b8d559875" xlink:to="loc_us-gaap_LitigationStatusDomain_df0fbb02-2104-4ddb-b1ec-c6865eb012cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_f5dbe8f3-5a29-47ac-9f99-de8caf005c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_df0fbb02-2104-4ddb-b1ec-c6865eb012cd" xlink:to="loc_us-gaap_PendingLitigationMember_f5dbe8f3-5a29-47ac-9f99-de8caf005c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0e5be90f-d7f5-4faf-841e-9edde3ecf8b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_dei_LegalEntityAxis_0e5be90f-d7f5-4faf-841e-9edde3ecf8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_772ccd83-ed40-4b8f-bf69-d29be1fc7c63" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_0e5be90f-d7f5-4faf-841e-9edde3ecf8b5" xlink:to="loc_dei_EntityDomain_772ccd83-ed40-4b8f-bf69-d29be1fc7c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_bbcc5e50-aab2-41d2-8991-32254e18a828" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_772ccd83-ed40-4b8f-bf69-d29be1fc7c63" xlink:to="loc_mo_PhilipMorrisUSAMember_bbcc5e50-aab2-41d2-8991-32254e18a828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7013b3c6-4b35-4def-9a4e-7ef0bc3d5070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7013b3c6-4b35-4def-9a4e-7ef0bc3d5070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7013b3c6-4b35-4def-9a4e-7ef0bc3d5070" xlink:to="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PreTrialResolutionMember_9efb54b2-66aa-473f-a9b9-25b91222cbb4" xlink:href="mo-20200930.xsd#mo_PreTrialResolutionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:to="loc_mo_PreTrialResolutionMember_9efb54b2-66aa-473f-a9b9-25b91222cbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_b9ea16fe-366b-496c-8e67-c8fe0c41e4d0" xlink:href="mo-20200930.xsd#mo_LitigationCasesResultsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:to="loc_mo_LitigationCasesResultsMember_b9ea16fe-366b-496c-8e67-c8fe0c41e4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember_39b63967-fe28-465b-ba22-cc728d131b20" xlink:href="mo-20200930.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_200d4bbb-9055-4b70-91ca-df5481766617" xlink:to="loc_mo_InterestExpenseRelatedToLitigationMember_39b63967-fe28-465b-ba22-cc728d131b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_709ba1ba-4e26-4cfd-a296-d23208e660b6" xlink:to="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_14ac5f68-e065-4ccc-ab55-92afd15a35a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_14ac5f68-e065-4ccc-ab55-92afd15a35a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_a7ba74e2-5c94-44a0-97b2-6070b0372a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_us-gaap_LitigationSettlementInterest_a7ba74e2-5c94-44a0-97b2-6070b0372a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_ae288739-8e35-474d-9747-9cbcabcf03b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_ae288739-8e35-474d-9747-9cbcabcf03b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_5b88bea3-f73b-42bd-b571-f9b673164b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_5b88bea3-f73b-42bd-b571-f9b673164b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_1d30f388-4915-4389-a65c-704df16581a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_1d30f388-4915-4389-a65c-704df16581a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_da238a04-b9cd-424a-8ba8-0007da5147f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_7dfc67e7-eaf3-47a1-8f7a-06a0f88e8dcc" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_da238a04-b9cd-424a-8ba8-0007da5147f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPreTrialResolutionCases_0e28f5c1-2a78-40e4-93e4-63f625980218" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfPreTrialResolutionCases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_mo_LossContingencyNumberOfPreTrialResolutionCases_0e28f5c1-2a78-40e4-93e4-63f625980218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit_3e9f2d1c-fa0e-4347-9537-36c09d7e6d48" xlink:href="mo-20200930.xsd#mo_LitigationEscrowDeposit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8c3c85a4-fc22-42ac-9d01-81e8e88de689" xlink:to="loc_mo_LitigationEscrowDeposit_3e9f2d1c-fa0e-4347-9537-36c09d7e6d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesNonEngleProgenyLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fe39903b-f4b9-41db-9abe-4e7fa9c358c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_be480105-bed8-4845-8875-fdbdeae55cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fe39903b-f4b9-41db-9abe-4e7fa9c358c5" xlink:to="loc_us-gaap_LossContingenciesTable_be480105-bed8-4845-8875-fdbdeae55cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_da41b7d4-dad4-489a-940b-540d15020661" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_be480105-bed8-4845-8875-fdbdeae55cea" xlink:to="loc_srt_LitigationCaseAxis_da41b7d4-dad4-489a-940b-540d15020661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_da41b7d4-dad4-489a-940b-540d15020661" xlink:to="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_175e535a-a421-46a3-9e8f-0cb71dd46b2f" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_175e535a-a421-46a3-9e8f-0cb71dd46b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_b2ac48f2-c0ea-4c26-a29a-83d5fbcf979e" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_b2ac48f2-c0ea-4c26-a29a-83d5fbcf979e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_40050cac-770c-4728-a4b5-c720712460fe" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingandHealthCaseLaramieMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_40050cac-770c-4728-a4b5-c720712460fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember_73f6d1e1-8ed9-4682-825c-a94569c3e38d" xlink:href="mo-20200930.xsd#mo_NonEngleProgenySmokingandHealthCaseGentileMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ade52076-bb16-4f42-8588-1e4f5b4f4c58" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGentileMember_73f6d1e1-8ed9-4682-825c-a94569c3e38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d2df54b1-5f93-4191-8376-21ceecf5a04c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_be480105-bed8-4845-8875-fdbdeae55cea" xlink:to="loc_dei_LegalEntityAxis_d2df54b1-5f93-4191-8376-21ceecf5a04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6a048340-3d1f-4dd5-bdb5-7ec9aa2381f4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d2df54b1-5f93-4191-8376-21ceecf5a04c" xlink:to="loc_dei_EntityDomain_6a048340-3d1f-4dd5-bdb5-7ec9aa2381f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a773d0df-2131-4ace-b72d-3f51552f0f01" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_6a048340-3d1f-4dd5-bdb5-7ec9aa2381f4" xlink:to="loc_mo_PhilipMorrisUSAMember_a773d0df-2131-4ace-b72d-3f51552f0f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_be480105-bed8-4845-8875-fdbdeae55cea" xlink:to="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_270d1e20-759e-43ed-88af-95f2cc2138f1" xlink:href="mo-20200930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_270d1e20-759e-43ed-88af-95f2cc2138f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_2b39e9b6-6255-4b47-8a32-a81366dcc5bf" xlink:href="mo-20200930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_2b39e9b6-6255-4b47-8a32-a81366dcc5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_628a65d5-23f3-4b4b-a4d2-034f9c301413" xlink:href="mo-20200930.xsd#mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ec425e94-1e17-451d-8761-06ba48fe3e63" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage_628a65d5-23f3-4b4b-a4d2-034f9c301413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a5708058-52d7-4525-828d-7e47f4ef71bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a5708058-52d7-4525-828d-7e47f4ef71bb" xlink:to="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ea486f34-4033-4bc6-bad2-257928747e0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ea486f34-4033-4bc6-bad2-257928747e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5f09fb07-bbca-4953-a39a-a639d91e12e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ea486f34-4033-4bc6-bad2-257928747e0d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5f09fb07-bbca-4953-a39a-a639d91e12e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ffe70b82-3a64-4167-abb4-722587767187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5f09fb07-bbca-4953-a39a-a639d91e12e2" xlink:to="loc_us-gaap_SubsequentEventMember_ffe70b82-3a64-4167-abb4-722587767187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0405c15a-1081-4021-a27b-622331bfb3ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:to="loc_srt_LitigationCaseAxis_0405c15a-1081-4021-a27b-622331bfb3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_0405c15a-1081-4021-a27b-622331bfb3ea" xlink:to="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_c2b4db31-a0ac-4a6d-a2aa-900c0d3d06dc" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesMember_c2b4db31-a0ac-4a6d-a2aa-900c0d3d06dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_1f7ffa64-f5f0-4322-ad24-e08eeac64239" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_EngleProgenyCasesMember_c2b4db31-a0ac-4a6d-a2aa-900c0d3d06dc" xlink:to="loc_mo_EngleProgenyCasesStateMember_1f7ffa64-f5f0-4322-ad24-e08eeac64239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFederalMember_c48d2952-8183-4bfb-b254-edb9f353b6ab" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesFederalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_EngleProgenyCasesMember_c2b4db31-a0ac-4a6d-a2aa-900c0d3d06dc" xlink:to="loc_mo_EngleProgenyCasesFederalMember_c48d2952-8183-4bfb-b254-edb9f353b6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_ead144b5-d140-4b48-a03a-33c914717703" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_ead144b5-d140-4b48-a03a-33c914717703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember_851fbf95-d02c-4709-9d3b-da875b875f55" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesReiderandBanksMember_851fbf95-d02c-4709-9d3b-da875b875f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember_8aa01131-aae5-4c95-9c09-9837b3f73461" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesWeingartandHancockMember_8aa01131-aae5-4c95-9c09-9837b3f73461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember_a65aa050-6e1e-4acd-9a5d-519abd8d06c3" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesPollariMember_a65aa050-6e1e-4acd-9a5d-519abd8d06c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_621bbe4e-705a-45bd-a99a-e7b88a86d726" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_621bbe4e-705a-45bd-a99a-e7b88a86d726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanMember_751178fd-9d64-414e-be37-a1a328f61f3e" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesFreemanMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e0b19b66-094a-426b-98d3-b152f3650661" xlink:to="loc_mo_EngleProgenyCasesFreemanMember_751178fd-9d64-414e-be37-a1a328f61f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_94dd2826-36dc-451a-9198-e78bc967d38f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:to="loc_dei_LegalEntityAxis_94dd2826-36dc-451a-9198-e78bc967d38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9df42339-800c-4100-bcc4-bb18debd343b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_94dd2826-36dc-451a-9198-e78bc967d38f" xlink:to="loc_dei_EntityDomain_9df42339-800c-4100-bcc4-bb18debd343b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_efaecbb3-8255-42c5-a07c-559b1617ef3e" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9df42339-800c-4100-bcc4-bb18debd343b" xlink:to="loc_mo_PhilipMorrisUSAMember_efaecbb3-8255-42c5-a07c-559b1617ef3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b58bb8b8-5684-413a-981f-7b78880170f9" xlink:to="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_b1b3d205-e36b-4816-9d49-434c44598739" xlink:href="mo-20200930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_b1b3d205-e36b-4816-9d49-434c44598739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_afd16f3b-e95f-481b-988c-184f382c371a" xlink:href="mo-20200930.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_afd16f3b-e95f-481b-988c-184f382c371a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d4d1e020-ee8e-4589-aaa1-a2ac74679f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d4d1e020-ee8e-4589-aaa1-a2ac74679f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_3ad0f044-b981-436f-9c24-66ad1281579c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_3ad0f044-b981-436f-9c24-66ad1281579c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_a854e2e1-f596-457f-b4d0-6e3b9791f0be" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecided"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyClaimsDecided_a854e2e1-f596-457f-b4d0-6e3b9791f0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_7e96b7f0-def7-41b6-b317-33ea6a90b569" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_7e96b7f0-def7-41b6-b317-33ea6a90b569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_1aabc981-4df4-4fef-a49f-8f9af752e443" xlink:href="mo-20200930.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_1aabc981-4df4-4fef-a49f-8f9af752e443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_62430f8b-c1f9-4a62-a509-2b30688a6d10" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_62430f8b-c1f9-4a62-a509-2b30688a6d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_4471c262-55dd-4ff5-ae9d-a40fbc64e746" xlink:href="mo-20200930.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_4471c262-55dd-4ff5-ae9d-a40fbc64e746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts_6debc7fb-9075-45c8-b4b3-364ed57cfdae" xlink:href="mo-20200930.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyZeroDamagesVerdicts_6debc7fb-9075-45c8-b4b3-364ed57cfdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_f6bbf987-f779-4760-8a91-e430cf9a2207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_f6bbf987-f779-4760-8a91-e430cf9a2207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified_b881065f-a136-4b6d-9d7d-0905c6a467a6" xlink:href="mo-20200930.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_855778a7-eac6-44f0-8a3f-4e59eeddbe45" xlink:to="loc_mo_LossContingencyZeroDamagesVerdictModified_b881065f-a136-4b6d-9d7d-0905c6a467a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0b3b4a96-baa6-496c-89e7-9056b1d5c767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0b3b4a96-baa6-496c-89e7-9056b1d5c767" xlink:to="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a38aafe7-6857-4f2a-b12c-337ecb9d512a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:to="loc_srt_LitigationCaseAxis_a38aafe7-6857-4f2a-b12c-337ecb9d512a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_a38aafe7-6857-4f2a-b12c-337ecb9d512a" xlink:to="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesBergerMember_9d20e29c-eb8d-4695-8db1-4f1bf5c6b4e9" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesBergerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesBergerMember_9d20e29c-eb8d-4695-8db1-4f1bf5c6b4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSantoroMember_56624f78-8008-4ee3-86ad-dfc021a1381b" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesSantoroMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesSantoroMember_56624f78-8008-4ee3-86ad-dfc021a1381b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember_15606cad-e13b-41f5-9203-4179a66fab03" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesDuignanMember_15606cad-e13b-41f5-9203-4179a66fab03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember_6fc24e49-e55a-4d5f-b3e5-2a7abba3ddb1" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesCuddiheeMember_6fc24e49-e55a-4d5f-b3e5-2a7abba3ddb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesRintoulMember_3404ac0b-4424-4d8f-8095-598478121504" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesRintoulMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesRintoulMember_3404ac0b-4424-4d8f-8095-598478121504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerMember_2c0850d8-3573-477d-9293-7b7121d6d11d" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesGlogerMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesGlogerMember_2c0850d8-3573-477d-9293-7b7121d6d11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember_9b59109e-fdc4-4eed-ba40-9904e3ef4995" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesMcCallMember_9b59109e-fdc4-4eed-ba40-9904e3ef4995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNeffMember_4fb53488-2c7d-4c54-876f-37198b0339e4" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesNeffMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesNeffMember_4fb53488-2c7d-4c54-876f-37198b0339e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFrogelMember_09b51e14-8d2a-4460-ba12-4222645feeb1" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesFrogelMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesFrogelMember_09b51e14-8d2a-4460-ba12-4222645feeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMahfuzMember_5f4e9bec-bfbf-45ec-849c-733209e6ebd1" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesMahfuzMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesMahfuzMember_5f4e9bec-bfbf-45ec-849c-733209e6ebd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember_5e71a55f-fa01-4320-a313-e2f405e57481" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesHollimanMember_5e71a55f-fa01-4320-a313-e2f405e57481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember_3198dc76-a216-40f7-9919-8e791ffa6c7c" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesChadwellMember_3198dc76-a216-40f7-9919-8e791ffa6c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMember_a0114f4b-acd2-4768-b2cb-4cd13b138a4f" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesKaplanMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesKaplanMember_a0114f4b-acd2-4768-b2cb-4cd13b138a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember_ab316085-164d-4b5c-9c81-ba21ef70d65d" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesR.DouglasMember_ab316085-164d-4b5c-9c81-ba21ef70d65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSommersMember_2e1249ab-8720-4876-9800-17b775d84081" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesSommersMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesSommersMember_2e1249ab-8720-4876-9800-17b775d84081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember_87d6d05c-2209-4de4-8af1-d7f673c34cb1" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesCooperMember_87d6d05c-2209-4de4-8af1-d7f673c34cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember_b9fd48a6-fa69-438b-a66b-b345d3fdca36" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesD.BrownMember_b9fd48a6-fa69-438b-a66b-b345d3fdca36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHarrisMember_467b4b77-2818-482b-bfd0-9c97355ce88e" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesHarrisMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesHarrisMember_467b4b77-2818-482b-bfd0-9c97355ce88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDeanKerrivanMember_74104e13-95ff-47cd-9c4b-9f2719679a7e" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesDeanKerrivanMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesDeanKerrivanMember_74104e13-95ff-47cd-9c4b-9f2719679a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLandiMember_cb981fef-81d9-4cc5-b44d-1be9151b41da" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesLandiMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesLandiMember_cb981fef-81d9-4cc5-b44d-1be9151b41da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesTheisMember_c797239b-bde1-4eb4-86c3-39a0d2e68c2d" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesTheisMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesTheisMember_c797239b-bde1-4eb4-86c3-39a0d2e68c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember_f27021cd-0f1c-4024-94b7-1f54684a8d6a" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember_f27021cd-0f1c-4024-94b7-1f54684a8d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesNaugleMember_d0147038-60ce-49ac-a3a4-7c84fd0aaba8" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesNaugleMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesNaugleMember_d0147038-60ce-49ac-a3a4-7c84fd0aaba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGoreMember_f42faf90-599b-419a-9a69-936fce20a0bf" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesGoreMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesGoreMember_f42faf90-599b-419a-9a69-936fce20a0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesM.BrownMember_ec5ca906-8aaa-414d-abf2-2618084aeb1b" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesM.BrownMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesM.BrownMember_ec5ca906-8aaa-414d-abf2-2618084aeb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesJordanMember_a7eca840-dbe0-44e2-9e0a-b3b93d3aeea5" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesJordanMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cd10641-057d-4903-b3ef-16dad11ad757" xlink:to="loc_mo_EngleProgenyCasesJordanMember_a7eca840-dbe0-44e2-9e0a-b3b93d3aeea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_75afeab6-190e-487d-8135-ee8882fbc1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:to="loc_us-gaap_LitigationStatusAxis_75afeab6-190e-487d-8135-ee8882fbc1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a8a9ed4c-8767-4ef1-aa8d-e6cea2b66c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_75afeab6-190e-487d-8135-ee8882fbc1c1" xlink:to="loc_us-gaap_LitigationStatusDomain_a8a9ed4c-8767-4ef1-aa8d-e6cea2b66c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_670ad84d-7eff-42b6-9450-d1a5f4c0603e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_a8a9ed4c-8767-4ef1-aa8d-e6cea2b66c7f" xlink:to="loc_us-gaap_PendingLitigationMember_670ad84d-7eff-42b6-9450-d1a5f4c0603e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_dfe17dd2-eba9-4621-b4df-8df4e70f572d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_a8a9ed4c-8767-4ef1-aa8d-e6cea2b66c7f" xlink:to="loc_us-gaap_SettledLitigationMember_dfe17dd2-eba9-4621-b4df-8df4e70f572d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_97633d4a-70af-4580-a002-bb9c63013098" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:to="loc_dei_LegalEntityAxis_97633d4a-70af-4580-a002-bb9c63013098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9a378eb7-72b4-4371-8749-65334c6474df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_97633d4a-70af-4580-a002-bb9c63013098" xlink:to="loc_dei_EntityDomain_9a378eb7-72b4-4371-8749-65334c6474df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_3d4fb5c6-8b0f-48ce-bca9-e4d93e0a20b3" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9a378eb7-72b4-4371-8749-65334c6474df" xlink:to="loc_mo_PhilipMorrisUSAMember_3d4fb5c6-8b0f-48ce-bca9-e4d93e0a20b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3eac721d-8f3d-4cda-8520-97831d94160b" xlink:to="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_a4ab923e-7621-4f28-8c8b-d73a9d5035c2" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo_a4ab923e-7621-4f28-8c8b-d73a9d5035c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_7dfdb270-22d0-4f4d-85dd-dcac82b15334" xlink:href="mo-20200930.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_7dfdb270-22d0-4f4d-85dd-dcac82b15334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_d22d4fd1-0bff-4e79-972d-a65875a61113" xlink:href="mo-20200930.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_d22d4fd1-0bff-4e79-972d-a65875a61113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_27a9507a-b1d2-447d-b755-0e3e07894651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_27a9507a-b1d2-447d-b755-0e3e07894651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_33254847-c37e-49a9-b325-bfa2a661d0ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_33254847-c37e-49a9-b325-bfa2a661d0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PreTaxChargesGainIncludedinNetEarning_20797381-30f7-4af3-9a60-d6ae80a0e229" xlink:href="mo-20200930.xsd#mo_PreTaxChargesGainIncludedinNetEarning"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ee429998-faf3-477f-931c-4e7cadebb8e5" xlink:to="loc_mo_PreTaxChargesGainIncludedinNetEarning_20797381-30f7-4af3-9a60-d6ae80a0e229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesFloridaBondStatuteDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_05e61293-d5de-41cf-b2a0-104bff45d033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_04260f8f-2867-4938-9426-3ab467ed4272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_05e61293-d5de-41cf-b2a0-104bff45d033" xlink:to="loc_us-gaap_LossContingenciesTable_04260f8f-2867-4938-9426-3ab467ed4272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_671a51c7-754b-4373-bba5-726fc389d14e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_04260f8f-2867-4938-9426-3ab467ed4272" xlink:to="loc_srt_StatementGeographicalAxis_671a51c7-754b-4373-bba5-726fc389d14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bf1e932b-4ecc-419c-95e9-04e74f05fefe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_671a51c7-754b-4373-bba5-726fc389d14e" xlink:to="loc_srt_SegmentGeographicalDomain_bf1e932b-4ecc-419c-95e9-04e74f05fefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_8bed1f8c-d528-4785-b97f-848f2944f187" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bf1e932b-4ecc-419c-95e9-04e74f05fefe" xlink:to="loc_stpr_FL_8bed1f8c-d528-4785-b97f-848f2944f187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2dc15d60-f3bc-4ac9-ba21-53636b24b61f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_04260f8f-2867-4938-9426-3ab467ed4272" xlink:to="loc_srt_LitigationCaseAxis_2dc15d60-f3bc-4ac9-ba21-53636b24b61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9023fa1b-a143-4d1e-863e-54f85a736598" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2dc15d60-f3bc-4ac9-ba21-53636b24b61f" xlink:to="loc_srt_LitigationCaseTypeDomain_9023fa1b-a143-4d1e-863e-54f85a736598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_09073b22-3d1f-42a2-880b-ab63d3e6e831" xlink:href="mo-20200930.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9023fa1b-a143-4d1e-863e-54f85a736598" xlink:to="loc_mo_EngleProgenyCasesStateMember_09073b22-3d1f-42a2-880b-ab63d3e6e831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_57058b5f-6110-47ed-96a6-a3697ce773ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_04260f8f-2867-4938-9426-3ab467ed4272" xlink:to="loc_us-gaap_LossContingenciesLineItems_57058b5f-6110-47ed-96a6-a3697ce773ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants_d707f0bb-577e-4e81-a33a-4675d49af8d5" xlink:href="mo-20200930.xsd#mo_MaximumBondForAllDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_57058b5f-6110-47ed-96a6-a3697ce773ac" xlink:to="loc_mo_MaximumBondForAllDefendants_d707f0bb-577e-4e81-a33a-4675d49af8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesOtherSmokingandHealthClassActionsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2eba5307-8527-4df9-aafa-2d61928a1845" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2eba5307-8527-4df9-aafa-2d61928a1845" xlink:to="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ea0cf159-b969-4025-841f-39e36d96cbe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ea0cf159-b969-4025-841f-39e36d96cbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f7c2113c-1d14-468b-a3fc-1c71156b0724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ea0cf159-b969-4025-841f-39e36d96cbe1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f7c2113c-1d14-468b-a3fc-1c71156b0724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_15d84cf3-9036-4109-8c64-abf6c73b064b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f7c2113c-1d14-468b-a3fc-1c71156b0724" xlink:to="loc_us-gaap_SubsequentEventMember_15d84cf3-9036-4109-8c64-abf6c73b064b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9739fb0a-89f0-45d6-8ce5-42d594e34391" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:to="loc_srt_StatementGeographicalAxis_9739fb0a-89f0-45d6-8ce5-42d594e34391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9739fb0a-89f0-45d6-8ce5-42d594e34391" xlink:to="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_9257309f-1b64-4472-97c4-c3d461912e44" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_AR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_AR_9257309f-1b64-4472-97c4-c3d461912e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_bed36a8d-d37c-4df8-90f8-14fde4c2951b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_CA_bed36a8d-d37c-4df8-90f8-14fde4c2951b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE_29fcdcbb-164f-46b7-84f0-d2d7573e204c" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_DE"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_DE_29fcdcbb-164f-46b7-84f0-d2d7573e204c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC_3984f23e-e1ba-4e61-a062-78359ebaf5c8" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_DC"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_DC_3984f23e-e1ba-4e61-a062-78359ebaf5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_08a27338-bfff-470a-9944-9166b215adca" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_FL"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_FL_08a27338-bfff-470a-9944-9166b215adca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_9286b4ee-059b-499d-ba85-134bbd23ff3d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_IL"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_IL_9286b4ee-059b-499d-ba85-134bbd23ff3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_32bfb1a1-1842-403c-bd86-208a5601fc3d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_IA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_IA_32bfb1a1-1842-403c-bd86-208a5601fc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_427dafa5-2675-4dfe-8d7f-f58b14cfb2a4" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_KS"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_KS_427dafa5-2675-4dfe-8d7f-f58b14cfb2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_04b257fc-01aa-4bcb-a0bd-d6143056c4c5" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_LA"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_LA_04b257fc-01aa-4bcb-a0bd-d6143056c4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD_8515e1d5-c2a9-4f56-948e-2a22f42174c5" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MD"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_MD_8515e1d5-c2a9-4f56-948e-2a22f42174c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_d5894bfa-21df-4ba8-b00c-693b23b93b1a" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MI"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_MI_d5894bfa-21df-4ba8-b00c-693b23b93b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_e03a8cee-f7d8-41d6-8c2d-5e9acc1d0ef9" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MN"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_MN_e03a8cee-f7d8-41d6-8c2d-5e9acc1d0ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV_032f5652-8726-48ea-9ea3-ece3d1ce1c11" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NV"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_NV_032f5652-8726-48ea-9ea3-ece3d1ce1c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_9a94e077-2214-4ab3-b8a5-8e46641a617b" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NJ"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_NJ_9a94e077-2214-4ab3-b8a5-8e46641a617b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_44aca307-c41a-4c52-9794-4efdeb2a823d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_NY_44aca307-c41a-4c52-9794-4efdeb2a823d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_29f046ad-bd02-4d04-9c29-95dc5d648e80" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OH"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_OH_29f046ad-bd02-4d04-9c29-95dc5d648e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_435d7a87-e7a2-4b40-a9b0-eae69923f72c" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OK"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_OK_435d7a87-e7a2-4b40-a9b0-eae69923f72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR_8a18b183-8857-49ed-87da-656053569506" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_OR"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_OR_8a18b183-8857-49ed-87da-656053569506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_5edcfe7b-d3dd-43ac-ad20-c542ffdbdbfc" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_PA"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_PA_5edcfe7b-d3dd-43ac-ad20-c542ffdbdbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_2653a3f1-f040-41c4-9414-35f7657a768f" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_PR"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_country_PR_2653a3f1-f040-41c4-9414-35f7657a768f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC_a45d19b6-753a-48ce-a65c-796f18d72cf4" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_SC"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_SC_a45d19b6-753a-48ce-a65c-796f18d72cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_31b5761b-20d5-4b2a-b6ed-418bd0816906" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_TX"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_TX_31b5761b-20d5-4b2a-b6ed-418bd0816906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI_e9123136-b52f-4886-8be1-5f65ed343066" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_WI"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_stpr_WI_e9123136-b52f-4886-8be1-5f65ed343066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_3e1c4a0c-dfe9-4b2f-b602-92359ce110a1" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_country_CA_3e1c4a0c-dfe9-4b2f-b602-92359ce110a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember_3ab04624-08db-47a5-9f8c-9140f9dc377f" xlink:href="mo-20200930.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_101acfa3-3f68-4e4f-818d-f84d1b896d82" xlink:to="loc_mo_BritishColumbiaSaskatchewanMember_3ab04624-08db-47a5-9f8c-9140f9dc377f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_149386ae-7e74-4d5d-bb94-d06f010fdc07" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:to="loc_dei_LegalEntityAxis_149386ae-7e74-4d5d-bb94-d06f010fdc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_149386ae-7e74-4d5d-bb94-d06f010fdc07" xlink:to="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_6a0ae144-e312-44a4-ba11-f46ec32eb5f5" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:to="loc_mo_PhilipMorrisUSAMember_6a0ae144-e312-44a4-ba11-f46ec32eb5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_cf636ab7-286d-4b17-971a-3212527f890b" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_cf636ab7-286d-4b17-971a-3212527f890b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_67e247ec-0387-4785-bc64-2bc3508f133c" xlink:href="mo-20200930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_54c3a866-e412-47f0-b734-ca6f1297d8fa" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_67e247ec-0387-4785-bc64-2bc3508f133c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e10ba02c-893f-477f-b3ef-7916c75b477b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:to="loc_srt_LitigationCaseAxis_e10ba02c-893f-477f-b3ef-7916c75b477b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e7146400-a2d4-44ff-b6b2-60856159bba7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_e10ba02c-893f-477f-b3ef-7916c75b477b" xlink:to="loc_srt_LitigationCaseTypeDomain_e7146400-a2d4-44ff-b6b2-60856159bba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_53bd797f-b791-4150-8df3-5eafb93c74b4" xlink:href="mo-20200930.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e7146400-a2d4-44ff-b6b2-60856159bba7" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_53bd797f-b791-4150-8df3-5eafb93c74b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_7e56975e-3a58-48d9-b064-27d6848b0cef" xlink:to="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber_08e3196f-2b4c-4671-b0ef-86057b00e178" xlink:href="mo-20200930.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_mo_LossContingencyClassNotCertifiedNumber_08e3196f-2b4c-4671-b0ef-86057b00e178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d33e3b51-1dcb-4240-a70d-b0f444e711ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d33e3b51-1dcb-4240-a70d-b0f444e711ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_acc4d089-c86e-4404-a5ec-a6a426ccca04" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_mo_LossContingencyNumberofManufacturers_acc4d089-c86e-4404-a5ec-a6a426ccca04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld_36a38aa5-d55b-4cf4-8517-e9488849f923" xlink:href="mo-20200930.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_mo_LossContingencyVerdictsUpheld_36a38aa5-d55b-4cf4-8517-e9488849f923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty_bb339309-6834-40d7-bbf9-affde7d55f5e" xlink:href="mo-20200930.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca60155b-cde3-41ec-9ef1-d650f0af73dd" xlink:to="loc_mo_AmountAwardedtoOtherParty_bb339309-6834-40d7-bbf9-affde7d55f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesHealthCareCostRecoveryLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b92d8ed-003f-4de6-b40c-1ac55041349a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b92d8ed-003f-4de6-b40c-1ac55041349a" xlink:to="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_781f6299-4f21-4c69-81e1-d12b4ce4e563" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:to="loc_dei_LegalEntityAxis_781f6299-4f21-4c69-81e1-d12b4ce4e563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c7ca7c43-5d78-4811-8110-3de348d5b163" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_781f6299-4f21-4c69-81e1-d12b4ce4e563" xlink:to="loc_dei_EntityDomain_c7ca7c43-5d78-4811-8110-3de348d5b163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_b3c8aa42-4bfc-4a7c-b6f8-1ad52557c52e" xlink:href="mo-20200930.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c7ca7c43-5d78-4811-8110-3de348d5b163" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_b3c8aa42-4bfc-4a7c-b6f8-1ad52557c52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c27fb628-f675-4432-a5de-609f7518610e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:to="loc_us-gaap_LitigationStatusAxis_c27fb628-f675-4432-a5de-609f7518610e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c94c9254-071f-45e2-97f5-7c2e887e031c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_c27fb628-f675-4432-a5de-609f7518610e" xlink:to="loc_us-gaap_LitigationStatusDomain_c94c9254-071f-45e2-97f5-7c2e887e031c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_898aeae4-1721-4308-8c2e-192c69a3bee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_c94c9254-071f-45e2-97f5-7c2e887e031c" xlink:to="loc_us-gaap_ThreatenedLitigationMember_898aeae4-1721-4308-8c2e-192c69a3bee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8bb535b0-ecd0-4bb2-bf4a-a15520669961" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:to="loc_srt_StatementGeographicalAxis_8bb535b0-ecd0-4bb2-bf4a-a15520669961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1e07ec91-a5c6-4e2e-a392-283510c304bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8bb535b0-ecd0-4bb2-bf4a-a15520669961" xlink:to="loc_srt_SegmentGeographicalDomain_1e07ec91-a5c6-4e2e-a392-283510c304bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_646f9ed0-5d8b-4c5d-9984-0014e9b5ed21" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1e07ec91-a5c6-4e2e-a392-283510c304bd" xlink:to="loc_country_CA_646f9ed0-5d8b-4c5d-9984-0014e9b5ed21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cdca13df-e8c6-4d06-8ca3-f6f00a30a119" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:to="loc_srt_LitigationCaseAxis_cdca13df-e8c6-4d06-8ca3-f6f00a30a119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e645de20-594b-42e0-a109-12b4d63aa319" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_cdca13df-e8c6-4d06-8ca3-f6f00a30a119" xlink:to="loc_srt_LitigationCaseTypeDomain_e645de20-594b-42e0-a109-12b4d63aa319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_187e00e8-b76c-4fcd-b9a3-5f4050a29d7d" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e645de20-594b-42e0-a109-12b4d63aa319" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_187e00e8-b76c-4fcd-b9a3-5f4050a29d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_8b7cc263-7823-4b5d-916f-5b6ea05b1ad7" xlink:href="mo-20200930.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e645de20-594b-42e0-a109-12b4d63aa319" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_8b7cc263-7823-4b5d-916f-5b6ea05b1ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5345362b-43bc-499f-bf0f-3595889398f8" xlink:to="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_1d613e7f-ab92-4862-8c1f-fb09424733bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_1d613e7f-ab92-4862-8c1f-fb09424733bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_8cfe3c8d-e41c-4b42-9da9-062b85f26dd4" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_mo_LossContingencyNumberofManufacturers_8cfe3c8d-e41c-4b42-9da9-062b85f26dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_5c4cbec9-41ad-4681-876b-a6fd240d679c" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_5c4cbec9-41ad-4681-876b-a6fd240d679c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount_02cad2f5-5e34-42c6-a01c-c923be607907" xlink:href="mo-20200930.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_mo_LitigationSettlementAnnualPaymentAmount_02cad2f5-5e34-42c6-a01c-c923be607907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_f2f932a3-f64b-476d-897f-aaf3271df74c" xlink:href="mo-20200930.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_f2f932a3-f64b-476d-897f-aaf3271df74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_16d829f3-a1a8-4722-91de-80371ea85594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_26d66844-5d2e-4219-8233-dc117ec2fe28" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_16d829f3-a1a8-4722-91de-80371ea85594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6a1c5772-c01f-4493-ae31-eaa234e54f88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6a1c5772-c01f-4493-ae31-eaa234e54f88" xlink:to="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9a3c6f76-96d0-4353-b932-5e5f262acbc2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_srt_StatementGeographicalAxis_9a3c6f76-96d0-4353-b932-5e5f262acbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_21b0f455-8b0a-4366-aa87-ba2bda7b54c6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9a3c6f76-96d0-4353-b932-5e5f262acbc2" xlink:to="loc_srt_SegmentGeographicalDomain_21b0f455-8b0a-4366-aa87-ba2bda7b54c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_875179e3-653f-4d64-8844-48ebe781fb0d" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_NY"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_21b0f455-8b0a-4366-aa87-ba2bda7b54c6" xlink:to="loc_stpr_NY_875179e3-653f-4d64-8844-48ebe781fb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarylandMissouriNewMexicoandPennsylvaniaMember_84908601-21c8-4cd1-bd82-8fde03c0334f" xlink:href="mo-20200930.xsd#mo_MarylandMissouriNewMexicoandPennsylvaniaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_21b0f455-8b0a-4366-aa87-ba2bda7b54c6" xlink:to="loc_mo_MarylandMissouriNewMexicoandPennsylvaniaMember_84908601-21c8-4cd1-bd82-8fde03c0334f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c8a35a25-17c1-45ad-b6ed-ec4f004ec86f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_dei_LegalEntityAxis_c8a35a25-17c1-45ad-b6ed-ec4f004ec86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5f853c49-5500-4707-acce-f78b8f4323c1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c8a35a25-17c1-45ad-b6ed-ec4f004ec86f" xlink:to="loc_dei_EntityDomain_5f853c49-5500-4707-acce-f78b8f4323c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_f42585f8-bc18-48c0-b06b-462a550841fd" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5f853c49-5500-4707-acce-f78b8f4323c1" xlink:to="loc_mo_PhilipMorrisUSAMember_f42585f8-bc18-48c0-b06b-462a550841fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cc7e2488-d711-4b9b-b462-9e832d6eec0f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_srt_LitigationCaseAxis_cc7e2488-d711-4b9b-b462-9e832d6eec0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_11273e4c-9eb8-47d5-96f9-dd6d6fcc2e99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_cc7e2488-d711-4b9b-b462-9e832d6eec0f" xlink:to="loc_srt_LitigationCaseTypeDomain_11273e4c-9eb8-47d5-96f9-dd6d6fcc2e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_11273e4c-9eb8-47d5-96f9-dd6d6fcc2e99" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember_19b7cb3d-131d-4dff-b3f1-74bbfa5c89b7" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember_19b7cb3d-131d-4dff-b3f1-74bbfa5c89b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20042017Member_9abb68db-1e87-4c31-8180-76a5aa32c53a" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions20042017Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions20042017Member_9abb68db-1e87-4c31-8180-76a5aa32c53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member_a1f14fb4-dc63-423b-8459-80b83d29c80e" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042018Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042018Member_a1f14fb4-dc63-423b-8459-80b83d29c80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember_2fc79949-a7d3-4495-8bbd-7e2c2468d5c5" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember_2fc79949-a7d3-4495-8bbd-7e2c2468d5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_4a6b053b-e206-474b-9d3e-456143438b96" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_4a6b053b-e206-474b-9d3e-456143438b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_95b2a165-7224-4c0a-b642-2967e6eedd91" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_95b2a165-7224-4c0a-b642-2967e6eedd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_94fb1a75-6c9d-4cc9-b8e0-8500fc243de6" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_94fb1a75-6c9d-4cc9-b8e0-8500fc243de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_88589e6c-6f2e-4b5e-b651-eb212e08f833" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_88589e6c-6f2e-4b5e-b651-eb212e08f833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_ebf7626d-f892-4a62-848e-4703cfb154ee" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_ebf7626d-f892-4a62-848e-4703cfb154ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_758e3c50-4348-4cf8-b86e-884c816c1720" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_758e3c50-4348-4cf8-b86e-884c816c1720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_fc3f8f82-3e34-46b3-a505-d21bc820f35f" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_fc3f8f82-3e34-46b3-a505-d21bc820f35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_9cfadda3-dbdc-4775-8cd6-731404142af7" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_9cfadda3-dbdc-4775-8cd6-731404142af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_3db9f9e4-b180-425b-87d4-385c57621eea" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_3db9f9e4-b180-425b-87d4-385c57621eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_16c49283-2b06-471d-bc17-a23003f93664" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_16c49283-2b06-471d-bc17-a23003f93664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_306b38c7-8f75-43d5-a984-3c9c030b2e03" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_306b38c7-8f75-43d5-a984-3c9c030b2e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_599590e5-f5b0-4ab6-9edf-b459e333dc3f" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_599590e5-f5b0-4ab6-9edf-b459e333dc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_13453ae1-eef0-43b6-8304-6c15dda2ccac" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_13453ae1-eef0-43b6-8304-6c15dda2ccac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_d503a6f1-274e-44a5-bcbc-5ee116906e30" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_d503a6f1-274e-44a5-bcbc-5ee116906e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_7bf0eff2-2e50-46b6-910a-0e68caee14e7" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_7bf0eff2-2e50-46b6-910a-0e68caee14e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_5b99539e-36f6-4c2d-b579-33e36a7914a0" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_83a96666-c8c4-4458-95a5-43de465b4aa8" xlink:to="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_5b99539e-36f6-4c2d-b579-33e36a7914a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember_04ec7f47-e422-4822-9a39-9cb9509074ad" xlink:href="mo-20200930.xsd#mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_11273e4c-9eb8-47d5-96f9-dd6d6fcc2e99" xlink:to="loc_mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember_04ec7f47-e422-4822-9a39-9cb9509074ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9d1a7872-e504-412d-a520-800b9b3cf2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_us-gaap_LitigationStatusAxis_9d1a7872-e504-412d-a520-800b9b3cf2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1e769194-19fe-432c-864d-c21a12d5bcdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_9d1a7872-e504-412d-a520-800b9b3cf2a3" xlink:to="loc_us-gaap_LitigationStatusDomain_1e769194-19fe-432c-864d-c21a12d5bcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_57531319-927d-4797-a4b8-5882c1e58a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_1e769194-19fe-432c-864d-c21a12d5bcdc" xlink:to="loc_us-gaap_SettledLitigationMember_57531319-927d-4797-a4b8-5882c1e58a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_3a39d948-f501-4c7e-845a-12e8fdf97981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_1e769194-19fe-432c-864d-c21a12d5bcdc" xlink:to="loc_us-gaap_PendingLitigationMember_3a39d948-f501-4c7e-845a-12e8fdf97981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b6d65649-74bb-4449-9bfd-793360d583e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b6d65649-74bb-4449-9bfd-793360d583e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8a3b93e4-83a5-4e86-880a-e4a4e4b71e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b6d65649-74bb-4449-9bfd-793360d583e4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8a3b93e4-83a5-4e86-880a-e4a4e4b71e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e45e90ee-c16d-4f23-a36a-3be42e9c66c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8a3b93e4-83a5-4e86-880a-e4a4e4b71e06" xlink:to="loc_us-gaap_CostOfSalesMember_e45e90ee-c16d-4f23-a36a-3be42e9c66c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e265b6d3-cc92-498c-9042-d83a0ce0c183" xlink:to="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_25ca5a3f-6568-4a9a-aff1-30e3b23c0e14" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_25ca5a3f-6568-4a9a-aff1-30e3b23c0e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencySettlementAgreementsNumber_cec6bae8-f183-4d74-a97c-2d5c7a1d76bc" xlink:href="mo-20200930.xsd#mo_LossContingencySettlementAgreementsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencySettlementAgreementsNumber_cec6bae8-f183-4d74-a97c-2d5c7a1d76bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_68dde1b0-bec5-46c6-989f-61944548000e" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_68dde1b0-bec5-46c6-989f-61944548000e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyProceedsfromLegalSettlements_77c107c9-a12a-45a0-ac11-028464718357" xlink:href="mo-20200930.xsd#mo_LossContingencyProceedsfromLegalSettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyProceedsfromLegalSettlements_77c107c9-a12a-45a0-ac11-028464718357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofSettlementDevelopments_a83d073e-5e4e-4153-b982-453abe4bd9ef" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofSettlementDevelopments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofSettlementDevelopments_a83d073e-5e4e-4153-b982-453abe4bd9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation_6086321d-30bc-463b-af67-c4d2c76632b6" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofAdditionalStateswithSettledLitigation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation_6086321d-30bc-463b-af67-c4d2c76632b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_aa8f4b61-4c0e-4f3d-92d2-8b6dd1ec61dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_aa8f4b61-4c0e-4f3d-92d2-8b6dd1ec61dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales_35e9dd4a-d801-4542-8e3a-863c346a0522" xlink:href="mo-20200930.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyReductionToCostOfSales_35e9dd4a-d801-4542-8e3a-863c346a0522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_3e27a7b3-61c9-4ec7-a9f7-d872b8c389e7" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_3e27a7b3-61c9-4ec7-a9f7-d872b8c389e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29ae44e2-d233-4952-b924-ff9dd8c7f4d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29ae44e2-d233-4952-b924-ff9dd8c7f4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencySettlementAgreementPaymentPeriod_51ac5302-71ed-4999-b255-177079f4fc3e" xlink:href="mo-20200930.xsd#mo_LossContingencySettlementAgreementPaymentPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencySettlementAgreementPaymentPeriod_51ac5302-71ed-4999-b255-177079f4fc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStates_219f3ab8-19d6-4571-b5ff-952ed20c58b7" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStates"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStates_219f3ab8-19d6-4571-b5ff-952ed20c58b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesWithoutDefense_4390ed74-5975-40b0-8399-533a0237d94c" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStatesWithoutDefense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStatesWithoutDefense_4390ed74-5975-40b0-8399-533a0237d94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesRemaining_69ec9b75-0706-49a2-9ac0-36c002c6bc87" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofStatesRemaining"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberofStatesRemaining_69ec9b75-0706-49a2-9ac0-36c002c6bc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfDisputesOutstanding_a591380e-996d-4815-8ed5-4a196374a1b9" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfDisputesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LossContingencyNumberOfDisputesOutstanding_a591380e-996d-4815-8ed5-4a196374a1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain_70869828-2899-414b-8ed8-be53214b4716" xlink:href="mo-20200930.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f663760f-12cd-4c03-9271-4e273b198358" xlink:to="loc_mo_LitigationSettlementEstimateofPossibleGain_70869828-2899-414b-8ed8-be53214b4716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cb27a4a0-1980-4c43-afc4-b043e70ec0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f165a7ad-035b-4d74-86a5-c8037af3f720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cb27a4a0-1980-4c43-afc4-b043e70ec0ee" xlink:to="loc_us-gaap_LossContingenciesTable_f165a7ad-035b-4d74-86a5-c8037af3f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e5fba95a-5efc-480f-9023-05ba892cd20f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f165a7ad-035b-4d74-86a5-c8037af3f720" xlink:to="loc_dei_LegalEntityAxis_e5fba95a-5efc-480f-9023-05ba892cd20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_dd28eaae-af21-42e2-97a1-3c9d4003e729" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e5fba95a-5efc-480f-9023-05ba892cd20f" xlink:to="loc_dei_EntityDomain_dd28eaae-af21-42e2-97a1-3c9d4003e729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_ecdb2a9e-366b-4da2-8aaa-4f09108c493c" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_dd28eaae-af21-42e2-97a1-3c9d4003e729" xlink:to="loc_mo_PhilipMorrisUSAMember_ecdb2a9e-366b-4da2-8aaa-4f09108c493c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8d5a00e6-5297-4ac4-981f-6d1d4747fa91" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f165a7ad-035b-4d74-86a5-c8037af3f720" xlink:to="loc_srt_LitigationCaseAxis_8d5a00e6-5297-4ac4-981f-6d1d4747fa91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6a0ee179-02a9-48b9-91a6-a50d2f60df1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8d5a00e6-5297-4ac4-981f-6d1d4747fa91" xlink:to="loc_srt_LitigationCaseTypeDomain_6a0ee179-02a9-48b9-91a6-a50d2f60df1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_abda2d5d-333b-4e51-b48b-2745b3ed1600" xlink:href="mo-20200930.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_6a0ee179-02a9-48b9-91a6-a50d2f60df1d" xlink:to="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_abda2d5d-333b-4e51-b48b-2745b3ed1600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_70c716ab-664d-4b33-b684-be0f739d70af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f165a7ad-035b-4d74-86a5-c8037af3f720" xlink:to="loc_us-gaap_LossContingenciesLineItems_70c716ab-664d-4b33-b684-be0f739d70af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_831597de-eeed-4534-bd69-1fae49fb90ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70c716ab-664d-4b33-b684-be0f739d70af" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_831597de-eeed-4534-bd69-1fae49fb90ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesFederalGovernmentsLawsuitDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5941c2c2-d394-4e22-8252-c1412aeacc8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5941c2c2-d394-4e22-8252-c1412aeacc8d" xlink:to="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9a1b2f4c-b17a-44cb-b93b-d2cbb1bc96a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9a1b2f4c-b17a-44cb-b93b-d2cbb1bc96a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9e838207-f937-4e38-a951-82f22990fc38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9a1b2f4c-b17a-44cb-b93b-d2cbb1bc96a3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9e838207-f937-4e38-a951-82f22990fc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember_79722aba-1c57-4806-a48c-d4fabbf92444" xlink:href="mo-20200930.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9e838207-f937-4e38-a951-82f22990fc38" xlink:to="loc_mo_ImplementationofCorrectiveCommunicationsMember_79722aba-1c57-4806-a48c-d4fabbf92444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2e115b9e-b962-475f-a6dc-0ca923f6e282" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:to="loc_srt_LitigationCaseAxis_2e115b9e-b962-475f-a6dc-0ca923f6e282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8088779b-5e86-422a-89fd-9780e1558065" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2e115b9e-b962-475f-a6dc-0ca923f6e282" xlink:to="loc_srt_LitigationCaseTypeDomain_8088779b-5e86-422a-89fd-9780e1558065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember_dc80118f-85eb-4ff9-9076-6f040111cefa" xlink:href="mo-20200930.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_8088779b-5e86-422a-89fd-9780e1558065" xlink:to="loc_mo_FederalGovernmentsLawsuitMember_dc80118f-85eb-4ff9-9076-6f040111cefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2e2cec8b-ecb8-4995-9533-2f8b7985de59" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:to="loc_dei_LegalEntityAxis_2e2cec8b-ecb8-4995-9533-2f8b7985de59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5111ac39-0eb3-4e10-8a76-5149982dfc05" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2e2cec8b-ecb8-4995-9533-2f8b7985de59" xlink:to="loc_dei_EntityDomain_5111ac39-0eb3-4e10-8a76-5149982dfc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_38dd296c-2672-4a57-88ec-91bca1c8d3a2" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5111ac39-0eb3-4e10-8a76-5149982dfc05" xlink:to="loc_mo_PhilipMorrisUSAMember_38dd296c-2672-4a57-88ec-91bca1c8d3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_10960776-8b73-454c-9199-c2c9fbbac289" xlink:href="mo-20200930.xsd#mo_AltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5111ac39-0eb3-4e10-8a76-5149982dfc05" xlink:to="loc_mo_AltriaGroupMember_10960776-8b73-454c-9199-c2c9fbbac289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2651ac23-a7bc-4f08-8d42-78d4cfc25ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9af1b254-55b1-46bd-b200-5ec806710ba2" xlink:to="loc_us-gaap_LossContingenciesLineItems_2651ac23-a7bc-4f08-8d42-78d4cfc25ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod_3b1b827d-f695-42af-8f3b-a2e62bdaa547" xlink:href="mo-20200930.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2651ac23-a7bc-4f08-8d42-78d4cfc25ea5" xlink:to="loc_mo_FederalTradeCommissionDisclosurePeriod_3b1b827d-f695-42af-8f3b-a2e62bdaa547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_d22032a7-9870-4de2-94f3-c73a8f03b6af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2651ac23-a7bc-4f08-8d42-78d4cfc25ea5" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_d22032a7-9870-4de2-94f3-c73a8f03b6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesEvaporProductLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bf2ee749-cf50-48e3-a187-bfca6144db0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bf2ee749-cf50-48e3-a187-bfca6144db0b" xlink:to="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_1ceb5f26-d05f-4429-bd4a-e09b71159f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:to="loc_us-gaap_LitigationStatusAxis_1ceb5f26-d05f-4429-bd4a-e09b71159f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_1ceb5f26-d05f-4429-bd4a-e09b71159f37" xlink:to="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_afc3c06b-1571-406c-917d-aa734e9b6f95" xlink:href="mo-20200930.xsd#mo_ClassActionLawsuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:to="loc_mo_ClassActionLawsuitMember_afc3c06b-1571-406c-917d-aa734e9b6f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_8e0f5498-bc41-47d4-bbb7-0b5d44cc5907" xlink:href="mo-20200930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:to="loc_mo_PendingIndividualLawsuitsMember_8e0f5498-bc41-47d4-bbb7-0b5d44cc5907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_9874e287-163b-4842-b5f8-6b65ef7805e0" xlink:href="mo-20200930.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_9874e287-163b-4842-b5f8-6b65ef7805e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_dbd21346-6c58-42cf-9d4c-af33936cab0f" xlink:href="mo-20200930.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_68a761af-1d25-46b7-a45c-c90346f9b707" xlink:to="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_dbd21346-6c58-42cf-9d4c-af33936cab0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_eb607f70-4a99-4654-a961-d17fd3fa27f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_eb607f70-4a99-4654-a961-d17fd3fa27f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f081bec6-59f1-466e-bac6-07c66a1020bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_eb607f70-4a99-4654-a961-d17fd3fa27f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f081bec6-59f1-466e-bac6-07c66a1020bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_49493a8d-02c5-47cb-b737-61cd26286d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f081bec6-59f1-466e-bac6-07c66a1020bd" xlink:to="loc_us-gaap_SubsequentEventMember_49493a8d-02c5-47cb-b737-61cd26286d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a6b54cc0-d8fc-4242-90fc-8c5cda51d750" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:to="loc_srt_LitigationCaseAxis_a6b54cc0-d8fc-4242-90fc-8c5cda51d750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c73efb1d-9dda-4a68-a327-5ac62e7e491e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_a6b54cc0-d8fc-4242-90fc-8c5cda51d750" xlink:to="loc_srt_LitigationCaseTypeDomain_c73efb1d-9dda-4a68-a327-5ac62e7e491e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_0ded9af9-96c6-4980-9517-14fe708b2737" xlink:href="mo-20200930.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c73efb1d-9dda-4a68-a327-5ac62e7e491e" xlink:to="loc_mo_EvaporLitigationMember_0ded9af9-96c6-4980-9517-14fe708b2737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1b3eb614-783e-4f80-a0dd-d2562a38759c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c8c3793b-c3e5-467a-867f-2c7a35e758a9" xlink:to="loc_us-gaap_LossContingenciesLineItems_1b3eb614-783e-4f80-a0dd-d2562a38759c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_11db8c62-c2f9-472c-ac67-1dc75639f70e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1b3eb614-783e-4f80-a0dd-d2562a38759c" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_11db8c62-c2f9-472c-ac67-1dc75639f70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_1877dac2-e7b5-4319-a65b-3278d385cccd" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1b3eb614-783e-4f80-a0dd-d2562a38759c" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_1877dac2-e7b5-4319-a65b-3278d385cccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesLightsUltraLightsCasesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ebcefe92-4ed4-4504-928c-153cd9ce9905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ebcefe92-4ed4-4504-928c-153cd9ce9905" xlink:to="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_649d6fd9-208e-4d53-958a-46d29c3ad035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_649d6fd9-208e-4d53-958a-46d29c3ad035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_db9f97e2-946f-45c8-8114-ddf0e827a549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_649d6fd9-208e-4d53-958a-46d29c3ad035" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_db9f97e2-946f-45c8-8114-ddf0e827a549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c296d0f2-8913-4abe-b8c4-8326b062a13a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_db9f97e2-946f-45c8-8114-ddf0e827a549" xlink:to="loc_us-gaap_SubsequentEventMember_c296d0f2-8913-4abe-b8c4-8326b062a13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ed38f675-bd9d-4682-927a-dd812663952f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:to="loc_srt_LitigationCaseAxis_ed38f675-bd9d-4682-927a-dd812663952f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b2e4a58b-0b6d-4091-bdbf-4dd557ae32f5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_ed38f675-bd9d-4682-927a-dd812663952f" xlink:to="loc_srt_LitigationCaseTypeDomain_b2e4a58b-0b6d-4091-bdbf-4dd557ae32f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember_805373e5-cd0e-4d7f-b310-b1dfb1d17767" xlink:href="mo-20200930.xsd#mo_LightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b2e4a58b-0b6d-4091-bdbf-4dd557ae32f5" xlink:to="loc_mo_LightsMember_805373e5-cd0e-4d7f-b310-b1dfb1d17767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsUltraLightsClassActionsMember_aa065741-c22b-4187-901b-f07ea20d3ccc" xlink:href="mo-20200930.xsd#mo_LightsUltraLightsClassActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b2e4a58b-0b6d-4091-bdbf-4dd557ae32f5" xlink:to="loc_mo_LightsUltraLightsClassActionsMember_aa065741-c22b-4187-901b-f07ea20d3ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a5cdb52a-497b-4bc6-b70e-7bfeda8775b7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:to="loc_dei_LegalEntityAxis_a5cdb52a-497b-4bc6-b70e-7bfeda8775b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8009c09b-8d5c-4059-927c-5d727802e177" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a5cdb52a-497b-4bc6-b70e-7bfeda8775b7" xlink:to="loc_dei_EntityDomain_8009c09b-8d5c-4059-927c-5d727802e177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_fa07d957-c5d4-4822-909a-832408e43c3d" xlink:href="mo-20200930.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8009c09b-8d5c-4059-927c-5d727802e177" xlink:to="loc_mo_PhilipMorrisUSAMember_fa07d957-c5d4-4822-909a-832408e43c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_714431e4-54b6-4933-a5f6-d4e486f57d49" xlink:to="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber_bfcdf439-3894-470c-9066-253ad594a39d" xlink:href="mo-20200930.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:to="loc_mo_LossContingencyStateCourtsNumber_bfcdf439-3894-470c-9066-253ad594a39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber_04b51b26-4264-4099-ab60-f845bc7fd244" xlink:href="mo-20200930.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:to="loc_mo_LossContingencyClaimsNotCertifiedNumber_04b51b26-4264-4099-ab60-f845bc7fd244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_bf0e91d8-8e30-41d9-a376-3650b2835c8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c0fb8cc7-c8fa-4ba8-8200-acf4adaf1efb" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_bf0e91d8-8e30-41d9-a376-3650b2835c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesUSTLitigationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_81561a6b-3fc8-49ae-a461-a059c0b9cf6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_81561a6b-3fc8-49ae-a461-a059c0b9cf6d" xlink:to="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_71269ed3-77b9-4912-ab63-afc3fcc07684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:to="loc_us-gaap_LitigationStatusAxis_71269ed3-77b9-4912-ab63-afc3fcc07684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_98bfd4a3-6cca-4bfb-925f-29bcd3d5d119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_71269ed3-77b9-4912-ab63-afc3fcc07684" xlink:to="loc_us-gaap_LitigationStatusDomain_98bfd4a3-6cca-4bfb-925f-29bcd3d5d119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_58030352-4103-41d4-bab1-218d9b5385c4" xlink:href="mo-20200930.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_98bfd4a3-6cca-4bfb-925f-29bcd3d5d119" xlink:to="loc_mo_PendingIndividualLawsuitsMember_58030352-4103-41d4-bab1-218d9b5385c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_86d784db-e8ee-4afa-9384-f018f4e232cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_86d784db-e8ee-4afa-9384-f018f4e232cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7fc56eac-645a-43f4-8f86-0a8171ae8722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_86d784db-e8ee-4afa-9384-f018f4e232cd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7fc56eac-645a-43f4-8f86-0a8171ae8722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_11fe91cc-5bc9-461d-815f-9062bb063b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7fc56eac-645a-43f4-8f86-0a8171ae8722" xlink:to="loc_us-gaap_SubsequentEventMember_11fe91cc-5bc9-461d-815f-9062bb063b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_718f387e-e274-4649-b12e-732b56c3f9a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:to="loc_srt_LitigationCaseAxis_718f387e-e274-4649-b12e-732b56c3f9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_5ad01a9b-78a7-4fbf-9606-b316c3dedd0a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_718f387e-e274-4649-b12e-732b56c3f9a2" xlink:to="loc_srt_LitigationCaseTypeDomain_5ad01a9b-78a7-4fbf-9606-b316c3dedd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_ece3688a-2d11-44c8-abb5-c4a4a235da55" xlink:href="mo-20200930.xsd#mo_USTLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_5ad01a9b-78a7-4fbf-9606-b316c3dedd0a" xlink:to="loc_mo_USTLitigationMember_ece3688a-2d11-44c8-abb5-c4a4a235da55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_06043d07-3675-4311-901e-49622e790359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0d995b6c-a24b-4b8d-a56a-6b166510a95b" xlink:to="loc_us-gaap_LossContingenciesLineItems_06043d07-3675-4311-901e-49622e790359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_77a78e85-c02d-4766-bf27-fe197f295f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06043d07-3675-4311-901e-49622e790359" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_77a78e85-c02d-4766-bf27-fe197f295f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_082a24cc-8303-4832-bcc3-9464b3be3e92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1e7bf31e-3b4f-48cd-8de7-003b1e7af033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_082a24cc-8303-4832-bcc3-9464b3be3e92" xlink:to="loc_us-gaap_LossContingenciesTable_1e7bf31e-3b4f-48cd-8de7-003b1e7af033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b12ee297-41a7-4e19-8370-2d7d7d56e940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1e7bf31e-3b4f-48cd-8de7-003b1e7af033" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b12ee297-41a7-4e19-8370-2d7d7d56e940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d850b12c-819c-4a49-b67c-9a72595d8ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b12ee297-41a7-4e19-8370-2d7d7d56e940" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d850b12c-819c-4a49-b67c-9a72595d8ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_702f8557-f738-4789-a558-dc2abe8ba838" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d850b12c-819c-4a49-b67c-9a72595d8ea6" xlink:to="loc_us-gaap_SubsequentEventMember_702f8557-f738-4789-a558-dc2abe8ba838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2200dc0e-9cd5-4e03-b8c7-372d24ad63db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1e7bf31e-3b4f-48cd-8de7-003b1e7af033" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2200dc0e-9cd5-4e03-b8c7-372d24ad63db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0750d720-acc2-4256-94f5-86cddcfbf8ae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2200dc0e-9cd5-4e03-b8c7-372d24ad63db" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0750d720-acc2-4256-94f5-86cddcfbf8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_6205a2c1-ff53-46b6-996b-a7f39a9b927d" xlink:href="mo-20200930.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_0750d720-acc2-4256-94f5-86cddcfbf8ae" xlink:to="loc_mo_JUULMember_6205a2c1-ff53-46b6-996b-a7f39a9b927d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1e7bf31e-3b4f-48cd-8de7-003b1e7af033" xlink:to="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_27cea787-51e6-4fba-81fd-955fc95ee2d3" xlink:href="mo-20200930.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_27cea787-51e6-4fba-81fd-955fc95ee2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_adc4044b-2d17-49b0-8841-627d8f1488e8" xlink:href="mo-20200930.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:to="loc_mo_LossContingencyClassActionLawsuit_adc4044b-2d17-49b0-8841-627d8f1488e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_ec4a7030-5406-4c18-ba86-e13e63ab6a2b" xlink:href="mo-20200930.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a68b8501-137f-4648-9bd8-88dea392bd51" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_ec4a7030-5406-4c18-ba86-e13e63ab6a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="simple" xlink:href="mo-20200930.xsd#ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fed44262-5044-47fd-bb5a-a6df31a85fa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fed44262-5044-47fd-bb5a-a6df31a85fa5" xlink:to="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_152b36ff-ac4b-40ee-8ef2-8ed827cff5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_152b36ff-ac4b-40ee-8ef2-8ed827cff5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b8002bf7-623b-4f13-815e-8ee87001c9af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_152b36ff-ac4b-40ee-8ef2-8ed827cff5e3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b8002bf7-623b-4f13-815e-8ee87001c9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5800e980-0ba8-4c6f-a135-2dc6b7404088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b8002bf7-623b-4f13-815e-8ee87001c9af" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5800e980-0ba8-4c6f-a135-2dc6b7404088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5895e6c4-3efd-4971-862e-d85d2247c4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:to="loc_us-gaap_DebtInstrumentAxis_5895e6c4-3efd-4971-862e-d85d2247c4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eb172aee-c574-4e90-918c-51273813a7fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5895e6c4-3efd-4971-862e-d85d2247c4f4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eb172aee-c574-4e90-918c-51273813a7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember_3718d367-e2f6-467d-8b5e-66eba8066d01" xlink:href="mo-20200930.xsd#mo_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eb172aee-c574-4e90-918c-51273813a7fb" xlink:to="loc_mo_CreditAgreementMember_3718d367-e2f6-467d-8b5e-66eba8066d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0c4bd7f4-301e-46b1-bcad-13597f7ff766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:to="loc_us-gaap_CreditFacilityAxis_0c4bd7f4-301e-46b1-bcad-13597f7ff766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_891463b4-d648-483d-8fb3-d9afc68a0d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0c4bd7f4-301e-46b1-bcad-13597f7ff766" xlink:to="loc_us-gaap_CreditFacilityDomain_891463b4-d648-483d-8fb3-d9afc68a0d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_88ecc12a-5ca9-4a9d-8f8c-6daac0c7aa73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_891463b4-d648-483d-8fb3-d9afc68a0d2f" xlink:to="loc_us-gaap_LetterOfCreditMember_88ecc12a-5ca9-4a9d-8f8c-6daac0c7aa73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20926367-39ea-40bc-801e-3391442eb804" xlink:to="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eedb7180-ae88-4729-8f36-339a53bf0481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_eedb7180-ae88-4729-8f36-339a53bf0481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_42ddeabd-85ad-4bcc-8e00-1aa552cf2bc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_42ddeabd-85ad-4bcc-8e00-1aa552cf2bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_af9a9c7d-c29a-4014-99da-a0c1301896e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ca1c9d24-997a-4bea-9915-4b04d883511a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_af9a9c7d-c29a-4014-99da-a0c1301896e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="simple" xlink:href="mo-20200930.xsd#NewAccountingGuidanceNotYetAdopted"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_7bff15d4-47af-40e8-b419-70574620c1ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_71f8c075-c80e-43fa-8ee7-1fcfd19c3da4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_7bff15d4-47af-40e8-b419-70574620c1ad" xlink:to="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_71f8c075-c80e-43fa-8ee7-1fcfd19c3da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="simple" xlink:href="mo-20200930.xsd#NewAccountingGuidanceNotYetAdoptedTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_e0665d9e-fa60-49c6-96db-f73f693d2c8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_cde47bdd-c459-42d3-95bd-0d9760f467fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_e0665d9e-fa60-49c6-96db-f73f693d2c8f" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_cde47bdd-c459-42d3-95bd-0d9760f467fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>mo-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mo="http://www.altria.com/20200930"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mo-20200930.xsd" xlink:type="simple"/>
    <context id="ib44959adae174705840aea192a7e8046_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i44440fa474754cb99393173d190110ec_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock0.3313ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8b31e1162044436b80fd4386757ac7bc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.000NotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic6745877610b42c1afa4746d9658080a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.700NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5ba03e348bf44a90a5e2da0fb8a1bcba_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock2.200NotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5ba9d9ce80bd4640949c31fb4e52f3d3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock3.125NotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i26603be02f7f4bf3b037387b1d8ccb26_I20201021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-10-21</instant>
        </period>
    </context>
    <context id="ia293f60845e647b181cfb7a59955fc58_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i72e09db783364478aeb09576c9febdcb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3656833207b740358727e6740c6f5754_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i04b4defec05c47cebe3e08fabfbe59fe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0a1fe382d2b64cedb36fbab69f63bb0b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibbb23df3172c47a6ad9b939e24083612_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id5979906ef954a38814196686ea7e5cc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7046cbf69cc14b679f3ace4e97364019_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ied0ebb716fa943be849401de264b7398_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib6729fd45e0e470ea191552125f035b0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1f38bf7309bc47bcb39556c8eb9545d7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic5e6cf6324ab408596c1e32ba2460534_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if9cda828d4e847eb909e17085a8abf3d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iff26aeafc2654f32b63277057cb5ba1f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idb61dea03e9f42f9b875b85705945971_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4d40817fa304462992d884e8d54ded54_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id2165dd6285c436395dd6d4adac5414f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibdcf612da0684543843d2a7497e76e83_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i34df390bf1094b3299c4c826e85fb609_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iabbca98f017e44a690fafbff723997c4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i389f8b70a3a74262938c581680019e9d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i68d18d178b0741ad9d0db863ab4222bc_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i820a924d574a40d381950cff0e1a0426_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i42ee75101e094c558a156cae6a325229_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i661a0f364aa74a089c89d944ccfa84de_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9fdefa86b95345148bfdd3202813cfe1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i65f80ce3d24c4093bace02242bc24d95_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iec8f8e259dd94eb9a288d8c6d9cdef4a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie610fa8db60e477bbafca3e2effe7047_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib3ab6e26183345d0b7aea46529dc8a26_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3652032d649844d6829c5e19d2777520_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="if85dc54c29fd4cf9846de7781b260f8a_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ic05a291f6c85442a9f8f27adea6622f7_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i4251896369a74d0aa90e3bc70584b869_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i119ca81462df4b8ab11c4bb6d9bd28ff_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i5ab95fccd8da4c0088db681978b22c60_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="idd09282688b34d21a437df741d91f326_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i720245015bd147958536b177867849c0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i03988acbbbf545258118de92761502f9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iee87940e501948388212ffaea5ef7269_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib857eef0de4e443fa7bfba0c972defc6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic28b55d0ec6f4c50b6d76a2006c84218_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i80b099f650834cefb3014164e0c16515_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i670aed569ab54abeacf39bd2a4edb1d7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idb6e42abcfda4205a7d8215451ffab57_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaab8a9d57c31475c8fa53d7137c08e2c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6ef8ce9277d64657ac41a5a6e20db257_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9ef63c18b31a43aa813ce3956360d746_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i20ef7fefce2f4952b179cadedd6fa194_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i2beebe6a93944228898bd1516baf7e5b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i43fbee378dc74b97a01b3c84b49540ae_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib371c96cf5004c8b8e72e342916dd913_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9ad1f4f9717f400dbf8bc1045b4fb85a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i38c16b54c71e4403ba91ef509c462a80_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iad67a6f5836647b68468a7cfc5e379e6_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i41826b41dd65441cab13757f1fda2bcf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2dc586e8441b48ad8423fa2f8e43592c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i47a6eaa90bd54796b8d3ac775e6acc2b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id40ae23bb96f4b34b5fff2e26a482860_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i52d5750b3f6b4059b628cc5c6120ffb1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idc0e7480ae994bbfae8f564a569b78db_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9925579f99854b05a2c1b01eab01c950_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iacac7d034158497ea761b6128d276bc9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i96e18cf03e374d0e8e09d680fdb0eb63_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i071cc6de3a8a4d14b919af0f81bed549_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i193bdf7d0e214572a3f99ff6320d3da9_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0eccbcc083c844ac8c436b9f78601a58_I20180131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-31</instant>
        </period>
    </context>
    <context id="ia217b44568db4f7bab6aa96e06106ae0_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i6a66e6dc6fc14f578f3db7088eb5c228_D20180101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ica759e56c7514b8ba6b11550c9f189e7_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="i0268f17a4fd248279ae397980a380ee7_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i9b7cdb52d8b648f0ae0d6f3123ee3585_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic2a909e9cbdb4c8d915bced44fe70c76_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i19988383bb3043e881752078a8364530_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2018ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i65a6568d2e72475ba89df5fcc752c87d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5c9cc8a9510f4a2382edf4448aedc3ca_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i414a3270f11947418d6c2125e509944a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4dae5a2ab67f4bb9bd50da276ee4860c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i76c7d7d2fbc34685ae18727c4cd65f70_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i61784cf3f3fc455b92d1549db42be0cc_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i966e35b143ba4a7cbf9890b21f017d74_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i513f9aefe4864f918aef77ec9b9464ca_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6b8c284910f9462da3a11aa8a2bdd9aa_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2db2f30e181740b58612f500d9f2221c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:MarketingAdministrationAndResearchCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iad12458b42414f73b54a930bd3423a7d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7b301f3d97e7423587fd5da2e57c027d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7138bb35916249cbb738270fd6fe93d7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i21ce1a07a551424683dbafbcfa3df273_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic9cd0e274519474a97c80be2216cc392_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4296ad893da549f0938808b2978e8ff6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id587ee8978da4dd9bfa35f34f890d144_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4076276bf701434cafde95786366cd18_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:MarketingAdministrationAndResearchCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia7474f88612244c1b64f1822399d6fb5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib0d8a29fd04b4af1b5328f9a73ce53e9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i75b30cbed6b345b390d2b06e4121969e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mo:InventoryWriteOffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iddfa3fe8e4ab41d696ebeee595b37982_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:PurchaseCommitmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i41086d5eceba4b10be60ded534b538d4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:PurchaseCommitmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i45fce82014e048088ddb663834e5b226_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c9f46db82b544bca919d37b619fa3c6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icfc10374e49f4210b26d83818840cffa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2c602bc808fd43b3aa8af711c461d8bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia5ab87ccfd644d7bbd87a7f9d985ce3a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie3301a69f1fc4456bc6cd43d61e2358b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3a07225f603b469a9e16277e68062cf2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4baac6d362ff43e1a624d2ca9bd47b9a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i94d483982eca44108fadfd7036741d3f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia87b4f2ccfa44ef480a0166d44944b46_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i44203766c22e443f90913f61f95be1a8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i37c3480e95d1469da93a1e2056153e63_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib911f814538a479eb5056f3c19bfd6c3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie496e5bcf31f4c2a9d472e2beb032d40_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if013f6bbc85345f1930ed240ff09ccf9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i64cdb3928d7c4bc89feb76f18d5b07e5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3c252077957546b2880b8ef2724625a6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4f3984a7b55343788f33878623e29f88_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8a153648856343c9b0ba005f24161faf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib0119e1289b840b9a4e48f08e6d51eb4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i90f0e22caf6240a283094f0495f14ec0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i581024f3ed014433a29610e67306704e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id6aea41f4cd944cbb4018c25bf22065f_D20181201-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0f8ac2e81fbf415d96b01883453526d6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-28</startDate>
            <endDate>2020-01-28</endDate>
        </period>
    </context>
    <context id="ibafdec850b6b45c6a0a6ebb40779d823_I20200128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-28</instant>
        </period>
    </context>
    <context id="i3a6bc5655b5c4d76b14ec49b161c5464_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5c77db08d832433681380e92e80fbc1c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5093f64aaa8d463a86be2d64338151f4_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib2202ef19f99485aaf1594cd36889bcf_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i03dc33411a5749d79909086adf33043e_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ide407e15cf49487193634a2048179491_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i3f6eaaca8b0c4eeab6e988d2d5cad4b1_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i789ffb64479c427c97456e2372a5a744_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i79d16ce41a6d4fb6a123927ea6298fb9_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i60560d0e627c422e839a25225ee19787_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i914d4a901ff34993a138eacf6ee3171c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie295981559fa47e9a12e6456173c067f_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="ieede284c3acf473cad8c0420cae67a03_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i23418c15a4834d4882c474b871c10616_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2ab928952e6f4199a2156a1db1c2ae25_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iff5dff53efdd45618f3b407706808ee9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0926d28c94bd4f0688d1cd87daf48de9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if543b4ab8bbb4e4cb31ce281dfc2c883_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i482f5b595eb642e1acc2d81bfa6d836f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if8c6262959ff4200998c8e9eaf5d9144_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i19091e36268a46e3b8306ee404fba8a2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i03cfa027e2c542a89ca61cb7216820a3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i327669e434c540969eed7f12fc78caa6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2f17aceb05f84391bfff69ba804a2d18_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i762330360e39458f831a1f465d0c4616_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i780f2a71201c4ff3bd694ea104911a0e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia8c7c188084b42a8ae2031212a1d2288_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id11a81bbc4f84fc78fa4cbe8a44fdf78_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0a8e1bf900f64f8b92b366a2c2d76fd1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cf3b63a008b40428ca6039b7d9a5c4b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia2c14274a4d64108b882de55d4502603_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic93a49eda1a94589ac79dd8b3c1b3e97_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i626546e4b3ef4715b47df81b5bb8b7b1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i429277c86fbe4b21bc95bdd8fbf00861_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icc73a7084aef4a0b8ed318ebd0e7d738_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7a183827598f443697de775b3cf99058_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic366f1f1f531476a8cd247a911c006fc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34064c893e694b50b8144376830b31e3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7227fbea894a4ca2b29fd716f8fd79a6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8f2e75b2f0094022af0e857ba9c1a24a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6fc7d0eb19de480baea8a1af985038d5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb03a2d5afcb4c62b621f8167bf67e8e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib8781d7757594520903cdddf6282cbf8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i086ec560279e4dfaa1563b87dbdbba88_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8990ee747e90489e8c4c40c9dd340a9e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i35e343023746419a9425bb816ac2a8e8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i42e4e208cef648d2a2e36df3b10bfc74_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6ecca4f968bc4f8daed7042afbac66f7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i31465b7042ac470797adf3cc3f8f4b1f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">mo:MeasurementInputWeightedAverageExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i519edb627c4f47b197d3fd3fb078bb6d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i932dd517d7a44c81ba630d3f06428863_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4c04c699c1c74515acd46e2303002b0b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i85c2ed22b70546a9afeb76348ddc2b55_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib3969c366e174823ba5e447d4d1d11fa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic79ee6d1277340d2a65bf968adbff27f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3023df6730344ca3962ddfd40ecab100_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0a361f15685848a39cda05ed04452b34_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i820ba03288e34f15a3e93d22d715d5cb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia4788092f78a4eb2b15070f6da8c3dea_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iffbb907af8094973ab26d4b85b6cb2e1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i490b0ad606f344d2b124a44527e6c990_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i895313ba107a45389016a7bbcfbd9f48_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb9212e88ebc4edd9d9a294e59c26753_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia65e91236a75413e94604e3795d0d4c4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i156d7b2e0ad84e2c8f2f415b7dcf205c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i709075a698fa4b7a895a75a9c6c5d1f4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i55629557f8fa4801a2be7e0427b33b06_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifa5700c0ced144f8ae5b03950397055c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i37e31bd7e2634c1dac8c62603a80a737_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i04baa8b6c1f845fa8d7e480d95aabb67_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mo:InvestmentsInEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ce59a1fcfb7407fa566d25fc62260e2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifb38fc3f5d2f4e6da207670f4cc54dd2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EquityContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d187570aa2540a88ab160136d28dc72_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia4215578af3347b0b7a3b29a129d6de7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia7f91a436b28422ea64fe38b472a5589_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib52d5131c24e46128d6b79389a025d30_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5e3ba701be024d09a42df0979733dce2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i742228ca73ae4006a165d270426b66aa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibe60396dea9d4e139bc5adf4aaef4cbc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i22bd417720914dd1a0bdbd9c0d152323_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaad15e2268ac481db81ebc0d57dbb586_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ief8d5ed5a7444a258532f6236eb7d10d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie54adf4b4f114073a2bbd31a27d6fbdc_D20190331-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i69363bfcc8fd412bbdb34aec0878e470_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i9da1982838c6484db523839f9172e06b_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i315cf96c2e2b4f1389be73d9bad6e25d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i75648dd74466420b86f28b4ffb6ef292_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifb694c29f27a46e4a6697f065ee75e35_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3703b6ae7e7341b18c2d327b431712cc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9c5bddfe927640169c96483cddb17379_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i41c9b1d77add44b9be802e5dd01b56c1_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2513d47f23844d9ba0ac7bdcd5c64e15_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i924ac9b83e4c4f0fb5b946287281a5bc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic095b1d9445c4bb79ac2c008e4f6fa83_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6858797d755940d5af5d63d4ebd944d0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i182d9ee236a64eff889aab36500df3ed_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i351326e926924511b4abbac946829f4c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie6377dd911ef4b1ab1d8dfb3730af782_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i36d2d484cfba4fb6ad475e2cfcf66462_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5162cf1b3ad7427d95b3b1edd5f61452_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i87eaf39b7366430e9f68266017701b5b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7ff69a497b0648929df0cbfb8bd32e75_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i10a65e697a2e4b2b84e0947bc730b6a7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifc218d99dbae4bc6925e235fb558f052_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1610ea0297f041709a85e25af892c5f4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9ce36a3023924317bfdc3b0e1809fdb9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i20745bf90a514b81888839906b4a8175_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib0026447ea51456899a37ff23aae7db6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8fc8febe647949e79218601be9537698_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i142eff51b3ab421c889c6d2bb5e2ac10_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie0494c954d344876932c1bdd4e2367e0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i46102449b128460b8ae18a5fe9e0fd56_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibf39d90acfc94fa8ae8510b5ee508977_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i3f18c4a56df2461bbfd5d9dee8b61589_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="iba075e861d6f4cc9998f78ffd3276986_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ie22dd2129baa4a278c19c2b770f10c74_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3d44379763c14be6b50fdea177e1105a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="if4ba820f281e46a0856811d6505d6c82_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i56d081780d6247f2a8f44b0cbac75f0e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9b93afd3a9384878a3d23d915edb9d34_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic9531ea2ec134d779a09cfd6999071fc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic552776954674567ad8ceaf455ff2df2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifd559242c87a4839848dc76f7cdba2b9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id30c8f591ff348eca5e129c73179556d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7749829bc252472e80afff2f43879e0c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifbdba2ebc8d24db9bde9d1ceeec106c5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie8ebfa9f82c6400c86cea2fa523e12bb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8a7d8dce58e1418492926f41ccd0a901_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i782ce7d0d6c04e66b91c4c3a13f4828b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iea1e2ba6af9c41ddb6f6b2e16f649711_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if2714d6deaf540cb865eebe43194b5a9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i40628f1e5dbf41ee82713505cf35318f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib49c01bfae724b45b528bcb25e34b3b5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6e3a17982ab540cdb38e40eaa9011fb7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i74d1129c13a243cfae74e7a2b330f4fb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i52bc6e7cfc6045cba8bc9b490b1083c3_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id84c0fe23d3344d8a09f8c4b47549357_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib56362e25fab48b69747801fbc413df0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7a22405436fc4f51965d8d905f04bd29_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id0c10cef408f4866a62e645271641b17_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7049d97f344641a984e6e5beb764d3d1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5dfaf8cc27be4772b848b7c1b8493b7c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0d1032796fa64fa4895bcb9f14b70233_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id429b5bd1c8d41978646f0f7f455e19f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i878e052a32df4da7a15671ffe7f6c60b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7356c82749654030be8f256d9f9a9745_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icba85968187d436ab30ed84caf5e41e0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i494ba59d5d0346ec8380c947bd3eb17e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5e6a83106cfb4c60a62a2096cd79a1bd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0c2ac469222e4237be6dcf3d6fa61beb_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6023956547cd406696d7cc717c5d63cc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2854d38153284db69df70b1b30e12c8b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5aa10928c42c437b8022ccb9de74838c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idf791c5f8e154ea99ad6848bebce7aea_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i763e7a556b7d49d7899ca7b7ab4b3ab5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie6bebe9ebc8645cc9f8335c03695b4c1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if454389f3a1945179f947caaa65a6c31_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic979af41ab9d413bb1ae38f66b2d9d11_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib3e639fdb4824b70bb2643899d44c0d0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1b13b9a1e91f4d60bd633bbdac2d3a0e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i18072db8ab9f45d4adbc775ff5720df9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibe3f5acfbb75415db5d1a986b38445b0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9a01c76ce7db4a9bb38f21611772ae4c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iffb9bd71b05044f1960dbd29fea9824d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4789cad0b6a54baaad569d4c6f6fbc61_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i941f9b86f58e457f869c24db7d24bb4d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2b48ad0497744f6aa97be20fde34f963_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6f398c78ea464bc29dfde286f3202ac5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i04eaaa915aec49bd9b52703167950623_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia8c1acc07f234535b9f59b5c08a35421_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia114b8b08be943bbaeec192f0c9546eb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie55438acc01a4f80a2a779c29e334eac_D20180801-20180801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-01</endDate>
        </period>
    </context>
    <context id="i55306d8676154351af21f6cfd76b5f55_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i56d738cab03146c5bcd9b95595aee05e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i15d84c7d97cd4a05857ded13946f92fe_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic3eeb744b8954855a6ff7c699a798982_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8cc84f59a87f4be8a5e634d905b909b6_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i004b9c845a7c477e9f161677be47d470_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDueTwoThousandAndTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="if92a65bfb9bf4139b4848310f21e030e_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDueTwoThousandAndThirtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="ib5bb50e3bc8e46f396e19b3dcbc7cefc_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesDueTwoThousandandFiftyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i6166eaee58bc4486a1dcd77e46be7115_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i524852ef9cf241f693dd67511cfcf6d0_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9f83a67a0b1041928670ec284b9f04b4_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="ibe6c5f25c0a14432894f98e00b688af4_I20191028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-28</instant>
        </period>
    </context>
    <context id="i088fe65173a649629285b737326fc8af_I20181022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-22</instant>
        </period>
    </context>
    <context id="ifa8f7e9351fa463481a1396bb9dbb0b3_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="ib6a114c3739645fb99b67e8b402fb09d_I20191028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-28</instant>
        </period>
    </context>
    <context id="ida5ccc93d1ad4e17b978d254db30a29b_I20181022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-22</instant>
        </period>
    </context>
    <context id="i1938f36d8dd1444f846a2c358e51a292_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="ib6b92183e81f4270b9b287aa21dc48b3_I20191028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-28</instant>
        </period>
    </context>
    <context id="if79ba42880fa4632945934c13e5390f4_I20181022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-22</instant>
        </period>
    </context>
    <context id="ic50f46d379fe4cb283f17d07d3231cca_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i991d327d70354aee8acfa77292becaf9_I20191028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-28</instant>
        </period>
    </context>
    <context id="if09d494ca9c04e36a8555873cb6b8cd5_I20181022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-22</instant>
        </period>
    </context>
    <context id="i74ee67e0b3a6432c9aa843c7b05d3a21_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i288268f2ad2f4afba0fe6dc3e2d647fc_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i1b3f238e8c2e470f941d469281cb5f59_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i90eafa508851421c88a1386dd9e708a7_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i79786dc9d3a34fe9b84f2581a59eae3c_D20180301-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="if906b9f3c170440f94e6baae57a1e8af_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i759cc82368a24da9b90d561f09b6df19_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i6732b65e853a4a2ebc98fc8672546c08_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i7b52d1ccf10645b8ac9e77afdbf09979_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitFiledBySchoolDistrictMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i327f425f4c0a4b958f4eb1c1e8e5b7a8_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i03acf33061544727a951d220b422409e_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="ie1a4cb788be34b7294823653c0ded68b_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i5370156fe8d14a8e8da1520ca797a308_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i5ae72485bc604c34b056b72db7e10bf3_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="ib640ca736ea64adfabeed83e8a20dfe7_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i42faf7ae646d43888ef8eb211eacf9ac_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i0f8e9338933b4ee6a3aa3a93e8059c2d_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i38158ae67bae43879aa2672ca2ab9fd5_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="iccba1eb229bd4dc390001b5b8df2bc45_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i9da4b44582904192921e6072055b4ac3_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="ibc1e2b1908b54d0ca3e4f21bb1d1e630_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i21bfaa9469a247b5bd27e94518726cb0_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MO</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="iae2caef6740d40259c9f84a490569169_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="ied53055005344f3bb2c452924e5a1528_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i3ae1fff42746471eb1d0f51a965259ab_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i31692ae6ae0d48948fb604426688e995_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="ic44878beb09c49beaa5574aad702cf2b_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="ie663a64cadad400db55d3b0fef5bd7d7_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:RI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i722c6dc101334a06958236d747b37fa6_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i77665d9f65aa408b8de4b3aff7a6e23a_D19990101-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i7b76f4a06e0d4000be39f89a1b20a4d9_D20041001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib42610cd85574a85ac22adfbd9232cc4_D20041001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic94346e89f4f4ef7864d5068b90b4f4e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1dd2f6de615e40518cd41e25874f2500_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5ef32b625acf4bd79754f47e5d1ec753_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iee3815bd69824e13833b90871d61a946_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib6bb1353452c4523bedf46d84d63f40c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i51f7bad91af248dcba16157131428d9c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i853e7e20eb29408fb2d7f8a14a1797da_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1f7118f93b4345d89a25d75afdb5a262_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie30f52b0c96d49a3a478a6a1e2ce47c4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:PreTrialResolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1e5bbf67f98443c0b7edd73a8250aa82_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:PreTrialResolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i03e3139f46334e698285c1dea0152ad0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:PreTrialResolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0cd199ca5a0f48ddb7de573598ef316e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:PreTrialResolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib01325dc5c474ef0a0a12a154bd77c51_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i81b724d4a8dd4812b7033d86eb830073_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCasePrincipeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="i7396e108206b484f903a260197ded70e_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id267dd8564a3488b94c7ba44126c87e8_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i3ebfc83154ce48dea39e1eade2ed1f02_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i08ab18a08fc2443ab1242f3a205e3fe4_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGentileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="if550a6c83d0d4c6292eefe757d6d7946_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGentileMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="i1a81a944b81a45a9b4aabeb561b3c720_I20000731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2000-07-31</instant>
        </period>
    </context>
    <context id="ibf8237cac01f4de89881354f8056ccab_I20000731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2000-07-31</instant>
        </period>
    </context>
    <context id="i21e01176f3244941b8c2577c07af928b_D20060701-20060731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-07-01</startDate>
            <endDate>2006-07-31</endDate>
        </period>
    </context>
    <context id="i2753d6b653574d7997560005050e6a03_I20080131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2008-01-31</instant>
        </period>
    </context>
    <context id="i282f01973b7a450996c72e13d164a16a_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="iab0a7a02a22144d58d64538e4a422159_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i78d2755130534b9f968f4c9ae194baf1_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFederalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="ibc72644f82dd4c06995b160fa2ebf6ac_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i121c8c8c92154161b47ce45a7725da25_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i386be72127664d83ad959975ff8d48c4_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPearsonDCohenCollarChaconMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i0790b75d3ef64acda7cf88fa64505882_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesReiderandBanksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="id594dce411764c92b6f7ed94ea6a2dee_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesWeingartandHancockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i055fbe8d8f0144a7aeb8622777fb5fb4_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPollariMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="id660194fbef544acb7a9ac3e9edd669b_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerRintoulandDuignamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i0bfe653a65cc453d9adba37e43c082ee_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFreemanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i09102d7949074727b6b071832c9c9a1b_I20140930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-30</instant>
        </period>
    </context>
    <context id="i68e27be8c5e340d2b5ab22ec89c6fbff_I20140930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-30</instant>
        </period>
    </context>
    <context id="i763f26f3f9864550bce1cb5f1d139b5f_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesBergerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2f379dd774a84c178271dd8ddf630a75_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i83bc2d39c8314c73ac43d49baca414d7_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i8a8b0e0c65974548b24e515426fd6cb4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSantoroMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i54e27c4d0aa94139a647bf051cb35c24_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="i73562f0789564c4ca3b746d86736d7f1_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="iee24c1e556fd401ebf1c14cc046a2c47_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i720d17586fc04494803d6a38d0d0a43a_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="icb420eb62e1c4abda0c90da42623cf66_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRintoulMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="ic0334756982249f5a738ecdc55a81329_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesRintoulMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i473d370813804ee9923d2d9d90726e86_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i5e8a0f49c0334761b75e98dc0a5ae0e3_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i7cb77069bc64499a9599c4b95646cbbc_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib37d24d3b5fc4f8d8fe8d58c3e41ba9b_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if7391ca337c34ee3812079caa09a47a8_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNeffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i9e8ceb1484f445ba829b403f9ca487cb_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNeffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ie8ee87d2eab14b2dadd569b18425aac6_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFrogelMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i157ee62daa634c5baba2332dda040742_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMahfuzMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="iccb40a3f593e44f1945490c8afa74e4a_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMahfuzMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="iaa873ae904e843a68f15a429f1ddca30_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="idbdcfd0b02f340638485ef5bf9030554_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i262382c0015d432f842b18237e28071e_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="i7ba2f37bcf6a402cbdc706a9755f41eb_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="ie7c4b24571604e75af7f7e9f3bb4d335_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i35caf9a0d822450fa81f75e68cd02338_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="ia3bacb16e4784de892ae8b6b2205a876_I20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-30</instant>
        </period>
    </context>
    <context id="i0cb589bcaaa645de9d8fdc23492ff483_I20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-30</instant>
        </period>
    </context>
    <context id="i67739f053413439ebc96236f3209b74e_I20170430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-30</instant>
        </period>
    </context>
    <context id="i78f0ea0e26e943ae806d1225535249a8_I20170430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSommersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-30</instant>
        </period>
    </context>
    <context id="ia0c617d528d64ef7961c5cff9cbf15ec_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="i06074dee810942e292ea731bda7a36a0_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="i6797d3f0b35047dda7ab8a8ec5357129_I20150131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-31</instant>
        </period>
    </context>
    <context id="i9a54fa21dad34042b8f605536d155127_I20150131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-31</instant>
        </period>
    </context>
    <context id="i82c91aed7e2542169faf3a41146a2257_I20140731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHarrisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-07-31</instant>
        </period>
    </context>
    <context id="i490bb998e16344949c52ff8781d7eb75_I20140731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHarrisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-07-31</instant>
        </period>
    </context>
    <context id="i5fedb4dbaee5495fb6536ab744945764_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDeanKerrivanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i62c4a7eb460c47c4abeef12cfe44cd6d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLandiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5bac0925a60d445ea8ad330c550cde67_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesTheisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ica94d523154c4c0fbf78887c8b5a2ecf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNaugleGoreM.BrownJordanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i06e101deca564c7faf4a806f5acf2373_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesNaugleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i05be0cce4caa4d2b8616b1209601e242_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGoreMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id8ade17230a6455891f64fe763188b45_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesM.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7458b6e8570f46858d3d5cfb65f8fed0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesJordanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4ced792544c54268bd9593f35eddb549_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3fcc4a28b47f436c803de4971a69b758_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2af34da3eecf4a8ebf87a01b040a2639_I20090630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-06-30</instant>
        </period>
    </context>
    <context id="i56d82ed761ef41faa02538a434851cba_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i478232b2660949908a92fbab33c32522_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i33543518d6fe4ed1953a1556411870d8_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a8b9d0cebed4ddb9c87e8c9b6beb170_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if01eeea512324def8fe5ddadb4933fad_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i699b979bc3384548b7b8bea7e04b6c80_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4ff54182d2e14c58b237baad2a9f2b83_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i21d1ad4f96264abdb7cc9a9a8779a95c_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i93b4623007a1413fa49810d6fcdcc0b4_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i838f2633ed9f400bbf26ccb953378742_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icf31645f50824ffea06b19db990ee06c_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i65cd4161393b493e93229e0b24630447_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i776efbde1566429f802bd97c318bb9de_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia1eed415a7f14ab7906e4688e423ad63_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NV</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3f246771a94496a8fe79e88a4c244f8_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i808cf4a891d345f1b854305991736a14_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i207d1b533ad342f0869af8557c242e8a_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6fa168360477427daf858f964b5cb335_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i56a3c4325e724588a97c6020a21a678d_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3ce9b9f166c94ef2abf45bab5d8b92ad_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iffac1ae1843149e283a93385a7627136_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2e4937e663604dd08163acaf12477d40_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:SC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id6abd61ba1fd4819a6eb7a7144ab2ed8_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0fb064a2cc7d473e8f865cbc2fb8885f_D19960501-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id3f5b7c4027d400398db6b1ad78239ab_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:BritishColumbiaSaskatchewanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i3f3875700c6945e4837cd9e5bda1f32b_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="idc79629711204f43abfeca4b62d5c1d8_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i8949cd3b364e4768928464fc8e22ebae_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id0f294b9d70d421f83088c1d9d8b30a9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i169d27beb37c49c5bf82654208714375_D19981101-19981130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1998-11-01</startDate>
            <endDate>1998-11-30</endDate>
        </period>
    </context>
    <context id="i97d740917fe440d1a50498a05140608e_I19981130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>1998-11-30</instant>
        </period>
    </context>
    <context id="iff56a70694624f4a924402ecc251143a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i047334242a4e4b4e9a23b88b2217bc5c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i06cf35adf4314057a6229713af6fc6f9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6fc84a4adae148e8b5c911a64d52cfdd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie19865eab4224177afee834778e21a4a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3e86e226235c4990a36636532147b9b9_D20171001-20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="i53f369577bd3484cbaee39e41e064c6b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib07a762a7c314cb981274ba805f9f3d9_D20171001-20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="ib7136524f70a44118cc4469581d243c9_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i905cb71d55944236820d53a9f8ba97b4_D20180401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i18398105d8324ad6807cd23593a48335_D20180401-20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="i7127e4e55f3b48cca9b37c8e7582d3db_D20190401-20190430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="i173ce1f840bf44efa105eaef9092cd54_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i71dd2d406d224d878f3ef54f28a29459_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ib1b513fdea0b44b19d5975639617c3f4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic2269ecdf1c64fb98097f29ff6e22692_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i5dc2309f4c184f1d91f181d088250c1c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20042017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i632a162da722437e9880fd3bbac52897_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9e5e9c280fc9404d8b6763a66a3c305f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-09-01</startDate>
            <endDate>2013-09-30</endDate>
        </period>
    </context>
    <context id="ifa9e64d794b84e179af595a489042961_D20130901-20130930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-09-01</startDate>
            <endDate>2013-09-30</endDate>
        </period>
    </context>
    <context id="icad6887108624ef19b7c544b38df9e85_D20130901-20130930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:MarylandMissouriNewMexicoandPennsylvaniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-09-01</startDate>
            <endDate>2013-09-30</endDate>
        </period>
    </context>
    <context id="ic184ac8ea193498a824e11bb3c6a380e_D20130901-20130930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-09-01</startDate>
            <endDate>2013-09-30</endDate>
        </period>
    </context>
    <context id="i32b1d9a333c54d99b2ca2e70af628ad9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i30652171c168469b95e7a480823eec6a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0e1757eedc104e8fb665fd9663ddfecc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i42170c8f1d6444caac8ca0392f6a2276_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4bc886e153d544dba8474e1686d381cc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i77fb9eb402e744f8b24e8258a74cd29f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if33f95674df24a7981e5f92d55c32bc3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i129667b4722345049e3eacc64888eda2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i23e21af60d684691875ed325f6132e92_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4a91eaf68d5c43dd926983f95d778cea_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2189369e507844d7aa734b62200b5014_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i320fe601fb2e4afa8201647bbf6c161e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic9c75caeda0440b2b7a8b44f6a3af45a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5cf05e684bcf452b891b222faeba6f5d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i024ba7dd2cb546cb91939fb3c737b4cd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i497ca0f28e5442c59124520e63eb5149_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3254354ec2ca4cc19c1da242682ccd9a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i70337240f7a84b3788b6f48a11439d6f_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherDisputesUndertheStateSettlementAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ie8789e2bcbf64769a038755249460300_D20060801-20060831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-08-01</startDate>
            <endDate>2006-08-31</endDate>
        </period>
    </context>
    <context id="i14beba11ec90485cb8c96048f72ff73f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaae00eba7cfd48bb8a759ff60030320a_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="i1c5a0e12db7b469bbcc33e36f758341a_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="ib15d032499ec49ce814afe877066b823_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifdb0e875b3484b01ad06905775a8272b_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i6f6c0c255f674e16970fc172f56b0c52_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i3a4a3638d5c14dd6930a6317db7cb2fe_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="if0cadfd7091b4c52acbda0b9e5844949_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsUltraLightsClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i365934f7ac7f46b589e0fbf8c5a01204_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:USTLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="i5a9a9ea271534fef8e2574fa16175c11_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i94b8b0bd9cd64fb1b726bdd03fce49cf_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="ibaad81b69d5b4f30a76662311f1a3c69_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5e48f7ae862f4927a706bfb1d1bdff5f_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i221381c6c8174016a6e3bd28d276c6f7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4e875a907d9e4fc9a48992750104acbd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="director">
        <measure>mo:director</measure>
    </unit>
    <unit id="cadPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="board_member">
        <measure>mo:board_member</measure>
    </unit>
    <unit id="year">
        <measure>mo:year</measure>
    </unit>
    <unit id="extension">
        <measure>mo:Extension</measure>
    </unit>
    <unit id="state">
        <measure>mo:state</measure>
    </unit>
    <unit id="claim">
        <measure>mo:claim</measure>
    </unit>
    <unit id="case">
        <measure>mo:case</measure>
    </unit>
    <unit id="lawsuit">
        <measure>mo:lawsuit</measure>
    </unit>
    <unit id="plantiff">
        <measure>mo:plantiff</measure>
    </unit>
    <unit id="manufacture">
        <measure>mo:manufacture</measure>
    </unit>
    <unit id="ruling">
        <measure>mo:ruling</measure>
    </unit>
    <unit id="settlement_development">
        <measure>mo:settlement_development</measure>
    </unit>
    <unit id="court">
        <measure>mo:court</measure>
    </unit>
    <unit id="shareholder">
        <measure>mo:shareholder</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M18xLTEtMS0xLTA_669ab71f-744d-4ff3-894d-f81621d61342">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M18yLTEtMS0xLTA_89ee4e38-d9ee-4e6a-a778-cc4ebef837fb">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M18zLTEtMS0xLTA_f8638f29-86d5-4a5b-af1a-fb1c3c0e7a0e">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M180LTEtMS0xLTA_12d2c99e-a8b6-4765-b8fb-d912e62441cd">0000764180</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80L2ZyYWc6NTM3MmQ1ZWY5NzcyNGQ3M2FhOTczMjYyYTQxZGExNDAvdGFibGU6NWYyM2RiN2I2MjA0NDFmNzhlNmIyOWZhZmVlZmUwNDMvdGFibGVyYW5nZTo1ZjIzZGI3YjYyMDQ0MWY3OGU2YjI5ZmFmZWVmZTA0M181LTEtMS0xLTA_4e3c7f35-611e-4dcb-bddb-3e79cecc0f59">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMy9mcmFnOmQyZjQ2NTdmOTM3NzRmOWRiMWNlODkxODlkMjhiMTkwL3RhYmxlOjMwZmRjNWQzZGIyZjQ2MTU4YjA3YTkzZGFjNDg5NzNmL3RhYmxlcmFuZ2U6MzBmZGM1ZDNkYjJmNDYxNThiMDdhOTNkYWM0ODk3M2ZfMy0xLTEtMS0w_a9c1cc00-54a8-4b83-969e-194ca7c9cc40"
      unitRef="usdPerShare">0.3333</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMy9mcmFnOmQyZjQ2NTdmOTM3NzRmOWRiMWNlODkxODlkMjhiMTkwL3RhYmxlOjMwZmRjNWQzZGIyZjQ2MTU4YjA3YTkzZGFjNDg5NzNmL3RhYmxlcmFuZ2U6MzBmZGM1ZDNkYjJmNDYxNThiMDdhOTNkYWM0ODk3M2ZfMy0yLTEtMS0w_5089fd4e-9587-4b7d-8fdb-311484463477"
      unitRef="usdPerShare">0.3333</us-gaap:CommonStockParOrStatedValuePerShare>
    <mo:AllowanceForSalesDiscountsGoods
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80OS9mcmFnOjAyY2UxOGI1YzI0NTQ2MzJhNmEyZGMyMDdlOWJiNDcxL3RleHRyZWdpb246MDJjZTE4YjVjMjQ1NDYzMmE2YTJkYzIwN2U5YmI0NzFfNDY_b52272ac-83ae-4a99-9cd6-83a7a5f351fd"
      unitRef="usd">0</mo:AllowanceForSalesDiscountsGoods>
    <mo:AllowanceForSalesDiscountsGoods
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80OS9mcmFnOjAyY2UxOGI1YzI0NTQ2MzJhNmEyZGMyMDdlOWJiNDcxL3RleHRyZWdpb246MDJjZTE4YjVjMjQ1NDYzMmE2YTJkYzIwN2U5YmI0NzFfODc_98f9cd14-8a24-4cfc-893a-076c5884e815"
      unitRef="usd">0</mo:AllowanceForSalesDiscountsGoods>
    <dei:DocumentType
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl84Mg_a2af7003-0997-4b08-b23a-c88babd4214f">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6ZWI5YTkxNDZkMGJhNGNkYzg3ZTg2Yjc4YmEyMmMzZWIvdGFibGVyYW5nZTplYjlhOTE0NmQwYmE0Y2RjODdlODZiNzhiYTIyYzNlYl8wLTAtMS0xLTA_912107c3-b816-4d5d-836e-b83a287b9559">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMTk5MDIzMjU3Njcw_19b26ac8-1c98-41be-89f2-a45a5df4c718">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6ZGMyZTFjOWIyNzZiNDY5YTk3NWQzODk2M2EzNWUzZTgvdGFibGVyYW5nZTpkYzJlMWM5YjI3NmI0NjlhOTc1ZDM4OTYzYTM1ZTNlOF8wLTAtMS0xLTA_003d4466-4323-4716-b347-d763c055ecd7">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDg1_96ec2ce7-a26f-460b-8a8e-84fbd44bf686">1-08940</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDc5_711bb92f-8532-452a-bb4f-7cbec4e1d29d">Altria Group, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV8xLTAtMS0xLTA_30b9e669-690b-4caa-80ca-5f7d64e838ac">VA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV8xLTMtMS0xLTA_6c537e67-54fc-4fe7-bcbe-6bbdf0f06e5e">13-3260245</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV80LTAtMS0xLTA_83539a03-64e9-4893-8cca-d07290af52df">6601 West Broad Street,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV80LTEtMS0xLTA_36a2de22-25a1-43c9-9393-0653d351527b">Richmond,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV80LTItMS0xLTA_fb52be4b-6a08-4b1a-9a47-836a27478775">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjEzMTgyNmZiY2Y1NDdhNzk3NDk3ZGJjMDBiNTQwZTEvdGFibGVyYW5nZTpiMTMxODI2ZmJjZjU0N2E3OTc0OTdkYmMwMGI1NDBlMV80LTMtMS0xLTA_087eb9e6-adde-4b5e-a680-b679bdfa8c5b">23230</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDgw_a6c2ccba-182c-4fa6-92a3-41f02b1d8abd">804</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDgx_a4cf30e7-edd6-4402-b513-4bd9ac25e9b6">274-2200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i44440fa474754cb99393173d190110ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8xLTAtMS0xLTA_7db07c55-a621-4556-9f59-99f4c11c37af">Common Stock, $0.33 1/3 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i44440fa474754cb99393173d190110ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8xLTEtMS0xLTA_b8da2937-d9aa-4136-a5b2-9ce3bf1dffc0">MO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i44440fa474754cb99393173d190110ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8xLTItMS0xLTA_af1dbf4e-32ba-438d-822a-080eac5d2640">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i8b31e1162044436b80fd4386757ac7bc_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8yLTAtMS0xLTA_1d4e9bf1-ee64-4202-992b-c6322966576d">1.000% Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8b31e1162044436b80fd4386757ac7bc_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8yLTEtMS0xLTA_99f776f6-d453-494b-a5d7-36edd0f8ff06">MO23A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8b31e1162044436b80fd4386757ac7bc_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8yLTItMS0xLTA_3ce54218-9b54-4fbe-8d7c-b583c0375e0c">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic6745877610b42c1afa4746d9658080a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8zLTAtMS0xLTA_7be88df8-7fcb-4cad-b7da-bffc0039e3c9">1.700% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic6745877610b42c1afa4746d9658080a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8zLTEtMS0xLTA_b40fd2e4-7420-477a-a570-13c5d32fb4a0">MO25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic6745877610b42c1afa4746d9658080a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV8zLTItMS0xLTA_0abfb757-d383-4156-b3e9-0664532eea40">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i5ba03e348bf44a90a5e2da0fb8a1bcba_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV80LTAtMS0xLTA_fdc8ee78-aaba-49fe-87ee-fab324464635">2.200% Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5ba03e348bf44a90a5e2da0fb8a1bcba_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV80LTEtMS0xLTA_d6fecea0-1db8-4a38-878a-34e1c4e5d096">MO27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5ba03e348bf44a90a5e2da0fb8a1bcba_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV80LTItMS0xLTA_6f1536cc-2903-4633-a9a1-12400fb04085">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i5ba9d9ce80bd4640949c31fb4e52f3d3_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV81LTAtMS0xLTA_d0eb8b1d-5687-4fab-8b7e-13d367a7fd71">3.125% Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5ba9d9ce80bd4640949c31fb4e52f3d3_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV81LTEtMS0xLTA_0e4d36fb-95fe-4ef0-989b-d670365b2033">MO31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5ba9d9ce80bd4640949c31fb4e52f3d3_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6YjU4NmM1YzIwODQ0NDM3ZGIzYzBkOTU0ZDlhMGQ0OTkvdGFibGVyYW5nZTpiNTg2YzVjMjA4NDQ0MzdkYjNjMGQ5NTRkOWEwZDQ5OV81LTItMS0xLTA_9d5ecd0e-aa34-42a7-ac01-49ee49eecfff">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDgy_ddb60a8b-4242-4674-b2a2-69f5c7223d5b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDgz_cc41c93d-7e5b-4899-88b7-3e5a0ea91b1c">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6Yjc1MjZkOTU5ZTU3NDBmMjkwZGUzODlhMmZkYjNjZmMvdGFibGVyYW5nZTpiNzUyNmQ5NTllNTc0MGYyOTBkZTM4OWEyZmRiM2NmY18wLTAtMS0xLTA_2ad0a278-d071-4f61-9b2b-a8532c8697e4">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6Yjc1MjZkOTU5ZTU3NDBmMjkwZGUzODlhMmZkYjNjZmMvdGFibGVyYW5nZTpiNzUyNmQ5NTllNTc0MGYyOTBkZTM4OWEyZmRiM2NmY18yLTYtMS0xLTA_f25e3eac-9321-4d6f-9362-bd2b2744510e">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGFibGU6Yjc1MjZkOTU5ZTU3NDBmMjkwZGUzODlhMmZkYjNjZmMvdGFibGVyYW5nZTpiNzUyNmQ5NTllNTc0MGYyOTBkZTM4OWEyZmRiM2NmY18zLTYtMS0xLTA_24acafd5-e6ed-4059-a278-a0f79aa77dc0">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMDg0_40c0fa0a-afac-4742-9c1c-ab16e6d01783">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i26603be02f7f4bf3b037387b1d8ccb26_I20201021"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xL2ZyYWc6ZDA2ZmJmYTEwMWFmNDI0MGI0NTZlNmMwNjYzMDAzYzYvdGV4dHJlZ2lvbjpkMDZmYmZhMTAxYWY0MjQwYjQ1NmU2YzA2NjMwMDNjNl8yMTk5MDIzMjU4NDMw_743676f3-6afc-47a1-b5fd-1bb660fdfeee"
      unitRef="shares">1858419165</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMi0yLTEtMS0w_7f1bf063-9111-4638-8855-46a835790356"
      unitRef="usd">4123000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMi00LTEtMS0w_f5f00405-5baf-4b2a-878f-1e521332c217"
      unitRef="usd">2117000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMy0yLTEtMS0w_2a26747e-039b-4b1b-a6a4-3e2ed5bec629"
      unitRef="usd">151000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMy00LTEtMS0w_a323705b-0e55-43a2-bd5c-5cc62da88973"
      unitRef="usd">152000000</us-gaap:ReceivablesNetCurrent>
    <mo:InventoryRawMaterialsPlantMaterialNetofReserves
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNS0yLTEtMS0w_5c79d9bf-2c71-426b-86dd-472b96041d73"
      unitRef="usd">754000000</mo:InventoryRawMaterialsPlantMaterialNetofReserves>
    <mo:InventoryRawMaterialsPlantMaterialNetofReserves
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNS00LTEtMS0w_73bbe89b-b848-49f7-888b-8225c1238b47"
      unitRef="usd">874000000</mo:InventoryRawMaterialsPlantMaterialNetofReserves>
    <mo:OtherInventoryRawMaterialsNetofReserves
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNi0yLTEtMS0w_99f2e703-a3a8-485d-bfa2-aab5222c6cae"
      unitRef="usd">206000000</mo:OtherInventoryRawMaterialsNetofReserves>
    <mo:OtherInventoryRawMaterialsNetofReserves
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNi00LTEtMS0w_159b36db-cfd8-4b19-a8c3-2d8154b67161"
      unitRef="usd">192000000</mo:OtherInventoryRawMaterialsNetofReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNy0yLTEtMS0w_ed26ebfb-9814-42c1-928e-dfa26abb6dd0"
      unitRef="usd">450000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfNy00LTEtMS0w_d359ce25-7a2c-49ca-b0a5-e0684f1d8282"
      unitRef="usd">696000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfOC0yLTEtMS0w_94470ed6-bdad-47c5-9d01-eb69c769d67b"
      unitRef="usd">452000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfOC00LTEtMS0w_1fed5bc7-f54b-4fab-b802-ec44df9f68b3"
      unitRef="usd">531000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfOS0yLTEtMS0w_4ea51589-95ae-4757-b823-cb03908c9ffb"
      unitRef="usd">1862000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfOS00LTEtMS0w_ba69d808-feba-4ef1-9f81-3b309ee1032b"
      unitRef="usd">2293000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTEtMi0xLTEtMA_c659759e-b7f6-438b-9955-b0ca20a73699"
      unitRef="usd">263000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTEtNC0xLTEtMA_6d3a222e-de4a-403c-a15f-da0045db8b52"
      unitRef="usd">262000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTItMi0xLTEtMA_86505920-696d-424f-a742-88936224d0b7"
      unitRef="usd">6399000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTItNC0xLTEtMA_25b9bbe8-6640-401a-bf66-b00ee2f5e00e"
      unitRef="usd">4824000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTMtMi0xLTEtMA_765070cc-66b4-403f-8e78-813f79944d06"
      unitRef="usd">5173000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTMtNC0xLTEtMA_816b43a0-01d6-47d9-941e-d22076fd44c5"
      unitRef="usd">5074000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTQtMi0xLTEtMA_a17da068-7b67-42eb-b72f-da33e6c01aa5"
      unitRef="usd">3164000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTQtNC0xLTEtMA_a8c7cd91-3102-4907-9d65-407dc813107e"
      unitRef="usd">3075000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTUtMi0xLTEtMA_3fb95610-3fe1-457e-86ef-1f17342769af"
      unitRef="usd">2009000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTUtNC0xLTEtMA_5fda5c40-d6b6-4eb9-8727-0e0f16b260d2"
      unitRef="usd">1999000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTYtMi0xLTEtMA_d5074d7e-03a8-479e-82b9-1eddd4e0e9b4"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTYtNC0xLTEtMA_33240f0d-61bb-4a68-9972-33f2fe7d476a"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTctMi0xLTEtMA_2d5ab521-8067-46da-99f8-a93280524a50"
      unitRef="usd">12633000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTctNC0xLTEtMA_236a1957-78cd-4749-b324-4960d2e606fb"
      unitRef="usd">12687000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <mo:EquitySecurityInvestments
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTgtMi0xLTEtMA_debb4f36-c96a-431c-bfd4-1d0b0341aaad"
      unitRef="usd">19408000000</mo:EquitySecurityInvestments>
    <mo:EquitySecurityInvestments
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMTgtNC0xLTEtMA_0e9e25fd-c753-41dc-a027-7b611ec62803"
      unitRef="usd">23581000000</mo:EquitySecurityInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMjAtMi0xLTEtMA_44e84a59-776c-4905-9bd5-00c2f92f04e0"
      unitRef="usd">1025000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMjAtNC0xLTEtMA_1d120f5e-f0c4-4c63-bf07-a3777b75acb1"
      unitRef="usd">1003000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMjEtMi0xLTEtMA_17fa434c-8a05-490f-a022-7d1953e847ac"
      unitRef="usd">46651000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjk3NWY2ZTQ0ZjRjNjRkM2FiNGU0NGMyOGNhZGY3ZGNlL3RhYmxlcmFuZ2U6OTc1ZjZlNDRmNGM2NGQzYWI0ZTQ0YzI4Y2FkZjdkY2VfMjEtNC0xLTEtMA_f220c897-e28e-4e16-b4f1-7623db220e0c"
      unitRef="usd">49271000000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMy0yLTEtMS0w_4a5225ef-4221-4958-bbda-63d5d796fcfb"
      unitRef="usd">1500000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMy00LTEtMS0w_0661345e-9a78-4a16-85b9-524d73883e3d"
      unitRef="usd">1000000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfNC0yLTEtMS0w_95a3fbb9-8355-4a3a-a846-493c91e6eb12"
      unitRef="usd">348000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfNC00LTEtMS0w_1c2a61d4-e265-4448-ae9c-79b76461881e"
      unitRef="usd">325000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfNi0yLTEtMS0w_9c4e6383-5fe3-4aac-b1b5-4be6e230c383"
      unitRef="usd">521000000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfNi00LTEtMS0w_6f868611-966a-4dc8-9aba-d2845709340f"
      unitRef="usd">393000000</us-gaap:AccruedMarketingCostsCurrent>
    <mo:AccruedSettlementLiabilityCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfOS0yLTEtMS0w_8e2ea8cb-ef86-4c1a-91df-d1218b0f361d"
      unitRef="usd">3206000000</mo:AccruedSettlementLiabilityCurrent>
    <mo:AccruedSettlementLiabilityCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfOS00LTEtMS0w_3d6fc19e-e348-45cd-8cb9-bff34d3e4029"
      unitRef="usd">3346000000</mo:AccruedSettlementLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTAtMi0xLTEtMA_87c6dfaf-93ed-43e4-8e45-5e5ffb5f31d6"
      unitRef="usd">1113000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTAtNC0xLTEtMA_9a6687cf-9fa3-4df9-8480-6ebdcf3a9373"
      unitRef="usd">1545000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTItMi0xLTEtMA_adeec0db-57cf-4503-b493-db27694da8c5"
      unitRef="usd">1602000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTItNC0xLTEtMA_a5bfd674-4094-4bd5-8412-fccf87567e34"
      unitRef="usd">1565000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTMtMi0xLTEtMA_e29505fd-0099-4812-94a8-d8f38f370e46"
      unitRef="usd">8290000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTMtNC0xLTEtMA_66f31144-f4dd-46cc-ba92-65c26e842a3b"
      unitRef="usd">8174000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTQtMi0xLTEtMA_f5547bc0-2cd1-405b-81ea-004a10151046"
      unitRef="usd">27755000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTQtNC0xLTEtMA_f43cb255-0197-41ee-a462-7e948dced1c2"
      unitRef="usd">27042000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTUtMi0xLTEtMA_31ae09da-7373-410c-b45b-2099a442bed0"
      unitRef="usd">4724000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTUtNC0xLTEtMA_08a5615a-6373-4613-939d-1b72d05c4609"
      unitRef="usd">5083000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTYtMi0xLTEtMA_5522ecf4-a768-4884-a22c-5e4b794e6329"
      unitRef="usd">404000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTYtNC0xLTEtMA_e61f0786-4b8f-4265-83f8-a6abc02954b8"
      unitRef="usd">473000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTctMi0xLTEtMA_c4e864ce-6112-4785-a7e4-d88991aff303"
      unitRef="usd">1798000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTctNC0xLTEtMA_b252b27f-7c86-4119-b7ce-b08443f3711f"
      unitRef="usd">1797000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTgtMi0xLTEtMA_c41c564a-f58e-4253-807f-af0723303e18"
      unitRef="usd">409000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTgtNC0xLTEtMA_5bd2ef27-5dc3-442f-b6ca-dd94416e2cf3"
      unitRef="usd">345000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTktMi0xLTEtMA_82db3dd1-8a6b-49c5-b7a7-50f64f77d74c"
      unitRef="usd">43380000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMTktNC0xLTEtMA_83fd4929-3d3e-4aef-9531-1e4803da681b"
      unitRef="usd">42914000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjAtMi0xLTEtMA_70adc128-7f9b-4265-9725-61b4620af902"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjAtNC0xLTEtMA_1708b5dc-d462-445b-9061-353197ef2383"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjEtMi0xLTEtMA_56bc1eab-0ffc-4ef2-ae16-0b8e1b740615"
      unitRef="usd">39000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjEtNC0xLTEtMA_2de94c3a-693b-4244-a9d6-ab88e4ef5414"
      unitRef="usd">38000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockSharesIssued
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmE1ZDZmM2JhZDU2MDRmNzJhMzA0Yjg3YmU4NGQ0MTAxXzIxOTkwMjMyNTU2MzA_a7ec046e-98f4-4fcd-9956-01041f6dd826"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOmE1ZDZmM2JhZDU2MDRmNzJhMzA0Yjg3YmU4NGQ0MTAxXzIxOTkwMjMyNTU2MzA_dc3fb5e3-daac-4cff-84b7-23daf509ed67"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjMtMi0xLTEtMA_60d7580d-67c2-4322-a91b-a8ccee9db44b"
      unitRef="usd">935000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjMtNC0xLTEtMA_f2f80d16-e626-4dcd-916d-a1d127a97dad"
      unitRef="usd">935000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjQtMi0xLTEtMA_f4f4f63c-4085-4713-b2c0-a6c7d4d3c118"
      unitRef="usd">5973000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjQtNC0xLTEtMA_588e846c-a172-4243-a1dc-7fae98bbafda"
      unitRef="usd">5970000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjUtMi0xLTEtMA_cacf06d7-08d5-4e2c-a056-414b78566f65"
      unitRef="usd">34356000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjUtNC0xLTEtMA_bb15e0ba-db0f-4c4a-afbd-d493dcfc21f3"
      unitRef="usd">36539000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjYtMi0xLTEtMA_97971a62-c9df-491d-9669-941813e5ca7f"
      unitRef="usd">-3781000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjYtNC0xLTEtMA_e2319bd2-e683-4f22-83da-8ed8df8fab2f"
      unitRef="usd">-2864000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjQ2YTU5MGI5ZmYyZTQ5MDRhYmY4YjdhOWE2MjFmMWVkXzIxOTkwMjMyNTU3NDQ_fa5377a4-55ed-41cb-9551-3514510301dd"
      unitRef="shares">947542152</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjQ2YTU5MGI5ZmYyZTQ5MDRhYmY4YjdhOWE2MjFmMWVkXzIxOTkwMjMyNTU3NTc_c4227816-095f-4a49-83a7-f2a61dc026ac"
      unitRef="shares">947979763</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjctMi0xLTEtMA_0930df9c-5c82-4915-af79-e259d3f3274a"
      unitRef="usd">34344000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjctNC0xLTEtMA_c0331b92-1fa0-41e6-948d-fde0e2e2b4c3"
      unitRef="usd">34358000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjgtMi0xLTEtMA_0867272e-1d66-4fea-a2ff-180d89ce9323"
      unitRef="usd">3139000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjgtNC0xLTEtMA_12540b2d-c5a4-418c-81cc-e3199da76171"
      unitRef="usd">6222000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjktMi0xLTEtMA_9c2c39f9-e6d5-46ff-a2bf-656c0069d4f3"
      unitRef="usd">93000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMjktNC0xLTEtMA_bd576ce8-fa97-4e94-852f-227d06e73220"
      unitRef="usd">97000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMzAtMi0xLTEtMA_86121d63-2fc7-4ae4-a853-19df80f9eebe"
      unitRef="usd">3232000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMzAtNC0xLTEtMA_26a636f7-ecfa-48d0-a945-ff30ccb6bbb0"
      unitRef="usd">6319000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMzEtMi0xLTEtMA_13d0e936-9c36-42ce-a7d5-6273243eef7c"
      unitRef="usd">46651000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMC9mcmFnOjFjODY3NGNkNTU0ZDQwYjRiYzVjNmFiNjFhZmU3NWUyL3RhYmxlOjAxMWQ3YzAzMmJlNTQ3M2M5ZTBlMjc0MjU3Mzk3MmNlL3RhYmxlcmFuZ2U6MDExZDdjMDMyYmU1NDczYzllMGUyNzQyNTczOTcyY2VfMzEtNC0xLTEtMA_e4c99c6b-dad6-4ed5-a660-b3d4c747fb83"
      unitRef="usd">49271000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMi0yLTEtMS0w_5ff63e3e-6f9b-4ae6-8ae0-6b1ed254b277"
      unitRef="usd">19849000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMi00LTEtMS0w_bdf66785-abe0-4520-9b65-663a2942f29f"
      unitRef="usd">19103000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMi02LTEtMS0w_5dd897fe-76ac-41dd-b7b0-b960c4d2b47a"
      unitRef="usd">7123000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMi04LTEtMS0w_8aef5495-d01a-42af-9b65-1e60ec93ab21"
      unitRef="usd">6856000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMy0yLTEtMS0w_da2181eb-ba9b-46a0-9180-3e6e3e5dc8a0"
      unitRef="usd">5909000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMy00LTEtMS0w_c8382f7d-04c2-4294-ae14-e0ab389c89f2"
      unitRef="usd">5367000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMy02LTEtMS0w_d3b05373-a429-420e-ade4-b24e6c254e2c"
      unitRef="usd">1961000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMy04LTEtMS0w_68b5140d-f1a3-4b28-9576-098821d29118"
      unitRef="usd">1915000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNC0yLTEtMS0w_a84ea930-fbba-440d-aee1-8ced096deac8"
      unitRef="usd">4063000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNC00LTEtMS0w_2e06f76a-9b3b-4e55-9109-9864949e73a7"
      unitRef="usd">4109000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNC02LTEtMS0w_1eedce6e-cc99-4a13-8a18-4ddf45d002ee"
      unitRef="usd">1445000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNC04LTEtMS0w_ba2f6e38-8925-4cfa-bf27-9f264793a849"
      unitRef="usd">1444000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:GrossProfit
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNS0yLTEtMS0w_fc77a94c-7bc9-4b98-b6a5-055997d26d83"
      unitRef="usd">9877000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNS00LTEtMS0w_cc533590-3cc5-4dbf-b0c0-21770d3a60cb"
      unitRef="usd">9627000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNS02LTEtMS0w_87d02eff-2171-490a-8ade-fcb70ce8aa14"
      unitRef="usd">3717000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNS04LTEtMS0w_a568324f-e0c2-4fdd-93df-53d467073088"
      unitRef="usd">3497000000</us-gaap:GrossProfit>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNi0yLTEtMS0w_e6f5c725-b58b-46d1-8f25-39482389a774"
      unitRef="usd">1585000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNi00LTEtMS0w_3e324201-ffcd-400c-b262-541e422851ad"
      unitRef="usd">1654000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNi02LTEtMS0w_1596dc3c-b8f1-49b4-b649-f4ca18b736f6"
      unitRef="usd">557000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNi04LTEtMS0w_c8e712cd-2b4d-41ee-91d5-02eb1dbb70ee"
      unitRef="usd">552000000</mo:MarketingAdministrationandResearchCosts>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNy0yLTEtMS0w_2bb28d94-3dd9-461c-a1ad-cfb7e3e395cf"
      unitRef="usd">0</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNy00LTEtMS0w_f94ba20d-4022-4943-aa5f-c080974c51df"
      unitRef="usd">74000000</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNy02LTEtMS0w_49565975-8b43-4cdd-b95b-ab01b98bb80f"
      unitRef="usd">0</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfNy04LTEtMS0w_3599ea8a-be02-4225-bf4f-8af32617611b"
      unitRef="usd">1000000</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOC0yLTEtMS0w_568d374c-7d4d-4879-bbfe-4d8c4b63d980"
      unitRef="usd">8292000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOC00LTEtMS0w_a39872df-243a-44e2-8a6d-39f02456df4b"
      unitRef="usd">7899000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOC02LTEtMS0w_930d42c5-a106-4170-b60c-84cc69907ce5"
      unitRef="usd">3160000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOC04LTEtMS0w_d60101db-c9dc-4948-aa01-2533ab8da93e"
      unitRef="usd">2944000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOS0yLTEtMS0w_84c41910-be05-41c9-ad87-04fcc0445fbd"
      unitRef="usd">-893000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOS00LTEtMS0w_50066aba-85ca-4094-aafe-6dc9b43a11ac"
      unitRef="usd">-989000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOS02LTEtMS0w_0484f6c8-87a3-4a73-8711-daa69dcd7998"
      unitRef="usd">-310000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfOS04LTEtMS0w_3feaa674-fb08-4d38-bd42-f73fcab1e78e"
      unitRef="usd">-293000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTAtMi0xLTEtMA_506241c3-4186-4151-9763-ba56ea408720"
      unitRef="usd">-58000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTAtNC0xLTEtMA_dbe852d8-383f-4a49-a054-0a98c754d778"
      unitRef="usd">-40000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTAtNi0xLTEtMA_dd386e5b-f41c-4375-a8eb-53653988483b"
      unitRef="usd">-3000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTAtOC0xLTEtMA_2049f4e2-5e20-4f7e-a767-30eeed88219b"
      unitRef="usd">-24000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTEtMi0xLTEtMA_846cf895-f0db-4857-b2d5-c10244880ff7"
      unitRef="usd">-306000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTEtNC0xLTEtMA_b093e567-fd64-42df-bc0f-4f9ba2f2724c"
      unitRef="usd">866000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTEtNi0xLTEtMA_be73b0f9-416e-4c27-a0bd-751d79034cf3"
      unitRef="usd">-472000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTEtOC0xLTEtMA_4e064ac4-5e28-4e12-9243-dfa4ebba2a4b"
      unitRef="usd">333000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTItMi0xLTEtMA_66da33cf-7166-4035-af3b-0020286e7001"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTItNC0xLTEtMA_83daaa2d-53d4-4004-81ad-04224e77e2ae"
      unitRef="usd">4500000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTItNi0xLTEtMA_3638b101-3c80-4652-88b7-242c0930170b"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTItOC0xLTEtNDk3_34ae785f-33b9-4bce-886e-3c01d45e4309"
      unitRef="usd">4500000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTMtMi0xLTEtMA_453d1fac-2b9c-441d-9a71-821c3b87ddfc"
      unitRef="usd">-202000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTMtNC0xLTEtMA_c564898b-083e-4b9d-a9ac-41f0432e9019"
      unitRef="usd">-1327000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTMtNi0xLTEtMA_62ca772d-4db0-4673-b864-a61bc559f7fa"
      unitRef="usd">-105000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTMtOC0xLTEtMA_8b8df587-df63-4dfb-b433-ea3913ab8dad"
      unitRef="usd">-636000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTUtMi0xLTEtMA_5486961d-4d5e-44f5-838d-533a295b8298"
      unitRef="usd">4349000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTUtNC0xLTEtMA_5ddacdb8-1b7a-40e9-931e-efa045d5681b"
      unitRef="usd">1989000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTUtNi0xLTEtMA_2e7419b6-06f4-40a9-aaa9-683628ad8440"
      unitRef="usd">-324000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTUtOC0xLTEtMA_428547da-7ab6-42ae-839c-5d90835627cb"
      unitRef="usd">-2128000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTYtMi0xLTEtMA_41c3e43a-f937-4e5e-9cd5-772d8d1ece7c"
      unitRef="usd">1817000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTYtNC0xLTEtMA_63834175-b423-4312-a43f-569e63fb2594"
      unitRef="usd">1473000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTYtNi0xLTEtMA_211b17cf-c48c-479f-98b8-6b005bfb102b"
      unitRef="usd">632000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTYtOC0xLTEtMA_f9d0aa16-8848-4274-ade0-0c4b5e4293eb"
      unitRef="usd">474000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTctMi0xLTEtMA_9afec5a5-9e7a-4f90-9266-7a98837c06c7"
      unitRef="usd">2532000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTctNC0xLTEtMA_4eb6092b-da0f-4b0e-9c25-942449c5f84b"
      unitRef="usd">516000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTctNi0xLTEtMA_9906f6f4-bde1-4780-a69d-81993fb7d620"
      unitRef="usd">-956000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTctOC0xLTEtMA_ee6b13a7-f337-4b72-a4ef-7247de3d902b"
      unitRef="usd">-2602000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTgtMi0xLTEtMA_552078dc-3645-4d42-a082-f9463a2523f1"
      unitRef="usd">-11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTgtNC0xLTEtMA_deee0ef2-b91a-45f9-bab6-e053b43a9123"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTgtNi0xLTEtMA_62399e5f-c598-419f-9400-29b58c51b565"
      unitRef="usd">-4000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTgtOC0xLTEtMA_eea83b58-ad08-4964-8484-ec0f834d2e06"
      unitRef="usd">-2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTktMi0xLTEtMA_384e3240-b573-4f25-a307-abefe39039a7"
      unitRef="usd">2543000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTktNC0xLTEtMA_c4603b6c-d59d-4ecd-aa5c-b56e72ee9a72"
      unitRef="usd">516000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTktNi0xLTEtMA_3e3fc365-af04-4c61-9c50-353ec7cb67f8"
      unitRef="usd">-952000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMTktOC0xLTEtMA_2174132f-21a1-428d-9bbf-b288d2597889"
      unitRef="usd">-2600000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjEtMi0xLTEtMA_8c5974e4-ef40-40fe-aace-28b759f8cf83"
      unitRef="usdPerShare">1.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjEtNC0xLTEtMA_9652c60a-9922-4004-a740-54404dffa50d"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjEtNi0xLTEtMA_57898316-45b0-4ca4-a6db-2bbc4982fcef"
      unitRef="usdPerShare">-0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjEtOC0xLTEtMA_3310e51a-6d1a-4a23-822c-35dea0380636"
      unitRef="usdPerShare">-1.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjItMi0xLTEtMA_1dff095e-c1a4-4a35-8df4-1fe54af1b9b1"
      unitRef="usdPerShare">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjItNC0xLTEtMA_a3f10f90-68e7-4144-a69b-981e5702cac7"
      unitRef="usdPerShare">0.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjItNi0xLTEtMA_2bb8d743-81ea-4f29-872d-62a5118878c3"
      unitRef="usdPerShare">-0.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNi9mcmFnOmUzZjUyZGI1MjcyOTQyOTA5NGQ5MzQ1NzJiZTMzMmE1L3RhYmxlOjJkYTYyMTc5MjU4YzRlYWU5ZGIwYTk4YzMzMmYyYTU5L3RhYmxlcmFuZ2U6MmRhNjIxNzkyNThjNGVhZTlkYjBhOThjMzMyZjJhNTlfMjItOC0xLTEtMA_8160423d-295f-468e-854c-e9b53bdb4995"
      unitRef="usdPerShare">-1.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMi0yLTEtMS0w_8c4c7d14-f017-4a8b-a59a-77ed2fd68a19"
      unitRef="usd">2532000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMi00LTEtMS0w_d33519cd-f6de-449b-8475-9f1ed0f69255"
      unitRef="usd">516000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMi02LTEtMS0w_81c4b748-03f8-4447-95d6-c779416319ff"
      unitRef="usd">-956000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMi04LTEtMS0w_bb623d61-4116-447f-9b7e-1fecfb4f71dc"
      unitRef="usd">-2602000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNC0yLTEtMS0w_e6f08a7c-4edf-4642-b035-c2fe8b704a5f"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNC00LTEtMS0w_0b6767ce-234f-4ece-8c3e-a952a7912272"
      unitRef="usd">-84000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNC02LTEtMS0w_4a60c6aa-69ca-42ed-a7a9-cc92cbe477db"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNC04LTEtMS0w_c2cf363e-295a-4d42-9de8-6a9e6bc0505b"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNS0yLTEtMS0w_9d91001a-2fd0-4510-bb64-9c91d68f2016"
      unitRef="usd">-928000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNS00LTEtMS0w_0330bb21-3942-45a8-af40-ee18b883b67d"
      unitRef="usd">53000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNS02LTEtMS0w_19d763eb-e06e-4762-86c5-8851a33e9bd8"
      unitRef="usd">-15000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNS04LTEtMS0w_26c4bebf-fef4-4c05-9d38-d8bc005d7fd0"
      unitRef="usd">221000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNi0yLTEtMS0w_48e16e8f-b115-4067-a72f-80880ea12528"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNi00LTEtMS0w_42f5a44f-e8aa-4c44-9c49-d24fe57ef295"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNi02LTEtMS0w_c442eb00-2b28-46ac-9fca-2c4a36eb67e3"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNi04LTEtMS0w_095e783e-4d25-4ffe-bc8b-7cd1d8e2b365"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNy0yLTEtMS0w_5e178052-cdee-4248-a15a-0e60b7b7692c"
      unitRef="usd">-917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNy00LTEtMS0w_f26b00b0-d843-4539-95de-3325af092e53"
      unitRef="usd">145000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNy02LTEtMS0w_9a30862d-da9d-4ae1-86ce-60bbf6b8135f"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfNy04LTEtMS0w_e0355b2e-4ddf-4484-b005-0aefcd77dd69"
      unitRef="usd">244000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfOS0yLTEtMS0w_66aee009-ac7e-4e7c-9779-01501165cd92"
      unitRef="usd">1615000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfOS00LTEtMS0w_c320ef0f-5ea5-4eca-a0b4-ef2784892551"
      unitRef="usd">661000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfOS02LTEtMS0w_7049eb86-a451-4c44-bc08-f6d1612eb8da"
      unitRef="usd">-963000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfOS04LTEtMS0w_935516f2-94d9-444a-91c3-2f7f80e8239f"
      unitRef="usd">-2358000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTAtMi0xLTEtMA_b58a1a90-9628-440b-83c9-2106fe2ed73b"
      unitRef="usd">-11000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTAtNC0xLTEtMA_01c4f0a5-57f7-4d8c-b502-18c5aecb163f"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTAtNi0xLTEtMA_58976d07-1905-4648-aa8e-20445816f3b3"
      unitRef="usd">-4000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTAtOC0xLTEtMA_ab54f21c-0c4e-479b-a5d7-b2b835dbee4b"
      unitRef="usd">-2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTEtMi0xLTEtMA_68b9cbb8-dd66-4ecf-a2f0-f61fcf04946b"
      unitRef="usd">1626000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTEtNC0xLTEtMA_77d7e1d4-fc7d-4966-ba6a-2f62bf378657"
      unitRef="usd">661000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTEtNi0xLTEtMA_27121a4d-e3dc-465b-a834-d45e907ee6ab"
      unitRef="usd">-959000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xOS9mcmFnOjcwZDhjNjM3MzhkODQ0NjViZjFhYjk4NTQxMzZjOGFhL3RhYmxlOmEyYWVmZGEwMTA1YjRiOWFiZjc0ZTZkNjllNWJkYWU4L3RhYmxlcmFuZ2U6YTJhZWZkYTAxMDViNGI5YWJmNzRlNmQ2OWU1YmRhZThfMTEtOC0xLTEtMA_d328eeaa-afb7-4ae5-b692-3d14ce3478c7"
      unitRef="usd">-2356000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04b4defec05c47cebe3e08fabfbe59fe_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi0yLTEtMS0w_8202220a-7c1a-4b29-ad13-21dc0ad50c2f"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a1fe382d2b64cedb36fbab69f63bb0b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi00LTEtMS0w_c44eefaa-8722-48e1-b87e-5b9d03e6fe65"
      unitRef="usd">5970000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbb23df3172c47a6ad9b939e24083612_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi02LTEtMS0w_3981d9e0-6e2e-482d-ad48-f21502b34ddd"
      unitRef="usd">36539000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5979906ef954a38814196686ea7e5cc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi04LTEtMS0w_12bc0421-aaa4-4631-989e-84044cdd1f87"
      unitRef="usd">-2864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7046cbf69cc14b679f3ace4e97364019_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi0xMC0xLTEtMA_2a1f9c4b-002e-4735-8c69-d537d33bb4b1"
      unitRef="usd">-34358000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ied0ebb716fa943be849401de264b7398_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi0xMi0xLTEtMA_5c588e88-7506-4b31-8438-ff73675938cf"
      unitRef="usd">97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMi0xNC0xLTEtMA_bdf49528-e4a7-44ac-ae1e-a218bd6a65b7"
      unitRef="usd">6319000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ib6729fd45e0e470ea191552125f035b0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy02LTEtMS0w_c1ac318b-9f4f-474a-8516-8447b3e09bc6"
      unitRef="usd">2543000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i1f38bf7309bc47bcb39556c8eb9545d7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xMi0xLTEtMA_daa767f6-3e95-44c7-89d5-cafc550d0300"
      unitRef="usd">-13000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xNC0xLTEtMA_277440a4-0139-4102-93a7-427461701cb4"
      unitRef="usd">2530000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNC04LTEtMS0w_926db531-40ea-492a-bf1e-dad3f829abf1"
      unitRef="usd">-917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNC0xNC0xLTEtMA_4651206b-b6ae-4e20-ac78-19b9dd412de6"
      unitRef="usd">-917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ic5e6cf6324ab408596c1e32ba2460534_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNS00LTEtMS0w_a891884a-a1da-4ed5-83ef-266281b758c4"
      unitRef="usd">3000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="if9cda828d4e847eb909e17085a8abf3d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNS0xMC0xLTEtMA_3b700d63-08ab-492d-b45b-17688e8b29c8"
      unitRef="usd">14000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNS0xNC0xLTEtMA_af3ad8e4-ee3b-4d03-8e8d-4888b1cd7356"
      unitRef="usd">17000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNi0wLTEtMS0wL3RleHRyZWdpb246ZjEyZDUwNzRlMmNiNDQ0NThlNTIwOWE1M2RkOThmOTdfMjE5OTAyMzI1NTY1MQ_d32a564d-2552-418b-a85e-2605fd52f2a2"
      unitRef="usdPerShare">2.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib6729fd45e0e470ea191552125f035b0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNi02LTEtMS0w_efe2c54a-56e8-4101-ace1-220404843e0a"
      unitRef="usd">4726000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfNi0xNC0xLTEtMA_51c3c5fd-5250-49fc-a877-f529b3f08366"
      unitRef="usd">4726000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i1f38bf7309bc47bcb39556c8eb9545d7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOC0xMi0xLTEtMA_f5eff5a3-3dc8-4e45-bc3a-737539f75ebe"
      unitRef="usd">-9000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOC0xNC0xLTEtMA_80c638bc-48c8-4135-8b11-5cdca2342462"
      unitRef="usd">-9000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff26aeafc2654f32b63277057cb5ba1f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS0yLTEtMS0w_bc05a035-63ca-42d6-bd87-492b2991aa78"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb61dea03e9f42f9b875b85705945971_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS00LTEtMS0w_bcd1c5d5-c5c9-4b0c-8370-1877305d6e78"
      unitRef="usd">5973000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4d40817fa304462992d884e8d54ded54_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS02LTEtMS0w_5da692c5-1a89-4d47-abcd-9836e327d3e8"
      unitRef="usd">34356000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id2165dd6285c436395dd6d4adac5414f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS04LTEtMS0w_06d2d16d-8d90-498e-ac5f-5378d6fb3b74"
      unitRef="usd">-3781000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibdcf612da0684543843d2a7497e76e83_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS0xMC0xLTEtMA_39797eac-9c2d-4860-b6a9-359a90ea02fb"
      unitRef="usd">-34344000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34df390bf1094b3299c4c826e85fb609_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS0xMi0xLTEtMA_e8ebb361-b871-4444-a5e7-c26caf642d55"
      unitRef="usd">93000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfOS0xNC0xLTEtMA_673f9232-72fe-4f80-ac0f-641a911ffd42"
      unitRef="usd">3232000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iabbca98f017e44a690fafbff723997c4_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi0yLTEtMS0w_50d7c774-3e37-4694-86ab-6d2caccf0365"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i389f8b70a3a74262938c581680019e9d_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi00LTEtMS0w_1538580b-d6e3-4714-9e30-c15fac132a18"
      unitRef="usd">5961000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i68d18d178b0741ad9d0db863ab4222bc_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi02LTEtMS0w_06140f65-86c5-4ba5-b8e5-4257e14c0294"
      unitRef="usd">43962000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i820a924d574a40d381950cff0e1a0426_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi04LTEtMS0w_82d10965-bbd6-4100-855d-7acda886dcb5"
      unitRef="usd">-2547000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42ee75101e094c558a156cae6a325229_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi0xMC0xLTEtMA_ba6cea10-830e-4d2f-8911-5665432ef5f7"
      unitRef="usd">-33524000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i661a0f364aa74a089c89d944ccfa84de_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi0xMi0xLTEtMA_19d351c2-04f3-46bd-88d5-5e0e17bfa47c"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9fdefa86b95345148bfdd3202813cfe1_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMi0xNC0xLTEtMA_714decaa-e260-4a40-88d1-023ccc2b1749"
      unitRef="usd">14789000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i65f80ce3d24c4093bace02242bc24d95_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy02LTEtMS0w_25371da7-04cc-4898-985d-73ebdb05a779"
      unitRef="usd">516000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iec8f8e259dd94eb9a288d8c6d9cdef4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xMi0xLTEtMA_6374442d-f542-43ff-996c-cd0f38a9d2ed"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xNC0xLTEtMA_1365353b-ff29-4c18-9e19-f97fac58e22c"
      unitRef="usd">513000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNC04LTEtMS0w_70fe6df2-a4df-4d3f-9c6d-204762f78a20"
      unitRef="usd">145000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNC0xNC0xLTEtMA_7da8364a-e8d0-49ae-833f-6b955d83f1a6"
      unitRef="usd">145000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ie610fa8db60e477bbafca3e2effe7047_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNS00LTEtMS0w_c85b6e15-e041-4bc7-a433-40ece3a4233d"
      unitRef="usd">-1000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ib3ab6e26183345d0b7aea46529dc8a26_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNS0xMC0xLTEtMA_d93371bc-0ff9-4e0b-8475-b8ed9f41f7fc"
      unitRef="usd">12000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNS0xNC0xLTEtMA_7bea7fa4-dd07-4468-b0b3-99da38e01a07"
      unitRef="usd">11000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNi0wLTEtMS0wL3RleHRyZWdpb246NzBjNTExYmJiOTZjNDNiZTg2OWYyMWM2NzYxOWFkZGFfMjE5OTAyMzI1NTY1MA_0c1e8e7f-7434-43e7-b85f-745076b1dd28"
      unitRef="usdPerShare">2.44</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i65f80ce3d24c4093bace02242bc24d95_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNi02LTEtMS0w_099e7c31-2790-48ae-b7c1-f7a6823dfb9f"
      unitRef="usd">4568000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNi0xNC0xLTEtMA_d6b08a56-f369-4ea7-845a-0b1df3c909a9"
      unitRef="usd">4568000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib3ab6e26183345d0b7aea46529dc8a26_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNy0xMC0xLTEtMA_6d1840c0-eae0-4373-950e-ee1796c3fdd8"
      unitRef="usd">346000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfNy0xNC0xLTEtMA_bd29c101-8e50-4694-8a74-c93036f803bb"
      unitRef="usd">346000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="iec8f8e259dd94eb9a288d8c6d9cdef4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOC0xMi0xLTEtMzYy_bd43e41f-ce7e-434e-b6a4-e6e02e1b3e7d"
      unitRef="usd">88000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOC0xNC0xLTEtNzAy_62e666eb-e89c-4fdd-b176-3912d032f102"
      unitRef="usd">88000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:StockholdersEquityOther
      contextRef="iec8f8e259dd94eb9a288d8c6d9cdef4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOC0xMi0xLTEtMA_43a05af1-21cc-4c75-9c6d-f490e18e66d6"
      unitRef="usd">-5000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOC0xNC0xLTEtMA_e9375009-135b-4d2e-861d-761fbba879bc"
      unitRef="usd">-5000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3652032d649844d6829c5e19d2777520_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS0yLTEtMS0w_c9dc9901-a8f6-47d0-9bd6-85e61a42c873"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if85dc54c29fd4cf9846de7781b260f8a_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS00LTEtMS0w_4aa2314d-1adf-4892-8c1f-3c14cfd02507"
      unitRef="usd">5960000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic05a291f6c85442a9f8f27adea6622f7_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS02LTEtMS0w_30a75314-7382-4622-b292-716e02d52078"
      unitRef="usd">39910000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4251896369a74d0aa90e3bc70584b869_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS04LTEtMS0w_3fb18d6c-cd1e-48da-8239-ae74514f7575"
      unitRef="usd">-2402000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i119ca81462df4b8ab11c4bb6d9bd28ff_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS0xMC0xLTEtMA_f8e16327-5526-4e1e-ac02-40b80502ce30"
      unitRef="usd">-33858000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ab95fccd8da4c0088db681978b22c60_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS0xMi0xLTEtMA_cf553848-5403-4c2d-a24f-82fcfdc24100"
      unitRef="usd">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd09282688b34d21a437df741d91f326_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfOS0xNC0xLTEtMA_962b1e19-f450-436e-acac-2a51a0f1f764"
      unitRef="usd">10637000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfMjE5OTAyMzI1NjE1OA_e3231a07-09b1-401b-a140-4b20efabce26"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfMjE5OTAyMzI1NjE3NA_23620a66-a59c-4648-a296-cce5c4a058e6"
      unitRef="usd">3000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i720245015bd147958536b177867849c0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi0yLTEtMS0w_b3c33c53-9590-4b2d-b2c2-971a1b3ef001"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03988acbbbf545258118de92761502f9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi00LTEtMS0w_9a1d1c09-fbed-4d2b-8f7b-8c23ff499e48"
      unitRef="usd">5964000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee87940e501948388212ffaea5ef7269_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi02LTEtMS0w_654979d0-6941-4157-b1b5-562237fee103"
      unitRef="usd">36908000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib857eef0de4e443fa7bfba0c972defc6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi04LTEtMS0w_ee4d6649-b558-4b43-8640-824d491e6e10"
      unitRef="usd">-3774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic28b55d0ec6f4c50b6d76a2006c84218_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi0xMC0xLTEtMA_0ece479d-1c31-45c0-aa5a-6e8b8ba36e26"
      unitRef="usd">-34345000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80b099f650834cefb3014164e0c16515_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi0xMi0xLTEtMA_03d0a209-9605-4c73-b4e8-0dc54b0884a7"
      unitRef="usd">98000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i670aed569ab54abeacf39bd2a4edb1d7_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMi0xNC0xLTEtMA_b13defd1-4680-4811-a17e-a5a1a46bbfb4"
      unitRef="usd">5786000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="idb6e42abcfda4205a7d8215451ffab57_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy02LTEtMS0w_b057b873-ca49-491d-896f-78e148d40186"
      unitRef="usd">-952000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iaab8a9d57c31475c8fa53d7137c08e2c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xMi0xLTEtMA_92b43da6-2611-4ca9-a4aa-fe91a87e8d2c"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xNC0xLTEtMA_de3e948b-bbca-4c2e-b5e7-5f50627b0389"
      unitRef="usd">-957000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNC04LTEtMS0w_57c617af-3b1a-4e72-85b4-8918aacb4d02"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNC0xNC0xLTEtMA_c13c35cd-04fb-465e-adfd-24c47f6fa7a0"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i6ef8ce9277d64657ac41a5a6e20db257_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNS00LTEtMS0w_285c2364-f5d3-4474-aa90-0a540dd99ab8"
      unitRef="usd">9000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i9ef63c18b31a43aa813ce3956360d746_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNS0xMC0xLTEtMA_6caa13d4-87a5-46c8-912b-1dd66687eb38"
      unitRef="usd">1000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNS0xNC0xLTEtMA_ee90b27a-24f7-4a56-a6a4-4bf12193acd8"
      unitRef="usd">10000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNi0wLTEtMS0wL3RleHRyZWdpb246MjcwMTA1MDYwMTBkNGY1OThlNzg5YThkYWUwMWM1NDlfMjE5OTAyMzI1NTY0OA_1670a0e1-6227-4bdc-98a7-974ec1db0b44"
      unitRef="usdPerShare">0.86</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="idb6e42abcfda4205a7d8215451ffab57_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNi02LTEtMS0w_4e69f7c2-b30f-434b-8328-b306acbf2dd7"
      unitRef="usd">1600000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfNi0xNC0xLTEtMA_517be789-1691-4302-a68e-906e38b672fd"
      unitRef="usd">1600000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff26aeafc2654f32b63277057cb5ba1f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC0yLTEtMS0w_ea3624a7-7381-4b88-b03c-49e0a9a3bcfe"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb61dea03e9f42f9b875b85705945971_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC00LTEtMS0w_19db87d4-342b-4f5f-9ac2-1736a1dd6e26"
      unitRef="usd">5973000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4d40817fa304462992d884e8d54ded54_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC02LTEtMS0w_32653eed-89a8-484b-a20f-0a4e270c3923"
      unitRef="usd">34356000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id2165dd6285c436395dd6d4adac5414f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC04LTEtMS0w_6d89d0a6-5623-4a05-8454-67bbf177ba0d"
      unitRef="usd">-3781000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibdcf612da0684543843d2a7497e76e83_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC0xMC0xLTEtMA_3a57723f-659f-44be-9276-f3b3554c969f"
      unitRef="usd">-34344000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34df390bf1094b3299c4c826e85fb609_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC0xMi0xLTEtMA_46381f2d-bb7d-4361-a1f0-41e3a0d80a63"
      unitRef="usd">93000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfOC0xNC0xLTEtMA_796c0c11-36ae-4086-81ae-edd5d9a40683"
      unitRef="usd">3232000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i20ef7fefce2f4952b179cadedd6fa194_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS0yLTEtMS0w_9bbe6930-f19f-4499-98b9-cb6bd791e493"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2beebe6a93944228898bd1516baf7e5b_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS00LTEtMS0w_8d836b1c-41f8-4aba-a0ae-0a8cf10bc6a5"
      unitRef="usd">5953000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i43fbee378dc74b97a01b3c84b49540ae_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS02LTEtMS0w_4e27b8f4-a586-4180-957c-b9c16c086251"
      unitRef="usd">44081000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib371c96cf5004c8b8e72e342916dd913_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS04LTEtMS0w_3293cc0a-9c45-43b1-8e72-bb6de90af1d7"
      unitRef="usd">-2646000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ad1f4f9717f400dbf8bc1045b4fb85a_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS0xMC0xLTEtMA_8613f973-ee79-4e8a-85c2-8ca34135c733"
      unitRef="usd">-33859000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i38c16b54c71e4403ba91ef509c462a80_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS0xMi0xLTEtMA_ad263072-bcf3-4402-9c93-332265901f97"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iad67a6f5836647b68468a7cfc5e379e6_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfOS0xNC0xLTEtMA_954266b6-1cc9-472a-a976-90920ae3c09b"
      unitRef="usd">14466000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i41826b41dd65441cab13757f1fda2bcf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtNi0xLTEtMA_152297ec-d10d-4dae-a5da-3ef65d848c38"
      unitRef="usd">-2600000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i2dc586e8441b48ad8423fa2f8e43592c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTItMS0xLTA_ddaf8c78-7472-4f94-ae7b-8f418194e190"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTQtMS0xLTA_32bef1b2-a36e-4bb9-8683-bebcf17c1d46"
      unitRef="usd">-2603000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTEtOC0xLTEtMA_e0b9468b-63bb-40ac-9ce6-51a310abea09"
      unitRef="usd">244000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTEtMTQtMS0xLTA_d9d0ffdf-d0c2-4fc8-a54b-7dfcbeee037a"
      unitRef="usd">244000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i47a6eaa90bd54796b8d3ac775e6acc2b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTItNC0xLTEtMA_c36016df-aac9-4b58-a675-6e5134ff8a34"
      unitRef="usd">7000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="id40ae23bb96f4b34b5fff2e26a482860_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTItMTAtMS0xLTA_f43af357-bf48-41b2-a6d5-750613352296"
      unitRef="usd">1000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTItMTQtMS0xLTA_74ebebe2-160d-41b6-bb70-d80caa407f75"
      unitRef="usd">8000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjhkNDQ2ZmJmMGRiNTQ4OTg5YWNhMWZkYzFlZjdhOTllXzIxOTkwMjMyNTU2NDc_7a6a5f67-7d43-4989-bd7f-7f3ad27e66f3"
      unitRef="usdPerShare">0.84</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i41826b41dd65441cab13757f1fda2bcf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTMtNi0xLTEtMA_4b50f2aa-39e3-4ca5-adab-2c13bfe580d5"
      unitRef="usd">1571000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTMtMTQtMS0xLTA_bff3ea0b-b685-4253-85ef-36796c6a10ae"
      unitRef="usd">1571000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i2dc586e8441b48ad8423fa2f8e43592c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTQtMTItMS0xLTA_a911f5fb-095a-4e27-b688-8019a748efde"
      unitRef="usd">88000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTQtMTQtMS0xLTA_e3a0c405-faf6-4351-bd4a-0d5426e8f2b7"
      unitRef="usd">88000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:StockholdersEquityOther
      contextRef="i2dc586e8441b48ad8423fa2f8e43592c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTUtMTItMS0xLTQ0NQ_275fa855-8862-496a-b5d1-7bf7e32db7d5"
      unitRef="usd">-5000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTUtMTQtMS0xLTY3Nw_5aae8876-b7f0-4cd6-98b4-85fe2205f350"
      unitRef="usd">-5000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3652032d649844d6829c5e19d2777520_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtMi0xLTEtMA_9aedd18e-3501-490a-837d-5b3e820a9668"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if85dc54c29fd4cf9846de7781b260f8a_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtNC0xLTEtMA_9201f088-16ee-4451-a21e-7001ccdb3ab3"
      unitRef="usd">5960000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic05a291f6c85442a9f8f27adea6622f7_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtNi0xLTEtMA_0828f7ff-8bc8-4dfc-a0e1-df2c935d8316"
      unitRef="usd">39910000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4251896369a74d0aa90e3bc70584b869_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtOC0xLTEtMA_c9096b60-f8d7-4e0e-a80f-29a90f97b51b"
      unitRef="usd">-2402000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i119ca81462df4b8ab11c4bb6d9bd28ff_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtMTAtMS0xLTA_9ebec0d8-c6be-4293-bcd3-89a201406909"
      unitRef="usd">-33858000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ab95fccd8da4c0088db681978b22c60_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtMTItMS0xLTA_ac93b8f8-7301-40b1-9231-4d8b9825f201"
      unitRef="usd">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd09282688b34d21a437df741d91f326_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTYtMTQtMS0xLTA_127843b7-e315-4d9b-b72c-9ecb1ea7eb11"
      unitRef="usd">10637000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfMjE5OTAyMzI1NjIyMw_0b9ad177-1131-49b1-8884-bec3694cf889"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfMjE5OTAyMzI1NjIyMw_33504470-5e56-40f3-803e-b4b4364853d2"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMy0yLTEtMS0w_b43c9131-f019-4f26-a880-63a3fbe806d0"
      unitRef="usd">2532000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMy00LTEtMS0w_bea1157a-58f4-4718-9a9d-9e470705db49"
      unitRef="usd">516000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNS0yLTEtMS0w_5a66aff7-17e7-403a-aefb-dcb7a189589f"
      unitRef="usd">192000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNS00LTEtMS0w_026ff775-1530-4fa9-882f-c95d01a88b85"
      unitRef="usd">163000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNi0yLTEtMS0w_909dbb6f-4910-47ee-9979-45620573d47e"
      unitRef="usd">-111000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNi00LTEtMS0w_c32b91d3-49de-45e3-b4ff-513fc22167a0"
      unitRef="usd">-261000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNy0yLTEtMS0w_60f129ec-c9d9-4ca7-bce0-a88630ba7684"
      unitRef="usd">-306000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfNy00LTEtMS0w_f70dc7a2-1877-4900-bb12-cd771a759088"
      unitRef="usd">866000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfOC0yLTEtMS0w_8d7aaea5-263f-4105-b0d5-4032dadfea92"
      unitRef="usd">108000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfOC00LTEtMS0w_bb303773-af2d-4f75-a37f-d735b7733f22"
      unitRef="usd">221000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTAtMi0xLTEtMA_437e4d79-19c6-4128-90c4-a91b1eaa2e23"
      unitRef="usd">-202000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTAtNC0xLTEtMA_7d3dc172-cc4e-4719-8a33-151e2b164040"
      unitRef="usd">-1327000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTEtMi0xLTEtMzc2OQ_36631cab-5253-473c-ac5b-bae778d00ea0"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTEtNC0xLTEtMjQ0OA_9d5fb701-26d3-4a1e-ba3e-c394b1876f2f"
      unitRef="usd">4500000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:RestructuringCosts
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTItMi0xLTEtMA_203eb2db-9678-4d1e-94c6-758c945e0d79"
      unitRef="usd">-42000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTItNC0xLTEtMA_8b7a6c3c-1b99-494c-80ef-500e8624fc03"
      unitRef="usd">-33000000</us-gaap:RestructuringCosts>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTUtMi0xLTEtMA_23c1dfb0-f3a6-412e-b478-85b4a99fcdaf"
      unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTUtNC0xLTEtMA_9769c128-8c90-4a5f-8ac3-c4e69d81231f"
      unitRef="usd">21000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTYtMi0xLTEtMA_648efbbb-fc4a-4440-a370-f38cc9464532"
      unitRef="usd">-136000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTYtNC0xLTEtMA_24f7bdf3-8e4f-470d-a763-e1acef2d9281"
      unitRef="usd">-147000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTctMi0xLTEtMA_8c796d3e-76ea-46c0-bcea-24c5e567c5bc"
      unitRef="usd">24000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTctNC0xLTEtMA_08ac022d-b847-4590-957f-6517231bbb4e"
      unitRef="usd">-157000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTgtMi0xLTEtMA_5cc3f1a8-f074-40ec-be54-e0807f6ae114"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTgtNC0xLTEtMA_675f608f-e9be-4bb0-b01d-1937175d2ec3"
      unitRef="usd">174000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTktMi0xLTEtMA_226cfea1-b155-4efd-8bde-2536e155be5f"
      unitRef="usd">504000000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMTktNC0xLTEtMA_cee50f82-4a75-4761-a2e1-f30a515b72c1"
      unitRef="usd">359000000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <mo:IncreaseDecreaseInSettlementPayable
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjAtMi0xLTEtMA_557fc222-ba64-4e9a-aa7e-6ea5ad920bad"
      unitRef="usd">-140000000</mo:IncreaseDecreaseInSettlementPayable>
    <mo:IncreaseDecreaseInSettlementPayable
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjAtNC0xLTEtMA_8dabc6d7-5166-41c3-acde-f6f8f3cc7d0a"
      unitRef="usd">-360000000</mo:IncreaseDecreaseInSettlementPayable>
    <us-gaap:PensionAndOtherPostretirementBenefitContributions
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjEtMi0xLTEtMA_2cbd41dc-26ea-46c0-9987-7fb17ee1397f"
      unitRef="usd">16000000</us-gaap:PensionAndOtherPostretirementBenefitContributions>
    <us-gaap:PensionAndOtherPostretirementBenefitContributions
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjEtNC0xLTEtMA_007df296-e28b-41f1-8050-51bab85532b1"
      unitRef="usd">51000000</us-gaap:PensionAndOtherPostretirementBenefitContributions>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjItMi0xLTEtMA_7a473e02-f135-4914-bcea-59948fa0b361"
      unitRef="usd">-35000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjItNC0xLTEtMA_e97ee8c8-086b-4dc2-8491-383c96fa6740"
      unitRef="usd">-42000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjMtMi0xLTEtMA_12364489-6954-45d0-b62b-c2c2ad6ec365"
      unitRef="usd">591000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjMtNC0xLTEtMA_0230745f-9e94-444f-b79f-13ea3699d179"
      unitRef="usd">376000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjQtMi0xLTEtMA_f793873a-cf72-4e2d-b3f6-dacdaee581c8"
      unitRef="usd">5844000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjQtNC0xLTEtMA_647fd7ac-67db-48a4-b87f-28be7e9a7c99"
      unitRef="usd">5274000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjYtMi0xLTEtMA_697da6ff-6d8c-454d-a751-442c74f1a573"
      unitRef="usd">162000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjYtNC0xLTEtMA_bc6a0641-0eaf-45b6-a713-0c2f2d741bff"
      unitRef="usd">160000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <mo:PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjctMi0xLTEtMA_f1d7a3b8-c6e6-4342-ae16-e352a1b9f36f"
      unitRef="usd">0</mo:PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities>
    <mo:PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjctNC0xLTEtMA_d4fd6bfb-de6e-49f0-945b-cfe424ccbe41"
      unitRef="usd">1863000000</mo:PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities>
    <mo:PaymentsToAcquireBusinessesAndAssets
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjgtMi0xLTEtMA_8874725b-a1d5-41d5-b3ee-def56fa8a84b"
      unitRef="usd">0</mo:PaymentsToAcquireBusinessesAndAssets>
    <mo:PaymentsToAcquireBusinessesAndAssets
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMjgtNC0xLTEtMA_bbaaaa12-04fe-470b-a8f2-14131fe0cafe"
      unitRef="usd">421000000</mo:PaymentsToAcquireBusinessesAndAssets>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMzEtMi0xLTEtMA_c6021888-e7fc-4c0e-8214-dbb1ee6ff87f"
      unitRef="usd">-55000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMzEtNC0xLTEtMA_71d68403-22c0-486e-9c65-df2f3d0ebd38"
      unitRef="usd">-32000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMzItMi0xLTEtMA_7869c579-8d12-4ed4-b66f-d96b78726ddb"
      unitRef="usd">-107000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjZjNzYzN2Y5NzQxMjQxMmY5ODI4YTRiYjgxZjg0OGZhL3RhYmxlcmFuZ2U6NmM3NjM3Zjk3NDEyNDEyZjk4MjhhNGJiODFmODQ4ZmFfMzItNC0xLTEtMA_0d6193cf-fe2e-4cdd-aa79-0c3799c1d30c"
      unitRef="usd">-2412000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMy0yLTEtMS0w_5df41593-14c6-4b20-bf29-e5c58f8fba73"
      unitRef="usd">3000000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMy00LTEtMS0w_b7d886f9-f458-400f-a841-909aa3d74247"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNC0yLTEtMS0w_4b4cdaa7-11be-41c2-96ce-17be9efdbd01"
      unitRef="usd">3000000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNC00LTEtMS0w_e30f21db-ae75-4916-8565-1f070a2fe367"
      unitRef="usd">12800000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNS0yLTEtMS0w_d0fdf83e-8410-45a6-a80a-56e9a7c1e32f"
      unitRef="usd">1993000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNS00LTEtMS0w_a4cc487a-4191-4819-a6fb-14a0670950f4"
      unitRef="usd">16265000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNi0yLTEtMS0w_821b288c-b484-43a3-83d4-ee60ec23618e"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNi00LTEtMS0w_bf01b047-3cce-42a5-b733-9b3c2a8705b4"
      unitRef="usd">1144000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNy0yLTEtMS0w_601a3d3f-38b7-4536-9db2-7e5d664da481"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfNy00LTEtMS0w_d8f92e5b-c20f-42ac-87e9-103459b0fe57"
      unitRef="usd">346000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfOC0yLTEtMS0w_a00d28a3-56e3-4139-ac15-e04af22a8b32"
      unitRef="usd">4690000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfOC00LTEtMS0w_36627edb-43ee-43e1-b9a4-4339fcc9517c"
      unitRef="usd">4498000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTItMi0xLTEtMA_b92610f4-8f36-4e69-8f72-a4d73b5c6296"
      unitRef="usd">-16000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTItNC0xLTEtMA_f7d78f85-fbd3-4cc5-864c-dd4eabe57f9f"
      unitRef="usd">-127000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTMtMi0xLTEtMA_922286d2-9452-4211-b461-50498d96a06f"
      unitRef="usd">-3713000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTMtNC0xLTEtMA_20212dd6-ab86-4483-8974-f79287cc1be7"
      unitRef="usd">-2650000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTUtMi0xLTEtMA_84cb9016-f09a-4736-9650-89bb4ed51c24"
      unitRef="usd">2024000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTUtNC0xLTEtMA_064d8866-7da0-41ec-adb6-b1743171445b"
      unitRef="usd">212000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTYtMi0xLTEtMA_f369fb74-9ad1-4b48-afe1-26298562f077"
      unitRef="usd">2160000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9fdefa86b95345148bfdd3202813cfe1_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTYtNC0xLTEtMA_e8f24368-bd18-4475-a984-6411d67b3e21"
      unitRef="usd">1433000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTctMi0xLTEtMA_651c41b2-b93d-4a31-8ff3-aaae200e1200"
      unitRef="usd">4184000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idd09282688b34d21a437df741d91f326_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMTctNC0xLTEtMA_445f5976-2849-4f41-b727-fa52fcd55539"
      unitRef="usd">1645000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjEtMi0xLTEtMA_cf5245d2-ddb9-466a-a94c-81d1f3cd36b0"
      unitRef="usd">4123000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjEtNC0xLTEtMA_a65fa8f8-4199-4a9c-a515-aa6e3005ca0b"
      unitRef="usd">2117000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItMi0xLTEtMA_8b2de181-c594-4861-82f2-16775637f7aa"
      unitRef="usd">1000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItNC0xLTEtMA_fb9e1f1b-6613-49b9-a770-61217d261122"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtMi0xLTEtMA_7c50127c-8405-4552-83d6-3a0c8f1f729a"
      unitRef="usd">60000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtNC0xLTEtMA_f860a248-690d-4c89-b56c-5007bb75c513"
      unitRef="usd">43000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjQtMi0xLTEtMA_3ff3207c-7f74-401f-b61f-002fe7d0eb55"
      unitRef="usd">4184000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjQtNC0xLTEtMA_e151c54e-eb13-45d1-b774-2c3d07219c4f"
      unitRef="usd">2160000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMTg2OTE2OTc2ODA1OTY_050dfdac-663a-4c0e-aefa-0a1378605a70">Background and Basis of Presentation:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Background &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;When used in these notes, the term "Altria&#x201d; refers to Altria Group, Inc. and its subsidiaries, unless otherwise specified or unless otherwise required.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, Altria Group, Inc.&#x2019;s wholly owned subsidiaries included Philip Morris USA Inc. (&#x201c;PM USA&#x201d;), which is engaged in the manufacture and sale of cigarettes in the United States (including super premium cigarettes previously manufactured and sold by Sherman Holdings, LLC and its subsidiaries (&#x201c;Nat Sherman&#x201d;)); John Middleton Co. (&#x201c;Middleton&#x201d;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA;  UST LLC (&#x201c;UST&#x201d;), which through its wholly owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (&#x201c;USSTC&#x201d;) and Ste. Michelle Wine Estates Ltd. (&#x201c;Ste. Michelle&#x201d;), is engaged in the manufacture and sale of moist smokeless tobacco (&#x201c;MST&#x201d;) and snus products and wine; and Philip Morris Capital Corporation (&#x201c;PMCC&#x201d;), which maintains a portfolio of finance assets, substantially all of which are leveraged leases.  In addition, Altria owned an 80% interest in Helix Innovations LLC (&#x201c;Helix&#x201d;), which is engaged in the manufacture and sale of oral nicotine pouches.  Other Altria wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries.  Altria&#x2019;s access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  At September&#160;30, 2020, Altria&#x2019;s significant wholly owned subsidiaries were not limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, Altria had a 10.0% ownership in Anheuser-Busch InBev SA/NV (&#x201c;ABI&#x201d;), which Altria accounts for under the equity method of accounting using a one-quarter lag.  Altria receives cash dividends on its interest in ABI and will continue to do so as long as ABI pays dividends. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, Altria had a 35% economic interest in JUUL Labs, Inc. (&#x201c;JUUL&#x201d;), which Altria accounts for as an investment in an equity security.  JUUL is engaged in the manufacture and sale of e-vapor products in the U.S. and certain international markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2019, Helix acquired Burger S&#xf6;hne Holding and its subsidiaries as well as certain affiliated companies (the &#x201c;Burger Group&#x201d;) that are engaged in the manufacture and sale of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;on!&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; oral nicotine pouches.  At closing, Altria indirectly owned an 80% interest in Helix, for which Altria paid $353 million in third quarter of 2019.  The financial results of Helix are included in Altria&#x2019;s condensed consolidated financial statements as part of its oral tobacco products segment (formerly smokeless products segment), with the 20% minority ownership interest in Helix (held by the former shareholders of the Burger Group) included as a non-controlling interest.  The purchase price allocation has been completed, and there were no changes subsequent to the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, Altria had a 44% ownership in Cronos Group Inc. (&#x201c;Cronos&#x201d;), a global cannabinoid company headquartered in Toronto, Canada, which Altria accounts for under the equity method of accounting using a one-quarter lag. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For further discussion of Altria&#x2019;s investments in equity securities, see Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends and Share Repurchases &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, Altria&#x2019;s Board of Directors (the &#x201c;Board of Directors&#x201d;) declared a 2.4% increase in the quarterly dividend rate to $0.86 per share of Altria common stock versus the previous rate of $0.84 per share.  The current annualized dividend rate is $3.44.  Future dividend payments remain subject to the discretion of the Board of Directors.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2018, the Board of Directors authorized a $1.0 billion share repurchase program that it expanded to $2.0 billion in May 2018 (as expanded, the &#x201c;January 2018 share repurchase program&#x201d;).  In June 2019, Altria completed the January 2018 share &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;repurchase program, under which it purchased a total of 34.0 million shares of its common stock at an average price of $58.86 per share. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, the Board of Directors authorized a $1.0 billion share repurchase program (the &#x201c;July 2019 share repurchase program&#x201d;).  In April 2020, the Board of Directors rescinded the $500 million remaining in this program as part of Altria&#x2019;s efforts to enhance its liquidity position in response to the COVID-19 pandemic.  There were no share repurchases made in 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:15.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s 2019 share repurchase activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interim condensed consolidated financial statements of Altria are unaudited.  It is the opinion of Altria&#x2019;s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain immaterial prior year amounts have been reclassified to conform with the current year&#x2019;s presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These statements should be read in conjunction with Altria&#x2019;s audited consolidated financial statements and related notes, which appear in Altria&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2020, Altria began complying early, as permitted, with Regulation S-X Rules 13-01 and 13-02 regarding the financial disclosure requirements for registered debt securities with subsidiary guarantees.  On October 23, 2020, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-09,  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt (Topic 470): Amendments to SEC Paragraphs Pursuant to SEC Release No. 33-10762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to reflect changes the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) has made to its disclosure rules on guaranteed debt securities offerings.  The new rules replace the previously required condensed consolidating financial information with summarized financial information of the issuer and the guarantor and, among other things, require expanded qualitative disclosures.  Altria has elected to provide this information in the Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations section in its Quarterly Report on Form 10-Q as permitted by the new rules.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2020, Altria adopted ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and all related ASU amendments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(collectively &#x201c;ASU No. 2016-13&#x201d;).  This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity&#x2019;s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses.  The adoption of ASU No. 2016-13 did not have a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU No. 2018-15&#x201d;).  This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license).  The adoption of ASU No. 2018-15 did not have a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Accounting Guidance Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i52d5750b3f6b4059b628cc5c6120ffb1_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMjE5OTAyMzI2Mzc1Mw_4050bdd6-76a1-454e-8766-654b0bb25eef"
      unitRef="number">0.80</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMjIzNQ_1350fda7-8542-4496-822c-c69a2a16fc27"
      unitRef="number">0.100</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMjUxMQ_2bc1443a-0ac3-4209-b010-3a96a4b98878"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="iacac7d034158497ea761b6128d276bc9_I20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzAwNA_75251fbd-859e-418f-89ee-1a612c9fcdf3"
      unitRef="number">0.80</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i96e18cf03e374d0e8e09d680fdb0eb63_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzA0OA_f8fafd0e-609e-4bc7-ae67-b5da64ed665c"
      unitRef="usd">353000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i52d5750b3f6b4059b628cc5c6120ffb1_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzI3MQ_7e2ee29b-5024-4496-ba00-74fff9a38ea7"
      unitRef="number">0.20</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzUxODQzNzIwOTgzMzE_dffbad4c-bf74-454b-af91-008bab9ac1ea"
      unitRef="number">0.44</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:CommonStockDividendRatePercentageIncrease
      contextRef="i071cc6de3a8a4d14b919af0f81bed549_D20200701-20200731"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfMzk4Nw_0b993bca-6ca0-4fcb-aba0-9324f683aa3b"
      unitRef="number">0.024</mo:CommonStockDividendRatePercentageIncrease>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i071cc6de3a8a4d14b919af0f81bed549_D20200701-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDAzMw_7699ca7b-38d4-4873-a083-728eb998a18d"
      unitRef="usdPerShare">0.86</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i193bdf7d0e214572a3f99ff6320d3da9_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDA5Nw_ac170d2a-92ae-4fb7-830e-bc33a1f23d6a"
      unitRef="usdPerShare">0.84</us-gaap:CommonStockDividendsPerShareDeclared>
    <mo:CommonStockDividendRateAnnualPerShare
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDE1Mg_2d8e15f8-8080-4bde-9624-b7789e9fe8b5"
      unitRef="usdPerShare">3.44</mo:CommonStockDividendRateAnnualPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i0eccbcc083c844ac8c436b9f78601a58_I20180131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDMzMg_39d6a615-b147-4dd1-b8cf-6940fea46c92"
      unitRef="usd">1000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ia217b44568db4f7bab6aa96e06106ae0_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDM4MA_76520363-d7b0-4d3b-983b-969d5a26eac7"
      unitRef="usd">2000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6a66e6dc6fc14f578f3db7088eb5c228_D20180101-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDU2Ng_ea2bba61-4c24-4246-87ea-7e9384ec272c"
      unitRef="shares">34000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i6a66e6dc6fc14f578f3db7088eb5c228_D20180101-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDYxOQ_05db92ff-8a84-4b1b-a3b7-a8723c927729"
      unitRef="usdPerShare">58.86</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ica759e56c7514b8ba6b11550c9f189e7_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDY4NQ_21a453cd-f2c7-4b70-b6a5-1d86d65fabb9"
      unitRef="usd">1000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <mo:StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount
      contextRef="i0268f17a4fd248279ae397980a380ee7_I20200430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDgxMA_86f959a6-711b-45bf-9408-cf432471677d"
      unitRef="usd">500000000</mo:StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9b7cdb52d8b648f0ae0d6f3123ee3585_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfNDkyMA_c9fcd3e9-e3dc-479f-b520-212e97cab412"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfODE5MQ_e38defcf-00f5-4aa0-b4cb-68d2b95ad164">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s 2019 share repurchase activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic2a909e9cbdb4c8d915bced44fe70c76_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMS0yLTEtMS0w_836feeb7-1e1d-45aa-b5ea-2606dc46775a"
      unitRef="shares">6400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i19988383bb3043e881752078a8364530_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMS02LTEtMS0w_af212298-7f89-442a-b038-fe44970f2610"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic2a909e9cbdb4c8d915bced44fe70c76_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMi0yLTEtMS0w_4e1e85a3-4c95-429e-a140-c1df1de03978"
      unitRef="usd">346000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i19988383bb3043e881752078a8364530_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMi02LTEtMS0w_300a9461-2565-470a-979c-c8146e2892c1"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ic2a909e9cbdb4c8d915bced44fe70c76_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMy0yLTEtMS0w_a1622bc1-8a56-4d43-8dbd-07548247c621"
      unitRef="usdPerShare">54.36</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i19988383bb3043e881752078a8364530_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RhYmxlOmI3ZWRjNTg2MzgzZDRkNTQ5MjA2NDg1NWU1ODcyNTM5L3RhYmxlcmFuZ2U6YjdlZGM1ODYzODNkNGQ1NDkyMDY0ODU1ZTU4NzI1MzlfMy02LTEtMS0w_cf99d833-af2c-4a20-8914-f624c1d1f896"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80MC9mcmFnOjkyMDJkOGRjMmEwODQ2NzBhMzlhNjE5NjQ1N2UzNjJiL3RleHRyZWdpb246OTIwMmQ4ZGMyYTA4NDY3MGEzOWE2MTk2NDU3ZTM2MmJfODE4NQ_369b0d9c-75b6-441a-abe8-97dfe4034a56">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2020, Altria began complying early, as permitted, with Regulation S-X Rules 13-01 and 13-02 regarding the financial disclosure requirements for registered debt securities with subsidiary guarantees.  On October 23, 2020, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-09,  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt (Topic 470): Amendments to SEC Paragraphs Pursuant to SEC Release No. 33-10762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to reflect changes the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) has made to its disclosure rules on guaranteed debt securities offerings.  The new rules replace the previously required condensed consolidating financial information with summarized financial information of the issuer and the guarantor and, among other things, require expanded qualitative disclosures.  Altria has elected to provide this information in the Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations section in its Quarterly Report on Form 10-Q as permitted by the new rules.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2020, Altria adopted ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and all related ASU amendments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(collectively &#x201c;ASU No. 2016-13&#x201d;).  This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity&#x2019;s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses.  The adoption of ASU No. 2016-13 did not have a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU No. 2018-15&#x201d;).  This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license).  The adoption of ASU No. 2018-15 did not have a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.232%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect on Financial Statements &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2019-12 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Simplifying the Accounting for Income Taxes (Topic 740)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. &lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2020-01 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. &lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;s Own Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTg2OTE2OTc2NzYzMTM_94c796ad-07aa-469a-b340-34543243b9d3">Revenues from Contracts with Customers:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria disaggregates net revenues based on product type.  For further discussion, see Note 9. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s businesses offer cash discounts to customers for prompt payment and calculate cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms.  Altria&#x2019;s businesses record an allowance for cash discounts, which is included as a contra-asset against receivables on Altria&#x2019;s condensed consolidated balance sheets.  Cash discounts at September&#160;30, 2020 and December&#160;31, 2019 were de minimis, and there were no differences between amounts recorded as an allowance for cash discounts and cash discounts subsequently given to customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s businesses that receive payments in advance of product shipment record such payments as deferred revenue.  These payments are included in other accrued liabilities on Altria&#x2019;s condensed consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue was $250 million and $362 million at September&#160;30, 2020 and December&#160;31, 2019, respectively.  When cash is received in advance of product shipment, Altria&#x2019;s businesses satisfy their performance obligations within three days of receiving payment.  At September&#160;30, 2020 and December&#160;31, 2019, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables, which primarily reflect sales of wine produced and/or distributed by Ste. Michelle, were $151 million and $152 million at September&#160;30, 2020 and December&#160;31, 2019, respectively.  At September&#160;30, 2020 and December&#160;31, 2019, there were no expected differences between amounts recorded and subsequently received, and Altria&#x2019;s businesses did not record an allowance for doubtful accounts against these receivables.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria&#x2019;s condensed consolidated balance sheets.  While all of Altria&#x2019;s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC&#x2019;s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC&#x2019;s MST and snus products.  Altria&#x2019;s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  Altria&#x2019;s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on Altria&#x2019;s condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, Altria&#x2019;s businesses do not record an asset for their right to recover goods from customers upon return.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales incentives include variable payments related to goods sold by Altria&#x2019;s businesses.  Altria&#x2019;s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Price promotion payments- &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s businesses make price promotion payments, substantially all of which are made to their retail partners, to incent the promotion of certain product offerings in select geographic areas. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wholesale and retail participation payments-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Altria&#x2019;s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business&#x2019;s trade agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on Altria&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTAyMA_0954771d-cc08-4401-8c31-2448c9701f4f"
      unitRef="usd">250000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTAyNw_cb6df361-a24a-495b-95b3-ff53039eb067"
      unitRef="usd">362000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTE3OA_93237773-b1cb-4f08-8aaf-d3e17bb769ae">three days</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTQ0MA_fa55f202-0811-4bb9-af5a-a935efc59842"
      unitRef="usd">151000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl80Ni9mcmFnOjQ5NjIxODY4MGUxNzRkM2ZhMmU1OWJlMTU2NjkxMGU4L3RleHRyZWdpb246NDk2MjE4NjgwZTE3NGQzZmEyZTU5YmUxNTY2OTEwZThfMTQ0Nw_a81cf03f-3b73-41fd-9c06-685d58200513"
      unitRef="usd">152000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMTg2OTE2OTc2NzYwMTY_2fe4de01-a60e-40db-9bf0-cf0d587cd23b">Asset Impairment, Exit and Implementation Costs:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax asset impairment, exit and implementation costs consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:right"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Implementation Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset Impairment and Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Implementation Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus amounts included in net periodic benefit income, excluding &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;service cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Included in cost of sales in Altria&#x2019;s condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Included in cost of sales ($1 million cost reversal) and marketing, administration and research costs ($26 million) in Altria&#x2019;s condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Represents curtailment costs.  See Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Implementation Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset Impairment and Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Implementation Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Included in cost of sales in Altria&#x2019;s condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Included in cost of sales ($1 million) and marketing, administration and research costs ($3 million) in Altria&#x2019;s condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Implementation costs for 2020 were related to Ste. Michelle&#x2019;s strategic reset as discussed below.  The 2019 pre-tax asset impairment, exit and implementation costs were primarily related to the cost reduction program announced in December 2018, which was completed in 2019.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash spent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Wine Business Strategic Reset&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Evolving adult consumer preferences have posed strategic challenges for Ste. Michelle, which has seen slowing growth in the wine category and increased inventory levels in recent periods.  Against a backdrop of product volume demand uncertainty and long-term non-cancelable grape purchase commitments, which have been further negatively impacted by government actions which restrict direct-to-consumer sales and on-premise sales and economic uncertainty surrounding the COVID-19 pandemic, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ste. Michelle experienced additional increases in inventory levels that at March 31, 2020 significantly exceeded long-term forecasted demand. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine and three months ended September 30, 2020, Ste. Michelle recorded pre-tax charges of $395 million and $1 million, respectively, which were included in cost of sales in Altria&#x2019;s condensed consolidated statements of earnings.  The charges consisted primarily of the following: (i) write-off of inventory ($292 million recorded in the first quarter of 2020) as Ste. Michelle no longer believes that the benefit of the blending and production plans for its inventory outweighs inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believes no longer have a future economic benefit ($100 million recorded in the first quarter of 2020).  The non-cancelable grape purchase commitments will continue to require cash payments as grape commitments are fulfilled over the next five years.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Given such uncertainty in economic conditions and product volume demand, as well as long-term supply-side contractual challenges, Altria and Ste. Michelle undertook a review of the wine business.  As a result, Altria and Ste. Michelle implemented a strategic reset in order to maximize Ste. Michelle&#x2019;s profitability and achieve improved long-term cash-flow generation.  This strategic reset includes: (i) an updated approach to forecasting demand; (ii) supply chain optimization; (iii) SKU rationalization to reduce the number of products and eliminate underperforming brands; and (iv) streamlining operations by reducing future capital expenditures, working capital requirements and ongoing operating costs. &lt;/span&gt;&lt;/div&gt;Ste. Michelle expects to record charges of approximately $20 million in 2020, consisting of inventory disposal costs and other charges.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMzU4Mw_7d2d100d-b3d1-4e87-97b9-5ed49bb5e37d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax asset impairment, exit and implementation costs consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:right"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Implementation Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset Impairment and Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Implementation Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus amounts included in net periodic benefit income, excluding &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;service cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Included in cost of sales in Altria&#x2019;s condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Included in cost of sales ($1 million cost reversal) and marketing, administration and research costs ($26 million) in Altria&#x2019;s condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Represents curtailment costs.  See Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Implementation Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset Impairment and Exit Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Implementation Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Included in cost of sales in Altria&#x2019;s condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Included in cost of sales ($1 million) and marketing, administration and research costs ($3 million) in Altria&#x2019;s condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i65a6568d2e72475ba89df5fcc752c87d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC00LTEtMS0w_d3ed3abb-ee8b-4247-8dd1-db2906731973"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i65a6568d2e72475ba89df5fcc752c87d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC02LTEtMS0w_1dd2ed34-a6e2-456b-a994-81a37cd61166"
      unitRef="usd">0</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i5c9cc8a9510f4a2382edf4448aedc3ca_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC04LTEtMS0w_fd16d78b-dbc0-4f20-b805-cefc9e7b8317"
      unitRef="usd">50000000</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i5c9cc8a9510f4a2382edf4448aedc3ca_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC0xMC0xLTEtMA_e435d38d-9231-4078-a6bb-2d3621281e6a"
      unitRef="usd">29000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i5c9cc8a9510f4a2382edf4448aedc3ca_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNC0xMi0xLTEtMA_7b14043d-dab5-4c71-b80d-a6d980b02819"
      unitRef="usd">79000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i414a3270f11947418d6c2125e509944a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS00LTEtMS0w_11c67e6e-d717-4f96-bff9-f13505c1e836"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i414a3270f11947418d6c2125e509944a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS02LTEtMS0w_4368455b-b692-4eb0-b8de-7fbf498cb866"
      unitRef="usd">0</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i4dae5a2ab67f4bb9bd50da276ee4860c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS04LTEtMS0w_af59264e-2499-413c-9c4e-9952f89b5d36"
      unitRef="usd">9000000</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i4dae5a2ab67f4bb9bd50da276ee4860c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS0xMC0xLTEtMA_481b4cca-e4ba-4287-bdea-97c5ecbda69f"
      unitRef="usd">3000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i4dae5a2ab67f4bb9bd50da276ee4860c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNS0xMi0xLTEtMA_63d3835d-f995-4316-9422-3f38393588b5"
      unitRef="usd">12000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i76c7d7d2fbc34685ae18727c4cd65f70_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi00LTEtMS0w_11fa4157-4c14-4e69-aec3-c75d6f1eb2b2"
      unitRef="usd">395000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i76c7d7d2fbc34685ae18727c4cd65f70_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi02LTEtMS0w_97f765ac-9924-44cb-856e-eeeedc798414"
      unitRef="usd">395000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i61784cf3f3fc455b92d1549db42be0cc_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi04LTEtMS0w_e68f6e8b-4b18-43fd-a3c4-7d19fe519dc4"
      unitRef="usd">0</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i61784cf3f3fc455b92d1549db42be0cc_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi0xMC0xLTEtMA_e4da0185-992a-4ac7-afe3-311d99936bf2"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i61784cf3f3fc455b92d1549db42be0cc_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNi0xMi0xLTEtMA_44934038-8463-47c1-8b46-3b95bcc1deb0"
      unitRef="usd">0</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i966e35b143ba4a7cbf9890b21f017d74_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy00LTEtMS0w_05c0b342-5778-4d15-a0e7-4a1b682b821d"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i966e35b143ba4a7cbf9890b21f017d74_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy02LTEtMS0w_69ccb17b-5c99-4f62-a588-694e348aad4b"
      unitRef="usd">0</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i513f9aefe4864f918aef77ec9b9464ca_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy04LTEtMS0w_c214da07-5d4e-4648-8c55-4ae5a0123372"
      unitRef="usd">14000000</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i513f9aefe4864f918aef77ec9b9464ca_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy0xMC0xLTEtMA_0e8981da-4def-4a71-a4ea-d1fa28c03122"
      unitRef="usd">-7000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i513f9aefe4864f918aef77ec9b9464ca_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfNy0xMi0xLTEtMA_76a999fe-8075-4998-8c7e-4f63391556ea"
      unitRef="usd">7000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC00LTEtMS0w_0ed93712-1eca-41bc-a999-7a2c9f730b7a"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC02LTEtMS0w_cbc70bdb-a8aa-43e1-97e3-81f6bb48d90b"
      unitRef="usd">0</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC04LTEtMS0w_100bac85-1cf7-4e98-a602-736eff7f2e2a"
      unitRef="usd">1000000</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC0xMC0xLTEtMA_5eeda246-9bfb-4e44-b337-85fcc0a60473"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOC0xMi0xLTEtMA_78d73fcb-89fd-4372-b91c-1ad90648cbc0"
      unitRef="usd">1000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS00LTEtMS0w_6701c392-e11e-4f58-8c18-e95a1a5ec4e0"
      unitRef="usd">395000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS02LTEtMS0w_42e44862-141f-4ac1-8950-603c7cc3a3a8"
      unitRef="usd">395000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS04LTEtMS0w_0034cb81-d480-40c4-b907-9e8e0dcc8a1f"
      unitRef="usd">74000000</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS0xMC0xLTEtMA_d6dd34eb-bba4-4942-a1b6-ab18f4a96b2c"
      unitRef="usd">25000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfOS0xMi0xLTEtMA_5ea6b742-7818-464e-a668-01d55b35d051"
      unitRef="usd">99000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtNC0xLTEtMA_eac5cffe-a49e-46fc-a333-c75e6ef906e6"
      unitRef="usd">0</mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts>
    <mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtNi0xLTEtMA_ddfbe43d-348f-4029-85b0-ee9b8e833f4b"
      unitRef="usd">0</mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges>
    <mo:NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtOC0xLTEtMA_0657c792-6bb4-47a9-b567-c7255f7c35d2"
      unitRef="usd">12000000</mo:NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts>
    <mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtMTAtMS0xLTA_0f0dcf51-2733-46d4-9cfb-e5bfcf24e10b"
      unitRef="usd">0</mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts>
    <mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTAtMTItMS0xLTA_b3e06410-315c-4f8a-86b5-cef13d175f56"
      unitRef="usd">12000000</mo:NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges>
    <us-gaap:OtherRestructuringCosts
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtNC0xLTEtMA_a4bed3d4-8b3b-425f-8083-c07c19bec6d1"
      unitRef="usd">395000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtNi0xLTEtMA_532b758c-63ae-4fb7-93e1-aeb449e9846d"
      unitRef="usd">395000000</us-gaap:RestructuringCharges>
    <mo:AssetImpairmentandBusinessExitCosts
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtOC0xLTEtMA_4ac380af-07b2-4d51-868e-56c49de9a2f3"
      unitRef="usd">86000000</mo:AssetImpairmentandBusinessExitCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtMTAtMS0xLTA_fc545758-aab6-43e0-bd11-c2c51e9f4bec"
      unitRef="usd">25000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjM0N2QzMGVkNjM2NDQ2ODc5OTQwOTVjNDJjYmY2MjEyL3RhYmxlcmFuZ2U6MzQ3ZDMwZWQ2MzY0NDY4Nzk5NDA5NWM0MmNiZjYyMTJfMTEtMTItMS0xLTA_17fe45a8-059d-4d30-ac50-7c059997a50c"
      unitRef="usd">111000000</us-gaap:RestructuringCharges>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i6b8c284910f9462da3a11aa8a2bdd9aa_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMjY1_34ab7bb8-17ef-4c4a-bc02-bd0a2e237ad6"
      unitRef="usd">-1000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i2db2f30e181740b58612f500d9f2221c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMzMz_7867a8b1-8d31-4837-adf9-33913c572841"
      unitRef="usd">26000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="iad12458b42414f73b54a930bd3423a7d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC0zLTEtMS0w_e610404c-6c96-479f-ae63-007cec295ae9"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="iad12458b42414f73b54a930bd3423a7d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC01LTEtMS0w_b9f6a132-48b9-4c41-adc4-3afab5507de9"
      unitRef="usd">0</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i7b301f3d97e7423587fd5da2e57c027d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC03LTEtMS0w_f975e278-eb89-443b-9de3-78717ca34baa"
      unitRef="usd">0</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i7b301f3d97e7423587fd5da2e57c027d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC05LTEtMS0w_892f3a7b-ea93-4fb7-bf6b-36d89e584236"
      unitRef="usd">4000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i7b301f3d97e7423587fd5da2e57c027d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNC0xMS0xLTEtMA_5c4ed204-c868-4427-83dc-775669c4e829"
      unitRef="usd">4000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i7138bb35916249cbb738270fd6fe93d7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS0zLTEtMS0w_c1ff3c6a-4d52-42af-a069-7246045bde33"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i7138bb35916249cbb738270fd6fe93d7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS01LTEtMS0w_1053704d-c817-44db-a464-22cc0df74a3b"
      unitRef="usd">0</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i21ce1a07a551424683dbafbcfa3df273_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS03LTEtMS0w_abd1caa9-ee0c-4f80-a2a5-266511dbd8c8"
      unitRef="usd">1000000</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i21ce1a07a551424683dbafbcfa3df273_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS05LTEtMS0w_0fedf376-4d83-4d3d-a5fb-43612a480671"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i21ce1a07a551424683dbafbcfa3df273_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNS0xMS0xLTEtMA_626c8ae1-bf17-42a8-ac72-4e31d534f21b"
      unitRef="usd">1000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="ic9cd0e274519474a97c80be2216cc392_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi0zLTEtMS0w_f33fc45a-6649-44f5-98d6-95958e6cf10f"
      unitRef="usd">1000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="ic9cd0e274519474a97c80be2216cc392_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi01LTEtMS0w_39ec64ed-b144-4665-bb38-3c46399c93ad"
      unitRef="usd">1000000</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit
      contextRef="i4296ad893da549f0938808b2978e8ff6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi03LTEtMS0w_ea569bbd-7ae8-4a0e-a4ee-a320cf83fb79"
      unitRef="usd">0</mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i4296ad893da549f0938808b2978e8ff6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi05LTEtMS0w_aa1c7e8a-9e36-4a97-abf8-a270c80df3da"
      unitRef="usd">0</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:RestructuringChargesIncludingNetPensionCostCredit
      contextRef="i4296ad893da549f0938808b2978e8ff6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfNi0xMS0xLTEtMA_570991fa-c23d-4e5b-b402-141c2ff61b27"
      unitRef="usd">0</mo:RestructuringChargesIncludingNetPensionCostCredit>
    <us-gaap:OtherRestructuringCosts
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS0zLTEtMS0w_a7f5583a-4841-4f09-8a78-757c79044780"
      unitRef="usd">1000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS01LTEtMS0w_614b9413-51fe-4883-bcd6-9c883ae9c950"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <mo:AssetImpairmentandBusinessExitCosts
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS03LTEtMS0w_a3b7222f-203d-4d29-84be-8b96440193d2"
      unitRef="usd">1000000</mo:AssetImpairmentandBusinessExitCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS05LTEtMS0w_f9b9afee-0b8b-4605-af37-c59b21424267"
      unitRef="usd">4000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOmE2MGRjMjQ1NGIwNzRkZmFhODRmOGU2N2M2YTE3NTZhL3RhYmxlcmFuZ2U6YTYwZGMyNDU0YjA3NGRmYWE4NGY4ZTY3YzZhMTc1NmFfOS0xMS0xLTEtMA_a0da3b07-3a81-4e34-a714-1f2e80630f11"
      unitRef="usd">5000000</us-gaap:RestructuringCharges>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="id587ee8978da4dd9bfa35f34f890d144_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfNTc1_e17329d9-bbc0-4f1d-a651-3d213bed92fb"
      unitRef="usd">1000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <mo:OtherRestructuringCostsIncludingNetPensionCostCredit
      contextRef="i4076276bf701434cafde95786366cd18_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfNjQz_52ce203d-72b6-451c-97e6-d6ef5ed307c0"
      unitRef="usd">3000000</mo:OtherRestructuringCostsIncludingNetPensionCostCredit>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMzYwNA_0595a41a-b47d-4fb9-8022-7663e5eae6ff">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash spent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjVmMDM1ZjAzZDZiMDRlNmI5ZTEwMTVmYmFmNGYzMjdhL3RhYmxlcmFuZ2U6NWYwMzVmMDNkNmIwNGU2YjllMTAxNWZiYWY0ZjMyN2FfMS0xLTEtMS0w_02312625-0dc7-4d7b-b0be-7a2c5f8e8e4a"
      unitRef="usd">67000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjVmMDM1ZjAzZDZiMDRlNmI5ZTEwMTVmYmFmNGYzMjdhL3RhYmxlcmFuZ2U6NWYwMzVmMDNkNmIwNGU2YjllMTAxNWZiYWY0ZjMyN2FfMi0xLTEtMS0w_e326837d-60c4-461b-b7bd-63b69f53b686"
      unitRef="usd">0</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjVmMDM1ZjAzZDZiMDRlNmI5ZTEwMTVmYmFmNGYzMjdhL3RhYmxlcmFuZ2U6NWYwMzVmMDNkNmIwNGU2YjllMTAxNWZiYWY0ZjMyN2FfMy0xLTEtMS0w_65af6721-17a4-4b2a-88cf-2e9a3ca86bab"
      unitRef="usd">42000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RhYmxlOjVmMDM1ZjAzZDZiMDRlNmI5ZTEwMTVmYmFmNGYzMjdhL3RhYmxlcmFuZ2U6NWYwMzVmMDNkNmIwNGU2YjllMTAxNWZiYWY0ZjMyN2FfNC0xLTEtMS0w_1effd47a-d969-49a8-a40b-ddd480a703e9"
      unitRef="usd">25000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ia7474f88612244c1b64f1822399d6fb5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMTg5Mw_217782bf-33cb-47ee-9f23-6f72946f8844"
      unitRef="usd">395000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib0d8a29fd04b4af1b5328f9a73ce53e9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMTkwMA_d5e97ea1-8b11-4e30-9c00-779784d11acd"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i75b30cbed6b345b390d2b06e4121969e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMjA4Mg_3f26ab7f-0f67-41bc-9af3-3a2131f6300e"
      unitRef="usd">292000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iddfa3fe8e4ab41d696ebeee595b37982_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMjQ1MQ_a1e797ef-1942-46b8-b4e8-705691071968"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:LongtermPurchaseCommitmentPeriod
      contextRef="i41086d5eceba4b10be60ded534b538d4_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMjcyNw_cfbb40e4-0026-4adc-85e6-1d6e48f4b41c">P5Y</us-gaap:LongtermPurchaseCommitmentPeriod>
    <us-gaap:RestructuringCharges
      contextRef="i45fce82014e048088ddb663834e5b226_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl81Mi9mcmFnOjdiMmZlNjIyZDdmZDQzMGI4OGU1NjllZTAxNDg1Nzg3L3RleHRyZWdpb246N2IyZmU2MjJkN2ZkNDMwYjg4ZTU2OWVlMDE0ODU3ODdfMzUxMw_a13d7622-fb1c-4412-868e-a5822e6564c0"
      unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <us-gaap:InvestmentTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfODc5NjA5MzAyODQxNA_4d4f15b6-1412-450c-a80b-1c2b1a1a20ec">Investments in Equity Securities:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s investments consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; September 30, 2020 includes Altria&#x2019;s equity method investment in Cronos ($986 million), the Cronos warrant ($86 million) and the Fixed-price Preemptive Rights ($15 million) and December 31, 2019 includes Altria&#x2019;s equity method investment in Cronos ($1,002 million), the Cronos warrant ($234 million) and the Fixed -price Preemptive Rights ($69 million), as discussed further below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings (losses) from equity investments accounted for under the equity method of accounting consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt; At September 30, 2020 Altria recorded pre-tax losses associated with its share of ABI&#x2019;s completion of the sale of its Australia subsidiary and ABI&#x2019;s goodwill impairment charge associated with its Africa businesses.  These amounts include Altria&#x2019;s share of amounts recorded by ABI in its second quarter of 2020, as well as additional adjustments related to (i) conversion from international financial reporting standards to United States generally accepted accounting principles, and (ii) adjustments to Altria&#x2019;s investment required under the equity method of accounting.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value.  If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements.  If this qualitative assessment indicates that Altria&#x2019;s investment in JUUL may be impaired, a quantitative assessment is performed.  If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in ABI&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, Altria had a 10.0% ownership in ABI, consisting of 185 million restricted shares of ABI (the &#x201c;Restricted Shares&#x201d;) and 12 million ordinary shares of ABI.  Altria&#x2019;s ownership percentage decreased from 10.1% at March 31, 2020 due to the issuance of additional shares by ABI.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#x2019;s board of directors and certain ABI board committees.  Through this representation, Altria participates in ABI policy making processes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria reports its share of ABI&#x2019;s results using a one-quarter lag because ABI&#x2019;s results are not available in time for Altria to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Altria&#x2019;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#x2019;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares.  In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Altria&#x2019;s equity investment in ABI at September&#160;30, 2020 and December&#160;31, 2019 was $10.7 billion (carrying value of $16.7 billion) and $16.1 billion (carrying value of $18.1 billion), respectively, which was less than its carrying value by approximately 36% and 11%, respectively.  In October 2019, the fair value of Altria&#x2019;s equity investment in ABI declined below its carrying value and has not recovered.  Altria has evaluated the factors related to the fair value decline, including the recent impact on the fair value of ABI&#x2019;s shares amidst the COVID-19 pandemic.  The economic uncertainties of the COVID-19 pandemic have also impacted ABI&#x2019;s business.  Altria has evaluated the duration and magnitude of the fair value decline at September 30, 2020, ABI&#x2019;s financial condition and near-term prospects, and Altria&#x2019;s intent and ability to hold its investment in ABI until recovery.  Altria concluded, both at September 30, 2020 and December 31, 2019, that the decline in fair value of its investment in ABI below its carrying value was temporary and, therefore, no impairment was recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in JUUL&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2018, Altria made a minority investment in JUUL for $12.8 billion.  In exchange for the investment, Altria received a 35% economic interest in JUUL through non-voting shares, which are convertible at Altria&#x2019;s election into voting shares (&#x201c;Share Conversion&#x201d;), and for no additional payment, a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#x201c;JUUL Transaction&#x201d;).  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its 35% interest.  Furthermore, Altria agreed not to sell or transfer any of its JUUL shares until December 20, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 28, 2020, Altria and JUUL amended certain JUUL Transaction agreements and entered into a new cooperation agreement, which included the following provisions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Altria will continue to provide regulatory affairs support for JUUL&#x2019;s pursuit of its pre-market tobacco applications (&#x201c;PMTA&#x201d;) and/or its modified risk tobacco products authorization (&#x201c;MRTP&#x201d;) and discontinued all other services as of March 31, 2020;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Altria will have the option to be released from its non-compete obligation (i) in the event JUUL is prohibited by federal law from selling e-vapor products in the U.S. for a continuous period of at least 12 months (subject to tolling of this period in certain circumstances) or (ii) if the carrying value of Altria&#x2019;s investment in JUUL is not more than 10% of its initial carrying value of $12.8 billion;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Altria and JUUL agreed that for a period of one year they will not pursue any litigation against each other in connection with any conduct that occurred prior to the date of such cooperation agreement, with statutes of limitation being tolled during the one-year period; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;with respect to certain litigation in which Altria and JUUL are both defendants against third-party plaintiffs, Altria will not pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against Altria and JUUL; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;in the event of Share Conversion, JUUL will:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;restructure JUUL&#x2019;s current seven-member board of directors to a nine-member board that will include independent board members.  The new structure will include: (i) three independent directors (one of whom will be designated by Altria and two of whom will be designated by JUUL stockholders other than Altria) unanimously certified as independent by a nominating committee, which will include at least one Altria designee, (ii) two directors designated by Altria, (iii) three directors designated by JUUL stockholders other than Altria, and (iv) the JUUL Chief Executive Officer; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;create a Litigation Oversight Committee, which will include two Altria designated directors (one of whom will chair the Litigation Oversight Committee) that will have oversight authority and review of litigation management for matters in which JUUL and Altria are co-defendants and have or reasonably could have a written joint defense agreement in effect between them.  Subject to certain limitations, the Litigation Oversight Committee will recommend to JUUL changes to outside counsel and litigation strategy by majority vote, with disagreements by JUUL&#x2019;s management being resolved by majority vote of JUUL&#x2019;s board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2020, the U.S. Federal Trade Commission (&#x201c;FTC&#x201d;) issued an administrative complaint challenging Altria&#x2019;s investment in JUUL.  The FTC has not sought to preliminarily enjoin Altria from converting its non-voting JUUL shares to voting shares.  Altria has not converted its non-voting JUUL shares to voting shares and is considering whether to do so as well as which, if any, of its voting and governance rights to exercise if Altria does elect to effect such conversion.  Altria has until November 30, 2020 to convert its JUUL shares under the regulations of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (&#x201c;HSR Act&#x201d;), after which Altria would have to re-file for antitrust review with the FTC to again seek the ability to convert.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For further discussion on the FTC litigation, see Note 12. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies -&#160; Antitrust Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of Share Conversion, Altria expects to account for its investment in JUUL under the fair value option.  Under this option, Altria&#x2019;s consolidated statement of earnings will include any cash dividends received from its investment in JUUL as well as any changes in the fair value of the investment, which will be calculated quarterly. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020 and December&#160;31, 2019, Altria had a 35% economic interest in JUUL.  Altria accounted for its investment in JUUL as an investment in an equity security as of September&#160;30, 2020.  Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There have been no upward or downward adjustments to the carrying value of Altria&#x2019;s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;JUUL announced a strategic update in September 2020, which includes its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of Altria&#x2019;s financial statements for the period ended September 30, 2020, Altria performed its qualitative assessment of impairment indicators for its investment in JUUL and determined that JUUL&#x2019;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#x2019;s business prospects. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Given the existence of this impairment indicator, Altria performed a quantitative valuation of its investment in JUUL as of September 30, 2020 and recorded a non-cash pre-tax charge of $2.6 billion for the nine and three months ended September 30, 2020, reported as impairment of JUUL equity securities in its condensed consolidated statements of earnings.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The impairment charge was driven by Altria&#x2019;s projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of: (i) JUUL&#x2019;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, Altria recorded total non-cash pre-tax impairment charges of $8.6 billion ($4.5 billion in the third quarter of 2019 and $4.1 billion in the fourth quarter of 2019) related to its investment in JUUL resulting in a $4.2 billion carrying value of its investment in JUUL at December 31, 2019.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2019, Altria performed a qualitative assessment for impairment indicators and concluded that impairment indicators existed.  These indicators included significant adverse changes in both the e-vapor regulatory environment and the industry in which JUUL operates.  While there was no single determinative event or factor, Altria considered in totality the following indicators of impairment: the increased likelihood of a United States Food and Drug Administration (&#x201c;FDA&#x201d;) compliance policy prohibiting the sale of certain flavored e-vapor products in the U.S. market without a pre-market authorization; various e-vapor bans put in place by certain states and cities in the U.S. and in certain international markets, coupled with the increased potential for additional bans in the future; and the impact of heightened adverse publicity, including news reports and public health advisories concerning vaping-related lung injuries and deaths.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on its quantitative valuation of its investment in JUUL, the third-quarter 2019 impairment charge was due primarily to lower e-vapor sales volume assumptions in the U.S. and international markets and a delay in achieving operating margin performance as compared to the assumptions at the time of the JUUL Transaction, which resulted in a non-cash pre-tax charge of $4.5 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2019, Altria determined that a significant increase in the number of legal cases pending against JUUL in the fourth quarter of 2019 resulted in an additional indicator of impairment, which included a variety of class action lawsuits and personal injury claims, as well as cases brought by state attorneys general and local governments.  The fourth-quarter impairment charge resulted substantially from increased discount rates applied to future cash flow projections, due to the significant risk created by the increase in the number of legal cases pending against JUUL, which resulted in an additional non-cash pre-tax charge of $4.1 billion at December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria used an income approach to estimate the fair value of its investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.  Future cash flows were based on a range of scenarios that consider various potential regulatory and market outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the fair value of its investment in JUUL as of September 30, 2020, December 31, 2019 and September 30, 2019, Altria made various judgments, estimates and assumptions, the most significant of which were sales volume, operating margins, discount rates and perpetual growth rates.  Additionally, Altria made significant assumptions regarding the likelihood and extent of various potential regulatory actions and the continued adverse public perception impacting the e-vapor category and specifically JUUL, as well as expectations of competitive dynamics and the future state of the e-vapor category.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in Cronos&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, Altria completed its acquisition of:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;149.8 million newly issued common shares of Cronos (&#x201c;Acquired Common Shares&#x201d;), which represented a 45% economic and voting interest; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain its ownership percentage.  Certain of the anti-dilution protections provide Altria the ability to purchase additional Cronos common shares at a per share exercise price of Canadian dollar (&#x201c;CAD&#x201d;) $16.25 upon the occurrence of specified events (&#x201c;Fixed-price Preemptive Rights&#x201d;).  Based on Altria&#x2019;s assumptions as of September 30, 2020, Altria estimates the Fixed-price  Preemptive Rights allows Altria to purchase up to an additional approximately 35 million common shares of Cronos; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;a warrant providing Altria the ability to purchase up to an additional 10% of common shares of Cronos (approximately  79 million common shares at September 30, 2020) at a per share exercise price of CAD $19.00, which expires on March 8, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price for the Acquired Common Shares, Fixed-price Preemptive Rights and warrant (collectively, &#x201c;Investment in Cronos&#x201d;) was CAD $2.4 billion (U.S. dollar (&#x201c;USD&#x201d;) $1.8 billion).  Upon full exercise of the Fixed-price Preemptive Rights, to the extent such rights become available, and the warrant, Altria would own a maximum of 55% of the outstanding common shares of Cronos. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accounting for the acquisition of these assets as of the date of closing, the Fixed-price Preemptive Rights and warrant were recorded at each of their fair values using Black-Scholes option-pricing models, based on the assumptions described in Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  In addition, a deferred tax liability related to the Fixed-price Preemptive Rights and warrant was &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recorded.  The residual of the purchase price was allocated to the Acquired Common Shares.  Accordingly, the CAD $2.4 billion (USD $1.8 billion) purchase price was recorded in USD as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$1.2 billion to the warrant;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$0.5 billion to the Fixed-price Preemptive Rights; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$0.4 billion to the Acquired Common Shares; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$0.3 billion to a deferred tax liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $1.5 billion and CAD $0.6 billion (approximately USD $1.1 billion and $0.4 billion, respectively, based on the CAD to USD exchange rate on October 27, 2020). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a discussion of derivatives related to Altria&#x2019;s investment in Cronos, including Altria&#x2019;s accounting for changes in the fair value of these derivatives, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, Altria had a 44% ownership in Cronos, consisting of 156.6&#160;million shares, which Altria accounts for under the equity method of accounting.  Altria&#x2019;s ownership percentage decreased from 45% at June 30, 2020 due to the issuance of additional shares by Cronos.  Altria reports its share of Cronos&#x2019;s results using a one-quarter lag because Cronos&#x2019;s results are not available in time for Altria to record them in the concurrent period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria nominated four directors, including one director who is independent from Altria, who serve on Cronos&#x2019;s seven-member board of directors.&lt;/span&gt;&lt;/div&gt;The fair value of Altria&#x2019;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#x2019;s common shares and was classified in Level 1 of the fair value hierarchy.  The fair value of Altria&#x2019;s equity method investment in Cronos at September&#160;30, 2020 and December&#160;31, 2019 was $0.8 billion and $1.2 billion, respectively, compared with its carrying value of $1.0 billion at September&#160;30, 2020 and December&#160;31, 2019.  At September&#160;30, 2020, the fair value of Altria&#x2019;s equity method investment in Cronos was less than its carrying value by approximately 20%.  Based on Altria&#x2019;s evaluation of the duration and magnitude of the fair value decline, Altria&#x2019;s evaluation of Cronos&#x2019;s financial condition (including its strong cash position) and near-term prospects and Altria&#x2019;s intent and ability to hold its investment in Cronos until recovery, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded.</us-gaap:InvestmentTextBlock>
    <us-gaap:InvestmentTableTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNTI0OA_21a633d7-5680-45c2-b620-c7775852a59b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s investments consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; September 30, 2020 includes Altria&#x2019;s equity method investment in Cronos ($986 million), the Cronos warrant ($86 million) and the Fixed-price Preemptive Rights ($15 million) and December 31, 2019 includes Altria&#x2019;s equity method investment in Cronos ($1,002 million), the Cronos warrant ($234 million) and the Fixed -price Preemptive Rights ($69 million), as discussed further below.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfMy0yLTEtMS0w_ae34113a-c1ba-422b-b857-e507cb27b605"
      unitRef="usd">16716000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i5c9f46db82b544bca919d37b619fa3c6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfMy00LTEtMS0w_cbf2443a-bf87-474d-935d-54dfe0f5b133"
      unitRef="usd">18071000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNC0yLTEtMS0w_cd84a6ea-a958-4396-a7cb-08675d15877a"
      unitRef="usd">1605000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="icfc10374e49f4210b26d83818840cffa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNC00LTEtMS0w_1bf464ad-008d-4812-9a79-929d36189b77"
      unitRef="usd">4205000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNS0yLTEtMS0w_37f490da-4b0b-4bf9-8b43-14a52dfb3bb6"
      unitRef="usd">1087000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i2c602bc808fd43b3aa8af711c461d8bb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNS00LTEtMS0w_73a08134-2297-4ed1-998b-ab7a8b362b4e"
      unitRef="usd">1305000000</us-gaap:EquityMethodInvestments>
    <us-gaap:Investments
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNi0yLTEtMS0w_981b2675-2ec0-40f4-b7ac-41328a8acf73"
      unitRef="usd">19408000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOjZmMTU3NGIwNDUwNzQ3YjNiNDg3ZmYzZGYzZmYyMGIwL3RhYmxlcmFuZ2U6NmYxNTc0YjA0NTA3NDdiM2I0ODdmZjNkZjNmZjIwYjBfNi00LTEtMS0w_f249c7de-f122-455a-83e3-0400d114f28d"
      unitRef="usd">23581000000</us-gaap:Investments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia5ab87ccfd644d7bbd87a7f9d985ce3a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNjIy_ad58066c-fdc0-4390-a07c-ba8c69cd4a61"
      unitRef="usd">986000000</us-gaap:EquityMethodInvestments>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie3301a69f1fc4456bc6cd43d61e2358b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNjQ3_2d245a58-c50e-4604-85a1-8e68d3306aac"
      unitRef="usd">86000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3a07225f603b469a9e16277e68062cf2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNjkw_732e12cf-9a3a-423f-bf60-61e7ffe7fd49"
      unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:EquityMethodInvestments
      contextRef="i4baac6d362ff43e1a624d2ca9bd47b9a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNzcw_be780405-4f00-49c3-868f-90727b96c03a"
      unitRef="usd">1002000000</us-gaap:EquityMethodInvestments>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i94d483982eca44108fadfd7036741d3f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNzk1_37f97c6a-b8ce-4d07-85d0-79a0b94c7dd0"
      unitRef="usd">234000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia87b4f2ccfa44ef480a0166d44944b46_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfODM5_be8b831f-0060-465e-80ee-4b457b9e5e31"
      unitRef="usd">69000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNTI1Mw_52e2e6d7-2f8b-4c62-9e83-d9af819048ab">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings (losses) from equity investments accounted for under the equity method of accounting consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt; At September 30, 2020 Altria recorded pre-tax losses associated with its share of ABI&#x2019;s completion of the sale of its Australia subsidiary and ABI&#x2019;s goodwill impairment charge associated with its Africa businesses.  These amounts include Altria&#x2019;s share of amounts recorded by ABI in its second quarter of 2020, as well as additional adjustments related to (i) conversion from international financial reporting standards to United States generally accepted accounting principles, and (ii) adjustments to Altria&#x2019;s investment required under the equity method of accounting.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i44203766c22e443f90913f61f95be1a8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfMy0yLTEtMS0w_87a992aa-c0e1-4d15-923e-460af32bc085"
      unitRef="usd">-306000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i37c3480e95d1469da93a1e2056153e63_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfMy00LTEtMS0w_59616e2e-9337-4abb-82d4-6eab871bd45e"
      unitRef="usd">640000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib911f814538a479eb5056f3c19bfd6c3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfMy02LTEtMS0w_65f8b769-0ac3-45b1-9f87-524c6fae5f47"
      unitRef="usd">-418000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie496e5bcf31f4c2a9d472e2beb032d40_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfMy04LTEtMS0w_d606fd70-429d-4380-a25d-56793c744350"
      unitRef="usd">252000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if013f6bbc85345f1930ed240ff09ccf9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNC0yLTEtMS0w_f841deb5-b571-453a-bb02-663c77a1da9e"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i64cdb3928d7c4bc89feb76f18d5b07e5_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNC00LTEtMS0w_a618794f-abfe-4ca5-a2d1-bfa6491415f7"
      unitRef="usd">226000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3c252077957546b2880b8ef2724625a6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNC02LTEtMS0w_dab572b3-a863-48ca-96a3-535b4fc49c80"
      unitRef="usd">-54000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4f3984a7b55343788f33878623e29f88_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNC04LTEtMS0w_3ae33be8-97b5-4d24-a9c6-f43956183502"
      unitRef="usd">81000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNS0yLTEtMS0w_1cbc07d5-826a-4869-8fa4-31ab7052b6d2"
      unitRef="usd">-306000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNS00LTEtMS0w_93695126-cd1f-4ba2-a32f-5590098ff727"
      unitRef="usd">866000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNS02LTEtMS0w_9e6f3c88-e3ce-4afe-bf31-322b38090534"
      unitRef="usd">-472000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RhYmxlOmE1MzM1NzgxYzZkZTRmOWY5NTQ0NTA4ZTYxZmU2YWZhL3RhYmxlcmFuZ2U6YTUzMzU3ODFjNmRlNGY5Zjk1NDQ1MDhlNjFmZTZhZmFfNS04LTEtMS0w_804713f4-1209-4986-aed7-6c1ab27dbd01"
      unitRef="usd">333000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNTI1Ng_5413e16a-9c3b-4318-8aaf-14ef89059224">Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value.  If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements.  If this qualitative assessment indicates that Altria&#x2019;s investment in JUUL may be impaired, a quantitative assessment is performed.  If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value.  The fair value of Altria&#x2019;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#x2019;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares.  In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.The fair value of Altria&#x2019;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#x2019;s common shares and was classified in Level 1 of the fair value hierarchy.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMTU2OQ_1350fda7-8542-4496-822c-c69a2a16fc27"
      unitRef="number">0.100</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentNumberofSharesOwnedRestricted
      contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMTYwNA_974d0dc9-c41e-4600-b5fb-4c777990f20d"
      unitRef="shares">185000000</mo:EquityMethodInvestmentNumberofSharesOwnedRestricted>
    <mo:EquityMethodInvestmentNumberofSharesOwnedCommon
      contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMTY2Mg_e89bb733-628d-44fd-ac82-d0aeba695713"
      unitRef="shares">12000000</mo:EquityMethodInvestmentNumberofSharesOwnedCommon>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i8a153648856343c9b0ba005f24161faf_I20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMTczOQ_623ebdbc-dfa1-4b27-97d3-39f3037086d4"
      unitRef="number">0.101</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="ib0119e1289b840b9a4e48f08e6d51eb4_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzIxMg_2137815d-7e92-4904-a690-9b03d879acbd"
      unitRef="usd">10700000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="idc0e7480ae994bbfae8f564a569b78db_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzIzNA_c93bb390-0ea6-4ecf-a783-5d20b4f90e14"
      unitRef="usd">16700000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i90f0e22caf6240a283094f0495f14ec0_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzI0Mg_ecd49b30-9865-4769-b4ed-deb07dc7622d"
      unitRef="usd">16100000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="i5c9f46db82b544bca919d37b619fa3c6_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzI2NA_9d90e4ba-2c30-4fc8-afc6-3ec7ab2c0509"
      unitRef="usd">18100000000</us-gaap:EquityMethodInvestments>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="i44203766c22e443f90913f61f95be1a8_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzMzOQ_f4b5f0e7-362c-4231-8a2d-c74b6b238176"
      unitRef="number">-0.36</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="i581024f3ed014433a29610e67306704e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfMzM0Ng_70a33d34-6df8-4eab-a3f3-6aaadee47ca4"
      unitRef="number">-0.11</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <mo:EquityMethodInvestmentImpairment
      contextRef="i581024f3ed014433a29610e67306704e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNDM5MQ_597329d0-0401-45d5-9745-d4deac7590e6"
      unitRef="usd">0</mo:EquityMethodInvestmentImpairment>
    <mo:EquityMethodInvestmentImpairment
      contextRef="i44203766c22e443f90913f61f95be1a8_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl82NC9mcmFnOmZkMGQwNjBiZGFiNzQ1YjA4MTkyMmYzMWE3ZTZiNGNjL3RleHRyZWdpb246ZmQwZDA2MGJkYWI3NDViMDgxOTIyZjMxYTdlNmI0Y2NfNDM5MQ_be9ad233-18e4-4396-b901-8cc66980d6d3"
      unitRef="usd">0</mo:EquityMethodInvestmentImpairment>
    <mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
      contextRef="id6aea41f4cd944cbb4018c25bf22065f_D20181201-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfODk_042a49a5-b5a7-4514-aab9-de548a44959e"
      unitRef="usd">12800000000</mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="icfc10374e49f4210b26d83818840cffa_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTQ0_624efe59-6ce8-4318-b7c2-1a427a40974d"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTQ0_ae24a49a-a4a5-4252-aeed-2ee6ebae2a90"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i0f8ac2e81fbf415d96b01883453526d6_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfOTI5_c5d6a5a1-69d9-44d1-a4bf-313d5ad13599"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod
      contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTY2Mg_97f57bb6-f81b-4031-a61e-462be30684fc">P12M</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue
      contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTgwNA_bcdf61cb-52f3-4be2-a0ed-d480dfa9032c"
      unitRef="number">0.10</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount
      contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTg0MA_f4de12e6-ac3b-4a13-9a95-e0b01f8b5cff"
      unitRef="usd">12800000000</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod
      contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMTg4OA_51d5d509-e900-4278-8cb2-43d732011b7c">P1Y</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers
      contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjQ5OQ_8f3a580c-f264-456e-84f5-f3678071a1d5"
      unitRef="director">7</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion
      contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjUzMw_01753f9e-f3a8-43c4-917f-10a30f07fdf7"
      unitRef="director">9</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion
      contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjYzMQ_76725bc4-6f6b-4370-a951-c4083ae9fb53"
      unitRef="director">3</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion
      contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjY1Nw_54825eed-832f-4c6a-a28c-052ffbc7d94d"
      unitRef="director">1</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion
      contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjcwMQ_10e75a5f-69b3-4c1b-8c92-f35d3d02362d"
      unitRef="director">2</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion
      contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjg2Mw_75614e2c-cb14-49d1-9ecc-eee5d98df24a"
      unitRef="director">1</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion
      contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjg4OA_c6ca1373-de67-4693-acf9-ab9fde33ae38"
      unitRef="director">2</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion
      contextRef="ibafdec850b6b45c6a0a6ebb40779d823_I20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjkyOQ_ff0fc084-2d21-4419-a1bc-31bf01f7e0f0"
      unitRef="director">3</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion
      contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMzEwMA_f726765e-fb39-4c50-b293-80908ca506b7"
      unitRef="director">2</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion
      contextRef="i71a96c8e1ae948e49a485790a1ad5672_D20200128-20200128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMzEzMg_4f9e8361-5bd1-4c41-bb70-7eec26b0471e"
      unitRef="director">1</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="icfc10374e49f4210b26d83818840cffa_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfNDE2Mw_624efe59-6ce8-4318-b7c2-1a427a40974d"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfNDE2Mw_ae24a49a-a4a5-4252-aeed-2ee6ebae2a90"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfNjEyNA_f433a6c2-bb49-46af-a685-f4b3dc9f2adb">Altria accounted for its investment in JUUL as an investment in an equity security as of September&#160;30, 2020.  Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There have been no upward or downward adjustments to the carrying value of Altria&#x2019;s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through September 30, 2020.JUUL announced a strategic update in September 2020, which includes its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of Altria&#x2019;s financial statements for the period ended September 30, 2020, Altria performed its qualitative assessment of impairment indicators for its investment in JUUL and determined that JUUL&#x2019;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#x2019;s business prospects.</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="i9925579f99854b05a2c1b01eab01c950_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfNDYxMw_dc0850eb-6abc-48ca-acb7-c3f2f153ec8f"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i3a6bc5655b5c4d76b14ec49b161c5464_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODU1Ng_a815b32b-2b63-4847-87d7-40b0fbb2d086"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i5c77db08d832433681380e92e80fbc1c_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODU2Mg_80c1a4f9-7e91-4c68-bfe9-b3e18be5034e"
      unitRef="usd">8600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i5093f64aaa8d463a86be2d64338151f4_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODU4OQ_4cb530b1-1a56-487c-a13f-efd1afff4858"
      unitRef="usd">4500000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib2202ef19f99485aaf1594cd36889bcf_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODYwNQ_c4eba859-416b-48af-bb9c-8b44665fb1fe"
      unitRef="usd">4100000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="icfc10374e49f4210b26d83818840cffa_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfMjE5OTAyMzI3ODYyNw_601c75a8-8abb-4f49-beb6-5369ff353000"
      unitRef="usd">4200000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i5093f64aaa8d463a86be2d64338151f4_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfODc5NjA5MzA1MDMyOA_ba7002b5-bdad-4ee6-b52f-eda4863810df"
      unitRef="usd">4500000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib2202ef19f99485aaf1594cd36889bcf_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83MC9mcmFnOmIxYmQzNzE1MTA3MzRiZDU4ZWUyMTBhNzZmN2UzODNhL3RleHRyZWdpb246YjFiZDM3MTUxMDczNGJkNThlZTIxMGE3NmY3ZTM4M2FfODc5NjA5MzA1MDMyNw_400a0297-dd5d-472e-99b8-1ed76d716cfd"
      unitRef="usd">4100000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <mo:EquityMethodInvestmentNumberofSharesOwnedCommon
      contextRef="i03dc33411a5749d79909086adf33043e_I20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfODA_09b51d69-b9c5-45fb-992c-3f85876cafa0"
      unitRef="shares">149800000</mo:EquityMethodInvestmentNumberofSharesOwnedCommon>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i03dc33411a5749d79909086adf33043e_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTY4_11446299-a41b-454a-af11-ebad2f500290"
      unitRef="number">0.45</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentPricePerShareIfExercised
      contextRef="ide407e15cf49487193634a2048179491_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfNTEw_2c3da9bb-f238-4d64-bb0d-5b423360f0b8"
      unitRef="cadPerShare">16.25</mo:EquityMethodInvestmentPricePerShareIfExercised>
    <mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase
      contextRef="i3a07225f603b469a9e16277e68062cf2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjE5OTAyMzI1OTQ1OQ_a3d86160-7e2f-467b-b0c3-02b60e5222d0"
      unitRef="shares">35000000</mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase
      contextRef="i3f6eaaca8b0c4eeab6e988d2d5cad4b1_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfODU1_55a13e52-efa7-4392-bd83-1e58471c5611"
      unitRef="number">0.10</mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase
      contextRef="ie3301a69f1fc4456bc6cd43d61e2358b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjE5OTAyMzI1OTQ0OA_de7da6af-eb43-48d0-b1ef-0a72b4a6160f"
      unitRef="shares">79000000</mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentPricePerShareIfExercised
      contextRef="i3f6eaaca8b0c4eeab6e988d2d5cad4b1_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfOTcz_4366efbf-4513-4180-a197-668493b53773"
      unitRef="cadPerShare">19.00</mo:EquityMethodInvestmentPricePerShareIfExercised>
    <mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting
      contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTE1NQ_d907b072-9542-432e-b13a-95f4043a954e"
      unitRef="cad">2400000000</mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting>
    <mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting
      contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTE3OQ_651eda54-87eb-45c3-99e5-9454175a5ab7"
      unitRef="usd">1800000000</mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting>
    <mo:EquityMethodInvestmentWarrantExercisedOwnershipPercentage
      contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTMzMw_989ec378-1ab8-4f07-bb62-9d2764103748"
      unitRef="number">0.55</mo:EquityMethodInvestmentWarrantExercisedOwnershipPercentage>
    <mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting
      contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTg2OA_722e405f-5627-4313-a5ce-028ea0a85ca5"
      unitRef="cad">2400000000</mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting>
    <mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting
      contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTg3Ng_88a0840e-d006-45a9-b34d-46c09aefbe41"
      unitRef="usd">1800000000</mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting>
    <us-gaap:PaymentsForDerivativeInstrumentInvestingActivities
      contextRef="i789ffb64479c427c97456e2372a5a744_D20190301-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTkyOA_4287b7c7-2126-42cc-b27a-5ac54fc33e9a"
      unitRef="usd">1200000000</us-gaap:PaymentsForDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsForDerivativeInstrumentInvestingActivities
      contextRef="i79d16ce41a6d4fb6a123927ea6298fb9_D20190301-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTk0Nw_f25fd6cc-6aed-4bd8-8d09-606221df5aaf"
      unitRef="usd">500000000</us-gaap:PaymentsForDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i8a5f17d45b4b4e5c8e5b156ff417b8c9_D20190301-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTk4OQ_441e272c-46e1-4678-9cc2-a5d7fdce5e98"
      unitRef="usd">400000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i03dc33411a5749d79909086adf33043e_I20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjAyOA_34f50c90-a331-4466-b26f-881ede806467"
      unitRef="usd">300000000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="i60560d0e627c422e839a25225ee19787_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjE3Ng_a25e0681-4742-4991-9554-5805faaa8308"
      unitRef="cad">1500000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="i914d4a901ff34993a138eacf6ee3171c_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjE4Nw_bd5bc8f0-f7c6-4231-b2d3-cb7e23672a54"
      unitRef="cad">600000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="ie295981559fa47e9a12e6456173c067f_D20201027-20201027"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjIwOQ_dca58a76-442d-485a-a0cd-e579c72b04f1"
      unitRef="usd">1100000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="ieede284c3acf473cad8c0420cae67a03_D20201027-20201027"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjIxNg_ac0ee6a8-a91d-4831-9b2c-6dce457925f3"
      unitRef="usd">400000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjQ5OQ_dffbad4c-bf74-454b-af91-008bab9ac1ea"
      unitRef="number">0.44</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentNumberofSharesOwnedCommon
      contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTU5NDI5MTg2MDY4MTU_771156b0-5a64-44d5-bc2c-c23bd7dddd17"
      unitRef="shares">156600000</mo:EquityMethodInvestmentNumberofSharesOwnedCommon>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i23418c15a4834d4882c474b871c10616_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTUzOTMxNjI3OTMwODU_d08d87e4-ebf5-4241-9b23-bbdaa1b34626"
      unitRef="number">0.45</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:NumberofDirectorsNominated
      contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjc4MA_105700a1-1455-4481-8566-10956c9dc75a"
      unitRef="director">4</mo:NumberofDirectorsNominated>
    <mo:EquityMethodInvestmentNumberofIndependentDirectorsNominated
      contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjgwNA_a297e73e-effd-4db0-a128-2cea971f6cd1"
      unitRef="director">1</mo:EquityMethodInvestmentNumberofIndependentDirectorsNominated>
    <mo:NumberofMembersOntheBoardofDirectors
      contextRef="ifbd09d9f3f1d410cb0f85a3c7e1a7046_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMjg3MA_30db830f-f3ea-48e6-9a51-326f7af1ad40"
      unitRef="board_member">7</mo:NumberofMembersOntheBoardofDirectors>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i2ab928952e6f4199a2156a1db1c2ae25_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMzE4NA_9fe14d61-cea3-4772-9d14-8043fb231858"
      unitRef="usd">800000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="iff5dff53efdd45618f3b407706808ee9_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMzE5MQ_cd180e55-ba37-4701-b31b-0643791b2a70"
      unitRef="usd">1200000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="i4baac6d362ff43e1a624d2ca9bd47b9a_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTY0OTI2NzQ0MjA2MDg_144a1f52-67df-4639-9934-8384a9f4e313"
      unitRef="usd">1000000000.0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia5ab87ccfd644d7bbd87a7f9d985ce3a_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTY0OTI2NzQ0MjA2MDg_32a89ccb-a2a6-4c6f-bca4-db433d5286ff"
      unitRef="usd">1000000000.0</us-gaap:EquityMethodInvestments>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="if013f6bbc85345f1930ed240ff09ccf9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMTY0OTI2NzQ0MjA2Mjg_d4a62b17-2436-4cbb-af88-47aa61c20ff6"
      unitRef="number">0.20</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i0926d28c94bd4f0688d1cd87daf48de9_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl83Ni9mcmFnOjY0YWUwZDQ3N2E2MjRiOTk5ODg3ZTFlOTMzYjA2Y2ExL3RleHRyZWdpb246NjRhZTBkNDc3YTYyNGI5OTk4ODdlMWU5MzNiMDZjYTFfMzgxMQ_267eeb2e-4e0f-4601-ac3e-7dc6e62cd779"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNjk4NA_f17eaae5-1eda-443b-b654-55f12d37277a">Financial Instruments:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria enters into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  Altria uses various types of derivative financial instruments, including forward contracts, options and swaps.  Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s investment in ABI, whose functional currency is the Euro, exposes Altria to foreign currency exchange risk on the carrying value of its investment.  To manage this risk, Altria designates certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#x201c;foreign currency contracts&#x201d;), and Euro denominated unsecured long-term notes (&#x201c;foreign currency denominated debt&#x201d;) as net investment hedges of Altria&#x2019;s investment in ABI.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020 and December&#160;31, 2019, Altria had foreign currency contracts with aggregate notional amounts of $1,402 million and $2,246 million, respectively.  At September&#160;30, 2020, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $5,368 million and $4,960 million, respectively.  At December&#160;31, 2019, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $5,057 million and $4,741 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s estimates of the fair values of its foreign currency contracts are determined using valuation models with significant inputs that are readily available in public markets, or can be derived from observable market transactions, and therefore are classified in Level 2 of the fair value hierarchy.  An adjustment for credit risk and nonperformance risk is included in the fair values of foreign currency contracts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s estimate of the fair value of its total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.  The aggregate fair value of Altria&#x2019;s total long-term debt at September&#160;30, 2020 and December&#160;31, 2019 was $33.8 billion and $30.7 billion, respectively, as compared with its carrying value of $29.3 billion and $28.0 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Fixed-price Preemptive Rights and Cronos warrant, which are further discussed in Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, are derivative financial instruments, which are required to be recorded at fair value.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$9.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$9.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.67 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.43 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.71%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 5.25 years at September 30, 2020 and 0.25 year to 6 years at December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.12% to 0.36% at September 30, 2020 and 1.66% to 1.74% at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6) Based on Cronos&#x2019;s expected dividend payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax earnings (losses) recognized in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria elects to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on its condensed consolidated balance sheets.  The fair values of Altria&#x2019;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair Value of Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair Value of Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="30" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-align:center;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria records in its condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.  For the nine and three months ended September&#160;30, 2020 and 2019, Altria recognized pre-tax unrealized gains/(losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, in January and February 2019, Altria entered into derivative financial instruments in the form of forward contracts, which were settled in March 2019, to hedge Altria&#x2019;s exposure to CAD to USD foreign currency exchange rate movements, in relation to the CAD $2.4 billion purchase price for the Cronos transaction.  The aggregate notional amounts of the forward contracts were USD $1.8 billion (CAD $2.4 billion).  The forward contracts did not qualify for hedge accounting; therefore, in the first quarter of 2019, pre-tax losses of USD $31 million representing changes in the fair values of the forward contracts were recorded in loss on Cronos-related financial instruments in Altria&#x2019;s condensed consolidated statement of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Counterparties to Altria&#x2019;s foreign currency contracts are domestic and international financial institutions.  Altria is exposed to potential losses due to non-performance by these counterparties.  Altria manages its credit risk by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure Altria has with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require Altria to maintain an investment grade credit rating.  In the event Altria&#x2019;s credit rating falls below investment grade, counterparties to Altria&#x2019;s foreign currency contracts can require Altria to post collateral.  No collateral was received or posted related to derivative assets and liabilities at September&#160;30, 2020 and December&#160;31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Investment Hedging&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pre-tax effects of Altria&#x2019;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.893%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Net Earnings (Losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Net Earnings (Losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="45" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Related to amounts excluded from effectiveness testing. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to USD exchange rate were recognized in accumulated other comprehensive losses related to ABI.  Gains on the foreign currency contracts arising from components excluded from effectiveness testing were recognized in interest and other debt expense, net in the condensed consolidated statements of earnings based on an amortization approach.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if543b4ab8bbb4e4cb31ce281dfc2c883_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfOTgx_877ab7e9-0589-4507-a806-933230fbfe98"
      unitRef="usd">1402000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i482f5b595eb642e1acc2d81bfa6d836f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfOTg4_9b8a02f2-8609-42de-80cf-e331532c5de3"
      unitRef="usd">2246000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if8c6262959ff4200998c8e9eaf5d9144_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTExMA_3cc12614-571e-4f61-aa7d-4274fab463de"
      unitRef="usd">5368000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="if8c6262959ff4200998c8e9eaf5d9144_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTExNw_7200a847-9c36-4dbe-84a3-8b9cf4a31f07"
      unitRef="usd">4960000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i19091e36268a46e3b8306ee404fba8a2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTIzOQ_67764d75-849a-4427-b16b-d3bd09fa581f"
      unitRef="usd">5057000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i19091e36268a46e3b8306ee404fba8a2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTI0Ng_6b2daafb-9609-434b-a9c3-422ca69938ed"
      unitRef="usd">4741000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="i03cfa027e2c542a89ca61cb7216820a3_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTk3MA_addabe35-3cc9-4677-98f0-b905d72a7fbb"
      unitRef="usd">33800000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i327669e434c540969eed7f12fc78caa6_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMTk3Nw_f7d5c74d-7992-4bbe-b6da-72288177bdcb"
      unitRef="usd">30700000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i2f17aceb05f84391bfff69ba804a2d18_I20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMjAzNA_55f3299a-782d-4ad9-b4f6-42d272709d14"
      unitRef="usd">29300000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i762330360e39458f831a1f465d0c4616_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMjA0MQ_f450af3f-65ba-4a78-abb5-992197759f3f"
      unitRef="usd">28000000000.0</us-gaap:LongTermDebtFairValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNzAwNQ_7554fb25-21ed-41a7-8523-222fe8b95232">The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$9.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$9.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.67 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.43 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.18 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.68%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.71%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 5.25 years at September 30, 2020 and 0.25 year to 6 years at December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.12% to 0.36% at September 30, 2020 and 1.66% to 1.74% at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6) Based on Cronos&#x2019;s expected dividend payments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i780f2a71201c4ff3bd694ea104911a0e_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMi0yLTEtMS0w_9c007e8a-a7ef-4c1a-bd5f-d65464c46df9"
      unitRef="number">6.69</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ia8c7c188084b42a8ae2031212a1d2288_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMi00LTEtMS0w_6a2f18c3-8791-4a79-adf0-3685153eed59"
      unitRef="number">9.97</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="id11a81bbc4f84fc78fa4cbe8a44fdf78_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMi02LTEtMS0w_dc032b92-1842-4204-af90-dcadf34455e7"
      unitRef="number">6.69</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i0a8e1bf900f64f8b92b366a2c2d76fd1_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMi04LTEtMS0w_cbd73833-4df8-4b42-94ee-0f31a96c0941"
      unitRef="number">9.97</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i6cf3b63a008b40428ca6039b7d9a5c4b_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMy0yLTEtMS0w_2f0bb635-29d2-48eb-8d64-2a43e8c0606d"
      unitRef="year">1.18</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ia2c14274a4d64108b882de55d4502603_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMy00LTEtMS0w_6fe3512e-eb90-4a4e-b6e8-943ba08be23d"
      unitRef="year">1.67</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ic93a49eda1a94589ac79dd8b3c1b3e97_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMy02LTEtMS0w_18bc9a2f-e2a0-44c9-be84-dda3168c20ce"
      unitRef="year">2.43</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i626546e4b3ef4715b47df81b5bb8b7b1_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfMy04LTEtMS0w_249548d3-290e-4780-b229-fb8414b9187a"
      unitRef="year">3.18</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i429277c86fbe4b21bc95bdd8fbf00861_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNC0yLTEtMS0w_bdc3f217-cdda-491b-8bf0-4ba2f38417d1"
      unitRef="number">0.8068</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="icc73a7084aef4a0b8ed318ebd0e7d738_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNC00LTEtMS0w_f3f56300-1879-429b-b4eb-127f64b797bf"
      unitRef="number">0.8161</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i7a183827598f443697de775b3cf99058_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNC02LTEtMS0w_81785ac1-3508-4341-8d89-308ab6e41b9e"
      unitRef="number">0.8068</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ic366f1f1f531476a8cd247a911c006fc_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNC04LTEtMS0w_793ba327-3ee6-43a9-8278-865df3b10c90"
      unitRef="number">0.8161</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i34064c893e694b50b8144376830b31e3_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNS0yLTEtMS0w_b3262313-98fa-481e-94aa-70a0b3f7e64d"
      unitRef="number">0.0020</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i7227fbea894a4ca2b29fd716f8fd79a6_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNS00LTEtMS0w_1406f441-024e-488e-8b6b-b3b44b2b0409"
      unitRef="number">0.0171</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i8f2e75b2f0094022af0e857ba9c1a24a_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNS02LTEtMS0w_f29e11a2-1983-4d8a-a3d9-6153ec836e00"
      unitRef="number">0.0025</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i6fc7d0eb19de480baea8a1af985038d5_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNS04LTEtMS0w_936e85c1-0f92-464c-8078-03b5934a1b25"
      unitRef="number">0.0169</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ieb03a2d5afcb4c62b621f8167bf67e8e_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNi0yLTEtMS0w_5cf5b0c0-a61f-4f37-8d74-d546d91bc672"
      unitRef="number">0</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="ib8781d7757594520903cdddf6282cbf8_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNi00LTEtMS0w_ab057994-b33f-4a9f-ba77-ff57387cf003"
      unitRef="number">0</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i086ec560279e4dfaa1563b87dbdbba88_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNi02LTEtMS0w_88096c05-6b05-40e2-ba97-c58494a2be1a"
      unitRef="number">0</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i8990ee747e90489e8c4c40c9dd340a9e_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjZlOTAzMWI4NGU0ODQ1NTE4ZGE1Yjg0ZGU5ZjU3ZDdmL3RhYmxlcmFuZ2U6NmU5MDMxYjg0ZTQ4NDU1MThkYTViODRkZTlmNTdkN2ZfNi04LTEtMS0w_5c7beac9-b7f4-4f53-b77c-7d8a2f848489"
      unitRef="number">0</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i35e343023746419a9425bb816ac2a8e8_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzAyMQ_1f45d96a-255a-4d5f-9c23-dc1be21fd8b2"
      unitRef="year">0.25</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i42e4e208cef648d2a2e36df3b10bfc74_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzAzMg_0d450695-1506-4f83-bdbb-6e32f7cee330"
      unitRef="year">5.25</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i6ecca4f968bc4f8daed7042afbac66f7_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzUxODQzNzIwOTU5OTc_20b3f0d9-166c-4dbd-8643-971b1f036ad8"
      unitRef="year">0.25</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i31465b7042ac470797adf3cc3f8f4b1f_I20191231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzUxODQzNzIwOTYwMDk_ba062f0b-0685-4a0e-a195-9e53f177a43c"
      unitRef="year">6</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i519edb627c4f47b197d3fd3fb078bb6d_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzM3Mw_ca089004-5ffb-4def-8818-42c0c4f27e31"
      unitRef="year">0.0012</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i932dd517d7a44c81ba630d3f06428863_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzM3OQ_798ad78f-de76-4be3-92b4-092c31cd1c5b"
      unitRef="year">0.0036</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i4c04c699c1c74515acd46e2303002b0b_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzQwMw_622feb4c-b516-4d82-88b9-23347752c49a"
      unitRef="year">0.0166</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:DerivativeAssetMeasurementInput
      contextRef="i85c2ed22b70546a9afeb76348ddc2b55_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfMzQwOQ_71c3bf8b-f973-4f8e-99dc-1e82494f52d1"
      unitRef="year">0.0174</us-gaap:DerivativeAssetMeasurementInput>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNjk5MA_cc40d854-91d9-448d-976a-13bed3978edc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax earnings (losses) recognized in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ib3969c366e174823ba5e447d4d1d11fa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjA2ODY3NjllOWJiMTRjYjNiZWNlYjUxMDVlMWM3YTJhL3RhYmxlcmFuZ2U6MDY4Njc2OWU5YmIxNGNiM2JlY2ViNTEwNWUxYzdhMmFfMS0yLTEtMS0w_8d869f85-ace4-4aca-bd89-3d002acdb3d0"
      unitRef="usd">303000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="ic79ee6d1277340d2a65bf968adbff27f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjA2ODY3NjllOWJiMTRjYjNiZWNlYjUxMDVlMWM3YTJhL3RhYmxlcmFuZ2U6MDY4Njc2OWU5YmIxNGNiM2JlY2ViNTEwNWUxYzdhMmFfMy0yLTEtMS0w_76cc63fd-4892-4a10-859b-83c209ff4393"
      unitRef="usd">-202000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i3023df6730344ca3962ddfd40ecab100_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjA2ODY3NjllOWJiMTRjYjNiZWNlYjUxMDVlMWM3YTJhL3RhYmxlcmFuZ2U6MDY4Njc2OWU5YmIxNGNiM2JlY2ViNTEwNWUxYzdhMmFfNC0yLTEtMS0w_97f39f01-8ee0-4f26-bf1b-b79e5bdd63d6"
      unitRef="usd">101000000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNjk5Mw_6ca3f769-7ad7-483e-9859-1e4a6e0fef81">The fair values of Altria&#x2019;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair Value of Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair Value of Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="30" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-align:center;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0a361f15685848a39cda05ed04452b34_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMy0zLTEtMS0w_7723b86f-b133-44a2-8654-726546f68911"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i820ba03288e34f15a3e93d22d715d5cb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMy01LTEtMS0w_34c5f03d-7706-44c5-8322-72b3aed29b65"
      unitRef="usd">46000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia4788092f78a4eb2b15070f6da8c3dea_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMy04LTEtMS0w_7c25ce2e-2634-404e-96b7-b630aa89c309"
      unitRef="usd">39000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iffbb907af8094973ab26d4b85b6cb2e1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMy0xMC0xLTEtMA_ecaf899b-b3f2-483c-b6fd-b57096b6b7a6"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i490b0ad606f344d2b124a44527e6c990_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNC0zLTEtMS0w_9a0e5f61-07c9-430a-8970-48faf3353d57"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i895313ba107a45389016a7bbcfbd9f48_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNC01LTEtMS0w_cb7c9f4d-8cb5-4814-87ab-445fbcac8a5e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ieb9212e88ebc4edd9d9a294e59c26753_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNC04LTEtMS0w_09062aac-fe80-4c22-9cb8-909f10f726e1"
      unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia65e91236a75413e94604e3795d0d4c4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNC0xMC0xLTEtMA_1458fae2-8cb1-4101-ab1a-2178b27d347e"
      unitRef="usd">21000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i156d7b2e0ad84e2c8f2f415b7dcf205c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNi0zLTEtMS0w_01433f68-eef0-48fa-87ff-720e9527ebaa"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i709075a698fa4b7a895a75a9c6c5d1f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNi01LTEtMS0w_bf4d850e-8681-4829-8d7a-b62f6cf06de9"
      unitRef="usd">46000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i156d7b2e0ad84e2c8f2f415b7dcf205c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNi04LTEtMS0w_d939e6e0-a666-432a-86c2-c19d52cc49b8"
      unitRef="usd">55000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i709075a698fa4b7a895a75a9c6c5d1f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfNi0xMC0xLTEtMA_2378bf8c-3631-48fb-9eff-1b42d79ecaea"
      unitRef="usd">28000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i55629557f8fa4801a2be7e0427b33b06_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfOS0zLTEtMS0w_33289f7c-db3b-4191-80a1-3840e15d67c0"
      unitRef="usd">86000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifa5700c0ced144f8ae5b03950397055c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfOS01LTEtMS0w_0192ba64-7f90-42ee-89bd-014cf92670e0"
      unitRef="usd">234000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i37e31bd7e2634c1dac8c62603a80a737_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTAtMy0xLTEtMA_c93113f4-47b5-4c2c-96ae-e9dbf8c75c87"
      unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i04baa8b6c1f845fa8d7e480d95aabb67_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTAtNS0xLTEtMA_d07e7d0a-462a-4f30-b1a5-30972eb601fd"
      unitRef="usd">69000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1ce59a1fcfb7407fa566d25fc62260e2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTEtMy0xLTEtMA_cdbcf02d-9b15-4376-bcd4-dcf37b5156c5"
      unitRef="usd">101000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifb38fc3f5d2f4e6da207670f4cc54dd2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTEtNS0xLTEtMA_e9cbf535-ea97-47c7-acea-73c2e344e2b4"
      unitRef="usd">303000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0d187570aa2540a88ab160136d28dc72_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTMtMy0xLTEtMA_1486761e-02b7-4084-94c0-40ee6a089b81"
      unitRef="usd">104000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia4215578af3347b0b7a3b29a129d6de7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTMtNS0xLTEtMA_8b9af06c-3934-4bb3-bf97-292ea86a4a17"
      unitRef="usd">349000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0d187570aa2540a88ab160136d28dc72_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTMtOC0xLTEtMA_5a806ec8-2768-4046-b462-cbd753800d40"
      unitRef="usd">55000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia4215578af3347b0b7a3b29a129d6de7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOmI3N2U3YTkzYjgyNDRiMTQ4NDFjYWQ2NzZiMjdlZmRkL3RhYmxlcmFuZ2U6Yjc3ZTdhOTNiODI0NGIxNDg0MWNhZDY3NmIyN2VmZGRfMTMtMTAtMS0xLTA_b820e1bd-a4ce-4c0f-ae2c-9d05e357146b"
      unitRef="usd">28000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNjk4OA_b0411b5b-f994-4996-b362-c53c914e7f63">For the nine and three months ended September&#160;30, 2020 and 2019, Altria recognized pre-tax unrealized gains/(losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pre-tax effects of Altria&#x2019;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.893%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Net Earnings (Losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Net Earnings (Losses) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="45" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Related to amounts excluded from effectiveness testing.</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ia7f91a436b28422ea64fe38b472a5589_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfMy0xLTEtMS0w_da0cf5a7-b7d8-45ed-97cb-e77fad7f9eb7"
      unitRef="usd">-54000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ib52d5131c24e46128d6b79389a025d30_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfMy0zLTEtMS0w_d5271dd8-7e52-45d6-a2d6-db37d5f0bd32"
      unitRef="usd">-400000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i5e3ba701be024d09a42df0979733dce2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfMy01LTEtMS0w_100024f4-9c3f-4762-a500-705a449863e4"
      unitRef="usd">-25000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i742228ca73ae4006a165d270426b66aa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfMy03LTEtMS0w_c7a2043f-2b0b-4aef-9cad-fc4f8a5a0c13"
      unitRef="usd">-188000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ibe60396dea9d4e139bc5adf4aaef4cbc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNC0xLTEtMS0w_ce9134fb-2f08-4861-97a0-400b152908a9"
      unitRef="usd">-148000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i22bd417720914dd1a0bdbd9c0d152323_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNC0zLTEtMS0w_13b9c006-f5c2-476d-ada9-e2273a3fc92d"
      unitRef="usd">-896000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="iaad15e2268ac481db81ebc0d57dbb586_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNC01LTEtMS0w_3a86e94e-a74d-4290-b7a8-65afb5e26b96"
      unitRef="usd">-80000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ief8d5ed5a7444a258532f6236eb7d10d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNC03LTEtMS0w_1b85b9b2-0133-4e4e-a84d-838df68c3330"
      unitRef="usd">-448000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNS0xLTEtMS0w_69b4102e-c968-4cf0-a694-2800071c4171"
      unitRef="usd">-202000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNS0zLTEtMS0w_c6a09fb7-69fe-473e-9ee8-ea7947f23907"
      unitRef="usd">-1296000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNS01LTEtMS0w_3a7261d5-d324-461e-bde4-16a8f83f7639"
      unitRef="usd">-105000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdjOTYzOGQwOGM0ZjQ2MWU4YTM4ZTVmZWY2NGZhMzg4L3RhYmxlcmFuZ2U6N2M5NjM4ZDA4YzRmNDYxZThhMzhlNWZlZjY0ZmEzODhfNS03LTEtMS0w_fedec2ad-ba2d-42e4-a588-557bf1ec9de1"
      unitRef="usd">-636000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting
      contextRef="ie54adf4b4f114073a2bbd31a27d6fbdc_D20190331-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNDk3Nw_a75fbd11-30ae-408a-ae8b-ee7e55755050"
      unitRef="cad">2400000000</mo:PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i69363bfcc8fd412bbdb34aec0878e470_I20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNTA4OQ_8e41bf08-9050-4339-8a63-2e8bfc50cf22"
      unitRef="usd">1800000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i69363bfcc8fd412bbdb34aec0878e470_I20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNTA5Nw_49bcea4b-8593-47f8-894b-8804b4d0403e"
      unitRef="cad">2400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i9da1982838c6484db523839f9172e06b_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RleHRyZWdpb246ODhhN2NiZWNiMTEwNDA1MThhOTVlNDA5MDNkOTJiZjJfNTIyNg_a2960963-acfe-4e0f-8a48-58dd922051d5"
      unitRef="usd">-31000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i315cf96c2e2b4f1389be73d9bad6e25d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0yLTEtMS0w_ad520db6-0921-4170-ac6a-72645cdb15d1"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i75648dd74466420b86f28b4ffb6ef292_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC00LTEtMS0w_f17a8e90-be6a-4c72-88b1-b589e448e5dd"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i315cf96c2e2b4f1389be73d9bad6e25d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC02LTEtMS0w_e6e80018-97e7-4247-9985-e9713255ecab"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i75648dd74466420b86f28b4ffb6ef292_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC04LTEtMS0w_728bc527-3582-412e-bb34-0ae48a1cbd27"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ifb694c29f27a46e4a6697f065ee75e35_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0xMC0xLTEtMA_a1bdc566-f4b2-4c7f-8918-4d18325a8e50"
      unitRef="usd">-66000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3703b6ae7e7341b18c2d327b431712cc_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0xMi0xLTEtMA_1781db1c-1080-4a53-ad06-f71c1e5236e1"
      unitRef="usd">57000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ifb694c29f27a46e4a6697f065ee75e35_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0xNC0xLTEtMA_21f70c5c-ad08-4ea5-a358-93b7b04e51c7"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i3703b6ae7e7341b18c2d327b431712cc_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNC0xNi0xLTEtMA_b3b9bdd4-874d-44ae-a0ba-1565687d8cd0"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9c5bddfe927640169c96483cddb17379_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0yLTEtMS0w_02706222-6fc3-4351-892c-f4578a5b0c1d"
      unitRef="usd">-215000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i41c9b1d77add44b9be802e5dd01b56c1_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS00LTEtMS0w_33af89e2-dab3-476b-bc86-9f03509da62e"
      unitRef="usd">168000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i9c5bddfe927640169c96483cddb17379_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS02LTEtMS0w_fe52828c-e45d-4ef5-8e45-b1c9a90b4561"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i41c9b1d77add44b9be802e5dd01b56c1_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS04LTEtMS0w_4f89b179-c768-47db-9995-e4fd51f8d662"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2513d47f23844d9ba0ac7bdcd5c64e15_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0xMC0xLTEtMA_840fbc43-b27e-4e4a-adaa-74a8fc1723ca"
      unitRef="usd">-206000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i924ac9b83e4c4f0fb5b946287281a5bc_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0xMi0xLTEtMA_36d80e5c-a380-4dcd-80f8-79f213fb964d"
      unitRef="usd">200000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i2513d47f23844d9ba0ac7bdcd5c64e15_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0xNC0xLTEtMA_675fac3a-5659-4e61-bf5b-33337551ec04"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i924ac9b83e4c4f0fb5b946287281a5bc_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNS0xNi0xLTEtMA_9c809fba-dcd4-4538-a8f9-9d45e0362b2e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic095b1d9445c4bb79ac2c008e4f6fa83_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0yLTEtMS0w_79d631db-bbc8-44bc-aad5-de88f0291132"
      unitRef="usd">-243000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6858797d755940d5af5d63d4ebd944d0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi00LTEtMS0w_aea9f528-a46b-44a2-aeef-d424570dc52d"
      unitRef="usd">238000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ic095b1d9445c4bb79ac2c008e4f6fa83_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi02LTEtMS0w_c2f8a2b0-d8bf-4f97-8790-a5ea5fe8abfa"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i6858797d755940d5af5d63d4ebd944d0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi04LTEtMS0w_db581505-299d-425e-bb2b-3af806ed2c53"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i182d9ee236a64eff889aab36500df3ed_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0xMC0xLTEtMA_c5a0fa65-116c-46f4-977c-5c3fa5ce8598"
      unitRef="usd">-272000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i351326e926924511b4abbac946829f4c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0xMi0xLTEtMA_7d5c6de5-cc5b-41a8-8506-e818fb563ffb"
      unitRef="usd">257000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i182d9ee236a64eff889aab36500df3ed_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0xNC0xLTEtMA_8aedcc57-dc5c-42cf-a1d9-2adb5f8e22f1"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i351326e926924511b4abbac946829f4c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84Mi9mcmFnOjg4YTdjYmVjYjExMDQwNTE4YTk1ZTQwOTAzZDkyYmYyL3RhYmxlOjdiNjUzMzAwZTBjODRkYzY4ODRmNDhmNjlmOTY1NmUxL3RhYmxlcmFuZ2U6N2I2NTMzMDBlMGM4NGRjNjg4NGY0OGY2OWY5NjU2ZTFfNi0xNi0xLTEtMA_8954626d-388d-4ee0-9224-434a9dd849d3"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfMTI5MA_835d9c7e-eb7e-4363-9f5b-2c688971b159">Benefit Plans:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Components of Net Periodic Benefit (Income) Cost&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit (income) cost consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(income) cost &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Curtailment costs shown in the table above were related to the cost reduction program announced in December 2018, which was completed in 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employer Contributions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations.  Altria made employer contributions of $16 million to its pension plans during the nine months ended September 30, 2020.  Currently, Altria anticipates making additional employer contributions to its pension plans during the remainder of 2020 of up to approximately $20 million based on current tax law.  Altria did not make any employer contributions to its postretirement plans during the nine months ended September 30, 2020.  Currently, Altria anticipates making employer contributions to its postretirement plans of up to approximately $60 million  in 2020.  However, these estimates may be subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on assets, changes in interest rates or other considerations.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfMTI3OA_0daba9f9-fa6f-47d9-9c0f-4e1ee124c7b0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit (income) cost consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(income) cost &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0xLTEtMS0w_77c83c96-7fe0-4752-ab6a-7d1cf6698cab"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0zLTEtMS0w_43a9d2f1-bd88-420e-9b06-6f8e750024ac"
      unitRef="usd">52000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC01LTEtMS0w_84bae343-0240-414c-b386-b7dc7a38905f"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC03LTEtMS0w_6a113346-6683-42f6-aa12-692f3984950c"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC05LTEtMS0w_04de6a3b-dc1d-40df-93d1-2e91bac3ca7a"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0xMS0xLTEtMA_1554041d-adb7-4211-abb2-83001e976981"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0xMy0xLTEtMA_546811c2-c6ac-44f7-95d0-091847718d06"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNC0xNS0xLTEtMA_66b71099-4e36-4ee0-9680-c82f6d9db98e"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0xLTEtMS0w_43235172-4ec9-462d-8e70-26ca3c6f70f2"
      unitRef="usd">188000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0zLTEtMS0w_a8c6e026-3d60-4cae-9e7f-6d802de9d326"
      unitRef="usd">229000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS01LTEtMS0w_ada65c57-a81e-4282-85a8-57b48e722861"
      unitRef="usd">44000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS03LTEtMS0w_df914989-9927-4f43-a67a-faabae1f2823"
      unitRef="usd">57000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS05LTEtMS0w_727a6dce-3f8e-43cb-b0f2-5d0239e00de9"
      unitRef="usd">62000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0xMS0xLTEtMA_f096002f-8b2d-458d-a6db-96179579641f"
      unitRef="usd">77000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0xMy0xLTEtMA_e64746a8-547a-4b02-913b-1e97c72e2c83"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNS0xNS0xLTEtMA_53f03056-634e-4d1c-9ae3-199913489a24"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0xLTEtMS0w_70ca375e-b8ea-4316-b36c-45fdf76c535e"
      unitRef="usd">376000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0zLTEtMS0w_fc2e7e8a-3388-49d5-af8c-c6c6f76154b3"
      unitRef="usd">431000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi01LTEtMS0w_012284f5-8180-4044-b2c4-6cb2b2c882d3"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi03LTEtMS0w_111ffd94-9350-4b44-a2f9-ea6d1012024a"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi05LTEtMS0w_ddd5f819-e770-400b-acd5-11bcec6fe2c0"
      unitRef="usd">125000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0xMS0xLTEtMA_77f04eb5-4d25-45b9-83cc-5f344fdb7aba"
      unitRef="usd">143000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0xMy0xLTEtMA_3e533794-a534-4e10-bcc0-6a7b6c893e45"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfNi0xNS0xLTEtMA_2422ad25-b217-49dd-93d7-aec7db42f28c"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0xLTEtMS0w_137906e0-16aa-4c98-a81e-2c8ea8f2aefc"
      unitRef="usd">-108000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0zLTEtMS0w_37b0eb1e-cdc3-44cb-86de-fc1e55e0eb8b"
      unitRef="usd">-119000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC01LTEtMS0w_5657088f-8328-4177-8430-0341389e8a91"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC03LTEtMS0w_cd69548b-c74c-4274-9dbc-ebb0eb404178"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC05LTEtMS0w_787783fb-bad2-4afa-aadb-1c80b4923655"
      unitRef="usd">-55000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0xMS0xLTEtMA_1c82e241-a88d-4aeb-8b53-0e21b3f68b5a"
      unitRef="usd">-39000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0xMy0xLTEtMA_fd2207a6-d263-4476-ad82-f88f30da674f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOC0xNS0xLTEtMA_1505395d-a145-461c-979c-36de49e111dc"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0xLTEtMS0w_cef2360f-c8e1-426f-aa72-02c836e89d65"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0zLTEtMS0w_c3523aa4-3135-44f5-b3fe-fd0e315c518b"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS01LTEtMS0w_a4d8ac43-ea09-4f2e-8e0f-074759a80ba7"
      unitRef="usd">-22000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS03LTEtMS0w_e1fe5f0c-09f3-49a3-90f4-2ee14a74c2b6"
      unitRef="usd">-22000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS05LTEtMS0w_08bf4f8d-16a2-4738-8052-bc98030648f4"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0xMS0xLTEtMA_61c5f2df-b411-4c97-b068-ada3aaeda4f3"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0xMy0xLTEtMA_6155d876-787d-4204-9592-84d5f4332b00"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfOS0xNS0xLTEtMA_6468ca6c-588a-4b63-8b95-a0354752d46a"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMS0xLTEtMA_dcd04cc6-3009-48df-b996-46e9c34155ee"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMy0xLTEtMA_bb3d5299-15fc-4aa9-82a5-bbb60a2939fb"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtNS0xLTEtMA_985704db-c62e-40ec-86c4-160eb2a76a66"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtNy0xLTEtMA_ba4c704e-2098-4a87-a238-bc6050e9b594"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtOS0xLTEtMA_b3c71060-2657-40ae-aaab-d95395950d62"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMTEtMS0xLTA_7ff635c0-dae1-40e7-9b43-ea2285fcb22a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMTMtMS0xLTA_cabfe343-e5ef-4fe5-b292-c0b69fd086c9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTAtMTUtMS0xLTA_8a9639a5-e736-44ca-ba34-273ad356fa72"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMS0xLTEtMA_8929a806-d2b0-499d-adc8-6f4fd1e447b7"
      unitRef="usd">-21000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iccaf3f2225074f07a8e32f13eb9084f0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMy0xLTEtMA_26c2cf3c-7d2f-47ae-a0ad-a19091f835e5"
      unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtNS0xLTEtMA_8eea666e-b7f3-443e-9873-aea2a092551a"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i92e7a5cd719b47dd96d9d31e8b020fcb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtNy0xLTEtMA_92bac6af-d191-4d70-a0d1-84673e2294e7"
      unitRef="usd">44000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtOS0xLTEtMA_064b00c5-7dc0-41f1-b4a1-b489bb88322d"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie4802d5cc8664a51ad5df8ef88207db8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMTEtMS0xLTA_449a124d-4769-4d92-aa07-f051fc756984"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i82f87da0dd9847138122e04ccdc844a9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMTMtMS0xLTA_85665319-54e7-461e-9583-489a7a566f39"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia859ed497ade432f9aa5e496520ff615_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RhYmxlOjI0N2JjMGIxMmM1ZDQzYTM5NGJkODYxNjU4NzQ5ZDFmL3RhYmxlcmFuZ2U6MjQ3YmMwYjEyYzVkNDNhMzk0YmQ4NjE2NTg3NDlkMWZfMTEtMTUtMS0xLTA_a50b7356-320b-4110-824d-088a3666d42f"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfNTgz_cf0dc59e-f87b-41aa-bb8d-c47f5762ab34"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="ie6377dd911ef4b1ab1d8dfb3730af782_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfNzY1_e09a7b52-5484-4772-8be7-aa03fdc18fd0"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i698e79020417485ebd1c42eabd0b640e_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfODA2_09194448-a111-4090-a8dc-b491c6960ae4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i36d2d484cfba4fb6ad475e2cfcf66462_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl84OC9mcmFnOmZhZTBlNzIxOGE2NzQzNzk4NTdhYmIyZmQ0MzBhYTEwL3RleHRyZWdpb246ZmFlMGU3MjE4YTY3NDM3OTg1N2FiYjJmZDQzMGFhMTBfOTk3_d952c784-574b-42d0-aad8-fce08a2e23cf"
      unitRef="usd">60000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RleHRyZWdpb246MmVmOTYzYTQ2NTY4NGJhMjlmNTI5YzliNTU3OWRjNWNfMTE2_6eb650f5-2939-446e-b770-b4f1ad941953">Earnings (Losses) Per Share:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (losses) per share (&#x201c;EPS&#x201d;) were calculated using the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses) attributable to Altria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed earnings attributable to share-based awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for basic EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: contingently issuable performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RleHRyZWdpb246MmVmOTYzYTQ2NTY4NGJhMjlmNTI5YzliNTU3OWRjNWNfMTI3_503ca56a-663e-4814-a967-c685be8e35ef">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (losses) per share (&#x201c;EPS&#x201d;) were calculated using the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses) attributable to Altria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed earnings attributable to share-based awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for basic EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: contingently issuable performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfMy0yLTEtMS0w_522870bb-9626-41cf-88ab-2ee8bb5330da"
      unitRef="usd">2543000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfMy00LTEtMS0w_3d71242e-88e6-4009-abbb-d4bfceb0d2ef"
      unitRef="usd">516000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfMy02LTEtMS0w_e8b84380-064a-4c1f-a1f2-22bc0995f7b2"
      unitRef="usd">-952000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfMy04LTEtMS0w_0e8f2694-bc0d-4226-86ab-d696f2f30082"
      unitRef="usd">-2600000000</us-gaap:NetIncomeLoss>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNC0yLTEtMS0w_b9058027-969e-4fbf-9287-a9e9c07a52a0"
      unitRef="usd">6000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNC00LTEtMS0w_5f9d7b28-5808-488a-8cbe-492efcbabbf7"
      unitRef="usd">5000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNC02LTEtMS0w_fecde2a8-5d10-4844-a306-d3b8e1ab5753"
      unitRef="usd">1000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNC04LTEtMS0w_302d38ed-8bc5-4341-a770-fae008038c9a"
      unitRef="usd">1000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNS0yLTEtMS0w_5092efa7-ddb1-496b-9ba1-bdf9ac0ae9f8"
      unitRef="usd">2537000000</mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted>
    <mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNS00LTEtMS0w_5aea139d-56d8-4606-81a2-12f6d4197bfb"
      unitRef="usd">511000000</mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted>
    <mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNS02LTEtMS0w_9b5f73f9-9f6d-4140-b21a-ce734205532d"
      unitRef="usd">-953000000</mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted>
    <mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNS04LTEtMS0w_7edc9f6b-7978-4dd5-9a87-91bac6181713"
      unitRef="usd">-2601000000</mo:NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNy0yLTEtMS0w_0a6b2dd5-267d-48a0-8331-835eb3e8594d"
      unitRef="shares">1858000000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNy00LTEtMS0w_b51dabd4-8c59-4be2-9b9d-7b7c27dc8396"
      unitRef="shares">1871000000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNy02LTEtMS0w_d32bea14-d7cb-4f38-8ef8-ea7792f8425a"
      unitRef="shares">1858000000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfNy04LTEtMS0w_f3368589-6f28-42ec-9c86-eeb339c1f373"
      unitRef="shares">1868000000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOC0yLTEtMS0w_2eec08d0-8d46-4f3e-ac57-3179ce49b757"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOC00LTEtMS0w_d9eef664-7b4e-42a4-a28e-6d41f98db348"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOC02LTEtMS0w_37536914-1272-41a4-ba79-b40f1af420c3"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOC04LTEtMS0w_0188a3a5-6622-4499-9c19-ef44c28cea0f"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOS0yLTEtMS0w_f3a631ce-9d60-4b0d-941c-a45af28847e1"
      unitRef="shares">1859000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOS00LTEtMS0w_1bfd30d4-ad54-41a7-82d9-b9152d26f523"
      unitRef="shares">1871000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOS02LTEtMS0w_3f72f9e4-a2e7-45aa-aec2-d086367246a1"
      unitRef="shares">1859000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85MS9mcmFnOjJlZjk2M2E0NjU2ODRiYTI5ZjUyOWM5YjU1NzlkYzVjL3RhYmxlOjc5OTc0ZWQwNjJhOTQyMmE5NjgxNWNjM2I4MWRjOWVlL3RhYmxlcmFuZ2U6Nzk5NzRlZDA2MmE5NDIyYTk2ODE1Y2MzYjgxZGM5ZWVfOS04LTEtMS0w_7cc35c27-3fbb-4a79-9148-6b2768d418b2"
      unitRef="shares">1868000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RleHRyZWdpb246Y2JjN2NjYmVjOTRmNGFjZWIyYzg5MjQ0MzU0ZjA1ZTdfMjE4_3c22321d-9b88-4688-888a-3bee355eceec">Other Comprehensive Earnings/Losses:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Primarily reflects Altria&#x2019;s share of ABI&#x2019;s currency translation adjustments and the impact of Altria&#x2019;s designated net investment hedges.  For further discussion of designated net investment hedges, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Amounts are included in net defined benefit plan costs.  For further details, see Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Amounts are included in earnings (losses) from equity investments.  For further information, see Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RleHRyZWdpb246Y2JjN2NjYmVjOTRmNGFjZWIyYzg5MjQ0MzU0ZjA1ZTdfMjM4_e5b314d9-40f9-4d3f-8ddc-d56996df37cd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,023)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,547)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5162cf1b3ad7427d95b3b1edd5f61452_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMy0yLTEtMS0w_01776931-34ef-4b08-b4f9-f7f22a28dc83"
      unitRef="usd">-2192000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87eaf39b7366430e9f68266017701b5b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMy00LTEtMS0w_29394bb9-d103-4b6b-90bb-0912e5c38cc5"
      unitRef="usd">-693000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ff69a497b0648929df0cbfb8bd32e75_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMy02LTEtMS0w_e0737d29-1cea-4de3-b93a-35d5c66d0ad8"
      unitRef="usd">21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5979906ef954a38814196686ea7e5cc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMy04LTEtMS0w_29f1f477-8fa8-498d-8be6-3739568cfe52"
      unitRef="usd">-2864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNS0yLTEtMS0w_e229107e-df8d-4bb9-98ac-0cad103a6b67"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNS00LTEtMS0w_31c2349e-777b-4ce3-bdc1-f7a5489ffa76"
      unitRef="usd">-1211000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNS02LTEtMS0w_3be17f94-0d78-4e34-b910-74ffda1af2f9"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNS04LTEtMS0w_5bda9a29-153d-4979-8c95-b9a7e7a7633e"
      unitRef="usd">-1302000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNi0yLTEtMS0w_e1af82e4-ff3b-440f-a12e-ba1d6fba2ae5"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNi00LTEtMS0w_86680e5c-acc9-4fb5-ac58-8a264ef5bfea"
      unitRef="usd">-260000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNi02LTEtMS0w_7f42e21a-4a2e-4266-9fe0-68d4fc68e359"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNi04LTEtMS0w_b9ef50a3-bd2e-41c6-af03-d2190e7c70b7"
      unitRef="usd">-279000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNy0yLTEtMS0w_d1806930-3ba1-40d2-955f-915c53f73d8f"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNy00LTEtMS0w_03c8327a-584e-4776-845f-33ee14781d5e"
      unitRef="usd">-951000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNy02LTEtMS0w_1f0ff1a3-06b1-4e04-9a04-129bf95f9840"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfNy04LTEtMS0w_6ed088bf-8dbb-4278-994e-5c2d18ce47f8"
      unitRef="usd">-1023000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfOS0yLTEtMS0w_bcbc9b5e-abc6-46f4-b4bf-db49b50a737b"
      unitRef="usd">-111000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfOS00LTEtMS0w_67df19ad-3346-4c45-b06d-c605dacf6a9f"
      unitRef="usd">-29000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfOS02LTEtMS0w_5de2dc82-49d5-44cc-ba12-b4d258263e66"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfOS04LTEtMS0w_1a7c8603-93be-453a-a599-86814edfd7af"
      unitRef="usd">-140000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTAtMi0xLTEtMA_1e930764-1f2c-401e-859d-9bbdb1a6e769"
      unitRef="usd">-28000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTAtNC0xLTEtMA_216c35d0-9fb6-4fb7-89ee-1e0498879627"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTAtNi0xLTEtMA_84ff658f-19b4-4c6b-b4e2-da686b707c53"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTAtOC0xLTEtMA_e7651f7e-4d1b-44b0-a408-19ac7c7862d4"
      unitRef="usd">-34000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTEtMi0xLTEtMA_c4757430-3aa6-4328-85ad-363d6ee35915"
      unitRef="usd">-83000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTEtNC0xLTEtMA_acf9e124-9bc1-41a8-b779-a0d989e8d84b"
      unitRef="usd">-23000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTEtNi0xLTEtMA_7bcfaa5c-08be-433b-8db3-4dab74528745"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTEtOC0xLTEtMA_01607795-52d5-467f-9627-af619a792406"
      unitRef="usd">-106000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic33f3690e7154677bfdfc88d3521f5b7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTMtMi0xLTEtMA_847a21a0-2812-4217-bf7c-5865a0a7ff58"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0cdfaeeb5c294ba7baf4a426ed5eca08_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTMtNC0xLTEtMA_5a44f1b3-ac68-4a41-86d7-4475d37dd79b"
      unitRef="usd">-928000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0ceeba6c7b384b1391bfb29f77157535_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTMtNi0xLTEtMA_57e72510-6c73-4144-be74-a20cbbabf9f3"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i68f9f932d6734e16b2cea745dbde2c50_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTMtOC0xLTEtMA_257ea399-7ef3-484e-889b-734b192a5047"
      unitRef="usd">-917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i10a65e697a2e4b2b84e0947bc730b6a7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTUtMi0xLTEtMA_b49306bb-9c16-4e4c-a1b8-252ed143b564"
      unitRef="usd">-2165000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifc218d99dbae4bc6925e235fb558f052_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTUtNC0xLTEtMA_9cf8a736-fa4d-4253-9902-91bf27fc6c74"
      unitRef="usd">-1621000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1610ea0297f041709a85e25af892c5f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTUtNi0xLTEtMA_0f342253-d9ae-4496-a8af-e98c3d2fd24f"
      unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id2165dd6285c436395dd6d4adac5414f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85NC9mcmFnOmNiYzdjY2JlYzk0ZjRhY2ViMmM4OTI0NDM1NGYwNWU3L3RhYmxlOjZmMmJkOGY1NDg5MDRkMjdiM2I1ZmY0ZjJjNzFkNDI1L3RhYmxlcmFuZ2U6NmYyYmQ4ZjU0ODkwNGQyN2IzYjVmZjRmMmM3MWQ0MjVfMTUtOC0xLTEtMA_a8b0d55b-ca5d-4b8a-840e-1fc48058eb8f"
      unitRef="usd">-3781000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ce36a3023924317bfdc3b0e1809fdb9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMy0yLTEtMS0w_39ed5c01-2d30-4f9b-8865-f7158b40d070"
      unitRef="usd">-2150000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i20745bf90a514b81888839906b4a8175_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMy00LTEtMS0w_88eb34fd-c333-41e2-9427-e8c55ca7bdef"
      unitRef="usd">-1606000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0026447ea51456899a37ff23aae7db6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMy02LTEtMS0w_95ada13f-63bd-4181-84b2-db0b1833f54c"
      unitRef="usd">-18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib857eef0de4e443fa7bfba0c972defc6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMy04LTEtMS0w_949f2957-6a16-48d1-becb-5717f311df37"
      unitRef="usd">-3774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNS0yLTEtMS0w_74b3c574-f44c-4839-b800-32fce0e6a572"
      unitRef="usd">-75000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNS00LTEtMS0w_5c8dc006-c153-40bc-8b7c-79e98f666a27"
      unitRef="usd">-71000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNS02LTEtMS0w_e2e80348-e22b-4043-b730-4eca7e7c96e0"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNS04LTEtMS0w_e4779e63-fec5-40a1-92f6-bc991fe1f3a9"
      unitRef="usd">-123000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNi0yLTEtMS0w_b1f0a022-c46e-4fd3-bfbb-c990c6af404d"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNi00LTEtMS0w_165e0447-c068-4dc6-95bb-4bbdb1d7b02b"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNi02LTEtMS0w_99403d5c-8118-44c4-8995-a23edfc493a5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNi04LTEtMS0w_8639b72d-842f-4651-a758-e57d6f7283ee"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNy0yLTEtMS0w_d88fbef6-d36c-4075-9a0f-ec247e8a4f34"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNy00LTEtMS0w_d5c45b5c-3dc1-47b0-88f5-2c95b056416e"
      unitRef="usd">-49000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNy02LTEtMS0w_a1055008-f7e2-431c-a6f2-c6812fd84d7b"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfNy04LTEtMS0w_c690a611-65ec-4aa2-b397-96a8d09e79e4"
      unitRef="usd">-82000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfOS0yLTEtMS0w_af379a14-0d95-4bda-bee7-9e094a8ff49d"
      unitRef="usd">-55000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfOS00LTEtMS0w_3ed33d14-d7cd-4841-b927-c8e68a11cd31"
      unitRef="usd">-44000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfOS02LTEtMS0w_e8528ae8-0c9b-4604-87c1-3e86a0ca3fa6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfOS04LTEtMS0w_90b9b2a4-b86f-48d1-831e-1d50f801e4fe"
      unitRef="usd">-99000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTAtMi0xLTEtMA_b5da8e14-2ba6-4184-8af1-a4a055cefa3b"
      unitRef="usd">-14000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTAtNC0xLTEtMA_b64fa3ec-ecee-4bf5-947f-f3220abeadfa"
      unitRef="usd">-10000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTAtNi0xLTEtMA_b527b84e-794c-44ee-a615-5c2b9b5f2859"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTAtOC0xLTEtMA_59795e50-3886-4e99-b6ac-58e76fef797a"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTEtMi0xLTEtMA_1a1bcfcd-a65d-41c5-8f9f-15752c8ec783"
      unitRef="usd">-41000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTEtNC0xLTEtMA_c3fe04b4-8b56-4412-9716-cec0864a4c93"
      unitRef="usd">-34000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTEtNi0xLTEtMA_013e2030-ed29-4c13-8e49-00fc0e7ca58e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTEtOC0xLTEtMA_1f094215-f9c3-483e-9950-b271ec31e16d"
      unitRef="usd">-75000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i996693dba6b1457b8d1ca32c8e4b6089_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTMtMi0xLTEtMA_0e8f9253-4a9d-46b6-bcb3-8d8344234494"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8fc8febe647949e79218601be9537698_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTMtNC0xLTEtMA_f8efd309-19e3-4f44-81e9-04626cfbd2bb"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iffbc05d35eb44074b9989cd024dfbdb3_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTMtNi0xLTEtMA_14a71913-c04a-400b-9c79-3c5575c0c816"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTMtOC0xLTEtMA_ab48970d-35dd-43cd-aabc-efade4581d83"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i10a65e697a2e4b2b84e0947bc730b6a7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTUtMi0xLTEtMA_e3b7c6be-fa83-4038-8c08-42b71feaaeb0"
      unitRef="usd">-2165000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifc218d99dbae4bc6925e235fb558f052_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTUtNC0xLTEtMA_db22853c-7c39-4e65-8c2b-2a74dcee5d27"
      unitRef="usd">-1621000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1610ea0297f041709a85e25af892c5f4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTUtNi0xLTEtMA_c4167e1d-85f0-4dab-8bf3-22c94a2e49f9"
      unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id2165dd6285c436395dd6d4adac5414f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl85Ny9mcmFnOjdkZmY5Y2M1Y2M2YzQyNDRhZjMwZDBiYWE1ZGRmMDEyL3RhYmxlOjYyMjdhMmY1NzA4YTRlZTM4OGFlNGI0ZjUyM2IyNDEzL3RhYmxlcmFuZ2U6NjIyN2EyZjU3MDhhNGVlMzg4YWU0YjRmNTIzYjI0MTNfMTUtOC0xLTEtMA_ec059890-6d19-40b4-ac98-6212e4921be8"
      unitRef="usd">-3781000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i142eff51b3ab421c889c6d2bb5e2ac10_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzMtMi0xLTEtMA_788af74d-462d-49a8-aa2e-336665d916e2"
      unitRef="usd">-2168000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0494c954d344876932c1bdd4e2367e0_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzMtNC0xLTEtMA_f6ac480d-0431-4296-a9b6-090ec7c2f8b1"
      unitRef="usd">-374000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46102449b128460b8ae18a5fe9e0fd56_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzMtNi0xLTEtMA_0abd4670-219d-4780-b75d-218ae4db20e3"
      unitRef="usd">-5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i820a924d574a40d381950cff0e1a0426_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzMtOC0xLTEtMA_5cd018cb-32d8-48c6-b255-32371698818d"
      unitRef="usd">-2547000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzUtMi0xLTEtMA_47c1cae2-edc2-48e5-b854-42c3d4d17f3d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzUtNC0xLTEtMA_3bd925b3-c1ef-4986-9c6d-b4a3f54677ca"
      unitRef="usd">108000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzUtNi0xLTEtMA_8e0b7aa5-480e-414c-9178-b11f252949dc"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzUtOC0xLTEtMA_8f08abbe-0d4f-4e92-8c5a-f36f2d86e02d"
      unitRef="usd">116000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzYtMi0xLTEtMA_e457ad37-6d08-4c29-be70-458de7bb72b3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzYtNC0xLTEtMA_b5f1fb86-d343-4c7e-9e64-141a1a3d64b3"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzYtNi0xLTEtMA_84e4a8ed-a727-41b2-9bcd-8e96391ce38d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzYtOC0xLTEtMA_04c9ce14-0bed-4abb-b1c1-43cfe9859bf9"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzctMi0xLTEtMA_fadf3dab-5357-4a4c-bf53-ad73b6026987"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzctNC0xLTEtMA_4f0c3ccb-0b7f-4807-a616-71d35c7f7f37"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzctNi0xLTEtMA_7fead27a-2c69-431a-8389-69e1cc31170e"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzctOC0xLTEtMA_6a4c49d9-c1bf-42dc-9c6d-16f7e6c905f3"
      unitRef="usd">88000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzktMi0xLTEtMA_f437700f-1db9-4746-a2da-3b0cadc54ce6"
      unitRef="usd">-113000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzktNC0xLTEtMA_9843deda-0d9d-4762-81d7-fe481a7a2814"
      unitRef="usd">35000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzktNi0xLTEtMA_f62315c8-2a77-43b2-aba4-f67ab07ac1d1"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzktOC0xLTEtMA_7f6d7d95-1573-40ac-8115-4c87d9e7c360"
      unitRef="usd">-78000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEwLTItMS0xLTA_c1fca43e-7f10-4f72-a6af-48c949001b15"
      unitRef="usd">-29000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEwLTQtMS0xLTA_18666ca2-2035-4889-9218-8d376dd95a43"
      unitRef="usd">8000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEwLTYtMS0xLTA_0396260e-9bdf-4eb8-abf6-828f4930aad5"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEwLTgtMS0xLTA_1153b85e-26ab-4934-bf94-6d879603a653"
      unitRef="usd">-21000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzExLTItMS0xLTA_db199b4d-45aa-4cf3-b8bd-9f37b56ee118"
      unitRef="usd">-84000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzExLTQtMS0xLTA_44ac2c21-576d-42a5-84ab-13f3e00cdce8"
      unitRef="usd">27000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzExLTYtMS0xLTA_dab4da2b-1ef8-4eba-88f2-34f68f57223a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzExLTgtMS0xLTA_2f82a92b-2ec0-4e1c-814b-a64032da5828"
      unitRef="usd">-57000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i83affb2b2cdf430899a8d587f5c37734_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEzLTItMS0xLTA_c961b7f5-e4d3-4782-9edb-6c73a28a030d"
      unitRef="usd">84000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i06a309cdcec14688bed249fb6477ca4a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEzLTQtMS0xLTA_0679d710-341f-484a-8291-1409b5edf05f"
      unitRef="usd">53000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8fd9e4bffbda4cd0b41b9e3abf769ed2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEzLTYtMS0xLTA_668a6ba0-95b7-4a3d-b9c4-73e06fd8ade6"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i31f2e12449f14c3097e5a3e7a9dae3a8_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzEzLTgtMS0xLTA_a02a050e-3489-4440-9f45-2b0b4bb9c6d7"
      unitRef="usd">145000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf39d90acfc94fa8ae8510b5ee508977_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzE1LTItMS0xLTA_cb54544a-0818-49d1-94a9-1fa533e72b66"
      unitRef="usd">-2084000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f18c4a56df2461bbfd5d9dee8b61589_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzE1LTQtMS0xLTA_f522dab0-a22a-433f-9a96-c631c0ab6cf7"
      unitRef="usd">-321000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba075e861d6f4cc9998f78ffd3276986_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzE1LTYtMS0xLTA_510b7c68-3e6c-4d39-bf9d-bb48685ded64"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4251896369a74d0aa90e3bc70584b869_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDAvZnJhZzplMWFlYjZmZGI0ZjU0NjU5OTgxYjE3NGVmZmU0ZmUzMS90YWJsZTpkMDM0MGZmOTY3ZDU0ODUxOTEyZWE3NTBjNjRhZmJmMC90YWJsZXJhbmdlOmQwMzQwZmY5NjdkNTQ4NTE5MTJlYTc1MGM2NGFmYmYwXzE1LTgtMS0xLTA_bb5d2821-5c98-4628-a1db-ce50e550b0bf"
      unitRef="usd">-2402000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie22dd2129baa4a278c19c2b770f10c74_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzMtMi0xLTEtMA_21a4a630-6ae6-4035-9149-a46ceb1026e4"
      unitRef="usd">-2110000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d44379763c14be6b50fdea177e1105a_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzMtNC0xLTEtMA_e80e039e-e7c2-48fc-8f26-3002b6cb77d8"
      unitRef="usd">-542000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4ba820f281e46a0856811d6505d6c82_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzMtNi0xLTEtMA_20f92a37-0c7d-4203-aad0-4d9d974580fa"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib371c96cf5004c8b8e72e342916dd913_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzMtOC0xLTEtMA_445a29e0-dc76-4b04-af8a-293338d4759c"
      unitRef="usd">-2646000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzUtMi0xLTEtMA_ef9b02b8-d448-424f-9593-87b9273243d6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzUtNC0xLTEtMA_f744f853-b7c8-4c41-a486-34c8e4ed10f1"
      unitRef="usd">290000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzUtNi0xLTEtMA_bd2680b2-3203-4fca-94b9-98dd37518fad"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzUtOC0xLTEtMA_9f252d71-03c8-4a87-8f34-91fdfacc43db"
      unitRef="usd">285000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzYtMi0xLTEtMA_5c1e42b1-4a44-4790-98a9-2623e59ca37d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzYtNC0xLTEtMA_3ab90dcb-7d58-441d-a467-942d053efd13"
      unitRef="usd">67000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzYtNi0xLTEtMA_2cfde99f-f82f-4813-a8ca-1beb3ad186a7"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzYtOC0xLTEtMA_fdcea9d0-5bd9-4138-8c08-b4e0174047d5"
      unitRef="usd">65000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzctMi0xLTEtMA_a10c8aad-ee00-4ebb-80e4-23f779830a76"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzctNC0xLTEtMA_0e275e03-05b5-4f84-ac15-78e9bbd37a9c"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzctNi0xLTEtMA_8bab11d2-d229-4b24-938b-1daa07a0ddf5"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzctOC0xLTEtMA_622cb131-6a1e-4b16-af35-4321b9068fb2"
      unitRef="usd">220000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzktMi0xLTEtMA_d557023f-a9ee-47fd-8e1d-c1565796f3f8"
      unitRef="usd">-35000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzktNC0xLTEtMA_911f9058-8755-4d4b-894a-f166d3cee72f"
      unitRef="usd">4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzktNi0xLTEtMA_3d798cf6-ac09-43b9-acc0-9a65ae61db40"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzktOC0xLTEtMA_6206473e-8567-4026-ba13-f02605f27c8d"
      unitRef="usd">-31000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEwLTItMS0xLTA_3bc8cf5f-be8a-4590-b011-3ff651b35700"
      unitRef="usd">-9000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEwLTQtMS0xLTA_5ebc71e8-b5aa-4543-9007-6a655ece3ba2"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEwLTYtMS0xLTA_cb4cb947-c99f-43f8-a8c3-6d12c08f465f"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEwLTgtMS0xLTA_b68690f1-1779-441c-8cb1-2695b354a8d8"
      unitRef="usd">-7000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzExLTItMS0xLTA_a96bbf8f-c5ac-4eeb-a9bf-8ddca29380dd"
      unitRef="usd">-26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzExLTQtMS0xLTA_610b82c3-e3a4-4ec8-a87a-eb675b839a15"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzExLTYtMS0xLTA_4b4d9cd6-19c6-4cf9-9e82-9b4ec661dd80"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzExLTgtMS0xLTA_9dae156a-0812-4948-9ef2-d3724270f615"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if187dd839c0d44c7a0b43bc2846e9ab3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEzLTItMS0xLTA_b32e4c61-2af8-48ed-8418-3b3944663f88"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id40b8c6e48414c18975664b2a81a4fae_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEzLTQtMS0xLTA_8a40a41e-de7e-40d1-a138-4505a9211644"
      unitRef="usd">221000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5c279e9c84545e58200369279b79d0f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEzLTYtMS0xLTA_9ad6d1cd-b6b5-4920-9256-3420f10610bb"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i581f616bc22040e89c01ee4d52587f77_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzEzLTgtMS0xLTA_95940239-2abc-40ae-bdf1-dd6a0296effe"
      unitRef="usd">244000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf39d90acfc94fa8ae8510b5ee508977_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzE1LTItMS0xLTA_f71dc47f-fdef-47c9-9ee6-bece5d20e95e"
      unitRef="usd">-2084000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f18c4a56df2461bbfd5d9dee8b61589_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzE1LTQtMS0xLTA_4592b858-fa5f-4109-9e24-070e802d0e5b"
      unitRef="usd">-321000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba075e861d6f4cc9998f78ffd3276986_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzE1LTYtMS0xLTA_65bad788-8a2f-4428-b54a-a0108866f958"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4251896369a74d0aa90e3bc70584b869_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDMvZnJhZzplMTdlNDVhZjdhODE0NzEzYWJlZWQ3OWMxMzYyOTZlZC90YWJsZToyZjkxMjNhNWY0NWQ0OTk2YTQzZDg1M2VkNWFkYWY1MC90YWJsZXJhbmdlOjJmOTEyM2E1ZjQ1ZDQ5OTZhNDNkODUzZWQ1YWRhZjUwXzE1LTgtMS0xLTA_2405fd91-9982-4914-b3ce-b75183692c91"
      unitRef="usd">-2402000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90ZXh0cmVnaW9uOmE1YTAyNjlmNzAyMDQ1YjU4NjQ3MzY4MmU2ZDNlNzVmXzM5Ng_5708dd12-4881-49f4-a82c-8d6b918b6b0e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Amounts are included in net defined benefit plan costs.  For further details, see Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2) Amounts are included in earnings (losses) from equity investments.  For further information, see Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i56d081780d6247f2a8f44b0cbac75f0e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzQtMi0xLTEtMA_26de25e6-f559-40a5-ba6c-8beb7eda3e71"
      unitRef="usd">129000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i9b93afd3a9384878a3d23d915edb9d34_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzQtNC0xLTEtMA_d65fa2a4-bd87-4893-aa27-6ced4f652e4b"
      unitRef="usd">135000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ic9531ea2ec134d779a09cfd6999071fc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzQtNi0xLTEtMA_2c317cc5-2da9-46a9-8577-e4a64841d8df"
      unitRef="usd">60000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ic552776954674567ad8ceaf455ff2df2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzQtOC0xLTEtMA_fdee35c5-ba70-4c5c-9bf6-171776644697"
      unitRef="usd">42000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ifd559242c87a4839848dc76f7cdba2b9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzUtMi0xLTEtMA_87c80ff2-31ef-4cf4-874f-b42b6ef8057b"
      unitRef="usd">-18000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="id30c8f591ff348eca5e129c73179556d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzUtNC0xLTEtMA_68355a7b-6964-4f83-8c86-74817327fef0"
      unitRef="usd">-22000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i7749829bc252472e80afff2f43879e0c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzUtNi0xLTEtMA_8cccb8fd-5181-4734-961d-95e12575812f"
      unitRef="usd">-5000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ifbdba2ebc8d24db9bde9d1ceeec106c5_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzUtOC0xLTEtMA_a2b675ec-e3ad-405f-96c7-2970630c86ae"
      unitRef="usd">-7000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ie8ebfa9f82c6400c86cea2fa523e12bb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzYtMi0xLTEtMA_11577b97-7845-44c2-b016-b433c09609f6"
      unitRef="usd">111000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i8a7d8dce58e1418492926f41ccd0a901_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzYtNC0xLTEtMA_f3ef7430-e1df-425a-bfa3-a9c69ac8a67a"
      unitRef="usd">113000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i782ce7d0d6c04e66b91c4c3a13f4828b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzYtNi0xLTEtMA_279a48b9-e40d-45c3-b411-092696e19682"
      unitRef="usd">55000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="iea1e2ba6af9c41ddb6f6b2e16f649711_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzYtOC0xLTEtMA_b2bb68b2-2521-4542-9079-dc322b48a989"
      unitRef="usd">35000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if2714d6deaf540cb865eebe43194b5a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzgtMi0xLTEtMA_1f6a7844-277c-4db2-8400-02c18c6e6d5a"
      unitRef="usd">-29000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i40628f1e5dbf41ee82713505cf35318f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzgtNC0xLTEtMA_8b51c257-86c3-4d75-9a43-1494aa6225c8"
      unitRef="usd">35000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib49c01bfae724b45b528bcb25e34b3b5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzgtNi0xLTEtMA_969a28d6-2d7f-4ec8-8c7a-fb38fe286f1d"
      unitRef="usd">-44000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6e3a17982ab540cdb38e40eaa9011fb7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzgtOC0xLTEtMA_b683f7db-230a-45c0-bc67-8006f78ee12c"
      unitRef="usd">4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="if2714d6deaf540cb865eebe43194b5a9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzEwLTItMS0xLTA_5a391c3b-aacc-481c-b976-38b0ede0ec9d"
      unitRef="usd">-140000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i40628f1e5dbf41ee82713505cf35318f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzEwLTQtMS0xLTA_74c87d80-6b5a-4c17-bbcf-5b9e983ad41b"
      unitRef="usd">-78000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib49c01bfae724b45b528bcb25e34b3b5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzEwLTYtMS0xLTA_7c5e25d9-aab3-4be8-b59e-90022f073208"
      unitRef="usd">-99000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6e3a17982ab540cdb38e40eaa9011fb7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDYvZnJhZzphNWEwMjY5ZjcwMjA0NWI1ODY0NzM2ODJlNmQzZTc1Zi90YWJsZTo5ZjUxMTZjNWVmZjQ0N2FjYjMxNWExNTYwYjM4YjY5OS90YWJsZXJhbmdlOjlmNTExNmM1ZWZmNDQ3YWNiMzE1YTE1NjBiMzhiNjk5XzEwLTgtMS0xLTA_6455d999-fe18-4bb5-9e77-f226a7446a11"
      unitRef="usd">-31000000</us-gaap:ProfitLoss>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzMwOTM_1f615e55-860a-4952-aefc-7431e856d884">Segment Reporting:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The products of Altria&#x2019;s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA (including super premium cigarettes previously manufactured and sold by Nat Sherman), machine-made large cigars and pipe tobacco manufactured and sold by Middleton; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC and oral nicotine pouches manufactured and sold by Helix; and wine produced and/or distributed by Ste. Michelle.  The products and services of these subsidiaries constitute Altria&#x2019;s reportable segments of smokeable products, oral tobacco products (formerly smokeless products) and wine.  The financial services and the innovative tobacco products businesses are included in all other. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria&#x2019;s chief operating decision maker (the &#x201c;CODM&#x201d;) reviews operating companies income (loss) (&#x201c;OCI&#x201d;) to evaluate the performance of, and allocate resources to, the segments.  OCI for the segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, net periodic benefit income/cost, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate asset impairment and exit costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income, excluding service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of JUUL equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on Cronos-related financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The comparability of OCI for the reportable segments was affected by the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tobacco and Health Litigation Items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria&#x2019;s condensed consolidated statements of earnings as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts shown in the table above for the smokeable products segment were recorded in marketing, administration and research costs.  For further discussion, see Note 12. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;COVID-19 Special Items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Net pre-tax charges of $50 million ($41 million in the smokeable products segment and $9 million in the oral tobacco products segment) related to COVID-19 were recorded in Altria&#x2019;s condensed consolidated statements of earnings for the nine months ended September 30, 2020.  The net pre-tax charges, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic, were all recorded in costs of sales in the second quarter of 2020 and included premium pay, personal protective equipment and health screenings, which were partially offset by certain employment tax credits.  The COVID-19 special items do not include the inventory-related implementation costs associated with the wine business strategic reset, which are included in asset impairment, exit and implementation costs.  These implementation costs were due to increased inventory levels, which were further negatively impacted by government restrictions and economic uncertainty surrounding the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Asset Impairment, Exit and Implementation Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - See Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Asset Impairment, Exit and Implementation Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a breakdown of these costs by segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzMwOTA_ad23ac4b-a95d-4f14-ad26-968b5dbeb86c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate asset impairment and exit costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:22.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income, excluding service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of JUUL equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on Cronos-related financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74d1129c13a243cfae74e7a2b330f4fb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzQtMi0xLTEtMA_414be3e4-d827-44e4-a27e-216e1afe6fe0"
      unitRef="usd">17522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52bc6e7cfc6045cba8bc9b490b1083c3_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzQtNC0xLTEtMA_b71ea26b-d188-435a-a01a-9988dc80ed6b"
      unitRef="usd">16837000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id84c0fe23d3344d8a09f8c4b47549357_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzQtNi0xLTEtMA_a27f3f58-1762-448a-9c92-b983aef73fbc"
      unitRef="usd">6313000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib56362e25fab48b69747801fbc413df0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzQtOC0xLTEtMA_2d8bbaef-5274-4472-a80c-bd17a76cf1d0"
      unitRef="usd">6049000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a22405436fc4f51965d8d905f04bd29_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzUtMi0xLTEtMA_11a24340-503f-4909-a5e3-14791179694a"
      unitRef="usd">1901000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0c10cef408f4866a62e645271641b17_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzUtNC0xLTEtMA_02b9ed1a-359f-444a-977d-69de9593e370"
      unitRef="usd">1762000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7049d97f344641a984e6e5beb764d3d1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzUtNi0xLTEtMA_a71ba2f1-5b70-4ef9-b179-5cceac9b3942"
      unitRef="usd">640000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5dfaf8cc27be4772b848b7c1b8493b7c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzUtOC0xLTEtMA_9d3f5b2e-802c-4ac5-b4ec-2d2ab9123938"
      unitRef="usd">620000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d1032796fa64fa4895bcb9f14b70233_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzYtMi0xLTEtMA_e0529a84-e8b7-44d7-b1a6-5fc8b3d5d2b5"
      unitRef="usd">434000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id429b5bd1c8d41978646f0f7f455e19f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzYtNC0xLTEtMA_7ec1c31f-8661-49c1-810a-bf5e97f7ceb9"
      unitRef="usd">483000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i878e052a32df4da7a15671ffe7f6c60b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzYtNi0xLTEtMA_7e9a86fe-627d-4656-8036-4085ebc58b93"
      unitRef="usd">157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7356c82749654030be8f256d9f9a9745_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzYtOC0xLTEtMA_7ef249ab-d81f-4842-a5e6-55bcee4d3250"
      unitRef="usd">167000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icba85968187d436ab30ed84caf5e41e0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzctMi0xLTEtMA_2dc999cc-55a3-4a94-9cb9-acbffbb1bba3"
      unitRef="usd">-8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i494ba59d5d0346ec8380c947bd3eb17e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzctNC0xLTEtMA_865194b7-b821-469f-b23d-bb0f3be74f00"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e6a83106cfb4c60a62a2096cd79a1bd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzctNi0xLTEtMA_7883877a-2dba-48ae-9198-8753d5356bac"
      unitRef="usd">13000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c2ac469222e4237be6dcf3d6fa61beb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzctOC0xLTEtMA_abc3383b-cf90-4f02-b22b-be9495051e5e"
      unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzgtMi0xLTEtMA_06a6a063-dbaf-4d17-8528-efa1aad8e38c"
      unitRef="usd">19849000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzgtNC0xLTEtMA_25b0a936-7da3-4f44-8ad6-fd4d14e00783"
      unitRef="usd">19103000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzgtNi0xLTEtMA_a06d90be-8946-46aa-a466-da5c3b69536a"
      unitRef="usd">7123000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzgtOC0xLTEtMA_f8550de2-24d5-409b-9bae-6874c875f83b"
      unitRef="usd">6856000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i74d1129c13a243cfae74e7a2b330f4fb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzExLTItMS0xLTA_dfeb313e-ca25-423f-a124-9ba02d9975b4"
      unitRef="usd">7609000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i52bc6e7cfc6045cba8bc9b490b1083c3_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzExLTQtMS0xLTA_48d1ef34-baff-4472-9f56-22684610bf4c"
      unitRef="usd">6864000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="id84c0fe23d3344d8a09f8c4b47549357_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzExLTYtMS0xLTA_9e16cd73-9f68-40c4-b1f4-122391627a52"
      unitRef="usd">2789000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="ib56362e25fab48b69747801fbc413df0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzExLTgtMS0xLTA_446881b1-eef1-4d39-9b5e-0853e535cbbe"
      unitRef="usd">2561000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i7a22405436fc4f51965d8d905f04bd29_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEyLTItMS0xLTA_d194265c-d418-4a32-846f-312a1d8b15c0"
      unitRef="usd">1297000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="id0c10cef408f4866a62e645271641b17_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEyLTQtMS0xLTA_91fc7e51-bb21-426f-b3b0-cb7d44e4cce4"
      unitRef="usd">1195000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i7049d97f344641a984e6e5beb764d3d1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEyLTYtMS0xLTA_ba68b170-e0b2-4c6e-b7fc-b5e8ac6d18ab"
      unitRef="usd">436000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i5dfaf8cc27be4772b848b7c1b8493b7c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEyLTgtMS0xLTA_f847bb81-68e3-47fe-9e15-4e2e3f448345"
      unitRef="usd">417000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i0d1032796fa64fa4895bcb9f14b70233_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEzLTItMS0xLTA_fa1ead7e-9ec4-4a92-a23a-10513ac414e7"
      unitRef="usd">-347000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="id429b5bd1c8d41978646f0f7f455e19f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEzLTQtMS0xLTA_3583234e-45b5-4440-836a-72e6351f9b8f"
      unitRef="usd">50000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i878e052a32df4da7a15671ffe7f6c60b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEzLTYtMS0xLTA_77eda22c-33f5-45f3-8c89-4a95c182067e"
      unitRef="usd">19000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i7356c82749654030be8f256d9f9a9745_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzEzLTgtMS0xLTA_2cdbe929-d376-489a-8675-203fc1bd1c65"
      unitRef="usd">16000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="icba85968187d436ab30ed84caf5e41e0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE0LTItMS0xLTA_f624f45f-c96f-4bec-acac-d1aa33613d58"
      unitRef="usd">-63000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i494ba59d5d0346ec8380c947bd3eb17e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE0LTQtMS0xLTA_961cb490-f233-4bd3-b5c2-6520119cabf8"
      unitRef="usd">-27000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i5e6a83106cfb4c60a62a2096cd79a1bd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE0LTYtMS0xLTA_c3367265-9d9f-40c9-b6e1-3d555b978051"
      unitRef="usd">-7000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i0c2ac469222e4237be6dcf3d6fa61beb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE0LTgtMS0xLTA_b5814a4e-0827-4410-8921-ae1b47c176a1"
      unitRef="usd">8000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6023956547cd406696d7cc717c5d63cc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE1LTItMS0xLTA_01bda48d-405c-4700-8d09-56e9ab85064e"
      unitRef="usd">54000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2854d38153284db69df70b1b30e12c8b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE1LTQtMS0xLTA_6a02f7a8-8798-498c-a765-16c8fb274602"
      unitRef="usd">28000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5aa10928c42c437b8022ccb9de74838c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE1LTYtMS0xLTA_49876dfa-988e-460d-b285-c6e424e7824f"
      unitRef="usd">17000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idf791c5f8e154ea99ad6848bebce7aea_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE1LTgtMS0xLTA_f029592a-5f95-46b2-9075-dc4e8b66fea2"
      unitRef="usd">12000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE2LTItMS0xLTA_fe555abe-bb11-4c2f-bf1e-edb98cfd1af0"
      unitRef="usd">150000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE2LTQtMS0xLTA_e4cfdc04-8450-41f9-86bd-6bc49dd4b9bd"
      unitRef="usd">154000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i763e7a556b7d49d7899ca7b7ab4b3ab5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE2LTYtMS0xLTA_3b0e0045-a25e-4a67-b79f-2e2cab757704"
      unitRef="usd">60000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie6bebe9ebc8645cc9f8335c03695b4c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE2LTgtMS0xLTA_ee329958-e9d1-43f5-ae0f-bcc9c4013eed"
      unitRef="usd">46000000</us-gaap:GeneralAndAdministrativeExpense>
    <mo:AssetImpairmentandBusinessExitCosts
      contextRef="ie150072c11204059ad8f12d74ddfe374_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE3LTItMS0xLTA_0730a2e4-809f-4fa9-b744-b2f8e6230857"
      unitRef="usd">0</mo:AssetImpairmentandBusinessExitCosts>
    <mo:AssetImpairmentandBusinessExitCosts
      contextRef="i97e3b8d46de74739bdc338732ab80249_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE3LTQtMS0xLTA_86ea3109-ad8d-483c-9dd5-e7b807a4973c"
      unitRef="usd">1000000</mo:AssetImpairmentandBusinessExitCosts>
    <mo:AssetImpairmentandBusinessExitCosts
      contextRef="i763e7a556b7d49d7899ca7b7ab4b3ab5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE3LTYtMS0xLTA_b02a2e76-7669-4f36-ad19-37334eb64cc6"
      unitRef="usd">0</mo:AssetImpairmentandBusinessExitCosts>
    <mo:AssetImpairmentandBusinessExitCosts
      contextRef="ie6bebe9ebc8645cc9f8335c03695b4c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE3LTgtMS0xLTA_5796fd71-ffff-49b0-a5e2-3bb9be89b015"
      unitRef="usd">0</mo:AssetImpairmentandBusinessExitCosts>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE4LTItMS0xLTA_3c9f1746-ece4-4498-8f69-41e88c548635"
      unitRef="usd">8292000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE4LTQtMS0xLTA_66be1db5-545e-467f-8705-b2b8ac2b38df"
      unitRef="usd">7899000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE4LTYtMS0xLTA_773a0b62-ea2a-43ec-a42d-d48fb09080c7"
      unitRef="usd">3160000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE4LTgtMS0xLTA_cf6f986f-f4d2-4951-a419-6b677645bd29"
      unitRef="usd">2944000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE5LTItMS0xLTA_de82dace-78d2-40d2-a051-bdaf50665f87"
      unitRef="usd">-893000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE5LTQtMS0xLTA_16e797d5-713f-4628-9413-5f4ca0620308"
      unitRef="usd">-989000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE5LTYtMS0xLTA_f169d3fa-4866-401f-9f26-e1ce8e2f7e03"
      unitRef="usd">-310000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzE5LTgtMS0xLTA_5c839ef3-b9d7-4742-86c8-ee39c7045c63"
      unitRef="usd">-293000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIwLTItMS0xLTA_92c7a852-5459-41ef-bffe-57d01f37133c"
      unitRef="usd">-58000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIwLTQtMS0xLTA_f1d43101-e8b0-4b97-8d99-e5475150fc6f"
      unitRef="usd">-40000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIwLTYtMS0xLTA_4dce8b96-6675-4337-b8bd-204f29e0df51"
      unitRef="usd">-3000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIwLTgtMS0xLTA_c4779c5f-7f2c-4fd3-9e42-e6b84f568112"
      unitRef="usd">-24000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIxLTItMS0xLTA_e7b31a90-d66e-4e55-a4ef-4d569ff1a062"
      unitRef="usd">-306000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIxLTQtMS0xLTA_6f110e85-7132-4e07-ae22-71d618ffc0b6"
      unitRef="usd">866000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIxLTYtMS0xLTA_3f9b5e4d-a54e-402e-8267-51e0fe9aaaa6"
      unitRef="usd">-472000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIxLTgtMS0xLTA_7d51e856-ded3-4e59-8d83-0231622c5fd6"
      unitRef="usd">333000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTItMS0xLTE0NzM_9990c180-cdf7-4d90-be55-21cf8061afad"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTQtMS0xLTE0Nzc_e2dcdfac-632a-4629-a784-534c0a07120c"
      unitRef="usd">4500000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTYtMS0xLTE0ODE_13c8218d-e313-4a5d-b035-20aa5e1026ff"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTgtMS0xLTE0ODU_e0093db5-5fe1-4d4d-b34b-04aa0a68d010"
      unitRef="usd">4500000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTItMS0xLTA_dc95cb3b-53db-4247-9c3a-54eab029c247"
      unitRef="usd">-202000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTQtMS0xLTA_bec251b0-b935-4545-b932-5f702ffe5270"
      unitRef="usd">-1327000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTYtMS0xLTA_26b79f93-e960-4844-bb0e-7b93b4a7108c"
      unitRef="usd">-105000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIyLTgtMS0xLTA_53506f46-caf0-4223-899c-c7df1aa55fc9"
      unitRef="usd">-636000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIzLTItMS0xLTA_8a64e7b5-c50e-427d-8008-97ad111a19db"
      unitRef="usd">4349000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIzLTQtMS0xLTA_77c52a9b-c10e-4306-8f58-0ca90f9a5348"
      unitRef="usd">1989000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIzLTYtMS0xLTA_e6e576f3-f114-4fb6-bd37-c14fd59740d2"
      unitRef="usd">-324000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTo1ODZjMTc2ZjhmNGY0NzJhYTUyMjhhYTA4NmY3ZGRiNS90YWJsZXJhbmdlOjU4NmMxNzZmOGY0ZjQ3MmFhNTIyOGFhMDg2ZjdkZGI1XzIzLTgtMS0xLTA_c096e07d-6f87-48ff-82f3-0546b548ce0a"
      unitRef="usd">-2128000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzMwOTg_c748df39-069e-4d48-81ee-f95410a96326">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tobacco and Health Litigation Items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria&#x2019;s condensed consolidated statements of earnings as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="if454389f3a1945179f947caaa65a6c31_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzMtMi0xLTEtMA_ba0d4632-0808-4c5c-9aef-4ef62b979a8e"
      unitRef="usd">73000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ic979af41ab9d413bb1ae38f66b2d9d11_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzMtNC0xLTEtMA_5585702e-09da-4eaf-9ee5-cd8c9f207369"
      unitRef="usd">43000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ib3e639fdb4824b70bb2643899d44c0d0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzMtNi0xLTEtMA_00d02700-aa8f-41bb-a842-73da8026a9b6"
      unitRef="usd">34000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i1b13b9a1e91f4d60bd633bbdac2d3a0e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzMtOC0xLTEtMA_2181036e-35ef-4239-84d8-99fb52ac77f0"
      unitRef="usd">3000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i18072db8ab9f45d4adbc775ff5720df9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzQtMi0xLTEtMA_4575b4f3-109e-4c6b-9503-4bd8b058f0a3"
      unitRef="usd">3000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ibe3f5acfbb75415db5d1a986b38445b0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzQtNC0xLTEtMA_533da7cf-cf05-41fc-8707-6babe9ed60d2"
      unitRef="usd">5000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i9a01c76ce7db4a9bb38f21611772ae4c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzQtNi0xLTEtMA_743a4c89-4179-4a79-92be-5270916d5d58"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="iffb9bd71b05044f1960dbd29fea9824d_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzQtOC0xLTEtMA_5c56d32a-4fe7-4240-b32a-00b0f86c577f"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i4789cad0b6a54baaad569d4c6f6fbc61_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzUtMi0xLTEtMA_952b3e30-65fc-43ae-a09c-60d4e30c3a97"
      unitRef="usd">76000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i941f9b86f58e457f869c24db7d24bb4d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzUtNC0xLTEtMA_3a0a80d8-6e98-4207-8b4b-dc4c30152b05"
      unitRef="usd">48000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i2b48ad0497744f6aa97be20fde34f963_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzUtNi0xLTEtMA_12d74eb3-36ac-40e0-b687-4e35fe47e1a3"
      unitRef="usd">34000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i6f398c78ea464bc29dfde286f3202ac5_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90YWJsZTpkOGMzZGU0ZGQ1NmY0OGY5YTdkZjcyNjFmMDVkZDJjZS90YWJsZXJhbmdlOmQ4YzNkZTRkZDU2ZjQ4ZjlhN2RmNzI2MWYwNWRkMmNlXzUtOC0xLTEtMA_39ffed3e-ea22-4aca-ae7a-3d362c2cefdc"
      unitRef="usd">3000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i04eaaa915aec49bd9b52703167950623_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzM4NDgyOTA3MDI4MDM_08417dac-67aa-48fc-916f-69c5fb230f39"
      unitRef="usd">50000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia8c1acc07f234535b9f59b5c08a35421_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzM4NDgyOTA3MDI4MDg_ddc2a6a1-abc4-4d5e-b37c-5ab1403a18d5"
      unitRef="usd">41000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia114b8b08be943bbaeec192f0c9546eb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMDkvZnJhZzo5YmExMTJlZjAzMzk0MGVlYjk3ZTY0YzYzOWFjZGI1Mi90ZXh0cmVnaW9uOjliYTExMmVmMDMzOTQwZWViOTdlNjRjNjM5YWNkYjUyXzM4NDgyOTA3MDI4NTA_b045dee2-1282-487b-80de-9e0c9bf44e08"
      unitRef="usd">9000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzQ0NTM_750c4584-bef9-4bcd-adad-5bc41c2a56e4">Debt:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Short-term Borrowings and Borrowing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020 and December 31, 2019, Altria had no short-term borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2020, Altria had a senior unsecured 5-year revolving credit agreement (as amended, the &#x201c;Credit Agreement&#x201d;) that provides for borrowings up to an aggregate principal amount of $3.0 billion.  The Credit Agreement, which is used for general corporate purposes, expires on August&#160;1, 2023 and includes an option, subject to certain conditions, for Altria to extend the Credit Agreement for two additional one-year periods.  Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of Altria&#x2019;s long-term senior unsecured debt.  Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), or a mutually agreed upon benchmark rate, plus a percentage based on the higher of the ratings of Altria&#x2019;s long-term senior unsecured debt from Moody&#x2019;s Investors Service, Inc. (&#x201c;Moody&#x2019;s&#x201d;) and Standard&#160;&amp;amp; Poor&#x2019;s Ratings Services (&#x201c;Standard &amp;amp; Poor&#x2019;s&#x201d;).  The applicable percentage based on Altria&#x2019;s long-term senior unsecured debt ratings&#160;at September 30, 2020 for borrowings under the Credit Agreement was 1.0%.  The Credit Agreement does not include any other rating triggers, or any provisions that could require the posting of collateral.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, due to the uncertainty at that time in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the full $3.0 billion available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility.  In June 2020, Altria repaid the full amount outstanding under the Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At September 30, 2020, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 9.2 to 1.0.  At September 30, 2020, Altria was in compliance with its covenants in the Credit Agreement.  The terms &#x201c;Consolidated EBITDA&#x201d; and &#x201c;Consolidated Interest Expense,&#x201d; each as defined in the Credit Agreement, include certain adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM&#160;USA. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying value of Altria&#x2019;s total long-term debt at September 30, 2020 and December 31, 2019 was $29.3 billion and $28.0 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, Altria issued USD denominated long-term senior unsecured notes in the aggregate principal amount of $2.0 billion (collectively, the &#x201c;Notes&#x201d;).  The net proceeds from the Notes were used for general corporate purposes, which included repayment of the outstanding balance of the Credit Agreement.  The Notes contain the following terms:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$0.750 billion at 2.350%, due 2025, interest payable semiannually beginning November 6, 2020;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$0.750 billion at 3.400%, due 2030, interest payable semiannually beginning November 6, 2020; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;$0.500 billion at 4.450%, due 2050, interest payable semiannually beginning November 6, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Notes are Altria&#x2019;s senior unsecured obligations and rank equally in right of payment with all of Altria&#x2019;s existing and future senior unsecured indebtedness.  Upon the occurrence of both (i) a change of control of Altria and (ii) the Notes ceasing to be rated investment grade by each of Moody&#x2019;s, Standard &amp;amp; Poor&#x2019;s and Fitch Ratings Ltd. within a specified time period, Altria will be required to make an offer to purchase the Notes at a price equal to 101% of the aggregate principal amount of such Notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the Notes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The obligations of Altria under the Notes are guaranteed by PM USA. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2020, Altria repaid in full at maturity senior unsecured notes in the aggregate principal amount of $1.0 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020 and December&#160;31, 2019, accrued interest on long-term debt of $244 million and $470 million, respectively, was included in other accrued liabilities on Altria&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a discussion of the fair value of Altria&#x2019;s long-term debt and the designation of its Euro denominated senior unsecured notes as a net investment hedge of its investment in ABI, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzExNw_a0091be3-9270-4893-b5eb-51e404b1903a"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzExNw_b8a13924-9682-4c06-95cb-e3834a4047f5"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentTerm
      contextRef="ie55438acc01a4f80a2a779c29e334eac_D20180801-20180801"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzE5Mg_161c19cb-02b8-4733-9cc7-c75d05821df8">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i55306d8676154351af21f6cfd76b5f55_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzM1NQ_b51900f0-2634-4f8a-a8c4-d689dbc5a226"
      unitRef="usd">3000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <mo:DebtInstrumentNumberofExtensions
      contextRef="i55306d8676154351af21f6cfd76b5f55_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzU1NQ_d6f44eb0-0ab8-44b7-987a-aef6988ece3f"
      unitRef="extension">2</mo:DebtInstrumentNumberofExtensions>
    <mo:DebtInstrumentExtensionTerm
      contextRef="i56d738cab03146c5bcd9b95595aee05e_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzg3OTYwOTMwMjY3NTU_3708630e-5153-476d-8927-e52153053320">P1Y</mo:DebtInstrumentExtensionTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i15d84c7d97cd4a05857ded13946f92fe_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzEyNzI_387345e8-2b7e-4210-991b-88d34093e2a0"
      unitRef="number">0.010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ic3eeb744b8954855a6ff7c699a798982_D20200301-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzE2MDE_3d5d9cc0-e862-48f8-afc4-830e3401d994"
      unitRef="usd">3000000000.0</us-gaap:ProceedsFromIssuanceOfDebt>
    <mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzIwNTk_f7111392-640a-4383-9f81-79e3c3c98ecd"
      unitRef="number">4.0</mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum>
    <mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzIyOTc_a23eacb0-7751-4e70-ad19-ca6af249a312"
      unitRef="number">9.2</mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio>
    <us-gaap:LongTermDebt
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzI3NDg3NzkwNzQ1NjA_8053f668-372d-4bfa-92f0-1384cf3d9ed1"
      unitRef="usd">29300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzI3NDg3NzkwNzQ1Nzg_9d17605e-6e7e-4782-81a1-51560cd988dd"
      unitRef="usd">28000000000.0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8cc84f59a87f4be8a5e634d905b909b6_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzI3NzM_28999e6a-094d-4269-b397-1143feb3b587"
      unitRef="usd">2000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i004b9c845a7c477e9f161677be47d470_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzI5OTk_f39772c4-db87-49a4-b5e0-2420c9c4f332"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i004b9c845a7c477e9f161677be47d470_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMwMDU_5c580e74-58f5-4bbb-8fec-f8d6f7f8f86f"
      unitRef="number">0.02350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if92a65bfb9bf4139b4848310f21e030e_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMwNzc_14101d3e-db84-4f4e-9c04-8ab26806cc30"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if92a65bfb9bf4139b4848310f21e030e_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMwODM_a0e81944-e558-42a2-83ee-8c0fc5c8c376"
      unitRef="number">0.03400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib5bb50e3bc8e46f396e19b3dcbc7cefc_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMxNTk_2885d2c8-9e5c-4ea0-9b53-a65c0f62bc33"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib5bb50e3bc8e46f396e19b3dcbc7cefc_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzMxNjU_2dbff8ae-2d85-4d5f-9088-068b7a5d63b2"
      unitRef="number">0.04450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i6166eaee58bc4486a1dcd77e46be7115_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzM2OTQ_87def520-e97e-4064-89c6-91b6417bb825"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i524852ef9cf241f693dd67511cfcf6d0_D20200101-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzQwNjM_f273eebf-5609-4021-b5c4-c06eeae9e4ee"
      unitRef="usd">1000000000.0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzQxMjA_0b6bc7f3-bf5b-447d-9dcd-764929a20888"
      unitRef="usd">244000000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMTgvZnJhZzoyMzRlNzA0MjE4ODU0MDgwYTFlNzNjMGRkYTVmMTMyMy90ZXh0cmVnaW9uOjIzNGU3MDQyMTg4NTQwODBhMWU3M2MwZGRhNWYxMzIzXzQxMjc_b3f69faa-d9c5-49f7-a148-34fad4ecc341"
      unitRef="usd">470000000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI1ODY_a931af1e-e39c-43b0-9f04-a892489446cc">Income Taxes:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax rate for the nine and three months ended September 30, 2020 was 41.8% and (195.1)%, respectively, versus 74.1% and (22.3)% for the nine and three months ended September 30, 2019, respectively.  The changes in the tax rates were due primarily to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;a full valuation allowance in 2019 attributable to the tax benefits associated with the impairment of JUUL equity securities;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;partially offset by:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;a full valuation allowance in 2020 attributable to the tax benefits associated with the impairment of JUUL equity securities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;tax benefits recorded in 2019 for the reversal of tax accruals no longer required;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;net tax expense in 2020 related to Altria&#x2019;s equity investment in Cronos, which included a valuation allowance release on a deferred tax asset; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;net tax benefit in 2019 related to Altria&#x2019;s equity investment in Cronos, which included a valuation allowance release on a deferred tax asset.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending valuation allowances for the period ended September 30, 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to valuation allowance charged to income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions to valuation allowance credited to income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The current year addition to the valuation allowance was due primarily to valuation allowances recorded for deferred tax assets related to Altria&#x2019;s equity investments in JUUL and Cronos.  The current year reduction to the valuation allowance was due primarily to the write-off of a deferred tax asset related to Altria&#x2019;s equity investment in Cronos for which a valuation allowance had previously been established.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria is subject to income taxation in many jurisdictions.  Unrecognized tax benefits reflect the difference between tax positions taken or expected to be taken on income tax returns and the amounts recognized in the financial statements.  Resolution of the related tax positions with the relevant tax authorities may take many years to complete, and such timing is not entirely within the control of Altria.  At September&#160;30, 2020, Altria&#x2019;s total unrecognized tax benefits were $74 million.  The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at September&#160;30, 2020 was $41 million, along with $33 million affecting deferred taxes.  It is reasonably possible that within the next 12 months certain examinations will be resolved, which could result in a decrease in unrecognized tax benefits of approximately $8 million.  At December 31, 2019, Altria&#x2019;s total unrecognized tax benefits were $64 million.  The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December&#160;31, 2019 was $40 million, along with $24 million affecting deferred taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzQ5NDc4MDIzMjgxNzI_fc4dcacf-7fac-4be7-a873-71fa16d9cf4d"
      unitRef="number">0.418</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzM4NDgyOTA3MDgwOTA_bd57a4fd-3135-40b3-abbb-fbefd6898c43"
      unitRef="number">-1.951</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzQ5NDc4MDIzMjg0MjA_e59de28e-b59f-4769-b1f6-bfe130638fb0"
      unitRef="number">0.741</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzM4NDgyOTA3MDgwMTQ_d4927672-4a41-426f-b70e-6531eff2643b"
      unitRef="number">-0.223</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI1OTI_c6270d19-d1ae-4819-8993-1ee986217764">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending valuation allowances for the period ended September 30, 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to valuation allowance charged to income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions to valuation allowance credited to income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzEtMi0xLTEtMA_d9cb3d64-af1c-43b3-b1f4-cf411837e489"
      unitRef="usd">2324000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <mo:ValuationAllowanceDeferredTaxAssetIncreaseInAmount
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzItMi0xLTEtMA_078cec05-0531-44b3-8779-d7291cb61381"
      unitRef="usd">673000000</mo:ValuationAllowanceDeferredTaxAssetIncreaseInAmount>
    <mo:ValuationAllowanceDeferredTaxAssetDecreaseInAmount
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzMtMi0xLTEtMA_0b688811-cf07-49a7-9cf7-82c4f9428795"
      unitRef="usd">145000000</mo:ValuationAllowanceDeferredTaxAssetDecreaseInAmount>
    <mo:ValuationAllowanceForeignCurrencyTranslationAdjustment
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzQtMi0xLTEtMA_fa0c44c5-1ad2-4268-80c8-cd51330807de"
      unitRef="usd">4000000</mo:ValuationAllowanceForeignCurrencyTranslationAdjustment>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90YWJsZTo2Y2E5ZWQxMTU1ZjY0MmFlOTk4YTU4MjVjNjQ0MzJmZC90YWJsZXJhbmdlOjZjYTllZDExNTVmNjQyYWU5OThhNTgyNWM2NDQzMmZkXzUtMi0xLTEtMA_c0a18578-c46f-4670-ae86-1dfa15c4f9f1"
      unitRef="usd">2856000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzIwNDI_959c0757-0b67-4f95-8d33-830de2e72195"
      unitRef="usd">74000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzIxNTQ_e68b9250-bb3a-4824-8d78-0221e183473a"
      unitRef="usd">41000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzIxNjk_52640bce-2d63-45e6-a69f-ede17658a3fe"
      unitRef="usd">33000000</mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzIzNzQ_1a5aa852-c4dd-4afb-bca1-698c570d2d1b"
      unitRef="usd">8000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI0Mjk_6fc48421-eba7-4f35-ad1f-8fd0062295c2"
      unitRef="usd">64000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI1NDE_4a87a0a1-07b0-4109-8c3e-5d2d2d23dbfc"
      unitRef="usd">40000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMjQvZnJhZzoyMjg1NjViMGM2OWQ0ZGRhOTgwY2FkNTIzOTY0NDM1ZC90ZXh0cmVnaW9uOjIyODU2NWIwYzY5ZDRkZGE5ODBjYWQ1MjM5NjQ0MzVkXzI1NTY_5fe11333-3498-4f4c-8151-0d22c9d6c7f6"
      unitRef="usd">24000000</mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU4NjYx_8bd29255-88d3-4068-bc87-0ce55e42e81f">Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and its subsidiaries, including PM USA and USSTC, as well as their respective indemnitees and Altria&#x2019;s investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#x2019; liability is joint and several.  In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries also may be required to pay interest and attorneys&#x2019; fees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#x2019;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 12. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:  (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and its subsidiaries have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts.  Each of the companies has defended, and will continue to defend, vigorously against litigation challenges.  However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview of Altria and/or PM USA Tobacco-Related Litigation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Types and Number of U.S. Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), fraud, failure to warn, design defect, negligence and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#x2019; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 27, 2020, October 28, 2019 and October 22, 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 22, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Smoking and Health Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Cost Recovery Actions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-vapor Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Tobacco-Related Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes 15 cases filed in New Mexico, 26 cases filed in Massachusetts and 54 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;case (these &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; progeny cases are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  Also does not include 1,471 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#x201c;ETS&#x201d;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Broin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  In March 2018, 923 of these cases were voluntarily dismissed without prejudice.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes 25 class action lawsuits, two of which were filed in Canada, 1,064 individual lawsuits, 31 state or local government lawsuits and 25 lawsuits filed by school districts relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes two inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including one case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and two inactive class action lawsuits alleging that use of the terms &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;International Tobacco-Related Cases  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 27, 2020, Altria is named as a defendant in two e-vapor class action lawsuits in Canada.  PM USA also is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant.  PM USA and Altria are also named defendants in seven smoking and health class actions filed in various Canadian provinces.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (&#x201c;PMI&#x201d;) that provides for indemnities for certain liabilities concerning tobacco products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tobacco-Related Cases Set for Trial  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 27, 2020, no &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases or individual smoking and health cases against PM USA are set for trial through December 31, 2020.  Cases against other companies in the tobacco industry may be scheduled for trial during this period.  Trial dates are subject to change and some trials have been postponed due to the COVID-19 pandemic.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trial Results&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1999, excluding the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases (separately discussed below), verdicts have been returned in 69 tobacco-related cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in 44 of the 69 cases.  These 44 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (4), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the 25 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in which verdicts were returned in favor of plaintiffs, 20 have reached final resolution, and one case (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gentile&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that was initially returned in favor of plaintiff was reversed post-trial and remains pending. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Progeny Trial Results&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of verdicts in state and federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases involving PM USA as of October 27, 2020.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Judgments Paid and Provisions for Tobacco and Health Litigation Items (Including Engle Progeny Litigation)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $798 million and interest totaling approximately $217 million as of September 30, 2020.  These amounts include payments for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny judgments (and related costs and fees) totaling approximately $364 million and related interest totaling approximately $55 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in Altria&#x2019;s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health litigation items at beginning of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax charges for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tobacco and health litigation &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related interest costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health litigation items at end of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes amounts related to the costs of implementing the corrective communications remedy related to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes approximately $20 million related to pre-trial resolution of approximately 240 tobacco and health cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes approximately $20 million in payments related to above-mentioned pre-trial resolution of approximately 240 tobacco and health cases and $2 million for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accrued liability for tobacco and health litigation items, including related interest costs, was included in accrued liabilities on Altria&#x2019;s condensed consolidated balance sheets.  Pre-tax charges for tobacco and health litigation were included in marketing, administration and research costs on Altria&#x2019;s condensed consolidated statements of earnings.  Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria&#x2019;s condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Security for Judgments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of September 30, 2020, PM USA has posted appeal bonds totaling approximately $61 million, which have been collateralized with restricted cash that are included in assets on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Smoking and Health Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plaintiffs&#x2019; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Engle Progeny Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny smoking and health cases pending during 2020 in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases can be found in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Progeny Trial Results&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:  In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages.  There was no claim for punitive damages.  PM USA&#x2019;s appeal is pending in the Third District Court of Appeal.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Greene&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#x2019; remaining claim and trebled the compensatory damages award to approximately $30 million.  PM USA plans to file post-trial motions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laramie&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:  In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff, awarding $11 million in compensatory damages and $10 million in punitive damages.  PM USA and plaintiff have appealed.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gentile&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:  In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff, awarding approximately $7.1 million in compensatory damages and allocating 75% of the fault to PM USA (an amount of approximately $5.3 million).  PM USA appealed.  In September 2019, the Florida Fourth District Court of Appeal reversed the judgment entered by the trial court, granted PM USA judgment on certain claims and remanded for a new trial on the remaining claims.  Plaintiff has petitioned the Florida Supreme Court for further review.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the verdict and post-trial developments in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; health care cost recovery case.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle Class Action&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2000, in the second phase of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate.  The court further declared the following Phase I findings are entitled to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;res judicata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effect in such individual actions brought within one year of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#x2019; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;res judicata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pending Engle Progeny Cases  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The deadline for filing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending.  As of October 27, 2020, approximately 1,300 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 1,600 state court plaintiffs.&#160; Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates.  While the Federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Agreement (discussed below) resolved nearly all &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases pending in federal court, as of October 27, 2020, three cases were pending against PM USA in federal court representing the cases excluded from that agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle Progeny Trial Results&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 27, 2020, 134 federal and state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; decision.  Seventy-eight verdicts were returned in favor of plaintiffs and five verdicts (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Skolnick&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Calloway&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Oshinsky-Blacker,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;McCoy &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Frogel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forty-eight verdicts were returned in favor of PM USA, of which 43 were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of October 27, 2020.  Four verdicts (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearson, D. Cohen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collar &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Chacon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in two cases (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reider &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Banks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;returned zero damages verdicts in favor of PM USA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Juries in two other cases (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Weingart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hancock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages.  One case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pollari, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Appeals by plaintiff and defendants are pending.  Three cases, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gloger,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rintoul &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Duignan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  Post-trial motions or appeals are pending.  One case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freeman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The charts below list the verdicts and post-trial developments in certain &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists such cases that are pending as of October 27, 2020 where PM USA has recorded a provision in its consolidated financial statements because PM USA has determined that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated; the second chart lists other such cases that are pending as of October 27, 2020 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated; and the third chart lists other such cases that have concluded within the previous 12 months.  Unless otherwise noted for a particular case, the jury&#x2019;s award for compensatory damages will not be reduced by any finding of plaintiff&#x2019;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Currently Pending Engle Cases with Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages (All Defendants)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages (PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Berger &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cote&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2014&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$6&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$21&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court.  PM USA&#x2019;s challenge to the punitive damages award was denied by the district court.  Appeal by PM USA to Eleventh Circuit Court of Appeals pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$6&#160;million accrual in the fourth quarter of 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Santoro&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA, R.J. Reynolds and Liggett Group&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million (&amp;lt;$1&#160;million PM USA) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The Fourth District Court of Appeal affirmed the compensatory damages award and reinstated the punitive damages award.  Defendants&#x2019; motion for rehearing was denied. Appeal by defendants of punitive damages award to Florida Supreme Court pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million accrual for compensatory damages award in the second quarter of 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrual amounts include interest and associated costs, if applicable.  For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff&#x2019;s favor after taking into account any portion potentially payable by the other defendant(s). &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; References to &#x201c;R.J. Reynolds,&#x201d; &#x201c;Lorillard&#x201d; and &#x201c;Liggett Group&#x201d; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Currently Pending Engle Cases with Verdicts Against PM USA &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Duignan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and &lt;br/&gt;R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pinellas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendants to Second District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cuddihee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by plaintiff and defendant to First District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Rintoul &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$9&#160;million ($5&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$74 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gloger&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15&#160;million ($5&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$11 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendants to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McCall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New trial ordered on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Neff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$4&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Frogel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Palm Beach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal reversed the judgment against PM USA and ordered a new trial.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Mahfuz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$10 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Holliman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendant&#x2019;s appeal to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chadwell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kaplan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;R. Douglas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awaiting entry of final judgment by the trial court.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sommers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA's petition for review.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cooper (Blackwood)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;D. Brown&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$9&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Harris&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA, &lt;br/&gt;R.J. Reynolds and Lorillard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PM USA&#x2019;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff&#x2019;s verdict following a retrial of an initial verdict in favor of plaintiff.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; PM USA is not a defendant in this case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle Cases Concluded Within Past 12 Months&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Amount&lt;br/&gt;(if any)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dean (Kerrivan)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third quarter of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$26&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;August 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Landi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Second quarter of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$10&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Theis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and &lt;br/&gt;R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sarasota&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;First quarter of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$17&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In four cases in which PM USA paid the judgments more than a year ago, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Naugle,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gore&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;M. Brown &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jordan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, plaintiffs were awarded approximately $8 million, $2 million, $9 million and $4 million in fees and costs, respectively.  PM USA has appealed in all of these cases. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; In August 2020, the U.S. Court of Appeals for the Eleventh Circuit denied the defendants&#x2019; petition for rehearing.  As a result, in the third quarter of 2020, PM USA recorded a pre-tax provision of approximately $26 million, reflecting its portion of the judgment plus interest, and paid this amount in August 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; In June 2020, the Fourth District Court of Appeal affirmed the compensatory damages award.  As a result, in the second quarter of 2020, PM USA recorded a pre-tax provision of approximately $10 million for the judgment plus interest and paid this amount in July 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; In February 2020, the Florida Second District Court of Appeal denied PM USA&#x2019;s petition for review.&#160; As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately $17 million for the judgment plus interest and paid this amount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Florida Bond Statute  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny lawsuits in the aggregate and establishes individual bond caps for individual &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases tried in federal court.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Smoking and Health Class Actions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases purport to be brought on behalf of residents of a particular state or states (although a few cases purport to be nationwide in scope) and raise addiction claims and, in many cases, claims of physical injury as well.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1)&#160;and Wisconsin (1).  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Other Tobacco-Related Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below for a discussion of &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; class action cases and medical monitoring class action cases pending against PM USA. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 27, 2020, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#x2019; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#x2019; cigarettes.  In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to Altria or its subsidiaries) seeking protection under Canada&#x2019;s Companies&#x2019; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the U.S.).  The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Health Care Cost Recovery Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Overview  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although there have been some decisions to the contrary, most judicial decisions in the U.S. have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#x2019; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The United States Supreme Court has refused to consider plaintiffs&#x2019; appeals from the cases decided by five federal circuit courts of appeal. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the cases brought in the U.S., health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases),&#160;and other entities have stated that they are considering filing such actions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with Altria or its subsidiaries) under the Companies&#x2019; Creditors Arrangement Act discussed above.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Other Smoking and Health Class Actions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above for a discussion of these proceedings.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Settlements of Health Care Cost Recovery Litigation  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 1998, PM USA and certain other tobacco product manufacturers entered into the MSA with 46 states, the District of Columbia and certain U.S. territories to settle asserted and unasserted health care cost recovery and other claims. PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#x201c;State Settlement Agreements&#x201d;). The State Settlement Agreements require that the original participating manufacturers or &#x201c;OPMs&#x201d; (now PM USA and R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#x201c;ITG&#x201d;)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#x2019; attorneys&#x2019; fees, subject to an annual cap of $500 million.  For the three months ended September 30, 2020 and 2019, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.2 billion and $1.1 billion, respectively.  For the nine months ended September 30, 2020 and 2019, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $3.3 billion and $3.2 billion, respectively.  These amounts include PM USA&#x2019;s estimate of amounts related to NPM Adjustments discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;NPM Adjustment Disputes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PM USA is participating in proceedings regarding the NPM Adjustment for 2003-2019.  The &#x201c;NPM Adjustment&#x201d; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#x201c;participating manufacturers&#x201d; or &#x201c;PMs&#x201d;) that applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses. The independent auditor (the &#x201c;IA&#x201d;) appointed under the MSA calculates the maximum amount of the NPM Adjustment, if any, for each year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;NPM Adjustment Disputes - Settlement with 36 States and Territories and Settlement with New York&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PM USA has entered into two settlements of NPM Adjustment disputes with a total of 37 states and territories, one with 36 states and territories (the &#x201c;multi-state settlement&#x201d;) and the other with the State of New York.  In the multi-state settlement, PM USA, by the end of October 2017, had settled the NPM Adjustment disputes for 2003-2015 with 26 states in exchange for a total of $740 million.  In 2018, there were two principal developments with respect to this settlement.  First, PM USA agreed to settle the NPM Adjustment disputes for 2016 and 2017 with the 26 states mentioned above.  Second, PM USA settled the NPM Adjustment disputes for 2004-2017 with ten additional states.  As a result of these two developments, PM USA will receive approximately $248 million, $68 million of which it received in April 2018, $121 million of which it received in April 2019 and $47 million of which it received in April 2020.  In connection with these two developments, PM USA recorded a reduction to cost of sales in the amount of $39 million in 2017 and in the amount of $209 million in 2018.  In the first quarter of 2019, PM USA also recorded a reduction to cost of sales in the amount of $52 million for its estimate of the 2018 NPM Adjustment settlement credit it expects to receive under the multi-state settlement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2020, the PMs agreed that certain conditions set forth in the multi-state settlement had been met.  As a result, PM USA&#x2019;s and the other PMs&#x2019; settlement with Pennsylvania was extended to include NPM Adjustments for 2018-2024.  In the third quarter of 2020, PM USA and the other PMs also agreed with the other 35 states to extend the settlement with those &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;states to include NPM Adjustments for 2018-2022.  As a result of these two developments, PM USA will receive approximately $361 million in credits to offset PM USA&#x2019;s MSA payments over the following nine years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the NPM Adjustment settlement with New York, which was entered into in 2015, PM USA has received approximately $317 million for 2004-2018.  PM USA and the other participating manufacturers are involved in a proceeding pursuant to the New York settlement in which an independent investigator will determine the amounts due to the participating manufacturers from New York for 2019 and 2020.  PM USA expects to receive such amounts in April 2021 and April 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Both the New York settlement and the multi-state settlement also contain provisions resolving certain disputes regarding the application of the NPM Adjustment going forward.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;2003 and Subsequent NPM Adjustments - Continuing Disputes with States that have not Settled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;2003 NPM Adjustment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  In September 2013, an arbitration panel issued rulings regarding the 15 states and territories that remained in the arbitration, ruling that six of them did not establish valid defenses to the NPM Adjustment for 2003.  In June 2014, two of these six states joined the multi-state settlement discussed above.  With respect to the remaining four states, following the outcome of challenges in state courts, PM USA ultimately recorded $74 million primarily as a reduction to cost of sales, with the final adjustment being recorded in the third quarter of 2017.  Subsequently, another one of the six states joined the multi-state settlement.  Two potential disputes remain outstanding regarding the amount of interest due to PM USA and there is no assurance that PM USA will prevail in either of these disputes.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;2004 and Subsequent NPM Adjustments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  PM USA has continued to pursue the NPM Adjustments for 2004 and subsequent years in multi-state arbitrations against the states that did not join either of the settlements discussed above.   In September 2019, a New Mexico state appellate court affirmed a trial court&#x2019;s order compelling New Mexico to arbitrate the 2004 NPM Adjustment claims in the multi-state arbitration with the other states.  In November 2019, the New Mexico Supreme Court declined to review that decision.  The arbitration hearing has not yet been scheduled.  The Montana state courts ruled that Montana may litigate its claims in state court, rather than participate in a multi-state arbitration and the PMs have agreed not to contest the applicability of the 2004 NPM Adjustment to Montana.  In April 2020, the State of Montana filed a motion in Montana state court against the PMs, including PM USA, claiming that Montana&#x2019;s share of the NPM Adjustment amounts should be paid to the state in advance of the resolution of disputes over the applicability of those adjustments.  PM USA has been placing the disputed NPM Adjustment amounts in the disputed payments account established pursuant to the terms of the MSA.  Montana seeks a total of approximately $43 million in disputed payments from all defendants combined, as well as treble and punitive damages.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than Montana and New Mexico, all of the non-settling states participated in a 2004 multi-state arbitration.  That arbitration initially concluded in July 2019, although Missouri was granted a hearing in June 2020.  As of October 27, 2020, no decisions have resulted from the arbitration.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The PMs have reached an agreement with the states that have not settled (with the exception of Missouri and Montana) that the next round of NPM arbitrations will encompass three years, 2005-2007, and the parties have selected an arbitration panel for the 2005-2007 arbitration.  Missouri is participating in the arbitration, but has agreed to arbitrate only one year, 2005, before the panel.  The hearings in this arbitration have not yet been scheduled.  No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The IA has calculated that PM USA&#x2019;s share of the maximum potential NPM Adjustments for 2004-2019 is (exclusive of interest or earnings): $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $305 million for 2016; $297 million for 2017; $340 million for 2018 and $441 million for 2019.  These maximum amounts will be reduced, likely substantially, to reflect the settlements with the signatory states and New York, and potentially for current and future calculation disputes and other developments. Finally, PM USA&#x2019;s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Disputes Under the State Settlement Agreements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#x2019;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#x201c;ITG brands&#x201d;).  In particular, R.J. Reynolds and ITG have asserted that they do not have to make payments on the ITG brands under the Florida, Minnesota and Texas State Settlement Agreements or include the ITG brands for purposes of certain calculations under the State Settlement Agreements. PM USA believes that R.J. Reynolds&#x2019;s and ITG&#x2019;s position violates the State Settlement Agreements and applicable law.  PM USA further believes that these actions: (i) improperly increased PM USA&#x2019;s payments for 2015-2019; (ii) may improperly increase PM USA&#x2019;s payments for subsequent years; (iii) improperly decreased PM USA&#x2019;s share of the 2015-2019 NPM Adjustments and of the settlements of related disputes; and (iv) may improperly decrease PM USA&#x2019;s share of NPM Adjustments and related settlements for subsequent years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, PM USA and the State of Florida each filed a motion in Florida state court against R.J. Reynolds and ITG seeking to enforce the Florida State Settlement Agreement.  In August 2018, the Florida trial court entered final judgment ruling that R.J. Reynolds (and not ITG) must make settlement payments under the Florida State Settlement Agreement on the ITG brands, and ordering R.J. Reynolds to pay PM USA approximately $9.8 million (inclusive of interest) for the 2015-2017 period.  Both R.J. Reynolds and PM USA filed notices of appeal and, in July 2020, the Florida Fourth District Court of Appeal affirmed the trial court&#x2019;s decision.  In September 2020, the Florida Fourth District Court of Appeal denied R.J. Reynolds&#x2019;s motions for rehearing.  In October 2020, R.J. Reynolds petitioned the Florida Supreme Court to review the appellate court decision.     &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2018, PM USA and the State of Minnesota filed pleadings in Minnesota state court asserting claims against R.J. Reynolds and ITG, similar to those made in Florida, and seeking to enforce the Minnesota State Settlement Agreement.  In September 2019, the Minnesota court granted the State of Minnesota&#x2019;s and PM USA&#x2019;s motions to enforce the agreement against R.J. Reynolds.  The Minnesota court concluded, however, that it could not yet resolve the question of ITG&#x2019;s liability under the Minnesota State Settlement Agreement.  An evidentiary hearing on the question of ITG&#x2019;s potential liability was held in the third quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2018, PM USA filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against R.J. Reynolds and ITG with respect to the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of payments relating to the ITG brands.  A hearing in the case is currently scheduled for May 2021.  In December 2019, in a separate matter, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the calculation of the April 2019 payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2019, PM USA and the State of Texas each filed a motion in federal court in the Eastern District of Texas asserting claims against R.J. Reynolds and ITG, similar to those made in Florida and Minnesota, seeking to enforce the Texas State Settlement Agreement.  On February 25, 2020, the Texas court granted the State of Texas&#x2019; and PM USA&#x2019;s motions to enforce the settlement agreement against R.J. Reynolds.  The Texas court, however, deferred the ultimate resolution of the motions to enforce against ITG, because it concluded that question was dependent upon the outcome of separate litigation pending between ITG and R.J. Reynolds in the Delaware Court of Chancery.  In August 2020, R.J. Reynolds appealed the Eastern District of Texas&#x2019;s ruling to the U.S. Court of Appeals for the Fifth Circuit.  ITG and the State of Texas also have filed notices of appeal, each of which is limited to the issue of how payments of statutory fees are treated under the Eastern District of Texas&#x2019;s ruling.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 1999, the United States government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#x201c;sub-schemes&#x201d; to defraud that the government had alleged.  Specifically, the court found that: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants hid from the public that cigarette smoking and nicotine are addictive; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely marketed and promoted &#x201c;low tar/light&#x201d; cigarettes as less harmful than full-flavor cigarettes; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied that they intentionally marketed to youth; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants publicly and falsely denied that ETS is hazardous to non-smokers; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants suppressed scientific research.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#x201c;committing any act of racketeering&#x201d; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii)&#160;an injunction against &#x201c;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#x201d; (iv)&#160;an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#x201c;lights,&#x201d; &#x201c;ultra lights&#x201d; and &#x201c;low tar,&#x201d; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v)&#160;the issuance of &#x201c;corrective statements&#x201d; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#x201c;low tar&#x201d; or &#x201c;light&#x201d; cigarettes, defendants&#x2019; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi)&#160;the disclosure on defendants&#x2019; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the U.S.; and (ix)&#160;payment of the government&#x2019;s costs in bringing the action.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#x2019; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014 and 2019, Altria and PM USA recorded provisions totaling approximately $36 million for the estimated costs of implementing the corrective communications remedy. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The requirements related to corrective statements at point-of-sale remain outstanding.  In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014.  In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing is currently scheduled for July 2021.    &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the United States government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; a heated tobacco product used with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device.  In August 2020, Altria and PM USA filed an opposition to the government&#x2019;s motion and, in the alternative, a motion to modify the injunction to make clear it does not apply to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  Regardless of the district court&#x2019;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the FDA for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.    &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;E-vapor Product Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 27, 2020, Altria and/or its subsidiaries, including PM USA, were named as defendants in 25 class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs also sought to add antitrust claims due to the recent action by the FTC.  Although the court denied this request in the class action lawsuits, the individual antitrust claims remain pending before the same court.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Antitrust Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for further discussion.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and/or its subsidiaries, including PM USA, also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 1,064 individual lawsuits, 25 lawsuits filed by school districts and 31 lawsuits filed by state or local governments, including the state of Hawaii.  JUUL is an additional named defendant in each of these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the individual and class action lawsuits mentioned above were filed in federal court.  In October 2019, the United States Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of these lawsuits in the U.S. District Court for the Northern District of California for pretrial purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;Altria and its subsidiaries filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%"&gt;The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No case in which Altria or any of its subsidiaries is named has been set for trial.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of its subsidiaries is currently named.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Certain Other Tobacco-Related Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate Philip Morris Products S.A., in the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims of patent infringement based on the sale of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#x2019; fees.  Altria and PMI have been dismissed from the lawsuit.  In June 2020, the remaining defendants filed a motion to dismiss certain of plaintiffs&#x2019; claims and also filed counterclaims against the plaintiffs for infringement of various patents owned by the remaining defendants.      &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also in April 2020, a related action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the United States International Trade Commission (&#x201c;ITC&#x201d;).  There, the plaintiffs also allege patent infringement, but the remedies sought include a prohibition on the importation of the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and component parts into the United States.  No damages are recoverable in the proceedings before the ITC.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Lights/Ultra Lights&#x201d; Cases and Other Smoking and Health Class Actions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#x201c;Lights&#x201d; and/or &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or its other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment. Twenty-one state courts in 23 &#x201c;Lights&#x201d; cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of October 27, 2020, two &#x201c;Lights/Ultra Lights&#x201d; class actions are pending in U.S. state court.  Neither case is active.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 27, 2020, two smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, are pending in their respective U.S. state courts.  Neither case is active.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;UST Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#x2019; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases include lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of October 27, 2020, there is one case pending against USSTC.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Antitrust Litigation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria&#x2019;s 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#x201c;Sherman Act&#x201d;) and Section 5 of the Federal Trade Commission Act of 1914 (&#x201c;FTC Act&#x201d;), and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#x201c;Clayton Act&#x201d;).  If the FTC&#x2019;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of Altria&#x2019;s minority investment in JUUL, rescission of the transaction and all associated agreements, and prohibition against any officer or director of either Altria or JUUL serving on the other party&#x2019;s board of directors or attending meetings of the other party&#x2019;s board of directors.  The administrative trial will take place before an FTC administrative law judge and is currently scheduled to begin April 2021.  The administrative law judge&#x2019;s decision is then submitted to the FTC, which decision is subject to review by the FTC on its own motion or at the request of any party.  The FTC then issues its ruling, which is subject to appellate review.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also as of October 27, 2020, 16 putative class action lawsuits have been filed against Altria and JUUL in the United States District Court for the Northern District of California.  The lawsuits cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act, Section 7 of the Clayton Act and various state antitrust laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#x2019; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of Altria&#x2019;s minority investment in JUUL and rescission of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Neither the FTC nor the private plaintiffs has sought to preliminarily enjoin Altria from converting Altria&#x2019;s non-voting JUUL shares to voting shares or appointing directors to the JUUL board of directors.  As of October 27, 2020, Altria has not exercised these rights, but has until November 30, 2020 to convert its JUUL shares under the regulations of the HSR Act, after which Altria would have to re-file for antitrust review with the FTC to again seek the ability to convert.  For further discussion of Altria&#x2019;s rights in the event of share conversion, see Note. 4.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities - Investment in JUUL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shareholder Class Action and Shareholder Derivative Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, Altria&#x2019;s former Chairman and Chief Executive Officer, and William F. Gifford, Jr., Altria&#x2019;s former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the United States District Court for the Eastern District of New York.  In December 2019, the court consolidated the two lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders, and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to Altria&#x2019;s investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#x2019; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#x2019; claims. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, two purported Altria shareholders filed separate derivative lawsuits in the United States District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of its executives and officers.  These derivative lawsuits relate to Altria&#x2019;s investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  A third derivative lawsuit was filed in September 2020 in the Circuit Court for Henrico County, Virginia against Mr. Willard, Mr. Gifford, Kevin C. Crosthwaite, Altria&#x2019;s former Chief Growth Officer and current JUUL Chief Executive Officer, and members of Altria&#x2019;s Board of Directors.  This suit asserts a claim for breach of fiduciary duty.  Plaintiffs seek various remedies, including damages, disgorgement of profits, reformation of Altria&#x2019;s corporate governance and internal procedures, and attorneys&#x2019; fees.  The plaintiffs have agreed to stay the Virginia derivative case pending the outcome of defendants&#x2019; motions to dismiss the shareholder class action.  A fourth derivative lawsuit was filed in October 2020 in the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States District Court for the Eastern District of Virginia against the same defendants in the Virginia lawsuit, JUUL, its founders and some of its current and former executives.  The remedies sought are similar to those sought by plaintiffs in the Virginia lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental Regulation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#x201c;Superfund&#x201d;), which can impose joint and several liability on each responsible party.  Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  Altria&#x2019;s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that subsidiaries of Altria may undertake in the future.  In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria&#x2019;s consolidated results of operations, capital expenditures, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, certain subsidiaries of Altria have agreed to indemnify a limited number of third parties in the event of future litigation.  At September&#160;30, 2020, Altria and certain of its subsidiaries (i) had $49 million of unused letters of credit obtained in the ordinary course of business; (ii) were contingently liable for guarantees related to their own performance, including $25 million for surety bonds; and (iii) had a redeemable noncontrolling interest of $39 million recorded on its condensed consolidated balance sheet.  In addition, from time to time, subsidiaries of Altria issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on Altria&#x2019;s liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of a distribution agreement between Altria and PMI (the &#x201c;Distribution Agreement&#x201d;), entered into as a result of Altria&#x2019;s 2008 spin-off of its former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  Altria does not have a related liability recorded on its condensed consolidated balance sheet at September&#160;30, 2020 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; patent litigation discussed above under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Other Tobacco-Related Litigation - IQOS Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PM USA has issued guarantees relating to Altria&#x2019;s obligations under its outstanding debt securities, borrowings under its $3.0 billion Credit Agreement and amounts outstanding under its commercial paper program.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxOTQ_d1f6336e-f127-4818-b9c7-8e637cba2b5b"
      unitRef="state">47</mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg3OTYwOTMwODUyMzk_ef510992-22fc-45a3-985c-863ffd61fe58">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 27, 2020, October 28, 2019 and October 22, 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;October 22, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Smoking and Health Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Cost Recovery Actions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-vapor Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,145&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Tobacco-Related Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes 15 cases filed in New Mexico, 26 cases filed in Massachusetts and 54 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;case (these &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; progeny cases are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  Also does not include 1,471 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#x201c;ETS&#x201d;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Broin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  In March 2018, 923 of these cases were voluntarily dismissed without prejudice.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes 25 class action lawsuits, two of which were filed in Canada, 1,064 individual lawsuits, 31 state or local government lawsuits and 25 lawsuits filed by school districts relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes two inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including one case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and two inactive class action lawsuits alleging that use of the terms &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in Altria&#x2019;s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;For the Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health litigation items at beginning of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax charges for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tobacco and health litigation &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related interest costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health litigation items at end of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes amounts related to the costs of implementing the corrective communications remedy related to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes approximately $20 million related to pre-trial resolution of approximately 240 tobacco and health cases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes approximately $20 million in payments related to above-mentioned pre-trial resolution of approximately 240 tobacco and health cases and $2 million for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.027%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages (All Defendants)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages (PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Berger &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cote&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2014&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$6&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$21&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court.  PM USA&#x2019;s challenge to the punitive damages award was denied by the district court.  Appeal by PM USA to Eleventh Circuit Court of Appeals pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$6&#160;million accrual in the fourth quarter of 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Santoro&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2017&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA, R.J. Reynolds and Liggett Group&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million (&amp;lt;$1&#160;million PM USA) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The Fourth District Court of Appeal affirmed the compensatory damages award and reinstated the punitive damages award.  Defendants&#x2019; motion for rehearing was denied. Appeal by defendants of punitive damages award to Florida Supreme Court pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million accrual for compensatory damages award in the second quarter of 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrual amounts include interest and associated costs, if applicable.  For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff&#x2019;s favor after taking into account any portion potentially payable by the other defendant(s). &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; References to &#x201c;R.J. Reynolds,&#x201d; &#x201c;Lorillard&#x201d; and &#x201c;Liggett Group&#x201d; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Currently Pending Engle Cases with Verdicts Against PM USA &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Duignan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and &lt;br/&gt;R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pinellas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendants to Second District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cuddihee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by plaintiff and defendant to First District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Rintoul &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$9&#160;million ($5&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$74 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gloger&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15&#160;million ($5&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$11 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendants to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McCall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New trial ordered on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Neff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$4&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Frogel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Palm Beach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal reversed the judgment against PM USA and ordered a new trial.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Mahfuz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$10 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Holliman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendant&#x2019;s appeal to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Appeal Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chadwell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kaplan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;R. Douglas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awaiting entry of final judgment by the trial court.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sommers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA's petition for review.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cooper (Blackwood)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;D. Brown&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$9&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Harris&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA, &lt;br/&gt;R.J. Reynolds and Lorillard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PM USA&#x2019;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff&#x2019;s verdict following a retrial of an initial verdict in favor of plaintiff.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; PM USA is not a defendant in this case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle Cases Concluded Within Past 12 Months&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Amount&lt;br/&gt;(if any)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dean (Kerrivan)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 2014&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third quarter of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$26&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;August 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Landi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Second quarter of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$10&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Theis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and &lt;br/&gt;R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sarasota&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;First quarter of 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$17&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In four cases in which PM USA paid the judgments more than a year ago, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Naugle,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gore&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;M. Brown &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jordan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, plaintiffs were awarded approximately $8 million, $2 million, $9 million and $4 million in fees and costs, respectively.  PM USA has appealed in all of these cases. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; In August 2020, the U.S. Court of Appeals for the Eleventh Circuit denied the defendants&#x2019; petition for rehearing.  As a result, in the third quarter of 2020, PM USA recorded a pre-tax provision of approximately $26 million, reflecting its portion of the judgment plus interest, and paid this amount in August 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; In June 2020, the Fourth District Court of Appeal affirmed the compensatory damages award.  As a result, in the second quarter of 2020, PM USA recorded a pre-tax provision of approximately $10 million for the judgment plus interest and paid this amount in July 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; In February 2020, the Florida Second District Court of Appeal denied PM USA&#x2019;s petition for review.&#160; As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately $17 million for the judgment plus interest and paid this amount.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i9f83a67a0b1041928670ec284b9f04b4_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzEtMS0xLTEtMA_3e391cb5-b603-4fcc-8700-9fe0abbca17e"
      unitRef="claim">142</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ibe6c5f25c0a14432894f98e00b688af4_I20191028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzEtMy0xLTEtMA_28da82b8-1d70-439c-ab1e-241c8e259b57"
      unitRef="claim">95</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i088fe65173a649629285b737326fc8af_I20181022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzEtNS0xLTEtMA_2bda5b11-e7d7-4b35-ba7e-e20fd4dfb523"
      unitRef="claim">101</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ifa8f7e9351fa463481a1396bb9dbb0b3_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzItMS0xLTEtMA_492d56dc-4748-4ec7-99d5-10811aa47d37"
      unitRef="claim">0</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib6a114c3739645fb99b67e8b402fb09d_I20191028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzItMy0xLTEtMA_c8f0c24c-eb7c-4798-bc35-9ae73c2919b3"
      unitRef="claim">0</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ida5ccc93d1ad4e17b978d254db30a29b_I20181022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzItNS0xLTEtMA_4a638e17-9290-401a-9396-28423733c05e"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i1938f36d8dd1444f846a2c358e51a292_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzMtMS0xLTEtMA_a5f14ee5-dc1a-4f6c-8171-9fcc7b9bb8fb"
      unitRef="claim">1145</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib6b92183e81f4270b9b287aa21dc48b3_I20191028"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzMtMy0xLTEtMA_0fbfb025-0bda-4456-9551-93380360ce9e"
      unitRef="claim"
      xsi:nil="true"/>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if79ba42880fa4632945934c13e5390f4_I20181022"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzMtNS0xLTEtMA_10a40247-333a-4d93-8112-8664d54d508a"
      unitRef="claim"
      xsi:nil="true"/>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ic50f46d379fe4cb283f17d07d3231cca_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzQtMS0xLTEtMA_95fbf382-b769-4be8-b8b3-16eda0d4c8ca"
      unitRef="claim">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i991d327d70354aee8acfa77292becaf9_I20191028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzQtMy0xLTEtMA_15b9b2c6-18f5-471c-832c-e2f2d6ac8d1e"
      unitRef="claim">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if09d494ca9c04e36a8555873cb6b8cd5_I20181022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkMDZmOTE3YjljMTM0ZjcxODlmZDQwOWFhY2Q4NmFjYi90YWJsZXJhbmdlOmQwNmY5MTdiOWMxMzRmNzE4OWZkNDA5YWFjZDg2YWNiXzQtNS0xLTEtMA_35fd0f08-9232-4ac4-a8ae-266b16fd7e19"
      unitRef="claim">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i74ee67e0b3a6432c9aa843c7b05d3a21_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTkwNzY_23a1cd24-8e49-43e4-871f-2ff5d601238f"
      unitRef="claim">15</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i288268f2ad2f4afba0fe6dc3e2d647fc_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU5NDI_188e8dee-e7ae-476e-b65f-d65f2494cf48"
      unitRef="claim">26</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i1b3f238e8c2e470f941d469281cb5f59_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU5Nzg_fc870b6f-1879-4c45-a6ea-6328fe6a8a4b"
      unitRef="claim">54</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberOfCases
      contextRef="i90eafa508851421c88a1386dd9e708a7_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzYzMTc_314edf96-def4-4a9b-97ed-54ed83cfed78"
      unitRef="case">1471</mo:LossContingencyNumberOfCases>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="i79786dc9d3a34fe9b84f2581a59eae3c_D20180301-20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzY4MjA_374db4e4-34c8-4ef2-ae1a-64d4bc58c555"
      unitRef="case">923</us-gaap:LossContingencyClaimsDismissedNumber>
    <mo:LossContingencyClassActionLawsuit
      contextRef="i1938f36d8dd1444f846a2c358e51a292_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzY5ODI_84af76d7-a3c9-4920-94c4-ba8f40235beb"
      unitRef="lawsuit">25</mo:LossContingencyClassActionLawsuit>
    <mo:LossContingencyClassActionLawsuit
      contextRef="if906b9f3c170440f94e6baae57a1e8af_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTgyNDQ_fb7df670-9bad-4133-a28d-bd59aa73ffea"
      unitRef="lawsuit">2</mo:LossContingencyClassActionLawsuit>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i759cc82368a24da9b90d561f09b6df19_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzcwMDg_b4ec6655-50df-4861-b6de-323be1b06137"
      unitRef="claim">1064</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i6732b65e853a4a2ebc98fc8672546c08_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzcwMzI_d18ed7f1-e71f-4455-80b6-da5ce370cd45"
      unitRef="claim">31</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7b52d1ccf10645b8ac9e77afdbf09979_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzcwNzQ_6fd9b088-f248-4890-8f75-afed2d961b6c"
      unitRef="claim">25</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberOfInactiveCases
      contextRef="ic50f46d379fe4cb283f17d07d3231cca_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzcyMjc_60c51320-69ad-4e28-8af5-3d96b3adc89e"
      unitRef="case">2</mo:LossContingencyNumberOfInactiveCases>
    <mo:LossContingencyNumberOfCasesTriedinASingleProceeding
      contextRef="ic50f46d379fe4cb283f17d07d3231cca_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzc0NDI_f9ef736d-a95a-49b9-9b0b-1144d1a7e978"
      unitRef="case">1</mo:LossContingencyNumberOfCasesTriedinASingleProceeding>
    <mo:LossContingencyNumberOfInactiveClassActionLawsuits
      contextRef="ic50f46d379fe4cb283f17d07d3231cca_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzc1NjI_d946ae7a-69f7-44a3-b941-62fd58aaa562"
      unitRef="case">2</mo:LossContingencyNumberOfInactiveClassActionLawsuits>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i327f425f4c0a4b958f4eb1c1e8e5b7a8_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTgyNTA_fdd7574c-8787-4c53-ba00-a3ba0d2a6229"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i03acf33061544727a951d220b422409e_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzc4ODg_6a723861-e1c3-4877-bd18-63a3e7fb46ad"
      unitRef="claim">10</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ie1a4cb788be34b7294823653c0ded68b_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzc5MzY_ab913ef0-e3ee-4b2c-afbc-f37ea457a1e1"
      unitRef="claim">8</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i5370156fe8d14a8e8da1520ca797a308_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzgwMjk_df40c37a-d1b4-45eb-8710-fbe8a8773222"
      unitRef="claim">7</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofCasesSetforTrial
      contextRef="i5ae72485bc604c34b056b72db7e10bf3_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg0MDI_2ab3f13d-e989-4afb-9254-be80ff3ed275"
      unitRef="case">0</mo:LossContingencyNumberofCasesSetforTrial>
    <mo:LossContingencyClaimsDecided
      contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg4NjI_217e5852-f2d9-4264-81a8-0c3e55d5d1c8"
      unitRef="case">69</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg5ODY_e37fbc76-6744-46af-9c2a-6d7c6a6c2a50"
      unitRef="case">44</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecided
      contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzg5OTY_217e5852-f2d9-4264-81a8-0c3e55d5d1c8"
      unitRef="case">69</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwMTM_e37fbc76-6744-46af-9c2a-6d7c6a6c2a50"
      unitRef="case">44</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ib640ca736ea64adfabeed83e8a20dfe7_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwNDQ_e24a375a-c79c-4f15-acfe-6bd5504e6619"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i42faf7ae646d43888ef8eb211eacf9ac_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwNjE_cebb520b-1931-4c30-8aa2-a66b49491a7a"
      unitRef="case">7</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i0f8e9338933b4ee6a3aa3a93e8059c2d_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwNzk_c00916ea-06cc-473b-86d3-a2f1e0a70d09"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i38158ae67bae43879aa2672ca2ab9fd5_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkwOTM_d88dcad0-b170-4c57-86c8-65b73c2aaee6"
      unitRef="case">10</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="iccba1eb229bd4dc390001b5b8df2bc45_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxMDk_e31057ec-781c-4a92-983d-1a5c5e467df7"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i9da4b44582904192921e6072055b4ac3_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxMjk_cbef2f94-c0a4-42a1-bcf2-8b438875edd7"
      unitRef="case">4</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ibc1e2b1908b54d0ca3e4f21bb1d1e630_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxNDc_400c0561-cc90-4140-a05f-a5408ff2996a"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i21bfaa9469a247b5bd27e94518726cb0_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxNjI_a8e25998-45ea-40f9-83f5-25f69057da5d"
      unitRef="case">4</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="iae2caef6740d40259c9f84a490569169_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxODI_0b0880c1-0e58-4289-bde5-472af3f22a09"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ied53055005344f3bb2c452924e5a1528_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkxOTk_2fc9841c-0e70-44ce-9cb0-38b4f74a4c84"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i3ae1fff42746471eb1d0f51a965259ab_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyMTQ_55683e56-19ec-4a6a-8d81-ffd255eb9713"
      unitRef="case">5</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i31692ae6ae0d48948fb604426688e995_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyMjU_95bcc905-1aef-4c1b-80ba-b1b2faca2622"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ic44878beb09c49beaa5574aad702cf2b_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyNDQ_192e5a42-cde9-44a0-a7d2-589e8e489516"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ie663a64cadad400db55d3b0fef5bd7d7_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyNjM_058b4f55-b3e1-4aa9-9edb-0381a6c0de2d"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i722c6dc101334a06958236d747b37fa6_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkyNzk_aa965775-b12c-47a6-8a1b-90f9456a207b"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i77665d9f65aa408b8de4b3aff7a6e23a_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzMDI_a83888e3-1e23-4ae2-b145-efdb0dd36d7b"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedUnfavorableNumber
      contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzMTU_ea3da7f8-4333-4511-b0c5-4f978636540a"
      unitRef="case">25</mo:LossContingencyClaimsDecidedUnfavorableNumber>
    <mo:LossContingencyClaimsResolvedNumber
      contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzOTg_a81e089e-b9ef-4994-af82-0b7c0bb33758"
      unitRef="case">20</mo:LossContingencyClaimsResolvedNumber>
    <mo:LossContingencyVerdictReversedNumber
      contextRef="i218ca1e25c27437f84cd9522af660be3_D19990101-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzk0MzY_cf614c72-7384-4255-bbad-d15d06892f4f"
      unitRef="case">1</mo:LossContingencyVerdictReversedNumber>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i7b76f4a06e0d4000be39f89a1b20a4d9_D20041001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwMDgw_713158a1-2bc6-45f2-a168-c86084a7b044"
      unitRef="usd">798000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LitigationSettlementInterest
      contextRef="i7b76f4a06e0d4000be39f89a1b20a4d9_D20041001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwMTE5_4e4ee0c4-cd9f-4d35-8592-cb683a112017"
      unitRef="usd">217000000</us-gaap:LitigationSettlementInterest>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="ib42610cd85574a85ac22adfbd9232cc4_D20041001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwMjU1_71b13c8b-9d5a-436c-bc1d-75e57154a31d"
      unitRef="usd">364000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LitigationSettlementInterest
      contextRef="ib42610cd85574a85ac22adfbd9232cc4_D20041001-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwMzAy_32c6f53e-bbe8-4fba-a9ca-2db6ac726f02"
      unitRef="usd">55000000</us-gaap:LitigationSettlementInterest>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i72e09db783364478aeb09576c9febdcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzItMS0xLTEtMA_9f8161e9-e59d-46f0-8152-6436a69ce6f8"
      unitRef="usd">14000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i9fdefa86b95345148bfdd3202813cfe1_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzItMy0xLTEtMA_26fa191a-9804-4616-a7ef-cf4c4c9d21d1"
      unitRef="usd">112000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i670aed569ab54abeacf39bd2a4edb1d7_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzItNy0xLTEtMA_32a48943-14e0-495c-b0ab-05bbe08236c9"
      unitRef="usd">22000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="iad67a6f5836647b68468a7cfc5e379e6_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzItOS0xLTEtMA_106d4af4-8bd2-4ea0-a5fc-552e0787cb9d"
      unitRef="usd">13000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ic94346e89f4f4ef7864d5068b90b4f4e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzQtMS0xLTEtMA_fce2048b-f096-4e83-87d7-cc68dd403475"
      unitRef="usd">73000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i1dd2f6de615e40518cd41e25874f2500_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzQtMy0xLTEtMA_67a79eba-4fdb-4c88-8d0e-7ec71eedb57c"
      unitRef="usd">43000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i5ef32b625acf4bd79754f47e5d1ec753_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzQtNy0xLTEtMA_6f9b8d31-19b6-4daa-aac0-7cd67a784d54"
      unitRef="usd">34000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="iee3815bd69824e13833b90871d61a946_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzQtOS0xLTEtMA_b7354810-1026-42d2-938d-efd3e58c0d31"
      unitRef="usd">3000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ib6bb1353452c4523bedf46d84d63f40c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzUtMS0xLTEtMA_a6adb4a1-7f2a-40f5-b309-c46242498eb1"
      unitRef="usd">3000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i51f7bad91af248dcba16157131428d9c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzUtMy0xLTEtMA_e18079b4-a613-4647-8f39-78a11850c512"
      unitRef="usd">5000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i853e7e20eb29408fb2d7f8a14a1797da_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzUtNy0xLTEtMA_f618337b-41df-48a0-8370-b16be35274b2"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i1f7118f93b4345d89a25d75afdb5a262_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzUtOS0xLTEtMA_82ceb4f1-0714-41e7-9fa0-6c191ea55554"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzktMS0xLTEtMA_d58e249c-5cf2-4d74-951e-b690b9039d2f"
      unitRef="usd">81000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzktMy0xLTEtMA_3162a89d-4d09-4245-b6ab-49479c0b7ad1"
      unitRef="usd">151000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i3656833207b740358727e6740c6f5754_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzktNy0xLTEtMA_24a1aa6c-9bcd-47d0-98f0-7ee17c8c9f79"
      unitRef="usd">47000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i968caebdcbba4e889a7d286dd42539cb_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzktOS0xLTEtMA_e53c554a-ad08-4a91-9aea-4f25bc03a209"
      unitRef="usd">7000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzEwLTEtMS0xLTA_b0aae36f-a268-4d79-acfa-5b60d5ad63b5"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="idd09282688b34d21a437df741d91f326_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzEwLTMtMS0xLTA_887551a9-599b-432c-8f05-b66829169ef0"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzEwLTctMS0xLTA_636fb22e-3ed7-46bb-90d2-42e141b4271b"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="idd09282688b34d21a437df741d91f326_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZToyZWRmMDRlZTAzN2E0OWUyYmQ5N2Y5NTk2OGZkNmJiMi90YWJsZXJhbmdlOjJlZGYwNGVlMDM3YTQ5ZTJiZDk3Zjk1OTY4ZmQ2YmIyXzEwLTktMS0xLTA_06549db9-678d-4c46-9bbd-9254f6c4487b"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ie30f52b0c96d49a3a478a6a1e2ce47c4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwNjU3_f8bdd502-9aa0-4fba-871a-587af9fdff6f"
      unitRef="usd">20000000</us-gaap:LossContingencyAccrualProvision>
    <mo:LossContingencyNumberOfPreTrialResolutionCases
      contextRef="i1e5bbf67f98443c0b7edd73a8250aa82_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwNzA5_01f0cefd-0672-43f2-99a8-bfe6f1328f07"
      unitRef="case">240</mo:LossContingencyNumberOfPreTrialResolutionCases>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i03e3139f46334e698285c1dea0152ad0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwNzY1_4c2553dd-23a8-4e40-9f2a-21740c89b676"
      unitRef="usd">20000000</us-gaap:LossContingencyAccrualPayments>
    <mo:LossContingencyNumberOfPreTrialResolutionCases
      contextRef="i1e5bbf67f98443c0b7edd73a8250aa82_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwODQ1_01f0cefd-0672-43f2-99a8-bfe6f1328f07"
      unitRef="case">240</mo:LossContingencyNumberOfPreTrialResolutionCases>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i0cd199ca5a0f48ddb7de573598ef316e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEwODc3_a90505d2-0fbb-4845-9e5d-3b7f5ed44086"
      unitRef="usd">2000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <mo:LitigationEscrowDeposit
      contextRef="ib01325dc5c474ef0a0a12a154bd77c51_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzExNzE1_c890cab2-2e7c-4f36-8b0d-670eb7c263cb"
      unitRef="usd">61000000</mo:LitigationEscrowDeposit>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i81b724d4a8dd4812b7033d86eb830073_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEzMzk5_9a220da1-977d-487a-9712-f033254e3e90"
      unitRef="usd">11000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i81b724d4a8dd4812b7033d86eb830073_I20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEzNDM4_d89fac75-4803-4cf9-a953-4211af53e674"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i7396e108206b484f903a260197ded70e_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEzNjkw_db97ef30-ac59-410e-a15e-f13f22cba5e0"
      unitRef="usd">10000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="id267dd8564a3488b94c7ba44126c87e8_I20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzEzODM5_d3729bf1-422c-4536-a9dd-c1a47698b80e"
      unitRef="usd">30000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i3ebfc83154ce48dea39e1eade2ed1f02_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MDAx_69d99574-0104-4f54-bdb8-f351d07d2341"
      unitRef="usd">11000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i3ebfc83154ce48dea39e1eade2ed1f02_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MDMy_273d0a3d-b1c6-4b74-a7d2-3ffb535222a4"
      unitRef="usd">10000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i08ab18a08fc2443ab1242f3a205e3fe4_I20171031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MjIw_1d79499c-b1d5-46c2-9bf0-5faecc4e555d"
      unitRef="usd">7100000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedAllocationPercentage
      contextRef="if550a6c83d0d4c6292eefe757d6d7946_I20171031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MjYy_9a663463-836b-44df-ab62-84d60f80bb7d"
      unitRef="number">0.75</mo:LossContingencyCompensatoryDamagesAwardedAllocationPercentage>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="if550a6c83d0d4c6292eefe757d6d7946_I20171031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE0MzE2_d0a3c8c4-a3ac-4dcc-a1bd-9046f0479318"
      unitRef="usd">5300000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i1a81a944b81a45a9b4aabeb561b3c720_I20000731"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE1MDQz_4702c120-124b-41ce-97e5-5757bd8d969f"
      unitRef="usd">145000000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ibf8237cac01f4de89881354f8056ccab_I20000731"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE1MDg0_d3e2cdf2-9e6e-4e1f-b40f-11b9178c4757"
      unitRef="usd">74000000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants
      contextRef="i21e01176f3244941b8c2577c07af928b_D20060701-20060731"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE1NjQ5_8639da94-58fd-4f48-99b1-d1379f557f7e">P1Y</mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants>
    <mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants
      contextRef="i21e01176f3244941b8c2577c07af928b_D20060701-20060731"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE1ODE3_80fc853f-405e-40a4-9739-f5df1fb46689">P1Y</mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i2753d6b653574d7997560005050e6a03_I20080131"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE3NTUx_b97d5378-3a78-4a60-a53f-7c1694c0ce13"
      unitRef="claim">9300</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i282f01973b7a450996c72e13d164a16a_I20201027"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE3NjI5_31b66d63-6142-4e80-86c3-c993b8be8379"
      unitRef="claim">1300</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="iab0a7a02a22144d58d64538e4a422159_D20201027-20201027"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE3NzQ5_d091a7a0-a731-424b-9b7a-fa3a990a5411"
      unitRef="plantiff">1600</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i78d2755130534b9f968f4c9ae194baf1_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4MDU5_fdeb333f-801a-4839-988b-b3515b824c90"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyClaimsDecided
      contextRef="ibc72644f82dd4c06995b160fa2ebf6ac_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4MjE5_c2008196-1210-42d7-9b41-0f399ac0d557"
      unitRef="case">134</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedUnfavorableNumber
      contextRef="ibc72644f82dd4c06995b160fa2ebf6ac_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4MzUy_e4bfe089-4812-4764-ab28-284ea93a6c5a"
      unitRef="case">78</mo:LossContingencyClaimsDecidedUnfavorableNumber>
    <mo:LossContingencyUnfavorableVerdictsPendingReversed
      contextRef="i5ae72485bc604c34b056b72db7e10bf3_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4NDA1_96305386-aa5a-4a8f-9871-38de2a9531cc"
      unitRef="case">5</mo:LossContingencyUnfavorableVerdictsPendingReversed>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ibc72644f82dd4c06995b160fa2ebf6ac_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4NTc4_83793f35-a9ca-4385-aaf7-567081a150fb"
      unitRef="case">48</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i121c8c8c92154161b47ce45a7725da25_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4NjMz_7144ae83-9fde-49be-9b54-1ac70eded347"
      unitRef="case">43</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyVerdictReversedNumber
      contextRef="i386be72127664d83ad959975ff8d48c4_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4Nzc2_dbc26d4e-542d-4ba4-b661-0c5e4659dd55"
      unitRef="case">4</mo:LossContingencyVerdictReversedNumber>
    <mo:LossContingencyZeroDamagesVerdicts
      contextRef="i0790b75d3ef64acda7cf88fa64505882_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4OTE5_a1a81ae4-0383-432e-ad8e-2bc3d6011979"
      unitRef="case">2</mo:LossContingencyZeroDamagesVerdicts>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i0790b75d3ef64acda7cf88fa64505882_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4OTU2_c132523f-47cb-4c88-be03-43ae08b59c54"
      unitRef="usd">0</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyZeroDamagesVerdictModified
      contextRef="id594dce411764c92b6f7ed94ea6a2dee_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5MDA3_1d3c072c-6da8-42ae-9ae3-6f1f20a904d4"
      unitRef="case">2</mo:LossContingencyZeroDamagesVerdictModified>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="id594dce411764c92b6f7ed94ea6a2dee_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5MDg3_591e7ebc-d7cf-4d21-ab60-c48da2de16d0"
      unitRef="usd">0</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i055fbe8d8f0144a7aeb8622777fb5fb4_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5MTcw_85a9ca38-60ba-461b-b4f3-1ba09b17923c"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="id660194fbef544acb7a9ac3e9edd669b_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5MzU0_296725c5-f8cb-4ba0-92c2-9922929bcddb"
      unitRef="case">3</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i0bfe653a65cc453d9adba37e43c082ee_D20201027-20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE5NTYy_7319e02a-6281-47ad-a08d-ca5a086c736c"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i09102d7949074727b6b071832c9c9a1b_I20140930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzEtNC0xLTEtMC90ZXh0cmVnaW9uOjk5YmM1Y2MxMWE1MzQwZjVhMjBjZDIwYjQzYWE0NzUxXzkzNDU4NDg4MzYxMjA_bbe051ab-73a2-4b82-930c-e7e774cca099"
      unitRef="usd">6000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i68e27be8c5e340d2b5ab22ec89c6fbff_I20140930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzEtNS0xLTEtMC90ZXh0cmVnaW9uOjQ4MjFmMTE2ZGRjNDQwNjg5ZTkzODdjNzBkZjZkODZmXzkzNDU4NDg4MzYxMjI_adbca49f-f38e-4bea-944d-ec74528a7d59"
      unitRef="usd">21000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i763f26f3f9864550bce1cb5f1d139b5f_D20181001-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzEtNy0xLTEtMC90ZXh0cmVnaW9uOjgyYTY5NTZiZDU1NjQzNjFhNGExZGNlZTI0MTIxOTg2XzkzNDU4NDg4MzYxNjE_5a85c535-fc3a-47a2-9fb2-5cdccaf4de67"
      unitRef="usd">6000000</us-gaap:LossContingencyAccrualProvision>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i2f379dd774a84c178271dd8ddf630a75_I20170331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzItNC0xLTEtMC90ZXh0cmVnaW9uOjNmNmY5YWM0MWVlOTRlNDc5ZDEyMWU0NWUwMjkwMTVhXzkzNDU4NDg4MzYxNDE_ae874734-11fc-4f4c-a606-2cad553d8a19"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i83bc2d39c8314c73ac43d49baca414d7_I20170331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzItNC0xLTEtMC90ZXh0cmVnaW9uOjNmNmY5YWM0MWVlOTRlNDc5ZDEyMWU0NWUwMjkwMTVhXzkzNDU4NDg4MzYxOTU_32fa515d-f151-436e-9bd8-59a5ec4c15d1"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i83bc2d39c8314c73ac43d49baca414d7_I20170331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzItNS0xLTEtMC90ZXh0cmVnaW9uOjJkMTdmY2QzNDQwODQ3NjQ5N2IxMDBkZTQ2YjJmZjk0XzkzNDU4NDg4MzYxMjI_f41912f0-4283-4835-ae31-c4142265cc50"
      unitRef="usd">1000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i8a8b0e0c65974548b24e515426fd6cb4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo0MmJkYmJlOGQ4ZGE0OTVkOWIxZDg0ZjY4ZTdmZmMzYy90YWJsZXJhbmdlOjQyYmRiYmU4ZDhkYTQ5NWQ5YjFkODRmNjhlN2ZmYzNjXzItNy0xLTEtMC90ZXh0cmVnaW9uOmJkN2VjNjdmZjVhOTQ2MDk5ZDdlYjEwNDlhMTJjODllXzkzNDU4NDg4MzYxOTA_cefe3bed-e568-412c-a2fa-6e98ab151313"
      unitRef="usd">1000000</us-gaap:LossContingencyAccrualProvision>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i54e27c4d0aa94139a647bf051cb35c24_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEtNC0xLTEtMC90ZXh0cmVnaW9uOjgxOGU3ZjJhODJjZjQyNDNhYTMwYjU1YjQ4NzhmNTE2XzE4NjkxNjk3NjcyMjE2_26f54060-f544-494b-803c-3c6a1b8c84a0"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i73562f0789564c4ca3b746d86736d7f1_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEtNS0xLTEtMC90ZXh0cmVnaW9uOjJiNDM1MWQ0NDdhNDRiMWM5ZWFiNmM2NTZlOWI4NjBhXzE4NjkxNjk3NjcyMjE4_cd61018b-ea5d-4a2f-91b0-8b70bd237a16"
      unitRef="usd">12000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="iee24c1e556fd401ebf1c14cc046a2c47_I20200131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzItNC0xLTEtMC90ZXh0cmVnaW9uOjg0MmMzZjMzMTBlNjQzYmU4NjA4OGJmY2I0MDBhYzFhXzg3OTYwOTMwMjIyMzI_6bf291d9-93df-4bcb-8c36-3b5fe4cf62dc"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i720d17586fc04494803d6a38d0d0a43a_I20200131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzItNS0xLTEtMC90ZXh0cmVnaW9uOjAxZWRhNmU1OGQxYzQ0Mzg4NTkwOWViN2I3ZGNlOGIyXzg3OTYwOTMwMjIyMTQ_19963286-de04-47d2-8d3c-c910bdfbffba"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="icb420eb62e1c4abda0c90da42623cf66_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzMtNC0xLTEtMC90ZXh0cmVnaW9uOmUzYWEwNWUyM2ExYjQxYWY5ODFmMWI0YWFhYjA3OTI0Xzg3OTYwOTMwMjIyNTI_c0e7390d-82ee-4ccb-90f3-393deaf09c37"
      unitRef="usd">9000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ic0334756982249f5a738ecdc55a81329_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzMtNC0xLTEtMC90ZXh0cmVnaW9uOmUzYWEwNWUyM2ExYjQxYWY5ODFmMWI0YWFhYjA3OTI0Xzg3OTYwOTMwMjIyNjU_43fa99a4-112f-48dc-81bf-c2f385a239c0"
      unitRef="usd">5000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ic0334756982249f5a738ecdc55a81329_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzMtNS0xLTEtMC90ZXh0cmVnaW9uOmZhODE4NzNjNGQzMDQyODRiOGZkNDJmNWE3YmQ0OWViXzg3OTYwOTMwMjIyMzQ_1f96162f-bc21-456b-a68e-99ffdfc993e4"
      unitRef="usd">74000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i473d370813804ee9923d2d9d90726e86_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzQtNC0xLTEtMC90ZXh0cmVnaW9uOmZiNjhkYmE5NWI4YTQzNmY4NTI0ZTEzZjZmMzU1ZjM3Xzg3OTYwOTMwMjIyNTQ_63ff815f-7398-42f9-b878-2a45467747a1"
      unitRef="usd">15000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i5e8a0f49c0334761b75e98dc0a5ae0e3_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzQtNC0xLTEtMC90ZXh0cmVnaW9uOmZiNjhkYmE5NWI4YTQzNmY4NTI0ZTEzZjZmMzU1ZjM3Xzg3OTYwOTMwMjIyNjc_a3e53b76-f438-48ad-ad92-6c573ed594c6"
      unitRef="usd">5000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i5e8a0f49c0334761b75e98dc0a5ae0e3_I20191130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzQtNS0xLTEtMC90ZXh0cmVnaW9uOjY1NDQzMzQyODFmMzQ4YjViOWMzZTgxZmJjNzVlYmM0Xzg3OTYwOTMwMjIyMzQ_fe2ab3da-a737-4c9a-b93d-760e33ddf03c"
      unitRef="usd">11000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i7cb77069bc64499a9599c4b95646cbbc_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzUtNC0xLTEtMC90ZXh0cmVnaW9uOjdiOTc4Yzg2MThhMDRkZGNiMmYzYTJmM2U2NTIwN2M5Xzg3OTYwOTMwMjIyNTQ_7f685b92-3236-4fdc-b7f7-cc56a172c4c5"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ib37d24d3b5fc4f8d8fe8d58c3e41ba9b_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzUtNC0xLTEtMC90ZXh0cmVnaW9uOjdiOTc4Yzg2MThhMDRkZGNiMmYzYTJmM2U2NTIwN2M5Xzg3OTYwOTMwMjIyNjc_cbb1f3cb-ddf9-4819-bb5c-9723f3019da8"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ib37d24d3b5fc4f8d8fe8d58c3e41ba9b_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzUtNS0xLTEtMC90ZXh0cmVnaW9uOmRjN2Y0YzMxOTFiNjRiOTI5OWY0Mjg3Y2Q2MTZkOTJhXzg3OTYwOTMwMjIyMzM_8aea9007-61ad-49df-9e88-50cc08aa30b3"
      unitRef="usd">1000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="if7391ca337c34ee3812079caa09a47a8_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzYtNC0xLTEtMC90ZXh0cmVnaW9uOjZhMjdjYmQwYWYzODQ4MDE5NWUwNjAzNTM0NmVkNzhkXzg3OTYwOTMwMjIyMzI_aa49390f-5dc9-4a9f-926f-50d2af088786"
      unitRef="usd">4000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i9e8ceb1484f445ba829b403f9ca487cb_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzYtNS0xLTEtMC90ZXh0cmVnaW9uOjE3NmQwMzY1YWZlMzQ5NjlhN2FkZGMwMjk4MzAxYmUzXzg3OTYwOTMwMjIyMzI_883ee8a8-46a3-43ef-9103-dce2594114ec"
      unitRef="usd">2000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ie8ee87d2eab14b2dadd569b18425aac6_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzctNC0xLTEtMC90ZXh0cmVnaW9uOjg1NWQzMWE2Y2EzNzRmOTk4YzQyNmE2NTBiOWM3NmMzXzg3OTYwOTMwMjIyNTQ_a6bbd16e-0604-496d-ad7b-93561bccf8b4"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ie8ee87d2eab14b2dadd569b18425aac6_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzctNC0xLTEtMC90ZXh0cmVnaW9uOjg1NWQzMWE2Y2EzNzRmOTk4YzQyNmE2NTBiOWM3NmMzXzg3OTYwOTMwMjIyNjc_32b7c3b7-57de-489b-8624-2fe62ddbd302"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ie8ee87d2eab14b2dadd569b18425aac6_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzctNS0xLTEtMC90ZXh0cmVnaW9uOjkwZmMwOTJmZWZhNjQ0MzhhMzg3MTE2NDVlZTE3OGFkXzg3OTYwOTMwMjIyMTQ_d80f4987-307a-4afe-ab09-f31794f424f5"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i157ee62daa634c5baba2332dda040742_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzgtNC0xLTEtMC90ZXh0cmVnaW9uOmRlYzJhZDE1NjVjYjQ0MDI5YjMzNWZlNDA3Y2ZlZjlkXzg3OTYwOTMwMjIyMzQ_5669ce12-c80f-4c25-a32c-5ba899163560"
      unitRef="usd">12000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="iccb40a3f593e44f1945490c8afa74e4a_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzgtNS0xLTEtMC90ZXh0cmVnaW9uOjI3MGU5NWNmM2ZjNDRlOWFhNGM3ZTM5YzJlYTE2MzJjXzg3OTYwOTMwMjIyMzQ_f21fda08-b463-4470-b4d2-b02490e1d72c"
      unitRef="usd">10000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="iaa873ae904e843a68f15a429f1ddca30_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzktNC0xLTEtMC90ZXh0cmVnaW9uOjEwZWU0MmVmMDYxYTQ4MTBhNTU5MGQzYTA4NTM0ZDRiXzg3OTYwOTMwMjIyMzI_5acc4765-5846-4b90-b757-948b4a0713f8"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="idbdcfd0b02f340638485ef5bf9030554_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzktNS0xLTEtMC90ZXh0cmVnaW9uOjM3NDhhMzk3NDFkYzRjNTJhNmIyNWZjZTU4N2U0ODA0Xzg3OTYwOTMwMjIyMTQ_e9266db3-f298-4210-8ab2-501515567e75"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i262382c0015d432f842b18237e28071e_I20180930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEwLTQtMS0xLTAvdGV4dHJlZ2lvbjpkMmUyNDgzMTYyYzU0NTIxYjA3MTFiZmQ3N2IzNTA0NF84Nzk2MDkzMDIyMjMy_b937fc8d-d55d-4e0a-8df4-17b72afe193a"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i7ba2f37bcf6a402cbdc706a9755f41eb_I20180930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEwLTUtMS0xLTAvdGV4dHJlZ2lvbjpmZWM0NzBlZTUyMDQ0N2I0YTlkZGM5YzZjY2I4NGY4M184Nzk2MDkzMDIyMjE0_fcf5fd08-f947-4416-96b1-d2babba8ff05"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ie7c4b24571604e75af7f7e9f3bb4d335_I20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzExLTQtMS0xLTAvdGV4dHJlZ2lvbjo0NTk2ODJmZTNlMWY0Y2FkODMzMzI2MjA3OWM3ZmIxZl84Nzk2MDkzMDIyMjMy_14dbc155-a50b-4308-a339-a6939792da48"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i35caf9a0d822450fa81f75e68cd02338_I20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzExLTUtMS0xLTAvdGV4dHJlZ2lvbjo2ZjIzZTdhZjU4YTg0NTkyYTUxZmQ5ZDI1M2FmNjFiYl84Nzk2MDkzMDIyMjI4_a7959e6e-fb80-467b-ba75-872178573e3a"
      unitRef="usd">2000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ia3bacb16e4784de892ae8b6b2205a876_I20171130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEyLTQtMS0xLTAvdGV4dHJlZ2lvbjo2Y2VhYTg2OGJmYmI0NjY0OWU0ZDBmZGJiZmI4NzJiMF84Nzk2MDkzMDIyMjMz_3286e52f-f33c-4152-b17b-5f84c0746e54"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i0cb589bcaaa645de9d8fdc23492ff483_I20171130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEyLTUtMS0xLTAvdGV4dHJlZ2lvbjpkNmU5ZmY5ZWEyNGE0NmI4YjFhZDNkMmE1NmVhMjNkZF84Nzk2MDkzMDIyMjE2_4bc8b7a7-40ee-4041-8ff3-b7e8dffdaec9"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i67739f053413439ebc96236f3209b74e_I20170430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEzLTQtMS0xLTAvdGV4dHJlZ2lvbjoxNTgxMjNlMjZhYmQ0N2UxOTg0MDE0M2Q2NjE1YzZiMl84Nzk2MDkzMDIyMjMy_91e20f8e-3617-4e11-b2a0-f595c542690e"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i78f0ea0e26e943ae806d1225535249a8_I20170430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzEzLTUtMS0xLTAvdGV4dHJlZ2lvbjo1N2Q5YmVjYjcwYWY0NTJjYjY4Nzk1NjdlMDIzYjQyOF84Nzk2MDkzMDIyMjE2_02360d2b-2e22-4bef-8dfd-350772a33c92"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ia0c617d528d64ef7961c5cff9cbf15ec_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE0LTQtMS0xLTAvdGV4dHJlZ2lvbjo1NDVkNThiNjA2ZWE0MTEzYmU3ZTBhNzk4Mzg5NzllYl84Nzk2MDkzMDIyMjU0_bd640148-8ddd-4d8e-8d6d-97229ca3b3c6"
      unitRef="usd">5000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i06074dee810942e292ea731bda7a36a0_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE0LTQtMS0xLTAvdGV4dHJlZ2lvbjo1NDVkNThiNjA2ZWE0MTEzYmU3ZTBhNzk4Mzg5NzllYl84Nzk2MDkzMDIyMjY3_9171fe15-79f5-4ba8-b4f4-7565d66bfdf9"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i06074dee810942e292ea731bda7a36a0_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE0LTUtMS0xLTAvdGV4dHJlZ2lvbjoyY2ViYmVhMGViMWE0OGI1ODQ3ZDI2MzQyNGI0NDAzY184Nzk2MDkzMDIyMjE2_e461fc5b-4151-45e1-8617-206abcf7c8d8"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i6797d3f0b35047dda7ab8a8ec5357129_I20150131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE1LTQtMS0xLTAvdGV4dHJlZ2lvbjowMGM0NDZhYmVhZTA0OGQxOTE4NjRmNWU4ZGFlYjEwNF84Nzk2MDkzMDIyMjMy_e4cb4861-094c-43b6-86b5-eb9dd1a0fbeb"
      unitRef="usd">8000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i9a54fa21dad34042b8f605536d155127_I20150131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE1LTUtMS0xLTAvdGV4dHJlZ2lvbjo5MWEyZDAzODJkYzQ0MDE2ODA5YTk0NTYyOTk3MjgwZl84Nzk2MDkzMDIyMjMy_017f9d24-26db-45ca-bd22-4f37628dd7a6"
      unitRef="usd">9000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i82c91aed7e2542169faf3a41146a2257_I20140731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE3LTQtMS0xLTAvdGV4dHJlZ2lvbjo2YmU1NWQwYzYxMGY0NWNjYWExZTY1MmEyNzAwNWY2Y184Nzk2MDkzMDIyMjU0_8716d35a-be28-424b-b00e-ed4aca7906df"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i490bb998e16344949c52ff8781d7eb75_I20140731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE3LTQtMS0xLTAvdGV4dHJlZ2lvbjo2YmU1NWQwYzYxMGY0NWNjYWExZTY1MmEyNzAwNWY2Y184Nzk2MDkzMDIyMjY4_794f18d4-5615-49cd-83a2-3f8ba36a796e"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i490bb998e16344949c52ff8781d7eb75_I20140731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTpkYzIxNzI4ZmJlZDA0ZjM3YjM1OTYyNzZhZjY4MWI1OC90YWJsZXJhbmdlOmRjMjE3MjhmYmVkMDRmMzdiMzU5NjI3NmFmNjgxYjU4XzE3LTUtMS0xLTAvdGV4dHJlZ2lvbjpjZGE0N2RkMmQ5ZjA0NjJiOWZjMjc1NGI3OWNhOWFhZl84Nzk2MDkzMDIyMjE2_b8d3114e-bcb3-42a5-935c-d2e4378d5e76"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i5fedb4dbaee5495fb6536ab744945764_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo4ODQ5NDZjYWEzYjQ0YTEyOTM0OGQ1MGUzNjg1NTU0My90YWJsZXJhbmdlOjg4NDk0NmNhYTNiNDRhMTI5MzQ4ZDUwZTM2ODU1NTQzXzEtNS0xLTEtMzg1NS90ZXh0cmVnaW9uOjI5YWE2NDJlNGVkMjQ0ZmViMDM3YjkzMWQ5MGRhNTg3Xzg3OTYwOTMwMjIyMzQ_358e07a5-61e7-48ed-9131-4a03638122c6"
      unitRef="usd">26000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i62c4a7eb460c47c4abeef12cfe44cd6d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo4ODQ5NDZjYWEzYjQ0YTEyOTM0OGQ1MGUzNjg1NTU0My90YWJsZXJhbmdlOjg4NDk0NmNhYTNiNDRhMTI5MzQ4ZDUwZTM2ODU1NTQzXzEtNS0xLTEtMC90ZXh0cmVnaW9uOjQxNmZlOWRlNDUzZjRkMWNiMTEyNzMzNGU4ZGQzNzYwXzg3OTYwOTMwMjIyMzQ_e5353ce4-ac40-4a5e-945c-68389ef42ca4"
      unitRef="usd">10000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i5bac0925a60d445ea8ad330c550cde67_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90YWJsZTo4ODQ5NDZjYWEzYjQ0YTEyOTM0OGQ1MGUzNjg1NTU0My90YWJsZXJhbmdlOjg4NDk0NmNhYTNiNDRhMTI5MzQ4ZDUwZTM2ODU1NTQzXzItNS0xLTEtMC90ZXh0cmVnaW9uOmM2MDU1OGNhZTBkMDQzY2RiNmRlMjJkNWJiMTc4M2NkXzg3OTYwOTMwMjIyMzQ_25ba6ff8-7450-4f8e-9c2e-0f649c225c8f"
      unitRef="usd">17000000</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo
      contextRef="ica94d523154c4c0fbf78887c8b5a2ecf_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxNjk3_baa8d7df-88be-4741-ac4f-d7dc337f2f0d"
      unitRef="case">4</mo:LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i06e101deca564c7faf4a806f5acf2373_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxODM2_128df1be-dcf9-4db6-83d2-43ab8f85b1f8"
      unitRef="usd">8000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i05be0cce4caa4d2b8616b1209601e242_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxODQw_ea7c01ec-17dd-46e9-9482-88554b43cc4e"
      unitRef="usd">2000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="id8ade17230a6455891f64fe763188b45_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxODQ0_282f8b24-45b4-4ee7-b2da-13381f017895"
      unitRef="usd">9000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i7458b6e8570f46858d3d5cfb65f8fed0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIxODUx_6b149a3d-c5aa-4403-8566-fda5228a26ee"
      unitRef="usd">4000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i5fedb4dbaee5495fb6536ab744945764_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg5MDMyMzU_358e07a5-61e7-48ed-9131-4a03638122c6"
      unitRef="usd">26000000</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:PreTaxChargesGainIncludedinNetEarning
      contextRef="i4ced792544c54268bd9593f35eddb549_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIyMjM2_b4c730d5-aa28-419b-8773-613f990e2911"
      unitRef="usd">10000000</mo:PreTaxChargesGainIncludedinNetEarning>
    <mo:PreTaxChargesGainIncludedinNetEarning
      contextRef="i3fcc4a28b47f436c803de4971a69b758_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIyNTA1_d8f35fd6-63fc-483a-bb93-25aee930af18"
      unitRef="usd">17000000</mo:PreTaxChargesGainIncludedinNetEarning>
    <mo:MaximumBondForAllDefendants
      contextRef="i2af34da3eecf4a8ebf87a01b040a2639_I20090630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIyNjU4_e2e00175-4926-4295-86a6-ea14d1791dd3"
      unitRef="usd">200000000</mo:MaximumBondForAllDefendants>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i56d82ed761ef41faa02538a434851cba_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIzOTI5_61f56a36-a6c9-4a98-b455-e23aadc2f34f"
      unitRef="case">61</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i478232b2660949908a92fbab33c32522_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzIzOTk1_85f90b9b-45c5-4572-8c6d-984497ffebd5"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i33543518d6fe4ed1953a1556411870d8_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDEy_d07d7ba8-725d-4c82-b4b7-7d29d9f472ef"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i6a8b9d0cebed4ddb9c87e8c9b6beb170_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDI3_546d28d9-9909-4958-b53f-2e787f5e3f17"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="if01eeea512324def8fe5ddadb4933fad_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDU4_a89799b7-7c54-4682-b9d5-9029c2e9007c"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i699b979bc3384548b7b8bea7e04b6c80_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDcy_f8164133-f86c-4946-91c0-be1025ffb853"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i4ff54182d2e14c58b237baad2a9f2b83_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDg3_43954d27-b195-4ad5-8689-419d72923910"
      unitRef="case">3</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i21d1ad4f96264abdb7cc9a9a8779a95c_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MDk4_91f8a91c-6414-45d6-9391-a6d82b842e50"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i93b4623007a1413fa49810d6fcdcc0b4_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTEx_34f50511-9dc2-409d-9ec5-fe35bae0f38c"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i838f2633ed9f400bbf26ccb953378742_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTI3_4c65cb6b-f352-41c2-a6cb-b0573b64f62b"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="icf31645f50824ffea06b19db990ee06c_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTQy_01fef3f8-da3b-40d8-8636-f9140c187f80"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i65cd4161393b493e93229e0b24630447_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTU3_ebb8b8e7-33b3-4ff0-a257-e15693d1cbfd"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i776efbde1566429f802bd97c318bb9de_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTcz_8e18d650-acfe-4c0a-b22d-644859fe7e97"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ia1eed415a7f14ab7906e4688e423ad63_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MTg2_3d6ee935-e9c1-4c56-a7c2-92b7b19a589a"
      unitRef="case">29</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ib3f246771a94496a8fe79e88a4c244f8_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjAz_d34cf1f1-bf84-4309-a02a-2e98b5c529e1"
      unitRef="case">6</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i808cf4a891d345f1b854305991736a14_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjE4_cd3607a1-f660-4d73-8b6e-71e7dc28da92"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i207d1b533ad342f0869af8557c242e8a_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjI5_af11b620-4f19-4643-a6bc-1bc71246aacc"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i6fa168360477427daf858f964b5cb335_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjQ0_1094bbe4-51e0-442c-9c17-6c0826675e7c"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i56a3c4325e724588a97c6020a21a678d_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MjU3_dd760f60-6c7e-498c-a1b6-cefe1e136274"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i3ce9b9f166c94ef2abf45bab5d8b92ad_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0Mjc2_fb9b066f-eae2-4199-9287-cdf1113a6ad8"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="iffac1ae1843149e283a93385a7627136_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0Mjk0_264d4da5-e4ed-4e0a-8f8c-f4371cd29de6"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i2e4937e663604dd08163acaf12477d40_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MzE1_aefcbd67-e17b-4c83-a056-081a3f5dd864"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="id6abd61ba1fd4819a6eb7a7144ab2ed8_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MzI3_613de21b-c918-4da0-837e-4be063e7b5b0"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i0fb064a2cc7d473e8f865cbc2fb8885f_D19960501-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0MzQ2_1ceabfc4-8521-4b49-9740-4a3c092b89c9"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i5370156fe8d14a8e8da1520ca797a308_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0NjQ3_90a9974c-2cf3-4536-a8fb-6bbb2ef62181"
      unitRef="claim">7</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="id3f5b7c4027d400398db6b1ad78239ab_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI0ODEx_0e5aa241-8782-430c-8ec2-159f31bd1a0a"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofManufacturers
      contextRef="i3f3875700c6945e4837cd9e5bda1f32b_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI1MzAz_2277ace6-4a20-4596-bf4d-01fff3444db9"
      unitRef="manufacture">3</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyVerdictsUpheld
      contextRef="i3f3875700c6945e4837cd9e5bda1f32b_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI1NjE1_bfc2496e-5001-4815-8819-d760df2a1978"
      unitRef="ruling">2</mo:LossContingencyVerdictsUpheld>
    <mo:AmountAwardedtoOtherParty
      contextRef="idc79629711204f43abfeca4b62d5c1d8_D20190301-20190331"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI1NzEw_799793a7-ddfe-4a8b-b1db-f2aff5d4474f"
      unitRef="cad">13000000000</mo:AmountAwardedtoOtherParty>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i8949cd3b364e4768928464fc8e22ebae_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI3Mjg0_b39d9384-b332-4c34-8d47-1352d4d8f619"
      unitRef="claim">10</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofManufacturers
      contextRef="id0f294b9d70d421f83088c1d9d8b30a9_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI4MTY2_47c288c9-a238-4497-8334-98d321700166"
      unitRef="manufacture">3</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyNumberofStateswithSettledLitigation
      contextRef="i169d27beb37c49c5bf82654208714375_D19981101-19981130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI4Nzc1_e3561a28-e932-446a-8709-5e6a75bc4570"
      unitRef="state">46</mo:LossContingencyNumberofStateswithSettledLitigation>
    <mo:LitigationSettlementAnnualPaymentAmount
      contextRef="i169d27beb37c49c5bf82654208714375_D19981101-19981130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI5Mzc2_97d3c690-7091-4d2f-8b4f-c4475fd84e48"
      unitRef="usd">9400000000</mo:LitigationSettlementAnnualPaymentAmount>
    <mo:LitigationSettlementAnnualLegalFeesPayableMaximum
      contextRef="i97d740917fe440d1a50498a05140608e_I19981130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI5NTg4_6e1484db-8045-483e-b477-aa58db07543d"
      unitRef="usd">500000000</mo:LitigationSettlementAnnualLegalFeesPayableMaximum>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="iff56a70694624f4a924402ecc251143a_D20200701-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI5NzU3_17f20300-e148-449c-a8f5-13d6fe9f9892"
      unitRef="usd">1200000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i047334242a4e4b4e9a23b88b2217bc5c_D20190701-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzI5NzY0_0da9a087-8f8f-45f8-aa0d-2263772a4faa"
      unitRef="usd">1100000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i06cf35adf4314057a6229713af6fc6f9_D20200101-20200930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTc5NTc_9ffcdb22-d682-408e-9f09-12459e7b7fa6"
      unitRef="usd">3300000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i6fc84a4adae148e8b5c911a64d52cfdd_D20190101-20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzk4OTU2MDQ3MTE4NjU_15439107-38ec-42e1-a77c-ee6d3bded959"
      unitRef="usd">3200000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="ie19865eab4224177afee834778e21a4a_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMwNzIy_bfb45f72-02bd-4711-832f-7f45cbd3bdf2"
      unitRef="state">36</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencySettlementAgreementsNumber
      contextRef="ie19865eab4224177afee834778e21a4a_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMwODA0_7f356d5e-c116-443f-9f76-02c3f194384d"
      unitRef="claim">2</mo:LossContingencySettlementAgreementsNumber>
    <mo:LossContingencyNumberofStateswithSettledLitigation
      contextRef="ie19865eab4224177afee834778e21a4a_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMwODYy_65054ebe-d6d4-4f93-92c9-62f81b39d201"
      unitRef="state">37</mo:LossContingencyNumberofStateswithSettledLitigation>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="ie19865eab4224177afee834778e21a4a_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMwODk4_b1df4e09-75a9-42d9-923a-a2105b16e568"
      unitRef="state">36</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="i3e86e226235c4990a36636532147b9b9_D20171001-20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxMTI0_b3e6018d-2da1-4a7b-9309-571ce72bb6a0"
      unitRef="state">26</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencyProceedsfromLegalSettlements
      contextRef="i3e86e226235c4990a36636532147b9b9_D20171001-20171031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxMTYx_11eb95ed-8b05-439d-9e23-4f6218c6f055"
      unitRef="usd">740000000</mo:LossContingencyProceedsfromLegalSettlements>
    <mo:LossContingencyNumberofSettlementDevelopments
      contextRef="i53f369577bd3484cbaee39e41e064c6b_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxMTg2_1a7e7eb8-0294-4163-97d1-a4be8d9b7059"
      unitRef="settlement_development">2</mo:LossContingencyNumberofSettlementDevelopments>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="i3e86e226235c4990a36636532147b9b9_D20171001-20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxMzMy_724f48a3-8f02-4122-b459-b426cf82c6d8"
      unitRef="state">26</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencyNumberofAdditionalStateswithSettledLitigation
      contextRef="ib07a762a7c314cb981274ba805f9f3d9_D20171001-20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNDMw_31d5201c-6b60-4a82-b468-dccd4899ec99"
      unitRef="state">10</mo:LossContingencyNumberofAdditionalStateswithSettledLitigation>
    <mo:LossContingencyNumberofSettlementDevelopments
      contextRef="ib7136524f70a44118cc4469581d243c9_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNDc0_7c452cc4-cc2a-43fb-b1d7-a03cc09d1d66"
      unitRef="settlement_development">2</mo:LossContingencyNumberofSettlementDevelopments>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i905cb71d55944236820d53a9f8ba97b4_D20180401-20200430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNTI1_462fe3f6-9371-45b6-abe2-da5faa2dd81b"
      unitRef="usd">248000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i18398105d8324ad6807cd23593a48335_D20180401-20180430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNTI5_bbac8b5e-1d3c-4c0c-9c75-a81049c30f0d"
      unitRef="usd">68000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i7127e4e55f3b48cca9b37c8e7582d3db_D20190401-20190430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNTY4_2ca32cd7-10bf-44da-8bf6-c2eea960ccca"
      unitRef="usd">121000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i173ce1f840bf44efa105eaef9092cd54_D20200401-20200430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNjEw_0814e5d7-2207-4b29-bac4-1592c2978471"
      unitRef="usd">47000000</us-gaap:ProceedsFromLegalSettlements>
    <mo:LossContingencyNumberofSettlementDevelopments
      contextRef="ib7136524f70a44118cc4469581d243c9_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNjc1_7c452cc4-cc2a-43fb-b1d7-a03cc09d1d66"
      unitRef="settlement_development">2</mo:LossContingencyNumberofSettlementDevelopments>
    <mo:LossContingencyReductionToCostOfSales
      contextRef="i71dd2d406d224d878f3ef54f28a29459_D20170101-20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNzU0_e6243023-3602-4a78-a6f7-575fd41cc94e"
      unitRef="usd">39000000</mo:LossContingencyReductionToCostOfSales>
    <mo:LossContingencyReductionToCostOfSales
      contextRef="ib1b513fdea0b44b19d5975639617c3f4_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxNzg2_5124874c-c0b8-4086-b52d-584cb13ab7c3"
      unitRef="usd">209000000</mo:LossContingencyReductionToCostOfSales>
    <mo:LossContingencyReductionToCostOfSales
      contextRef="ic2269ecdf1c64fb98097f29ff6e22692_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMxODk2_848ff402-06e5-4e4b-8edf-4f509815a88f"
      unitRef="usd">52000000</mo:LossContingencyReductionToCostOfSales>
    <mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation
      contextRef="i5dc2309f4c184f1d91f181d088250c1c_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMyMzU1_afa7a133-38b3-4b46-bbb7-165a6e219039"
      unitRef="state">35</mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i632a162da722437e9880fd3bbac52897_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMyNDg5_c7a84dd5-399c-4850-ab11-ec930f172bd0"
      unitRef="usd">361000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <mo:LossContingencySettlementAgreementPaymentPeriod
      contextRef="i632a162da722437e9880fd3bbac52897_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMyNTQw_5f075b8f-fc6e-44a2-a70d-3e14c476e380">P9Y</mo:LossContingencySettlementAgreementPaymentPeriod>
    <mo:LossContingencyProceedsfromLegalSettlements
      contextRef="i9e5e9c280fc9404d8b6763a66a3c305f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMyNjU5_8e8cced4-f47e-4327-9a0b-44dd9d3b0a4b"
      unitRef="usd">317000000</mo:LossContingencyProceedsfromLegalSettlements>
    <mo:LossContingencyNumberofStates
      contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzMzc2_7ef66d6a-16ba-4bcf-ad6c-96baa5a1719a"
      unitRef="state">15</mo:LossContingencyNumberofStates>
    <mo:LossContingencyNumberofStatesWithoutDefense
      contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNDQ4_a618b649-9a51-476e-add5-68c69099a9a7"
      unitRef="state">6</mo:LossContingencyNumberofStatesWithoutDefense>
    <mo:LossContingencyNumberofStateswithSettledLitigation
      contextRef="ifa9e64d794b84e179af595a489042961_D20130901-20130930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNTM5_4de767bb-a255-4534-85ba-7a89f4eb6dfb"
      unitRef="state">2</mo:LossContingencyNumberofStateswithSettledLitigation>
    <mo:LossContingencyNumberofStatesWithoutDefense
      contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNTUx_59504c57-116f-4c56-a152-10b823f46853"
      unitRef="state">6</mo:LossContingencyNumberofStatesWithoutDefense>
    <mo:LossContingencyNumberofStatesRemaining
      contextRef="icad6887108624ef19b7c544b38df9e85_D20130901-20130930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNjQz_1208b1b7-af5f-49f8-bae7-90b7313fffef"
      unitRef="state">4</mo:LossContingencyNumberofStatesRemaining>
    <mo:LossContingencyReductionToCostOfSales
      contextRef="ic184ac8ea193498a824e11bb3c6a380e_D20130901-20130930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzNzM0_e8e959b1-39ea-4955-ae92-8e9e1ba6b62c"
      unitRef="usd">74000000</mo:LossContingencyReductionToCostOfSales>
    <mo:LossContingencyNumberofStatesWithoutDefense
      contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzODg0_59504c57-116f-4c56-a152-10b823f46853"
      unitRef="state">6</mo:LossContingencyNumberofStatesWithoutDefense>
    <mo:LossContingencyNumberOfDisputesOutstanding
      contextRef="if2dcc858f924477bb741ea6cea8d7486_D20130901-20130930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzMzOTMw_15d32232-7306-472d-ba18-c02673b378e9"
      unitRef="state">2</mo:LossContingencyNumberOfDisputesOutstanding>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i32b1d9a333c54d99b2ca2e70af628ad9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM1NDI2_ada8f005-27f1-4410-a0c6-6b425a854e1a"
      unitRef="usd">43000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i30652171c168469b95e7a480823eec6a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTE4_ed8ef021-1701-4ea4-bd6f-ec0b8cdd2217"
      unitRef="usd">388000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i0e1757eedc104e8fb665fd9663ddfecc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTMx_0526665d-8888-4eed-bbb1-f95e7117b54e"
      unitRef="usd">181000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i42170c8f1d6444caac8ca0392f6a2276_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTQ0_a0bb7f88-cb9f-40eb-8a10-3729279d45ec"
      unitRef="usd">154000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i4bc886e153d544dba8474e1686d381cc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTU3_c94d65c5-c16c-4b46-9d77-ba7c82106372"
      unitRef="usd">185000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i77fb9eb402e744f8b24e8258a74cd29f_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTcw_f6b208bb-b3fd-4d6a-8921-5430f5a56b8a"
      unitRef="usd">250000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="if33f95674df24a7981e5f92d55c32bc3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTgz_3e51aba7-dbf5-447f-aec1-0552992a0d26"
      unitRef="usd">211000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i129667b4722345049e3eacc64888eda2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NTk2_8de25229-3ea6-4f18-a255-1319c98a733d"
      unitRef="usd">218000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i23e21af60d684691875ed325f6132e92_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjA5_66e0bd0c-3af9-4609-96df-420eb91cb5cf"
      unitRef="usd">166000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i4a91eaf68d5c43dd926983f95d778cea_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjIy_42037af6-22f2-43ed-a875-74185761fd24"
      unitRef="usd">214000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i2189369e507844d7aa734b62200b5014_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjM1_5ce8ff97-0dd5-45fe-9dfb-948e973409a0"
      unitRef="usd">224000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i320fe601fb2e4afa8201647bbf6c161e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjQ4_dc8f73df-b898-4b34-89a0-26b9d58bdc9d"
      unitRef="usd">258000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ic9c75caeda0440b2b7a8b44f6a3af45a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NjYx_2e96af9f-9b8f-4c4e-a97e-ddc7814154e3"
      unitRef="usd">313000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i5cf05e684bcf452b891b222faeba6f5d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2Njc0_5a38eb1e-5049-4154-9980-77897d6f3066"
      unitRef="usd">305000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i024ba7dd2cb546cb91939fb3c737b4cd_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2Njg3_c2aa232f-f531-4868-a688-d6cb126d5d88"
      unitRef="usd">297000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i497ca0f28e5442c59124520e63eb5149_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NzAw_e0e67375-b321-4196-9dd6-27bc91807619"
      unitRef="usd">340000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i3254354ec2ca4cc19c1da242682ccd9a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM2NzE2_ef980a67-9a95-462f-947a-44e62f59fa51"
      unitRef="usd">441000000</mo:LitigationSettlementEstimateofPossibleGain>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i70337240f7a84b3788b6f48a11439d6f_D20180801-20180831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzM4NzYz_0b38e9aa-942e-43b9-9e57-6b9ecc5c411a"
      unitRef="usd">9800000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <mo:FederalTradeCommissionDisclosurePeriod
      contextRef="ie8789e2bcbf64769a038755249460300_D20060801-20060831"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ0MTY3_e3808e63-a55a-4a8d-b500-086b2d8a9633">P10Y</mo:FederalTradeCommissionDisclosurePeriod>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i14beba11ec90485cb8c96048f72ff73f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ1MTI0_4354c339-ca93-4178-9674-cad2ee90b74b"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="iaae00eba7cfd48bb8a759ff60030320a_D20140101-20141231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ1MTI0_4eca7335-355c-4686-bb51-402a735acd56"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i1c5a0e12db7b469bbcc33e36f758341a_D20140101-20141231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ1MTI0_534d2d24-cac4-4812-a254-36becd2296d1"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ib15d032499ec49ce814afe877066b823_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ1MTI0_84474a19-24b3-4cf3-9f59-7e4ece334a73"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ifdb0e875b3484b01ad06905775a8272b_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ2MDU5_2d1d705e-f803-4aef-a6ad-489ea11612ba"
      unitRef="claim">25</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i759cc82368a24da9b90d561f09b6df19_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ2ODcw_2ce3ddb3-7100-4aaf-b551-db9f9997a78f"
      unitRef="claim">1064</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7b52d1ccf10645b8ac9e77afdbf09979_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ2ODk0_6bb4ecbd-20fc-489c-a953-2bf7f2706c5b"
      unitRef="claim">25</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i6732b65e853a4a2ebc98fc8672546c08_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ2OTM2_2d8fb717-1e91-47be-a53c-cffbe2643375"
      unitRef="claim">31</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofCasesSetforTrial
      contextRef="i1938f36d8dd1444f846a2c358e51a292_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzQ3ODYw_d7458cd8-327c-48f1-a170-7196a6264a3d"
      unitRef="claim">0</mo:LossContingencyNumberofCasesSetforTrial>
    <mo:LossContingencyStateCourtsNumber
      contextRef="i6f6c0c255f674e16970fc172f56b0c52_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzE4NjkxNjk3NzM0MDgy_760f585b-69f8-4137-aa43-1d0766080c73"
      unitRef="court">21</mo:LossContingencyStateCourtsNumber>
    <mo:LossContingencyClaimsNotCertifiedNumber
      contextRef="i3a4a3638d5c14dd6930a6317db7cb2fe_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUwNDQy_dce2f515-a876-4723-aa3e-22ca7de108d5"
      unitRef="case">23</mo:LossContingencyClaimsNotCertifiedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3a4a3638d5c14dd6930a6317db7cb2fe_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUwNjQ3_78bef126-c005-4082-8f73-3d0ab771998f"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if0cadfd7091b4c52acbda0b9e5844949_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUwNzY2_85b92ac2-3657-4787-b70e-0a9f2a123f22"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i365934f7ac7f46b589e0fbf8c5a01204_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUxODIy_71319e4b-e701-4523-9086-675496106271"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i5a9a9ea271534fef8e2574fa16175c11_I20200430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzUxOTgy_b2fe9379-382f-4785-8b39-b855fcf2bf60"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:LossContingencyClassActionLawsuit
      contextRef="i94b8b0bd9cd64fb1b726bdd03fce49cf_I20201027"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzk4OTU2MDQ3MTA2NDE_95f1659a-8131-42df-a353-90e4812d978b"
      unitRef="lawsuit">16</mo:LossContingencyClassActionLawsuit>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="ibaad81b69d5b4f30a76662311f1a3c69_D20191201-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU0MDQx_758fa7bb-fad5-4cef-b795-e66f4f4bf461"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="ibaad81b69d5b4f30a76662311f1a3c69_D20191201-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU0NDQ4_758fa7bb-fad5-4cef-b795-e66f4f4bf461"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="i5e48f7ae862f4927a706bfb1d1bdff5f_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzkzNDU4NDg4OTc5Mjk_bf06a951-1c32-479c-b4a8-e50001ea5ea4"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i221381c6c8174016a6e3bd28d276c6f7_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU3MDM2_9b78f1d5-03dd-4c33-93b0-097b895564c1"
      unitRef="usd">49000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU3MjAx_2da11c4c-b0aa-46c3-87cf-716f2fd0d19b"
      unitRef="usd">25000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ia293f60845e647b181cfb7a59955fc58_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU3Mjc2_56bc1eab-0ffc-4ef2-ae16-0b8e1b740615"
      unitRef="usd">39000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4e875a907d9e4fc9a48992750104acbd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xMzAvZnJhZzozN2IyODk5NTYwNGI0NGYzYTFmNTA2MTc3NmZhOThhMC90ZXh0cmVnaW9uOjM3YjI4OTk1NjA0YjQ0ZjNhMWY1MDYxNzc2ZmE5OGEwXzU4NTc3_6b3eb6ac-933d-41af-96e6-7476cdddf3b6"
      unitRef="usd">3000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNTEvZnJhZzphNDVhZGJkYmNkOTg0MGMyYTBmNTRjMjgzODZmZGJlMS90ZXh0cmVnaW9uOmE0NWFkYmRiY2Q5ODQwYzJhMGY1NGMyODM4NmZkYmUxXzE4Ng_802fa562-4b80-4f17-928d-9cc194a42720">New Accounting Guidance Not Yet Adopted:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.232%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect on Financial Statements &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2019-12 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Simplifying the Accounting for Income Taxes (Topic 740)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. &lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2020-01 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. &lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;s Own Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="ib44959adae174705840aea192a7e8046_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8xNTEvZnJhZzphNDVhZGJkYmNkOTg0MGMyYTBmNTRjMjgzODZmZGJlMS90ZXh0cmVnaW9uOmE0NWFkYmRiY2Q5ODQwYzJhMGY1NGMyODM4NmZkYmUxXzE3NA_b03382eb-3c57-410e-9f30-065d6479a241">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.615%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.232%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect on Financial Statements &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2019-12 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Simplifying the Accounting for Income Taxes (Topic 740)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. &lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2020-01 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. &lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2020-06 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;s Own Equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtNi0xLTEtMA_152297ec-d10d-4dae-a5da-3ef65d848c38"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtNi0xLTEtMA_152297ec-d10d-4dae-a5da-3ef65d848c38"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTQtMS0xLTA_32bef1b2-a36e-4bb9-8683-bebcf17c1d46"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTQtMS0xLTA_32bef1b2-a36e-4bb9-8683-bebcf17c1d46"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xMi0xLTEtMA_92b43da6-2611-4ca9-a4aa-fe91a87e8d2c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xMi0xLTEtMA_92b43da6-2611-4ca9-a4aa-fe91a87e8d2c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy02LTEtMS0w_b057b873-ca49-491d-896f-78e148d40186"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy02LTEtMS0w_b057b873-ca49-491d-896f-78e148d40186"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTItMS0xLTA_ddaf8c78-7472-4f94-ae7b-8f418194e190"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTItMS0xLTA_ddaf8c78-7472-4f94-ae7b-8f418194e190"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xNC0xLTEtMA_de3e948b-bbca-4c2e-b5e7-5f50627b0389"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xNC0xLTEtMA_de3e948b-bbca-4c2e-b5e7-5f50627b0389"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts attributable to noncontrolling interests for the three months ended September 30, 2020 and 2019 exclude net earnings of $1 million due to the redeemable noncontrolling interest related to Stag&#x2019;s Leap Wine Cellars<xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets. </xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtNi0xLTEtMA_152297ec-d10d-4dae-a5da-3ef65d848c38"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTQtMS0xLTA_32bef1b2-a36e-4bb9-8683-bebcf17c1d46"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xMi0xLTEtMA_92b43da6-2611-4ca9-a4aa-fe91a87e8d2c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy02LTEtMS0w_b057b873-ca49-491d-896f-78e148d40186"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjkzZWIzZTBhYjEzNjQzN2Y5NWU2YzA4MDBhYzI1NzhkL3RhYmxlcmFuZ2U6OTNlYjNlMGFiMTM2NDM3Zjk1ZTZjMDgwMGFjMjU3OGRfMTAtMTItMS0xLTA_ddaf8c78-7472-4f94-ae7b-8f418194e190"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RhYmxlOjBmYjgxNDkyN2UxNjQ4MzRhMWUwNzcxZDFmZmQ0M2M3L3RhYmxlcmFuZ2U6MGZiODE0OTI3ZTE2NDgzNGExZTA3NzFkMWZmZDQzYzdfMy0xNC0xLTEtMA_de3e948b-bbca-4c2e-b5e7-5f50627b0389"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yOC9mcmFnOmE4YmFiMjc3ZTI3ZjQyMjM5Y2RjMjY4NmRlYzVmODIxL3RleHRyZWdpb246YThiYWIyNzdlMjdmNDIyMzljZGMyNjg2ZGVjNWY4MjFfNTU5_763a26ce-02a4-40e1-ad65-34e3e00b69c0"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItMi0xLTEtMA_8b2de181-c594-4861-82f2-16775637f7aa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItMi0xLTEtMA_8b2de181-c594-4861-82f2-16775637f7aa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItNC0xLTEtMA_fb9e1f1b-6613-49b9-a770-61217d261122"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItNC0xLTEtMA_fb9e1f1b-6613-49b9-a770-61217d261122"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtNC0xLTEtMA_f860a248-690d-4c89-b56c-5007bb75c513"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtNC0xLTEtMA_f860a248-690d-4c89-b56c-5007bb75c513"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtMi0xLTEtMA_7c50127c-8405-4552-83d6-3a0c8f1f729a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtMi0xLTEtMA_7c50127c-8405-4552-83d6-3a0c8f1f729a"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RleHRyZWdpb246YTY0NjhiZGQ5MGE5NGMwYjk0NDkyN2JlN2FjZjBhMDZfNTQ1_d0bfd329-a1e4-4202-8c50-456f2cc3558d" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RleHRyZWdpb246YTY0NjhiZGQ5MGE5NGMwYjk0NDkyN2JlN2FjZjBhMDZfNTQ1_d0bfd329-a1e4-4202-8c50-456f2cc3558d" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 12. </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItMi0xLTEtMA_8b2de181-c594-4861-82f2-16775637f7aa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RleHRyZWdpb246YTY0NjhiZGQ5MGE5NGMwYjk0NDkyN2JlN2FjZjBhMDZfNTQ1_d0bfd329-a1e4-4202-8c50-456f2cc3558d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjItNC0xLTEtMA_fb9e1f1b-6613-49b9-a770-61217d261122"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RleHRyZWdpb246YTY0NjhiZGQ5MGE5NGMwYjk0NDkyN2JlN2FjZjBhMDZfNTQ1_d0bfd329-a1e4-4202-8c50-456f2cc3558d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtNC0xLTEtMA_f860a248-690d-4c89-b56c-5007bb75c513"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RleHRyZWdpb246YTY0NjhiZGQ5MGE5NGMwYjk0NDkyN2JlN2FjZjBhMDZfNTQ1_d0bfd329-a1e4-4202-8c50-456f2cc3558d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RhYmxlOjNmMTgxY2IyYmQxNTQ1NWJiYzVkMzU0MDhkYWQ3NjhiL3RhYmxlcmFuZ2U6M2YxODFjYjJiZDE1NDU1YmJjNWQzNTQwOGRhZDc2OGJfMjMtMi0xLTEtMA_7c50127c-8405-4552-83d6-3a0c8f1f729a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8zNC9mcmFnOmE2NDY4YmRkOTBhOTRjMGI5NDQ5MjdiZTdhY2YwYTA2L3RleHRyZWdpb246YTY0NjhiZGQ5MGE5NGMwYjk0NDkyN2JlN2FjZjBhMDZfNTQ1_d0bfd329-a1e4-4202-8c50-456f2cc3558d"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xNC0xLTEtMA_1365353b-ff29-4c18-9e19-f97fac58e22c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xNC0xLTEtMA_1365353b-ff29-4c18-9e19-f97fac58e22c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xNC0xLTEtMA_277440a4-0139-4102-93a7-427461701cb4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xNC0xLTEtMA_277440a4-0139-4102-93a7-427461701cb4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy02LTEtMS0w_25371da7-04cc-4898-985d-73ebdb05a779"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy02LTEtMS0w_25371da7-04cc-4898-985d-73ebdb05a779"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xMi0xLTEtMA_daa767f6-3e95-44c7-89d5-cafc550d0300"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xMi0xLTEtMA_daa767f6-3e95-44c7-89d5-cafc550d0300"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xMi0xLTEtMA_6374442d-f542-43ff-996c-cd0f38a9d2ed"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xMi0xLTEtMA_6374442d-f542-43ff-996c-cd0f38a9d2ed"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy02LTEtMS0w_c1ac318b-9f4f-474a-8516-8447b3e09bc6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy02LTEtMS0w_c1ac318b-9f4f-474a-8516-8447b3e09bc6"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts attributable to noncontrolling interests for the nine months ended September 30, 2020 and 2019 exclude net earnings of $2 million and $3 million, respectively, due to the redeemable noncontrolling interest related to Stag&#x2019;s Leap Wine Cellars</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets. </xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xNC0xLTEtMA_1365353b-ff29-4c18-9e19-f97fac58e22c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xNC0xLTEtMA_277440a4-0139-4102-93a7-427461701cb4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy02LTEtMS0w_25371da7-04cc-4898-985d-73ebdb05a779"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy0xMi0xLTEtMA_daa767f6-3e95-44c7-89d5-cafc550d0300"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjNlYmI1ZDY3ZDM3MDQzNDY5N2NhMGJhYTgyNDlhMGNhL3RhYmxlcmFuZ2U6M2ViYjVkNjdkMzcwNDM0Njk3Y2EwYmFhODI0OWEwY2FfMy0xMi0xLTEtMA_6374442d-f542-43ff-996c-cd0f38a9d2ed"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RhYmxlOjQ5NmZlZmRmZmNlOTQyYmViZjA0MjYyNGI0ZjZiZTk5L3RhYmxlcmFuZ2U6NDk2ZmVmZGZmY2U5NDJiZWJmMDQyNjI0YjRmNmJlOTlfMy02LTEtMS0w_c1ac318b-9f4f-474a-8516-8447b3e09bc6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg1OTg2NjU0ZDE4ZDQyYjNiOGI5NjQ0OTI4OGYwYjhmL3NlYzo4NTk4NjY1NGQxOGQ0MmIzYjhiOTY0NDkyODhmMGI4Zl8yMi9mcmFnOjg0Nzg4ODZmZjQ5ZTQ2Yzg5MDMxM2ZmYzcwODg0ZTlmL3RleHRyZWdpb246ODQ3ODg4NmZmNDllNDZjODkwMzEzZmZjNzA4ODRlOWZfNTU0_1320b040-6616-4c96-bb1a-d4bc701b41c9"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201445214296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Oct. 21, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-08940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Altria Group, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3260245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6601 West Broad Street,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Richmond,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">23230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">274-2200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,858,419,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000764180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember', window );">Common Stock, $0.33 1/3 par value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.33 1/3 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.000NotesDue2023Member', window );">1.000% Notes due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO23A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member', window );">1.700% Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.700% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member', window );">2.200% Notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.200% Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member', window );">3.125% Notes due 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.000NotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock1.000NotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449639240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,123<span></span>
</td>
<td class="nump">$ 2,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InventoryRawMaterialsPlantMaterialNetofReserves', window );">Leaf tobacco</a></td>
<td class="nump">754<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherInventoryRawMaterialsNetofReserves', window );">Other raw materials</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished product</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="nump">2,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,399<span></span>
</td>
<td class="nump">4,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">5,173<span></span>
</td>
<td class="nump">5,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="nump">3,164<span></span>
</td>
<td class="nump">3,075<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,009<span></span>
</td>
<td class="nump">1,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,177<span></span>
</td>
<td class="nump">5,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">12,633<span></span>
</td>
<td class="nump">12,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecurityInvestments', window );">Investments in equity securities</a></td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">23,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,025<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">46,651<span></span>
</td>
<td class="nump">49,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Marketing</a></td>
<td class="nump">521<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AccruedSettlementLiabilityCurrent', window );">Settlement charges</a></td>
<td class="nump">3,206<span></span>
</td>
<td class="nump">3,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,113<span></span>
</td>
<td class="nump">1,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">1,602<span></span>
</td>
<td class="nump">1,565<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,290<span></span>
</td>
<td class="nump">8,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">27,755<span></span>
</td>
<td class="nump">27,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">4,724<span></span>
</td>
<td class="nump">5,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Accrued pension costs</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent', window );">Accrued postretirement health care costs</a></td>
<td class="nump">1,798<span></span>
</td>
<td class="nump">1,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">409<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">43,380<span></span>
</td>
<td class="nump">42,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.33 1/3&#160;per share (2,805,961,317 shares issued)</a></td>
<td class="nump">935<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,973<span></span>
</td>
<td class="nump">5,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Earnings reinvested in the business</a></td>
<td class="nump">34,356<span></span>
</td>
<td class="nump">36,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive losses</a></td>
<td class="num">(3,781)<span></span>
</td>
<td class="num">(2,864)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Cost of repurchased stock (947,542,152 shares at September 30, 2020 and 947,979,763 shares at December 31, 2019)</a></td>
<td class="num">(34,344)<span></span>
</td>
<td class="num">(34,358)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity attributable to Altria</a></td>
<td class="nump">3,139<span></span>
</td>
<td class="nump">6,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">3,232<span></span>
</td>
<td class="nump">6,319<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">$ 46,651<span></span>
</td>
<td class="nump">$ 49,271<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AccruedSettlementLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Settlement Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AccruedSettlementLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecurityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Security Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecurityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InventoryRawMaterialsPlantMaterialNetofReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InventoryRawMaterialsPlantMaterialNetofReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherInventoryRawMaterialsNetofReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Inventory, Raw Materials, Net of Reserves</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherInventoryRawMaterialsNetofReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201445403576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.3333<span></span>
</td>
<td class="nump">$ 0.3333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Shares repurchased (in shares)</a></td>
<td class="nump">947,542,152<span></span>
</td>
<td class="nump">947,979,763<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448657576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Earnings - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 7,123<span></span>
</td>
<td class="nump">$ 6,856<span></span>
</td>
<td class="nump">$ 19,849<span></span>
</td>
<td class="nump">$ 19,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,961<span></span>
</td>
<td class="nump">1,915<span></span>
</td>
<td class="nump">5,909<span></span>
</td>
<td class="nump">5,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Excise taxes on products</a></td>
<td class="nump">1,445<span></span>
</td>
<td class="nump">1,444<span></span>
</td>
<td class="nump">4,063<span></span>
</td>
<td class="nump">4,109<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,717<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
<td class="nump">9,877<span></span>
</td>
<td class="nump">9,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_MarketingAdministrationandResearchCosts', window );">Marketing, administration and research costs</a></td>
<td class="nump">557<span></span>
</td>
<td class="nump">552<span></span>
</td>
<td class="nump">1,585<span></span>
</td>
<td class="nump">1,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit', window );">Asset impairment and exit costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">3,160<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">8,292<span></span>
</td>
<td class="nump">7,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest and other debt expense, net</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">893<span></span>
</td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Earnings) losses from equity investments</a></td>
<td class="nump">472<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="num">(866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Loss on Cronos-related financial instruments</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">(324)<span></span>
</td>
<td class="num">(2,128)<span></span>
</td>
<td class="nump">4,349<span></span>
</td>
<td class="nump">1,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">632<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="nump">1,817<span></span>
</td>
<td class="nump">1,473<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">(956)<span></span>
</td>
<td class="num">(2,602)<span></span>
</td>
<td class="nump">2,532<span></span>
</td>
<td class="nump">516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (earnings) losses attributable to noncontrolling interests</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (losses) attributable to Altria</a></td>
<td class="num">$ (952)<span></span>
</td>
<td class="num">$ (2,600)<span></span>
</td>
<td class="nump">$ 2,543<span></span>
</td>
<td class="nump">$ 516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Per share data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (losses) per share attributable to Altria (in usd per share)</a></td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="num">$ (1.39)<span></span>
</td>
<td class="nump">$ 1.37<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (losses) per share attributable to Altria (in usd per share)</a></td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="num">$ (1.39)<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MarketingAdministrationandResearchCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MarketingAdministrationandResearchCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448517512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Earnings - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">$ (956)<span></span>
</td>
<td class="num">$ (2,602)<span></span>
</td>
<td class="nump">$ 2,532<span></span>
</td>
<td class="nump">$ 516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive earnings (losses), net of deferred income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Benefit plans</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentAfterTax', window );">ABI</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="num">(928)<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustments and other</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive earnings (losses)</a></td>
<td class="num">(963)<span></span>
</td>
<td class="num">(2,358)<span></span>
</td>
<td class="nump">1,615<span></span>
</td>
<td class="nump">661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive (earnings) losses attributable to noncontrolling interests</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive earnings (losses) attributable to Altria</a></td>
<td class="num">$ (959)<span></span>
</td>
<td class="num">$ (2,356)<span></span>
</td>
<td class="nump">$ 1,626<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32472-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448238120">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Earnings Reinvested in the Business [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Losses [Member]</div></th>
<th class="th"><div>Cost of Repurchased Stock [Member]</div></th>
<th class="th"><div>Non-controlling Interests [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 14,789<span></span>
</td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">$ 5,961<span></span>
</td>
<td class="nump">$ 43,962<span></span>
</td>
<td class="num">$ (2,547)<span></span>
</td>
<td class="num">$ (33,524)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Issuance of noncontrolling interest in Helix</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,637<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,960<span></span>
</td>
<td class="nump">39,910<span></span>
</td>
<td class="num">(2,402)<span></span>
</td>
<td class="num">(33,858)<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,466<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,953<span></span>
</td>
<td class="nump">44,081<span></span>
</td>
<td class="num">(2,646)<span></span>
</td>
<td class="num">(33,859)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(2,603)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,571)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,571)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Issuance of noncontrolling interest in Helix</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,637<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,960<span></span>
</td>
<td class="nump">39,910<span></span>
</td>
<td class="num">(2,402)<span></span>
</td>
<td class="num">(33,858)<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,319<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,970<span></span>
</td>
<td class="nump">36,539<span></span>
</td>
<td class="num">(2,864)<span></span>
</td>
<td class="num">(34,358)<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(917)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,232<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,973<span></span>
</td>
<td class="nump">34,356<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
<td class="num">(34,344)<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,786<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,964<span></span>
</td>
<td class="nump">36,908<span></span>
</td>
<td class="num">(3,774)<span></span>
</td>
<td class="num">(34,345)<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(957)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(952)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,232<span></span>
</td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">$ 5,973<span></span>
</td>
<td class="nump">$ 34,356<span></span>
</td>
<td class="num">$ (3,781)<span></span>
</td>
<td class="num">$ (34,344)<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts attributable to noncontrolling interests for the nine months ended September 30, 2020 and 2019 exclude net earnings of $2 million and $3 million, respectively, due to the redeemable noncontrolling interest related to Stag&#8217;s Leap Wine Cellars</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets. </span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts attributable to noncontrolling interests for the three months ended September 30, 2020 and 2019 exclude net earnings of $1 million due to the redeemable noncontrolling interest related to Stag&#8217;s Leap Wine Cellars<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which is reported in the mezzanine equity section on the condensed consolidated balance sheets. </span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201565653608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (usd per share)</a></td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="nump">$ 2.54<span></span>
</td>
<td class="nump">$ 2.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net earnings attributable to noncontrolling interests</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201443602344">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Operating Activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (956)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,602)<span></span>
</td>
<td class="nump">$ 2,532<span></span>
</td>
<td class="nump">$ 516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings (losses) to operating cash flows:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision (benefit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(111)<span></span>
</td>
<td class="num">(261)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Earnings) losses from equity investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="num">(866)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends from ABI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Loss on Cronos-related financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Asset impairment and exit costs, net of cash paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Cash effects of changes:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet', window );">Accrued liabilities and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(504)<span></span>
</td>
<td class="num">(359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncreaseDecreaseInSettlementPayable', window );">Accrued settlement charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="num">(360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitContributions', window );">Pension plan contributions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash', window );">Pension provisions and postretirement, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(591)<span></span>
</td>
<td class="num">(376)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,844<span></span>
</td>
<td class="nump">5,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Investing Activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="num">(160)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities', window );">Investment in Cronos</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,863)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_PaymentsToAcquireBusinessesAndAssets', window );">Acquisitions of businesses and assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(421)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="num">(2,412)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Financing Activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayment of short-term borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="num">(12,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Long-term debt issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,993<span></span>
</td>
<td class="nump">16,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(1,144)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid on common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,690)<span></span>
</td>
<td class="num">(4,498)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,713)<span></span>
</td>
<td class="num">(2,650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract', window );"><strong>Cash, cash equivalents and restricted cash:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,024<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Balance at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
<td class="nump">1,433<span></span>
</td>
<td class="nump">$ 1,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Balance at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,184<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
<td class="nump">1,645<span></span>
</td>
<td class="nump">4,184<span></span>
</td>
<td class="nump">1,645<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,123<span></span>
</td>
<td class="nump">$ 2,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash included in other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash included in other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,184<span></span>
</td>
<td class="nump">$ 2,160<span></span>
</td>
<td class="nump">$ 1,645<span></span>
</td>
<td class="nump">$ 2,160<span></span>
</td>
<td class="nump">$ 1,645<span></span>
</td>
<td class="nump">$ 2,160<span></span>
</td>
<td class="nump">$ 4,184<span></span>
</td>
<td class="nump">$ 2,160<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncreaseDecreaseInSettlementPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the period in Settlement payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncreaseDecreaseInSettlementPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_PaymentsToAcquireBusinessesAndAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Businesses And Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_PaymentsToAcquireBusinessesAndAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Equity Method Investments And Derivative Instruments, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373277208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Background and Basis of Presentation</a></td>
<td class="text">Background and Basis of Presentation:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in these notes, the term "Altria&#8221; refers to Altria Group, Inc. and its subsidiaries, unless otherwise specified or unless otherwise required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria Group, Inc.&#8217;s wholly owned subsidiaries included Philip Morris USA Inc. (&#8220;PM USA&#8221;), which is engaged in the manufacture and sale of cigarettes in the United States (including super premium cigarettes previously manufactured and sold by Sherman Holdings, LLC and its subsidiaries (&#8220;Nat Sherman&#8221;)); John Middleton Co. (&#8220;Middleton&#8221;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA;  UST LLC (&#8220;UST&#8221;), which through its wholly owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;) and Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;), is engaged in the manufacture and sale of moist smokeless tobacco (&#8220;MST&#8221;) and snus products and wine; and Philip Morris Capital Corporation (&#8220;PMCC&#8221;), which maintains a portfolio of finance assets, substantially all of which are leveraged leases.  In addition, Altria owned an 80% interest in Helix Innovations LLC (&#8220;Helix&#8221;), which is engaged in the manufacture and sale of oral nicotine pouches.  Other Altria wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries.  Altria&#8217;s access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  At September&#160;30, 2020, Altria&#8217;s significant wholly owned subsidiaries were not limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a 10.0% ownership in Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;), which Altria accounts for under the equity method of accounting using a one-quarter lag.  Altria receives cash dividends on its interest in ABI and will continue to do so as long as ABI pays dividends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a 35% economic interest in JUUL Labs, Inc. (&#8220;JUUL&#8221;), which Altria accounts for as an investment in an equity security.  JUUL is engaged in the manufacture and sale of e-vapor products in the U.S. and certain international markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, Helix acquired Burger S&#246;hne Holding and its subsidiaries as well as certain affiliated companies (the &#8220;Burger Group&#8221;) that are engaged in the manufacture and sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> oral nicotine pouches.  At closing, Altria indirectly owned an 80% interest in Helix, for which Altria paid $353 million in third quarter of 2019.  The financial results of Helix are included in Altria&#8217;s condensed consolidated financial statements as part of its oral tobacco products segment (formerly smokeless products segment), with the 20% minority ownership interest in Helix (held by the former shareholders of the Burger Group) included as a non-controlling interest.  The purchase price allocation has been completed, and there were no changes subsequent to the acquisition date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a 44% ownership in Cronos Group Inc. (&#8220;Cronos&#8221;), a global cannabinoid company headquartered in Toronto, Canada, which Altria accounts for under the equity method of accounting using a one-quarter lag. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of Altria&#8217;s investments in equity securities, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends and Share Repurchases </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, Altria&#8217;s Board of Directors (the &#8220;Board of Directors&#8221;) declared a 2.4% increase in the quarterly dividend rate to $0.86 per share of Altria common stock versus the previous rate of $0.84 per share.  The current annualized dividend rate is $3.44.  Future dividend payments remain subject to the discretion of the Board of Directors.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the Board of Directors authorized a $1.0 billion share repurchase program that it expanded to $2.0 billion in May 2018 (as expanded, the &#8220;January 2018 share repurchase program&#8221;).  In June 2019, Altria completed the January 2018 share </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">repurchase program, under which it purchased a total of 34.0 million shares of its common stock at an average price of $58.86 per share. </span></div><div><span><br/></span></div><div style="padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board of Directors authorized a $1.0 billion share repurchase program (the &#8220;July 2019 share repurchase program&#8221;).  In April 2020, the Board of Directors rescinded the $500 million remaining in this program as part of Altria&#8217;s efforts to enhance its liquidity position in response to the COVID-19 pandemic.  There were no share repurchases made in 2020. </span></div><div style="padding-right:15.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s 2019 share repurchase activity was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements of Altria are unaudited.  It is the opinion of Altria&#8217;s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain immaterial prior year amounts have been reclassified to conform with the current year&#8217;s presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements should be read in conjunction with Altria&#8217;s audited consolidated financial statements and related notes, which appear in Altria&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, Altria began complying early, as permitted, with Regulation S-X Rules 13-01 and 13-02 regarding the financial disclosure requirements for registered debt securities with subsidiary guarantees.  On October 23, 2020, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-09,  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt (Topic 470): Amendments to SEC Paragraphs Pursuant to SEC Release No. 33-10762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to reflect changes the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) has made to its disclosure rules on guaranteed debt securities offerings.  The new rules replace the previously required condensed consolidating financial information with summarized financial information of the issuer and the guarantor and, among other things, require expanded qualitative disclosures.  Altria has elected to provide this information in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section in its Quarterly Report on Form 10-Q as permitted by the new rules.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, Altria adopted ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and all related ASU amendments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(collectively &#8220;ASU No. 2016-13&#8221;).  This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity&#8217;s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses.  The adoption of ASU No. 2016-13 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU No. 2018-15&#8221;).  This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license).  The adoption of ASU No. 2018-15 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201375082120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues from Contracts with Customers</a></td>
<td class="text">Revenues from Contracts with Customers:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria disaggregates net revenues based on product type.  For further discussion, see Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses offer cash discounts to customers for prompt payment and calculate cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms.  Altria&#8217;s businesses record an allowance for cash discounts, which is included as a contra-asset against receivables on Altria&#8217;s condensed consolidated balance sheets.  Cash discounts at September&#160;30, 2020 and December&#160;31, 2019 were de minimis, and there were no differences between amounts recorded as an allowance for cash discounts and cash discounts subsequently given to customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses that receive payments in advance of product shipment record such payments as deferred revenue.  These payments are included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue was $250 million and $362 million at September&#160;30, 2020 and December&#160;31, 2019, respectively.  When cash is received in advance of product shipment, Altria&#8217;s businesses satisfy their performance obligations within three days of receiving payment.  At September&#160;30, 2020 and December&#160;31, 2019, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables, which primarily reflect sales of wine produced and/or distributed by Ste. Michelle, were $151 million and $152 million at September&#160;30, 2020 and December&#160;31, 2019, respectively.  At September&#160;30, 2020 and December&#160;31, 2019, there were no expected differences between amounts recorded and subsequently received, and Altria&#8217;s businesses did not record an allowance for doubtful accounts against these receivables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.  While all of Altria&#8217;s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC&#8217;s MST and snus products.  Altria&#8217;s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  Altria&#8217;s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on Altria&#8217;s condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, Altria&#8217;s businesses do not record an asset for their right to recover goods from customers upon return.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales incentives include variable payments related to goods sold by Altria&#8217;s businesses.  Altria&#8217;s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Price promotion payments- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s businesses make price promotion payments, substantially all of which are made to their retail partners, to incent the promotion of certain product offerings in select geographic areas. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wholesale and retail participation payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Altria&#8217;s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business&#8217;s trade agreements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373277208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairment, Exit and Implementation Costs<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Asset Impairment, Exit and Implementation Costs</a></td>
<td class="text">Asset Impairment, Exit and Implementation Costs:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax asset impairment, exit and implementation costs consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.388%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Impairment and Exit Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus amounts included in net periodic benefit income, excluding </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">service cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Included in cost of sales ($1 million cost reversal) and marketing, administration and research costs ($26 million) in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Represents curtailment costs.  See Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:30.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.228%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Impairment and Exit Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Included in cost of sales ($1 million) and marketing, administration and research costs ($3 million) in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Implementation costs for 2020 were related to Ste. Michelle&#8217;s strategic reset as discussed below.  The 2019 pre-tax asset impairment, exit and implementation costs were primarily related to the cost reduction program announced in December 2018, which was completed in 2019.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.631%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash spent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Wine Business Strategic Reset</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolving adult consumer preferences have posed strategic challenges for Ste. Michelle, which has seen slowing growth in the wine category and increased inventory levels in recent periods.  Against a backdrop of product volume demand uncertainty and long-term non-cancelable grape purchase commitments, which have been further negatively impacted by government actions which restrict direct-to-consumer sales and on-premise sales and economic uncertainty surrounding the COVID-19 pandemic, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ste. Michelle experienced additional increases in inventory levels that at March 31, 2020 significantly exceeded long-term forecasted demand. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine and three months ended September 30, 2020, Ste. Michelle recorded pre-tax charges of $395 million and $1 million, respectively, which were included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings.  The charges consisted primarily of the following: (i) write-off of inventory ($292 million recorded in the first quarter of 2020) as Ste. Michelle no longer believes that the benefit of the blending and production plans for its inventory outweighs inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believes no longer have a future economic benefit ($100 million recorded in the first quarter of 2020).  The non-cancelable grape purchase commitments will continue to require cash payments as grape commitments are fulfilled over the next five years.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given such uncertainty in economic conditions and product volume demand, as well as long-term supply-side contractual challenges, Altria and Ste. Michelle undertook a review of the wine business.  As a result, Altria and Ste. Michelle implemented a strategic reset in order to maximize Ste. Michelle&#8217;s profitability and achieve improved long-term cash-flow generation.  This strategic reset includes: (i) an updated approach to forecasting demand; (ii) supply chain optimization; (iii) SKU rationalization to reduce the number of products and eliminate underperforming brands; and (iv) streamlining operations by reducing future capital expenditures, working capital requirements and ongoing operating costs. </span></div>Ste. Michelle expects to record charges of approximately $20 million in 2020, consisting of inventory disposal costs and other charges.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201374662648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments in Equity Securities</a></td>
<td class="text">Investments in Equity Securities:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s investments consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:63.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> September 30, 2020 includes Altria&#8217;s equity method investment in Cronos ($986 million), the Cronos warrant ($86 million) and the Fixed-price Preemptive Rights ($15 million) and December 31, 2019 includes Altria&#8217;s equity method investment in Cronos ($1,002 million), the Cronos warrant ($234 million) and the Fixed -price Preemptive Rights ($69 million), as discussed further below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (losses) from equity investments accounted for under the equity method of accounting consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:47.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.504%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> At September 30, 2020 Altria recorded pre-tax losses associated with its share of ABI&#8217;s completion of the sale of its Australia subsidiary and ABI&#8217;s goodwill impairment charge associated with its Africa businesses.  These amounts include Altria&#8217;s share of amounts recorded by ABI in its second quarter of 2020, as well as additional adjustments related to (i) conversion from international financial reporting standards to United States generally accepted accounting principles, and (ii) adjustments to Altria&#8217;s investment required under the equity method of accounting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value.  If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements.  If this qualitative assessment indicates that Altria&#8217;s investment in JUUL may be impaired, a quantitative assessment is performed.  If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a 10.0% ownership in ABI, consisting of 185 million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and 12 million ordinary shares of ABI.  Altria&#8217;s ownership percentage decreased from 10.1% at March 31, 2020 due to the issuance of additional shares by ABI.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, Altria participates in ABI policy making processes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria reports its share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for Altria to record them in the concurrent period.</span></div><div style="margin-bottom:4pt;text-align:justify"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares.  In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.  </span></div><div style="padding-right:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Altria&#8217;s equity investment in ABI at September&#160;30, 2020 and December&#160;31, 2019 was $10.7 billion (carrying value of $16.7 billion) and $16.1 billion (carrying value of $18.1 billion), respectively, which was less than its carrying value by approximately 36% and 11%, respectively.  In October 2019, the fair value of Altria&#8217;s equity investment in ABI declined below its carrying value and has not recovered.  Altria has evaluated the factors related to the fair value decline, including the recent impact on the fair value of ABI&#8217;s shares amidst the COVID-19 pandemic.  The economic uncertainties of the COVID-19 pandemic have also impacted ABI&#8217;s business.  Altria has evaluated the duration and magnitude of the fair value decline at September 30, 2020, ABI&#8217;s financial condition and near-term prospects, and Altria&#8217;s intent and ability to hold its investment in ABI until recovery.  Altria concluded, both at September 30, 2020 and December 31, 2019, that the decline in fair value of its investment in ABI below its carrying value was temporary and, therefore, no impairment was recorded.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, Altria made a minority investment in JUUL for $12.8 billion.  In exchange for the investment, Altria received a 35% economic interest in JUUL through non-voting shares, which are convertible at Altria&#8217;s election into voting shares (&#8220;Share Conversion&#8221;), and for no additional payment, a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#8220;JUUL Transaction&#8221;).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its 35% interest.  Furthermore, Altria agreed not to sell or transfer any of its JUUL shares until December 20, 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 28, 2020, Altria and JUUL amended certain JUUL Transaction agreements and entered into a new cooperation agreement, which included the following provisions:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Altria will continue to provide regulatory affairs support for JUUL&#8217;s pursuit of its pre-market tobacco applications (&#8220;PMTA&#8221;) and/or its modified risk tobacco products authorization (&#8220;MRTP&#8221;) and discontinued all other services as of March 31, 2020;</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Altria will have the option to be released from its non-compete obligation (i) in the event JUUL is prohibited by federal law from selling e-vapor products in the U.S. for a continuous period of at least 12 months (subject to tolling of this period in certain circumstances) or (ii) if the carrying value of Altria&#8217;s investment in JUUL is not more than 10% of its initial carrying value of $12.8 billion;</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Altria and JUUL agreed that for a period of one year they will not pursue any litigation against each other in connection with any conduct that occurred prior to the date of such cooperation agreement, with statutes of limitation being tolled during the one-year period; </span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">with respect to certain litigation in which Altria and JUUL are both defendants against third-party plaintiffs, Altria will not pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against Altria and JUUL; and</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">in the event of Share Conversion, JUUL will:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restructure JUUL&#8217;s current seven-member board of directors to a nine-member board that will include independent board members.  The new structure will include: (i) three independent directors (one of whom will be designated by Altria and two of whom will be designated by JUUL stockholders other than Altria) unanimously certified as independent by a nominating committee, which will include at least one Altria designee, (ii) two directors designated by Altria, (iii) three directors designated by JUUL stockholders other than Altria, and (iv) the JUUL Chief Executive Officer; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">create a Litigation Oversight Committee, which will include two Altria designated directors (one of whom will chair the Litigation Oversight Committee) that will have oversight authority and review of litigation management for matters in which JUUL and Altria are co-defendants and have or reasonably could have a written joint defense agreement in effect between them.  Subject to certain limitations, the Litigation Oversight Committee will recommend to JUUL changes to outside counsel and litigation strategy by majority vote, with disagreements by JUUL&#8217;s management being resolved by majority vote of JUUL&#8217;s board of directors.</span></div><div style="margin-bottom:5pt;padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the U.S. Federal Trade Commission (&#8220;FTC&#8221;) issued an administrative complaint challenging Altria&#8217;s investment in JUUL.  The FTC has not sought to preliminarily enjoin Altria from converting its non-voting JUUL shares to voting shares.  Altria has not converted its non-voting JUUL shares to voting shares and is considering whether to do so as well as which, if any, of its voting and governance rights to exercise if Altria does elect to effect such conversion.  Altria has until November 30, 2020 to convert its JUUL shares under the regulations of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (&#8220;HSR Act&#8221;), after which Altria would have to re-file for antitrust review with the FTC to again seek the ability to convert.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion on the FTC litigation, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies -&#160; Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of Share Conversion, Altria expects to account for its investment in JUUL under the fair value option.  Under this option, Altria&#8217;s consolidated statement of earnings will include any cash dividends received from its investment in JUUL as well as any changes in the fair value of the investment, which will be calculated quarterly. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and December&#160;31, 2019, Altria had a 35% economic interest in JUUL.  Altria accounted for its investment in JUUL as an investment in an equity security as of September&#160;30, 2020.  Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There have been no upward or downward adjustments to the carrying value of Altria&#8217;s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through September 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL announced a strategic update in September 2020, which includes its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of Altria&#8217;s financial statements for the period ended September 30, 2020, Altria performed its qualitative assessment of impairment indicators for its investment in JUUL and determined that JUUL&#8217;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#8217;s business prospects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the existence of this impairment indicator, Altria performed a quantitative valuation of its investment in JUUL as of September 30, 2020 and recorded a non-cash pre-tax charge of $2.6 billion for the nine and three months ended September 30, 2020, reported as impairment of JUUL equity securities in its condensed consolidated statements of earnings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The impairment charge was driven by Altria&#8217;s projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of: (i) JUUL&#8217;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, Altria recorded total non-cash pre-tax impairment charges of $8.6 billion ($4.5 billion in the third quarter of 2019 and $4.1 billion in the fourth quarter of 2019) related to its investment in JUUL resulting in a $4.2 billion carrying value of its investment in JUUL at December 31, 2019.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2019, Altria performed a qualitative assessment for impairment indicators and concluded that impairment indicators existed.  These indicators included significant adverse changes in both the e-vapor regulatory environment and the industry in which JUUL operates.  While there was no single determinative event or factor, Altria considered in totality the following indicators of impairment: the increased likelihood of a United States Food and Drug Administration (&#8220;FDA&#8221;) compliance policy prohibiting the sale of certain flavored e-vapor products in the U.S. market without a pre-market authorization; various e-vapor bans put in place by certain states and cities in the U.S. and in certain international markets, coupled with the increased potential for additional bans in the future; and the impact of heightened adverse publicity, including news reports and public health advisories concerning vaping-related lung injuries and deaths.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its quantitative valuation of its investment in JUUL, the third-quarter 2019 impairment charge was due primarily to lower e-vapor sales volume assumptions in the U.S. and international markets and a delay in achieving operating margin performance as compared to the assumptions at the time of the JUUL Transaction, which resulted in a non-cash pre-tax charge of $4.5 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2019, Altria determined that a significant increase in the number of legal cases pending against JUUL in the fourth quarter of 2019 resulted in an additional indicator of impairment, which included a variety of class action lawsuits and personal injury claims, as well as cases brought by state attorneys general and local governments.  The fourth-quarter impairment charge resulted substantially from increased discount rates applied to future cash flow projections, due to the significant risk created by the increase in the number of legal cases pending against JUUL, which resulted in an additional non-cash pre-tax charge of $4.1 billion at December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria used an income approach to estimate the fair value of its investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.  Future cash flows were based on a range of scenarios that consider various potential regulatory and market outcomes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the fair value of its investment in JUUL as of September 30, 2020, December 31, 2019 and September 30, 2019, Altria made various judgments, estimates and assumptions, the most significant of which were sales volume, operating margins, discount rates and perpetual growth rates.  Additionally, Altria made significant assumptions regarding the likelihood and extent of various potential regulatory actions and the continued adverse public perception impacting the e-vapor category and specifically JUUL, as well as expectations of competitive dynamics and the future state of the e-vapor category.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Altria completed its acquisition of:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">149.8 million newly issued common shares of Cronos (&#8220;Acquired Common Shares&#8221;), which represented a 45% economic and voting interest; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain its ownership percentage.  Certain of the anti-dilution protections provide Altria the ability to purchase additional Cronos common shares at a per share exercise price of Canadian dollar (&#8220;CAD&#8221;) $16.25 upon the occurrence of specified events (&#8220;Fixed-price Preemptive Rights&#8221;).  Based on Altria&#8217;s assumptions as of September 30, 2020, Altria estimates the Fixed-price  Preemptive Rights allows Altria to purchase up to an additional approximately 35 million common shares of Cronos; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a warrant providing Altria the ability to purchase up to an additional 10% of common shares of Cronos (approximately  79 million common shares at September 30, 2020) at a per share exercise price of CAD $19.00, which expires on March 8, 2023.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price for the Acquired Common Shares, Fixed-price Preemptive Rights and warrant (collectively, &#8220;Investment in Cronos&#8221;) was CAD $2.4 billion (U.S. dollar (&#8220;USD&#8221;) $1.8 billion).  Upon full exercise of the Fixed-price Preemptive Rights, to the extent such rights become available, and the warrant, Altria would own a maximum of 55% of the outstanding common shares of Cronos. </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for the acquisition of these assets as of the date of closing, the Fixed-price Preemptive Rights and warrant were recorded at each of their fair values using Black-Scholes option-pricing models, based on the assumptions described in Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In addition, a deferred tax liability related to the Fixed-price Preemptive Rights and warrant was </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded.  The residual of the purchase price was allocated to the Acquired Common Shares.  Accordingly, the CAD $2.4 billion (USD $1.8 billion) purchase price was recorded in USD as follows:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$1.2 billion to the warrant;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$0.5 billion to the Fixed-price Preemptive Rights; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$0.4 billion to the Acquired Common Shares; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$0.3 billion to a deferred tax liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $1.5 billion and CAD $0.6 billion (approximately USD $1.1 billion and $0.4 billion, respectively, based on the CAD to USD exchange rate on October 27, 2020). </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of derivatives related to Altria&#8217;s investment in Cronos, including Altria&#8217;s accounting for changes in the fair value of these derivatives, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, Altria had a 44% ownership in Cronos, consisting of 156.6&#160;million shares, which Altria accounts for under the equity method of accounting.  Altria&#8217;s ownership percentage decreased from 45% at June 30, 2020 due to the issuance of additional shares by Cronos.  Altria reports its share of Cronos&#8217;s results using a one-quarter lag because Cronos&#8217;s results are not available in time for Altria to record them in the concurrent period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria nominated four directors, including one director who is independent from Altria, who serve on Cronos&#8217;s seven-member board of directors.</span></div>The fair value of Altria&#8217;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.  The fair value of Altria&#8217;s equity method investment in Cronos at September&#160;30, 2020 and December&#160;31, 2019 was $0.8 billion and $1.2 billion, respectively, compared with its carrying value of $1.0 billion at September&#160;30, 2020 and December&#160;31, 2019.  At September&#160;30, 2020, the fair value of Altria&#8217;s equity method investment in Cronos was less than its carrying value by approximately 20%.  Based on Altria&#8217;s evaluation of the duration and magnitude of the fair value decline, Altria&#8217;s evaluation of Cronos&#8217;s financial condition (including its strong cash position) and near-term prospects and Altria&#8217;s intent and ability to hold its investment in Cronos until recovery, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI http://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI http://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373181288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria enters into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  Altria uses various types of derivative financial instruments, including forward contracts, options and swaps.  Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s investment in ABI, whose functional currency is the Euro, exposes Altria to foreign currency exchange risk on the carrying value of its investment.  To manage this risk, Altria designates certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#8220;foreign currency contracts&#8221;), and Euro denominated unsecured long-term notes (&#8220;foreign currency denominated debt&#8221;) as net investment hedges of Altria&#8217;s investment in ABI.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 and December&#160;31, 2019, Altria had foreign currency contracts with aggregate notional amounts of $1,402 million and $2,246 million, respectively.  At September&#160;30, 2020, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $5,368 million and $4,960 million, respectively.  At December&#160;31, 2019, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $5,057 million and $4,741 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s estimates of the fair values of its foreign currency contracts are determined using valuation models with significant inputs that are readily available in public markets, or can be derived from observable market transactions, and therefore are classified in Level 2 of the fair value hierarchy.  An adjustment for credit risk and nonperformance risk is included in the fair values of foreign currency contracts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s estimate of the fair value of its total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.  The aggregate fair value of Altria&#8217;s total long-term debt at September&#160;30, 2020 and December&#160;31, 2019 was $33.8 billion and $30.7 billion, respectively, as compared with its carrying value of $29.3 billion and $28.0 billion, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fixed-price Preemptive Rights and Cronos warrant, which are further discussed in Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are derivative financial instruments, which are required to be recorded at fair value.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Warrant</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.69</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$9.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.69</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$9.97</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.18 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.18 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.68%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.61%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.68%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.61%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 5.25 years at September 30, 2020 and 0.25 year to 6 years at December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.12% to 0.36% at September 30, 2020 and 1.66% to 1.74% at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6) Based on Cronos&#8217;s expected dividend payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.861%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax earnings (losses) recognized in net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria elects to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on its condensed consolidated balance sheets.  The fair values of Altria&#8217;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:23.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.034%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair Value of Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></div></td><td colspan="30" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cronos warrant</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria records in its condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.  For the nine and three months ended September&#160;30, 2020 and 2019, Altria recognized pre-tax unrealized gains/(losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,296)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in January and February 2019, Altria entered into derivative financial instruments in the form of forward contracts, which were settled in March 2019, to hedge Altria&#8217;s exposure to CAD to USD foreign currency exchange rate movements, in relation to the CAD $2.4 billion purchase price for the Cronos transaction.  The aggregate notional amounts of the forward contracts were USD $1.8 billion (CAD $2.4 billion).  The forward contracts did not qualify for hedge accounting; therefore, in the first quarter of 2019, pre-tax losses of USD $31 million representing changes in the fair values of the forward contracts were recorded in loss on Cronos-related financial instruments in Altria&#8217;s condensed consolidated statement of earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Counterparties to Altria&#8217;s foreign currency contracts are domestic and international financial institutions.  Altria is exposed to potential losses due to non-performance by these counterparties.  Altria manages its credit risk by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure Altria has with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require Altria to maintain an investment grade credit rating.  In the event Altria&#8217;s credit rating falls below investment grade, counterparties to Altria&#8217;s foreign currency contracts can require Altria to post collateral.  No collateral was received or posted related to derivative assets and liabilities at September&#160;30, 2020 and December&#160;31, 2019. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedging</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of Altria&#8217;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:20.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.893%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Net Earnings (Losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Net Earnings (Losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="45" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Related to amounts excluded from effectiveness testing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to USD exchange rate were recognized in accumulated other comprehensive losses related to ABI.  Gains on the foreign currency contracts arising from components excluded from effectiveness testing were recognized in interest and other debt expense, net in the condensed consolidated statements of earnings based on an amortization approach.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201447053816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of Net Periodic Benefit (Income) Cost</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit (income) cost consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Postretirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit </span></div><div style="padding-left:9pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(income) cost </span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Curtailment costs shown in the table above were related to the cost reduction program announced in December 2018, which was completed in 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations.  Altria made employer contributions of $16 million to its pension plans during the nine months ended September 30, 2020.  Currently, Altria anticipates making additional employer contributions to its pension plans during the remainder of 2020 of up to approximately $20 million based on current tax law.  Altria did not make any employer contributions to its postretirement plans during the nine months ended September 30, 2020.  Currently, Altria anticipates making employer contributions to its postretirement plans of up to approximately $60 million  in 2020.  However, these estimates may be subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on assets, changes in interest rates or other considerations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373231288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Losses) Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Losses) Per Share</a></td>
<td class="text">Earnings (Losses) Per Share:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (losses) per share (&#8220;EPS&#8221;) were calculated using the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:47.211%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.211%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(953)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,601)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: contingently issuable performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201374659896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Earnings/Losses</a></td>
<td class="text">Other Comprehensive Earnings/Losses:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,165)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,774)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,165)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(374)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,402)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,402)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Primarily reflects Altria&#8217;s share of ABI&#8217;s currency translation adjustments and the impact of Altria&#8217;s designated net investment hedges.  For further discussion of designated net investment hedges, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):  </span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Amounts are included in net defined benefit plan costs.  For further details, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Amounts are included in earnings (losses) from equity investments.  For further information, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201467585640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products of Altria&#8217;s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA (including super premium cigarettes previously manufactured and sold by Nat Sherman), machine-made large cigars and pipe tobacco manufactured and sold by Middleton; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC and oral nicotine pouches manufactured and sold by Helix; and wine produced and/or distributed by Ste. Michelle.  The products and services of these subsidiaries constitute Altria&#8217;s reportable segments of smokeable products, oral tobacco products (formerly smokeless products) and wine.  The financial services and the innovative tobacco products businesses are included in all other. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) reviews operating companies income (loss) (&#8220;OCI&#8221;) to evaluate the performance of, and allocate resources to, the segments.  OCI for the segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, net periodic benefit income/cost, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.585%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,849&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,103&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,856&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset impairment and exit costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,899&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,327)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparability of OCI for the reportable segments was affected by the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco and Health Litigation Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria&#8217;s condensed consolidated statements of earnings as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.113%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts shown in the table above for the smokeable products segment were recorded in marketing, administration and research costs.  For further discussion, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Special Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Net pre-tax charges of $50 million ($41 million in the smokeable products segment and $9 million in the oral tobacco products segment) related to COVID-19 were recorded in Altria&#8217;s condensed consolidated statements of earnings for the nine months ended September 30, 2020.  The net pre-tax charges, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic, were all recorded in costs of sales in the second quarter of 2020 and included premium pay, personal protective equipment and health screenings, which were partially offset by certain employment tax credits.  The COVID-19 special items do not include the inventory-related implementation costs associated with the wine business strategic reset, which are included in asset impairment, exit and implementation costs.  These implementation costs were due to increased inventory levels, which were further negatively impacted by government restrictions and economic uncertainty surrounding the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment, Exit and Implementation Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - See Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment, Exit and Implementation Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a breakdown of these costs by segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448160584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Borrowings and Borrowing Arrangements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020 and December 31, 2019, Altria had no short-term borrowings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2020, Altria had a senior unsecured 5-year revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;) that provides for borrowings up to an aggregate principal amount of $3.0 billion.  The Credit Agreement, which is used for general corporate purposes, expires on August&#160;1, 2023 and includes an option, subject to certain conditions, for Altria to extend the Credit Agreement for two additional one-year periods.  Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of Altria&#8217;s long-term senior unsecured debt.  Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate (&#8220;LIBOR&#8221;), or a mutually agreed upon benchmark rate, plus a percentage based on the higher of the ratings of Altria&#8217;s long-term senior unsecured debt from Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and Standard&#160;&amp; Poor&#8217;s Ratings Services (&#8220;Standard &amp; Poor&#8217;s&#8221;).  The applicable percentage based on Altria&#8217;s long-term senior unsecured debt ratings&#160;at September 30, 2020 for borrowings under the Credit Agreement was 1.0%.  The Credit Agreement does not include any other rating triggers, or any provisions that could require the posting of collateral.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, due to the uncertainty at that time in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the full $3.0 billion available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility.  In June 2020, Altria repaid the full amount outstanding under the Credit Agreement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At September 30, 2020, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 9.2 to 1.0.  At September 30, 2020, Altria was in compliance with its covenants in the Credit Agreement.  The terms &#8220;Consolidated EBITDA&#8221; and &#8220;Consolidated Interest Expense,&#8221; each as defined in the Credit Agreement, include certain adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM&#160;USA. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying value of Altria&#8217;s total long-term debt at September 30, 2020 and December 31, 2019 was $29.3 billion and $28.0 billion, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Altria issued USD denominated long-term senior unsecured notes in the aggregate principal amount of $2.0 billion (collectively, the &#8220;Notes&#8221;).  The net proceeds from the Notes were used for general corporate purposes, which included repayment of the outstanding balance of the Credit Agreement.  The Notes contain the following terms:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$0.750 billion at 2.350%, due 2025, interest payable semiannually beginning November 6, 2020;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$0.750 billion at 3.400%, due 2030, interest payable semiannually beginning November 6, 2020; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">$0.500 billion at 4.450%, due 2050, interest payable semiannually beginning November 6, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are Altria&#8217;s senior unsecured obligations and rank equally in right of payment with all of Altria&#8217;s existing and future senior unsecured indebtedness.  Upon the occurrence of both (i) a change of control of Altria and (ii) the Notes ceasing to be rated investment grade by each of Moody&#8217;s, Standard &amp; Poor&#8217;s and Fitch Ratings Ltd. within a specified time period, Altria will be required to make an offer to purchase the Notes at a price equal to 101% of the aggregate principal amount of such Notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the Notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of Altria under the Notes are guaranteed by PM USA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, Altria repaid in full at maturity senior unsecured notes in the aggregate principal amount of $1.0 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020 and December&#160;31, 2019, accrued interest on long-term debt of $244 million and $470 million, respectively, was included in other accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the fair value of Altria&#8217;s long-term debt and the designation of its Euro denominated senior unsecured notes as a net investment hedge of its investment in ABI, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373201672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax rate for the nine and three months ended September 30, 2020 was 41.8% and (195.1)%, respectively, versus 74.1% and (22.3)% for the nine and three months ended September 30, 2019, respectively.  The changes in the tax rates were due primarily to the following:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a full valuation allowance in 2019 attributable to the tax benefits associated with the impairment of JUUL equity securities;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a full valuation allowance in 2020 attributable to the tax benefits associated with the impairment of JUUL equity securities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">tax benefits recorded in 2019 for the reversal of tax accruals no longer required;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">net tax expense in 2020 related to Altria&#8217;s equity investment in Cronos, which included a valuation allowance release on a deferred tax asset; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">net tax benefit in 2019 related to Altria&#8217;s equity investment in Cronos, which included a valuation allowance release on a deferred tax asset.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending valuation allowances for the period ended September 30, 2020 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,856&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current year addition to the valuation allowance was due primarily to valuation allowances recorded for deferred tax assets related to Altria&#8217;s equity investments in JUUL and Cronos.  The current year reduction to the valuation allowance was due primarily to the write-off of a deferred tax asset related to Altria&#8217;s equity investment in Cronos for which a valuation allowance had previously been established.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria is subject to income taxation in many jurisdictions.  Unrecognized tax benefits reflect the difference between tax positions taken or expected to be taken on income tax returns and the amounts recognized in the financial statements.  Resolution of the related tax positions with the relevant tax authorities may take many years to complete, and such timing is not entirely within the control of Altria.  At September&#160;30, 2020, Altria&#8217;s total unrecognized tax benefits were $74 million.  The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at September&#160;30, 2020 was $41 million, along with $33 million affecting deferred taxes.  It is reasonably possible that within the next 12 months certain examinations will be resolved, which could result in a decrease in unrecognized tax benefits of approximately $8 million.  At December 31, 2019, Altria&#8217;s total unrecognized tax benefits were $64 million.  The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December&#160;31, 2019 was $40 million, along with $24 million affecting deferred taxes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373122488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and its subsidiaries, including PM USA and USSTC, as well as their respective indemnitees and Altria&#8217;s investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#8217; liability is joint and several.  In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries also may be required to pay interest and attorneys&#8217; fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#8217;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts.  Each of the companies has defended, and will continue to defend, vigorously against litigation challenges.  However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Altria and/or PM USA Tobacco-Related Litigation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Types and Number of U.S. Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), fraud, failure to warn, design defect, negligence and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#8217; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 27, 2020, October 28, 2019 and October 22, 2018:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.076%"><tr><td style="width:1.0%"/><td style="width:59.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.551%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 22, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes 15 cases filed in New Mexico, 26 cases filed in Massachusetts and 54 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include 1,471 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  In March 2018, 923 of these cases were voluntarily dismissed without prejudice.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes 25 class action lawsuits, two of which were filed in Canada, 1,064 individual lawsuits, 31 state or local government lawsuits and 25 lawsuits filed by school districts relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes two inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including one case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and two inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Tobacco-Related Cases  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, Altria is named as a defendant in two e-vapor class action lawsuits in Canada.  PM USA also is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant.  PM USA and Altria are also named defendants in seven smoking and health class actions filed in various Canadian provinces.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (&#8220;PMI&#8221;) that provides for indemnities for certain liabilities concerning tobacco products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco-Related Cases Set for Trial  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, no </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases or individual smoking and health cases against PM USA are set for trial through December 31, 2020.  Cases against other companies in the tobacco industry may be scheduled for trial during this period.  Trial dates are subject to change and some trials have been postponed due to the COVID-19 pandemic.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trial Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1999, excluding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases (separately discussed below), verdicts have been returned in 69 tobacco-related cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in 44 of the 69 cases.  These 44 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (4), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the 25 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs, 20 have reached final resolution, and one case (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gentile</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that was initially returned in favor of plaintiff was reversed post-trial and remains pending. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of verdicts in state and federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA as of October 27, 2020.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Judgments Paid and Provisions for Tobacco and Health Litigation Items (Including Engle Progeny Litigation)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $798 million and interest totaling approximately $217 million as of September 30, 2020.  These amounts include payments for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny judgments (and related costs and fees) totaling approximately $364 million and related interest totaling approximately $55 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in Altria&#8217;s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.245%"><tr><td style="width:1.0%"/><td style="width:54.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.786%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:2.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health litigation items at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health litigation items at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes amounts related to the costs of implementing the corrective communications remedy related to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> discussed below.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes approximately $20 million related to pre-trial resolution of approximately 240 tobacco and health cases.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes approximately $20 million in payments related to above-mentioned pre-trial resolution of approximately 240 tobacco and health cases and $2 million for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accrued liability for tobacco and health litigation items, including related interest costs, was included in accrued liabilities on Altria&#8217;s condensed consolidated balance sheets.  Pre-tax charges for tobacco and health litigation were included in marketing, administration and research costs on Altria&#8217;s condensed consolidated statements of earnings.  Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria&#8217;s condensed consolidated statements of earnings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security for Judgments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of September 30, 2020, PM USA has posted appeal bonds totaling approximately $61 million, which have been collateralized with restricted cash that are included in assets on the condensed consolidated balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smoking and Health Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs&#8217; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Engle Progeny Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny smoking and health cases pending during 2020 in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases can be found in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages.  There was no claim for punitive damages.  PM USA&#8217;s appeal is pending in the Third District Court of Appeal.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#8217; remaining claim and trebled the compensatory damages award to approximately $30 million.  PM USA plans to file post-trial motions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laramie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff, awarding $11 million in compensatory damages and $10 million in punitive damages.  PM USA and plaintiff have appealed.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gentile</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff, awarding approximately $7.1 million in compensatory damages and allocating 75% of the fault to PM USA (an amount of approximately $5.3 million).  PM USA appealed.  In September 2019, the Florida Fourth District Court of Appeal reversed the judgment entered by the trial court, granted PM USA judgment on certain claims and remanded for a new trial on the remaining claims.  Plaintiff has petitioned the Florida Supreme Court for further review.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the verdict and post-trial developments in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> health care cost recovery case.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle Class Action</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2000, in the second phase of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate.  The court further declared the following Phase I findings are entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect in such individual actions brought within one year of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#8217; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pending Engle Progeny Cases  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deadline for filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending.  As of October 27, 2020, approximately 1,300 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 1,600 state court plaintiffs.&#160; Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates.  While the Federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement (discussed below) resolved nearly all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases pending in federal court, as of October 27, 2020, three cases were pending against PM USA in federal court representing the cases excluded from that agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, 134 federal and state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decision.  Seventy-eight verdicts were returned in favor of plaintiffs and five verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skolnick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Calloway</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oshinsky-Blacker,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCoy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Frogel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forty-eight verdicts were returned in favor of PM USA, of which 43 were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of October 27, 2020.  Four verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearson, D. Cohen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collar </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chacon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in two cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reider </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Banks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">returned zero damages verdicts in favor of PM USA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Juries in two other cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Weingart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hancock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages.  One case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pollari, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Appeals by plaintiff and defendants are pending.  Three cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  Post-trial motions or appeals are pending.  One case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freeman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below list the verdicts and post-trial developments in certain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists such cases that are pending as of October 27, 2020 where PM USA has recorded a provision in its consolidated financial statements because PM USA has determined that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated; the second chart lists other such cases that are pending as of October 27, 2020 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated; and the third chart lists other such cases that have concluded within the previous 12 months.  Unless otherwise noted for a particular case, the jury&#8217;s award for compensatory damages will not be reduced by any finding of plaintiff&#8217;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Accrued Liabilities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages (All Defendants)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages (PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Berger </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cote</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2014</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$21&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court.  PM USA&#8217;s challenge to the punitive damages award was denied by the district court.  Appeal by PM USA to Eleventh Circuit Court of Appeals pending.</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6&#160;million accrual in the fourth quarter of 2018</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Santoro</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2017</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA, R.J. Reynolds and Liggett Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million (&lt;$1&#160;million PM USA) </span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Fourth District Court of Appeal affirmed the compensatory damages award and reinstated the punitive damages award.  Defendants&#8217; motion for rehearing was denied. Appeal by defendants of punitive damages award to Florida Supreme Court pending.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million accrual for compensatory damages award in the second quarter of 2020</span></div></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrual amounts include interest and associated costs, if applicable.  For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff&#8217;s favor after taking into account any portion potentially payable by the other defendant(s). </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> References to &#8220;R.J. Reynolds,&#8221; &#8220;Lorillard&#8221; and &#8220;Liggett Group&#8221; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.912%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and <br/>R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Second District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by plaintiff and defendant to First District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9&#160;million ($5&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$74 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Gloger</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15&#160;million ($5&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$11 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial ordered on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Neff</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Frogel</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palm Beach</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal reversed the judgment against PM USA and ordered a new trial.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Mahfuz</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$10 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendant&#8217;s appeal to Third District Court of Appeal pending.</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.912%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">R. Douglas</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awaiting entry of final judgment by the trial court.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Sommers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2017</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA's petition for review.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper (Blackwood)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Harris</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2014</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA, <br/>R.J. Reynolds and Lorillard</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in this case.</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.196%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount<br/>(if any)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Dean (Kerrivan)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2014</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$26&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$10&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Theis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and <br/>R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sarasota</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">First quarter of 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$17&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In four cases in which PM USA paid the judgments more than a year ago, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Naugle,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Gore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">M. Brown </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Jordan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, plaintiffs were awarded approximately $8 million, $2 million, $9 million and $4 million in fees and costs, respectively.  PM USA has appealed in all of these cases. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In August 2020, the U.S. Court of Appeals for the Eleventh Circuit denied the defendants&#8217; petition for rehearing.  As a result, in the third quarter of 2020, PM USA recorded a pre-tax provision of approximately $26 million, reflecting its portion of the judgment plus interest, and paid this amount in August 2020.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In June 2020, the Fourth District Court of Appeal affirmed the compensatory damages award.  As a result, in the second quarter of 2020, PM USA recorded a pre-tax provision of approximately $10 million for the judgment plus interest and paid this amount in July 2020.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In February 2020, the Florida Second District Court of Appeal denied PM USA&#8217;s petition for review.&#160; As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately $17 million for the judgment plus interest and paid this amount.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Florida Bond Statute  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny lawsuits in the aggregate and establishes individual bond caps for individual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases tried in federal court.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases purport to be brought on behalf of residents of a particular state or states (although a few cases purport to be nationwide in scope) and raise addiction claims and, in many cases, claims of physical injury as well.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1)&#160;and Wisconsin (1).  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; class action cases and medical monitoring class action cases pending against PM USA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#8217; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#8217; cigarettes.  In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to Altria or its subsidiaries) seeking protection under Canada&#8217;s Companies&#8217; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the U.S.).  The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Cost Recovery Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there have been some decisions to the contrary, most judicial decisions in the U.S. have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#8217; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The United States Supreme Court has refused to consider plaintiffs&#8217; appeals from the cases decided by five federal circuit courts of appeal. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the cases brought in the U.S., health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases),&#160;and other entities have stated that they are considering filing such actions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with Altria or its subsidiaries) under the Companies&#8217; Creditors Arrangement Act discussed above.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for a discussion of these proceedings.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Settlements of Health Care Cost Recovery Litigation  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, PM USA and certain other tobacco product manufacturers entered into the MSA with 46 states, the District of Columbia and certain U.S. territories to settle asserted and unasserted health care cost recovery and other claims. PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#8220;State Settlement Agreements&#8221;). The State Settlement Agreements require that the original participating manufacturers or &#8220;OPMs&#8221; (now PM USA and R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#8220;ITG&#8221;)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#8217; attorneys&#8217; fees, subject to an annual cap of $500 million.  For the three months ended September 30, 2020 and 2019, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.2 billion and $1.1 billion, respectively.  For the nine months ended September 30, 2020 and 2019, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $3.3 billion and $3.2 billion, respectively.  These amounts include PM USA&#8217;s estimate of amounts related to NPM Adjustments discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA is participating in proceedings regarding the NPM Adjustment for 2003-2019.  The &#8220;NPM Adjustment&#8221; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#8220;participating manufacturers&#8221; or &#8220;PMs&#8221;) that applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses. The independent auditor (the &#8220;IA&#8221;) appointed under the MSA calculates the maximum amount of the NPM Adjustment, if any, for each year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NPM Adjustment Disputes - Settlement with 36 States and Territories and Settlement with New York</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has entered into two settlements of NPM Adjustment disputes with a total of 37 states and territories, one with 36 states and territories (the &#8220;multi-state settlement&#8221;) and the other with the State of New York.  In the multi-state settlement, PM USA, by the end of October 2017, had settled the NPM Adjustment disputes for 2003-2015 with 26 states in exchange for a total of $740 million.  In 2018, there were two principal developments with respect to this settlement.  First, PM USA agreed to settle the NPM Adjustment disputes for 2016 and 2017 with the 26 states mentioned above.  Second, PM USA settled the NPM Adjustment disputes for 2004-2017 with ten additional states.  As a result of these two developments, PM USA will receive approximately $248 million, $68 million of which it received in April 2018, $121 million of which it received in April 2019 and $47 million of which it received in April 2020.  In connection with these two developments, PM USA recorded a reduction to cost of sales in the amount of $39 million in 2017 and in the amount of $209 million in 2018.  In the first quarter of 2019, PM USA also recorded a reduction to cost of sales in the amount of $52 million for its estimate of the 2018 NPM Adjustment settlement credit it expects to receive under the multi-state settlement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, the PMs agreed that certain conditions set forth in the multi-state settlement had been met.  As a result, PM USA&#8217;s and the other PMs&#8217; settlement with Pennsylvania was extended to include NPM Adjustments for 2018-2024.  In the third quarter of 2020, PM USA and the other PMs also agreed with the other 35 states to extend the settlement with those </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">states to include NPM Adjustments for 2018-2022.  As a result of these two developments, PM USA will receive approximately $361 million in credits to offset PM USA&#8217;s MSA payments over the following nine years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the NPM Adjustment settlement with New York, which was entered into in 2015, PM USA has received approximately $317 million for 2004-2018.  PM USA and the other participating manufacturers are involved in a proceeding pursuant to the New York settlement in which an independent investigator will determine the amounts due to the participating manufacturers from New York for 2019 and 2020.  PM USA expects to receive such amounts in April 2021 and April 2022, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the New York settlement and the multi-state settlement also contain provisions resolving certain disputes regarding the application of the NPM Adjustment going forward.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2003 and Subsequent NPM Adjustments - Continuing Disputes with States that have not Settled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2003 NPM Adjustment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  In September 2013, an arbitration panel issued rulings regarding the 15 states and territories that remained in the arbitration, ruling that six of them did not establish valid defenses to the NPM Adjustment for 2003.  In June 2014, two of these six states joined the multi-state settlement discussed above.  With respect to the remaining four states, following the outcome of challenges in state courts, PM USA ultimately recorded $74 million primarily as a reduction to cost of sales, with the final adjustment being recorded in the third quarter of 2017.  Subsequently, another one of the six states joined the multi-state settlement.  Two potential disputes remain outstanding regarding the amount of interest due to PM USA and there is no assurance that PM USA will prevail in either of these disputes.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2004 and Subsequent NPM Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  PM USA has continued to pursue the NPM Adjustments for 2004 and subsequent years in multi-state arbitrations against the states that did not join either of the settlements discussed above.   In September 2019, a New Mexico state appellate court affirmed a trial court&#8217;s order compelling New Mexico to arbitrate the 2004 NPM Adjustment claims in the multi-state arbitration with the other states.  In November 2019, the New Mexico Supreme Court declined to review that decision.  The arbitration hearing has not yet been scheduled.  The Montana state courts ruled that Montana may litigate its claims in state court, rather than participate in a multi-state arbitration and the PMs have agreed not to contest the applicability of the 2004 NPM Adjustment to Montana.  In April 2020, the State of Montana filed a motion in Montana state court against the PMs, including PM USA, claiming that Montana&#8217;s share of the NPM Adjustment amounts should be paid to the state in advance of the resolution of disputes over the applicability of those adjustments.  PM USA has been placing the disputed NPM Adjustment amounts in the disputed payments account established pursuant to the terms of the MSA.  Montana seeks a total of approximately $43 million in disputed payments from all defendants combined, as well as treble and punitive damages.  </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than Montana and New Mexico, all of the non-settling states participated in a 2004 multi-state arbitration.  That arbitration initially concluded in July 2019, although Missouri was granted a hearing in June 2020.  As of October 27, 2020, no decisions have resulted from the arbitration.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PMs have reached an agreement with the states that have not settled (with the exception of Missouri and Montana) that the next round of NPM arbitrations will encompass three years, 2005-2007, and the parties have selected an arbitration panel for the 2005-2007 arbitration.  Missouri is participating in the arbitration, but has agreed to arbitrate only one year, 2005, before the panel.  The hearings in this arbitration have not yet been scheduled.  No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IA has calculated that PM USA&#8217;s share of the maximum potential NPM Adjustments for 2004-2019 is (exclusive of interest or earnings): $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $305 million for 2016; $297 million for 2017; $340 million for 2018 and $441 million for 2019.  These maximum amounts will be reduced, likely substantially, to reflect the settlements with the signatory states and New York, and potentially for current and future calculation disputes and other developments. Finally, PM USA&#8217;s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Disputes Under the State Settlement Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#8217;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#8220;ITG brands&#8221;).  In particular, R.J. Reynolds and ITG have asserted that they do not have to make payments on the ITG brands under the Florida, Minnesota and Texas State Settlement Agreements or include the ITG brands for purposes of certain calculations under the State Settlement Agreements. PM USA believes that R.J. Reynolds&#8217;s and ITG&#8217;s position violates the State Settlement Agreements and applicable law.  PM USA further believes that these actions: (i) improperly increased PM USA&#8217;s payments for 2015-2019; (ii) may improperly increase PM USA&#8217;s payments for subsequent years; (iii) improperly decreased PM USA&#8217;s share of the 2015-2019 NPM Adjustments and of the settlements of related disputes; and (iv) may improperly decrease PM USA&#8217;s share of NPM Adjustments and related settlements for subsequent years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, PM USA and the State of Florida each filed a motion in Florida state court against R.J. Reynolds and ITG seeking to enforce the Florida State Settlement Agreement.  In August 2018, the Florida trial court entered final judgment ruling that R.J. Reynolds (and not ITG) must make settlement payments under the Florida State Settlement Agreement on the ITG brands, and ordering R.J. Reynolds to pay PM USA approximately $9.8 million (inclusive of interest) for the 2015-2017 period.  Both R.J. Reynolds and PM USA filed notices of appeal and, in July 2020, the Florida Fourth District Court of Appeal affirmed the trial court&#8217;s decision.  In September 2020, the Florida Fourth District Court of Appeal denied R.J. Reynolds&#8217;s motions for rehearing.  In October 2020, R.J. Reynolds petitioned the Florida Supreme Court to review the appellate court decision.     </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, PM USA and the State of Minnesota filed pleadings in Minnesota state court asserting claims against R.J. Reynolds and ITG, similar to those made in Florida, and seeking to enforce the Minnesota State Settlement Agreement.  In September 2019, the Minnesota court granted the State of Minnesota&#8217;s and PM USA&#8217;s motions to enforce the agreement against R.J. Reynolds.  The Minnesota court concluded, however, that it could not yet resolve the question of ITG&#8217;s liability under the Minnesota State Settlement Agreement.  An evidentiary hearing on the question of ITG&#8217;s potential liability was held in the third quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, PM USA filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against R.J. Reynolds and ITG with respect to the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of payments relating to the ITG brands.  A hearing in the case is currently scheduled for May 2021.  In December 2019, in a separate matter, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the calculation of the April 2019 payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, PM USA and the State of Texas each filed a motion in federal court in the Eastern District of Texas asserting claims against R.J. Reynolds and ITG, similar to those made in Florida and Minnesota, seeking to enforce the Texas State Settlement Agreement.  On February 25, 2020, the Texas court granted the State of Texas&#8217; and PM USA&#8217;s motions to enforce the settlement agreement against R.J. Reynolds.  The Texas court, however, deferred the ultimate resolution of the motions to enforce against ITG, because it concluded that question was dependent upon the outcome of separate litigation pending between ITG and R.J. Reynolds in the Delaware Court of Chancery.  In August 2020, R.J. Reynolds appealed the Eastern District of Texas&#8217;s ruling to the U.S. Court of Appeals for the Fifth Circuit.  ITG and the State of Texas also have filed notices of appeal, each of which is limited to the issue of how payments of statutory fees are treated under the Eastern District of Texas&#8217;s ruling.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999, the United States government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#8220;sub-schemes&#8221; to defraud that the government had alleged.  Specifically, the court found that: </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants hid from the public that cigarette smoking and nicotine are addictive; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely marketed and promoted &#8220;low tar/light&#8221; cigarettes as less harmful than full-flavor cigarettes; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they intentionally marketed to youth; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants publicly and falsely denied that ETS is hazardous to non-smokers; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants suppressed scientific research.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#8220;committing any act of racketeering&#8221; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii)&#160;an injunction against &#8220;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#8221; (iv)&#160;an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#8220;lights,&#8221; &#8220;ultra lights&#8221; and &#8220;low tar,&#8221; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v)&#160;the issuance of &#8220;corrective statements&#8221; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#8220;low tar&#8221; or &#8220;light&#8221; cigarettes, defendants&#8217; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi)&#160;the disclosure on defendants&#8217; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the U.S.; and (ix)&#160;payment of the government&#8217;s costs in bringing the action.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#8217; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014 and 2019, Altria and PM USA recorded provisions totaling approximately $36 million for the estimated costs of implementing the corrective communications remedy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The requirements related to corrective statements at point-of-sale remain outstanding.  In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014.  In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing is currently scheduled for July 2021.    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the United States government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a heated tobacco product used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device.  In August 2020, Altria and PM USA filed an opposition to the government&#8217;s motion and, in the alternative, a motion to modify the injunction to make clear it does not apply to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of the district court&#8217;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the FDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E-vapor Product Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, Altria and/or its subsidiaries, including PM USA, were named as defendants in 25 class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs also sought to add antitrust claims due to the recent action by the FTC.  Although the court denied this request in the class action lawsuits, the individual antitrust claims remain pending before the same court.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for further discussion.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and/or its subsidiaries, including PM USA, also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 1,064 individual lawsuits, 25 lawsuits filed by school districts and 31 lawsuits filed by state or local governments, including the state of Hawaii.  JUUL is an additional named defendant in each of these lawsuits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the individual and class action lawsuits mentioned above were filed in federal court.  In October 2019, the United States Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of these lawsuits in the U.S. District Court for the Northern District of California for pretrial purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Altria and its subsidiaries filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No case in which Altria or any of its subsidiaries is named has been set for trial.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of its subsidiaries is currently named.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Other Tobacco-Related Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate Philip Morris Products S.A., in the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims of patent infringement based on the sale of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#8217; fees.  Altria and PMI have been dismissed from the lawsuit.  In June 2020, the remaining defendants filed a motion to dismiss certain of plaintiffs&#8217; claims and also filed counterclaims against the plaintiffs for infringement of various patents owned by the remaining defendants.      </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in April 2020, a related action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the United States International Trade Commission (&#8220;ITC&#8221;).  There, the plaintiffs also allege patent infringement, but the remedies sought include a prohibition on the importation of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and component parts into the United States.  No damages are recoverable in the proceedings before the ITC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Lights/Ultra Lights&#8221; Cases and Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#8220;Lights&#8221; and/or &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or its other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment. Twenty-one state courts in 23 &#8220;Lights&#8221; cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of October 27, 2020, two &#8220;Lights/Ultra Lights&#8221; class actions are pending in U.S. state court.  Neither case is active.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 27, 2020, two smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, are pending in their respective U.S. state courts.  Neither case is active.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">UST Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#8217; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases include lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of October 27, 2020, there is one case pending against USSTC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria&#8217;s 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#8220;Sherman Act&#8221;) and Section 5 of the Federal Trade Commission Act of 1914 (&#8220;FTC Act&#8221;), and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#8220;Clayton Act&#8221;).  If the FTC&#8217;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of Altria&#8217;s minority investment in JUUL, rescission of the transaction and all associated agreements, and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors.  The administrative trial will take place before an FTC administrative law judge and is currently scheduled to begin April 2021.  The administrative law judge&#8217;s decision is then submitted to the FTC, which decision is subject to review by the FTC on its own motion or at the request of any party.  The FTC then issues its ruling, which is subject to appellate review.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as of October 27, 2020, 16 putative class action lawsuits have been filed against Altria and JUUL in the United States District Court for the Northern District of California.  The lawsuits cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act, Section 7 of the Clayton Act and various state antitrust laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#8217; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of Altria&#8217;s minority investment in JUUL and rescission of the transaction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither the FTC nor the private plaintiffs has sought to preliminarily enjoin Altria from converting Altria&#8217;s non-voting JUUL shares to voting shares or appointing directors to the JUUL board of directors.  As of October 27, 2020, Altria has not exercised these rights, but has until November 30, 2020 to convert its JUUL shares under the regulations of the HSR Act, after which Altria would have to re-file for antitrust review with the FTC to again seek the ability to convert.  For further discussion of Altria&#8217;s rights in the event of share conversion, see Note. 4.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities - Investment in JUUL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Class Action and Shareholder Derivative Lawsuits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, Altria&#8217;s former Chairman and Chief Executive Officer, and William F. Gifford, Jr., Altria&#8217;s former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the United States District Court for the Eastern District of New York.  In December 2019, the court consolidated the two lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the United States District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders, and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to Altria&#8217;s investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#8217; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#8217; claims. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, two purported Altria shareholders filed separate derivative lawsuits in the United States District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of its executives and officers.  These derivative lawsuits relate to Altria&#8217;s investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  A third derivative lawsuit was filed in September 2020 in the Circuit Court for Henrico County, Virginia against Mr. Willard, Mr. Gifford, Kevin C. Crosthwaite, Altria&#8217;s former Chief Growth Officer and current JUUL Chief Executive Officer, and members of Altria&#8217;s Board of Directors.  This suit asserts a claim for breach of fiduciary duty.  Plaintiffs seek various remedies, including damages, disgorgement of profits, reformation of Altria&#8217;s corporate governance and internal procedures, and attorneys&#8217; fees.  The plaintiffs have agreed to stay the Virginia derivative case pending the outcome of defendants&#8217; motions to dismiss the shareholder class action.  A fourth derivative lawsuit was filed in October 2020 in the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States District Court for the Eastern District of Virginia against the same defendants in the Virginia lawsuit, JUUL, its founders and some of its current and former executives.  The remedies sought are similar to those sought by plaintiffs in the Virginia lawsuit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  Altria&#8217;s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that subsidiaries of Altria may undertake in the future.  In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria&#8217;s consolidated results of operations, capital expenditures, financial position or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Similar Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, certain subsidiaries of Altria have agreed to indemnify a limited number of third parties in the event of future litigation.  At September&#160;30, 2020, Altria and certain of its subsidiaries (i) had $49 million of unused letters of credit obtained in the ordinary course of business; (ii) were contingently liable for guarantees related to their own performance, including $25 million for surety bonds; and (iii) had a redeemable noncontrolling interest of $39 million recorded on its condensed consolidated balance sheet.  In addition, from time to time, subsidiaries of Altria issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on Altria&#8217;s liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of a distribution agreement between Altria and PMI (the &#8220;Distribution Agreement&#8221;), entered into as a result of Altria&#8217;s 2008 spin-off of its former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  Altria does not have a related liability recorded on its condensed consolidated balance sheet at September&#160;30, 2020 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent litigation discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation - IQOS Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has issued guarantees relating to Altria&#8217;s obligations under its outstanding debt securities, borrowings under its $3.0 billion Credit Agreement and amounts outstanding under its commercial paper program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373197208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Guidance Not Yet Adopted<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">New Accounting Guidance Not Yet Adopted</a></td>
<td class="text">New Accounting Guidance Not Yet Adopted:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:16.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2019-12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Simplifying the Accounting for Income Taxes (Topic 740)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-01 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Accounting for Convertible Instruments and Contracts in an Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">s Own Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.<br/></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. </span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449084168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, Altria began complying early, as permitted, with Regulation S-X Rules 13-01 and 13-02 regarding the financial disclosure requirements for registered debt securities with subsidiary guarantees.  On October 23, 2020, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-09,  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt (Topic 470): Amendments to SEC Paragraphs Pursuant to SEC Release No. 33-10762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to reflect changes the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) has made to its disclosure rules on guaranteed debt securities offerings.  The new rules replace the previously required condensed consolidating financial information with summarized financial information of the issuer and the guarantor and, among other things, require expanded qualitative disclosures.  Altria has elected to provide this information in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section in its Quarterly Report on Form 10-Q as permitted by the new rules.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, Altria adopted ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and all related ASU amendments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(collectively &#8220;ASU No. 2016-13&#8221;).  This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity&#8217;s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses.  The adoption of ASU No. 2016-13 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU No. 2018-15&#8221;).  This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license).  The adoption of ASU No. 2018-15 did not have a material impact on Altria&#8217;s condensed consolidated financial statements.</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:16.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2019-12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Simplifying the Accounting for Income Taxes (Topic 740)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-01 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Accounting for Convertible Instruments and Contracts in an Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">s Own Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.<br/></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. </span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text">Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value.  If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements.  If this qualitative assessment indicates that Altria&#8217;s investment in JUUL may be impaired, a quantitative assessment is performed.  If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value.  The fair value of Altria&#8217;s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares.  In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.The fair value of Altria&#8217;s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock', window );">Equity Securities Without Readily Determinable Fair Value</a></td>
<td class="text">Altria accounted for its investment in JUUL as an investment in an equity security as of September&#160;30, 2020.  Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There have been no upward or downward adjustments to the carrying value of Altria&#8217;s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through September 30, 2020.JUUL announced a strategic update in September 2020, which includes its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of Altria&#8217;s financial statements for the period ended September 30, 2020, Altria performed its qualitative assessment of impairment indicators for its investment in JUUL and determined that JUUL&#8217;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#8217;s business prospects.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201374464936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share Repurchase Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s 2019 share repurchase activity was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201374521672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairment, Exit and Implementation Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax asset impairment, exit and implementation costs consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.022%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.417%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.388%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Impairment and Exit Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus amounts included in net periodic benefit income, excluding </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">service cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Included in cost of sales ($1 million cost reversal) and marketing, administration and research costs ($26 million) in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Represents curtailment costs.  See Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:30.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.228%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Impairment and Exit Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Implementation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Included in cost of sales in Altria&#8217;s condensed consolidated statements of earnings.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Included in cost of sales ($1 million) and marketing, administration and research costs ($3 million) in Altria&#8217;s condensed consolidated statements of earnings.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.631%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash spent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373226632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities Investments in Equity Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTableTextBlock', window );">Investment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria&#8217;s investments consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:63.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> September 30, 2020 includes Altria&#8217;s equity method investment in Cronos ($986 million), the Cronos warrant ($86 million) and the Fixed-price Preemptive Rights ($15 million) and December 31, 2019 includes Altria&#8217;s equity method investment in Cronos ($1,002 million), the Cronos warrant ($234 million) and the Fixed -price Preemptive Rights ($69 million), as discussed further below.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (losses) from equity investments accounted for under the equity method of accounting consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:47.798%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.504%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> At September 30, 2020 Altria recorded pre-tax losses associated with its share of ABI&#8217;s completion of the sale of its Australia subsidiary and ABI&#8217;s goodwill impairment charge associated with its Africa businesses.  These amounts include Altria&#8217;s share of amounts recorded by ABI in its second quarter of 2020, as well as additional adjustments related to (i) conversion from international financial reporting standards to United States generally accepted accounting principles, and (ii) adjustments to Altria&#8217;s investment required under the equity method of accounting.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI http://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI http://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201374768024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text">The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:<div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Warrant</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.69</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$9.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.69</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$9.97</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.18 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.18 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.68%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.61%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.68%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.61%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 5.25 years at September 30, 2020 and 0.25 year to 6 years at December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.12% to 0.36% at September 30, 2020 and 1.66% to 1.74% at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6) Based on Cronos&#8217;s expected dividend payments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.861%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax earnings (losses) recognized in net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Derivative Liabilities at Fair Value</a></td>
<td class="text">The fair values of Altria&#8217;s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:23.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.034%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair Value of Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></div></td><td colspan="30" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cronos warrant</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity securities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses</a></td>
<td class="text">For the nine and three months ended September&#160;30, 2020 and 2019, Altria recognized pre-tax unrealized gains/(losses), representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,296)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of Altria&#8217;s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:20.254%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.893%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Net Earnings (Losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Net Earnings (Losses) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="45" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Related to amounts excluded from effectiveness testing.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373154904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Periodic Benefit (Income) Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit (income) cost consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Postretirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit </span></div><div style="padding-left:9pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(income) cost </span></div></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373253960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Losses) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (losses) per share (&#8220;EPS&#8221;) were calculated using the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:47.211%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.211%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(952)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(953)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,601)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: contingently issuable performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201373226632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,165)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,774)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,165)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(374)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,402)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,402)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings (losses):  </span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Amounts are included in net defined benefit plan costs.  For further details, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Amounts are included in earnings (losses) from equity investments.  For further information, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448149256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.585%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,849&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,103&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,856&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate asset impairment and exit costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,899&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,327)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock', window );">Schedule of Pre-tax Tobacco and Health Litigation Items</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco and Health Litigation Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria&#8217;s condensed consolidated statements of earnings as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.113%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201374662648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes update (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending valuation allowances for the period ended September 30, 2020 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,856&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201375260136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Contingencies</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and/or Altria as of October 27, 2020, October 28, 2019 and October 22, 2018:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.076%"><tr><td style="width:1.0%"/><td style="width:59.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.551%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">October 22, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes 15 cases filed in New Mexico, 26 cases filed in Massachusetts and 54 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include 1,471 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  In March 2018, 923 of these cases were voluntarily dismissed without prejudice.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes 25 class action lawsuits, two of which were filed in Canada, 1,064 individual lawsuits, 31 state or local government lawsuits and 25 lawsuits filed by school districts relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes two inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including one case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and two inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in Altria&#8217;s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.245%"><tr><td style="width:1.0%"/><td style="width:54.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.786%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:2.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.786%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For the Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health litigation items at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health litigation </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health litigation items at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes amounts related to the costs of implementing the corrective communications remedy related to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> discussed below.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes approximately $20 million related to pre-trial resolution of approximately 240 tobacco and health cases.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes approximately $20 million in payments related to above-mentioned pre-trial resolution of approximately 240 tobacco and health cases and $2 million for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:7.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.301%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages (All Defendants)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages (PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Berger </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cote</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2014</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$21&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court.  PM USA&#8217;s challenge to the punitive damages award was denied by the district court.  Appeal by PM USA to Eleventh Circuit Court of Appeals pending.</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6&#160;million accrual in the fourth quarter of 2018</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Santoro</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2017</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA, R.J. Reynolds and Liggett Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million (&lt;$1&#160;million PM USA) </span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Fourth District Court of Appeal affirmed the compensatory damages award and reinstated the punitive damages award.  Defendants&#8217; motion for rehearing was denied. Appeal by defendants of punitive damages award to Florida Supreme Court pending.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million accrual for compensatory damages award in the second quarter of 2020</span></div></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrual amounts include interest and associated costs, if applicable.  For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff&#8217;s favor after taking into account any portion potentially payable by the other defendant(s). </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> References to &#8220;R.J. Reynolds,&#8221; &#8220;Lorillard&#8221; and &#8220;Liggett Group&#8221; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.912%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and <br/>R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Second District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by plaintiff and defendant to First District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9&#160;million ($5&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$74 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Gloger</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15&#160;million ($5&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$11 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendants to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial ordered on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Neff</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Frogel</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Palm Beach</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal reversed the judgment against PM USA and ordered a new trial.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Mahfuz</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$10 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendant&#8217;s appeal to Third District Court of Appeal pending.</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.912%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Appeal Status</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed the compensatory damages award.  PM USA petitioned Florida Supreme Court for review.  Case stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">R. Douglas</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awaiting entry of final judgment by the trial court.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Sommers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2017</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages.  Florida Supreme Court denied PM USA's petition for review.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper (Blackwood)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$9&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit stayed pending Florida Supreme Court decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Harris</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2014</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA, <br/>R.J. Reynolds and Lorillard</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in this case.</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.196%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount<br/>(if any)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Dean (Kerrivan)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2014</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$26&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Landi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$10&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Theis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and <br/>R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sarasota</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">First quarter of 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$17&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020</span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In four cases in which PM USA paid the judgments more than a year ago, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Naugle,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Gore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">M. Brown </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Jordan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, plaintiffs were awarded approximately $8 million, $2 million, $9 million and $4 million in fees and costs, respectively.  PM USA has appealed in all of these cases. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In August 2020, the U.S. Court of Appeals for the Eleventh Circuit denied the defendants&#8217; petition for rehearing.  As a result, in the third quarter of 2020, PM USA recorded a pre-tax provision of approximately $26 million, reflecting its portion of the judgment plus interest, and paid this amount in August 2020.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In June 2020, the Fourth District Court of Appeal affirmed the compensatory damages award.  As a result, in the second quarter of 2020, PM USA recorded a pre-tax provision of approximately $10 million for the judgment plus interest and paid this amount in July 2020.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In February 2020, the Florida Second District Court of Appeal denied PM USA&#8217;s petition for review.&#160; As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately $17 million for the judgment plus interest and paid this amount.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14472-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14453-108349<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12021-110248<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14394-108349<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201372966120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Guidance Not Yet Adopted (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recent Accounting Guidance Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:16.615%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.232%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2019-12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Simplifying the Accounting for Income Taxes (Topic 740)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-01 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020.  Early application is permitted, including adoption in any interim period. </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria's adoption of this guidance is not expected to have a material impact on its consolidated financial statements. <br/></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2020-06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Accounting for Convertible Instruments and Contracts in an Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">s Own Equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.&#160; Key provisions of the guidance include reducing the number of accounting models, simplifying the earnings per share calculations and expanding the disclosures related to convertible instruments.<br/></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021.  Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. </span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201375367896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Jan. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_CommonStockDividendRatePercentageIncrease', window );">Common stock, dividend rate, percentage increase</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (usd per share)</a></td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="nump">$ 2.54<span></span>
</td>
<td class="nump">$ 2.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_CommonStockDividendRateAnnualPerShare', window );">Common stock, dividend rate, annual (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Equity securities, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2018ShareRepurchaseProgramMember', window );">January 2018 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Planned share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
<td class="nump">34,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price of repurchased shares, per share (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.36<span></span>
</td>
<td class="nump">$ 58.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_July2019ShareRepurchaseProgramMember', window );">July 2019 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Planned share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount', window );">Stock repurchase program, rescinded authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mo_HelixInnovationsLLCMember', window );">Helix Innovations LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling interest, ownership percentage by parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 353,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest, ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CommonStockDividendRateAnnualPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividend Rate, Annual, Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CommonStockDividendRateAnnualPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CommonStockDividendRatePercentageIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividend Rate, Percentage Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CommonStockDividendRatePercentageIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Rescinded Authorized Repurchase Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2018ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_January2018ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_July2019ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_July2019ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mo_HelixInnovationsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mo_HelixInnovationsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449338872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Share Repurchase Table) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Aggregate cost of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2018ShareRepurchaseProgramMember', window );">January 2018 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total number of shares repurchased (shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">34.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Aggregate cost of shares repurchased</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share of shares repurchased (usd per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 54.36<span></span>
</td>
<td class="nump">$ 58.86<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2018ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_January2018ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449524456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AllowanceForSalesDiscountsGoods', window );">Allowance for sales discounts, goods</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming', window );">Expected period for satisfaction of performance obligation</a></td>
<td class="text">three days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AllowanceForSalesDiscountsGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allowance For Sales Discounts, Goods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AllowanceForSalesDiscountsGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfTiming</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201444839288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherRestructuringCostsIncludingNetPensionCostCredit', window );">Total, Implementation Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts', window );">Plus amounts included in net period benefit income, excluding service cost, Implementation Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Implementation Costs</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_RestructuringChargesIncludingNetPensionCostCredit', window );">Total restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges', window );">Plus amounts included in net periodic benefit income, excluding service cost, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit', window );">Total, Asset Impairment and Exit Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts', window );">Plus amounts included in net periodic benefit income, excluding service cost, Asset Impairment and Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCosts', window );">Asset Impairment and Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Smokeable Products Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherRestructuringCostsIncludingNetPensionCostCredit', window );">Total, Implementation Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_RestructuringChargesIncludingNetPensionCostCredit', window );">Total restructuring</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit', window );">Total, Asset Impairment and Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Oral Tobacco Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherRestructuringCostsIncludingNetPensionCostCredit', window );">Total, Implementation Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_RestructuringChargesIncludingNetPensionCostCredit', window );">Total restructuring</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit', window );">Total, Asset Impairment and Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Wine Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherRestructuringCostsIncludingNetPensionCostCredit', window );">Total, Implementation Costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_RestructuringChargesIncludingNetPensionCostCredit', window );">Total restructuring</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit', window );">Total, Asset Impairment and Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | All Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherRestructuringCostsIncludingNetPensionCostCredit', window );">Total, Implementation Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_RestructuringChargesIncludingNetPensionCostCredit', window );">Total restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit', window );">Total, Asset Impairment and Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherRestructuringCostsIncludingNetPensionCostCredit', window );">Total, Implementation Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_RestructuringChargesIncludingNetPensionCostCredit', window );">Total restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit', window );">Total, Asset Impairment and Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCosts', window );">Asset Impairment and Exit Costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherRestructuringCostsIncludingNetPensionCostCredit', window );">Total, Implementation Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mo_MarketingAdministrationAndResearchCostsMember', window );">Marketing Administration And Research Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherRestructuringCostsIncludingNetPensionCostCredit', window );">Total, Implementation Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AssetImpairmentandBusinessExitCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment and Business Exit Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AssetImpairmentandBusinessExitCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Implementation Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Restructuring Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Periodic Defined Benefits Income (Reversal of Income), Excluding Service Cost Component, Asset Impairment And Business Exit Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherRestructuringCostsIncludingNetPensionCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Restructuring Costs, Including Net Pension Cost (Credit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherRestructuringCostsIncludingNetPensionCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_RestructuringChargesIncludingNetPensionCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges, Including Net Pension Cost (Credit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_RestructuringChargesIncludingNetPensionCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mo_MarketingAdministrationAndResearchCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mo_MarketingAdministrationAndResearchCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201456554344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, beginning of period</a></td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Charges</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash spent</a></td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve, end of period</a></td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449653272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairment, Exit and Implementation Costs (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember', window );">Wine Business Strategic Reset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=mo_InventoryWriteOffMember', window );">Inventory Write-Off [Member] | Wine Business Strategic Reset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_PurchaseCommitmentMember', window );">Purchase Commitment [Member] | Wine Business Strategic Reset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermPurchaseCommitmentPeriod', window );">Fulfillment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Wine Business Strategic Reset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermPurchaseCommitmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermPurchaseCommitmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mo_InventoryWriteOffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mo_InventoryWriteOffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_PurchaseCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_PurchaseCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201450032104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments in Equity Securities (Summary of Investments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 19,408<span></span>
</td>
<td class="nump">$ 23,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">16,716<span></span>
</td>
<td class="nump">18,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities without readily determinable fair value, amount</a></td>
<td class="nump">1,605<span></span>
</td>
<td class="nump">4,205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">1,087<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Equity Contract, Warrant [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">$ 986<span></span>
</td>
<td class="nump">$ 1,002<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448970648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Earnings in Equity Securities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings (losses) from equity investments</a></td>
<td class="num">$ (472)<span></span>
</td>
<td class="nump">$ 333<span></span>
</td>
<td class="num">$ (306)<span></span>
</td>
<td class="nump">$ 866<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings (losses) from equity investments</a></td>
<td class="num">(418)<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings (losses) from equity investments</a></td>
<td class="num">$ (54)<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201371723512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in ABI Narrative) (Details) - ABI [Member] - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted', window );">Number of restricted shares owned (in shares)</a></td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon', window );">Number of ordinary shares owned (in shares)</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">$ 16,716,000,000<span></span>
</td>
<td class="nump">$ 18,071,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage', window );">Difference between carrying amount and fair value, percentage (approximately)</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentImpairment', window );">Equity method investment, impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of equity investment</a></td>
<td class="nump">$ 10,700,000,000<span></span>
</td>
<td class="nump">$ 16,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Common</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedCommon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Restricted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117311354&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201375319176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in JUUL Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 28, 2020 </div>
<div>USD ($) </div>
<div>director</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>director</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>director</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000,000<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="nump">$ 4,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue', window );">Payments to acquire equity securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Equity securities, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities without readily determinable fair value, amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,605,000,000<span></span>
</td>
<td class="nump">$ 4,205,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,605,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,205,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod', window );">Equity securities without readily determinable fair value, non-compete release trigger period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue', window );">Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount', window );">Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount | $</a></td>
<td class="nump">$ 12,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod', window );">Equity securities without readily determinable fair value, no litigation period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers', window );">Equity securities without readily determinable fair value, number of board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion', window );">Equity securities without readily determinable fair value, number of board members upon share conversion</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion', window );">Equity securities without readily determinable fair value, number of independent board members upon share conversion</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion', window );">Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion', window );">Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion', window );">Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion', window );">Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion', window );">Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion', window );">Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion', window );">Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Equity securities without readily determinable fair value, upward price adjustment, cumulative amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000,000<span></span>
</td>
<td class="nump">$ 4,500,000,000<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, No Litigation Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Board Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Equity Securities Without Readily Determinable Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201445885336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in Cronos Narrative) (Details) - Cronos [Member]<br> $ / shares in Units, shares in Thousands, $ in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>director </div>
<div>board_member </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon', window );">Number of ordinary shares owned (approximately) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting', window );">Equity method investments, purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage', window );">Equity method investment, warrant exercised, ownership percentage (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestments', window );">Payments for deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_NumberofDirectorsNominated', window );">Number of directors nominated | director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated', window );">Equity method investment, number of independent directors nominated | director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_NumberofMembersOntheBoardofDirectors', window );">Number of members on the Board of Directors | board_member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,087,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,305,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage', window );">Equity method investment, difference between carrying amount and fair value, percentage (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentPricePerShareIfExercised', window );">Equity method investment, shares purchased, (CAD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase', window );">Equity method investment, number of shares eligible for purchase (approximately) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities', window );">Payments for derivative instrument, investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Equity Contract, Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentPricePerShareIfExercised', window );">Equity method investment, shares purchased, (CAD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase', window );">Equity method investment, number of shares eligible for purchase (approximately) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase', window );">Equity method investment, percentage of shares eligible for purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities', window );">Payments for derivative instrument, investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Equity Contract, Warrant [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 986,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,002,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Equity method investment, impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentAggregateExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Aggregate Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentAggregateExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Independent Directors Nominated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Eligible For Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Common</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedCommon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Percentage of Shares Eligible For Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentPricePerShareIfExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Price Per Share If Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentPricePerShareIfExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Warrant Exercised, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NumberofDirectorsNominated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Directors Nominated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NumberofDirectorsNominated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NumberofMembersOntheBoardofDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Members On the Board of Directors</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NumberofMembersOntheBoardofDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Equity Method Investments and Derivative Instruments, Investing</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117311354&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448040680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Narrative) (Details)<br> $ in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Loss on Cronos-related financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">$ 636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="nump">$ 1,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Loss on Cronos-related financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting', window );">Equity method investments, purchase price</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember', window );">Foreign Currency Denominated Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt instrument, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Foreign currency contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Estimate of Fair Value Measurement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Equity Method Investments and Derivative Instruments, Investing</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201447884840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>year</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>year</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Share price [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">6.69<span></span>
</td>
<td class="nump">9.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Share price [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">6.69<span></span>
</td>
<td class="nump">9.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Life [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">1.18<span></span>
</td>
<td class="nump">1.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Life [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">2.43<span></span>
</td>
<td class="nump">3.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected Volatility [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.8068<span></span>
</td>
<td class="nump">0.8161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected Volatility [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.8068<span></span>
</td>
<td class="nump">0.8161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.0020<span></span>
</td>
<td class="nump">0.0171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Fixed-price Preemptive Rights [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.0012<span></span>
</td>
<td class="nump">0.0166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Fixed-price Preemptive Rights [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.0036<span></span>
</td>
<td class="nump">0.0174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Interest Rate [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.0025<span></span>
</td>
<td class="nump">0.0169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected Dividend Yield [Member] | Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected Dividend Yield [Member] | Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=mo_MeasurementInputWeightedAverageExpectedTermMember', window );">Weighted Average Expected Term [Member] | Fixed-price Preemptive Rights [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">0.25<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=mo_MeasurementInputWeightedAverageExpectedTermMember', window );">Weighted Average Expected Term [Member] | Fixed-price Preemptive Rights [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetMeasurementInput', window );">Derivative asset, measurement input</a></td>
<td class="nump">5.25<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=mo_MeasurementInputWeightedAverageExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=mo_MeasurementInputWeightedAverageExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201445241096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details) - Fair Value, Inputs, Level 3 [Member] - Equity Contract [Member]<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Balance at begging of period</a></td>
<td class="nump">$ 303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Pre-tax earnings (losses) recognized in net earnings</a></td>
<td class="num">(202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Balance at end of period</a></td>
<td class="nump">$ 101<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EquityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EquityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201445036392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Fair Value Derivative Financial Instruments) (Details) - Net Investment Hedging [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">$ 349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value of Liabilities</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value of Liabilities</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value of Liabilities</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value of Liabilities</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Equity Contract [Member] | Not Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Cronos Warrant [Member] | Not Designated as Hedging Instrument [Member] | Investments In Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Fixed-price Preemptive Rights [Member] | Not Designated as Hedging Instrument [Member] | Investments In Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value of Assets</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mo_OtherAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mo_OtherAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EquityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EquityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mo_InvestmentsInEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mo_InvestmentsInEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448001256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="num">$ (105)<span></span>
</td>
<td class="num">$ (636)<span></span>
</td>
<td class="num">$ (202)<span></span>
</td>
<td class="num">$ (1,296)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(188)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="num">$ (80)<span></span>
</td>
<td class="num">$ (448)<span></span>
</td>
<td class="num">$ (148)<span></span>
</td>
<td class="num">$ (896)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201375324648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details) - Net Investment Hedging [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="num">$ (272)<span></span>
</td>
<td class="nump">$ 257<span></span>
</td>
<td class="num">$ (243)<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Gain (Loss) Recognized in Net Earnings</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="num">(66)<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Gain (Loss) Recognized in Net Earnings</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember', window );">Foreign currency denominated debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="num">(206)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Gain (Loss) Recognized in Net Earnings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448649320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(143)<span></span>
</td>
<td class="num">(376)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net loss</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost (credit)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost (credit)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201450086888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined benefit plan, plan assets, contributions by employer</a></td>
<td class="nump">$ 16,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Anticipated additional employer contributions</a></td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined benefit plan, plan assets, contributions by employer</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Anticipated additional employer contributions</a></td>
<td class="nump">$ 60,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449678424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Losses) Per Share (Basic and Diluted Earnings Per Share) (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (losses) attributable to Altria</a></td>
<td class="num">$ (952)<span></span>
</td>
<td class="num">$ (2,600)<span></span>
</td>
<td class="nump">$ 2,543<span></span>
</td>
<td class="nump">$ 516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted', window );">Less: Distributed and undistributed earnings attributable to share-based awards</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted', window );">Earnings (losses) for basic and diluted EPS</a></td>
<td class="num">$ (953)<span></span>
</td>
<td class="num">$ (2,601)<span></span>
</td>
<td class="nump">$ 2,537<span></span>
</td>
<td class="nump">$ 511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares for basic and diluted EPS (in shares)</a></td>
<td class="nump">1,858<span></span>
</td>
<td class="nump">1,868<span></span>
</td>
<td class="nump">1,858<span></span>
</td>
<td class="nump">1,871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable', window );">Plus: contingently issuable performance stock units (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares for diluted EPS (in shares)</a></td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">1,868<span></span>
</td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">1,871<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) Available to Common Stockholders, Basic and Diluted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201375393144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 5,786<span></span>
</td>
<td class="nump">$ 14,466<span></span>
</td>
<td class="nump">$ 6,319<span></span>
</td>
<td class="nump">$ 14,789<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">3,232<span></span>
</td>
<td class="nump">10,637<span></span>
</td>
<td class="nump">3,232<span></span>
</td>
<td class="nump">10,637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(3,774)<span></span>
</td>
<td class="num">(2,646)<span></span>
</td>
<td class="num">(2,864)<span></span>
</td>
<td class="num">(2,547)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="num">(123)<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="num">(1,302)<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="nump">41<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="num">(82)<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="num">(1,023)<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings (losses)</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings (losses), net of deferred income taxes</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(3,781)<span></span>
</td>
<td class="num">(2,402)<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
<td class="num">(2,402)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(2,150)<span></span>
</td>
<td class="num">(2,110)<span></span>
</td>
<td class="num">(2,192)<span></span>
</td>
<td class="num">(2,168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="num">(75)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings (losses)</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings (losses), net of deferred income taxes</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(2,165)<span></span>
</td>
<td class="num">(2,084)<span></span>
</td>
<td class="num">(2,165)<span></span>
</td>
<td class="num">(2,084)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,606)<span></span>
</td>
<td class="num">(542)<span></span>
</td>
<td class="num">(693)<span></span>
</td>
<td class="num">(374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="num">(71)<span></span>
</td>
<td class="nump">290<span></span>
</td>
<td class="num">(1,211)<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="num">(49)<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="num">(951)<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings (losses)</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings (losses), net of deferred income taxes</a></td>
<td class="nump">34<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="num">(928)<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,621)<span></span>
</td>
<td class="num">(321)<span></span>
</td>
<td class="num">(1,621)<span></span>
</td>
<td class="num">(321)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Currency Translation Adjustments and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings (losses)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings (losses), net of deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448395064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Reclassifications) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="num">$ (58)<span></span>
</td>
<td class="num">$ (40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Earnings) losses from equity investments</a></td>
<td class="nump">472<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="num">(866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</a></td>
<td class="nump">956<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
<td class="num">(2,532)<span></span>
</td>
<td class="num">(516)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Earnings) losses from equity investments</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit Plans [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Net loss [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember', window );">Prior service cost/credit [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (18)<span></span>
</td>
<td class="num">$ (22)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449188232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Segment Data Schedule) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 7,123<span></span>
</td>
<td class="nump">$ 6,856<span></span>
</td>
<td class="nump">$ 19,849<span></span>
</td>
<td class="nump">$ 19,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCosts', window );">Corporate asset impairment and exit costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">3,160<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">8,292<span></span>
</td>
<td class="nump">7,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest and other debt expense, net</a></td>
<td class="num">(310)<span></span>
</td>
<td class="num">(293)<span></span>
</td>
<td class="num">(893)<span></span>
</td>
<td class="num">(989)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings (losses) from equity investments</a></td>
<td class="num">(472)<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="nump">866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="num">(2,600)<span></span>
</td>
<td class="num">(4,500)<span></span>
</td>
<td class="num">(2,600)<span></span>
</td>
<td class="num">(4,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Loss on Cronos-related financial instruments</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(636)<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="num">(1,327)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) before income taxes</a></td>
<td class="num">(324)<span></span>
</td>
<td class="num">(2,128)<span></span>
</td>
<td class="nump">4,349<span></span>
</td>
<td class="nump">1,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">6,313<span></span>
</td>
<td class="nump">6,049<span></span>
</td>
<td class="nump">17,522<span></span>
</td>
<td class="nump">16,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="nump">2,789<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="nump">7,609<span></span>
</td>
<td class="nump">6,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">640<span></span>
</td>
<td class="nump">620<span></span>
</td>
<td class="nump">1,901<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="nump">1,297<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember', window );">Wine Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(347)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">General corporate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General corporate expenses</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AssetImpairmentandBusinessExitCosts', window );">Corporate asset impairment and exit costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AssetImpairmentandBusinessExitCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment and Business Exit Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AssetImpairmentandBusinessExitCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449239064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details) - Tobacco and Health Litigation Cases [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Segment Reconciling Items [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Operating Segments [Member] | Smokeable Products Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448440008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Schedule of COVID-19 Related Items (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleOfPretaxCOVID19ChargesLineItems', window );"><strong>Schedule Of Pre-tax COVID-19 Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">$ 1,961<span></span>
</td>
<td class="nump">$ 1,915<span></span>
</td>
<td class="nump">$ 5,909<span></span>
</td>
<td class="nump">$ 5,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member', window );">COVID-19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleOfPretaxCOVID19ChargesLineItems', window );"><strong>Schedule Of Pre-tax COVID-19 Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member', window );">COVID-19 [Member] | Smokeable Products Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleOfPretaxCOVID19ChargesLineItems', window );"><strong>Schedule Of Pre-tax COVID-19 Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member', window );">COVID-19 [Member] | Oral Tobacco Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleOfPretaxCOVID19ChargesLineItems', window );"><strong>Schedule Of Pre-tax COVID-19 Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleOfPretaxCOVID19ChargesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule Of Pre-tax COVID-19 Charges [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleOfPretaxCOVID19ChargesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201445188168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 01, 2018</div></th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Extension</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum', window );">Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio', window );">Debt instrument, consolidated EBITDA to interest expense ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">$ 1,144,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 470,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes Due 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes Due 2050 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Line of Credit [Member] | Revolving Credit Facility Due August 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentNumberofExtensions', window );">Debt instrument, number of extensions | Extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentExtensionTerm', window );">Debt instrument, extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member] | Revolving Credit Facility [Member] | Line of Credit [Member] | Revolving Credit Facility Due August 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember', window );">Debt Instrument, Redemption, Period One [Member] | Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentNumberofExtensions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Extensions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentNumberofExtensions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDueTwoThousandAndThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDueTwoThousandAndThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDueTwoThousandandFiftyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesDueTwoThousandandFiftyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_RevolvingCreditFacilityDueAugust2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_RevolvingCreditFacilityDueAugust2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201445382104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax rate</a></td>
<td class="num">(195.10%)<span></span>
</td>
<td class="num">(22.30%)<span></span>
</td>
<td class="nump">41.80%<span></span>
</td>
<td class="nump">74.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceRollforwardRollForward', window );"><strong>Valuation Allowance Rollforward [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount', window );">Additions to valuation allowance charged to income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount', window );">Reductions to valuation allowance credited to income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at end of period</a></td>
<td class="nump">$ 2,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact the effective tax rate</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Possible decrease in unrecognized tax benefits</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate', window );">Unrecognized tax benefits that would impact deferred taxes</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits that Would Impact Deferred Tax Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Decrease In Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Increase In Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceRollforwardRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance Rollforward [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceRollforwardRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201374796648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (General Information) (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>state</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond', window );">Number of states that cap bond or require no bond</a></td>
<td class="nump">47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States That Cap Bond or Require No Bond</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201464073128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Schedule of Pending Cases) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>claim </div>
<div>lawsuit </div>
<div>case</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>case</div>
</th>
<th class="th">
<div>Oct. 28, 2019 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 22, 2018 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember', window );">ETS Smoking and Health Case, Flight Attendants [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Number of claims dismissed | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember', window );">Other Tabacco-Related Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | NEW MEXICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | ETS Smoking and Health Case, Flight Attendants [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfCases', window );">Number of cases | case</a></td>
<td class="nump">1,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">1,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Individual Lawsuits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">1,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Lawsuits Filed By State Or Local Governments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Lawsuit Filed By School District [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Other Tabacco-Related Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfInactiveCases', window );">Loss contingency, number of inactive cases | case</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfCasesTriedinASingleProceeding', window );">Loss contingency, number of cases tried in a single proceeding | case</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfInactiveClassActionLawsuits', window );">Loss contingency, number of inactive class action lawsuits | case</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassActionLawsuit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action Lawsuit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassActionLawsuit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCasesTriedinASingleProceeding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases Tried in A Single Proceeding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCasesTriedinASingleProceeding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfInactiveCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Inactive Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfInactiveCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfInactiveClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Inactive Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfInactiveClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201500248600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">262 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>claim </div>
<div>case</div>
</th>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>case </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 28, 2019 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 22, 2018 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofCasesSetforTrial', window );">Number of cases set for trial</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsResolvedNumber', window );">Number of claims resolved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyVerdictReversedNumber', window );">Number of verdicts reversed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Alaska [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Connecticut [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Louisiana [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Mississippi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Missouri [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Hampshire [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Jersey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Ohio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Pennsylvania [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Rhode Island [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Tennessee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | West Virginia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedFavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Favorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedFavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedUnfavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Unfavorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedUnfavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsResolvedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Resolved, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsResolvedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofCasesSetforTrial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases Set for Trial</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofCasesSetforTrial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictReversedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdict Reversed, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictReversedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_LA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_LA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_PA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_PA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_RI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_RI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WV">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WV</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201371532472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">192 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>case</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>case</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>case</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liability for tobacco and health litigation items at beginning of period</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Payments</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liability for tobacco and health litigation items at end of period</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_PreTrialResolutionMember', window );">Pre-Trial Resolution [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liability for tobacco and health litigation items at end of period</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember', window );">Interest Expense Related to Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationEscrowDeposit', window );">Security posted for appeal of judgments</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Litigation settlement interest expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member] | Pre-Trial Resolution [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfPreTrialResolutionCases', window );">Loss contingency, number of pre-trial resolution cases | case</a></td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member] | Litigation Cases Results [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Litigation settlement interest expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationEscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Escrow Deposit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationEscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfPreTrialResolutionCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Pre-Trial Resolution Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfPreTrialResolutionCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense (income) directly attributable to an award in settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_PreTrialResolutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_PreTrialResolutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201448683240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Non-Engle Progeny Litigation) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember', window );">Non-Engle Progeny Smoking And Health Case, Principe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember', window );">Non-Engle Progeny Smoking and Health Case, Greene [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseLaramieMember', window );">Non-Engle Progeny Smoking and Health Case, Laramie [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGentileMember', window );">Non-Engle Progeny Smoking and Health Case, Gentile [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGentileMember', window );">Non-Engle Progeny Smoking and Health Case, Gentile [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage', window );">Compensatory damages award, allocation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Allocation Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseLaramieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseLaramieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGentileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGentileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201446448200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>USD ($) </div>
<div>case </div>
<div>claim </div>
<div>plantiff</div>
</th>
<th class="th"><div>Jul. 31, 2006</div></th>
<th class="th">
<div>Jan. 31, 2008 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jul. 31, 2000 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants', window );">Loss contingency, period for decertified class members to file individual actions against defendants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember', window );">Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyUnfavorableVerdictsPendingReversed', window );">Number of claims with unfavorable verdicts pending/reversed</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plantiff</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, State [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Federal [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, D Cohen, Collar, Chacon [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyVerdictReversedNumber', window );">Number of verdicts reversed</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Reider and Banks [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyZeroDamagesVerdicts', window );">Zero damages verdicts</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Weingart and Hancock [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyZeroDamagesVerdictModified', window );">Zero damages verdict modified</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Pollari [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Gloger, Rintoul and Duignam [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Freeman [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedFavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Favorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedFavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedUnfavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Unfavorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedUnfavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyUnfavorableVerdictsPendingReversed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Unfavorable Verdicts Pending/Reversed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyUnfavorableVerdictsPendingReversed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictReversedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdict Reversed, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictReversedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyZeroDamagesVerdictModified">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Zero Damages Verdict Modified</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyZeroDamagesVerdictModified</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyZeroDamagesVerdicts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Zero Damages Verdicts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyZeroDamagesVerdicts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesFederalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesFederalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesReiderandBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesReiderandBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesWeingartandHancockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesWeingartandHancockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesPollariMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesPollariMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerRintoulandDuignamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerRintoulandDuignamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesFreemanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesFreemanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201362961448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>case</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>case</div>
</th>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_PreTaxChargesGainIncludedinNetEarning', window );">Pre-tax charges (gain) included in net earning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesBergerMember', window );">Engle Progeny Cases, Berger [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesBergerMember', window );">Engle Progeny Cases, Berger [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSantoroMember', window );">Engle Progeny Cases, Santoro [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSantoroMember', window );">Engle Progeny Cases, Santoro [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember', window );">Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember', window );">Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember', window );">Engle Progeny Cases, Cuddihee [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember', window );">Engle Progeny Cases, Cuddihee [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesRintoulMember', window );">Engle Progeny Cases, Rintoul [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesRintoulMember', window );">Engle Progeny Cases, Rintoul [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerMember', window );">Engle Progeny Cases, Gloger [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerMember', window );">Engle Progeny Cases, Gloger [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember', window );">Engle Progeny Cases, McCall [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember', window );">Engle Progeny Cases, McCall [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNeffMember', window );">Engle Progeny Cases, Neff [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNeffMember', window );">Engle Progeny Cases, Neff [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesFrogelMember', window );">Engle Progeny Cases, Frogel [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMahfuzMember', window );">Engle Progeny Cases, Mahfuz [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMahfuzMember', window );">Engle Progeny Cases, Mahfuz [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember', window );">Engle Progeny Cases, Holliman [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember', window );">Engle Progeny Cases, Holliman [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember', window );">Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember', window );">Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember', window );">Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember', window );">Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember', window );">Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember', window );">Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSommersMember', window );">Engle Progeny Cases, Sommers [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSommersMember', window );">Engle Progeny Cases, Sommers [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember', window );">Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember', window );">Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember', window );">Engle Progeny Cases, D. Brown [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember', window );">Engle Progeny Cases, D. Brown [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHarrisMember', window );">Engle Progeny Cases, Harris [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHarrisMember', window );">Engle Progeny Cases, Harris [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDeanKerrivanMember', window );">Engle Progeny Cases, Dean (Kerrivan) [Member] | Settled Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLandiMember', window );">Engle Progeny Cases, Landi [Member] | Settled Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesTheisMember', window );">Engle Progeny Cases, Theis [Member] | Settled Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember', window );">Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo', window );">Loss Contingency, Number Of Cases With Payments A Year Or More Ago | case</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleMember', window );">Engle Progeny Cases, Naugle [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGoreMember', window );">Engle Progeny Cases, Gore [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesM.BrownMember', window );">Engle Progeny Cases, M. Brown [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesJordanMember', window );">Engle Progeny Cases, Jordan [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases With Payments A Year Or More Ago</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_PreTaxChargesGainIncludedinNetEarning">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Charges (Gain) Included in Net Earning</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_PreTaxChargesGainIncludedinNetEarning</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesBergerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesBergerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSantoroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesSantoroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesRintoulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesRintoulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNeffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesNeffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesFrogelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesFrogelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMahfuzMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMahfuzMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSommersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesSommersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHarrisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesHarrisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDeanKerrivanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesDeanKerrivanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLandiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesLandiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesTheisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesTheisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesNaugleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesM.BrownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesM.BrownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesJordanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesJordanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201467511480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Florida Bond Statute) (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2009 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida [Member] | Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_MaximumBondForAllDefendants', window );">Maximum bond for all defendants</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MaximumBondForAllDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Bond For All Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MaximumBondForAllDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201446606120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Other Smoking and Health Class Actions) (Details) - Smoking and Health Class Actions and Aggregated Claims Litigation [Member]<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">293 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CAD ($) </div>
<div>manufacture </div>
<div>ruling</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>case</div>
</th>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>manufacture</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_AR', window );">Arkansas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_DE', window );">Delaware [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_DC', window );">District of Columbia [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IA', window );">Iowa [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_KS', window );">Kansas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_LA', window );">Louisiana [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MD', window );">Maryland [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MI', window );">Michigan [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MN', window );">Minnesota [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NV', window );">Nevada [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">New Jersey [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">New York [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OH', window );">Ohio [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OK', window );">Oklahoma [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OR', window );">Oregon [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_PA', window );">Pennsylvania [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">Puerto Rico [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_SC', window );">South Carolina [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_WI', window );">Wisconsin [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member] | Canadian Tobacco Manufacturers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyVerdictsUpheld', window );">Number of verdicts upheld | ruling</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AmountAwardedtoOtherParty', window );">Amount awarded to other party | $</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Canada [Member] | Philip Morris USA and Altria Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | British Columbia and Saskatchewan [Member] | Philip Morris USA and Altria Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AmountAwardedtoOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount Awarded to Other Party</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AmountAwardedtoOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassNotCertifiedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Not Certified, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassNotCertifiedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictsUpheld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdicts Upheld</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictsUpheld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_DC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_DC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_KS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_KS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_LA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_LA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NV">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NV</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_PA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_PA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_SC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_SC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201447903000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Health Care Cost Recovery Litigation) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 1998 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Oct. 28, 2019 </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Oct. 22, 2018 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigation', window );">Number of states with settled litigation | state</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementAnnualPaymentAmount', window );">State settlement agreements annual payments</a></td>
<td class="nump">$ 9,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementAnnualLegalFeesPayableMaximum', window );">State settlement agreements attorney fees annual cap</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="nump">$ 3,300,000,000<span></span>
</td>
<td class="nump">$ 3,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember', window );">Threatened Litigation [Member] | Canada [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember', window );">Canadian Tobacco Manufacturers [Member] | Canada [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAnnualLegalFeesPayableMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Annual Legal Fees Payable, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAnnualLegalFeesPayableMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAnnualPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Annual Payment Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAnnualPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStateswithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStateswithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201443438888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">25 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2017 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2013 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Nov. 30, 1998 </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>state </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>settlement_development</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($) </div>
<div>settlement_development</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigation', window );">Number of states with settled litigation | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyReductionToCostOfSales', window );">Loss contingency, reduction to cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Loss contingency, credits to offset payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencySettlementAgreementPaymentPeriod', window );">Loss contingency, settlement agreement, payment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne', window );">Loss contingency, number of states with settled litigation including New York, subsequent expansion | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencySettlementAgreementsNumber', window );">Settlement agreements, number | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigation', window );">Number of states with settled litigation | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne', window );">Loss contingency, number of states with settled litigation including New York, subsequent expansion | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyProceedsfromLegalSettlements', window );">&#8203;Proceeds from legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofSettlementDevelopments', window );">Loss contingency, number of settlement developments | settlement_development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004-2017 [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation', window );">Loss contingency, number of additional states added | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Payments received from litigation settlement</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation', window );">Loss contingency, number of additional states extended with settled litigation | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigation', window );">Number of states with settled litigation | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStates', window );">Loss contingency, number of states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStatesWithoutDefense', window );">Number of states without defense | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfDisputesOutstanding', window );">Loss contingency, number of disputes outstanding | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyReductionToCostOfSales', window );">Loss contingency, reduction to cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 And Subsequent NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Loss contingency, credits to offset payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">New York [Member] | PM USA [Member] | Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyProceedsfromLegalSettlements', window );">&#8203;Proceeds from legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mo_MarylandMissouriNewMexicoandPennsylvaniaMember', window );">Maryland, Missouri, New Mexico and Pennsylvania [Member] | PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStatesRemaining', window );">Loss contingency, number of states remaining | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementEstimateofPossibleGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Estimate of Possible Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementEstimateofPossibleGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfDisputesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Disputes Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfDisputesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional States Extended with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofAdditionalStateswithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional States with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofAdditionalStateswithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofSettlementDevelopments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Settlement Developments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofSettlementDevelopments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStatesRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States Remaining</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStatesRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStatesWithoutDefense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States Without Defense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStatesWithoutDefense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStateswithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStateswithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States with Settled Litigation, Settlement One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyProceedsfromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, &#8203;Proceeds from Legal Settlements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyProceedsfromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyReductionToCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Reduction To Cost Of Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyReductionToCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencySettlementAgreementPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencySettlementAgreementPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencySettlementAgreementsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreements, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencySettlementAgreementsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20042017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20042017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mo_MarylandMissouriNewMexicoandPennsylvaniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mo_MarylandMissouriNewMexicoandPennsylvaniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449197384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Other Disputes Under the State Settlement Agreements) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Other Disputes Under the State Settlement Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount ordered to be paid from other party</a></td>
<td class="nump">$ 9.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_OtherDisputesUndertheStateSettlementAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_OtherDisputesUndertheStateSettlementAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201375161912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Federal Government's Lawsuit) (Details) - Federal Governments Lawsuit [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2006</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_FederalTradeCommissionDisclosurePeriod', window );">Disclosure period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember', window );">Implementation of Corrective Communications [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember', window );">Implementation of Corrective Communications [Member] | Altria Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_FederalTradeCommissionDisclosurePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal Trade Commission, Disclosure Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_FederalTradeCommissionDisclosurePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_AltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_AltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449166104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (E-vapor Product Litigation) (Details) - E-vapor Litigation [Member] - claim<br></strong></div></th>
<th class="th"><div>Oct. 27, 2020</div></th>
<th class="th"><div>Oct. 28, 2019</div></th>
<th class="th"><div>Oct. 22, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">1,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofCasesSetforTrial', window );">Number of cases set for trial</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember', window );">Class Action Lawsuit [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember', window );">Pending Individual Lawsuits [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">1,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember', window );">Pending Lawsuits Filed By State Or Local Governments [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember', window );">Pending Lawsuit Filed By School District [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofCasesSetforTrial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases Set for Trial</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofCasesSetforTrial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201466713384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Lights/Ultra Lights Cases) (Details) - Subsequent Event [Member]<br></strong></div></th>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>court </div>
<div>claim </div>
<div>case</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsNotCertifiedNumber', window );">Claims not certified, number | case</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lights [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyStateCourtsNumber', window );">Number of state courts | court</a></td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lights Ultra Lights Class Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsNotCertifiedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Not Certified, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsNotCertifiedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyStateCourtsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, State Courts, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyStateCourtsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_LightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_LightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_LightsUltraLightsClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_LightsUltraLightsClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201464048536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (UST Litigations Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember', window );">Pending Individual Lawsuits [Member] | Subsequent Event [Member] | UST Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Claims filed, number</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_USTLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_USTLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201449241624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Oct. 27, 2020 </div>
<div>lawsuit</div>
</th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits', window );">Loss contingency, number of shareholders filing class action lawsuits | shareholder</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Equity securities, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassActionLawsuit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action Lawsuit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassActionLawsuit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140201447845288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Guarantees and Other Similar Matters Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Contingent liability related to performance surety bonds</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">39,000,000<span></span>
</td>
<td class="nump">$ 38,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line available under the agreement</a></td>
<td class="nump">49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line available under the agreement</a></td>
<td class="nump">$ 3,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>92
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MZG/V:L>H>?5%^%X9H])J<R9%)'5Y 9R?*.C*]4YY@^U_*CC]'U!+ P04
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MR%70^4S1FFJ"5 ;JW%V12XUTX;IE2D,73 F@[RNM<6N4#IHQ/OH#4$L#!!0
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MB?_7^:(?(.T&#S/G,<0M4B3>(1#4SG1T,08\.AQU1HG8C/1.R=.W(O42V8T
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MG%3RX)1+\NX^;.5A"#2 60TP\,Q -//U.=T#@!>;C-;QUE:Y+&* [CY].]W
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M\K,B%)SG!W"_<"X.%VQ@_#1[\U]02P,$%     @ 5%1>4=Z)#\$:"   ^A4
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M&/?^0BS>O%;S,1TF]"S)$_2G!AJ=NH\T4)\-9DEK::52K*4YB@N;"O@$E9N
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MN_&NG94[1MJJZ[J+10Y=FOX/Z-5,3+\OEAGJVTSQ=[0;L&8,3O*-]N/IV->
MG45?KU;H:L5?(E=SWV(CW[06/@W?4W<K7\_6#9<ON?M-(NXDUTN:>CY]<O5
M((/_I;$;_K*VA6T:6_"/:TW1=84!]/>E)55QOV"#\.U]+_\74$L#!!0    (
M %147E&$.)9ZZPP  !@I   9    >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM
M;,5:67/;.!+^*RBOO257R;)$R;*<J\IQDCDJ,YN*,S,/6_L D9"$#4EP -*.
MY]?OUPV0(G79R<SN/MCB 32Z/_0-OK@W]K-;*56*+UF:NY='J[(LGIV?NWBE
M,ND&IE YWBR,S62)6[L\=X55,N%)67H>#8?3\TSJ_.C5"W[VP;YZ8:HRU;GZ
M8(6KLDS:A]<J-?<OCT9']8./>KDJZ<'YJQ>%7*I;5?Y2?+"X.V^H)#I3N=,F
M%U8M7AY=CYZ]GM!X'O"K5O>N=2U(DKDQG^GFA^3ET9 84JF*2Z(@\7.G;E2:
M$B&P\7N@>=0L21/;US7U=RP[9)E+IVY,^IM.RM7+H]F12-1"5FGYT=Q_KX(\
M%T0O-JGC_^+>CYUB<%RYTF1A,CC(=.Y_Y9> 0VO";+AG0A0F1,RW7XBY?"-+
M^>J%-??"TFA0HPL6E6>#.9W3IMR6%F\UYI6OWNE<YK&6J?@A=Z6M@'?I7IR7
M($T#SN- YK4G$^TA<R5^,GFY<N)MGJBD._\<+#5\135?KZ.#!&]5,1#C85]$
MPVAX@-ZXD7/,],9[Z+U15M])TH"VH$+FB?A>)4N=+\4U*8@NM7+BC79Q:EQE
ME?CG]1S#H3S_.L#%I.%BPEQ,_BS:WT#FF;A.2ZNEP(VR3NB\--#/1NQ%,TFW
M ,"8##(O9:E$N5*B,"6>\ZBL@-3"+$2L; GSAMK9SW 35KO/K@\J<5HE!!Q<
M Y0_A[I:J_+X0:@O\4KF2R4LD:7Q@YJYR@'>.VFUJ;#X0X$[K/ 8FQNKW4N;
MB!@*1_N"EZ8@"_>[Z>YEX9KE$H,%<E-Z4#PFQHJ529/'L<%* DOPJKATA8JK
MU$\H*EL8B%(O]/>_S:+1Y7-"_4ZYDN;C4ER__J$O[E<8*195SGX(:S0X:<>8
MOZVLZ0,TIEAS#D8/X I(!7P:S8ZEM0_$XIU,*T5HZK+-QT!\PA[+'"X6X[$D
M3>XW "F');!-KMGF>MEFM1;2ZVV(K7'NK&&-8%\/Y)W8VBC1@[=B=WRGTH>^
M(-"BX?,M,9L)/&#T_+3/] @F\)L;N$$PG(@J=]@1BZO4Y,LS;'!&>PU1>OM(
MMZ<G:E[6*P@)-5%E>_M6< M>.Q_;8BA!*>"P2I7-H62UUV*FWZ@X/!W1T]%5
M@_Q*)ML[O,;J7I<K(9=+J]@V(9=7'IF9BI03?!V/^I-A!/M-4PYP6.XXZD>3
M:?VHC[!)6NL!W\/F888V 0M\Y2W6%E+;H'S$PK8^'E_TQ]-9E\])_VHZ/,#G
M5^+V%[$YO+C<9/-R,MK+9E<OH!0Z8TL",;+,]8JN-LL#&RX1;!)%2@QO#^5V
M-7.2TY?,)"H-:D$FJQ<ZEJR"145^?"5+)D&9F4X?A+R3.I7S5)&2%M4\U7%P
MX.0P+>3/Q5QY)XCE%M9DPLR=LG<\*?AZ\)8[R8[+>2N$8,B;( :O%J?2.; "
M"ECFO0(P(MJ67ZRTLM+&*T(-T";_KH(%D8^-8<+:QQ5>(C=YH2PGG'D<G)UV
MP??XE7; NQ_:O3NU@]&P3Z4I86MKM\(Z!1XH 4S(\VY#I7.?(M-F=5"5Y'9M
M<E9(6SZ(PNJ8=M:9RL9>%4'W&W#\A#<[M7O;8^V41C[=9XE[N,?C\7@P$_.V
M=8R'@\OZ2=<X^N108X,4@MPS*RW!NL/HHJO!N$LUF@V&NZEZH=_I+PIH D<E
M/EBELH)#,M<3/O+<6),;V I6@XE0!-;QBO5U45E28)$@P:N<\W#_C)@A)@,D
M4[5C)V43;W^O-#;LEF*,3PO[P4@?2U;6ZUD%(@0!POF<;F-C284!_GK'O%@;
MZEQ^@Z2\9*W<M0MYG<KX\]EMC)R'*'.J=%9KH?<J_6"1BCUK6[>#=^FM)=JE
MJ:-#FGK:SAK<BFBP1-Z=5/G6:NWQA35S"5V@C5C EHWU<M]SM<6)V8(R)V@(
MI0%Z ;)WAI(TGI(2>WX&>9&S!4"D)! NS)6<G3XJV_B@;&N'P$.0WIA[X@IT
MJJS.2LMGNRQMV\J>-.BP3@1]^"WHP^T:;M$;G8J;X^E@>H6?J\'5Y<;=VS:*
MHA>=BM%@-!,/2@+ST6!Z&2ZCP60<+L?K <WL%OJ]\:F8#0?3V8F8@<#H9./N
MX^XM$;W):>_B5 P'T? $*U]B**XOZ'IZ=;)>*D&YAL"?B >MD,_WIJ><4HZB
MYR>'+@B(U^UMHU*/C<$[<@\7&4) $WXLPU#4XG&3=7\R> >CON6';^M4.;Q-
M2 R=)PC18'3 :':6]/J+C91W4"5,[.CPT^R_YW,<8$8K^U!3P&"^L/DC!2#0
M>'O(^US4-^Z Y^_,F*Z';ZGA:9T+B)_($,2,B8Q)#&U##&P%V*Z;&K!F-'A(
M =L'-8Q%>0(3!VKI#BL.M*H<#CCE***\AW;>0S\P3X4"FQQY<DWU&92I"SWJ
MVI0LW"N-SQ;*3L*$@3>HEQ*-%.D3\BE7V0?QAT+U$9NJP%L-ZU9/VH!1=$)0
M#@?CZ<D!W*'84QX(;9^<[$&\UAE?EZXHFE#7C8'X:NT!,!?_-6!JW=C)UI8N
M3%M\^)?K1&W+U OYP$$VQ,S&X9;,(,"G<8XV!:$6H3G57AO#XG.UU#E#1CR"
M(%W.9<J)YC=&W7:\_^H(\DSTJ+/BLQU'2'A>=JF .(;6C(FGLU)^$3!.D@1Z
M"/_E%":3S*@,_O"K4SV['@-=ZU#?H8G'8C0<-5TD*M2Y/^23%I9@244_!3<5
MD "\')WUT_HXV%#8:EFGA$32R8PZ#!5% )\ADQY1KFA@Z#GI!:Z<277"24V]
M6=SR=#M3IXWL]U&FV =YT1#.VY5&'2">P@KLDXHB%Y32/1/OB*U?FYS<H]9]
M^+Z%7[TYM]R,OPF:%'O]?5)N\.<IK-ND;MT:2DBJ5>B2ZG;'L:N[[_87M__@
MK#OXE%J!H,[XFTS#6QG'ME)=G<(04OO+QVD'FB'*-[_^99OD:"JB$>(WE40-
M!\?BX@+_HED' 6H</@&%C21\HXSH!BDOU(Q6C,:31WS-HY1&%P()7"T+6:]W
M$?Y)TA*%WD[H[>2J)6RP=6_AO,8!RW,E?H+%+-:>1>;8#,Y^W)[*_-M*&2>6
MB&Z.>A7>OZWCPYE5*;.TVYX#%P7$-UXJ[Z#9E .G)@:( U(K?@Q15 A;E(]F
M_C!#T6'&OIC=:4JU/&\1W'.5(T*F_(@%.:_=--6T&.2HSTZ1J\757X=?O^N)
M@I@_DYCMDYH-X>IQGQB% P,9!?88ZZL-9W"0X6.D'TC,\#,9#ODWNN"?T6QV
MNJD*O=$$#WNSJRG]Q_#>A!X<AZ!&L_H1O:2KH:<S'>/^.DFT;YM21P+L_2CS
M2EJ?*+Y3<\LWG8WD<P*.GT\Y/:GWR]@LM* VCR:\YG%H@'\J4Q^:?=+L%\8Z
MW&K>:E+1>0"=0&' S?4;^OGE]LUCARV9N5/-D8E@.R'GC\F<>X'.,0JXIN%2
M5& $R5>KZ&GE:*WNWV:_:5<_.D"QT?1GV8GSXU&K?]3;9.6TSN@VYR<Z84?\
M>P5K6CPPCQXP! Q:&T;T?-V6[#>;HJWC699.?L">A[LVS]JG+#QOXZ;+V[7.
MQRUSC\1-JP<S::VO\5X;FO"8/VZ[XX&X6>=2%"*P\QOD'NM!FXQ:2+%O31*I
M7(:][C*LRXH;',UAFPY*Z]M=ZY/$ '52L2[GU'YJM7?G#P2CZR2!>GVR%HZN
MG(],K4XQYK&Q^G!,"M[J5?O\LDLQM"'7IS=+*Q/5T)2TWS";5-.!:'#,7KM#
MD\F;8W,,$0@J&:^Z"2P!APBBJ90-=-;(T6;JNB39FNN-H$MM2=Z358,VBD[H
MN,QQ+"?W_4.7L75T2(4A#T6E=EAB:GOZ8NV.1FRJ7GLHM#]%'3ZG+SFVJ/8W
MT?XJQ:/3B&TI@'@IZ,P0BFYE.A _F]8M=Z5A9HI;[? *-!Q7M7EU'?B>HN4K
MNN!87K6SN^;# =JRVJVHQ8+KINTR9,_Q(GV8$E=9Y7DV/D\V&>BMZ-,7<![,
MIRZJORX[VRI*OB.MZ+T'S5/QL5,O7K?X\&GS38>/]YZ/_00(GK=-P?D^%*74
M;ON_+/H_27J>D CMUWK*8#B1N:3B>TRU2#3E[(63F8M+*A4X==^FLG7BV8M&
M2'U&T]E6#80T"?2BX7#K35TY]*+)^)1+DEF7D>B2$ZRHS0IA^W%M8W4"@#S$
M%\W<"/-V@!W,%6)?21&%?,VG0\EN*Z+N#5!Y<_RW?9:T<^X63B$,;7#!'Q>$
M%*N;4371?*US3[38EB/BKP2^\_5,_JB0B&_L;@E(HFQR]42$=W';--<)/,\N
M T'--?B1?O!,W^!<FL,/.FC/#/S^'S[=Y#8H8MM@US=3YZVOU3)EE_Q-GO/A
MPW^XUCQM/ON[]E^[K8?[;P:11R\)TU0M,'4XN+PX0G+ W^'YF](4_.W;W)2E
MR?ARI1"M+ W ^X5!EA)N:('F8\A7_P%02P,$%     @ 5%1>4<0_< [L!
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M]ANNA/7%RPIFK]D#:E+).K]I(3J4N#<>CEU['C_;HS&L1$65IK3SQ >E%4_
MC:E\+701O*;+E$"M2N]I![@U$(.[#7%RT;).L6A7XW)/6CPF!QY_>EIA2[0*
MU#LOS8;(5M+6^M7,-NI_68O>LWO]Z[AA>L>E 8%;"HW.SH<!Z%J.ZX%5I9?
MC;(DJ-[,Z0^&VCG0^E8I>QRX!,T_<?$#4$L#!!0    ( %147E'@ZCQ#TP4
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ML4)CI'IRC1O/3CL'33X*'=Z'\(6-O3M6O&Q4 $E%QRW:PV#B]9O4'H49^VE
MF[I68N5/:HAL $C T0H,8Y2/*5&;D5E FI]$D'L-Q+!*U2F@UEL9 \+R;?]%
M?.%0YSV^WO/X8^/Q]5.OKKQ7IZB7FFC2ORY-5<C9 K&XRXE!V\-T"-GN!-%[
MZ8-4?^_['D[$*_\5DX@ G!P^];5OVP^EE^'[X&YY^,IZ@WK&,($D+"$ZZ$U&
M'6;"E\OPX/3&?RU<:.=TZ6]1#+DPM #_7VJ$H'Z@#=K/QQ?_ 5!+ P04
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M<G>]B]3"5&-#7:OPTUK80+&K4AJHYW/E?$P.?&42HC'#1U)*;)FEX+KO):B
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M&]?5NOA,:T2$ZSAK<Y!BMZ[OG,7H&TLV\2RD JQ,H]M1VP)I3[A":LH '1=
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M=:#TXE;3(M>F6M#P0%HU;!EH!D0-PH/E2ZZ8V'$PMR$ -I/1"+"YA/& 7ZJ
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M3NC_<!'O6?FTR>14(#P'Y9F0^PG$X$?]#>QOV-CS]MV/REHX-FH4SBSU3D]
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MKFZW$TRTXF?G "8L6.C/!!B).?!'G<^\5Q>SB3E4S3L=)U<]\>\H)N,T_PP
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MM['Q5O_=$)%-CD]ZZ/1!*4"2-H7C2YZI<U%RCLRP@.7A@8DI+0C#8]@69'/
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M-3SJ(T6?7-8( 7&E< @%=6L0 @&/G+^)'#Q51P+Z8W"5U=9[P3@,)T1A7)<
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M2:\N;?&SSL/R[=[+/9&KN:R+<&M7?U5)G^>T7V8+S_^+57IVO">RV@=;IL5
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MSA UT1.H1M#.$1!_F#T S/2_!DS%C:-F'7 A:-A13%*HSGZP6P5UJ&=\0YW
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MJM%5-@E MX.WW5C5^&&W599&IV=+^E>A=@)TOU/*]AMG8/C[K?X#4$L#!!0
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MZ,"THHEOOI2XX20*!DT\=@WF#?6A[TP?P)RC+SG6G[1@2N7+/&6FG.",.!Q
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M\& "<NE^A^M?K%KYO6FF++8P?T7=:]9. +_/E;*[%V=@OTA/_P%02P,$%
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M[6@PA&5-DQB--Z#[2FNWVWB"<;8OW@!02P,$%     @ 5%1>4?OA(BDM#@
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M4'80:A\4."PKE94(+@WF_9+\ME>17H>G*350O08H!_:PU\E5L&_$$@GS!K6
M/DB$S?G2N1'0F\ZI/!%5 I$2$!F)H4P]0E:Y;>6.4[X$$WQ* K+\J^]B$?@#
M=4$GT5Z1MP!F837\]Y:.]"TS[YL>K=,&E/J8=XT1(_)$N&HU)+(M;^G%5#:F
MO[ 'I:#%C@RXY535<Y^DMUTP9CN$Y$[\U;;KCS:]%9,_C'L4CA8^+5"W_="\
M&I=(%7(+_J]"RR\T3FHC"+$%L-]N .Y@:X^7FN5P'3*R[6C8NS\=G 8=\:@=
MALY+.<M1/%Z("0P1:[TS#!&%ZAXENT)"##D5;/NP#BR#&K(Z/1PLW7A?NQ.?
M*H\>ERA>YTBFW_.\)B-0<%XN,;=Y]$'CQ,IZ':5US4LP(@WD^?#IUV3<I:(
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M TW \ZE&< \_Z(#JG=V7_P=02P,$%     @ 5%1>45%X"Q\0!0  FPT  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL[5=;;]LV%/XKA 9L+9#ZEJ1)
ML\2 D[9;,+0+<MDP#'N@J6.+*$6J)!7;_WX?24F6C2;+PX"][,46R7/YSCG?
M.:+.5\9^<0619^M2:7>1%=Y79\.A$P65W U,11HG"V-+[K&TRZ&K+/$\*I5J
M.!F-W@Y++G4V/8][-W9Z;FJOI*8;RUQ=EMQN+DF9U44VSMJ-6[DL?-@83L\K
MOJ0[\@_5C<5JV%G)94G:2:.9I<5%-AN?71X%^2CPFZ25ZSVS$,G<F"]A<9U?
M9*, B!0)'RQP_#W2%2D5# '&U\9FUKD,BOWGUOK'&#MBF7-'5T;]+G-?7&2G
M&<MIP6OE;\WJ9VKB.0[VA%$N_K)5DCTYRIBHG3=EHPP$I=3IGZ^;//043D=/
M*$P:A4G$G1Q%E.^YY]-S:U;,!FE8"P\QU*@-<%*'HMQYBU,)/3_]C+S-A#"U
M]E(OV4^US+D6Q#X;S_X )V:YJ3SE[-4]GRMRK\^''EZ#[E T'BZ3A\D3'MZQ
M3T;[PK$/.J=\5W\(M!WD20OY<O*LP3NJ!NQP=, FH\GH&7N'70H.H[W#)^SU
MPK_S7.?<YHX]5#GWQ+!D5P772V)2]Q-U8Z46LE+$_IS-G;=@UU_/8#GJL!Q%
M+$=/8+DE0=J_I"+?*L2SMD-[G[F*"[K(T+^.["-ET_N"V,(H]&9PYD.1667-
MH\S),0Y^.V%E%1O(+)ATK@89^!;>LH7'JTI)$?6].6#SVC,-Q!L@Y@V'YIL#
M-E/>2G[6R_3[GHL/BP7%-F7O0_8Q<]A-/8==D,=+OVD$&$0_2@V_DJM@RA/F
MA'=L=O< 5HS?O1E/V)TL@6BQB7$AREY.@]UK+4Q)[)ZO$>BK>U/!R<G1Z#4+
M&>FBLE2:1P@(LAX3CM%:4(3JHA&I<>BC[P,L0(.*K#3($#(J>!(,',(9#DHF
MN!*U2@<'\83GR$'GSQNXS&L\ 1W8M0Y!2]W/>/(;P?L ?K"+6#I&71:#[$(Z
M>$4AN&U<MF 25H>)XPOX\(5QM"<^IZ74.KCE"RBA6(+*.1[&QZG_!NP#MVK3
MEC]6$1!@NI0>10]I$:K.HXG @RB @/1F#\>@X<8/;BL(R@&:VXDNL(K6%2($
MI9"O@B-0CID8C $YRLX31208(9!HHV1HYARQM9QQ'6<&#6DFHS>C,;M2W/8X
M<QT0<I'J.">_(M(L<>5P,C[H'@]38M/R='R\6Y*NGT2TWJ8I!D<I"\E'V+(U
MQFPL''VM0_4=B=I*+PGE"/+-=DFH5QXTMMQ(**"[0F>%T.-<2@RL:BL*O+Z8
M:?@+=RVK_::"3YC:^OJ?5?\:J][NCYXK@[%AO0RS\EKCY5&GZ15?-EW18CCM
MW/O^N]/)^.1'YMBO*VPF"NQ4R*5QA])%ENP-C+;26ZRRYSB4BH$=P3'"=5Z*
M2 <E^5RJR(<(+E&OGWS1"T7NA2+V0J$82A,)[".09'# ?J%-ZA*7J)DZ8UN?
MZ(_2:&Q[4]>1,CL-P$J3DP+#W-[P!^\"WR*%F$.DM#.*4W3K"G^M1@[&*N-J
MO"GA5_&&%T\$_)^VR[AKEZX5=GHEO8M##I2$EL=]9L?#/_=CO^0O!MZV7D 3
M!>(D%.1B@>F1JYK[-MUM?^VWYDL;+N:TK5.O=@/VK5O9L'=A+LDNXV=!\ (:
MI;MSM]M]><S2A7LKGCY;/G&+Y#FF: '5T>#D.&,V?0JDA3=5O'[/C<=E/CX6
M^'HB&P1POC#&MXO@H/L>F_X-4$L#!!0    ( %147E$%($#'\P4  /H=   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;+U96V^C.!3^*U:T*W6D;((-
MN55II.;2V[3=:+K=?1CM@TO<!!5LQC;)='_]FDN )& 8*K526PSG.Q<?'W\'
M/-XQ_B8VA$CPTW.IN&AMI/3/NUUA;XB'18?YA*HGKXQ[6*HA7W>%SPE>12#/
M[2+#Z'<][-#69!S=6_+)F 72=2A9<B "S\/\?4I<MKMHP=;^QC=GO9'AC>YD
M[.,U>2+RV5]R->JF6E:.1ZAP& 6<O%ZT+N'YTC1"0"3QMT-V(G<-PE!>&'L+
M![>KBY81>D1<8LM0!5;_MF1&7#?4I/SXD2AMI39#8/YZK_TJ"EX%\X(%F3'W
M'V<E-Q>M80NLR"L.7/F-[6Y($E OU&<S5T1_P2Z6'2B+=B D\Q*P&GL.C?_C
MG\E$Y !*3S$ )0!4%V F /,88)4 K 1@U07T$D"OKDO]!-"O:V&0  ;'@'X)
M8)@ AG4MC!+ J"X &OO,&;4A:;)/LCTH@^S3#4_R76IEGW!8.^-PGW)XDO-2
MQ_9)AR=9+X7LTPZCO'?C(HDJ;(XEGHPYVP$>RBM]X454IA%>%99#PQWE27+U
MU%$X.9EB^VW-64!7 *O?*1:. .P5+#D1A$H<E?W9(^8<AZ7_!9S-B<2.*[Z
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MEIGY0$)I >;^3@C]M+$&FD^NQ4]02P,$%     @ 5%1>4<2@E*.Y @  $P<
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MMDUE1_=L8N3:GWZGTMBSM!^N[$L,E NPZPLIS?/$':B+#ZCA;U!+ P04
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M/K(<YLJ-%KD;;U9"FV')+1,S (.T N;[6@B]WU@#]4@]_0502P,$%     @
M5%1>4?I9_>XX!0  8AL  !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL
MQ5EM;^(X$/XK%MJ36JE7$O.^HDC;EFVIMJ=JJ]Y]6-T'DPS$UR1.;:<LTO[X
MLX-)H"3>P)8[/D!"YAG/XYEQGCC#!>//(@"0Z'L4QN*B$4B9?&PVA1= 1,0Y
M2R!65V:,1T2J4SYOBH0#\3-0%#:QXW2;$:%Q8S3,_GO@HR%+94AC>.!(I%%$
M^/(20K:X:+B-]1]?Z3R0^H_F:)B0.3R"?$H>N#IKYEY\&D$L*(L1A]E%XY/[
M\0ZW-2"S^)/"0FP<(TUERMBS/IGX%PU'1P0A>%*[(.KG%:X@#+4G%<>+<=K(
MQ]3 S>.U]\\9>45F2@1<L? OZLO@HM%O(!]F) WE5[:X!4.HH_UY+!39-UH8
M6Z>!O%1(%AFPBB"B\>J7?#<3L0' @PH -@#\%N!6 %H&T*H[0ML VG5'Z!A
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M-Y;C!+GM0Q?;(D52Y/.0]O6&BY_1BE*)GGPOB&X:*RG#UZU6-%]1GT1-'M(
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M70#+/)FN4!B+^0IZ!!0*-J=EL)>J5MR1'Q%NMHO'.$X7=7>/$<XZ_5=<>G=
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M J>A?&2;&U($U--\/@M%]@DVA:W= 7XJ)(L*L/(@HG'^C7\7#Z(&0/   !4
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M>J16Z3USFS,W*$,:_,O*O1[L.>[ 9H^&I4?#5H]R3TP* MK5"F ?N21@;;V
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MYOY<"/U^DKXS*-X13?\'4$L#!!0    ( %147E'"_)D3[@(  &@&   9
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;(U5WV_:,!#^5T[1'JC4-B$4ME6
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M^ZJA;0_3'DRX@+7$9K:!5MH?_]DAC5,2?DVPO10G.??Z^)[KT\3=M9 _U1Q
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MC]Y?Q/DZ:5Y40^?#)#J/AE%%GG9E:U4Q)&SLD- 9.#E@X.P!)J\7DL6 [B5
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M.;3"1>?ZB[[HHY^QW%&N$"-;6"IXZ(.KLNA-BX$6!]M\K86&5LZ^[J&=)](
MX/M6"'T:F 6J/PB3GU!+ P04    " !45%Y1T3;!-\ '   S,0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970U-"YX;6R]FUUOVS84AO\*8>PB!>I:_)!L!TF
M1-:P @L6-.MV4>Q"L>E8JSXR24[:?S]*5DSK\(A2FS@WC2R_?,ESQ(]'-'OV
ME.5?BXV4)?F6Q&EQ/MJ4Y</I9%(L-S()BP_9@TS5-^LL3\)2?<SO)\5#+L-5
M72B))\QQO$D21NGHXJR^=Y-?G&7;,HY2>9.38ILD8?[]2L;9T_F(CIYO?(KN
M-V5U8W)Q]A#>RUM9?GZXR=6GR=YE%24R+:(L);E<GX\NZ6G@.E6!6O%7))^*
M@VM2A7*795^K#Q]7YR.G:I&,Y;*L+$+UYU'Z,HXK)]6._QK3T;[.JN#A];/[
MKW7P*IB[L)!^%O\=K<K-^6@V(BNY#K=Q^2E[^DTV ;F5WS*+B_I?\M1HG1%9
M;HLR2YK"J@5)E.[^AM^:1!P44#YX =848+" Z"C FP)\: VB*2"&UN V!>K0
M)[O8Z\0MPC*\.,NS)Y)7:N567=39KTNK?$5IU5%NRUQ]&ZERY<4?Y4;FQ,\2
MU<TVU?-_E"0(\S1*[XO)[UE1R(*<^)LPO5<74:J^6VYJ>9;*M"39FEPNE]MD
M&X>E7!',;6?RCIPL9!E&L;H:D\^W"W+RRSOR2V5Y'<6QZC/%V:14 57-FBR;
MQE_M&L\Z&L_)=9:6FX($Z4JND/(+>_FYI?Q$)7*?3?:<S2MF-;R5#Q\(=]X3
MYC ':8\_N#B=8^&\K/;@IVMO)8/ONQ:O_7B'7U_'^)@NLT22+Y^R."9JU#^%
M^>H?2[UB7Z^HZQ4=]5[)^RBM.K":0>(P74JL8^TLO-JBFDP?+]SIS#N;/!X^
M+5-$A?" :F&J/%XE\% 48%;3F5:U(G7WD;K62'=97;:R*IO!2T[BW<![3U)9
M#U0U?<H\5P\CVB6^#+])=-#M*G4/VCJ>@LR8$B8$R MB,Z? *#!%5+AX5KQ]
M5CQK5M1@[GGXGE$I9YR!$$T1=3P.VK\88A7T6;7"G.[#G%K#'#;ODB_7,KF3
MN6U@S?8USMYT0,_W]<Y?/J#G9F_CTRGHDSZB8IZ (QI3S3S@%6 J5W0\5>KH
M!=EY^: F=U)!HE2HMHS#HHC6T3(L.Q=1QVPI91RD!E&QF0LR@UIQ!W9X1$:I
MUY&9 U2AULPLADY@C<]A]8+"<$W-V#/"-45L"J=VS(G-.H)E.EAVQ&[PXY-^
MTYQ6%#,X)R(B5J%&.VF($W5@?PL0V:PK:QHY*+=/BDFV3<OB("$J]#*KLV%D
M#TT#-UHUG\,LF!I.81),#14.3($IFG:E0-,/M>//\%$BD'X+)TQ,!-= 3,/A
M;(G61CN"U0!$[03T0\_[)P:%B2=3%V8(8R&8(01S' ]FR!2Y7:N)9B%JAZ$C
M(2(UD<9@1$1C0B)F9%(BHNK$1*H!BMH)JA\4&P- %3-C+4%D3,!5<3',+>AU
M:X>KZ8W.>C JE>NH)#<JW$%<2#6@T?F;DB'3M,3LM#2(#1E"+8RZ8#KV<1F%
MZQLNFT,&PF5>Q_S.- 4Q.P6]/A\R!&",:0X1&8D9X!-8?=HIT:S$[*PT>,EC
M)G/ -W4?T1B!]ML$5IMVG)INF)UNWIH)F<DG8Q=NDB B(U\#? *K3SMAFH68
MG85>C(/,I!;7&!FFAL,7"41#*9SX41'OR(%&)&9'I.&# ]FPH9 ',=$<!HMH
M#EZ(FF Q4<=^&-.XP^RX<V0>9":'&"^6B(;!#09$,X/O1YA&=.1'(P^S(\^1
M<) AR$*-<6**S,0@&@B#B*8S,1J.F!V.^EFP,8#KN1$E)G-FD'N'N06];NUP
M-; Q^Y;:Y=7'(03(-8=QYTT)D&L>XG8>&D2 '$$3ZL%7,!^3N0)R/*;RYG#\
M8BH^[7AR7+,./^:^$)H;9+]F"F<U1,3F<)W'G"@SUCE$1IT.+N8'OS;9X6CP
M.L=-T&!PHPO1C#VX[X$9>7"/!W/JVAWD&FRX'6S>F@0YLGLC(#DC(@:W_1:8
MT]PUNHBIFG70(-<DQ%]QLPC-@LDL<$/#1S1C./DC&@;?'S ?WK'EP34?<3L?
M#1\DR+X,?!/V$9$Q5R(^D/P13=< T:##>WX=.RX(<I-!X(ZGCVC&1GH0WC$6
M$LRG8V.0:^#A=N Y$@ER!%@,$D1$C,$==,QI;KQ&("JWXY6):SKB=CKJAT&.
M_/A'/1B#C\FX&>D@LZ#/K'U80I.;L.^@^5OU8-/E=_)G'J9%7*\0Y'+U[[8H
M$UD-H3!]1KH!Q"@TMPGZIL0H-$().T(-.R""L0SH?3XB,DZ'(. $GRQ65\=4
M+S0/B6-N%J$I07@'_HJ,:,9P,P334+@H(**.14$<' QZI9_&A(D?<.U#)'!R
M[W<)K))VE!ISA!USWIH-!4(S1K? : :F"]M_,KJ%*>KJ%AJ*Q"MN&J$9, '&
MZ"Z]DD6_)+!*VM%K4A)V4AH^*$P.,:+LE2SZ)8%5THY2XXZPX\Z1>5"8&&+D
MIE>RZ)<$5DD[-QIWA!UWCH2"PN05<U[ F 9F!<4CF!=3U#$ON)J,7#L9]6-@
M8] Z1@HB1"0PP'Z7P.JR"V]R< @\D?E]??J^4(]5]?O=H=W]W?T)_\OZ7#NX
M?T5/?8K<7]#38'=^7]OO_CO!=9@KHBI(+->J*N?#5#V&?'="?_>AS![J(^AW
M65EF27VYD>%*YI5 ?;_.LO+Y0U7!_O])7/P/4$L#!!0    ( %147E%[+*(/
M4 0  &\3   9    >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;,U86X_:.!C]
M*Q;J R.529P0+B- &BZK':FSBV;4[4.U#R;Y &^3F-H&IE)__-I)"."8[.QN
M.^(%$N=\MY/SV8X'>\:_B#6 1"])G(IA8RWEYLYQ1+B&A(A;MH%4/5DRGA"I
M;OG*$1L.),J,DMCQ7+?C)(2FC=$@&YOST8!M94Q3F',DMDE"^+<QQ&P_;.#&
M8>")KM92#SBCP8:LX!GDQ\V<JSNG]!+1!%)!68HX+(>->WPWPWUMD"'^H+ 7
M)]=(E[)@[(N^>8B&#5=G!#&$4KL@ZF\'$XAC[4GE\;5PVBAC:L/3ZX/W7[+B
M53$+(F#"XD\TDNMAH]= $2S)-I9/;/\K% 4%VE_(8I']HGV!=1LHW K)DL)8
M99#0-/\G+P41)P;*C]W *PP\TZ!]P< O#/S71F@7!NW71@@*@ZQT)Z\](VY*
M)!D-.-LCKM'*F[[(V,^L%5\TU4)YEEP]I<I.CGZ7:^!HPA(EL[5^_SM ,\)3
MFJZ$\X$) 0(UGR",B1!T24.B7Z^X0<TI2$)C==5"'Y^GJ/GN!KU#-$6/-(XU
M9.!(E9X.XH1%*N,\%>]"*CYZ9*E<"S1+(X@L]M-Z^WZ-O:-H*;GQ#MR,O5J'
MS["Y1;[['GFNYUKRF;S:'/=MY?R_Z+/_'/V,#+\4BI_Y\R_X,S6 [J._E#S5
MG"&1FH 06Z+[,-PFVYA(B)!-5P]IR!) GS\HU^A!0B+^K$FL72;6SA)K7TCL
M-S6;;H!3%M$0+2"%)95*B#K4>P0O8;R-E)B1 +ZC(:"0"6G39AZDDP71L^MN
MU/('SN[T=5L@7OL<,[5@@MXY9F;!M-T2<T9"4)(0U)+0//3L#8KSIEUREB#X
MNJ7RFV)C!_FKLK9E[CHXR:?=]8S:JYB6[QL$3:L@W^T8Q5L<]3H=>_6=LOI.
M;?5S#BU)7A!)V%;5J!:P@U:5$C,BR(DT62;-\$R:!6F2H53)"0HR43,?O[&Q
MUJD4T@^,8B=5C-=Q#6JG55#+"WP#-;.@ GR!MV[)6[>6MTI/_\M&?H1D ;RN
MB7ME)KWKFEWZ96+]G]=8_6IC&?/%I IIF5-*%>+U#7%8O/B!71O8/>X,W.OK
MJB*GL[8RJIU8,#XV2+-@\,DDF]-F 75[%V@[V5#A6MK&Q1(TCTDJRAY!W]'/
M[S;L'9/TKJO?\'&?@?VW6,^+**?O-@A,(54Q?F *J8K!&)M"LH'\"THZ;FSP
M/^]L=*N\L8B.>PX<7)F(CAL"7+\C^%$BJJZZ'=<44173-I=X"P97)G$;Z.(L
M?ESB<?T:/U<D\+-"G9!#I.AX6U4==P+XRK8"^+@7P/6;@1^EJK[E(\%4E073
M-55EP6#S8\,&\CQ#5<[) 4("?)6=W A5@%KX\T_$<K0\';K/SD2,\3&^FV#+
M^%2?)F4'%D?W^5'4(^$KJA;*&)8JE'O;5?KG^>E.?B/9)CN^6# I69)=KH%$
MP#5 /5\R)@\W.D!YQC;Z&U!+ P04    " !45%Y1+NY0<D8&   5'0  &0
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MXM['!X<[4-@]8E@!Q\@/QZ=DVS3K;PYZ5& T.C=&HP*CT=DP>IR)WDO#D<T
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M\A#]A]Y517FCK9]I2Z&W&ONTU]U^1MZJPI9>84OOX&""/=.OZ/'ANDUX^\6
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M#._4V9[A60+S<_EKCPG>3<QN\*OD_>'N /8<4Q,\!P#F##K!.W.V)WB1P-X
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M5O-?D(=D"+J'0+W0,65JP%<HG[AI1ONDEE.(]A#P%LKQ]GYSZ\4Z<"_T33D
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M* ?C 3J\7AR,M^]@@@8A@2B>G2A&R'^XN.LH(^##&\K"^$ .OQ<+X[>V,#X
MQ;<#Y2IEO)N$/I##'\J^^, -OQ?[XN_;EP8P^H 3WXZ3J[N,I#SOB$9_YW/J
M4!;&!VCXO5@8O[6%\8$EOITE5X(N><?!C@_8\(>R,#X@P^_%POBM+4P ) GL
M)+FF12$?LGO2^>-M .@(AG(Q : CZ,7%!*U=3 !$"5Z9<BEUB1Q]9G%'0 9
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MH,_?<JX>=TP!]?+/X_\ 4$L#!!0    ( %147E'=0_<$$P0  *(/   9
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MM>, \CE:6F4L;955B@$P='3UO,[&X0MUG==/^4Y3^42F?$ ^1TN'BX=TN Z
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M!.O&D=$[,"O0LFJ_XF4WAP- EAX!9#M %G2WA8+*J2 Q&EBS!>NSF<T;H=6
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MQ!; \NP&M"I ZSV@NP?0K@#M]X#.'D"G G1\9$I7?!PFQ)!!3\DU*&=MV=S
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M28^"35W<ZP[JA2^H$XU4GGUS3@\B&+> YJ=:XVO'U>CVB<W^ %!+ P04
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M$#E%*#"UCH+1:X4C%,(QD8[?%6E0QW3 [?:&_<HG3\E,F<&1$C]Y9A>#H!M
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M91?U: ZBB>KE'V9[KE<7[-^:PK]02P,$%     @ 5%1>49>*NQS     $P(
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M[?^4]:?W^T^.GY_UX+KQ)9_-?WJ^_@U02P$"% ,4    " !45%Y1!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( %147E'4@C"@[0   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %147E&97)PC$ 8  )PG   3
M          "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M5%1>42A_>.%-!@  8"   !@              ("!# @  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %147E'9"WS]M@<  +<@   8
M          " @8\.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M    " !45%Y1\ZB@VV8"  #Y!0  &               @(%[%@  >&PO=V]R
M:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 5%1>49J>]/4*!@  X1@
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M965T."YX;6Q02P$"% ,4    " !45%Y1I1F)Q90.  "Y)P  &
M    @('M-P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @
M5%1>48U3_@1?!P  IA4  !D              ("!MT8  'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6Q02P$"% ,4    " !45%Y1WHD/P1H(  #Z%0  &0
M            @(%-3@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4
M Q0    ( %147E&SU-]MHAD  ,E/   9              " @9Y6  !X;"]W
M;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ 5%1>480XEGKK#
M&"D  !D              ("!=W   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6Q02P$"% ,4    " !45%Y1Q#]P#NP$  #*"P  &0              @(&9
M?0  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( %147E%?
MFYSY%P,  !\'   9              " @;R"  !X;"]W;W)K<VAE971S+W-H
M965T,34N>&UL4$L! A0#%     @ 5%1>4>#J/$/3!0  P10  !D
M     ("!"H8  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
M" !45%Y1'X6O0NH(  !*%@  &0              @($4C   >&PO=V]R:W-H
M965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( %147E$#C[ (U @  &P7   9
M              " @365  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L!
M A0#%     @ 5%1>40Y2JWVS!0  I0\  !D              ("!0)X  'AL
M+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !45%Y1.9-@1%@H
M  #$A0  &0              @($JI   >&PO=V]R:W-H965T<R]S:&5E=#(P
M+GAM;%!+ 0(4 Q0    ( %147E&2Y?/_  4  +@-   9              "
M@;G,  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ 5%1>
M44/II7%K#   =20  !D              ("!\-$  'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"% ,4    " !45%Y1_G%*=,8"   9!@  &0
M        @(&2W@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0
M   ( %147E&I]E)O?@0  &D,   9              " @8_A  !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ 5%1>4;5#B!)Y!   ^0H
M !D              ("!1.8  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q0
M2P$"% ,4    " !45%Y1]CUN60D(  "X%P  &0              @('TZ@
M>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( %147E&X?QUD
M+@,   D'   9              " @33S  !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&UL4$L! A0#%     @ 5%1>43$+*>$= P   @<  !D
M ("!F?8  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !4
M5%Y1?'HJ=9H%  !O%   &0              @('M^0  >&PO=V]R:W-H965T
M<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( %147E$><AGWX 0  %0+   9
M          " @;[_  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#
M%     @ 5%1>42<@5H:W @  YP4  !D              ("!U00! 'AL+W=O
M<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !45%Y1^^$B*2T.  "_
M*P  &0              @('#!P$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM
M;%!+ 0(4 Q0    ( %147E%1> L?$ 4  )L-   9              " @2<6
M 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ 5%1>404@
M0,?S!0  ^AT  !D              ("!;AL! 'AL+W=O<FMS:&5E=',O<VAE
M970S-"YX;6Q02P$"% ,4    " !45%Y1 P^G'Q\#  !^"0  &0
M    @(&8(0$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (
M %147E'$H)2CN0(  !,'   9              " @>XD 0!X;"]W;W)K<VAE
M971S+W-H965T,S8N>&UL4$L! A0#%     @ 5%1>440/M<W)!0  \"   !D
M             ("!WB<! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"
M% ,4    " !45%Y1( $0"'\"   =!@  &0              @('>+0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( %147E'%(23-B ,
M #D.   9              " @90P 0!X;"]W;W)K<VAE971S+W-H965T,SDN
M>&UL4$L! A0#%     @ 5%1>4<99$5AQ P  3 T  !D              ("!
M4S0! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !45%Y1
M^$\X^_P"  !G"@  &0              @('[-P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;%!+ 0(4 Q0    ( %147E%&A?URG ,  %X+   9
M      " @2X[ 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%
M  @ 5%1>4?I9_>XX!0  8AL  !D              ("! 3\! 'AL+W=O<FMS
M:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !45%Y1=K DU&$&  "A'@
M&0              @(%P1 $ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+
M 0(4 Q0    ( %147E&8LMD$K@0  +L4   9              " @0A+ 0!X
M;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ 5%1>4:G , :5
M!   +QH  !D              ("![4\! 'AL+W=O<FMS:&5E=',O<VAE970T
M-BYX;6Q02P$"% ,4    " !45%Y1POR9$^X"  !H!@  &0
M@(&Y5 $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( %14
M7E$@D+?#^P,  +<3   9              " @=Y7 0!X;"]W;W)K<VAE971S
M+W-H965T-#@N>&UL4$L! A0#%     @ 5%1>41L'28P0 P  +@H  !D
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M=#4S+GAM;%!+ 0(4 Q0    ( %147E'1-L$WP <  #,Q   9
M  " @;MN 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @
M5%1>47LLH@]0!   ;Q,  !D              ("!LG8! 'AL+W=O<FMS:&5E
M=',O<VAE970U-2YX;6Q02P$"% ,4    " !45%Y1+NY0<D8&   5'0  &0
M            @($Y>P$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4
M Q0    ( %147E'KB-)X,@,  &T+   9              " @;:! 0!X;"]W
M;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ 5%1>490:1! - P
MN0H  !D              ("!'X4! 'AL+W=O<FMS:&5E=',O<VAE970U."YX
M;6Q02P$"% ,4    " !45%Y16,%@"& %  !2&@  &0              @(%C
MB $ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( %147E%"
M$<9@[P,   \.   9              " @?J- 0!X;"]W;W)K<VAE971S+W-H
M965T-C N>&UL4$L! A0#%     @ 5%1>49;%1&+] 0  _ ,  !D
M     ("!()(! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %147E$Y<ZV#5P4  +@;   9              "
M@=6J 0!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ 5%1>
M4:&(]]!3"@  $U(  !D              ("!8[ ! 'AL+W=O<FMS:&5E=',O
M<VAE970V-RYX;6Q02P$"% ,4    " !45%Y19J65*A@"  !9!   &0
M        @('MN@$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0
M   ( %147E'E:T<RN 8   HJ   9              " @3R] 0!X;"]W;W)K
M<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ 5%1>4=U#]P03!   H@\
M !D              ("!*\0! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q0
M2P$"% ,4    " !45%Y1*VXCB?\(   R/   &0              @(%UR $
M>&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( %147E&RJ 5H
M6@(  $ %   9              " @:O1 0!X;"]W;W)K<VAE971S+W-H965T
M-S(N>&UL4$L! A0#%     @ 5%1>4> +)='L @  *@D  !D
M ("!/-0! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    " !4
M5%Y1@>S>!SL#  #$#   &0              @(%?UP$ >&PO=V]R:W-H965T
M<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( %147E&.S722B0(  &X'   9
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M;',O+G)E;'-02P$"% ,4    " !45%Y1(/:%Q <&  "[,P  #P
M    @ '6Z0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 5%1>47H$ UU<
M @  (2X  !H              ( !"O ! 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ 5%1>42XH"M@5 @  _"P  !,
M ( !GO(! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %8 5@"1%P  Y/0!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>556</ContextCount>
  <ElementCount>420</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>208</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>20</UnitCount>
  <MyReports>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings</Role>
      <ShortName>Condensed Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Background and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentation</Role>
      <ShortName>Background and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106102 - Disclosure - Revenues from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/RevenuesfromContractswithCustomers</Role>
      <ShortName>Revenues from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Asset Impairment, Exit and Implementation Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AssetImpairmentExitandImplementationCosts</Role>
      <ShortName>Asset Impairment, Exit and Implementation Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - Investments in Equity Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecurities</Role>
      <ShortName>Investments in Equity Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2120105 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2128106 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2132107 - Disclosure - Earnings (Losses) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsLossesPerShare</Role>
      <ShortName>Earnings (Losses) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2135108 - Disclosure - Other Comprehensive Earnings/Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLosses</Role>
      <ShortName>Other Comprehensive Earnings/Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2139109 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2144110 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2146111 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2149112 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2169113 - Disclosure - New Accounting Guidance Not Yet Adopted</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</Role>
      <ShortName>New Accounting Guidance Not Yet Adopted</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Background and Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationPolicies</Role>
      <ShortName>Background and Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Background and Basis of Presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationTables</Role>
      <ShortName>Background and Basis of Presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Asset Impairment, Exit and Implementation Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables</Role>
      <ShortName>Asset Impairment, Exit and Implementation Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/AssetImpairmentExitandImplementationCosts</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Investments in Equity Securities Investments in Equity Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables</Role>
      <ShortName>Investments in Equity Securities Investments in Equity Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2321304 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstruments</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2329305 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlans</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - Earnings (Losses) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsLossesPerShareTables</Role>
      <ShortName>Earnings (Losses) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/EarningsLossesPerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - Other Comprehensive Earnings/Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesTables</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLosses</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReporting</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2347309 - Disclosure - Income Taxes update (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesupdateTables</Role>
      <ShortName>Income Taxes update (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2350310 - Disclosure - Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesTables</Role>
      <ShortName>Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/Contingencies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2370311 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables</Role>
      <ShortName>New Accounting Guidance Not Yet Adopted (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Background and Basis of Presentation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails</Role>
      <ShortName>Background and Basis of Presentation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentationTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails</Role>
      <ShortName>Background and Basis of Presentation (Share Repurchase Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentationTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails</Role>
      <ShortName>Revenues from Contracts with Customers (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/RevenuesfromContractswithCustomers</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails</Role>
      <ShortName>Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails</Role>
      <ShortName>Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Asset Impairment, Exit and Implementation Costs (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails</Role>
      <ShortName>Asset Impairment, Exit and Implementation Costs (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails</Role>
      <ShortName>Investments in Equity Securities (Summary of Investments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails</Role>
      <ShortName>Investments in Equity Securities (Earnings in Equity Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in ABI Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in JUUL Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in Cronos Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2422412 - Disclosure - Financial Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2423413 - Disclosure - Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails</Role>
      <ShortName>Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails</Role>
      <ShortName>Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2425415 - Disclosure - Financial Instruments (Fair Value Derivative Financial Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Financial Instruments (Fair Value Derivative Financial Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2426416 - Disclosure - Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails</Role>
      <ShortName>Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2427417 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails</Role>
      <ShortName>Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2430418 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails</Role>
      <ShortName>Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2431419 - Disclosure - Benefit Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansNarrativeDetails</Role>
      <ShortName>Benefit Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2434420 - Disclosure - Earnings (Losses) Per Share (Basic and Diluted Earnings Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings (Losses) Per Share (Basic and Diluted Earnings Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/EarningsLossesPerShareTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2437421 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLossesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Reclassifications) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLossesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails</Role>
      <ShortName>Segment Reporting (Segment Data Schedule) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails</Role>
      <ShortName>Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - Segment Reporting (Schedule of COVID-19 Related Items (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails</Role>
      <ShortName>Segment Reporting (Schedule of COVID-19 Related Items (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2445426 - Disclosure - Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/Debt</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2448427 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxesupdateTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2451428 - Disclosure - Contingencies (General Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesGeneralInformationDetails</Role>
      <ShortName>Contingencies (General Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2452429 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails</Role>
      <ShortName>Contingencies (Schedule of Pending Cases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2453430 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails</Role>
      <ShortName>Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2454431 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails</Role>
      <ShortName>Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2455432 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails</Role>
      <ShortName>Contingencies (Non-Engle Progeny Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2456433 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails</Role>
      <ShortName>Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2457434 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails</Role>
      <ShortName>Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2458435 - Disclosure - Contingencies (Florida Bond Statute) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails</Role>
      <ShortName>Contingencies (Florida Bond Statute) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2459436 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails</Role>
      <ShortName>Contingencies (Other Smoking and Health Class Actions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2460437 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails</Role>
      <ShortName>Contingencies (Health Care Cost Recovery Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2461438 - Disclosure - Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails</Role>
      <ShortName>Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2462439 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails</Role>
      <ShortName>Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2463440 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails</Role>
      <ShortName>Contingencies (Federal Government's Lawsuit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2464441 - Disclosure - Contingencies (E-vapor Product Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails</Role>
      <ShortName>Contingencies (E-vapor Product Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2465442 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails</Role>
      <ShortName>Contingencies (Lights/Ultra Lights Cases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2466443 - Disclosure - Contingencies (UST Litigations Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails</Role>
      <ShortName>Contingencies (UST Litigations Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2467444 - Disclosure - Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails</Role>
      <ShortName>Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="mo-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2468445 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails</Role>
      <ShortName>Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mo-20200930.htm">mo-20200930.htm</File>
    <File>exhibit311q32020.htm</File>
    <File>exhibit312q32020.htm</File>
    <File>exhibit321q32020.htm</File>
    <File>exhibit322q32020.htm</File>
    <File>exhibit991q32020.htm</File>
    <File>exhibit992q32020.htm</File>
    <File>mo-20200930.xsd</File>
    <File>mo-20200930_cal.xml</File>
    <File>mo-20200930_def.xml</File>
    <File>mo-20200930_lab.xml</File>
    <File>mo-20200930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/stpr/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mo-20200930.htm": {
   "axisCustom": 0,
   "axisStandard": 34,
   "contextCount": 556,
   "dts": {
    "calculationLink": {
     "local": [
      "mo-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mo-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "mo-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mo-20200930_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mo-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mo-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 700,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 2,
    "http://www.altria.com/20200930": 2,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 9
   },
   "keyCustom": 109,
   "keyStandard": 311,
   "memberCustom": 119,
   "memberStandard": 86,
   "nsprefix": "mo",
   "nsuri": "http://www.altria.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.altria.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106102 - Disclosure - Revenues from Contracts with Customers",
     "role": "http://www.altria.com/role/RevenuesfromContractswithCustomers",
     "shortName": "Revenues from Contracts with Customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Asset Impairment, Exit and Implementation Costs",
     "role": "http://www.altria.com/role/AssetImpairmentExitandImplementationCosts",
     "shortName": "Asset Impairment, Exit and Implementation Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - Investments in Equity Securities",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecurities",
     "shortName": "Investments in Equity Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120105 - Disclosure - Financial Instruments",
     "role": "http://www.altria.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128106 - Disclosure - Benefit Plans",
     "role": "http://www.altria.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132107 - Disclosure - Earnings (Losses) Per Share",
     "role": "http://www.altria.com/role/EarningsLossesPerShare",
     "shortName": "Earnings (Losses) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135108 - Disclosure - Other Comprehensive Earnings/Losses",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLosses",
     "shortName": "Other Comprehensive Earnings/Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139109 - Disclosure - Segment Reporting",
     "role": "http://www.altria.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144110 - Disclosure - Debt",
     "role": "http://www.altria.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146111 - Disclosure - Income Taxes",
     "role": "http://www.altria.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:InventoryRawMaterialsPlantMaterialNetofReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149112 - Disclosure - Contingencies",
     "role": "http://www.altria.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169113 - Disclosure - New Accounting Guidance Not Yet Adopted",
     "role": "http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted",
     "shortName": "New Accounting Guidance Not Yet Adopted",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Background and Basis of Presentation (Policies)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies",
     "shortName": "Background and Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Background and Basis of Presentation (Tables)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationTables",
     "shortName": "Background and Basis of Presentation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Asset Impairment, Exit and Implementation Costs (Tables)",
     "role": "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables",
     "shortName": "Asset Impairment, Exit and Implementation Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Investments in Equity Securities Investments in Equity Securities (Tables)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables",
     "shortName": "Investments in Equity Securities Investments in Equity Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321304 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.altria.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329305 - Disclosure - Benefit Plans (Tables)",
     "role": "http://www.altria.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - Earnings (Losses) Per Share (Tables)",
     "role": "http://www.altria.com/role/EarningsLossesPerShareTables",
     "shortName": "Earnings (Losses) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - Other Comprehensive Earnings/Losses (Tables)",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables",
     "shortName": "Other Comprehensive Earnings/Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.altria.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347309 - Disclosure - Income Taxes update (Tables)",
     "role": "http://www.altria.com/role/IncomeTaxesupdateTables",
     "shortName": "Income Taxes update (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350310 - Disclosure - Contingencies (Tables)",
     "role": "http://www.altria.com/role/ContingenciesTables",
     "shortName": "Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370311 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)",
     "role": "http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables",
     "shortName": "New Accounting Guidance Not Yet Adopted (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i071cc6de3a8a4d14b919af0f81bed549_D20200701-20200731",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "mo:CommonStockDividendRatePercentageIncrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Background and Basis of Presentation (Narrative) (Details)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
     "shortName": "Background and Basis of Presentation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i071cc6de3a8a4d14b919af0f81bed549_D20200701-20200731",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "mo:CommonStockDividendRatePercentageIncrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ic9958df4c9a745cfb958b75b5e00fab2_D20190101-20190930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails",
     "shortName": "Background and Basis of Presentation (Share Repurchase Table) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i19988383bb3043e881752078a8364530_D20190701-20190930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)",
     "role": "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
     "shortName": "Revenues from Contracts with Customers (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:OtherRestructuringCostsIncludingNetPensionCostCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details)",
     "role": "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
     "shortName": "Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:OtherRestructuringCostsIncludingNetPensionCostCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i72e09db783364478aeb09576c9febdcb_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details)",
     "role": "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails",
     "shortName": "Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i72e09db783364478aeb09576c9febdcb_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Asset Impairment, Exit and Implementation Costs (Narrative) (Details)",
     "role": "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails",
     "shortName": "Asset Impairment, Exit and Implementation Costs (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib0d8a29fd04b4af1b5328f9a73ce53e9_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Earnings",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
     "shortName": "Condensed Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherCostOfOperatingRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails",
     "shortName": "Investments in Equity Securities (Summary of Investments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
     "shortName": "Investments in Equity Securities (Earnings in Equity Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib911f814538a479eb5056f3c19bfd6c3_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "idc0e7480ae994bbfae8f564a569b78db_I20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in ABI Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "idc0e7480ae994bbfae8f564a569b78db_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:EquityMethodInvestmentNumberofSharesOwnedRestricted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in JUUL Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "id6aea41f4cd944cbb4018c25bf22065f_D20181201-20181231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i03dc33411a5749d79909086adf33043e_I20190331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mo:EquityMethodInvestmentNumberofSharesOwnedCommon",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in Cronos Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i03dc33411a5749d79909086adf33043e_I20190331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mo:EquityMethodInvestmentNumberofSharesOwnedCommon",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422412 - Disclosure - Financial Instruments (Narrative) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i69363bfcc8fd412bbdb34aec0878e470_I20190331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i780f2a71201c4ff3bd694ea104911a0e_I20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423413 - Disclosure - Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
     "shortName": "Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i780f2a71201c4ff3bd694ea104911a0e_I20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib3969c366e174823ba5e447d4d1d11fa_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
     "shortName": "Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib3969c366e174823ba5e447d4d1d11fa_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i0d187570aa2540a88ab160136d28dc72_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425415 - Disclosure - Financial Instruments (Fair Value Derivative Financial Instruments) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
     "shortName": "Financial Instruments (Fair Value Derivative Financial Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i0d187570aa2540a88ab160136d28dc72_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426416 - Disclosure - Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
     "shortName": "Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Earnings",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings",
     "shortName": "Condensed Consolidated Statements of Comprehensive Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i182d9ee236a64eff889aab36500df3ed_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427417 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
     "shortName": "Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i182d9ee236a64eff889aab36500df3ed_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430418 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)",
     "role": "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails",
     "shortName": "Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i5ab7cd063dea4bc9bc8110851bf5838b_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431419 - Disclosure - Benefit Plans (Narrative) (Details)",
     "role": "http://www.altria.com/role/BenefitPlansNarrativeDetails",
     "shortName": "Benefit Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i73e7896a970c49a2852f02614ab3e1d6_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434420 - Disclosure - Earnings (Losses) Per Share (Basic and Diluted Earnings Per Share) (Details)",
     "role": "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails",
     "shortName": "Earnings (Losses) Per Share (Basic and Diluted Earnings Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i670aed569ab54abeacf39bd2a4edb1d7_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437421 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
     "shortName": "Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i7e1c6162ce4f4a86953361561a9ba9d8_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails",
     "shortName": "Other Comprehensive Earnings/Losses (Reclassifications) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib49c01bfae724b45b528bcb25e34b3b5_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)",
     "role": "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails",
     "shortName": "Segment Reporting (Segment Data Schedule) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "id84c0fe23d3344d8a09f8c4b47549357_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i9a01c76ce7db4a9bb38f21611772ae4c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details)",
     "role": "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails",
     "shortName": "Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i9a01c76ce7db4a9bb38f21611772ae4c_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - Segment Reporting (Schedule of COVID-19 Related Items (Details)",
     "role": "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails",
     "shortName": "Segment Reporting (Schedule of COVID-19 Related Items (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i04eaaa915aec49bd9b52703167950623_D20200101-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445426 - Disclosure - Debt (Narrative) (Details)",
     "role": "http://www.altria.com/role/DebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i9fdefa86b95345148bfdd3202813cfe1_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "iabbca98f017e44a690fafbff723997c4_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448427 - Disclosure - Income Taxes (Details)",
     "role": "http://www.altria.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451428 - Disclosure - Contingencies (General Information) (Details)",
     "role": "http://www.altria.com/role/ContingenciesGeneralInformationDetails",
     "shortName": "Contingencies (General Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ibe6c5f25c0a14432894f98e00b688af4_I20191028",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452429 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)",
     "role": "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
     "shortName": "Contingencies (Schedule of Pending Cases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i79786dc9d3a34fe9b84f2581a59eae3c_D20180301-20180331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyClaimsDismissedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib6a114c3739645fb99b67e8b402fb09d_I20191028",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453430 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)",
     "role": "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
     "shortName": "Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i218ca1e25c27437f84cd9522af660be3_D19990101-20201027",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsDecided",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i670aed569ab54abeacf39bd2a4edb1d7_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454431 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
     "shortName": "Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i670aed569ab54abeacf39bd2a4edb1d7_I20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i81b724d4a8dd4812b7033d86eb830073_I20200229",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455432 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
     "shortName": "Contingencies (Non-Engle Progeny Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i81b724d4a8dd4812b7033d86eb830073_I20200229",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i1a81a944b81a45a9b4aabeb561b3c720_I20000731",
      "decimals": "-9",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyPunitiveDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456433 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)",
     "role": "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
     "shortName": "Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i1a81a944b81a45a9b4aabeb561b3c720_I20000731",
      "decimals": "-9",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyPunitiveDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i4ced792544c54268bd9593f35eddb549_D20200401-20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:PreTaxChargesGainIncludedinNetEarning",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457434 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)",
     "role": "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
     "shortName": "Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i4ced792544c54268bd9593f35eddb549_D20200401-20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:PreTaxChargesGainIncludedinNetEarning",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i2af34da3eecf4a8ebf87a01b040a2639_I20090630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:MaximumBondForAllDefendants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458435 - Disclosure - Contingencies (Florida Bond Statute) (Details)",
     "role": "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
     "shortName": "Contingencies (Florida Bond Statute) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i2af34da3eecf4a8ebf87a01b040a2639_I20090630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:MaximumBondForAllDefendants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i56d82ed761ef41faa02538a434851cba_D19960501-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClassNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459436 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)",
     "role": "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
     "shortName": "Contingencies (Other Smoking and Health Class Actions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i56d82ed761ef41faa02538a434851cba_D19960501-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClassNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib6a114c3739645fb99b67e8b402fb09d_I20191028",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460437 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
     "shortName": "Contingencies (Health Care Cost Recovery Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i169d27beb37c49c5bf82654208714375_D19981101-19981130",
      "decimals": "-8",
      "lang": "en-US",
      "name": "mo:LitigationSettlementAnnualPaymentAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i169d27beb37c49c5bf82654208714375_D19981101-19981130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStateswithSettledLitigation",
      "reportCount": 1,
      "unitRef": "state",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461438 - Disclosure - Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details)",
     "role": "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
     "shortName": "Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ic2269ecdf1c64fb98097f29ff6e22692_D20190101-20190331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:LossContingencyReductionToCostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i70337240f7a84b3788b6f48a11439d6f_D20180801-20180831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462439 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)",
     "role": "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
     "shortName": "Contingencies (Other Disputes Under the State Settlement Agreements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i70337240f7a84b3788b6f48a11439d6f_D20180801-20180831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ie8789e2bcbf64769a038755249460300_D20060801-20060831",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mo:FederalTradeCommissionDisclosurePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463440 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)",
     "role": "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
     "shortName": "Contingencies (Federal Government's Lawsuit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ie8789e2bcbf64769a038755249460300_D20060801-20060831",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mo:FederalTradeCommissionDisclosurePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib6b92183e81f4270b9b287aa21dc48b3_I20191028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "true"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464441 - Disclosure - Contingencies (E-vapor Product Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
     "shortName": "Contingencies (E-vapor Product Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i1938f36d8dd1444f846a2c358e51a292_I20201027",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofCasesSetforTrial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3a4a3638d5c14dd6930a6317db7cb2fe_I20201027",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465442 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)",
     "role": "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
     "shortName": "Contingencies (Lights/Ultra Lights Cases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3a4a3638d5c14dd6930a6317db7cb2fe_I20201027",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i365934f7ac7f46b589e0fbf8c5a01204_I20201027",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466443 - Disclosure - Contingencies (UST Litigations Narrative) (Details)",
     "role": "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
     "shortName": "Contingencies (UST Litigations Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i365934f7ac7f46b589e0fbf8c5a01204_I20201027",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i5e48f7ae862f4927a706bfb1d1bdff5f_D20200801-20200831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shareholder",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467444 - Disclosure - Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)",
     "role": "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
     "shortName": "Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i5e48f7ae862f4927a706bfb1d1bdff5f_D20200801-20200831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shareholder",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468445 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)",
     "role": "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
     "shortName": "Contingencies (Guarantees and Other Similar Matters Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ia293f60845e647b181cfb7a59955fc58_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "i3656833207b740358727e6740c6f5754_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Background and Basis of Presentation",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentation",
     "shortName": "Background and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20200930.htm",
      "contextRef": "ib44959adae174705840aea192a7e8046_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 208,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PR": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "PUERTO RICO",
        "terseLabel": "Puerto Rico [Member]"
       }
      }
     },
     "localname": "PR",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mo_ABInBevMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "AB InBev [Member]",
        "label": "AB InBev [Member]",
        "terseLabel": "ABI [Member]"
       }
      }
     },
     "localname": "ABInBevMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AccruedSettlementLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Settlement Liability, Current",
        "label": "Accrued Settlement Liability, Current",
        "terseLabel": "Settlement charges"
       }
      }
     },
     "localname": "AccruedSettlementLiabilityCurrent",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated Equity Method Investments Attributable To Parent [Member]",
        "label": "Accumulated Equity Method Investments Attributable To Parent [Member]",
        "terseLabel": "ABI [Member]"
       }
      }
     },
     "localname": "AccumulatedEquityMethodInvestmentsAttributableToParentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards",
        "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net",
        "terseLabel": "Stock award activity"
       }
      }
     },
     "localname": "AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AllowanceForSalesDiscountsGoods": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Allowance For Sales Discounts, Goods",
        "label": "Allowance For Sales Discounts, Goods",
        "terseLabel": "Allowance for sales discounts, goods"
       }
      }
     },
     "localname": "AllowanceForSalesDiscountsGoods",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AltriaGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Altria Group",
        "label": "Altria Group [Member]",
        "terseLabel": "Altria Group [Member]"
       }
      }
     },
     "localname": "AltriaGroupMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AmountAwardedtoOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount Awarded to Other Party",
        "label": "Amount Awarded to Other Party",
        "terseLabel": "Amount awarded to other party"
       }
      }
     },
     "localname": "AmountAwardedtoOtherParty",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AssetImpairmentandBusinessExitCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Impairment and Business Exit Costs",
        "label": "Asset Impairment and Business Exit Costs",
        "negatedTerseLabel": "Corporate asset impairment and exit costs",
        "totalLabel": "Asset Impairment and Exit Costs"
       }
      }
     },
     "localname": "AssetImpairmentandBusinessExitCosts",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails": {
       "order": 2.0,
       "parentTag": "mo_RestructuringChargesIncludingNetPensionCostCredit",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit)",
        "label": "Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit)",
        "terseLabel": "Asset impairment and exit costs",
        "verboseLabel": "Total, Asset Impairment and Exit Costs"
       }
      }
     },
     "localname": "AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_BritishColumbiaSaskatchewanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "British Columbia, Saskatchewan [Member]",
        "label": "British Columbia, Saskatchewan [Member]",
        "terseLabel": "British Columbia and Saskatchewan [Member]"
       }
      }
     },
     "localname": "BritishColumbiaSaskatchewanMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_COVID19Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "COVID-19 [Member]",
        "label": "COVID-19 [Member]",
        "terseLabel": "COVID-19 [Member]"
       }
      }
     },
     "localname": "COVID19Member",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CanadianTobaccoManufacturersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Canadian Tobacco Manufacturers [Member]",
        "label": "Canadian Tobacco Manufacturers [Member]",
        "terseLabel": "Canadian Tobacco Manufacturers [Member]"
       }
      }
     },
     "localname": "CanadianTobaccoManufacturersMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ClassActionLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class Action Lawsuit [Member]",
        "label": "Class Action Lawsuit [Member]",
        "terseLabel": "Class Action Lawsuit [Member]"
       }
      }
     },
     "localname": "ClassActionLawsuitMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock0.3313ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, 0.33 1/3 Par Value [Member]",
        "label": "Common Stock, 0.33 1/3 Par Value [Member]",
        "terseLabel": "Common Stock, $0.33 1/3 par value [Member]"
       }
      }
     },
     "localname": "CommonStock0.3313ParValueMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock1.000NotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, 1.000% Notes Due 2023 [Member]",
        "label": "Common Stock, 1.000% Notes Due 2023 [Member]",
        "terseLabel": "1.000% Notes due 2023 [Member]"
       }
      }
     },
     "localname": "CommonStock1.000NotesDue2023Member",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock1.700NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, 1.700% Notes Due 2025 [Member]",
        "label": "Common Stock, 1.700% Notes Due 2025 [Member]",
        "terseLabel": "1.700% Notes due 2025 [Member]"
       }
      }
     },
     "localname": "CommonStock1.700NotesDue2025Member",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock2.200NotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, 2.200% Notes Due 2027 [Member]",
        "label": "Common Stock, 2.200% Notes Due 2027 [Member]",
        "terseLabel": "2.200% Notes due 2027 [Member]"
       }
      }
     },
     "localname": "CommonStock2.200NotesDue2027Member",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock3.125NotesDue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, 3.125% Notes Due 2031 [Member]",
        "label": "Common Stock, 3.125% Notes Due 2031 [Member]",
        "terseLabel": "3.125% Notes due 2031 [Member]"
       }
      }
     },
     "localname": "CommonStock3.125NotesDue2031Member",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStockDividendRateAnnualPerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, Dividend Rate, Annual, Per Share",
        "label": "Common Stock, Dividend Rate, Annual, Per Share",
        "terseLabel": "Common stock, dividend rate, annual (in usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendRateAnnualPerShare",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mo_CommonStockDividendRatePercentageIncrease": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, Dividend Rate, Percentage Increase",
        "label": "Common Stock, Dividend Rate, Percentage Increase",
        "terseLabel": "Common stock, dividend rate, percentage increase"
       }
      }
     },
     "localname": "CommonStockDividendRatePercentageIncrease",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement [Member]"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CronosGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cronos Group Inc. [Member]",
        "label": "Cronos Group Inc. [Member]",
        "verboseLabel": "Cronos [Member]"
       }
      }
     },
     "localname": "CronosGroupInc.Member",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio",
        "label": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio",
        "terseLabel": "Debt instrument, consolidated EBITDA to interest expense ratio"
       }
      }
     },
     "localname": "DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mo_DebtInstrumentExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Extension Term",
        "label": "Debt Instrument, Extension Term",
        "terseLabel": "Debt instrument, extension term"
       }
      }
     },
     "localname": "DebtInstrumentExtensionTerm",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_DebtInstrumentNumberofExtensions": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Number of Extensions",
        "label": "Debt Instrument, Number of Extensions",
        "terseLabel": "Debt instrument, number of extensions"
       }
      }
     },
     "localname": "DebtInstrumentNumberofExtensions",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_ETSSmokingandHealthCaseFlightAttendantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ETS Smoking and Health Case, Flight Attendants [Member]",
        "label": "ETS Smoking and Health Case, Flight Attendants [Member]",
        "terseLabel": "ETS Smoking and Health Case, Flight Attendants [Member]"
       }
      }
     },
     "localname": "ETSSmokingandHealthCaseFlightAttendantsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesBergerMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Berger [Member]",
        "label": "Engle Progeny Cases, Berger [Member]",
        "terseLabel": "Engle Progeny Cases, Berger [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesBergerMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesChadwellMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Chadwell [Member] [Member]",
        "label": "Engle Progeny Cases, Chadwell [Member]",
        "terseLabel": "Engle Progeny Cases, Chadwell [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesChadwellMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesCooperMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Cooper [Member]",
        "label": "Engle Progeny Cases, Cooper [Member]",
        "terseLabel": "Engle Progeny Cases, Cooper [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesCooperMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesCuddiheeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Cuddihee",
        "label": "Engle Progeny Cases, Cuddihee [Member]",
        "terseLabel": "Engle Progeny Cases, Cuddihee [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesCuddiheeMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesD.BrownMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, D. Brown [Member]",
        "label": "Engle Progeny Cases, D. Brown [Member]",
        "terseLabel": "Engle Progeny Cases, D. Brown [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesD.BrownMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesDeanKerrivanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Dean Kerrivan [Member]",
        "label": "Engle Progeny Cases, Dean Kerrivan [Member]",
        "terseLabel": "Engle Progeny Cases, Dean (Kerrivan) [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesDeanKerrivanMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesDuignanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Duignan [Member]",
        "label": "Engle Progeny Cases, Duignan [Member]",
        "terseLabel": "Engle Progeny Cases, Duignan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesDuignanMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesFederalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Federal [Member]",
        "label": "Engle Progeny Cases, Federal [Member]",
        "terseLabel": "Engle Progeny Cases, Federal [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesFederalMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesFreemanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Freeman [Member]",
        "label": "Engle Progeny Cases, Freeman [Member]",
        "terseLabel": "Engle Progeny Cases, Freeman [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesFreemanMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesFrogelMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Frogel [Member]",
        "label": "Engle Progeny Cases, Frogel [Member]",
        "terseLabel": "Engle Progeny Cases, Frogel [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesFrogelMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGlogerMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Gloger [Member]",
        "label": "Engle Progeny Cases, Gloger [Member]",
        "terseLabel": "Engle Progeny Cases, Gloger [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGlogerMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGlogerRintoulandDuignamMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]",
        "label": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]",
        "terseLabel": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGlogerRintoulandDuignamMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGoreMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Gore [Member]",
        "label": "Engle Progeny Cases, Gore [Member]",
        "terseLabel": "Engle Progeny Cases, Gore [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGoreMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesHarrisMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Harris [Member]",
        "label": "Engle Progeny Cases, Harris [Member]",
        "terseLabel": "Engle Progeny Cases, Harris [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesHarrisMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesHollimanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Holliman [Member]",
        "label": "Engle Progeny Cases, Holliman [Member]",
        "terseLabel": "Engle Progeny Cases, Holliman [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesHollimanMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesJordanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Jordan [Member]",
        "label": "Engle Progeny Cases, Jordan [Member]",
        "terseLabel": "Engle Progeny Cases, Jordan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesJordanMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesKaplanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Kaplan [Member]",
        "label": "Engle Progeny Cases, Kaplan [Member]",
        "terseLabel": "Engle Progeny Cases, Kaplan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesKaplanMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesLandiMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Landi [Member]",
        "label": "Engle Progeny Cases, Landi [Member]",
        "terseLabel": "Engle Progeny Cases, Landi [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesLandiMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesM.BrownMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, M. Brown [Member]",
        "label": "Engle Progeny Cases, M. Brown [Member]",
        "terseLabel": "Engle Progeny Cases, M. Brown [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesM.BrownMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMahfuzMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Mahfuz [Member]",
        "label": "Engle Progeny Cases, Mahfuz [Member]",
        "terseLabel": "Engle Progeny Cases, Mahfuz [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMahfuzMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMcCallMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, McCall [Member]",
        "label": "Engle Progeny Cases, McCall [Member]",
        "terseLabel": "Engle Progeny Cases, McCall [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMcCallMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases [Member]",
        "label": "Engle Progeny Cases [Member]",
        "terseLabel": "Engle Progeny Cases [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesNaugleGoreM.BrownJordanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan [Member]",
        "label": "Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan [Member]",
        "terseLabel": "Engle Progeny Cases, Naugle, Gore, M. Brown, Jordan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesNaugleGoreM.BrownJordanMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesNaugleMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Naugle [Member]",
        "label": "Engle Progeny Cases, Naugle [Member]",
        "terseLabel": "Engle Progeny Cases, Naugle [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesNaugleMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesNeffMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Neff [Member]",
        "label": "Engle Progeny Cases, Neff [Member]",
        "terseLabel": "Engle Progeny Cases, Neff [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesNeffMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]",
        "label": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]",
        "terseLabel": "Engle Progeny Cases, D Cohen, Collar, Chacon [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesPearsonDCohenCollarChaconMemberMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesPollariMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Pollari [Member]",
        "label": "Engle Progeny Cases, Pollari [Member]",
        "terseLabel": "Engle Progeny Cases, Pollari [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesPollariMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesR.DouglasMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, R. Douglas [Member]",
        "label": "Engle Progeny Cases, R. Douglas [Member]",
        "terseLabel": "Engle Progeny Cases, R. Douglas [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesR.DouglasMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesReiderandBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Reider and Banks [Member]",
        "label": "Engle Progeny Cases, Reider and Banks [Member]",
        "terseLabel": "Engle Progeny Cases, Reider and Banks [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesReiderandBanksMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesRintoulMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Rintoul",
        "label": "Engle Progeny Cases, Rintoul [Member]",
        "terseLabel": "Engle Progeny Cases, Rintoul [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesRintoulMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesSantoroMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Santoro [Member]",
        "label": "Engle Progeny Cases, Santoro [Member]",
        "terseLabel": "Engle Progeny Cases, Santoro [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesSantoroMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesSommersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Sommers [Member]",
        "label": "Engle Progeny Cases, Sommers [Member]",
        "terseLabel": "Engle Progeny Cases, Sommers [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesSommersMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesStateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, State [Member]",
        "label": "Engle Progeny Cases, State [Member]",
        "terseLabel": "Engle Progeny Cases, State [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesStateMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesTheisMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Theis [Member]",
        "label": "Engle Progeny Cases, Theis [Member]",
        "terseLabel": "Engle Progeny Cases, Theis [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesTheisMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesWeingartandHancockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Engle Progeny Cases, Weingart and Hancock [Member]",
        "label": "Engle Progeny Cases, Weingart and Hancock [Member]",
        "terseLabel": "Engle Progeny Cases, Weingart and Hancock [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesWeingartandHancockMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractPreemptiveRIghtsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Contract, Preemptive RIghts [Member]",
        "label": "Equity Contract, Preemptive RIghts [Member]",
        "terseLabel": "Fixed-price Preemptive Rights [Member]",
        "verboseLabel": "Equity Contract, Preemptive Rights [Member]"
       }
      }
     },
     "localname": "EquityContractPreemptiveRIghtsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Contract, Warrant [Member]",
        "label": "Equity Contract, Warrant [Member]",
        "terseLabel": "Equity Contract, Warrant [Member]",
        "verboseLabel": "Cronos Warrant [Member]"
       }
      }
     },
     "localname": "EquityContractWarrantMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityMethodInvestmentAggregateExercisePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Aggregate Exercise Price",
        "label": "Equity Method Investment, Aggregate Exercise Price",
        "terseLabel": "Equity method investment, aggregate exercise price"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateExercisePrice",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage",
        "negatedTerseLabel": "Difference between carrying amount and fair value, percentage (approximately)",
        "terseLabel": "Equity method investment, difference between carrying amount and fair value, percentage (approximately)"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Impairment",
        "label": "Equity Method Investment, Impairment",
        "terseLabel": "Equity method investment, impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentImpairment",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Number of Independent Directors Nominated",
        "label": "Equity Method Investment, Number of Independent Directors Nominated",
        "terseLabel": "Equity method investment, number of independent directors nominated"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofIndependentDirectorsNominated",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Eligible For Purchase",
        "label": "Equity Method Investment, Number of Shares Eligible For Purchase",
        "terseLabel": "Equity method investment, number of shares eligible for purchase (approximately) (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesEligibleForPurchase",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesOwnedCommon": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Owned, Common",
        "label": "Equity Method Investment, Number of Shares Owned, Common",
        "terseLabel": "Number of ordinary shares owned (in shares)",
        "verboseLabel": "Number of ordinary shares owned (approximately) (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesOwnedCommon",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesOwnedRestricted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Owned, Restricted",
        "label": "Equity Method Investment, Number of Shares Owned, Restricted",
        "terseLabel": "Number of restricted shares owned (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesOwnedRestricted",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Percentage of Shares Eligible For Purchase",
        "label": "Equity Method Investment, Percentage of Shares Eligible For Purchase",
        "terseLabel": "Equity method investment, percentage of shares eligible for purchase"
       }
      }
     },
     "localname": "EquityMethodInvestmentPercentageofSharesEligibleForPurchase",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentPricePerShareIfExercised": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Price Per Share If Exercised",
        "label": "Equity Method Investment, Price Per Share If Exercised",
        "terseLabel": "Equity method investment, shares purchased, (CAD per share)"
       }
      }
     },
     "localname": "EquityMethodInvestmentPricePerShareIfExercised",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment, Warrant Exercised, Ownership Percentage",
        "label": "Equity Method Investment, Warrant Exercised, Ownership Percentage",
        "verboseLabel": "Equity method investment, warrant exercised, ownership percentage (approximately)"
       }
      }
     },
     "localname": "EquityMethodInvestmentWarrantExercisedOwnershipPercentage",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, No Litigation Period",
        "label": "Equity Securities Without Readily Determinable Fair Value, No Litigation Period",
        "terseLabel": "Equity securities without readily determinable fair value, no litigation period"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value",
        "label": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value",
        "terseLabel": "Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Period",
        "label": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Period",
        "terseLabel": "Equity securities without readily determinable fair value, non-compete release trigger period"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members",
        "terseLabel": "Equity securities without readily determinable fair value, number of board members"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of board members upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of independent board members upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage",
        "label": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage",
        "terseLabel": "Equity securities, ownership percentage"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount",
        "label": "Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount",
        "terseLabel": "Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquitySecurityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Security Investments",
        "label": "Equity Security Investments",
        "verboseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecurityInvestments",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EvaporLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "E-vapor Litigation [Member]",
        "label": "E-vapor Litigation [Member]",
        "terseLabel": "E-vapor Litigation [Member]"
       }
      }
     },
     "localname": "EvaporLitigationMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_FederalGovernmentsLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Federal Government's Lawsuit [Member]",
        "label": "Federal Governments Lawsuit [Member]",
        "terseLabel": "Federal Governments Lawsuit [Member]"
       }
      }
     },
     "localname": "FederalGovernmentsLawsuitMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_FederalTradeCommissionDisclosurePeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Federal Trade Commission, Disclosure Period",
        "label": "Federal Trade Commission, Disclosure Period",
        "terseLabel": "Disclosure period"
       }
      }
     },
     "localname": "FederalTradeCommissionDisclosurePeriod",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_ForeignCurrencyDenominatedDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign Currency Denominated Debt [Member]",
        "label": "Foreign Currency Denominated Debt [Member]",
        "terseLabel": "Foreign Currency Denominated Debt [Member]",
        "verboseLabel": "Foreign currency denominated debt [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions20032015NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2003NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions20042017Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2004-2017 [Member]",
        "label": "Health Care Cost Recovery Actions, 2004-2017 [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2004-2017 [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions20042017Member",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2004 And Subsequent NPM Adjustment",
        "label": "Health Care Cost Recovery Actions, 2004 And Subsequent NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2004 And Subsequent NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2004AndSubsequentNPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2004NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2005NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2006NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2007NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2008NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2009NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2010NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2011NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2012NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2013NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2014NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2015NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2017NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2018NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2019NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions [Member]",
        "label": "Health Care Cost Recovery Actions [Member]",
        "terseLabel": "Health Care Cost Recovery Actions [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsTransitionYears20042018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]",
        "label": "Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsTransitionYears20042018Member",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HelixInnovationsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Helix Innovations LLC [Member]",
        "label": "Helix Innovations LLC [Member]",
        "terseLabel": "Helix Innovations LLC [Member]"
       }
      }
     },
     "localname": "HelixInnovationsLLCMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ImplementationofCorrectiveCommunicationsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Implementation of Corrective Communications [Member]",
        "label": "Implementation of Corrective Communications [Member]",
        "terseLabel": "Implementation of Corrective Communications [Member]"
       }
      }
     },
     "localname": "ImplementationofCorrectiveCommunicationsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IncreaseDecreaseInSettlementPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net change during the period in Settlement payable.",
        "label": "Increase (Decrease) In Settlement Payable",
        "terseLabel": "Accrued settlement charges"
       }
      }
     },
     "localname": "IncreaseDecreaseInSettlementPayable",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IndividualSmokingAndHealthCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Individual Smoking and Health Cases [Member]",
        "label": "Individual Smoking And Health Cases [Member]",
        "terseLabel": "Individual Smoking and Health Cases [Member]"
       }
      }
     },
     "localname": "IndividualSmokingAndHealthCasesMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InterestExpenseRelatedToLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest Expense Related To Litigation [Member]",
        "label": "Interest Expense Related To Litigation [Member]",
        "terseLabel": "Interest Expense Related to Litigation [Member]"
       }
      }
     },
     "localname": "InterestExpenseRelatedToLitigationMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InventoryRawMaterialsPlantMaterialNetofReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods",
        "label": "Inventory, Raw Materials, Plant Material, Net of Reserves",
        "terseLabel": "Leaf tobacco"
       }
      }
     },
     "localname": "InventoryRawMaterialsPlantMaterialNetofReserves",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_InventoryWriteOffMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inventory Write-Off [Member]",
        "label": "Inventory Write-Off [Member]",
        "terseLabel": "Inventory Write-Off [Member]"
       }
      }
     },
     "localname": "InventoryWriteOffMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InvestmentsInEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments In Equity Securities [Member]",
        "label": "Investments In Equity Securities [Member]",
        "terseLabel": "Investments In Equity Securities [Member]"
       }
      }
     },
     "localname": "InvestmentsInEquitySecuritiesMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Investments [Table]",
        "label": "Investments [Line Items]",
        "terseLabel": "Investments [Line Items]"
       }
      }
     },
     "localname": "InvestmentsLineItems",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_InvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments [Table]",
        "label": "Investments [Table]",
        "terseLabel": "Investments [Table]"
       }
      }
     },
     "localname": "InvestmentsTable",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_JUULMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "JUUL [Member]",
        "label": "JUUL [Member]",
        "terseLabel": "JUUL [Member]"
       }
      }
     },
     "localname": "JUULMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_January2018ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "January 2018 Share Repurchase Program [Member]",
        "label": "January 2018 Share Repurchase Program [Member]",
        "terseLabel": "January 2018 Share Repurchase Program [Member]"
       }
      }
     },
     "localname": "January2018ShareRepurchaseProgramMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_July2019ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "July 2019 Share Repurchase Program [Member]",
        "label": "July 2019 Share Repurchase Program [Member]",
        "terseLabel": "July 2019 Share Repurchase Program [Member]"
       }
      }
     },
     "localname": "July2019ShareRepurchaseProgramMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LightsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lights [Member]",
        "label": "Lights [Member]",
        "terseLabel": "Lights [Member]"
       }
      }
     },
     "localname": "LightsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LightsUltraLightsClassActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lights/Ultra Lights Class Actions [Member]",
        "label": "Lights Ultra Lights Class Actions [Member]",
        "terseLabel": "Lights Ultra Lights Class Actions [Member]"
       }
      }
     },
     "localname": "LightsUltraLightsClassActionsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LitigationCasesResultsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation Cases Results [Member]",
        "label": "Litigation Cases Results [Member]",
        "terseLabel": "Litigation Cases Results [Member]"
       }
      }
     },
     "localname": "LitigationCasesResultsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LitigationEscrowDeposit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation Escrow Deposit",
        "label": "Litigation Escrow Deposit",
        "terseLabel": "Security posted for appeal of judgments"
       }
      }
     },
     "localname": "LitigationEscrowDeposit",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAnnualLegalFeesPayableMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation Settlement, Annual Legal Fees Payable, Maximum",
        "label": "Litigation Settlement, Annual Legal Fees Payable, Maximum",
        "terseLabel": "State settlement agreements attorney fees annual cap"
       }
      }
     },
     "localname": "LitigationSettlementAnnualLegalFeesPayableMaximum",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAnnualPaymentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation Settlement, Annual Payment Amount",
        "label": "Litigation Settlement, Annual Payment Amount",
        "terseLabel": "State settlement agreements annual payments"
       }
      }
     },
     "localname": "LitigationSettlementAnnualPaymentAmount",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementEstimateofPossibleGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation Settlement, Estimate of Possible Gain",
        "label": "Litigation Settlement, Estimate of Possible Gain",
        "terseLabel": "Estimate of possible gain"
       }
      }
     },
     "localname": "LitigationSettlementEstimateofPossibleGain",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyClaimsDecided": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided",
        "label": "Loss Contingency, Claims Decided",
        "terseLabel": "Number of verdicts returned"
       }
      }
     },
     "localname": "LossContingencyClaimsDecided",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsDecidedFavorableNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided Favorable, Number",
        "label": "Loss Contingency, Claims Decided Favorable, Number",
        "terseLabel": "Number of favorable verdicts"
       }
      }
     },
     "localname": "LossContingencyClaimsDecidedFavorableNumber",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsDecidedUnfavorableNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided Unfavorable, Number",
        "label": "Loss Contingency, Claims Decided Unfavorable, Number",
        "terseLabel": "Number of unfavorable verdicts"
       }
      }
     },
     "localname": "LossContingencyClaimsDecidedUnfavorableNumber",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsNotCertifiedNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Claims Not Certified, Number",
        "label": "Loss Contingency, Claims Not Certified, Number",
        "terseLabel": "Claims not certified, number"
       }
      }
     },
     "localname": "LossContingencyClaimsNotCertifiedNumber",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsResolvedNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Claims Resolved, Number",
        "label": "Loss Contingency, Claims Resolved, Number",
        "terseLabel": "Number of claims resolved"
       }
      }
     },
     "localname": "LossContingencyClaimsResolvedNumber",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClassActionLawsuit": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Class Action Lawsuit",
        "label": "Loss Contingency, Class Action Lawsuit",
        "terseLabel": "Loss contingency, class action lawsuit"
       }
      }
     },
     "localname": "LossContingencyClassActionLawsuit",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClassNotCertifiedNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Class Not Certified, Number",
        "label": "Loss Contingency, Class Not Certified, Number",
        "terseLabel": "Class not certified"
       }
      }
     },
     "localname": "LossContingencyClassNotCertifiedNumber",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Compensatory Damages Awarded, Allocation Percentage",
        "label": "Loss Contingency, Compensatory Damages Awarded, Allocation Percentage",
        "terseLabel": "Compensatory damages award, allocation percentage"
       }
      }
     },
     "localname": "LossContingencyCompensatoryDamagesAwardedAllocationPercentage",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_LossContingencyCompensatoryDamagesAwardedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Compensatory Damages Awarded, Value",
        "label": "Loss Contingency, Compensatory Damages Awarded, Value",
        "terseLabel": "Compensatory damages awarded"
       }
      }
     },
     "localname": "LossContingencyCompensatoryDamagesAwardedValue",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyNumberOfCases": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases",
        "label": "Loss Contingency, Number Of Cases",
        "verboseLabel": "Number of cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfCases",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfCasesTriedinASingleProceeding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases Tried in A Single Proceeding",
        "label": "Loss Contingency, Number Of Cases Tried in A Single Proceeding",
        "terseLabel": "Loss contingency, number of cases tried in a single proceeding"
       }
      }
     },
     "localname": "LossContingencyNumberOfCasesTriedinASingleProceeding",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases With Payments A Year Or More Ago",
        "label": "Loss Contingency, Number Of Cases With Payments A Year Or More Ago",
        "terseLabel": "Loss Contingency, Number Of Cases With Payments A Year Or More Ago"
       }
      }
     },
     "localname": "LossContingencyNumberOfCasesWithPaymentsAYearOrMoreAgo",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfDisputesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Disputes Outstanding",
        "label": "Loss Contingency, Number Of Disputes Outstanding",
        "terseLabel": "Loss contingency, number of disputes outstanding"
       }
      }
     },
     "localname": "LossContingencyNumberOfDisputesOutstanding",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfInactiveCases": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Inactive Cases",
        "label": "Loss Contingency, Number Of Inactive Cases",
        "terseLabel": "Loss contingency, number of inactive cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfInactiveCases",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfInactiveClassActionLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Inactive Class Action Lawsuits",
        "label": "Loss Contingency, Number Of Inactive Class Action Lawsuits",
        "terseLabel": "Loss contingency, number of inactive class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfInactiveClassActionLawsuits",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfPreTrialResolutionCases": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Pre-Trial Resolution Cases",
        "label": "Loss Contingency, Number Of Pre-Trial Resolution Cases",
        "terseLabel": "Loss contingency, number of pre-trial resolution cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfPreTrialResolutionCases",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits",
        "label": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits",
        "terseLabel": "Loss contingency, number of shareholders filing class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfShareholdersFilingClassActionLawsuits",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional States Extended with Settled Litigation",
        "label": "Loss Contingency, Number of Additional States Extended with Settled Litigation",
        "terseLabel": "Loss contingency, number of additional states extended with settled litigation"
       }
      }
     },
     "localname": "LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofAdditionalStateswithSettledLitigation": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional States with Settled Litigation",
        "label": "Loss Contingency, Number of Additional States with Settled Litigation",
        "terseLabel": "Loss contingency, number of additional states added"
       }
      }
     },
     "localname": "LossContingencyNumberofAdditionalStateswithSettledLitigation",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofCasesSetforTrial": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases Set for Trial",
        "label": "Loss Contingency, Number of Cases Set for Trial",
        "terseLabel": "Number of cases set for trial"
       }
      }
     },
     "localname": "LossContingencyNumberofCasesSetforTrial",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Manufacturers",
        "label": "Loss Contingency, Number of Manufacturers",
        "terseLabel": "Number of manufacturers"
       }
      }
     },
     "localname": "LossContingencyNumberofManufacturers",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofSettlementDevelopments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of Settlement Developments",
        "label": "Loss Contingency, Number of Settlement Developments",
        "terseLabel": "Loss contingency, number of settlement developments"
       }
      }
     },
     "localname": "LossContingencyNumberofSettlementDevelopments",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStates": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Loss contingency, number of states"
       }
      }
     },
     "localname": "LossContingencyNumberofStates",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStatesRemaining": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of States Remaining",
        "label": "Loss Contingency, Number of States Remaining",
        "terseLabel": "Loss contingency, number of states remaining"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesRemaining",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of States That Cap Bond or Require No Bond",
        "label": "Loss Contingency, Number of States That Cap Bond or Require No Bond",
        "terseLabel": "Number of states that cap bond or require no bond"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesThatCapBondorRequireNoBond",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGeneralInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStatesWithoutDefense": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of States Without Defense",
        "label": "Loss Contingency, Number of States Without Defense",
        "terseLabel": "Number of states without defense"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesWithoutDefense",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStateswithSettledLitigation": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of States with Settled Litigation",
        "label": "Loss Contingency, Number of States with Settled Litigation",
        "terseLabel": "Number of states with settled litigation"
       }
      }
     },
     "localname": "LossContingencyNumberofStateswithSettledLitigation",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Number of States with Settled Litigation, Settlement One",
        "label": "Loss Contingency, Number of States with Settled Litigation, Settlement One",
        "terseLabel": "Loss contingency, number of states with settled litigation including New York, subsequent expansion"
       }
      }
     },
     "localname": "LossContingencyNumberofStateswithSettledLitigationSettlementOne",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants",
        "label": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants",
        "terseLabel": "Loss contingency, period for decertified class members to file individual actions against defendants"
       }
      }
     },
     "localname": "LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_LossContingencyProceedsfromLegalSettlements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, \u200bProceeds from Legal Settlements",
        "label": "Loss Contingency, \u200bProceeds from Legal Settlements",
        "terseLabel": "\u200bProceeds from legal settlements"
       }
      }
     },
     "localname": "LossContingencyProceedsfromLegalSettlements",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyPunitiveDamagesAwardedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Punitive Damages Awarded, Value",
        "label": "Loss Contingency, Punitive Damages Awarded, Value",
        "terseLabel": "Punitive damages awarded"
       }
      }
     },
     "localname": "LossContingencyPunitiveDamagesAwardedValue",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyReductionToCostOfSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Reduction To Cost Of Sales",
        "label": "Loss Contingency, Reduction To Cost Of Sales",
        "terseLabel": "Loss contingency, reduction to cost of sales"
       }
      }
     },
     "localname": "LossContingencyReductionToCostOfSales",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencySettlementAgreementPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Payment Period",
        "label": "Loss Contingency, Settlement Agreement, Payment Period",
        "terseLabel": "Loss contingency, settlement agreement, payment period"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementPaymentPeriod",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_LossContingencySettlementAgreementsNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreements, Number",
        "label": "Loss Contingency, Settlement Agreements, Number",
        "terseLabel": "Settlement agreements, number"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementsNumber",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyStateCourtsNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, State Courts, Number",
        "label": "Loss Contingency, State Courts, Number",
        "terseLabel": "Number of state courts"
       }
      }
     },
     "localname": "LossContingencyStateCourtsNumber",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyUnfavorableVerdictsPendingReversed": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Unfavorable Verdicts Pending/Reversed",
        "label": "Loss Contingency, Unfavorable Verdicts Pending/Reversed",
        "terseLabel": "Number of claims with unfavorable verdicts pending/reversed"
       }
      }
     },
     "localname": "LossContingencyUnfavorableVerdictsPendingReversed",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyVerdictReversedNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Verdict Reversed, Number",
        "label": "Loss Contingency, Verdict Reversed, Number",
        "terseLabel": "Number of verdicts reversed"
       }
      }
     },
     "localname": "LossContingencyVerdictReversedNumber",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyVerdictsUpheld": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Verdicts Upheld",
        "label": "Loss Contingency, Verdicts Upheld",
        "terseLabel": "Number of verdicts upheld"
       }
      }
     },
     "localname": "LossContingencyVerdictsUpheld",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyZeroDamagesVerdictModified": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Zero Damages Verdict Modified",
        "label": "Loss Contingency, Zero Damages Verdict Modified",
        "terseLabel": "Zero damages verdict modified"
       }
      }
     },
     "localname": "LossContingencyZeroDamagesVerdictModified",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyZeroDamagesVerdicts": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Zero Damages Verdicts",
        "label": "Loss Contingency, Zero Damages Verdicts",
        "terseLabel": "Zero damages verdicts"
       }
      }
     },
     "localname": "LossContingencyZeroDamagesVerdicts",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_MarketingAdministrationAndResearchCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Marketing Administration And Research Costs [Member]",
        "label": "Marketing Administration And Research Costs [Member]",
        "terseLabel": "Marketing Administration And Research Costs [Member]"
       }
      }
     },
     "localname": "MarketingAdministrationAndResearchCostsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_MarketingAdministrationandResearchCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.",
        "label": "Marketing, Administration and Research Costs",
        "terseLabel": "Marketing, administration and research costs"
       }
      }
     },
     "localname": "MarketingAdministrationandResearchCosts",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_MarylandMissouriNewMexicoandPennsylvaniaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maryland, Missouri, New Mexico and Pennsylvania [Member]",
        "label": "Maryland, Missouri, New Mexico and Pennsylvania [Member]",
        "terseLabel": "Maryland, Missouri, New Mexico and Pennsylvania [Member]"
       }
      }
     },
     "localname": "MarylandMissouriNewMexicoandPennsylvaniaMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_MaximumBondForAllDefendants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum Bond For All Defendants",
        "label": "Maximum Bond For All Defendants",
        "terseLabel": "Maximum bond for all defendants"
       }
      }
     },
     "localname": "MaximumBondForAllDefendants",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_MeasurementInputWeightedAverageExpectedTermMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement Input, Weighted Average Expected Term [Member]",
        "label": "Measurement Input, Weighted Average Expected Term [Member]",
        "terseLabel": "Weighted Average Expected Term [Member]"
       }
      }
     },
     "localname": "MeasurementInputWeightedAverageExpectedTermMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Income (Loss) Available to Common Stockholders, Basic and Diluted",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic and Diluted",
        "totalLabel": "Earnings (losses) for basic and diluted EPS"
       }
      }
     },
     "localname": "NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherRestructuringCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Implementation Costs",
        "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Implementation Costs",
        "terseLabel": "Plus amounts included in net period benefit income, excluding service cost, Implementation Costs"
       }
      }
     },
     "localname": "NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Restructuring Charges",
        "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Restructuring Charges",
        "totalLabel": "Plus amounts included in net periodic benefit income, excluding service cost, Total"
       }
      }
     },
     "localname": "NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails": {
       "order": 2.0,
       "parentTag": "mo_AssetImpairmentandBusinessExitCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Periodic Defined Benefits Income (Reversal of Income), Excluding Service Cost Component, Asset Impairment And Business Exit Costs",
        "label": "Net Periodic Defined Benefits Income (Reversal of Income), Excluding Service Cost Component, Asset Impairment And Business Exit Costs",
        "terseLabel": "Plus amounts included in net periodic benefit income, excluding service cost, Asset Impairment and Exit Costs"
       }
      }
     },
     "localname": "NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_NonEngleProgenyCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non Engle Progeny Cases [Member]",
        "label": "Non Engle Progeny Cases [Member]",
        "terseLabel": "Non Engle Progeny Cases [Member]"
       }
      }
     },
     "localname": "NonEngleProgenyCasesMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingAndHealthCasePrincipeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking And Health Case, Principe",
        "label": "Non-Engle Progeny Smoking And Health Case, Principe [Member]",
        "terseLabel": "Non-Engle Progeny Smoking And Health Case, Principe [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingAndHealthCasePrincipeMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingandHealthCaseGentileMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking and Health Case, Gentile",
        "label": "Non-Engle Progeny Smoking and Health Case, Gentile [Member]",
        "terseLabel": "Non-Engle Progeny Smoking and Health Case, Gentile [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingandHealthCaseGentileMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingandHealthCaseGreeneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking and Health Case, Greene [Member]",
        "label": "Non-Engle Progeny Smoking and Health Case, Greene [Member]",
        "terseLabel": "Non-Engle Progeny Smoking and Health Case, Greene [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingandHealthCaseGreeneMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingandHealthCaseLaramieMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking and Health Case, Laramie [Member] [Member]",
        "label": "Non-Engle Progeny Smoking and Health Case, Laramie [Member]",
        "terseLabel": "Non-Engle Progeny Smoking and Health Case, Laramie [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingandHealthCaseLaramieMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NumberofDirectorsNominated": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Directors Nominated",
        "label": "Number of Directors Nominated",
        "terseLabel": "Number of directors nominated"
       }
      }
     },
     "localname": "NumberofDirectorsNominated",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_NumberofMembersOntheBoardofDirectors": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Members On the Board of Directors",
        "label": "Number of Members On the Board of Directors",
        "terseLabel": "Number of members on the Board of Directors"
       }
      }
     },
     "localname": "NumberofMembersOntheBoardofDirectors",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles",
        "label": "Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles",
        "terseLabel": "OCI"
       }
      }
     },
     "localname": "OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OralTobaccoSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Oral Tobacco Segment [Member]",
        "label": "Oral Tobacco Segment [Member]",
        "terseLabel": "Oral Tobacco Segment [Member]",
        "verboseLabel": "Oral Tobacco Segment [Member]"
       }
      }
     },
     "localname": "OralTobaccoSegmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Accrued Liabilities [Member]",
        "label": "Other Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities [Member]"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherDisputesUndertheStateSettlementAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Disputes Under the State Settlement Agreements [Member]",
        "label": "Other Disputes Under the State Settlement Agreements [Member]",
        "terseLabel": "Other Disputes Under the State Settlement Agreements [Member]"
       }
      }
     },
     "localname": "OtherDisputesUndertheStateSettlementAgreementsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherInventoryRawMaterialsNetofReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Inventory, Raw Materials, Net of Reserves",
        "label": "Other Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Other raw materials"
       }
      }
     },
     "localname": "OtherInventoryRawMaterialsNetofReserves",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OtherRestructuringCostsIncludingNetPensionCostCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherRestructuringCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Restructuring Costs, Including Net Pension Cost (Credit)",
        "label": "Other Restructuring Costs, Including Net Pension Cost (Credit)",
        "terseLabel": "Total, Implementation Costs"
       }
      }
     },
     "localname": "OtherRestructuringCostsIncludingNetPensionCostCredit",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OtherTabaccoRelatedCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Tabacco-Related Cases [Member]",
        "label": "Other Tabacco-Related Cases [Member]",
        "terseLabel": "Other Tabacco-Related Cases [Member]"
       }
      }
     },
     "localname": "OtherTabaccoRelatedCasesMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted",
        "negatedLabel": "Less: Distributed and undistributed earnings attributable to share-based awards"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PaymentsToAcquireBusinessesAndAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments To Acquire Businesses And Assets",
        "label": "Payments To Acquire Businesses And Assets",
        "negatedTerseLabel": "Acquisitions of businesses and assets"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesAndAssets",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments To Acquire Equity Method Investments And Derivative Instruments, Investing Activities",
        "label": "Payments To Acquire Equity Method Investments And Derivative Instruments, Investing Activities",
        "negatedTerseLabel": "Investment in Cronos"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments to Acquire Equity Method Investments and Derivative Instruments, Investing",
        "label": "Payments to Acquire Equity Method Investments and Derivative Instruments, Investing",
        "terseLabel": "Equity method investments, purchase price"
       }
      }
     },
     "localname": "PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments to Acquire Equity Securities Without Readily Determinable Fair Value",
        "label": "Payments to Acquire Equity Securities Without Readily Determinable Fair Value",
        "terseLabel": "Payments to acquire equity securities"
       }
      }
     },
     "localname": "PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PendingIndividualLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pending Individual Lawsuits [Member]",
        "label": "Pending Individual Lawsuits [Member]",
        "terseLabel": "Pending Individual Lawsuits [Member]"
       }
      }
     },
     "localname": "PendingIndividualLawsuitsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingLawsuitFiledBySchoolDistrictMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pending Lawsuit Filed By School District [Member]",
        "label": "Pending Lawsuit Filed By School District [Member]",
        "terseLabel": "Pending Lawsuit Filed By School District [Member]"
       }
      }
     },
     "localname": "PendingLawsuitFiledBySchoolDistrictMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pending Lawsuits Filed By State Or Local Governments [Member]",
        "label": "Pending Lawsuits Filed By State Or Local Governments [Member]",
        "terseLabel": "Pending Lawsuits Filed By State Or Local Governments [Member]"
       }
      }
     },
     "localname": "PendingLawsuitsFiledByStateOrLocalGovernmentsMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisUSAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Philip Morris USA [Member]",
        "label": "Philip Morris USA [Member]",
        "terseLabel": "PM USA [Member]"
       }
      }
     },
     "localname": "PhilipMorrisUSAMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisUSAandAltriaGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Philip Morris USA and Altria Group [Member]",
        "label": "Philip Morris USA and Altria Group [Member]",
        "terseLabel": "Philip Morris USA and Altria Group [Member]"
       }
      }
     },
     "localname": "PhilipMorrisUSAandAltriaGroupMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PreTaxChargesGainIncludedinNetEarning": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pre-Tax Charges (Gain) Included in Net Earning",
        "label": "Pre-Tax Charges (Gain) Included in Net Earning",
        "terseLabel": "Pre-tax charges (gain) included in net earning"
       }
      }
     },
     "localname": "PreTaxChargesGainIncludedinNetEarning",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PreTrialResolutionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pre-Trial Resolution [Member]",
        "label": "Pre-Trial Resolution [Member]",
        "terseLabel": "Pre-Trial Resolution [Member]"
       }
      }
     },
     "localname": "PreTrialResolutionMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_RestructuringChargesIncludingNetPensionCostCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring Charges, Including Net Pension Cost (Credit)",
        "label": "Restructuring Charges, Including Net Pension Cost (Credit)",
        "totalLabel": "Total restructuring"
       }
      }
     },
     "localname": "RestructuringChargesIncludingNetPensionCostCredit",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_RevolvingCreditFacilityDueAugust2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolving Credit Facility Due August 2023 [Member]",
        "label": "Revolving Credit Facility Due August 2023 [Member]",
        "terseLabel": "Revolving Credit Facility Due August 2023 [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityDueAugust2023Member",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ScheduleOfPretaxCOVID19ChargesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Schedule Of Pre-tax COVID-19 Charges [Table]",
        "label": "Schedule Of Pre-tax COVID-19 Charges [Line Items]",
        "terseLabel": "Schedule Of Pre-tax COVID-19 Charges [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfPretaxCOVID19ChargesLineItems",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ScheduleOfPretaxCOVID19ChargesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule Of Pre-tax COVID-19 Charges [Table]",
        "label": "Schedule Of Pre-tax COVID-19 Charges [Table]",
        "terseLabel": "Schedule Of Pre-tax COVID-19 Charges [Table]"
       }
      }
     },
     "localname": "ScheduleOfPretaxCOVID19ChargesTable",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesTable",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Table Text Block] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table Text Block]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Items"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_SmokeableProductsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Smokeable Products Segment [Member]",
        "label": "Smokeable Products Segment [Member]",
        "terseLabel": "Smokeable Products Segment [Member]"
       }
      }
     },
     "localname": "SmokeableProductsSegmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Smoking and Health Class Actions and Aggregated Claims Litigation [Member]",
        "label": "Smoking And Health Class Actions And Aggregated Claims Litigation [Member]",
        "terseLabel": "Smoking and Health Class Actions and Aggregated Claims Litigation [Member]"
       }
      }
     },
     "localname": "SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Repurchase Program, Rescinded Authorized Repurchase Amount",
        "label": "Stock Repurchase Program, Rescinded Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, rescinded authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_TobaccoandHealthJudgmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tobacco and Health Judgment [Member]",
        "label": "Tobacco and Health Judgment [Member]",
        "terseLabel": "Tobacco and Health Judgment [Member]"
       }
      }
     },
     "localname": "TobaccoandHealthJudgmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_TobaccoandHealthLitigationCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tobacco and Health Litigation Cases [Member]",
        "label": "Tobacco and Health Litigation Cases [Member]",
        "terseLabel": "Tobacco and Health Litigation Cases [Member]"
       }
      }
     },
     "localname": "TobaccoandHealthLitigationCasesMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesDueTwoThousandAndThirtyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "USD Denominated Notes Due Two Thousand And Thirty [Member]",
        "label": "USD Denominated Notes Due Two Thousand And Thirty [Member]",
        "terseLabel": "USD Denominated Notes Due 2030 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesDueTwoThousandAndThirtyMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesDueTwoThousandAndTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "USD Denominated Notes Due Two Thousand And Twenty Five [Member]",
        "label": "USD Denominated Notes Due Two Thousand And Twenty Five [Member]",
        "terseLabel": "USD Denominated Notes Due 2025 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesDueTwoThousandAndTwentyFiveMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesDueTwoThousandandFiftyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "USD Denominated Notes Due Two Thousand and Fifty [Member]",
        "label": "USD Denominated Notes Due Two Thousand and Fifty [Member]",
        "terseLabel": "USD Denominated Notes Due 2050 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesDueTwoThousandandFiftyMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "USD Denominated Notes [Member]",
        "label": "USD Denominated Notes [Member]",
        "terseLabel": "USD Denominated Notes [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USTLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "UST Litigation [Member]",
        "label": "UST Litigation [Member]",
        "terseLabel": "UST Litigation [Member]"
       }
      }
     },
     "localname": "USTLitigationMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrecognized Tax Benefits that Would Impact Deferred Tax Rate",
        "label": "Unrecognized Tax Benefits that Would Impact Deferred Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact deferred taxes"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Decrease In Amount",
        "label": "Valuation Allowance, Deferred Tax Asset, Decrease In Amount",
        "negatedTerseLabel": "Reductions to valuation allowance credited to income tax benefit"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetDecreaseInAmount",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Increase In Amount",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase In Amount",
        "terseLabel": "Additions to valuation allowance charged to income tax expense"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetIncreaseInAmount",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation Allowance, Foreign Currency Translation Adjustment",
        "label": "Valuation Allowance, Foreign Currency Translation Adjustment",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ValuationAllowanceForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceRollforwardRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation Allowance Rollforward [Roll Forward]",
        "label": "Valuation Allowance Rollforward [Roll Forward]",
        "terseLabel": "Valuation Allowance Rollforward [Roll Forward]"
       }
      }
     },
     "localname": "ValuationAllowanceRollforwardRollForward",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_WineBusinessStrategicResetMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Wine Business Strategic Reset [Member]",
        "label": "Wine Business Strategic Reset [Member]",
        "terseLabel": "Wine Business Strategic Reset [Member]"
       }
      }
     },
     "localname": "WineBusinessStrategicResetMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_WineSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Wine Segment [Member]",
        "label": "Wine Segment [Member]",
        "terseLabel": "Wine Segment [Member]"
       }
      }
     },
     "localname": "WineSegmentMember",
     "nsuri": "http://www.altria.com/20200930",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r161",
      "r174",
      "r175",
      "r176",
      "r177",
      "r179",
      "r181",
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r161",
      "r174",
      "r175",
      "r176",
      "r177",
      "r179",
      "r181",
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]",
        "verboseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]",
        "verboseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r382",
      "r388",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r530",
      "r578",
      "r580"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r382",
      "r388",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r530",
      "r578",
      "r580"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r326",
      "r382",
      "r388",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r530",
      "r578",
      "r580"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r326",
      "r382",
      "r388",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r530",
      "r578",
      "r580"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]",
        "verboseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r189",
      "r190",
      "r294",
      "r297",
      "r579",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r189",
      "r190",
      "r294",
      "r297",
      "r579",
      "r588",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r252",
      "r383",
      "r498"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_AK": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "ALASKA",
        "terseLabel": "Alaska [Member]"
       }
      }
     },
     "localname": "AK",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_AR": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "ARKANSAS",
        "terseLabel": "Arkansas [Member]"
       }
      }
     },
     "localname": "AR",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CT": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "CONNECTICUT",
        "terseLabel": "Connecticut [Member]"
       }
      }
     },
     "localname": "CT",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_DC": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "DISTRICT OF COLUMBIA",
        "terseLabel": "District of Columbia [Member]"
       }
      }
     },
     "localname": "DC",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_DE": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "DELAWARE",
        "terseLabel": "Delaware [Member]"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_FL": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "FLORIDA",
        "terseLabel": "Florida [Member]"
       }
      }
     },
     "localname": "FL",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_IA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "IOWA",
        "terseLabel": "Iowa [Member]"
       }
      }
     },
     "localname": "IA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_IL": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "ILLINOIS",
        "terseLabel": "Illinois [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_KS": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "KANSAS",
        "terseLabel": "Kansas [Member]"
       }
      }
     },
     "localname": "KS",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_LA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "LOUISIANA",
        "terseLabel": "Louisiana [Member]"
       }
      }
     },
     "localname": "LA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "MASSACHUSETTS",
        "verboseLabel": "Massachusetts [Member]"
       }
      }
     },
     "localname": "MA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MD": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "MARYLAND",
        "terseLabel": "Maryland [Member]"
       }
      }
     },
     "localname": "MD",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MI": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "MICHIGAN",
        "terseLabel": "Michigan [Member]"
       }
      }
     },
     "localname": "MI",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MN": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "MINNESOTA",
        "terseLabel": "Minnesota [Member]"
       }
      }
     },
     "localname": "MN",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MO": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "MISSOURI",
        "terseLabel": "Missouri [Member]"
       }
      }
     },
     "localname": "MO",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MS": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "MISSISSIPPI",
        "terseLabel": "Mississippi [Member]"
       }
      }
     },
     "localname": "MS",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NH": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "NEW HAMPSHIRE",
        "terseLabel": "New Hampshire [Member]"
       }
      }
     },
     "localname": "NH",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NJ": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "NEW JERSEY",
        "terseLabel": "New Jersey [Member]"
       }
      }
     },
     "localname": "NJ",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NM": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "NEW MEXICO",
        "terseLabel": "NEW MEXICO"
       }
      }
     },
     "localname": "NM",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NV": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "NEVADA",
        "terseLabel": "Nevada [Member]"
       }
      }
     },
     "localname": "NV",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NY": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "NEW YORK",
        "terseLabel": "New York [Member]"
       }
      }
     },
     "localname": "NY",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OH": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "OHIO",
        "terseLabel": "Ohio [Member]"
       }
      }
     },
     "localname": "OH",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OK": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "OKLAHOMA",
        "terseLabel": "Oklahoma [Member]"
       }
      }
     },
     "localname": "OK",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OR": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "OREGON",
        "terseLabel": "Oregon [Member]"
       }
      }
     },
     "localname": "OR",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_PA": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "PENNSYLVANIA",
        "terseLabel": "Pennsylvania [Member]"
       }
      }
     },
     "localname": "PA",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_RI": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "RHODE ISLAND",
        "terseLabel": "Rhode Island [Member]"
       }
      }
     },
     "localname": "RI",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_SC": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SOUTH CAROLINA",
        "terseLabel": "South Carolina [Member]"
       }
      }
     },
     "localname": "SC",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TN": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "TENNESSEE",
        "terseLabel": "Tennessee [Member]"
       }
      }
     },
     "localname": "TN",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "Texas [Member]"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WI": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "WISCONSIN",
        "terseLabel": "Wisconsin [Member]"
       }
      }
     },
     "localname": "WI",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WV": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "WEST VIRGINIA",
        "terseLabel": "West Virginia [Member]"
       }
      }
     },
     "localname": "WV",
     "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued liabilities:"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Marketing"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r61",
      "r68",
      "r70",
      "r434"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Benefit Plans [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "auth_ref": [
      "r63",
      "r68",
      "r70",
      "r434"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "terseLabel": "Prior service cost/credit [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r60",
      "r68",
      "r70",
      "r434"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Net loss [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r37",
      "r233"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r65",
      "r67",
      "r68",
      "r559",
      "r585",
      "r586"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive losses"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r64",
      "r68",
      "r70",
      "r120",
      "r121",
      "r122",
      "r434",
      "r581",
      "r582"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Losses [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r58",
      "r68",
      "r70",
      "r434",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Currency Translation Adjustments and Other [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r390",
      "r391",
      "r392"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings (losses) to operating cash flows:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r157",
      "r174",
      "r175",
      "r176",
      "r177",
      "r179"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All Other [Member]"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r110",
      "r229",
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r116",
      "r169",
      "r176",
      "r183",
      "r210",
      "r428",
      "r435",
      "r484",
      "r534",
      "r555"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r54",
      "r116",
      "r210",
      "r428",
      "r435",
      "r484"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets [Member]"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r449",
      "r454"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r420",
      "r421",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business combination, consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r482",
      "r483"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Reported Value Measurement [Member]"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r34",
      "r112"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash, cash equivalents and restricted cash:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r105",
      "r112",
      "r113"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r105",
      "r485"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease)"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r115",
      "r116",
      "r138",
      "r139",
      "r140",
      "r142",
      "r144",
      "r154",
      "r155",
      "r156",
      "r210",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r48",
      "r251",
      "r541",
      "r565"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends declared (usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.33 1/3\u00a0per share (2,805,961,317 shares issued)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r76",
      "r84",
      "r548",
      "r573"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive earnings (losses) attributable to Altria"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r73",
      "r75",
      "r83",
      "r426",
      "r427",
      "r439",
      "r547",
      "r572"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive (earnings) losses attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r73",
      "r75",
      "r82",
      "r425",
      "r439",
      "r546",
      "r571"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive earnings (losses)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r81",
      "r92",
      "r545",
      "r570"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Earnings/Losses"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r283",
      "r284",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r179",
      "r185",
      "r187"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment [Member]",
        "verboseLabel": "General corporate [Member]"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r88",
      "r531"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r535",
      "r536",
      "r554"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r495",
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt instrument, fair value disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One [Member]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt instrument, redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r46",
      "r118",
      "r273",
      "r274",
      "r275",
      "r276",
      "r494",
      "r495",
      "r496",
      "r553"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Possible decrease in unrecognized tax benefits"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r117",
      "r406",
      "r411",
      "r412",
      "r413"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax provision (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r404"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Liabilities, Investments",
        "terseLabel": "Payments for deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r19",
      "r301",
      "r302",
      "r325"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Accrued pension costs"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r303",
      "r342",
      "r366",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Net loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r303",
      "r343",
      "r367",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "verboseLabel": "Prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r319",
      "r327",
      "r329",
      "r370",
      "r372",
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Defined benefit plan, plan assets, contributions by employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": {
     "auth_ref": [
      "r370",
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
        "terseLabel": "Anticipated additional employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r303",
      "r341",
      "r365",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r303",
      "r308",
      "r340",
      "r364",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r338",
      "r362",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit (income) cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Amortization:"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r304",
      "r345",
      "r369"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedLabel": "Curtailment"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r306",
      "r339",
      "r363",
      "r372",
      "r373"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r110",
      "r164"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetMeasurementInput": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of input used to measure derivative asset.",
        "label": "Derivative Asset, Measurement Input",
        "terseLabel": "Derivative asset, measurement input"
       }
      }
     },
     "localname": "DerivativeAssetMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r442",
      "r443",
      "r445"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Derivative asset, notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r55",
      "r56",
      "r452",
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair Value of Assets",
        "verboseLabel": "Derivative asset, fair value, gross asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r55",
      "r56",
      "r452",
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Fair Value of Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedLabel": "Loss on Cronos-related financial instruments",
        "negatedTerseLabel": "Loss on Cronos-related financial instruments",
        "terseLabel": "Loss on Cronos-related financial instruments"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r450",
      "r453",
      "r458",
      "r464"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r447",
      "r450",
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r447",
      "r450",
      "r458",
      "r464",
      "r465",
      "r468",
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r443",
      "r445"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r441",
      "r444",
      "r445",
      "r447",
      "r448",
      "r455",
      "r458",
      "r466",
      "r467",
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.",
        "label": "Description of New Accounting Pronouncements Not yet Adopted [Text Block]",
        "terseLabel": "New Accounting Guidance Not Yet Adopted"
       }
      }
     },
     "localname": "DescriptionOfNewAccountingPronouncementsNotYetAdopted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r9",
      "r43"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Per share data:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r85",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r135",
      "r138",
      "r142",
      "r143",
      "r144",
      "r148",
      "r149",
      "r549",
      "r574"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings (losses) per share attributable to Altria (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r85",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r138",
      "r142",
      "r143",
      "r144",
      "r148",
      "r149",
      "r549",
      "r574"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings (losses) per share attributable to Altria (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Losses) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r124",
      "r131",
      "r133",
      "r153",
      "r214",
      "r272",
      "r277",
      "r390",
      "r391",
      "r392",
      "r407",
      "r408",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityContractMember": {
     "auth_ref": [
      "r327",
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to share prices.",
        "label": "Equity Contract [Member]",
        "terseLabel": "Equity Contract [Member]"
       }
      }
     },
     "localname": "EquityContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r79",
      "r104",
      "r110",
      "r568"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Dividends from ABI"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Equity method investment, impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage",
        "verboseLabel": "Ownership percentage (approximately)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r35",
      "r170",
      "r206"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments",
        "verboseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investments accounted under the equity method.",
        "label": "Equity Method Investments, Fair Value Disclosure",
        "terseLabel": "Fair value of equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r35",
      "r104",
      "r114",
      "r208",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "verboseLabel": "Equity securities without readily determinable fair value, amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "negatedTerseLabel": "Impairment of JUUL equity securities",
        "terseLabel": "Impairment of JUUL equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.",
        "label": "Equity Securities without Readily Determinable Fair Value [Policy Text Block]",
        "terseLabel": "Equity Securities Without Readily Determinable Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r200"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity securities without readily determinable fair value, upward price adjustment, cumulative amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r372",
      "r473",
      "r502",
      "r503",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r472",
      "r479"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r327",
      "r329",
      "r334",
      "r372",
      "r473",
      "r502"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r327",
      "r329",
      "r334",
      "r372",
      "r473",
      "r503"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r372",
      "r473",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r372",
      "r502",
      "r503",
      "r504"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [
      "r476",
      "r478"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": {
     "auth_ref": [
      "r477",
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings",
        "terseLabel": "Pre-tax earnings (losses) recognized in net earnings"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": {
     "auth_ref": [
      "r472",
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at begging of period"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsBeginningandEndingBalancesofFixedpricePreemptiveRightsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r449",
      "r455",
      "r468"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r195",
      "r196",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r327",
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency contracts [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts [Member]"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedTerseLabel": "General corporate expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r225",
      "r226",
      "r533"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r86",
      "r116",
      "r169",
      "r175",
      "r179",
      "r182",
      "r185",
      "r210",
      "r484"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Contingent liability related to performance surety bonds"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r447",
      "r465"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r78",
      "r169",
      "r175",
      "r179",
      "r182",
      "r185",
      "r532",
      "r543",
      "r551",
      "r575"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings (losses) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r79",
      "r110",
      "r166",
      "r206",
      "r542",
      "r568"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "(Earnings) losses from equity investments",
        "terseLabel": "Earnings (losses) from equity investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r399",
      "r403",
      "r405",
      "r409",
      "r414",
      "r416",
      "r417",
      "r418"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r132",
      "r133",
      "r167",
      "r397",
      "r410",
      "r415",
      "r576"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Cash effects of changes:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net",
        "negatedLabel": "Accrued liabilities and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r228",
      "r230"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedTerseLabel": "Interest and other debt expense, net",
        "terseLabel": "Interest and other debt expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r540",
      "r567"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Accrued interest on long-term debt"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r32",
      "r224"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished product"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r52"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "verboseLabel": "Inventories:"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r33",
      "r224"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTableTextBlock": {
     "auth_ref": [
      "r197",
      "r202",
      "r212",
      "r213"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment.",
        "label": "Investment [Table Text Block]",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "InvestmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r197",
      "r202",
      "r212",
      "r213"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Investments in Equity Securities"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r566"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit [Member]"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r42",
      "r116",
      "r177",
      "r210",
      "r429",
      "r435",
      "r436",
      "r484"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities [Abstract]",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r30",
      "r116",
      "r210",
      "r484",
      "r539",
      "r562"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r116",
      "r210",
      "r429",
      "r435",
      "r436",
      "r484"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit line available under the agreement"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Loss contingency, credits to offset payments",
        "verboseLabel": "Amount ordered to be paid from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation settlement"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest expense (income) directly attributable to an award in settlement of litigation.",
        "label": "Litigation Settlement Interest",
        "netLabel": "Litigation settlement interest expense (income)"
       }
      }
     },
     "localname": "LitigationSettlementInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r18",
      "r265",
      "r536",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r46",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermPurchaseCommitmentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Purchase Commitment, Period",
        "terseLabel": "Fulfillment term"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "periodEndLabel": "Accrued liability for tobacco and health litigation items at end of period",
        "periodStartLabel": "Accrued liability for tobacco and health litigation items at beginning of period"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Provision related to litigation recorded"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Loss Contingency Accrual [Roll Forward]",
        "terseLabel": "Loss Contingency Accrual [Roll Forward]"
       }
      }
     },
     "localname": "LossContingencyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Number of claims dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r251",
      "r254",
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded, value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r251",
      "r254",
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Judgments paid (approximately)"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Claims filed, number",
        "verboseLabel": "Number of cases pending"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items [Member]"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Expected Dividend Yield [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Expected Life [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Expected Volatility [Member]"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "verboseLabel": "Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Share price [Member]"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r51",
      "r116",
      "r210",
      "r484",
      "r538",
      "r561"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest, ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling interest, ownership percentage by parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r105",
      "r108",
      "r111"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r71",
      "r74",
      "r80",
      "r111",
      "r116",
      "r123",
      "r126",
      "r127",
      "r128",
      "r129",
      "r132",
      "r133",
      "r141",
      "r169",
      "r175",
      "r179",
      "r182",
      "r185",
      "r210",
      "r484",
      "r544",
      "r569"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings (losses) attributable to Altria",
        "verboseLabel": "Net earnings (losses) attributable to Altria"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r71",
      "r74",
      "r132",
      "r133",
      "r431",
      "r438"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net (earnings) losses attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r269",
      "r431",
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net earnings (losses)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.",
        "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component",
        "negatedLabel": "Net periodic benefit income, excluding service cost",
        "terseLabel": "Net periodic benefit income, excluding service cost"
       }
      }
     },
     "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r278",
      "r419",
      "r433"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Issuance of noncontrolling interest in Helix"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r277",
      "r423"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OciEquityMethodInvestmentAfterTax": {
     "auth_ref": [
      "r204"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI.",
        "label": "OCI, Equity Method Investment, after Tax",
        "terseLabel": "ABI"
       }
      }
     },
     "localname": "OciEquityMethodInvestmentAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r169",
      "r175",
      "r179",
      "r182",
      "r185"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r179",
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r440"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Background and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r43"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r449",
      "r468"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r68",
      "r486",
      "r488",
      "r492"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive earnings (losses) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r68",
      "r77",
      "r486",
      "r488",
      "r492"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "totalLabel": "Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": {
     "auth_ref": [
      "r59",
      "r65",
      "r457",
      "r460",
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax",
        "terseLabel": "Gain (Loss) Recognized in Net Earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain (Loss) Recognized in Accumulated Other Comprehensive Losses"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r72",
      "r75",
      "r77",
      "r81",
      "r272",
      "r486",
      "r491",
      "r492",
      "r545",
      "r570"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive earnings (losses), net of deferred income taxes",
        "verboseLabel": "Other comprehensive earnings (losses), net of deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive earnings (losses), net of deferred income taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r62",
      "r65"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.",
        "label": "Other Cost of Operating Revenue",
        "terseLabel": "Excise taxes on products"
       }
      }
     },
     "localname": "OtherCostOfOperatingRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r449",
      "r468"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets [Member]"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r449",
      "r468"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities [Member]"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r300",
      "r301",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r355",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "verboseLabel": "Postretirement [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r19",
      "r301",
      "r302",
      "r325"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.",
        "label": "Liability, Other Postretirement Defined Benefit Plan, Noncurrent",
        "terseLabel": "Accrued postretirement health care costs"
       }
      }
     },
     "localname": "OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r110",
      "r237",
      "r243",
      "r248"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "totalLabel": "Implementation Costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForDerivativeInstrumentInvestingActivities": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Payments for Derivative Instrument, Investing Activities",
        "terseLabel": "Payments for derivative instrument, investing activities"
       }
      }
     },
     "localname": "PaymentsForDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r93",
      "r96",
      "r119"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r102",
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash spent"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to acquire equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation [Member]"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitContributions": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.",
        "label": "Payment for Pension and Other Postretirement Benefits",
        "negatedLabel": "Pension plan contributions"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitContributions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r326",
      "r328",
      "r334",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r372",
      "r374",
      "r375",
      "r376",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash",
        "terseLabel": "Pension provisions and postretirement, net"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r299",
      "r301",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r355",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r377",
      "r384",
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension [Member]",
        "verboseLabel": "Pension [Member]"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "verboseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Long-term debt issued"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Payments received from litigation settlement"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r98",
      "r101",
      "r119"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r71",
      "r74",
      "r103",
      "r116",
      "r123",
      "r132",
      "r133",
      "r169",
      "r175",
      "r179",
      "r182",
      "r185",
      "r210",
      "r425",
      "r430",
      "r432",
      "r438",
      "r439",
      "r484",
      "r551"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "negatedLabel": "Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (losses)",
        "terseLabel": "Net earnings (losses)",
        "totalLabel": "Net earnings (losses)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r36",
      "r232"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r234",
      "r564"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseCommitmentMember": {
     "auth_ref": [
      "r20",
      "r537",
      "r558"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier. Excludes long-term commitments.",
        "label": "Purchase Commitment [Member]",
        "terseLabel": "Purchase Commitment [Member]"
       }
      }
     },
     "localname": "PurchaseCommitmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r24",
      "r31",
      "r563",
      "r587"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r68",
      "r70",
      "r486",
      "r490",
      "r492"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedLabel": "Amounts reclassified to net earnings (losses)"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r68",
      "r70",
      "r77",
      "r486",
      "r490",
      "r492"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTotalLabel": "Amounts reclassified to net earnings (losses), net of deferred income taxes"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r66",
      "r69"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r267",
      "r268",
      "r270",
      "r271"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Long-term debt repaid",
        "terseLabel": "Long-term debt repaid"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedTerseLabel": "Repayment of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r3",
      "r11",
      "r113"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash included in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r7",
      "r14",
      "r113",
      "r589"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash included in other assets"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Asset Impairment, Exit and Implementation Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r238",
      "r240",
      "r246",
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r110",
      "r237",
      "r243",
      "r248"
     ],
     "calculation": {
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges",
        "totalLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails",
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails",
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Asset impairment and exit costs, net of cash paid"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r239",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring reserve, end of period",
        "periodStartLabel": "Restructuring reserve, beginning of period"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsMovementinRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r277",
      "r393",
      "r560",
      "r584",
      "r586"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Earnings reinvested in the business"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r124",
      "r131",
      "r133",
      "r214",
      "r390",
      "r391",
      "r392",
      "r407",
      "r408",
      "r581",
      "r583"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Earnings Reinvested in the Business [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r355",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384",
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r355",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384",
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r160",
      "r161",
      "r174",
      "r180",
      "r181",
      "r188",
      "r189",
      "r192",
      "r293",
      "r294",
      "r531"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "verboseLabel": "Net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r296",
      "r298"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues from Contracts with Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.",
        "label": "Revenue, Performance Obligation, Description of Timing",
        "terseLabel": "Expected period for satisfaction of performance obligation"
       }
      }
     },
     "localname": "RevenuePerformanceObligationDescriptionOfTiming",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r68",
      "r491",
      "r492"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r358",
      "r359",
      "r360",
      "r361",
      "r372"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r450",
      "r458",
      "r465"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r1",
      "r116",
      "r209",
      "r210",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r259",
      "r261",
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Contingencies"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Periodic Benefit (Income) Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Derivative Liabilities at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r125",
      "r128",
      "r151",
      "r152"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Recent Accounting Guidance Not Yet Adopted"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r241",
      "r242",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails",
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r241",
      "r242",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r239",
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r169",
      "r172",
      "r178",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r169",
      "r172",
      "r178",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of Share Repurchase Activity"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r174",
      "r175",
      "r176",
      "r177",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r192",
      "r577"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Reporting Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r169",
      "r173",
      "r179",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r191",
      "r192",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation [Member]"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesSettlementwith20StatesandTerritoriesandSettlementwithNewYorkDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r15",
      "r535",
      "r556"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r174",
      "r175",
      "r176",
      "r177",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r192",
      "r227",
      "r236",
      "r240",
      "r249",
      "r577"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsPretaxAssetImpairmentExitandImplementationCostsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r115",
      "r116",
      "r138",
      "r139",
      "r140",
      "r142",
      "r144",
      "r154",
      "r155",
      "r156",
      "r210",
      "r272",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r50",
      "r120",
      "r121",
      "r122",
      "r124",
      "r131",
      "r133",
      "r153",
      "r214",
      "r272",
      "r277",
      "r390",
      "r391",
      "r392",
      "r407",
      "r408",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]",
        "verboseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r153",
      "r531"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "verboseLabel": "Planned share repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r28",
      "r29",
      "r116",
      "r194",
      "r210",
      "r484"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity attributable to Altria"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r116",
      "r120",
      "r121",
      "r122",
      "r124",
      "r131",
      "r210",
      "r214",
      "r277",
      "r390",
      "r391",
      "r392",
      "r407",
      "r408",
      "r423",
      "r424",
      "r437",
      "r484",
      "r486",
      "r487",
      "r492",
      "r582",
      "r583"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r493",
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r493",
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r493",
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesupdateTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ThreatenedLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of threatened litigation against the entity.",
        "label": "Threatened Litigation [Member]",
        "terseLabel": "Threatened Litigation [Member]"
       }
      }
     },
     "localname": "ThreatenedLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r195",
      "r196",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price of repurchased shares, per share (usd per share)",
        "verboseLabel": "Average price per share of shares repurchased (usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r49",
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Cost of Repurchased Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r23",
      "r272",
      "r277"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (shares)",
        "verboseLabel": "Total number of shares repurchased (shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r49",
      "r279",
      "r282"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Cost of repurchased stock (947,542,152 shares at September 30, 2020 and 947,979,763 shares at December 31, 2019)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r272",
      "r277",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Repurchases of common stock",
        "terseLabel": "Aggregate cost of shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/AssetImpairmentExitandImplementationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsPretaxUnrealizedGainsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r394",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofCOVID19RelatedItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r137",
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares for diluted EPS (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted-average shares for basic and diluted EPS (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares, Contingently Issuable",
        "terseLabel": "Plus: contingently issuable performance stock units (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesContingentlyIssuable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.altria.com/role/EarningsLossesPerShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 20
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "http://asc.fasb.org/topic&trid=75115024"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=121548190&loc=d3e32472-111569"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=121548190&loc=d3e32787-111569"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "http://asc.fasb.org/topic&trid=2197064"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r599": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r601": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r602": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r603": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r604": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0000764180-20-000106-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000764180-20-000106-xbrl.zip
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M >H(+RD0,IRE>(6H42SA,=XR3*>8]9P.[98:9!"#M=Q,J$G*;P#'7;!I\9Y
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M+2!2,;4D<S1A@62^Z%#+$E$O%0&E9)(Z0,LN_ :"  $U0B"'XX@10F)![9[
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M-<"]]*S&"VEO^,BU>; ['=U9R(/Y21&UWQN31(?U CS__JE+O%YUH[9< Y7
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M)\60>Q:+SF0YEX&G1O@D(+[V0?A]D.R9X3"N.]30;4[>-WK.//-ZMV1#DS=
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MD (3YMIZW19%N6 :9:.V[T\7DZDL%@_/+K&X1/CAR>PW(3[N@-;3LKPXXP/
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MJXQ 4XX-O'6N7D\M6P(?V2$X)Q2AB4>&Y"@$S"/:S3DX&;K]O90<7 W6V^)
M(%IUII%3]IC)N%"]Z>C:?(ZN_K!']Z^AJP;YL>CV4]>$;A#/E(QE,0ZJR>J(
M:S,YY>1]+9J1G-ENVMONY]MNVKCM)G7'O>5Q\B1@3"0;5<SWFG.18R0ZM]VT
MM]W/M]V/1'>-MLO26UFK/*)<0:S/7 +5!M2; A8NNQMWKZU7UO;#K7-<P:;D
M3+::9%LR7+GFHNE-<-[YW0VW&P%U.U&62-$3YR)2 ;25T0HKI"%5YH!Q=Z/L
MQBQU\\%5&M8@-5 " '(!@W<M.A^%4[6F[FYPW9BE;CZF2H >0AF:M6!4-SGF
MZBVY5&/C6LY!]?X<5#^\$8E>3>VAWK&>'LM1.T/NOBR?S>J; 88_ORIR2"=O
MRO?>FL^FL\6/\]GIB[O3\LWU0^W?&HOX -1OG_H94,?LH^=6"C:-N!UG]D!2
M#"842.9LS&F("(]@>/O.;/X[S>N%Q[CN";HKG/B<DK.5;$:''DL$A,JJN=#G
MEFUR8B*_J[[VY!@F.3Y#\JW)NW@;2LNQ.'$]F'C,+,G7S%2CN%!W)CG;KX<>
M5/Z80N^X4E63Q@C.,,;F4!G8.$ISV>U,_KCGW:!27.57AN)R<XD@"E",.343
M@T@*XL/.I+A[W@TJ"_?)>(XD2:,K6+987/4N,7B;K"ME9[+P/>\&-5"02^!:
MFV2G1# VYI(U\/9&L&R33SLUZ7U.N;.J?^7U;9G.3B:KO.&V\!?,O.TH/+ E
M<^\_3+4"L.85:)R$6HWE$(O=&86W9][ -)X+UE=(S7D$Z*FLH9*XEAI*!+&[
MH_'VS!N8RLL.2+T>>H$"S30.G"$Z3 XM!=X=E;=GWL!T7C$Y:+3- *$ <\I4
M7#$&!5ILA'[D.F_8D&]'8/5> "FGFD+(8&J@%FK4P"?<:5#'ON)QV)!O1]E8
M=#6+]!):JF1:0\Q$[&,PIC8O=>3*9MB0;VG@2,6LBYJ_1Q47P5H&8E:1 1%=
M;C!V23%LR+<3RY.7A#E23J9 )H?!->.B5>2]V!I'%,L?R')RUKSNIV.:_KF[
MW4]G;^@'%[>E3:92OY>I_K"3BR9+H>:;<RZ8I.E!(A3OFO7"V:"^,**(/51@
MMQ.78T9)6:D"O:5@4 5F"S@AKH8C&-DABUV53OQIIO[[\L1S8+\0(\Y.$H52
MD\T,J=8<:Z[>"K+>I94_K;W98SU>NP[$J503>W,;X)*YH+4&@^46T"./2&\/
MU6%O:5$TH'$UE((Q @5+-=2&H@F5,ZDRCDA5#Q78[6AG= U3):-^&2%9C]8Y
M,5!*+0A >8<L=D#>>3M&3!BR5,B)JH *Z4R]DW..0>-PBV?S/#MBQ /">DL;
M'J)/76Q9*PW8$MN*M;%/WE!+.."R&=??1'Y($>!:RF[TXB@5$$IC@L:1*J0@
MKK32-'S'/?C#]1S7PH=@HX)OV5--X%+-@3U;J36HVX<P@HI/#Y?J!_M[+G:L
MG;R83?MPZ%7P;I9R>G)Z?#:I^C90*^QNUN>G9X.AU[QM95T56# )-9\Y>35;
M;R2WB"Y&8U,O[1!&T(+W [B=S-Z&[/U[VA8WE\OYA$^7Q,?R:/83S<<#8%)=
ME4D5%YL(F%VNS11NC%R]DQ1&#^![#._17$WM;$IB= 97O&\^9B/)!H@I<:NM
M(%8?G&V!TXC&)0?O,;<_,FE*;23"H;@,3(FI 8&+4H,4,K@[: _(SPX!=L6<
M8DGL45,CGZUZ9)=;4J-/X7)+RP[ OCWOO'V4K>GMTV).Y 38,8*8#(F+9L":
M$8V@$OS@/?CU5*<MSF+-N3(I;B5FIYFK#XU#P&;"@'/7\?GB:P'01FN$C.O;
M!,$FDPD5P4!-]6\)9]VJ1@W@$#3O&O'*17PD;YS/KN^N4\U;/!O1AYI;Y7R.
M5]PEO+;J*.-Z<',F0>"6#04+C!;U'Y^SB0R$]BRW'#5N@W64:P*0C7$1($D'
M,$3,F7QJS7DB297CZ $<BJ-<$UXYQYB]ZI+(BE=BK+:0=P55IT2#8YHJ';S'
MW/YD*;:"35@BI Q94E99&GM!W1Q\BAEW!^T!^=GMP]X:%Q.J#\( &F$Y9\RE
M]BK*K5<2VQW8AS,XL'F4+3AI+?09,09G"RK&L3IFS52HV+,:<;A;X_+;FQ##
MM8W/BX$,)0>H'@#5#6OXM5PK]"T^2<:/VX!\\;4 "-&J*X7,UB%$PTB:9U)H
MDL6T&N+H 1R"YETC7NA)(Z)C5VH#;WJ.@C5@:J'XE#R,:/'VX#WF]I=OFSX.
MI&JG2+$0$5FJ@]Q8-7 J!+0[: _(SVX?=FPU:PZKAEX)5.LR6,ZBTJAIA%4*
M[ [LP]"\VT&9F\\U&RJM9&BDD1>#-:IX):A?3^>]N'8+W&TN EO;8LYFL0"%
M6)M3^<2L.JGF*H(<;6_#-7;<!N2+KP5 )I."8+0U]AZ;.6=L"5OK]0QCQCAZ
M  >A>=>'ESA7J[,N,ZGF<0F+S<5Q2J994Q*<X[53X_);=91K&I_W%<"GG*)7
M]<H2.6A**613$FM-H-'C-EA'N28 &S"A,\VA%8AD,$2TZC6#"346=*,'<"B.
M<EUX64RUHN]=K !*(LT</)<^LB.9V(]H/]G@/>;V=Y15,(PE"B!8*%93AA C
ML".TI/F$[ [: _*SVX>]A.)2EEP0 @0)ZJ"-CUE?XY2K:;L#^W &!S:/LF:7
M!FU"4Z/KE6 )&P";PE12:",KR%*.:;'0JY05<$>GRZ/V%J:K#7X=^[D\Z^_M
MU;7*[.2=;8!_]2KKVJ:XYH!T*,M?IG0RFR\G?TB]J"&VB^N^,V=/FEM3]@B8
MD'QUOF8;I'*NHYJQV#-Y($S>SH!MR<%;(2?%>J@I93*YM!ISUG!K6QG14I0]
MDP?"Y.TLMRDAN)1B[GLJ(<1$%8M0@Q!:<[6Y$6G(/9,'PN3MZ.160\@.7,%$
M@#ZKQ*@EQ99*97(\IO8P>R:_G\D_*1GF#V7^<E+DUFRQO#67NIN5&:LW!5O(
MMC4/*(6"6)=+\C;EH!GA7BKOR3P:M9P29'29BPL.DA,TU%1=-/"8LIB]6MZ3
M>3R"N6\UT,2/"U8'E3-7R=46$<T%32SCJM2W)_-0R+RE4H0HW"@W="6"4<D1
M-?ESC8+SJC>81Z29-SM-N!LV-DIIC)2J9G824*R2"++++C:PI51#*HE')(WW
MG-TX9[>D@-7!2JJFQF) 8N1L"Q1/UC= -ZKBZWO.;L7/;J&N/%EQ3)%:+F!K
MY=@B.['Z%^1D[8B$[IZS6_&S6Q@#=LE"C56H!3"%,081%O V P?:CP$/@QQ;
MZN)MHL-F)516N2B"2A8?3"C-!V^QC4@X[C(YMK0%"W(Q5I-A20X8 @>5985=
M$ _L>4R-MG>9'-N10E%4JJ>,CKB'E<H>!8Q03S=M.ZL]/!(IM,ODV%*+2ZBV
MS\U93PY\Z1X$))%C[TV#-LHQM.]/%RI_%XN'9Y=XL_CZX<GL-^GKJG^:S^II
M65Z<L8MZ(3@N45)I)1H(A0E[VS3(AJU!7_R(],)0@=U.K*\(Q31QOGH/4)%,
M;E@TZJ< V8<THE@_5&"W$Z<Y1!^=N-"( 3GF! F-1N@"UM?+IK1CB--#!79+
M,9:< Q/ QU:@!9MCJ%BS"<T 5S>FO/[#P![-Z?C1C*F4V0Y'UVJ*-44:&&R
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MJ$#J% "MXV2\KQB%T2LYSDN.&N?RT.CV\<L9WM?^\*?Y1+W("[ENF-R!RVN
M*?D<Q1IT)C(@M&R\IGV:<:@?K\G(6:_S(7J%3X;I2M^W'^<BTVL%Z=VD[3-
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MOT%CAT>03T%NM8?C6FT7^U#N>FP77>O9O.>DP=/D'#5DBO75:C)I(PVW\\L
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MO5<<49C F\OST@ECYD<FBGYKHI[72DQ2#&&^"N2M%FX8_&+'9,%VP^1/J34
M0-;R$070GBEG?G0/8Z@-LMM5:]O!L-8OLGY?Z+C?_69[#_A.OS5LP0U'F2VQ
M#V,X/>L/SG**R[!7VXNC+0!"?W&_9K:4TR_7_?#5XU)<")E;CHLQ:UJPQZ2X
M,+8FS/TR,1Z4.:/7&)U]/C_C:TK=+\EE3OG\4XL]O@7*U\/BKM&[CEK,ET5\
MC^[.XV>S-6P7^6#1^J.:S[V%GBO'=Y94?#Z^R#U7I]FW!>'<N^@X&,L\HB<O
M.K[&.&6P@$C\,C(0-5"EYT<M^,N5OOTV#_]ND1WKRD*5G@YK@UZ[%6J3L<Q
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MKZ><VB CUE9YQ"'DD'U.D4NK7>1I!.T4YE:DA=1S3%=7X+Y 7VV!>YWA/O$
M8R>55#D=+N,QEXP"I#T#9(U(Y&X(I;EDE)Z[5G&!>XV] @MP;1:8UQ#F$_<H
MMS()TUHDC;>(4PC(*FN0]X9Z!URIX#:VB:A'YK6"\)6I1EZ07@ND3QR%GOK(
M9-+@U(B$]"1A9 )H)*T!Z3P66"2DTT7MZ-;(&[@RCHN=W]X]JF/O1W1WR]"M
M"-W-8M \HK_"M][\WUEK>+X'P^->>-?] B/FVLGG; MSS<A<'Z8\#R:8)&EB
M$8T!(RX(1LY)CHPW)$@=DV:2&]N&ZOES!=0H7<HS1^TR(\0*5A>,U2FW 6/8
M.4H0,\G X,)J9'-Y'0"BG=;,214VM@5;4'ZY@M<Z:MG'BX@JR%TP<B>> &*"
M2LL#AP!+0%Q)BK3T FDMB&4,C MZ3D]  6U]E>P"/ $%JH\*U<E2GDK/';B(
M(L1<_QR+M)1G&@6=UO%8!)7LY+24IS?3#RY/RZY;$,+KLWX?NOZ\,>RGN[2K
M/$$->^G/&E29:7K9_54B%%9UR?\#%^?;7C]UN'LQ"P[R)!CU=:<;#B93HG@X
MYZ/%Z6-W7 .1H"-RA C$L53(*AJ1QEKC)'(J:+9@%A#I7?8R:FC!+-Y-4/!=
M WQ/? N<1F$YCPBTM<GLX=D%R T*E$<0"B+-24-O>@%+1,*SP?B3!B04C#\5
MQB=>B 1J"@YC1!W5B$OKD8G>(NJY91*<5,#2TF9N_V$!>8U-]N5$)12X/Q7<
M)YZ,7,E+:0:(!YI,]A@!.:\=4CZ0H(&Z1/@;VS?1OLIU'^_MMIA*+CJ^!<KM
M7W*ZI2[='ZV<+G;X$A&V)2H^6:$C37?F4KWRN(+4[7&GCV)=2XV\)-_T?$=V
M5UM;+,?!4[C_(=Q_/N6N$4E>&@N*?("D "C7R!)A$0:)7;+OI:%^8]N0FR=*
M'EH"8ODG\POD5\[34X#^,*!/_#:1RK2B<Q@%S1GBR83/*3@ I76\L!$;"B*M
MZ0B_N;4\5]'!@O8:H[TFX20%]PO'_<278RS#6M* @C4!\62?Y8@20$F]NRB=
M)BR?&"WJ?2T O]10E +SA<-\XL.!1,G"T>S#R0?#N>8HJ7N!TBHL^J!4"#)G
M.^5S'Q5]*K2/_3P7';F8QB-_PZ*]O4]TCX6E,2^=?)Z=7.19*VI6(#[KQ\[*
M<@ZKYFEC[IUD[A:]?Z'ST[OV61[F/WO]:F=G..RWW%E57^N@U^QU<Z?[O79Z
MUD_O<AD&& R+G3"#G; _?8Q+2@N09(FL5\E8 .614<H@3 0F1 H?#-W8)IOR
MEACS<CKDV6!_X<Z[ O"E GSBY_.,8H@X(@%6Y)0Q%EGL.()(E>8ZYPPG&]M2
MUBDLO<![=;QU!>A+!?K$L:<P-^"T1)8+,@K$=![K7"R 2$+35\%N;!LY3]Q&
MP7B-,;Z4;-$%_DN%_\3A9UA2Y#)29'@P.:6^189XAFA446/0E)F<"7(S<7\]
M"."IZ]/=%<E$](TP)KVT(*:K#I!?+CP@_VZ,/" -.X6AQK#7Z%Y!4:,UAM$\
M 5#K'1%;BQ"G'Y!J(=%%Y^T_V!GNM?"WBDAW_G%"6V(-1D;F4'>.'=+,&T0)
MEA$H!,5RZKVY5TLEU+V^P%Z ,V3:?OH._5ZP@^."\N6BO/GZ$N68>!ZQ%4BH
MJ! /VB,G,$V:WPL+WA')DK'T__^/IH2^*E!_OE!?BE^DH/LQT#W1X4(;)0-6
M*'&SR$GQ-;)60Y(@YT*G11)S;&.[),E^QKA^O,-J!==/B^O]B=:V3O!(B4?8
M\YP,R^0*SD$A1YUF(C@ GI/EU@C7)7[C2OS&#??%3CN]MX\1UG'/>+71:+UD
M:8Q#[RSWZF*0UK;>XN('Z-EHE9I$R!0=,I,.>3/MWY':)?7O- I!RKP='I&E
M$:,H2?01<\.EJ^)=YL^YOG @+7FKK5!JH=0Z^MH*;SX6;TYYS)0*"DC@*'H5
M$#>)/)V5.?N[I"XRI:50BPPC*JQ96'/-6+/V\5R%/V?ESXG=216AQ/* @ 6/
MN!0.6<TX"ER P0I VF1WIM7%P@Y>%NHLU%FHL_YA<H559V35*8]P8%0#6(ML
M="H?9A?(24,1"X1[8%QIKT9!;_/D%ZX-KU;NY!>5]_26_%P=V__4ZE8_;ZXR
MF8>\^_#TV*09FQ\ &MW>,-UPV,M(# D$D!5$MQH@.TQO8JMKN[YEVZESZ8,J
M%_O6G8G(QK?GV1M^VANTLCA?]B$G OP"K[ZVPO#X8B$Z==58;GARB76I!V?#
MNR^IRQ#*:^%\4W]S;RO6T,)H*04/1"<F<\QI9R3GAFH=L=/Q'THW+BXZOCQ&
M?6H_ 7)]L)\3A-(#OK3MK_9\L/'BZLQ*T^IBT,=I[JX/V9T#$^.C#<QHBB?&
M[?6K') O$V:AGUNE/MG:]*5QW,^*YW]^+J+$50?5UD@O-EYGG=7-D9QV^T+\
MRYA[H^7[S;^W3<D:0F>TP]3X/1'ZZ68C:=ZMJL;#AS,W:(66[;>N)PNLX3.\
MOB3-U].D^>&2*O-\^3#L^<_'O7::=8,J<$F]:HQ*O=3^^9(5U1@>0Z.9OFGL
MI>;'@\:;],CI$>$T/:*#?H/AS49>R5;2RW;9W7DJZ_)8O[2ZC73;=F*#2D*A
MUV[;_F"S =]\>J[&:7JLP;'M0R/)T_Z[_L_S=]>>A5::>C?[NN >F1FHZ<YQ
M&]M#8[V?E=:4A23NL)!&6].7)D-ET/DLN-,!O+QX\2JT!J=M>_ZRU:UZ55UT
MW71+OS+6DL9L*:RRHAR' HQO/]:A6Y4.O6:%CKZC;$OJN[_&6^3.[WYT6[;%
MN5CX7=66-.I!=_WQ=X*QTM<5Z2O!6Y@_[+9/WUF]I=7#P+6,2: Y7Y&^ZBU%
MS;WN^I/XJ(<>]7I:781OT45W>T%_'KNI[O/\(X7U-".@[U<G_:&Q73.D5JK%
MA+C?<"QN0CR7QR]@_^'NR S.PWH3P>M>I]/K_NKZ+[:K1>E]PCL7E;[MV0SB
M3NIK]B/9=C60?]I60*W1H+ZVIZUA^KP,Z^S#^F8<DEP-Y'MH5?5O(51OTW)]
M> S5R]_.!NG2P:",\4.FKO=GG;.VO1C7*M'K:.9.[X)5G_RG"@POP_P@FAWD
MPBWCF7QZUO?'=C >\L*[#QW5YEAS31W=J=Z_NY%9X;$MNOJ-S4%O.%9'MSB;
MJ\^O.9R7D>9C">;@;[9MNQX&FXU=\&-W-=FLO-2/44;Z9]>M2M3+_0;W_D$O
M,S_^DF):[O?<,T2T8.YX+M_EL?!<>7#  .MH770@3(1_WN6I2"@C/PZ=GD;U
M",FKG,+I?*]U$<_R"3>_?^+[NT>=HY._Q-'!7_3P^R>QM[OW;8\>=0Z_^Z_[
MNY_PT4&[<QG/DMHU.T?MH\[[SE&GV=X_2'WKY!B8';QW<GC>_/T=/CHY:AT=
M?!;7XUE2/])=<RQ,NC?]6S1W_V@=??RCLY>>KWGR#A^>O.\T.W^D>[;CWG2I
M;$TQI11;I#RQB#MJD V$(4J"QS8([&G<V#9L[DRLLR)ER<>:"^$5PKM*>)9$
M8)H&ZB3W$!R3T5DG393,.>SN)KQ[!^P5+EP&%^+IDL-I<EN+M*(4<0T$.:T
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M0\7"B?1,FC,BA!4(.P?D3Q*#C)8"Z4*3P@3J"FTWMC';9.+&Z?#O"A"?2BW
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MN V#8O2,G]5(7G19?]!KWPH8^/3:-SF7\'LKY$R4;;\S,:7UJKC$JKC_?H*
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M>9@[/&PJ_#W;R/XQ",C1<1Z/*^5BLS&>CP];[[<:[T\ZWT+6G,.J72\[)Z
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M<QK#Y\,S7'6.=;A CXYZ).SIY;,/C:/0R8=GFBZ]S/06J)<S*Q /5HX^'G=
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MLO*9$NJFS[_Q:S'^5%7ZBVY[#XN%V[+JL2SV4>VL>$H?S\[2IYR;&]WVFJS
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MN(I)PC)/AFI!,V-/GMWRE/D[ K FV#%=14.SHAY0^) G".%^K(R0WF:<0?O
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M$V';E#I1$6[H,0-Z*J213.::PY\ *8O%)__9)%B?#F*=_C?LCC[,;@$+BY.
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MTI)0P<>,ZIZ6"[(]?8(3*<&(6O&8346N?=.#7EECB5=.6\D%%(N#>E@,ON8
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M2CZ>SH==:")Y,NC%#0-E&@;#^$6ON'(_IN'%XN37Q9FW97_JUR[)E&O#:F[
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MPI>,'.\5LPIK;D']L=CI&!C1T04<57:+3U9_"G*>&3DC@SRQ)"3#&($VD_.
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M2GV;A8&<H$$01CSED4M"=9!.&::-Q50$AC,#$3-@(/A0&&A)##3*H1H$520
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MC()V"?%D%((U%B,KHA4I:NN2G6/RI<*ZA74+ZZZ$@EM8=]&L.PHR"TYH(K!
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M1M<#'Y]WXCZ\^Y=FVW]=LKJY]^M W3P]/ :5L5F_>@_WO*/UJ[^OZE?PG/T
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M6L\RJ8==4X^TA##&0<V1FH'6DR2REE D#4W,:&X$!JV'%*VG4,^Z4(^P3OF
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M-UK2'?.*8(D1E4+!DFXCLM8Z%$P^+6$$#I*6)?T'@/P<=K\+Y%<7\KO]Z!2
M_?87E9)DPF,4;#Z0@*-"H,;E&$U*-9CQCE);,/\#8'YI9Y0+YA>#^=UKS'OK
M4F09Y"(FQ%/,*;4-11X[:5+ 8,>;@OD? /-SV.DOF%]ES'^ZQKRV1C)C!8J*
MR9R3TR)G&4=4,1N8D,FJE=3M%WSZ>87*O>=4WV=P:SLT?,WUL5.[>0[ZH;W@
MFV)IW7C5:/GV:7S=/\\]^1SW4)#:G1 [J#]);QE(3&B?NV:L#5LYN*#7/GN;
MY:G;;C;"]8_W4O7*!8G\]S1 S6\<5GNIFB4J;9%YW0%Z?PV0-_@V1Z.5]6>F
M]>?=> "(-C2?\,LY<QQ&W)B +!@62":> HF<*Y?/_LU0GG1N&%E,&&FAN$)Q
MJQ0<4RAN/A0WVBJCTE.?F$<J4+"J5?:>8YMS#,%,D:29B (H#A>**Q3WHBAN
ML>%!A=@60FQCD3XZ1BNEC,BI?'"<LXB,5@S9:*G%A@I!<@;3&4_2%78K[/;"
MV&T.D5"%W1;#;B.US5!GO;0)!6((XD%A4-L"09I+Q2*EAD>P3/F,F:$*NQ5V
M>V'LMH!<)(7=YL)N8R%=6'*'L1=@E'J,.$D$.6[S']HXIS6C-&QLD1D3D!1V
M*^RV#NPVB_-MD84V"L_-Q_DV%L?&N;&$\H"XD@;4.$.1M5BAA 5)7@EI--_8
MNEMEHSC?"L6M,\4M-L*O$-N"B&T4K*>%E((1@P08HKE6040&]&T$"IQ5%GY,
MS$S*X%$4N,)N/Q*[+: 62V&W.;';*"S1"NP4$Q(QBAW8IP0CG;4XK+5E4LK
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MZPJB%^[E*8A>+J)'#B*13 !K3"/ M49<:XNT=X!M0V/RSCJ7U*3BNBN$Z!F
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MG2).R\L<'5(!T,8M[4S9.<^DQLF0P&KN9()@3+"2,9^$*:<SI8\_#_IX;''
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M68.@)+&8"7#I""X#@C@;E'7!.*5=H89[9QZKU+".U*#17$@ZTJ@"A:1*CH(
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M8R#>@2$G/$52 #6)\=8E$&_Z->'$5KS76+SO8/Q"*][K)MZS\(,'%:VH%,B
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M(28M6)PX8N1D[K<2F4B1JTC*H=M=Y2VUP-D"9PN<-P&G3,QHKW2T7'+GJ0F
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M_>4F>;JRD&L;\O71N!^V9YQI>\:MP5J^8<^X3P;/KD<*90S"Q$A\D#PIIEG
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MA(+%-&P 850 871<SJ ZV]&7!/P.([6X@29\?N42]03@V2CY9A#I!#UA-6/
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M)G"NB<MM/"SXVHXFZRV5.1.4+J/R7['7&UYTS^S* 5+/N5;:18>-Y\9%:X4
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MJV<!6K"H(L7149-GHCD:5 *4 L&@C KV'IZ R6X=Y['?"W9P4#.&^3*&"?]
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M4(A+YY#!N9L:C803QZDB[J?GX36_K?GMB^:WM<Z\V/SVZ(+?8BFX"<X@J71
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MJ!NSC=X;QE(*9#4&[$1807$%G ](HL(N* @_55':_&6A\33R@A$\&K2^"$@
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M,_,>:+9\Z/?V8QW0JP-Z=4#O&AALI]OX,UI_L%B@>"F>VJA!$JI HP4%R=$
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M"#!ESN#=Y^LKGV ]>5SA*EU?618[FT<8]G*VOGD$[]D_G5J-B8E*)N1YZC*
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M14?GK94MWEK9%\V5YEGS?.OQN;676DD_IDYF0L?[C?;P1A.JBRE:)YU1]J\
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M$?!4I:K(P)#.P6X*$K";4AEXG!4JDWF1^ABIGK2KS[$1I3RG7N]N2R<298@
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MZ"JN\M"#CU50\*1(,.^83HP0<''%;FPT;ZXM8)MW)26:9F=T P=FA3)C[SI
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M^J*L*QIR@;#@;0KE?JW]ID%1N]"%W_6.NO_%]^9<NTJ-MJC:E%O-VS2NM%-
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M4@:YJE>SP/=^[\:[N4^Z#K.NE<U>8P$V[17NTTLU_F3;N ^0/.V'U;9VGX*
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M\GY97X19 .:'$ISVW'+S%S6XK.R  P8A,3>(CF,(24X3%'&7'7&T#EQK3!'
M(L<!NKV?(=[#6A X2ZM9^::[VP[1.9FU0OA%,V%Q>67(MB86G_Z9'3C(NY&#
M.TYUHZYY;&/&"]X_6(=G;LF=0CBQ2[X_5/-5.+*/GO_KZ6,OR+^&M:(Q[-8[
MP\R?6I6"D!3L4'$'FFER$HT#L:$QN2B!3Y=@0BYGR'W5RB5*G:U+AH&H%38F
MV"O$##OX*!M+&,(@ ,X0ZGNV0GS6WG>P$X@^ P1(3F1CL43-"@=)*%B5W/:L
M8A!T!EVU(G3A?J4)+'MRU:!KMT/88C>#H</^M!9WU4Q-TS5%UC2]UXJTP1ZL
M*E#45OFLN*BK=C? O']#1E9["O08V#9007J+RMQFAU0/"]F.C;!^356_H8<8
MQ!!E[HF0MR8X)- DZ%EL..P$2^($:>S*%#EU][:[A;"7FQ[XU'P @THZ^8H>
M/\!V$F=T<X)"7G=G+IQI>=^04/=;T@Z\:A\8UQPE_SD.RR;\^PLR.Y:V%-XX
M?".$!S,R&K\^X340^\!_!O%6*JSB-^#!:'K81.<$MNP.C^&14H$#GYW!>RB+
M/>O0C2C-NT8#9VGG&Z/;JPP 5GM[C:7\!C[)#!I&O0P&!)TL(F-9%3;?]PJ$
M+6+M123=V7]'1WX+DL$O.%B.J%D[% R<PTV!2ZJ4A)_&'N:+<1QPM;P@5\!
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M$!_"&"'FLA%<:,NC0P_E@+!UNVJG^# A[1ZLY5"W].G-O_&8(.PI<L/03(#
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M'&]K!M4DK^9^Z36(MCGR2?+ @<I..CD=D-)?0#5CUD=^H[Y_IJ3WZ&*=CDP
M1TZ=M"N?9[QO,L>>M\(4.1(BQS,*1BL3(5L\;X];%=H&UR9\8$Q4OIYC,F&&
MH>E1\/J565M\@<J"H_HWV#+?6<7LC?R7M]+AZ 5$>'JIZ'>#KPA;9SQNWW9N
MT=P1+DPQO+"$VF0)%;SE_+?AL#WN#2I_[K3MRM\V#6OW8$+CG8;=]%NW;?>'
M!YFL7?VS/NPS;N(:*90;XI&<51H5CMBJEJ4LA,7Y6YR0E^',;3G4:1"T*@_T
MI0PV+M)KJX+GAA/K"NX6H6V"*L*^N2#(T5P4!AW<ILYU'2J>19+ A^TO1GML
M<HU/.>_S]-MA&7X[*7ZSV[T:/7WVGV-<"(L<#42CT6.<6X[%6=S*/'<\1N>3
MI_HZHL[BP3\]TQFZ,K?KY$MISGR#=@-;/N'RDZ-)#],B>HTL)U_A<.8;='0D
M]HM1+4RSZ/6R@=:@4Q=EUJ@/K\V\[;Y].;K#D4M7JSI''R:)Z*!EJA55JF=^
MGU[9-;K<&6WGM7>GLTM_*:/FU!!AIN5UIM[TZIH_1KEYY2WJM+M'!'.]',?(
MBWK>GO!],S;-KAN\.Z -U.@^9;2!77O:%GO>OT0/.+>6I_W6J%L7!^;$6GQ<
M\O9VVX-10W>W81'[PW6U/>HD+T'44X78O0F15RH:-7Q"Q@0\B0B8L0+K2P@3
M'E]/#SV._6'L0^,M/C9UI=)@@N+GEC)^[AMDM_O'V9^+T10JX^"7IA_TC^2@
M- K"E@I"MVL4A$-* A-.UNZ=?@UF,VK!$:R%X_AYSK^<Z%3UF$N->]MUDRJ,
MZO+JB2^=NEF]1GW9-?X-DL#$OZNNS5[+'M;(DC&Q[]/96KM]6]]18N+>EQ#W
M/@.E] 3OI&ITT4LQTH;&L][@W0&MM-=$$_HL+-)U3-H+L74&1[1TC#6ZI35Z
M1(_!)=S\-3#G,FS:O:OL9PH0MOWZFWT,K\:#^A&&4['$#1-?"!-WVH,:65O&
MZ]"#%4W#%+&M&^QVV':6EW"9DT?Y#[8*H[4VYU4(SR^V%AM'A+.&\=SE(CZA
MN]9P6Y/6MMN-:=PN-0K@]R2LM[7P&T>$[8]/V1(;?GQJ)FPWS[MD^.VD^*T>
MQK=QE-5KWV[Q(-F%!<:&O?:.* 0O9*RC[/$V_6],;*[((,=!2CH^@Y2[;NR^
MZ6UPR?Z7.]F0/*?28VVS^J6J592QD$_,0NZVNO;I]SDP/'=*/&>W[?'E@%(<
M&7=Y)UF^U^D>%(O9J@!C-H;_*4D$N(5J0\499Y/AN5>^A8S#R3B<M@HZ]5\[
MYG1\5X+Q-34=DNWX/')NE3-G,6%ZY<?$F?A,*M'P#_G&THGF7D!Y2JB'"Q:\
MP;OF3;^M_RF2:5^<([U@RH+DS0T]M&_N&[1'S]H4W4TVA;U=@Y>]3GJ\Q8S!
MH/D4>6&$G<2]<&HY2Y #26PMG =F31@+K(BY3IQ820C[&\S":&D]>LG"<M,H
M0JPQ\=XJ8K$"+(6G+!?6ZG@!X@]9L*=?84=O\/_!*G3($$2DLMA*%DYB/;*(
M64&8X"@/7IC&_I/EX6YZ,P_L1"<N=/!!:Y)>=.B]1^R&[J>8@#V+PJ5UYR>1
MYY#DNWT;B\_ACU[@!#3,DCEQ"C-N'X3NF:BB$=]X">RWN\U6')8-FC6;C=_&
M'/M9&B4+%ED@0]PTCH&Q6E;,D"O]\+&=M\(U ;(N,80P^/FG2?3CSVOO-67S
M<<F.MEA$\6,/=$B<V8RY"2R*Z@[<<+ER(F?B^0CN!T_%<.P8/T[XCO*YB*.,
MIP4.<0BL[WN\:@F?4\<B>R&!<S-)23+C>>?GB,,/RX>GF>^FXGF^23C1=_ E
M3/XEN"%1,@5K^(/%J0_SBG%-L,YG]E,0J4^B?TV\/GK39"'N?OTMKH2\Z62O
M.!.8#,R]\A5-KW&!F"QZ?16&&*$_*GB8M'\NHHS-Y^QF$C'GZXTS@\F^<?Q'
MYRG^[L?\;0I7J4[ XMHK5SB;'6R%_+J> D?R&KHWH'BRB%^$/SF-F8NUB-CL
M[]_]S1L-QJ/A<-"?VJ-IOSOI34:3\;#?'W='HUEG,IK][^UW/W^A,P"G"G@^
MP9/XTX_.SP>^7#8R$5?XU_]9QEJ*#RHD9%&R*L7K< >DINRL+L8^!NW?6-87
ME--KD[(>09691B"W E!U/%"'X./6Y,D" 4@7W0-J/=-8J#'_N'_^EBONQ<EN
MX7I)[1&WS@M<D*PQG>CO![8%7_()6!MN935/*UZ$C_0WJ@8D">!,P@>QS2G3
M]AANQP5\!C89A@Z7C.\POA<OPZ^,WEU%X31UZ6*<XVW>LN":3T!=]?&6G\6@
M.2M647=VF<(K8'^]X(%)-5LHXGB5<QC "^*LG"[)P"CQXZUU%"38^E]A&_Z1
MQO"A.+8^\\V2VDQ<I<Z<.!$I3P,H2<8@D$J0XLAG56BH@1-%<"RF8![&'"-J
MEOK^S1.<DG+-%8[CA,F3&Y&8QI/>;_<Z^!O^RZ@%2K.P:G'O'6L.WP##EP1Y
M\=7N#_A>_P<+CG\DIF&/GYO&1(J8?KMKMU'T>#$:SY+(^A>%B1O3=_D:LP>%
M4$%N9=]6+(!AN:4LYAFC^C\5,HHSJ%64&@6Z*0DS3^%T!"Z,&-.$IQ8(PL*[
M^ 8:^'B,T". ;@)Z!V?D!3'N&OQ_@@T++.1Q/"I@A_^5@H0#@@$-4#RI;\)L
MN6F!)PJF>A@VL[=BL_\Y)H\O/)]I.[Z9G=1.86L(,OUF9%,J+HW!KH'[* 3Y
MAV."ZLLBW 86/'AP*Y <B]C2@1VSID\!+,A5?&(]PAU(&^,%*9E[RS#P$O3T
M &MY7/;1]Z8@&.!WWJ "?HS3)8O@D\"DP,%XEM* +5=^^,0_"#P#OZ*G,(R)
M004W7STN/'=A+9TG.JQ@]+JX4A"^JQ!U;'3DS-(DC:2J1>P^QQ/(EQ(GWC+U
M4R[%9PP4>W@C]^T)"]C,2^"BI?^.KUNP*F%8XTNK-(*A8YSSA"V<!R^,@!VE
M7>S'85[TX-ES$R>CQ29YQ+A1_\ R]5"))6W/NOWV@(1+=P#_4GUM"[^IL'O1
MUBMX4LO,6RX0E,E,%:+ VKZSBMD;^2]OI1/7"XA!Z:6B+Q.^DAF7[0XW,(5?
M6(PO?F[33X40!/]MU&_;O5[ESYVV7?G;IF'M7GLXO-UJV%)W]O"[POU<%@SE
M-#U2+.2V-!;R1\[I0\R4*Z#Z)7\CYM-WJA(NGXLC[PN"K481>6.VH3HMJA8)
MSR$4G^>TZ>[9NP9+XFRP)!J,8'G69;-W,?H./-4?J 6*B@?_]&JT&;0J<R_.
M%4:K=I:Z2=:J1>%#M; [W5R=':#;3CA-_1@4UGJD@96UQQYIIROH^NUAYW($
MW=%J(RK;<!W&MW70$HB*"H@SE\Z@P-K#)D*[-#CC\)B#G\6%M?>>7:=[477:
MO2-6[%R$1BY;+.UF[)VT:*_3'-(HW2\H"]W%%9B'L!0ACA(4RXOU%>Z?0,T^
ML!@OW^TNV!^)7G3DMRE_Z)75.IC"ANT+&RB=@F=!6PLG-N4,QRIGV)7+G\F6
M>NVSLF7.!B80SD+?#Q\Q;^"*9S-<%Q)S<*LW;G,QQ4?/!5I%(6:*3GFZX9O=
M<@)&%20[1$[ >-3N]@<[I@2 ^G"(E(#;4?6K9YL2<'4ON/&]X,;W.1XL9OF9
M;("# %Y=7#; _4LBC29#X#(R!$#HWNX6_C)9 @V.QYZRQ]&TTCKXO7"8>.SI
M^B+M=K]N/-;X(_<<BKT8^=8U@%2G%;X[7;D&E^G(R+6#,MOO_WW_RXT]OO H
M<:=[.3+M:.E,*E1\>ME+UD5F+^UP+AHD?NL"GYI(L8D4"W=KNW.FD>*7(>,U
M-K16,\98AIHE8[655?'YP%M"\3H5\X@D] /&UO8-9M5\<(V-U"[$*+>N1\?Z
M:_6LI+6JD-Y4$BVVBK: EX!OL\-ZL7FR"-7&!R%'2Z#AFA4L_RT,;OYY=_?)
M^J#"^A]%6/^8  1YQF[Q/ 48U9DS44'O>^R!Q2)W(2',&MPB#J3UA#N00>:L
MHTYH0[E.@ ,P+-O'K<= $?+(HQ--;_PP_$IE^$[LQ05N@/]2.TRNZABA.]8J
M3RW!;NJW$G:; &>F,=.';%D<A\ -4W^*]?DQ2&IO!E(;*^D$.D$:I'$*6X:?
M"&81^RNE.CLDRM2;P<,<$P$S0J8>S!HY5KR*N$#^D_7@ %E TB.)8@0 (,'2
MDF #TY#%(J>$8O_PA!M&\- *T1> ,,0[(A$$J=;"N>1A_V "K?R!*SVMU:?2
M8/0IC+YQP8HP&'W'F,M%8?0U31E00E->Z&>K]E!&%UPV811;4Q:[D3=IJAKQ
MSB'0)"=ZLCZ(&7_!*_LC7#9W),BM#QPSIP$(7DJYX)>XEC77+*+^DID7U,@H
M</PG4$..2CH%3B8QF9!LD1=_C5'/2'0D,9Y@&A*)0X+!*VI5&H+PTID*>#,8
MX0/FQ]J=F_]ZM:-=]9HW_?MWSTMY>SC\[MF/=3OM[@$@XI_/P-N&EVK-O1:-
MC[OL=QC,=T%#ON/89,AUG\">=CW&$Z#?"[7_()3()\*.FF(_NY(H3D:4E4X4
M:0O%PI(@UN%7#ZKH=T& 1@>'V4'31Y[7_Y]L:SSO',LO0&?'+\QERPF<_I[=
MXF!/5_@$SJ;;>4M_4._3'^VWUV]Q$/ATU@X@""V<480&JH1=X[(%#*;M%X08
M)"Y;)9@-SZWR9SPG:UN8;PUACXK>+OMXV_Q__@9BJ?OV=>Z'LO-6H$V_W1\B
M,>[7$&%; @Z6-@?S;[9-)C_V&;*PM((]QAQW;QWP5C @^OC@))#%P#$/^:-+
MEBS"*<'@9YQZE8?(O>8.JBQ%"=0HG^%]*F KL:PCP.LW$&H,59+@5^!J1HA^
MJ=O@'+-J#>VRG3P)-'^)[3^#;UD/CI\R#N7O+N3[^N+X>8,G72>*R,5"K[0M
MZYXK4OF_TS(#;00Z>VS*B:=]DA>B,,L/8V(0_E?0 [C6D,!QMV#J(&U O^08
MDMJ@'N%VQAZ0&D44T0UK%*C]P#1U&2DAV>=:ZGL:C;V8G!;S #A"J=BB*">K
MH:DA)IK#I3JI1+);@<$0VI*#IW+$6> SWTO(B0)R,F9Q3(\A1^B)<U,0N:3I
MD\<L8T[N*WL9BTJ>@H$J9B.^ST3Q4^&**UFT!NB)#-+B<X:=+1D[E@2!/5?<
M7?FT-I/B45KG51_1FXFE<>WY$U/&VX]PMR5P 4X1]!L8.7]V7L+,S]9)O08W
MUS2)[G/["H*S"6O8?"(3ZS,H'$(%ZK2HV*6UF5_Q0B"91HY08"-[-%!@\&!^
MP:N$21LO0#^+)8RQKE;]D3WTF1Z2FA7QB]U5HX417-AHMN?&:G,\^CPO/P?W
M+F>N 3:_L:Z\:[@&E5/WKY24KA7,C>/F.MS%RVL:.7HMC*$^4IP>SAYA[ET?
M#B"O:X1!?F4/S+=L9<]GTUYX#"X-=\%Q=:\\F$TX@9U\$(B_JS3)73-R)#[!
MEA6G<!4Z<6'>.,O8 Q)B" I1[N!)J?FN4;ZU<=+=39/.4)!!>+5(I*H(%,C*
M@*:X\MET3NYS6L>C!PKQ/')0<9#IS+A+()MA9D1RGP(&,F*" F5MTBCUN-R@
M7D!<@M"'Z$OKXRY"'W4=JD'%ZQ9] #Y&P,*@BBPT>N"F>#(XM'O^"0[]#"+;
M2>$(.Z3A^ZBY!!B^1@D>PF&#+]W _[<XSG>!7S@?1PRGTZK2=(H?SB&.XSNZ
M-I/_0/,5@MV/L5,FN(B7URTZY.[O[4[[UIH(N7*UK@M^;P^S![@@PC_9F]\9
M90]<(S8^9AFBR/"?9(0,/[[I5D7]QEFMHO ;V8# 0KWA#UP.VC_DA\0#EUB_
MNTF(R^O>2FF]SCF;Y#=OXD%J9_Z[W]MVNY,MMS"I_@_<&"U9PC4_CVIB0/,M
M)E6YM5,XF\ IT\KO\6H<;B.3+O& 1S031_@3PR<I+2'1_-0RYUCX_;3YB8_F
M8^0,1Z>9B;!J4+8L[4*0]\#2F\9<+*G\4SA=4\:QXY'K,089PG_"]2.D)I9U
M2'&[]A;W-1"XNL)\US\\$9TW\D2@Y_.4F*915FZX=$ +2S"38%W,"X*4'[16
M[N.9BJQ0[VGX@!H@L&B)\5EB8W'=K+%G0I8D%D *G'EL#0,RN\1$0 Y!T]27
M.Z_=0QC7Y3DL%;,F"HB%P5CYC2S_5B438L1=FGTX]Q;W"G%A'H2ZRHLR &<;
M39%-"8&!3Y4\GOAK3J)G'G_!M]7^AYQ+HS>\5'=/.3I'J;MG=[D$VP:;(>YY
M[BS /2IA#3B++M/EX1!O R8[A("2AP=>]$< RXE%\<);Y=0@<D,INY2[!0N9
M7-QFBM$NC<A5 W_+F!Z^.GIK^&9O?..(_>?-);-L%R6&D/SP@/N5Z^$H:7%3
M^&T(1_R1@;Z(0CG(.FE1JMU'U*:%MM*E5COK5SS7)03[J/2BS+;GW,K[CLS0
MBG:9X*(,(B43K0KCFAA0WATP>XQ<SZ5;>LI\^$KDS,EA[0-!#3_M5PX)KP=>
MOA[V=LFK7&@'P]B+^%HXD4 &"06#M '8K:G2DHI!E)Q ,ONVWWV3#7_04IZF
M<&R>, P5I2NE^CR$F.;%6^;$<0C*$2I@2IZOZ7<MD=HFQ+B0(WK/*&"%N7"]
M+%<L\4B?U9R+63*<$ \4'0-]Q!=Y:N363U+J]J.R$,5E1UP2OZWVN1D^J<LG
MNN@55@0<;N%0<D1;/)[\B!X?IFG1L&7?/*WA$NSXTN.JB'"Q^L ,7+/."6D/
MM'F//,!%.R93*>6GN8ZR9BQSGY@^^4'G!QZJ$-F2RBON<^M:-N@$7O;(=602
M(B5O#CIE66LF(=(D1+Y>0J22V,=*B,PZ+6J-#96WCN>>N]S^#T+TADA!!W??
M/!16.>96""0N)6\XK" EH&>9&%((<:&'#4Z+GWW+'>VZB,,KU6=ZTEWL^,HG
M<(<W/$@38.AT$GM3S^'*_H:5H;O]>SOS'9)K8S;SHJ7(.<>IXVB)$XAFMNCW
MA@N"AZ!5"0XL%K-#*#=1.IQ3X;WC\6.X 2;)6QE *"S,F<\C-L=T5#@!_'[!
MTH-9;G+)(@K3^<+RXCA5E2DP.%L*?0;O++B+6KR&>B8L8)@C[#TC-U(B8$FX
MFQMO)VPK2SI/]J/10@^C7<S]< *7,5AH"4%W7CV&D3]5/_M.-$>G MPPV"1Y
M\H3*:2H*A,) ^?[R;R7ARL+ KFQ5F35BIMR, #<;AHHP ).R:Z[:PCE!+55
M@,K[FB)I7]F3#*.UK#D+YY&S IN6&#R*B:GPV1:5+$4>&K!3O0XF8<ZR9?%0
MB*8J8?:7MR)_WA4"I>FO4&H5EIG@:$_7JB"*G*>JJRKYDC/+7M.Y#;_NUVJ2
M[@67.Q,R+P3O7TK!60H@KT*L61,^>F>*#"(KFZH]Y$6-5W-W" V98:*2WB%<
M>&X\Q;(8]L-NHPG*<LF^-#'1,S:<P%V0>7PHSL"]+;2$G.S5^IYR>8]WB6[2
MY:^0A>//^.(\WCI8R7LQ'YYHA->:%\581N4G"Y+;/%*YWJQ6V*#\H*LP@TZG
MK&5LQ +VR.L\Z8C)8QL3Z7Q)'[IGS+'8GQC/>VTR5S PPGHFQ8116GHZ^1=6
M+&#\#GCA@?$"4C]TO]ZD*^M*^]WWP&Y$82?=Q_$UIKWB*-+%://8B%WE8A25
M=6 OID*4)MQ9A9]'FY(?#51Q$OAYY?!JX<PENNYO+XVS/)]+7U1D*[*;CYK9
M5MD.NG3-19&5*]XLB0&&06G,3X3RZ,[EL3[8:9X8)J<E\AYD?(S+H^I@6&5R
MHQR/E.XI0P\$Q0B#:9;3U:K,Z6H54\'6F"%?5LI=8KSULTJOEO<!+\ L:;ON
MZC7IF::@Q'F8M7%?9[JF)<Z_* &-9^PV81E[20(1Z<E>R1IS23$U$[KX"+HM
M"(?VQ1E=-7+4-JVK=II+ISW*69W?V^VN_$,Q085G64N_=$D<DPQ%+2>DQFQX
MKDI5#/ZE9*&0>55@?BVA!K@,IE/89]I@$:K#7(G,I\\;SBOM2<3Q<-J@FT7E
M;HPLUMOMP+?^9X%O'GRE&[(<=OLNCVJ+P/3ZQV3D.:'C_QQA>*Z'LU/&TC9'
M?D,F4Z<]KDIDLKN;$YF.DD-4QILQ!8OE)5BE%"C&5@P<"P96>4)P'N1K+=@T
MNNPIO1*>FZ.>QLT&'ABP$*;!HXW%#,F4LFXCI4F&KIO"I]TGKJ$"-V!>?!AQ
MZ8HS_#.@!S]CLKQ(U$0%CAOW&LN4>\Y4Z8U,EZ%P>:8QN OT9B 1YV$X)76+
MO(A!X@1S#SVW/..UC':9>B7) =/[A[PUB@RH-"GYNLJ<NL*]\S''$@O,\C'<
MZQ?G56V:1H%-RO*NKC+>0_X6'AG7B1=* [H^7'*6V+Q\?E9K/3WK&?U3Z(5;
M"(']9V<U7EW:QM1XGG([V!X%[CL;\Z.*6$<W1IK&>0@K-L.0"CKW<^!BE?G&
MLJ12JR#DZ&&_@6)N]=L-PS0HU(*^YYSQ>0UV_2C@!D+A0%F/H%[3*N;22BEA
M#??P[V"J7(G2&TYW66_3")Y[D8V+Q7--\0'%JFJE3KFK+,V1Z9R\+KW"SB)#
MK]3@4M)1U096U";&U:62LU)/%=4G\H1 (7'%!:X76>:&9-^H-JRF>^4XNR96
MQT//4ZQ*4F&*=(5'JYA6FZ5C\AN4\4)6'M/@<0(]/51$YQ[#Z"O\Z+(LEX;#
MCN4U/!X.C\,4GT3_JIMEZQ.3A"!SA1J&%4+?O(3K/!&VU..!\H!>R9SV'#QM
M VL6 0R?Y])*)BWA0EQ2W9K=FHR(/V3&4W'_'F72K1B^\-D*17P.<Q4!&FTW
MZ<N>2#&1<UI7B91*O4&?O+QL*-MD0S5@+A>5#=7 "^>?2K#P:Y+0)47<MTP:
MEHC4 C; V@U2)C;ICJ[0*C)G"YC&P0WW%D38P/*;\KC,K.^[[:'RJLG[() &
M6 )LQ43"^H;K0>&,.G'!%"MO=&0)5)\*K5>[H:A@5IA2W/F^[C?"JV :T09@
MQD'^W@.A_2\F0M\PF!]BN@S-2F2YP)\?T"K%\.>4&]W\(?0B4VYM'*<\:4I5
M4(#HRO; 77CL@0+O60]<#60Y5 #*7/O6LP7XDL#4I.E'L3"JR;THG%P\=3=W
M(>%G.#22KA>P;\#V9+IQI445G_.*ZM"G.?[9_MRVV,V#L\*R$KQ20^Y*T3/:
M93(ZLN'T*8#SXM:-JAWG%-X'>:U9'8$D!$-D_1BL\1+QR/<C[4A<?=]O#]1_
M"2]$B6=<:/#PM%U\NBQCT1Y?ZS[GBO.=*Q]P<' 5]BF)ZE0)B:0TD',*^UD2
M;"JUB2KQ8PJH,YHRRE/P<Z[+\@>EV2./JO:3)U_7E4GI/9*(8; -H-Z)A!YQ
M\"(V3WV'LM/T'!^%JR+K3^!=;I301G))@OYW%8F*N/0+0LS\GV-<2RC1G!(<
M2 $=/!3FT'VV"KPHX(>#7,"YFH(J0_"-F*,,U/C>5^9[BU" 3.5C!=8'_#O9
MME$ZM^ZF,#>/E'DZ7,)_\>&7.P460FF['N52$9[:$XKP!9A'B0HRB#1>&;B:
M^<Y#B&N1Y%59C3)Z@4)/.#,Q*AJF"%2!0D#V-4_ACY'W;YK56V5XR?$F*$]7
M*1TI$*XN12/EUV.^3N(G=;FIK_(XAH:A46+*8<PV1:2+K)0HHVZ6S456J BZ
MP'_2I*2$(9S3MSE@'N[WY<>)H5$E&7.53A"F+GG2O<4!0C?Q:YROA3\EVV/"
MNUX,%&*\QIG1C0QT6A%*H9!C?DI<\Z\TRHH-'5 <3N+J4"$C8=G64L1:V:UP
M(\4\70D5RDI*,6K8?EA'IG!(=D/^CE4^KZ9]K#-6"3?QRYQK*3PY0NHGFS01
M*F95J0,R2U/7?+AOG]0DX7 @H?0E J([PO7!A16_M;AL<<I43NU&/0G>N"NY
M03.X^H+;(N\H4D7!8N\"@IXA393-,<8'OV$"*<_?<^:8X\E='YNUASR1 UTP
M5+A$Y.YDMY9#@HYQIQ/EPLAPL>\\QJDG)0%(#3$P'.TG?-+#7@%:]3-?Q80J
M#@C;C80B\ S,(F"@+,]! F'&*8Z'[B]?BU''Q;54+$ FWQ ]U#%;/V%JM'PI
M!B4'9W(50QV(ADBXWC&F&OB>@.WCH-&D*,XP$*F9$"UI(A1=2 A';.'8(C:O
M"_'Z>U]ZDG*;7'JJ;#VG9UWG.XFCQ@\55<,X6=>3%559+I#RJFG&-CFH2$QI
M-Q:&$D6TL:C(B14V)@Q49(',4ZID[\8;W2(Y0(CQ/*,BC62Z.,PBPLBGQ.Y#
MQKF9H94M >;IS]B9@\0LXEG-TF JP:MDJ8,<W MF?MZ;S)&QBP7*P(F^]V^"
M'RDN#@CT86W!9(FJ[#M<3,#Y+'99@/J1J%.6JJ12FO3T<ZGEMI#CO=@7^GD6
M6@9-#'>ES*/:0.8$\U)*^W(4TRKM0"&J39FBT[_2Z9S$7TO'/N:&N+QU^9XO
ML01&%S;P)0%#A9NDJPNMM4L>159!U'&9#A8^EHW/H_ 1V4,D]GS1#H-X/A4P
MS!I>IT0HXZUN.&^(%E/V;;OS Y[3;J<]^*'*#V_W\$=XRAY6/"7L:1!;_,%N
M#\>ML&6_\!A&R9*VF3U55C"JIB";;=JB%=%9P25=X4JN<1(=,8?:<3R,UBCA
M[3_E.2)G/6HJ%Q;Y12J70S.S>,U3(EQLFPX>OW#UL^=FCJP\Z$'>/$!Z270:
M;DW(>90ZCW(UA)SG-?5 *YHA6[+,OZ1F),03UR"$IEG\)F7T^05%BW 5Y7;G
M]IA $\J2?7L;DWU/023=R7JA@MM3GF'TYBE%QB$$?K8FW#6>*P.VU1M798X#
M5&V FR>B%,G11T223K \T7EP/%_@7I*ID0CM1-D2*FLH/[DI[@_(,IGBA>E#
M^G9+Z:DV7!?,93=<L02F%))+0+!(F9N=J$0BM$EE$,7=VIU9S$@KT#%G2!("
MN35C4]2+6YS=6T(W7K?M-IQH02FZ2M[F'<7L&W-3W7(54=2GM]GIU87E6WG0
M,I,>#NE<;)JFG[[5*TC9#!:,N*!O):[%:3J/N5.MFO<UUA$L*^_MZ59J0'6T
MQHNY6KJ*/.*"W"8*>)>R&D-*5:5L3TSFQ910^H^R]FW^$W5GPYU*^*VFA2A,
M-%M%L[LFFMV N5Q@-/NU)ZG+$^'3T"(6>FD$[UE"/6+A'OT](#3F98@Z&B)5
MR[?6$FHUC]1ZF T^]SQ\/OKV^24KTNA.PTS\D'?4ZYK/>BYQF;FHI=+NHY:Q
M=Z162)N$S>8>PS5:XVCMFWF/)&HBG5U%U+@:UNL[JYB]D?_R%O3CE>\\O?$"
MFC6]5&Q1#6,*H3T&*W1HH]P6G=W%\$*DMTFD%[IM\]]Z_?;H=ECY<Z=M5_ZV
M:5BPGV][U:]N&G;S;X->_U0F:[?[]N!4)MMMV_WQ82;;VVI8ZK NN!=. 9ZO
MOW_7^ZY0C_^F@RW<M?'4H^.U1T6_][=KNEMEJ_=7%L8=*8SQ-OL-4YH^\D2F
M]^N)3$KB%-=]023Z0LE>6]+HI?R4/2ID-$IP>-:B:\&2JSXM2J(UMP4GB16+
M6VQ]T5M19'O*ONP[IT)Y>[P'RAOB&K9N%N4+;/U2L=NUSU'N7H'I)+I+Q==U
MZ#5QW*_S* 3#Y$;,U749F\TVK1\ABQJU^M]8HI*9WVQS3I];]#9GT(QQY#%J
M<_:,_E?D;(O^?]1P%O^\#+\R,NQE;F>1S^LLNV.=PK'^_D5+U)=&;:0;M3;[
MMC7H=@MNT1V6*1FXQG)K'<#")XN'V##=23'=L#7JW1JF,TSWBFL;MGIVS_"<
MX;E7Y;E.?WP\GMN3S74:FNGO$:4'P:+<L%(YS<SO>E0H/4K-XS>[->[8-?EM
MPYX?2L9M:Y&=ZR;=#NMJW&:37EMR]SMFBQJ^1=TC;M%%.7W^!_ZRTTVZK5+:
M/.;J]_HG;RN<^Q:-3M^<._,ML@>G[^4Y]RT:'G&++LI Q4(I MZ],*/T:G1M
ME.BF;D[7N L:OD.UG=9FAUX]-^CD[=!&7YQZ6DU=+67KW*HS#99LO_YFGS%[
MW!KM&DJIDU_7Y-B>X>6SX66[LZ/OPO"RX>4F+?RV97<-*QM6/@-6'K9&@V%#
M65FH^7(B<MZBT/;U$Z&U!?=@2=,PQ93@74I(S"S/=I:78)N^_^9Z,;,2YQM"
ME@<J\6BW\H]M0Q%FC.:,<5$QC!>4?VSKWVO<FK=7B,J6V&R=I]<:#TX_T<GP
MW(GQW'AD>,[PW*OFW/8[=?,<#,\9GGLIS]7U)S0O,G@:>NG^BC].-Y.K]J5J
M<NU>>X=V="^:'7HUW=2D%)L=,NFJ+RKZ.-U$+KMNS4?S3(1SWZ&!V:%F[Y#9
M(+-!QB1]<;G'Z2IH=0L*C ;]RAM$B/?=8BL$LTUFF\PVG> V70*P:E6635TE
MYF)3-6NOO]F'KM_J#'<LBVM,UO$+8WV&E<^%E>U.W;HFP\J&E1O(RG:KW]_1
MNV!8V;!RDQ:.K+QC,. T:D'VF!5]P/H%,\MSF>4E6*E9]T0O<,,E,RU +F6,
MUZYT*C9L]H(I"X -1Z_08+2"]]_=9^S.V^HVJ4C'C-'LPJ?NN-T=-%R\F]JG
M\\K/OFT-=_6\G)!%:GBN26L;MD;#TT\R,SQW2CS7;=V.C)PS//>Z/#<8'A%9
M=)^)9J>@FIKR)W39=L<&;;SQFV2/ZX:(S":]=DBZ9^K4FKY%]IF@]I_"[7J!
ME5!7O?ZM0>UO[/:< 6;/F>^0??H6][GOT)E@<YS"#7JIM5!7P][VMZA1HE][
M=[HU=!RS.Z^].V9SFKLY1X0:>NU,LN;EVMPM0YCJOYW$"P,KG%E>D#C!W)OX
M6GN<\A2<\]3DK@9]8ZLV=W>ZIO]?@W?'-GZ>)N].]RB[8_)9_\D"AD%5-XQ6
M8>0DS&+?5BR(7W3%GJZ^=V4/.D8=;_+VU%"!S/:\NAO(')X&[TY_>)3=,8;L
M.W6Y.G',$LM;KAPO6L*L+">8PHWK)?G;MGE+X'Z0S?]TPSBY3,M\-W <8V:\
MNOI@;,#&;HXY0V:;FFBS'R7/N5!AO6.?3KZ&LMKUB\7OV#^!FGU<1ZWNN/NB
M9J][H-&1[3IS6LQIV;94=C2NF]!F3HLY+9=Y6GHM."CFM)C38D[+5J6BX]I0
M:XTY+61T_9@@*DB)CU)\X88&>M/M4**N(////TVB'W]><V^^^AYT*:,HMJ9>
M[*9QS*;6+(TP51=,+.NW,&'6N&W):1YH;C3B&R\!"KM;S/8SFY./^ ^VPD2H
M8'[@Z6V<C)6$%I +A";ZHI%^\&_$:$Z"Q/0")W ]QX=YP1]PWC%2]A[^W;*M
M*W0;=#MO.:'I/^RWURWKSD\BSR&?PNW;V'(7'IM9H;)^I\SU8LS^6CI?8:?D
M*.]^_^6C',.*V(/''F/K]W?W.$?VX/@INMIQLC#0+(Q@[2ZSPEF+O.V.[X<N
M/A"Q.$PC%TB4A"UZ/.8$C]L6C0:OYOYL>< ^#%8*ZW5B;9K<2+<F#-Y@UKPR
MI,Z_7YW5!M^M."@5IT@R@=BI/N;'K\+8P['?1,R'CSRPMX_>-%D(*:2_)>1)
M)WO%F<".IDGU*YK4<($D+'I]84K<..@5X@S:/Q=1)I?F[&82,>?KC3.#R;YQ
M_$?G*?[NQ]R:EEYPHQ.PN/;*%<YF!ULA%\_ _LA N#-P*; (GX(Y.8V9B[6(
MV.SOW_W-&PW&H^%PT)_:HVF_.^E-1I/QL-\?=T>C66<RFOWO[7<_?R%,*>#X
M=_!!/$\__>C\?$R15A7'*F.MHUU97T  S4*068\H:1*)R_7@35&>@! #,>QZ
MOJ?DB3/]5QJC2 Y88C$G"N"]V+KR0[CTXFO+24#B3E(^$,A++H&Y9))O3CT4
M E/K_:?/5<]+V0BC,VL)JUC$%@.^F%J?V0ID_@3$=:_SIE)B+9UH#N=.B" \
M=N(OJ,,4RGR4I.&34-*+=![8!]]9Q>R-_)>W<,.O?.?IC1<0->FEHG8#7Q'G
M?#QNCP8]/.K"IRR&%U*@35*@H*CQWWJC]NBV^N=.VZ[\;=.PMMT>]PXP;*?=
M'P[W/BS08+#_4>U!^[9WN_=A;]N#?O6;A5%+K$/)64%(<GB;<,0I11VN0%^#
M87T0)#%*DBF>J"AN@?[BPJ%&;<J*%PZH.*#S.6NAU'JKYX>Z4>M_KX3EKT)8
M"HWNGNMW7[ MR]FM^A->)J1DHTP_ZZ7^!C?BVB9?QBJM._T>)VM"7>9G1X%?
M,OUEB[7M(-7/ L:[V^EVA&^!34V'J4.MO]E>R7ZKUV]P6Q[#AI?!AG9K5!OI
MR;"A8</]PWGVZF;+&#8T;+A_-NPWN.VC8</+8$.[71L@\[AM[G:PY,I>N>0G
M+R&[^NX?]S<4'&7 R2M&46LO8<M+0Y(>UH;+/U#-YGF2UZ[=)-20MPXVZ*[9
M5(:\AKQ')V^GW6V(\&V6([PDJQ"??S.68XA2Z)OQT4JA[Y<KGQ+<>,H%94ZX
M?Z4>SZ%2F@550Q?RN2ZD1K!O[]@>^S5EQ^F2U^X<L>7,^9.W9S>D<YDAKR'O
M#HK%KH&4ABL6+W0T'".!DS;DBVA7A7K"@CE^LK!\T!3F7'O(^1WV.KUA>[#%
M_$K2Q=%K=].CMXO$=&+&<Y!?HM><KM)^VY!^0>=)W=JM) QUZ]CS#>D99ZAK
MJ%M?I^G4#8=>A+/D2-X/B5T7SJS__///7RWV5^HE3U;,W#0"76)#XO!YJMS=
MUK#3D$95YTG@HV-.G3^)#0\; I\V@>UVOR'T;9;CXQA[\2X*@S V21:4!6#B
MJ(<DKR'N(7FW(6:7(:\A[RY>@R.V;S->@YQ"\/M_W_]R8X_WH J<KH;:E&[6
MYTE=>\>*"4/=K:+V#0DJ&^H:ZNZ@".Q8U-=P1> $/0-?G&\7Z0;8S85M]/TZ
M\$6]&@U8#67K7$\-L:,,=0UU7^'R-UZ 0R(.W4F4280;^RS< ?=E*L%S2S=U
MYN=19SYJ];H&[J INW&Q;-AM=09UKV+#AH8-]UV5W^H.=RR?,VQHV'"/;%B[
MW,&PH6'#?1O'[5U]X\W#()*/*'Q_*F'?T=E;V79VBS$TTI0T$S)?.+DO7*Y#
MP1[O#&%\ ;? "0EZNS6N#4>UWRB=X9?3XI?^[7$S/@R_G!*_#.P=K1G#+89;
M#+<8;MD88^PV)('+8.&>,!;NT2!JG@7$W>ND#@M,8U\D,HUMZJ .Z68PQ#T<
M<0WJCR'N:1*W43F]S7(&GP",[UT<L\3R%)P-MCGUX)^>@?=][CHT\+X']3TT
MI%CE/*EK#TV=H"'OJ9)WAYKV)GJ:SJ.4[7E@7ZNX2V>N$?=-*<LA9:OQ0QPR
MT\R .QOJGBAU39%;<_;" .26-)D?&.S+YGDB#8D-#QL"7PR!N^U^0_J&&=^!
M <C5$GD[8X.#><AS?VN:DQR0O*/:J:*&O(:\32%OI]T4?'+C.7@9-M[I*J;&
M>CU\3L%QRQG.G+I7@^'VR(.&LH:R3: L-M4[.FV-)X!*V/> B2>6+B %^)+*
M4 4N%AAE_P1J]@&_;8UJW_I[I]$A2B -IQM.+W@01[<[AK\-IQM./R%.'[3&
MHQW=-8;3#:<;3C><;CB]89S>:]L[5FDV@M'W8\HW#_RAT= 3S9NP(=<)/6G(
M9<AER&6(8(C0J">)7#\F#JAP/PM$ 0U'8>E$<R\@90X1D'*P"OVV_B=2W-:A
M%NBA?2NYX^=TW"[JN*H.<J_?W@)(JKLSD)1]D"EO1ZY/D1=&U@K>#:>6LP35
M/XFMA?/ K EC@14QUXD3*PF!L8)9&"VM1R]96&X:15AU(MY;12Q6*!885W)A
MJ8X76'?_N+> F;X"*]W@_[/$<BC^A#4KL94LG,1Z9!&S@C#!41Z\,(W])\M#
M-O)F'H,YQ?F45:J!I1<=>N_18M]</YUB1"L*E]:=GT2>0WD>MV]C\3G\T0N<
M@(99,B=.8<;M/**&@D3[^:=)].//:S_*C1'DZ],Q6-OO1V^:+(2YI;\E+*=.
M]HHS 2,I3:I?T>PC%\C!HM>W&HE%!OT"](CVSX5"FE\Y<W8SB9CS]<:9P63?
M./ZC\Q1_]V->LH!8T0E87'OE"F>S@ZV0BZXI<\.(./@-F+\LXD?S)Z<Q<[$6
M$9O]_;N_>:/!>#0<#OI3>S3M=R>]R6@R'O;[X^YH-.M,1K/_O<7\+C3.PYGU
M#CZ(9^VG'YV?#R)FMF0B[G98_V<9:QT#G) F^67!0'SY?O@(=YM%MR-(I? !
MQ!%($A2&(8@0W^."#JBKI$L DHTY40#OQ=:5'\8QBZ\M)P%9-$GY0"!#N6SB
M.#_RS:F'0F!JO?_TN>IYE*@)3"T!#F#6$I:QB"T6H,C[S%8@%"<LLGJ=-Y4B
M2]SG0@;AN2O<\&6BAL]"B2]R[\!&^,XJ9F_DO[R5RH47$#GII>)-!U\1!WT\
M;H\&/3SK0E43PPLQT"8Q4/!)\=]ZH_;HMOKG3MNN_&W3L+;='O<.,&RGW1\.
M]SXLT&"P_U'M0?NV=[OW86_;@W[UFX51]Z/EGU(RSA6H1S"L#Y(D1E$RQ1,5
MQ0@-YL*A1M7*BA>HXTR=Q%G+GJJW>GZH&[7^]TI:_BJDY82!H&/6?>"&2V9]
M<;YM*%X^U55_PMLDEFKR62_U-[@2US;Y,E9IW>D7.9D3ZC8_.PK\DBDP6ZSM
M4@LNJ!_QKNV#+C9 >V8=YJYZW7[M/&C3XM PX-XZ;?9V!/PT3&B8<&]2<+Q#
MI8UA0,. >V3 KF' X^_#Y3)@ISVP&\F!)MI^A.2$LR@N?+:Q4ZUBU]-%N1C8
M!F'HD 58M4')#7GK(.-UZO;;,.0UY&T*>3OMKL$F/LT62?>F%=*^(?D-1DD=
MR6R(>SCB-J2/C"&N(6Y-XC8*+ZY93H:CM9#>HAG2"3:3OLA>TKV& (*>)W5-
M1]Y#)O082]Y0]T2IVVEWZK9GN @_R9$<'Z:'4^'PMX:F/<O%6#7G26+#PX;
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MX+I/(P=N^Y8U<2+^^"*,5W3-@!$ LTO5*)8;I3@(DE<S%EOTLTNJ3LK09IP
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MY142STO/D +C>;.C_B00$3/<T.= $<='*RA_57B)YP$.!P)=0A:)R<)VX+<
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MS\PFH)>(,!2=)<=:?4[@FZ*>UW2!Q BYN?()'GU6'K]@WURV$I)'?[AZYU!
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MPVKM)I'BD!B)Z&,5?5!XF%H 4 MISJ4ANO0*FV^RE@Z9TZ#U6Q9^7=P'EC6
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M^?K&2B+521OI E/C,VO&XVG@&)#;P(-V(H0CR0G8'@Q.2N!+D<>,"9[9GJ'
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M:H\[?;V7N-WO77&++.+"'DR-MC+=98D!F$[:EK.DMEJ(EJA4C3))<B<"][0
MENV&ZLG$DG"QAA 1B9T+LIK8(JV8PYZTV<;&2X!O5!=!UAQL(POQ4JS=,NF\
M:LWW+F$5G6^R%HMQP9:B?68[FVHPR"S(9'E:(*^WMC/KQ9WC/]&F%:GZIL6Z
MF@J: KD27A20ICC>(&ACJ7[;)--E>I;HL"M-7[7KJ7D:3=UQ+&)C:/3J-#O5
ML,(HQE6J1,I0A#A1?Q)I270$P#&?R&M9JBH0!X.'8^[&\J#X<<A&AB^/VWV-
MX76:3&3D^:]G&Q']-9J%HV5'06+0NA3+\.T\B,N.I*WO0C>\"SVK[T)+,)?Z
M+K144:1/>")%J!1$[@VF>"Y0E*EH#1(^#+QJZ#P0O_\)0M#L_Q0(AE_#"5BY
M OM9R]"/6!-V%X1H\_JJM5+!BE^A-)=5;!^O;JYT21H),;)_$!,;@[FHI#[R
M48CUJ8(?.JW6V1KKKCUH"^4C(J"(%<;%;29^]$,"/BH'^EV)/&>TRZ4#2S<M
MV"7.%3AD=!\%D\N *5"D#)TR"B2+N+RZ9H1G&Q(:!.]_4E>2T; +-2A3]W0-
M-2O]E^SE48JW'@>D5Y''QJ)#K;!=_X 5():&L.ZNP7B+N;KWAND0\#45QN$-
MM)OAQRP@92RX4T63 _*F,$9$O;A2T#)8R\2#W:065[[#,D6$QI6UOM$#BX+N
MV^FR'G2ON.0%_<94?,KLR"6N.+ V5V328D<)%6[!1<EIAEQ =3B1]4J":*AT
M:(3W1@, MEZ58KXV]DK=7.":T-+-VKDI"HJ*Z*E(2#X$*J RJQ'HN$%8%G$+
M;S@Q(E@#GI;!J$41'GGQ+YQA2BX,G!S/$W )_$6$0^CN1M2%IE'G?)E!G&TU
MH&[[*:DZ4XU#_="8T%0%8/B?]''3"*JB)0F"\-%7@B2VY?RTMR$7+I-)TFP!
MO*&E<\/2F9H,@D<PY?%,--FXF 7NC,6U;$%@F00("1L**V4E@R G=5006'\8
M7@ONY,35I&84TS"^I*/#18DCQJ58:=CUT53LFAR(DBQU<SPS8*<OV$FEW=%]
M!]O#X3EM(L:5&\MMJBF :3G WE$,LGQM,7=6MR*WK2&>CDY$^M=(R5.A(VUW
MSN@2,?L1[""#G8+,L\]\'V-Q*O-&A4UW3 N2]Z3T1SS8CY@HM"ZC)ILN5*YL
M(>L0TX4$-)XX$%+[KUT"A@SG'@,AZ&,H Y5V)F=(Q NR6F@-)TN;UKCJ-^[G
M4\:$HS9U1VZ:#E&DZ%2'>]6HU.B5NQ2E6 .,HL"ZI38(>?;KE(L0.X&,BL8A
M[ !8HZ.0PI?I%!II#MS8"!L2[43J!**\ F$Q7CZGZJ97HFF%#AB=!CZV]1$)
M(F NO]YN@XIH)/M'B=GZ&*B/YI@I$493=RY(8_R&4:@EK#496S(H D-3:ZLL
MY)KQ.6Q$$P0&:EB4SU*[3RXHH:C+[^A^@[K5PM_ ]J6;PSF(<^ S#%\)K2WN
MK;5%K#NZJGEIIKBT=*&FP<R8Y142 X(Q/J(X,5H'M[0;E\C)(I],V/@H][P
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M"7FTDP=1SAZ!/29B59JVY^LE2YW?5NWTJ4V.3J62J YSF[8-191X@ZH2LZZ
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MIAI@PD]'P @_3MD8)GO!O#NVB$[>9,\.'!R3@/FUKUSA>/QD*Q3*RN%V$!(
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M->.A/84!77@+%F('_BWW:8$-#2P++R :8BCF+:;M)2/\@,/A7V$<CE]'^*2
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M@OKRO'T/C'#E]>+ZT[2!>53-75V?[GNLN[J1."W?VEO-CC6?UVS=;@YJMC[
M75T?/#K67:VLL!KDA=5S9\GMS>9]5]!IN8HV[P-*![)^V,JFIX<&T7W>N4<W
M/3VE#D@V/FD:U!&RYL-PD&K6?.[ 4"7XJM5L;^:5U*?Y<4_SCE@)]6FN67._
MP<2:-6M%LY.BZ1=ZE&]B-O*X\E*,JF[A>2EVZCY^%?=9LZ-F3D->N#'0R5Z_
MELYJ?PR<AXW\L4==Q&"G)9R\M?3-#I6?%[F\+.06+,1.1#DZBZQPU3L-^ D+
MRY 8WJ)AP3:Z#OPT6NAFO$70]<VLBZH]_K>_C,(W;U?\^(R,V\EW%&Y8=U/7
MGEJN;WN)PS.+L4:NY\&:X\"R@3#!C(?P_#@(K7C*+1_&M6;PL6ED<1]I<\WG
M,9^->"BD;;?5L+!/.(X=<N :QWK1[@XM6)&'* &OSIO#EZ^!M FWYJ$+FP1+
MQ8]-8:X\Q+_9( RL5R_:K3/UUNO<A*/TZ6 6( ]C):!_RZ,8\0A@OKBS\IEH
MZL[QK]9MX"4S#B-WVWK@IF5E[@8?MLY6)UWGH'GVO.O4RVL/C/'F#,XQ\^#;
MP7B,. [ R_(%8R#X]Z<)#:7,N>7!#OS_U7SB&:T7+-9VASJ7Z]+#F-:R@+US
MG7@J-8GYEM0.K?05-@+#(HE7O[+4MOWY%6)'^ "Y )WQSZE. 9JS"3\=P4'Y
M<<K&,-D+YMVQ173R)JLK05&:!,RO?>4*Q^,G6Z$P1QQN!R'AG%R  <-#H0M_
M8:69BS4-^?C7D[^Y@[/AH-\_ZSGM@=/KC+JCP6C8[_6&G<%@W!H-QO]S?O+V
M!FT5U&)7\$$\_[^\86_W>=J$3%W^9Q%K[4V#9@+J#U04;5-1=&M%\2!%L4_.
M;6ZI)ZIL_,4@8[9G=O@OS>O=9F<S7N_T=V?U(D[V@KM"4W!PKR6XVZ+;AL7;
M:_;+M>AVRUAU%=BW4/+NN#$#<V-0\I9S7ZJP+3>P"^/ @^4@G2@ 8D7)#"GY
M7_@*&"D>T'/$;#M  CF)#0HDXA-:=7[Y<Q["SL*<;'ZQTKK.!E/01)1_P<C%
MF4@O%]-0=C7%ZH @'IM'_$+]RZ7C1G./+2Y<GY9%+^5C'C!F:H$V6\(*E9D#
M<GSY<Y-^R@48Q6\=./W]WLJ?6\WVRM_6#3ML#MKG.XVZ_HN]UJYOUG-=_5NG
MV>X,*C+7*M'UZ>8ZW&C4#=/D5P?'C>CX/;<.:X+DPOTO593\6@GW?Y-PWR8!
MZUZBM<_R1-OH*J;D%/LHK9HOZ$]^%D;-AZQ18X$]L\E=S8.J3@Z;NC=D,VY(
MW@>?[D.D)-K3FS/APRY1-Z?LHUS6EI[R[6%-^7U0_FK*_ E_!-K7Y*U%2KDH
M7XN4THB4QW<F#H%0KVR&.1R^8\V9_8/N'V2,+'J]U[J.O=]^"#X*YMR?L@GW
MCPP#N3L\NZ=4JU)0G(>Z2=WFMJAS]28]>T9CW>^NYH_5-&MWV_4A+O\FG36W
M10NK-^FY;=ENL_7ZZ*3L@:"%;VF87_\(F+>335Y=P+OVV?G60JC$?7@.=)/Z
MO7J3RKY)F)JTN:8X%-C(FC<VZG36V1.N:+U'F^_1V=8P!_4>/;>,[3?;QR=C
MCP;^Z&L\Y>%1PAU5\"SVZV!^Z??HK X#EGZ/.ML[X(<29JH99",&Z6[M/-2'
M^+DC-(-:T)9]CSJ#77'L*B]H#R2>OW;%-T',O.("MH?$]+,);EW8?2=(L%SM
M4%&X^NV=;P0>CU85"J,<'X.T!LU>S2"''&=K[[K!E=>4M0!YCA3V_JZA]J,4
M($?((,.M8XO'S" 5W.)7[:.]R5F"'7W^NXXU4*(;MS-[9FIV] 51"N12+E2K
M[U29G&:0[8- 5'53+K+L&^RK"J@\[[PX=-G?_S;HM,\O(XM'L3LCY-M,.,/U
MG22*P\42#H^"5[*3,,0_(Q/8P6S.0@+6F<.D B=*S\WGZYN&%?F)*-*B;_BN
M'<2(8S /$GNJ(R>5H-[78M"B')'TZG/5:6 !. V$&+[CGH?_:^)");Z+B%"C
M)$;,-?&^BP5W/I-/B-$UQE2D-L%;6'X06[B-L+4X/]JBM0!+38M($B_F",4T
M+GXX,U<?'L=EL G".=F!/W8GB0":C 3DL0N\!#^M&&K&%O 3_0_.=L0M_E?B
MWC(/"0=3UN\#RZ33#7R+(1E/@?%.X7\MT ]N!+._"5+89DD9FD:>Y+ U<PY4
M#Y#AX$_X#/$CS 7_AF.J]6<Y$['PW#"%?,;'"-,Q(3P(^"_Y&%8=X@]B^!"'
M;.#VL"B"61%<WM)JC4_#>BO!^^\BRW$C.XD0*8V-@EM@1;GRL1M&L?57PL)8
M4 :+MAM63M9$L^ ']W@4+<-]W1'NML^(7!OP[C<0,R'247P(7UDS>LACYGK
M"PCV;2")">D%##0)0-1IF2=/L1*-6IHYQ)KX#C%0RMK&F;U'QEF2)M:4%AS%
M)'KGM!HA.U=/UF$QHZ^G,GOEW($R(1][P+A$&UI A*AVQ:Q>+2'\(&"YE>1]
M)780ARP2NZ]KV+F#@_$Z[KG6L'-5FVL-._? -N\D^J]1]->8<_>2J\:<JS'G
MJD#)[0"B'@N&Z# HMPW 4TVYE'+?>(BS8A-N?0O 7; V!H$[3GK59[0^HV4\
MHS4LV [IBME.F >3"M#M[)I87??\W)88C]"K]G#X;GO$A9KO:KY[>%Y,9YN\
MF&=@N7K7GT/:M)N#6MK4TN;9^:Y;\UW-=WO1<MNCZCVYECN0*KDM_<ZC1+WK
M[9I?7F>(/]L>;8^.6N_1\V?Q=YX[B[_>GBT0AIO]^@B5?(^VAU&J]^CYQ5QO
M+V*N1GY[CFJH&OEMN\W:WGBNL6Z>.["S=0%_O47/O$6MK6VS>HN>7=#MI\U.
MO45;"+IZBTJ^1>U]F@L'$M.MD<^> RVWM76N41E01ZIS759CXCRHA<2V5[4U
M<];,^6SWN>=;!\B.$JKIZ%BC-VP.:[E5RZU24GSWODPU<];,^?1*=?M;I_TK
MU1KCKL:X>U("E1/CKA(@/=]-G)V01XD71X0>5PS/@T_AL7 0\8N0CL9A,+,^
M??]D??+'P35A:C$K#D$:(40/S.K6M;D53UEL)1',FUD1F\T]@NF*X@ ^B2A(
M\($_$05IQL(?/);3P5UU^-RUU1_BD/M.U!3ZV;J9NE'Z@5#@B#$O!?H:!X'3
ML)PPF2"L6119,Q[:4QC5A;>B!H*CW7+?Y;[-X0'7@\T-%_ "XOR$8G(">LI+
M1O@!A\._PCB<\,ZR&&,%$')JGL5@=#!WAX]A/QQKM" "L@U@^'CT4$2XE?!(
MDBUZ* B7I:3&,GIYDGE+JI56^@H;P>*3>/4K2^6HSZ]-B?7/N[F[>N.?TU#-
M9LXF_'04<O;CE(UALA?,NV.+Z.1-%EO*]4]- N;7OG*%X_&3K5!H:8?;@8#_
MNP#;@(="H?W"2C,7:QKR\:\G?W,'9\-!OW_6<]H#I]<9=4>#T;#?ZPT[@\&X
M-1J,_^?\Y.T- 70!VU_!!X%YHE_>L+?[5#WBC"__LXBU]B;D]XX"B2@J_"?)
M_;)#/%K6;]QFH*I@($._A'P.WT>.6PU-%_@>0OQ9/_A"J0O0-C[W</JHPX+$
M<Q0]84\B%\X @C0"!;D-2@D4%(N2D!,"'LR'V7$"Q# _J)3*IQC7!6HCA6V,
M06>P$&$*X3W2B8$$*T2;%J8&YPS6,(6Y1%I;JP5&"J_4IDE*S,/L6I5Y0,K\
MCN/J0W[K!DE$@WN<# /:@I1RE;""D#^9@LV4^(L*HI%L#M+'8Z!K$,KUNS-@
M,@TEBS^OX@O0Z)R7S#R]D2?^&A;!K5/KMR2"9R*$-KIUP\!'#MRO18_ I97@
MG9O[<%#U"049$H2(!^H$,P0'M8L0B4-QBMK-WDN-XNRC))P%A#W%L]A30AQT
M6PT)L>J$(!]]A"I%G$TXEV!<"FA1@3RJ)S,)@[MX:H%.  :=,W!\248$XW$$
M!OAHD65G+R"S]U4ZKI-PA6 LAUHENU^#3/W/%";%G#]A#C![6A<)2!<M\!BA
M46>PWS.2KV3ZDLLK#USC?JS9+6B\-5&-70&R (.EP*[MYMG+YK))?>!<"F:<
MYM)VRJ4Q0:3MSJ:/QW -Q)SFJ U!IH_'H*E # O&6LEVQ8?@OJ.SS*R%S%XT
MG<;^C\#F.[;F#/1>5D-,KTZ)68W/O'K5?3CY%NQ7*.W-".P[]Z>D93%_2[8!
M^VB58W]PDL0XT @=CNDT+XFY\0XPI]_H=&XA0E)WP%LT2A@!7$9OVHLA!7X&
M<%FBG1^D-UCJSI+S-PJ1AG<N2C9SXT#*(N22V#>$I7C$?0.>OS;%/0X\ L$G
MD.(E%'B)MW:?.^L+%VQSM=BLAGSYY*NX,/$B.&5QZ(X2#%TT2L8'>VYD8S%[
MZO);BB#DCRR<6/1!%;+>')'U(A4WR9Q[K?PV,(PM=8RW5/DZ3)J!X._2S>\^
M*/?']?7-E<5_<CN)92N+M%,!*&T;_Q>C*!@N<Y(0_Y/,()1%"/5XL>512J/)
M=)UZBAG#%]V^NG &NP,VZN*T/=@'2=IG%,@<]GN=RSWQ,TSA,D.;=J_9ZR,Q
M/H#!+()^7\$21A[L:%4BMC$UTDBW@;R@+<1X'(6Z2B,SB,X$KK&OZV2:P6_H
MBZ16&UBF+\ N.T-Q@8%04!."KLR+@ON(6R[:6O],HA^+?=*V7,8*34E=T.^5
MY\BX%'YM^8[DWBWULK).!@AH+S29!_,$+^.%S,G)K-; D%F?,.3BN,),O%\Q
MX%]&S!/W-N.:*6NFW((I<VQXKMGP@(Q">;N]3Z.0\O7N,0K_E7@+J].NJ$78
M68);VXL?>9]%*.^<-S<+2T;A?9J%-(&R!2[JI,TRAVP-8[G,9DI)A%>MC<NC
MC3_R49BP<&&U!Y77R'M-^?^_IS??W^59^ZR_4XRFC,0MH;G3MVRZ>Y<D%K&*
M2E&V-G-*:N:4BRI6;>944&AM8>:LM&1.:@/HB0T@?4?5:= ]86W_/(K]@S(B
MXAY6B)6+4JDHW2NY\L)A> B&(IDS>R5K^2(4I;!HJJ2X2V+KE(^3RF?1] RA
MM;I,M39J]G3'TJV\1;-7;J^>15,JX3 X&(NFUD.U17, ![1\G+1_KS4OM+KU
M5=3>C)9WH <\F:]>6RVUU;(/JZ5]7J?0'+#"*9OI4CZN*<FQ+!_K[%^RK\VL
M;G?R@NN TJMKSJR6%;W!3>?Q8=?U:NRZ$LSEJ+#K=HW N\ZO)_<3J#WHG:SY
M&,$,7PSG&81F1%AQQXM'^O[YR9)__G0[<KXET_\'B[*O!2)"N:KXBU9R\K8(
M4*P2\ /7,6]:GUU[RCTXK8@=J.$RA&(2@(/_8=$4_A8'.$$$ KK#Y38,Q)=R
MJ?6K*4R2)59V>?7ENCFC=L_Z)SI3^TVA).RG.S\BC@I= 6H9A"D0!A<_10)Z
M.>*W'.$<!%R4AGPBO,(@A*%]>MH*^031#!!Q)<,"T\ C]]$:(*#1'7P2T:+@
MFV OP%#X<?7LZ3N$D@E"MV']_ON5 HRDN99K(Z]C-M$H1+]S-K=(?%YQ!';>
MZ_8B.;^P.;/^S8"@BZ7=H,A0"2D*)HMO786<_R@1]<J6;OR-Q?^U_LYF\TN0
M(]Y^W7N@U'7@PT E=#$_@'DSW3=UOH) #)8*QW/:?X9(>B*X)I#IRW8NE42N
M@QB9*?W;!4EO?09#C%D?R#[;*X&$NBX?F< HG,W9!%3C%Q=FP2+K(T^0=/&>
M"29AO/_P781GNL8-7+9<[H+P!S6/F'$>6_PV\&X)MLE)O)C@M9,9Q_@FUP"@
M J\19HJA)0<,)R^8PRL->;CI;>PYH2''M-%/J-=AD$P0O]$/;LD_JP;R:X9H
MVBH:*?\,D;J3$37? %)&8"^Z8]=F/I)P-@>B",$HNL\@08P_"PL49KBPP+":
M\+!!32=.$3Q\Y+G1U 0A%?548%7Z1#PP67$DYKL\VZXB'3.:H9H/A?VJG"\"
M6,4_*'A <SZP& -R4_4I^2N!\Q O&B(\W4AY(P6$I4_$C##MJ3.('/-6_O1G
MXDR(4^*I&SJG"!6[L)AM>\R=T3#,H>9!0-0),FHR0CAV"2<+_T"7L7@C1,>2
MP+:3L)#M-=^1&#N%@\U]7)=F4H$Y6V!&1O"O=#[T%JB%IX-*V#A< 3^%56.'
ME!2V7OS]IU""0HC%06X3,_.HPGEXMUH^L%F (L"S _"*%#">*T4WHA'*#2*6
MT+AYA*(_=<>QPF)DUBUP((\12#@%\#5.$)!W(OPZ9#ENSJ$!<FD63$(V!^>*
M6B-$@>TB7!_AT OWT!C XRYV#(#77%_)KQ&YA!,N%SFGHS%'H1[*)C7<1MM0
M<(0P?9"'/FP@0N=!1/P!7$93D-"3&8HHSW#*$!.6 W4DLIY$U94XE6:!):TE
M14+V4#87^*HPX @'!)Y$U]BW#0F=HE//<.0$IAL"<_MQ9C[T^C@)R5OV^80)
M(%()YZ_:%W!K[(;@_)I0B BJB!" $A5:D]#X$$C2D%JPX;3PH:NO__[T_K0]
M!.K[,"_7SB])BP''#4$$G\;!J2:[D P4#O!/80]FV"%"-SBB#@U)R BZ>@1N
M+3TY#:(YJ7^8#! ST0-8=IC@^QZ=XBD#P8:DD/P4"(Q8 1';**0+:DPW"I.Y
M $4$!D=9)Z1UX5(5U4D682,1^BB<%=DY 9N%$)\)WM&B:1+0N$%XQT*G(IBE
M[R*"X,3V&,@GM*(\-YNZ%0C+?]J<.W*IW&:$%5[(RGFO),0 L4-/\].8_<3C
M&.)9A"^_Z [/L)651]KP'E8&XB*8LWH]U9RRU1SBBK[H##O&@&I)=R&H*,1)
M%^)$PV)+'%^<2;O5TB^BJ9#$(*<L'WC9QFMACVY#4-"!_$NP+Q<*%M! ;CR3
M;5;D,C/+ %T>QB($*Y>0)0Y*!K+6 CF 21TV!P+_I*G"*E]T6B:I!%P!M661
MK7'&QH*!]T'TD=$290#:Y?"RR8V2+$8KD?(U_W@7(;K])SB&;HBT;E@??KH"
M9_D3MNC!OY%ZMZYPL?OV!+X$P&K=S?23P,D'6RI$TU#+:">X\X']2-P!B\0"
MUC:59Q1BS0O9@-#W79*ET32)<1#X '=IA_&(^M@P#I^;H&=!=QRG>&+Q*#32
M3CHX61=;(RGN0'V(HUF%]H3FK3N<BY":%O)LB'8 &9KP=TZ9CGBRBA4*C:FL
M?$D6(!@V]Z23JIKY(%HT*%/1&@H;)T13:PSS$^MW?3BK^%EU1;YDR%;#YI-@
MTN+(L@GX ;#X)!1.R"Q &PB91X@CZ2^(RU R[F_!2&8CP0K4UPK%^]A+D.=(
M-<X]])BPL2"*,6'9C*F'$GE/AGL##Z-U*%MQN8CBS6A6RD!K@!6!:C-"B2?U
M=S0+?H Z8#.TZDCETF^F41E/R3+#SE4T(]LC.2=MQ7P/+I)WF!8[#CG_+[W/
M9\0&"7XSY.AK.4H\"ZV$NR_Z'"'G",$\YG<P=7H,;2LZG()8'ED365:QK'<R
MTH9^45ZOH7FF#3L8/@IF7!D+VLP  UW8!T0;=7Z TD"ZI7C!.V)O79-]KC!I
MJ*N'&!@_*CIR@5VH#QG,_)T';@T#TRJ)<_-4UI*(/03P30F<#2<DD8&!2E@M
M'[F#5T<->8.)>^L%-BP_%6<H<"9H9Q-33!(/'Z3D+N5C*&])M\Y0KB5R>9!@
MTTWF9SA5N+#X;R%V8@MU_Q6)NQTF'K(V\!!VWYWDW6NR?.%1*;"R 1O)H@;'
MSD'BX?3Q!$CQ*Q>"LM8<"P4>T_R)!AK*7VQ.1V^!I<5UXT^@?8*>72);A*+&
M( M#4 -4CB)0)/6 LGZ7Y+<0,QL(\1V+"(XO-^IL=6[4%OD@PY;.!ZDSJNJ,
MJJ?,J))M$; 3>?\92GJ*,W:^"BL0!.QW:1I608?=9%HW4(]YL)]FZ,C^%\6U
M7I2T=Y4BXD:?+*%@9+NNKU>?++$?4KF +KEU\7E&'J6/'@%3IK > U_#T)\Y
MC&JH<6>$JR]6RNEL;PP4&P9;G&43W[1\E0M6,AO\Y?#4QO[5\XA?J'^Y1.?5
M8XL+UR<"TDOY9O?PE51.-5M"5L4A_)^CQI<_-^FG-[&S_%NGU^SW>RM_QO9/
MJWY;-^RP.6B?[S3J^B_V6KN^6<]U]6^=9KLSJ,A<JT37IYOK<*-1WY T$!(!
M1 N*L5]/NB>Y3-V+EM4F':;&2Q]-GY622LHZ>-ZBP(2E](4:JS/_B:,MB[Z\
M]!(C/;_!V2K4G%K&/P;9VF=YLJ%"J#K-/DK=^ 5UXV<1EOZPW&PJ0\EB FY$
ME".E[@WUY=N0O \^WX=(20P8/3D3'BCEVL.:<KM0[HI"MAO0[CC)4Q_)^DB6
MX$C>HRY'S/XQH6204SE)V^9\/%ZW<*RH*]6RO_#8"KE(),DSSGWKW'CW6U85
M2/'BZ=9OKIOJ'$NU\%ZWEPMB/C8!\-<M";%.ZMQW\/*2JV;D(V'D0?>P&5F/
MT;E_C(<Q=?DV]U6[U6R_+M/.[H,*+S>Q[FKY6,O'HH6WS\X/6S[6C'PDC-P_
M<$8^:D7?;[9J/?^P2,28_E^E(A$?1#8>)>&M-'+6'8>"-5>%X]N]S1F^>&N?
M5%CE/KF3L*KR[IP=Q.Z498P#Y9+#8))Z<TJ\.;N.<0P7&=_E)8;E<ZK0Y&O,
MB=I-/ XWL==I';:;6#/RD3!R?W#8C%R6,>H#=1P'JGW6.>P#53/RD3!R_\ 9
M^<%C2.='O:QKR^B)/7AHCY9[=_23+,L8E2!6)29YQ-&+M,IT6TE^!-JZ0@KY
M5;=WOO7M98GT;<UM5>*VLQT#7"5BN$<2Z>7;FU=49O_ZY?_>1\I>?4S+M+;V
ML/+'M&:X2C%<O_(,M]&5]*;,5\(=&C1WC.G7V6P5$"XYF%7;A%D]DJ2+[O!L
M2P8O<>K%86X1P1!V\A!F%=ZFLHQQF.S2/AQ&.<P-JL_S$<6,WQE(A'6&VW%>
M__8./"^HYN/CX.-=X]A5X>,##V:\ZNU0LE?Y.$8MXVH9MQ4VUV'+N)J/CX./
M=[U;J H?'[BN[IPU]Y,TL'^%O2(5]*Q.!:WZ),LR1B6(58E)EB*LMX^F)TOY
MH*I9R9.TO>DWSS:84$%;*>2>TRZ]G:<>B[CH.F2U<QUFCD3%OAITFOW:'Z[M
MKT+SN=7<$;RJ9I!#SQ@==IO=U]9\7A^K[8]5I[EMNDE]K(Z)08;-_23A'AY_
M')K8!6,M+W.?.T5Q;X[&NX*NB%5T-![@9V2]XI4=RPX-9K/=;FX+^__8E#IH
M:?J(F6A'QYK;NT@U:^XW3%<)O@*VVM6YJD_S[J>YV]P6HZ0^S35KEM,GK#FS
MUC/W5SXUNX4.Y1OJR_[VOL[P7:+2HT[\K-E1,Z<A+]P8Z&2O7TMGM3_6:0[6
M^6/M)W$A!SLM ;Q#?9O&?/B_ H_78B&W8"%V HO$YR(K7/5. WZ*YMQ&8GB+
MA@7;Z&+;W=%"-](KPJ!M9CU4[?"__644OGF[XL=G9-Q.OAM@P[J;NO;4<GW;
M2QR>68PU<CT/UAP'E@V$"68\A.?'LB>QCQV?9P&U).;9EL1"VG9;#0M[?%H.
MMT,.7.-8+WI#"Q;D8;$D=7IZ^1I(FW!K'KJP2;!4_)@7W/'0BJ;N'$LKK=O
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MUU[$L5/BJ] (#P-3V $PM-10L9^#P%EHS2AN[8(P G4;WKHV;\"?[*;U"I\
M3S/S-/VM?;D$)O8<="PA>PF[Y-MIY\GI\1#TDX,C^+MN3>_GI/<U&:)'US0/
MENT[+'2LO[/9_-+Z%@2AEIK2954R,]+B<LU+#Q*>]].OM.SS;D?Y^#SUNB4D
MVV^__583;#]B*BO"I8_?J;2Y]]&-[:D66+_'3O,1M.<NE"DMXWQ\#/OM7HH\
M@DEQ(%3?5;[5!'\2^7@?#@0:LMV]79'L=J7P._RP[PN%CW3#ZV(Y2T#_VS!+
M*8INX"V?KHKA\1GG,5TQY*LK0OY7XH9<EO7XCJKT]!:8F!?1.TN7$:J>1PT<
M3X.(BX]5XS+@IN!F0Y=>1R(E$:/^JNS5#L(YWIMQ:Y[ OU$UIBQ"$75*YMW)
M'.D":V(3&'I"+X6N;[MSK)^=@7 0-\/=]/*^:5F??.LS"^'SXD8"TQ%E$B(6
M3%'V:[S BV$J^T4FD%4I$R\8X0RS%2P*04$E0ZZZ3WHMJ[CP.9U!</7UWY_>
MG[:'\*CO\)EK:T83R\0:=,R.Q+ML<QD6NV6N1S<3:RZ0J'9L'G*;)53"'RZ
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MDIG0);U*_*>XH@#D/V%=_H"'@_7!,B2R6>3=2/VB((CN<%"W$$N*\0%S@#@
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M2?$[\52@3B'?M8$E)D I7=ZLN&M8_8@?Q?+/S(\5C53$!#;D)[ 50PQ0PEX
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M?#V7N%W6P=Y&L+>S.-B[#MNNP[:W&;9=$]DM&;3I1QEPZ$&%A\\W@Z"1T!K
M.DVB#2J+ZM3% 0]6,A9!8(499?( _OV0J#=A/()4T5"Y1A/%AAD0%\BN*@O
MR3$W\*8R6V.@A-"3Y?YG#&V5\:U/.VC@Y&HB?&A,4S7SH/UN=GOQ?%%E-791
M2PE;1& 5MD+1FVA4"5,,Q],N;0S&#H(9M[1VH[A^[&9CC(X!@34WF!O^\%3H
MX!T<__W;J\).K!PM9#]R:_?)'BRS?DB>"X).,H7+.::;JJ\]!;]B\%/ABIM]
M'ZC=( LYH%8D%D?I8U@PRHE3H%,G(DV%^T.-K)(D^A2P57N]MV^^@]M7&-X
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MQ%-4?.?(T,;G<]U?C3Q%A2FH.T4HDPC-^O&<8/]Q=%OD(</\13&,-')_J)!
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M]%'T97!,F[G^^F[A9JXYHN/(4*YCO:%^J]=88VD^07S!G0U3KBGD&P2/VLC
M)$+W&E;N6 O.ZN7BK>]%M)I[WH<2L3+/M3Y;,VE?82QG#Q/&4M2FW4[+P'G
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M[GO_"M^:UXLV]J6CNR?DK<83KK+#2_?,$P-+0N(41>H>4E[ZU]_$H793$A>
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M9]/CC]"=OH"PN''<:#F4H+HGVJ")+*U#KH(-1&AKE,H!F&FR]JTF9T@K8#4
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M3<\13<PQ K<$@A0E#NJ(0R@2)"!*[\%DT29;_[%SQ!WC7(PC[0X%FC/JS#)
MT4HD)$8CF;!)R?W&N0Z[,NZJ^>]Z>FXIZAIWCJYN/AVETU(%>[%<E/TTE1+8
M^.R3_DK4""<JFE:*D22911N;II+)&X@0-H@H%,[ .ZO;BIM':PXVJ*6KEK(;
MR;K*O;/2:/#Z?!'I>78^'T]ACCOQ>-'3=!54[%- ^I)R?2I'!PE!F[47 LUO
MDJ,/1%*0* ^=<&&'(&3$'9H]WN)B5RH&%:RIB)J]:F??><TW$UAO5:9HF)2[
M>IP]9.BNP6"E=-VU*GUHJ0PUU"$ )6XUJI093KZTB^=9Z> !Q=HPX+I!09:Z
M KB8(4?3M***X8WRA?.C]#_GRQ/N*YD)'@2E*I*<2OP!1"2A%Z')1@7-%&]S
MHMR(GPVMJL9K9FW0WA/Y/B@HZKD?<;PZ&^,HHW=<R*(L@0"C"2CM2T9<($X+
M28*V)20JJ&J35_\H94.J,]$>=%7U5/LD;B7?KV8=BGZZO.,:OWWL$/8^7MRE
MZE]=J.O[J9 CI3QS0Q#Y%-V7F$GP7)(LLG:L]&C(>]]3MF=G2+FX!UT=]X2(
MFBV<[[)Q39"32GHCB>#H6$D 1[S".<=E!BHU%4XU24E\@*:&[&[7FH7::"3*
M)"A4G#2.DF#!E/TM6N\-3[[)255E/H84,ZJ%R!5E9P^F^GU,U_5Z*BNK:3*,
M:*'1P]74$\L\)R&#CIE&J6B3-C4[TCVH.-<! %I=M_L Y':S"I01PI7JC%'@
MONP$<2)QDJUP0B>C4FCB-C9=4'=+BXE9Y9R*E>O1Z/4V$V=*11U)3:1)41!-
M$@"'F19S2+P]E%BS@9+VXIE<K4CH6H/U/!//9*G5$"BQ@1EB(&I@QG.7FYQ(
MU2HFO"_W=DC JJ[80P:K5S1MJ!^IOJ\S1-LP]6.L-2_(\3T!+2J>;#+B0:1^
MR)HHS_W\Y-5D]J7)^<O5L_=QYK*:D4KG++ALE0%PRRSEX=*S;Y_FI6W;J_'4
M3V,YZ(V+\>=E\YS,M8J6*^)P3R4R*T>"#(YPQI*,S*K4IF_5^B16L.XB0.KS
MO#Z<X*9R67EYY'T*45M)O$R =@3^< 8M"HN[B%4F,.N:I,7<2]&0;+]&&%IA
MUE703L7&(V?^6S]'W^;;Y&3+N)7"$Q89(]*8<K\/73]#-<\I 9>\2?#I7HH&
MY:;O"2UUU%,S)_H*O*_G\_-2..QMOEG=?>2LH5*#*>E2)4812ILRI"L:8U%0
M.079Y+3K<=*&=(IP@,6F@KZ:K#JWJ&&6,L]8)APL1?\V4^*2B:6W#E.QG,G=
M+:Q=?]'9%#-[JZ)Q@#5G:^746W(N:'DUZY"P\RZ>^#EB^&;'+F.<HBD;$GG$
MC9-[4_H(),(#QW51.V"J3=W91TD;5,N:?:TY=156'4AO\U41Z9LT26]#8DJ2
MD)Q$ZXOA?JJE)B \YSEG'=HT@GF8K T+5/Q4 *J@J":&SPV ]Z&T5?Q3(U1B
M6I)D:"@16TD<\$@L*)Z<4"6WO+45M :=Z\#+_+PF46U-UCOW0D&4_Y< U&<_
M*32^A_FB&\<%I/*'HSY7_<8;-SZY+ WX>AI+3S%X <M_K\+,+[_BBCP]AO=^
M 2]SAK@8<8FKKV*6*!M,J;B<R[6'3'0(I8,9,XPUR1;:+YL5;AJO#="DI;.(
M2)1@Z0DI#'$H0P)2A)0IFM2J2:!EVR#3@4_=AHOV%7>76V"@YFWX5?1=78.X
M01_/3G ?&#'1('V.!1*L-41PD."B\48TV:+6)W%0!W@_/$9WQ4!KC"XS<F_3
MI[F3*AI)*"_U[)32Q)=.J#%[:Q3J,9I6I1K6)'%(0:4?'Z.[8N 0&!4ZV9BC
M(2HZ3F3 ==X&%4B9/U%0KQ@TR2G:%J,;74F\M) _SHXB8J6#>RI/(K*N:P*^
MGB+&SOOW5PD,G;1(;43?C5I/),N1.*> >,,M9!8TY7>LS16W%!L0-JA+.(T
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M!Q/HYU]6L"CP6-X"\<(;'J0@5FA54HPX\4D#44*;(()(/#Q>/&3?5 \AN#M
MS-](:APTCFHDS%:6_8J%<@11B\R\)UIG2Z1PF80 F>0@@Y:1">'VOMS<:V4=
M-DK]HTZ&@V"E!OQ7B>>J6&+/;Y_/U]/=01HO1LQ8R-XRPG)IXFAH(I;:0&Q6
M+%D:.0?S*)HW'G8'%OM4G._O+3[,I=9*!^2'2)XHD1158'.TQ**"E/)*F" ?
MY7*;D0>R);7%Q8TYU5P[-6;)G8W+K]BXKF;Z:N& 9-1J1G2*Y:)L2B1H?*DX
MMY;18))_'$Z[4C&0!7YOT-JKUO8$LY&(U AK->&X.1!IRX6B2#5QAGMJ/6.R
M#I(..5MT1KX@>))YZ55 @R#!1T: 9>I\UMR)-(C9LH>%N#8F:LZ/3?34UE9O
MY8Q0%D2Y@\ \Y6@G9D"+T>(J8$-21G&P\<=T:O>PS#<$[J!Q4/="RHIZ&SXH
MQWG":>8%6D# #"FO<7-D-FL%J5$^]CWT[-LR5TE34%$1&V7!#'/$XS:-IJ"*
M(;@<5;0_K65>$QN[&N&;*.('B=1([G22,1!O2SY1E#C/HQ/$: /,QA0"S3NL
M]S]3I*81$@>FY$9UK"["4 @:"4:5>XX"MQ7<"8EGI05<THH[%!"/38K-5#YK
M6&>GIU!JT.E  G*&K,;2],PSPHW2Z,V+'/CC-0<V=EL.NTCOK//-;/6-9-S<
M2J$Y.VI<(L(+] TR4F0U1U>: 7 CE09W."OEL$MF-5S4U$'#]-BUCY1_FWWN
MWQE/;S%SX\YD^W/Z]6G8X]'\EH+96[;%[KE5VP^U1S6TS;2Z4;%U/+U[7VYS
MB3[\N-VEM@&Y327SX!^W3:O:><3&\MV8Z:8J^% VONY;";=<?6KKE6#KD1J+
M?&TF=\R!NJXI<%W 65N0DF9#M#%H(4@+Q'L0A+%H& 3<V'V3RZ/W5M?>RSWP
MB\N^)D3.7<J$AAC1/(HE[@:*4"DYS:55%S1ICK$UQ4/R0;9%487[VUNHKW&)
M"Q2!UXJE% @U&HF1.A-K)24V02DK!#Z[AO4#MBI9OR^OI"Y2=A-]0V?DP37^
MI>^F:%>O^$N;[>SQ\1IO:ALRO"=#;CP]>O9Z=Y]BI]'V9L"MP>S>Q/Z?GSZ]
MV:/<5PZW1\$_SN[>)/^\FTUG%?SH70?<H_3787E7^5\TM/>3&PU?-Q?JRJ?L
M+JG'B6O!_K8N\0//:B.*%F[LJG%VGW1K/;6-D/8_?:[L^T\XOX^?37S\XT,\
MP4_/WY[UE^"[<<0__#9+,*DJT6T&;B/TG4700B_/X'@\+<:<GZ:7TW(@^LQ/
M\%,PG^57XZ^0SI J>-<!G)X5P+PO/L4</_S/ J%=(C9-J6FCP3;":CK=KILQ
MK?I8FYFVWIB-)]D6C+=0Q/)ZY*=I!WXR_A>DTB9K7BK3[> <;CE.&X%ORF +
M(;_,&>(")^'OL+BV%?\#TC'.S-)FX?RT< O+ZM(ES:.#DY*9]!D:J*(:-6T4
MUD98.Y<)6>;KE)[WV]3]N/GM"H4\[B6F)IM;5^#Y_AEU66Y26>?&\]'J@70^
M@;?Y*N-J_C;?R.&ZZD8P7RQ3<;<O"%-EV+KBK<1^I0.CV_ERA<#5E(RX=,D9
MSTDR%(BD3I/ O24N9BT- ^[]G5RL:JV UR*P0BOD.^/<2 T<6:8L_H\1(T,F
MTCM3TLTU\8XGZ1E0+YMTE'B0JB$=&37!T8HFR)5T5+%A[5V27D\7T,%\R6W.
MV3L)@MBD%)%<!J0)U<P23MT@+&6R24+;PV0-Z03I0,#96DL-D5-RDTN]RO>P
M..^F;Z?EO64/@%')O!/62L*B00IEN?.2'$(].> B\:1=JT;L:Q.Y8=G1MCT<
M#@2K2BIL"+*CTUFW&/^KE^';?,-=&PF7/=A213=91V0V4.JB2A)#=$;I3(4T
M^\'8O32N [&]=6L_$,3J*'!O"'N'\NANWK)8W@,*3$BMHR(BEV(:P91;H Z(
MMM*H*)FQ61X";*O)70=WZN?>,*MKM2$"WT.<'4]+. I%<]F9_L4Y?)Q=-U<L
M?76>GW?%L^I?LI&" "QQG#[2EHO)T1$',1!&F5$^.JM]DSZ\E>A?!Z/Z)U\;
MVRN^94'P&T&""I6&'WI:W8A&V^/$RVRCY2:'&.KKZ&XND'N>L[LHUB&PC1"V
M#2$^^+16 FD15EP]4JF]'/TTO1A/SM$6O_S0Y9^WGE([C=9*K-LP6Z7@YC(V
MV7=9^HQ#%.TN9L]GIZ>SZ8?%+/YQ,IO@GC._0]\(#5+KO<XDI%+^PR>!BZU@
MQ 5F- /&)5OKMO1VP^]J:]P:>"1#D-%G2IBPADA%.;&4,:)HIMP%$0TTB0K>
MHF((4<"](>*N";"]/FH4%WCGT22.XS._Z&^27V7!7C;0@U()_M,T7;^^.8?O
MRB$GZ;(4Y>(EUT0:8TE ADC0PC@%23,='IT954G:,$[8QJ3<.[8.JMB&]N7W
M![JW=Y3--\1'G[C[IK<9T;O:$X^-MJW!M>9SVXNKA1'VV)C/3_ST&$I>KX\G
M5V>>L]PR,6,/-+575FW!53HR1B=[XN?S<<9%KK#\"I?J!TE:KMT7O=N600!<
MT=_FC_[KR&DE@T.W6P5?CEY8)$YIW+P-KHY*&AH#M#"A:C*Q>YF7W6EY!GE6
M?*RO(_ @J$^1L*0XD0P4<:6]6?0F11.,\$8,5:)77 S!J#TXWK_O:'<HG%2L
M:+2"A5D<WZ*Q4!>35+[4"5,BH)PBTNES!N*8BTY3;H3<W[JP@L!!F,8_!D)W
M56_=JD,KY-#;[/V\N$O__$HJTJ9 BQALQ(DB+8+'2X4O?>8R" !FFE3=VH'F
M XCK>G4QS*'CE8#H( J*(KKBO 3W#>=)IF1<;G*8O O10]IT]H75E56A]J'T
M0\[J0JNR6DNM$E%:,B*=%T@K+:3;1)5'OUPW.>W;CMQ!;3<_$#8WU?1>4'DM
M#,-LT!%*= K0!!.X"UJ>B3 R1"N9R;))5M<ZQ W!J;D2%.4)M.>*>,5*3?VL
MT5*P@FCM/:"=R@*-0_5I5@OTT=WE<%-X*WBV\%6V4O\@K$4NL[59*I)R:<BC
MG"6>.XF^54#7*HJ0[Y: 'YBU.(#RP"W1N2_='C":_QT#S6*I]X[4/D*Z'I.[
M!K@_P'')%'H/9R4%;GJ\N0B_>\+NHGF8J-HL;WOP<<]SZK/?XF#C[A@7KU_X
MA;^\Q+7UI-K@V?6%M2XCU05X,=@L?YP%'^/,3]-_ '[KY,UX,3[N^7J-.\/V
M:]7.(S80]DY,MU/!\[?_>/V"N??0&V2MQ/[ *"U%O2YSNXKW!83%YN+JO[4[
M^]\/7H.=W5-/5SZE#KNM"V\5(Q"-O.VJ_UY_N49!K'M(J<CC^5G"V;%]M>/5
M#ZK*^_TD5I3##G73OGM&5>Z;@/SYK-11.X9IW*I"^.VO[\[N ^14Y71;F*]Z
M2&6N6\#[U@"_PA2Z4@4$/=NE [XUY-=\;F4)K<E 5:%=&Q/OH"_V]-SODI&T
MP;,K"V\#1JH*\.WG<C\,OLSR4?\QM'MGW;O?/GTXNC"$+ZRS:S-X=].C-@&5
M55%;)%7U]9_GZ7A9T\F/2W[KNV[V>5S:M\UQUMWON]31U8Z#5]9335%4U='O
ML^G+Z?$$D"!\YUMM+3SZ^,IRWHR=JI+LQWU>HH='L0]SEYI^UZ1\Q&].WJ,!
M.MFA3-ZN U:6]JXLUY?_Q<C]AG1S^(N-"J<8?J=TZH-440E;C-I"$[LR7U4=
MKR:S#I>Z9[-I^K#PB_-%I3WX_N=6%NF:#-2U<,KQQ(?3V1]+=2VW@QL3K-+*
ML?8PM:V5K=BK*N&+,7W75QDHU[O1@JJ^[:T[2F7Y;L5<77/BW6]'Z7_.ES4@
M7XSG9SAMYM=7Y;^,%R><END$I8SM1^BZ\0*G6?_J]L=^AR__/>O^J&2&M"*K
MMOFR%_'57[(N2?V$C^WPC9[$:X*.CDL)XYT*!%<8L\5BMAOC=3=<2"6D\6N9
M\]-^S#?^R_Q\O*BT[S[V^-K;[T;LU+4D/_LS]**[63J/B]I;PR,/KVT7;L!*
M51F^Z4N5?\*/^.6O%8-=#S^[L@0W8*2J #]]^'BMKPKE6S9Y>&41;L)*51D>
MX>^+#K?3Z^'+1EG*6"RO=]^P/6__X;K:^\6J4PFZ+2BJK*WF0JM[$G'N2R<$
MZ$V@I7\Q/AU/?/>;7RR@JSUQ-AZN]KG%3NSN*GDT*H]B+/T4D:!?STLD,\+O
ML\5_P^(HS<Y*@8>-Q;O&,W>7X::$MQ?4MJ>':S]Y'T)[[)SQ(CVU_ BX:_[]
M3_\?4$L#!!0    ( %547E&!!GU;N\,  ']^"  3    ;6\M,C R,# Y,S!?
M9&5F+GAM;.R]6W=;1Y(F^MZ_PL?S>M+.^Z565\^29;M;?5261K*GYIP7K+Q$
M4N@B 0T RM+\^A,)$*0(;A ;0.8&B=*J53)%4MA?QA<[,R(R+O_ZWS]?77[W
M"6;S\73RU^_9#_3[[V 2IVD\N?CK]W_\_BNQW__W?_N7?_G7_XN0__73N]??
M_3R-UU<P67SW<@9^ >F[/\>+#]_]/<'\']_EV?3JN[]/9_\8?_*$_-OR'[V<
M?OPR&U]\6'S'*:>;/YW]!;0)X,$2KG@@4N9(O,^40- Q6,M!1O-_7_Q%9..M
M2I9$8(S(Y#T)5BK"$G=4BB2LX<L/O1Q/_O&7\D?P<_@.%S>9+__ZU^\_+!8?
M__+CCW_^^></G\/L\H?I[.)'3JGX<?W;W]_\^N<'O_^G6/XV<\[]N/SI[:_.
MQUV_B!_+?OQ??WO]/GZ *T_&D_G"3^+= _#Q:7'[#[]&HWY<_1!_=3[^RWSY
M[U]/HU\LZ=FYA.^V_D;Y&UG_&BG?(HP3P7[X/$_?_]N_?/?=2G)^%F?32W@'
M^;N;+_]X]^HATO%D\6,:7_UX\SL_^LM+1+S\A,67C_#7[^?CJX^7L/[>AQGD
MK>C72RZ@5('SW\JG_7@TI@\(9!:O Q#\+DR*@E?$V/7IQV.^_2R2(/OKRT5%
MQ \_NRK>Z94?UQ3P@X^N@';Y0>0*K@+,:D*]][E?X5R#W$18/M)?+F9C_T.<
M7OVX!/=RBKOP6W\!NX%=34G93*D3=/G\NW_ZU;.1Y/%D7/:-U_C7FW]?GG0(
M"OB\@$F"]/UWX_37[\<TT"B==9DY*8.602H7I=!"<BXS@]'=QQ1 :TB7TWCO
M4R_+QC:]9>+2![A<?G>48#SZ9;(8+[Z\FN3I[,K?K ->+>!J/@K1!N.U(\Z$
M2*0W@@1*#>&!T<#PAYJQAUS.U[HQA_C#Q?33C_B4'XL@RQ=+B1+*;K;$__8X
M@I6@#UO7^@3]'7]WQ*G.0B1);':92)"9.,<B$<EI/-H,L$0KK.3K9]['?J<F
M+V;K5=R\+P>^4,4*J,[B8EI!@"MV$/SWWTUG"69__9[6(/)_7/O9 F:77][!
MQ^EL,>+:"8]V"W')HTD3O4*3QE,2<I)16'Q-5*K(Z<;CSX;>8\3ZD&E6@^FW
M,!M/TR^3]#.:OJ-(C4J>1T(S&#1=01 G4R+6>6DMI,"J[$*=#S\;E@\7Z4..
M>95M>>;1["B+O-&[;).7"B(!#IS($"CQT4<2&"AA+;-!N)I;],;SSX;IHP3[
MD&QQ#-FK9?XZOH3?KHLP1HJ9F&EP)%$\/"1P2RQWN$(GC3#2,L/K611WSWWV
MY!XER(>DRN-)?0<7X_D"=6WQF[^"$4C'-<4M1 KFB50&$(^BA'-J\<1P7BA3
MC=C[SSX3<H\0Z$."U?$$OYK$Z0PWD.4BWR_PV'@YO9XL9E]>3A/"T]K*) !W
M$8U6@O"<6!8T@<QL-"8E1%C1-7@$RIG07T_<#[5!'Z\-O_O/KQ*>+N,\7D7)
M;O8A?'K((@DB#&JH=#F0H)PA(NL@(5E<<PTC_%$09Z(!-43\D'MS//<O4IK!
M?'[SG[)<-G+*2*DH\L25Q*521XJ105+D+%DNDZ.R&N\= ,Z$\V-%^Y!O6XWO
ME_CEF]GOTS\G(P$.J$Z.")KQ1"HW E8(3IB0DN7L?98UPB=;'G]>7!\HUH=,
MNVI,+X^;-[.WL^FG\23"R,08&?!,8E:,R!P#<3%[ H99BJODC-K:=&]@."_.
MCQ%P1XSEJ'#:/6!OI_.%O_S_QA^75H8+7&>N$IXOR)0,Z%0X49P*0R/SRKM4
MT:CK0G!>K!\NW [.CPJLE3WGQ0S\$HAUUF<&FM#B5,A$$8C5AG@=0 D5F6&J
M LM?/_/9\WJP #N8/"I\5BZI+]]^F$[6@0!K=* \6 )"XQG"2B! "$4TY]%8
M%YD5H0*;F\]]]HP>)<@.5H^*D[V'>#W#%3(>?A\O+F'DK4)-X@9Q4%0Q*2CQ
MG",CR8*UEIOD:X13-I_[[%D]2I =K!X5*/M]YDM^S_LO5V%Z.7)11&T,(UR@
M\R8CYP3M.T\R+;<J8)V4-3RF>P]]]GP>+L(.,H\*BJTUZY?/\8.?7, R2*>=
MT[9@X=&;8L=EX@*5)%$.D/$#DJ[A%W4]^]E3>[1 .QBN$.AZ>3V;P62QNCLI
MJH>F^_5\Q+F+V@M!>$J:2)5P'[&9$>:\$C;RK$R-8_8Q#,^>\6H"[F"^0ICK
MU60!,Q\7XT_PLU_X&YPCQFAT2022(2 P"HIXB>O&/2A90TVPM&:DNPO#F3!?
M0< =S%<(>)5[M=E+=-$OIK,O(\N"TID9$D+&11J/AJ#2ED3'C> L"N[JA3;O
M/?I,>#Y<G!WT5HARO;_REY<_7<]Q>?/Y2#KI@@B&V!@H'C$VHT7H. $T_R7U
M'(2H=P5][]%G0N_AXNQ():D0ROKE"F87>)#\^VSZY^+#R^G51S_Y,@I,::?Q
M/"D9[>42%7<5"A(-BTB#S+C-^'K;=B>$,Z'[>/%VT'Y4-.M&#3_ Y>4:CLC"
M1*XS :YPB2$*@OX=$*THC5$$JT*-F-;#)Y\)R0<+LX/;H^);-S;B].JJW()/
MXS_>?_ SF+^Y7I3:CN(+C@)$W%.X($+9A =*UJ0X#<2[K"-SUGG-ZYGBCR Y
M$^ZK";M#%XZ*BKVX@DDJ*6V_7OJ+D1$T>7PV@D"NI$B&.-"(Q-H@O(]>T!H>
MV+V'/GN&#Q=A!YE'!</6Z8F_CN?17_Z_X&>_XG?FHYRMEQS52N;LB 0;B8]E
MLV%XG&@5P/@:M&YY_+,GN(98.Z@^*E1V'],J\WB%R@K*0&<@X%0FDN$?'JU%
MHI(+R5.M#-1PK;8".#.Z#Q5M!^$U(F>(:^8O7TT2?/Y_X,O(:VTDQ^W%>HJ(
M3*3$"25)!.F9]CXK62^+8./ASY[HXT7:0?)10;*;<,W=1K,N)I"6*8O. ,D*
M_0&)6D="%D!,H!$RXUF**O?)6Y[_[*FN(M@.MH\/C(UA_KL/ES R5%@6C,;G
M UJ!42(2(3,)3C./"W6>5\OR7#^T(J]?E4T/\^(>)+BN8JKO5C6P?XF7TSFD
MOWZ_F%W#W3>GDP5\7OQR">5(^.OW<[BX>A M[D_[]9Q<>/]QM$Q6*A_T\M+/
MYV_RTC-X\7F,,@G19QL\ >K0?O31K+8?8RWCSD;M0L>.OF8F^WE8TG/SH)4J
MP.5BOO[.ID[L1%111QXI8^_0F<,(GK80=,4:O#6PK_'\O-P3>R$:;133UU2!
MAY!J[OO;V@'<,5^9LVD3@0^C"E(YQGBTQ&C'2NF1(9[Y0(+,6CG-@>J.W)3G
MHP+W.BR<4 /VD7-%YJ^FHZ\B0O0'(9AXZV?_TU]>P]^6EM'(Q(1K$8HD'3B1
MMA@FP/& C-$EIS2EFS=DFZT4=C]D.+.N%@73)O*K6$Q_'QG[@5+ZVW0!\Y^O
M <D1-^!$3)2EA."6U[&&46(C,T1PE;V0#M)FKO_CY&YYSIGP6T.*S5Y>]H.Y
M!T[=@...ITR9(C1'M&VUQ8W*(M:@DN$Q"D&IWH_BSN><#<7'2[%B$?U]</P'
M?@^<N0'GM=0*MQ'"K-?E+ +B.(\$]Q8==?8V;-;C/D[QEN><"<4UI%BQ=/X^
M./$#X^H.G&!K_8O*&,$S80H$;C'2H=?!@&0\4%P.3&KI]J%XRW/.A.(:4MQ:
M2/^O/VX(YS7^]=#^5).$EB@D_&(^O1RGTOWO)W]9&MN]_P"PF-]'TZ]QU<[/
MK-#1:C_<&ZVNC '*A,D\^"R#$\XX=*:C\($F!5*,]EM#78FC^8;V_@=8C*/O
MT8!O?_'??\  7#RRHLT>9!HR4F&M54)ZP5RF-''N>8A),G ]B-FZNJ-9NO7%
MYM/\BY]-QI.+6J]'YT>W86;W*C8X49;JQ S3S!D9E')2<<YS\, 5Y7$+)[M6
M5)6-DDLR@P_%I_X$#:GI?DY[GGJL;X.T3(.6PB<O19)9@DM,1<&-]8HGG6$W
M:3O76I7!Y:GY87J)Y]S\E_]]/5Y\:4!?QT/:<[=K91O$!1D9VG_)<DNE$MP+
MD_"EHY8GGT/J\;9U/+!2B/[NOB*7LD.:'4DEN5;23-$;X8R ,]ER 4[[MK'Y
M6RC'AAQ?3>(,_!Q^AM5_7TT>RN_=]/+RU^GL3S]+(^2A5.A9HEU)40K+#-0H
M""@:049\Z4+'Y=3Q*]\3Y_!V])%:LAFB;,E+Q2C7W>HWP>$"+J]+5MO;4GF"
MDE_@QA&N%^4BY_?I;]-)N5!# >,G7BQK%6"^&%'#2MM#0X0O-6<R:>*]".5:
MD&F3G:(BMGFO:L ?7NF::LF#"[3!*6YPQ?(;+$KSIRMX/9W/=RY@!@G@JOQU
MRVH\'E(Q:46$E+1D[P;BA7#X%4V9*C3<LVZAL'67<=Z*>T+**T8BUZMY@[[=
M[)YQ>K<X7.F;_+O_/$H&Y:42)]G%<CG&2OL+"J7]1>"V9+/HCBRAX]6R#[CS
M5K;J]-2-=+Y(_W4]7RPMY<7T14I+R?O+MWZ,[\1+_W&\\)?+O/0R42&5=> B
M_*J_*<II/E[ >YA]&D=8I4.^@SB]6/'G)VFU5%SA+SE#7.!Z1Z57'BB>2<I,
M$FD4)59P-(EL2#I2BZ?![MO+H5&?IXH^=?HK=DY=B_7G\:<Q>HMI_E5L^J6?
M?Q@!XT)KE%J2.A+<T'$3!RC)! R<LT%GZ"AK.7Z#W ;H/#6N*@T5^ZZN<?U>
M5GX]^[($M,P9>!%QX;.B^O/%WV#Q89I&DJ)):G&?YH:FTH (2#%22? VV,@4
MB[J)B=<'W'FK375Z*C9KO34N.XW$M91^1?FMBW=1]\-XLMQ,1]IQ07V0)"2/
MEJ/3*!6#7_F8 '$S[[I*,RJX#8>@/6\E:T]@Q3:QVWWQI=TYRII1*O"D%3KR
M53/KH!,EV9@<O4&3,S>*2W;B.6_-J4%"Q9:RE>,T1B8N5&)$2F50,K@>:U-I
MTT:M],$D:\5S"<4=$?-?)9Y3=-@ !!)I"J4Z>V)9J=FVGAJO*"C?9+^^#Z-U
MD4:C4/81LGQR51HKC2R.T712O*AE*C)(SZT0C&@J2PF_*"8(PQ49XR4$E3UO
M$FUY%-70U1HUV-ZF.$=+O4$@>0/33>I4'U M*S<Z49VX>.-X]J:M1#^87N2L
MG=<0B8MH;$A$1YQ IP4\\\9IH-$TN=@:4!_Z5G(,I [[2+Q%*<]=I.,F]]$9
MB;:@EB2*+(GD1A-G7#E"05F17 #1Q#9_@&1XJ[P"0YL5/$>)M\$%^/U@ZJMU
M,/4&'&6E]RTX=!=-F3(1T(X.3A 5)8< L73B;,']HZC.00_JB;W!'O .%K@^
M2.OLL34J[\ D)0E/9:]+"O<Z1A/),C$F&>HQ:U+2UPWG'+2@@J ;W-2^B/'Z
MZOJRY*=MNQ6\ 9I3%$H!1ZO8EJZ--!,'E)+(@5D:T.V&)@Y$;X3GH"1MZ*AX
M/=L9]KZ!I+F.F:/N,EOFQ#H\YVSPLM0TAIP%MRYT]-&L? EQ/KIPK(@;7%5V
MQ['6.YE2WGB;B*6B'&2E7S-W 9TPG9432%[H&-?:ZK[@?/2@FM"W7DZV+E9Z
M//.Y12W-/D\\17IY_VH;'G3@2+(5W*/_67(2!#":I0LF _!#<LV'*;\IE^>_
M7D[_;%+D<?O9 Q1V=*]C@R='558V:0LN2V5\T&C*@8(<&!IR//0HYNA:TSZ,
M_.3C/RYFT^M)\I/TDY^/\4/?XEZ!'[^Z(]V;AYV?>+3T]\.\64 3*-=H[("W
M@&=A=,M*>MST)&.&ICS:!W]-2;]%?N,8#M#\WI_<7/+=:]C4^J"U<9 A92$M
M2TB"USY39X1&=NA.!KK64Y.)98"_ 0\WG]N<A2[\#SAPCD,93X4[3P#PP+4*
M*BK.7 "[FX.':ZG)P&]^5D88?X*?BP-\V8"+!T]HSLKC:]K@1V0GA&61"I8E
M%0$M=:<3""T]Q,CC3GX>/*U*\']54G_/R7A]>Y4*PCBC/)J5DM&2L+1L9T:)
M@"A3Q@5YVO(JX#%LQ_HP?QM/IK/U[!$TI-_\.4'#Z,/XXUN8Q2+R"_CIQD(:
M)4H9SRX213DCDEH@SE*TXI,742*Q-#7Q:/? >#(/IYK^;/H[K0AJ$%!?B6*5
MY/=J\@E6:<L=@$<I)D_+C5&2J@S%")D$JP$AA^A20@/?-<E4Z8WP_/2H#3EU
M6S.M,-X,/D,SZ.]C1'N]> <^C2^_X'X/LZOQI)S/O_KQJF-8UP*$\(J7W 5O
MRV!#(QP)-'"B,K4I>1/00MM9P% 'R_GHT6GH:1#C[\@-+3[H&#]]9?_-_&2>
M83:#Q$8\B62=#,0'+HDL19 V<4V2XTY;$[(V32Y^]@%Y/CK6G*(&H?]>Y_/]
MH.7J5T;11&.$B"3BSD.D<H(XZ071QMK %*/2-[EA/ACQ^2G:,.15O'JXW[-K
M7:3SSB_@#O$ZH7HDI+71:4\ <B)2XA]NV8#9\: I34FXO3I5/OZX\]&.9D)N
M4 _5 72.*)<5@3]#O,3_I%%4- &GEBA;E-59/''1(R@G+@?-.)@$+7::/N#.
M1VV:45*Q!FJ[:K^83*Z7$U.6.$?,1!>UH83SZ%$ >*H&H*C;/C-#@U;1[K:A
M>SWJ?!2@B7!;E2*]@X_7L_@!M["WL^G%S%^]N$9K?C;^/Y!>7$VO)PLV4A3A
MA!R(8CP@3!9)B-008Q5/3$B=1,?HJ4KU)+OQG8_BM"2F0;G2O96O1N*MJSQ'
MTF1K'"X?C%;E:M\2FV4F1B7G*7@6>)/(SB.8SD]/:A'P4#<.GB;<"6T-ZL4G
M=-PNH)0 W^Z!QG+%!0=")?,ERE1TV' B!&5>)-P4>?OTJ$< GKG6U**F(P!X
M3/_][AWP'<SCN-PAW6V%=[^SVA1',5@5E9;$ +-$>@<D*(='K,[,!QE!);[3
M8#GX\>>C+8.1T*$YM::QW!/'JJ@M>AV409/+JU(;BT;VJN< $YRGZ$S G;&)
M"[0-T5"5H<V]G2HB/W75Z'RV&-T&?Y;E3=2R@(>G(V4J#9&EK;IW!DCVGFE'
M%<38)_*+'_R5LN#?-A7EP9-/505:B<AI#8%6O%:Z!^0F_[0/E#U*/O?C^!0%
MGD>RT<7I$:)LS&Y*-C$N-6$I<2*=PMU,LT"R!:^C8R')/B[(TV%U2YEF.U+W
MD6#=&^#_@,OQYU>3R?33\J)G_OKURYO4[B2TE%(IDGPL/J_)Q*HENJPH!>H,
M8SOMNZT?/YS]=K2\IY6%53$1I(Q_? T7_G(U-W2IDSE;&J/WQ-L4B81LB0^E
MC:PVPGJ@$%-^^#;N/1IUX['G<8@>*\^*M^=WTV!O:SAVX]A^AAXXQ?H49^?1
M)#R86GV$!"ONM@_P2"EX2@B R9@0C_/$.:F(Y#1JG7,0K,;P^?9,;CDOFQ&Y
MC^"&.B[Q\/?<HR-GA"Y)-C'B=A-PG8I9C:MS0>UNXOH$CLOCA-WGK-Q'4BW:
M\)>0V\.8_U(Y'15)<X[V6Q#%G-/$\2P(3<)[#NBGNR:#&[9#.H]CM;+H&R05
M=2-;GQL]L+5L6/08N!/U+:I$9"_].(*%!@TK'L4H)?I\UJ,_J"V4(:N1!!"1
M\)P-1/0JE&_3$'!P#=G5R>@$"K*/\.M:!?_I)]=^]H539KL1KJ=W9LMX!%L0
MED9OZ""ZD".R&:0RRM.X>;YTV @]'W:"Z3[5R)DVE6S= =;_>7U9X+E'X:D4
M-<BP'(#!RP6?)U9I3R*4X5U6>Q;L;N)[/.E,6*\MT\H!T/?Q Z3K2WB3NXL\
M'GX7X#=_!:O]3_+2;TN29*$,XD8#RCNM\0_0CN64H^QS,=8K6GH,T/,P/0>E
MJV+><<&]#=?:(.J!K/:ERN.0AK]C&8[::5->*F]0.Q &[:DP>%H&0'IE8J7[
MF]"D))N(X'V4OD]Y[9/5F$?N;YZBPNQ#1UW#]<5/KR8_P:=U3Z^0<]!&$2EB
MZ1+D\+0.GA*05#*@UGJ9=UHI]SYRV%N>FF*>5I!194/SCS]>KT?$2VMYC)18
MX&6R C5H[6I&N)$E&B<=-WZW.7G[>>? TH'2J?LZO9Q-)]/YO\^FUQ]?3>(/
M:]]$<1&C3*54J13U:C1;@$D2E6%HR61F^F3V=WWT.1!WO,RV7KI5["NVJT?&
MAJ>RM%>;-1QY[&'->X_T7NEF(S&F/>Z;/J*I+KVT(294&"TD0$;G3>]L0_+8
M@]MW)(F>)@=!X6YO)6JW%"0XBZY(\ %=7!<,;3+=8H".)(\EMP>#?K@,D>A8
M)D>QR' OE8:DXH(E_!-<1S+!/V%UP3[ZL4]UP3X$-+@LZS=>3&@%##S)7N)F
M[9Q#OSQS],NI"V"D8JI)MYZG.?UM4&VI04F#2Y+>E0]:!!%%!A(R%43RI%&]
M4R!.R)0"-\ILNAS?BE(JJD\M:AIT#=D>!@PZ9 T"B$#3@<BHBWV/KKCQD*,*
MS)DV9]*SJ"PX1C7JB/S4E04]KB"3ITX;[0BCMJAVJ;?2J-J:,:N,X%;9)JVB
MGU.>QUZ4]\_SV$?T0]_>]\'V+<_C$"+WN<8_A(6A-44(Z5C@""IDA2^'L,1S
M:4E@/&8\,]&I;=))Z#GE>313D'V$?YH\#ZT4BY1[XH5'Z]L6<& S,2%YG4HC
M@<T^#F>3Y[$7.?OG>>PCV:WN<,6XX#OX!)-KF!<IO2P]JWQ<S/\<+SZ\O)XO
MIE>EA]?>X;\>GWETE&]?W!O!/ ].42Z-M-Q*%YD/04M!$S692NEAM-\:ZDK\
M^([/!SQC $;VZOJ<N&#1LPS>.4F=\PK-?R8-I%2:<Z<>##VVQGT8>S&?P^+5
MU4<_GBUO6#^/%WZ27A4:KM;!W>)Y'D!4_X\^FI\#5['9+#TK:B&:J!R53$?G
M8Y;,ZXA.F\S2C0Y:41,V#FU=O^\#AF.F1S-['K*G7"6M#6YND*U2$AUI[41R
M-/#8GY_CNMKW?LS;&;Z<GWO_^L%;8FM PVE!#8EM:DWTG&8N.,]X#.)V2ZD&
MY8/&PQ%$2OVUYD!PQ\Y@G"]FUW%Q/1M/+LKGOI@D_![,/L%=8(D'S[V7DBB>
M(Y&"*;2\0!$KC?!))^MCD]&L?< =8=(OQ]P]>,;\U21>7B?\VV^P>+ORA<KW
M7\X@C1<CT(:*;"S1H!F1WJ 8*% 2A$!#U%'AF=AIWQ_RY.&-_>JZ\971WUSV
M=1-PEG!FXVD:QY^+Y"']!!/\8C'_Y?/',EJIF%2SN;^<YIMO_/+Y9B7O45[C
MN(ROWXYFZWB=1SY+*TJJ= ;MT7L"2VR9JHCVM2]-88P,:J=BM<=Y7FKXQ'AM
M$,O:\J*-5,)3"D\HPADO!9TH.JL#)>@X2.&Y+4TS6^SI6_"<D5K5E'S%RS74
M]OM@/OC9!>S8<7-F*:04"6.AS'BTCOB(I%+)8]!.9[8YC*=C4]K[L6>D#,VE
M7K$@MOY^V+7T$5"5M7&>X*:(I[CRN"&BMI!,<^!@K?9\=_/  8">EQ8^-68;
MC CNQ"1\X#Q83IC1H50'9N(I]80%$QR+#H)LDJ!TYAI53>85V_27A/W[WG/)
M)KT9;U(<Z>7Y>ZO6G5NO,4: DJ7;L]-$)D^)H_B'E&!RZ:CI>8\ZB"-1G)&>
M#,U)W?;]VS=-/,"G5U_MF:N_/[IE;LCA18<<1I8[ITQ$$7N-2]54%&>!X8::
MI:%:Q&AVJ]_0J,]+79\TYQ4'%/1[,T=)H8N:+=JB1AKT5K0E7DM'LL'#W'&K
M\+ROL2&>EQ+5EFR#P0)WU9#W!+$4PF49$'YWE3$* J(KVAFU#R43/1%+A2-&
MENERZ*IH2UL847M@'"H1L[E%U8J7IY*;N=HU;Z?/OR[_H/!4\H8$L]&"]83:
MA Y$R(983\NT.6^H\9"4::)GCV Z579F,S68MJ&C0>AR"[1UME$/<"TS-A]%
M=YJ4S6I<]M.1(X@87%N\X\& 2\18BX=MY)($:S*A3HO >-),#KFSG#!M\S1*
MLH_\&RA'V2S?Y/?^$N8WV80@I&=!4X)_HBL)@1&KHB,L"!.]9$;H1F/Z-I ,
M;_A69.K!-+YCQ%SWRO9O?O8/6)0C,UVA2/$,7>GYRES#IWQ8GJ W.$UD48(Q
MA :01)H$Q):O4LJ0DP'/]>YK_;T>>0Z\-Q5SY;XX9:CQ]'*<EO"69OIRR_/:
M2 ;.$JJ=(E+ABD,&1AQ$Q4 YYFBUEES=$,[5PJPD](I7H-V(UOK? U/MEEK;
MP S?3*L&48_R?H24FV\$ZRXF1N;,M"(@A"U>NRTMGH X$R5SIF2X]VD!_029
M?Z0IUE#$[R/<%FDP'Y?C[$N4=AG%6!](V9MHC8[$Y0BXSA!(B,X13W7,REA&
MO6]A!F[!,VQ7GSID;::]5)!T@VX6+Z>SCU,$!K]-)S?(UCVCHJ*.T4RT+ ->
M66ER3V,@,5/E:$Z:BR;M7;8B.@,EJ"/M%J6=:^MW'8]?:^FJR9_(C 7&2'(B
MHH[22+Q"K#FHY 5SH#:OWVH-87X$U;G:A_4I:3$<8(5EW=ZS!YBF5>)?HSE1
M67@]MC;UX&A1M]@O[H%BVEB-VQ<1%%#-33#%?>5$.V$C+7>UEC]3WG<5>P]$
M^SX2KEO@_?YJ^@\HF]G;V33A9C>_?VXYX-JH1$F@Q7QQI3D.#8QD,*"R%RF)
MW??@CS_C!.7<A\M^VD)P=2. ;V;^\O=I\#%.-R#Y*($!)=9*7"AZ-^5Z5N.1
MY9/T8)*BNS-0MWWZ,V6QBK#JOI%_QXWF/A83G.,>[4:K$WJE07B$H1,)@6M0
M$).,NXE[\+'/E+'CQ-.@;=>+R\MES<.&XQ>ID(%91W+6G$@:%/'XZA/&I0.9
MM%!=0RF//S2[X3Q'LBL*>*N)7+$Q1N\2UK]-/RV_,Y[<\S!>CWT87R((&*!F
MN3^&X<J4#Y3+1F5R=I8QEJV')&4I(G%:,I,\Y2Q9F7C_RN2#9-1$8X[O[W'X
MHX;C?Z]N']HA&GS5N1%*LF"\!RZ4<"9#S#28_C0_>.P I>6Y3'%AI<N<#&7"
M)'H.SO!$(#J=:/2909.I:2U+RQ^MC;!),%LJ0?$40%?)&$%LPJ6S)%TRAH.7
M3:*-SZ@>91^=Z%6/LH_,&X2>7T\G%PN87;V]:6OU<GIU-5Y.'%DEFH^<<T*4
MC!M<=#G M2".,T%T@N"HS8&K/G?0>^O$+F!GJ!]5N6@1;]HCZ"JHU(QS1Y1&
M(U_JY(D'EHA22B9FI8RA32O39YJ5?8S>M.+EU%G9R[E(Z]C>^P@3CV_!*J:'
M<&D)Y&=5XC9&FS+MQA)@TF7+A.6Z3ZRSWZRZ+@3/X=YC+ZJG-45>?:SA"L<?
MD_E'B.,\AK0.Q/< 53LO9BN:$TR9.YZI:2LQ#Z<#OG0PL9Z8TFX' 6428D2M
MY\);E0.-K-K0N(&Y?VQ>W%#4[R'=1I3_.IU!]//;2WKCC=?&$5"ED%^8$J1R
M"-#SD&UR)ID^7ME>?-^',&P.1"5N.M@^0K -/)%'S*2E;BL\P(31&5=;ZM:<
MI^@RE=%;R40>HTI9-\F&VH'K7"V!%K0TB.O_CK^W(8*;MZ,/L);Y$%N1G28W
MHBJ/F[-;JI+08N[/5H R!"E90( JH$L=E"9>,4:,\<!5%L;1)G[JP-JQ(X/B
M-,JQC^SKWMZ6,9$3_.F7O\_&"T27UWF@VD4N@D)$)B B'DF@-A$JF6 <,H6P
M$0#MN,/=\N'#!ZPJ27Y:56P-+(>'\;)U>D 9!B,EVD9:X1_11>(2+I,:E@4U
M ?_7I+!R&Z#GK@)5!=Y@F[^WSK>7?E4X&GD.2GC<K:)&IRA804JHE C#((8,
MT>4FB7&=:/ZIS,6#*&B0*/L U,T[T =62Q-Q"ZXG8" >QMPN73A"[$/L%NN=
MD5N6(Y1=*UC<Q"0C7B@HOC5GD(T"WJ3Z>E!MV,<@;*H,^TB[?@K?;<9P*0V&
MBW$L5N_Z---1&<ZH(YE)W >SU\0I9PGD0(VQ5$6[.ZUVUU-.?(]Y*!/3-F(<
M8C;2:D;\,DEM/%G-KGP/$:51DH7V3]IY_...3LS9 ^WF] =P0"$#F!PE^FC>
M<ZK*T"OCDPH&1KV15Y/NHS\\=+#+T4]LR]'>:]Z@,2H-UG&1#0N2&6:#"SJ7
MND0>/*0=-.ZY_FI,O[^^NO*S+Z41X>UO'9P7=_"3VC+;>XV;C*;L)-=!&,\D
MD\XQT-93&I/C2MOP.*.//?6H@,C-9[V^S4DP,2D=;232E_L%AAZ]#RX3JD-R
M@5OTZ':??UV??*SEMA+):J3X5Y\_"DXQ87@@6>32@C4E8IG# RV[9*SWD9DF
MP;PM>(8[VFLPN&FPU1!R@V#/YNOP]S$"O%Z\ Y_&EU_P18#9U7A2-K9?_7BV
MFD-_-;V>+$8V1$&S4B@,Q"QEF=:(-BM)0JE44M&=-.VTXP#$YZ _K8EJTJSM
M3MF=I3;9+(ATI?]MJ2WR26:"AA5GQF>><I/I4F>SBQPJS 97A3_#;/QIF4-^
MJW!O\MTWEZGH(P$J^L0",9R73A#HYX8RXT)Y/+6]9J!TDQ3H/N">MR94%W_=
MZ2)?K7<5!54:'2;G)'JLY5*#*4VL2Q:A.*T<XR9N&A./6S^#Y)S6).Y8H9PZ
M?72M>+_B*3.)8W_Y:E("'^4C5]&L0)-U@1)O$\I$)$5<:?F!IX_+U*A@-Z=A
MUWG5M^ 9^F;@:'JG]<7<XNI_YB?S#+/YBTE:=<$?3R[>Y ZT\W)9-N_^T3IR
MW6,M37-**B[F-+<,5;1D,\/@U!0_=;6%Z&4"?(^U*K77$:WJH%DBT8>H/0@K
M;9.=[NFKZXYKD">OK?LPVZ1U\=75=/)^,8W_N GV2] R #>$JF5C+LU)"$P0
M!2HQ%J+1LLEE^P,D)\BU.!FQ#QJ<'<-*@YC-G95_M]!WX_D_5MT<6;"<6R ,
M+-H<&5?J-)HN7GA+'56\4='I8Z">NRU63>!-W?"7:._/?%R4MV'=@K4'MI8&
MUF/@3F,PU:-RJXY4XJ'!^?(H1@D\Z8"'L(:H2[&+)5[QDK D:+8L*+K9*>FY
MZL@.*^4T*K*/^.LF;JPBRVM(?R^=(6XS$"V/U CKB!;2EBE\>-)%HT@6RG*?
M+!ILNR>5/_* X<V*>B1,JTNP;D^T^ZC>S@"N/I9UOWMU\>&VH9".0OM2Y11B
MZ5$DO<1CT1D""6&#$]EPMB?!W4\Z1Z8KR+1ZD=\Z+[7[OO'A=P%^\U>KL@3*
M3(P4K6+*BB2X0-R1 1%H)6NK@XRJ8NGGX4"?JSDY*$$5P_D%]S9<-Z]3'V2U
M*\<?AW2"\O'!J)TVY:7REK0#H7(^.R84"5XP1 B>!*8XR<:PQ#+@6]8G/?C)
M:LQC1>=/4&'VH:.N&?KBIU>3G^#3NM&AHT&#R<3XDCT;@B3>>$5X\-2[Q(Q@
MN]M_WOO(8<O,:XIY6D%&=4W+__SCC]=K^S9DE[U"$)J5)DJER;]WG+" S[>*
MB;!YP]]!U-WGG0-+!TJG[NOT<C:=3.?_/IM>?WPUB3_<X/$"*"^%!M24VVL>
M(@E6"N)4,IG9J(VU.]GJ_.AS(.YXF6T-\ V5</^+GTW&DXN.G[1)%][]O+9)
MPWNN=R-U6$0J/0-'->72,=P\LP1P1H%0QBK[>.KP[F?7:A"W)7GT]6U""DBI
M34R&.,-L:34<B,V,$6Y!XSIXR75O$;SK#['.S-?7T_G\5]P)MF73ZNA%2)82
MYFPINM&9>.IHV7098S+CV]^DQV@O="?H1]U&@[KGP=;DIL&MV4Y9K!S[G+/U
M"@QAE./187)IK"XC23D8I82P+.J3O$F#-ED<2'$:<'+J-+FC'3L3C=<Q".)!
M"R*9CL1Z%&_(43NG6*D.^&>,PK74F5H!NGVX&S;,T@?9MP!=+6K[QUL.X658
MS<DNJ.R<)CEZW-\M+<,</?I2W$L;J&<J5&L0>$X!ND8*LP\=30-TW)=,=T_4
MLC<-X$(#Y9HH065R@$Y5R(_[E4\Z0+>7F+<&Z/:04=T 77<DPV1I-0V)^,@R
MD8IYXKG-:(&CJ28 G>$>E[U//_IS('?'RVSK^S94].?NA^,)JN+Q(U2.>MI0
MC0!ZK'4C[I-21.Z42\);*60*D*0U4:#W0@V Z-L$H/O)@T5]J"RY1\:3)#A'
M&[<TD%&*$4C@2H42.M5-HAW#17VZ/__-GQ.8S3^,/[Y%MZ',M;F D6 I:5IJ
M(&UIP*:#)8ZAO8^O*+CDM6*Q27.ZW@B?=/1G'TWJ5]E^+$<M<J$V,?YV700X
MS>\_^!G,"^*T[.8SC@M((^HMVF\>;3>!9XF,I3Z!RY)"'EUFRAJV6>"^-35J
MKP>?G:(,(/\6&9$]T*Y* T:)Y^!1 +@WH($ON0'BDI0D4>V]T5HBX'J:LGKH
M/[66'"#W!JGW6\1P6X_]\WA>(H[7,QCYX+B*RA-&48UEB4MYS3T!%7-"_<[>
M-VF"UQ_BV>E38Y8:]-7<=G&26"[K3X2'H-"?\8[X9 U!4Y5:F94%VV2JZG.\
MQFJ@*7O)_Z%:R.H'T<_CG&$&DP@_P>)/@,E+]$"^E/:SRX8O?I)NE?LKX\N:
M9#CG@NB2P2"%H<1)C[Q[YWAFRWR4 P^I@P"=G1J=D*^'6J>J:]W=6-&1"%9#
MZ3[)H,1$C W$V5C^4"[:8!3OD?.UZRG_//IQH&0?DJX'NB.W)4DF&DVXTR6]
MRD=B&6JJ$<P)!]D$T7@:X3.[(S_F5&K R:GOR&_[ :RWO9^^W'[Y'V.8(;(/
M7U[#)[A<WJ0 -\Y%RHG+4/HDQU)/PQ)Q <6:K(\I-@ES]8/WQ._!]]*+S1XT
M]?EI4-5Z"^UOX(L9?]^\O\6[[@30 VS+DNB]T)ZHJ4P#VK=I5C/.3JYHA@?*
M66(D!B/+'%I\\:#<_QJKA!<ALM!DP-H34+!=;6">FG[M0U5+O7HU^7B-9D.1
M +N;!12H<4 \-^@%!(;BH-R0[(3!?3VGK)MTS'P$T_"&>4,VM^G-D514O+TX
M.A%%)"V=0,^191!$TJ")XS23DH$2 E7<]<H-_V=/*#S$D!J4NXH1[AY)%GV0
M?4LHK$5M__RP0W@9.!4U19"">T*5*Z7S-)5[/46\RSXX<)SY:M/FSRFAL)'"
M[$-'RX1"7 -:=C$1G4N473!&O,J,I(2[;N99Y;R1P/&L$@KW$O.VA,)]9'3R
MV3]?ITF5DM@!L]$Z'S=<.MKNU6[6(0)U/$4:/;,R4A:TC$%DR(X'@79K_WRT
MSD</EI#&E*-2+=MW"D=D*I-+8[:$QLR\%M*9V&0F1/N$-'P5W_HOR\]:3%]$
M?,H,#AC),$KX!J,E*8C6$25$A20^YD 8YTQP:[,S:><N5P/)D[Y>V4>/OMHL
M!V>H19+:7FB[LNPT3<57D2@M 43FK$IS^E0&SZE$<9/1/3+SZV Y1R4[ 4L-
M8DX'K.)FG$PP(EDM*;&TF*$:96>#="0;@!P<Q5.M82K3DY[[,Y 2#LMAQ;#"
M86_/;]/)R^G51_S1.[@$/X??9^.+"YCARS2>IE%T/GL: U%6:K2)RZIP641P
MZCU$(:W>?:)6AW5V2G=R[NK.IZF[EIM-_<U70P37.3XKHT+(''B4ABBWE#C:
M$\%S*)8%H+2=R"X,K*2[,'_3X$%9;Y$XN-="_\>U1P=R<3L]:CXO"WJ1_NMZ
MM;07D\FUO[PY0 3S//D$1$=5VB![(,YF3G12-GE/38B[9UDV!OE-@=ORVB+I
M<,]7\S7^ZH4OI-X<*!(<4]$JPB7^(;F7Q"FTKQUS+!O)8^[=SOA(*-^TKP9'
M%7,<#\2_+#YYDW^:^EE:16'G(VT,R, D$<J@[^: $2=1?#D &LXF2B[;F)P=
M8+[I61V>'FJ:.;VF_?%Q.EF6/;V<HGAGY7YI!%SS)#E'HT)&E*E!F[E4/@&C
M,K&@LJ!Z*.7KP/=-'YNQ^5!%[6E4]-4DP<=R?S%9[%J?8=H;BQ*/2L42364D
M.$Y)Y&7WYY'RW+?JI#'4;XH[!,</==B=?IM]\?'C%#F$]-.7E?2GL\YUNL2X
M4X8P@7:QA"")A2R(I\A%%C;RU"2P?CCD;SH]).<=8?J!KX-Z+11@.<ONP_0R
M;7FAHP&6(L/76#B.7B!^925D$B!K93*R9G9WB3X9_&]*?RI=Z'@!CF_#<.#I
MM7JE?YN6WUB,)Q>E9<!X@0O^&>;CBPE YVJ]R39)88E2S!!IN""624VBH5'%
MQ)EA;>*TQ^'^IO*#L]^AZT/?B]VL]N?Q#")^\'RU-K_S3 .&?K%1Z'-HG8AD
M7.';+''5W/F<D\\\-K5C]@7\3;N'X[M#K8>^9KM99M?+NWWE %TK3U9SER(G
MWH72@],HM-Z8(D8$$V.R1N;84M,KK.&;\I]4*SK>AX'OY=8K?[.$?_%AT6?A
MW1L!Y=X*ECC1QN+Y9B5:=8EZ8H5EV8F@O&YS.U)M"=_>AE/J1,?+,/25W]:%
MO_R O[/WZK6RH;1P)8"&'E+F/6X*&BFSRF?@67+7M\??*=?Q[;4XN79TO!M'
MMV,Y0 1_?/P3W?VWLW&$NRO^E]=7UY>K!(#5-;]/3.2(1- @:8G8<A)4LH0K
MF26^\532/I->A\CA[+6@L]/_)Z4!':I]\-WH$0N[:Y-4)@W=2UM)AE/)4B#<
M.+3H\/4D3K-,4M0R6^><$ T[Y%5:Q3<EKLYUA^8>?&6Z9[FXH30(!HPP*/-G
M=$"8KHP@%#H 8M0B-FG<\&Q[9!VC80TX.76/K*/+A6/D-$969L(N"TY9*I=6
MG BJHBON+Y.JAP+^L[=]V$MG:K5]V(>[88OW^R#[UO:A%K7]J_@/X658S4F6
MFYA3)#EG1,BE("$;02!SH(EFH"$\9XUIU?:AD<+L0T?=M@]?C<<.B2:OT/<
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M<]?ASBP2.HA,IVSZ3#LX8HWW 9TR7G\8\]OOW8X0=9,\CK"X>W]N4WY'-/K
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M4:T@Z19J=AC<<_#N!B"J05.=#EBWG5QV VOIXFU%]G3:Z=2F=]J2FP9GWW:
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MUR=[*<#VH;FUB&AI#O4:+=T';,LTFB<PVWV/^;G5:#]JN/LAG)U<T22EADD
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MD@=B4BF*3AJMK291\2?4-/48MH\1YU.NKKS-1I6HK8S:,O::XJFK*"56IDR
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M_C'/F-Y=_0,IO*:<^@->9SZ)Q:3B1(:"=7_%.$,QA42PUE%0X5/)IHL^^[X
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MK7&:G,CM1G?\ .%0&A^?TC7FH$,P\(H@36M]ZO1RU3R(WLU+J6J[8NE >:4
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MZ>(J_?XO>OT_?YE^794GY:22X,R!-)[R6&0>@F3+&J4<,V:.N/O#'C/R6?I
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M>+P%>^NW?(?U"WZ=S>L.Y]W$8Y/34A/ P"/6'6^:>*2W8)*5I39&]FEW^>6
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MH!46BI(I!R6JMKO+R_99^858R7S4.W>7[I)7#CI1N6(IJ*&DDGG#8W<JY.+
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M(.98(^;:HF/$@]C3GB5E"582:W-42LNU?6K9YV8 W"R?-^5ZOM'KOU%.&D,
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M<+5AX?/$3Q*%H?15HIG*\R#&?@*E1VD<>%S[ [:YD8>09W8.4JF3R5Q."ZV
M/+P]:6W8#C)BK7[,U.,P=KA);0A*A4#G*V;3#I6UES'UD$WD1TPS="X>PI!
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MQV[1Y]S6&B.IJ:3[5,CJ9D_;8&QG0P^,W,@+Q$[:,U#A5TJ\B\ZII![.5G:
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MQ)HTJ(\%]GGLQY8)R.NMSHT1C&N2;K9Y&N#ZSL\?1EB'^PI[V$XS06<P)O"
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MV;G?^#'=/#WK]GY;Z7?T+_+6O\KMMJC(>GZ?R?R'ZMX)$0D1.)004W-L('D
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MB5SL>X!*Z#-0C4)NTVK!BQV1X1815ZR&7$^L^YYT:7%%Y'"5<7Z_;ZX!D[U
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M[H>,8O>2L]]\*[^ME]_,!ETF1;K]3'E>?/3CLSQ_OG_>;#6:867\XY#ZL9?
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MI)%(L73+./ C9'C*<TTGF#>$ FYZ8_S$:UH=.X]XKHRUN.H8[>YEF&$ M!P
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MWRTM9N">FFSI#@H3!88^I.LW%&F]NHT#X[GK<@X]O$]CDM%8B-04[$@@BHB
MB*@$$AQ'4.O;#$L>YUQ898JUXPU-F-[._J)>34E&5DU)G/CMVK][]\]1J(8D
MH[="P*LAR:C/AB2CW9VV^VMGZW"G2_C]<EH:S^ -?::/<C[ZB^IAQ#_H9"G'
M!249186">9%1B I>0)S&$L8XR;3.0T2>6>TCIUF'MMM6I +1T IH0ZRU)>0
M^$D;LAL8N[[7U42#+:JOP!K3EG#04GX%:MJ[@-;:YNP&XIY,T'!0NQBE[I =
MM%$=ANK+9'7G;LN"]7C96:*OFL%^G8WXOY=E)??'T)LHGAM9E=_HHBZ*O3*K
MVRZ:FL*1N2-JXDBR*"I2RE/(<1YKNQ9I[4D2!1,9J[0PK2U1LJJ\\=7J!.B
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M69&E>:JLDB4V0PYMG]PO967J:Y7<=;MLP71\Q_@QW_&FN?_]_9>O=^#+[76
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MR&R]RI'37.\*#XLW_"1&4V_/R*8/FDQSE[_X\4DNGF9B,]]\G#*4Y_I3@;'
M=>:B@CA#0D.,%.)9CA1-/ *'K":WVA;]QPS]]+XMU/DS: IU K/.0-9,M)4@
M:OK=Y(O=>FB\4Z[M BBDML!-M"5D$B-(A40I2PK&F%-YCG +T:-<?_^F4FJ/
M*V G[(/CVK'<?U4PM8&S(1HT5&\="@&+:SBA%/(\L)NXUZ/!"8O=4\+M9;\#
MXV$QXW]^D2_ZDWNB<Q,-]EC1Y]%2SU*5_R/%J.[,&H]QE(JT*"*8TXB;6)$,
MXJ*0D BDF"PP39/4+L?"<6:7[=1/+H:)E)MJP[BND0JJ-0>F/:UAP4T^V2Z
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MLQP.-QD5@II(J$QBTR::8TB20L!<<!+C-$I8JE9.MDZ0>^U$Z]HHJB1<T.^
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M6YN=G2+?DQW:P0JX6*;>$!XT5=U'[,MV]>9URYCU'\-/L=MD;\W'!,6<TZR
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M[177ADRO_KW'0=8H,E1(!7F1YA#Q6$(:DP*2A""%E:)%1IU,NE 0]Q@QT2G
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M@5+(6$$ABA0Q0=L,XB27"I$HS9@6$K,%G?BZK_9/["0TUM-WZ[EZ:<D$K'7
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MENV^WG7;6EM];\SVAPH\I9I;9FFJ2FYK?OT")*N*JBJ2 /@0;W2$6Y9)(/.
M.$@DD)GE/8/U9OM.ZG\H]DIOG\O2#>O-[X]ZPC_0C;Q9Y\6;>G,O!%,JC 6,
M(R(A"DQYC"R6,"+Z7R*B*,NLIN=K*S(W7BC!T,;('@WP9PF'N0Q@\ "B!@A0
MYB[B#P-)/>7#>@]+<;9?X%+=O]# Z ;VR)C@V&6%#7AZ-$:00<?$@%3PV,>=
MO>K7V.GE^Z?YQD9FXNKS.@(!*B1 !06H8U&[ZGK(Y?!%@0,BX  ).& "CJ"
MM\]@#PLPN( "&'#SS_9YV4=-_K-\9E,%9?Z3?&Y.X9]S&./FZ-)7E6ZRX-4Y
MC$$]-G86\O@F"?TJ[XN[:/GNLY[+"Q(HI)2B4&4)@LA4W*2$8AAC$7,FTR"+
MK0)GFSJ8G<E59KD\"@F,E*ZY0$] ;+=(AH!F;$O!#16/E)^75>^=ZO.DV8E3
M?%Y6ZCRU9\-SGM4/G]BVO.KP_H?^XTZW\F[]G2[S14K3F$=2;WX5,XF9,@$Q
M2S'$,8X3/:M3Z5;'JK&GN4WJHZ"@D!084<$?I;".-YN:X;7SY@X"VLC3W1,O
M]XI^75@,6IFOL;-I*^QUZ7Q6*:_S!6=O47'.]%4^ZN_EH2B^NK[?T.]?Y98O
M<R'%]9,V6#;+_Y+B^$SIV5UD 5*)TD8 2Z@I9B52R# B4,0)XE%$26)]E\E;
MB-FQBU'$Q)!44IIX#Z.*B:ZHE 'TH$W]05KH8[WO]1^V3I?()(,Q-FL5XW 4
M$-SNQ^&@!S@J4G_P>JIQL/8=3#(>$^W[1QL7EXUZ;T ;-]G^+4^U0>ZM>VUS
MV[\MY]7JD+?O8Y%EW62;>"O5>B.K0+B;]>9QK9^0[ZOH-YJ+EZ73/NIO/+]?
MZAWW=I%P(0DG#*8LB" * PYIQ@6,A I%2%2<$=NSBD$%F]NJ]N7FHS4A#CM"
MG8O5J^$^\@)V3$A:*K8OX%,J=XC[/*@'WA]B;7/QLO[C%P5J.K[20%JO=J\V
MH!.M@-,/K,O2. KZC<OEL+U-M82.@E%M61VG_;Z)D^Z,DWI!69Q&*@QAF"F]
MYXMC ;$,,AA%H=[O41ZF)/9+E52T/[>%KU92[8]"0.]42"5\=FZA'J",O"HY
MX-$CN=$+K<=)9U1V\4H)C%[HUYRRZ.5CG@Y@O9P5M_&^J,):?UBO],O;\ECJ
MD/\=<1JR, D@DS*#"&GDF$R11A Q29A)5Y0Y.8-M>IW;7#\(;2[*U,7^%U"=
M5EOD@^\Q")8NXZ&A'=T1,P"J[LYD%Y0&=2Q;=3RMD]D%BS.'L]/+?5,\[RN6
M'"\1OSOFY]DN5)2&J>"!-CXHUC3%%:18"9@H' 1I&@11:INJQ*GCN3'5>3KF
MXPV_8[!"/;>1=];=CA'IW)Z/AO/(M'6>$?=8L>@H/'@W/L2^Z8J'@_K5DA#[
M0]XCI[ =;K:9@CM:>Z7\OW8Z-F?UM7S?>3FXV:SS]?;7S?KI4>]]_U(%CU,<
M(H%3#/7>4T#$,P59$E'(%0T(PAF506!70ZJI"Y?9,%&%J$),]\#\RPAVTG1O
M5$:FXPJ.0D#C-_O+4,A8LVMOA"9B40^D7,BR%89&4KS\UE3DURISC>3:GW,F
ML[LU,ZDA:2[^*NEJ]W",D2N*I%0?H$(1%U' H$H2!1%&*:11PF'*XT@&42+B
MQ+88B56'<[-E*Z$+YW8I-JC%BA:"N\]U.^@[67%P0$=FR5?$TII'!\=TJL3
M0V#KPK1.0#4RKUTK4S&QDTXU9G9[S\]3^E7NEIO"EC4EJFM7.17+ HHT+RM%
MI69HF4(<DA@BI@U02J,@%=C%.=K4T=R8^2AG48:]SSW91FSM?)Y#(#8R]?J!
MY>S7[$)B2%=F8U^3>B^[-#YU6'8^[WL.RC=2<\W'_/=\(_GZ/C?WFN[HSZJ
M_?;C]JO^][4)Y7F^U;ME<_BZD$ABCD0&"0\Q1&D:0XI4!*.4DU2B$$ML5?&S
MEQ1SXY6]7*9P7*&-R53T5-,'[.A/P"J-7,];?8;)]E1V9/!'/[L]PEW7 &@5
MP%X'L-R"HQ9@K\:0I[P]4!SV+-A'D(E/C'M@=7ZNW*<QS]-G4Z3@:26_J/+
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M,W9)E]Y#.&A%%W]IYES0I3?&/>NY].^_1]CBBYKQA0<V0C$53,8PP51 A$@
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M1X,$4A8ED*:,:AL)AV'H5/?H4B=SXXI21K,05]MHOW/!BWC:$41?E$8F!G>
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MJ9GSH\C <CC""3#51D^@8)*F&"*.C(,<15 &+,X0Q3%/N=M)F+L0\SLG,PJ
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ME/L+*U_I3E:'Y2A&A,@ 0TPB!1%)E38A"8<\TG0EM.4H2.;&3/:=SX^>C*S
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M\9>[#<VW2FXV4H2++**<B22"820P1$3O&"D*,YC&5,8RBI7F$A<SR*7SN=E
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M4"&E?Q.+(%#,Q4YPZ'MNM%");E*,&IG+]**@GMO/+T>BRW#8V1@C@3PRJ0R
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MF#!UIBF$4THE1]HD<^&, 66;&].<J@:.NH'U4Y&#W#)SN7]%BB&'WH[<7FE
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MG(>FT^ =%?#1?6,'>^@H_!4HQ0>%_, H "H-KD"EPXB V\<6C0G\5*%&@P^
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M&ERO]-^IFQ/O):B9I"R@2$&)4PD1SQ0D*24081X(@6E&$7>+#_&&=9K(D*F
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M?;I=5K NS\(+<3+IR7E9:;T]9R],S<#D>5+J\0\/^I1_)DL=HM[V6M3_H"R
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M]6.(N)"0I@F% ?;\./5$A,VJ=(YO,S<-\2975H>Q!K4O.@"JF6HX'ZJ1]<(
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M=^+BI[RLBG67B_]7P>^5<7W-U#_5/=*WW=NN:5E? BR$D#&2:0H%CI4W@T4
MJ4PQ9&F,J.?QU//YL&F,UK3,[5#K#1KL\=)V>ZJY 5MV7G5@[#BR+%(_1XYF
MOLM$TAGY>!M3,&=,B!P,Z3C3(^W)N=!DR<&X'9XZ.7Q):V?BBZBZFKO755-E
M6_F@1\L5)5FN9/N+CS_;1LRWHGC.F-#19^WUK')%;YU@N&;5NE ?:%N-+3SD
M18'O13 .D8"(QPDDW!,P(22(4>"%(>&&]Z<3D#NW^U==^-^.Y2EUV93B1F@G
MI0Y /77UDK2ME\S:@(;HV 9EPW=]5W@%ZI$4QM;Q%&_'2:=F9C(?^71X507[
MIE"VW%:$=3QK8[O]Y2]78,,X:#EOZF<WO+?YXAWW79/'6;T/QE[5S-Z+B;RO
M6;T?-N[:A.(ZZ-9-0<-4[M^$>/;<Q"EWM39F=%'WIC4'>]&[* KT*_GR@3P2
MM?;U#Z*6XDT+O0C1)(A8 JG B1['D,(T(.J'X"F-U;]XW*C'D/7.<W,5^^0"
MWM +2$.P\=E@"?[)8W\\2$>_1R]+T*/\"KS"MR4>M-1?G6AW>";,QJ?I>'!/
M=#"ZA=WF9!L&W<%#RG*YJ<Z;85SVCHZ!"UB? CIZF>M5_UYDE?@J99MJ3CC%
MC"0,1B)F4/F=%-(@I5#]/]"CU1!//$-U?V"+N>GU#9F@IA,J0NVS]P_!>5*!
M.P!I9$T]*C[&FM<!3A.IV$%XV6C2$U <5)F'GIM*-YZ@NZ<$3WWRW"N4S\HD
MKX>A+ (4^ $B @8QDSJ)4T <DP2R-&02BS3D+!UV-;+98V[ZKA=9_T,3V8R%
M&7R-L<72]GIB$$+373L8@7/&5<(.^^-<$6RWN5#H?X?/PR']W8^>[=TN2?98
M?A L4R;3[[DDSZM"%Y.WJ<A45\;JJU D0_7#)Q02K$P>GLK4\UE*?3S4N3VZ
M\=QTPC8G8;TE%3R+@F?,HN[##GQKY]89I-/[MC7IH*4=](B_LLJGM\9XL&?K
M#.O+.;;#,3_'KS4"SMBM/;[:I;Q:(QZ/.+5FSP_LLE*GZ-P*MB[J>^"_9]7#
M:EU]%X1GRY</0L_1R'*]W6::P[9F2!-ZG>=KLFP2VA<12HA,_13B)"$0Q3A2
M!T2$H:3*24XI)5YJU6'=*75S.T5ZU6[J)/FOWW__7+?"JEY N6'8LE&+4V$B
M0GT_QA*2F"AAICZ%F*@?+.0>]6-.$2(6A;.7D^GT=;9S%ZV9[W&Q;]_(!D>;
M;+IE#/QH. ,M:Z#/6V]^T%6_0E4S> 4:%D'#H\-N06- [[3'D%,"I^U,- :V
M._V,1MG$VK_[C?S,'M>/-ZN<_[HJKI?+#T**G!/=[)#0B+ XP=#W$P01)@CJ
MH#5,PT1@3_T=!T8#U(YO,[=3MR454$5KW36:+)> ;\@U=BR.(7O257.$U\AZ
MLH-*DPD4G4 1"CZXA<K8XW($V43^U5#H;%PI T0..D['GIW*33*@O^<4F7S:
MODW!1^5E52_7G"OAE^U_=%C-7Q#.F$P2Y<"$NFE!@BFD,2<P4!H\#GT:".:;
M]BLXN,O<E&-#*&A)O.K^ .K8[M?<,*/@.+#'E:,SN,:V(8<B9=7FX"029_0[
M.+SV9(T/3K+7[X!P^L,#&^AWS;^4A?9^75:K1U%\S@C-EFJ[1<1#0=7_8((C
MHHN!8IA&'$,O0"%!'(5(&K4M,=IM;NI J]BB$+HE][/(;6?,'@?6S 5U!M?(
MZJ"CL_8D04?I%=C0ZK!)M@DD3IM@']UPVB;7)KSO-+$V>FBH[?!1K:9+:?Y2
MK'ZH]5?*B<M?%GXBDE D'"9^P"!"#$$L20R18(F71!'S(F%G/>S=9VX*HR,2
M-%2"EDQ;LV$_IJ:&P]E(36,ZV&(UP' XBL39IL/^U2<V'HZRN&L^'/_X, /B
M3B%)*I$+_CFKLOO:LVSSM6+NQY@&(8S2U(>(2Z*L!RFA3 5F,D+<BV,;Z^'P
M5G/3!%M*P994RT0X X#-K @WL(VL%@8B9FT_G ;#I?%P9+=)+8?37+\U&PR>
M&#R5M;:J#PV=BQA/4QYS2##E$/FZ@WHD8^C'7L0)01'!1CG%AOO-37-LG([M
M.#_PM)GS]XZ>&ELW"',S/>(0R9&5R0;$:2;_&0+C>$;IT2VGGCUJPO^>F:)&
MCYV;P+NY8OHJ^]F#G2O.B2^D3M.@GE0*)PQ]F!)/P#!"0BJ-PZ/8*FO#=..Y
M:9[M1:^^M>_(M+ZJ-\;=5.FX1W-T[;-)"]Z0=_7J'EW9WW6PU'ETQ!:M<;*(
M3^Q]H=1B,T0.YQL;/C],6VT6_R*J[>IUD^K-%K\)HCN4\*]Z]O*ZT/6]-Z3,
MRM_S%=4M*?1U^J?\25^S:W#4,[75=J=_?R=^5C<*ES\7C*$H2AF!S \D1"B(
M(6$IAQ&-$4N"B,C RBF;C/+YZLMFT'KO:]_T<W^WX?\7T"$ E!&WP0#4(%R!
M/@R@Q@&\!L). T_W+IFI\%F^(2.? 1.^'."/&@6@80 U#@[=Y<EEY_)$FH[X
M28^TR67R]DR<G@#KS*^_9[GH!CK<5GKFRWW&O@M%85=+BL.8>U$"D?0#B&@B
M82H1AS[F"8ZCE#)D-$?38*^Y'5R:WNUTD0W%H";9OEKW)-3'3PG' (ZLUZ?&
MSCA!S"6&$V6)G8FE3;*8*3H',\9.+C!5VI@I)[W<,>-'AKDNG]7"7^5[I>NS
MZE?"&NW?I:L5Q>J'[D-$U#N@G?X 42'2((2<R!#JWN@PU7/@$DD1PCZ+46J4
M=3MD\[GIX89JL-1? _),LF5MQJUS!3VH'M3O[@LA]/?0SORWDH>9!3\6RB,K
M:TVVCF6U0'>47X%M?FI+/.BH=V<Y#\',I?%KM?^D]NL09-Z:H(/6L+8B_RK(
MLGIX3XJZQ9JV5)]%\:+;QJ[R4K&>?OGVVS7_Q[KI[-T>V8&'PD3?>A,<*O/2
MDQ*2%,>0\C@5J8<2*HT"+ /WGYN6:W@ FHFF-6+'!FCYN *:$Z!8 5M>[$VI
M0;(Z:9J.+8&1->"LP3>V;<<6PD3V[EC"L#&$SX'RH'$\:-&I#.9S..X9T6<M
MXZ Q25DV>WTF/\IU5BU()#VJK&D8T3" *$ ^3!,20\\3.$AP$@L9#FY&\F:S
MN1TI=?L&UF_?4$^1 J0F&BP;JL]HDO$6[)/'A%,(Q[:*]S6_4+]JZ 6?G:-W
M1EN1,U"\9"L1<S3/:QYR !Z+AB%O5[A<DY #O!QM#'+HF6&!C"^B:E)1]$:?
M\K;'\K=5H;>XKJHBH^NJCD^OOJQRY7HH[[SN1**XU4GVJZ5:_/Y3KE2@**M%
MB"1+,8MUS9S0@^Z%+C!&D(HH\AA#81Q8=8MS2][<=/J7\V=_.I:?66CD<E(9
M^9C0 FG3Y]YIWGZY AOV0,L?Z#.H)[B^8A&\YA%T3+J+L8P#OLLHC&,*)XW3
MC(/NVTC.2+O8'0%E474EUJUSZO'8EY)@*$(/0Q2G <0Z;DV3!*$0!Y1RHT#U
MSLIS4[Q=+-3.Y]\%[+BZ/ N&D36=,0+&^ND@MT=4BWJFIU;4W]ZJE-U%)]$&
M!WGIOLB'/S#0#-O[Q6[?LI1[L9]Z 0R5!051@C@D$8D@]=,H)5PIA]3.J#JR
MV=R^J8I6N.\\+0<6%AT%VM#Z<03?V+;,?D-DA/(B$T"<VA?']IO66C#@?.?L
M-WG&^:U-O"\839#T,4T99%B?]R%7BH6S!/I<^C0F8>H9CS(8LO_<=(U9K#H>
M_>)@KZS.OK4Y5P*SN+6Y$/C.;FW.%<*L;FWLA>'RUN88E(-O;?8N.I=;FV,<
M6]S:'%UF8-U9]IQQD?/R_>KQ<97?5BOVYWM2/BR(1#B-I.Z'@=0/'$6ZEXX/
M8QY['DI)(HD8T%#VT'Y&7Z7I>\-JT@#O: 9<L*62CN%,M),8FUFM9T$V40U9
M1V(]<TL1"6HJU=\4G0[KQ4X@X;0^[-!>T]:#G>!XI_[KU.>=FZ=HWZF+_%0(
MCCV8D%A")'@$21H%,(EBC*2'4Q%'CLS3??O_:YJG:'0+::^LSC9/SY7 +,S3
M"X'OS#P]5PBS,D_MA>'2/#T&Y6#S=.^B<S%/CW%L89X>76:8>?I=5$3/&/[8
MWK6V7QM?<AR&C$%UEB"(HE1"D@0^)(RGB9(+Y]2HW^OQ;>9VC'34J2]-EC^+
MLJK[KM3)]YNZE&&QU0,PF]FGYX,W\@G0$0@V +J/I!X'P:5A>F"G2<W2X]R^
M-4I/?/K,%@0W7?&F5CIUT>;USZQ<!($?XUCYKR'G2#=FHI"F/H-IRF3"D%!*
MPJABTG"_N>F*'HU-:3;X0Y-IJ1=.@6RF(!Q"-_;=JBUJPRO4CV,Q2EWY@2TO
M4PU^G/^#-=PG'ALX5TM*P711^*:WTW=2B29Y;ZTTUM<G4=2&<;F@%%.$@P B
M1+5:"5-(0T(@ICC%,DF%M!R:9;SUW#3,IVW'-UVD:3DAR1QQ,QTS#HXCJYL-
MT?W.;YKN-STSKL WH;9T.K/(&B^G XG,=Y]VVI U*CNCA.Q7&*:S;MF#X.NE
M^"J_B*KM0:?=LO)-TQO/TT,P=#O\B$J(N.X7QPB&5,91'$H2A0&Q45B&^\Y-
M6W5DZP);G2NJOE#9BF<,M"R =XW ?JG#$G;*S%049IIL!(!'5F-OL>T@K:D>
MM=^/)58N59CIUI/J+TL\WBHOV\<'%R[H*XEONDTL%_SFY?=2=]7\5(<TE(K4
M :7GNI7C@ON2"L_S8(IQHM-:$Y@&!$$N(B$\YGLR4-;6JB)+,^5EOK65_MH0
M,&).F/I>,7T9^=32#N@+>+<NZQ#0+R#K.*BKRIX'-,*TD(J9'AL'ZY%5F8:Y
MOO/]UH?Y]P[F#?'@^C3,0^H#+!%SG/MONOO4>?V6J.S)V;==P?J:]/KF4WXC
MGKN\7X])+Z4^%"A0EA?2&@P1 769:YJDR"/,M*G"JX7G9E4IXNPOREY#=?+Z
M<3  (ZN*ZQM0$W8N ,97@(.!F.ANSQP0F]NZO5P?O(9[_>FI[M?VTMB[.-O_
M[\.LIV\BUQ5'.\,U?"^*$QV8XH'NXT+#$*9IBJ!D6 H2I03'5E=B!_:9FP9J
MR3Q_;LDA7,V,'0=HC:RNA@!E;<&<@,&EN7)HJTEMDQ/\OC5$3GW<VNKX>'=[
M^[CZ4ZU)<MY=SY?BUV5V_U!=5U4[<[5]E7&:"AHA#G%"0XA"D4 BL8 BQ(C%
M(O(X-\W*LMIX;CI#$0]:ZH$B'VR24DIQ!1H6P)8'^_/=3BHG#:#1L!X[NCTK
MF(W-K-'@GL@,<PV[C;$V"+N#QIS=:E,9>X-X[!F#PYZW/AI^(\6+>B_X;UFI
MWZWLB_CQF_B9L97ZG3J'\O)E^4SRC&R&WT6IY$D,<:#G6(4I@SB-&$RP1P2*
M<9@&W/!LL-MY;H=#1_T5Z.C7+?%_@(:%^AO59\)>;5D*YN3Q,![<(Y\/<T/:
M^(08#_&)C@CGR-N<$</0.WA(6"XWU2DQC,O>,3%P@6%!A:_5@RB^K<JJ$%76
MYM8TUS_?% WE!_6G7/#V5^W7)4$XE%(Y$C&C%"+A*V\BX3'T9(Q%0&0LPW3Q
M+ JZ,@TY#*#"YLO5IV5$/_L5_0.#$4/D81:H&!GCD8^,FGKP!N*6V!)H#D8(
M:IP!F<N QQ R)@V&G('3VT#).4N=FT[S7:AMUZQ:ZR$P>NY \2QN7N[4LE^E
MO@S?YG/$A/O4(R'$H2Z138BRF1/?AT'L^3$2L?!]J]ED VB8F_7<3P5YQ01H
MN=#WJ9J/NM']&9DVYE(RTXLC8S^R7K2&?:*L'&LLQ\G0,2?C0MDZUC@=SMRQ
M7\I.87*1+>X*HN/8MR^/=+5<\!0+*:,0!GX20T2]$*9$V84X9EPPQ)DR%$W4
MX,[*<U-N+7&@H<Y,<^W"=5P?G07"R%K&D']C?7&0UZT6*#LU4 KV[_>KY_]0
MSS0:0/WA[1=_=[U)OLX'V>B^I(<_8!W5NUM1PFH?L(D<_M>:W_?+B8D?13@.
M880$AXCY$4QUUW44,2]*/.8)R0RC>,=WFMU7LZ&V'_#N"+:/&YT ^61$SAUT
M8W^A)T3-.+KF#KV)HFEGH6@3.3-#YF"D[,3C4T7&S+CH1<(,'QCF]UTS]8ZL
ME[J?4.UTOE\]/A7B0>3EIH9#=_JMK>5%2)E',48PY0&&"(4($I(2*%).A,<1
M3<W4ZY#-YZ9Q>[2#)BSSBOK7S;A;=\,R"F8E&S,W;RS$1U;4;L&V=NB&H.;2
MD[/:?U(7;@@R;WVW06L,'7[991[=JE-Q77Y8/9(L7T1Q*GA".(P3(B&*20()
M)1@&'&.)DS */:-NHL>WF9L&ZV7"-62"/QI"+=74 5#-%-+Y4(VL>@:@-&#X
MY#$0W(Z9W+O3Q ,ECW&[.SKRZ*?/G=7U9:V-J*_R6R'NBHPLOZM79[G6V^FD
ME'(1TX"%GDA@**,4(H\SB'F$($Y))%**DX"9#AZWVWEVVF)GBE=>,Z CJDI=
MPTKS (H-$[I:R[0&RUXL)WW0\< >6]_L3*AJ: =?)5#4PYI\L*6_3FP;#>>A
MP\ <XGVQR6!GX7[&I#!#[$S'AIU:[D(SQ RY/#Q0S'0!^Q-B<^)\+!5S/SZ(
MIU695<I*1#1)$P^B)(HA"H2$A/-8_0A9(@E59J)I^OB!+>:F\V\%6Q=9]0(4
M==KUDJL"D*<GH;X(2NO_HXU#6"B? \B>UN;GXS6=F=B0"%H:SP;'7 6?#])4
MNM8:+"MU>AR'PWKSP'.3*<CC=/<UX8E/#DP!63\^DN+EJ]2-INK5KY?+U0^B
MZ-YF$RCG6"*B5%\LB)[HH]0A832 B..4^U&2"B2M<CX,-IV=6FQHUCIP0S78
MD&V9T6$"NIDK[1K*D37F<13'3="P0,II1H;)OM.F8%@@L9-S8?/L,)5T5]3-
M[E[J/NYU_[L%T94:RN2"/L7*"O-I"HG01AE.9$B"F,<H[.8RF*F@W4V,OB6O
MAS&,K'+JG"7U32G$DUKR@>B&'*6F%[S#*+F*4'#E1P$H'XC:%9 *W"KAU_=#
M(/1T3^G J^_G](=Q@J^2..Q]^(-@[6=]_5D?6XYRW2,F,Y4U$/JITCT:XKI9
M#C5][I308=Y=JIP]NTRJ8 YS^5:='/GDP*Z6;;O=;Z*XU:_Z]CSE0K*8!S'T
M"%.F"TDQ3&,OAH)[U%-_0B@)K)I8'MII;I;+I@%T?5,FRE]T'SA0TVS9O_(@
MMF9??">(C?S]WX"UP4@9)6.8(R?!<-IZ\N!FTW::/,7S3F/)DP\,[B=2*M/E
M<%V)[Y' K_6$]+A2%@Q![,441A[S6.1AEF)A5^=S:DN;[\!$13T-Q<-;BQR'
MF(@@]@,F((]]K' 6%-(PX= /2<RDX%ABH\C:& !/U,1E3'C-5+)+T$;6S!U>
M(Q4\F2+AN)W+\3VG[NMBA,">!B]FSPTLTRSN29[]L_8UWZ_R<K7,>.-XYOR;
M>L&ZR.57^6N6*S\T(TM]:5S73Y77M*P*PJH%X7$@$C^&E"$)4<2Q[@B<Z*)_
M0FG$&0NHC;9Q0M7<5%*?*3W4KL=64Q_=8TP[IAO6P)8W\$?'G6WYIQ,YFZF]
MR:4WLFZ<2G#V9:0N@79:6.J$L&E+35UBN5-\ZG3QH7.ON!"/.@*\?^CXQ_]>
M9]7+>U(4+[J!Z>-JG5<+9:CC))!(F>:1LM03I=BQ5NP>8Z$O?4*BP*@0ZQPB
MYJ;'MSR _!43(&NYL)V4-4 P9IIX;+A'5KP]I%_3#SH&KD##@AX+VS !&BY<
MCN$:CJ';(5T#Z)AXA-=PI'8'?)VQEGWYZ<>\4LO=/HCE4N=*D_QED222^X(C
M2/U V[0I@MA7;K0?IXQARD0BC4KQ]R\_-Z764 AJ$D%+HWDYZA[XCBNH\T$9
M.U)I@X=5>>IAML^H4=VSZ&2%JH<9ZE>K'OF4ZP'2?KAW+FXD4$B0KJ_BJ?H^
MRP@2CAED820]Q 0/?:,;BH'[S^T+;S0VUP_'GF&\7U;'E<<$$AA9N\P:?%<#
MI,\6PIP&2 \0AL,!TD>A'#I >O^B,QD@?91C\P'2QY<9F-0GZAS=[^)I552U
M22I7Q6/]DG[.<O%)N>WE(O2Q%]'$@XD4ZK01Z@>)I ]%F$1<$)3&OM6L6)--
MYW;$M#2##=&@1S7X0],-:L(M8YE& C!SD%W#.O*YX0!1^\P^"XB<9O:9[#MM
M9I\%$CN9?3;/GG7M?IWSP[WN=+%'D=&ZIJ-<H%@JYY:$,$XBW=%%]]L,4 P]
M%(H($QP'R+=+_+.FP>C+-6E>8'<3^J1O0EF?UD%WR!;BL+I4=@SQ1+?,Y*76
M7[KJI<-9WZ <;<+I_!;:'KH1KJ4MB+C$/;4]1@<NK@<L-'0&Y(]KQG0<4*G7
M;\4J5W]DS0W*M]4R8R_-SVU:G8]HPA")]=V&T)?62OO%ZH=D:1R%.(GBQ*K7
MIBT!<S/7=+ON+0/@-0>VDQ\M96&F^L9$>&3-=Q3<*] 0#OYH_SM*3N10]-Q.
MA+2D8>*YD,,0VIT..7 =^VE-]35(6U2:B?+O6?6P6BLSD_!L^?)!*+WQF.7Z
M&N57DA5U"GA7Y'NS(@5O'.+R]Z=57J> *H6L_&>MMQ=!1&E$)((B%9'.Z"80
M^ZGZD[(0L8RD3'AB.MII-"KGID,;3D&Y817\:'@%1<,LX#UN@53L@F?-;[_W
M ]4\@\>&:;!67#>%)=H:;?DVGV@TW@MR,D@[#[&/?5'42'S+)6C9!"V?H,\H
MT)PV92_];@@UNZ#E%VB&V^SX][.2N/G JUE(?JKI6)=^ ZS&:8TNF<.SM\;;
M>K)!7:.CUY_J-?YF P/@76I:+UWMFZZ6U^Y>ERH:!HP& D4P(.H'PHQ#XC,"
MTQ@E#!/*/&$7 #?8=&[6P(;FUUFA'=F#DWF-!& 8 '<,Z]@!\/,1M0^ 6T#D
M- !NLN^T 7 +)'8"X#;/'M)+?:%^5G_ZSW_K?J-^4%**__RW_P]02P,$%
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M2ZW .L>%=\GXZ!Y#X1H))2SBBNBKA=9PP,ER<?V3A[AXD:+^<'* AF<MQ#T
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MRP5)8[$8*:]\E-&"2Y'1*>H*.=M> %)4IE@0*&5W-23WEMX.&J>5*]U?MH.
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MS36C^;5FXO\ZGRT6(V.0\YP8Z%BY$>3G.QXI5C3::V3<BTT=? Y'RO-D]=.
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MA_K$XFH'C9S+CD>1P)&[22>]9A "LW322X.V:"QMPH5G:.I[WF3W4.I* 0/
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M2M)B"P!VS$>_;7M:X+9/10_@E+VU]35?M[[S^!677V;Y[J@KY\G2,\N@V!)
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M@F+(B8>0(4@G76(EL="D4N0>%=NAZ:3N1/:7\@ ,UW7UZ779^HU$M%:ZEK9
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M%UJ/>2.)([E%="A0W)E]BL)P$)CL>A/&HA+9?9VDC>2SNR8YV&>I&MH+_6[
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M8T?E7>EL&%'YG6/@TY?9?$EF^.(-QN4(DQ,*"2$\^UC+"3CX'#T4AH9K*^L
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M>AWLM?"6_@]:.P\J1W)@L7HBBJ(E5-PJU61>4->,])O]/#ZR'S77Z!,8PYQ
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M2>KY$4RGYT7'"A@LE&[V&3G1+I"#;1S2MN )(LH$HA2+B5PM'9KDSY\CJM^
MM"O%;X6G/;30[['TW\+T,LR_"\;=9HZNS&THCHN$KG)$GK8A=]O'D@@&46E;
MRY8?&JD-A]26BPT1+_LH=M94RCWCYG)2V?'/LJ-S,JBB!Q49L5/H>';:!$@H
M@K3.!![=RZ#98J6>IQ.U0$S7\NTY%W9[)[:Y9N;Q3Q%_"Q>XMM-*H$>M(#LT
M)$,Z]X,WIEZ4&<]++DEMDZ[?*G%V"*']=DCI/O-Z-*7U^E*S<OH4)U>;.)K
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MO2<T'F5(N];3"3ZYOOW'\93._\,':AVTVO&ZCVS!;<ND5M3,%2; JYJ09\I
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MH\3<'5#N[+,2W-N,6,#$VJN27*BK/"P4I4DB&#6F1KT!VPD:^UH[3M%/XN9
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M SG%&#776F*;Q/A#6L;UL9J Z%B)=P":;3["TFR[)+4/QM?%B+6'MTZ/#RZ
M3%9K9%+P-K-:'B-HW%%BG?I7@VBO4Q2NSR?WC&-*":10Q(G2"F*=BL7KVK'
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MQC2"X_9D_$V>,CH?.<98$Y-DTQ/G$)BDV,H6[XI/0O!&LY[W(W3<E0ACP')
MQ75I)U]]G\TO)_^[U.''<F<R[1GZ3"QP 9@SL29D!%\#?,U*#-Z*(&*37/ >
M-/;F" X)EF>1.8SF.K67]YG[1#*=W_&!WQ"1D\LS7I1E,M2'G?H?@;#D=/9@
M>0G6%D:WQ8DN\EW([<VC'!&L ^BST\CF,Z;9^;3.V2+Q7E?@OKW"K[,O>'EY
M@=<UKV^NYO4%?OE'?J9]<+F>4,_J]/A<%#CF,PCM';<A!-]F9?M ](^[L&0,
MKZ"]FCNUR]N-QAFSH;!D+:#2"*HH 1&% 9-="LONMWBB&'X[@3LAU/R5$#J
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M[\0:>1FWY/K/;\-EN!;.P4T1>_QV@]MT5TY:W[#2,T^.5 "9(H5[+#!P0CE
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MS10Y_9K+U*17Y2$I?2'F$ 5O8N8X:7> ER\XG<SFO\\N;^8C9C1T61<%3/L
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M3C>,-='%( K]S\\/?MWA0^/X+"ULSM!2'=GB_ P_9O-;&:T9,-ZS@-X#)J]
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ML8,DZ ,G^,/-,B,N-+-:9"BESDX+U<7A@>)CNK%JM.QC;I-"?Y2D<4?>M'B
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MJDZQSJ*(J.F"T'&*M9\^%4T?U'2DHNFCC :"HP]19,@H>-!TI629R+$1W$+
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ME\ LA%#[;WHM:_]-!#32)T\FB<CB2 !J@<QH%'WOQ]  X;>'HELFT9(M"TZ
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MZ^75ZJ?E>?[E(BT_+5/E)-TD.E^>_4XG^>75<YK^1<+*BUL[79@B V2O2Y5
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MAMWO_3$.=!Z83UO8&:+JU?AR;P ^;_/5U3F->G\9J61N4Q*0 WI01O#*<5O
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MG/FN/%0#;0-,[UJ>UT$@-QJL$"3*R&J_<25 >&,S><\I>7XPP':-/$^:XKP
M.U@#;0/,[%P>7?\<K083/;DN,7H(+C-PFK%"1S1)]/ 3;-?(G0!FGQ; #M9
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ML!2"!<LR"!E9YH.[2W6=1&,$RP-A<$B_H.$Z:0I]=UI!_+[.FV]NV[+%'$W
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M              "  8P(  !E>&AI8FET,S$R<3,R,#(P+FAT;5!+ 0(4 Q0
M   ( %147E&F^0R0'@0  #P1   4              "  0L1  !E>&AI8FET
M,S(Q<3,R,#(P+FAT;5!+ 0(4 Q0    ( %147E$G"GWH) 0  *H1   4
M          "  5L5  !E>&AI8FET,S(R<3,R,#(P+FAT;5!+ 0(4 Q0    (
M %147E'R*%:YOA$   .?   4              "  ;$9  !E>&AI8FET.3DQ
M<3,R,#(P+FAT;5!+ 0(4 Q0    ( %147E&< F,'7 0  ,LH   4
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M,# Y,S!?9&5F+GAM;%!+ 0(4 Q0    ( %547E$#M7ZD\TP! #OX#0 3
M          "  >YE!0!M;RTR,#(P,#DS,%]L86(N>&UL4$L! A0#%     @
M551>41&-NXU/Z@  ))$* !,              ( !$K,& &UO+3(P,C P.3,P
>7W!R92YX;6Q02P4&      P #  * P  DIT'

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
